Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264129-218270178	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	Cytosol	"CAB017717: , HPA031868: AB_2674078"	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	66.5	66.4	65.0	46.2	66.1	27.5	65.2	67.1	80.1	62.6	63.2	76.3	62.8	61.7	43.8	75.1	60.8	56.1	65.4	65.7	67.2	60.2	77.5	46.6	47.8	69.2	66.6	79.8	70.7	72.7	62.1	54.9	66.4	58.0	58.0	38.4	66.9	58.7	90.4	76.6	61.7	50.7	67.5	53.0	86.9	53.8	67.1	54.0	66.6	62.0	52.6	70.0	57.4	70.3	126.1	104.6	75.1	102.2	111.9	75.7	146.0	89.6	136.3	167.1	124.5	226.2	100.1	64.6	121.8	112.6	158.8	94.3	150.7	133.4	129.3	103.5	200.9	147.4	108.2	237.4	158.9	139.3	92.4	97.8	152.7	172.2	149.7	99.7	97.6	124.3	202.6	82.4	108.9	198.0	112.4	234.9	121.0	182.4	75.4	90.6	97.5	105.8	100.3	160.5	96.2	92.9	59.4	128.7	134.7	119.1	99.1	104.6	84.7	110.2	82.3	81.2	106.8	105.7	198.1	108.4	111.0	88.6	77.4	75.9	166.2	60.3	101.1	209.2	105.1	100.3	90.1	94.9	191.4	105.7	111.1	100.7	26.2	114.9	210.6	114.1	109.3	179.4	65.0	66.1	67.1	80.1	65.7	67.2	69.2	66.6	66.4	67.5	67.1	70.3	57.8	41.7	35.2	11.4	50.4	90.5	86.1	122.9	66.0	47.7	50.7	45.2	35.5	41.5	74.0	42.3	12.5	160.0	42.2	74.3	103.7	95.7	3.5	33.5	46.4	50.6	75.5	34.0	11.5	95.4	130.3	63.4	80.5	38.2	34.8	57.6	42.5	46.2	91.9	63.9	12.9	89.9	93.6	37.0	65.3	8.8	83.3	38.5	62.2	5.6	64.8	80.2	41.2	8.0	10.5	86.6	72.0	74.9	51.2	116.0	99.5	85.3	47.4	37.1	65.7	38.4	86.5	72.0	53.3	70.2	97.3	202.6	44.4	62.5	103.5	119.9
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44298731-44313347	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	4.7	5.2	6.5	5.6	6.2	5.4	4.9	9.4	6.7	7.6	6.7	5.8	6.5	6.1	3.2	9.2	6.4	4.6	6.0	6.8	5.1	5.7	6.9	4.3	6.0	6.1	5.8	8.3	6.5	5.9	6.3	4.1	6.4	7.0	4.1	5.4	6.2	4.3	4.8	7.2	7.9	4.1	5.4	7.2	5.4	3.7	6.0	6.2	6.2	3.3	5.3	5.6	7.4	6.7	14.6	9.9	13.9	23.8	8.1	7.2	18.3	10.9	5.7	11.2	10.6	11.4	7.1	16.3	16.2	4.8	12.2	10.0	14.7	16.0	4.7	10.9	23.7	18.9	10.6	14.5	4.8	17.9	16.0	5.9	9.8	9.0	10.2	7.3	9.5	21.8	21.0	15.4	6.2	16.0	14.2	15.9	9.9	40.3	9.8	16.4	8.7	10.4	6.7	12.7	32.0	11.4	9.4	10.9	15.5	9.7	9.9	21.6	8.4	12.1	13.5	7.6	13.9	8.8	8.7	16.5	6.8	15.9	22.1	2.2	1.1	0.1	1.3	1.3	2.1	1.5	1.9	1.7	1.0	2.9	1.8	1.7	0.2	1.9	1.4	1.3	1.2	1.3	6.5	6.2	9.4	6.7	6.8	5.1	6.1	5.8	6.4	5.4	6.0	6.7	2.6	6.4	3.3	5.2	3.7	0.6	2.1	1.9	4.0	6.6	2.8	2.7	3.5	5.7	2.8	0.0	12.5	5.0	4.9	3.0	0.0	2.3	10.1	3.5	5.4	3.0	0.0	8.2	5.5	0.4	5.0	3.4	5.1	6.2	0.0	5.9	3.9	2.5	3.3	0.0	9.0	2.2	2.0	2.8	1.8	1.0	4.7	2.5	0.0	1.9	3.9	2.0	4.1	3.0	3.6	1.4	0.7	4.5	6.9	1.6	6.3	1.0	3.0	7.1	0.0	4.7	2.8	4.3	6.1	4.4	0.4	5.3	4.1	4.5	3.7	1.6
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141895	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 77.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Fibroblasts: 117.6;Hepatocytes: 110.3;Inhibitory neurons: 77.8;Leydig cells: 51.3;Microglial cells: 93.7;Theca cells: 45.4"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.9;ASC TERT1: 56.0;HSkMC: 25.3;HUVEC TERT2: 54.8;RT4: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	23.3	5.5	1.3	2.6	5.5	0.0	15.9	5.1	3.2	10.5	3.1	8.0	2.2	5.9	2.8	5.9	11.3	10.1	17.5	1.1	4.1	3.6	77.9	10.9	5.0	14.3	3.0	29.8	2.3	1.3	2.1	2.1	9.4	2.9	4.4	0.8	9.0	2.0	5.4	6.6	5.5	3.7	7.1	1.5	5.7	1.8	3.4	1.4	8.6	11.7	3.2	14.2	8.9	21.3	0.0	0.0	0.0	0.0	39.9	56.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	25.3	0.1	3.2	0.9	1.5	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	5.5	5.1	3.2	1.1	4.1	14.3	3.0	9.4	7.1	3.4	21.3	12.5	0.0	0.0	2.9	2.0	3.1	1.5	0.4	4.0	11.6	1.8	2.2	6.0	4.3	0.9	3.7	6.2	0.0	1.7	1.8	0.0	0.5	3.3	0.7	5.1	3.2	2.4	2.7	62.5	0.2	0.0	117.6	2.0	2.5	0.0	4.0	3.3	110.3	1.6	0.0	77.8	0.7	0.0	2.5	42.1	2.7	51.3	20.3	5.4	93.7	0.7	3.2	0.0	4.5	33.4	0.4	1.1	12.0	1.2	0.1	0.5	0.9	0.7	13.3	0.0	20.0	14.3	2.0	0.9	1.4	2.8	0.0	1.2	45.4	0.3	0.5
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418389-94518666	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA		12000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	16.8	18.7	19.8	16.2	23.2	25.1	32.8	22.7	24.3	22.4	22.6	44.6	44.5	14.7	21.2	26.7	16.7	26.8	26.0	18.7	21.8	59.4	126.6	23.3	13.3	22.1	21.2	10.1	28.6	29.6	13.3	14.4	22.7	21.5	40.2	26.3	17.5	27.0	23.5	35.5	46.1	17.7	23.7	11.0	43.5	16.3	21.4	47.5	27.5	29.8	21.2	22.9	16.2	27.3	81.5	37.6	37.8	36.1	28.3	31.0	55.8	41.4	32.0	46.8	51.5	117.5	25.0	49.8	52.1	52.8	50.0	58.2	43.7	53.7	64.9	40.1	36.9	56.7	52.3	102.5	27.5	51.2	17.0	26.2	29.6	54.2	20.8	30.2	29.0	47.0	25.8	29.2	48.6	11.4	86.4	26.8	43.7	61.7	50.7	48.0	78.4	19.4	45.6	122.2	28.5	46.7	71.5	75.2	55.7	28.4	27.7	41.8	28.9	34.5	49.5	61.3	55.9	16.5	16.5	48.4	27.1	25.6	16.4	0.4	3.8	2.9	4.2	4.3	4.0	1.8	3.8	4.9	5.9	1.8	4.5	4.4	0.9	5.9	3.8	1.5	4.6	3.3	19.8	23.2	22.7	24.3	18.7	21.8	22.1	21.2	22.7	23.7	21.4	27.3	16.9	35.3	48.8	64.3	10.2	23.3	16.2	32.8	14.8	27.5	43.7	21.1	39.1	58.6	43.2	42.3	22.9	25.0	12.3	72.1	23.5	22.8	9.0	37.5	16.8	16.4	39.7	8.4	32.7	44.5	12.0	18.3	37.8	30.6	27.9	19.1	18.2	108.9	11.0	33.7	47.5	37.5	26.4	21.9	7.4	8.2	13.7	15.0	16.0	40.3	15.1	78.4	11.3	67.3	96.5	37.5	33.0	24.5	15.4	20.4	75.7	72.3	49.8	26.3	19.7	19.0	17.7	14.5	23.2	21.0	34.0	15.3	15.4	16.7	39.5	32.5
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145098288-145129524	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Translation regulation"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No		380000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	30.0	21.5	11.2	33.6	12.5	27.2	33.1	13.7	16.0	20.7	10.7	22.7	20.2	24.4	16.0	35.1	22.5	22.4	24.9	12.5	14.3	23.8	39.7	18.5	40.5	12.6	11.2	29.1	29.4	27.0	10.0	28.7	14.4	19.4	27.7	14.4	24.1	16.9	28.0	25.2	17.7	28.9	13.8	26.4	20.1	26.5	11.8	34.2	26.9	30.3	42.1	40.5	15.9	18.1	117.1	61.2	89.5	62.2	74.6	107.5	89.4	124.6	86.4	145.1	101.3	95.5	105.9	187.6	39.3	109.2	77.7	75.4	132.5	157.7	193.1	108.6	82.9	106.9	44.0	80.6	98.3	244.3	81.3	80.0	108.4	153.8	213.7	74.8	157.4	139.1	219.5	136.1	156.3	70.4	234.5	82.2	74.8	177.5	142.9	124.0	107.9	135.7	108.1	79.9	111.1	55.1	74.7	124.6	89.5	66.7	74.2	98.1	105.3	143.3	89.4	101.3	152.5	120.6	209.6	199.5	87.7	214.6	163.7	2.2	10.0	0.9	12.3	13.1	25.4	13.2	15.4	16.0	19.5	13.0	21.0	18.1	0.8	16.4	13.4	10.9	18.5	14.8	11.2	12.5	13.7	16.0	12.5	14.3	12.6	11.2	14.4	13.8	11.8	18.1	56.4	25.6	18.7	15.3	55.9	59.9	109.0	38.7	45.5	37.2	35.0	30.6	24.0	17.2	45.4	25.8	20.9	39.4	44.4	9.8	39.2	39.4	40.1	29.0	61.8	53.7	20.4	47.5	24.2	28.2	45.1	50.6	35.7	23.4	32.9	50.3	21.4	32.9	41.5	42.1	27.8	22.5	24.4	22.4	40.3	15.4	46.9	34.6	19.6	12.2	33.2	18.1	33.0	18.1	37.5	39.1	10.3	34.6	58.3	112.2	8.0	39.8	28.5	34.9	32.9	71.7	47.5	92.4	79.4	65.5	59.5	26.5	47.2	98.4	36.6	72.2
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151211484-151227205	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA		51000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	19.0	18.8	16.1	11.1	16.2	7.6	14.8	15.1	19.5	13.8	14.2	18.8	6.0	16.6	12.1	19.2	14.4	8.9	27.9	16.0	16.7	20.2	12.3	14.6	11.6	18.0	16.5	15.0	15.0	14.3	17.0	10.3	17.3	16.1	10.8	10.8	14.2	10.2	61.2	16.3	13.4	14.1	16.2	15.6	16.6	18.7	16.5	11.5	13.8	20.2	15.2	19.5	13.9	16.9	33.0	50.3	18.8	66.0	36.6	31.1	25.1	40.6	33.0	49.9	42.1	47.9	22.1	57.4	34.3	42.8	40.9	25.2	58.9	47.8	49.5	28.1	48.8	23.1	26.3	27.4	43.3	58.0	35.7	42.3	39.6	54.6	34.4	21.2	40.7	32.5	68.4	22.9	43.2	80.1	60.4	70.3	46.8	37.6	54.5	40.3	30.1	50.5	35.4	24.0	32.9	31.0	39.5	37.5	26.8	19.5	16.2	29.0	40.7	31.7	12.8	39.6	61.7	46.9	54.5	42.7	43.5	56.4	60.3	7.9	11.3	3.8	13.8	13.3	19.5	11.9	14.2	13.7	13.1	13.1	13.3	13.8	1.6	14.5	15.1	9.8	15.8	14.7	16.1	16.2	15.1	19.5	16.0	16.7	18.0	16.5	17.3	16.2	16.5	16.9	4.7	0.0	0.5	10.1	15.9	27.1	25.9	22.5	14.2	17.4	0.3	0.6	23.5	7.2	9.5	0.0	8.4	29.5	10.0	28.4	0.0	0.0	47.0	0.1	0.1	12.8	6.7	18.3	12.6	0.0	28.8	13.8	16.3	0.0	10.2	0.0	12.5	12.9	20.7	10.1	12.6	9.1	12.2	10.4	11.5	55.9	10.5	6.7	19.6	7.5	6.2	14.1	14.4	7.1	10.4	0.0	18.9	14.7	14.0	29.8	15.7	0.0	6.6	16.9	13.1	25.7	15.1	31.0	12.4	21.5	25.1	32.3	10.9	0.1	15.1	19.6
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090150-88231628	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 88.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6"	"Cancer enhanced"	"Detected in many"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.3	4.0	30.8	1.0	29.1	2.3	4.0	30.0	33.1	22.1	17.4	15.7	48.2	23.1	6.8	2.3	9.8	5.1	2.9	25.4	32.3	3.5	36.0	5.1	1.2	40.1	31.3	8.3	0.8	4.4	8.9	11.7	40.1	7.1	13.9	2.5	5.0	33.8	0.3	0.6	88.3	19.8	31.1	1.4	1.9	3.0	40.0	1.3	6.4	0.9	2.0	2.3	4.0	31.9	1.7	43.5	11.9	0.0	0.4	0.0	75.8	1.9	1.3	2.1	3.5	9.8	0.5	0.0	0.4	0.3	5.4	13.2	0.4	1.2	3.1	13.2	1.9	0.6	0.3	13.0	0.0	0.6	0.1	0.2	5.1	4.8	0.3	1.2	4.1	1.0	1.1	0.0	1.3	26.2	6.3	0.2	4.1	58.6	0.0	3.2	0.0	38.9	0.1	9.5	0.2	0.5	8.9	0.9	1.2	26.1	0.3	0.1	0.0	1.7	1.6	0.4	0.2	11.9	4.7	0.0	3.1	0.0	1.8	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.2	0.2	0.0	0.5	0.2	0.1	0.0	1.1	0.1	0.2	0.8	0.2	30.8	29.1	30.0	33.1	25.4	32.3	40.1	31.3	40.1	31.1	40.0	31.9	9.4	3.2	1.1	3.9	0.9	3.8	0.3	0.0	0.0	0.4	24.3	1.9	1.6	1.5	0.2	0.0	0.0	16.8	0.6	106.7	1.9	0.0	3.3	0.4	3.8	45.8	3.0	20.6	1.1	0.2	81.7	2.4	0.5	0.5	5.7	0.2	31.4	23.4	137.4	0.0	0.7	12.0	0.0	1.3	2.5	1.2	1.2	2.8	5.4	185.5	0.1	0.7	2.1	11.1	0.9	0.1	44.3	0.4	2.0	0.2	216.6	7.6	0.8	0.9	0.0	0.4	4.3	1.0	4.3	1.1	0.4	37.6	1.0	4.3	6.1	0.2
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 124.3;Rod photoreceptor cells: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles		NA	NA		420000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA038153: AB_2675868, HPA056913: AB_2683275"	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	23.5	48.6	65.2	8.3	64.5	13.5	18.4	72.3	78.0	25.1	67.6	18.1	10.6	15.0	28.3	8.4	24.2	12.1	36.1	64.8	69.3	35.3	26.1	14.3	11.4	59.6	60.0	27.1	26.6	27.1	49.6	8.9	59.7	19.0	6.9	43.5	23.2	14.5	34.8	7.6	12.9	7.5	59.2	14.6	17.7	13.2	69.4	11.5	32.8	39.1	8.4	19.4	16.7	59.8	6.9	12.9	8.2	24.7	79.8	39.9	4.5	9.0	14.8	10.6	14.3	14.8	27.0	7.8	6.0	22.4	12.1	6.2	9.0	10.0	3.4	25.1	10.0	22.7	37.4	50.0	22.4	31.4	29.0	37.9	6.6	9.0	4.6	23.7	13.8	14.6	9.3	25.4	16.8	7.8	14.5	31.8	4.7	32.4	30.4	10.3	4.2	73.9	20.7	10.6	16.8	26.1	22.5	4.7	13.5	1.7	7.1	33.7	8.2	9.6	10.4	23.4	10.7	37.0	37.4	6.6	18.1	49.6	14.1	6.9	20.3	15.2	94.0	12.7	96.5	49.0	80.9	83.5	36.2	41.5	73.7	79.0	2.1	45.5	8.6	46.0	88.4	54.9	65.2	64.5	72.3	78.0	64.8	69.3	59.6	60.0	59.7	59.2	69.4	59.8	15.9	6.4	21.7	0.0	20.2	9.7	25.1	29.0	4.0	90.8	21.0	22.9	24.3	20.0	20.8	33.1	25.0	10.3	29.6	7.1	33.2	15.5	4.7	23.5	18.0	14.1	40.2	2.5	0.0	12.4	15.3	36.9	4.6	14.9	15.2	12.8	17.2	16.2	29.3	58.9	0.0	14.0	24.4	14.2	18.5	24.9	88.0	14.6	12.4	0.0	7.4	59.9	41.2	0.0	0.0	17.1	5.6	33.1	16.3	17.0	13.8	124.3	29.5	115.2	19.7	24.7	16.8	18.2	57.8	1.8	5.5	4.9	28.9	20.6	15.3	19.5
ABHD16B	"C20orf135, dJ591C20.1"	ENSG00000183260	"Abhydrolase domain containing 16B"	Q9H3Z7	20	63861498-63862988	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.9"	"Group enriched"	"Detected in some"	77	"Early spermatids: 131.8;Late spermatids: 270.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.0;PC-3: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059272, HPA075886"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA059272: AB_2683963, HPA075886: "																		2.1	1.5	2.2	2.5	1.6	1.0	0.1	1.7	3.0	0.2	0.8	0.8	1.8	1.0	0.0	0.4	0.2	0.4	1.0	1.7	2.1	1.0	0.3	1.0	1.7	2.0	2.2	0.9	2.1	0.0	0.1	0.6	2.3	1.3	0.0	0.3	1.6	0.0	1.6	1.1	1.6	0.0	1.3	3.6	2.3	15.9	4.6	0.0	0.4	0.0	0.0	0.1	0.2	2.1	4.9	3.2	0.6	1.2	0.0	0.0	7.2	5.7	0.0	0.1	0.0	16.0	6.3	4.5	4.6	0.0	1.4	12.6	0.0	0.0	0.0	3.1	3.8	2.9	6.7	11.8	0.0	1.7	7.9	0.0	0.0	0.0	0.0	0.3	0.0	3.4	5.6	5.2	0.0	8.5	2.7	4.8	1.3	0.6	18.8	5.8	0.7	1.7	0.0	3.3	2.2	1.9	5.4	3.1	0.8	0.2	6.3	0.8	1.9	3.3	5.8	1.7	2.4	4.2	2.6	2.9	2.4	1.8	2.4	0.1	0.7	2.7	0.7	0.4	0.4	0.3	0.2	0.5	0.6	0.6	0.5	0.4	0.2	0.2	0.3	0.6	0.8	0.8	2.2	1.6	1.7	3.0	1.7	2.1	2.0	2.2	2.3	1.3	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	131.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	270.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713016-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 71.2;Oligodendrocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	50.9	30.7	27.4	25.3	38.9	23.4	45.8	33.6	31.4	60.5	40.4	96.4	23.1	63.0	11.6	33.8	55.6	35.7	36.1	26.6	28.3	23.1	17.5	37.3	16.3	39.3	38.5	56.0	24.9	32.5	34.9	26.5	35.8	43.5	26.7	14.2	32.4	33.6	29.4	36.3	45.2	41.2	31.3	23.3	51.6	20.1	34.9	22.4	46.7	30.8	15.4	79.3	42.7	41.3	22.5	48.3	53.6	62.9	76.5	93.3	18.8	38.8	60.4	44.8	38.1	36.4	28.3	32.3	22.3	52.0	47.6	42.5	23.5	36.0	30.7	20.6	16.3	23.7	84.1	33.4	51.8	36.5	32.3	68.8	37.2	80.6	50.0	64.1	61.0	47.9	135.8	26.5	54.9	42.0	49.2	30.5	57.9	34.3	33.8	55.9	67.9	35.9	45.0	25.7	47.9	60.1	66.1	23.5	29.2	31.0	46.2	33.1	71.1	170.7	44.1	66.3	62.6	8.4	20.3	47.9	72.1	27.6	55.1	0.0	0.7	0.3	0.6	0.4	0.8	1.3	0.6	0.6	0.7	0.4	0.6	0.5	0.0	0.8	1.9	1.0	0.3	0.6	27.4	38.9	33.6	31.4	26.6	28.3	39.3	38.5	35.8	31.3	34.9	41.3	16.2	9.6	13.6	54.9	4.7	9.2	7.3	9.8	5.2	8.2	11.6	10.2	6.2	7.2	7.2	14.7	12.5	13.6	12.1	21.2	1.9	14.4	5.9	8.6	29.7	18.1	22.1	4.6	52.5	11.1	4.3	36.7	5.6	12.4	2.5	22.1	20.3	15.9	16.6	10.1	63.7	17.5	6.1	16.4	11.7	8.8	28.0	10.2	5.4	71.2	6.6	19.2	6.2	66.9	116.0	17.9	18.3	25.6	5.6	8.6	11.6	10.3	7.8	9.1	19.7	29.5	19.8	16.9	16.5	6.6	6.8	15.2	7.9	20.1	21.4	7.2
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128924003	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	16.7	20.5	9.0	6.1	8.5	4.7	14.5	9.6	10.2	14.4	9.1	13.6	9.0	14.6	7.7	23.2	12.9	7.3	21.9	8.3	8.7	15.6	20.6	11.0	6.6	8.2	8.7	12.9	14.4	27.7	14.6	8.4	8.4	12.1	9.4	4.1	14.2	12.0	30.4	48.0	11.2	11.1	7.4	12.2	15.9	12.5	8.7	12.1	13.6	28.7	11.2	12.9	14.5	9.0	46.2	22.6	18.0	12.6	28.7	20.7	17.5	22.4	26.2	43.6	36.8	33.3	27.1	33.3	21.1	29.5	29.0	35.5	33.8	45.9	32.8	21.2	23.1	29.3	46.8	24.4	21.6	23.9	10.6	22.5	16.8	23.6	26.7	25.1	35.8	25.2	14.4	11.4	29.5	46.5	36.7	19.0	9.9	49.3	33.8	25.5	17.4	35.1	30.9	25.1	19.0	11.6	37.0	32.9	23.2	17.4	44.5	54.8	18.2	13.2	13.4	14.2	20.3	14.5	5.8	28.3	28.3	21.4	22.7	2.4	15.1	4.9	8.3	18.3	7.8	8.1	7.6	7.3	17.5	5.4	6.2	8.0	0.7	6.8	25.2	9.9	8.3	12.1	9.0	8.5	9.6	10.2	8.3	8.7	8.2	8.7	8.4	7.4	8.7	9.0	10.4	16.0	21.7	13.1	9.3	6.2	11.4	16.7	8.6	14.1	11.9	9.5	30.5	15.7	14.8	14.7	10.4	26.2	10.5	11.7	21.5	20.6	20.2	10.4	11.5	11.2	5.4	14.3	14.3	17.8	18.8	12.9	16.8	12.9	16.5	12.0	15.7	26.7	31.5	10.1	17.7	7.4	16.2	9.5	4.0	17.3	10.2	10.8	16.0	7.5	13.4	15.0	12.3	6.0	12.2	14.1	8.7	14.7	9.5	8.1	9.4	26.3	12.0	11.9	13.1	12.7	14.9	22.6	9.6	13.5	14.2	30.6	8.2	18.1	14.3	8.4
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724431-75787575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 367.3;skeletal muscle: 380.0;tongue: 475.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 289.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		930000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	81.9	82.2	25.2	24.3	25.0	17.3	69.9	26.6	42.2	29.3	30.4	46.8	103.9	20.0	25.3	51.3	30.6	27.8	217.8	24.3	25.9	295.9	367.3	22.6	42.6	26.9	26.8	35.7	35.9	66.3	19.2	16.9	25.8	26.8	49.5	21.2	31.4	26.2	380.0	14.4	75.6	25.5	26.2	27.4	52.8	35.7	25.8	29.7	38.4	475.9	44.3	32.7	21.3	25.2	25.8	20.5	61.0	26.8	53.1	42.1	17.5	48.1	40.4	46.1	38.5	38.3	39.5	289.1	40.7	34.4	39.0	22.8	54.9	41.8	57.8	113.0	25.5	94.4	58.5	58.3	36.4	80.0	23.9	50.7	23.5	39.8	22.8	35.0	36.2	56.6	102.3	60.4	50.5	9.6	96.3	40.6	50.2	80.4	49.5	118.8	83.8	30.6	77.9	70.7	33.8	43.0	38.0	111.6	102.0	43.1	32.7	107.6	20.2	29.9	29.6	26.6	78.1	38.6	62.0	128.1	25.8	67.0	35.3	15.3	14.2	19.3	17.1	20.9	27.3	40.7	17.8	21.5	21.4	24.6	20.3	23.6	0.5	25.0	20.4	23.2	19.5	19.5	25.2	25.0	26.6	42.2	24.3	25.9	26.9	26.8	25.8	26.2	25.8	25.2	42.9	57.7	58.3	29.7	56.5	27.3	41.8	69.0	44.3	39.0	49.0	40.9	373.1	52.9	63.0	58.8	25.0	35.8	39.4	42.6	344.4	37.9	55.4	27.1	32.2	36.2	40.7	67.6	51.6	26.5	19.5	47.6	26.0	25.4	44.9	61.5	43.9	261.2	75.7	30.3	46.7	38.7	63.1	45.6	22.2	24.4	46.9	38.2	51.6	19.7	32.8	53.7	29.9	36.2	36.0	21.2	49.7	45.5	74.9	24.2	88.0	564.8	106.7	30.0	0.0	38.6	43.7	76.3	86.1	46.6	27.0	15.3	39.4	72.5	46.7	35.9
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 622.7;liver: 969.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 420.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		1400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	135.4	151.3	45.2	24.3	45.3	38.4	56.9	47.1	60.1	41.0	91.8	96.3	103.9	44.0	34.1	45.0	39.1	25.6	289.4	42.7	46.8	622.7	969.5	43.7	28.2	44.8	45.2	64.7	110.6	95.9	30.9	24.7	45.2	45.6	85.6	26.2	104.1	60.2	461.1	45.3	53.2	57.1	46.7	29.3	81.9	66.3	45.6	19.1	65.5	410.8	29.7	44.1	34.6	47.7	76.9	57.7	48.2	139.3	155.9	138.7	25.1	71.7	78.8	77.7	91.7	168.1	77.3	41.3	116.8	83.6	119.7	78.1	142.3	70.3	83.3	84.9	114.6	117.4	64.6	163.9	107.6	112.9	64.9	124.6	77.1	69.2	127.4	91.5	85.0	92.3	172.1	61.8	128.6	45.8	57.4	122.4	48.2	103.1	135.0	88.1	96.9	420.4	114.7	50.4	75.7	88.1	111.6	152.7	83.0	37.0	132.2	97.6	87.4	83.2	44.5	73.5	88.8	18.9	57.8	77.7	37.6	233.1	59.6	1.4	17.1	4.7	25.3	25.5	29.9	29.2	28.8	30.0	33.5	13.8	25.5	22.4	1.8	13.4	27.8	11.3	35.7	23.4	45.2	45.3	47.1	60.1	42.7	46.8	44.8	45.2	45.2	46.7	45.6	47.7	50.5	54.5	91.8	17.9	37.2	43.1	52.2	48.9	23.9	30.1	34.6	29.6	508.4	78.6	33.5	104.8	27.1	39.9	29.2	125.0	698.5	43.1	345.7	62.2	42.1	62.5	30.0	74.7	35.1	60.5	41.5	57.1	29.0	25.7	27.8	48.6	99.2	663.4	97.9	38.7	37.8	38.5	97.6	73.6	27.8	65.3	66.5	39.1	58.7	30.0	50.1	39.1	25.7	22.6	26.5	33.8	93.8	82.4	52.7	27.8	51.4	1484.0	101.8	28.8	65.7	54.2	69.2	172.7	27.2	39.2	48.4	25.2	38.1	61.6	84.5	24.4
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27168135-27243046	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Transport"		Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavorable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	14.6	25.1	31.0	13.5	37.0	18.2	12.3	36.2	37.1	13.2	24.2	20.3	39.8	9.4	9.7	12.0	12.0	15.4	40.4	27.6	33.1	37.3	73.8	14.7	14.7	37.2	34.0	9.9	11.1	31.2	6.4	13.4	38.1	15.2	20.9	36.2	10.3	11.4	31.0	17.3	39.2	8.8	36.7	14.7	21.0	19.3	36.1	12.2	27.8	36.6	12.7	13.5	7.5	38.8	25.8	76.5	17.1	18.0	19.1	17.3	20.1	32.3	12.1	28.1	33.5	19.4	39.9	10.7	27.0	22.4	23.4	21.1	23.2	16.3	23.0	26.2	23.9	16.5	23.1	15.2	20.6	11.0	20.9	16.7	17.7	23.5	12.8	24.9	20.5	16.7	13.6	19.5	35.7	20.0	21.1	9.4	13.1	35.2	10.0	17.4	42.5	20.2	44.1	22.4	21.3	45.5	35.4	38.3	17.9	18.9	18.8	11.5	30.4	27.2	15.2	43.7	25.9	19.4	28.1	20.7	27.4	24.6	12.0	12.5	13.0	10.2	15.3	12.7	15.2	6.4	7.5	12.4	13.0	7.0	5.0	11.0	11.1	10.3	15.1	8.5	7.4	8.0	31.0	37.0	36.2	37.1	27.6	33.1	37.2	34.0	38.1	36.7	36.1	38.8	23.3	25.6	29.9	17.9	16.0	9.7	4.1	14.5	7.4	30.8	14.5	10.8	83.0	15.7	25.2	31.3	25.0	9.6	27.4	22.4	33.2	22.1	43.1	33.7	20.2	18.7	10.2	8.6	20.6	16.2	12.6	16.4	19.4	41.1	12.6	11.5	12.8	56.9	19.0	23.5	26.9	30.4	10.2	25.5	12.5	16.9	16.4	22.4	21.4	15.9	22.4	47.7	29.9	17.6	24.8	17.8	26.1	16.6	14.2	11.7	64.4	48.2	32.7	47.2	19.7	20.9	16.1	41.0	8.3	16.5	15.5	10.4	22.3	27.1	26.5	9.2
ACD	"Pip1, Ptop, Tint1, Tpp1"	ENSG00000102977	"ACD shelterin complex subunit and telomerase recruitment factor"	Q96AP0	16	67657512-67660815	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049411, HPA057660"	Approved		Enhanced	"Nuclear bodies"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA049411: AB_2680752, HPA057660: AB_2683493"	"unprognostic (1.47e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.50e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-1)"	13.0	9.9	14.2	7.3	14.4	10.1	12.9	14.4	17.7	17.1	12.0	14.8	4.2	16.4	4.0	9.1	15.6	5.2	11.2	14.6	14.2	10.8	6.7	9.9	10.1	14.6	14.2	19.9	12.4	6.3	13.7	4.7	15.0	12.2	2.3	2.7	9.4	6.3	9.8	11.4	12.1	4.6	14.1	14.9	11.2	23.7	14.6	5.5	10.0	3.2	5.6	15.5	12.2	14.6	42.1	32.3	18.4	19.2	8.3	5.8	39.5	17.1	11.3	25.0	30.3	42.0	20.3	11.6	19.4	9.4	22.5	32.7	11.3	32.8	8.2	12.6	37.4	24.9	13.4	42.4	5.8	32.5	37.6	8.3	10.0	33.7	17.7	9.4	15.9	34.3	15.7	8.1	12.6	45.2	31.8	31.8	23.5	16.3	21.5	44.1	19.8	48.0	10.5	16.6	26.3	23.1	64.0	6.7	14.5	5.3	15.8	17.9	13.8	26.6	22.4	31.9	26.1	21.7	28.6	35.9	24.7	20.5	23.3	34.5	18.2	22.8	40.2	22.2	34.1	46.4	36.7	34.8	21.0	37.7	28.5	30.3	25.9	43.5	25.8	22.9	39.5	24.7	14.2	14.4	14.4	17.7	14.6	14.2	14.6	14.2	15.0	14.1	14.6	14.6	19.4	6.4	11.9	5.5	22.3	14.4	15.9	22.6	21.6	14.7	13.7	16.0	2.8	8.6	12.6	11.0	4.2	25.1	22.5	5.5	9.8	21.3	59.3	6.6	7.7	15.4	12.5	11.6	6.2	19.6	22.8	14.1	9.7	6.8	27.9	13.6	12.8	4.7	15.5	13.5	6.1	6.4	6.1	7.6	20.6	71.4	15.2	13.4	23.2	4.7	19.3	14.3	30.9	4.0	3.6	18.4	9.2	11.7	17.0	9.9	10.2	13.2	16.1	10.8	6.6	11.8	14.8	58.1	24.1	7.1	9.7	11.4	27.0	6.9	9.0	10.0
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562886-179588407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 243.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	19.7	20.4	8.3	23.5	9.8	17.8	33.0	10.1	12.4	24.6	11.0	31.1	24.7	27.6	25.9	25.3	25.0	15.6	18.6	7.9	9.5	22.3	21.8	19.0	32.0	10.4	9.8	31.9	20.6	24.3	13.1	23.5	10.8	21.3	37.8	16.3	21.3	21.4	12.3	26.8	23.8	26.3	9.4	19.9	22.3	62.5	8.9	46.0	20.5	13.9	41.4	24.8	20.7	11.9	196.4	59.5	142.2	75.7	53.4	58.0	111.7	78.1	60.2	142.3	119.8	126.6	94.8	154.0	136.8	73.5	164.7	88.7	126.3	95.7	174.6	156.7	105.0	125.5	58.2	101.9	61.0	157.4	75.2	40.7	96.1	91.5	76.6	44.5	82.5	90.7	100.1	85.1	103.6	135.6	140.1	96.8	127.6	178.0	129.5	128.7	118.0	284.4	113.4	76.2	116.9	83.2	119.1	118.5	125.2	71.2	231.5	128.8	62.5	101.0	87.1	104.1	237.8	54.6	86.5	231.3	55.6	165.0	113.5	5.7	19.3	14.7	24.5	25.5	32.4	29.2	27.8	28.5	34.1	24.1	30.2	31.3	2.6	26.7	30.1	19.3	39.1	24.3	8.3	9.8	10.1	12.4	7.9	9.5	10.4	9.8	10.8	9.4	8.9	11.9	31.1	22.4	23.1	6.2	27.1	47.2	48.0	60.4	29.0	6.1	24.5	23.9	6.7	30.0	38.1	27.6	8.4	51.2	21.6	13.4	35.2	51.1	53.5	27.1	28.8	26.7	30.5	62.3	2.8	44.7	67.5	28.1	23.4	20.8	14.5	31.0	13.6	16.8	34.9	0.0	3.8	26.7	48.8	17.1	18.7	17.7	32.3	15.4	30.2	3.7	27.1	16.7	18.6	6.6	19.0	38.8	18.8	30.1	25.8	45.4	18.2	25.8	35.6	14.9	26.3	25.0	49.0	243.2	92.1	42.7	45.9	30.6	21.6	35.1	40.4	38.5
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449090	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;heart muscle: 105.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2"	"Region enriched"	"Detected in all"	5	"basal ganglia: 388.0"	"Region enriched"	"Detected in all"	6	"basal ganglia: 155.9"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	18.9	3.3	25.5	4.9	97.7	0.0	10.6	13.9	43.9	9.8	0.0	35.1	5.2	14.7	5.7	18.8	12.7	10.0	105.2	25.8	15.9	12.8	3.3	4.1	2.3	20.5	18.3	13.2	7.5	0.8	14.3	6.1	17.4	19.8	5.6	4.5	4.0	21.5	2.7	2.6	13.0	18.2	10.8	6.5	21.2	8.2	34.4	1.3	1.9	5.8	3.0	23.2	7.8	30.1	0.0	0.6	1.3	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.2	2.3	0.5	0.6	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	15.5	0.0	0.0	0.8	0.0	0.1	0.0	0.3	2.7	5.2	0.5	1.8	1.6	0.0	0.5	0.1	1.7	0.0	0.1	0.0	0.1	1.2	0.1	0.2	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	97.7	13.9	43.9	25.8	15.9	20.5	18.3	17.4	10.8	34.4	30.1	0.3	0.0	0.0	8.1	0.1	0.3	0.1	0.2	0.0	21.8	0.4	5.8	75.5	8.6	0.0	7.3	0.0	1.4	0.0	2.6	0.0	15.9	0.9	1.5	7.1	1.8	0.0	0.0	34.0	6.9	4.0	5.2	0.0	4.0	0.0	4.6	3.9	0.1	0.3	0.0	44.0	0.3	0.0	0.0	0.3	3.0	20.5	0.1	0.0	6.5	1.0	1.0	0.0	19.1	89.7	0.4	59.6	73.7	0.0	0.1	0.3	0.8	0.0	2.2	65.7	0.6	21.4	0.8	6.3	0.2	0.9	12.4	0.2	1.0	2.0	0.1
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052308-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 57.1;Inhibitory neurons: 45.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;NTERA-2: 4.8;SCLC-21H: 4.1;SH-SY5Y: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	7.4	11.4	91.8	2.3	79.8	0.0	4.0	53.4	57.6	13.1	3.5	7.1	0.8	5.3	1.5	2.9	29.5	1.3	3.8	69.7	106.5	0.1	0.2	0.8	0.1	96.0	102.7	1.8	1.6	1.6	9.8	0.0	88.9	1.8	1.3	2.7	2.2	3.2	1.3	1.1	2.2	3.7	67.9	0.5	3.5	1.6	148.0	0.8	2.1	8.0	0.8	1.8	4.3	43.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	7.4	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.6	0.8	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	79.8	53.4	57.6	69.7	106.5	96.0	102.7	88.9	67.9	148.0	43.7	4.2	0.0	0.0	57.1	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.7	0.0	0.0	10.8	0.0	0.0	4.6	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.7	0.9	11.5	0.0	1.8	2.8	0.0	0.0	0.0	11.6	1.5	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	5.8	0.3	1.5	0.0	0.3	0.0	0.2	0.1	0.0	0.1
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497366-3519531	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 590.7"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	55.1	76.9	31.1	28.0	32.6	31.7	50.4	31.7	42.1	54.2	43.3	58.3	105.2	45.6	43.3	48.2	45.2	66.7	146.4	32.0	31.0	200.2	590.7	44.6	30.1	33.0	32.2	50.0	34.9	49.6	33.5	41.3	33.6	101.1	52.3	17.1	53.6	55.9	121.1	35.7	68.9	37.9	31.6	57.2	82.4	16.7	31.6	26.9	36.5	56.0	34.5	57.9	36.5	34.7	46.5	64.5	55.9	50.2	187.5	85.0	91.9	95.6	124.1	102.7	74.5	86.9	59.2	22.1	143.4	109.5	21.4	45.1	62.9	49.0	59.2	39.5	131.4	67.6	42.2	184.1	165.4	71.2	151.3	91.4	72.3	55.0	63.7	45.3	75.8	36.1	51.8	45.3	87.4	137.8	25.6	147.1	44.4	131.9	86.4	27.1	31.3	128.2	90.2	83.3	57.0	54.0	53.0	75.0	37.2	36.8	55.6	95.5	54.1	75.9	29.0	35.9	56.6	35.4	91.6	88.7	58.6	115.5	41.0	87.6	134.3	336.9	28.5	126.5	31.8	66.8	67.4	26.7	127.7	53.4	79.3	25.6	59.4	54.5	117.4	186.3	67.4	189.0	31.1	32.6	31.7	42.1	32.0	31.0	33.0	32.2	33.6	31.6	31.6	34.7	44.8	67.3	111.1	25.1	73.1	76.0	154.5	107.8	92.2	9.2	103.0	88.9	275.8	338.8	109.5	152.6	14.6	395.0	80.6	140.1	888.3	157.2	8.8	65.9	116.3	61.6	57.2	123.1	9.4	87.2	247.1	129.1	66.3	116.3	41.8	75.1	207.8	1234.6	263.2	8.4	15.0	146.1	236.0	168.8	67.6	23.8	137.0	90.0	204.5	7.5	108.2	197.2	40.2	5.5	19.0	79.7	272.5	210.3	97.4	143.6	409.8	1546.8	38.0	15.3	164.3	45.5	109.3	5.3	11.3	113.6	76.9	381.4	53.0	120.8	147.2	156.9
ADPRS	"ADPRHL2, ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylserine hydrolase"	Q9NX46	1	36088892-36093932	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		54000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	19.0	36.7	28.4	16.0	30.0	19.7	18.5	31.3	30.3	20.7	33.4	19.6	15.6	17.6	15.0	36.1	33.5	13.3	20.7	28.6	29.1	27.7	22.4	20.6	21.5	32.5	29.7	19.7	17.9	17.6	17.7	20.8	31.2	19.9	12.4	9.1	20.9	16.3	34.4	34.1	16.8	16.4	31.9	23.1	17.6	28.7	29.7	20.9	19.4	21.8	20.2	21.3	22.2	33.9	54.3	22.4	26.2	37.2	23.6	17.1	37.3	39.4	32.9	62.1	60.9	26.8	47.7	38.4	37.5	39.5	32.0	32.9	33.4	60.5	37.0	27.7	41.8	34.9	27.0	36.3	44.4	40.2	19.9	20.3	45.4	56.5	24.5	47.2	39.9	36.2	30.8	30.9	29.6	26.0	40.9	60.5	56.5	31.8	46.0	32.9	27.6	38.8	56.5	43.8	32.1	50.8	28.9	29.9	65.9	34.4	30.9	34.3	27.6	35.7	37.0	50.1	53.0	39.8	41.2	34.2	51.7	39.6	22.4	40.6	58.3	65.8	43.4	74.1	41.5	43.5	47.6	50.8	71.4	51.5	47.7	40.3	57.1	47.9	77.7	44.8	43.4	57.8	28.4	30.0	31.3	30.3	28.6	29.1	32.5	29.7	31.2	31.9	29.7	33.9	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	79.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	70.6	1.3	0.0	0.0	0.0
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346461-40390463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 345.1;tongue: 242.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		440000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	29.8	33.9	10.6	31.1	11.2	40.6	33.1	12.5	13.3	30.7	12.9	36.5	22.7	34.9	21.9	29.8	33.5	20.6	47.4	10.9	10.6	33.6	32.1	22.7	46.9	10.5	11.7	33.5	45.2	29.3	22.0	30.2	10.9	23.8	35.4	10.3	25.7	22.3	345.1	22.2	28.8	41.1	10.0	33.5	28.0	29.2	10.5	50.5	29.6	242.3	48.5	36.0	25.2	10.8	98.0	110.2	88.3	124.9	62.6	89.5	106.5	82.0	85.2	187.3	138.1	189.0	51.9	279.0	73.2	102.3	84.9	67.3	203.5	137.4	187.7	75.3	197.5	126.5	98.4	166.5	134.6	423.0	96.3	97.7	76.5	161.5	169.8	91.3	138.9	127.3	153.1	114.3	136.4	105.0	130.2	131.2	152.5	121.3	119.3	195.1	203.6	198.2	118.9	67.8	58.8	54.4	106.2	54.1	170.7	78.5	76.8	134.7	91.2	93.3	173.7	85.3	168.8	109.0	212.6	218.2	80.9	149.5	97.7	29.0	47.2	19.9	35.5	55.2	49.5	34.6	76.1	48.5	68.1	33.5	58.3	45.0	4.1	48.2	49.7	34.4	81.7	62.3	10.6	11.2	12.5	13.3	10.9	10.6	10.5	11.7	10.9	10.0	10.5	10.8	10.0	12.8	10.8	9.4	28.3	18.1	18.8	48.6	23.9	16.1	14.8	15.0	30.0	30.0	20.8	3.7	37.5	85.3	15.5	13.0	7.9	61.3	44.0	5.6	9.2	21.6	13.8	54.6	11.4	43.7	78.9	21.2	21.4	5.6	36.8	8.8	28.9	25.6	60.3	6.7	10.7	24.1	24.4	44.8	26.7	25.2	24.8	22.7	12.4	1.0	41.9	45.1	19.6	9.5	9.8	33.7	15.6	14.3	52.4	21.3	21.4	19.7	12.3	18.1	26.3	38.5	20.8	61.2	82.8	35.7	15.2	33.1	32.2	8.7	37.7	14.1
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	19.0	27.2	9.9	20.0	11.6	20.5	23.5	13.0	16.5	25.8	12.5	18.8	16.3	34.0	20.2	35.1	28.0	21.8	17.8	17.7	7.2	27.8	20.3	20.7	27.7	1.9	6.7	35.1	17.5	29.9	8.9	44.1	2.0	24.8	20.6	27.7	19.3	30.7	13.6	29.4	16.7	31.1	0.3	23.1	16.1	20.8	11.8	29.2	30.8	19.8	32.3	25.0	18.2	14.7	32.4	42.4	42.6	20.1	31.1	38.6	95.2	29.9	34.1	43.5	45.7	48.0	54.5	51.0	24.3	41.4	27.6	38.0	93.7	34.6	69.1	149.4	30.6	46.7	60.8	30.0	36.4	60.1	30.8	36.2	36.3	35.6	52.8	52.0	35.6	34.8	25.2	1.4	41.2	38.5	63.0	71.7	82.6	26.6	18.9	50.3	82.3	35.9	32.2	68.2	10.0	23.4	60.6	25.7	29.8	91.3	32.8	35.0	40.5	40.7	30.9	12.8	44.9	14.0	24.9	106.0	30.3	25.1	29.2	4.3	2.5	2.5	4.2	2.7	4.4	2.2	4.4	3.6	2.0	2.8	3.7	5.8	2.7	6.0	2.2	2.6	4.5	1.2	9.9	11.6	13.0	16.5	17.7	7.2	1.9	6.7	2.0	0.3	11.8	14.7	23.9	25.6	14.3	31.6	20.5	75.2	25.1	15.5	53.5	29.8	22.0	13.3	22.1	12.8	24.2	12.9	43.8	60.3	24.3	9.5	17.6	12.3	1.3	31.1	31.5	22.2	22.7	11.6	57.2	12.2	24.8	28.3	14.3	28.8	27.8	17.7	14.3	12.9	15.4	52.2	59.4	11.2	4.1	17.0	47.9	2.3	24.5	17.8	28.4	30.0	17.7	21.5	14.4	42.3	51.6	11.5	10.3	29.0	18.3	24.5	9.0	18.3	26.1	16.1	19.7	46.7	40.1	16.2	26.3	51.0	76.0	83.0	28.1	34.2	10.7	28.2
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 31.3"	"Low region specificity"	"Detected in all"							"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	12.3	24.3	10.6	3.8	8.4	2.5	12.6	12.5	11.3	23.5	0.0	16.2	2.6	26.8	2.2	35.8	19.5	3.4	18.2	9.1	8.1	11.5	7.6	12.0	3.2	5.5	9.2	22.7	8.5	2.0	18.7	4.6	3.8	12.0	1.1	2.7	16.8	6.9	30.3	31.2	7.8	5.2	3.2	16.6	11.3	9.7	9.0	6.3	20.9	15.5	2.0	15.2	24.2	5.1	10.5	9.5	13.0	6.9	4.1	6.7	13.2	9.6	6.8	6.5	5.3	3.7	9.5	1.6	6.9	6.5	3.9	10.3	1.4	12.5	1.9	3.9	5.0	8.3	9.0	5.0	3.8	2.2	4.1	6.3	5.0	4.6	2.9	6.7	3.4	4.8	10.0	1.1	11.1	5.1	7.2	11.8	9.5	2.6	11.5	31.3	15.7	0.8	4.4	1.4	22.3	8.6	6.8	10.8	2.7	4.4	5.3	1.9	6.6	11.2	9.2	8.4	3.0	3.3	2.4	1.6	9.5	6.5	6.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.1	10.6	8.4	12.5	11.3	9.1	8.1	5.5	9.2	3.8	3.2	9.0	5.1	20.3	6.4	5.2	39.2	5.8	49.5	9.1	25.3	41.5	33.4	37.9	44.4	14.5	4.3	14.4	18.4	0.0	11.5	23.0	10.3	3.9	10.4	0.8	13.2	33.0	19.7	9.7	3.4	26.4	13.7	4.3	24.5	15.8	14.1	0.0	5.5	17.2	11.7	14.2	35.3	19.9	5.5	6.1	3.5	24.8	4.1	51.9	5.8	16.0	16.9	3.6	12.8	14.4	21.6	8.1	16.2	4.5	63.6	5.6	11.6	4.3	4.3	17.7	2.0	39.5	46.2	20.9	4.6	6.8	61.6	56.1	5.6	10.5	67.5	6.6	13.6
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 561.4;fHDF/TERT166: 554.5;TIME: 582.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 395.4"	"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		10000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.47e-6)"	243.1	27.9	62.6	43.4	50.2	44.1	190.3	33.7	45.4	183.3	61.0	276.2	49.0	183.3	51.7	248.2	145.5	74.8	115.1	65.0	98.0	59.7	60.1	144.1	36.7	76.2	48.3	125.8	30.3	26.3	16.9	97.3	62.9	88.5	96.6	10.1	127.5	105.7	188.5	334.7	136.6	113.1	60.8	59.5	133.5	18.0	49.0	27.9	64.9	172.2	63.7	142.0	213.3	78.4	188.2	107.9	9.8	44.1	421.8	561.4	70.3	166.0	201.4	103.0	57.4	93.7	64.9	0.2	61.7	554.5	79.8	244.1	41.2	203.7	130.7	154.2	7.3	22.6	173.4	27.9	80.8	31.5	142.2	204.2	233.0	202.4	183.6	131.5	215.4	2.7	21.8	138.8	211.7	72.1	0.4	60.7	3.0	59.6	171.7	0.4	45.1	113.9	227.1	120.2	0.3	9.2	167.5	69.3	69.0	198.8	133.7	28.4	582.1	182.4	119.8	229.8	74.4	25.0	5.4	0.6	138.2	10.1	60.9	44.1	75.6	0.3	38.7	45.0	25.8	20.0	24.8	31.7	73.8	16.1	3.2	17.3	1.1	31.5	37.8	20.2	21.5	36.8	62.6	50.2	33.7	45.4	65.0	98.0	76.2	48.3	62.9	60.8	49.0	78.4	413.1	439.1	106.3	49.3	171.4	479.4	133.8	285.0	253.2	1.4	173.0	226.8	199.9	195.9	224.1	193.1	0.0	110.8	194.3	400.8	13.7	99.6	10.6	188.5	195.0	282.5	47.6	43.7	0.9	64.1	145.6	312.9	538.2	351.2	238.9	4.3	201.4	88.5	79.4	1.7	0.8	164.8	138.4	329.8	458.3	33.2	451.4	292.3	318.4	43.1	284.8	30.7	138.0	0.5	0.4	262.5	195.5	466.0	329.0	202.4	262.3	6.8	149.3	1.2	177.5	349.5	244.4	3.1	8.1	596.4	610.3	102.2	256.5	3.0	101.8	198.0
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978374	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 305.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 114.3;Basal respiratory cells: 83.8;Horizontal cells: 60.6;Ionocytes: 61.1;Pancreatic endocrine cells: 68.2;Respiratory ciliated cells: 66.8;Squamous epithelial cells: 63.7;Suprabasal keratinocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 135.1;HBEC3-KT: 124.9;hTCEpi: 308.7;hTERT-HME1: 130.3;TIME: 138.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"medulla oblongata: 11.3;midbrain: 10.6;pons: 13.2;spinal cord: 38.9;thalamus: 15.0"	"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		40000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.23e-5)"	30.4	2.3	9.8	2.4	9.9	0.0	16.4	9.3	15.9	84.5	4.6	105.3	1.4	64.3	2.9	114.1	29.2	5.1	4.5	9.7	16.0	3.5	6.2	5.1	0.1	38.1	15.3	3.5	1.6	0.7	3.4	1.8	40.8	18.6	8.6	19.0	24.0	28.6	3.6	305.9	20.2	31.6	12.4	0.9	25.2	7.7	18.1	0.4	2.8	4.5	4.7	49.4	86.6	18.5	2.9	107.6	0.1	6.0	120.0	135.1	0.2	10.5	22.3	3.8	1.9	0.3	38.9	0.1	14.5	82.9	85.3	62.9	0.3	124.9	1.7	0.0	0.4	0.0	67.5	0.5	11.0	0.0	3.8	17.6	308.7	12.1	130.3	52.3	54.7	0.0	0.0	0.2	62.8	8.0	0.0	0.0	0.3	9.5	42.9	0.3	5.7	0.1	84.4	0.0	0.6	0.6	46.2	0.1	2.3	2.8	6.0	0.0	138.4	29.3	17.9	33.8	9.9	0.0	0.0	0.0	88.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.8	9.9	9.3	15.9	9.7	16.0	38.1	15.3	40.8	12.4	18.1	18.5	3.8	12.8	1.1	0.3	0.0	114.3	4.9	83.8	13.1	8.9	2.2	1.3	1.5	0.0	38.2	1.8	2.1	0.2	0.3	0.4	0.0	11.9	24.2	16.0	10.5	13.0	0.0	0.0	8.2	8.7	0.5	31.9	0.0	18.9	17.1	0.1	3.6	2.1	1.0	60.6	5.1	0.0	61.1	0.3	12.7	3.1	0.6	0.7	32.0	3.7	0.0	3.2	0.0	1.5	3.3	68.2	0.0	0.4	0.0	4.5	0.0	0.3	66.8	13.9	0.0	13.1	8.6	0.4	4.3	63.7	164.7	0.1	0.9	0.1	0.2	6.2
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4302	"liver: 5817.6"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5817.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349456	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000	35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	32.5	33.4	23.3	31.4	25.9	60.1	44.4	25.8	32.9	32.2	25.2	42.1	39.9	34.5	35.1	37.7	32.1	32.1	34.4	23.2	25.0	40.3	35.8	29.0	38.6	25.8	25.7	42.3	32.4	37.8	25.6	30.1	25.7	33.1	41.6	36.0	35.0	35.1	65.3	29.4	37.8	32.3	24.3	33.5	34.8	23.5	24.8	35.4	38.9	50.4	39.2	40.9	30.7	27.8	66.7	46.1	47.3	60.3	51.0	78.0	68.1	80.8	69.7	73.9	87.7	81.9	97.8	109.4	61.6	79.6	50.5	61.4	69.6	86.6	98.8	62.1	47.4	64.2	63.8	134.0	101.3	147.4	75.4	62.9	100.2	74.5	117.5	56.3	64.3	68.2	120.8	58.0	82.4	58.5	99.2	78.2	51.4	94.6	46.5	81.1	86.3	101.5	94.7	60.5	72.9	56.9	52.7	158.1	86.4	61.7	75.2	107.8	50.5	87.9	73.1	66.1	105.9	71.5	98.9	110.0	74.6	112.7	97.0	60.6	54.7	55.0	42.9	61.8	51.7	57.4	54.0	43.9	58.5	55.8	55.8	51.0	7.7	51.9	73.4	74.7	72.2	34.9	23.3	25.9	25.8	32.9	23.2	25.0	25.8	25.7	25.7	24.3	24.8	27.8	87.4	70.5	55.2	18.6	72.7	50.2	147.0	166.1	50.7	49.7	71.3	87.8	95.4	82.9	130.2	66.2	35.5	124.5	58.1	83.3	156.5	121.1	79.0	75.4	83.8	60.8	73.8	66.7	17.3	126.6	144.8	66.0	48.9	130.8	79.3	64.2	61.4	109.8	109.6	25.2	20.4	144.4	116.0	90.1	53.3	19.4	99.1	68.8	32.0	16.9	117.2	56.0	74.2	24.6	38.3	118.3	93.7	85.4	40.9	141.8	146.8	166.1	105.6	45.5	59.2	77.5	128.4	127.2	74.3	66.4	50.2	150.9	68.9	74.3	142.2	173.1
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.6"	"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	3.5	3.1	8.1	3.3	9.9	3.7	4.8	13.5	17.2	3.5	10.9	4.6	3.6	4.3	7.6	4.3	7.9	3.5	4.9	6.4	11.0	5.3	3.1	4.1	4.2	8.8	10.7	3.6	3.4	9.2	7.7	3.1	9.5	3.9	4.5	14.1	5.1	3.9	4.8	3.9	3.6	3.9	10.7	4.0	4.5	16.6	8.7	7.6	6.9	3.5	3.6	3.4	3.2	13.4	2.3	1.6	6.6	11.5	6.1	3.7	4.8	3.5	4.3	3.6	4.9	2.6	4.6	4.9	1.7	3.4	7.9	3.7	1.9	3.9	7.6	10.2	4.0	3.8	3.8	2.6	4.8	4.4	2.3	3.1	7.3	6.6	8.6	8.8	4.2	7.2	3.6	4.0	2.7	4.7	4.1	3.2	1.5	5.1	2.5	5.5	3.7	4.7	5.0	4.3	7.8	6.4	4.2	3.9	5.9	3.7	5.1	5.8	5.2	3.1	2.2	5.1	2.3	2.0	1.8	2.8	6.8	5.9	2.0	17.1	2.8	7.1	5.1	1.5	4.4	13.1	4.9	6.2	2.1	10.8	6.2	5.4	5.6	5.6	4.8	3.1	3.9	1.6	8.1	9.9	13.5	17.2	6.4	11.0	8.8	10.7	9.5	10.7	8.7	13.4	13.3	28.9	17.2	21.2	13.6	2.7	7.7	14.7	3.4	18.3	10.4	6.7	18.9	5.7	19.9	9.2	14.6	3.4	8.6	13.1	0.0	9.1	70.9	76.3	5.4	10.0	19.8	4.2	34.8	4.5	1.5	6.0	12.2	7.3	22.1	10.6	8.9	2.1	3.6	20.2	37.0	15.5	14.2	5.3	3.9	41.7	7.5	5.6	5.4	25.3	5.0	12.6	18.6	22.6	46.9	7.4	8.9	6.4	5.5	5.6	22.9	6.8	152.0	50.7	26.3	9.1	6.9	174.3	34.1	4.0	2.6	5.6	10.3	4.7	11.4	7.9
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239967-151358559	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 39.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	235	"basophil: 37.2"	"Lineage enriched"	"Detected in single"	235	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in many"		"REH: 193.0;TIME: 188.2;U-251 MG: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	105.6	16.0	13.8	17.1	16.6	2.2	59.7	99.7	57.5	19.8	4.5	60.1	8.6	31.1	9.3	18.6	31.2	31.5	51.8	14.7	66.8	35.8	30.6	44.3	6.9	67.0	35.3	87.8	10.8	1.6	23.3	38.3	74.7	23.1	13.2	109.4	6.5	20.8	11.9	9.4	24.9	42.9	10.9	14.3	25.6	100.0	39.4	5.9	22.1	14.5	3.4	33.0	21.2	24.3	7.8	37.8	53.2	0.1	98.2	145.9	18.8	43.9	23.7	19.3	19.4	0.9	141.6	0.0	17.1	33.2	160.4	1.0	102.2	32.5	17.2	50.2	37.6	0.6	40.8	35.6	10.9	0.0	9.6	104.0	0.0	81.9	4.3	25.4	127.8	0.6	9.8	0.9	70.7	0.5	0.3	0.1	33.3	0.1	43.9	193.0	2.3	0.2	110.2	6.3	37.9	22.0	14.1	0.5	24.9	74.6	2.8	0.5	188.2	2.6	34.0	110.4	202.9	0.4	0.1	0.2	63.2	0.1	37.4	37.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.6	99.7	57.5	14.7	66.8	67.0	35.3	74.7	10.9	39.4	24.3	352.6	12.8	16.2	34.3	6.8	19.6	19.6	63.2	1.2	14.5	1.2	3.9	12.1	5.7	31.1	51.5	2.1	2.4	0.9	1.2	1.9	107.0	101.4	14.2	195.4	278.4	1.8	3.2	75.8	6.7	10.1	270.0	3.6	31.6	64.2	14.7	194.5	4.8	26.9	0.0	33.3	0.7	4.1	15.7	45.4	116.3	39.7	13.9	58.7	37.5	0.6	583.0	1.0	59.8	5.1	322.1	1.1	110.6	6.7	49.5	0.0	89.4	6.0	31.0	98.6	208.3	243.0	325.4	33.0	1.6	11.4	10.0	5.1	9.3	2.5	105.3
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940840-92110673	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 2230.9;Rod photoreceptor cells: 1279.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	7.1	8.3	8.6	6.2	9.0	8.6	11.0	15.3	14.1	6.5	15.5	16.0	16.5	6.4	3.9	7.9	8.4	10.4	6.5	8.6	11.0	13.2	16.2	7.8	5.8	8.8	9.6	11.9	9.5	12.7	8.6	5.4	9.0	7.5	14.6	31.4	9.6	3.8	16.2	6.8	18.6	4.0	7.7	5.0	9.4	4.1	11.9	9.3	9.3	10.0	5.3	5.5	7.2	9.7	11.7	8.1	9.6	5.8	11.6	11.3	6.2	8.7	6.3	4.9	5.9	10.3	8.0	9.2	12.5	7.3	7.5	8.3	10.5	5.6	9.2	9.8	8.2	10.9	11.6	7.3	4.0	18.5	9.6	6.2	6.2	9.1	8.8	7.7	10.3	10.6	19.3	13.0	7.4	14.1	10.4	7.0	8.3	6.5	8.4	7.6	18.2	6.2	4.9	11.5	13.3	11.0	19.0	16.9	10.1	11.1	5.1	9.8	17.5	9.5	11.2	14.5	12.6	7.3	13.0	13.6	6.2	7.8	9.4	1.1	0.6	0.9	1.3	0.6	0.9	1.9	1.1	1.1	0.4	1.6	1.2	1.0	0.7	1.2	0.6	3.2	1.0	0.2	8.6	9.0	15.3	14.1	8.6	11.0	8.8	9.6	9.0	7.7	11.9	9.7	123.3	525.6	357.0	141.3	143.3	103.5	126.5	112.6	170.8	273.5	165.4	150.9	253.2	297.4	208.4	176.6	2230.9	141.4	201.5	293.4	101.8	131.0	22.5	392.3	157.7	115.9	185.1	129.4	142.6	92.6	81.9	123.5	152.9	185.0	136.6	386.1	98.2	153.5	57.2	360.1	182.6	350.8	136.3	78.3	88.4	17.5	173.4	101.6	58.7	115.2	121.5	155.7	119.4	169.9	187.1	102.4	218.9	135.8	193.5	91.4	298.5	47.2	506.3	1279.6	138.1	206.1	116.1	83.0	129.0	87.3	111.8	333.8	145.7	135.8	171.4	97.6
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 623.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2;lung cancer: 53.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	185.7	14.3	12.3	13.5	16.5	5.8	116.2	16.0	11.5	12.9	6.9	23.2	25.3	6.6	6.6	103.9	11.5	65.7	135.5	10.9	18.7	45.4	623.2	28.9	4.7	22.1	18.4	15.5	23.3	0.8	9.7	1.7	23.2	17.3	12.2	11.5	73.7	12.5	120.4	35.3	23.4	8.7	19.6	4.1	142.9	13.0	22.2	4.6	46.7	27.3	7.8	71.1	31.3	20.3	0.0	429.6	2.4	426.7	2988.3	358.2	0.2	13.7	95.9	5.4	4.1	8.4	0.5	0.0	6.1	97.7	72.5	3.6	1.6	22.4	2.5	0.1	0.2	12.6	65.6	5415.7	30.0	1.8	0.0	183.9	27.3	44.2	26.7	0.4	10.2	2.9	95.8	0.4	74.7	2.4	0.1	0.4	1.2	2297.1	1.5	0.1	0.8	4.2	24.3	81.4	0.4	1.7	23.8	0.7	0.8	1.3	0.5	7.8	85.3	36.0	2.3	97.6	4.5	1.6	0.5	0.3	129.3	12.1	0.9	1.5	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.2	12.3	16.5	16.0	11.5	10.9	18.7	22.1	18.4	23.2	19.6	22.2	20.3	21.6	67.3	34.4	2.0	2.4	21.2	27.8	253.8	262.4	3.1	7.6	1.0	3.2	284.5	144.5	62.5	0.0	0.1	0.2	5.9	13.7	67.0	24.0	3.3	1.7	17.1	1.8	52.6	3.4	328.0	0.1	176.3	139.1	4.6	4.5	0.8	21.0	597.7	0.4	0.0	3.1	6.8	20.3	16.1	15.6	9.9	151.6	3.3	106.7	13.1	4.6	51.5	0.0	4.5	0.5	120.2	3.6	147.4	0.4	41.3	20.2	61.9	72.2	4.5	0.0	16.4	24.3	1.9	1.1	229.3	20.5	0.1	2.1	6.4	20.3	306.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605941-95656711	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 120.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		48000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	15.3	16.1	12.2	21.2	12.6	16.7	20.2	12.4	13.1	33.4	21.0	51.9	89.3	18.5	30.9	21.0	21.9	25.2	11.5	12.2	13.6	17.7	24.3	10.8	22.0	12.4	14.7	16.7	61.8	33.5	28.2	26.3	13.1	24.2	49.3	11.4	120.1	24.9	4.3	22.4	73.1	26.3	12.7	12.1	40.5	11.7	14.0	17.2	37.5	5.5	26.9	25.2	14.3	13.1	66.5	61.6	57.9	152.7	76.0	72.9	62.2	75.6	112.8	75.1	93.7	124.4	51.6	223.7	68.9	119.7	36.2	85.6	117.1	77.8	84.6	64.0	92.0	71.2	40.5	177.9	49.7	125.6	76.1	77.0	46.8	61.5	119.1	124.5	79.9	82.6	67.5	46.0	57.1	95.0	114.5	80.5	68.6	109.2	60.7	105.9	66.3	76.9	88.3	49.7	57.5	56.9	60.1	47.1	56.9	66.0	70.5	57.9	66.7	31.1	49.0	80.9	88.2	52.4	41.7	135.8	60.4	142.8	40.7	0.1	2.6	0.2	27.3	5.2	28.7	23.0	24.5	28.3	9.6	16.1	20.7	23.1	0.5	26.3	8.3	5.9	25.8	15.5	12.2	12.6	12.4	13.1	12.2	13.6	12.4	14.7	13.1	12.7	14.0	13.1	4.6	6.4	9.2	7.2	12.6	11.2	8.3	8.9	14.2	6.3	15.6	12.4	4.6	11.5	14.3	20.2	0.0	43.9	6.7	80.5	1.9	13.7	1.3	12.7	18.1	8.0	19.8	17.9	15.7	21.1	31.6	16.2	18.8	16.9	8.2	81.6	5.3	27.3	11.5	10.1	13.6	41.3	8.2	3.5	3.8	1.6	9.3	3.5	16.0	11.2	2.6	7.1	8.2	17.6	12.8	11.7	56.4	12.0	30.1	18.4	79.4	8.4	15.2	3.4	0.0	10.5	10.1	8.2	9.9	17.6	8.1	30.2	9.0	10.8	38.7	9.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105107643	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pancreas: 40.7;salivary gland: 13.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.1;Inhibitory neurons: 24.0;Oligodendrocyte precursor cells: 25.1;Plasma cells: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.8;ASC TERT1: 85.2;fHDF/TERT166: 102.4;HHSteC: 55.6;HSkMC: 69.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No				"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	3.7	0.6	1.3	3.1	1.2	0.6	2.3	2.3	1.6	5.3	0.7	2.2	2.6	2.0	1.0	1.3	1.5	2.8	1.9	1.1	1.6	0.4	0.2	1.8	1.0	1.4	1.3	0.6	40.7	0.6	1.3	1.1	1.5	3.6	2.3	0.7	13.0	4.6	0.8	1.0	1.4	4.2	1.8	0.7	3.3	1.1	1.6	0.5	2.1	1.2	1.7	3.4	1.5	2.5	13.0	1.3	0.7	27.3	62.8	85.2	1.6	40.8	26.0	5.2	13.5	1.6	0.0	0.0	1.6	102.4	0.2	0.1	0.1	1.0	6.5	0.0	0.3	0.8	0.1	3.4	55.6	5.3	0.1	69.7	3.1	13.6	25.2	0.0	3.0	0.2	2.1	37.7	10.6	0.0	0.0	0.3	1.6	0.0	0.3	0.0	0.1	4.3	0.0	0.0	9.4	4.5	0.0	8.3	20.5	0.4	6.0	44.0	0.3	3.9	3.8	0.0	2.2	45.5	12.8	0.1	16.2	19.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.2	2.3	1.6	1.1	1.6	1.4	1.3	1.5	1.8	1.6	2.5	1.4	0.0	0.6	3.3	2.6	0.5	0.1	0.7	0.0	1.7	0.3	1.1	1.6	0.0	0.2	0.0	0.0	0.2	1.5	0.1	0.0	0.3	4.1	0.7	8.5	0.9	0.0	0.0	23.1	9.8	0.6	10.5	1.5	1.6	0.0	0.1	1.1	0.0	0.4	5.0	24.0	0.0	0.0	0.6	1.7	5.9	3.7	1.0	5.4	1.0	4.0	1.3	0.0	25.1	8.5	3.7	0.0	6.8	14.6	0.4	0.0	0.1	0.2	0.8	0.0	3.6	8.4	1.7	0.1	0.0	0.6	0.3	0.9	0.1	0.1	0.2
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 496.1;salivary gland: 128.0;stomach 1: 224.8"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 389.5;Basal squamous epithelial cells: 274.3;Club cells: 150.1;Gastric mucus-secreting cells: 437.9;Respiratory ciliated cells: 412.7;Squamous epithelial cells: 342.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 64.4;lung cancer: 60.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"A549: 5094.7;OE19: 6071.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		52000	"Cluster 22: NK-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	1.7	1.0	0.4	1.3	0.7	0.1	3.2	0.3	0.4	6.7	17.5	4.5	6.2	0.3	0.2	496.1	5.5	10.3	0.3	1.0	0.4	1.3	1.9	10.9	0.5	0.6	2.1	0.4	0.5	0.0	0.9	0.0	0.5	1.9	3.3	0.1	128.0	1.5	1.3	72.6	3.5	0.4	0.9	0.9	224.8	1.6	1.3	0.6	0.5	0.3	33.7	6.2	22.3	0.9	0.1	5094.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	10.7	246.5	0.0	2.7	0.5	2.0	29.3	0.7	12.8	0.0	0.0	0.8	0.1	116.6	1.0	0.3	0.1	0.5	0.0	14.9	0.5	0.4	0.2	0.5	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.4	6071.6	19.8	0.0	0.0	0.0	0.0	87.0	0.2	0.6	24.8	0.0	0.0	0.2	0.2	0.9	0.6	0.3	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.7	0.3	0.4	1.0	0.4	0.6	2.1	0.5	0.9	1.3	0.9	0.7	3.2	5.5	0.0	0.7	44.1	46.8	389.5	274.3	0.0	0.1	1.5	0.4	2.8	150.1	0.0	0.0	0.0	0.0	5.1	0.0	1.4	1.5	12.4	0.2	1.3	1.8	0.0	0.1	0.5	0.0	1.6	437.9	0.8	2.5	0.3	1.4	3.2	0.2	0.0	0.0	4.8	83.4	0.3	1.8	5.2	0.9	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	9.5	4.7	1.9	3.2	5.8	3.4	5.0	412.7	0.2	0.0	1.7	20.1	1.7	8.6	342.2	32.0	0.0	0.5	0.2	8.4	64.3
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056847-74084492	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 379.1;liver: 367.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 43.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.2"	"Cell line enhanced"	"Detected in all"		"T-47d: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	38.7	14.7	58.6	4.8	66.0	3.3	14.4	58.8	59.3	17.3	61.4	15.2	26.6	11.4	9.8	9.8	12.8	9.4	40.3	51.0	54.0	379.1	367.1	9.4	5.1	63.3	54.0	28.3	23.4	37.0	6.6	7.6	55.6	25.4	15.8	15.2	19.8	16.1	27.5	6.2	23.4	9.0	56.4	5.4	24.0	17.1	69.8	5.7	28.3	34.8	5.3	11.4	7.0	62.6	8.9	7.8	11.0	23.5	39.3	19.2	17.5	6.3	11.8	6.8	11.5	17.3	10.2	10.5	13.6	13.5	5.3	4.8	24.9	7.0	14.5	9.5	3.5	5.1	8.0	19.2	45.0	2.7	2.4	28.2	12.0	8.7	20.7	17.0	12.0	23.7	8.1	14.7	4.6	36.2	7.6	4.0	8.7	32.6	5.2	15.1	11.2	14.6	9.2	5.8	4.4	7.0	21.0	21.9	5.7	18.0	57.5	9.6	3.8	7.4	9.0	11.7	2.4	9.3	18.9	10.2	9.9	3.2	7.3	29.1	6.2	43.2	6.9	4.8	10.6	7.2	7.8	8.4	9.2	6.1	9.9	7.0	2.4	9.7	4.2	5.3	6.1	4.9	58.6	66.0	58.8	59.3	51.0	54.0	63.3	54.0	55.6	56.4	69.8	62.6	15.4	38.5	60.4	24.5	11.8	9.2	26.8	10.0	20.5	20.6	28.4	18.9	81.4	67.2	22.9	66.2	4.2	31.0	7.1	18.9	201.5	11.6	23.4	26.2	27.5	27.0	16.9	28.6	5.5	3.1	14.8	25.9	34.7	90.2	7.6	27.1	87.4	523.6	17.7	11.8	10.0	39.3	8.2	26.5	8.9	19.0	28.9	13.4	24.9	1.9	15.8	98.5	9.2	12.5	23.4	4.1	16.3	48.2	8.0	27.6	55.3	962.4	15.4	17.0	13.1	25.6	16.9	11.0	4.2	25.2	7.4	30.6	11.0	10.2	35.7	17.2
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	22.1	14.7	17.0	13.1	18.8	8.5	22.3	17.9	18.5	19.9	15.0	16.7	7.9	21.6	9.3	18.0	20.4	8.2	14.6	17.1	18.1	15.2	31.8	12.3	16.8	18.5	18.3	21.8	19.1	6.1	9.8	7.2	18.6	15.4	9.1	4.5	15.6	11.3	25.3	27.7	15.0	13.8	17.7	15.1	16.8	11.3	18.1	11.3	15.1	12.1	14.0	19.1	18.6	20.8	35.1	58.6	33.0	74.1	22.7	30.3	52.2	22.9	15.2	23.7	26.7	62.3	24.6	53.5	22.1	13.3	11.1	25.1	55.9	23.0	13.8	48.0	50.0	26.8	35.3	57.9	30.1	37.2	23.9	31.4	48.9	22.2	56.5	28.7	9.1	50.5	40.3	31.0	16.3	61.6	34.8	74.5	45.6	36.6	59.1	30.4	32.0	57.7	31.5	48.1	33.8	58.0	24.2	77.4	50.9	12.3	47.5	22.1	9.6	26.0	28.5	25.0	34.1	43.1	54.6	119.2	22.4	31.8	42.7	2.9	8.1	1.4	12.4	11.2	21.8	27.4	18.4	17.5	8.5	27.6	27.1	16.2	1.5	16.7	7.6	21.6	15.8	10.4	17.0	18.8	17.9	18.5	17.1	18.1	18.5	18.3	18.6	17.7	18.1	20.8	23.7	9.6	6.3	4.2	15.9	50.9	52.2	19.4	42.1	3.6	25.2	44.3	6.2	12.8	16.3	9.2	2.1	17.5	12.5	3.1	15.6	26.5	12.2	7.2	27.9	17.3	8.4	10.9	3.5	24.0	25.0	20.6	14.3	8.6	6.3	9.5	6.1	21.4	9.8	5.0	3.6	11.6	18.3	8.2	11.7	5.4	26.8	6.8	26.6	3.7	4.9	11.2	7.2	6.0	7.6	24.1	5.1	17.3	13.1	46.7	7.4	20.2	10.0	7.4	0.0	44.5	26.0	7.9	32.0	35.9	60.0	5.1	12.6	24.5	14.8	25.3
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase"	Q96Q83	11	43880811-43920274	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 90.9;Late spermatids: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	20.6	15.7	14.6	9.1	16.0	7.9	20.6	18.3	20.9	21.3	15.7	18.3	10.9	20.5	24.7	18.5	19.5	9.2	15.3	15.3	15.4	16.7	18.5	13.2	13.8	15.5	15.2	22.9	23.6	16.9	18.2	7.3	15.3	21.9	12.8	17.0	19.3	13.5	35.2	23.4	15.9	13.6	15.3	19.6	20.0	20.4	15.2	15.9	15.3	25.8	14.6	19.2	19.9	17.6	15.8	26.0	10.7	0.0	20.3	26.1	0.0	19.5	42.0	36.9	34.7	10.7	12.0	2.6	12.2	28.7	20.5	21.3	14.6	32.3	33.1	0.0	49.6	23.7	17.1	27.4	51.9	44.5	30.5	27.8	55.7	17.0	81.4	15.2	26.5	44.7	33.9	25.9	18.3	18.4	38.6	21.9	20.6	16.2	38.5	11.6	23.8	30.3	21.3	23.2	20.3	16.1	15.7	22.6	37.1	9.7	32.9	26.3	20.6	21.6	12.5	35.7	28.0	23.1	25.1	26.3	31.3	18.3	17.6	34.4	16.4	9.4	19.8	18.4	19.3	18.6	20.9	18.2	23.5	21.8	24.8	22.9	2.9	24.6	29.4	20.9	21.3	17.4	14.6	16.0	18.3	20.9	15.3	15.4	15.5	15.2	15.3	15.3	15.2	17.6	12.0	16.0	10.9	15.0	12.6	10.3	8.8	16.5	10.8	11.5	10.9	12.8	6.8	14.3	13.3	16.5	4.2	3.4	13.7	9.8	31.3	24.6	90.9	6.3	7.3	14.6	9.5	9.9	15.8	32.6	4.6	14.0	10.2	4.8	7.6	12.5	13.2	12.9	19.0	10.1	15.8	11.3	6.1	11.2	7.0	103.3	16.1	13.1	17.8	3.7	14.1	20.4	22.6	13.0	16.1	27.7	8.6	10.5	12.4	9.3	15.5	17.1	14.0	13.0	6.6	9.9	15.3	29.3	12.6	20.6	7.1	2.2	12.7	15.7	12.5	8.3
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887835-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"bone marrow: 148.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	39.0	30.0	19.2	50.2	19.6	148.9	34.9	20.2	22.9	33.1	17.7	37.4	32.9	35.1	17.1	57.6	31.3	19.6	37.8	19.8	20.0	37.7	29.6	36.0	62.4	19.6	20.7	32.4	26.9	21.3	28.9	32.1	20.9	30.0	24.3	9.4	30.3	15.9	61.5	45.7	34.5	21.1	20.9	44.7	31.6	72.7	19.8	65.7	30.6	21.2	48.8	35.7	36.4	22.1	263.7	237.8	165.5	164.6	34.4	44.8	213.8	130.0	68.0	257.0	161.0	269.4	173.7	291.4	100.8	104.9	155.6	150.5	241.9	137.5	111.7	111.8	425.9	210.8	151.2	295.1	68.6	341.4	183.0	46.1	61.8	155.3	62.0	37.8	155.5	204.6	275.9	175.2	97.2	279.8	721.2	587.2	231.3	152.0	254.2	472.3	206.1	155.1	54.1	152.1	229.8	299.0	123.9	304.8	110.4	89.9	222.1	343.3	103.9	275.1	270.9	130.0	443.2	201.8	107.3	377.6	143.7	217.0	238.2	0.3	1.1	0.1	1.5	1.2	1.0	1.0	1.1	1.0	1.2	1.2	0.3	0.8	0.2	0.9	1.1	2.2	0.6	0.6	19.2	19.6	20.2	22.9	19.8	20.0	19.6	20.7	20.9	20.9	19.8	22.1	68.4	0.0	16.0	1.3	22.9	34.9	22.9	7.5	9.1	11.0	24.7	32.5	13.0	11.5	8.4	20.2	0.0	9.8	59.0	16.1	1.9	5.2	2.3	52.9	49.0	23.4	12.6	43.3	1.7	8.4	23.1	24.9	17.3	53.7	15.2	39.1	8.9	14.8	17.9	5.0	1.7	24.3	6.1	13.9	33.8	3.2	3.4	31.3	14.2	3.7	12.7	21.5	8.2	2.5	5.0	10.5	10.1	4.1	46.4	33.1	7.4	4.3	8.4	7.6	0.0	27.9	30.6	16.5	8.8	22.6	43.0	16.6	27.6	38.2	21.9	31.6
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760"	Approved		Enhanced	Cytosol		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	9.3	17.5	31.2	12.0	41.6	28.6	7.4	22.9	34.7	13.1	36.6	7.5	10.7	11.5	4.1	7.2	13.1	8.8	7.2	34.8	37.0	10.5	16.2	13.4	7.6	34.7	31.7	17.5	10.0	9.4	45.8	7.6	33.6	10.8	4.1	10.5	9.2	12.0	3.3	8.5	10.8	7.1	27.9	19.0	8.6	4.3	39.3	4.9	10.6	1.5	5.9	7.5	11.4	29.0	20.6	22.5	20.5	20.1	18.0	18.7	8.6	25.6	57.2	24.9	25.0	19.1	7.0	10.5	21.8	39.1	16.0	11.3	15.8	20.0	13.4	13.0	20.7	46.0	15.6	19.3	24.9	15.7	45.7	23.3	13.2	32.5	24.1	28.2	26.7	17.0	17.4	13.0	16.0	23.2	26.7	29.0	20.6	17.1	22.9	18.6	15.8	17.3	24.2	8.7	19.3	22.4	17.4	19.8	24.6	5.7	10.4	16.2	16.7	27.7	39.0	33.7	25.4	48.4	28.4	12.1	50.8	25.9	35.1	0.5	19.4	19.2	5.3	40.7	8.0	5.3	5.2	4.9	18.9	2.7	6.4	5.1	61.1	4.3	44.6	2.6	4.0	12.3	31.2	41.6	22.9	34.7	34.8	37.0	34.7	31.7	33.6	27.9	39.3	29.0	3.6	3.2	5.5	13.7	9.4	8.9	5.4	5.0	9.1	41.0	8.8	11.4	3.2	12.8	5.4	0.0	62.6	4.9	10.0	4.2	7.9	9.8	3.5	4.4	9.4	7.1	17.5	5.0	13.3	11.2	8.6	12.6	14.3	5.5	3.8	11.0	6.1	20.5	10.8	52.2	17.6	9.6	2.0	42.1	42.0	1.3	13.1	52.5	5.4	6.5	16.1	10.5	6.2	12.1	10.6	10.3	3.0	21.4	11.1	11.1	6.1	4.5	4.2	7.2	13.1	8.8	10.6	4.2	3.8	7.9	8.1	2.6	15.4	8.5	10.7	4.0
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1161.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	112.1	120.5	104.8	52.1	108.6	109.3	103.4	110.9	149.5	85.9	100.7	126.0	61.0	86.4	39.0	125.8	80.3	58.0	231.3	106.4	106.8	127.3	185.7	89.3	73.0	110.0	105.1	76.4	108.1	59.0	92.0	54.8	105.0	105.7	27.3	19.3	117.6	42.0	272.8	99.7	83.4	36.5	110.4	86.7	117.9	189.7	113.0	50.1	90.6	126.5	34.0	95.9	94.7	118.1	262.4	605.0	139.0	209.7	118.7	132.8	164.3	123.4	100.6	111.4	127.1	248.6	226.9	82.1	133.3	114.4	121.8	148.9	58.1	166.4	40.5	122.5	437.1	126.8	257.9	379.0	131.3	95.3	103.6	145.6	151.8	120.4	98.2	73.4	184.9	111.9	173.7	233.8	120.8	474.1	225.5	150.6	131.2	259.2	448.7	92.3	136.2	168.0	104.9	229.3	175.8	282.6	133.5	205.7	253.8	96.7	254.1	222.7	108.4	215.0	169.5	229.4	234.1	110.5	52.1	107.0	228.7	144.5	177.7	495.1	419.8	418.8	229.7	359.9	218.7	309.0	232.0	252.9	348.0	296.2	223.0	212.3	212.1	258.5	345.4	581.1	297.9	506.0	104.8	108.6	110.9	149.5	106.4	106.8	110.0	105.1	105.0	110.4	113.0	118.1	137.2	128.2	157.2	11.4	110.5	148.6	215.0	406.1	145.7	59.5	272.5	332.7	360.2	201.6	272.3	198.6	20.9	467.8	119.5	239.6	522.3	260.6	451.9	157.0	151.3	152.9	190.3	201.6	9.8	337.7	524.6	182.9	124.4	169.5	108.3	158.3	159.2	496.4	448.2	33.7	10.2	272.6	319.4	174.6	194.3	1161.0	181.7	170.1	261.5	13.1	251.4	227.7	176.1	7.1	17.0	324.3	274.0	164.7	226.8	334.2	290.7	548.0	199.8	78.9	105.2	115.9	245.0	435.8	252.5	257.4	186.7	508.7	117.3	156.0	271.4	307.0
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188560	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.4	17.7	8.8	11.3	9.6	15.0	15.8	8.9	13.4	15.2	8.6	14.4	11.9	15.8	3.1	15.8	14.7	8.6	15.6	9.7	8.1	14.2	20.2	13.1	14.5	11.5	9.1	15.2	20.7	7.4	13.8	7.2	10.2	17.5	3.1	4.3	18.2	8.9	18.9	19.2	16.5	5.3	8.1	19.9	17.0	25.5	8.8	10.2	15.5	8.3	6.1	13.8	13.4	12.9	20.9	45.6	10.7	17.5	12.6	7.5	33.5	18.5	11.5	16.9	12.8	27.8	20.9	22.4	21.3	12.3	15.8	41.9	12.9	13.8	2.5	28.9	22.5	13.3	55.1	24.9	14.9	20.7	22.1	15.0	10.9	11.3	6.1	8.3	20.8	20.7	20.3	26.4	8.0	58.2	24.7	28.7	21.6	27.4	34.6	29.3	26.5	41.4	13.1	18.1	14.1	21.3	28.2	36.5	11.9	5.1	39.2	27.8	22.4	24.8	19.8	30.1	16.7	12.9	20.5	24.5	20.1	14.1	18.3	0.3	0.6	0.1	0.5	0.6	0.3	0.3	0.3	0.4	0.5	0.2	0.3	0.4	0.2	0.3	0.9	0.6	0.3	1.1	8.8	9.6	8.9	13.4	9.7	8.1	11.5	9.1	10.2	8.1	8.8	12.9	9.3	0.0	0.5	6.2	12.2	9.3	7.9	14.2	6.2	5.7	13.0	12.6	3.2	11.5	11.5	11.0	4.2	25.9	11.1	19.0	13.7	10.0	40.5	4.2	4.0	9.0	10.2	9.5	2.4	10.9	11.1	9.0	27.0	5.0	11.4	8.5	12.1	11.1	15.6	1.7	2.5	19.1	12.2	8.8	7.8	58.4	11.1	7.6	14.2	1.0	13.9	3.7	6.2	1.5	4.3	8.6	8.0	9.4	15.3	6.8	21.2	15.8	10.2	4.7	0.0	9.8	17.4	40.5	26.4	11.9	9.5	24.5	9.4	5.9	15.4	7.1
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163821-4263995	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: AB_2685567"	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	13.8	16.1	18.9	13.5	25.4	16.4	12.5	23.4	19.0	15.2	15.1	25.8	11.4	18.0	10.6	13.6	15.1	11.9	11.4	17.8	23.9	11.3	13.9	15.3	14.0	27.5	23.6	19.9	9.6	19.0	12.3	14.2	25.4	12.1	13.9	13.1	13.7	12.2	14.1	19.8	13.7	14.8	25.8	15.0	13.0	5.9	22.9	20.3	14.4	11.4	12.8	14.6	13.9	28.1	20.6	47.2	31.5	21.3	41.7	31.6	20.5	22.5	23.4	35.5	35.2	21.0	13.7	17.8	18.0	34.1	19.0	32.0	29.3	24.0	31.2	9.7	29.7	17.6	34.0	19.6	23.2	10.6	20.4	33.3	24.8	25.5	18.7	19.0	21.3	17.2	17.3	16.7	24.5	16.0	15.9	11.3	13.3	16.0	16.4	23.9	21.0	9.9	18.5	27.7	10.5	16.4	31.9	15.1	20.2	24.3	17.5	13.7	27.3	22.5	11.7	31.0	30.3	5.5	4.6	5.9	27.5	21.1	27.5	1.0	3.9	1.7	2.7	6.4	2.5	0.9	1.8	1.9	2.7	0.9	1.8	1.7	1.6	1.0	7.3	1.1	1.7	2.2	18.9	25.4	23.4	19.0	17.8	23.9	27.5	23.6	25.4	25.8	22.9	28.1	14.5	28.9	24.6	43.1	8.7	12.4	8.9	12.7	13.1	24.1	12.2	13.2	4.6	8.6	13.6	18.4	29.2	11.2	15.1	13.8	1.9	9.8	4.3	13.9	20.0	15.1	12.1	6.3	59.9	9.7	9.8	15.2	18.8	12.5	3.8	21.1	24.7	19.7	20.2	26.9	60.5	10.9	6.1	24.4	7.6	3.8	14.6	19.1	17.8	39.4	18.8	9.8	19.6	36.7	46.4	13.2	6.4	19.2	7.4	15.4	11.4	7.6	22.4	30.2	6.6	25.5	11.9	12.9	12.8	17.2	11.6	6.2	15.5	16.6	12.5	14.5
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267630-89490561	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA041593, HPA049470"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780"	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	21.1	33.1	26.0	29.3	53.9	14.5	23.2	39.1	18.0	18.7	17.6	21.4	22.0	12.8	22.5	18.4	18.6	22.3	36.8	22.1	15.7	12.2	18.9	26.3	29.8	25.7	29.2	26.6	24.7	24.1	17.9	25.3	16.1	13.6	14.1	20.1	17.0	24.8	35.0	21.0	14.5	19.2	26.6	21.7	18.4	26.7	24.9	19.4	15.0	19.0	19.3	16.5	28.8	55.5	67.9	66.8	51.5	40.3	41.4	64.5	61.7	41.1	36.5	25.8	79.7	57.8	51.0	41.6	44.9	41.1	54.6	46.0	56.8	41.2	25.5	55.3	40.3	49.3	64.7	60.8	30.0	44.0	46.4	56.4	47.9	61.5	52.8	44.4	84.1	88.4	39.6	46.5	52.5	50.1	75.2	58.8	28.7	61.9	101.6	77.0	43.3	38.0	45.7	39.1	47.9	89.0	18.5	65.1	33.9	43.3	46.6	83.2	76.4	71.4	42.9	68.7	71.5	27.1	62.9	61.6	48.6	42.2	7.6	2.9	3.0	2.7	3.1	3.1	2.6	3.1	3.3	1.6	3.0	2.7	2.4	8.5	7.1	5.1	5.4	3.3	1.5	33.1	29.3	23.2	39.1	36.8	22.1	29.8	25.7	25.3	19.2	26.7	28.8	133.0	131.4	103.0	94.7	136.3	116.5	150.3	49.5	91.6	181.3	57.4	65.8	233.3	84.4	52.5	71.7	158.4	42.7	203.7	109.7	31.3	80.1	118.5	200.9	162.6	135.4	106.9	58.5	122.1	72.7	36.3	118.2	96.8	312.8	55.7	164.5	80.7	69.4	48.4	156.5	97.7	89.8	30.5	63.5	117.9	39.5	103.8	112.0	48.0	119.0	110.9	83.1	146.2	117.1	110.0	122.4	66.9	106.1	143.3	147.6	64.6	35.1	45.6	112.9	39.5	148.3	126.3	92.2	98.9	102.6	122.2	38.7	133.8	137.4	87.3	179.0
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	63	"heart muscle: 437.1;skeletal muscle: 981.2;tongue: 823.8"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 218.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.9;testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles		NA	NA		110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	0.4	0.8	2.5	0.1	2.3	0.0	0.5	2.5	3.7	0.2	2.0	0.3	0.0	0.3	0.3	1.0	0.1	0.3	437.1	2.5	2.7	11.8	0.3	0.8	0.2	2.5	2.4	0.1	0.9	0.0	0.6	0.0	2.5	2.9	0.0	0.3	3.4	0.9	981.2	2.7	0.2	0.2	1.9	0.1	0.2	0.5	2.7	0.0	0.5	823.8	0.1	0.1	0.4	2.5	17.6	5.4	0.0	0.0	0.2	0.0	0.4	0.9	0.0	7.3	4.7	0.3	5.3	0.0	0.6	0.2	0.4	13.0	0.0	4.7	5.0	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.8	2.1	4.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.4	0.8	0.0	0.0	0.0	4.4	0.0	0.4	2.1	0.3	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.5	3.7	2.5	2.7	2.5	2.4	2.5	1.9	2.7	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.7	1.7	1.2	0.0	0.2	0.4	218.3	2.8	0.2	3.7	0.0	0.2	0.0	0.0	31.3	1.2	0.6	0.1	0.3	1.6	0.0	0.0	1.3	0.2	0.4	1.0	0.0	0.1	0.0	0.7	0.4	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.5	0.4	0.9	0.0	1.9	0.0	0.1	0.0	19.1	0.0	0.1	0.0	13.6	1.1	2.5	3.5	0.6	0.3	0.3	0.2	0.1	0.0	0.5
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959441-145964575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 6.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.7;Excitatory neurons: 6.1;Inhibitory neurons: 5.8;Microglial cells: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.7;U-266/84: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.6	0.7	3.8	1.2	5.9	0.2	0.6	4.8	14.1	0.8	0.0	1.1	0.9	1.6	0.6	0.6	1.0	0.6	1.4	6.0	1.6	0.5	0.5	0.6	0.9	0.9	1.1	1.2	0.3	0.9	2.9	0.2	0.9	1.2	0.2	3.4	1.0	1.1	6.4	0.4	1.1	0.8	0.0	1.0	0.8	0.4	3.2	0.4	0.6	2.6	0.9	1.1	0.8	5.0	1.2	0.6	0.6	2.0	2.8	2.2	0.3	2.2	4.3	0.5	1.3	0.2	0.6	2.4	0.2	2.9	1.1	0.5	0.9	0.6	0.3	5.0	1.4	0.1	1.8	0.0	0.4	0.3	1.9	2.0	0.2	1.8	2.0	3.0	0.7	1.9	1.2	5.3	3.3	2.2	1.0	0.7	0.2	0.1	2.5	0.2	0.5	10.7	0.9	0.0	2.8	2.0	0.4	0.1	1.3	0.2	3.0	0.3	0.7	5.1	3.5	4.4	1.1	3.6	7.5	0.3	5.0	1.9	0.4	0.0	0.0	0.2	1.1	0.1	0.8	0.5	0.5	0.6	0.1	0.6	0.7	1.1	0.1	0.1	0.0	0.0	0.6	0.3	3.8	5.9	4.8	14.1	6.0	1.6	0.9	1.1	0.9	0.0	3.2	5.0	0.4	0.0	0.0	0.3	1.4	0.3	0.4	0.3	1.2	9.7	0.6	0.6	3.0	0.0	0.2	0.0	0.0	0.0	1.0	0.3	1.9	0.3	0.8	0.2	0.6	0.8	0.0	0.0	6.1	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.4	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.0	3.7	0.2	2.1	1.0	2.0	1.3	0.1	0.3	1.5	0.1	0.3	0.0	0.5	0.0	2.1	0.0	0.6	0.9	0.7	0.4	0.6	0.1	0.1	1.4	0.7	0.1	0.1
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173608336-173669851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 6.7;choroid plexus: 14.3;fallopian tube: 12.7;parathyroid gland: 9.3;testis: 11.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Early spermatids: 48.8;Endometrial ciliated cells: 23.7;Late spermatids: 16.8;Respiratory ciliated cells: 31.8;Spermatocytes: 54.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.5;BJ hTERT+: 2.0;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;GAMG: 1.9;HBF TERT88: 1.9;SH-SY5Y: 5.7"									"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.2	0.6	2.8	0.0	5.4	0.2	0.1	1.9	2.5	1.3	14.3	0.2	0.0	1.6	0.7	0.0	12.7	0.3	0.4	4.3	2.8	1.3	0.0	1.2	0.0	5.2	6.7	0.7	0.3	9.3	1.8	0.0	3.9	0.8	0.1	2.6	0.0	0.3	0.2	0.0	0.0	1.1	3.3	0.4	0.1	11.0	3.8	0.2	0.5	0.0	0.0	0.1	0.1	4.0	0.0	0.0	5.5	0.0	0.0	0.3	0.1	0.0	2.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	5.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	5.4	1.9	2.5	4.3	2.8	5.2	6.7	3.9	3.3	3.8	4.0	0.2	0.0	1.7	12.4	0.0	0.3	0.3	1.1	0.0	0.7	0.1	0.4	0.9	0.0	1.5	5.5	37.5	0.2	0.0	0.3	1.9	0.6	48.8	23.7	1.3	1.3	0.0	0.0	4.6	0.5	0.3	0.4	0.0	0.6	0.0	1.1	3.3	0.0	0.1	0.0	4.1	0.0	6.1	0.0	0.0	16.8	1.8	0.2	0.0	2.8	0.0	3.3	0.0	0.5	3.2	0.1	0.0	0.4	0.0	0.2	0.0	0.4	31.8	1.7	0.0	0.1	0.8	54.9	7.9	0.0	0.0	0.1	0.0	5.5	0.4	0.1
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433152-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.3;Granulosa cells: 53.9;Inhibitory neurons: 54.3;Oligodendrocyte precursor cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BEWO: 44.9;HAP1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310"	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.5	1.8	15.3	2.6	16.5	1.4	3.6	24.7	14.8	5.0	10.5	2.8	0.7	5.2	1.8	4.1	9.1	4.7	7.8	13.6	17.6	4.9	4.1	4.9	2.3	11.2	9.7	12.8	3.8	6.5	3.4	3.7	9.5	2.6	0.9	3.0	5.1	1.7	3.8	1.6	1.5	4.0	8.8	1.8	2.2	5.3	26.7	3.8	4.7	3.1	1.7	3.5	2.8	6.7	0.0	2.0	15.1	6.6	0.1	0.7	44.9	0.2	0.2	0.1	1.0	0.5	1.2	0.0	1.5	0.0	7.0	0.0	15.2	8.2	0.6	0.1	10.0	5.5	0.0	0.5	0.2	0.0	2.0	1.0	2.3	0.0	0.0	0.0	1.6	1.4	0.4	3.6	0.0	1.9	0.2	0.6	4.4	0.6	1.5	5.7	0.0	0.0	2.9	8.0	9.5	3.6	1.2	10.7	4.6	9.0	3.1	3.5	0.0	2.3	0.9	0.2	1.3	0.5	0.1	0.0	0.4	0.0	1.8	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	15.3	16.5	24.7	14.8	13.6	17.6	11.2	9.7	9.5	8.8	26.7	6.7	6.8	16.0	19.4	35.3	1.6	0.9	5.6	4.7	10.2	0.9	4.4	4.6	5.7	11.5	6.4	1.8	12.5	3.6	1.3	0.1	11.7	5.9	2.6	12.0	2.9	5.7	1.8	1.7	23.8	11.2	10.8	7.2	5.6	3.9	10.8	53.9	5.0	2.8	2.6	0.0	54.3	0.0	8.2	2.6	2.1	6.1	9.6	2.5	3.6	25.3	2.9	7.2	3.1	32.6	6.6	5.1	0.1	27.8	4.0	2.5	0.0	4.1	8.2	1.7	6.6	3.4	5.2	5.3	5.3	4.3	1.1	1.9	1.5	4.3	0.0	4.9
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036552	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"bone marrow: 6.1;testis: 5.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 58.5;Late spermatids: 23.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.4	0.4	0.2	0.6	0.3	6.1	0.5	1.2	0.4	0.4	0.8	0.4	0.5	0.4	0.0	0.3	0.4	0.2	0.4	0.1	0.4	0.2	0.4	0.4	0.8	0.4	0.3	0.5	0.7	0.0	0.4	0.4	0.6	0.3	0.0	0.7	0.6	0.0	0.5	1.2	0.6	0.1	0.1	0.7	0.6	5.6	0.5	0.1	0.6	0.2	0.0	0.3	0.4	1.1	1.4	3.4	1.2	1.7	0.2	0.1	1.6	0.9	0.2	0.3	0.3	1.7	3.5	0.7	0.3	0.1	1.6	1.3	0.6	0.0	0.3	0.2	0.4	1.0	9.3	0.2	0.1	1.0	1.5	0.2	0.7	0.3	0.6	0.8	0.3	1.1	1.2	1.0	0.4	2.3	0.2	1.1	0.6	0.3	0.4	1.0	0.3	0.2	0.3	1.7	0.8	1.5	0.9	1.0	0.1	1.7	1.7	0.6	0.7	1.4	2.9	1.7	1.0	0.9	1.1	0.5	0.4	0.9	0.9	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.2	0.4	0.1	0.4	0.4	0.3	0.6	0.1	0.5	1.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	58.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.9	0.0	0.2	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	431	"testis: 860.1"	"Group enriched"	"Detected in some"	61	"Early spermatids: 3367.0;Late spermatids: 861.1;Spermatocytes: 3073.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;JURKAT: 4.6;SCLC-21H: 7.8;U-266/70: 9.8;WM-115: 3.1"									"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.5	0.3	0.1	0.4	0.0	0.5	0.0	0.7	0.3	0.1	0.2	0.5	0.1	1.9	0.1	0.4	0.1	0.3	0.4	1.0	0.7	0.2	0.1	0.2	0.6	0.7	0.2	0.7	0.1	0.7	0.0	0.9	0.6	0.1	0.3	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.1	860.1	1.1	0.1	0.9	0.1	0.2	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	2.3	0.0	0.0	0.2	0.1	1.2	0.8	0.0	0.0	0.0	1.4	0.0	0.0	1.7	0.3	0.5	0.0	0.3	0.0	4.6	0.0	1.7	1.1	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	2.0	0.0	0.0	1.5	0.0	0.0	1.0	0.3	0.0	0.8	0.2	0.0	9.8	0.5	0.4	1.4	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.7	0.4	1.0	0.6	0.7	0.9	0.1	1.1	0.5	0.3	0.0	0.0	0.3	0.3	0.0	0.3	0.4	0.0	0.9	0.1	0.3	0.5	1.5	0.1	0.0	0.0	0.1	0.0	0.1	5.9	0.2	3367.0	0.5	0.3	1.6	0.0	0.4	2.8	0.2	0.1	0.2	0.0	0.0	0.0	1.2	0.4	0.0	0.1	3.3	2.8	0.0	0.0	0.0	0.0	861.1	39.4	2.7	1.8	1.0	0.0	1.8	0.0	0.0	1.0	0.1	0.0	29.3	0.1	0.1	0.0	2.0	0.2	0.0	26.3	0.2	0.2	3073.6	29.9	0.0	0.1	0.0	0.1	2.5	0.0	0.1
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389821-36453791	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 266.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 156.4;Oligodendrocytes: 441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBF TERT88: 655.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.2	0.7	59.8	5.2	134.5	36.4	2.0	125.1	72.7	1.8	18.4	6.0	4.4	1.8	0.2	10.4	0.9	2.1	0.8	59.3	83.6	0.4	1.2	1.4	6.7	162.3	106.5	0.9	0.6	0.2	0.2	8.9	160.2	0.9	8.0	0.3	1.7	0.4	0.3	13.6	4.3	14.9	99.2	1.2	4.8	12.4	102.3	16.0	0.8	0.3	9.5	3.2	3.2	266.0	476.1	96.5	79.3	61.0	10.7	26.9	85.6	292.5	169.3	344.4	256.0	66.4	142.7	23.9	82.1	148.6	182.8	237.0	63.4	170.7	655.4	16.1	46.0	32.7	104.8	55.8	1.7	47.3	36.7	6.0	7.7	225.3	147.2	40.8	109.3	31.2	69.6	48.8	284.4	71.0	40.0	54.8	88.5	71.9	102.3	29.1	238.2	15.9	76.5	76.5	33.5	39.5	154.1	175.8	26.1	109.6	119.0	53.6	104.5	214.2	239.0	127.6	346.6	20.1	34.2	43.2	72.9	74.9	460.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.3	59.8	134.5	125.1	72.7	59.3	83.6	162.3	106.5	160.2	99.2	102.3	266.0	0.4	0.0	1.1	2.3	1.0	14.1	1.9	8.3	7.4	0.0	1.9	2.0	0.6	0.0	3.2	0.0	0.0	13.8	1.1	2.8	0.0	0.7	156.4	18.9	3.2	1.9	0.0	35.3	3.4	0.2	23.2	6.9	10.2	12.8	0.0	15.4	1.1	0.5	9.8	0.0	5.7	3.4	6.1	1.6	5.9	53.3	1.2	2.7	0.0	0.0	0.0	0.0	0.0	1.5	441.3	0.6	0.1	0.0	8.8	1.6	0.8	0.3	10.4	0.0	0.0	0.4	5.2	20.0	17.7	27.1	9.2	2.9	2.6	1.7	6.0	3.3
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		770000	"Cluster 52: Eosinophils - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	50.8	34.7	50.2	87.3	60.5	137.0	71.6	62.3	59.1	54.0	33.3	81.0	70.8	59.1	50.7	65.8	75.1	59.8	127.9	48.8	57.3	75.1	76.4	71.0	156.2	60.0	56.5	57.8	53.7	61.4	27.5	101.5	65.4	75.4	89.0	106.0	54.0	66.8	62.4	36.1	76.9	57.0	62.7	85.5	78.9	20.8	54.3	203.0	73.6	64.5	141.2	76.4	43.6	71.0	196.4	234.7	303.2	263.2	104.2	90.9	200.5	101.0	134.3	193.5	161.8	195.3	358.0	629.8	184.5	114.5	114.2	279.9	709.5	206.6	230.8	286.6	241.2	478.6	192.7	247.8	64.5	380.8	247.4	72.9	143.1	106.3	210.2	126.6	285.9	300.0	354.5	239.1	168.2	136.1	386.1	311.6	270.1	192.5	118.2	531.7	280.7	375.3	170.5	304.5	399.8	247.8	153.7	170.8	282.7	301.1	227.2	491.4	129.0	199.0	313.5	139.3	275.2	143.8	433.9	733.8	132.2	632.1	186.7	12.9	26.4	44.9	16.8	30.6	14.2	18.7	13.8	17.8	30.0	17.9	16.5	14.9	27.2	28.8	27.5	26.8	17.2	16.0	50.2	60.5	62.3	59.1	48.8	57.3	60.0	56.5	65.4	62.7	54.3	71.0	100.2	109.0	118.0	20.2	98.1	64.7	67.7	147.0	91.0	92.2	57.3	70.6	80.0	60.1	105.4	69.9	35.5	258.2	119.7	57.1	107.6	112.5	6.7	61.2	67.7	91.8	78.5	144.2	16.8	96.1	172.4	57.5	69.3	70.1	92.4	63.6	78.1	81.8	194.1	65.6	17.4	92.1	114.0	150.1	112.6	6.3	34.8	111.6	78.2	37.5	158.9	103.7	84.5	15.6	55.4	79.8	57.0	29.7	92.6	59.7	99.3	148.0	113.7	87.2	26.3	49.9	75.1	8.8	18.2	86.4	34.9	232.5	99.5	82.5	94.7	52.0
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983341-98015943	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		570000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	144.0	77.1	134.8	124.0	155.9	365.7	138.6	134.0	187.6	161.6	112.0	145.5	95.1	116.2	104.7	140.9	127.2	60.4	92.3	113.7	150.0	100.2	103.5	122.4	222.6	171.4	149.8	168.5	156.4	68.7	68.1	110.5	158.5	98.6	118.7	46.2	110.6	71.4	109.6	148.0	127.3	78.0	155.6	123.8	131.9	59.6	142.6	271.5	96.9	50.6	248.4	132.5	146.6	173.4	659.7	347.4	378.6	318.4	208.1	365.2	344.4	332.6	292.4	349.2	291.9	438.3	313.1	798.2	194.2	224.6	266.3	423.9	516.1	375.2	397.1	523.0	290.9	692.4	289.1	478.4	266.9	1201.9	386.8	278.7	268.8	280.9	574.0	283.2	307.9	701.5	1359.2	548.8	272.6	875.7	913.5	1062.0	148.2	638.8	341.2	537.8	589.5	381.7	228.8	269.9	304.2	265.8	390.4	376.2	364.5	185.3	213.2	444.0	377.0	226.5	367.3	288.3	355.5	493.2	601.3	469.1	209.7	472.7	432.1	91.3	83.6	118.8	65.2	95.5	89.3	106.1	122.5	92.8	100.5	93.0	143.8	112.1	34.2	74.1	149.7	96.4	162.5	85.3	134.8	155.9	134.0	187.6	113.7	150.0	171.4	149.8	158.5	155.6	142.6	173.4	127.9	86.6	101.8	7.8	227.7	180.7	201.3	180.0	208.9	61.1	100.4	126.0	85.8	112.9	120.7	75.4	25.0	345.5	159.5	159.1	97.8	144.9	114.9	73.8	176.3	146.9	149.9	709.4	5.8	171.6	537.9	121.9	123.3	117.5	119.7	247.9	159.5	96.6	284.7	119.5	6.2	242.2	75.3	310.6	152.0	95.2	146.3	222.5	128.1	14.0	263.5	68.9	149.3	8.0	18.8	137.1	151.1	145.2	266.5	260.6	177.7	101.9	56.3	42.1	151.2	113.4	189.4	204.3	339.0	243.0	154.1	333.1	217.6	188.9	302.7	234.1
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472559-48473622	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Smooth muscle cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: AB_2684947, HPA067561: AB_2685861"		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		280000	"Cluster 44: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	20.0	30.4	36.1	38.9	37.8	75.7	18.1	54.9	45.0	20.5	30.4	19.9	22.5	26.3	34.4	18.7	21.2	20.2	35.1	32.8	39.9	30.8	29.0	23.0	71.0	43.5	41.5	23.3	8.9	33.1	16.4	21.6	40.5	16.2	18.2	98.6	12.9	24.5	49.8	21.6	25.7	21.0	39.7	33.1	17.3	10.3	40.7	88.2	30.5	26.0	62.2	21.8	16.2	35.6	224.0	141.7	289.7	144.0	22.3	32.7	109.8	117.7	66.6	111.8	106.0	105.6	154.0	405.1	101.8	68.3	66.3	76.6	164.9	73.6	158.4	466.1	101.3	280.7	175.6	153.2	21.1	572.0	136.6	26.8	11.9	104.1	95.4	54.8	84.6	193.3	274.8	231.2	103.6	232.3	231.5	148.3	292.5	72.9	64.8	245.4	161.2	214.1	80.2	88.8	94.5	161.2	245.4	39.6	70.7	127.5	105.3	287.7	87.4	56.7	158.4	59.1	239.1	297.6	325.6	388.7	64.5	403.6	105.5	56.6	20.8	35.9	35.0	15.6	53.2	54.5	46.4	38.5	17.4	39.5	32.6	40.7	14.7	31.5	20.3	12.2	56.2	36.5	36.1	37.8	54.9	45.0	32.8	39.9	43.5	41.5	40.5	39.7	40.7	35.6	48.7	12.8	84.0	16.3	88.9	97.3	37.6	36.8	40.5	117.5	33.8	37.7	99.9	24.3	32.8	73.5	33.3	58.4	98.2	12.1	86.1	36.4	1.4	52.5	64.0	52.3	14.4	222.5	7.9	26.5	133.1	57.6	20.9	41.9	63.3	28.4	39.7	59.0	52.3	63.9	9.9	19.9	28.5	48.0	108.9	1.9	30.4	54.3	67.6	6.5	57.0	134.3	60.8	3.0	6.6	27.0	14.2	33.4	116.3	21.6	20.4	58.6	59.6	135.1	26.3	56.8	75.1	12.4	22.7	55.2	98.5	40.6	108.9	27.9	37.8	25.8
AP002495.1		ENSG00000254469	"XRCC1 N-terminal domain containing 1-like"	Q6ZNB5	11	71865504-71928665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	1.9	2.1	1.9	2.2	2.8	4.7	3.2	4.3	2.6	2.8	2.8	2.2	2.6	3.7	5.3	2.6	2.4	2.1	2.1	1.7	2.2	2.9	2.2	1.8	4.2	2.5	1.5	4.6	3.1	2.9	2.5	2.0	2.4	3.1	3.5	7.3	2.2	2.8	1.6	4.2	2.6	2.4	0.6	2.9	2.4	3.3	2.8	3.2	3.2	1.5	3.4	2.3	2.2	5.0	2.6	6.2	4.7	4.5	1.8	1.6	3.1	2.9	2.3	3.1	3.0	6.5	6.4	5.8	2.6	2.0	3.9	8.4	4.9	3.3	3.2	8.4	4.5	9.4	7.7	4.2	1.1	4.2	3.1	2.2	1.6	5.2	3.6	2.6	4.9	8.0	6.3	7.6	3.0	4.9	4.8	3.5	4.9	9.6	4.5	3.6	16.3	4.0	3.5	3.1	6.9	6.6	4.6	4.1	9.2	3.3	5.1	2.3	4.6	2.5	4.1	4.9	1.9	5.5	8.4	7.0	4.0	4.6	3.7	2.7	1.9	1.7	2.9	3.0	1.7	2.5	5.1	3.8	2.2	3.3	4.8	4.1	2.0	1.2	1.9	4.8	4.9	1.9	1.9	2.8	4.3	2.6	1.7	2.2	2.5	1.5	2.4	0.6	2.8	5.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 subunit gamma 1"	O43747	16	71729000-71809201	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		62000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	19.0	25.7	15.4	23.4	16.4	76.7	24.8	19.6	20.8	20.3	26.9	23.6	22.6	17.8	25.5	26.7	18.0	18.9	13.6	16.8	14.9	36.4	33.2	21.4	24.6	14.4	14.5	15.3	24.2	40.4	16.8	17.5	15.8	22.5	25.7	52.8	22.6	16.3	28.2	26.6	23.6	16.1	13.5	22.4	29.3	30.7	15.6	24.9	24.0	36.5	30.4	20.6	18.4	24.3	43.9	62.4	46.3	48.1	48.2	45.4	41.0	44.6	42.1	56.8	54.5	64.3	47.1	55.0	41.9	60.4	41.5	55.4	62.7	49.3	74.4	21.6	33.8	36.2	31.7	46.5	28.9	44.7	114.1	39.1	33.4	76.0	46.9	36.1	50.2	35.8	47.8	23.0	56.1	80.0	39.2	35.3	43.7	34.6	26.8	62.9	37.3	59.3	53.7	49.3	42.5	25.5	55.7	34.8	24.5	46.6	61.0	33.7	60.2	49.4	37.9	27.3	32.9	35.1	50.2	109.2	40.3	34.4	43.3	5.7	6.9	10.0	6.7	7.6	6.8	5.4	5.9	7.5	7.5	5.7	4.6	5.8	14.9	6.7	6.4	5.2	6.6	4.2	15.4	16.4	19.6	20.8	16.8	14.9	14.4	14.5	15.8	13.5	15.6	24.3	32.6	32.1	31.1	42.4	34.2	28.8	27.4	17.3	22.8	26.8	47.6	25.4	13.4	35.8	25.2	36.8	73.0	14.4	40.6	39.3	19.6	21.1	268.8	55.8	37.9	26.0	23.4	9.9	54.2	21.8	13.3	24.0	46.4	84.8	21.0	26.2	21.4	58.5	16.7	30.3	59.0	25.7	12.2	30.4	27.2	130.7	17.7	32.4	23.2	36.5	25.1	16.4	24.7	53.8	79.2	30.5	24.2	19.9	30.6	36.9	30.5	46.4	31.7	66.6	19.7	33.0	26.4	35.8	37.1	32.4	38.6	24.5	33.4	23.0	26.4	47.8
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.0	1.6	4.3	0.7	4.4	0.7	0.9	8.7	8.4	2.9	0.0	1.3	0.4	1.2	0.4	1.7	1.6	0.3	0.4	8.0	2.5	0.9	0.9	3.3	0.6	3.3	2.4	1.1	5.9	0.0	7.6	0.1	2.4	2.5	0.2	1.1	0.4	0.1	0.1	1.0	4.9	0.0	2.2	10.7	1.4	5.7	3.0	1.4	2.7	0.0	0.7	1.3	1.5	4.9	0.0	1.6	0.7	3.7	0.0	0.0	0.0	0.9	1.4	0.1	0.5	0.0	0.0	0.0	3.5	0.0	2.3	0.0	0.5	0.0	0.0	0.0	3.1	8.4	0.0	0.1	3.1	0.0	0.2	0.4	2.5	0.4	0.0	0.4	4.4	1.8	5.0	0.2	0.0	0.5	0.2	2.4	1.1	0.0	3.3	0.0	0.4	0.2	0.0	0.0	5.4	20.0	0.0	0.0	0.2	0.1	0.0	1.0	4.4	0.0	4.4	0.0	0.9	0.0	0.1	0.0	0.1	14.9	1.7	0.0	0.0	0.0	0.9	0.0	0.2	0.0	1.5	3.3	0.0	0.0	5.4	5.6	0.1	1.3	0.0	0.0	0.0	2.0	4.3	4.4	8.7	8.4	8.0	2.5	3.3	2.4	2.4	2.2	3.0	4.9	0.5	0.0	0.6	53.2	1.8	0.4	0.2	0.0	0.0	21.5	1.9	2.3	1.4	0.0	0.1	0.0	0.0	0.1	36.5	0.1	1.9	1.8	18.9	2.9	6.4	1.2	0.0	2.1	142.7	5.8	0.2	2.2	0.0	2.1	0.0	1.9	3.6	0.5	1.2	89.2	106.1	0.3	0.0	1.6	0.4	10.4	1.8	0.8	3.6	33.7	1.9	1.3	63.8	97.0	74.1	3.3	0.0	3.8	12.3	0.1	0.0	0.3	0.2	4.5	0.0	0.4	2.1	1.6	14.5	0.4	0.3	0.1	30.7	10.6	0.0	0.1
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438341-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 145.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 182.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	30.7	4.7	7.0	47.8	8.0	45.5	14.5	10.4	7.6	3.5	5.7	6.1	7.1	2.2	1.6	3.4	5.9	11.6	5.7	7.6	10.4	5.0	38.3	15.5	50.0	16.4	12.5	1.5	4.3	1.6	2.8	8.8	18.0	2.6	6.7	0.6	5.1	2.1	1.4	3.4	17.8	7.5	16.0	56.6	9.2	0.8	15.5	145.4	3.5	2.7	44.3	10.5	3.6	27.3	0.1	1.8	0.0	0.0	12.8	21.2	11.3	37.0	7.2	20.8	19.8	0.0	0.0	101.0	0.5	24.9	22.2	0.1	0.0	0.0	28.6	0.0	0.0	73.3	0.2	0.0	0.0	13.9	0.1	30.3	0.0	0.7	0.0	2.6	0.0	40.5	0.1	62.0	0.0	0.0	87.7	19.5	0.1	7.9	0.0	195.4	0.1	72.4	5.8	0.0	0.1	0.0	3.4	0.3	0.1	0.3	0.1	47.6	0.1	0.0	0.5	6.8	0.1	16.8	0.0	204.7	16.9	71.0	0.0	81.5	23.8	58.5	30.2	23.6	24.9	32.6	25.8	25.9	15.4	39.5	29.3	28.8	182.9	19.1	38.9	50.3	27.2	13.4	7.0	8.0	10.4	7.6	7.6	10.4	16.4	12.5	18.0	16.0	15.5	27.3	3.2	0.0	25.3	1.6	88.2	1.1	0.1	0.1	0.6	0.1	1.6	3.2	1.0	8.6	2.6	3.7	0.0	2.2	149.1	0.1	0.0	3.9	0.4	0.7	12.8	4.7	0.0	28.2	1.1	0.0	20.7	15.0	3.6	0.4	23.4	0.1	6.8	28.9	59.9	0.0	2.9	0.2	0.0	117.7	18.4	0.3	0.0	93.4	3.6	381.3	65.2	0.0	134.9	4.0	1.5	0.1	0.1	0.0	41.7	0.1	0.0	5.1	3.7	0.2	0.0	0.9	11.3	0.1	1.1	0.4	0.1	1.4	125.9	0.4	0.1	0.1
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	37.6	33.1	29.2	43.4	31.1	35.3	45.7	38.5	37.4	39.3	25.9	44.3	42.8	42.1	34.5	44.6	36.6	32.4	28.2	32.0	30.6	49.1	57.7	34.8	53.5	29.2	28.5	35.1	45.9	46.6	19.0	29.9	30.8	40.4	46.6	44.1	39.0	39.5	37.1	40.0	45.5	46.6	32.8	40.3	41.1	26.8	29.9	62.1	51.4	35.9	57.2	44.2	27.6	38.6	90.2	93.0	119.4	75.2	82.7	82.4	82.9	83.8	89.4	116.3	110.2	69.4	38.8	106.4	67.2	90.2	86.9	107.7	143.2	99.7	160.6	122.4	134.9	96.5	53.0	60.8	74.8	165.6	88.9	64.2	104.6	59.0	102.9	72.4	98.9	65.8	160.3	93.9	82.1	57.0	141.2	71.1	214.6	111.1	86.0	145.2	126.3	85.3	89.5	103.8	95.5	64.2	100.7	88.7	81.4	88.4	109.1	76.6	86.5	102.0	78.3	139.8	144.5	77.5	122.7	172.1	88.8	95.0	62.3	61.3	47.3	51.5	66.5	64.5	75.1	61.7	64.8	69.3	62.1	60.4	66.3	68.7	9.9	116.3	67.3	40.0	61.4	88.4	29.2	31.1	38.5	37.4	32.0	30.6	29.2	28.5	30.8	32.8	29.9	38.6	26.4	16.0	27.3	30.0	35.9	43.8	16.6	21.6	47.3	23.8	27.8	17.8	14.4	31.5	28.0	20.2	10.4	30.4	31.8	20.1	31.3	21.3	13.6	23.5	25.8	26.2	24.0	48.0	40.2	19.7	30.4	28.3	35.2	28.2	32.3	25.9	22.1	48.0	26.3	28.6	33.5	27.5	12.2	33.6	28.8	6.5	18.6	30.0	32.0	27.2	41.7	21.1	17.5	25.1	45.4	24.9	19.8	20.3	44.2	24.0	29.4	37.3	20.8	19.0	6.6	28.9	31.1	28.4	26.6	43.1	51.9	38.9	33.8	26.6	31.4	19.2
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	3.7	3.9	4.5	3.4	5.7	4.0	5.9	7.8	5.2	5.7	3.9	4.2	3.4	4.5	4.1	3.5	4.4	3.1	2.7	4.7	5.0	5.2	4.0	3.6	4.2	4.1	4.7	5.0	4.1	5.2	2.5	4.4	4.5	4.0	4.2	8.0	3.3	3.7	2.8	4.2	3.6	3.8	4.5	4.7	3.8	5.6	4.9	7.0	5.4	3.5	4.7	4.0	3.5	5.8	5.3	13.5	8.7	9.3	11.6	10.7	4.5	6.4	8.1	8.3	7.4	6.1	3.2	4.3	4.0	10.8	5.4	8.2	14.8	9.1	9.1	6.1	6.0	13.8	11.4	5.6	6.6	11.3	6.2	8.4	5.9	6.5	6.9	7.7	7.1	3.3	9.9	4.2	8.3	3.6	6.6	7.5	8.7	12.2	5.5	8.9	15.0	4.3	8.3	9.2	9.5	7.4	10.3	9.7	2.3	7.6	6.9	8.7	9.3	6.1	3.4	4.3	5.7	5.0	6.6	8.5	7.7	9.6	6.3	3.6	2.0	1.2	2.6	2.2	2.3	1.6	2.3	2.6	1.7	2.3	2.3	2.6	1.0	2.1	1.4	2.3	2.0	1.4	4.5	5.7	7.8	5.2	4.7	5.0	4.1	4.7	4.5	4.5	4.9	5.8	27.0	12.8	26.0	45.4	27.9	9.6	13.7	17.0	15.4	28.6	19.9	15.6	14.7	17.2	28.1	14.7	114.7	16.4	31.4	18.2	3.9	13.4	38.2	20.6	26.7	24.1	13.2	21.0	39.8	14.3	14.4	18.6	20.4	22.1	24.1	28.8	31.1	18.5	14.9	25.2	44.0	19.1	12.2	18.6	5.1	8.4	20.8	21.8	16.0	29.0	27.9	14.3	22.6	42.3	42.2	18.5	12.1	18.4	22.9	18.8	17.4	12.9	27.1	41.1	6.6	42.8	16.9	19.4	22.2	22.4	9.7	13.3	27.0	46.5	21.6	13.5
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343781	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavorable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	11.4	10.3	5.6	14.6	5.3	27.5	13.6	8.2	6.8	14.2	10.1	19.2	16.9	10.5	11.0	15.2	11.8	12.5	9.6	4.6	5.5	22.8	15.2	13.8	15.4	6.2	6.5	10.3	17.5	28.0	5.4	14.4	6.7	13.0	17.2	36.5	14.8	12.1	12.8	13.7	17.5	10.8	5.2	13.8	19.6	28.3	6.4	22.2	22.4	14.0	17.2	19.7	7.9	7.3	31.8	20.4	19.3	7.3	21.9	29.8	22.5	21.4	24.3	21.7	22.0	12.6	30.0	23.9	8.9	27.6	26.2	22.2	23.5	30.4	26.6	28.3	16.0	40.2	12.0	13.5	18.6	20.9	37.3	18.4	21.6	19.2	31.8	22.3	31.5	24.6	24.5	25.3	25.5	7.2	48.1	9.7	42.5	34.5	18.5	22.4	13.9	4.8	35.8	58.2	7.6	14.9	14.1	33.9	19.5	29.5	58.5	18.3	38.6	14.4	19.3	19.5	16.4	20.4	22.6	17.5	23.6	20.8	14.2	6.1	1.6	4.3	2.8	2.3	3.6	1.2	1.8	2.3	1.6	1.3	3.0	2.6	5.1	2.5	0.9	2.2	3.9	0.9	5.6	5.3	8.2	6.8	4.6	5.5	6.2	6.5	6.7	5.2	6.4	7.3	38.5	44.8	23.1	73.1	32.7	23.7	34.0	23.8	19.9	36.8	32.7	18.9	33.1	18.6	31.9	38.6	139.7	20.0	47.0	43.2	11.7	29.7	25.4	42.5	34.7	28.5	29.4	16.2	119.0	25.6	15.4	22.9	57.6	53.0	15.2	40.0	23.2	19.6	15.8	43.7	146.3	27.9	14.2	31.3	20.4	36.0	40.0	35.2	17.8	105.9	47.1	22.9	46.4	151.8	126.6	40.1	25.7	30.1	29.8	38.2	30.8	24.7	33.9	100.8	6.6	23.6	26.5	69.4	50.7	26.0	29.5	24.9	42.4	32.1	28.0	60.4
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568137	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	35.0	25.5	17.9	4.5	18.4	11.0	36.3	19.5	25.2	43.7	13.5	41.2	3.5	43.1	6.2	30.8	47.0	2.9	31.1	17.8	16.4	28.2	22.9	46.3	6.7	15.2	15.6	50.4	29.3	3.7	34.1	6.1	15.3	34.7	4.7	8.6	35.1	4.5	28.4	32.1	42.6	6.3	15.3	40.8	38.2	23.7	16.2	7.0	36.3	7.5	5.7	35.6	37.6	18.2	10.5	9.4	26.0	6.4	9.0	4.6	9.1	10.2	6.5	9.1	6.6	16.8	8.3	21.5	6.1	9.2	8.4	6.9	17.4	9.9	11.4	24.5	12.3	18.8	9.2	11.6	9.3	36.0	8.2	5.0	6.8	6.9	7.2	9.2	8.1	13.0	13.4	11.4	11.4	7.7	16.4	13.9	18.6	23.6	4.0	17.3	19.7	8.9	10.6	7.3	7.0	13.8	9.9	12.7	6.1	17.6	5.8	27.0	9.2	7.5	6.2	5.9	10.0	11.1	14.2	27.4	10.6	15.6	6.7	44.6	24.2	17.2	15.4	17.7	14.1	30.2	13.5	12.1	17.1	32.4	15.3	14.6	45.7	18.8	14.8	34.2	15.7	12.8	17.9	18.4	19.5	25.2	17.8	16.4	15.2	15.6	15.3	15.3	16.2	18.2	342.0	141.1	230.6	198.8	242.0	261.7	268.5	179.3	186.1	222.7	153.9	104.0	88.3	90.1	204.9	114.0	135.5	141.9	329.3	195.3	99.7	120.7	42.0	201.2	308.3	298.1	187.7	160.3	208.8	113.2	137.7	204.7	355.7	290.6	168.7	331.2	280.2	81.5	101.3	304.5	155.6	218.5	148.5	90.7	186.2	34.0	255.1	142.1	128.1	161.1	182.1	223.3	301.8	200.6	367.2	145.0	173.8	217.7	194.9	251.0	153.7	58.6	190.7	271.2	216.9	179.6	196.8	199.8	125.9	164.1	262.3	185.2	257.8	280.7	193.1	316.0
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane"		"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	3.2	2.1	2.4	7.1	3.9	18.8	7.6	2.9	2.0	3.7	0.6	4.3	3.6	5.5	2.6	4.0	4.7	3.4	3.3	1.6	3.2	3.9	2.4	4.7	13.3	4.3	3.2	9.3	1.6	5.5	0.5	5.3	4.4	3.6	4.5	3.2	3.2	3.0	1.8	3.6	5.3	4.5	3.3	7.9	3.6	18.5	2.9	21.3	3.2	4.2	13.2	2.9	2.0	5.9	18.5	6.0	31.9	56.0	2.1	8.3	9.8	9.0	9.1	13.9	9.9	11.2	16.1	40.9	7.4	6.2	8.3	12.3	27.1	11.2	17.8	20.4	14.7	27.0	7.8	7.8	2.1	42.1	27.8	4.2	3.9	9.8	22.3	4.7	19.6	57.3	27.1	21.0	12.1	8.9	39.3	9.1	16.9	12.2	5.5	45.5	27.1	11.4	4.2	7.8	2.5	14.5	6.7	3.1	14.5	11.9	19.4	22.2	9.1	5.7	6.8	8.9	23.6	18.6	20.7	54.3	7.0	48.7	6.4	21.5	7.2	11.1	5.0	6.8	4.7	5.5	4.9	4.7	5.4	5.3	5.6	5.0	15.8	4.4	6.1	3.0	6.3	5.5	2.4	3.9	2.9	2.0	1.6	3.2	4.3	3.2	4.4	3.3	2.9	5.9	5.8	3.2	3.2	0.0	4.1	0.9	1.4	2.8	3.4	2.8	3.6	8.8	1.9	2.8	1.6	0.0	0.0	2.0	3.6	2.2	0.0	1.3	9.1	2.4	2.6	5.4	0.0	6.7	0.0	1.6	3.5	3.9	1.5	3.6	5.1	5.6	11.7	2.6	3.5	6.7	0.0	1.9	2.0	9.3	1.9	6.3	3.4	6.1	1.8	0.0	5.4	1.7	5.2	0.0	0.0	1.4	2.9	4.1	5.8	2.6	2.6	0.7	4.8	1.3	0.0	3.1	2.2	13.7	10.4	5.3	2.4	1.0	3.5	3.4	3.5	1.6
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883173-41930150	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 156.2;NK-cells: 187.4;T-cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	50.2	20.9	17.1	79.1	21.8	113.5	39.9	19.1	21.9	37.2	17.8	37.5	26.8	33.4	3.6	34.1	36.4	23.5	26.2	16.1	18.2	31.9	30.0	67.7	127.5	24.1	20.2	32.9	27.4	12.6	25.9	18.3	22.0	32.1	10.4	5.6	28.8	11.8	15.4	37.6	87.1	13.4	19.0	168.4	34.9	10.9	21.4	96.5	36.7	8.9	48.9	33.9	33.2	27.9	58.8	69.9	15.8	19.9	21.9	22.9	18.4	30.1	45.7	37.4	32.8	21.5	49.2	77.9	54.6	27.8	19.8	33.8	20.3	46.9	11.8	74.1	23.6	63.1	30.6	28.4	31.9	68.4	100.8	27.8	30.5	36.3	23.5	19.9	36.2	68.2	25.5	46.7	21.8	40.4	48.0	52.9	17.9	46.4	54.0	71.8	29.7	46.3	23.2	31.8	10.3	43.8	42.3	18.7	36.0	8.1	21.9	114.4	49.6	49.7	33.2	26.8	47.7	63.0	43.2	68.4	40.5	107.6	80.2	10.4	20.5	29.2	47.0	39.5	37.2	20.1	35.6	49.4	21.5	19.5	36.1	39.4	27.4	32.1	57.5	11.3	38.7	36.4	17.1	21.8	19.1	21.9	16.1	18.2	24.1	20.2	22.0	19.0	21.4	27.9	46.6	6.4	22.0	35.3	97.3	14.5	13.9	15.0	20.5	18.7	13.1	12.4	4.2	8.6	8.8	7.3	27.1	13.3	156.2	21.7	3.9	23.6	1.4	12.2	16.7	29.0	21.7	23.8	8.0	24.9	22.8	17.7	56.6	16.8	31.7	19.3	26.7	9.3	38.2	11.8	7.9	29.2	16.2	52.5	31.9	1.8	19.3	58.9	19.6	18.7	39.0	8.8	187.4	13.6	27.6	55.9	22.7	16.6	66.4	15.7	10.1	7.3	6.3	19.1	26.3	17.6	17.3	7.3	10.1	17.3	14.8	10.1	159.0	20.4	26.4	11.1
ARHGEF18	"KIAA0521, MGC15913, P114-RhoGEF, p114RhoGEF"	ENSG00000104880	"Rho/Rac guanine nucleotide exchange factor 18"	Q6ZSZ5	19	7348937-7472485	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.0;Excitatory neurons: 22.2;Inhibitory neurons: 18.0;Microglial cells: 14.0;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042689, HPA049151, HPA071867"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042689: AB_10794385, HPA049151: AB_2680654, HPA071867: AB_2686466"	"unprognostic (2.55e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.26e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.79e-3)"	8.2	15.9	10.4	20.0	13.3	27.1	8.1	9.7	12.1	12.2	7.0	22.1	13.3	16.8	3.1	19.9	9.7	10.7	7.1	9.8	8.8	24.1	13.1	14.6	29.8	12.1	13.0	10.1	21.0	11.2	15.8	7.8	10.8	14.2	7.7	5.0	11.0	7.3	5.3	13.8	31.1	13.9	9.5	35.9	22.6	8.9	12.2	33.1	10.8	3.0	17.5	14.0	12.1	15.3	31.2	17.9	10.2	13.9	9.4	7.8	30.8	13.4	12.9	20.5	20.8	24.5	17.4	62.9	29.4	15.2	15.3	24.6	12.7	29.7	11.8	37.6	16.1	15.5	11.7	16.4	22.1	31.2	30.4	12.8	20.2	19.7	16.3	10.1	11.2	20.2	13.4	14.7	21.3	11.0	36.0	26.8	16.0	16.9	29.2	42.2	17.6	17.2	9.0	34.6	9.8	13.7	16.4	16.1	18.8	9.6	17.4	36.4	21.9	16.8	20.1	25.9	17.2	35.6	23.2	40.2	16.7	27.5	15.1	6.4	3.7	23.0	3.9	4.5	4.0	8.8	5.3	4.3	2.3	12.4	5.4	4.1	12.5	0.9	6.9	2.8	3.9	3.5	10.4	13.3	9.7	12.1	9.8	8.8	12.1	13.0	10.8	9.5	12.2	15.3	0.2	0.0	1.1	17.0	2.2	2.9	0.0	6.5	2.8	0.2	0.4	0.1	0.2	0.0	4.3	0.0	4.2	0.1	0.3	0.5	0.0	0.3	0.1	2.4	0.8	0.5	1.8	3.0	22.2	0.4	0.1	1.1	6.1	2.9	0.0	0.5	0.0	0.0	0.2	0.0	18.0	0.0	4.1	0.3	2.1	0.1	0.0	1.6	1.8	14.0	0.7	0.0	0.0	18.1	30.5	0.6	2.3	0.0	4.3	0.0	0.7	0.1	9.3	0.4	0.0	0.1	1.2	0.0	0.0	3.9	3.8	0.0	1.6	0.0	0.0	0.3
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782104	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	16.4	16.3	10.1	22.7	9.4	37.0	16.4	12.9	24.3	16.2	0.0	18.0	15.4	20.4	15.8	22.2	18.3	14.0	17.4	6.3	35.8	13.3	16.8	16.8	25.8	20.8	6.8	20.8	23.2	19.3	14.3	18.6	9.9	15.1	15.3	20.1	19.3	14.4	21.6	20.5	20.3	17.5	3.0	24.3	19.5	16.7	17.9	46.4	22.6	17.6	23.7	18.4	17.8	9.0	53.2	49.5	68.6	71.5	19.6	18.5	32.3	24.4	21.1	32.7	23.0	36.3	34.1	74.3	20.7	31.8	20.7	31.6	60.3	26.9	37.9	92.7	22.6	63.6	33.0	24.7	16.1	95.2	19.6	21.7	18.8	38.7	27.5	18.2	28.6	52.5	77.7	81.1	21.5	25.1	80.1	36.8	72.4	34.5	22.9	82.2	45.3	42.1	20.3	35.3	62.9	50.7	42.7	35.7	29.0	37.8	10.6	53.4	50.6	34.9	33.5	32.4	39.9	38.0	54.9	34.1	21.2	59.8	31.5	0.2	1.5	1.5	1.6	1.2	2.1	1.8	1.3	2.1	1.4	1.6	1.7	1.9	3.3	2.1	1.3	2.4	0.7	1.9	10.1	9.4	12.9	24.3	6.3	35.8	20.8	6.8	9.9	3.0	17.9	9.0	49.9	60.9	40.4	99.9	66.6	73.4	21.0	32.5	90.0	68.0	77.2	61.5	33.0	38.6	35.9	38.6	52.1	36.5	56.1	46.5	1.9	35.3	23.3	48.8	59.3	46.3	47.5	56.6	47.1	37.6	40.2	35.9	35.7	72.3	61.2	68.4	49.6	65.6	51.0	74.0	59.8	50.2	28.5	89.0	47.5	9.0	38.5	73.2	40.9	89.9	86.4	30.8	53.5	78.9	116.1	49.7	36.4	41.8	48.5	50.0	32.4	16.7	36.1	42.3	52.6	38.2	47.3	44.1	52.2	101.8	94.3	36.7	57.0	45.8	52.1	43.2
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552634	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 137.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 295.3;RPMI-8226: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	32.6	4.5	8.1	19.5	8.9	11.8	38.8	8.7	11.1	18.5	7.7	25.9	5.0	25.2	2.0	7.8	24.1	12.3	28.8	7.8	8.7	12.3	8.5	48.1	19.0	14.3	10.8	10.8	6.9	2.2	9.3	9.6	11.5	23.2	2.3	2.2	10.2	2.6	23.5	11.3	19.8	7.3	10.6	22.8	14.6	5.6	10.2	10.3	13.0	2.3	9.9	19.9	15.4	9.6	3.4	1.9	1.6	5.4	2.7	3.0	7.5	5.1	17.2	6.1	5.3	3.1	0.9	1.1	3.8	2.9	9.1	4.6	1.4	0.3	2.1	295.3	4.1	6.9	1.1	5.8	3.4	4.7	4.9	2.1	5.7	5.0	0.9	5.3	5.4	8.1	5.4	38.5	2.4	2.9	8.7	16.1	3.3	1.5	0.2	12.2	11.3	117.5	0.7	2.5	2.2	1.1	0.5	0.6	4.3	1.3	0.2	10.0	6.0	5.4	6.7	6.2	4.6	24.7	21.5	3.1	3.0	11.1	4.9	10.5	7.9	32.8	15.3	6.9	14.9	5.9	13.1	14.6	10.3	6.5	14.1	14.4	21.5	27.5	5.5	18.4	16.0	14.9	8.1	8.9	8.7	11.1	7.8	8.7	14.3	10.8	11.5	10.6	10.2	9.6	97.1	3.2	18.3	3.9	59.9	52.4	46.5	17.0	5.7	24.8	80.3	44.7	14.7	8.6	14.7	3.7	31.3	4.9	121.1	10.8	3.9	33.7	14.2	16.7	26.8	82.2	0.0	3.4	1.5	30.9	9.0	41.2	11.2	32.4	61.9	2.1	38.6	28.7	72.6	0.0	1.6	10.7	20.3	41.5	137.1	36.7	3.7	61.6	58.7	15.9	66.6	6.5	123.6	3.5	1.3	29.1	23.9	6.4	54.5	28.2	0.6	10.6	8.3	25.7	46.0	49.1	120.1	3.2	17.9	1.1	32.5	4.0	98.2	2.1	7.8	26.9
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	20.6	22.9	21.4	16.0	24.5	23.0	19.8	24.2	23.7	21.4	24.7	29.4	11.7	24.5	33.8	19.5	21.3	15.0	53.9	21.3	23.4	22.7	21.3	19.7	20.7	22.9	22.9	20.7	24.1	24.4	26.0	18.4	23.8	23.1	17.7	32.4	18.6	21.9	100.4	16.5	21.2	24.4	22.0	24.3	22.5	27.0	22.8	26.1	22.0	79.6	21.4	23.6	17.4	27.7	40.4	39.6	37.6	53.2	54.3	29.7	52.4	46.3	53.5	56.5	62.1	42.0	35.0	84.1	21.4	49.8	82.0	23.5	77.9	47.2	68.7	57.0	48.1	85.3	51.7	34.5	48.9	63.4	39.5	31.9	70.2	70.9	94.9	32.2	43.1	38.3	68.4	54.6	50.7	27.8	65.4	25.8	64.3	43.3	59.5	23.5	42.8	70.2	32.9	54.1	16.4	44.8	47.7	56.1	45.0	44.1	28.6	43.8	41.4	34.1	49.4	52.5	74.0	72.8	148.1	103.3	37.3	51.9	43.7	53.1	34.6	39.9	44.2	32.2	30.5	28.8	28.2	37.1	32.3	34.2	29.2	37.3	25.6	25.8	20.9	29.9	35.5	39.3	21.4	24.5	24.2	23.7	21.3	23.4	22.9	22.9	23.8	22.0	22.8	27.7	37.0	35.3	31.4	54.9	50.2	50.9	51.5	27.3	68.3	57.0	35.5	35.3	74.6	32.9	44.0	29.5	87.6	36.4	76.0	31.3	29.4	33.8	15.3	33.5	48.3	38.4	16.7	76.2	50.0	43.2	36.2	40.1	42.3	38.1	45.5	42.3	28.5	44.6	26.6	57.2	59.1	26.2	14.2	32.8	35.7	11.3	41.7	44.6	30.2	38.4	45.2	42.2	95.8	42.3	128.6	42.1	23.0	43.2	85.0	78.9	20.8	34.3	30.6	82.5	26.3	51.5	48.6	165.7	89.7	59.4	54.0	53.4	66.8	37.7	31.6	67.0
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099759	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	20.9	22.8	11.2	9.3	11.9	7.2	18.1	10.5	12.7	22.3	12.2	19.4	9.8	17.8	17.0	21.0	18.6	11.3	16.6	11.4	11.9	24.0	24.4	15.5	10.8	10.7	11.4	24.4	24.4	17.2	11.9	10.9	11.4	18.0	12.7	13.8	16.4	15.7	18.4	25.8	12.1	14.4	13.7	12.3	19.8	12.2	11.6	13.6	17.6	8.6	11.5	21.3	19.5	15.9	30.1	25.5	16.1	28.8	30.0	28.4	15.1	19.3	22.2	14.7	17.4	13.7	34.8	57.3	42.4	18.0	43.4	25.6	20.9	23.3	20.9	19.2	22.3	19.4	10.9	7.8	31.9	55.8	21.3	19.3	40.4	18.8	30.2	45.7	33.6	29.6	45.9	32.8	26.5	58.8	38.8	43.9	36.2	54.5	26.8	22.9	15.5	69.2	37.7	20.8	16.3	25.1	30.3	43.8	35.3	26.9	17.6	26.9	23.4	22.9	23.6	52.0	31.8	47.8	77.6	42.9	25.5	50.1	30.2	0.0	2.3	3.8	1.4	3.1	2.2	2.2	2.2	2.2	3.4	3.0	2.3	2.4	0.5	2.1	1.6	3.1	2.4	1.1	11.2	11.9	10.5	12.7	11.4	11.9	10.7	11.4	11.4	13.7	11.6	15.9	30.1	25.6	17.9	12.1	31.8	78.8	60.2	7.9	54.7	24.4	53.3	56.1	17.4	34.3	12.4	27.6	14.6	45.3	41.1	17.6	66.5	19.7	12.6	31.4	32.3	28.4	15.0	51.5	20.7	15.5	52.2	35.4	33.6	23.8	17.2	37.9	30.4	37.6	46.7	8.4	18.5	32.6	6.1	38.8	39.5	8.3	33.8	32.7	46.2	14.0	28.7	38.3	25.7	20.6	44.0	23.2	20.5	34.3	41.9	87.1	21.9	97.4	10.5	28.6	32.9	28.6	37.5	15.6	35.1	67.2	104.3	45.0	31.4	31.9	41.3	71.9
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 110.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA041420: AB_2677469, HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	11.9	16.6	20.4	11.4	20.4	16.7	11.7	21.6	27.8	13.9	19.8	12.4	10.0	14.7	6.1	18.7	11.7	6.9	17.9	21.2	21.7	16.9	110.5	11.9	15.8	22.9	21.2	12.0	11.2	11.9	17.8	8.8	22.7	15.6	8.9	7.7	13.3	8.0	21.3	12.7	12.3	9.1	19.5	17.8	12.3	24.0	20.3	23.2	19.4	18.2	12.4	14.4	12.6	20.8	64.1	42.8	30.7	38.0	14.5	24.7	39.7	40.3	23.5	64.5	47.7	59.8	56.0	96.3	63.8	34.1	23.8	31.8	73.7	47.8	35.5	20.4	104.0	48.5	39.0	49.0	32.0	87.1	54.3	31.2	44.9	44.0	30.7	14.5	41.6	56.3	86.4	36.0	36.0	78.0	93.2	70.5	71.5	71.9	86.8	76.3	27.7	68.9	31.9	42.6	70.5	30.6	32.4	41.1	33.9	20.7	35.0	54.1	27.2	33.0	28.8	47.3	83.8	27.5	53.2	93.2	27.3	117.1	44.0	10.6	19.0	5.3	22.1	20.3	16.6	13.4	12.0	19.3	28.3	15.1	15.7	18.0	3.8	30.6	16.7	18.2	23.4	18.3	20.4	20.4	21.6	27.8	21.2	21.7	22.9	21.2	22.7	19.5	20.3	20.8	7.1	0.0	5.9	4.6	10.7	6.6	6.8	9.2	9.1	14.1	11.5	11.4	5.9	17.2	8.9	12.9	12.5	20.5	21.3	12.3	7.9	16.0	25.5	6.3	11.8	10.2	15.0	13.7	4.0	10.7	20.3	10.7	12.2	9.6	1.3	11.1	8.2	52.4	20.7	5.0	5.0	10.9	6.1	15.6	6.0	47.9	10.2	9.2	5.4	0.0	14.9	16.4	20.6	5.0	5.5	10.8	10.8	8.2	10.3	12.4	10.4	12.3	4.5	17.9	13.1	7.4	9.1	22.0	31.0	10.0	10.1	13.0	10.3	16.5	17.3	5.5
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Astrocytes: 44.1;Basal prostatic cells: 60.3;Prostatic glandular cells: 49.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 46.4;HUVEC TERT2: 42.2;LHCN-M2: 42.8;TIME: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	1.8	1.3	1.5	1.3	1.1	0.0	1.0	5.0	1.4	4.5	0.2	2.4	0.6	2.0	0.9	3.1	2.8	3.6	2.5	1.2	0.9	2.7	1.7	3.3	0.6	0.9	1.1	2.0	1.1	3.0	0.7	4.3	0.7	3.9	3.3	0.6	5.8	2.2	0.2	0.7	0.7	2.2	0.6	0.2	3.5	0.1	1.9	1.5	0.7	0.6	0.3	3.8	2.1	1.1	2.7	5.3	0.6	0.0	10.1	20.5	0.0	46.4	35.5	29.0	11.3	1.3	3.4	0.0	5.7	22.6	10.3	5.0	0.2	11.7	36.2	0.0	2.1	0.0	4.2	0.0	30.6	0.0	0.0	12.7	11.5	19.7	40.0	20.5	42.2	0.0	0.0	0.0	42.8	0.4	0.0	0.0	1.5	0.0	8.4	0.0	5.1	0.0	38.0	0.0	0.0	1.7	3.1	0.5	2.2	7.5	0.2	0.0	53.6	33.3	8.7	5.0	22.3	0.0	0.0	0.0	16.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	5.0	1.4	1.2	0.9	0.9	1.1	0.7	0.6	1.9	1.1	0.7	35.3	9.8	44.1	0.2	2.9	60.3	23.7	15.9	0.2	4.7	2.9	1.3	11.5	10.8	25.8	0.0	0.3	0.1	7.0	0.0	9.2	0.0	6.2	21.1	4.3	23.4	0.0	27.1	0.9	0.2	13.6	4.6	8.2	0.0	0.0	4.2	1.2	0.5	1.7	1.5	17.3	16.2	0.3	1.6	0.3	2.5	0.3	3.6	7.5	0.0	6.8	1.0	3.0	0.5	5.2	5.0	1.5	0.0	49.6	0.1	4.1	4.6	0.2	0.0	8.6	10.5	0.1	0.3	16.9	1.1	0.4	0.6	3.3	4.1	25.6
ARVCF		ENSG00000099889	"ARVCF delta catenin family member"	O00192	22	19969896-20016823	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.2;Cone photoreceptor cells: 22.9;Muller glia cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 20.1;REH: 10.5;SCLC-21H: 18.0;SH-SY5Y: 13.8;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016162, HPA055264, HPA063675"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane, Cell Junctions"		"CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.76e-6)"	3.8	3.1	6.4	0.7	5.4	3.2	4.4	18.4	6.2	4.3	1.2	5.9	1.0	4.8	3.2	1.3	3.5	1.3	6.4	5.6	7.1	6.2	6.8	4.5	0.5	7.0	5.2	3.5	5.1	1.7	9.4	1.0	5.7	5.7	0.3	1.4	7.0	1.7	7.4	4.7	2.8	0.7	4.9	10.8	4.8	4.9	8.3	0.2	15.6	1.2	0.1	2.8	2.8	5.1	4.1	0.4	5.5	7.1	0.1	0.0	5.6	1.0	0.4	0.3	0.6	1.1	0.9	1.7	4.5	0.5	0.5	3.8	0.9	1.8	0.0	0.5	6.8	0.5	0.5	4.4	1.6	0.6	1.3	0.1	0.7	0.3	0.2	0.3	4.5	1.3	20.1	0.6	0.1	3.8	0.3	2.6	5.6	1.3	2.3	10.5	0.3	0.5	0.9	0.9	18.0	13.8	1.1	1.7	2.7	0.9	1.5	0.5	1.7	0.1	15.6	0.7	0.3	2.2	0.7	0.5	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.4	18.4	6.2	5.6	7.1	7.0	5.2	5.7	4.9	8.3	5.1	2.3	3.2	2.6	24.2	0.7	2.0	3.0	4.4	0.6	9.7	6.6	7.9	6.0	5.7	3.2	1.8	22.9	5.6	2.3	1.8	0.0	8.9	2.7	2.4	0.9	3.0	9.0	4.0	4.7	5.5	2.2	2.4	1.5	4.5	0.0	4.7	2.5	4.1	1.4	5.0	6.2	7.0	10.2	1.0	1.2	1.7	4.1	0.8	3.6	5.6	0.0	21.7	7.2	8.0	1.8	10.7	0.6	3.4	0.9	4.7	0.8	5.6	4.9	8.6	0.0	7.7	6.2	2.3	8.4	0.4	1.8	4.4	0.6	1.6	2.1	1.5
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894152-118909171	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA030502: AB_2673504, HPA071495: AB_2686404"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.4	10.2	13.0	8.7	14.4	8.3	12.5	14.8	17.1	8.5	11.2	9.4	7.7	10.6	13.0	8.9	10.5	7.9	13.3	12.4	14.2	12.6	12.0	13.4	16.0	13.6	13.7	17.5	9.4	15.8	6.3	8.2	14.0	9.8	10.9	11.5	10.7	11.0	16.6	11.6	8.8	7.4	14.5	11.5	10.9	9.7	13.9	24.4	15.1	16.1	15.1	9.4	6.7	15.7	14.7	9.2	31.2	21.2	26.0	15.2	25.3	19.3	18.8	24.3	27.2	11.7	12.2	24.0	30.8	13.7	21.5	15.3	27.2	24.7	30.8	17.5	25.4	35.1	20.7	72.9	18.5	60.6	17.4	13.8	24.3	21.2	32.0	32.6	32.9	75.2	55.2	61.9	28.9	15.7	70.8	47.4	12.9	21.6	30.5	38.7	13.1	30.1	32.7	18.4	20.1	15.8	19.6	19.4	23.3	9.8	11.4	55.3	29.1	11.3	17.0	16.1	30.1	19.4	34.5	35.6	29.7	47.5	25.0	18.8	15.4	32.9	40.3	17.1	56.5	35.7	64.0	51.8	34.1	24.7	69.0	56.8	2.7	34.3	23.1	26.1	83.9	47.4	13.0	14.4	14.8	17.1	12.4	14.2	13.6	13.7	14.0	14.5	13.9	15.7	16.0	16.0	22.6	11.1	24.7	29.4	14.8	36.7	28.5	16.7	14.0	19.2	27.1	18.6	23.0	9.2	4.2	67.5	19.8	11.6	62.6	33.9	40.9	10.2	13.9	23.3	29.5	82.1	5.8	23.5	71.5	24.0	17.9	9.1	22.8	39.9	17.2	15.1	24.6	25.2	6.3	12.4	10.2	16.3	16.7	10.8	25.4	16.5	16.0	9.4	24.9	27.8	24.7	9.0	10.0	20.7	10.1	23.3	22.7	10.9	11.5	27.2	21.2	13.7	13.1	17.0	37.2	32.7	48.0	20.8	33.0	46.7	49.1	28.1	17.5	12.5
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 92.5;monocytes: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 131.0"					"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	28.1	21.8	15.6	15.7	15.1	17.4	26.8	15.1	20.3	29.1	23.0	30.8	11.7	29.4	14.3	15.1	28.6	13.6	34.5	15.7	16.5	23.1	32.1	18.3	21.4	20.4	18.4	33.9	23.6	22.4	31.0	11.2	18.3	26.8	7.8	9.4	24.8	23.4	23.8	27.7	20.6	12.2	15.9	24.1	23.1	13.0	16.6	20.0	29.5	15.3	12.4	25.1	22.9	18.0	14.0	24.0	28.0	21.4	16.5	25.5	38.9	16.3	21.3	18.2	23.2	22.0	16.5	24.6	9.0	21.5	19.7	5.1	7.4	7.9	11.4	36.7	23.9	21.4	17.0	26.6	37.5	10.1	131.0	33.9	13.4	13.9	13.4	20.3	21.7	18.7	11.0	19.3	14.6	52.4	43.5	39.6	33.9	12.9	15.0	35.2	26.7	60.0	12.8	7.6	1.1	13.2	21.9	27.8	20.7	18.9	6.4	13.4	28.6	15.2	16.5	29.0	6.1	24.8	8.0	62.9	19.3	14.5	4.6	45.7	25.5	65.9	28.8	30.9	25.6	24.2	26.1	26.9	22.0	37.7	22.5	17.7	37.2	52.9	22.5	42.1	31.4	23.2	15.6	15.1	15.1	20.3	15.7	16.5	20.4	18.4	18.3	15.9	16.6	18.0	20.6	12.8	9.4	5.2	19.3	18.4	25.3	17.2	23.3	17.7	16.4	17.4	21.3	10.0	9.9	14.7	4.2	33.4	28.8	16.1	27.4	15.2	0.9	8.8	14.3	19.5	14.4	7.4	8.3	17.1	24.1	23.8	14.8	10.4	54.6	27.0	17.9	30.8	20.3	92.5	6.7	17.9	8.2	12.3	31.0	2.8	26.1	18.8	12.4	9.4	106.2	17.1	26.8	5.0	7.1	10.9	18.3	43.2	21.8	22.1	19.9	34.2	11.1	12.6	32.9	21.4	23.2	2.5	8.2	22.3	15.6	66.4	20.4	21.9	20.4	18.4
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97851677-97872542	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 233.9;Late spermatids: 217.0;Smooth muscle cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 8.9;T-cells: 14.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No		47000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	17.3	18.0	49.9	19.5	52.3	13.7	17.8	52.7	66.3	19.9	28.2	24.5	9.7	19.0	31.5	27.0	20.1	11.2	19.4	55.3	51.0	28.9	9.3	25.6	28.8	58.7	43.5	20.8	121.4	26.3	44.1	4.6	59.4	21.5	19.9	35.3	41.6	14.5	8.0	22.9	22.6	18.0	43.6	30.3	46.0	33.3	49.7	13.3	27.5	8.6	25.7	21.7	18.6	63.8	124.6	46.6	51.6	415.9	35.3	57.9	109.1	85.7	62.5	41.6	134.8	64.2	49.3	101.7	45.3	189.8	92.3	57.4	118.2	151.2	102.2	122.4	85.3	31.0	24.6	50.8	347.8	207.1	89.9	106.2	508.8	55.8	361.2	23.5	41.4	94.4	177.1	365.2	76.3	286.5	6.4	54.4	68.1	308.4	125.4	14.0	10.0	282.7	28.4	22.3	218.1	156.7	23.2	136.7	499.0	60.6	57.1	139.1	7.6	21.6	138.5	56.7	40.7	412.6	239.7	401.1	288.7	90.3	220.8	1.9	0.3	0.4	3.6	1.1	4.3	8.9	7.2	3.4	1.5	6.0	10.1	5.5	1.8	2.0	1.0	0.2	14.2	3.3	49.9	52.3	52.7	66.3	55.3	51.0	58.7	43.5	59.4	43.6	49.7	63.8	5.8	9.6	7.2	11.1	14.4	12.4	26.1	20.9	6.2	20.3	9.7	11.2	7.6	7.2	12.3	9.2	25.0	3.1	6.7	10.5	7.9	30.9	233.9	2.9	8.6	6.7	24.4	46.1	51.8	61.6	7.8	8.9	14.3	4.5	8.2	8.8	2.9	1.3	1.1	25.2	48.6	19.6	32.6	1.3	3.2	217.0	9.6	2.1	8.8	5.6	7.3	9.2	5.2	16.1	16.9	36.6	14.7	9.4	19.9	26.1	1.1	3.9	4.5	24.9	6.6	10.2	112.3	3.4	20.2	5.5	10.9	5.6	11.2	6.0	9.9	14.9
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"ASXL transcriptional regulator 2"	Q76L83	2	25733753-25878487	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA034646: AB_2674261, HPA058040: AB_2683586"	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	6.8	6.2	3.8	9.5	5.1	8.3	7.2	4.8	3.9	8.2	4.5	9.1	6.4	7.1	5.0	7.7	7.2	6.8	7.1	3.5	7.7	8.7	6.1	6.9	11.1	7.5	5.0	6.6	7.7	14.1	3.5	7.1	7.5	6.3	8.9	8.8	6.6	6.3	8.0	7.6	7.1	8.2	3.6	9.9	7.8	17.7	6.3	13.9	10.5	7.3	10.5	7.5	4.2	6.4	25.1	23.1	11.0	7.8	9.8	13.7	12.9	16.0	19.0	12.4	10.5	19.4	12.6	14.8	9.7	13.9	13.8	14.1	21.1	14.9	16.9	22.5	10.2	32.9	20.1	16.6	8.3	42.2	25.1	6.8	15.2	17.9	15.3	10.4	15.2	8.8	29.0	12.2	12.5	9.2	15.5	9.2	14.4	13.2	9.4	15.4	48.2	11.4	10.7	30.1	11.3	12.5	22.2	13.9	13.5	10.4	8.9	12.3	31.4	16.6	22.0	15.9	22.4	26.8	39.8	41.0	15.5	27.4	13.2	1.7	2.7	4.2	2.7	1.4	2.3	2.2	1.9	1.9	1.5	2.0	2.2	2.5	6.0	1.2	3.3	2.3	2.2	0.8	3.8	5.1	4.8	3.9	3.5	7.7	7.5	5.0	7.5	3.6	6.3	6.4	16.1	25.6	24.1	54.2	25.9	32.4	8.9	15.9	29.0	22.3	19.1	10.8	27.0	14.3	19.1	9.2	25.0	10.2	22.5	20.1	15.6	15.7	48.9	25.8	20.4	22.0	10.3	33.6	62.5	14.4	9.4	17.3	24.5	19.8	23.5	12.6	28.5	12.6	18.2	25.2	47.6	16.8	18.3	25.7	23.6	26.9	19.6	25.2	23.2	68.4	34.4	12.4	12.3	46.3	72.8	18.4	14.2	13.2	29.8	13.4	12.4	14.3	41.3	24.9	39.5	20.6	16.8	34.4	26.6	29.7	41.1	14.6	45.0	17.2	19.7	19.3
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 294.4"					"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	2.9	3.4	3.8	7.7	3.6	26.5	6.8	2.6	3.9	12.8	2.0	5.3	5.0	4.3	3.8	6.8	3.4	3.2	5.8	3.2	4.5	1.4	9.9	4.1	14.4	2.9	3.8	7.0	3.3	1.9	3.9	4.8	2.6	10.3	6.9	1.4	4.3	4.7	9.3	6.8	5.2	4.1	2.8	4.9	4.7	18.9	5.1	28.3	3.9	3.2	12.8	4.8	3.9	2.8	103.7	39.6	55.0	19.0	9.7	12.3	24.3	79.2	27.2	66.8	73.9	30.1	43.8	67.2	23.6	25.2	26.5	48.3	74.2	25.6	106.1	94.3	39.0	121.2	41.0	61.4	3.8	44.6	57.4	4.1	3.8	63.6	21.0	14.3	20.7	38.6	57.7	66.4	50.4	107.1	129.5	32.8	10.0	77.8	38.4	66.5	65.6	36.4	23.8	46.7	70.2	30.5	114.4	294.4	20.8	22.1	60.2	41.2	13.0	50.4	69.3	40.2	96.6	21.2	40.7	60.8	32.9	72.9	40.4	5.3	0.8	3.3	1.6	0.8	2.2	2.6	2.3	2.7	1.4	1.5	1.5	1.7	0.2	2.5	1.9	0.1	4.6	1.0	3.8	3.6	2.6	3.9	3.2	4.5	2.9	3.8	2.6	2.8	5.1	2.8	4.8	6.4	11.0	9.4	18.5	15.8	27.9	9.1	14.2	2.8	17.3	21.2	27.3	2.8	10.2	3.7	4.2	14.9	15.3	9.0	1.9	3.5	54.9	7.9	17.3	9.6	1.2	79.1	25.6	2.2	26.2	17.1	13.3	17.5	14.5	37.9	7.1	16.3	11.2	1.7	16.4	13.1	4.1	8.2	6.9	24.4	7.5	11.7	1.8	14.0	6.3	6.3	17.5	11.6	2.8	3.5	4.3	13.9	34.0	20.7	3.1	1.0	5.4	1.9	0.0	9.5	17.5	106.0	82.4	23.7	12.1	13.5	22.8	3.7	14.6	24.5
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family AAA domain containing 3A"	Q9NVI7	1	1512162-1534685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA		27000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.9	13.6	8.3	12.3	8.4	18.1	10.7	8.5	11.1	10.6	9.7	11.2	11.4	12.8	2.0	17.2	10.4	4.4	15.5	9.0	7.7	10.6	18.5	10.0	10.4	8.4	8.2	8.4	19.5	5.2	14.6	6.6	8.0	9.5	3.0	2.0	13.4	5.5	28.8	14.3	9.8	3.8	7.5	11.7	12.9	9.3	8.2	6.2	9.6	8.3	4.7	11.4	10.7	8.3	79.2	47.9	18.0	49.3	8.3	10.6	45.6	62.9	16.8	52.7	32.1	127.2	52.8	45.9	41.5	24.9	19.7	65.8	27.5	36.5	9.2	42.7	110.3	75.0	131.9	97.0	17.3	112.5	42.7	12.8	11.2	44.2	16.2	6.1	23.2	44.2	120.1	27.3	19.7	64.5	83.1	95.2	40.9	25.9	91.5	88.5	35.7	91.9	14.7	40.3	91.8	35.3	39.8	58.1	53.0	5.9	24.8	55.7	32.6	52.5	45.0	85.8	79.2	45.6	52.6	172.7	54.2	160.5	25.4	0.5	1.8	0.6	1.5	1.5	1.0	1.4	1.5	1.7	2.2	1.5	1.3	0.6	0.1	2.5	3.4	2.2	1.5	1.1	8.3	8.4	8.5	11.1	9.0	7.7	8.4	8.2	8.0	7.5	8.2	8.3	8.5	3.2	9.0	10.7	11.7	20.4	11.2	5.9	8.0	10.5	11.6	8.3	9.5	8.6	6.4	7.3	6.2	21.6	10.0	18.8	7.9	22.5	9.5	14.7	9.3	11.8	13.8	28.4	8.8	21.3	43.4	10.4	13.7	8.7	8.9	21.9	4.6	12.5	22.4	23.5	8.3	19.6	14.2	7.5	12.5	10.1	5.6	7.7	16.0	6.5	5.9	10.9	6.2	4.5	6.1	25.3	5.2	7.9	27.5	38.3	13.8	12.8	7.9	9.4	0.0	9.4	14.8	5.8	20.1	17.4	24.3	19.7	7.7	35.6	27.7	15.7
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family AAA domain containing 3B"	Q5T9A4	1	1471765-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	9.1	10.0	5.7	3.6	5.8	5.0	8.5	5.5	9.7	9.8	5.8	9.1	2.4	7.2	0.0	12.4	9.1	0.7	8.0	5.6	5.6	13.7	15.7	8.6	3.5	5.9	5.5	10.2	9.7	0.4	13.6	1.3	5.9	11.7	0.3	0.1	7.5	0.7	6.2	10.7	9.2	0.5	5.3	14.1	8.7	10.8	6.0	2.3	9.6	0.2	0.7	9.9	8.6	6.1	13.4	0.1	3.2	21.9	1.3	1.4	29.0	20.7	4.8	20.7	15.7	47.8	38.6	16.9	6.7	7.9	13.4	21.8	28.1	13.6	4.7	16.3	29.0	12.2	32.9	31.9	5.3	20.4	14.3	4.7	0.7	35.9	1.5	0.0	7.6	7.1	37.2	3.2	8.1	5.4	26.3	28.7	44.1	9.8	51.7	21.5	6.3	12.0	6.2	7.7	15.6	13.2	14.0	18.7	20.2	2.4	2.4	7.5	7.5	4.5	12.0	32.4	23.0	12.2	18.5	45.7	17.7	35.1	5.8	0.2	0.2	0.4	0.4	1.1	0.5	0.1	0.3	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	5.7	5.8	5.5	9.7	5.6	5.6	5.9	5.5	5.9	5.3	6.0	6.1	8.6	6.4	22.1	17.6	9.4	26.3	7.8	5.2	10.2	16.0	9.3	7.1	5.9	8.6	7.5	9.2	20.9	15.3	12.9	17.8	1.9	7.7	3.6	10.1	7.8	8.2	7.2	7.6	13.3	7.9	40.3	8.7	23.9	10.2	11.4	16.7	4.2	7.6	12.4	13.5	12.9	13.8	6.1	4.7	12.3	3.8	4.4	7.9	10.6	8.4	5.4	5.8	1.0	4.5	8.3	11.3	9.7	3.0	22.8	14.4	6.7	2.6	8.3	17.1	6.6	8.3	10.2	5.4	10.6	11.1	23.4	17.8	9.9	15.0	20.6	10.8
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821162	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	13.8	21.2	4.9	15.8	5.1	14.8	16.8	14.2	7.1	16.7	8.2	18.0	16.0	18.2	13.7	17.0	17.8	16.5	14.6	4.8	7.9	17.4	20.8	15.8	21.5	5.3	5.8	23.1	9.1	19.8	10.1	16.7	5.4	14.3	18.6	11.9	14.5	13.5	32.4	10.4	14.7	16.7	5.4	17.9	14.3	8.6	6.6	29.2	22.7	23.7	21.5	16.5	12.9	6.9	28.6	20.4	21.0	21.4	29.0	30.4	52.2	29.5	50.7	45.7	35.8	41.7	43.7	38.7	47.6	34.5	20.0	22.8	24.9	30.6	47.6	39.0	25.8	42.8	43.1	22.6	56.5	62.3	39.6	33.7	45.7	32.8	52.8	47.6	22.5	27.1	53.2	36.2	33.9	42.4	39.6	37.3	30.0	33.0	32.1	37.5	32.3	45.9	33.6	19.5	27.9	14.9	61.8	26.5	44.7	28.5	37.3	37.6	16.1	32.1	38.2	26.4	24.1	20.2	25.8	63.6	30.9	33.9	15.3	6.6	17.9	42.7	20.2	18.8	23.1	20.2	21.7	24.1	21.1	21.7	26.4	20.4	11.2	20.8	12.7	9.6	28.8	19.1	4.9	5.1	14.2	7.1	4.8	7.9	5.3	5.8	5.4	5.4	6.6	6.9	25.5	54.5	18.5	22.2	41.5	75.3	48.4	34.8	52.3	12.1	26.0	18.5	14.6	15.7	26.7	12.9	0.0	34.6	25.4	23.4	52.8	24.9	9.2	24.6	20.8	23.8	6.0	46.7	25.8	21.1	77.1	33.1	14.3	21.0	10.1	14.1	20.0	16.2	27.5	13.5	29.2	18.7	24.4	25.2	48.4	5.9	32.0	24.2	23.2	16.9	24.6	14.2	27.8	12.5	25.3	22.8	17.9	27.8	22.1	43.7	20.7	34.6	19.9	7.2	39.5	34.1	33.7	10.9	10.3	30.3	54.6	80.6	38.4	20.4	22.8	36.9
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	16.8	20.2	15.6	15.2	17.6	16.4	19.5	23.3	25.7	25.7	4.1	15.1	13.0	21.8	21.6	14.3	18.9	17.8	12.1	19.3	15.5	22.5	27.8	15.4	19.7	16.2	14.9	26.0	18.9	24.0	13.9	20.4	17.2	18.3	15.7	21.8	17.9	17.7	12.5	10.0	13.6	18.1	12.3	17.6	14.3	21.0	13.3	30.2	32.3	23.1	21.1	18.8	13.0	19.8	14.1	12.1	35.1	23.4	30.6	32.3	16.1	22.3	38.1	26.6	38.1	26.6	25.4	21.1	23.9	26.6	31.2	13.3	26.9	13.5	41.2	26.6	15.6	29.3	19.8	58.3	34.4	27.8	29.7	24.4	29.8	34.4	40.5	35.0	37.0	19.4	24.4	31.6	30.1	10.5	45.2	34.4	32.7	23.6	27.2	38.3	16.1	32.5	39.1	11.8	29.3	23.9	27.9	8.6	33.0	28.2	19.3	30.4	23.5	30.8	16.1	16.9	13.6	30.3	48.9	26.9	24.2	26.0	21.2	35.5	16.9	20.1	20.1	15.1	24.3	16.6	17.0	20.9	21.9	14.1	19.6	21.5	10.8	19.8	19.1	12.1	24.4	18.0	15.6	17.6	23.3	25.7	19.3	15.5	16.2	14.9	17.2	12.3	13.3	19.8	43.4	16.0	13.2	47.7	33.5	33.0	15.4	15.6	52.9	22.7	34.0	24.4	22.5	20.0	15.5	23.9	10.4	14.1	37.4	16.5	13.7	12.1	115.4	19.5	30.5	33.8	16.3	20.8	86.6	7.0	13.0	32.2	18.3	28.4	29.8	27.1	17.2	27.0	18.9	40.4	71.3	14.4	18.3	23.3	30.2	153.0	32.6	23.6	30.2	54.4	20.4	32.3	24.7	75.9	84.9	11.9	9.1	28.6	38.8	15.6	11.5	21.6	19.3	27.3	13.1	31.5	33.9	36.3	17.6	30.4	25.3	6.3	32.9	23.7	16.1	13.6
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	12.4	10.4	12.1	16.8	18.8	30.9	14.7	32.8	11.7	12.8	21.7	11.2	8.3	15.6	13.7	14.3	13.4	11.8	16.3	9.9	14.1	11.0	14.4	13.3	28.2	16.9	15.5	17.9	11.5	17.2	8.5	14.2	15.8	13.4	13.0	17.1	20.6	12.0	16.4	16.7	11.9	16.4	11.2	20.8	14.2	33.8	18.8	32.5	21.7	21.2	28.1	12.6	11.4	21.3	23.2	13.8	54.3	31.7	27.9	35.2	11.4	24.4	13.7	18.8	28.6	31.4	23.9	38.5	16.2	16.6	34.3	23.0	34.3	22.4	42.3	27.5	20.1	25.8	23.3	6.5	16.6	17.7	15.1	19.0	18.3	23.2	23.9	29.3	41.5	13.6	15.6	19.7	29.9	21.7	25.5	15.4	35.1	11.9	12.7	52.3	60.3	21.0	16.2	44.6	17.4	14.2	27.7	16.0	15.4	44.0	16.2	20.5	19.2	26.3	16.7	14.9	20.3	13.2	13.9	53.1	16.7	16.5	29.0	29.2	11.6	19.4	16.2	8.3	16.8	23.1	13.6	16.0	9.8	30.9	10.9	15.5	17.8	11.4	14.2	12.9	18.7	11.0	12.1	18.8	32.8	11.7	9.9	14.1	16.9	15.5	15.8	11.2	18.8	21.3	46.6	67.3	42.5	67.9	121.2	6.6	12.8	9.7	75.1	50.2	31.6	24.6	73.0	20.0	26.6	35.0	68.8	17.2	112.1	13.2	7.9	16.6	79.6	31.1	34.7	40.3	28.1	55.1	62.6	12.2	10.9	32.0	41.8	31.9	25.9	34.8	30.0	31.3	20.5	63.9	73.9	19.6	10.2	48.4	11.2	19.6	29.2	46.3	5.4	107.7	47.9	23.5	64.9	136.7	147.9	14.5	13.5	29.3	85.9	13.6	12.0	16.4	24.3	39.8	13.1	40.0	33.3	42.4	25.0	62.7	6.7	15.5	98.5	35.1	18.3	12.1
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814406-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 136.8;lymphoid tissue: 129.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 45.4;neutrophil: 59.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	20.2	18.1	18.1	33.0	19.2	136.8	14.9	20.2	24.1	21.6	16.2	20.4	10.8	14.6	7.5	26.1	22.1	18.9	20.8	18.0	16.0	20.1	18.5	41.2	34.3	18.9	17.7	23.4	15.1	6.3	13.7	10.2	18.0	14.4	17.0	2.9	13.6	8.2	7.7	72.9	34.0	15.0	15.3	129.0	17.7	6.5	21.1	9.7	15.9	7.4	25.2	18.9	22.2	20.9	2.7	2.5	7.5	5.9	8.7	7.2	4.6	6.1	5.9	2.9	4.4	3.1	6.4	18.3	4.0	7.7	5.3	5.2	0.9	20.1	5.0	14.2	3.0	14.5	14.4	5.1	6.4	18.8	58.2	6.9	2.7	6.6	8.0	32.2	9.0	32.7	1.9	24.1	3.4	9.1	22.5	32.0	1.1	12.0	2.9	10.6	5.5	8.6	9.7	9.2	5.5	4.4	2.6	13.2	5.8	5.9	6.6	25.5	12.6	7.9	2.9	14.4	5.0	11.0	2.9	8.1	3.5	16.4	4.5	5.9	16.3	45.4	2.7	9.3	2.7	2.6	3.9	5.4	10.9	4.6	2.2	2.6	59.6	5.2	11.8	1.7	4.0	4.0	18.1	19.2	20.2	24.1	18.0	16.0	18.9	17.7	18.0	15.3	21.1	20.9	19.5	6.4	14.4	11.4	37.6	16.7	5.1	6.1	10.2	3.6	8.7	9.0	5.0	4.3	6.2	5.5	2.1	9.6	29.0	13.0	0.0	5.0	0.8	8.9	12.0	12.7	13.1	9.9	14.0	1.0	3.7	7.1	17.9	7.9	22.9	10.6	18.9	3.8	16.2	5.0	11.1	9.1	8.2	48.5	18.1	2.1	10.2	45.7	3.6	23.4	39.2	4.4	30.9	18.1	9.7	2.7	59.1	7.9	17.3	2.5	8.3	2.5	8.1	3.5	0.0	8.8	11.4	4.9	13.4	15.7	17.3	12.3	21.3	7.2	14.0	6.0
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 264.4;Late spermatids: 728.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		58000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	30.6	18.1	11.6	17.9	16.6	13.2	22.1	14.9	12.6	23.0	22.0	26.0	9.9	24.3	16.5	24.5	20.1	15.9	11.5	9.8	13.9	12.6	17.7	18.8	12.6	19.8	16.4	16.9	15.4	13.3	6.6	14.9	18.9	16.7	16.6	4.0	15.4	20.4	6.3	25.2	13.7	33.2	16.8	16.9	17.4	36.9	15.5	10.8	20.9	9.6	15.4	27.1	19.4	20.6	44.2	39.4	11.7	28.4	59.2	82.5	0.2	53.2	60.0	51.9	35.0	32.9	69.7	26.3	53.8	93.6	40.0	28.3	21.8	34.8	69.8	40.4	5.8	27.9	41.8	0.2	40.7	53.2	39.2	54.0	55.6	69.1	42.8	34.7	56.3	28.5	30.6	70.2	59.6	46.6	19.2	30.7	14.9	14.1	33.7	40.7	29.3	37.8	41.2	29.7	6.3	17.0	174.3	37.6	50.5	14.5	65.7	19.1	79.1	109.0	51.9	105.3	38.3	19.0	29.6	51.4	57.7	33.6	67.1	7.1	8.3	3.7	8.9	11.4	9.8	5.3	7.4	7.3	8.6	4.2	5.9	8.2	3.5	6.9	13.4	4.3	9.3	7.8	11.6	16.6	14.9	12.6	9.8	13.9	19.8	16.4	18.9	16.8	15.5	20.6	56.7	44.8	27.2	16.6	18.8	43.7	45.7	36.4	30.1	4.8	31.9	18.4	8.5	30.0	29.9	33.1	0.0	6.7	28.5	45.2	1.9	41.2	264.4	23.8	46.4	48.2	10.7	29.5	13.5	50.2	20.1	46.2	19.4	63.8	17.1	20.3	49.6	51.3	37.6	5.0	12.1	21.0	28.5	55.3	43.0	728.4	54.3	35.7	42.7	16.9	49.5	12.6	24.7	16.6	35.6	72.7	24.7	67.4	21.0	55.3	27.7	24.7	21.5	8.5	72.3	35.9	55.2	36.0	29.0	32.9	40.6	4.0	28.2	25.6	19.8	50.9
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	125.2	148.3	71.7	33.7	60.1	6.9	120.6	94.2	120.0	143.8	14.5	155.4	36.3	146.4	25.5	71.9	148.9	43.2	94.2	66.8	75.7	95.5	42.7	109.0	20.4	81.3	70.6	234.6	79.6	56.7	188.9	43.8	60.0	117.6	21.1	58.8	89.8	59.5	81.9	79.2	82.0	49.4	41.2	74.2	100.4	33.3	71.5	16.3	189.0	34.4	14.0	122.2	108.8	67.4	56.4	72.1	75.9	154.7	69.6	61.7	126.3	65.5	55.4	65.1	45.8	73.6	65.6	15.2	20.4	80.8	54.1	36.8	46.2	63.8	33.3	178.0	46.3	70.6	71.7	35.6	108.3	14.6	103.8	101.8	46.1	82.4	63.6	112.5	64.4	22.4	61.1	29.9	58.2	81.2	31.9	13.5	156.0	26.2	30.1	65.9	40.6	11.2	48.3	78.3	23.4	75.3	66.5	77.2	47.1	73.6	29.5	40.3	85.2	76.7	97.9	61.1	102.2	22.7	8.1	10.7	60.1	18.7	82.3	0.5	0.1	0.7	0.6	0.0	0.5	0.7	0.2	0.3	0.1	0.5	0.3	0.4	0.0	0.1	0.0	0.5	0.3	0.2	71.7	60.1	94.2	120.0	66.8	75.7	81.3	70.6	60.0	41.2	71.5	67.4	66.3	16.0	17.2	76.4	9.1	30.2	13.5	22.9	30.1	26.6	51.5	57.4	16.4	24.3	20.4	29.5	18.8	27.4	11.4	37.4	15.6	20.5	2.3	39.9	61.2	40.7	21.7	4.8	23.8	30.3	15.3	30.9	34.7	51.7	10.1	37.1	39.7	8.0	11.9	25.2	29.7	23.0	8.2	10.9	21.0	3.5	63.6	13.7	21.4	23.4	4.8	17.3	3.1	17.6	18.2	29.9	25.3	52.6	9.5	17.4	24.2	12.1	15.4	23.9	19.7	29.4	39.5	9.7	7.7	22.1	24.9	37.1	10.9	26.2	20.4	17.9
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57906039-57959148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 12.7;Cytotrophoblasts: 14.4;Distal tubular cells: 17.6;Extravillous trophoblasts: 15.2;Proximal tubular cells: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.0;Karpas-707: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	7.5	4.9	0.6	0.4	0.5	0.1	5.6	0.6	0.9	4.1	0.5	8.1	0.2	3.1	0.0	5.6	3.2	0.0	4.6	1.0	0.3	4.0	5.2	2.6	0.1	0.4	0.2	3.1	5.9	0.0	2.8	0.1	0.4	3.3	0.0	0.5	3.6	0.0	12.4	4.4	4.3	0.0	0.3	3.2	4.2	27.8	0.5	0.0	3.5	0.0	0.1	4.7	4.0	0.3	0.6	1.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.9	0.2	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.6	2.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.8	0.1	0.0	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.3	0.2	0.2	1.6	0.1	0.1	0.1	0.1	0.0	0.6	0.5	0.6	0.9	1.0	0.3	0.4	0.2	0.4	0.3	0.5	0.3	8.0	0.0	9.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	7.4	12.7	0.0	0.0	1.8	3.7	0.0	14.4	4.2	0.0	17.6	6.1	0.0	5.6	4.9	2.8	0.0	0.0	0.0	10.7	15.2	2.3	0.0	6.0	11.4	6.8	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	26.1	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	3.4	3.0	9.5	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56645984	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2590.4;tongue: 3205.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 821.1;Distal tubular cells: 1238.5;Extravillous trophoblasts: 592.7;Hofbauer cells: 608.9;Proximal tubular cells: 951.7;Syncytiotrophoblasts: 1138.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		19000000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	432.7	555.5	217.6	300.5	231.4	465.8	301.5	281.6	303.8	241.8	443.3	741.6	689.5	235.4	223.4	527.6	277.9	225.7	2011.6	233.0	307.1	945.9	609.3	253.4	294.6	264.2	242.9	200.2	301.7	1311.6	252.6	301.4	280.4	280.9	767.6	484.2	407.7	356.4	2590.4	398.6	575.5	332.5	230.9	272.5	494.9	236.0	277.5	390.9	342.8	3205.3	458.3	404.1	311.2	244.7	693.6	834.9	632.3	1003.6	578.3	596.7	1159.8	683.2	645.6	1179.1	663.9	1375.7	755.6	1236.3	723.0	863.5	482.9	906.1	1378.1	851.5	1039.4	579.9	987.5	1333.1	726.4	872.5	716.6	1509.7	912.9	755.1	843.3	918.0	1171.2	870.2	985.8	901.7	1246.3	1363.1	992.2	671.5	1134.4	941.3	1085.9	905.6	1637.6	1079.3	711.0	1603.5	1315.6	1196.7	737.5	658.2	1042.3	1481.3	1214.0	663.4	1404.1	1151.8	657.6	454.8	507.9	671.9	751.0	659.5	865.7	1254.8	684.7	1007.8	718.4	403.5	549.4	281.8	293.5	643.6	326.3	303.2	275.4	313.6	713.4	248.4	221.0	266.8	137.1	296.9	750.6	360.9	372.9	1077.1	217.6	231.4	281.6	303.8	233.0	307.1	264.2	242.9	280.4	230.9	277.5	244.7	172.3	134.6	173.2	0.0	48.6	0.0	0.0	0.0	0.0	0.0	176.8	149.1	0.0	0.0	81.1	277.7	0.0	821.1	141.5	0.0	1238.5	517.7	0.0	194.1	169.2	115.7	0.0	0.0	0.0	367.9	592.7	115.0	0.0	163.3	145.1	267.6	0.0	0.0	608.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	281.2	0.0	0.0	0.0	0.0	333.3	0.0	0.0	26.8	0.0	0.0	951.7	102.7	0.0	0.0	0.0	151.1	0.0	0.0	0.0	0.0	1138.6	77.4	518.4	0.0	0.0
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 1035.0;Endometrial ciliated cells: 1524.2;Exocrine glandular cells: 672.1;Granulosa cells: 1030.6;Proximal tubular cells: 1502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	96.9	215.1	98.4	50.6	98.6	144.3	108.8	95.6	140.0	123.3	95.2	234.8	163.1	113.0	44.5	184.5	139.4	28.0	585.8	100.0	106.5	384.9	342.6	116.0	64.5	99.6	96.8	134.9	163.4	90.1	246.5	37.6	97.8	156.0	59.4	71.0	145.3	37.1	456.7	165.0	199.6	28.5	93.7	153.7	215.7	355.5	99.6	60.0	169.2	179.8	47.9	116.6	134.0	104.1	271.9	136.4	79.3	75.1	58.0	62.7	94.1	118.6	57.9	98.6	96.2	132.0	192.5	189.1	173.8	72.1	37.6	161.5	91.2	118.0	77.6	143.9	306.0	162.9	612.7	180.8	62.9	125.5	158.1	73.5	190.2	88.2	70.4	96.2	95.7	222.0	292.9	167.9	71.2	178.0	187.6	230.4	262.7	100.9	167.8	177.3	87.5	270.2	196.9	175.5	158.9	114.2	146.5	150.8	160.4	76.5	224.4	136.6	100.6	31.9	88.0	126.5	142.1	432.0	282.8	268.6	151.1	338.8	38.1	133.3	116.6	126.1	144.2	111.1	145.8	195.2	154.3	155.5	142.8	154.0	144.1	139.3	102.7	142.9	102.7	213.5	226.9	214.1	98.4	98.6	95.6	140.0	100.0	106.5	99.6	96.8	97.8	93.7	99.6	104.1	207.3	205.1	284.9	0.0	61.7	0.0	0.0	0.0	0.0	0.0	251.1	314.3	0.0	0.0	150.4	546.2	0.0	453.8	165.4	0.0	1035.0	396.6	0.0	1524.2	210.6	84.0	0.0	0.0	0.0	672.1	226.0	114.6	0.0	453.2	172.8	1030.6	0.0	0.0	372.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.6	0.0	0.0	123.0	0.0	0.0	0.0	0.0	550.3	0.0	0.0	30.3	0.0	0.0	1502.7	621.6	0.0	0.0	0.0	90.6	0.0	0.0	0.0	0.0	251.7	92.0	281.6	0.0	0.0
ATPAF2	"ATP12, Atp12p, LP3663, MGC29736"	ENSG00000171953	"ATP synthase mitochondrial F1 complex assembly factor 2"	Q8N5M1	17	17977409-18039209	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 104.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023329, HPA059422"	Supported		Enhanced	Cytosol		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023329: AB_1845209, HPA059422: AB_2684011"	"unprognostic (3.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.00e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.15e-1)"	"unprognostic (2.62e-2)"	8.6	18.5	7.4	8.6	7.6	15.9	8.7	8.3	11.1	8.4	8.3	11.1	8.7	6.8	8.7	14.4	8.1	4.9	23.9	7.5	9.1	16.1	19.7	7.8	10.5	7.9	8.1	7.3	9.8	26.3	9.3	7.7	8.4	9.1	10.4	6.4	10.7	6.6	24.7	14.6	10.2	8.4	7.8	10.4	12.0	10.9	7.8	10.8	10.6	27.8	14.5	9.1	9.5	8.4	13.0	24.1	15.4	14.7	15.1	16.2	15.6	11.2	16.4	23.7	20.1	31.8	19.3	26.0	24.6	19.5	13.1	19.9	14.8	24.1	20.7	20.9	11.7	5.8	14.8	18.6	25.5	8.2	17.3	19.5	16.8	21.4	11.9	16.7	27.4	21.3	9.3	8.9	13.1	26.8	19.4	12.8	10.4	48.3	13.3	19.8	27.1	29.9	19.0	11.4	9.9	13.5	14.9	7.6	14.0	104.2	24.4	16.2	11.6	6.0	12.4	22.2	10.9	6.2	8.4	9.6	10.7	11.9	31.4	7.8	41.5	14.7	9.3	28.6	10.4	27.9	6.9	8.9	49.2	19.7	10.7	8.0	3.0	8.9	22.3	41.6	12.9	20.7	7.4	7.6	8.3	11.1	7.5	9.1	7.9	8.1	8.4	7.8	7.8	8.4	8.8	6.4	7.8	9.4	20.3	15.3	12.0	23.7	9.6	10.5	13.9	10.8	28.2	20.0	14.4	12.9	33.3	32.5	20.7	10.9	66.5	19.3	52.9	10.5	6.0	10.0	14.5	13.7	13.7	12.3	30.9	9.1	8.2	8.5	13.3	25.7	9.3	20.8	45.5	10.1	14.1	18.2	16.2	22.3	22.5	42.6	6.5	18.2	17.8	7.5	28.1	13.8	13.4	9.0	9.6	16.0	24.4	6.8	18.6	13.8	25.8	58.8	17.2	17.7	0.0	8.4	10.4	28.2	20.9	17.6	18.9	28.7	9.0	15.9	20.5	12.3
ATXN1L	BOAT1	ENSG00000224470	"Ataxin 1 like"	P0C7T5	16	71845976-71885268	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 263.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062596, HPA062789"			Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA062596: AB_2684802, HPA062789: AB_2684868"	"unprognostic (1.51e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.33e-8)"	"unprognostic (1.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (8.42e-4)"	14.0	8.0	11.5	9.9	12.7	39.5	10.9	9.0	9.7	11.1	5.6	10.4	8.2	12.3	7.3	9.7	10.9	9.0	9.5	9.3	9.4	18.7	6.6	12.0	10.0	10.9	11.7	12.7	12.5	16.5	5.2	10.8	10.3	8.1	9.2	8.0	9.4	10.4	10.4	12.1	9.4	12.9	10.3	11.8	10.0	12.2	12.5	12.8	11.9	13.7	10.5	8.9	7.4	11.9	11.8	15.7	15.7	11.5	18.1	8.9	18.4	9.8	10.8	17.4	13.2	22.6	12.9	13.2	15.0	15.4	8.0	20.3	13.4	14.9	18.9	3.6	11.9	9.7	17.7	15.9	13.5	11.9	19.0	12.8	18.6	19.8	14.2	11.4	16.0	17.0	11.1	10.2	10.4	33.6	20.2	11.7	14.3	9.3	7.4	21.4	15.9	15.8	12.1	16.4	8.3	14.2	19.5	10.2	11.9	16.4	16.0	12.5	19.4	19.0	19.9	12.1	13.3	23.0	20.8	30.7	11.8	7.9	16.3	0.6	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.4	0.2	0.2	0.5	0.5	0.4	0.4	0.2	0.1	0.7	0.3	11.5	12.7	9.0	9.7	9.3	9.4	10.9	11.7	10.3	10.3	12.5	11.9	11.1	0.0	10.6	4.2	14.9	22.8	15.3	11.4	14.2	11.2	16.0	10.2	15.7	14.3	9.5	14.7	14.6	8.3	19.9	15.2	17.6	11.9	44.2	19.1	15.0	14.2	7.8	5.7	6.8	11.8	7.9	11.0	5.6	35.4	12.7	8.0	14.3	12.3	8.5	15.2	5.7	8.7	8.2	14.3	25.2	263.0	14.9	11.8	12.4	5.6	16.9	6.3	29.9	3.5	9.1	14.4	19.6	12.8	16.0	18.3	13.3	15.8	9.9	17.2	13.1	15.5	14.3	22.4	21.1	13.1	24.9	11.5	15.8	8.0	10.6	28.4
ATXN2	"ATX2, SCA2, TNRC13"	ENSG00000204842	"Ataxin 2"	Q99700	12	111443485-111599676	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 209.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018295, HPA020339, HPA021146"	Enhanced		Enhanced	Cytosol		NA	NA		9600	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132"	"unprognostic (3.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (2.34e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-2)"	19.6	23.5	20.5	11.2	21.9	8.0	17.5	22.8	30.3	21.6	20.8	22.8	11.2	21.7	13.9	14.2	20.4	12.0	22.2	20.5	29.9	17.5	20.1	19.7	9.5	25.2	26.0	25.9	13.8	18.6	21.9	16.3	24.5	19.4	11.6	15.7	14.5	15.6	25.8	15.6	14.9	18.3	18.6	14.1	16.3	23.2	22.7	12.8	17.1	20.8	8.9	19.6	18.3	25.8	31.0	38.0	30.3	38.2	35.9	29.0	29.4	35.8	25.9	28.8	23.4	25.2	25.7	25.8	14.2	47.7	23.8	25.5	45.0	18.2	36.0	23.3	33.9	38.2	22.8	42.4	49.7	27.1	21.4	32.4	20.1	38.0	42.6	48.0	27.8	20.2	46.8	13.1	37.2	24.7	23.2	24.2	30.1	19.4	24.6	21.8	18.6	19.2	30.1	34.5	28.7	25.2	38.5	49.3	24.7	29.1	30.9	16.5	34.9	36.9	21.6	30.4	20.6	23.4	30.0	22.5	19.0	20.9	23.5	4.5	3.6	5.8	3.9	3.4	5.2	5.1	4.9	5.3	5.0	2.7	4.1	3.6	3.5	5.6	6.4	2.7	2.2	2.8	20.5	21.9	22.8	30.3	20.5	29.9	25.2	26.0	24.5	18.6	22.7	25.8	43.0	80.1	72.6	175.3	26.7	35.3	34.3	18.4	35.9	101.0	33.6	26.3	36.6	30.0	36.6	36.8	135.5	32.5	28.9	25.6	3.9	26.0	11.1	87.2	72.2	43.9	41.4	34.9	146.7	25.3	25.4	40.0	23.9	50.3	23.5	67.2	63.5	38.1	24.5	65.6	171.8	26.7	24.4	35.9	35.9	11.9	65.6	30.6	32.0	106.8	35.1	32.6	48.4	128.7	209.6	32.6	16.0	47.4	24.2	43.0	22.7	16.9	56.0	90.4	32.9	41.5	46.6	78.0	70.7	25.7	35.2	46.9	27.4	68.7	31.5	42.2
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478"	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	67.8	78.2	80.2	51.6	86.2	82.9	65.3	89.9	116.8	83.3	72.7	75.6	43.8	71.3	20.9	81.9	77.8	29.2	68.8	82.2	82.2	85.7	96.1	85.9	62.7	83.2	80.4	81.3	96.8	33.7	116.4	39.0	83.4	80.6	27.0	56.5	70.1	27.9	63.8	76.9	86.3	33.4	75.5	117.0	82.6	178.9	83.5	52.5	83.0	23.7	46.9	75.5	77.7	86.0	77.8	97.6	99.0	112.1	59.9	61.5	116.1	76.3	73.7	82.1	91.3	124.1	90.1	178.6	95.4	54.4	128.6	110.2	93.9	76.9	90.5	140.9	83.3	119.5	124.3	127.4	107.5	135.9	161.2	78.8	90.1	116.4	166.1	72.4	73.2	174.4	158.9	219.9	68.4	109.9	166.1	228.0	100.6	46.9	67.2	216.4	68.5	125.6	48.9	79.6	102.8	81.9	44.6	83.5	95.8	62.3	91.3	141.0	88.2	101.2	83.6	65.8	106.2	311.9	238.1	159.4	76.3	128.1	119.6	0.4	2.1	1.4	1.6	1.9	1.6	4.3	1.9	2.0	1.6	2.9	1.8	2.3	2.4	1.9	1.6	5.6	1.7	1.1	80.2	86.2	89.9	116.8	82.2	82.2	83.2	80.4	83.4	75.5	83.5	86.0	30.2	28.9	33.3	26.1	48.2	36.6	25.1	20.2	66.0	31.6	29.8	26.3	2.1	21.5	19.8	20.2	45.9	23.0	39.1	19.8	1.9	17.8	71.7	37.7	34.9	27.8	24.6	23.1	37.3	20.2	21.9	20.8	31.6	53.1	25.9	23.4	27.1	14.7	24.8	26.9	37.5	23.4	14.2	29.3	33.3	25.7	21.5	36.5	8.8	24.4	26.4	10.0	33.0	18.6	31.5	32.2	19.4	19.9	65.1	33.0	19.7	4.8	18.8	48.9	13.1	28.9	22.1	83.9	28.3	46.3	31.1	34.3	48.4	24.5	23.4	27.4
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"bone marrow: 1578.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.5;Breast myoepithelial cells: 4.6;Endometrial ciliated cells: 8.9;Erythroid cells: 8.8;Respiratory ciliated cells: 4.5;Skeletal myocytes: 5.7;Spermatogonia: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in some"	15	"THP-1: 659.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		320000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.8	0.2	0.4	0.0	0.4	1578.1	1.5	0.2	0.9	0.2	0.2	0.2	0.0	0.5	0.0	0.1	1.4	0.0	2.0	0.4	0.3	0.4	2.8	15.9	0.6	0.3	0.3	0.2	0.2	0.0	0.9	0.9	0.4	0.4	0.0	0.0	2.6	0.0	0.5	0.6	0.2	0.0	0.2	33.1	0.2	2.4	0.4	3.1	0.5	0.0	0.0	0.3	0.2	0.3	1.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	44.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	0.6	659.5	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.6	0.0	34.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.2	0.9	0.4	0.3	0.3	0.3	0.4	0.2	0.4	0.3	3.5	0.0	0.0	0.0	0.6	0.0	0.1	1.2	0.0	0.0	4.5	4.6	0.7	0.0	0.5	0.0	0.0	0.2	2.8	0.6	0.0	0.1	0.0	8.9	1.2	1.0	0.0	8.8	0.8	0.0	0.3	0.8	0.0	2.3	0.0	0.1	0.0	0.4	3.2	0.0	1.4	0.4	0.0	3.7	0.4	0.7	0.0	3.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.0	4.5	0.0	0.0	5.7	1.2	0.1	6.4	0.9	0.1	0.0	1.0	0.0	0.6	0.0
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711487-44718851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	Immunity		"Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 31919.3;NK-cells: 24726.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	1790000000	2100000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	3160.2	3214.7	697.6	5686.5	705.1	7839.2	2606.9	711.8	1145.0	2539.9	789.6	5139.0	5180.7	2192.2	1735.6	2283.9	1648.3	4948.8	2327.2	651.0	769.9	2462.6	6206.2	6159.2	9311.8	889.5	763.2	1945.7	1310.9	1940.5	318.4	3502.0	815.3	2345.0	5593.5	139.3	5657.1	1784.5	931.7	3015.6	5693.3	2545.3	838.3	7896.1	4878.2	615.6	771.9	4217.4	2340.8	2026.5	5333.4	5753.1	549.4	909.5	1735.4	378.9	226.0	633.6	4348.7	4719.4	1662.5	2045.5	4961.9	3609.7	6561.4	425.3	5417.9	554.8	2567.9	1948.8	2410.2	2537.0	497.2	878.7	1226.2	4762.2	435.9	2956.9	2263.6	600.3	3609.3	2074.5	3328.6	2735.9	609.8	1075.7	1044.4	2442.6	1884.1	965.4	611.9	3649.1	2195.5	476.9	1518.4	3213.8	206.5	629.8	1014.3	2240.2	1926.6	4789.2	2425.5	3486.4	254.1	179.1	1288.4	1571.2	1338.5	394.3	655.3	6180.6	2548.7	4531.4	676.5	5389.2	2193.3	4771.7	7118.6	1683.1	5384.6	3783.6	2567.3	48105.4	18117.1	33178.9	20639.1	17775.0	20836.8	15768.0	23783.0	22245.1	9978.8	11988.4	17122.9	22791.8	50453.6	18779.6	19034.9	12052.6	29659.1	56957.2	697.6	705.1	711.8	1145.0	651.0	769.9	889.5	763.2	815.3	838.3	771.9	909.5	12048.3	3387.8	3505.1	28.7	8472.8	7843.7	3197.1	8420.8	1628.8	33.3	2399.5	2015.2	1068.8	3593.1	5347.4	2100.3	27.1	1354.6	14028.8	8753.6	1038.9	13898.6	43.1	2073.7	2414.0	8385.6	2266.0	2087.2	7.3	9034.5	4397.5	3691.1	1981.7	2282.2	3029.5	1270.6	6835.7	3832.6	11985.7	5.0	22.0	5982.6	8701.4	12536.8	14507.0	158.8	3018.0	10687.9	6744.8	368.2	31919.3	322.0	24726.3	95.0	129.2	10115.7	7085.6	1688.8	11026.6	5300.4	18327.7	3122.5	8367.9	52.5	4016.7	2055.2	4107.1	64.2	72.1	1541.4	8619.8	804.8	14266.2	3229.8	3063.4	8248.6
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134412242	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 195.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 27.4;Bipolar cells: 37.0;Excitatory neurons: 37.2;Inhibitory neurons: 30.4;Muller glia cells: 116.2;Oligodendrocyte precursor cells: 33.2;Oligodendrocytes: 77.8"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.1;HMC-1: 25.3;NTERA-2: 22.1;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	0.2	4.2	146.6	0.4	135.6	1.0	3.9	114.3	195.2	0.4	32.5	0.9	0.5	1.4	0.2	0.2	0.4	0.3	0.3	191.8	85.5	1.8	5.8	0.6	2.1	133.6	145.2	0.2	0.4	0.0	4.5	0.1	118.9	2.8	0.1	23.8	1.2	0.4	0.1	0.5	0.6	0.1	115.0	1.4	34.9	0.9	133.6	0.4	6.2	0.2	0.4	0.7	0.3	176.0	0.0	0.0	23.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.9	0.0	0.9	1.2	1.6	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.1	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.1	22.1	1.1	0.0	0.4	0.0	1.7	0.0	0.1	3.1	8.4	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	2.3	0.1	0.0	0.1	0.0	0.1	0.2	0.1	5.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	146.6	135.6	114.3	195.2	191.8	85.5	133.6	145.2	118.9	115.0	133.6	176.0	0.1	0.0	0.0	27.4	0.1	0.0	0.0	0.0	0.0	37.0	1.2	0.8	1.1	2.8	0.0	0.0	4.2	0.0	14.4	0.1	0.0	0.0	1.8	0.1	0.1	0.4	1.8	0.4	37.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	4.7	0.1	23.5	30.4	0.0	0.0	0.3	0.0	3.9	0.0	0.2	0.0	3.7	0.0	116.2	15.5	33.2	77.8	0.0	0.0	0.4	7.5	0.9	0.0	1.9	0.0	8.6	0.0	0.1	0.2	0.2	0.8	0.0	0.0	0.1	3.8	0.0	0.0	0.3
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 333.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 215.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 346.6;SiHa: 635.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		97000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	52.4	39.2	5.6	43.9	5.1	80.2	91.1	7.3	6.4	64.9	17.9	38.0	21.9	35.7	35.7	49.7	49.3	47.8	55.4	5.4	6.8	42.1	89.4	50.1	33.3	8.6	6.4	77.4	43.9	77.1	21.2	52.9	7.7	38.8	34.3	26.2	70.3	34.0	30.9	35.8	28.1	55.2	8.1	39.7	52.1	38.3	8.3	26.8	60.8	16.7	41.2	79.4	44.9	9.4	99.1	71.8	13.1	18.1	64.9	113.7	235.9	100.6	125.7	59.5	58.8	44.0	112.1	37.8	62.4	147.3	77.2	51.9	13.7	124.5	59.4	346.6	13.6	21.6	277.6	34.1	127.4	17.9	35.0	128.0	218.1	68.0	82.2	127.6	64.0	11.5	24.9	45.5	57.0	86.1	16.3	35.4	8.1	54.1	21.8	21.0	12.2	25.1	177.0	84.6	9.8	12.7	635.5	122.2	25.8	40.4	154.8	32.3	59.9	42.2	49.4	137.2	39.8	7.6	17.9	23.3	131.0	24.2	15.8	30.6	33.2	20.3	45.2	30.5	59.2	87.1	30.4	40.7	23.3	69.9	17.9	23.3	96.5	72.4	24.8	215.3	22.0	24.0	5.6	5.1	7.3	6.4	5.4	6.8	8.6	6.4	7.7	8.1	8.3	9.4	104.4	86.6	71.9	3.3	112.0	141.9	53.0	59.2	75.7	3.8	215.8	66.7	37.2	88.6	59.5	167.3	20.9	94.9	206.2	146.1	15.6	78.2	21.9	108.6	39.7	60.6	8.4	12.8	4.1	125.9	155.8	99.9	80.0	163.7	36.8	19.6	91.1	195.4	53.9	0.0	4.5	64.0	24.4	82.3	333.3	11.1	50.7	129.0	96.0	33.7	31.3	7.7	39.1	3.0	1.0	157.8	57.4	44.4	116.4	89.0	23.9	57.7	33.8	40.1	52.6	80.0	50.8	6.4	13.8	86.1	108.4	173.9	92.7	33.9	41.6	93.2
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267376-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 47: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	45.8	54.1	51.9	40.0	55.4	70.4	46.8	44.7	66.7	49.9	39.4	60.6	41.6	50.3	28.7	48.3	44.5	28.9	72.1	58.3	53.9	53.3	55.3	42.8	55.4	50.4	51.5	44.2	49.9	46.8	32.2	46.7	54.1	48.0	36.3	26.4	50.2	37.1	134.1	46.1	50.6	37.3	44.0	60.7	54.2	41.6	51.4	51.3	37.3	96.9	51.3	49.2	43.4	54.7	126.8	69.5	68.8	66.0	72.9	51.9	154.9	73.5	96.0	143.2	142.1	78.2	146.5	87.8	172.1	102.2	64.9	61.2	79.7	102.2	89.1	127.5	130.9	78.6	91.6	99.0	60.4	142.4	96.0	79.6	68.3	96.4	56.1	79.3	122.5	123.9	132.9	101.1	103.3	104.1	138.7	135.8	182.0	106.3	147.0	95.5	92.2	119.4	104.1	62.1	66.3	120.3	90.5	92.8	84.6	77.2	81.4	115.2	91.7	87.8	55.7	108.8	124.3	133.1	172.5	119.7	125.6	187.0	85.5	201.3	154.3	167.7	132.9	148.1	128.3	141.9	121.7	129.2	161.3	143.4	111.8	109.9	37.9	114.3	147.8	134.3	180.2	214.1	51.9	55.4	44.7	66.7	58.3	53.9	50.4	51.5	54.1	44.0	51.4	54.7	40.8	12.8	29.7	11.1	45.0	34.9	41.5	63.4	19.4	21.9	53.9	60.7	37.8	41.5	44.9	35.0	14.6	172.4	51.0	51.1	101.8	70.1	65.8	18.4	30.4	39.9	43.8	78.5	18.6	72.4	155.4	41.4	26.0	28.1	46.3	54.3	40.0	50.4	98.7	16.8	16.2	60.6	48.8	46.8	45.6	106.3	36.7	43.2	65.8	8.4	80.4	35.3	68.0	8.5	12.3	69.8	63.8	44.4	51.7	44.6	68.1	89.3	23.5	18.5	39.5	34.7	52.5	57.8	74.2	27.9	41.3	158.0	46.4	43.0	64.7	45.5
BAD	"BBC2, BCL2L8"	ENSG00000002330	"BCL2 associated agonist of cell death"	Q92934	11	64269830-64284704	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004205, HPA028185, HPA062105"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-2)"	60.8	85.1	94.0	13.2	91.1	23.3	58.8	89.0	133.1	64.9	86.6	81.7	26.5	64.8	12.7	72.9	58.8	15.5	118.0	93.1	87.8	87.6	96.1	58.7	14.7	93.4	92.7	55.2	53.7	35.6	55.3	21.7	89.4	79.7	15.1	17.2	57.7	27.6	50.7	70.6	44.7	14.0	89.9	45.0	87.1	55.1	98.9	17.2	75.8	15.1	12.4	65.9	57.7	92.7	95.0	85.1	25.2	38.3	30.0	36.4	36.9	38.2	45.9	60.0	47.5	54.8	53.1	19.5	67.7	37.4	46.9	49.9	16.8	62.7	11.9	77.6	58.7	24.9	81.4	26.1	45.9	20.7	45.0	35.3	53.7	45.8	28.3	45.9	37.5	44.1	10.1	42.9	26.6	94.7	49.8	49.7	9.8	27.7	109.6	46.7	13.8	57.9	36.8	44.3	51.2	67.1	39.2	46.8	49.9	9.6	70.5	32.0	30.3	72.8	48.1	112.8	43.8	79.6	64.0	21.3	59.2	15.6	40.6	88.0	69.7	102.3	52.9	56.7	54.7	58.6	55.4	51.9	50.5	57.5	39.8	40.9	92.4	59.5	55.3	94.0	71.8	51.4	94.0	91.1	89.0	133.1	93.1	87.8	93.4	92.7	89.4	89.9	98.9	92.7	56.3	32.1	45.1	7.8	32.9	103.1	54.1	170.2	51.2	67.7	76.7	74.8	51.6	70.1	66.4	53.3	18.8	162.5	32.4	214.4	137.0	101.2	43.5	71.5	64.8	56.8	104.1	69.2	10.4	109.9	197.8	75.3	53.0	45.4	24.1	58.2	62.4	51.0	73.8	47.1	7.5	141.8	89.5	24.1	72.6	93.3	74.3	32.9	110.3	2.8	52.4	95.9	36.0	4.0	8.9	120.7	210.0	85.4	33.2	62.1	138.1	152.8	83.2	52.0	59.2	36.2	72.6	69.5	25.0	57.7	119.1	255.0	36.0	57.8	117.1	63.4
BAG6	"BAT3, D6S52E, G3, Scythe"	ENSG00000204463	"BAG cochaperone 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 261.8;Late spermatids: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		26000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	70.1	77.3	10.4	18.1	11.5	24.1	67.7	11.9	10.8	68.0	23.3	69.2	38.1	72.2	26.3	73.6	67.0	15.2	96.3	11.3	12.3	58.1	65.4	71.3	24.6	12.9	11.8	76.0	64.1	23.9	65.4	21.8	13.3	62.2	24.8	16.0	70.7	12.3	204.6	84.2	76.4	17.4	10.0	76.4	65.3	136.8	13.4	23.1	74.6	51.8	28.0	69.8	64.7	12.5	28.3	47.3	63.7	63.0	28.7	47.8	49.0	33.1	34.1	49.1	42.5	121.2	26.5	44.0	98.2	101.2	72.1	22.3	17.3	110.7	19.1	45.4	139.8	62.2	18.8	77.5	42.5	47.4	125.6	37.2	52.8	27.0	24.0	52.9	47.9	76.3	85.7	46.1	82.6	34.4	25.4	46.7	20.1	16.7	23.8	37.0	26.3	52.1	38.3	31.2	29.4	41.6	22.7	27.3	42.0	16.8	112.6	91.2	31.8	57.8	40.0	28.2	53.6	59.9	87.0	88.4	56.0	45.8	40.2	3.3	2.5	2.8	2.2	3.0	1.7	1.4	1.0	1.1	2.2	1.3	1.2	1.4	1.5	1.6	3.4	1.6	0.9	1.9	10.4	11.5	11.9	10.8	11.3	12.3	12.9	11.8	13.3	10.0	13.4	12.5	39.0	48.1	39.9	11.1	39.0	32.1	39.0	44.5	23.3	28.4	34.5	30.2	77.7	42.9	51.3	36.8	18.8	62.2	33.0	82.4	31.3	66.0	261.8	39.1	22.4	40.8	76.7	52.2	7.6	50.0	67.1	38.4	40.8	34.1	48.2	41.4	38.6	45.4	55.9	50.5	8.6	56.4	61.1	39.9	29.9	483.4	33.2	40.5	28.4	12.2	38.5	34.0	44.3	5.0	10.8	64.0	63.4	39.5	51.6	35.0	105.6	47.9	54.6	48.3	39.5	35.4	65.8	115.0	87.9	33.3	35.5	119.4	34.8	31.7	68.8	40.1
BAIAP2	"BAP2, IRSp53, WAML"	ENSG00000175866	"BAR/IMD domain containing adaptor protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Urothelial cells: 185.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 19.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		18000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (7.58e-6)"	23.9	18.2	129.1	7.4	140.0	2.6	27.1	95.7	176.1	49.9	104.6	44.0	6.7	30.9	46.5	132.9	37.6	29.3	24.2	163.7	103.1	38.0	85.7	49.1	6.9	68.0	81.0	13.7	13.4	19.9	56.3	31.8	68.3	61.3	12.1	16.2	57.5	27.6	13.1	132.4	14.7	19.3	70.5	11.8	62.3	26.3	119.9	11.8	27.1	9.8	25.3	23.3	73.2	121.9	99.9	45.1	28.1	36.6	22.2	29.0	32.8	40.2	26.1	35.7	15.8	60.9	49.1	0.5	28.3	35.8	73.5	93.6	26.1	46.1	13.7	0.4	32.8	20.2	41.3	46.4	20.7	0.0	28.2	12.5	53.0	29.5	15.4	32.7	19.5	1.1	26.4	0.6	20.6	51.2	4.0	22.3	11.8	65.6	38.1	6.0	6.6	81.3	108.5	34.5	36.8	39.9	64.2	91.3	110.1	23.1	80.4	22.6	23.8	81.6	78.4	13.8	43.4	1.4	0.3	1.4	72.0	3.3	18.3	0.0	7.9	0.5	3.2	9.4	1.0	0.1	1.2	1.0	10.3	0.1	1.3	1.8	5.4	1.9	9.2	19.5	0.5	3.2	129.1	140.0	95.7	176.1	163.7	103.1	68.0	81.0	68.3	70.5	119.9	121.9	74.1	76.9	39.0	13.4	6.2	63.7	138.4	42.3	94.4	37.1	49.4	37.1	22.5	25.8	47.2	22.0	79.2	77.1	16.6	18.8	7.9	9.8	10.5	80.8	10.4	35.7	49.3	0.8	65.3	5.1	9.2	28.0	88.2	79.7	13.4	3.1	45.0	78.6	43.2	11.8	13.6	29.1	24.4	18.3	58.2	29.4	6.8	31.2	40.9	13.1	18.6	18.5	0.0	4.5	5.9	14.8	8.0	3.8	3.1	77.0	3.7	25.4	110.8	19.1	0.0	10.4	13.3	7.6	33.0	103.6	75.3	101.0	13.9	8.2	14.7	185.1
BAIAP2L1	IRTKS	ENSG00000006453	"BAR/IMD domain containing adaptor protein 2 like 1"	Q9UHR4	7	98291650-98401090	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 108.1;Prostatic glandular cells: 114.7;Urothelial cells: 147.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 72.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA019484, HPA021257, HPA023874, HPA029503"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"	Cytosol	"HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330"	"unprognostic (1.75e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.31e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	5.8	20.7	1.5	6.2	1.5	0.4	7.8	1.3	1.7	10.1	3.1	23.0	28.6	2.8	1.4	29.2	11.6	15.5	5.2	1.4	2.1	13.9	33.4	14.0	1.4	1.7	1.7	1.3	31.2	13.1	13.0	10.2	1.8	26.2	21.4	0.6	23.6	2.6	2.8	19.9	25.4	2.6	1.5	1.9	58.8	9.8	1.8	2.1	14.9	1.6	4.6	16.8	17.1	1.8	43.2	33.6	0.9	0.7	0.0	1.5	55.0	10.9	7.1	5.6	4.1	47.0	62.9	1.8	15.9	4.1	47.4	37.3	15.6	46.1	5.0	0.2	20.3	0.0	14.3	27.0	6.7	0.0	14.7	1.5	61.0	3.2	44.4	12.3	0.2	0.1	26.4	0.1	4.8	36.1	0.1	0.1	26.3	61.8	18.5	0.1	0.5	7.0	35.2	37.2	23.5	4.6	25.3	72.2	12.8	35.3	20.2	1.0	1.4	8.3	39.6	1.6	5.1	0.9	13.1	21.8	0.9	5.4	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.5	1.3	1.7	1.4	2.1	1.7	1.7	1.8	1.5	1.8	1.8	16.9	12.8	22.9	23.5	0.8	16.7	64.8	31.5	14.2	0.6	17.4	7.6	2.3	30.0	36.3	22.0	4.2	11.8	5.5	100.3	9.8	60.8	33.1	25.2	3.0	11.2	32.2	2.7	23.1	77.6	78.4	2.2	108.1	33.4	0.0	4.5	0.7	16.6	2.4	1.7	26.1	53.6	18.3	0.3	1.7	52.5	0.9	1.0	8.8	37.5	2.6	1.2	0.0	26.7	31.4	102.6	84.7	0.7	0.6	114.7	35.3	2.4	58.6	0.8	0.0	1.9	6.7	50.0	56.3	22.4	19.5	12.2	1.9	0.2	44.7	147.8
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401008-52410008	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	45.2	63.5	97.6	25.0	99.2	73.9	42.9	78.9	135.5	39.1	71.4	47.7	21.6	40.5	23.1	59.3	36.0	25.7	57.0	114.1	83.3	57.3	65.2	46.0	29.4	81.2	85.7	43.9	52.7	40.2	36.9	24.6	81.7	50.0	24.1	20.1	43.0	22.5	74.7	73.4	43.4	23.8	79.9	54.2	48.1	140.0	89.2	33.1	49.1	43.5	27.9	44.6	41.7	90.5	39.1	43.1	52.2	44.8	50.1	31.4	59.3	37.8	50.1	62.4	48.0	52.5	35.8	55.7	18.3	54.7	69.3	31.4	55.7	63.0	37.9	55.1	51.4	68.6	94.4	53.2	45.7	65.6	58.5	48.0	80.1	68.5	36.1	33.3	50.3	107.7	59.9	48.3	44.5	33.7	79.1	89.5	58.0	31.0	52.8	33.7	41.7	55.8	37.4	61.2	19.8	63.6	46.1	13.7	56.9	29.2	37.7	90.6	52.5	54.1	49.3	66.0	70.9	71.7	101.6	81.2	58.5	68.2	66.1	2.9	3.2	5.4	5.4	2.8	2.6	3.2	4.3	4.4	2.2	4.1	3.1	4.0	7.4	2.2	2.2	5.6	4.2	2.7	97.6	99.2	78.9	135.5	114.1	83.3	81.2	85.7	81.7	79.9	89.2	90.5	13.5	0.0	16.0	8.1	12.2	31.6	10.5	13.2	23.3	16.6	16.4	12.6	23.6	11.5	10.2	25.8	0.0	14.0	17.7	23.2	11.7	13.5	103.4	9.2	12.4	14.7	10.8	8.2	7.5	16.7	15.8	13.6	14.8	13.6	21.0	18.1	14.6	29.2	12.6	10.1	7.7	16.6	6.1	17.4	10.7	48.0	10.2	12.0	12.4	5.6	15.2	16.1	16.5	7.1	6.7	15.8	16.5	11.7	16.2	11.7	13.3	18.5	8.2	12.3	19.7	14.7	14.2	37.8	13.9	23.0	23.4	12.0	12.2	15.9	19.8	9.6
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 486.3;epididymis: 303.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 128.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 128.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 467.0;HeLa: 800.8;SiHa: 830.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		63000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	35.3	13.8	235.9	73.6	257.0	87.6	14.0	103.0	486.3	56.9	79.9	12.5	7.3	37.3	303.3	10.9	11.4	29.2	13.9	247.3	210.9	15.1	17.2	36.5	80.9	134.7	153.1	36.6	3.7	3.4	21.2	92.1	184.3	79.7	10.8	74.3	13.2	21.6	2.3	22.0	22.2	33.4	107.7	76.5	22.7	2.9	157.1	24.1	11.3	6.8	91.5	57.9	27.3	281.8	0.1	125.6	152.7	0.2	71.7	76.1	227.1	161.7	50.9	127.9	135.0	6.1	0.1	51.3	22.4	112.0	467.0	10.6	98.2	109.2	164.8	21.3	57.9	0.4	800.8	0.3	158.9	101.3	1.4	131.2	132.7	145.6	121.0	163.9	140.1	0.2	0.4	0.5	138.2	183.7	0.3	92.5	115.7	0.3	39.6	0.1	0.5	28.0	46.5	31.3	99.3	21.3	830.7	72.3	0.2	336.5	0.3	101.9	187.7	169.3	0.6	14.2	26.1	1.7	0.2	27.1	171.2	123.0	23.1	25.0	3.1	25.3	0.0	1.5	0.0	5.4	0.0	0.0	4.9	7.9	0.0	0.0	128.5	1.8	2.1	0.5	0.3	0.8	235.9	257.0	103.0	486.3	247.3	210.9	134.7	153.1	184.3	107.7	157.1	281.8	8.0	9.6	4.8	22.2	158.7	215.9	88.0	21.3	58.1	54.8	9.8	10.2	1.6	0.0	15.8	9.2	12.5	155.0	3.8	0.6	0.0	0.6	0.9	98.4	345.6	30.2	0.0	18.1	254.0	3.4	362.9	102.6	23.4	156.4	27.3	18.1	35.7	2.5	53.8	244.0	125.3	0.7	12.2	227.9	489.4	0.0	0.6	298.5	28.4	53.4	275.1	796.9	1.0	115.1	23.7	1.0	0.2	0.0	173.0	121.0	0.0	0.3	93.5	58.4	0.0	2.0	66.2	0.4	3.4	21.0	58.8	738.5	11.9	8.3	1.8	13.2
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522455-75546993	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.7;lymphoid tissue: 30.6"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 105.4;Breast myoepithelial cells: 73.9;granulocytes: 243.7;NK-cells: 103.0;T-cells: 116.5;Urothelial cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 130.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 368.9;MCF7: 134.7;RT4: 83.3;SK-BR-3: 64.8;U-937: 101.6"	"Not detected"	"Not detected"							"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (8.30e-4)"	"prognostic favorable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (4.30e-4)"	5.5	1.3	1.0	20.5	1.8	21.7	7.8	1.0	1.4	2.2	1.1	3.0	2.6	1.3	1.1	2.9	1.9	5.8	2.4	1.0	1.2	1.4	2.9	8.0	30.6	1.5	1.4	0.5	0.9	8.0	0.5	4.1	1.7	5.5	1.4	0.0	6.5	1.8	0.4	2.9	9.7	2.3	1.2	26.9	7.8	0.6	2.2	7.2	1.9	1.0	20.4	18.2	2.9	1.5	4.7	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	368.9	0.0	7.5	0.0	1.6	11.5	10.0	36.3	0.1	0.0	0.0	0.0	0.0	0.0	8.1	2.0	10.3	0.0	134.7	4.7	30.8	0.2	54.9	0.0	1.1	0.0	6.3	0.0	83.3	0.1	0.0	0.0	64.8	2.7	0.0	6.1	18.7	0.0	0.0	0.0	4.4	0.3	32.8	36.9	0.3	0.0	101.6	0.1	3.6	25.5	8.2	55.0	13.7	43.4	21.3	59.7	74.2	25.2	17.5	23.1	50.4	14.4	21.3	13.2	2.9	130.3	27.8	1.0	1.8	1.0	1.4	1.0	1.2	1.5	1.4	1.7	1.2	2.2	1.5	2.9	9.6	29.3	0.0	17.1	5.4	50.8	5.7	0.6	0.0	105.4	73.9	0.3	1.5	13.5	3.7	0.0	0.4	36.9	0.0	0.0	0.8	0.5	0.9	0.6	5.0	0.0	7.2	0.2	2.5	0.4	4.4	10.2	1.9	243.7	0.0	2.5	0.7	61.3	0.0	0.1	0.0	34.6	15.4	10.7	0.6	0.0	21.7	5.4	1.0	16.7	0.0	103.0	0.0	0.1	11.0	0.1	0.0	29.9	22.1	0.0	0.2	12.8	0.0	0.0	1.0	2.0	0.0	0.1	0.4	3.4	1.1	116.5	0.2	0.5	74.3
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: AB_2685128"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	29.1	23.9	10.3	30.8	13.3	65.9	27.2	22.9	18.7	29.3	19.1	27.0	25.5	25.4	22.9	30.9	24.9	20.9	21.1	10.3	20.0	19.8	21.7	35.9	33.4	17.2	13.0	36.3	30.8	33.4	27.7	35.4	14.6	23.3	26.6	48.8	25.7	21.0	28.2	29.9	31.1	23.1	5.5	35.3	26.2	47.4	19.0	50.6	27.3	32.0	30.6	24.8	30.6	19.8	50.3	45.6	61.9	52.5	35.3	35.4	66.5	32.6	44.2	46.9	34.1	56.2	59.3	69.2	49.2	38.6	44.3	41.5	70.6	46.3	40.6	48.1	37.1	80.8	35.5	28.8	38.5	47.1	60.2	31.0	43.8	40.2	55.7	50.8	46.3	28.4	87.7	94.1	26.3	30.7	40.2	30.9	54.9	32.7	34.6	33.9	45.0	48.3	32.6	48.8	41.0	33.8	54.8	57.0	30.0	66.0	65.6	41.7	65.2	24.3	49.1	30.0	23.0	46.0	48.4	65.1	22.5	33.4	34.6	12.1	7.6	5.6	4.8	6.2	4.2	6.8	3.8	3.7	3.0	6.0	3.1	2.7	28.6	17.2	15.5	11.7	3.6	3.0	10.3	13.3	22.9	18.7	10.3	20.0	17.2	13.0	14.6	5.5	19.0	19.8	47.6	67.3	61.3	29.4	74.7	50.9	43.2	35.3	60.3	70.5	43.3	26.7	26.4	30.0	36.9	25.8	137.6	48.0	62.8	71.6	7.9	32.0	66.8	29.4	33.7	50.1	44.8	53.4	29.3	28.7	37.2	35.6	34.1	41.7	43.6	34.8	53.9	32.5	24.3	32.0	27.4	39.6	26.4	62.1	65.6	73.7	60.6	38.5	39.2	40.3	80.1	24.4	116.4	25.6	33.2	34.8	39.4	57.6	78.0	65.1	44.7	12.6	34.4	67.3	85.5	44.9	44.0	134.1	131.2	59.5	61.8	95.6	58.0	41.6	34.8	67.6
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX high mobility group box domain containing"	Q8WY36	3	107522936-107811339	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1071.7;Late spermatids: 571.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA006049: AB_2667504, HPA050646: AB_2681200"	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	13.9	25.0	19.3	12.8	39.0	18.5	14.5	23.7	22.2	17.2	18.7	11.5	9.5	19.0	38.6	12.9	16.8	16.7	16.5	17.0	29.4	19.5	10.2	13.3	13.9	31.0	26.3	27.0	12.3	46.4	10.2	24.2	32.8	22.7	9.3	20.0	13.4	31.6	6.7	8.1	9.1	16.5	25.6	18.9	12.1	58.1	28.5	16.4	26.2	16.2	13.7	14.6	8.7	59.9	40.0	39.7	31.1	47.0	26.5	35.1	25.5	38.6	36.5	33.2	35.4	4.4	31.4	20.2	46.5	23.4	37.5	26.9	34.4	44.2	45.7	29.0	16.3	31.9	30.0	9.4	31.1	43.3	18.2	31.6	31.3	32.5	62.4	44.5	26.2	23.8	14.9	29.6	27.7	13.5	25.2	4.6	15.5	0.4	30.2	35.8	30.1	22.9	20.8	32.2	22.5	22.0	69.0	6.3	31.5	30.7	25.4	8.6	38.3	38.7	30.7	15.3	26.8	12.9	10.3	25.0	36.9	21.4	23.2	76.0	19.9	50.4	47.0	20.8	54.4	75.9	42.2	48.3	28.3	75.0	52.5	43.3	32.0	58.0	42.7	36.2	30.8	27.7	19.3	39.0	23.7	22.2	17.0	29.4	31.0	26.3	32.8	25.6	28.5	59.9	76.9	64.1	84.1	106.7	123.0	85.1	145.6	103.3	80.8	92.8	72.7	79.4	112.7	85.8	72.5	95.6	64.6	208.2	87.7	18.1	49.0	92.9	1071.7	76.8	62.1	78.4	66.4	51.7	96.3	73.8	92.1	86.2	40.8	88.0	32.3	151.7	66.4	30.8	47.9	171.6	78.4	41.4	114.0	62.2	73.0	571.4	156.3	70.7	67.6	112.4	48.2	149.9	101.0	163.3	323.2	65.4	37.8	206.1	66.4	115.7	19.7	112.8	60.9	64.5	144.7	108.5	114.9	94.1	159.0	59.0	75.6	198.4	100.8	107.1	39.3	128.9
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724565	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		170000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	294.1	213.9	171.5	100.9	175.5	151.3	210.9	171.8	213.9	139.5	202.5	157.7	133.3	127.4	228.9	214.0	151.0	118.0	123.5	183.0	192.1	160.7	185.5	144.5	111.8	190.8	187.5	130.9	266.4	193.7	123.5	143.3	195.3	154.6	166.5	63.9	179.7	177.7	81.9	187.3	143.8	155.0	183.4	138.5	129.3	117.3	186.9	99.7	161.4	75.5	134.6	177.9	145.8	185.0	505.5	482.4	128.0	650.6	593.8	179.1	295.3	269.9	287.5	291.6	371.6	386.8	361.9	315.9	1068.1	412.2	373.9	506.8	337.3	518.6	221.0	152.8	436.9	198.4	350.4	323.3	276.4	335.1	373.2	233.8	454.2	282.3	330.1	298.4	372.6	172.0	268.0	528.3	332.7	535.3	187.3	402.5	145.8	704.6	431.7	207.5	152.8	693.2	459.3	546.8	173.3	241.8	111.8	520.6	350.0	200.3	196.2	320.2	380.0	248.9	234.7	338.9	495.1	518.0	1120.1	397.3	460.9	402.6	223.7	630.5	484.2	489.1	507.5	535.7	454.7	436.1	504.5	507.4	420.7	463.6	439.1	474.7	624.5	449.8	632.3	666.9	457.1	1110.8	171.5	175.5	171.8	213.9	183.0	192.1	190.8	187.5	195.3	183.4	186.9	185.0	184.9	112.2	114.1	14.7	97.5	141.9	232.2	374.0	172.4	53.0	127.3	165.7	60.3	134.4	222.8	128.8	45.9	467.5	113.5	194.1	37.2	252.4	7.8	99.7	70.1	165.5	103.2	59.3	16.9	210.0	444.8	103.6	78.5	103.9	95.6	68.5	199.6	216.0	356.2	32.0	12.8	155.1	244.1	148.4	125.6	20.6	105.3	166.2	160.1	17.8	137.5	138.2	111.2	11.6	12.9	247.1	187.4	98.9	120.8	191.8	242.8	170.9	172.6	51.8	157.8	42.9	106.5	310.3	231.3	174.0	130.4	538.1	114.6	120.4	187.0	260.4
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA		100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	13.4	13.3	8.7	5.7	11.6	10.8	11.5	8.4	12.8	7.7	1.4	10.0	6.0	7.9	8.8	12.3	7.4	6.8	19.7	9.4	9.9	14.0	16.4	8.4	7.6	11.6	13.7	7.5	11.8	14.8	7.8	9.2	12.1	8.2	10.3	43.8	10.0	6.8	59.6	14.1	7.8	7.6	9.2	6.4	9.5	10.7	9.7	9.2	9.6	40.5	8.7	10.3	8.7	9.4	16.2	6.1	10.6	11.1	19.6	18.8	17.2	11.4	21.3	17.1	19.8	8.3	11.7	14.6	7.5	15.4	13.9	21.3	12.6	18.4	20.9	12.2	12.3	14.5	7.5	6.1	22.3	21.3	10.0	14.5	21.1	14.0	40.1	24.2	14.7	11.3	34.5	15.2	18.9	11.6	11.7	8.9	10.7	26.8	9.7	10.9	20.7	5.3	20.1	12.4	15.6	11.5	16.4	15.6	31.0	38.0	11.9	18.0	17.2	9.9	5.0	15.3	10.5	11.9	10.5	14.7	14.9	16.1	16.4	5.1	9.5	2.3	2.3	8.0	2.8	3.1	3.1	2.7	5.4	3.2	2.8	2.3	3.6	6.5	6.4	2.9	4.5	4.7	8.7	11.6	8.4	12.8	9.4	9.9	11.6	13.7	12.1	9.2	9.7	9.4	18.7	22.4	16.7	32.3	21.5	24.6	33.6	22.7	30.1	180.5	21.8	22.4	42.7	12.8	25.3	18.4	12.5	48.5	19.7	31.7	52.8	29.1	34.8	17.7	16.0	17.5	23.4	19.8	41.9	31.6	35.0	20.0	13.3	23.5	8.8	19.7	15.7	36.0	26.0	48.8	38.1	25.4	18.3	30.8	19.8	15.5	14.0	26.3	16.0	27.2	54.7	57.9	12.3	27.6	45.4	36.4	17.8	15.4	15.4	40.3	32.6	44.4	19.6	35.2	0.0	21.3	15.6	33.1	22.6	32.1	27.1	95.9	19.3	22.9	24.0	43.1
BCL9L	"B9L, Bcl9-2, DLNB11"	ENSG00000186174	"BCL9 like"	Q86UU0	11	118893875-118925608	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049370, HPA053421"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049370: AB_2680732, HPA053421: AB_2682145"	"unprognostic (1.67e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.90e-3)"	24.3	24.8	5.7	24.1	4.6	20.5	21.1	17.7	6.7	28.5	4.7	23.8	17.4	32.3	4.7	26.4	29.6	18.1	20.9	4.9	1.2	12.1	10.8	24.4	19.5	3.3	3.7	29.4	21.3	8.5	7.8	24.4	1.3	18.1	5.4	2.9	25.9	16.6	29.0	30.8	19.8	17.7	1.1	19.6	18.5	6.4	5.3	13.7	16.8	12.3	12.8	24.6	24.8	1.8	40.5	71.6	10.2	18.5	32.2	30.8	64.3	54.6	41.4	16.9	9.9	77.0	78.2	11.0	70.8	57.4	68.7	76.0	5.0	99.9	4.4	13.4	2.6	10.9	41.2	26.8	36.1	3.7	10.0	39.2	60.8	20.3	40.5	32.5	15.1	6.4	14.3	12.4	11.9	67.2	8.2	3.1	12.1	24.1	40.8	17.2	4.3	7.4	17.5	27.6	5.5	8.1	76.7	114.2	10.3	18.0	90.3	4.5	51.1	53.7	40.7	16.4	46.9	2.6	0.1	3.3	29.0	12.5	31.3	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.2	5.7	4.6	17.7	6.7	4.9	1.2	3.3	3.7	1.3	1.1	5.3	1.8	16.3	16.0	11.5	9.1	18.3	38.7	9.3	18.5	13.1	20.0	23.8	16.5	2.4	15.7	14.1	7.3	4.2	12.7	42.2	10.9	0.0	14.0	0.1	36.6	31.5	12.3	5.4	1.3	3.9	15.1	8.4	14.1	13.3	61.9	2.5	12.2	11.4	9.7	4.4	13.5	4.8	5.4	4.1	6.1	11.6	0.5	14.6	8.0	7.2	12.2	16.5	5.5	32.0	5.0	1.1	29.3	7.4	14.3	14.8	23.5	10.8	3.3	14.0	3.1	26.3	12.4	26.4	0.6	1.4	34.7	45.3	35.4	33.0	8.6	6.8	11.1
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 135.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		21000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	24.4	22.3	14.3	26.9	17.3	135.0	32.9	23.6	18.6	21.4	19.7	29.5	18.8	23.2	24.0	24.3	21.3	14.8	16.7	15.9	19.2	21.5	27.4	24.6	28.2	11.1	12.9	24.4	25.5	33.4	18.0	21.3	12.0	21.2	28.4	34.8	21.2	20.5	27.5	21.8	21.1	28.3	14.7	24.8	27.9	21.3	16.7	35.2	30.4	24.3	32.9	23.0	19.3	19.3	82.4	70.0	162.5	136.2	50.4	42.6	82.3	153.0	94.4	100.6	106.5	100.4	54.4	172.7	92.8	117.9	112.8	78.0	183.5	101.1	125.5	95.1	114.2	213.7	96.0	110.3	58.6	362.6	131.0	58.3	49.2	142.8	88.6	37.2	90.9	77.6	193.6	82.3	107.0	97.4	145.3	40.2	120.2	55.2	72.0	130.3	203.2	76.4	76.3	155.0	137.2	94.5	150.0	71.3	60.4	60.6	66.9	71.5	125.7	79.2	116.7	95.9	151.2	69.5	134.8	227.9	47.2	113.3	94.2	32.6	27.1	42.1	32.4	33.2	32.7	36.6	29.9	28.1	42.3	32.9	37.7	34.5	57.9	49.5	35.3	24.7	25.5	24.5	14.3	17.3	23.6	18.6	15.9	19.2	11.1	12.9	12.0	14.7	16.7	19.3	165.3	205.1	178.7	68.9	174.3	68.2	118.9	99.5	104.2	129.7	86.9	71.5	88.4	65.8	131.6	57.0	210.6	111.9	173.3	86.3	33.2	96.8	12.6	157.2	173.5	117.5	118.9	134.6	80.5	65.2	99.4	138.0	128.0	169.8	156.4	130.5	74.3	60.0	74.0	102.6	82.6	106.0	93.6	92.5	88.9	13.8	122.1	121.8	69.4	56.2	136.9	91.6	118.4	63.3	93.4	77.5	81.4	109.4	197.8	128.6	83.3	42.9	147.1	139.9	111.7	259.8	130.7	102.2	129.7	121.4	71.2	128.3	174.8	154.8	101.6	123.8
BCOR	"FLJ20285, KIAA1575"	ENSG00000183337	"BCL6 corepressor"	Q6W2J9	X	40049815-40177329	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056308, HPA073591"			Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA056308: AB_2683095, HPA073591: AB_2732227"	"unprognostic (2.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (3.82e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.83e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.55e-1)"	10.2	14.0	2.4	8.3	3.8	22.2	10.0	3.0	3.7	11.5	3.8	14.7	8.8	11.0	5.4	14.4	10.9	7.5	14.0	1.9	2.9	12.9	14.6	12.3	15.0	4.5	3.3	20.0	13.9	14.0	12.0	12.3	2.8	12.5	6.8	14.2	11.9	8.4	20.6	14.7	11.2	8.7	2.0	10.7	12.2	9.0	3.8	25.8	15.6	7.2	12.5	10.9	11.4	5.1	35.5	21.9	45.1	50.5	4.7	3.3	7.8	11.4	18.6	14.4	11.7	8.9	13.5	31.3	13.3	21.7	8.9	31.0	70.8	9.3	12.0	56.0	67.4	36.2	31.8	31.7	7.6	28.7	19.3	5.6	12.0	16.7	7.0	20.0	19.8	20.2	94.7	74.3	14.8	17.9	65.8	27.2	43.4	14.2	33.9	32.3	47.5	36.2	17.3	20.8	32.5	57.6	25.5	20.5	15.5	18.9	22.8	51.5	16.8	15.5	18.5	23.1	12.8	39.1	36.1	33.8	13.1	23.5	24.6	4.6	3.1	2.1	3.8	3.6	2.7	1.9	2.5	2.4	4.5	2.5	2.1	2.3	0.5	3.3	3.9	1.4	2.7	8.8	2.4	3.8	3.0	3.7	1.9	2.9	4.5	3.3	2.8	2.0	3.8	5.1	20.3	22.4	24.5	24.2	16.8	14.7	4.7	8.0	33.6	35.7	10.4	13.1	9.2	10.0	5.9	11.0	12.5	4.5	20.6	6.4	1.9	5.4	2.1	24.1	8.6	15.9	16.3	20.4	21.6	10.5	6.3	11.9	11.7	25.6	24.6	12.8	16.4	10.7	7.5	15.2	20.4	11.4	10.2	8.4	25.6	2.4	10.5	11.5	5.4	27.2	12.0	7.6	7.2	27.6	31.3	6.4	3.9	7.9	16.9	7.6	6.5	4.1	7.1	23.8	0.0	16.4	17.4	2.0	13.2	21.0	13.9	2.1	21.1	6.4	8.8	2.8
BDP1	"HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR"	ENSG00000145734	"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB"	A6H8Y1	5	71455651-71567820	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064166, HPA077984"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA064166: , HPA077984: "	"unprognostic (4.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.86e-2)"	2.5	2.7	0.5	1.3	0.6	0.9	3.4	0.8	1.7	1.8	0.2	0.9	0.0	1.2	0.0	0.8	1.2	2.0	0.7	0.5	0.5	2.7	1.6	1.4	1.2	0.5	0.5	1.8	4.0	0.3	0.3	1.4	0.5	1.5	2.3	5.8	0.8	1.9	2.2	1.9	0.8	2.0	0.5	0.7	1.0	0.9	0.4	2.3	2.8	3.5	1.6	0.9	0.6	0.9	1.3	2.1	10.1	3.1	1.6	5.0	7.7	0.2	0.1	2.4	0.0	0.7	1.0	0.5	9.4	4.0	11.0	0.0	3.2	0.2	11.0	0.0	0.0	1.6	7.0	3.1	4.2	4.4	0.4	0.0	0.1	0.9	5.9	5.4	7.9	0.0	12.7	0.7	5.0	3.9	0.0	1.2	0.0	1.0	7.7	10.5	1.3	7.9	4.4	6.6	1.2	7.3	0.2	2.1	6.4	7.2	0.0	0.0	16.1	5.6	0.9	3.6	0.5	3.4	8.5	0.1	0.0	3.8	8.6	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.6	0.8	1.7	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.9	69.5	60.9	96.2	52.5	79.7	44.5	63.7	26.9	55.8	78.2	57.9	55.8	110.7	38.6	57.3	35.0	102.2	37.9	101.1	38.7	1.9	48.1	37.8	88.7	109.5	71.7	58.6	59.7	116.7	36.3	50.2	57.0	57.1	127.3	58.2	66.0	28.9	32.0	31.7	94.2	96.4	39.3	24.4	27.7	36.9	21.1	58.7	53.3	28.4	57.1	62.3	41.7	76.2	57.3	86.8	52.2	26.0	54.5	72.3	57.9	18.5	10.9	39.9	125.1	52.6	104.3	74.0	85.8	60.4	60.0	43.3	48.2	86.3	69.0	50.0	64.5
BHLHE41	"BHLHB3, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120030-26125037	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 122.4;skeletal muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 347.5;Cone photoreceptor cells: 183.5;Horizontal cells: 250.7;Muller glia cells: 239.8;Rod photoreceptor cells: 309.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 78.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 92.4;RT4: 126.6;U-266/70: 52.6;U-87 MG: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	10.6	14.6	35.4	7.4	46.7	0.5	13.6	52.5	35.2	38.8	11.8	9.5	2.7	8.1	19.3	3.2	45.5	18.3	20.0	30.5	39.5	3.8	0.7	11.6	7.9	58.1	48.7	12.9	7.7	6.5	16.7	10.5	62.3	9.7	11.1	122.4	18.4	14.0	92.5	5.6	6.3	4.1	60.2	9.1	4.9	4.3	49.8	6.3	57.8	12.9	17.9	21.3	9.9	67.1	11.4	0.1	0.3	0.0	20.4	9.4	4.7	2.2	3.8	0.4	1.4	0.0	13.4	0.0	1.9	4.4	31.4	11.3	0.4	1.9	1.1	0.1	1.7	1.0	0.2	0.0	0.9	5.7	0.3	1.5	1.1	7.8	15.0	92.4	0.0	0.1	0.0	39.6	2.4	1.3	0.0	3.9	10.4	3.7	7.8	0.0	1.9	31.6	4.9	126.6	0.2	0.2	1.4	0.6	29.7	0.6	0.0	0.2	6.7	7.1	8.2	0.8	5.9	52.6	32.3	0.1	44.9	4.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.4	46.7	52.5	35.2	30.5	39.5	58.1	48.7	62.3	60.2	49.8	67.1	1.6	0.0	1.1	46.0	25.0	6.0	59.8	34.1	10.8	347.5	9.2	56.0	46.7	37.1	11.2	29.5	183.5	26.6	0.2	55.0	0.0	40.6	0.6	78.5	27.1	12.0	13.1	0.0	10.1	21.9	3.6	22.7	3.1	60.8	5.7	0.2	2.5	0.1	91.1	250.7	12.4	4.4	0.0	4.0	4.4	1.3	30.1	39.8	14.2	120.9	27.4	239.8	0.0	22.1	56.2	21.9	12.0	26.7	61.8	49.0	0.4	2.3	34.8	309.5	6.6	13.0	7.5	0.5	3.7	3.5	3.3	7.1	2.4	2.3	5.0	83.8
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240495	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 6.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 12.4;Extravillous trophoblasts: 16.5;Hofbauer cells: 75.8;Melanocytes: 26.6;Muller glia cells: 54.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 196.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: AB_2680181, HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	0.8	0.8	0.7	0.3	0.4	0.1	0.4	0.3	1.3	1.7	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.7	0.9	0.9	0.3	1.1	1.3	0.8	0.7	0.1	0.0	0.0	0.3	6.5	1.1	0.1	0.0	0.6	0.2	0.0	0.0	2.4	0.2	0.0	0.7	0.9	0.1	0.1	1.2	0.0	0.2	0.0	0.2	0.2	0.7	1.5	0.3	4.3	0.1	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	6.6	1.1	0.0	17.8	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	20.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	196.8	4.4	1.3	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.3	1.3	0.7	0.9	0.8	0.7	1.1	0.7	1.2	1.5	0.3	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	1.8	0.0	12.4	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.6	16.5	0.7	0.0	0.0	2.5	0.1	0.0	0.0	75.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	26.6	0.0	0.0	54.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0
BMP2	BMP2A	ENSG00000125845	"Bone morphogenetic protein 2"	P12643	20	6767686-6780246	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 155.9;Basal keratinocytes: 167.1;Distal enterocytes: 125.6;Suprabasal keratinocytes: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 31.6;HeLa: 19.6;hTERT-HME1: 17.8;RT4: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA058610, CAB078457"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	24400	21000		"Cluster 19: Lung - Lung function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB078457: AB_2532532, HPA058610: AB_2683777"	"unprognostic (2.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.12e-3)"	"unprognostic (8.51e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.39e-3)"	"unprognostic (7.81e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.49e-2)"	18.6	1.6	1.2	4.0	1.5	1.6	6.0	1.3	1.6	5.2	0.9	15.1	6.6	5.2	0.6	5.5	3.8	16.1	4.0	1.8	1.4	3.9	5.8	18.8	1.9	1.9	2.2	2.8	9.2	3.2	2.3	11.5	2.1	1.9	13.6	1.3	2.1	1.2	2.2	10.6	9.7	2.6	1.5	12.4	20.7	0.5	2.1	0.4	18.9	2.7	1.8	17.2	6.4	2.2	0.1	0.3	0.0	0.0	0.5	0.2	0.0	0.8	3.4	0.0	0.0	31.6	0.1	0.0	0.5	1.1	0.0	10.5	6.2	2.7	0.0	0.0	5.5	0.0	19.6	0.1	1.5	0.0	0.8	0.2	9.2	0.0	17.8	4.0	6.3	0.0	0.0	0.0	0.2	0.0	0.0	6.0	0.8	3.7	0.8	6.2	0.1	0.4	2.3	25.0	1.1	1.6	7.3	0.0	0.0	5.5	0.0	6.5	1.5	1.8	2.7	0.0	0.9	0.3	0.9	0.0	3.0	1.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	1.5	1.3	1.6	1.8	1.4	1.9	2.2	2.1	1.5	2.1	2.2	9.4	80.1	155.9	0.3	1.1	167.1	45.1	11.0	70.0	0.4	1.4	2.2	4.7	42.9	10.5	1.8	0.0	0.1	3.8	125.6	0.0	23.3	0.3	1.7	34.8	24.1	11.3	0.0	1.1	9.8	0.2	20.2	33.6	3.0	8.8	1.9	41.4	3.4	3.6	0.0	3.5	23.8	0.0	2.9	16.8	0.2	5.9	2.9	8.8	2.8	0.6	6.2	0.0	8.5	1.4	33.5	60.3	0.0	1.3	47.5	28.3	2.1	0.8	0.2	19.7	36.5	48.8	0.0	0.3	43.1	119.3	0.1	2.1	4.3	48.2	43.3
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1 ribosome biogenesis factor"	Q14692	10	42782795-42834937	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	8.1	8.3	6.5	8.9	7.2	10.7	8.5	8.6	8.2	8.2	8.5	7.7	6.3	8.2	6.8	9.6	7.3	5.1	9.0	6.1	7.8	8.1	8.1	7.6	10.0	7.4	7.8	8.4	8.8	11.4	7.6	8.2	7.7	7.3	7.9	6.5	8.8	6.9	17.7	10.2	7.8	7.7	6.5	8.7	7.4	8.1	7.0	9.6	7.2	13.4	10.8	10.1	8.3	7.2	32.0	26.7	25.3	29.0	18.8	15.5	24.5	26.1	27.5	30.3	25.9	37.1	24.4	16.9	18.1	22.7	17.0	27.3	42.0	33.8	39.4	24.7	29.3	22.7	20.7	31.9	16.2	61.7	20.4	13.9	16.9	32.7	31.5	16.9	23.2	19.4	40.4	17.7	21.8	27.1	34.6	20.3	32.3	22.0	28.0	31.3	26.7	18.1	16.8	27.7	19.3	20.4	22.9	25.1	21.7	26.2	30.6	17.6	28.3	14.0	50.7	28.4	43.2	14.1	18.7	48.5	20.5	44.9	11.0	3.8	4.6	2.7	7.2	8.2	8.5	8.7	8.9	7.9	7.5	6.1	9.6	8.3	0.6	6.1	7.1	3.9	6.9	5.3	6.5	7.2	8.6	8.2	6.1	7.8	7.4	7.8	7.7	6.5	7.0	7.2	25.6	32.1	33.1	19.6	29.7	22.9	33.9	28.4	14.2	20.7	18.8	17.1	48.0	20.0	37.4	23.9	10.4	27.7	23.6	10.2	21.5	32.3	14.6	28.8	34.5	31.3	16.8	19.5	31.4	34.9	30.0	26.4	16.3	30.0	22.1	36.8	21.4	18.6	19.7	21.9	28.8	11.5	22.4	15.3	22.6	12.1	23.6	19.9	33.8	10.3	35.2	12.8	24.7	20.1	24.0	38.2	8.9	16.6	31.3	32.2	8.8	30.1	49.5	28.7	19.7	35.3	31.4	40.3	56.1	17.1	25.4	24.9	25.3	33.5	18.7	41.4
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.0;esophagus: 12.5;testis: 30.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 88.6;Early spermatids: 45.5;Late spermatids: 103.4;Suprabasal keratinocytes: 58.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 51.1;HBEC3-KT: 116.6;hTCEpi: 128.1;hTERT-HME1: 123.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	15.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	3.1	0.0	0.1	0.0	0.0	8.1	12.5	0.9	0.1	1.4	0.2	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.7	0.0	1.0	0.0	1.8	0.0	0.2	0.0	0.1	2.0	0.2	0.0	9.3	0.0	0.0	0.0	0.0	0.1	30.8	0.3	4.2	0.1	0.3	2.1	0.3	6.5	0.4	25.9	0.1	0.0	0.0	4.2	6.4	0.0	2.0	0.3	21.9	30.3	0.0	0.5	0.0	1.0	13.8	0.0	51.1	2.7	116.6	39.3	0.0	0.2	0.0	0.0	0.0	32.6	0.0	0.0	5.6	128.1	19.6	123.8	4.5	21.7	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	11.6	0.0	0.0	14.2	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	88.6	14.8	15.5	14.8	0.0	0.0	0.1	0.4	1.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	5.5	103.4	0.6	0.1	8.8	1.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7	0.0	1.2	0.0	0.1	1.7	0.0	0.0	2.7	0.6	22.2	6.5	21.7	58.4	0.0	0.0	0.0	0.0	4.8
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26383054-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 913.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	130.6	53.4	42.7	37.2	60.4	192.6	77.9	55.6	62.0	63.9	38.9	39.6	22.2	52.8	66.3	48.3	50.5	54.7	63.2	50.0	49.6	79.4	45.4	62.9	39.4	60.7	54.0	119.7	20.1	55.1	25.4	104.5	58.4	44.4	28.2	146.5	44.1	64.4	38.9	71.5	28.4	51.3	46.6	40.7	28.9	68.6	48.8	39.9	41.9	31.7	52.1	48.9	49.5	80.8	90.6	33.8	79.1	53.9	214.5	134.0	66.8	89.0	259.9	81.9	179.6	15.3	42.7	27.7	82.5	169.0	113.4	44.8	39.6	114.5	270.0	17.8	21.8	114.9	32.0	26.9	119.3	10.3	191.1	162.5	89.2	92.9	55.3	269.2	106.2	66.9	52.6	65.0	173.7	39.1	72.7	38.5	26.2	56.7	36.6	38.4	99.9	55.6	85.3	58.3	83.9	74.4	43.2	8.8	70.0	85.9	43.7	21.7	140.4	152.2	64.6	96.2	20.5	93.2	46.0	36.8	232.6	20.6	35.1	334.9	298.3	182.9	39.5	154.8	34.9	68.4	58.4	43.3	166.9	78.0	89.3	65.5	369.0	47.6	104.1	38.0	86.1	239.3	42.7	60.4	55.6	62.0	50.0	49.6	60.7	54.0	58.4	46.6	48.8	80.8	118.3	86.6	157.4	28.7	72.2	98.8	56.0	231.7	82.6	142.5	90.6	85.3	34.0	50.1	126.4	103.0	33.3	33.2	55.6	32.7	49.0	115.4	194.1	173.5	140.8	101.2	120.6	913.9	50.6	39.1	166.5	179.9	38.7	341.2	120.9	96.5	167.0	32.2	132.1	82.4	39.4	46.8	118.0	221.3	300.4	206.7	320.3	233.6	106.7	30.0	165.0	406.4	32.0	29.1	75.8	154.1	39.8	347.5	64.6	83.6	44.0	306.4	107.6	64.0	144.7	59.1	183.9	154.4	110.7	65.4	126.6	162.5	67.0	117.6	27.6	79.3
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627725	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	15.9	10.6	11.8	17.6	12.8	41.6	16.2	17.5	15.0	14.3	10.1	16.1	10.8	16.6	16.8	12.8	14.8	12.4	11.9	11.2	14.4	13.5	11.1	12.9	21.8	13.5	12.3	23.0	13.7	22.6	9.1	16.6	13.1	12.3	12.5	22.0	14.5	12.7	11.3	17.7	18.8	11.8	10.6	21.9	14.2	16.7	12.9	25.3	13.7	14.1	20.8	12.7	14.0	15.7	17.6	23.2	22.7	16.3	27.0	28.4	17.4	20.0	21.0	16.3	18.1	17.6	18.7	23.6	8.9	22.0	30.2	11.7	18.7	19.9	31.2	16.3	10.7	33.2	31.0	21.6	16.6	50.5	26.4	22.9	22.1	33.7	25.9	22.3	17.0	16.4	23.8	27.4	20.6	10.5	26.2	33.4	29.2	11.3	19.9	19.8	33.6	9.6	30.6	17.5	13.5	24.6	22.0	7.7	18.2	24.3	9.1	19.3	38.9	25.1	13.2	15.6	26.7	32.3	20.3	29.0	24.6	23.4	20.3	2.5	1.1	2.3	1.1	1.1	0.9	1.3	0.7	0.8	0.7	1.5	1.0	0.8	9.2	0.6	0.7	1.9	0.7	0.4	11.8	12.8	17.5	15.0	11.2	14.4	13.5	12.3	13.1	10.6	12.9	15.7	113.2	83.3	95.8	72.1	93.7	26.3	22.6	17.4	33.0	170.8	39.6	67.8	88.5	51.5	49.7	36.8	89.6	16.5	105.8	31.0	3.9	30.2	20.8	135.4	108.7	68.7	34.7	57.4	56.1	25.3	18.6	60.0	29.6	193.7	63.3	110.1	41.0	32.7	21.5	161.5	62.8	29.1	6.1	41.5	29.0	17.6	50.4	70.9	24.9	56.2	64.1	87.6	57.7	57.8	96.5	33.2	23.8	57.9	68.4	24.8	22.4	7.6	40.0	198.3	46.0	103.4	78.8	83.1	32.1	29.7	28.8	18.6	73.5	106.7	24.3	27.4
BOP1	KIAA0124	ENSG00000261236	"BOP1 ribosomal biogenesis factor"	Q14137	8	144262045-144291438	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 223.5"	"Low region specificity"	"Detected in all"							"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	18.1	17.8	6.8	8.8	6.9	9.7	16.3	7.7	10.9	16.1	3.5	17.3	5.6	18.2	1.0	26.0	13.2	2.8	24.4	7.6	5.5	16.7	21.5	13.3	8.0	7.1	6.0	11.1	32.0	5.6	16.9	3.7	6.5	15.3	1.9	1.1	13.2	3.1	76.6	21.4	14.9	3.1	4.7	20.4	15.4	20.1	6.2	5.4	17.0	8.1	3.6	19.3	16.5	6.1	45.0	87.4	11.8	50.6	6.4	7.7	41.4	30.5	6.5	30.3	19.1	66.3	25.4	54.1	50.1	11.6	11.5	34.9	21.2	36.2	6.9	47.8	82.5	68.4	54.4	49.7	15.1	30.8	35.6	15.5	17.0	25.2	22.1	5.7	18.8	48.3	70.1	18.1	11.9	112.8	82.4	37.6	28.3	45.1	223.5	61.4	17.6	82.2	12.5	30.1	64.7	25.8	32.5	41.9	20.3	5.5	30.6	27.7	36.6	27.8	83.3	37.1	88.5	16.5	11.7	45.6	20.3	48.6	36.7	0.0	2.2	1.3	1.9	2.3	2.1	2.5	2.2	2.5	3.0	1.8	2.0	1.8	0.1	1.8	2.0	2.0	2.0	1.2	6.8	6.9	7.7	10.9	7.6	5.5	7.1	6.0	6.5	4.7	6.2	6.1	12.8	9.6	5.1	3.9	16.7	0.5	18.7	0.0	13.1	9.8	12.7	13.8	7.2	10.0	3.7	11.0	0.0	25.2	20.9	18.7	5.9	25.8	11.2	7.5	10.7	12.0	26.9	22.1	4.4	21.7	45.3	13.2	17.3	8.3	10.2	13.5	4.6	14.8	21.5	15.2	3.5	11.5	0.0	11.1	0.0	24.3	10.5	12.8	0.0	1.0	16.2	16.7	18.6	5.0	2.8	26.4	11.3	9.8	25.4	39.5	11.3	17.2	1.5	4.6	13.1	12.9	15.1	13.9	53.4	25.7	0.1	17.8	11.8	29.6	31.8	14.3
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825503-67984378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029069: AB_10602597, HPA048289: AB_2680342"	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	25.5	23.7	24.1	25.4	29.5	32.0	25.5	88.1	26.3	30.3	10.9	27.9	15.7	27.9	28.7	26.6	29.6	19.1	20.7	21.0	38.2	27.9	20.7	22.6	43.7	26.4	21.9	38.1	22.9	27.4	34.6	22.2	24.3	25.2	22.2	44.0	25.2	16.7	25.9	37.5	28.5	19.6	17.6	31.4	23.6	32.1	22.6	52.9	27.4	22.3	39.2	24.4	27.7	34.3	42.2	52.8	76.3	38.7	41.6	39.0	42.2	32.0	29.4	37.1	31.8	49.6	29.0	167.7	22.4	35.4	28.5	32.2	74.4	34.5	60.0	24.2	72.5	64.9	50.4	68.8	19.8	97.3	49.9	28.6	37.3	36.9	27.6	34.0	70.2	52.9	75.1	46.1	32.3	64.0	99.1	47.3	58.9	37.9	47.8	70.3	91.0	33.6	32.5	50.6	56.5	65.6	42.8	117.4	46.4	91.4	49.1	53.7	49.6	56.2	43.7	20.7	39.7	39.3	42.0	97.9	26.9	45.1	22.0	20.3	4.2	8.5	7.2	2.4	5.7	6.2	5.9	5.7	3.0	11.8	6.1	6.3	9.2	10.7	5.7	10.9	4.5	1.6	24.1	29.5	88.1	26.3	21.0	38.2	26.4	21.9	24.3	17.6	22.6	34.3	118.7	115.4	148.2	192.3	130.9	75.2	55.3	37.8	87.0	216.8	76.2	78.5	136.0	61.5	92.0	58.8	143.9	39.4	170.3	64.1	7.9	63.8	26.6	147.7	174.5	108.1	126.1	114.6	124.4	63.1	30.8	94.8	88.2	165.9	121.4	124.9	71.0	46.4	42.2	198.5	136.4	68.9	48.8	56.3	54.4	25.7	108.7	84.7	64.0	109.6	88.0	129.3	146.2	231.8	262.7	65.4	64.5	111.3	129.2	62.1	37.7	17.4	80.8	202.6	65.7	167.3	92.3	144.9	101.3	82.6	75.6	38.7	128.8	126.6	85.8	60.7
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968594-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	64.2	61.8	0.8	22.1	2.1	66.5	62.4	4.7	3.8	67.7	0.2	62.1	19.8	71.3	1.8	67.9	66.6	17.4	51.7	3.0	2.8	68.3	61.9	65.3	22.1	1.5	2.4	81.7	80.4	26.3	71.4	19.4	2.1	60.8	11.6	10.1	66.1	18.2	71.4	69.5	60.8	11.7	1.4	71.2	66.0	82.9	2.3	26.9	77.0	10.4	21.2	61.6	65.0	4.0	45.7	19.5	41.6	41.8	31.8	28.5	38.3	44.6	44.4	48.5	35.8	22.7	22.5	37.3	44.6	37.2	32.4	28.1	39.3	33.2	27.7	49.5	147.7	41.2	18.3	14.6	23.5	60.6	39.2	29.2	28.7	38.2	44.9	27.6	21.3	35.2	44.4	76.0	21.7	12.1	77.0	8.5	24.0	28.9	20.4	76.2	18.7	53.8	13.8	26.6	85.6	28.9	54.5	63.7	52.7	27.8	37.4	39.0	27.5	58.6	32.0	21.5	50.0	61.1	69.5	77.9	23.1	19.7	47.8	9.6	7.6	11.6	14.5	8.8	13.0	9.2	9.4	9.9	10.6	8.7	6.6	10.4	9.7	10.3	9.5	8.5	13.3	11.7	0.8	2.1	4.7	3.8	3.0	2.8	1.5	2.4	2.1	1.4	2.3	4.0	325.8	76.9	121.5	38.2	327.1	212.1	232.7	70.0	478.1	78.6	295.5	383.9	171.7	94.4	80.1	60.7	104.3	91.7	395.7	210.7	21.5	69.2	302.4	201.9	149.3	191.2	259.1	97.6	16.1	91.4	145.0	224.2	249.8	256.6	115.2	103.1	113.2	85.3	79.9	55.5	19.9	247.5	77.3	92.6	209.2	177.9	86.9	194.5	124.5	26.2	94.7	62.8	107.1	15.1	22.1	81.2	137.3	77.1	313.0	211.5	133.7	39.5	84.4	65.1	39.5	240.0	251.3	88.4	137.9	365.0	226.9	205.1	356.7	71.2	179.5	248.4
BRD4	"CAP, HUNK1, HUNKI, MCAP"	ENSG00000141867	"Bromodomain containing 4"	O60885	19	15235519-15332545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015055, HPA061646, CAB068177, CAB068178"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575"	"unprognostic (2.83e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.53e-3)"	"unprognostic (3.03e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.98e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	24.4	24.4	16.1	23.3	16.1	24.3	23.8	8.5	34.0	26.9	3.2	26.1	14.1	25.9	8.3	27.7	23.5	12.9	30.6	14.5	17.3	24.4	32.7	27.7	20.8	11.5	12.8	30.2	26.8	13.4	20.9	29.4	9.2	24.8	8.5	12.1	22.9	13.6	62.7	33.7	25.5	13.2	2.8	28.7	22.4	24.7	10.3	16.9	24.1	19.1	15.8	25.2	26.7	15.2	46.7	49.1	31.0	58.6	26.4	20.1	32.5	32.5	29.3	28.3	29.6	47.1	71.4	58.5	48.4	36.5	27.6	47.1	30.8	32.4	24.0	51.3	21.4	58.0	41.1	43.7	42.2	53.2	59.7	29.4	34.6	35.2	68.7	18.1	26.1	41.5	91.7	62.7	18.3	55.5	53.6	41.6	58.5	23.4	54.2	63.8	32.5	37.5	22.3	48.8	35.3	31.1	44.7	34.5	40.5	24.4	33.7	38.3	45.0	72.5	32.6	63.3	53.0	43.9	39.0	25.7	39.7	47.0	58.5	3.4	2.2	2.2	2.1	2.8	1.6	3.6	1.8	1.8	1.4	4.3	1.8	1.7	6.5	3.1	2.8	2.6	1.5	1.6	16.1	16.1	8.5	34.0	14.5	17.3	11.5	12.8	9.2	2.8	10.3	15.2	85.9	64.1	52.7	26.8	97.9	117.6	118.4	33.9	80.8	67.0	71.8	54.7	79.5	58.6	33.9	25.8	83.4	219.8	91.6	93.9	25.4	53.6	130.3	83.1	102.6	84.7	113.9	117.0	46.3	67.1	72.4	75.9	56.1	128.2	36.7	95.2	64.6	84.9	60.5	79.1	44.2	71.5	16.2	83.4	101.0	249.3	77.3	87.7	44.4	48.7	72.8	37.0	63.8	28.6	39.3	65.3	62.6	79.7	77.4	137.3	50.7	35.2	30.2	84.2	72.3	103.1	92.0	52.6	48.8	84.7	143.2	254.3	77.4	65.9	71.8	147.0
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368988	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	32.6	34.1	50.8	33.6	55.8	65.9	36.0	53.4	69.4	36.0	49.2	42.8	31.1	36.8	47.0	49.3	34.3	26.7	36.4	49.5	55.3	40.3	30.6	35.3	46.6	55.4	53.4	33.3	47.8	56.0	30.8	43.1	54.8	32.7	38.5	49.6	35.0	33.1	54.4	43.4	35.1	34.5	52.4	37.4	39.5	57.0	53.3	57.2	40.1	44.3	50.0	35.5	35.6	57.6	78.4	67.8	116.4	69.7	48.2	47.7	76.6	62.8	61.7	96.9	43.8	114.3	77.5	116.1	64.2	56.0	60.4	70.7	107.6	63.3	111.1	53.2	89.1	79.0	54.2	159.2	56.7	110.0	83.5	34.9	93.2	49.9	85.5	58.8	65.6	113.0	115.8	36.2	59.9	51.0	125.2	147.0	91.5	82.0	63.5	151.8	109.2	84.8	85.6	54.5	90.0	73.1	76.3	73.2	53.6	99.0	43.9	98.5	66.8	61.3	74.4	51.0	62.0	17.0	7.1	196.9	48.1	78.5	62.2	6.2	5.1	7.6	6.4	4.4	4.9	6.1	6.4	6.0	4.1	6.2	7.1	8.7	2.9	9.8	4.1	8.5	6.9	3.0	50.8	55.8	53.4	69.4	49.5	55.3	55.4	53.4	54.8	52.4	53.3	57.6	73.7	38.5	64.4	16.0	54.6	50.7	41.1	16.9	20.5	89.0	63.4	63.8	35.7	52.9	29.6	49.7	66.7	70.6	124.6	51.1	107.6	22.3	47.4	75.1	62.9	42.0	36.0	76.4	14.6	23.0	49.5	41.3	40.2	89.1	15.2	84.3	38.6	45.8	29.9	90.9	15.8	46.6	20.3	40.3	24.5	22.5	32.6	45.9	26.6	17.8	38.4	81.2	82.4	30.2	32.7	23.9	36.4	28.2	74.2	62.2	32.0	72.3	36.7	120.6	52.6	78.4	46.5	203.6	157.2	44.8	63.2	72.4	55.7	59.3	46.1	66.6
BRD9	FLJ13441	ENSG00000028310	"Bromodomain containing 9"	Q9H8M2	5	850291-892801	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 110.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021465, HPA023197"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021465: AB_1845441, HPA023197: AB_2671106"	"unprognostic (3.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.61e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (5.88e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.53e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.37e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.02e-2)"	7.7	7.4	14.3	9.1	14.2	8.1	8.5	13.0	15.0	6.9	12.6	7.3	6.8	8.6	7.3	6.6	7.4	5.9	10.5	13.2	12.7	5.8	5.5	7.8	10.0	15.0	14.1	8.8	8.7	9.0	4.5	6.9	13.5	6.6	7.0	3.6	8.8	8.2	16.9	6.8	7.6	7.9	13.5	8.0	7.9	7.5	15.1	13.2	8.0	9.9	8.5	8.6	6.0	14.7	14.4	14.2	27.5	28.6	11.7	23.7	32.5	28.2	19.4	29.7	23.5	26.6	19.5	17.9	46.0	30.4	33.3	14.1	20.4	27.7	27.5	110.2	17.0	22.2	37.0	17.9	23.7	34.0	20.3	17.7	9.9	20.8	19.0	22.1	29.6	34.2	29.5	12.8	25.4	22.9	40.0	32.1	18.5	15.0	22.4	26.9	16.4	16.5	17.2	21.5	16.8	29.7	56.3	19.1	13.4	14.9	17.1	43.1	28.7	24.2	18.8	12.4	29.3	23.3	10.0	32.5	22.7	35.5	32.3	7.0	3.3	3.7	3.0	1.5	4.0	4.9	4.2	4.5	3.0	6.0	3.8	3.2	2.0	4.2	2.9	3.1	5.2	1.4	14.3	14.2	13.0	15.0	13.2	12.7	15.0	14.1	13.5	13.5	15.1	14.7	36.8	19.2	14.4	13.1	32.1	25.4	18.2	12.5	39.3	70.2	23.5	21.7	25.2	25.8	13.8	23.9	45.9	17.1	39.5	33.9	23.5	23.4	93.5	46.7	80.7	25.0	16.3	21.0	9.3	20.0	30.3	24.0	42.8	52.7	19.0	40.9	27.8	22.2	21.0	101.0	8.2	33.9	4.1	25.4	14.9	56.8	22.7	25.3	14.2	6.5	31.3	29.1	42.2	9.0	11.8	31.1	27.4	19.5	44.8	20.6	21.3	18.7	7.7	87.8	26.3	28.5	25.0	49.2	68.2	32.0	20.3	19.7	47.8	27.1	27.6	16.5
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"Biogenesis of ribosomes BRX1"	Q8TDN6	5	34915677-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.6	17.1	13.3	17.6	13.8	37.1	24.7	15.2	18.7	15.1	12.8	15.6	12.9	17.4	17.8	17.7	16.1	12.2	14.7	13.2	14.1	15.1	18.5	13.0	26.4	13.7	13.6	18.5	13.7	18.2	9.5	25.7	13.8	15.7	17.1	11.6	12.9	14.5	10.4	14.6	12.8	16.1	13.9	14.3	13.1	13.9	13.5	20.7	15.8	12.2	25.8	30.1	12.3	15.2	66.1	57.0	64.2	87.1	26.0	37.8	121.6	74.9	52.7	100.0	63.5	74.5	81.0	138.8	38.7	45.5	113.5	52.1	108.5	79.8	117.3	75.1	101.3	93.9	125.7	71.9	67.4	150.8	63.8	44.4	49.8	93.3	85.9	31.0	48.5	72.9	158.4	43.8	66.2	63.6	108.3	163.9	101.0	75.2	86.8	94.6	112.5	60.5	59.3	70.7	75.1	68.8	157.6	109.7	76.1	50.0	66.4	92.7	28.4	78.7	87.5	58.1	151.0	39.3	87.7	177.6	66.3	171.3	100.3	15.0	21.4	10.0	34.5	21.0	50.1	63.7	43.2	44.3	27.8	49.9	53.3	46.6	1.2	43.7	30.6	37.5	43.5	44.6	13.3	13.8	15.2	18.7	13.2	14.1	13.7	13.6	13.8	13.9	13.5	15.2	35.5	28.9	30.7	8.5	40.0	108.7	114.3	110.2	55.2	20.8	27.3	41.3	23.2	25.8	63.0	23.9	12.5	127.1	37.0	13.5	49.0	52.5	24.8	29.9	45.1	40.6	21.0	45.2	11.9	42.7	100.6	44.4	19.4	31.6	20.2	30.0	20.0	11.9	42.7	21.9	13.4	19.0	63.1	10.7	20.1	8.4	39.4	18.4	32.0	4.7	31.1	22.3	21.6	10.6	13.6	44.7	13.1	29.0	21.4	70.9	9.9	37.9	45.8	37.2	6.6	54.3	55.7	59.9	77.6	46.0	95.8	126.1	37.1	31.7	31.9	85.1
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32364633-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 37.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	36.8	63.0	28.0	17.4	29.4	77.1	37.8	31.7	30.6	38.7	27.3	35.9	25.4	35.3	24.9	36.7	35.3	23.3	35.9	28.9	27.2	38.7	73.2	33.7	22.4	32.5	27.8	54.5	56.0	42.3	46.5	22.1	28.8	41.0	22.5	21.7	45.0	24.3	36.7	47.5	34.8	20.7	28.1	35.8	41.0	51.3	28.4	19.5	37.9	16.3	21.8	33.2	36.5	35.9	24.3	16.2	32.8	25.2	38.6	29.6	25.6	23.0	43.9	39.8	41.0	18.1	19.9	17.8	27.0	41.3	22.6	26.1	23.4	21.6	25.6	33.4	33.3	14.2	35.5	22.1	33.2	17.6	24.7	35.5	46.4	30.7	23.2	47.8	24.8	28.0	36.4	30.8	22.3	10.7	18.7	10.3	20.8	14.1	19.0	18.8	18.8	24.7	22.6	19.5	34.6	25.0	22.1	22.7	25.2	37.7	21.4	13.9	30.1	22.1	19.8	28.3	22.6	42.2	41.6	15.9	25.8	22.3	13.5	37.4	5.1	18.3	6.2	5.9	6.1	7.0	5.5	5.2	4.9	8.3	6.0	5.6	8.4	6.1	5.0	6.5	7.3	6.2	28.0	29.4	31.7	30.6	28.9	27.2	32.5	27.8	28.8	28.1	28.4	35.9	24.6	32.1	18.6	23.5	42.8	28.4	56.6	31.5	25.6	53.6	38.9	26.7	19.4	55.8	21.9	25.8	83.4	51.1	38.8	59.3	19.6	37.8	88.9	23.7	26.3	35.2	40.1	76.0	25.6	44.1	31.0	32.7	27.0	34.4	21.0	36.1	50.0	56.7	20.0	85.8	31.6	47.8	28.5	25.8	13.1	100.7	54.7	20.1	32.0	25.3	28.0	30.3	57.7	29.1	35.0	45.6	40.0	47.4	32.1	58.4	63.9	28.0	18.4	69.8	39.5	33.1	38.1	42.9	45.9	21.2	25.9	96.5	34.6	60.5	39.3	57.2
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772987	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	10.8	7.5	7.4	12.2	8.9	12.7	13.5	10.5	9.3	11.8	8.5	11.9	11.0	15.4	10.5	11.4	13.7	8.1	8.0	7.3	8.8	9.1	9.7	12.2	16.4	8.6	8.1	16.0	11.3	10.5	8.0	11.0	8.8	10.2	13.4	10.6	10.1	10.6	12.3	11.2	12.8	12.8	7.7	12.7	11.3	21.6	8.5	25.5	12.0	14.0	18.8	11.0	11.2	10.4	22.4	12.0	33.3	20.1	10.4	12.5	16.6	21.6	23.9	24.3	23.5	28.6	33.0	47.1	26.8	17.9	25.4	30.7	27.2	16.8	26.6	27.8	11.1	55.1	8.8	21.8	12.7	46.9	31.6	11.3	19.2	20.6	20.8	15.6	24.0	46.1	36.0	22.8	20.2	17.7	57.5	41.0	20.0	31.6	19.0	42.9	28.6	36.3	17.0	25.5	19.7	26.2	25.3	18.3	10.0	21.0	25.1	30.6	13.7	27.7	17.5	14.3	29.0	9.3	12.4	39.1	9.0	42.6	25.3	15.8	7.6	20.2	10.0	7.8	10.8	10.4	8.6	7.9	8.2	7.4	9.5	8.1	9.1	7.5	8.7	7.2	8.1	5.7	7.4	8.9	10.5	9.3	7.3	8.8	8.6	8.1	8.8	7.7	8.5	10.4	11.7	9.6	5.6	6.2	14.3	7.6	10.8	7.1	11.4	6.8	6.6	6.0	4.9	2.8	6.5	9.2	12.5	9.2	9.5	11.7	7.9	8.5	13.5	10.4	8.7	8.5	9.6	17.7	7.2	8.1	10.5	7.8	7.1	9.3	11.4	9.6	7.1	8.0	8.2	3.3	6.8	6.9	2.0	12.0	6.7	5.3	9.0	7.8	7.2	3.7	9.4	7.3	26.8	9.0	11.2	6.4	8.5	10.9	16.6	6.4	15.4	5.8	10.9	7.3	6.6	8.5	7.7	51.2	21.8	11.0	4.8	9.9	13.1	7.9	11.3	7.0
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
C11orf1	FLJ23499	ENSG00000137720	"Chromosome 11 open reading frame 1"	Q9H5F2	11	111878935-111885975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 402.4;Late spermatids: 1147.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038410, HPA057519"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038410: AB_10672591, HPA057519: AB_2683454"	"unprognostic (1.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.86e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.08e-1)"	21.5	37.0	25.9	10.4	29.0	18.1	49.2	26.4	36.1	20.5	24.6	26.3	20.4	17.2	64.2	24.0	28.6	19.6	33.0	26.1	27.5	70.3	54.9	16.3	15.1	26.1	26.7	28.0	48.0	39.9	28.4	9.4	26.5	27.4	26.4	22.3	33.0	26.8	16.2	34.8	21.4	14.9	25.7	11.6	30.6	61.2	27.1	20.3	41.1	21.1	17.8	22.7	18.4	27.0	25.1	31.9	40.3	44.6	45.6	34.3	42.0	13.5	34.2	10.9	13.8	54.5	45.6	91.9	63.5	23.2	31.4	28.9	16.5	50.2	17.0	40.6	23.4	30.9	6.9	42.0	28.6	45.7	20.9	63.8	76.9	39.0	74.4	48.4	13.5	96.2	45.3	66.8	36.9	25.0	62.2	70.8	46.3	86.8	48.0	31.5	42.0	127.6	69.4	46.0	36.3	34.1	8.7	31.5	31.3	38.4	63.1	31.8	11.7	40.2	28.8	17.6	19.1	38.8	61.2	136.7	20.3	53.1	24.9	6.5	7.4	9.0	13.0	14.6	24.9	26.0	22.0	17.0	11.1	17.7	34.5	26.5	1.7	16.7	10.1	32.8	17.6	10.2	25.9	29.0	26.4	36.1	26.1	27.5	26.1	26.7	26.5	25.7	27.1	27.0	14.3	25.6	19.8	3.6	22.6	23.7	67.5	60.6	71.2	8.6	56.5	79.6	57.6	28.6	43.4	35.0	6.2	28.9	17.3	15.1	201.5	21.8	402.4	30.5	17.3	15.3	26.4	26.3	3.5	27.2	22.5	16.5	22.4	22.6	29.2	23.3	11.0	43.4	23.0	15.2	4.7	39.8	28.5	7.9	11.4	1147.2	27.4	14.3	24.9	3.7	19.3	43.5	20.6	1.0	3.7	18.9	22.3	24.5	41.9	36.4	40.6	197.9	44.4	15.5	19.7	10.8	17.0	54.4	30.9	53.4	29.5	21.1	22.6	49.2	44.4	72.7
C11orf52	"FLJ25219, MGC14839"	ENSG00000149300	"Chromosome 11 open reading frame 52"	Q96A22	11	111918032-111926871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.8;Breast glandular cells: 3.3;Cholangiocytes: 2.8;Endometrial ciliated cells: 3.1;Gastric mucus-secreting cells: 4.1;Respiratory ciliated cells: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;CAPAN-2: 23.5;Hep G2: 18.2;MCF7: 17.6;RPTEC TERT1: 27.1;SK-BR-3: 22.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038387, HPA038388"	Uncertain		Enhanced	"Cell Junctions"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions"		"HPA038387: AB_10670167, HPA038388: AB_2675987"	"unprognostic (1.30e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.57e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.44e-1)"		"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	3.3	0.7	1.0	0.4	0.9	0.0	25.9	4.1	1.3	3.8	2.2	5.2	10.4	2.3	23.7	6.4	17.7	12.3	3.2	0.9	0.9	43.9	22.8	9.7	0.1	1.1	1.0	1.5	25.8	30.8	16.4	10.1	1.7	15.4	6.2	0.1	26.8	10.2	9.3	9.7	9.2	0.8	1.1	0.9	20.9	1.0	1.1	1.0	20.1	8.3	1.3	4.6	3.2	1.5	4.3	0.0	0.0	0.0	2.9	0.4	17.7	1.0	0.8	0.1	0.0	6.8	23.5	0.0	10.6	2.3	0.0	5.4	0.0	1.4	0.1	0.0	0.7	0.0	0.5	18.2	0.0	0.0	0.0	0.3	5.2	0.0	0.2	0.2	1.0	0.0	0.0	0.0	1.5	17.6	0.0	0.2	0.1	12.5	1.8	0.0	1.5	0.0	27.1	15.6	1.2	0.0	0.0	22.9	0.0	2.4	76.5	1.6	2.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	4.1	1.3	0.9	0.9	1.1	1.0	1.7	1.1	1.1	1.5	0.0	6.4	2.8	0.0	0.0	0.1	1.6	0.2	1.2	0.0	3.3	0.9	0.6	2.8	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.3	0.0	3.1	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.5	4.1	1.9	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	1.9	1.3	6.7	0.0	0.0	0.3	0.3	0.1	0.1	0.6	0.3	1.4	0.0	0.2	0.2	0.7
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 139.0"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 2360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063943, HPA074787"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA063943: AB_2685157, HPA074787: AB_2686712"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	5.8	10.7	11.8	5.1	13.7	3.7	7.6	12.3	13.8	5.5	10.8	6.9	7.6	5.1	22.6	4.3	7.1	4.4	9.3	11.7	13.9	13.9	22.1	5.9	6.7	14.0	16.7	7.2	8.7	8.9	13.4	3.7	13.2	8.5	6.2	15.9	9.8	5.7	15.0	9.4	7.5	2.9	12.2	9.4	7.3	139.0	12.7	8.9	12.4	15.2	4.7	4.6	4.1	16.0	1.2	3.9	4.2	13.6	6.2	3.6	2.9	0.6	1.7	1.7	1.5	3.0	23.6	6.8	7.8	1.0	8.1	6.3	2.8	2.9	2.1	7.5	1.6	5.1	3.2	6.9	5.9	3.0	5.5	5.9	3.2	2.2	6.7	1.9	2.1	10.8	5.1	6.0	3.2	5.5	5.5	4.6	2.2	5.5	2.5	3.9	3.4	17.3	3.8	3.0	11.6	4.6	15.3	1.8	2.4	4.4	11.5	1.6	2.1	0.4	5.9	4.6	1.2	5.8	10.1	5.2	0.9	6.9	1.7	15.9	15.4	10.3	8.8	9.8	5.5	5.9	5.7	6.0	9.3	8.3	9.5	9.9	12.3	12.1	11.9	12.0	7.1	10.1	11.8	13.7	12.3	13.8	11.7	13.9	14.0	16.7	13.2	12.2	12.7	16.0	12.7	3.2	13.4	5.2	8.0	2.7	15.7	6.3	8.6	10.3	18.3	15.9	19.0	0.0	6.2	5.5	4.2	16.1	6.4	15.0	82.2	15.7	589.6	21.2	8.1	8.7	18.1	7.2	4.7	18.9	3.4	9.5	18.8	12.8	6.3	14.1	0.0	0.0	11.5	13.5	5.6	16.7	10.2	0.0	4.1	2360.8	13.1	13.6	5.4	2.8	11.2	31.5	7.2	4.0	18.5	10.5	15.5	9.1	17.2	9.2	33.0	78.6	18.9	14.1	6.6	7.6	8.0	70.6	9.9	10.4	2.6	14.6	7.4	19.6	12.7	11.4
C12orf43	"Custos, FLJ12448"	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	9.8	8.1	11.7	6.9	11.9	7.4	9.3	8.8	13.6	7.8	7.2	11.2	5.0	9.5	4.4	7.2	9.0	5.1	7.4	12.3	9.5	8.2	10.5	6.7	8.7	10.9	9.6	11.2	7.5	9.0	7.4	7.2	10.8	7.7	5.3	6.0	8.7	6.2	7.2	6.7	6.7	8.4	8.6	7.8	8.2	6.1	9.4	7.2	6.4	5.9	7.4	9.6	7.0	10.4	14.2	31.4	16.2	12.8	14.0	11.0	17.8	17.2	17.5	28.3	17.9	22.8	13.0	26.2	17.2	16.8	15.0	15.7	19.2	26.3	16.8	31.6	21.4	21.1	12.4	17.1	16.7	28.1	16.2	12.9	13.6	26.0	16.4	17.9	16.4	27.0	25.5	6.7	15.1	23.3	30.9	22.0	28.8	11.1	23.2	27.4	19.0	19.8	17.5	20.8	22.0	14.0	23.0	9.9	18.6	13.4	27.0	13.1	15.9	15.6	18.7	12.8	18.4	12.3	19.1	20.5	20.5	16.5	23.6	5.7	15.6	9.0	23.8	21.3	21.8	23.8	23.5	23.2	16.1	19.0	27.5	23.6	2.2	18.4	18.5	13.3	23.8	20.6	11.7	11.9	8.8	13.6	12.3	9.5	10.9	9.6	10.8	8.6	9.4	10.4	16.1	25.6	18.1	3.3	17.3	8.8	16.4	12.2	6.8	19.6	12.4	12.4	7.0	11.5	9.6	18.4	20.9	24.3	13.9	8.6	23.5	16.5	5.9	9.8	17.1	16.0	2.4	10.7	6.8	18.5	22.3	16.3	8.2	10.1	14.5	22.3	12.5	11.7	16.7	16.8	6.4	9.5	10.2	10.4	7.3	13.8	13.7	13.2	14.2	3.7	21.7	18.8	24.7	4.0	4.8	15.6	12.3	12.8	11.3	13.8	5.3	16.7	16.3	15.7	19.7	19.6	16.9	16.3	16.4	12.7	7.7	13.7	17.6	16.0	10.9	14.0
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	254.8	199.9	230.6	76.1	231.7	128.4	282.7	235.0	329.3	411.9	239.0	242.7	76.5	296.1	85.9	143.9	328.1	134.2	327.9	221.9	240.4	225.2	205.5	217.9	183.5	233.4	235.7	574.0	300.7	117.2	332.4	75.2	233.9	297.0	69.5	37.0	173.2	157.1	194.2	307.1	163.3	85.2	227.6	160.7	220.3	82.1	252.6	262.6	214.2	179.8	77.0	263.9	270.0	236.8	88.3	253.6	291.0	288.0	196.6	233.8	96.1	113.7	277.0	96.4	153.0	101.4	146.8	27.0	88.1	178.1	124.4	83.6	111.2	140.6	23.1	158.1	232.8	234.8	191.4	145.2	372.3	96.9	220.7	281.9	164.7	74.6	101.7	188.8	164.2	216.5	82.2	230.3	90.5	264.3	204.6	124.8	522.0	146.3	92.2	224.4	259.7	404.8	131.2	218.8	128.9	377.5	182.8	184.3	242.6	136.7	46.8	501.1	174.3	192.7	181.8	77.9	173.0	169.8	150.0	149.8	198.6	2.4	132.2	75.7	20.0	19.3	187.8	34.2	123.6	133.2	208.5	199.6	29.5	163.8	248.0	203.7	7.9	99.9	87.0	225.2	204.5	160.1	230.6	231.7	235.0	329.3	221.9	240.4	233.4	235.7	233.9	227.6	252.6	236.8	260.9	64.1	129.2	11.1	256.4	264.5	285.2	255.3	546.9	90.6	284.2	624.3	219.4	211.6	146.0	123.2	25.0	131.4	216.3	262.8	365.9	191.9	175.7	122.1	336.7	206.8	312.1	81.6	7.4	423.9	219.4	340.3	179.4	146.9	148.9	86.2	204.9	307.0	67.2	37.0	11.0	686.2	162.8	88.9	138.1	299.5	453.3	120.2	231.3	15.0	58.4	197.5	200.8	7.1	8.9	205.5	240.0	377.3	216.6	279.5	146.8	244.4	89.0	94.9	289.3	389.2	473.4	75.1	86.0	301.7	215.0	154.2	328.2	157.0	349.5	215.6
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.9;testis: 73.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.9;Late spermatids: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.0;granulocytes: 23.5;monocytes: 16.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA039961: AB_10673024, HPA041907: AB_2677736"	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.9	15.5	4.4	12.7	4.6	61.9	13.7	2.4	8.3	13.7	4.6	10.8	11.5	14.4	1.9	20.4	16.1	7.9	14.4	3.3	5.7	8.6	4.3	15.3	10.9	6.3	5.4	18.2	14.5	15.7	8.9	15.2	4.6	8.8	5.3	1.8	14.4	6.8	4.1	15.3	10.2	7.2	5.0	25.5	9.6	73.7	7.7	8.7	11.1	3.8	6.7	15.0	14.4	4.2	20.5	41.2	8.8	10.3	11.7	7.6	26.4	5.8	11.7	6.7	7.2	51.2	27.8	45.9	19.1	8.6	24.0	27.0	37.6	17.5	1.9	45.0	42.7	91.0	19.6	35.4	13.3	26.4	90.1	10.0	13.7	14.2	6.6	8.3	17.2	17.1	39.7	66.4	2.2	12.3	25.5	32.2	27.4	13.6	16.3	23.0	6.6	49.3	4.1	15.9	25.4	8.1	13.4	30.6	21.2	8.8	10.5	33.2	14.7	11.6	17.3	20.6	17.0	47.8	32.9	26.3	11.4	50.3	11.5	8.5	6.4	18.6	1.7	11.7	1.3	1.1	1.0	1.2	3.9	0.7	0.7	1.1	23.5	3.4	16.2	8.0	1.4	4.1	4.4	4.6	2.4	8.3	3.3	5.7	6.3	5.4	4.6	5.0	7.7	4.2	13.0	25.6	5.5	0.7	7.8	14.9	7.0	5.5	19.9	0.3	8.1	5.8	2.3	7.2	9.6	3.7	0.0	12.6	17.7	13.5	0.0	15.8	50.9	17.2	10.0	10.4	7.7	5.9	0.4	14.6	16.8	7.8	8.6	30.0	17.7	14.3	10.8	2.8	12.4	0.0	1.0	6.1	6.1	23.6	10.5	68.8	11.8	24.0	7.2	1.9	31.6	0.7	12.3	1.0	0.1	18.1	26.1	10.9	19.9	5.2	3.4	1.6	8.1	2.2	13.1	6.5	10.0	37.2	5.6	15.5	14.2	20.9	7.3	3.7	8.6	17.8
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 90.0;skeletal muscle: 259.4;tongue: 139.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.2;Late spermatids: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 29.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	6.7	5.9	16.0	6.6	16.1	8.3	8.3	11.6	14.7	8.6	1.8	7.6	5.6	7.7	4.0	12.6	6.0	3.5	90.0	12.2	10.0	5.8	7.7	6.4	7.6	15.4	15.0	6.7	5.2	6.6	7.5	6.5	14.0	8.8	2.9	2.5	10.5	6.4	259.4	12.3	6.0	3.9	13.1	7.4	6.2	26.5	13.9	7.3	6.9	139.1	4.4	8.5	8.7	17.1	20.3	30.5	12.7	13.8	7.4	6.6	17.4	20.6	9.3	19.1	22.9	25.5	8.3	23.5	11.1	9.7	10.0	9.9	15.5	18.9	7.9	29.1	19.1	19.3	18.2	19.6	5.5	19.5	11.9	6.6	11.0	25.6	9.0	5.1	11.7	21.5	24.0	13.4	15.9	19.9	29.4	11.0	8.2	16.2	11.5	28.8	20.7	11.8	6.1	17.6	16.2	13.2	22.1	20.5	8.1	7.4	12.2	15.9	15.7	23.7	16.6	16.2	28.4	16.0	24.2	24.1	10.1	18.6	16.7	29.0	2.2	6.6	1.6	2.0	2.0	2.0	3.0	2.7	2.1	2.5	2.0	1.4	7.3	2.5	2.3	2.1	2.3	2.1	16.0	16.1	11.6	14.7	12.2	10.0	15.4	15.0	14.0	13.1	13.9	17.1	2.6	3.2	2.8	9.1	2.6	4.8	3.2	2.6	4.0	3.1	4.9	5.0	45.2	2.8	2.3	0.0	2.1	11.0	1.5	3.6	0.0	3.5	12.5	2.5	2.3	4.3	3.6	1.7	19.2	4.7	13.8	6.2	2.6	2.7	4.5	3.6	5.7	5.0	6.6	3.3	15.4	3.4	0.0	6.2	4.1	27.4	1.8	2.8	5.4	8.4	3.3	2.9	3.1	9.5	11.2	4.4	1.4	6.8	6.5	2.0	2.8	2.8	1.3	2.0	6.6	7.1	3.8	18.2	6.3	4.1	7.0	15.9	3.3	1.4	2.4	1.8
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018522-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.3;lung: 72.9;stomach 1: 58.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 176.3;Alveolar cells type 2: 99.4;Club cells: 68.5;Urothelial cells: 128.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 65.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 57.7;CAPAN-2: 99.5;HaCaT: 123.1;HBEC3-KT: 118.6;hTCEpi: 61.4;RPTEC TERT1: 56.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		180000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.4	0.0	1.6	0.0	0.8	10.4	0.0	0.1	15.1	0.0	8.9	24.5	0.2	0.7	102.3	2.6	9.8	0.5	0.0	0.0	8.4	0.5	72.9	0.0	0.0	0.0	0.1	12.9	0.0	0.3	0.2	0.0	50.9	8.4	0.0	29.4	1.9	0.5	37.7	20.3	0.3	0.0	0.2	58.7	0.9	0.0	0.3	4.2	0.5	16.1	20.6	31.2	0.0	57.7	7.7	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.1	99.5	0.0	6.5	0.0	0.0	123.1	0.0	118.6	0.0	0.1	0.0	10.6	1.0	1.6	0.0	0.0	0.6	0.0	61.4	0.0	34.2	0.0	0.0	0.2	6.9	0.1	0.0	0.1	0.1	0.2	0.1	37.3	3.3	0.0	0.0	0.2	56.4	15.1	0.1	0.3	1.1	11.1	0.5	0.4	0.2	0.2	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	176.3	99.4	0.0	0.3	20.8	53.0	26.8	10.8	0.0	5.4	7.2	49.9	30.0	68.5	11.0	0.0	0.1	0.1	40.7	15.6	24.3	5.7	6.7	1.4	1.7	10.7	0.0	0.1	24.4	0.0	1.6	50.4	14.9	6.3	0.0	0.0	0.0	0.2	0.0	0.1	19.8	12.2	0.0	1.2	5.5	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	60.7	35.3	0.0	0.3	56.5	31.8	0.3	41.0	0.0	0.0	0.0	2.8	0.1	0.0	24.3	23.3	0.0	0.3	0.1	8.9	128.1
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA008270: AB_1845633, HPA065778: AB_2685557"	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	11.6	12.1	8.7	10.2	9.0	13.4	11.2	9.0	10.1	10.7	9.9	13.4	6.8	11.8	9.4	13.8	10.8	8.5	10.9	9.3	9.0	13.4	18.5	10.3	11.4	9.0	8.8	11.0	14.4	6.9	7.5	10.3	9.4	10.3	6.5	4.3	11.1	6.9	15.5	9.9	12.2	7.8	9.4	15.4	12.2	13.2	8.8	13.9	11.5	14.0	11.9	12.2	11.0	9.4	27.6	15.5	23.2	22.0	20.3	12.1	15.6	23.6	13.7	21.8	22.1	24.4	43.4	21.5	28.8	18.7	31.1	27.7	27.6	17.5	23.5	39.3	25.4	56.6	14.2	33.8	11.8	39.9	29.1	13.1	9.9	24.2	15.3	17.3	18.6	27.3	45.9	22.2	14.8	21.8	44.4	30.2	28.6	36.2	32.4	32.7	42.2	20.6	15.1	16.4	23.6	19.1	22.2	30.5	35.7	23.4	14.3	24.8	20.4	29.9	23.9	52.4	25.1	7.2	7.8	39.7	15.5	42.4	10.9	61.5	26.5	50.8	43.7	50.7	38.5	25.2	29.7	34.0	31.8	23.8	27.4	35.4	22.6	29.6	33.5	17.4	32.9	23.9	8.7	9.0	9.0	10.1	9.3	9.0	9.0	8.8	9.4	9.4	8.8	9.4	20.7	9.6	7.7	4.6	21.1	21.9	13.1	17.6	19.9	11.9	15.6	12.8	3.9	22.8	15.6	5.5	8.4	59.8	46.2	11.6	27.4	22.4	114.8	14.7	16.0	16.8	11.4	28.2	5.1	19.6	61.9	16.1	14.8	13.3	36.8	21.6	13.9	15.7	31.5	11.8	7.2	15.6	16.2	17.3	14.5	20.5	17.1	20.7	14.2	4.7	20.4	13.3	50.4	6.6	13.2	17.7	15.2	19.2	17.4	18.9	15.1	20.9	11.7	12.6	13.1	16.5	17.4	32.3	32.6	21.8	17.6	26.7	24.7	21.7	19.8	12.1
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA036072: AB_10602696, HPA061790: AB_2684610"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.93e-4)"	"prognostic unfavorable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	15.1	11.0	11.7	10.3	15.0	23.0	13.4	9.4	16.7	13.8	5.5	14.2	6.3	11.7	7.5	13.1	12.5	6.7	14.8	17.7	10.6	12.2	15.2	14.0	15.2	10.7	11.8	13.0	13.0	5.3	13.3	12.2	11.0	12.5	6.5	10.7	9.2	7.3	16.3	12.2	11.4	5.2	8.8	14.8	12.0	15.9	11.5	9.7	11.5	9.9	8.5	12.9	13.1	16.2	25.6	12.1	17.3	15.6	18.6	14.4	21.4	20.4	10.6	26.2	23.2	17.2	13.1	20.0	17.2	22.5	14.7	16.1	42.4	12.3	13.0	26.1	25.4	32.2	19.5	15.5	11.3	28.0	14.2	9.4	17.8	24.1	11.9	13.0	9.7	35.2	35.9	23.6	13.0	7.3	27.3	13.8	63.7	12.0	9.8	28.3	18.5	10.8	14.2	7.0	7.3	16.4	5.0	16.3	20.7	17.4	8.8	57.7	16.6	10.6	19.5	27.2	32.8	22.6	46.2	28.3	8.9	21.7	12.9	17.6	18.4	30.0	19.5	28.6	21.1	35.5	18.1	17.2	24.7	19.6	27.5	26.4	30.1	19.7	24.0	26.8	17.3	22.3	11.7	15.0	9.4	16.7	17.7	10.6	10.7	11.8	11.0	8.8	11.5	16.2	46.7	44.8	34.3	31.3	48.4	145.4	55.0	60.0	56.9	23.5	51.9	50.3	24.3	21.5	46.0	16.5	22.9	61.3	56.3	23.4	19.6	33.3	69.0	36.3	36.1	40.7	38.8	29.0	37.4	27.5	61.1	46.9	23.4	40.9	51.3	25.4	29.6	16.6	37.1	15.2	21.7	25.1	77.3	28.9	81.6	16.8	36.7	32.5	32.0	21.5	25.4	30.8	38.1	23.1	58.6	37.9	24.6	24.5	42.7	53.0	25.9	19.7	34.0	27.1	39.5	27.7	45.6	92.5	67.3	63.9	128.9	67.9	53.4	27.5	24.7	71.5
C2orf42	FLJ20558	ENSG00000115998	"Chromosome 2 open reading frame 42"	Q9NWW7	2	70149885-70248615	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 262.9;Late spermatids: 98.5;Spermatocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031840, HPA031841, HPA031842"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068"	"unprognostic (8.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.73e-1)"	"prognostic favorable (5.94e-5)"	"unprognostic (4.66e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-3)"	6.5	7.3	11.2	5.9	12.7	4.8	6.4	16.3	12.5	7.8	10.6	6.5	4.4	8.5	10.9	6.4	11.2	7.5	5.8	10.4	11.7	8.4	15.4	6.0	12.4	10.8	11.5	10.2	6.7	11.5	7.8	8.0	11.5	6.7	5.2	7.5	6.4	7.2	6.7	6.7	6.3	7.5	10.9	8.8	6.1	59.0	11.9	10.1	8.2	8.4	11.6	8.2	6.2	16.1	5.9	9.6	8.9	8.1	17.9	10.4	10.1	13.9	9.4	11.0	9.4	7.8	5.1	7.5	7.9	8.3	18.0	8.0	9.4	7.9	12.2	13.1	8.3	8.8	6.8	7.7	15.9	7.3	8.6	12.5	14.1	10.5	13.3	12.0	10.8	9.4	7.5	27.6	14.7	4.6	9.4	10.7	6.4	9.9	10.6	8.8	12.1	13.8	9.0	6.8	7.4	7.5	7.5	11.6	14.4	6.2	5.2	8.9	8.5	9.8	6.7	9.1	11.4	15.1	16.2	7.5	7.6	11.8	8.9	2.3	7.7	9.9	12.1	7.2	15.5	14.2	12.2	14.7	7.9	13.0	13.9	14.9	8.3	21.9	7.8	7.0	15.5	10.9	11.2	12.7	16.3	12.5	10.4	11.7	10.8	11.5	11.5	10.9	11.9	16.1	4.0	0.0	2.2	7.8	8.9	2.5	3.4	3.7	5.7	5.8	4.0	5.0	2.8	1.5	2.8	5.5	0.0	8.8	6.1	4.2	7.9	4.5	262.9	3.8	3.3	3.6	1.2	4.0	9.2	2.4	4.0	4.4	3.6	2.8	2.5	5.0	6.4	6.9	4.3	0.0	8.9	2.1	2.0	4.7	3.1	98.5	7.5	3.6	3.6	2.8	3.1	9.0	9.2	8.0	12.3	2.0	3.1	7.9	8.4	2.9	3.3	6.4	6.6	4.1	0.0	4.2	3.8	63.1	12.0	3.5	4.3	9.6	5.3	4.3	2.5	2.0
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	11.0	8.7	10.4	9.8	13.2	2.7	11.5	12.6	14.3	9.9	6.0	8.0	7.8	10.2	15.3	10.8	7.9	8.8	9.6	10.1	12.3	10.9	10.4	7.9	10.5	12.4	12.4	15.5	8.8	15.3	5.0	12.9	12.4	11.5	9.0	15.6	8.9	10.5	4.5	9.1	7.8	12.2	12.0	9.8	7.5	7.1	12.0	15.9	13.7	7.5	10.6	10.5	7.4	16.7	14.8	11.2	22.3	46.9	44.7	35.0	24.3	17.1	29.6	23.7	25.2	11.3	14.9	15.9	20.7	19.2	41.3	9.4	29.8	16.2	34.2	21.4	9.1	15.4	33.0	17.0	54.0	19.8	11.2	34.2	23.0	27.9	31.9	15.1	20.8	19.0	27.8	26.5	25.4	15.5	18.7	20.2	22.4	9.0	6.0	16.2	31.0	24.7	15.9	14.1	13.5	21.2	54.9	25.9	29.0	19.9	28.9	20.0	15.1	28.0	16.7	21.5	16.8	13.3	23.2	15.7	31.2	34.1	20.4	34.3	8.0	7.8	4.9	6.2	6.4	5.6	5.7	5.4	7.8	5.8	7.6	5.2	5.3	6.5	9.2	4.5	4.4	9.8	10.4	13.2	12.6	14.3	10.1	12.3	12.4	12.4	12.4	12.0	12.0	16.7	13.3	32.1	11.5	12.7	16.6	9.9	8.7	10.4	21.6	11.5	13.9	12.4	14.5	8.6	9.5	14.7	6.2	12.5	10.4	7.1	9.8	12.0	13.1	8.1	14.4	11.9	10.8	14.1	11.8	7.6	12.4	19.2	11.2	10.0	5.1	10.3	10.4	20.2	15.0	8.4	13.8	9.1	6.1	17.6	7.9	11.8	9.0	13.0	7.2	4.7	13.8	18.6	10.3	16.6	20.9	8.1	7.3	7.9	11.0	11.6	5.7	12.8	9.6	11.2	13.1	12.8	16.5	9.0	8.3	30.1	13.2	16.8	10.6	9.0	7.1	9.9
C9orf78	"CSU2, HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 414.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	38.4	36.9	53.7	33.4	55.5	113.6	35.7	53.8	62.3	35.3	49.7	41.7	27.2	36.1	35.4	36.9	32.4	31.3	37.5	54.0	55.4	47.8	61.0	29.7	49.6	55.5	55.3	36.3	38.2	29.2	29.4	27.9	54.8	35.5	33.5	20.7	35.5	30.8	67.6	40.9	37.1	29.1	54.4	37.3	36.5	33.2	56.5	60.5	37.9	36.5	44.4	40.9	34.3	56.3	36.0	36.3	36.9	59.8	66.4	44.4	44.4	51.7	41.0	44.7	32.5	37.0	38.3	57.9	41.6	60.5	72.6	71.8	52.8	41.9	36.9	57.2	37.8	92.1	63.6	40.8	42.7	131.5	91.1	39.2	78.2	56.5	47.9	44.2	42.9	242.6	235.4	68.3	57.3	87.4	175.0	160.3	53.2	143.9	81.4	47.8	57.1	117.8	46.3	24.9	31.6	60.0	76.2	73.0	63.3	35.8	63.9	88.6	47.2	68.5	50.1	68.2	63.6	30.2	94.6	89.9	57.1	105.1	57.3	164.4	82.1	219.5	150.2	131.0	150.4	105.3	156.0	164.3	69.7	106.5	174.8	159.8	63.8	147.9	172.7	82.7	184.6	138.6	53.7	55.5	53.8	62.3	54.0	55.4	55.5	55.3	54.8	54.4	56.5	56.3	55.7	89.8	84.6	7.8	93.9	78.1	64.8	60.2	55.2	39.8	57.3	58.5	55.5	57.2	81.6	57.0	37.5	71.9	160.1	60.7	125.2	65.1	58.8	46.7	57.7	58.4	84.4	414.9	12.5	89.6	78.3	55.4	39.3	41.1	134.1	34.8	45.7	83.3	66.3	32.0	12.8	64.5	109.9	66.6	78.2	17.7	59.0	75.0	72.9	8.4	102.6	62.3	178.2	5.0	9.9	65.7	44.0	60.9	73.9	68.4	102.8	183.4	72.8	35.1	78.9	59.9	68.0	119.8	117.7	63.2	85.0	67.6	172.4	45.3	58.0	55.9
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175012027	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 191.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	26.5	22.6	60.7	25.5	63.4	33.8	20.6	66.8	191.9	21.8	48.5	25.6	15.9	19.1	24.4	23.8	17.4	14.7	26.8	66.3	65.6	27.2	25.7	23.7	32.7	60.8	61.8	34.8	15.9	20.5	26.9	22.8	66.8	15.3	20.7	52.5	17.5	18.5	37.7	17.4	19.1	16.4	57.8	24.1	20.3	30.5	58.7	27.9	14.9	27.4	28.9	28.0	20.4	71.9	127.7	85.6	124.0	53.1	40.2	44.8	79.5	94.7	55.6	119.8	86.8	88.9	76.9	132.8	96.0	67.5	85.8	67.3	155.0	69.4	122.7	70.6	92.4	99.6	80.8	96.3	30.1	135.4	59.9	30.3	42.2	98.7	58.8	62.0	85.5	117.0	203.7	72.2	87.0	47.4	208.2	121.5	118.0	189.1	39.4	93.6	87.9	152.5	85.4	99.8	84.9	81.4	64.7	111.0	106.3	165.7	86.8	116.6	44.9	67.9	73.3	96.0	153.8	68.6	211.5	301.8	57.1	117.1	80.6	34.0	25.5	27.9	29.4	41.7	35.4	43.0	42.0	36.2	32.3	33.7	44.6	39.9	14.6	43.7	54.9	28.3	48.7	46.1	60.7	63.4	66.8	191.9	66.3	65.6	60.8	61.8	66.8	57.8	58.7	71.9	70.6	86.6	41.9	13.1	82.1	117.0	183.6	102.2	63.7	57.7	61.8	79.0	108.1	40.0	62.7	35.0	62.6	238.8	68.7	66.2	152.6	96.8	102.2	124.5	67.6	80.0	119.6	113.0	22.4	95.0	304.1	92.8	36.7	167.3	92.0	52.8	44.3	39.4	196.3	30.3	24.1	101.6	67.1	56.0	188.2	30.6	86.0	110.9	108.5	13.1	231.0	77.8	60.8	8.5	28.0	106.9	58.4	73.7	90.7	115.4	80.7	171.4	78.0	84.0	32.9	57.6	108.4	186.7	139.9	88.7	85.7	143.5	188.0	76.5	139.1	106.9
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 109.6;hTERT-RPE1: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	125.7	71.3	81.0	25.0	92.7	35.0	115.3	93.5	100.3	102.4	95.0	163.1	31.0	105.3	69.1	71.2	101.7	55.6	142.9	82.0	81.9	73.8	57.0	98.3	33.8	85.2	81.4	110.9	108.3	65.6	80.2	50.3	87.1	90.6	35.4	47.6	119.8	55.5	264.2	180.8	88.3	53.2	78.1	91.0	126.5	49.5	82.7	36.3	89.2	120.6	37.5	125.0	96.4	88.7	12.1	13.8	20.4	26.8	109.6	71.5	13.1	26.4	56.2	19.4	26.6	6.7	52.7	4.9	23.7	61.3	10.0	15.8	8.2	22.3	20.7	20.1	17.1	9.9	31.5	5.4	53.3	4.2	22.0	99.8	58.2	20.3	19.8	146.7	35.2	22.0	8.1	46.7	34.2	5.2	13.5	15.9	4.2	10.9	15.1	13.6	11.3	17.2	31.9	8.4	11.7	21.0	15.1	8.3	26.7	42.5	24.6	13.0	41.2	10.0	13.0	9.5	3.8	42.5	12.8	1.8	46.1	4.9	12.8	85.2	19.6	76.7	26.1	22.4	18.7	14.5	17.8	20.8	11.6	17.1	15.7	17.6	72.0	20.2	23.7	8.8	33.4	23.8	81.0	92.7	93.5	100.3	82.0	81.9	85.2	81.4	87.1	78.1	82.7	88.7	33.0	35.3	14.4	18.9	19.8	32.4	19.0	16.7	30.1	34.3	32.8	27.6	11.7	25.8	16.8	22.0	35.5	23.8	26.0	13.6	5.9	16.7	40.7	27.1	19.4	23.4	28.6	32.0	31.1	11.7	8.8	29.2	16.8	17.5	7.6	29.1	31.8	17.9	15.9	26.9	33.3	18.7	24.4	26.0	15.3	54.0	47.5	28.6	19.6	11.2	21.9	25.3	64.9	20.6	22.6	22.0	17.5	41.3	53.5	20.1	25.9	14.0	26.5	44.6	19.7	28.6	29.5	24.2	9.3	16.7	50.7	45.6	27.3	27.5	13.0	26.4
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987675	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	15.8	15.6	10.7	13.6	15.9	10.3	15.0	5.2	36.7	14.8	0.0	19.6	10.3	17.0	4.4	14.4	14.4	8.7	17.7	24.2	3.4	16.0	12.9	18.4	9.7	10.0	4.4	14.8	17.5	19.2	26.0	7.4	8.5	15.1	10.8	10.7	13.9	11.6	38.0	17.4	19.0	14.2	0.5	21.6	18.6	14.5	7.3	10.4	17.0	27.5	9.5	16.0	13.0	18.4	13.2	23.2	4.2	6.1	27.8	19.0	8.6	12.4	13.8	11.6	10.1	5.9	3.6	15.5	11.9	19.7	9.8	13.1	16.2	19.5	6.6	21.8	20.7	9.8	13.3	6.6	15.9	5.8	40.4	13.4	24.0	10.8	17.1	14.0	19.6	11.8	16.2	13.9	11.0	8.8	10.3	3.7	0.6	15.6	9.5	8.9	4.8	6.1	13.1	13.8	5.8	5.1	7.8	14.1	3.8	7.2	12.6	5.6	25.6	9.1	5.3	9.8	20.6	6.8	8.0	5.6	22.4	11.5	9.2	0.5	1.2	0.9	1.3	1.6	1.0	0.6	0.6	1.2	0.7	0.4	0.8	1.0	3.0	0.6	4.9	1.1	0.5	1.4	10.7	15.9	5.2	36.7	24.2	3.4	10.0	4.4	8.5	0.5	7.3	18.4	15.2	3.2	11.3	11.4	9.2	6.9	3.7	11.6	8.6	14.7	11.9	8.9	8.0	12.8	6.9	11.0	10.4	5.9	9.0	16.1	1.9	7.9	30.1	5.9	12.6	10.0	11.4	7.4	17.9	11.2	9.6	12.3	20.4	11.6	13.3	14.7	16.8	15.3	8.5	35.3	15.7	13.9	20.3	16.7	10.2	54.3	10.2	13.1	3.6	4.7	14.9	6.5	12.3	9.0	9.5	10.6	13.9	9.4	9.0	6.3	20.1	15.4	6.1	11.2	13.1	7.9	14.8	7.2	6.9	8.8	10.4	12.4	11.4	14.4	12.2	4.1
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269358-67319953	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		5900000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	18.4	23.1	19.6	19.9	21.4	22.6	25.9	25.3	21.8	21.4	15.9	19.8	19.5	21.2	27.8	22.5	19.2	18.3	12.6	20.9	21.7	24.3	27.4	16.8	27.5	18.8	19.0	25.0	18.7	28.3	19.3	23.2	21.2	22.4	20.6	37.5	16.5	20.0	9.9	29.3	18.5	21.6	19.5	19.1	18.2	27.8	19.5	38.8	26.0	11.4	30.8	23.3	19.3	19.5	62.1	62.6	93.1	66.6	69.7	54.3	62.4	60.2	51.6	62.0	54.2	58.4	34.5	132.9	51.0	60.6	38.9	57.8	101.1	68.3	70.6	50.8	60.5	75.1	46.5	55.7	45.7	89.5	40.9	51.5	51.0	56.8	51.9	75.8	58.7	63.9	60.4	72.3	67.7	61.0	81.6	60.3	98.8	47.4	43.1	78.4	79.8	56.3	57.3	103.9	95.2	47.3	74.9	68.0	49.9	77.8	73.2	40.7	50.3	49.0	31.5	34.1	46.1	23.5	31.1	111.5	58.3	52.2	51.4	9.3	6.4	7.4	14.0	7.4	17.0	10.9	16.8	15.3	10.0	14.7	17.7	14.9	2.7	19.0	14.0	8.6	19.3	5.7	19.6	21.4	25.3	21.8	20.9	21.7	18.8	19.0	21.2	19.5	19.5	19.5	37.6	60.9	36.3	38.5	61.2	58.1	50.2	51.6	57.5	92.4	51.4	40.6	17.0	42.9	42.0	44.1	116.7	37.4	61.5	47.3	13.7	30.7	3.9	45.2	53.9	44.6	45.4	34.9	48.8	28.6	42.7	47.7	41.3	51.1	7.6	71.0	40.4	49.8	31.3	87.5	61.7	50.4	34.6	42.4	52.4	11.0	69.0	35.9	33.8	32.8	54.6	53.8	48.4	49.8	63.5	35.2	28.6	60.9	55.1	56.6	59.8	32.3	55.3	115.3	26.3	52.1	50.7	82.5	47.7	47.1	63.9	44.6	59.3	66.4	46.5	64.2
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179731641	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 817.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 528.3;SK-MEL-30: 790.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		13000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.15e-1)"	128.3	112.8	15.0	36.3	17.6	76.0	110.6	18.8	31.1	121.4	25.1	108.7	45.0	137.7	171.7	106.7	109.8	6.2	137.5	13.8	24.1	121.4	193.2	112.7	18.4	24.7	24.1	129.6	209.7	9.6	96.5	75.0	20.2	96.0	62.6	68.0	123.3	17.8	111.6	83.5	97.4	85.0	19.2	73.2	115.2	75.0	17.9	9.0	159.2	53.6	16.6	112.0	95.6	22.6	13.0	91.5	89.5	53.0	295.4	229.3	37.9	261.4	342.8	341.2	298.2	148.2	49.6	309.3	351.0	127.8	121.4	18.7	120.2	121.1	405.9	64.6	6.3	63.0	247.8	22.9	399.9	82.9	50.0	39.1	313.5	118.6	528.3	56.1	93.9	23.9	43.2	99.9	39.9	51.2	40.9	15.1	9.4	11.7	6.4	43.2	71.3	24.9	252.1	82.8	24.4	8.0	62.7	16.7	790.3	182.7	267.3	16.3	234.7	49.9	56.5	36.1	200.2	19.7	87.2	46.1	53.3	50.4	46.5	51.8	61.8	17.4	29.9	38.9	34.4	14.4	21.2	25.0	47.6	10.0	15.3	15.6	9.6	32.1	30.1	38.7	16.4	74.1	15.0	17.6	18.8	31.1	13.8	24.1	24.7	24.1	20.2	19.2	17.9	22.6	187.0	198.7	296.6	53.5	109.4	148.5	115.4	181.3	152.0	117.4	245.8	153.5	537.0	185.8	247.0	182.1	158.4	162.5	148.6	174.3	49.0	173.6	225.5	160.9	253.9	204.0	178.0	133.3	45.5	153.5	245.8	202.8	156.5	255.5	197.9	137.7	157.5	438.7	227.7	159.9	77.0	250.0	134.3	206.4	215.6	817.5	159.1	218.3	176.1	44.0	181.1	213.8	84.5	63.3	79.4	153.1	125.1	191.1	327.3	249.5	188.2	196.4	294.3	160.9	92.1	114.6	211.2	158.4	72.7	182.3	161.8	244.8	105.8	183.1	251.0	157.8
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394753-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 548.8;Hofbauer cells: 1107.4;Macrophages: 432.1;monocytes: 432.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1136.5;classical monocyte: 1139.3;eosinophil: 712.7;intermediate monocyte: 431.6;memory B-cell: 575.6;myeloid DC: 1363.2;naive B-cell: 516.8;NK-cell: 605.5;plasmacytoid DC: 959.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 563.6;HMC-1: 972.7;SK-MEL-30: 722.2;THP-1: 513.5;U-937: 569.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm		Yes	No		5400000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	92.4	26.3	42.8	82.4	44.2	159.3	94.9	46.3	79.6	119.1	37.5	56.9	30.3	50.0	46.2	289.5	48.7	44.4	19.2	41.7	51.1	201.1	8.9	175.7	117.9	60.2	46.3	19.7	44.9	151.7	27.2	26.1	57.2	76.5	42.9	4.2	111.8	38.0	16.5	219.9	54.2	24.5	57.5	46.2	94.4	26.0	66.1	58.0	162.3	5.8	109.5	97.1	174.8	79.4	165.5	75.9	0.7	6.9	50.2	102.8	83.7	59.6	6.1	51.2	49.8	9.4	563.6	28.1	96.6	116.0	64.0	181.1	0.2	113.7	23.0	142.0	4.4	74.3	128.0	29.3	40.6	44.8	972.7	93.8	80.5	53.8	70.3	3.6	37.5	143.8	8.2	60.1	38.1	150.1	101.3	414.8	23.2	166.5	112.8	87.3	13.3	11.8	220.6	77.7	0.8	1.4	86.9	128.4	722.2	44.2	40.0	513.5	148.7	111.6	26.8	4.6	2.4	1.4	6.2	10.3	259.5	569.5	1.5	1136.5	1139.3	712.7	12.2	431.6	39.2	575.6	107.8	41.1	1363.2	516.8	30.5	13.9	162.9	605.5	131.3	959.7	122.1	977.9	42.8	44.2	46.3	79.6	41.7	51.1	60.2	46.3	57.2	57.5	66.1	79.4	6.6	19.2	24.5	3.3	84.7	121.2	167.5	265.0	60.9	0.8	86.8	70.4	1.3	51.5	119.6	316.3	0.0	34.3	91.5	211.0	211.3	113.8	4.1	33.0	10.3	16.2	28.8	16.0	0.2	91.5	324.0	34.7	124.9	63.9	548.8	1.2	3.6	1.1	1107.4	1.7	0.2	55.9	50.8	141.6	337.2	15.2	46.9	432.1	147.7	1.0	432.4	43.6	11.3	0.5	0.1	405.8	205.4	22.6	17.2	106.0	74.1	168.5	48.8	1.7	13.1	2.0	54.0	9.6	33.1	167.4	169.5	35.7	101.9	0.9	83.9	253.1
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051731-34102610	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.0;Late spermatids: 289.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol		NA	NA		43000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA018126: AB_1849929, HPA063617: AB_2685062"	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	45.2	30.6	26.1	42.2	28.6	70.3	56.8	25.0	30.9	56.8	21.8	48.8	46.0	52.7	30.5	47.1	61.8	41.7	44.9	28.7	28.3	49.9	39.9	43.3	42.9	26.1	26.7	60.5	47.5	59.9	21.6	53.8	27.3	45.7	60.5	58.7	38.6	53.5	45.3	30.3	41.1	66.2	32.3	40.1	42.1	123.0	26.9	77.6	53.3	54.0	62.6	58.9	31.8	36.7	134.7	168.8	245.6	137.2	180.9	182.5	117.5	168.0	175.8	202.4	188.2	154.9	80.8	211.1	104.9	213.9	169.4	173.1	311.9	204.3	244.9	134.7	155.5	174.1	153.3	131.9	109.4	282.0	122.8	164.0	109.2	129.1	236.3	174.7	204.2	153.7	228.1	103.6	211.3	114.5	243.7	55.8	114.8	155.3	150.6	191.8	339.2	93.7	120.4	263.1	155.5	147.7	202.6	101.1	88.8	150.5	183.5	104.4	205.3	172.7	116.4	167.9	190.8	110.9	175.5	238.7	117.2	116.3	191.7	25.0	33.3	13.9	18.8	39.7	27.3	19.4	20.9	23.2	39.0	17.8	21.6	21.1	13.5	30.7	43.4	18.2	28.1	31.0	26.1	28.6	25.0	30.9	28.7	28.3	26.1	26.7	27.3	32.3	26.9	36.7	42.1	35.3	43.5	37.9	46.0	77.8	45.5	51.5	68.9	38.1	63.7	43.9	55.4	24.3	37.2	64.4	18.8	46.7	47.2	46.0	31.3	56.6	483.0	90.0	116.5	52.1	71.8	79.0	37.4	60.1	60.2	54.6	65.7	132.2	17.1	63.1	39.7	46.1	57.2	25.2	38.8	51.1	54.9	75.8	72.3	289.3	47.8	57.9	39.2	37.5	57.0	36.7	35.0	44.2	53.1	71.3	40.4	72.6	83.0	72.7	42.9	47.4	49.5	32.3	39.5	40.4	64.3	201.7	74.8	93.2	72.9	45.8	46.5	53.9	65.5	77.7
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871553-10923075	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 110.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	20.3	17.1	24.7	19.6	26.6	22.7	17.6	18.9	34.1	30.6	17.2	28.4	17.3	31.7	7.8	36.7	23.4	14.7	25.4	27.6	23.7	18.8	20.1	16.4	19.8	22.8	21.8	21.9	22.3	11.5	14.8	20.4	22.6	20.2	14.3	6.4	20.2	17.5	110.5	22.6	20.9	21.3	19.9	18.6	20.3	45.4	22.6	10.9	13.4	72.4	15.4	26.3	28.0	26.0	62.5	46.8	64.9	88.3	52.5	71.1	63.2	42.8	75.6	63.9	61.0	73.4	21.8	85.2	52.4	77.4	32.1	58.0	65.4	66.2	40.1	98.4	52.7	26.5	29.1	89.9	44.8	39.3	33.9	49.0	42.4	43.8	52.4	35.9	82.1	67.9	65.8	79.2	38.2	116.7	70.0	34.3	81.4	40.7	74.8	97.5	32.8	100.7	38.9	29.7	47.0	45.1	30.7	36.2	43.6	31.7	38.4	35.3	48.7	75.4	43.2	72.3	54.0	75.0	64.1	77.2	51.1	63.8	35.3	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	24.7	26.6	18.9	34.1	27.6	23.7	22.8	21.8	22.6	19.9	22.6	26.0	12.9	9.6	12.2	7.2	11.6	7.8	5.9	4.1	12.0	36.4	14.0	13.7	1.1	14.3	6.5	9.2	52.1	18.5	6.4	42.3	7.9	13.4	32.7	20.1	30.8	12.7	27.6	30.7	12.9	19.7	33.1	13.8	13.7	25.4	1.3	17.8	12.8	27.8	26.7	45.4	10.6	24.9	4.1	20.0	10.9	23.5	28.3	14.8	5.4	5.6	23.9	8.7	4.1	10.6	5.8	24.8	27.2	19.2	11.7	14.1	22.6	9.2	7.4	21.1	6.6	19.6	13.0	23.8	17.5	25.7	7.0	12.0	6.5	6.6	25.7	11.8
CARS1	CARS	ENSG00000110619	"Cysteinyl-tRNA synthetase 1"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.3;Cardiomyocytes: 8.8;Cytotrophoblasts: 22.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 22.0;Syncytiotrophoblasts: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		200000	"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	22.1	17.4	8.1	12.0	8.5	7.3	19.9	8.7	21.6	13.6	8.4	21.8	12.0	15.9	7.5	19.2	12.8	10.3	13.3	8.2	9.8	13.7	21.1	17.5	12.7	9.6	9.9	8.9	32.8	9.6	18.6	10.3	10.6	12.7	12.8	5.3	20.6	6.8	31.7	23.8	17.4	16.0	9.7	17.2	23.5	16.8	9.9	14.6	17.3	14.7	17.8	18.1	14.9	11.5	29.2	14.0	17.8	55.6	67.3	61.4	16.2	70.0	78.6	46.7	84.1	34.2	64.7	43.1	20.1	88.2	0.0	68.7	58.3	78.6	64.0	123.7	13.5	24.4	23.7	25.8	161.1	50.9	50.2	102.2	64.1	40.1	46.8	0.0	62.3	103.6	42.2	147.0	47.1	41.9	35.7	0.0	65.2	97.9	25.0	17.2	29.7	54.9	0.0	46.1	39.0	49.7	17.1	48.1	80.1	13.3	0.0	0.1	21.8	19.5	18.2	48.2	0.2	107.8	106.8	27.2	0.1	26.6	40.3	16.3	18.6	13.5	20.9	15.4	17.4	10.9	18.3	18.6	19.4	8.5	9.9	16.0	25.4	23.7	37.9	7.5	27.0	19.2	8.1	8.5	8.7	21.6	8.2	9.8	9.6	9.9	10.6	9.7	9.9	11.5	10.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	22.2	8.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	40.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	32.3	1.4	0.0	0.0	0.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 858.4;Early spermatids: 979.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882, HPA075906"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (4.98e-4)"	144.4	68.4	32.3	86.1	36.3	119.1	104.1	35.0	40.8	147.2	55.5	160.1	120.5	83.8	49.0	342.8	79.7	78.7	303.7	30.7	42.2	82.0	116.8	112.1	52.9	46.7	43.2	83.1	56.1	111.7	51.2	116.1	44.4	100.2	148.2	17.1	130.0	78.7	317.3	157.4	137.2	92.2	38.3	64.1	100.5	98.8	39.1	43.1	97.9	166.4	104.3	129.4	216.4	41.7	300.3	239.7	42.6	112.1	240.1	390.1	145.4	220.9	288.8	169.1	215.8	60.4	189.6	44.1	189.8	286.1	263.1	465.6	81.3	283.5	202.8	292.4	78.5	65.9	251.0	71.1	172.9	38.9	100.1	201.8	254.8	239.6	375.0	222.9	194.8	33.5	51.7	144.5	196.4	98.0	17.9	2.0	35.4	85.0	89.9	18.2	141.9	78.3	327.1	114.1	179.6	45.0	222.6	118.2	142.5	94.0	77.4	39.5	263.9	239.0	94.6	154.9	211.4	51.2	140.4	22.1	264.7	21.8	67.5	10.5	156.6	24.1	75.6	85.3	74.1	79.4	68.2	76.9	107.5	79.1	34.8	45.7	38.2	61.6	109.8	28.8	79.2	108.1	32.3	36.3	35.0	40.8	30.7	42.2	46.7	43.2	44.4	38.3	39.1	41.7	251.6	403.8	221.4	58.1	153.8	239.6	439.8	223.6	169.0	39.4	133.6	84.5	858.4	163.0	277.0	108.5	18.8	181.2	227.1	484.0	133.1	263.6	979.7	348.0	213.4	188.5	142.1	229.3	60.2	249.7	96.2	259.0	153.4	327.8	177.1	71.8	138.8	169.3	113.7	13.5	53.0	253.9	103.7	209.4	259.1	414.4	172.1	243.8	131.6	63.7	354.4	36.9	293.6	33.2	70.2	325.1	346.8	146.3	126.3	314.7	302.9	152.3	379.0	19.5	92.1	267.8	175.0	23.6	17.9	348.9	251.7	140.8	207.7	69.8	221.2	548.5
CAT		ENSG00000121691	Catalase	P04040	11	34438934-34472060	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1217.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 722.4;Hepatocytes: 443.4;Proximal tubular cells: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	13	"eosinophil: 4736.8"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 4736.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 391.4;THP-1: 321.2;U-937: 265.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		760000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	281.3	115.1	27.1	52.1	29.6	407.7	123.6	27.9	35.5	82.0	39.4	82.6	145.1	53.1	34.8	40.1	86.8	59.8	58.1	26.6	29.4	296.6	1217.3	163.2	58.4	35.2	29.4	46.7	86.3	43.2	13.6	78.0	34.3	66.8	71.3	9.8	83.7	64.0	103.8	70.6	136.3	59.4	29.6	78.6	74.1	11.4	29.5	74.9	122.6	136.6	56.7	105.8	39.9	40.8	31.7	34.3	24.5	38.9	233.2	100.6	52.3	39.3	49.8	43.3	47.1	19.7	30.9	78.3	37.5	79.2	63.9	73.9	42.3	42.9	47.3	68.8	38.8	65.6	34.0	113.7	27.6	391.4	31.1	54.5	29.3	13.2	5.1	59.9	53.2	46.2	139.3	31.3	55.1	30.2	81.1	77.4	0.1	148.7	82.6	56.5	117.9	64.9	120.2	117.2	13.1	19.8	44.5	70.6	60.0	0.0	101.4	321.2	38.3	25.9	24.9	65.4	23.8	25.0	15.2	16.8	51.3	265.6	19.3	256.5	324.7	4736.8	54.4	265.1	64.6	133.9	63.7	61.0	353.5	124.1	61.7	66.7	290.2	105.7	298.5	235.8	92.7	397.9	27.1	29.6	27.9	35.5	26.6	29.4	35.2	29.4	34.3	29.6	29.5	40.8	196.9	227.6	275.9	41.1	53.8	28.9	93.7	44.9	27.9	13.5	42.6	36.1	44.9	82.9	66.9	73.5	27.1	96.8	92.0	59.4	225.0	36.0	2.7	72.2	41.4	43.8	48.0	722.4	12.6	26.2	30.0	53.1	54.6	29.3	24.0	38.7	57.1	443.4	138.5	0.0	1.2	56.9	91.6	125.5	95.8	6.2	78.3	93.9	26.6	16.9	253.4	19.5	28.8	22.6	45.6	15.3	44.8	77.5	25.4	37.0	151.6	333.2	96.9	19.4	78.9	46.6	68.0	6.3	11.3	24.4	27.1	40.5	37.7	57.7	95.6	97.5
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834310-191847088	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 1296.7;Alveolar cells type 1: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 49.0;neutrophil: 24.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 49.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		88000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	164.9	25.1	17.9	13.0	20.1	6.5	60.9	16.9	20.2	56.8	13.1	69.4	11.5	38.9	13.2	48.2	53.9	51.8	96.7	15.1	16.5	25.9	31.2	93.9	15.3	19.5	17.3	53.0	22.5	12.9	7.1	34.0	19.5	30.2	24.9	1.1	7.1	30.0	32.3	6.9	21.1	58.1	15.9	111.9	15.0	4.3	22.3	4.1	78.3	59.9	5.6	42.7	19.5	17.0	0.0	20.2	6.8	0.1	1.0	3.4	0.1	4.1	3.5	0.8	1.5	0.0	0.0	0.1	24.8	162.3	0.0	3.4	0.0	31.8	2.3	0.1	0.0	119.8	1.4	45.6	43.6	0.0	0.0	8.4	20.5	3.4	9.6	2.2	362.3	0.0	43.9	0.0	561.1	0.0	0.0	0.1	0.1	0.0	1.0	0.0	32.3	0.2	41.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	0.0	0.1	148.9	0.0	12.4	7.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	49.0	2.4	1.2	0.2	0.8	0.3	0.1	0.0	0.0	2.3	0.3	0.2	0.0	24.3	1.3	1.5	3.1	0.5	121.3	17.9	20.1	16.9	20.2	15.1	16.5	19.5	17.3	19.5	15.9	22.3	17.0	1296.7	413.5	76.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	81.7	0.0	0.0	0.2	2.6	0.0	5.9	1.6	0.0	0.4	5.4	164.5	0.0	0.0	0.0	0.2	0.2	15.0	0.0	0.6	185.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	29.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	1.5	16.4	0.0	0.0
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 partner transcriptional co-repressor 3"	O75081	16	88874858-88977207	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;lymphoid tissue: 29.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.8;B-cells: 26.2;dendritic cells: 25.7;Erythroid cells: 21.0;Intestinal goblet cells: 19.2;Langerhans cells: 23.3;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 35.8"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 64.2;K-562: 114.9;MCF7: 52.3;MOLT-4: 58.0;NB-4: 70.1;REH: 113.6;T-47d: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575"	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	9.2	2.3	3.6	6.8	4.7	7.7	7.7	35.8	8.4	3.9	0.0	4.9	3.2	5.0	0.7	2.4	3.7	1.7	17.0	5.7	0.0	1.2	4.3	11.3	8.8	0.6	0.9	1.0	27.3	0.7	4.2	3.1	1.7	6.4	1.0	0.8	4.8	0.8	14.0	3.5	10.8	1.1	0.0	18.5	3.7	4.6	0.0	29.5	3.9	3.2	5.1	3.5	3.8	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	3.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.1	64.2	0.0	0.0	0.1	17.2	30.6	0.0	0.0	0.0	0.0	0.1	0.0	30.2	114.9	0.5	0.0	52.3	58.0	70.1	1.2	0.0	0.0	113.6	0.8	11.4	0.0	0.0	21.3	4.8	2.5	0.5	0.4	0.3	50.1	17.9	0.4	0.0	0.4	0.3	0.0	0.4	0.5	37.9	0.0	19.8	0.0	1.0	2.5	2.7	0.0	2.8	0.0	3.1	0.0	0.0	6.6	1.7	0.0	0.0	3.4	0.0	4.8	10.6	0.0	1.8	3.6	4.7	35.8	8.4	5.7	0.0	0.6	0.9	1.7	0.0	0.0	0.8	24.8	0.0	1.1	0.3	26.2	2.5	6.2	1.9	0.6	10.8	1.1	0.9	3.3	1.5	2.4	0.0	0.0	0.1	25.7	0.8	0.0	0.3	0.0	0.6	0.6	9.1	3.6	21.0	5.9	2.9	0.2	2.7	2.0	0.5	6.3	0.1	2.2	10.8	3.0	0.0	2.1	19.2	0.0	5.0	23.3	0.3	2.1	9.8	0.0	9.4	14.8	0.2	0.0	2.0	0.6	0.9	0.5	0.7	14.4	2.9	1.7	0.6	0.5	1.4	19.7	10.8	15.6	0.2	4.8	1.7	2.3	0.3	1.3	3.3	1.0	3.8
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839440	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 130.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 110.8;SK-MEL-30: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	9.3	14.2	9.6	11.1	10.8	130.3	9.0	8.8	12.5	9.1	0.0	7.9	7.1	6.3	4.6	20.7	8.1	6.3	16.0	12.4	9.7	10.6	21.6	12.3	14.6	11.5	9.5	9.6	19.0	17.0	19.1	15.2	10.7	9.3	3.2	12.3	13.2	4.6	3.4	31.6	11.9	3.8	8.2	20.9	12.9	6.9	12.2	23.1	8.6	1.4	7.2	6.7	10.3	16.6	32.1	28.3	8.4	36.3	5.2	4.7	23.5	14.3	8.5	5.1	5.4	20.5	17.5	12.3	19.7	5.6	11.4	16.3	9.3	9.5	3.8	13.3	17.7	7.0	28.0	38.4	25.4	37.0	52.5	6.5	54.4	4.7	8.4	8.5	4.3	35.5	21.7	67.5	5.5	23.0	50.9	37.7	4.6	33.2	28.2	51.9	8.6	56.3	7.2	15.3	8.7	16.6	21.4	110.8	130.9	3.5	26.3	58.3	11.2	29.8	26.3	18.4	18.6	58.0	32.4	35.0	18.7	31.6	40.4	1.6	0.5	1.8	0.9	0.6	0.6	1.5	1.2	1.3	0.3	1.5	1.4	1.3	2.1	0.4	0.7	1.7	0.2	0.6	9.6	10.8	8.8	12.5	12.4	9.7	11.5	9.5	10.7	8.2	12.2	16.6	40.4	3.2	15.7	4.6	31.8	23.3	5.4	13.4	36.5	31.7	65.2	79.8	51.6	30.0	12.1	1.8	22.9	34.2	77.6	26.6	0.0	7.5	0.2	63.9	19.3	21.6	52.7	7.8	5.5	7.3	5.0	15.8	20.9	62.8	7.0	22.3	15.7	16.3	13.8	20.2	5.5	49.5	2.0	19.8	17.0	1.0	4.4	35.4	17.8	12.2	15.4	39.2	15.5	6.0	11.6	10.0	18.4	5.7	26.1	6.3	9.6	2.8	14.6	44.3	6.6	15.3	24.4	0.5	2.4	65.7	30.7	8.6	42.5	13.7	29.7	5.2
CBX5	"HP1, HP1-ALPHA, HP1Hs-alpha"	ENSG00000094916	"Chromobox 5"	P45973	12	54230942-54280133	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 102.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016699, CAB017548"	Enhanced		Enhanced	Nucleoplasm		NA	NA		22000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017548: AB_2071368, HPA016699: AB_1850627"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.97e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.64e-2)"	8.1	14.0	20.9	12.6	22.4	17.2	13.8	14.1	19.8	10.9	102.6	10.5	7.5	9.7	15.0	9.4	16.0	8.9	20.8	19.3	37.3	17.2	8.0	9.5	18.8	18.7	25.7	18.3	9.9	25.6	19.8	12.3	22.3	11.5	10.9	22.9	8.6	11.8	13.8	17.3	8.7	10.8	24.4	10.7	10.3	25.4	39.1	31.0	23.9	7.7	21.5	7.1	8.4	28.8	33.1	96.3	147.9	68.5	19.3	41.4	34.2	50.1	35.8	41.5	42.8	37.8	102.8	91.0	65.3	49.7	49.4	27.1	106.1	31.2	70.2	144.7	23.1	80.1	108.4	13.5	15.0	42.8	32.8	20.6	20.6	71.0	62.1	46.8	46.4	82.6	92.8	87.4	69.2	57.4	137.2	44.8	118.6	13.9	11.5	133.9	82.7	50.6	43.1	30.0	73.9	113.5	93.6	21.0	10.7	58.0	80.6	71.5	61.4	69.3	59.5	26.6	59.8	22.0	25.9	169.4	44.3	43.0	74.3	1.0	5.4	4.7	6.8	6.0	5.5	11.7	7.3	6.5	9.3	14.3	7.2	6.7	0.8	7.7	8.1	21.8	10.0	4.3	20.9	22.4	14.1	19.8	19.3	37.3	18.7	25.7	22.3	24.4	39.1	28.8	39.4	38.5	50.5	33.3	46.5	46.3	42.6	46.5	40.9	120.5	59.6	55.4	138.2	55.8	47.0	82.8	45.9	58.2	32.1	25.9	105.7	61.7	117.4	53.9	58.9	49.1	27.0	102.2	28.4	59.7	56.5	69.0	22.4	37.0	30.9	81.3	38.6	37.5	38.7	183.4	38.9	37.6	48.8	22.9	35.8	58.3	64.7	25.9	35.6	23.4	44.5	68.6	36.0	46.3	40.0	45.4	14.1	80.5	49.2	41.4	11.6	63.2	79.3	64.1	32.9	70.2	67.9	221.4	80.1	40.8	32.7	26.1	40.5	83.5	44.1	29.8
CBX8	"HPC3, PC3, RC1"	ENSG00000141570	"Chromobox 8"	Q9HC52	17	79792132-79801683	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031462	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031462: AB_10601252"	"unprognostic (4.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.94e-6)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (3.84e-5)"	"unprognostic (4.74e-1)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (6.99e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.51e-1)"	"unprognostic (5.99e-2)"	4.3	3.3	1.9	2.5	1.8	2.1	3.3	1.9	1.8	3.3	1.9	2.5	2.9	2.4	10.9	2.9	8.5	1.9	3.8	1.6	1.9	7.3	5.6	3.2	3.1	2.0	1.9	2.1	3.6	6.6	7.6	2.5	2.1	2.2	0.7	4.5	2.5	2.0	2.4	2.9	2.7	1.1	1.4	3.0	2.8	10.9	2.3	3.8	3.0	0.8	2.0	2.0	1.8	2.9	12.4	24.9	6.5	23.7	3.5	2.2	8.0	6.2	4.4	5.2	3.6	13.6	6.2	9.1	17.1	3.5	4.6	11.6	8.5	1.9	2.3	7.0	11.9	3.3	13.9	14.8	4.1	13.8	27.4	1.9	3.8	3.3	0.9	5.2	1.1	10.7	8.2	4.0	1.6	15.2	15.7	20.3	2.7	9.0	13.4	14.5	5.8	16.9	4.1	8.5	9.5	19.3	8.9	28.2	14.8	2.3	14.8	17.7	2.8	10.9	15.0	4.4	9.9	11.3	4.8	6.0	6.8	13.5	6.2	0.9	5.0	15.0	3.2	6.8	1.1	4.5	1.8	1.9	5.7	1.8	1.7	1.7	6.3	3.3	7.3	4.6	1.9	2.0	1.9	1.8	1.9	1.8	1.6	1.9	2.0	1.9	2.1	1.4	2.3	2.9	2.3	0.0	0.5	0.7	2.8	1.8	1.2	4.4	4.0	5.3	2.7	2.2	4.1	8.6	2.3	3.7	8.4	7.1	4.1	3.9	0.0	4.6	2.8	15.6	4.9	2.1	9.1	0.0	0.2	5.4	2.8	2.4	5.6	5.2	5.7	2.3	0.7	2.5	5.0	8.4	0.3	7.1	2.0	2.2	1.0	0.4	0.9	2.3	1.8	0.0	1.9	7.2	2.1	0.0	1.0	4.4	5.1	2.2	2.7	0.9	4.3	2.3	5.4	11.0	0.0	0.6	3.9	6.2	11.5	3.8	1.1	2.5	3.4	4.0	4.7	0.4
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		19000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	64.1	68.3	39.2	75.4	44.2	145.5	64.4	40.2	52.4	65.6	45.6	68.5	52.1	75.0	33.0	63.4	67.9	59.7	52.0	47.0	33.8	54.8	41.1	61.4	86.7	36.9	42.3	74.6	56.4	59.8	65.1	54.0	38.6	61.1	45.6	59.8	61.5	46.9	101.4	89.0	69.3	44.9	34.7	85.6	60.0	89.4	39.6	96.0	60.6	43.5	74.3	65.4	57.6	47.9	133.7	242.8	230.8	120.8	89.5	74.7	154.0	127.7	124.9	184.3	163.9	219.5	107.4	218.6	156.4	140.5	169.6	163.2	214.5	151.9	132.9	89.2	128.2	259.1	189.5	172.8	82.9	143.6	212.0	77.8	133.1	147.0	90.0	106.4	134.4	194.4	276.2	134.8	138.0	157.5	435.0	150.5	337.6	143.2	88.1	286.7	190.7	116.8	95.2	311.7	115.1	267.6	143.7	163.0	112.6	110.7	148.8	133.2	219.3	135.8	178.4	165.3	171.1	98.5	134.0	261.4	152.7	123.4	215.7	25.9	16.2	23.5	34.8	26.6	29.4	18.7	26.5	26.6	16.6	17.5	25.7	28.4	5.7	19.9	35.6	15.5	32.6	25.8	39.2	44.2	40.2	52.4	47.0	33.8	36.9	42.3	38.6	34.7	39.6	47.9	14.4	16.0	4.2	11.1	14.1	13.9	9.5	12.2	17.6	12.9	13.5	13.1	7.5	15.7	9.4	16.5	16.7	27.3	19.4	24.1	9.8	18.1	4.7	14.1	12.3	13.1	22.2	16.4	12.5	18.0	22.2	12.8	18.8	14.3	8.8	20.2	11.7	12.0	15.7	10.1	11.9	19.6	14.2	11.9	8.5	7.3	14.9	11.0	12.4	10.3	11.2	15.9	20.6	11.1	10.3	23.6	10.4	12.0	14.8	11.7	14.4	9.4	19.5	12.9	19.7	12.4	12.2	30.0	24.1	16.9	15.3	23.7	19.3	23.5	21.7	10.5
CCDC124		ENSG00000007080	"Coiled-coil domain containing 124"	Q96CT7	19	17933015-17943991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041708, HPA046765"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA041708: AB_2677628, HPA046765: AB_2679793"	"unprognostic (9.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.22e-1)"	82.9	67.6	62.4	32.0	62.9	42.7	78.0	64.1	104.5	77.3	54.0	115.7	25.6	78.6	7.1	100.3	67.8	11.2	131.9	61.9	60.7	88.5	88.0	70.8	22.7	63.2	62.1	64.9	72.2	22.1	55.7	20.3	64.8	77.9	8.4	9.0	69.3	22.2	210.2	92.8	58.5	14.2	57.3	67.5	81.2	48.5	66.0	17.7	65.6	38.3	12.2	84.5	80.9	68.2	242.7	165.3	54.2	111.3	35.4	26.9	178.8	118.9	36.7	59.0	49.8	125.0	97.1	182.8	166.7	47.5	38.8	90.1	60.0	108.3	17.2	194.7	341.8	152.7	140.5	147.0	68.4	174.4	100.6	43.2	70.7	59.7	56.9	33.9	62.7	115.0	196.3	74.4	30.8	232.8	166.1	212.3	126.3	79.2	282.2	163.2	103.6	195.1	48.9	85.7	108.6	155.8	83.4	92.4	121.3	22.0	86.2	62.6	142.0	102.3	128.1	198.0	185.6	102.8	121.7	178.5	128.6	203.1	133.0	81.1	82.2	73.5	85.9	95.1	69.2	61.0	66.8	80.8	85.5	66.4	51.8	63.5	20.5	76.3	71.3	75.4	84.1	66.2	62.4	62.9	64.1	104.5	61.9	60.7	63.2	62.1	64.8	57.3	66.0	68.2	58.8	19.2	4.8	8.1	41.1	90.5	60.0	115.9	44.9	22.9	49.3	57.3	15.6	35.8	58.7	73.5	2.1	93.8	44.1	108.9	137.0	146.2	33.4	46.7	50.9	57.3	61.0	79.8	7.4	199.0	140.2	58.1	79.0	56.5	27.3	73.9	50.7	57.1	110.3	10.1	6.4	89.0	101.7	60.0	73.2	106.1	32.6	50.3	96.0	4.7	86.4	50.9	50.4	4.5	7.1	227.9	70.0	41.3	68.7	108.7	78.5	142.3	44.8	23.1	19.7	43.4	76.0	30.9	39.9	79.6	109.8	82.8	42.8	184.7	88.6	73.5
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666737-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	8.2	9.5	13.8	12.3	13.7	17.7	7.6	13.5	17.5	10.7	14.2	9.3	11.4	7.5	5.5	23.1	7.8	6.1	6.5	13.7	13.8	10.2	10.8	7.7	16.3	14.4	14.3	6.7	8.2	7.0	6.2	7.7	14.7	11.7	5.8	2.8	9.9	6.4	7.7	22.8	10.7	6.0	13.4	15.6	8.8	10.4	14.5	11.8	7.8	4.5	11.5	9.8	13.8	14.3	38.0	62.8	21.5	35.3	13.9	13.1	35.2	41.6	19.7	53.0	30.6	55.1	22.8	33.8	22.4	21.2	36.6	47.9	34.5	43.8	30.6	19.4	51.7	51.6	30.1	48.0	20.7	46.6	37.5	19.8	26.3	47.6	26.3	14.6	37.4	41.1	53.3	19.1	28.3	34.5	45.7	56.6	46.9	32.9	59.8	55.4	34.6	24.1	19.8	29.6	45.1	57.7	41.1	87.8	37.1	28.9	58.8	48.3	27.8	82.0	53.5	34.9	65.9	53.1	28.7	36.8	30.8	42.9	48.8	2.2	7.7	11.7	11.5	9.6	6.3	10.4	8.7	8.8	7.5	13.2	9.2	8.8	3.3	13.1	11.9	12.9	9.8	5.9	13.8	13.7	13.5	17.5	13.7	13.8	14.4	14.3	14.7	13.4	14.5	14.3	17.9	22.4	17.0	5.9	29.8	31.7	22.8	19.7	74.6	6.8	17.4	13.7	6.7	15.7	20.9	12.9	2.1	25.7	31.5	19.7	19.6	25.2	1.7	26.5	32.9	20.3	7.2	37.5	4.5	21.4	41.0	16.5	29.0	29.4	19.6	28.1	15.4	11.8	24.3	18.5	4.6	17.0	14.2	12.9	11.5	1.7	13.7	16.8	16.0	4.7	24.2	13.8	37.0	4.0	5.0	35.2	16.0	13.5	25.7	40.0	12.4	15.9	21.6	9.1	6.6	13.7	22.3	30.8	44.9	57.0	34.4	20.8	29.7	22.8	22.4	24.2
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	"Centriolar satellite"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite"		"HPA035278: AB_2674548, HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (4.76e-4)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.72e-5)"	11.8	9.6	5.3	12.8	8.5	36.6	21.4	6.4	7.5	17.1	4.6	22.5	12.8	22.1	35.5	10.0	14.5	13.6	8.6	5.1	8.7	14.4	15.3	13.7	16.6	8.8	7.5	17.4	16.8	5.6	13.7	10.6	9.0	16.3	34.8	43.2	14.9	7.9	6.2	23.8	15.4	14.2	7.7	12.4	13.9	23.7	10.1	20.5	13.2	2.9	15.0	12.0	12.4	10.0	42.6	22.5	72.1	28.0	10.6	16.1	34.0	79.9	26.2	41.6	45.2	17.5	28.5	12.4	19.9	19.1	30.1	44.5	27.1	14.8	55.9	10.5	20.0	49.9	50.7	17.7	9.0	31.2	29.9	15.1	9.7	20.7	21.9	49.0	19.7	48.9	25.8	21.0	28.1	18.3	26.4	17.3	22.2	19.0	28.0	47.2	29.0	15.2	23.3	34.1	25.4	28.3	45.2	13.0	33.4	46.5	27.5	31.2	22.9	91.1	45.8	28.5	26.5	20.0	15.8	32.8	32.2	25.6	31.5	1.1	0.6	1.3	1.4	0.9	1.0	0.8	1.2	1.2	0.3	0.7	1.3	1.1	0.1	2.5	0.2	1.8	2.6	0.7	5.3	8.5	6.4	7.5	5.1	8.7	8.8	7.5	9.0	7.7	10.1	10.0	22.1	22.4	71.5	72.8	21.3	21.9	36.4	31.2	25.6	35.9	48.9	37.7	14.6	38.6	29.4	36.8	60.5	27.5	27.6	67.9	0.0	26.1	38.6	33.7	44.0	23.8	89.7	72.1	83.8	13.8	22.9	32.3	26.0	29.9	25.9	67.9	28.5	22.3	20.9	28.6	67.7	85.6	67.1	19.7	29.9	17.3	32.6	21.0	24.9	41.2	20.1	18.6	49.4	91.0	77.1	22.8	63.7	31.2	25.3	20.4	41.6	12.6	18.9	75.5	19.7	39.2	29.4	144.0	49.6	18.2	16.1	11.6	30.3	33.5	77.7	22.9
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043468: AB_2678493, HPA060129: AB_2684208"	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.81e-5)"	9.5	7.0	7.7	7.0	8.5	17.2	9.2	8.8	8.5	10.9	6.8	9.8	9.4	10.4	7.5	8.9	9.4	6.8	8.2	7.7	8.0	8.9	8.7	7.1	9.6	8.1	8.4	14.7	10.1	11.9	8.6	8.6	8.1	9.7	7.3	6.7	8.6	8.0	11.1	9.7	9.5	7.9	7.5	10.6	10.3	9.1	8.2	11.6	9.0	10.7	10.2	9.6	9.5	9.6	6.2	6.7	10.0	10.7	13.6	11.1	25.3	8.1	11.6	10.0	7.8	7.5	7.0	12.8	5.8	7.2	6.8	5.3	7.3	6.8	7.8	9.7	8.9	13.0	8.1	8.1	19.7	12.9	14.5	12.9	17.0	13.5	16.5	14.0	8.6	13.4	13.2	11.4	7.6	10.9	13.6	11.3	13.5	10.1	10.9	10.1	9.3	10.6	10.4	10.8	4.8	13.1	9.5	7.4	13.4	11.6	11.2	18.1	8.0	8.0	7.8	7.4	9.5	15.0	14.3	14.7	8.0	9.8	11.1	25.4	10.7	22.2	12.9	11.3	15.2	17.4	16.1	15.1	9.7	16.4	17.4	13.8	20.5	18.8	12.2	10.9	12.5	10.0	7.7	8.5	8.8	8.5	7.7	8.0	8.1	8.4	8.1	7.5	8.2	9.6	29.5	9.6	34.5	11.4	48.0	16.2	31.3	38.0	26.7	32.8	25.0	28.4	37.0	32.9	35.7	12.9	20.9	32.1	42.3	27.3	56.7	34.7	152.5	27.3	35.4	31.0	18.5	43.4	12.8	34.9	25.2	33.7	20.4	34.7	52.0	22.0	38.6	29.3	26.5	15.2	16.6	34.1	32.6	27.2	16.5	59.1	33.5	30.5	14.2	5.6	45.2	22.2	34.0	11.1	15.8	38.2	34.9	40.3	34.9	28.8	36.8	46.4	31.1	24.9	32.9	28.4	37.2	78.7	33.5	19.9	13.5	65.7	41.6	23.5	23.1	31.8
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023078, HPA023391"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023078: , HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (3.42e-5)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	9.6	10.2	9.5	11.4	10.3	20.8	12.5	11.5	14.3	9.3	8.1	12.1	11.7	10.0	10.9	12.0	9.3	7.5	20.4	10.6	10.3	14.2	9.5	9.7	13.5	9.5	9.0	8.1	9.6	15.4	4.8	14.0	10.2	12.0	14.9	18.5	8.9	8.9	73.5	11.3	9.7	10.8	9.8	9.8	11.2	9.5	10.4	13.8	13.5	42.7	14.6	11.8	8.1	11.5	24.9	29.3	27.2	24.1	18.2	26.7	49.8	37.1	21.8	35.7	34.9	39.7	26.0	43.1	28.0	30.4	25.5	19.2	45.3	42.9	51.5	53.1	52.5	38.8	48.8	59.0	32.5	54.8	28.0	24.1	42.7	37.2	50.2	24.4	35.1	34.8	41.6	29.3	36.6	31.0	53.7	38.8	28.2	23.5	37.1	34.5	68.2	37.6	36.7	16.0	27.3	26.9	27.2	21.6	39.5	40.7	55.2	36.6	30.6	43.9	32.5	26.6	50.0	29.5	40.1	49.4	32.1	31.4	32.2	11.6	15.7	11.0	11.9	18.4	11.0	9.1	11.3	13.7	17.5	11.3	11.0	12.0	3.2	16.4	12.5	12.4	15.1	10.2	9.5	10.3	11.5	14.3	10.6	10.3	9.5	9.0	10.2	9.8	10.4	11.5	24.4	12.8	21.0	6.8	19.1	13.3	10.8	20.0	13.1	24.4	15.2	15.7	41.1	17.2	21.5	9.2	10.4	41.1	13.4	10.7	39.2	21.6	0.9	23.4	27.1	23.9	18.0	15.4	10.5	24.5	46.7	17.1	13.7	24.0	32.4	19.9	20.0	15.5	30.6	21.9	8.2	17.1	8.2	18.8	16.0	3.5	14.0	19.2	21.4	1.0	24.6	19.6	9.2	6.6	6.5	21.0	12.4	12.8	26.9	12.9	15.0	36.8	19.8	25.4	6.6	23.4	17.5	3.6	12.4	24.8	11.2	25.3	16.7	22.6	22.6	8.7
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842113-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 377.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	25.6	26.7	12.0	14.3	13.3	10.2	20.8	13.1	14.2	12.9	11.2	14.1	11.4	16.7	3.5	19.4	15.2	6.9	16.0	12.7	13.5	19.2	13.7	11.8	11.6	13.2	13.5	13.8	23.9	377.6	24.9	11.6	13.7	23.9	5.8	8.2	12.2	8.6	34.7	22.7	12.3	10.4	12.3	12.7	16.4	48.9	12.7	8.8	12.9	13.7	8.5	20.2	14.5	14.1	83.4	110.2	26.5	76.1	21.8	35.7	36.3	54.3	42.4	98.1	52.4	95.0	53.7	98.9	100.7	31.0	69.7	73.3	94.2	65.7	48.2	35.7	101.3	51.0	45.8	133.2	70.7	80.7	82.6	39.5	48.7	90.2	61.8	14.3	75.8	53.5	166.0	46.9	50.3	97.3	125.2	122.6	107.0	48.6	156.3	81.4	39.6	253.5	37.2	33.8	59.9	38.9	34.7	79.5	64.6	17.6	80.8	30.3	45.9	93.6	59.6	131.6	118.2	41.0	66.5	109.2	78.2	86.0	118.6	1.7	13.5	4.2	9.1	29.4	9.7	9.4	9.6	8.3	29.8	9.0	11.5	10.2	1.0	6.9	9.3	16.6	9.7	10.1	12.0	13.3	13.1	14.2	12.7	13.5	13.2	13.5	13.7	12.3	12.7	14.1	9.3	0.0	2.2	2.0	8.9	37.0	22.2	5.7	28.5	12.1	9.9	10.3	0.6	4.3	4.0	1.8	8.4	17.2	5.7	5.3	7.9	18.6	25.6	6.8	9.4	12.7	7.2	8.8	2.0	12.2	20.4	10.2	9.7	7.7	5.1	7.9	3.6	3.1	18.4	3.3	1.7	5.7	6.1	2.5	16.5	15.0	11.5	7.3	16.0	1.0	5.3	3.9	4.1	1.0	1.3	19.2	3.6	6.0	8.6	24.0	4.4	7.3	1.3	8.3	19.7	10.7	19.1	74.6	18.8	21.2	31.0	8.2	7.0	12.5	11.3	18.8
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 447.3;Late spermatids: 233.9;Spermatocytes: 333.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	16.4	37.3	23.2	13.0	24.5	16.1	21.3	24.2	29.8	17.1	23.3	18.1	14.7	14.7	33.8	16.2	15.6	18.2	22.1	22.9	25.4	18.4	38.9	13.5	20.5	25.3	25.0	22.3	18.3	14.9	19.4	22.2	25.0	16.0	17.3	12.6	17.1	16.3	16.2	14.1	16.6	16.7	25.2	15.5	16.9	54.5	24.4	17.2	25.6	17.7	17.0	15.3	14.2	27.1	19.1	27.3	46.1	15.2	59.6	44.7	27.7	37.4	31.6	22.7	24.3	32.2	63.0	46.7	47.7	55.0	47.5	23.5	20.1	47.3	30.3	31.9	16.0	28.2	17.7	27.3	50.1	29.2	23.5	50.2	62.3	29.5	83.8	45.3	52.3	49.6	41.9	37.9	83.7	33.5	29.4	36.7	37.9	80.2	33.4	33.1	40.9	39.3	47.3	27.5	22.2	50.9	26.4	21.0	26.1	60.8	53.9	26.4	51.6	44.8	28.8	85.9	26.0	36.3	51.2	46.8	18.1	23.2	45.5	77.7	18.7	71.6	24.2	41.3	31.2	39.8	34.7	34.2	27.0	37.9	30.2	30.2	9.8	50.7	43.8	20.4	46.0	27.4	23.2	24.5	24.2	29.8	22.9	25.4	25.3	25.0	25.0	25.2	24.4	27.1	50.8	12.8	13.1	14.0	40.5	23.6	49.6	102.8	26.7	36.3	33.5	49.7	58.0	28.6	48.3	36.8	14.6	74.0	41.4	21.0	68.4	59.4	447.3	39.5	38.0	45.8	33.6	36.2	16.0	48.5	55.4	44.5	26.5	31.4	49.4	83.0	35.7	43.3	63.7	42.1	23.3	35.2	52.9	34.6	32.4	233.9	42.6	38.6	21.4	10.3	52.8	35.3	53.5	31.2	48.2	67.6	32.9	25.6	44.6	38.9	44.1	78.0	32.6	50.0	26.3	40.3	43.5	333.0	107.8	32.5	29.0	51.7	37.1	86.8	31.2	49.9
CCDC93	FLJ10996	ENSG00000125633	"Coiled-coil domain containing 93"	Q567U6	2	117915478-118014133	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054183	Approved		Enhanced	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA054183: AB_2682408"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (2.51e-1)"	"unprognostic (8.12e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.40e-2)"	10.2	14.5	9.3	10.4	8.5	21.7	9.6	9.6	12.7	9.1	15.0	11.3	11.9	8.2	9.8	7.4	9.3	7.1	21.3	8.4	9.4	9.8	7.8	11.8	10.3	9.7	9.0	13.3	13.0	15.9	16.1	8.1	10.3	7.6	10.6	26.0	9.1	8.4	12.9	11.0	12.8	8.1	8.4	12.1	9.1	12.1	11.5	10.1	11.9	10.3	10.1	8.6	8.1	8.5	18.7	8.1	22.0	19.4	31.2	21.3	18.5	21.8	14.2	14.0	14.3	17.7	11.7	15.9	14.5	17.1	24.9	15.8	12.8	11.2	18.1	20.8	13.0	20.1	15.5	23.9	13.7	22.1	22.0	14.6	11.5	21.9	25.9	19.4	15.0	18.9	11.1	11.0	15.8	8.1	14.0	23.8	9.9	13.4	13.0	17.6	17.2	10.7	11.5	19.6	17.4	10.3	14.2	10.6	15.1	19.6	8.9	13.5	21.2	23.9	20.0	20.4	15.3	14.3	16.0	24.7	13.8	16.1	14.2	2.9	1.6	1.8	2.1	2.1	2.0	1.6	1.5	1.8	1.2	1.4	2.0	1.7	1.7	1.7	1.3	0.5	0.7	1.0	9.3	8.5	9.6	12.7	8.4	9.4	9.7	9.0	10.3	8.4	11.5	8.5	17.4	19.2	28.2	61.0	28.6	17.6	14.6	11.2	9.6	32.0	12.4	10.0	43.0	7.2	17.5	1.8	47.9	12.6	31.9	21.5	9.8	24.0	4.5	14.9	15.2	16.5	16.7	9.9	57.1	16.7	8.5	14.7	11.7	17.0	15.2	25.1	12.8	6.0	15.2	20.2	60.6	11.4	10.2	16.3	15.9	10.6	13.7	19.9	3.6	32.8	19.9	13.8	20.6	53.3	37.9	32.0	11.9	14.3	19.4	13.9	17.1	9.4	16.3	36.0	6.6	21.4	15.0	46.0	31.1	10.1	16.1	12.9	24.3	12.8	14.0	15.0
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffold protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 140.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	32.7	40.7	62.5	25.1	74.5	15.5	26.6	58.7	89.1	19.1	48.4	30.2	13.2	20.3	6.4	22.4	18.9	11.5	37.1	63.0	62.4	24.2	86.0	29.2	43.6	67.6	62.8	16.1	26.6	21.4	30.4	14.5	69.2	23.8	10.8	9.4	18.8	14.5	48.2	21.1	27.6	16.9	60.0	54.6	24.0	30.3	71.5	45.4	18.7	36.9	29.6	27.2	20.0	68.6	38.7	41.8	24.4	49.2	45.5	39.8	17.7	45.9	37.3	32.0	43.3	30.6	39.3	53.7	34.5	58.5	101.8	49.5	15.3	58.9	21.4	61.0	29.7	23.3	34.0	22.1	39.9	9.9	61.5	44.7	38.0	56.3	24.0	30.0	59.2	76.8	27.5	42.1	64.7	58.2	47.9	131.6	28.4	32.3	46.1	25.7	14.2	43.9	33.1	36.8	46.9	36.8	37.5	29.2	20.9	31.7	33.3	45.7	45.1	43.4	36.4	44.2	44.8	75.9	64.0	109.2	42.3	35.7	53.4	108.1	33.5	105.8	52.2	40.2	35.2	42.0	62.3	57.4	23.6	43.6	58.9	44.1	103.9	60.9	47.7	23.8	167.1	40.2	62.5	74.5	58.7	89.1	63.0	62.4	67.6	62.8	69.2	60.0	71.5	68.6	28.7	19.2	19.4	26.1	57.5	46.8	22.6	27.6	54.7	19.0	13.5	24.6	13.0	20.0	18.8	14.7	4.2	28.3	53.7	30.5	25.4	30.2	6.9	6.0	14.3	26.7	15.6	13.7	33.3	38.5	35.8	25.0	11.2	7.4	36.1	23.8	30.4	56.5	49.3	82.4	24.9	15.2	12.2	47.9	51.1	12.8	21.1	47.7	33.8	56.2	140.0	34.1	122.6	20.1	51.7	45.3	11.4	20.3	69.1	40.4	13.6	22.9	8.0	14.4	19.7	16.2	29.6	15.3	37.8	16.8	23.0	10.4	55.7	36.9	15.2	19.7
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823883	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.6;lymphoid tissue: 46.9;retina: 31.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 47.9;Erythroid cells: 102.1;Extravillous trophoblasts: 92.8;Plasma cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.4;white matter: 7.6"					"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	1.5	1.2	2.5	11.4	2.5	38.6	2.5	3.5	4.7	4.3	2.5	9.8	10.1	2.5	0.6	8.4	2.2	1.8	1.3	2.3	2.4	1.5	1.6	1.8	25.0	2.8	2.7	3.8	0.8	0.6	2.7	10.5	2.6	1.9	11.5	31.7	1.8	0.8	0.7	6.7	9.9	4.0	2.6	4.6	4.4	6.2	2.6	46.9	1.2	0.5	24.4	2.9	3.9	3.5	177.1	45.3	120.5	51.8	6.4	16.3	98.8	119.7	52.8	156.7	115.6	99.4	106.5	161.2	31.7	63.8	55.0	58.0	154.2	71.1	128.0	77.8	70.8	129.7	56.0	96.9	1.5	197.0	88.0	4.2	5.3	65.1	38.7	24.7	95.4	84.3	187.9	156.9	126.1	63.8	251.8	113.1	95.5	109.9	49.8	114.1	233.5	78.2	44.8	34.6	51.0	53.8	63.1	76.0	32.4	89.8	63.7	81.9	56.5	72.7	109.3	77.4	115.9	98.0	112.3	181.9	41.5	197.6	82.4	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.2	0.1	0.8	0.1	0.0	3.1	0.9	2.5	2.5	3.5	4.7	2.3	2.4	2.8	2.7	2.6	2.6	2.6	3.5	0.8	0.0	1.1	1.6	5.7	2.8	1.5	5.5	1.8	2.9	1.9	1.8	0.8	0.0	1.6	0.0	12.5	47.9	1.9	4.9	0.0	0.7	9.6	0.6	2.7	3.3	1.2	102.1	3.3	0.2	92.8	6.3	9.2	2.1	0.0	18.1	4.2	0.9	25.3	0.0	4.1	7.7	8.2	6.9	3.6	2.1	0.9	3.6	1.8	2.8	0.2	1.2	0.0	4.5	5.2	0.5	3.1	1.2	35.5	3.3	1.8	0.2	2.5	14.2	0.0	0.9	6.0	10.3	17.7	24.0	1.3	8.5	6.3	1.4	19.9	2.1
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.9;lymphoid tissue: 76.2"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.0	26.0	3.9	52.9	10.0	6.0	4.9	6.3	2.8	22.2	20.9	7.7	5.4	36.0	8.2	4.0	3.0	3.8	4.0	4.8	4.3	3.9	54.5	6.2	4.4	5.0	4.2	5.8	2.6	20.8	6.5	3.8	29.5	5.7	6.5	3.9	3.4	14.5	19.5	14.4	3.5	11.1	10.8	32.9	5.2	76.2	9.3	2.0	67.0	8.4	10.4	4.0	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.0	3.9	6.0	4.9	3.8	4.0	6.2	4.4	6.5	3.5	5.2	4.0	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4269771-4305353	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 354.3;Granulosa cells: 438.5;Langerhans cells: 255.3;Plasma cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 152.4;HBEC3-KT: 136.6;HDLM-2: 238.8;Karpas-707: 287.9;RH-30: 202.7;RPMI-8226: 114.2"									"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	20.0	52.6	5.4	8.7	12.9	20.3	13.0	0.0	13.5	26.9	0.0	40.8	17.4	26.1	7.5	12.2	22.1	2.7	51.9	14.4	1.1	9.7	1.9	17.2	5.3	9.6	0.2	14.2	24.5	9.9	23.5	12.9	2.7	20.7	10.4	0.7	10.8	9.1	1.8	12.6	25.9	9.8	7.8	19.7	12.7	4.0	0.0	3.2	20.3	0.0	5.1	26.5	19.9	4.5	0.0	0.0	152.4	0.0	10.1	0.4	0.0	0.0	0.0	0.0	0.0	62.8	0.0	0.0	0.4	0.0	0.0	16.2	0.1	136.6	0.0	238.8	2.5	0.7	0.0	0.0	0.0	57.0	12.6	23.8	2.4	0.0	97.0	0.0	0.0	0.8	17.0	287.9	6.8	0.0	0.0	52.8	50.8	0.0	0.0	0.0	202.7	114.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	89.6	0.0	0.0	4.2	0.0	39.3	0.0	0.0	1.4	60.7	0.0	0.0	32.3	0.0	6.6	0.4	4.7	11.1	0.0	17.1	3.1	16.3	13.8	0.4	1.7	10.4	12.1	1.1	9.4	0.0	1.1	13.6	6.8	5.4	12.9	0.0	13.5	14.4	1.1	9.6	0.2	2.7	7.8	0.0	4.5	23.9	60.9	46.6	10.1	82.9	106.8	23.9	73.4	174.2	7.6	3.4	41.8	354.3	2.8	37.4	12.9	0.0	4.0	128.7	37.5	0.0	3.1	0.8	3.3	110.8	35.7	64.8	37.2	54.1	68.3	2.7	123.6	4.6	3.6	55.8	438.5	19.6	2.2	13.0	3.3	55.2	147.7	12.2	11.9	255.3	3.3	52.5	39.3	39.2	19.7	9.8	170.0	89.6	55.3	4.0	20.7	49.4	124.1	371.2	35.8	34.4	1.4	10.3	6.5	26.3	21.4	112.6	0.8	5.1	50.9	39.6	6.3	122.6	41.5	159.7	8.4
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197177	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 20.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"HEL: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	3.2	1.4	2.3	1.3	2.1	20.0	2.1	3.8	2.6	1.4	1.9	1.7	1.5	1.4	2.1	1.2	2.0	1.0	1.3	2.0	2.4	1.5	1.7	2.7	2.2	2.4	2.3	0.7	1.3	1.1	1.2	1.4	2.5	1.3	1.9	1.8	1.5	1.1	1.7	2.8	2.6	1.2	1.8	2.6	2.1	0.9	2.6	1.5	1.7	1.2	1.9	1.7	1.1	2.4	0.2	0.2	0.4	0.2	1.3	0.8	0.4	0.3	1.6	0.3	0.3	0.4	0.3	0.5	0.4	1.1	0.1	0.5	1.1	0.5	0.2	0.7	1.1	13.5	0.6	0.5	0.9	0.7	0.7	1.5	1.2	0.1	0.2	1.3	1.0	0.2	0.8	0.4	0.4	0.0	0.4	1.4	0.9	0.5	0.3	0.4	0.5	1.2	1.7	0.6	0.6	0.9	0.5	0.4	0.3	0.5	0.0	1.1	1.2	0.2	0.1	1.0	0.2	1.4	0.6	0.1	1.3	1.4	0.4	21.8	1.9	5.6	5.1	3.7	5.4	4.7	5.5	5.2	1.8	5.3	5.6	5.9	6.2	4.8	9.5	3.0	8.4	1.8	2.3	2.1	3.8	2.6	2.0	2.4	2.4	2.3	2.5	1.8	2.6	2.4	59.8	48.1	54.9	11.1	81.8	34.7	55.7	83.3	25.0	28.9	38.0	40.9	52.6	40.0	78.6	29.5	20.9	362.7	92.0	63.6	90.1	64.0	24.2	61.6	33.8	45.2	46.2	361.2	20.7	59.3	82.1	55.9	45.3	37.0	57.0	40.2	53.6	31.0	85.4	45.4	17.8	47.7	154.6	83.5	36.2	12.6	47.2	57.1	64.0	11.2	137.8	55.9	74.2	9.5	23.4	68.6	55.8	29.3	54.2	42.1	85.8	47.5	128.0	66.0	46.0	35.2	49.4	124.3	61.6	27.8	40.3	1055.9	85.9	37.8	42.2	88.5
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811991-29824312	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8;placenta: 30.8"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"BEWO: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.2	5.7	1.9	4.3	2.1	35.8	0.8	2.8	2.7	1.0	0.9	3.9	3.0	1.4	0.6	4.4	0.9	1.0	2.3	2.0	2.5	1.0	0.7	1.1	6.1	2.0	2.1	0.8	1.8	2.8	0.9	30.8	2.0	1.0	4.7	2.0	1.5	1.4	2.1	4.1	2.5	2.2	1.7	4.2	2.1	12.1	2.5	4.5	1.6	1.8	7.8	3.0	1.8	2.3	15.6	31.8	24.3	34.0	5.2	6.0	293.1	24.7	5.3	10.8	13.2	33.0	31.2	13.3	55.9	11.1	14.0	4.9	28.8	12.8	15.2	41.9	17.7	11.2	30.0	34.5	4.1	44.0	28.7	6.2	7.1	14.8	1.9	3.4	13.3	13.2	45.6	5.8	16.8	24.4	24.5	13.0	40.1	36.2	7.2	36.2	28.6	10.1	8.4	24.6	20.5	17.4	35.4	42.7	3.9	35.4	9.5	32.7	8.0	25.0	92.8	14.9	16.9	24.1	18.2	91.6	13.8	5.6	13.7	0.0	0.0	0.0	0.1	0.5	0.3	0.6	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.3	0.1	1.9	2.1	2.8	2.7	2.0	2.5	2.0	2.1	2.0	1.7	2.5	2.3	3.1	0.0	0.6	0.7	4.8	4.8	1.5	0.3	2.2	2.9	8.2	11.3	3.1	0.0	1.4	0.0	0.0	122.4	3.7	3.5	0.0	0.4	14.6	7.5	4.1	1.9	3.0	30.7	2.9	0.7	1756.5	6.0	5.6	20.1	0.0	4.6	1.4	0.2	43.4	3.3	5.1	3.3	0.0	1.0	2.5	3.6	1.2	4.2	1.8	0.0	0.2	1.7	0.0	2.5	1.3	1.4	2.2	2.2	18.4	2.2	1.0	0.4	0.1	1.1	6.6	4.1	3.4	25.0	17.6	8.5	6.0	115.7	4.5	6.9	4.9	3.5
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047155-77076309	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	176.7	98.4	182.1	109.8	191.0	222.9	183.6	253.4	218.2	234.8	131.4	182.7	100.0	211.0	249.1	177.9	196.5	150.7	195.7	148.1	171.8	183.8	133.7	144.8	185.2	184.0	185.9	341.6	155.2	145.2	71.1	138.0	188.6	198.9	129.8	213.2	183.0	208.9	225.8	136.4	120.8	195.6	167.5	149.1	149.0	131.7	186.1	229.2	273.5	177.8	238.8	186.6	170.5	220.7	163.3	96.0	305.0	268.6	447.6	406.7	117.0	122.5	298.4	189.9	181.5	119.3	240.6	300.1	183.2	309.4	118.9	83.4	211.7	428.9	300.2	214.0	83.7	180.3	102.1	114.0	438.1	312.0	346.4	320.4	502.6	175.1	426.2	542.6	270.1	154.3	157.2	315.9	273.4	187.7	406.3	292.5	135.2	113.9	59.0	250.7	290.0	126.5	283.5	182.7	387.3	211.8	162.9	247.2	209.2	212.6	141.2	131.6	184.6	231.0	137.0	249.0	170.4	173.7	86.1	310.9	195.4	210.6	153.3	160.7	113.2	236.7	95.6	108.0	131.2	148.2	157.0	142.0	119.5	153.7	165.2	143.8	145.8	109.3	134.0	135.3	149.7	100.0	182.1	191.0	253.4	218.2	148.1	171.8	184.0	185.9	188.6	167.5	186.1	220.7	368.4	173.1	231.3	59.7	606.6	422.9	633.0	489.3	578.8	629.5	550.2	523.5	460.5	323.1	238.7	196.8	68.8	273.7	441.5	258.8	794.3	400.9	71.0	250.5	321.3	405.5	412.3	510.9	125.8	334.3	427.4	510.9	220.2	231.2	278.4	300.9	382.7	121.5	337.0	181.7	150.3	346.6	329.6	685.1	676.5	147.5	604.0	490.4	402.0	77.8	613.0	403.2	390.3	52.3	69.1	515.1	317.6	989.2	500.8	854.8	468.4	596.6	161.4	228.7	552.2	373.3	510.8	200.4	745.5	466.1	394.8	379.5	497.3	326.5	345.9	747.1
CCNK	CPR4	ENSG00000090061	"Cyclin K"	O75909	14	99481169-99535044	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Cyclin	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000645, HPA077073"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA000645: AB_1078606, HPA077073: AB_2732331"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"unprognostic (9.22e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.78e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.21e-2)"	20.7	18.0	8.8	26.6	10.2	102.1	16.9	11.5	12.8	17.9	10.5	26.3	25.5	18.9	18.8	25.5	22.1	18.5	19.3	9.8	11.8	16.6	17.9	21.7	28.4	11.9	10.8	25.8	16.7	13.5	19.7	19.8	10.9	17.0	28.0	16.3	20.7	16.2	39.2	22.1	27.7	19.8	9.1	24.9	25.0	45.4	10.6	33.3	20.0	22.4	34.1	21.5	19.1	12.9	53.9	59.3	59.7	50.2	47.5	49.4	109.3	69.9	62.2	71.4	82.3	86.3	69.7	84.3	47.7	75.9	53.1	59.9	64.3	89.9	99.5	83.0	33.7	78.1	38.6	75.2	62.4	111.1	85.6	53.7	68.2	71.1	81.4	33.8	54.4	82.9	72.1	72.8	62.7	115.1	85.9	44.6	59.0	66.2	52.1	76.5	80.2	44.7	39.8	101.1	49.1	36.5	62.7	31.9	28.6	57.7	87.4	49.6	66.5	25.6	40.7	226.1	63.3	61.7	86.6	101.5	65.5	50.9	53.4	5.3	5.3	12.6	7.2	5.7	6.3	5.4	5.6	6.4	4.7	4.9	6.5	6.0	12.8	5.1	6.2	5.0	6.3	3.4	8.8	10.2	11.5	12.8	9.8	11.8	11.9	10.8	10.9	9.1	10.6	12.9	29.6	12.8	37.9	13.7	41.8	36.8	48.6	31.3	33.6	16.9	29.5	23.6	11.5	14.3	37.7	22.0	20.9	23.5	52.7	36.0	13.7	20.1	51.5	39.2	39.6	24.1	19.7	39.2	13.7	24.7	29.3	27.6	49.5	56.7	20.3	29.3	25.7	18.7	24.2	18.5	14.0	34.2	30.5	32.7	32.1	22.0	22.4	41.1	17.8	16.9	38.0	13.4	47.4	14.1	18.5	31.8	26.4	18.0	44.9	42.1	26.2	17.2	43.4	28.8	0.0	40.1	23.0	78.9	64.3	35.7	45.3	27.2	46.5	24.9	32.4	70.2
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016, HPA072012"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: "	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	9.4	9.6	5.3	9.6	5.5	29.4	9.9	7.3	6.4	7.1	7.8	7.7	6.7	9.2	8.2	7.8	8.2	7.1	6.8	4.7	8.6	8.9	8.4	8.3	11.7	5.7	5.8	10.8	8.8	11.5	6.7	7.9	5.7	7.6	8.3	12.2	6.3	7.0	10.2	9.6	7.8	7.9	6.1	10.5	7.3	11.5	6.3	13.0	11.7	9.9	11.3	7.5	6.9	7.5	15.1	21.8	20.6	19.8	14.9	18.2	23.8	20.0	16.6	15.3	11.8	26.0	17.3	40.4	25.6	13.4	10.4	19.3	35.6	13.7	22.6	24.0	20.5	43.9	34.2	11.2	18.4	45.1	20.0	14.1	19.6	21.4	25.3	21.0	11.9	23.5	44.7	18.1	18.9	9.9	24.6	20.9	20.7	8.7	16.1	21.8	33.4	17.0	14.0	26.2	23.0	24.0	32.0	15.5	23.5	14.9	21.3	25.8	12.5	16.1	17.0	11.7	17.1	25.8	37.0	35.3	19.1	64.9	9.4	9.0	2.6	7.7	3.3	1.7	4.5	4.3	2.7	3.2	1.6	5.3	3.9	3.6	13.6	3.5	2.0	4.4	1.8	0.9	5.3	5.5	7.3	6.4	4.7	8.6	5.7	5.8	5.7	6.1	6.3	7.5	41.4	16.0	18.9	16.0	38.0	38.5	19.4	11.8	48.9	23.5	21.9	19.0	14.4	12.8	16.1	12.9	22.9	13.8	58.7	13.1	3.9	8.2	131.4	18.9	23.7	26.4	12.0	24.0	18.9	6.9	16.7	23.9	29.0	26.1	29.8	27.3	27.8	15.2	10.2	38.7	18.5	15.8	14.2	17.5	33.0	27.9	16.8	29.9	21.4	19.7	12.1	16.2	18.6	18.6	22.6	8.1	9.2	14.7	37.8	26.2	13.3	9.8	25.1	16.3	6.6	23.3	28.5	18.3	14.4	32.1	44.9	17.4	45.0	27.3	13.7	33.3
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;lymphoid tissue: 84.0"	"Group enriched"	"Detected in many"	4	"Langerhans cells: 415.0;monocytes: 1586.1;Syncytiotrophoblasts: 517.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 4597.2"	"Lineage enriched"	"Detected in all"	4	"T-cells: 4597.2"	"Cell line enriched"	"Detected in some"	82	"HDLM-2: 1386.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003796, HPA031383, HPA074467"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693"	"prognostic favorable (3.84e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	4.6	0.6	0.0	67.2	0.3	15.2	2.3	0.0	0.2	2.7	0.6	3.6	1.2	1.6	0.0	2.0	3.9	5.1	2.5	0.1	0.0	2.1	2.3	2.7	84.0	0.2	0.1	1.8	0.6	0.1	1.4	1.1	0.2	1.9	5.1	0.5	1.8	0.3	0.5	2.2	21.3	0.9	0.0	28.6	5.3	1.9	0.2	58.8	2.8	0.4	83.3	8.8	2.0	0.8	0.4	1.5	0.0	0.0	0.0	0.3	16.8	0.4	0.1	0.0	0.0	0.2	0.0	0.6	0.9	0.0	0.1	0.2	0.0	0.0	0.0	1386.6	0.1	0.0	0.2	0.5	0.0	3.9	0.0	0.5	0.0	0.0	0.0	1.9	0.0	0.3	0.8	0.2	0.0	0.4	1.2	3.0	0.1	0.0	0.0	4.5	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.2	1.0	0.6	1.6	0.0	0.4	0.1	1.6	0.7	7.5	0.9	9.0	1.9	0.1	0.0	25.6	6.5	4.2	61.1	3.5	69.2	794.6	996.2	285.4	4.2	1122.5	4597.2	2462.0	45.3	970.9	6.4	58.5	637.3	2489.9	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.8	1.2	0.0	3.7	0.0	201.4	5.0	1.5	0.0	0.0	0.0	0.7	0.4	0.3	0.0	1.3	1.8	0.0	143.8	9.5	0.0	0.0	0.6	0.3	0.5	0.3	1.0	0.0	0.4	0.0	8.3	24.2	1.6	1.1	0.4	2.5	0.0	0.4	0.0	12.8	0.0	0.0	0.0	0.0	0.0	415.0	0.2	0.0	75.7	16.0	0.0	1586.1	0.4	3.1	0.0	0.1	0.5	0.0	0.0	3.6	0.2	0.0	0.3	0.0	0.0	0.0	0.2	2.4	0.6	0.8	0.0	4.4	517.6	75.2	0.1	0.0	4.6
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	32.5	55.8	10.7	12.8	10.9	26.9	30.2	12.2	13.7	28.7	12.9	31.1	13.0	29.7	9.4	40.8	25.2	10.3	31.3	11.4	10.5	27.3	27.3	26.0	15.4	10.7	10.4	23.0	27.3	29.9	24.9	12.2	10.6	24.6	16.0	12.6	32.1	11.9	43.2	30.3	26.9	13.9	10.5	31.5	29.0	22.1	11.0	20.5	25.5	13.0	16.2	31.7	28.9	11.6	52.2	29.8	30.3	27.1	41.8	35.4	15.3	15.6	30.1	23.1	25.0	9.1	27.2	42.8	4.8	40.8	61.9	27.8	16.6	26.7	26.5	16.2	37.3	18.1	30.2	16.8	38.0	13.1	7.1	40.5	42.4	15.6	19.5	42.5	57.2	25.4	52.4	29.7	38.8	26.9	16.8	56.9	39.5	26.4	28.3	36.0	13.8	28.9	21.1	38.3	23.9	31.9	15.3	36.6	13.6	57.9	26.1	21.0	27.7	28.8	57.4	18.7	25.7	13.6	24.6	58.0	9.6	30.8	41.6	3.1	1.9	2.7	1.8	2.3	1.4	1.3	2.2	2.2	1.8	1.3	1.5	1.6	3.4	3.0	2.4	1.8	4.6	0.7	10.7	10.9	12.2	13.7	11.4	10.5	10.7	10.4	10.6	10.5	11.0	11.6	30.7	3.2	23.5	15.7	26.3	45.2	30.6	21.2	9.6	59.2	29.5	20.2	11.0	24.3	24.0	31.3	62.6	45.0	47.2	38.0	31.3	61.0	6.5	18.7	18.1	35.0	29.9	26.7	20.2	71.4	35.9	26.7	11.2	21.3	15.8	21.1	76.4	17.6	35.7	23.5	20.5	30.8	50.8	39.0	61.6	4.9	37.9	27.5	46.2	8.4	80.8	41.5	72.1	15.6	28.7	74.0	30.1	36.1	14.3	26.2	40.2	21.9	32.9	69.2	78.9	19.4	32.0	40.6	34.5	11.0	54.1	34.9	32.8	38.2	34.4	33.7
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	28.9	40.3	19.6	25.1	20.0	37.1	28.8	20.6	26.2	18.5	22.4	31.3	27.5	28.5	40.3	42.5	25.6	28.4	28.6	19.5	20.3	28.8	24.1	23.5	38.0	19.8	19.6	18.2	21.1	73.1	9.1	26.7	19.8	20.8	27.2	32.4	32.9	19.0	35.8	30.2	22.0	22.5	20.7	25.4	30.8	23.5	20.5	38.8	24.6	53.5	35.5	39.4	9.3	21.6	120.6	31.6	66.8	138.5	49.7	51.5	67.2	64.1	69.4	58.1	61.4	32.4	65.7	52.2	57.0	72.0	132.5	68.7	87.9	60.5	62.4	31.1	51.8	33.6	40.7	72.0	54.3	165.4	104.1	37.9	37.6	51.1	30.2	40.0	57.9	108.6	63.5	49.2	62.6	124.7	84.2	81.5	171.2	78.2	66.7	67.3	123.1	59.4	41.8	66.4	87.1	161.5	62.4	117.6	78.8	65.9	94.0	185.0	71.1	27.7	93.7	78.2	116.5	52.9	104.8	45.6	53.9	176.4	120.9	21.8	5.5	10.2	5.3	8.0	6.3	6.1	6.7	7.8	8.3	5.1	4.5	5.8	4.6	10.6	15.5	6.3	15.7	3.4	19.6	20.0	20.6	26.2	19.5	20.3	19.8	19.6	19.8	20.7	20.5	21.6	9.5	6.4	12.7	11.1	17.4	8.4	7.8	8.6	8.0	10.4	10.9	10.0	7.3	2.8	10.7	3.7	14.6	8.0	12.9	18.7	15.6	20.1	3.7	16.0	11.1	8.9	18.6	9.0	19.6	28.1	11.7	9.2	9.2	10.3	2.5	6.6	15.7	7.1	9.8	16.8	19.0	17.5	6.1	11.1	22.8	2.2	7.2	11.2	14.2	8.4	24.7	11.5	17.5	14.6	23.6	24.8	11.9	10.5	7.6	9.6	7.1	12.4	23.7	11.4	19.7	8.1	9.0	12.0	8.9	11.0	12.5	7.9	11.1	5.7	15.3	11.9
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1630.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7"	"Group enriched"	"Detected in many"	237	"B-cells: 61.1;granulocytes: 86.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	7.1	61.9	23.3	139.1	28.8	704.5	468.1	6.4	30.0	288.0	36.7	1071.8	89.0	181.5	229.6	1456.5	242.9	874.3	5.1	45.0	29.2	775.6	30.2	61.6	77.8	26.6	26.0	2.2	1383.4	2.5	12.5	151.7	17.2	148.8	740.8	2.6	952.4	546.9	1.4	77.2	69.8	117.7	19.5	29.6	601.7	4.9	38.6	15.2	1630.2	1.1	445.0	168.9	468.3	50.7	363.2	225.2	3.9	28.6	0.7	0.3	405.8	0.4	2.6	2.0	1.2	3.3	1.9	35.4	106.0	0.1	14.6	730.6	124.1	275.6	1.5	1.0	1.7	1.0	254.2	16.3	0.2	5.1	1.8	2.1	316.1	3.6	18.0	16.9	1.6	1.4	8.3	0.8	6.6	465.6	2.4	2.6	989.4	800.1	85.6	846.8	0.5	3.5	4702.6	931.5	612.4	448.7	250.0	1352.5	1.4	437.1	635.6	2.1	1.6	0.8	4.0	3.1	11.8	1.0	2.0	475.2	5.0	2.9	1.6	0.3	0.1	86.2	0.0	0.0	0.0	61.1	0.0	0.0	0.0	39.7	0.0	0.1	2.1	0.1	0.3	0.1	0.0	2.0	23.3	28.8	6.4	30.0	45.0	29.2	26.6	26.0	17.2	19.5	38.6	50.7	10.2	157.0	83.5	0.7	157.5	0.0	70.4	0.0	7.4	5.8	1109.4	325.4	1.5	1112.3	98.4	1302.1	2.1	749.2	13.7	1572.7	1590.6	1274.1	22.5	1237.6	254.2	38.6	575.4	5.3	0.6	3454.1	885.0	29.9	567.2	1441.8	10.8	0.6	97.5	9.7	70.8	0.0	5.7	463.6	0.0	7.6	0.0	53.4	10.2	17.6	0.0	1.0	32.6	1.0	0.0	0.0	0.1	1694.3	865.2	2.2	1.0	810.2	12.3	538.5	376.8	0.7	6.6	2.9	18.1	0.6	7.2	587.7	0.0	558.3	28.1	0.0	932.8	1043.7
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350773-30355308	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	31.1	49.3	38.9	34.0	39.7	23.9	32.9	38.0	41.5	39.6	34.0	39.3	29.9	45.0	24.9	35.3	41.0	22.0	35.2	39.9	41.2	42.8	27.3	32.8	38.8	41.4	39.8	36.9	40.7	42.5	42.7	24.4	39.1	38.3	23.7	16.2	30.0	35.5	46.9	33.6	35.2	31.6	39.0	46.4	36.9	24.0	41.6	35.7	42.5	26.6	43.7	37.0	30.1	42.0	55.4	65.7	54.4	49.4	44.3	41.9	46.0	60.0	71.5	66.8	71.3	50.6	64.9	84.6	72.3	65.5	61.4	59.4	57.0	70.3	53.6	50.6	66.6	35.9	67.7	60.3	63.6	51.3	63.4	45.2	58.7	74.2	47.3	45.6	70.3	62.1	41.4	63.2	67.7	132.1	71.6	43.6	73.8	42.9	38.5	104.2	45.3	64.3	54.2	54.7	44.7	85.1	40.2	69.9	42.0	44.7	66.4	41.1	50.6	76.3	53.3	38.9	53.1	105.0	82.3	78.5	52.5	47.2	64.0	107.4	61.7	116.6	71.3	76.3	56.8	87.5	57.3	66.7	55.8	97.3	47.6	58.9	121.9	74.5	102.7	67.1	94.4	79.6	38.9	39.7	38.0	41.5	39.9	41.2	41.4	39.8	39.1	39.0	41.6	42.0	38.1	32.1	29.0	7.2	39.5	28.8	49.6	58.4	31.9	29.8	33.2	29.6	26.5	45.8	41.2	36.8	20.9	61.0	57.0	50.5	60.7	83.6	19.9	41.7	30.7	42.8	33.0	22.3	6.7	97.5	58.1	36.4	28.1	45.2	47.6	33.4	28.2	13.9	69.7	11.8	7.1	32.7	36.7	38.3	23.6	14.2	35.4	34.0	39.2	8.4	84.1	47.6	97.9	3.5	10.7	87.8	64.9	35.7	52.7	40.7	60.3	81.5	46.3	29.0	39.5	30.5	44.6	38.5	40.1	27.4	30.4	88.7	41.9	38.9	31.6	50.7
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in many"		"granulocytes: 187.1;Hofbauer cells: 91.1;Kupffer cells: 177.0;Macrophages: 90.6;monocytes: 76.4;T-cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.8;HEL: 45.3;HL-60: 13.1;HMC-1: 49.7;MOLT-4: 12.9;U-698: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		35000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	3.3	2.4	1.9	19.4	2.1	7.9	2.7	2.3	2.4	2.8	1.9	3.2	2.4	1.4	0.9	2.2	1.1	6.2	1.4	1.7	1.9	0.8	5.2	7.8	24.2	5.2	3.1	1.5	2.0	0.9	0.4	7.1	4.5	1.1	4.5	0.2	1.4	3.4	0.4	1.3	4.6	4.0	3.8	15.2	3.6	1.9	5.2	9.9	1.1	0.7	13.2	4.7	0.8	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	45.3	0.1	0.0	0.0	13.1	49.7	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	0.1	0.0	0.0	12.9	9.7	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.8	0.0	2.9	0.0	32.7	9.6	15.0	8.2	8.0	6.5	6.3	7.0	10.1	7.1	6.0	4.0	7.4	1.2	1.4	3.2	4.1	10.5	8.8	1.9	2.1	2.3	2.4	1.7	1.9	5.2	3.1	4.5	3.8	5.2	7.2	1.3	0.0	6.4	0.0	27.4	2.4	0.7	0.0	0.6	0.2	0.6	1.5	1.2	2.8	1.3	0.0	0.0	0.5	20.5	0.2	0.0	0.1	0.9	0.5	0.2	4.2	0.0	21.5	0.1	0.2	0.5	1.2	2.6	0.2	187.1	0.1	3.3	1.1	91.1	0.0	0.2	0.1	0.0	177.0	42.2	1.5	0.6	90.6	5.4	34.7	76.4	0.0	4.1	0.0	0.1	0.0	0.0	0.0	10.8	0.9	0.3	0.3	0.7	0.2	0.0	1.6	1.5	0.1	0.4	0.5	2.4	1.0	46.8	2.9	0.2	0.6
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	4.0	5.0	2.1	3.6	2.2	8.1	4.3	4.3	3.1	7.7	3.2	4.5	2.8	5.9	4.4	4.1	6.1	2.5	2.9	2.1	0.9	3.2	4.0	3.5	4.2	3.0	1.5	11.3	4.8	3.5	5.1	3.2	2.7	6.9	2.5	2.6	5.4	3.5	4.2	4.9	4.2	2.8	0.7	4.6	4.5	6.3	1.4	5.2	5.1	2.8	3.4	5.8	5.6	2.6	8.1	5.4	7.2	10.4	6.3	5.4	8.6	10.4	4.3	9.9	7.2	13.6	4.2	3.9	11.2	5.8	9.7	15.5	7.7	4.7	2.9	9.9	7.2	14.5	10.3	5.3	4.7	10.8	13.2	7.4	5.2	6.3	4.5	6.1	7.6	13.0	18.9	5.7	8.2	4.5	8.4	14.2	3.6	7.7	8.5	11.9	9.0	3.4	3.1	7.9	5.9	6.8	8.2	11.3	1.7	4.6	8.6	15.9	5.6	10.4	9.2	8.6	12.1	11.2	12.7	8.7	5.4	15.8	8.6	1.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	2.1	2.2	4.3	3.1	2.1	0.9	3.0	1.5	2.7	0.7	1.4	2.6	2.0	0.0	3.7	4.6	2.4	1.9	2.0	1.5	1.8	3.3	3.2	1.8	2.2	2.8	1.5	7.3	4.2	3.0	2.6	1.9	0.0	1.5	0.4	2.0	2.8	2.3	4.8	1.7	7.6	1.8	1.6	2.9	3.6	2.0	1.3	9.0	3.9	3.6	2.1	1.7	6.3	1.6	4.1	2.5	0.9	1.2	4.4	1.6	0.0	4.7	1.5	4.5	2.1	5.5	3.8	1.6	0.5	4.9	2.5	2.3	2.2	1.3	1.9	4.7	19.7	3.4	2.4	5.4	2.1	2.8	1.3	2.2	2.5	4.6	2.6	1.7
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285269-138338355	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	0.2	0.2	0.2	2.1	0.2	5.8	0.7	0.3	0.3	0.3	0.2	3.4	3.0	0.4	0.2	1.4	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.3	3.2	0.2	0.3	0.0	0.4	0.1	0.1	1.2	0.2	0.2	4.1	0.1	0.3	0.1	0.0	1.4	3.0	0.8	0.1	0.9	1.1	18.1	0.2	8.9	0.1	0.0	4.6	0.5	0.5	0.2	27.9	11.0	38.4	28.9	0.9	3.6	9.9	16.4	17.5	36.2	50.3	27.3	52.8	13.3	13.8	10.1	40.5	14.9	31.7	25.9	34.9	11.1	21.5	9.6	15.0	21.2	0.3	6.3	10.0	0.8	0.9	22.0	18.0	3.8	24.6	28.9	14.8	24.2	22.9	15.5	19.3	16.7	9.7	22.3	12.2	11.9	34.2	15.0	6.4	8.4	19.2	11.9	36.8	11.0	16.9	32.6	18.7	13.9	7.2	19.9	16.8	13.9	26.5	15.0	13.4	13.0	8.3	14.3	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	1.3	0.9	0.6	0.3	1.1	1.8	0.0	0.9	0.8	0.3	0.0	0.2	0.0	0.0	5.0	0.5	1.8	0.0	0.1	41.4	0.4	0.9	0.6	0.0	9.5	1.3	0.0	6.9	1.1	3.6	1.2	0.0	5.5	1.4	0.4	2.7	0.0	1.0	3.9	2.0	0.6	0.5	42.1	1.8	1.2	0.0	1.0	0.6	0.0	0.0	1.0	0.3	0.0	1.4	0.4	4.5	0.3	0.9	0.1	0.1	0.0	0.0	0.2	0.9	53.6	13.0	4.3	0.4	1.4	0.6	0.2	4.9	0.6
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 149.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.38e-4)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	23.0	15.2	9.3	20.1	12.0	27.6	18.1	18.3	15.2	18.0	5.6	15.2	14.6	20.7	13.1	16.6	15.1	18.4	23.3	11.6	12.0	15.2	22.4	18.1	23.4	10.6	10.8	17.0	14.5	24.4	10.6	25.5	11.5	15.1	17.7	13.7	12.2	15.4	22.4	12.1	13.8	24.5	10.5	19.1	15.9	25.0	11.3	25.0	42.4	28.8	24.0	19.8	11.2	11.3	80.7	84.1	69.1	56.1	45.5	72.0	41.0	110.9	99.0	103.3	105.1	54.2	41.4	107.4	72.7	93.5	66.0	37.5	75.2	62.6	141.2	155.5	77.2	125.0	92.9	48.6	49.2	74.4	54.6	52.4	30.2	93.5	73.1	49.7	108.6	61.6	101.6	58.0	85.2	68.3	91.8	33.5	32.8	45.2	67.8	48.9	177.3	47.8	62.0	50.0	45.8	55.9	55.4	19.4	61.2	58.6	58.6	51.7	116.9	107.1	91.9	68.6	82.9	58.8	110.2	95.8	59.4	43.6	76.0	9.3	3.2	4.9	5.3	7.1	5.2	4.0	4.2	5.5	4.2	6.3	4.2	5.0	4.0	8.7	5.3	5.2	8.3	3.5	9.3	12.0	18.3	15.2	11.6	12.0	10.6	10.8	11.5	10.5	11.3	11.3	63.7	9.6	26.3	61.0	28.7	26.0	17.8	25.9	38.1	22.1	21.3	17.5	39.8	21.5	27.1	20.2	16.7	31.4	22.5	11.5	15.6	28.1	28.9	20.8	33.9	50.7	13.8	149.8	124.5	26.5	35.6	41.4	21.4	22.1	26.6	24.8	38.9	27.1	27.2	35.3	104.4	12.8	8.2	28.5	22.1	33.6	28.3	30.6	7.2	83.4	31.5	19.4	35.0	89.0	96.1	30.1	9.5	29.7	39.0	18.7	13.5	23.6	16.2	14.9	19.7	41.6	40.8	97.3	38.6	32.6	26.9	11.5	27.8	34.2	16.2	17.1
CDC42EP4	"BORG4, CEP4, KAIA1777, MGC17125, MGC3740"	ENSG00000179604	"CDC42 effector protein 4"	Q9H3Q1	17	73283624-73312005	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Horizontal cells: 753.7;Muller glia cells: 570.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023335, HPA024797"	Approved	Supported	Supported	"Plasma membrane,Actin filaments,Microtubules"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Actin filaments, Microtubules"	"Plasma membrane"	"HPA023335: AB_10603783, HPA024797: AB_10600696"	"unprognostic (8.76e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (6.29e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	94.5	54.9	84.9	15.3	84.7	14.9	74.5	90.6	76.3	47.4	75.0	55.6	35.7	52.7	60.1	33.3	69.4	19.1	50.5	82.2	103.1	28.6	32.2	38.6	16.1	141.9	104.5	70.7	77.5	20.5	45.0	22.9	83.7	38.7	17.4	98.1	41.5	43.1	28.8	40.6	36.0	25.5	103.5	24.1	42.4	20.5	105.9	20.2	45.4	18.8	27.6	33.8	39.5	109.5	30.1	70.1	24.7	20.9	48.8	40.5	65.0	26.2	32.6	24.3	17.9	14.8	42.1	0.1	22.9	31.6	27.6	20.6	17.2	18.0	14.6	1.4	17.0	6.7	35.2	34.7	24.3	1.1	7.3	51.4	14.9	21.2	10.5	19.2	27.9	0.6	18.9	1.4	14.9	23.2	1.2	8.6	13.5	87.8	48.4	0.8	11.0	3.1	28.8	34.3	16.4	24.8	19.7	53.1	18.4	19.0	64.3	9.8	28.7	22.7	47.6	18.1	18.9	1.4	1.2	0.2	37.3	4.7	60.7	3.3	3.2	5.9	0.1	8.5	0.2	0.1	0.0	0.0	4.3	0.0	0.2	0.0	5.4	0.3	20.1	0.1	0.0	2.1	84.9	84.7	90.6	76.3	82.2	103.1	141.9	104.5	83.7	103.5	105.9	109.5	117.1	12.8	15.6	54.9	2.8	48.7	58.5	54.9	97.9	11.5	45.8	37.1	10.8	31.5	29.1	12.9	6.2	32.1	2.5	47.3	11.7	29.4	0.6	29.7	47.6	43.8	31.2	9.1	1.0	43.6	35.0	46.1	31.1	41.2	13.3	19.6	42.8	27.7	6.1	753.7	1.3	41.3	14.2	5.5	30.1	2.7	18.3	9.1	30.2	6.5	11.1	570.4	0.0	2.5	2.5	30.4	33.5	15.4	2.5	42.6	53.1	8.0	18.0	26.2	131.5	98.0	69.9	1.1	2.0	83.2	44.9	84.3	6.0	13.6	30.2	124.1
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171748-89195492	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 24.4;skeletal muscle: 57.0"	"Cell type enriched"	"Detected in some"	13	"Skeletal myocytes: 76.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	15	"cerebellum: 24.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 145.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 15.7"	"Region enriched"	"Detected in some"	17	"cerebellum: 18.7"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		870000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.0	0.2	0.1	0.0	0.2	0.0	0.0	24.4	0.8	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	1.3	0.4	0.0	0.1	0.8	0.2	1.4	0.0	0.1	0.7	1.6	0.4	0.0	0.0	0.9	0.0	57.0	0.1	0.0	0.0	0.3	1.2	0.2	0.6	0.1	0.0	0.0	5.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.7	0.0	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	31.5	0.1	0.0	0.1	0.0	0.2	0.3	0.0	145.8	0.3	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	24.4	0.8	0.0	0.1	0.1	0.8	1.6	0.3	0.1	0.6	0.2	0.0	2.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.1	1.2	0.0	0.1	0.0	0.3	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.0	76.1	0.4	1.5	5.5	0.0	0.0	0.1	0.2	0.8	0.1	0.1
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461486-39564907	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 307.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	9.5	7.6	2.5	14.0	1.9	34.3	9.5	8.0	4.0	11.0	4.1	9.8	9.9	10.8	6.0	10.4	9.2	9.2	6.8	1.6	2.9	8.0	12.3	9.2	15.1	3.0	1.7	11.9	8.7	13.0	6.2	11.5	1.6	9.8	10.4	11.7	9.2	9.3	6.7	10.6	10.4	10.0	0.3	12.9	10.3	17.7	3.4	17.9	12.2	7.8	15.3	13.1	9.1	3.3	31.9	40.0	24.9	22.2	17.2	19.0	21.1	28.9	24.7	39.9	29.0	48.1	19.8	45.4	24.6	31.1	38.7	51.8	49.2	36.6	38.4	29.6	38.7	49.7	26.9	36.3	16.4	66.9	33.4	20.4	25.0	48.2	37.6	16.0	24.4	27.7	85.2	30.7	22.9	14.3	57.9	17.7	23.8	16.0	16.9	36.8	50.3	25.7	14.8	38.8	24.6	15.7	37.0	307.8	25.1	34.8	38.5	29.3	26.4	34.5	27.6	24.5	37.9	23.6	18.4	63.5	24.2	28.2	23.0	11.2	2.0	3.2	2.6	1.5	1.8	1.8	1.5	1.7	1.2	3.1	1.7	1.6	7.0	4.5	1.3	2.7	1.2	0.7	2.5	1.9	8.0	4.0	1.6	2.9	3.0	1.7	1.6	0.3	3.4	3.3	41.4	25.6	29.1	50.9	59.0	64.6	58.5	31.2	50.1	46.6	38.1	26.9	14.5	32.9	40.3	38.6	64.6	33.2	59.0	44.6	13.7	30.2	25.1	49.8	63.4	40.6	31.1	39.3	53.9	27.5	29.9	39.2	45.3	63.1	29.1	43.8	32.2	46.3	27.4	35.3	52.9	39.6	42.7	45.9	49.1	17.3	37.3	41.3	26.6	32.8	41.4	27.8	48.4	47.3	53.1	47.9	33.9	33.8	53.5	81.5	33.3	16.7	38.1	65.4	32.9	48.0	48.5	140.2	104.8	53.0	69.0	58.3	59.0	46.0	39.9	84.8
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.6	11.7	12.4	9.8	18.0	24.4	14.4	14.1	12.7	14.2	20.6	15.1	5.6	11.5	7.7	12.1	11.9	9.2	17.6	12.5	12.9	8.0	15.7	10.6	15.1	15.4	16.2	17.1	9.5	13.3	12.2	8.6	15.1	13.7	8.6	12.9	22.2	10.5	47.9	16.0	11.0	10.4	13.6	11.5	12.9	20.8	14.9	20.9	11.6	29.6	14.7	12.5	11.1	17.2	19.6	33.8	45.9	27.8	19.3	28.4	24.6	24.6	18.9	27.3	25.4	26.8	25.1	36.3	11.1	24.3	18.7	42.1	36.5	28.3	26.1	29.3	14.7	31.0	62.1	47.7	18.1	38.5	19.9	51.4	18.5	24.3	31.8	20.6	24.1	43.0	29.2	30.6	36.4	44.2	41.8	24.7	42.6	41.5	25.3	40.3	54.5	17.1	19.5	15.4	29.9	34.3	42.9	23.3	28.8	19.7	54.6	26.3	16.1	23.6	25.7	28.0	28.4	22.2	33.4	39.7	24.6	24.4	50.8	15.7	1.7	3.0	3.4	1.7	3.3	5.0	3.2	3.2	1.0	5.8	2.6	2.7	2.4	4.0	4.7	2.2	2.9	1.8	12.4	18.0	14.1	12.7	12.5	12.9	15.4	16.2	15.1	13.6	14.9	17.2	11.6	28.9	39.5	64.9	21.2	7.0	13.5	11.9	13.1	23.7	18.0	17.5	53.8	15.7	19.3	1.8	16.7	13.2	25.8	12.3	7.9	12.6	37.5	24.8	18.1	13.7	8.4	35.3	43.2	14.3	12.7	20.4	10.7	23.7	17.1	41.4	8.6	22.2	10.8	18.5	38.4	12.1	18.3	9.4	8.6	30.6	22.1	25.8	12.4	26.2	13.2	20.4	24.7	66.9	148.7	11.8	8.1	23.3	27.7	9.5	5.6	4.6	35.0	28.9	32.9	43.6	22.3	58.4	36.4	17.8	6.8	7.3	23.1	23.0	11.6	7.7
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50326265-50416461	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	13.5	3.6	3.4	4.9	4.4	3.6	3.5	1.4	9.0	13.9	3.7	8.8	13.2	13.9	3.2	5.2	15.4	5.2	2.3	5.5	2.3	19.4	1.6	6.5	6.5	2.0	2.1	13.8	1.3	1.2	0.6	6.5	2.9	5.9	6.6	20.2	2.8	9.0	7.1	13.5	6.9	8.5	2.9	7.0	4.9	2.0	1.8	1.9	7.9	1.0	2.6	6.9	6.6	8.1	7.7	4.9	3.5	4.3	5.3	6.1	2.3	2.2	3.2	1.9	2.0	4.0	5.9	6.1	2.8	3.2	3.2	5.9	0.8	0.3	1.9	8.9	3.1	12.2	4.6	3.9	6.2	9.7	5.3	1.5	3.0	3.2	8.0	2.4	6.7	10.3	3.3	4.8	1.1	2.5	2.8	4.7	1.9	2.6	3.9	3.3	3.8	3.1	5.3	6.6	4.6	3.4	4.2	18.3	2.1	1.3	2.4	6.2	4.0	6.7	4.1	7.1	5.0	2.4	1.8	2.9	1.7	8.7	7.6	3.2	1.4	2.6	3.5	1.4	3.1	2.6	2.3	3.2	0.8	3.0	1.9	1.9	0.7	2.3	0.2	0.8	2.4	1.3	3.4	4.4	1.4	9.0	5.5	2.3	2.0	2.1	2.9	2.9	1.8	8.1	3.2	19.2	9.9	6.5	3.0	3.1	4.1	0.2	3.4	0.7	0.4	0.5	0.5	0.0	2.6	11.0	0.0	0.1	2.3	7.2	5.9	1.4	0.4	23.4	9.6	3.3	1.8	6.1	46.2	1.8	0.1	7.6	1.1	4.9	1.3	3.2	6.4	0.3	0.4	0.0	20.6	2.1	2.0	0.9	1.5	1.5	9.0	1.5	0.0	7.5	0.8	0.9	2.1	46.8	25.4	1.9	4.8	3.4	0.2	3.1	4.9	8.0	20.4	0.7	0.0	4.0	4.6	0.0	0.3	4.7	2.7	0.3	4.2	3.6	5.2	2.2
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444635-183449064	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 207.0;Glandular and luminal cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 161.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	11.7	11.7	10.1	11.9	10.7	38.0	15.5	13.4	13.4	12.8	9.9	14.3	19.0	15.7	12.3	22.2	11.8	12.9	10.3	9.8	10.4	18.3	17.5	11.2	19.8	10.2	10.2	22.6	18.5	15.4	11.4	13.9	10.1	12.8	13.6	13.1	12.8	13.0	9.0	12.0	17.3	9.7	10.9	14.3	17.8	20.1	10.8	24.0	13.5	14.2	18.8	11.8	12.3	12.3	14.4	8.1	23.2	16.8	19.0	14.0	17.7	23.9	19.9	23.9	16.0	11.9	13.5	47.1	4.9	16.1	10.0	11.3	21.0	17.3	25.1	19.4	12.6	49.7	39.4	15.9	14.8	37.3	19.5	16.3	15.6	14.3	18.7	12.6	19.1	18.0	25.1	50.4	16.5	7.8	41.6	30.5	17.0	5.5	16.2	36.1	11.2	19.5	161.1	13.5	23.9	20.7	17.2	72.0	29.9	14.9	10.5	32.0	11.0	8.5	12.3	7.9	19.6	24.4	10.9	25.0	13.3	31.4	13.9	61.0	8.0	18.6	14.4	9.7	14.9	12.2	17.4	15.4	7.7	14.1	22.6	20.8	9.7	15.0	10.3	5.2	19.2	14.6	10.1	10.7	13.4	13.4	9.8	10.4	10.2	10.2	10.1	10.9	10.8	12.3	49.6	16.0	33.1	3.6	58.9	35.9	38.5	9.1	130.3	21.2	35.5	40.1	18.9	17.2	24.2	16.5	10.4	21.8	51.8	36.4	17.6	12.5	150.8	207.0	48.9	33.5	30.4	32.0	5.8	15.5	14.7	38.8	62.2	333.9	62.1	29.7	16.4	13.5	15.7	21.9	5.8	25.5	20.3	12.6	24.2	70.5	21.1	25.7	21.4	7.5	13.2	24.3	22.6	7.5	9.9	17.6	21.1	17.3	47.2	31.5	37.8	13.1	28.8	21.2	13.1	60.8	37.5	36.6	40.3	124.7	39.8	18.7	55.3	22.4	33.3	60.9
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 207.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.8"	"Group enriched"	"Detected in all"	6	"NK-cells: 6.4;T-cells: 18.8"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	3.4	1.6	2.8	12.2	2.7	43.4	3.4	5.0	4.2	2.2	3.4	13.9	12.4	2.8	0.4	10.2	1.3	2.9	5.3	2.9	3.1	2.0	2.4	2.1	28.4	2.5	2.7	1.3	1.1	0.5	1.6	6.7	3.3	1.6	16.9	2.6	3.3	0.7	3.0	5.9	12.6	7.4	2.1	4.9	5.0	207.0	3.5	30.9	1.7	4.1	30.0	5.8	4.1	2.6	276.7	102.5	74.0	78.2	12.5	15.3	46.5	63.1	97.0	135.8	146.9	81.8	136.5	139.9	44.4	96.7	135.9	195.9	114.6	78.3	245.6	169.5	59.3	65.8	69.0	126.8	10.1	86.2	47.6	5.4	4.9	84.3	138.3	44.4	88.4	129.8	36.1	162.2	159.8	186.9	118.1	67.9	27.9	254.7	216.4	72.7	66.6	29.7	70.5	56.9	30.6	42.0	118.7	67.4	52.5	54.6	142.9	69.4	33.0	59.2	195.8	91.7	155.0	38.6	47.4	91.4	98.6	120.4	110.9	0.0	1.3	1.3	1.6	1.7	0.7	2.1	5.5	4.8	1.8	0.9	2.9	2.3	1.0	6.4	1.2	1.5	18.8	3.1	2.8	2.7	5.0	4.2	2.9	3.1	2.5	2.7	3.3	2.1	3.5	2.6	1.4	0.0	0.0	0.7	10.5	9.3	4.3	9.7	4.6	3.2	6.4	11.6	9.7	0.0	2.4	1.8	2.1	42.6	2.7	7.3	0.0	3.5	2630.9	2.7	3.5	6.8	7.8	125.5	2.5	2.4	35.0	10.2	9.2	3.5	7.0	31.3	6.1	3.1	37.7	5.0	3.9	17.9	4.1	9.8	8.8	659.4	21.5	8.9	1.8	1.0	2.9	1.7	0.0	0.0	0.2	1.9	7.2	10.5	41.0	4.0	3.4	2.8	0.2	2.9	0.0	3.0	20.5	606.9	39.8	22.5	6.5	4.1	8.3	3.9	31.2	5.3
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27960918-27969315	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 287.5;Intestinal goblet cells: 214.5;Paneth cells: 181.7;Proximal enterocytes: 226.9;Undifferentiated cells: 194.4"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823"		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	31.3	0.0	0.0	0.1	0.0	0.0	35.9	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.7	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	287.5	0.0	28.9	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	214.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.9	181.7	0.0	0.0	0.2	226.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.4	0.0	194.4	0.3
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	27.3	32.2	36.5	31.9	44.8	46.0	25.8	59.0	37.3	29.7	35.4	34.5	22.4	31.7	23.9	32.0	28.4	24.4	30.1	34.7	31.5	26.9	56.1	32.1	39.4	24.1	26.0	26.0	28.0	48.0	23.4	27.6	20.7	23.6	25.8	29.2	26.1	22.6	74.3	30.7	30.6	29.0	20.2	34.6	26.6	29.8	30.3	28.9	28.8	58.0	38.5	29.4	29.4	24.9	48.6	84.4	68.8	71.0	52.9	55.8	58.5	51.0	52.5	62.9	65.4	72.3	56.0	127.6	34.6	55.2	75.6	70.6	107.5	72.3	104.9	53.5	46.9	39.2	117.3	52.2	51.3	62.2	41.4	43.0	43.7	68.5	82.5	44.4	58.0	54.2	75.0	50.5	40.6	64.8	64.5	49.3	96.5	60.0	49.3	65.5	54.8	49.9	54.3	85.4	64.3	54.3	67.9	62.0	41.1	70.0	87.8	40.5	67.0	71.3	69.7	69.1	70.0	42.9	42.2	99.7	57.6	29.2	59.3	13.9	11.6	22.8	12.5	10.2	15.8	14.4	13.3	14.6	13.1	15.0	14.0	11.9	14.9	7.9	17.7	8.0	10.1	9.5	36.5	44.8	59.0	37.3	34.7	31.5	24.1	26.0	20.7	20.2	30.3	24.9	56.2	54.5	41.9	90.8	74.6	107.7	78.0	82.1	79.6	82.4	78.8	59.3	51.1	72.9	56.2	79.1	95.9	52.6	84.1	51.6	21.5	57.3	16.3	76.5	68.4	73.2	85.6	81.0	134.4	56.1	48.8	48.8	57.1	94.4	21.5	92.6	92.4	233.5	72.4	127.9	108.5	62.3	52.9	123.2	98.2	12.4	52.8	81.3	42.7	91.8	106.2	52.2	98.9	76.4	65.8	86.5	53.7	55.3	55.3	103.5	46.2	43.5	106.1	42.9	52.6	52.3	72.0	50.1	69.7	70.2	109.1	36.0	68.8	50.2	70.0	101.1
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537620	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Basal respiratory cells: 28.1;Club cells: 31.1;Endometrial ciliated cells: 31.8;Glandular and luminal cells: 42.6;Respiratory ciliated cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 68.4;RPTEC TERT1: 48.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		280000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	0.7	0.8	0.4	3.1	0.9	0.8	7.8	1.5	0.5	9.9	1.2	1.6	0.9	3.7	10.2	11.5	15.4	1.4	3.4	1.0	0.4	17.1	5.2	12.5	5.9	2.4	3.9	0.2	2.6	6.3	2.4	1.0	1.4	5.0	1.8	0.5	12.0	3.9	0.2	31.5	1.6	1.1	1.6	3.3	5.4	1.3	2.2	2.4	3.7	0.1	7.9	3.9	3.7	1.0	22.3	68.4	11.3	10.6	0.0	0.0	6.5	2.3	3.4	2.3	1.3	21.7	21.9	0.2	32.1	1.3	22.0	35.0	7.5	28.7	2.0	0.0	10.2	0.0	25.6	2.0	1.0	3.2	1.8	0.0	43.5	0.0	26.2	31.6	0.4	1.7	0.3	0.4	0.0	38.4	0.1	11.9	4.5	12.1	8.1	0.1	0.1	8.1	48.7	13.5	0.7	0.9	16.1	17.3	3.7	7.9	39.7	16.7	0.9	0.1	0.3	0.0	0.4	10.6	1.1	10.5	15.2	0.1	12.9	0.0	0.0	0.0	0.2	0.1	0.2	2.2	0.1	0.1	0.0	1.9	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.9	1.5	0.5	1.0	0.4	2.4	3.9	1.4	1.6	2.2	1.0	0.5	41.7	23.5	0.0	5.8	17.1	4.1	28.1	8.0	0.2	14.2	5.2	12.7	2.8	31.1	5.5	0.0	1.9	2.3	0.8	0.0	1.8	2.3	31.8	5.0	5.6	1.2	0.0	1.2	0.7	1.9	1.0	2.6	42.6	0.0	0.6	1.8	1.5	2.4	0.0	1.2	2.8	6.1	0.0	4.1	10.3	0.0	1.1	5.4	1.0	1.1	1.1	0.0	0.5	0.7	4.0	0.3	0.0	1.1	4.3	0.0	8.2	60.3	0.3	0.0	0.1	2.8	0.4	0.6	12.6	15.6	0.8	1.1	0.0	1.7	5.1
CEMIP2	TMEM2	ENSG00000135048	"Cell migration inducing hyaluronidase 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 92.5;placenta: 79.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 143.4;BEWO: 117.4;OE19: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017080, HPA044889"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA017080: , HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	25.1	5.4	9.7	24.8	6.5	29.7	11.1	9.7	8.3	5.1	15.0	24.2	27.2	7.2	2.7	6.6	5.6	41.5	7.7	19.0	2.8	10.4	60.2	35.0	23.1	4.1	3.6	2.2	19.3	92.5	4.6	79.6	4.9	7.0	28.0	17.3	11.1	8.0	4.8	6.1	23.7	11.7	4.1	15.9	33.2	6.8	8.2	18.6	9.4	8.6	20.7	32.0	3.4	5.5	22.5	85.0	143.4	6.6	13.7	22.9	117.4	81.7	48.7	51.6	40.5	24.3	31.3	0.4	20.0	18.8	11.6	35.2	38.6	9.9	73.2	2.5	11.2	38.9	20.9	68.7	23.9	0.4	9.8	28.0	11.4	38.9	8.1	14.0	68.2	3.3	4.7	10.2	28.8	15.1	4.1	0.6	28.2	144.3	8.6	3.3	39.9	2.4	31.6	60.4	6.3	0.6	19.3	12.5	20.5	45.2	8.8	1.3	30.3	33.7	38.3	17.4	39.3	1.8	37.8	0.9	6.1	3.9	43.7	0.1	1.3	3.1	1.4	1.1	0.3	0.4	1.5	1.3	0.5	3.0	2.1	1.0	2.3	0.3	1.0	0.1	2.3	0.9	9.7	6.5	9.7	8.3	19.0	2.8	4.1	3.6	4.9	4.1	8.2	5.5	105.8	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	58.7	46.7	0.0	0.0	0.0	14.7	0.0	47.9	378.1	0.0	0.0	20.2	0.0	42.1	24.2	14.7	0.0	0.0	0.0	36.2	14.4	4.3	0.0	137.3	0.0	3.8	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.8	0.0	0.0	155.1	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	89.8	86.1	3.1	0.0	0.0
CENPB		ENSG00000125817	"Centromere protein B"	P07199	20	3783851-3786740	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011626, HPA053507, HPA054405"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	Nucleoplasm	"CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477"	"unprognostic (2.01e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	45.2	39.8	115.4	20.4	120.8	14.9	40.3	97.8	109.8	41.1	68.0	56.9	21.4	45.5	11.0	42.2	36.2	15.3	54.8	89.6	91.8	40.4	42.3	36.0	17.5	121.9	113.7	36.6	40.7	26.1	29.6	15.3	108.2	40.0	12.6	3.9	35.0	24.1	95.0	53.7	34.9	19.4	119.6	35.9	44.3	10.8	111.8	17.7	35.0	43.2	13.7	48.2	33.9	133.5	111.9	140.4	27.1	58.1	56.2	44.4	17.4	78.2	56.4	49.1	39.5	57.5	78.1	38.7	24.0	72.9	77.0	88.3	21.7	88.9	24.6	55.5	37.1	82.3	51.5	51.4	65.2	27.0	26.7	50.5	46.9	70.5	45.0	38.5	42.5	49.2	53.9	23.8	42.4	183.2	81.1	61.8	34.0	62.7	165.4	66.8	3.6	28.3	52.2	67.6	66.2	49.4	64.7	89.7	62.4	12.2	56.7	59.1	73.2	84.9	45.8	74.1	121.3	28.5	44.1	22.5	29.8	95.2	56.9	0.0	1.7	0.6	1.9	1.7	1.3	1.0	1.3	1.2	1.3	1.4	1.1	1.4	0.2	1.7	1.1	1.7	0.4	1.1	115.4	120.8	97.8	109.8	89.6	91.8	121.9	113.7	108.2	119.6	111.8	133.5	30.2	6.4	19.5	2.3	6.8	13.9	5.7	11.2	15.9	18.3	23.8	23.1	16.5	30.0	11.6	14.7	10.4	6.2	17.2	48.0	3.9	18.9	1.2	12.7	21.5	24.7	20.4	12.0	2.6	29.8	7.9	14.6	15.8	18.1	7.6	24.0	17.9	25.6	22.7	21.9	4.5	27.1	6.1	25.7	12.3	7.5	21.8	15.3	17.8	3.7	17.3	31.1	12.3	1.5	3.8	31.0	25.4	25.9	5.7	12.5	28.4	8.7	10.8	13.0	13.1	22.4	21.9	1.1	1.5	17.4	14.1	4.5	11.8	46.5	26.9	7.4
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105349-103198445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 10.0;lymphoid tissue: 9.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 75.1;Extravillous trophoblasts: 28.4;Granulosa cells: 32.0;Spermatocytes: 75.3;Spermatogonia: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011110, HPA042294"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA011110: , HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	0.4	0.2	0.4	2.7	0.4	10.0	0.6	0.3	0.5	0.4	0.4	1.8	1.5	0.6	0.0	2.0	0.2	0.8	0.2	0.3	0.6	0.2	0.5	0.8	5.6	0.5	0.5	0.1	0.1	0.3	0.0	1.4	0.9	0.3	2.0	0.4	0.3	0.2	0.0	2.0	1.7	1.1	0.3	1.2	1.1	4.1	0.5	9.2	0.2	0.6	4.9	0.8	0.6	0.5	42.6	11.8	42.2	20.5	2.7	6.2	8.4	36.7	18.2	26.9	17.9	19.6	22.2	28.6	9.2	13.7	19.2	18.2	30.3	15.1	42.2	35.9	11.3	33.5	26.8	13.6	0.4	39.9	18.6	1.8	1.1	21.7	18.0	6.0	22.9	25.2	34.4	32.5	34.8	15.6	31.5	18.9	13.8	17.0	17.9	20.9	38.5	9.3	8.0	8.4	19.3	11.5	32.9	22.9	9.0	16.0	12.9	13.9	26.1	25.8	27.2	27.2	38.6	15.9	28.6	28.8	14.2	21.7	27.8	2.9	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.5	0.2	0.6	0.0	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.9	0.3	0.5	0.5	1.4	3.2	2.2	1.0	6.6	3.6	1.5	2.9	0.0	7.6	1.8	2.7	1.9	0.0	1.3	0.0	8.4	12.7	3.9	4.7	0.0	0.5	7.7	3.5	5.7	4.2	1.2	75.1	2.0	0.0	28.4	6.5	4.6	6.9	7.0	32.0	4.2	0.9	14.1	0.0	1.9	4.3	4.1	10.4	5.7	3.5	0.9	9.6	0.0	0.0	6.0	1.3	2.1	0.5	3.1	1.8	1.4	2.6	16.0	1.4	0.8	0.3	0.3	2.6	0.0	5.7	7.4	75.3	51.0	8.3	2.8	3.6	6.6	7.0	11.6	1.9
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463370-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	4.8	4.7	4.7	5.4	5.8	4.9	5.4	5.8	6.9	3.1	3.8	3.9	2.8	4.7	3.0	4.3	4.0	3.5	6.4	4.2	5.1	3.8	4.4	3.8	7.0	5.8	5.2	6.2	2.5	3.6	2.3	5.9	6.0	4.5	4.7	4.2	2.8	3.3	5.0	4.0	3.3	4.4	5.3	4.7	3.8	6.0	4.8	9.4	3.7	8.4	8.4	3.7	3.3	7.6	35.3	9.7	30.1	18.9	8.0	12.4	26.4	44.6	25.5	41.9	58.4	11.9	13.8	23.7	21.7	12.7	32.8	12.5	15.8	16.2	61.6	25.9	22.0	17.5	14.6	19.2	3.4	37.4	21.2	5.7	8.7	51.5	17.9	10.7	15.5	20.4	27.3	22.9	31.4	10.2	26.4	17.6	18.8	30.6	8.7	18.8	35.6	25.8	12.3	14.3	16.2	16.0	21.0	12.4	23.9	29.6	15.9	33.8	9.2	32.3	25.2	25.7	40.4	10.4	28.9	21.4	21.9	27.8	32.0	2.2	1.2	4.1	2.0	1.4	2.0	4.4	2.1	2.3	1.3	4.5	2.3	2.3	0.9	2.4	1.8	2.7	3.2	1.2	4.7	5.8	5.8	6.9	4.2	5.1	5.8	5.2	6.0	5.3	4.8	7.6	8.6	0.0	2.7	7.2	9.5	8.7	9.9	10.4	8.6	6.3	4.1	4.7	6.2	4.3	5.2	7.3	2.1	17.3	8.7	4.2	7.9	7.8	1.3	8.8	5.6	8.0	2.4	5.9	3.0	7.9	30.8	9.3	6.6	5.4	4.5	6.3	14.3	3.4	10.1	6.7	3.1	3.7	2.0	11.4	6.0	2.3	8.7	5.9	3.6	11.2	7.6	14.5	13.4	6.6	13.5	7.8	8.0	10.9	7.5	5.4	1.7	4.4	9.4	5.1	6.6	15.2	6.5	17.7	34.6	6.5	7.0	12.4	5.9	4.2	5.9	6.2
CEP295	KIAA1731	ENSG00000166004	"Centrosomal protein 295"	Q9C0D2	11	93661682-93730358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038595, HPA038596, HPA038597"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.18e-2)"	6.6	5.8	7.5	6.3	8.1	16.0	8.3	14.4	10.5	7.6	5.0	8.7	6.2	7.0	7.4	5.8	6.8	5.2	5.3	7.3	6.9	6.2	5.0	6.0	11.1	6.3	5.9	8.3	6.6	4.7	8.4	6.3	6.6	8.3	6.8	14.7	5.5	5.2	5.3	8.9	7.5	5.5	4.9	9.4	6.2	12.0	7.6	10.3	8.7	5.8	7.4	7.7	6.6	10.2	10.5	9.4	23.9	20.4	10.8	10.4	11.6	13.2	9.7	12.2	14.2	17.3	19.2	3.1	19.1	8.3	16.9	18.7	11.8	9.5	12.4	15.0	9.4	19.0	28.2	8.6	6.5	17.1	17.4	7.7	5.6	11.6	10.0	11.5	10.4	16.9	21.6	19.4	15.8	8.8	8.9	28.1	7.5	19.6	9.7	17.7	22.6	12.6	10.1	17.9	13.9	12.9	20.9	13.8	3.7	14.8	22.8	9.4	9.6	11.3	14.8	20.9	10.1	6.9	16.7	20.2	6.7	19.7	15.9	3.3	1.7	3.6	1.5	0.9	1.2	3.2	1.3	1.0	0.8	3.5	1.6	1.4	5.2	1.6	1.3	1.7	1.1	0.4	7.5	8.1	14.4	10.5	7.3	6.9	6.3	5.9	6.6	4.9	7.6	10.2	10.9	9.6	14.3	24.2	14.0	0.0	3.3	0.0	5.2	30.5	7.0	8.9	9.4	5.7	5.6	5.5	27.1	12.8	8.6	2.5	3.9	7.8	78.7	12.4	15.0	9.6	3.6	25.7	41.2	7.8	10.3	8.8	11.2	10.2	16.4	48.8	6.8	4.2	8.0	18.5	40.8	5.5	0.0	7.9	0.0	21.4	12.8	7.7	0.0	15.0	10.3	10.3	10.3	23.6	33.5	5.3	4.1	14.3	12.2	5.6	5.8	4.0	5.1	38.1	6.6	9.4	8.7	48.8	18.6	7.5	0.0	6.6	9.8	15.8	5.8	2.8
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954773-180114875	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 835.2;Late spermatids: 824.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633"	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	10.9	7.0	10.7	11.5	22.1	24.6	11.4	20.8	13.4	9.1	6.0	11.2	9.3	8.6	7.5	9.3	8.3	8.7	7.8	7.7	14.0	8.9	10.4	7.9	15.5	16.7	16.7	14.0	10.6	16.9	7.5	10.0	17.0	7.7	11.1	20.9	7.5	9.2	31.4	11.8	11.6	8.4	11.4	11.7	11.0	24.9	15.6	24.0	11.3	36.9	14.0	10.5	8.6	25.5	23.8	16.4	21.2	7.5	17.6	16.2	20.0	15.8	21.0	13.2	14.5	18.7	13.8	26.0	16.8	14.2	11.4	28.8	16.1	9.0	17.2	25.9	11.4	18.6	20.6	11.9	19.2	37.1	16.7	16.3	13.7	17.3	22.5	9.7	16.4	24.4	36.9	19.5	14.3	17.2	21.9	10.4	19.8	23.0	4.3	18.9	23.4	20.3	9.3	48.2	14.8	15.9	26.2	17.3	29.7	14.9	19.0	32.8	16.8	18.7	13.0	16.7	16.9	33.5	46.2	49.9	8.7	15.9	28.6	1.4	2.1	5.0	2.9	1.9	3.3	2.3	2.1	1.8	1.7	3.7	2.2	1.9	3.8	1.9	1.7	3.4	3.4	0.8	10.7	22.1	20.8	13.4	7.7	14.0	16.7	16.7	17.0	11.4	15.6	25.5	63.6	118.6	67.4	138.4	75.9	38.0	28.4	23.9	45.5	56.8	34.3	27.4	84.3	37.1	42.2	12.9	85.5	19.7	76.4	35.3	5.9	23.3	835.2	61.0	59.5	49.4	46.2	81.4	108.3	38.9	23.9	47.5	47.9	53.6	29.7	42.9	74.6	28.4	29.4	62.2	121.3	29.3	22.4	72.3	60.9	824.3	53.7	79.0	19.6	89.0	101.0	36.2	70.0	121.2	172.9	37.2	22.4	42.2	100.1	37.5	52.0	11.8	57.3	56.4	26.3	74.0	51.3	233.9	45.0	48.5	46.7	26.3	75.2	40.7	29.5	40.0
CERT1	"CERT, COL4A3BP, GPBP, STARD11"	ENSG00000113163	"Ceramide transporter 1"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;Cardiomyocytes: 37.1;Cytotrophoblasts: 17.7;dendritic cells: 20.2;Extravillous trophoblasts: 16.8;Hofbauer cells: 36.8;Plasma cells: 12.4;Syncytiotrophoblasts: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 132.3;WM-115: 118.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	38.1	26.1	12.4	16.5	16.1	27.2	17.6	18.0	15.4	33.9	14.0	20.8	18.7	20.6	15.1	24.9	22.4	23.3	20.8	14.0	15.1	27.9	31.2	24.3	20.3	14.7	17.5	23.1	16.4	26.1	8.0	22.9	16.7	24.3	19.6	18.2	14.0	19.9	28.9	18.7	21.1	18.3	14.7	25.3	23.5	28.8	15.5	21.2	49.9	28.3	22.7	23.7	16.0	17.6	44.9	22.7	21.6	19.0	132.3	36.6	29.0	24.8	30.8	18.8	24.8	34.4	25.3	21.5	52.3	26.9	25.8	26.7	33.4	34.4	28.6	27.1	15.2	18.2	24.4	18.4	33.6	18.2	20.1	27.9	23.8	22.3	24.9	30.5	22.1	28.3	33.0	32.0	25.0	23.0	21.6	13.2	27.9	10.2	16.8	18.0	28.5	20.2	30.5	54.0	16.4	16.5	31.6	21.6	31.8	45.4	21.3	30.5	30.1	12.6	15.1	22.8	20.3	29.1	41.6	24.8	21.4	30.7	118.2	9.6	19.8	16.0	8.2	22.4	7.8	9.1	8.3	7.7	14.5	9.1	7.7	7.8	29.6	7.8	25.4	8.3	13.0	9.0	12.4	16.1	18.0	15.4	14.0	15.1	14.7	17.5	16.7	14.7	15.5	17.6	23.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	17.7	20.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	16.8	10.5	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	27.8	3.8	0.0	0.0	0.0
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706988-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;choroid plexus: 35.9;fallopian tube: 59.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 56.8;Endometrial ciliated cells: 153.5;Late spermatids: 85.0;Respiratory ciliated cells: 189.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 7.3;HeLa: 6.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.2	0.3	2.4	0.1	1.4	0.1	0.2	0.8	0.4	9.1	35.9	0.1	0.0	1.1	1.8	0.8	59.5	0.6	0.3	3.2	3.3	0.5	0.1	11.2	0.4	12.6	18.6	0.4	1.1	0.2	4.7	0.2	7.2	0.3	0.0	0.1	0.5	0.2	0.3	0.6	0.1	0.1	7.5	0.3	0.2	10.1	2.6	0.1	0.4	0.0	0.0	0.4	0.1	1.9	1.4	7.3	0.9	1.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.8	0.8	1.4	1.0	0.0	1.6	3.6	0.0	0.0	0.0	2.8	1.2	0.8	6.2	1.7	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.5	0.0	2.1	2.9	0.4	0.0	5.0	1.1	0.4	0.7	1.5	3.6	2.0	1.1	1.2	0.0	0.3	5.1	1.0	1.7	2.9	0.4	0.1	2.4	0.4	1.5	1.6	1.4	4.1	0.8	0.7	2.3	0.9	0.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.8	0.4	3.2	3.3	12.6	18.6	7.2	7.5	2.6	1.9	0.2	9.6	10.5	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.3	0.6	0.0	0.0	27.9	0.0	0.0	0.1	0.1	0.2	1.9	0.3	56.8	153.5	1.9	0.8	0.0	0.0	0.0	0.0	0.1	1.0	0.0	4.8	2.5	0.1	0.4	0.2	0.2	0.0	0.0	0.6	0.0	0.6	0.0	85.0	0.3	0.5	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.1	0.7	0.1	0.4	0.5	0.4	189.5	0.4	0.0	0.4	0.3	14.3	0.9	0.0	0.0	0.0	0.3	1.4	0.3	0.2
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.5;fallopian tube: 44.8;testis: 28.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;HEL: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.6	0.1	1.8	0.4	1.3	0.8	0.6	1.0	0.9	2.7	13.5	0.3	0.2	1.4	0.0	0.4	44.8	0.2	0.8	1.7	1.8	0.7	0.1	5.0	0.2	7.9	7.0	0.3	0.2	0.1	0.4	0.4	4.7	0.4	0.1	0.0	0.3	0.4	0.2	0.5	0.3	0.4	5.9	0.7	0.6	28.4	2.3	0.3	0.7	0.1	0.2	0.5	0.3	4.1	2.1	0.4	0.0	0.0	0.1	0.2	9.0	1.1	1.3	1.9	0.8	1.5	2.7	0.8	0.4	0.3	1.0	1.3	0.2	0.3	1.1	0.3	0.2	12.2	0.5	0.0	0.4	1.1	0.4	0.8	0.6	2.1	0.7	2.8	1.4	0.2	1.3	0.4	0.3	3.0	0.2	0.9	0.5	1.7	1.0	0.0	0.9	0.4	0.1	0.5	0.8	0.1	1.0	3.2	0.3	2.6	3.1	0.2	1.8	0.8	2.4	1.6	2.0	0.8	0.0	0.2	4.3	0.3	0.7	0.0	0.1	3.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	2.4	0.0	0.0	0.1	0.0	0.1	1.8	1.3	1.0	0.9	1.7	1.8	7.9	7.0	4.7	5.9	2.3	4.1	2.0	0.0	4.8	0.0	0.4	0.0	0.9	0.0	0.6	0.1	1.4	0.9	5.5	0.0	29.7	5.5	0.0	1.6	0.6	0.0	0.0	1.9	256.4	98.2	1.3	3.2	0.0	0.0	0.1	2.2	7.4	1.2	0.0	3.2	3.8	0.1	1.4	0.0	0.4	0.0	0.1	0.1	0.0	0.6	0.0	57.4	2.1	4.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.6	0.0	1.5	3.2	1.3	0.1	0.4	166.9	0.0	0.0	0.7	0.9	43.7	3.1	1.2	0.0	0.8	1.2	0.6	0.1	1.1
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 528.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	40.2	31.0	22.2	45.8	25.5	75.7	36.9	26.5	29.8	39.9	27.1	32.8	35.6	45.3	32.7	35.6	33.5	37.3	35.9	23.5	27.3	40.2	41.3	39.5	65.2	23.0	22.9	56.2	37.9	44.4	23.2	42.0	23.3	35.5	39.6	48.8	35.2	35.3	37.6	28.1	37.6	44.3	24.4	52.7	33.7	32.5	23.6	85.3	47.0	47.4	61.9	35.7	27.7	34.9	37.4	64.1	109.3	77.4	92.8	78.1	34.5	81.9	71.4	82.0	97.9	46.7	56.4	81.9	52.7	74.7	63.0	30.2	91.4	63.2	103.2	126.0	46.5	132.3	66.0	47.4	79.7	86.3	93.8	74.4	53.8	95.0	118.7	99.2	85.1	99.0	58.2	87.5	89.5	62.9	136.5	59.5	58.1	62.5	59.0	83.6	106.9	58.0	56.0	66.3	22.0	66.6	66.9	35.6	179.1	79.6	57.5	95.6	81.5	98.8	72.5	528.4	81.8	64.0	83.2	90.5	73.1	81.5	84.9	107.9	42.7	81.2	44.2	45.7	43.8	45.0	39.6	46.4	40.6	47.6	46.6	39.6	77.0	47.4	51.6	34.0	48.9	44.7	22.2	25.5	26.5	29.8	23.5	27.3	23.0	22.9	23.3	24.4	23.6	34.9	65.1	51.3	48.0	32.3	75.1	53.2	65.7	45.6	60.9	35.8	59.8	45.3	45.9	42.9	47.8	40.5	16.7	55.0	66.0	49.0	66.5	39.0	21.0	37.8	64.5	63.0	41.9	107.5	40.6	42.0	63.6	57.5	50.4	46.8	46.9	61.1	74.6	55.1	41.2	67.3	35.6	38.3	38.7	56.2	72.8	36.3	69.6	58.7	40.9	42.2	52.4	70.6	53.5	62.8	91.1	52.8	43.9	50.0	63.7	63.0	41.1	65.1	25.3	32.9	65.7	63.3	79.0	94.1	47.9	52.5	50.0	83.9	80.5	31.8	36.0	72.7
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314482-114337626	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	9.9	7.1	3.4	9.8	3.3	14.2	9.5	6.6	5.2	8.1	3.8	8.7	10.0	8.5	8.0	6.4	9.8	7.6	6.2	3.0	4.3	8.9	15.2	8.9	15.7	2.7	3.4	12.1	15.4	9.3	3.6	9.9	3.4	10.0	9.9	9.1	8.4	9.3	7.9	9.2	8.0	10.1	2.3	9.6	7.7	6.9	2.7	16.5	10.7	9.7	17.3	7.5	4.4	3.1	36.9	15.8	56.6	24.2	20.1	30.9	24.3	38.2	32.0	35.6	39.4	23.5	22.0	75.2	15.1	30.0	22.3	23.0	41.8	30.6	52.7	29.8	50.0	49.7	21.8	20.7	22.5	73.3	28.3	30.4	18.8	27.8	27.3	12.6	17.4	25.8	32.1	20.3	46.1	14.6	48.6	21.4	43.1	45.2	20.2	48.1	26.9	26.0	27.0	22.2	27.5	32.8	22.2	49.2	36.7	39.1	28.2	61.3	19.3	19.5	30.8	20.7	23.6	25.7	27.9	80.4	38.6	42.7	38.1	7.5	3.3	4.4	3.7	4.0	4.6	5.4	3.3	3.7	3.9	5.8	2.6	3.0	0.8	3.5	6.6	12.5	2.4	2.1	3.4	3.3	6.6	5.2	3.0	4.3	2.7	3.4	3.4	2.3	2.7	3.1	11.2	9.6	9.6	3.6	13.9	3.3	6.6	7.6	10.8	12.5	11.3	10.8	5.7	11.5	4.1	12.9	4.2	14.2	18.1	9.3	13.7	11.7	1.0	8.5	14.8	10.9	10.8	24.4	6.1	11.4	18.1	11.5	10.2	8.3	10.1	13.1	13.9	21.6	21.7	15.2	7.8	12.5	6.1	20.7	7.8	1.6	11.8	13.0	12.4	7.5	18.4	8.8	17.5	4.0	8.0	10.9	7.8	11.3	17.6	13.2	12.5	17.0	7.6	10.9	6.6	11.7	10.5	10.6	20.7	13.1	3.8	7.9	11.4	12.4	11.4	3.5
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"adrenal gland: 3466.0;pituitary gland: 1425.3"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.5	3466.0	17.1	5.3	9.9	0.8	2.1	134.2	90.9	0.6	0.0	7.9	60.2	1.6	4.2	0.6	13.7	0.4	71.9	101.9	92.2	8.3	0.7	2.4	3.1	76.5	100.2	25.8	92.8	6.4	1425.3	0.7	188.4	5.3	14.2	56.9	6.1	3.8	11.0	1.7	31.6	0.9	12.8	0.3	133.3	14.9	19.3	4.0	9.7	0.8	1.4	0.4	2.3	14.2	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.1	9.9	134.2	90.9	101.9	92.2	76.5	100.2	188.4	12.8	19.3	14.2	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CHIC2	BTL	ENSG00000109220	"Cysteine rich hydrophobic domain 2"	Q9UKJ5	4	54009789-54064605	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 348.7;Suprabasal keratinocytes: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 365.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA026784, HPA076603"	Uncertain		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"		"HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317"	"unprognostic (4.56e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.47e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.40e-2)"	20.8	15.9	9.1	12.9	8.5	27.1	18.1	12.6	9.6	16.0	12.1	12.4	12.3	12.3	10.3	27.4	12.1	20.5	15.1	8.6	9.2	14.2	20.3	19.7	14.7	8.6	8.5	13.0	9.9	6.5	9.3	13.5	9.0	12.9	8.9	5.9	15.2	5.7	9.8	27.5	13.2	10.5	7.8	17.3	12.9	39.6	9.2	21.9	11.9	6.6	13.3	15.1	18.1	9.7	25.4	4.6	12.8	11.9	21.5	16.8	13.1	34.6	36.1	20.1	20.3	18.1	22.0	21.4	29.5	22.0	17.2	7.7	17.9	25.1	22.0	11.9	9.5	11.7	4.2	13.6	65.1	19.2	23.4	22.6	19.8	30.3	45.3	38.3	30.0	22.2	13.0	15.4	40.6	7.1	22.3	30.7	8.7	11.2	16.9	14.3	7.3	8.4	23.3	8.1	19.7	18.3	8.3	12.2	26.6	18.3	6.1	26.8	51.3	25.2	19.9	36.6	21.4	18.4	9.5	17.2	18.7	18.7	18.7	365.5	79.3	171.5	60.1	64.7	57.7	41.3	60.0	68.6	55.9	40.1	54.6	59.6	325.0	74.2	68.3	47.0	81.5	77.9	9.1	8.5	12.6	9.6	8.6	9.2	8.6	8.5	9.0	7.8	9.2	9.7	58.1	6.4	7.3	35.6	42.5	348.7	95.5	61.0	68.3	8.1	61.6	33.5	4.1	15.7	25.9	7.3	8.4	27.8	57.8	27.2	17.6	42.8	55.4	64.1	58.0	64.3	25.8	72.6	39.7	28.0	38.7	80.8	32.6	34.2	36.3	36.8	38.6	23.9	24.7	13.5	40.2	21.9	40.7	36.4	144.2	13.4	17.1	50.3	67.6	49.6	32.6	9.0	28.8	74.4	23.2	61.8	42.1	24.5	40.2	85.1	41.9	29.2	56.0	7.2	19.7	53.9	45.1	163.5	89.9	97.4	373.8	47.7	65.8	39.8	21.0	135.9
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	42.4	44.8	48.1	36.5	54.1	62.5	44.2	54.7	56.0	52.5	48.3	44.2	30.3	45.2	36.2	50.3	47.5	21.9	63.3	47.8	51.1	66.5	54.8	39.3	46.6	51.9	50.7	55.2	63.4	35.9	48.7	33.4	52.2	48.4	32.7	59.9	44.4	29.6	124.4	52.6	46.8	30.5	50.0	65.4	47.9	37.6	49.6	65.7	55.8	68.4	44.4	45.1	47.9	63.5	74.3	63.9	106.2	65.0	45.2	33.1	84.3	51.2	47.0	71.3	61.2	71.6	72.9	83.5	75.6	48.0	46.6	66.8	103.4	74.7	46.9	97.8	95.7	65.5	102.2	60.0	56.1	101.8	78.8	38.5	84.8	69.0	97.5	59.2	57.7	89.4	82.1	62.2	54.1	94.3	109.8	102.6	123.6	106.9	79.1	67.5	65.0	92.5	69.8	100.5	64.3	74.5	54.6	77.8	91.6	69.9	83.7	138.6	50.0	47.7	70.4	60.7	83.8	86.2	77.8	95.5	50.1	81.9	56.8	84.9	42.9	40.9	46.0	44.8	46.2	46.2	45.3	45.3	54.4	43.3	45.2	41.0	30.8	35.1	43.0	41.7	51.9	46.4	48.1	54.1	54.7	56.0	47.8	51.1	51.9	50.7	52.2	50.0	49.6	63.5	46.4	32.1	37.3	32.3	50.1	63.0	103.6	59.7	37.5	40.8	45.6	33.5	74.1	57.2	43.5	53.3	33.3	91.7	47.7	49.2	50.9	69.5	34.9	50.6	42.6	54.2	60.3	81.9	16.1	64.8	121.9	47.1	42.3	63.4	46.3	59.7	43.9	41.2	69.7	43.7	17.6	56.4	42.7	48.9	38.2	18.0	44.7	40.9	35.6	14.0	69.3	44.0	52.5	16.6	40.1	61.3	58.1	42.2	48.2	101.8	48.4	49.0	33.2	57.5	19.7	34.9	59.7	125.2	115.2	46.5	61.7	128.6	45.7	57.9	52.3	110.2
CIAO2A	"CIA2A, FAM96A, FLJ22875"	ENSG00000166797	"Cytosolic iron-sulfur assembly component 2A"	Q9H5X1	15	64072565-64093857	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 262.4"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	27.8	68.6	23.1	53.6	26.0	70.7	48.5	25.7	26.7	31.5	39.1	82.8	107.9	22.6	41.1	30.1	32.1	43.0	78.0	22.0	24.6	81.3	262.4	43.4	105.3	26.1	24.0	20.6	59.8	75.5	24.6	65.5	26.6	39.1	68.4	24.7	44.0	26.8	125.5	19.4	86.8	23.8	26.4	52.8	68.8	20.7	26.9	60.3	80.2	97.4	66.9	46.3	20.3	32.0	114.6	168.6	104.3	71.7	91.7	110.7	61.2	92.7	105.4	120.2	133.5	157.7	172.9	186.9	157.4	56.2	155.7	118.3	197.9	90.2	95.4	171.3	124.2	156.2	137.7	161.2	70.7	240.5	123.1	90.8	87.2	76.7	67.6	84.5	130.1	118.5	222.3	148.8	89.5	197.8	100.1	202.8	144.6	148.9	96.3	154.5	139.8	410.4	154.3	127.0	112.2	87.5	76.8	150.9	180.6	113.9	120.6	243.6	83.0	98.2	129.4	104.7	193.6	144.4	353.8	186.4	109.5	429.3	96.9	122.4	255.8	117.0	67.3	254.1	83.0	346.0	94.8	88.1	231.6	345.5	75.5	74.4	132.0	86.9	228.3	386.5	146.1	269.0	23.1	26.0	25.7	26.7	22.0	24.6	26.1	24.0	26.6	26.4	26.9	32.0	10.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	116.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	100.6	13.2	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	88.8	2.0	0.0	0.0	0.0
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	9.4	6.5	6.4	39.2	5.9	9.2	7.8	7.3	7.9	10.7	8.9	6.7	20.5	7.3	2.6	5.5	7.4	15.0	5.4	5.4	11.5	7.2	4.7	24.1	57.3	15.0	8.3	3.6	3.9	2.6	3.0	2.6	11.9	4.8	8.2	1.4	12.1	6.9	5.0	8.7	24.8	7.3	11.5	51.2	12.9	2.1	13.0	15.9	5.2	2.4	57.0	9.0	4.1	16.4	0.4	0.4	0.7	0.6	0.1	0.0	0.5	0.2	0.0	0.3	0.4	0.6	12.0	11.2	1.6	0.0	1.7	1.8	0.0	0.0	0.2	51.1	0.6	6.3	2.6	1.3	0.0	0.9	0.9	2.1	0.0	0.2	0.0	1.8	0.0	0.7	0.8	4.1	0.2	0.7	0.6	1.0	0.3	0.4	0.3	89.5	0.6	7.9	0.1	3.6	1.8	0.3	2.1	0.6	2.1	0.6	1.0	3.8	0.5	4.3	0.7	1.2	0.5	18.0	1.4	25.8	16.0	1.1	14.7	0.7	29.1	17.5	0.8	23.5	0.4	47.3	0.3	1.4	46.2	63.3	0.2	0.4	6.8	1.8	29.0	48.3	1.2	5.4	6.4	5.9	7.3	7.9	5.4	11.5	15.0	8.3	11.9	11.5	13.0	16.4	14.5	6.4	19.5	0.3	48.8	2.3	0.3	1.3	1.2	0.8	1.7	2.0	5.3	1.5	1.5	3.7	0.0	0.2	17.9	2.0	0.0	5.5	0.8	1.5	0.4	7.3	2.4	6.9	1.4	2.0	0.3	1.2	4.6	1.4	10.8	7.7	1.4	0.7	8.7	0.0	1.8	1.9	0.0	16.1	51.8	0.0	0.6	43.8	7.2	42.2	51.8	0.2	2.1	0.0	0.3	1.1	0.1	0.0	1.1	0.4	12.3	4.8	5.6	1.6	0.0	1.0	1.2	0.0	0.0	1.0	2.8	0.1	3.0	0.4	1.5	0.5
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128161251-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	57.7	38.9	36.1	28.5	37.1	55.3	48.3	36.5	46.4	60.1	19.7	68.4	34.5	53.5	24.4	46.3	47.6	33.9	46.0	36.4	33.8	31.8	21.4	38.0	35.1	35.9	31.4	69.9	70.7	35.0	33.8	28.0	34.2	40.8	26.7	26.9	44.6	33.6	90.4	65.8	41.9	36.9	26.8	35.5	51.3	56.4	36.4	35.3	37.0	42.5	29.5	57.8	50.0	40.9	72.2	85.5	70.7	67.5	71.8	85.6	69.9	55.6	82.2	99.5	56.1	79.1	60.4	84.1	46.1	93.7	82.0	102.1	55.3	59.4	53.9	76.7	64.2	80.2	106.7	51.2	82.5	75.1	91.0	83.7	104.5	109.1	91.9	71.7	68.1	52.9	199.0	70.4	60.5	169.6	98.2	76.1	61.6	96.2	87.4	83.4	74.8	86.5	45.0	48.7	88.4	68.5	123.3	85.8	73.7	31.5	89.7	96.4	72.9	105.7	74.4	120.4	105.6	81.3	99.1	80.2	74.4	49.9	115.1	2.6	2.2	2.6	2.4	3.1	2.2	2.7	2.9	3.1	2.4	3.9	3.0	2.6	0.5	4.9	2.3	2.4	4.8	1.9	36.1	37.1	36.5	46.4	36.4	33.8	35.9	31.4	34.2	26.8	36.4	40.9	15.4	3.2	12.9	14.0	19.4	23.2	23.2	12.3	21.6	25.9	16.7	17.0	10.8	18.6	11.7	18.4	29.2	23.3	23.6	20.8	13.7	26.0	77.3	10.1	19.9	18.7	22.8	31.5	20.6	44.7	28.8	22.6	25.0	14.8	9.5	25.3	18.5	6.1	22.6	16.8	19.3	19.1	16.2	20.7	18.2	79.2	34.8	17.7	19.6	19.7	19.1	19.6	16.5	11.6	15.9	28.0	15.6	31.2	25.5	15.4	31.6	18.0	8.4	25.0	13.1	23.9	19.1	37.5	26.0	23.8	24.9	20.8	18.2	15.7	25.4	20.0
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 67.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.9;Granulosa cells: 88.6;Spermatocytes: 151.7;Spermatogonia: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centrosome"		Yes	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Centrosome	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	6.0	6.4	3.7	10.0	3.8	67.8	5.7	10.8	5.3	3.2	1.3	8.9	12.1	5.1	4.4	10.4	3.5	4.1	6.0	3.2	4.1	5.1	4.0	5.3	19.4	4.8	3.8	3.2	1.5	4.3	4.5	10.6	5.2	5.6	9.5	7.7	4.6	4.2	2.9	13.9	9.5	8.5	3.3	9.4	5.4	32.5	3.7	33.7	6.3	3.4	20.2	7.2	5.0	3.1	77.6	40.0	155.7	76.4	19.7	19.5	39.6	124.7	70.7	137.4	87.2	59.7	92.3	142.5	19.3	89.2	65.7	86.2	107.6	61.7	188.8	103.0	90.4	129.8	42.6	41.4	8.6	129.7	50.4	14.5	24.6	64.5	83.3	41.2	84.0	62.0	55.3	58.1	152.8	36.0	91.2	64.8	92.2	116.6	42.4	86.2	88.6	62.6	42.1	40.9	47.6	62.4	68.9	49.0	37.1	78.7	54.4	61.7	56.7	38.7	60.9	62.0	124.1	33.4	56.3	173.9	27.3	67.3	105.7	86.0	14.1	22.0	10.3	21.0	9.3	25.3	15.7	12.8	15.8	33.0	12.0	10.4	4.3	5.8	28.7	32.8	33.6	10.0	3.7	3.8	10.8	5.3	3.2	4.1	4.8	3.8	5.2	3.3	3.7	3.1	6.7	6.4	2.8	5.2	41.2	15.0	4.5	32.8	22.2	13.1	11.2	13.2	10.8	2.8	11.4	1.8	6.2	44.3	30.9	7.5	9.8	4.9	41.3	19.4	16.1	12.7	7.2	122.9	10.3	6.0	38.1	12.1	10.7	10.1	16.5	88.6	17.5	5.5	31.8	1.7	12.4	13.6	20.3	24.5	13.7	51.7	7.5	18.5	0.0	6.5	22.9	12.9	5.2	3.5	2.0	2.6	4.6	17.0	30.8	3.7	6.3	9.4	3.7	6.6	6.6	7.6	12.1	151.7	87.5	41.3	15.3	10.0	27.1	29.6	17.9	3.9
CLIP4	"FLJ21069, RSNL2"	ENSG00000115295	"CAP-Gly domain containing linker protein family member 4"	Q8N3C7	2	29097705-29189643	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 169.2;Inhibitory neurons: 142.8;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 25.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 83.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043366, HPA056246"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA043366: AB_10963051, HPA056246: AB_2683078"	"unprognostic (1.97e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.62e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-2)"	19.3	9.8	15.1	9.5	24.7	1.9	14.2	20.6	19.7	14.3	18.3	20.8	4.8	13.7	8.7	23.4	15.5	13.4	30.0	15.2	18.9	9.0	4.5	18.7	10.2	20.6	21.8	22.7	6.3	14.3	20.0	16.4	20.9	16.6	7.0	17.9	13.9	15.2	71.9	30.9	10.7	18.6	18.6	10.0	10.2	17.5	18.1	13.5	33.5	43.8	10.7	20.8	19.9	31.4	82.3	22.6	3.4	12.1	31.4	47.0	0.1	31.8	54.4	17.5	19.9	0.7	52.7	10.2	15.9	55.1	69.9	33.0	3.6	24.7	24.8	18.9	5.4	0.0	29.1	1.2	79.7	0.0	16.2	33.3	61.3	23.2	83.8	62.8	12.4	7.4	0.5	31.5	26.7	0.6	7.9	3.6	0.9	4.8	5.0	0.1	20.1	1.6	32.0	14.4	5.3	13.7	27.6	11.2	29.0	3.3	0.0	4.9	39.4	4.1	31.6	13.7	13.8	16.2	0.1	0.1	19.0	0.0	12.7	2.5	6.1	0.2	7.9	14.8	12.4	1.4	6.1	8.4	2.4	0.5	6.9	6.8	1.2	5.6	25.9	0.0	2.3	5.6	15.1	24.7	20.6	19.7	15.2	18.9	20.6	21.8	20.9	18.6	18.1	31.4	0.9	64.1	15.0	78.7	7.2	17.1	27.6	26.8	30.1	31.0	11.4	8.9	76.2	0.0	18.5	12.9	29.2	6.7	18.6	0.1	3.9	10.7	169.2	16.1	8.4	2.5	0.0	2.5	75.1	9.1	1.7	26.5	4.1	12.9	5.1	13.1	1.4	1.8	9.9	20.2	142.8	0.0	8.2	36.1	6.0	91.1	27.4	25.9	8.8	15.9	17.5	18.7	19.6	130.2	247.2	22.1	0.0	24.0	30.9	25.8	0.0	5.9	32.1	17.9	13.1	24.2	9.2	9.4	1.6	29.7	27.3	21.5	21.9	16.4	0.2	24.2
CLK2		ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	23.7	25.6	11.6	10.7	11.9	11.4	24.4	14.2	14.4	39.2	14.1	24.1	11.7	29.8	12.7	22.6	28.7	9.6	18.5	11.7	12.7	26.8	29.0	22.0	19.6	12.3	11.7	33.9	23.9	14.0	31.4	13.8	12.4	33.1	8.7	9.4	23.3	11.2	16.2	27.5	24.0	10.9	11.7	40.1	20.8	16.2	12.4	18.6	33.2	8.5	15.9	28.1	29.9	13.2	10.8	10.5	29.8	11.4	17.3	9.1	22.5	8.1	12.3	8.2	7.8	13.1	8.7	23.3	9.7	6.6	4.0	17.0	16.8	13.5	6.3	11.4	17.7	20.4	12.9	15.4	14.6	26.8	20.5	7.6	10.7	11.3	20.3	19.0	13.6	16.9	29.6	15.4	10.5	22.2	12.1	11.3	21.2	27.2	17.6	17.7	21.6	28.0	17.9	25.8	11.8	25.1	4.5	10.9	9.9	21.4	15.9	24.9	9.3	4.3	12.1	9.1	9.1	31.6	28.6	22.9	9.9	19.1	5.9	0.5	0.8	1.9	0.8	0.4	1.6	1.2	1.5	0.8	0.9	0.9	1.6	1.6	0.8	0.5	0.4	0.8	0.9	0.6	11.6	11.9	14.2	14.4	11.7	12.7	12.3	11.7	12.4	11.7	12.4	13.2	9.2	16.0	24.3	9.8	13.7	4.6	5.7	4.2	17.6	5.7	7.8	7.5	14.9	12.8	12.6	7.3	4.2	8.0	7.1	5.4	0.0	6.5	6.5	6.9	15.2	11.1	6.7	8.4	8.3	4.4	8.0	11.3	25.0	9.5	10.1	12.1	7.5	8.4	6.9	5.0	6.8	9.1	2.0	11.4	4.5	6.6	7.8	10.4	3.6	9.4	9.5	5.4	8.2	9.5	8.0	4.9	4.8	3.0	17.1	5.7	5.1	3.2	5.1	7.2	6.6	6.4	12.6	8.6	4.3	14.3	4.5	12.4	11.0	7.4	7.2	5.1
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55546909	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	5.5	6.1	3.7	4.2	4.2	1.3	5.9	8.9	5.4	8.0	5.5	5.1	4.9	6.9	5.7	9.2	5.3	4.3	7.5	4.7	5.3	6.5	5.5	4.6	2.9	2.8	3.7	6.2	5.1	10.3	5.5	5.5	3.3	6.2	5.7	11.6	4.6	6.1	9.8	6.8	5.6	7.1	3.8	4.5	6.9	14.1	3.8	3.0	10.1	9.2	3.7	5.6	6.8	5.0	20.0	9.1	7.5	11.6	11.8	11.5	3.6	18.7	16.4	12.9	12.7	5.1	14.8	5.1	9.9	22.8	10.3	15.9	9.5	15.4	23.2	6.9	3.1	4.4	9.4	6.7	10.3	7.0	4.7	6.7	15.8	18.8	18.7	10.4	13.1	4.6	10.1	10.1	21.3	10.6	4.0	4.1	5.0	16.3	9.4	2.5	8.7	3.3	11.0	10.9	7.6	6.2	13.5	16.7	8.9	6.2	5.7	4.2	17.1	18.4	19.5	6.0	26.6	9.1	7.5	3.1	15.6	5.8	14.6	0.0	0.7	0.2	0.7	0.7	1.3	0.4	0.9	0.8	1.1	0.7	0.4	0.6	0.2	0.9	0.7	0.5	0.9	0.4	3.7	4.2	8.9	5.4	4.7	5.3	2.8	3.7	3.3	3.8	3.8	5.0	32.2	41.7	27.7	49.3	15.2	31.1	21.8	28.5	27.9	63.4	21.5	14.9	55.2	14.3	27.4	14.7	43.8	11.3	11.9	21.5	1.9	13.6	34.5	34.2	39.9	32.1	39.7	3.8	95.9	16.5	6.8	28.0	25.0	32.0	3.8	16.6	28.9	27.7	11.6	33.7	114.6	18.5	18.3	17.0	26.1	16.9	23.9	16.9	10.6	70.3	14.0	26.7	19.6	82.0	93.1	28.3	13.2	36.1	18.5	34.0	29.6	19.7	25.2	41.4	13.1	36.5	28.2	64.9	72.5	55.1	37.5	5.2	14.0	21.7	15.6	51.6
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	172.8	174.2	131.6	80.8	139.1	67.2	165.6	144.7	165.1	170.9	137.5	163.3	107.9	165.6	100.7	207.1	158.9	64.4	98.1	133.3	143.8	236.0	146.8	146.2	84.1	145.1	138.5	205.6	164.3	104.3	139.3	124.4	151.4	145.0	108.6	84.8	162.8	71.2	87.7	163.2	136.0	84.9	141.6	153.0	161.4	108.5	141.7	85.2	160.1	51.5	93.4	150.9	158.4	151.5	326.3	257.2	188.4	146.3	270.0	269.8	302.6	328.5	248.2	258.1	301.5	194.2	143.9	243.8	177.0	220.9	460.7	136.2	238.8	228.2	238.4	166.0	193.1	187.5	255.0	199.8	359.4	201.0	166.5	297.3	250.5	297.4	234.3	241.0	329.6	129.3	166.0	126.4	399.0	113.3	182.2	254.8	301.8	218.8	360.3	173.3	124.8	142.1	353.7	229.1	146.1	245.3	137.3	160.0	289.4	220.2	146.9	244.2	418.4	209.4	234.0	240.3	347.9	83.0	208.9	259.5	256.9	278.0	188.9	142.2	221.7	115.4	97.1	239.6	101.9	121.0	104.9	100.2	222.6	119.6	92.9	82.0	86.7	96.2	191.8	192.2	162.9	209.4	131.6	139.1	144.7	165.1	133.3	143.8	145.1	138.5	151.4	141.6	141.7	151.5	291.5	128.2	143.9	14.4	105.9	197.3	274.3	374.3	169.0	139.4	274.0	315.0	51.5	217.3	247.4	180.3	60.5	958.0	140.1	349.3	463.7	480.5	51.9	241.5	174.3	244.0	183.8	154.8	28.5	335.6	469.1	187.5	142.2	182.7	73.5	198.4	312.7	170.6	903.7	92.5	30.4	350.5	248.2	391.7	172.0	97.6	262.9	249.3	195.7	20.6	343.5	282.8	117.4	16.1	49.0	465.2	426.4	215.5	97.7	320.5	411.5	651.7	304.7	127.3	177.5	170.0	310.4	288.0	216.8	210.9	193.2	1299.5	103.7	281.6	380.0	360.4
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	20.1	22.1	21.0	19.2	21.2	30.9	19.5	20.3	22.9	23.6	18.6	26.8	18.1	23.1	17.4	16.9	22.4	15.1	25.1	20.7	22.0	19.4	21.8	20.4	25.3	21.5	21.0	28.0	22.1	27.5	26.0	24.9	20.3	21.9	15.2	28.5	21.7	18.4	30.1	23.2	23.2	20.4	20.2	28.8	21.9	62.9	23.5	30.9	20.3	23.4	25.6	21.6	20.0	20.2	23.5	21.9	31.0	50.7	34.2	31.1	37.4	27.5	37.7	68.1	75.9	33.3	15.3	48.6	30.5	40.7	63.8	25.7	39.7	28.4	51.7	33.8	35.2	26.8	26.8	37.2	26.3	38.9	17.6	27.1	20.9	37.6	26.7	35.7	32.2	44.3	60.6	34.5	36.3	38.5	49.8	34.6	15.6	15.7	20.7	39.0	36.7	28.1	22.0	28.2	34.2	25.6	30.8	23.4	40.2	22.1	39.8	29.7	30.0	40.7	30.3	16.3	31.1	39.3	21.8	253.0	16.0	40.1	45.6	4.2	5.4	3.5	4.9	7.1	4.1	5.5	4.3	5.2	5.1	3.8	4.7	3.9	3.3	5.6	5.5	4.2	6.1	4.6	21.0	21.2	20.3	22.9	20.7	22.0	21.5	21.0	20.3	20.2	23.5	20.2	11.3	9.6	9.2	5.9	12.0	3.6	3.9	4.0	8.6	14.2	6.3	5.5	10.4	8.6	11.5	7.3	33.3	18.0	15.4	5.3	0.0	4.5	20.2	7.7	15.4	9.6	8.4	6.5	15.1	8.5	8.0	8.8	11.7	8.9	3.8	24.9	7.9	10.1	7.5	11.8	13.9	8.4	4.1	7.5	2.3	11.3	7.8	9.5	3.6	14.0	11.5	8.8	7.2	10.6	14.2	8.5	3.3	6.8	12.4	4.3	4.7	4.0	11.2	11.9	6.6	8.5	13.5	16.8	10.6	5.8	4.7	20.8	11.5	22.0	6.9	3.6
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927223	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 315.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 10.5;naive CD4 T-cell: 11.6"	"Group enriched"	"Detected in many"	12	"B-cells: 10.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"		NA	NA		660000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: AB_2681399"	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.99e-4)"	163.9	255.6	152.7	78.9	153.7	2.1	160.0	148.6	186.3	164.8	147.7	142.4	135.9	214.0	71.0	149.7	147.1	152.3	127.6	151.7	189.9	245.1	143.7	209.0	51.4	197.4	170.9	153.1	83.3	53.1	101.7	256.0	173.1	126.2	82.8	125.0	125.5	133.7	26.3	62.5	100.0	196.0	180.8	94.1	111.8	50.2	164.5	55.1	125.0	52.6	44.3	156.5	166.2	174.0	416.6	77.9	429.0	380.1	286.0	264.2	191.7	197.2	381.3	319.4	511.2	348.7	35.6	0.1	436.6	243.4	315.7	116.2	307.2	169.9	428.1	1.6	113.0	18.8	47.5	256.2	545.0	0.2	0.8	246.2	25.5	394.1	89.4	539.6	282.8	26.7	4.1	35.3	798.9	0.2	19.8	0.9	333.6	0.3	43.3	0.6	524.2	1.8	392.9	156.6	26.3	264.2	163.0	65.0	272.8	301.7	124.8	38.5	182.4	212.2	364.9	80.2	647.0	43.9	27.2	1.5	46.0	0.6	327.1	0.2	0.0	0.0	2.2	0.1	3.4	4.6	2.1	1.2	0.1	10.5	11.6	8.3	0.4	0.9	0.1	0.0	0.0	2.6	152.7	153.7	148.6	186.3	151.7	189.9	197.4	170.9	173.1	180.8	164.5	174.0	183.5	150.6	80.7	82.9	18.1	78.3	435.7	232.3	48.9	11.9	122.2	64.1	42.2	88.6	156.2	126.9	20.9	236.1	3.2	36.0	436.3	275.1	156.1	77.4	151.1	278.3	72.4	20.0	12.9	240.7	40.9	287.8	33.1	104.9	14.0	164.4	373.0	152.1	22.6	1.7	16.9	58.7	429.3	20.1	56.3	150.7	274.6	9.3	197.5	29.0	4.7	394.6	0.0	62.4	22.7	130.8	53.2	382.1	2.6	319.1	117.9	518.5	95.1	14.4	263.0	399.8	374.9	10.8	34.7	91.4	77.7	205.8	14.9	214.5	131.0	327.4
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918294-103090222	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 37.9;parathyroid gland: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	3.3	11.5	5.1	2.3	5.5	9.3	2.5	7.9	5.7	3.7	37.9	7.0	3.8	3.6	2.1	1.7	4.8	4.1	2.1	4.2	3.3	9.1	4.8	3.8	1.5	4.9	4.8	4.8	3.6	31.6	5.7	8.7	4.7	2.7	6.4	5.0	3.0	3.0	1.6	4.5	4.5	3.7	1.8	2.1	3.3	4.5	4.6	1.8	5.6	1.5	1.1	3.2	2.9	9.7	5.0	8.1	3.1	8.5	7.8	3.2	8.6	2.3	9.7	3.1	3.9	5.8	4.3	1.9	3.5	3.4	6.0	6.3	6.9	4.6	2.4	3.3	12.1	2.8	4.2	11.8	4.6	2.0	3.6	4.2	6.6	3.2	10.7	7.9	1.9	5.5	4.8	10.9	1.8	8.6	2.3	2.2	5.1	4.9	5.0	5.5	4.0	2.4	2.4	2.9	4.5	5.8	5.9	1.3	6.3	9.1	10.4	3.7	1.6	4.2	6.2	3.0	4.2	11.7	14.1	3.6	7.4	6.6	1.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.5	0.0	0.3	0.3	0.1	5.1	5.5	7.9	5.7	4.2	3.3	4.9	4.8	4.7	1.8	4.6	9.7	3.0	6.4	8.4	60.1	7.9	2.4	2.3	1.7	6.8	16.4	3.3	2.4	4.5	2.8	5.6	5.5	12.5	18.8	8.1	46.7	1.9	2.2	10.7	7.4	4.2	4.2	6.7	6.7	112.6	5.4	3.4	6.3	12.8	6.4	3.8	13.7	3.3	6.1	3.8	32.0	146.9	5.0	0.0	3.2	2.5	15.1	3.4	4.7	7.2	39.4	2.3	7.0	2.1	92.5	92.3	2.3	9.0	3.4	6.2	2.0	11.7	5.5	9.5	15.8	13.1	5.7	16.7	15.5	6.9	8.1	4.1	39.8	5.1	3.8	11.6	2.2
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Disease related genes, Predicted membrane proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 710.2;Proximal tubular cells: 729.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	64.8	73.0	122.8	30.8	122.9	15.3	63.7	128.2	160.5	71.5	125.8	110.8	106.0	55.6	172.3	128.4	73.7	42.9	102.4	125.6	124.5	223.4	158.9	45.7	41.0	124.6	125.4	55.8	172.6	106.8	59.7	38.9	127.2	84.9	89.7	34.9	66.1	66.7	119.6	58.0	81.1	41.5	125.8	50.5	128.5	25.2	125.5	42.7	57.9	94.3	49.8	60.5	78.6	125.3	66.8	219.9	99.4	54.7	89.5	75.8	61.0	51.1	77.2	119.2	107.3	87.5	81.8	3.9	141.0	62.5	112.4	63.5	77.3	124.8	111.9	65.1	202.8	44.7	96.3	280.8	63.4	61.0	52.0	77.4	92.0	112.7	64.2	61.0	96.1	31.6	72.9	55.5	106.9	108.9	20.2	132.9	45.7	135.9	78.5	79.4	145.1	113.6	122.6	90.2	73.8	61.9	52.2	54.9	91.5	85.3	170.3	78.5	59.3	129.6	67.5	55.4	69.0	65.1	76.3	36.2	97.3	60.1	89.8	206.7	209.6	141.5	136.2	208.1	143.5	218.9	140.0	138.3	178.8	187.5	128.4	126.2	22.7	187.5	177.7	120.3	191.1	245.9	122.8	122.9	128.2	160.5	125.6	124.5	124.6	125.4	127.2	125.8	125.5	125.3	55.4	28.9	68.7	7.5	44.5	36.8	52.2	192.7	50.7	36.5	99.9	110.9	263.9	173.0	113.8	266.7	20.9	153.9	30.3	233.8	710.2	136.5	13.2	203.0	70.0	65.4	79.9	54.3	8.1	239.8	177.5	72.5	103.5	154.6	35.5	77.5	69.3	390.1	121.6	45.4	9.2	205.9	195.3	75.3	33.4	18.8	55.9	54.8	88.9	6.5	86.0	94.7	63.8	6.6	11.8	134.7	201.6	45.1	73.2	79.0	221.7	729.1	145.2	37.0	39.5	46.2	88.0	48.4	52.1	242.0	55.5	102.2	43.4	97.6	258.9	67.7
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536701	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	11.2	15.0	7.5	9.3	7.7	11.8	15.6	10.5	9.3	15.2	10.5	16.2	12.6	13.0	16.8	12.4	12.2	9.5	11.8	7.4	7.2	12.3	29.5	10.4	10.7	7.0	7.0	15.1	20.8	12.3	14.9	13.0	7.0	18.7	18.9	10.0	18.0	12.4	11.4	13.2	13.2	12.1	6.8	12.4	14.7	9.7	7.5	12.2	17.0	9.7	10.9	12.7	13.1	9.4	8.3	7.4	13.9	12.6	17.9	20.4	13.2	13.5	19.1	15.4	12.8	10.8	14.9	11.3	5.9	16.2	11.4	17.7	11.6	13.7	23.3	8.9	9.3	12.7	9.2	19.2	22.1	18.8	11.7	15.4	20.3	10.3	36.1	18.6	15.2	11.0	8.3	6.8	18.7	12.9	10.5	17.6	11.4	41.5	8.7	12.1	8.1	10.6	14.4	13.4	6.9	12.5	8.7	17.1	18.2	13.1	11.7	19.3	14.4	7.4	5.7	13.9	8.7	9.4	5.4	11.7	14.2	9.4	13.5	3.5	1.9	3.6	3.4	2.2	3.6	2.2	2.6	2.9	1.4	2.3	2.9	2.7	1.7	2.5	1.3	3.4	3.0	1.7	7.5	7.7	10.5	9.3	7.4	7.2	7.0	7.0	7.0	6.8	7.5	9.4	15.8	9.6	31.4	23.2	18.9	15.8	15.2	13.1	14.2	9.7	22.0	17.9	19.7	24.3	19.8	12.9	14.6	14.2	35.5	32.5	15.6	11.6	24.1	15.0	20.1	16.7	22.2	11.4	39.3	37.9	18.8	14.3	26.0	30.8	17.1	22.4	18.9	72.8	10.8	10.1	34.7	54.5	6.1	20.9	9.0	9.0	14.0	13.3	10.6	22.5	13.2	7.6	15.5	34.2	36.9	22.7	32.8	13.5	31.3	26.6	29.4	17.3	11.7	11.2	6.6	12.8	11.7	12.7	8.9	17.7	16.1	32.8	21.2	21.7	24.4	37.3
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201372-107564261	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	11.4	12.1	6.7	9.5	7.7	14.2	10.8	7.7	8.5	20.4	8.1	12.0	9.3	17.1	10.0	12.8	9.0	12.9	19.7	7.1	7.5	9.7	6.8	10.2	9.5	7.0	7.5	12.4	14.7	19.4	10.2	10.5	7.6	17.8	12.4	11.8	22.8	11.0	14.0	12.9	10.1	14.4	6.3	9.0	11.7	8.6	7.5	6.2	20.3	15.4	10.4	10.5	16.7	9.4	39.3	14.9	16.1	15.1	14.7	16.2	12.6	27.0	28.2	11.7	20.5	12.0	17.5	7.9	14.9	27.0	26.5	15.5	10.7	16.0	18.2	23.5	9.6	8.7	9.9	15.1	17.4	18.8	19.0	15.4	15.3	20.4	24.0	32.1	31.7	17.1	16.6	25.1	21.5	18.5	19.2	17.8	5.9	30.0	19.1	6.8	13.6	18.6	13.6	17.9	7.6	21.8	16.6	27.2	31.2	23.8	6.2	12.2	36.6	12.6	16.0	39.7	17.2	16.3	16.9	17.3	24.2	21.0	33.9	9.4	6.6	7.5	6.1	7.6	8.4	6.0	7.7	6.9	5.4	5.8	6.4	6.4	3.4	5.1	9.3	3.7	6.5	5.9	6.7	7.7	7.7	8.5	7.1	7.5	7.0	7.5	7.6	6.3	7.5	9.4	14.8	3.2	15.5	124.4	21.7	12.2	15.0	11.1	24.5	23.2	10.0	7.7	27.6	7.2	16.5	14.7	33.3	10.2	16.5	15.8	1.9	10.5	22.6	11.8	21.8	11.0	10.3	5.9	147.0	10.9	8.5	14.4	14.8	19.8	3.8	12.3	9.7	5.8	11.3	11.8	196.1	36.2	18.3	14.8	12.3	22.1	11.8	15.3	12.4	147.1	15.7	9.0	11.3	136.7	183.2	10.8	10.1	12.4	20.7	20.6	14.5	6.5	16.3	17.4	26.3	15.4	10.2	18.2	14.0	19.0	13.4	10.5	18.9	7.5	14.9	16.1
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 818.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		43000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	78.1	180.7	99.3	39.6	108.9	71.8	85.5	114.4	140.4	105.3	119.6	80.1	55.0	76.9	47.7	198.0	65.2	60.3	81.7	96.6	107.4	94.2	292.3	93.3	49.7	117.4	107.9	107.4	74.0	61.5	48.7	116.9	117.3	87.2	20.7	17.2	133.7	70.5	98.6	119.7	64.1	38.3	109.2	63.6	99.8	51.7	102.7	26.9	59.1	49.9	26.0	86.9	124.1	124.3	131.3	131.7	15.0	128.3	141.2	122.5	6.0	143.9	178.8	120.3	133.6	112.1	148.6	51.7	62.7	208.9	48.6	172.9	23.6	152.0	26.2	115.1	163.4	92.5	65.1	267.1	265.1	155.0	35.3	159.2	180.7	104.3	101.3	116.6	113.2	82.0	383.2	109.4	100.6	818.5	63.4	267.9	32.4	361.1	42.9	88.2	127.9	72.8	129.0	404.5	60.4	53.8	47.7	405.7	125.7	7.6	84.0	436.6	137.5	212.7	82.2	71.0	109.6	37.5	18.0	41.2	236.0	211.3	152.5	62.2	312.2	59.6	77.9	218.1	64.0	56.8	52.6	62.6	251.5	57.8	45.5	51.7	12.0	73.5	151.5	291.4	72.6	178.6	99.3	108.9	114.4	140.4	96.6	107.4	117.4	107.9	117.3	109.2	102.7	124.3	99.1	125.0	88.1	22.9	33.1	102.1	231.9	248.1	188.4	73.4	174.9	218.4	41.9	104.4	162.7	152.6	10.4	885.9	80.1	53.0	320.8	201.0	4.6	59.1	72.2	86.7	84.5	70.0	16.8	193.0	113.5	103.1	46.4	46.9	71.7	95.7	77.1	262.0	311.4	25.2	17.2	97.7	191.2	177.0	107.7	13.3	134.2	137.0	240.1	20.6	137.0	158.7	41.2	25.1	45.7	170.2	108.8	179.8	45.5	132.4	179.9	73.8	135.8	43.2	138.1	143.3	113.1	8.4	5.7	236.4	123.5	648.5	41.8	222.0	122.3	206.6
COPB1	COPB	ENSG00000129083	"COPI coat complex subunit beta 1"	P53618	11	14443440-14500027	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	48.1	47.1	19.9	55.0	21.8	79.8	62.6	26.2	25.3	64.9	44.7	59.8	57.7	52.6	69.3	46.7	49.2	54.9	43.7	20.1	23.6	65.3	73.6	49.9	59.1	24.2	21.8	49.1	59.2	67.6	48.4	69.2	23.7	66.9	67.1	39.3	67.5	53.8	33.1	36.6	58.8	61.1	23.5	46.3	59.7	46.8	23.0	68.1	81.0	38.1	64.5	60.4	40.0	27.6	134.9	113.6	118.6	89.4	193.1	221.3	95.9	199.2	206.5	173.1	202.0	89.1	203.5	130.1	87.1	252.9	164.6	144.7	134.6	133.3	212.1	122.7	114.0	138.3	74.3	135.8	171.3	128.9	134.4	156.3	172.4	116.0	217.8	158.9	183.7	71.6	104.5	103.8	221.1	101.6	117.2	78.7	61.7	163.3	123.1	94.9	163.1	89.0	156.1	123.3	75.6	81.2	154.2	123.2	104.8	135.5	112.3	110.1	189.5	166.2	85.4	181.3	110.1	55.2	100.5	143.8	125.1	79.2	158.6	52.8	38.7	43.5	45.7	47.8	55.7	38.4	38.1	47.6	52.3	32.0	37.8	39.8	31.2	44.6	49.8	31.1	44.8	43.2	19.9	21.8	26.2	25.3	20.1	23.6	24.2	21.8	23.7	23.5	23.0	27.6	55.6	109.0	63.2	29.0	64.3	38.9	59.7	82.6	52.3	28.4	43.0	27.9	31.3	35.8	107.8	44.1	27.1	65.4	71.2	55.9	41.1	77.1	17.2	72.6	81.4	55.5	43.8	50.9	36.9	81.7	69.6	70.5	63.2	72.5	65.2	50.7	51.4	58.1	60.9	18.5	39.1	87.5	61.1	50.7	43.5	10.7	51.0	61.5	21.4	35.6	70.1	34.0	44.3	32.6	49.6	93.6	37.5	55.3	107.4	54.3	60.6	57.3	131.9	29.5	52.6	60.8	78.7	87.5	64.3	48.7	35.8	117.0	77.0	49.3	51.5	60.7
COPE	epsilon-COP	ENSG00000105669	"COPI coat complex subunit epsilon"	O14579	19	18899514-18919387	"Metabolic proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034345, HPA041605, HPA043576"	Supported		Enhanced	"Golgi apparatus"		NA	NA		66000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563"	"unprognostic (1.48e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.75e-2)"	102.3	163.7	127.2	85.5	133.4	159.6	100.3	139.4	176.0	101.3	131.3	113.8	90.5	104.1	45.0	160.3	89.8	44.1	135.2	122.4	131.0	141.9	194.3	108.3	91.7	140.6	132.0	80.8	152.0	80.8	160.1	59.3	130.0	127.4	37.7	23.5	144.2	65.4	128.0	120.9	107.8	42.9	137.1	150.0	126.8	171.9	135.9	82.4	123.7	50.0	56.9	99.2	107.1	151.2	186.7	177.4	99.3	177.3	89.0	104.7	287.2	159.2	150.8	174.8	198.7	215.1	148.2	150.8	210.5	134.9	112.9	123.2	82.5	161.0	33.9	94.2	369.9	89.6	150.9	331.1	236.1	180.0	221.1	128.3	149.2	106.2	115.6	92.5	138.9	170.5	140.2	373.6	90.0	443.0	196.9	341.0	188.4	243.0	420.2	222.4	89.6	448.2	115.8	185.4	138.8	222.4	100.0	159.1	181.1	44.9	134.8	291.3	140.9	110.5	81.5	283.3	170.9	357.7	337.5	187.7	189.1	309.9	187.3	656.0	598.5	639.1	337.1	533.1	298.1	391.2	321.9	298.6	528.4	381.9	236.4	270.9	594.9	344.4	468.5	659.3	449.3	930.0	127.2	133.4	139.4	176.0	122.4	131.0	140.6	132.0	130.0	137.1	135.9	151.2	110.5	3.2	16.2	22.2	204.7	159.8	197.9	390.9	54.1	53.2	140.5	111.6	10.4	111.5	205.8	115.8	29.2	386.5	242.8	408.9	463.7	323.7	179.7	134.4	131.8	127.1	168.5	130.5	8.6	368.7	439.1	140.7	166.2	187.8	102.9	176.7	113.6	153.4	447.2	57.2	11.3	445.5	303.2	189.4	286.8	381.0	144.8	217.8	245.5	4.7	373.5	251.9	187.4	8.5	20.8	336.7	421.4	133.2	417.5	255.7	425.6	493.1	152.6	72.1	124.9	92.8	200.5	178.4	202.1	108.6	196.6	542.2	174.9	235.3	297.4	267.2
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 347.5;Late spermatids: 427.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		37000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	43.5	43.8	52.1	33.3	54.2	39.4	45.2	58.3	62.6	34.2	52.0	45.5	45.6	34.0	43.6	42.2	35.6	31.6	100.0	53.2	57.1	56.3	71.0	33.1	40.9	55.1	53.3	33.4	43.0	58.5	31.1	50.9	56.8	36.4	51.6	39.7	42.3	36.6	125.2	36.0	47.8	47.6	57.4	33.4	37.6	58.7	56.2	52.6	37.8	134.9	48.7	42.2	30.0	59.7	104.0	97.8	79.6	74.4	83.1	88.3	63.3	89.0	74.0	121.2	108.9	62.6	125.4	96.5	39.9	93.6	86.8	84.1	109.2	98.9	134.0	92.4	92.1	135.9	95.2	87.3	82.2	86.3	79.1	81.0	126.2	99.1	132.6	95.2	121.2	100.3	163.0	64.6	111.8	96.5	154.3	157.6	107.1	217.2	108.6	97.2	56.7	76.4	131.3	91.6	48.6	66.7	51.0	98.4	91.6	71.2	160.9	90.8	89.9	60.1	74.9	74.7	70.3	81.4	108.5	127.7	89.1	97.6	84.1	65.8	52.0	64.5	35.8	55.7	37.2	36.8	34.6	39.9	63.9	33.7	36.1	32.4	38.3	51.9	56.6	34.0	53.2	43.8	52.1	54.2	58.3	62.6	53.2	57.1	55.1	53.3	56.8	57.4	56.2	59.7	55.0	22.4	26.0	19.2	40.6	49.3	45.1	102.6	28.5	36.4	43.7	51.8	119.9	58.6	61.2	31.3	33.3	143.8	58.0	38.1	88.0	73.4	347.5	44.6	38.2	46.4	34.2	69.2	21.5	60.0	101.4	45.2	25.5	37.1	36.1	50.9	34.2	35.5	79.3	25.2	21.5	41.5	59.0	31.7	28.5	427.2	43.2	40.2	28.4	10.3	59.9	62.0	56.7	18.6	32.4	50.1	48.6	51.1	46.6	54.0	87.8	81.9	46.1	53.0	32.9	49.1	87.8	123.4	49.6	42.9	47.5	127.8	42.3	72.5	55.4	50.6
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691514-40725784	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 16.5;Endometrial ciliated cells: 16.4;Theca cells: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	15.1	25.2	10.1	5.7	10.7	5.9	15.3	10.4	12.8	23.4	10.9	19.4	9.7	22.0	2.3	16.0	29.8	7.6	21.9	9.8	10.6	21.0	25.7	16.4	6.0	10.6	10.8	22.5	20.7	8.4	49.3	3.5	10.3	23.2	2.3	1.3	16.9	7.3	14.4	20.2	17.8	3.8	11.2	18.3	23.9	17.3	10.6	8.8	23.3	8.6	3.3	20.3	18.4	10.5	9.9	39.5	7.9	18.5	7.8	6.1	8.5	6.6	7.8	5.6	5.1	15.4	14.3	13.8	20.0	4.3	7.8	9.8	7.0	10.5	2.0	20.0	10.4	11.6	12.7	6.4	12.1	4.1	19.2	8.4	10.6	5.4	5.4	5.2	7.4	13.7	7.7	8.1	6.0	6.4	4.9	5.7	6.4	11.5	3.6	11.5	13.1	12.4	15.7	17.6	15.1	11.0	12.5	20.4	21.0	4.4	22.8	17.1	9.4	5.1	20.6	3.9	5.5	9.4	9.0	7.3	27.8	5.2	9.1	10.2	9.4	8.7	6.7	9.3	8.3	7.1	5.5	7.8	9.9	5.9	4.6	5.1	9.0	6.9	9.2	4.6	4.9	7.3	10.1	10.7	10.4	12.8	9.8	10.6	10.6	10.8	10.3	11.2	10.6	10.5	8.5	12.8	3.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	11.6	8.0	0.0	0.0	2.5	12.9	0.0	11.1	6.8	0.0	11.7	16.5	0.0	16.4	7.8	1.7	0.0	0.0	0.0	10.9	9.8	5.0	0.0	10.3	1.3	11.7	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	9.5	0.0	0.0	1.2	0.0	0.0	13.0	8.7	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.4	3.2	19.8	0.0	0.0
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"Cytochrome c oxidase assembly factor COX20"	Q5RI15	1	244835616-244845057	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 414.8;Proximal tubular cells: 464.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	17.5	44.2	28.1	23.3	30.9	20.1	22.1	37.4	49.2	13.9	23.6	23.9	24.3	24.8	29.9	21.5	17.2	15.3	42.9	27.9	30.1	50.2	29.6	15.8	21.4	30.3	30.3	35.4	23.2	22.8	11.1	17.7	28.8	28.7	18.7	58.3	17.1	18.6	43.3	15.2	25.0	20.5	29.2	15.0	23.1	25.0	29.3	16.3	37.0	37.4	16.5	20.4	9.6	30.1	132.6	34.1	33.5	100.4	22.5	17.3	75.2	54.0	35.7	31.0	27.2	93.9	88.9	21.3	65.7	36.6	58.3	36.1	17.8	43.0	40.8	56.0	15.6	38.6	47.6	85.7	28.7	95.7	57.5	16.0	20.2	44.5	30.8	44.9	35.2	22.7	81.2	80.2	63.0	33.0	53.5	43.5	84.2	94.9	68.6	38.5	42.0	121.5	59.5	33.1	19.6	54.2	68.1	36.1	79.6	32.1	67.0	28.7	69.3	67.3	88.7	59.9	120.1	128.0	188.7	43.7	90.9	108.2	65.3	14.5	15.3	21.4	27.1	36.4	26.3	34.2	31.3	30.2	26.5	32.6	21.2	28.7	3.9	24.2	34.5	26.1	43.4	20.4	28.1	30.9	37.4	49.2	27.9	30.1	30.3	30.3	28.8	29.2	29.3	30.1	66.7	19.2	52.1	44.1	77.7	85.1	115.1	144.3	38.1	111.5	104.4	110.1	68.6	183.0	90.5	191.3	45.9	231.5	74.4	97.7	414.8	154.1	38.6	78.4	74.1	61.4	61.8	82.0	16.6	188.9	164.6	56.1	57.6	119.5	73.4	53.1	42.5	294.8	122.1	89.2	24.4	91.7	77.3	64.8	79.6	75.9	69.6	73.4	72.9	9.4	97.6	195.2	110.2	27.6	34.1	178.6	87.0	80.1	51.9	75.9	134.8	464.0	67.7	133.4	65.7	83.2	85.0	67.1	122.4	61.6	75.6	264.5	81.4	63.6	115.3	87.8
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646062-97648383	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1151.3;skeletal muscle: 1332.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3614.3;Distal tubular cells: 3621.5;Proximal enterocytes: 2795.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		230000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	209.1	252.9	323.0	42.8	339.7	113.3	178.7	373.1	436.0	138.1	349.2	322.6	164.2	124.6	72.3	284.6	136.9	32.6	1151.3	319.2	357.2	478.6	372.8	120.4	40.3	341.7	339.9	138.4	165.6	234.0	169.0	47.1	339.9	158.2	113.4	74.5	196.7	90.1	1332.7	213.2	211.9	51.1	332.9	153.2	290.6	101.2	353.1	64.4	185.0	705.9	54.3	179.8	179.1	355.3	144.9	165.5	106.8	169.7	115.9	105.8	428.3	180.0	100.8	118.3	130.5	459.9	148.7	240.8	377.3	116.5	188.4	217.9	117.5	181.8	56.4	188.7	493.2	324.2	166.6	559.8	220.3	310.6	231.2	193.8	161.6	113.4	91.2	125.4	104.4	187.8	243.6	115.5	94.0	360.0	203.5	450.0	196.6	257.2	854.3	194.9	170.6	368.8	167.5	227.9	202.2	210.3	175.0	225.0	374.8	146.0	115.7	345.5	186.9	107.5	181.4	174.4	118.7	265.8	274.7	183.1	194.9	264.5	113.5	1086.6	1062.7	933.1	458.0	1057.0	445.1	801.5	547.4	481.8	990.1	666.0	528.0	468.8	1016.6	469.6	926.3	677.6	783.4	1543.0	323.0	339.7	373.1	436.0	319.2	357.2	341.7	339.9	339.9	332.9	353.1	355.3	461.0	221.2	256.0	33.3	292.7	386.6	629.5	1166.0	377.9	239.1	433.2	536.2	3614.3	567.6	618.5	800.0	227.2	736.0	257.4	1960.0	3621.5	599.5	207.5	399.4	300.8	380.0	740.3	308.8	27.3	604.1	897.1	391.6	616.7	439.7	330.6	392.2	361.3	1234.9	875.0	141.3	33.7	1430.5	1043.6	485.2	651.9	360.8	351.6	456.6	912.4	30.0	711.7	461.5	314.1	15.6	39.4	505.4	1836.0	304.6	353.3	468.2	2795.9	2663.5	485.4	386.3	447.0	340.2	569.9	265.2	310.7	944.2	479.9	613.2	291.9	455.7	1576.9	915.9
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	79.5	222.7	53.9	18.7	57.5	56.9	78.3	53.1	62.5	93.0	56.1	84.0	32.5	74.8	42.8	60.8	81.0	22.7	102.6	56.2	56.9	130.2	113.9	64.0	32.3	54.8	53.2	127.6	89.8	71.8	128.0	22.8	55.9	71.6	39.2	62.4	67.2	32.4	83.3	72.1	66.0	28.0	53.0	65.9	99.9	54.5	54.8	42.0	56.6	39.3	35.0	74.2	70.4	53.4	72.1	50.7	49.0	54.0	92.4	121.8	55.8	58.2	85.8	51.5	66.0	56.9	48.9	63.1	54.8	71.9	70.0	30.3	65.5	65.9	80.1	99.5	47.5	46.0	31.9	95.5	106.2	66.5	42.5	123.7	128.6	55.5	132.6	78.5	77.4	49.7	64.1	101.1	83.9	68.6	75.3	96.8	45.3	91.6	48.1	40.7	87.5	51.6	84.6	57.4	55.8	63.7	25.7	60.4	166.1	58.2	43.2	73.3	60.1	45.4	61.2	55.3	57.1	84.1	98.7	46.0	63.1	68.8	39.9	103.7	78.6	43.2	57.9	71.1	75.6	72.6	70.4	67.1	84.4	61.9	77.8	67.0	34.1	69.1	80.1	99.0	87.3	189.3	53.9	57.5	53.1	62.5	56.2	56.9	54.8	53.2	55.9	53.0	54.8	53.4	150.7	32.1	76.3	11.4	152.5	265.6	197.9	387.2	135.5	114.8	206.8	237.6	158.7	171.6	173.4	149.0	37.5	228.1	163.4	103.8	645.6	239.1	27.4	189.5	133.3	144.0	288.7	188.7	28.2	229.5	316.2	128.5	123.8	175.9	87.0	155.8	132.1	222.3	234.0	131.2	26.1	285.8	282.8	236.3	225.1	26.3	161.8	161.6	220.5	19.7	298.4	326.8	166.9	13.6	24.5	202.1	173.0	158.7	167.7	214.2	247.1	492.4	160.9	123.6	111.7	137.6	175.2	220.4	270.8	162.7	245.5	329.6	161.8	296.2	257.0	241.7
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409335	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA065167: AB_2685426, HPA068906: AB_2686055"	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	39.1	52.0	16.2	11.0	16.6	20.4	45.5	15.9	23.3	53.5	16.2	54.8	27.4	48.8	3.8	49.2	49.1	9.0	44.9	15.9	14.9	52.2	76.3	43.3	12.3	16.8	14.9	56.6	88.6	6.1	78.0	6.8	17.1	61.7	4.2	5.2	49.6	7.6	41.0	55.3	68.1	5.7	14.6	70.5	68.9	132.0	15.6	15.0	52.9	5.2	6.8	41.2	44.0	16.2	21.4	29.4	26.3	27.7	13.8	11.0	25.7	19.6	12.4	15.8	16.3	29.8	27.0	24.6	18.7	14.8	10.7	19.1	14.9	16.7	4.4	22.2	43.0	48.3	37.4	48.6	11.7	18.6	28.8	12.1	6.9	14.5	8.5	9.5	21.2	40.1	41.1	20.4	8.0	90.7	48.8	38.6	15.9	17.9	41.0	34.7	10.6	19.9	17.0	31.1	21.3	21.1	25.4	15.7	14.8	7.4	27.9	20.5	18.4	10.8	41.3	23.9	22.3	12.1	10.2	23.3	14.6	31.0	13.1	3.8	5.1	3.3	4.8	6.1	5.1	4.0	5.2	5.1	5.7	4.8	4.5	4.3	0.9	4.0	6.2	2.6	6.7	4.2	16.2	16.6	15.9	23.3	15.9	14.9	16.8	14.9	17.1	14.6	15.6	16.2	10.1	16.0	22.5	10.1	9.5	10.1	4.0	6.6	6.2	9.6	15.1	16.9	8.3	20.0	10.7	9.2	12.5	10.1	14.5	26.4	1.9	9.5	19.5	9.6	7.8	11.7	13.1	15.8	9.4	11.5	11.5	10.7	21.9	11.8	14.0	20.7	8.9	8.1	15.1	8.4	6.9	28.6	8.2	12.4	12.4	40.4	14.0	11.7	14.2	3.7	11.9	5.0	10.3	5.5	6.5	10.5	8.8	16.1	17.9	4.1	24.0	6.2	11.7	14.4	6.6	7.7	9.0	36.5	23.1	12.2	12.4	7.3	11.5	7.6	30.3	4.3
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239569-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	23.8	26.3	14.4	35.8	13.9	71.9	23.8	30.5	16.8	27.5	1.8	24.0	26.2	28.4	38.6	27.8	25.3	18.3	21.5	14.5	18.0	20.8	20.6	22.5	46.9	6.1	5.6	40.5	23.9	28.3	26.5	25.0	8.4	23.1	24.8	43.5	26.0	20.2	27.9	24.6	25.4	23.7	8.2	27.1	26.6	22.3	12.6	43.6	26.6	17.0	40.8	25.6	25.2	12.3	97.5	80.3	115.7	81.7	43.8	49.7	87.1	62.7	74.1	87.3	82.0	83.8	64.8	153.6	62.6	63.9	48.5	89.2	114.5	73.7	92.3	101.4	78.1	124.3	85.7	97.1	65.4	170.1	87.1	60.0	57.2	70.4	28.7	58.2	68.3	90.6	130.1	159.6	73.3	112.9	159.9	110.3	112.3	80.4	67.8	159.9	91.6	108.2	68.9	113.4	97.0	85.4	83.7	77.7	88.9	68.8	93.2	118.5	79.1	65.4	80.0	62.6	104.5	101.9	88.5	190.9	53.1	97.5	85.9	44.3	26.0	29.9	27.9	32.6	29.5	32.8	30.8	29.1	39.0	28.9	23.4	28.2	7.7	30.2	28.7	27.8	47.2	19.7	14.4	13.9	30.5	16.8	14.5	18.0	6.1	5.6	8.4	8.2	12.6	12.3	29.1	12.8	24.9	53.2	49.9	76.0	46.7	55.7	43.3	56.5	30.0	24.5	31.7	30.0	39.9	18.4	37.5	64.6	51.1	22.5	37.2	59.6	18.7	35.6	40.2	35.0	52.5	47.1	97.6	56.8	85.7	36.6	33.6	37.9	34.9	54.0	23.6	23.0	39.5	89.2	115.4	32.6	75.3	29.3	39.7	19.8	56.8	37.1	24.9	53.4	53.5	37.8	45.3	137.2	126.0	61.1	23.3	53.0	56.3	37.4	25.4	26.6	28.0	45.8	39.5	37.4	56.0	68.1	69.4	43.9	59.1	51.2	38.5	54.1	36.2	51.5
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207605988	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 417.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	13.0	8.7	10.6	15.3	11.4	22.4	14.7	17.5	11.1	15.8	11.9	11.4	10.0	15.7	10.8	15.0	13.1	14.0	11.5	10.3	10.7	12.4	11.6	13.6	22.1	10.6	9.9	17.2	8.7	15.6	6.9	18.0	10.4	13.0	14.0	17.8	8.9	12.6	6.7	11.5	10.6	16.3	9.7	17.1	12.1	32.4	9.9	28.7	18.1	14.6	25.0	16.8	9.6	15.0	24.9	20.9	38.6	15.6	22.9	22.4	21.8	15.9	23.5	26.6	26.5	21.6	22.9	15.4	19.8	21.1	29.8	19.5	34.8	20.4	37.7	25.1	13.2	29.2	18.9	23.0	18.7	27.7	20.0	16.0	16.3	21.1	31.1	25.4	34.9	28.9	20.5	22.5	30.4	16.8	41.0	16.1	27.8	24.2	13.1	31.4	22.1	20.2	25.1	24.6	27.1	23.4	21.6	16.2	18.1	35.5	16.5	30.1	18.5	21.8	22.6	22.1	20.5	19.6	27.5	36.4	25.2	25.3	22.0	33.6	28.2	28.2	27.0	29.2	23.7	36.7	25.3	26.2	34.1	34.8	30.0	20.7	56.1	45.6	34.9	18.6	38.6	26.7	10.6	11.4	17.5	11.1	10.3	10.7	10.6	9.9	10.4	9.7	9.9	15.0	46.7	19.2	18.2	47.0	52.3	70.9	47.1	33.3	34.1	38.9	25.3	18.5	26.3	17.2	29.0	12.9	33.3	29.1	35.5	25.3	23.5	23.6	417.8	19.6	39.2	47.2	32.4	54.7	56.1	20.3	24.9	35.8	18.8	21.0	43.7	41.5	35.7	15.8	29.4	40.4	51.1	28.2	30.5	48.8	75.9	47.2	26.1	35.8	44.4	68.4	60.9	42.1	33.0	66.9	70.7	26.4	27.5	29.3	29.1	56.5	22.8	19.7	18.9	40.2	39.5	37.4	40.7	44.5	29.4	33.5	57.8	18.6	42.6	19.6	25.7	62.6
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917407-20953747	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 344.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.7	14.8	34.5	18.4	34.9	53.7	16.3	34.6	35.7	17.5	26.0	18.4	22.0	19.4	13.0	26.6	20.4	14.3	25.1	33.7	33.5	17.1	27.3	20.7	25.5	36.8	37.0	27.4	23.5	19.1	16.1	25.9	34.0	16.5	19.6	22.4	14.8	19.0	54.3	24.9	19.7	19.5	38.8	22.4	14.7	13.3	38.9	33.3	14.8	43.0	27.6	18.9	18.4	36.0	43.9	25.8	56.7	44.8	37.5	23.9	61.0	29.0	35.5	43.7	49.1	42.8	19.2	56.1	22.9	30.8	30.0	54.8	67.2	46.3	51.7	47.7	65.5	77.7	28.6	47.3	37.4	83.5	38.0	24.3	60.3	38.1	64.6	35.7	39.1	44.3	344.9	44.8	35.7	41.2	49.0	39.0	44.8	45.5	27.7	62.7	89.9	13.5	29.2	37.8	36.5	46.9	48.6	42.4	36.4	67.7	36.4	45.9	31.9	69.0	77.8	26.2	37.2	42.7	44.4	64.1	51.1	34.8	43.3	16.2	15.0	22.1	18.5	13.9	19.3	12.1	16.2	18.4	16.5	11.4	19.7	18.9	15.9	12.9	26.1	8.3	14.4	21.2	34.5	34.9	34.6	35.7	33.7	33.5	36.8	37.0	34.0	38.8	38.9	36.0	11.8	9.6	17.8	17.3	18.6	54.2	13.5	15.2	29.6	17.8	19.7	14.2	23.1	7.2	12.2	5.5	14.6	19.6	26.4	19.6	1.9	7.7	30.4	19.3	15.3	15.0	20.4	28.6	23.9	8.6	42.4	16.5	10.2	18.4	1.3	15.8	20.7	25.0	17.5	18.5	18.6	19.9	8.2	19.5	20.8	52.5	15.2	15.2	24.9	9.4	19.0	17.5	21.6	16.6	25.0	11.2	11.8	15.4	14.1	19.0	18.5	10.7	14.8	13.2	13.1	15.7	12.1	12.7	11.0	40.2	60.4	27.2	17.8	12.7	18.5	18.6
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958615	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.12e-5)"	32.9	28.6	26.1	20.5	28.1	27.9	29.6	26.6	30.2	33.7	24.3	28.5	11.1	27.2	15.7	25.7	29.2	13.7	26.0	25.2	26.6	31.1	35.1	38.8	28.8	29.2	28.0	40.5	26.3	21.0	24.9	15.8	26.9	29.0	12.6	10.0	27.0	16.7	36.6	34.8	34.7	17.2	25.5	55.9	27.9	21.4	28.2	23.6	32.3	18.5	25.3	28.5	29.2	28.7	24.2	17.9	17.1	19.6	27.2	19.8	25.2	12.8	27.2	24.9	20.3	18.5	24.0	22.8	20.4	23.2	16.8	27.0	20.5	26.8	13.9	29.5	25.7	11.2	18.8	14.4	27.4	19.0	18.7	26.1	25.5	27.6	22.3	19.7	23.3	12.8	19.2	27.1	18.0	38.4	20.6	29.9	12.8	26.1	19.5	15.5	11.7	19.6	26.3	19.4	14.2	23.2	21.5	43.3	32.7	16.5	20.9	37.3	17.7	20.0	17.9	21.7	22.9	43.6	30.7	15.7	18.4	15.9	15.1	3.2	2.2	5.0	2.3	3.5	2.0	2.5	2.5	2.6	1.9	3.2	1.6	2.0	5.7	2.9	2.7	2.6	1.9	1.0	26.1	28.1	26.6	30.2	25.2	26.6	29.2	28.0	26.9	25.5	28.2	28.7	17.8	6.4	10.0	10.4	22.3	24.6	6.9	11.1	13.6	6.3	14.6	12.8	6.0	11.5	8.7	12.9	4.2	9.7	23.0	15.9	1.9	9.0	1.4	13.4	15.0	13.7	16.1	9.7	7.4	10.2	9.4	11.1	14.3	27.7	8.2	6.1	12.5	12.8	10.9	1.7	6.9	13.8	6.1	14.6	23.6	1.2	12.2	17.4	3.6	6.5	11.8	4.8	19.6	6.0	11.1	15.0	5.0	15.1	20.6	12.6	9.8	4.0	7.3	6.9	6.6	9.3	12.1	17.0	12.0	12.7	22.6	12.2	19.6	6.1	7.9	13.0
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529923-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: AB_2685092"	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	27.0	15.5	16.8	14.2	25.3	10.7	21.7	20.0	19.8	26.3	10.1	28.4	7.3	26.0	10.9	12.5	23.8	14.8	19.8	17.0	16.4	14.5	13.2	23.2	15.8	21.8	23.1	36.8	10.7	13.8	9.9	17.1	21.1	18.8	9.4	13.5	17.4	17.0	19.9	19.1	16.6	20.9	16.3	13.3	15.2	16.8	23.2	15.0	22.3	17.4	15.7	28.4	18.3	31.6	9.6	15.1	9.7	16.7	21.6	15.7	46.0	11.7	16.0	17.6	15.9	12.4	9.3	0.2	8.3	23.8	14.9	15.2	15.1	9.8	13.2	16.3	18.8	23.7	83.9	6.1	24.8	6.5	38.8	17.2	16.3	14.5	19.3	13.2	12.5	10.2	12.8	5.5	13.6	11.5	2.6	9.7	3.7	2.7	7.2	8.3	16.3	0.5	6.6	20.3	18.5	16.5	34.7	11.6	19.3	10.8	11.2	12.2	16.4	19.7	14.9	19.0	14.0	7.3	10.2	7.2	8.0	12.6	9.8	21.4	2.6	1.5	3.5	0.8	3.8	2.9	4.3	3.7	1.6	5.0	6.1	3.9	0.5	3.3	0.3	2.1	4.4	3.4	16.8	25.3	20.0	19.8	17.0	16.4	21.8	23.1	21.1	16.3	23.2	31.6	17.9	6.4	9.2	44.1	35.6	23.6	27.8	8.0	13.1	24.9	15.7	12.7	17.0	14.3	7.8	12.9	27.1	14.8	30.0	8.6	1.9	14.9	29.3	6.6	18.5	20.4	15.6	17.1	70.1	10.7	43.3	23.2	14.8	12.7	23.5	34.8	24.7	16.2	15.3	57.2	72.4	9.1	6.1	18.2	18.8	24.3	26.8	21.7	17.8	39.4	20.6	17.7	58.7	75.4	160.8	11.1	10.9	43.6	21.3	26.2	6.4	11.0	2.8	59.7	46.0	30.5	45.8	10.2	17.8	11.4	24.0	17.8	36.0	13.7	11.3	38.2
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908564-111923722	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5623.2;heart muscle: 10683.1;skeletal muscle: 6972.0;tongue: 9406.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 2889.5;Cardiomyocytes: 6878.2;Muller glia cells: 1664.3;Proximal tubular cells: 7285.9"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"ASC diff: 2663.1;fHDF/TERT166: 775.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000		"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.70e-5)"	1035.0	106.6	2466.0	113.9	3113.8	0.4	592.2	3032.2	5623.2	439.1	2077.7	678.9	24.6	351.4	179.1	312.2	204.0	71.7	10683.1	2424.9	2666.2	2123.2	37.2	253.4	15.0	3215.2	2856.7	136.0	50.6	24.9	209.2	107.8	3147.1	317.9	78.2	478.7	428.7	358.5	6972.0	317.3	158.5	338.1	2877.3	88.5	263.8	23.5	2815.5	20.9	477.7	9406.7	34.4	490.0	477.5	4060.6	0.1	0.5	0.1	45.0	2663.1	90.9	15.0	54.5	2.5	0.8	2.5	1.7	0.2	0.0	41.7	775.8	0.2	2.0	1.8	2.3	1.4	0.3	0.0	0.0	11.9	3.9	16.9	0.4	0.7	77.1	11.1	0.6	6.2	44.3	0.2	0.0	4.6	2.5	169.5	0.1	0.1	1.1	0.5	0.0	1.0	0.2	0.0	0.6	29.8	0.8	0.1	0.4	5.3	9.1	39.8	63.5	4.9	0.0	1.7	310.1	105.0	6.5	4.1	0.5	0.1	0.6	7.1	0.4	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2466.0	3113.8	3032.2	5623.2	2424.9	2666.2	3215.2	2856.7	3147.1	2877.3	2815.5	4060.6	38.4	83.3	4.1	96.0	51.3	174.9	2889.5	32.1	72.8	16.2	334.4	696.1	6878.2	84.4	15.2	1338.9	18.8	3.9	6.8	0.4	677.0	320.3	24.7	345.4	265.3	88.4	7.1	0.0	6.7	11.5	7.4	880.6	0.0	1008.4	0.0	16.1	35.7	0.7	5.8	10.1	12.6	2.4	8.2	0.3	85.8	12.6	228.6	67.7	483.8	11.2	3.6	1664.3	0.0	7.5	615.7	12.1	0.0	187.7	1.6	855.4	0.0	7285.9	23.2	59.4	138.1	799.9	1053.3	21.6	1.4	56.5	155.1	33.4	55.4	6.7	1.2	249.0
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300391	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 550.1;tongue: 600.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 239.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		670000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	154.2	93.6	29.2	61.7	30.0	111.0	66.3	33.7	49.9	55.4	40.5	110.1	97.7	56.4	32.2	95.6	58.3	42.4	319.3	30.9	34.6	86.6	39.0	58.0	67.2	39.4	32.0	56.0	61.5	127.6	28.9	45.7	39.4	59.0	124.1	128.9	73.7	60.5	550.1	70.5	81.2	77.5	22.5	49.0	66.5	24.4	41.0	69.4	53.0	600.7	106.1	70.2	58.2	31.6	168.9	176.8	141.6	198.2	188.4	173.8	93.3	136.9	132.0	231.1	160.6	271.2	158.2	322.9	128.2	172.6	99.3	182.1	396.8	200.8	234.9	109.3	200.2	222.9	136.1	261.4	107.3	288.4	166.6	188.2	201.6	182.4	232.0	202.2	268.6	163.7	233.2	193.7	214.7	160.8	229.8	121.9	117.5	128.0	247.8	222.3	167.1	247.6	166.2	194.6	189.3	125.2	175.2	251.7	157.7	137.5	297.6	174.3	178.3	127.1	165.3	167.4	147.4	124.5	200.4	206.2	120.4	206.4	119.5	59.6	73.3	205.7	47.0	93.0	61.9	60.6	56.5	45.1	119.3	51.8	59.2	47.9	31.3	51.6	94.0	65.6	63.4	71.2	29.2	30.0	33.7	49.9	30.9	34.6	39.4	32.0	39.4	22.5	41.0	31.6	14.5	16.0	39.5	32.3	31.6	39.0	23.5	26.9	46.7	22.8	38.3	29.7	239.9	15.7	21.5	12.9	62.6	18.5	24.1	66.9	35.2	32.5	6.6	25.1	31.5	27.2	16.9	36.0	21.5	45.1	31.3	25.8	42.3	53.5	27.9	21.3	18.9	29.7	34.3	10.1	24.6	43.9	20.3	39.4	35.0	4.8	20.2	34.6	10.6	9.4	44.8	16.7	16.5	18.6	18.8	44.6	35.7	19.9	46.7	33.1	50.4	22.0	14.9	38.3	13.1	27.8	38.2	29.7	25.8	74.8	52.1	16.8	25.8	32.0	71.3	34.5
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1408.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2403.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	412.5	166.8	149.0	170.9	168.8	276.4	241.9	160.5	170.8	193.8	163.5	300.1	187.3	226.7	196.2	247.2	162.9	172.0	414.8	137.6	169.8	228.2	233.6	182.8	172.4	166.4	169.5	258.8	216.2	273.8	85.8	182.4	172.6	229.8	199.6	177.6	230.0	245.6	1408.6	201.6	196.1	236.4	172.2	176.5	201.7	257.4	164.7	218.8	262.6	1039.4	208.2	238.4	137.0	187.3	658.8	226.6	395.5	396.1	440.7	561.4	550.1	566.7	420.5	373.0	301.1	334.0	193.7	514.9	465.6	543.1	217.0	272.3	442.4	439.6	539.2	632.1	302.8	506.1	390.3	299.9	388.2	380.7	288.7	414.7	468.2	447.0	583.2	502.2	433.5	426.5	523.3	327.3	458.9	2403.4	513.8	242.0	755.0	274.0	302.5	378.4	1221.9	244.0	295.4	508.4	485.6	320.7	553.9	455.8	433.3	411.9	234.5	599.4	526.9	437.8	597.3	579.6	629.1	495.7	587.9	567.7	564.9	422.2	1365.1	217.2	241.4	230.8	146.4	233.1	199.7	161.6	186.5	180.7	226.8	130.4	219.3	189.1	155.2	191.0	270.8	87.2	222.2	389.4	149.0	168.8	160.5	170.8	137.6	169.8	166.4	169.5	172.6	172.2	164.7	187.3	193.2	198.7	194.2	41.8	198.3	216.2	219.7	149.0	235.6	134.0	218.2	161.5	572.0	160.2	181.1	128.8	58.4	172.4	155.2	160.8	226.9	198.2	405.5	130.4	178.8	191.3	219.9	232.8	70.8	202.9	208.2	181.7	143.2	174.3	219.1	234.7	156.4	189.1	156.8	99.3	73.7	220.3	120.1	277.9	202.0	639.7	161.8	216.8	220.5	55.3	241.8	195.5	117.4	54.3	86.5	213.8	150.6	225.7	283.6	269.0	240.1	235.5	143.2	121.3	164.3	232.4	274.2	263.3	189.8	247.2	234.0	272.9	193.3	208.2	210.5	283.8
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 164.0;Spermatogonia: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	Yes		320000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	23.6	24.5	16.0	29.0	20.2	26.4	34.2	26.6	21.1	25.7	12.9	23.6	19.8	28.1	23.8	38.2	27.0	19.0	24.7	17.1	18.0	29.8	30.9	19.7	35.0	21.0	17.3	27.2	20.4	30.8	13.6	37.5	22.8	25.8	28.7	23.2	21.7	25.6	39.8	34.4	19.2	35.0	21.1	20.3	20.7	87.7	17.0	40.7	23.4	41.5	42.8	27.5	22.2	29.1	224.3	152.4	182.1	140.9	69.0	88.5	196.7	172.1	90.5	528.1	222.0	501.8	175.4	227.3	224.1	109.7	213.9	251.4	270.7	322.9	500.0	37.4	131.3	158.0	166.1	244.7	42.0	176.2	83.3	50.0	118.7	259.0	148.7	72.4	177.5	124.3	227.2	87.1	201.1	76.8	213.9	90.6	153.5	185.1	224.0	133.9	299.5	176.4	116.5	153.2	159.6	92.6	275.2	293.3	97.1	137.7	245.3	113.3	115.5	279.3	233.9	166.4	247.9	50.5	130.8	210.8	166.8	139.5	152.2	18.6	16.3	3.8	13.8	20.6	21.1	16.7	21.0	17.1	20.1	13.6	22.1	19.3	4.4	23.0	23.6	8.9	20.1	18.3	16.0	20.2	26.6	21.1	17.1	18.0	21.0	17.3	22.8	21.1	17.0	29.1	16.4	6.4	26.8	8.1	20.3	30.2	25.8	29.5	31.3	14.9	17.4	15.9	26.6	24.3	22.4	27.6	10.4	71.8	15.7	7.4	13.7	32.2	95.9	14.7	19.4	22.9	5.4	40.4	20.9	26.6	61.2	24.6	13.7	17.8	4.5	35.1	19.2	26.7	29.7	15.2	24.4	11.8	20.3	17.9	21.9	57.8	25.4	17.9	26.6	9.4	28.0	22.6	7.2	17.1	41.7	26.7	10.0	31.6	26.7	28.8	9.9	21.6	21.7	15.5	39.5	19.3	22.1	164.0	121.5	36.7	34.5	72.7	17.5	31.1	23.7	22.2
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073789-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lung: 2.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 11.4;Basal respiratory cells: 11.3;dendritic cells: 17.7;Ductal cells: 18.3;Pancreatic endocrine cells: 24.9;T-cells: 28.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 6.2"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 6.2"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 91.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	23900		"Cluster 15: NK-cells - Transcription"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	2.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	9.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	91.3	0.1	5.1	0.0	7.4	0.0	1.5	0.0	5.3	0.2	0.0	6.8	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	20.8	13.8	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.3	3.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	11.4	0.0	0.3	1.5	0.1	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	17.7	0.1	0.0	18.3	0.0	0.3	0.2	4.8	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.7	1.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.6	0.0	28.6	0.0	0.0	1.1
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 169.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 130.9;dendritic cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	21.4	19.9	23.4	89.1	26.2	50.6	19.4	26.5	26.7	26.8	18.2	33.6	36.7	22.4	8.0	98.5	20.0	22.9	29.3	22.5	23.9	21.3	48.8	32.0	169.3	31.0	29.8	19.0	17.2	15.8	21.1	17.6	31.6	24.8	19.5	6.9	31.6	14.1	14.8	36.7	59.9	18.7	29.1	127.9	30.0	19.2	28.2	68.5	19.5	15.8	106.3	33.0	32.8	28.4	62.2	85.6	41.2	68.1	38.5	29.2	35.3	40.7	38.8	75.7	53.6	78.9	56.0	275.7	52.6	37.0	70.2	62.9	87.2	82.1	21.2	134.7	107.8	233.8	29.5	80.2	53.3	123.6	285.1	41.7	39.6	54.0	48.1	37.9	58.1	127.5	68.7	93.1	45.7	104.6	89.7	72.7	51.2	55.7	60.6	98.0	35.4	201.9	34.9	135.6	68.1	47.2	52.8	109.5	72.3	26.2	75.5	179.5	50.7	91.1	47.8	72.5	71.7	49.6	108.7	283.8	47.1	232.5	63.1	88.7	68.0	176.1	74.3	146.8	63.4	95.6	63.6	73.9	76.6	113.6	48.3	57.0	130.8	58.6	169.8	44.3	106.2	79.5	23.4	26.2	26.5	26.7	22.5	23.9	31.0	29.8	31.6	29.1	28.2	28.4	21.3	3.2	9.2	8.5	130.9	9.3	8.2	7.6	13.1	16.6	16.7	17.1	11.5	12.8	9.3	9.2	6.2	7.5	99.1	40.6	1.9	9.3	15.8	10.0	15.1	15.3	9.5	29.2	5.3	14.0	13.7	11.3	27.0	15.3	26.6	19.0	12.5	34.3	50.7	28.6	10.0	23.2	6.1	91.2	44.9	3.3	9.0	85.1	8.8	23.4	86.9	6.4	90.6	3.5	4.7	21.2	18.4	8.2	56.7	13.9	27.5	8.0	9.3	5.1	6.6	6.9	18.1	5.7	12.5	49.4	9.1	5.6	90.3	21.5	27.5	14.9
CSPG4	"CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.4"	"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		48000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	29.6	1.8	9.0	7.3	7.1	0.0	18.5	6.6	9.3	16.0	1.8	55.4	2.8	34.5	1.4	8.3	15.0	5.6	14.6	7.5	8.2	4.9	0.9	19.4	0.4	11.7	7.8	8.9	2.1	1.2	2.2	15.5	9.7	14.4	2.2	0.1	4.7	11.2	39.6	7.8	15.3	22.7	6.7	5.6	19.1	1.3	7.7	0.6	5.6	10.0	0.3	30.3	12.6	9.8	11.9	0.1	1.0	7.1	1.6	9.8	0.1	64.7	28.6	44.4	28.8	0.1	45.0	0.0	1.5	45.4	6.2	0.6	0.1	0.3	13.6	0.6	0.2	0.0	19.2	0.0	10.0	0.0	0.1	4.8	0.1	13.5	1.5	16.5	0.0	0.0	0.1	0.1	7.6	0.1	0.0	0.2	1.2	0.0	0.3	0.1	4.0	0.1	0.0	0.0	0.1	0.2	1.7	0.1	146.1	1.2	0.9	1.2	0.1	92.1	17.9	3.6	0.8	0.0	0.2	0.0	20.3	0.5	138.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	7.1	6.6	9.3	7.5	8.2	11.7	7.8	9.7	6.7	7.7	9.8	4.9	0.0	0.0	1.0	0.0	2.8	0.7	4.7	0.0	1.4	0.1	0.8	11.4	0.0	0.8	1.8	0.0	0.2	0.5	0.1	0.0	0.0	0.6	0.7	0.7	2.7	0.0	0.0	0.4	0.0	0.6	5.9	1.5	0.4	0.0	1.8	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.3	0.3	12.4	3.7	0.0	0.0	0.0	57.3	0.1	0.0	0.0	0.4	0.0	4.3	0.0	0.1	1.0	0.2	118.3	3.1	47.1	0.0	1.3	0.1	1.8	0.3	0.3	0.1	0.0	0.4
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 193.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	88.9	55.8	13.6	34.0	13.7	193.1	51.7	17.2	22.5	34.7	15.4	35.6	12.0	30.2	6.4	61.7	79.8	67.5	49.9	12.8	18.0	29.2	67.3	80.8	14.9	21.3	16.2	41.5	39.4	23.5	43.3	25.0	15.7	32.7	15.4	5.8	21.3	18.5	36.9	57.1	26.4	64.1	18.3	20.3	48.0	14.7	17.1	34.9	33.8	19.0	8.7	51.6	27.7	15.4	4.4	9.7	2.5	4.8	4.7	4.9	7.8	15.9	22.1	13.0	10.6	13.7	4.0	14.4	3.3	12.1	9.3	4.9	3.0	21.0	6.4	21.6	4.0	16.4	8.0	10.5	5.8	4.1	15.7	2.3	11.3	20.4	3.2	11.6	17.8	3.9	12.7	24.9	10.7	13.9	0.8	6.7	11.4	7.4	8.1	6.8	10.4	23.7	10.3	15.9	7.0	1.1	8.7	64.2	5.5	14.5	7.2	7.5	9.0	6.6	28.2	5.6	11.9	6.3	5.8	6.6	14.4	5.2	8.4	0.1	3.0	3.8	1.7	5.9	2.1	3.6	1.6	2.0	3.3	3.7	2.0	1.3	17.1	2.6	11.0	4.2	2.7	2.3	13.6	13.7	17.2	22.5	12.8	18.0	21.3	16.2	15.7	18.3	17.1	15.4	200.8	48.1	66.3	6.8	75.0	103.2	88.1	40.2	153.1	1.4	121.1	95.8	15.8	37.1	31.2	11.0	0.0	19.7	86.3	77.3	9.8	37.6	54.4	119.6	65.2	92.8	59.3	13.2	3.5	38.5	43.0	98.1	75.4	199.4	96.5	4.2	73.9	40.7	38.7	0.0	1.5	54.7	22.4	36.7	165.2	46.8	1.5	94.5	69.4	4.7	14.8	7.6	7.2	1.5	1.3	49.2	60.9	4.1	74.3	49.4	54.1	6.0	21.0	1.7	13.1	154.4	103.9	0.6	4.7	85.7	79.6	90.7	132.4	8.9	38.0	38.9
CSTF1		ENSG00000101138	"Cleavage stimulation factor subunit 1"	Q05048	20	56392371-56406362	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019270, HPA047275, HPA065000"	Supported		Enhanced	Nucleoplasm		NA	NA		210000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	6.3	6.4	4.1	8.1	4.7	5.1	11.1	6.1	5.0	7.3	5.0	7.9	5.3	8.2	8.0	8.8	9.5	7.7	8.0	4.5	4.4	9.6	10.9	8.5	12.4	4.3	4.1	11.8	10.0	11.4	4.8	9.4	4.8	8.5	8.0	14.9	10.3	7.0	9.4	8.4	5.9	8.8	3.9	7.6	7.8	17.6	5.6	14.3	10.0	14.7	14.4	8.9	5.7	6.1	18.9	17.4	22.1	15.6	22.6	20.2	23.7	25.2	27.8	49.2	36.7	37.6	26.9	39.1	26.7	19.1	31.5	31.2	35.7	43.4	57.8	12.4	12.6	38.1	29.3	23.3	13.4	32.2	23.6	19.4	24.5	27.6	23.8	19.1	30.2	24.3	32.6	18.5	30.2	44.6	36.2	17.0	20.3	37.2	23.2	26.5	47.7	34.6	23.9	19.3	24.5	17.0	34.5	93.1	25.6	25.3	37.1	22.9	17.1	39.9	25.3	16.9	24.9	13.0	21.5	42.0	32.0	21.3	19.4	11.4	16.9	13.6	20.7	14.6	26.0	21.1	25.9	23.4	21.5	24.3	28.4	24.9	13.3	31.2	13.1	23.7	33.3	20.4	4.1	4.7	6.1	5.0	4.5	4.4	4.3	4.1	4.8	3.9	5.6	6.1	8.4	9.6	13.1	4.2	11.6	9.2	10.8	29.3	12.5	9.2	9.9	8.3	8.9	14.3	16.8	18.4	14.6	30.9	11.5	7.3	19.6	17.9	25.9	7.1	9.4	13.3	4.9	21.0	4.2	14.7	21.1	12.1	9.7	6.0	17.7	12.6	11.7	22.6	15.3	5.0	4.2	9.4	14.2	16.7	7.8	7.5	13.7	8.4	5.4	9.4	18.4	14.2	12.3	5.5	6.7	11.9	11.8	12.8	10.8	12.3	8.5	21.1	12.9	14.7	19.7	11.1	9.9	84.3	30.5	11.3	8.8	21.1	14.9	16.7	9.8	8.8
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100841520	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	6.3	7.2	5.7	9.9	6.0	10.5	7.7	6.7	6.3	7.0	5.0	12.0	8.6	7.5	8.2	19.2	8.1	6.4	6.1	5.9	6.4	8.0	5.3	6.3	12.5	5.4	5.4	7.1	4.7	8.9	5.3	7.2	5.3	7.5	13.1	8.5	7.9	8.4	4.5	8.4	8.2	7.6	5.3	7.0	6.6	12.7	6.6	12.0	6.7	5.1	19.9	10.0	8.4	6.3	36.0	41.7	27.5	24.9	14.7	11.4	37.2	29.6	24.0	47.6	68.0	45.4	32.1	35.6	35.2	19.1	61.2	35.1	64.2	35.3	57.2	36.5	39.9	32.8	38.8	29.8	19.4	46.9	33.8	11.3	16.5	49.8	32.6	12.7	29.0	31.3	56.2	33.7	29.2	41.9	38.4	31.8	76.8	55.7	39.9	35.8	46.3	42.3	17.5	34.4	24.1	30.4	49.1	20.5	20.4	27.6	20.5	20.3	25.8	26.2	42.3	38.1	37.8	22.8	52.3	45.9	22.5	48.6	32.4	20.0	16.1	11.1	23.4	18.9	17.9	17.4	21.1	21.8	23.3	16.9	19.0	17.8	2.6	23.9	25.8	16.7	24.2	15.3	5.7	6.0	6.7	6.3	5.9	6.4	5.4	5.4	5.3	5.3	6.6	6.3	4.1	3.2	1.1	3.9	8.2	4.2	4.6	20.7	9.6	2.2	3.1	3.0	4.9	2.8	12.9	0.0	2.1	16.7	3.6	5.9	5.9	12.5	13.3	6.3	4.9	4.6	4.2	12.8	10.4	8.3	18.4	4.3	6.1	4.3	3.8	5.5	2.5	1.5	10.8	3.3	10.8	3.7	14.2	2.5	3.7	2.4	4.7	4.3	1.8	1.0	5.9	4.5	4.1	7.1	5.7	15.4	6.7	4.1	6.2	2.0	5.4	4.0	9.9	2.9	6.6	2.7	5.7	18.8	25.5	14.4	4.1	7.7	7.1	5.0	6.4	5.0
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695486-51699595	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: AB_2684662"	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	13.5	13.2	10.6	17.4	13.1	13.6	11.7	13.4	13.4	11.0	11.2	10.4	11.7	11.7	10.3	9.0	14.8	10.2	14.4	10.4	11.5	11.9	12.6	9.6	19.6	13.3	12.6	17.9	12.3	18.0	6.0	11.9	13.1	11.9	10.6	13.8	10.7	9.3	22.2	10.9	11.6	12.2	13.9	17.6	11.1	9.5	12.0	21.5	11.5	22.8	19.4	12.4	6.3	18.4	16.2	18.9	27.9	29.4	38.5	26.2	1.9	22.5	20.7	25.4	24.7	25.3	23.2	46.5	12.7	19.7	15.4	24.8	21.2	23.6	22.9	27.1	24.0	26.8	19.9	4.7	18.6	10.5	23.6	38.0	18.0	22.4	25.8	16.1	19.3	26.9	29.3	25.6	22.2	13.9	42.9	16.8	10.3	19.7	40.3	33.7	56.2	9.9	19.6	13.4	23.3	30.1	18.8	19.4	20.4	28.9	36.2	19.2	20.7	16.2	22.1	15.1	28.5	32.5	13.0	32.9	33.7	24.1	14.3	2.8	4.1	4.5	3.5	3.8	4.9	1.7	2.6	2.8	4.3	3.0	4.4	4.0	1.1	10.9	2.8	2.7	4.6	2.9	10.6	13.1	13.4	13.4	10.4	11.5	13.3	12.6	13.1	13.9	12.0	18.4	13.4	9.6	7.5	2.9	15.8	9.1	7.1	15.7	12.5	18.2	8.7	5.6	14.3	8.6	11.1	9.2	8.4	24.1	13.7	7.5	23.5	16.4	1.7	9.2	13.5	17.7	6.1	17.7	4.6	15.3	14.6	12.4	9.7	7.8	20.3	10.9	17.9	16.7	15.4	20.2	5.7	8.7	10.2	14.8	8.3	2.7	23.9	8.9	0.0	3.7	22.5	13.2	33.0	3.0	19.3	13.9	6.1	19.9	7.1	4.1	9.3	13.6	17.8	13.7	6.6	16.1	9.1	37.0	15.7	8.5	6.5	6.2	17.2	12.0	11.2	5.1
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	13.8	21.2	28.5	20.8	30.9	12.7	19.5	34.7	39.8	24.2	30.5	20.3	19.1	19.8	61.1	26.7	21.2	14.9	17.1	30.0	32.4	28.9	34.6	21.3	26.6	26.3	26.8	25.9	21.1	18.2	57.6	19.1	27.4	30.4	20.0	31.9	20.6	15.0	16.9	26.1	20.2	13.7	26.1	25.5	18.6	32.9	31.1	23.8	29.8	11.8	21.5	22.0	24.7	32.9	45.8	43.3	82.8	56.4	22.0	38.7	59.8	44.2	28.5	48.5	66.2	31.7	34.9	49.3	31.2	28.5	32.4	58.5	73.8	42.9	77.5	52.7	128.3	50.6	109.1	58.2	24.9	66.5	30.9	28.2	30.6	37.6	36.7	39.1	64.4	39.2	67.9	34.2	66.4	32.3	66.8	35.7	40.3	34.6	54.0	52.2	80.5	39.7	54.6	58.2	61.4	34.9	50.9	29.9	37.6	52.7	54.4	44.1	39.5	40.3	49.7	64.5	59.7	32.3	46.8	41.9	47.4	68.9	40.2	4.6	4.8	7.0	5.8	6.9	6.8	6.5	7.2	5.8	7.7	5.0	7.5	7.9	1.9	6.9	8.3	5.7	9.1	3.7	28.5	30.9	34.7	39.8	30.0	32.4	26.3	26.8	27.4	26.1	31.1	32.9	12.8	19.2	18.7	38.5	19.0	18.9	50.6	50.1	10.2	33.3	22.3	19.9	21.8	17.2	43.5	58.8	6.2	63.0	12.7	15.1	62.6	24.3	37.6	31.4	20.7	21.2	31.8	34.9	75.2	16.9	32.0	23.1	15.3	18.9	14.5	29.0	11.0	57.3	28.4	13.5	59.1	30.0	77.3	22.0	21.1	10.3	29.8	17.0	28.4	42.2	28.1	35.7	14.4	62.4	56.9	20.8	18.6	29.7	14.0	33.0	20.6	47.0	68.0	25.2	26.3	26.1	25.4	77.3	57.6	19.1	19.5	33.8	18.3	25.3	29.6	55.6
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 5.4;testis: 10.4"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 77.3"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 104.1;K-562: 140.6;OE19: 203.6;RPMI-8226: 311.3;SK-BR-3: 195.4;U-266/84: 356.9"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.3	0.8	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.8	1.5	0.0	5.4	0.0	0.0	3.4	0.7	0.3	0.0	0.1	0.0	0.5	2.0	0.0	0.3	2.6	0.1	0.3	0.0	0.0	0.1	0.0	3.3	0.4	0.2	0.0	0.0	0.4	0.5	10.4	0.0	3.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.6	2.9	0.0	0.0	0.2	0.0	0.0	203.6	0.0	0.0	0.0	311.3	0.0	0.0	0.4	0.0	0.0	195.4	0.3	0.0	0.2	0.6	0.3	6.3	0.2	0.7	0.2	2.6	356.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	1.2	0.9	0.0	3.9	0.0	0.2	0.0	1.8	0.2	0.0	0.0	0.5	0.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.7	1.2	0.5	0.0	0.0	0.6	18.5	77.3	0.0	0.0	1.1	0.1	0.0	0.0	0.0
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211445-1249953	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	76.1	88.1	92.3	86.1	91.2	71.5	72.7	96.6	104.3	94.7	73.6	94.6	91.0	98.4	47.5	85.0	89.2	61.4	100.0	92.7	98.1	88.4	109.2	82.6	108.7	99.2	94.1	93.5	141.1	58.8	140.0	45.7	94.6	94.8	41.9	38.8	90.9	50.8	170.1	74.3	97.1	48.1	77.1	118.7	79.5	47.3	90.0	98.1	86.2	91.5	62.4	87.5	79.8	89.8	108.5	156.8	118.4	146.6	81.5	58.6	101.7	83.4	76.8	101.8	102.8	135.0	255.1	131.0	93.8	97.5	156.6	84.1	72.3	109.9	30.4	101.0	86.6	119.1	185.6	177.1	135.7	108.4	163.3	101.3	82.5	86.5	49.8	97.8	76.8	147.1	138.1	219.6	56.9	178.1	351.4	338.3	140.5	87.8	148.4	244.4	71.4	173.2	65.8	135.9	222.0	138.1	79.6	85.2	114.5	70.9	187.2	164.5	99.7	168.5	94.2	97.8	182.1	157.7	164.3	155.2	133.4	166.4	135.6	12.6	15.6	17.4	31.8	23.1	24.0	20.1	22.3	27.4	20.6	19.3	17.1	25.1	12.7	23.9	23.9	34.6	20.9	16.1	92.3	91.2	96.6	104.3	92.7	98.1	99.2	94.1	94.6	77.1	90.0	89.8	33.3	41.7	39.0	17.9	36.8	34.2	21.1	22.1	13.1	32.1	52.0	39.5	54.9	37.1	19.2	36.8	4.2	25.4	72.4	57.2	11.7	29.4	4.0	34.0	46.4	35.7	46.1	42.3	19.4	40.6	32.0	37.5	37.8	41.6	24.1	31.2	45.0	85.0	43.0	40.4	21.2	49.7	20.3	72.9	31.8	5.5	45.1	37.7	46.2	21.5	45.9	46.8	82.4	19.6	17.7	45.0	35.7	35.7	42.0	36.9	42.8	37.4	25.7	17.8	6.6	31.2	32.9	10.8	13.4	30.3	37.8	19.8	41.1	32.0	57.5	27.9
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		57000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033"	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favorable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	144.4	137.1	88.3	65.9	110.4	33.1	126.4	102.9	100.6	110.9	103.2	155.8	115.5	99.2	115.7	208.9	113.4	95.6	190.7	83.7	91.3	151.8	82.4	134.4	35.6	106.8	99.4	101.5	83.8	120.4	54.3	124.6	105.2	96.3	122.9	54.0	127.7	104.0	87.1	140.6	115.2	115.5	95.9	66.0	125.3	35.0	100.2	33.0	122.9	62.0	69.3	126.8	126.3	139.0	225.3	161.1	237.9	353.6	202.2	220.8	362.0	222.0	277.9	208.1	261.1	337.9	297.4	0.8	182.9	334.3	228.0	167.7	165.9	366.0	240.0	129.6	144.0	94.3	245.7	206.5	243.6	1.7	88.2	140.5	286.0	249.1	269.6	230.6	397.7	66.0	52.9	94.3	227.2	199.4	2.3	28.9	96.2	237.4	3.6	88.8	138.0	135.7	441.9	295.5	94.9	124.8	409.7	568.2	344.3	503.4	201.5	64.4	341.1	217.1	117.4	136.5	156.5	33.8	69.9	13.5	207.0	40.3	286.7	5.1	37.8	3.4	5.8	46.4	3.8	7.9	4.1	4.3	32.3	6.6	0.3	2.1	20.9	0.6	46.8	7.9	11.1	17.8	88.3	110.4	102.9	100.6	83.7	91.3	106.8	99.4	105.2	95.9	100.2	139.0	137.3	259.6	161.0	57.1	19.4	78.5	119.5	134.4	82.0	7.3	74.6	52.3	230.8	87.2	201.8	121.4	20.9	124.8	21.1	320.7	68.4	184.9	17.2	158.0	67.9	141.1	51.0	41.7	37.6	175.5	137.8	97.1	167.1	206.9	40.5	83.3	92.4	66.6	92.8	3.3	31.5	139.0	87.5	80.5	80.9	23.6	77.9	77.9	78.2	104.0	158.5	46.2	6.2	66.4	159.7	328.7	201.4	84.7	24.8	128.7	165.6	140.1	210.1	24.5	98.6	74.9	109.1	18.1	21.0	111.3	77.3	189.9	20.4	44.4	130.6	181.4
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 539.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		2000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	130.8	112.2	106.7	98.7	85.3	162.4	194.3	147.8	87.5	179.4	94.7	141.2	136.9	149.4	84.4	113.7	131.0	121.8	109.9	88.1	105.3	106.5	147.9	132.9	81.9	101.3	112.9	173.9	93.3	137.2	84.7	200.0	94.0	132.3	134.5	88.8	110.9	126.3	87.3	99.0	142.9	178.4	104.9	92.5	81.8	59.5	129.4	95.6	140.6	89.9	99.5	158.3	109.3	108.4	161.6	210.0	423.6	242.8	226.9	184.7	333.8	179.6	249.7	288.2	284.3	146.3	224.0	131.7	157.8	314.1	129.0	119.6	315.8	510.0	306.2	123.3	215.7	215.5	261.0	523.7	169.5	121.8	99.1	271.6	226.7	345.5	208.7	235.7	258.1	63.0	153.7	80.3	324.1	161.8	87.3	68.3	397.2	211.0	159.3	64.9	281.9	88.3	177.9	494.8	102.9	172.4	296.2	147.1	809.4	509.8	242.1	248.6	340.8	217.1	163.6	139.3	264.0	50.7	82.7	138.4	221.5	150.5	369.7	4.7	7.3	6.4	9.2	12.3	10.9	7.7	8.6	10.1	11.8	8.0	8.6	9.4	6.6	9.6	12.6	10.0	10.8	5.6	106.7	85.3	147.8	87.5	88.1	105.3	101.3	112.9	94.0	104.9	129.4	108.4	171.7	137.8	179.5	58.1	71.7	213.5	130.1	75.3	116.1	40.7	232.5	168.1	84.7	90.1	119.2	62.5	33.3	318.9	99.0	251.6	35.2	132.2	11.0	90.3	125.9	187.3	93.8	43.8	50.9	78.5	115.6	116.8	53.0	95.5	116.6	137.0	139.2	172.5	115.1	13.5	82.4	145.9	42.7	154.6	228.1	9.5	59.7	161.1	202.7	124.6	98.3	89.2	49.4	70.9	62.9	139.8	249.5	86.9	55.5	128.3	160.3	93.2	96.1	62.0	46.0	175.6	137.3	78.4	40.1	70.9	174.9	539.5	77.0	245.6	189.6	127.9
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 372.9;granulocytes: 263.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 308.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	26.9	16.8	20.9	27.3	22.8	41.8	23.8	21.6	24.8	23.7	23.4	31.8	21.7	27.7	31.1	23.4	25.3	19.8	32.3	22.0	22.4	22.9	46.8	25.3	39.3	22.8	22.3	27.1	17.3	19.7	18.2	22.1	21.7	23.4	23.1	18.8	18.5	30.6	33.3	25.3	25.1	30.6	21.6	54.0	34.8	43.3	22.1	40.1	17.1	20.9	41.2	25.8	20.4	23.6	66.7	60.3	56.7	44.6	40.3	32.8	89.2	41.9	43.7	98.0	86.0	224.8	52.4	73.9	59.6	42.7	94.4	69.8	77.1	98.6	105.3	36.1	38.0	243.0	33.2	110.2	41.8	77.4	308.0	35.1	58.9	55.6	54.8	34.1	59.8	103.8	66.8	29.6	53.5	54.9	127.0	101.4	51.4	74.9	85.8	87.9	109.1	56.3	42.9	55.0	45.1	53.6	72.5	102.3	75.4	52.3	50.6	61.1	44.5	97.4	58.0	64.9	68.8	34.1	46.6	85.5	68.5	48.6	52.7	267.9	77.7	103.3	51.0	103.0	49.1	88.9	49.9	53.8	110.3	83.4	49.8	53.6	16.9	79.9	109.6	86.9	66.2	71.3	20.9	22.8	21.6	24.8	22.0	22.4	22.8	22.3	21.7	21.6	22.1	23.6	28.6	28.9	26.4	21.2	40.0	22.8	32.9	40.7	13.1	26.1	13.0	13.2	39.8	17.2	34.1	18.4	18.8	147.8	40.4	21.1	37.2	34.8	372.9	24.2	24.9	32.5	20.9	43.7	31.6	34.7	69.4	28.7	48.4	21.6	263.6	34.4	44.3	45.2	49.3	18.5	35.6	27.3	42.7	36.0	35.5	131.2	34.2	44.5	26.6	14.0	89.8	32.1	40.2	30.7	39.8	31.9	21.5	33.4	21.6	22.3	34.7	43.1	26.1	25.8	19.7	25.4	48.0	79.4	45.2	10.7	22.4	52.9	38.8	23.7	24.2	20.6
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6"	"Group enriched"	"Detected in many"	19	"dendritic cells: 6.3;monocytes: 9.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	72.6	48.8	29.6	34.8	28.1	5.9	83.3	28.2	33.0	86.0	50.0	107.9	97.8	70.8	49.3	209.7	58.4	56.3	49.0	26.6	26.8	77.9	82.6	83.9	19.0	34.8	30.6	49.3	120.0	76.1	57.7	106.0	32.5	78.9	102.0	23.5	121.8	57.1	26.8	129.4	104.9	54.8	32.3	51.5	105.4	44.3	38.0	24.4	98.6	19.9	48.4	83.5	111.9	33.5	156.6	106.4	70.2	63.3	46.1	71.6	141.7	65.1	78.8	58.5	55.6	88.5	163.9	1.0	113.2	72.5	50.9	201.7	58.8	97.4	71.1	1.0	21.9	32.0	35.8	109.9	52.6	5.0	52.7	70.0	133.5	67.1	73.5	103.8	197.2	1.7	55.1	0.4	55.1	48.0	1.7	13.9	54.7	101.2	56.5	0.7	67.4	1.3	90.2	171.0	4.9	40.1	91.5	133.6	113.1	176.3	138.9	6.1	166.0	59.6	50.3	53.2	34.6	1.2	0.9	2.3	53.2	3.4	111.5	0.0	4.9	0.1	0.0	9.5	0.2	0.2	0.0	0.1	6.3	0.3	0.0	0.0	0.2	0.4	5.6	1.4	0.1	1.1	29.6	28.1	28.2	33.0	26.6	26.8	34.8	30.6	32.5	32.3	38.0	33.5	116.2	147.4	84.0	0.0	8.8	117.1	96.9	82.9	126.9	21.0	101.5	70.5	17.5	125.8	96.6	141.6	39.6	94.0	2.3	305.5	13.7	106.7	14.1	91.1	58.5	98.6	86.2	21.3	0.0	97.2	85.6	34.5	165.1	139.4	32.4	61.1	91.8	127.6	44.4	15.2	0.0	160.7	52.9	64.3	55.5	10.5	28.3	46.4	48.0	0.0	28.5	30.2	2.1	0.0	0.0	141.8	169.3	38.4	5.0	116.9	179.6	57.6	88.2	26.4	26.3	32.3	38.1	37.0	21.1	285.1	200.5	90.8	6.2	39.9	127.0	194.6
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10751246-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 186.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA061027: AB_2684418, HPA068122: AB_2685959"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	15.4	20.6	10.0	21.0	10.2	23.7	18.8	9.9	11.3	19.9	13.4	16.9	16.2	22.2	48.0	17.5	16.8	15.3	17.2	10.4	10.8	22.5	25.2	17.2	26.3	10.0	12.0	22.0	13.3	30.0	12.5	20.3	10.5	17.6	18.1	29.2	18.3	16.1	17.9	19.2	16.8	16.4	9.7	22.5	17.2	27.0	10.4	30.3	23.2	15.1	26.0	21.8	11.8	11.0	40.5	30.9	43.5	41.4	93.1	37.0	21.2	43.9	29.2	34.8	36.5	51.1	83.9	36.7	23.6	36.6	42.3	40.9	54.0	36.2	56.7	56.7	64.6	186.6	31.0	29.2	29.7	74.1	98.8	34.6	28.8	22.5	30.1	32.1	40.6	34.5	77.0	43.2	42.6	18.3	47.5	28.9	36.0	48.7	38.2	43.6	52.9	25.1	29.9	54.8	19.9	47.4	39.6	38.9	31.3	41.5	34.6	32.3	40.2	29.2	30.0	51.7	24.0	23.6	59.8	39.5	31.2	49.5	30.5	54.4	15.4	31.3	20.0	17.7	26.3	16.7	21.4	19.7	18.1	17.0	20.1	19.6	11.3	26.7	18.3	9.0	19.4	15.8	10.0	10.2	9.9	11.3	10.4	10.8	10.0	12.0	10.5	9.7	10.4	11.0	51.5	57.7	48.8	14.7	49.0	87.2	46.2	29.7	64.3	34.0	30.2	31.6	49.2	31.5	41.7	25.8	56.3	37.9	42.7	30.7	19.6	26.9	28.5	34.0	38.0	37.7	26.9	25.5	16.5	24.5	24.8	36.4	15.8	52.4	85.9	33.2	28.5	38.6	29.1	63.9	21.4	45.1	32.6	32.3	23.6	13.1	33.5	36.1	12.4	15.0	31.8	31.1	29.9	20.6	18.6	26.9	17.5	31.2	37.2	26.1	22.8	18.3	33.7	45.9	26.3	47.8	33.1	100.3	71.3	51.1	81.1	45.7	48.0	56.4	25.3	31.5
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432584	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: AB_2677694"	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	45.6	66.6	84.3	28.3	86.0	29.8	42.3	89.4	91.2	49.5	80.5	64.7	19.8	53.4	33.7	30.7	48.3	31.5	91.8	84.4	89.0	55.8	44.9	38.1	33.2	85.1	84.1	56.3	41.0	58.9	45.5	27.8	86.2	48.1	23.3	31.1	40.8	37.3	119.4	37.5	34.2	42.5	83.8	42.8	48.0	38.4	88.1	43.2	42.2	119.2	30.4	48.2	37.7	87.2	53.8	58.2	98.3	120.0	77.3	95.8	35.8	42.4	147.8	95.6	71.6	18.9	56.5	94.4	91.7	76.3	41.7	54.7	65.0	97.3	50.5	75.5	66.4	58.7	50.1	20.8	130.4	45.2	38.0	116.2	89.9	93.6	95.3	187.0	100.1	108.5	46.6	96.5	109.4	58.8	110.2	101.6	35.4	44.1	37.9	124.6	115.0	49.9	101.9	24.8	49.7	113.0	29.6	31.6	96.8	41.5	94.3	71.7	59.5	48.2	45.4	60.6	62.9	112.3	93.2	63.3	84.4	154.2	41.4	98.9	111.5	84.4	69.2	91.5	77.3	80.5	66.9	72.4	112.0	89.5	66.2	63.2	43.0	93.0	58.0	97.9	84.3	86.7	84.3	86.0	89.4	91.2	84.4	89.0	85.1	84.1	86.2	83.8	88.1	87.2	56.6	32.1	21.9	10.7	36.1	31.7	49.0	73.1	44.9	54.7	58.8	81.0	56.8	40.0	37.4	46.0	25.0	66.9	40.6	24.0	80.3	70.0	21.0	28.3	52.9	46.4	55.7	35.7	12.2	46.6	33.2	58.5	31.6	26.6	51.4	89.6	59.3	49.9	75.1	67.3	16.0	36.4	63.1	49.1	47.7	42.2	57.2	44.3	51.6	3.7	97.0	94.7	44.3	13.6	23.4	40.0	32.0	60.2	45.4	38.3	34.5	151.7	28.1	47.5	39.5	46.5	164.9	56.6	31.3	42.6	33.8	45.6	38.7	92.5	39.3	41.9
CUL2		ENSG00000108094	"Cullin 2"	Q13617	10	35008551-35090642	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 319.6;Late spermatids: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002677, HPA024578"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB002677: , HPA024578: AB_1847338"	"unprognostic (8.11e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (8.24e-6)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (2.26e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.29e-1)"	15.3	13.3	10.5	16.2	11.7	20.1	15.5	11.9	13.1	13.0	9.8	14.7	14.5	14.8	10.4	16.8	11.0	12.0	19.2	12.2	12.2	14.3	21.0	13.4	19.8	10.8	11.2	12.7	13.4	22.1	8.8	18.8	11.4	15.3	15.2	13.2	11.5	15.7	45.2	13.4	13.9	19.1	11.5	15.0	14.0	35.8	12.3	18.2	16.2	37.6	20.8	17.0	10.1	12.2	50.4	29.2	37.7	32.5	42.0	46.0	39.8	57.8	32.1	56.1	56.2	38.7	47.0	39.9	31.0	61.6	41.1	45.3	55.4	53.4	63.9	46.9	35.9	51.8	29.0	34.8	46.0	28.6	32.6	44.5	43.7	61.6	21.4	43.3	63.6	41.5	60.5	35.2	62.2	34.4	47.7	15.9	13.8	34.4	117.3	39.4	61.0	25.0	51.3	38.9	18.4	24.4	32.4	40.3	47.0	41.6	30.7	32.4	58.6	34.5	38.3	59.6	38.4	14.7	21.2	47.4	66.4	63.2	24.8	12.8	9.9	11.6	12.3	14.9	17.4	10.9	13.5	14.6	12.6	12.6	16.1	15.2	4.8	13.3	15.3	5.7	17.8	8.5	10.5	11.7	11.9	13.1	12.2	12.2	10.8	11.2	11.4	11.5	12.3	12.2	24.8	22.4	12.6	21.9	23.0	12.0	8.6	13.1	9.6	13.1	12.0	12.4	26.4	5.7	20.7	9.2	10.4	24.7	27.8	9.9	15.6	18.4	319.6	17.5	25.4	22.3	10.7	9.4	39.7	17.8	20.1	15.7	9.2	20.5	20.3	19.2	16.4	18.2	20.1	23.5	35.6	10.6	14.2	17.2	12.3	181.0	14.0	20.3	10.6	27.2	23.0	16.0	27.8	30.7	41.7	17.5	6.9	11.7	17.3	8.3	15.2	15.0	19.9	13.7	0.0	16.1	26.9	40.1	32.8	14.4	13.1	37.1	25.3	23.0	13.1	9.9
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120505920-120604074	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 106.9;Late spermatids: 169.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm		NA	NA		18000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868"	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	18.7	20.5	15.3	14.4	16.5	9.8	20.0	18.2	19.3	24.6	15.7	20.0	12.3	18.7	27.3	23.4	19.6	15.5	15.5	16.0	19.2	18.1	19.5	14.5	20.5	14.4	16.4	25.2	17.0	24.2	26.9	15.5	15.7	18.2	13.5	19.9	15.1	22.5	10.0	15.2	15.4	15.6	13.7	17.7	15.5	28.0	16.2	25.3	15.8	12.5	21.8	18.2	20.3	16.1	41.9	37.3	28.7	31.4	129.5	57.0	22.4	89.8	104.1	71.3	69.4	30.4	110.6	40.1	35.5	206.8	127.7	29.9	61.1	27.7	84.8	26.1	26.6	20.5	42.1	25.9	50.6	22.6	28.1	65.6	22.2	45.1	37.5	134.8	133.2	22.6	33.6	31.7	78.4	24.5	30.7	19.0	45.4	52.6	39.5	23.4	27.1	43.4	23.2	19.5	32.9	27.4	74.2	36.8	36.5	35.0	28.8	20.9	177.6	57.1	30.5	76.3	88.6	21.2	50.0	52.2	59.9	28.2	55.2	6.6	3.8	8.1	5.6	3.1	6.1	5.7	5.2	5.2	4.4	4.4	6.0	6.2	14.4	4.4	2.4	7.0	6.9	4.1	15.3	16.5	18.2	19.3	16.0	19.2	14.4	16.4	15.7	13.7	16.2	16.1	18.7	22.4	14.4	11.8	15.5	15.2	9.6	12.9	12.5	15.7	17.3	14.7	14.6	8.6	11.7	14.7	14.6	10.1	19.9	14.7	13.7	10.1	106.9	12.4	15.6	18.2	24.6	13.3	18.4	8.9	25.0	21.2	14.3	15.8	14.0	20.5	40.7	16.4	17.5	25.2	20.9	13.9	8.2	30.5	13.9	169.3	21.5	18.4	12.4	14.0	17.6	15.0	7.2	23.1	21.0	16.7	7.3	21.4	18.9	9.5	11.0	14.4	17.8	14.1	13.1	17.0	16.6	12.6	13.9	23.0	13.8	10.0	14.1	21.7	12.7	9.5
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800441-38825355	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 28.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB014874: , HPA062997: AB_2684917"	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	13.3	12.6	7.9	9.9	8.9	62.2	12.3	8.5	9.7	11.6	8.8	11.1	10.3	10.3	5.4	12.5	11.9	7.6	9.0	8.2	8.5	11.6	16.2	13.0	12.6	8.7	8.5	11.2	12.6	7.2	11.0	6.7	8.5	11.7	6.1	8.6	10.9	4.5	12.7	17.4	13.1	6.8	8.0	16.8	11.6	18.4	8.5	14.2	11.3	7.1	9.0	10.9	11.5	9.4	11.2	13.1	8.2	14.1	10.9	7.1	8.3	11.5	7.9	12.0	11.0	8.4	11.7	12.7	7.8	9.2	9.2	25.3	8.2	7.7	14.5	12.0	8.7	9.9	14.9	10.4	10.8	25.2	15.6	8.4	12.3	11.8	9.7	12.7	9.8	13.5	15.5	15.0	10.2	6.2	26.4	25.6	8.5	8.2	6.4	20.0	12.1	11.4	12.0	10.7	9.3	8.2	10.7	7.6	13.8	12.2	12.0	19.8	10.2	10.8	9.9	14.3	17.9	11.9	9.3	18.8	11.4	12.1	10.9	18.0	4.1	10.6	4.6	3.9	4.0	4.5	4.3	4.8	3.5	6.0	4.9	3.7	28.7	5.9	8.1	1.7	2.9	3.0	7.9	8.9	8.5	9.7	8.2	8.5	8.7	8.5	8.5	8.0	8.5	9.4	50.7	57.7	69.5	10.4	54.2	63.9	61.2	45.9	39.9	37.2	40.8	31.2	18.3	21.5	46.3	23.9	83.4	35.1	60.6	56.6	29.4	27.5	118.4	63.8	51.7	45.3	41.8	34.5	10.0	23.6	35.2	43.8	52.0	100.2	58.9	23.8	37.9	27.2	28.6	26.9	7.9	51.9	26.4	27.0	37.9	31.9	37.3	38.2	26.6	5.6	38.7	30.1	41.2	5.5	8.1	29.3	70.9	34.6	43.2	51.4	61.5	27.2	41.9	43.4	39.5	57.0	45.7	93.9	33.6	30.5	76.7	79.1	54.6	28.8	32.6	72.4
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated cyclophilin"	Q6UX04	5	64768930-65018750	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 255.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	13.4	13.0	13.6	13.0	14.6	20.5	13.4	16.7	18.4	12.6	10.7	14.3	9.8	15.5	12.3	11.8	11.8	11.2	18.9	13.1	15.5	14.1	10.2	10.7	15.4	14.5	13.7	18.2	9.0	16.9	8.8	14.6	14.4	13.9	15.0	14.0	10.5	12.3	22.2	11.5	10.1	14.3	13.5	12.8	11.1	17.2	14.1	21.7	13.9	26.4	16.0	13.2	11.5	15.4	32.7	21.4	37.5	69.9	31.4	38.2	41.8	33.5	27.7	36.7	38.2	36.0	40.3	48.0	57.0	35.0	41.2	20.2	39.8	60.5	66.2	40.4	32.4	36.2	35.6	30.3	48.0	38.3	23.5	25.6	45.7	46.3	58.3	32.3	39.4	53.9	35.8	30.8	36.8	32.6	53.5	34.7	30.4	16.9	25.6	49.0	50.4	50.3	35.0	28.0	44.4	19.6	40.8	16.4	39.7	35.5	35.9	55.5	32.9	21.4	37.8	34.6	54.2	23.9	33.1	46.5	40.1	65.9	38.8	13.2	13.1	9.6	13.6	13.2	16.8	17.5	15.3	17.4	16.9	13.2	16.2	16.9	2.7	20.4	10.2	13.8	18.0	10.4	13.6	14.6	16.7	18.4	13.1	15.5	14.5	13.7	14.4	13.5	14.1	15.4	24.2	9.6	26.2	64.3	26.0	16.4	27.7	37.5	13.6	31.4	17.4	20.3	63.6	18.6	23.2	14.7	14.6	44.0	16.8	11.6	21.5	44.1	255.6	21.0	27.2	27.2	29.9	37.8	114.1	33.1	54.5	25.1	13.7	20.2	19.6	40.7	16.4	11.4	33.0	20.2	110.3	17.0	40.7	17.1	15.2	57.9	38.5	22.3	14.2	61.8	33.6	34.2	36.0	103.0	103.2	40.4	16.0	36.1	21.0	22.1	13.3	24.4	28.6	51.3	32.9	31.3	33.6	74.2	28.3	20.6	20.0	30.8	26.2	30.7	28.6	23.8
CXADR	CAR	ENSG00000154639	"CXADR Ig-like cell adhesion molecule"	P78310	21	17513043-17593579	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4"					"Low region specificity"	"Detected in all"			"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted - unknown location"	NA	NA		18000	"Cluster 17: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	3.6	2.9	7.0	2.8	8.7	2.6	9.8	6.6	10.8	7.7	22.8	22.5	42.3	5.3	15.2	14.5	10.6	18.3	9.3	8.9	7.1	8.3	49.3	13.6	0.7	10.4	6.8	0.4	15.8	6.8	4.7	0.3	9.3	15.1	25.6	4.9	15.4	14.2	0.4	53.4	42.6	3.3	9.7	2.4	30.9	12.5	7.3	1.5	22.1	0.0	4.1	25.6	10.9	17.7	16.8	9.0	44.6	0.1	0.0	0.0	26.7	0.2	0.2	0.7	2.7	93.4	14.6	6.2	19.7	0.0	13.3	28.1	22.8	6.2	1.0	9.3	19.0	0.1	24.1	63.0	2.9	1.8	0.1	0.0	24.6	1.3	0.4	10.8	9.0	5.5	0.3	0.4	0.0	1.1	3.7	0.1	109.1	15.2	0.0	0.1	15.2	12.5	38.7	104.4	18.5	12.3	10.9	12.6	6.7	45.8	25.4	0.3	0.5	0.2	25.8	0.4	6.6	4.5	7.7	0.4	3.6	0.1	0.6	1.0	0.1	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.6	0.2	0.3	0.2	0.0	0.0	0.1	0.2	7.0	8.7	6.6	10.8	8.9	7.1	10.4	6.8	9.3	9.7	7.3	17.7	0.2	141.1	79.0	2.6	1.0	323.4	172.7	110.6	132.6	16.9	58.6	28.2	29.8	161.5	106.6	103.0	27.1	0.8	0.3	238.4	5.9	130.0	5.3	118.9	8.3	4.8	80.8	9.9	60.4	93.7	0.2	8.6	94.3	128.9	5.7	1.1	47.8	127.7	0.6	0.0	43.0	107.5	81.4	22.9	13.1	7.7	2.1	3.3	23.2	40.3	0.7	13.4	0.0	78.9	161.4	93.4	155.3	0.0	1.6	125.1	263.0	4.0	85.6	11.2	6.6	0.2	5.3	6.4	24.5	117.0	343.8	0.7	4.3	0.5	107.0	202.7
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50287839	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	18.1	26.7	24.4	22.8	25.4	45.9	19.3	29.8	30.5	28.0	25.9	23.6	27.3	23.3	10.3	23.6	24.9	17.5	19.9	24.6	24.6	25.5	24.5	19.2	34.3	24.6	24.5	30.0	38.7	20.3	21.0	16.0	25.2	24.4	15.9	13.6	32.4	21.4	20.2	29.5	23.5	14.9	22.8	29.6	25.7	22.8	25.0	30.7	23.2	13.1	21.1	25.6	23.7	26.3	24.6	31.9	33.4	46.9	28.9	16.2	46.9	34.3	28.4	38.5	32.1	21.6	19.6	60.2	17.6	22.0	18.5	44.6	51.6	37.0	21.7	51.9	33.0	57.9	42.3	39.5	19.6	126.4	68.7	19.5	32.9	38.0	51.0	26.0	25.0	58.8	29.9	63.8	27.3	37.7	71.6	67.7	47.8	16.9	22.4	74.5	26.9	56.5	26.8	13.9	48.4	47.2	18.0	17.8	21.6	21.2	22.9	56.9	29.2	45.1	28.4	18.4	29.6	119.1	87.7	52.5	28.4	58.6	35.5	24.7	18.8	34.0	24.0	22.0	25.0	26.9	21.6	23.6	21.9	27.5	23.1	18.9	8.1	22.6	18.8	15.5	26.4	20.6	24.4	25.4	29.8	30.5	24.6	24.6	24.6	24.5	25.2	22.8	25.0	26.3	18.1	19.2	27.4	21.9	27.8	26.8	13.1	21.7	21.1	15.3	20.2	17.4	7.3	18.6	23.8	18.4	14.6	34.5	23.7	31.4	13.7	19.4	13.8	20.9	13.8	18.3	35.3	14.9	10.2	21.8	39.2	16.6	33.1	17.6	8.2	20.5	16.8	15.3	22.0	8.4	8.7	25.0	26.4	20.2	17.2	9.8	19.9	21.0	8.8	7.5	21.3	19.3	43.3	9.5	9.4	21.8	26.1	19.5	41.5	13.3	26.5	14.9	21.4	13.5	6.6	19.5	16.9	49.4	22.1	24.5	30.1	37.1	27.7	18.3	26.5	12.0
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 889.6;liver: 2472.0"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	309.5	109.6	38.4	31.2	39.7	25.3	253.5	42.2	45.2	86.0	37.6	146.5	438.2	44.9	176.2	78.1	81.9	301.2	84.8	37.5	38.8	889.6	2472.0	356.6	43.7	43.1	39.7	223.9	461.3	236.0	58.5	81.8	41.9	95.9	103.4	10.3	59.1	122.8	41.4	118.4	381.7	46.7	40.8	75.6	194.8	57.9	40.0	51.6	42.5	42.1	35.2	155.5	68.3	43.5	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	38.4	39.7	42.2	45.2	37.5	38.8	43.1	39.7	41.9	40.8	40.0	43.5	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	2.1	4.4	1.6	1.4	1.8	2.3	2.5	1.7	2.0	2.4	2.7	2.5	2.7	2.7	2.5	2.3	2.8	2.2	3.4	1.7	1.2	2.5	2.9	1.8	2.6	1.4	1.4	4.4	4.2	2.9	3.7	1.6	1.4	2.4	2.8	2.7	3.7	1.7	4.1	3.8	2.1	2.5	1.2	3.1	3.1	1.4	1.5	1.7	3.1	4.1	2.6	2.0	1.9	1.8	3.6	4.7	6.3	6.6	5.0	4.8	2.2	2.8	4.0	5.3	5.7	4.4	3.9	6.0	3.2	1.9	12.1	3.3	10.1	2.9	6.0	6.8	4.1	6.8	8.0	4.7	3.8	5.8	3.4	2.6	3.8	6.3	2.8	3.7	4.7	5.3	7.5	2.8	3.9	4.3	5.9	3.2	6.4	4.1	3.7	9.3	7.8	5.6	2.4	4.0	9.3	4.6	1.9	6.3	5.7	5.1	4.4	4.4	2.1	4.0	3.3	6.0	5.0	4.3	7.1	8.5	4.5	12.2	6.3	0.7	0.4	0.4	0.2	0.9	0.1	0.2	0.3	0.1	0.4	0.3	0.2	0.2	0.5	0.8	0.2	0.4	0.1	0.3	1.6	1.8	1.7	2.0	1.7	1.2	1.4	1.4	1.4	1.2	1.5	1.8	1.6	0.0	7.2	1.3	1.3	0.1	1.1	0.9	0.0	4.0	2.3	2.4	5.1	2.8	3.0	3.7	4.2	1.9	0.4	1.1	7.9	3.0	0.1	3.6	2.0	6.1	2.4	6.1	2.4	4.2	2.3	2.4	1.1	2.1	2.5	4.8	3.9	2.9	5.3	0.0	2.2	1.2	4.1	1.6	0.4	1.0	1.5	1.2	0.0	2.8	1.2	1.9	4.1	2.5	3.1	1.4	0.8	1.9	2.0	0.8	1.4	2.7	5.9	4.0	0.0	2.6	1.4	1.2	5.1	0.8	0.9	0.3	1.6	2.9	2.3	0.9
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25118656-25125260	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 799.8"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		170000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	86.0	115.6	65.8	89.2	70.4	85.0	59.2	79.8	101.7	45.3	87.6	263.6	150.1	42.3	41.5	105.9	43.0	52.9	476.8	72.1	82.8	174.6	115.7	54.3	63.8	71.0	72.9	48.1	38.5	226.2	57.0	43.0	69.4	54.3	238.8	153.9	58.0	60.1	483.7	47.6	120.1	91.1	70.2	48.0	108.1	61.1	83.4	74.0	74.6	799.8	89.4	119.8	60.1	71.7	336.4	185.1	195.0	273.7	108.7	83.1	199.6	314.4	128.0	229.2	264.5	307.4	222.2	383.8	152.9	138.5	678.3	385.8	396.5	295.0	401.2	115.0	179.1	318.6	208.9	218.7	170.2	739.0	271.1	111.2	257.5	230.9	492.9	99.4	209.5	232.2	597.1	397.9	246.0	155.1	408.6	284.4	365.1	746.3	343.0	282.1	235.3	364.5	360.9	322.5	392.6	190.3	164.5	689.0	267.9	338.7	359.5	436.6	152.8	209.3	383.3	329.8	591.8	401.4	507.3	860.5	281.0	526.4	606.7	65.3	56.2	42.8	68.0	106.0	82.5	102.5	62.2	71.6	105.7	90.0	58.6	70.2	8.2	73.3	96.8	81.5	87.5	83.0	65.8	70.4	79.8	101.7	72.1	82.8	71.0	72.9	69.4	70.2	83.4	71.7	244.3	83.3	118.6	42.4	337.6	689.8	818.3	698.5	237.9	163.1	210.6	179.6	770.0	144.4	314.2	183.9	77.2	192.6	304.4	827.5	1663.0	278.3	496.4	154.8	120.2	183.3	384.9	162.6	53.2	216.0	351.0	257.3	287.5	197.5	212.6	68.7	81.0	210.8	353.0	132.9	64.6	522.5	502.5	141.5	715.2	161.8	90.1	329.2	590.5	16.9	245.8	220.9	197.8	17.1	24.2	303.8	570.5	93.6	358.7	551.9	392.8	638.6	146.1	195.2	138.1	294.7	962.3	423.1	211.1	402.7	715.2	349.3	349.7	146.9	600.2	884.1
CYHR1	"CHRP, KIAA0496, MGC13010"	ENSG00000187954	"Cysteine and histidine rich 1"	Q6ZMK1	8	144449582-144465667	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053653, HPA059543"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA053653: AB_2682219, HPA059543: AB_2684056"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.58e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.54e-2)"	33.6	57.9	61.2	9.2	60.3	11.1	37.1	58.2	76.1	50.5	57.1	46.8	15.8	41.0	22.8	34.7	43.1	16.0	58.9	61.7	59.5	43.1	48.8	26.6	15.3	63.7	59.9	44.7	60.9	28.9	67.5	10.2	58.6	70.5	8.8	11.2	40.5	27.6	45.9	41.5	30.0	12.0	60.5	35.0	42.1	69.8	59.6	13.7	44.1	22.6	8.5	48.9	40.3	61.2	23.0	27.6	18.3	22.6	30.8	20.7	22.9	15.5	15.9	14.6	18.4	12.8	30.6	10.4	32.5	23.3	18.1	34.0	14.4	22.6	5.6	25.3	23.9	23.6	33.7	22.1	42.9	6.0	12.4	35.6	29.9	18.2	22.7	32.2	16.9	29.0	34.8	27.7	14.0	51.5	28.9	16.6	12.0	34.5	57.5	27.3	7.7	29.6	22.5	19.5	26.7	16.4	33.5	27.9	36.6	13.9	37.5	23.8	20.1	18.4	21.5	20.5	15.6	14.0	9.9	8.4	26.5	20.2	15.2	2.9	11.7	7.0	9.5	8.4	15.5	12.9	11.9	7.8	12.7	14.0	22.2	12.5	5.8	5.3	9.5	27.0	5.0	9.6	61.2	60.3	58.2	76.1	61.7	59.5	63.7	59.9	58.6	60.5	59.6	61.2	32.6	35.3	26.5	52.5	18.5	30.5	46.2	31.8	43.9	75.6	68.7	69.6	19.0	45.8	28.7	58.8	25.0	29.2	33.3	43.2	43.0	28.1	12.5	37.2	37.3	28.9	33.7	23.4	45.9	28.7	20.1	36.4	32.6	32.7	5.1	42.9	37.9	45.6	25.6	90.9	39.4	44.0	36.7	26.7	23.2	44.1	50.7	23.0	26.6	18.7	31.0	120.5	22.6	31.7	37.2	23.2	42.9	39.9	26.2	48.5	47.6	35.0	41.7	59.0	39.5	37.4	35.5	45.8	32.3	36.8	38.8	16.7	24.3	82.2	47.3	35.6
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127183832-127220313	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 4.1;skin 1: 5.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 5.4;Collecting duct cells: 3.7;Endometrial stromal cells: 5.8;Leydig cells: 7.5;Pancreatic endocrine cells: 7.6;Suprabasal keratinocytes: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.6;HDLM-2: 11.8;hTERT-RPE1: 12.5;TIME: 11.6;U-138 MG: 10.9;U-251 MG: 7.9"									"HPA062460, HPA068731"			Enhanced	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA062460: AB_2732683, HPA068731: AB_2686023"	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	0.6	0.5	0.8	0.4	0.2	0.3	0.3	0.8	0.7	4.1	0.6	1.2	0.3	0.6	0.4	1.6	0.6	0.7	0.9	0.5	1.0	0.2	0.2	0.2	0.3	0.6	2.4	0.2	0.2	0.0	0.1	0.1	0.4	0.9	0.3	0.1	0.3	0.7	0.4	5.1	0.6	0.2	0.3	0.2	0.3	0.3	2.7	0.0	0.1	0.1	0.8	1.8	2.5	0.8	1.3	3.4	1.9	0.1	0.1	0.0	0.1	0.4	3.2	1.8	0.8	0.1	2.8	0.1	0.1	2.0	1.3	7.6	2.7	1.4	0.6	11.8	1.4	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.1	12.5	0.4	0.3	0.0	0.2	2.1	0.2	0.3	0.1	4.0	0.0	1.0	0.1	0.2	0.0	5.9	1.0	0.1	0.7	4.9	0.0	0.0	1.5	0.1	0.2	11.6	10.9	2.0	5.3	7.9	0.1	0.1	0.0	0.1	0.1	0.9	0.5	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.8	0.2	0.8	0.7	0.5	1.0	0.6	2.4	0.4	0.3	2.7	0.8	0.2	0.0	0.6	0.0	0.2	1.8	1.2	2.1	0.0	0.0	1.5	0.3	0.5	0.0	5.4	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	5.8	0.5	0.0	0.0	0.6	0.2	0.0	2.4	0.0	0.5	0.0	0.2	0.4	0.1	0.0	0.0	0.7	0.0	2.0	0.0	1.9	0.1	7.5	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.2	7.6	0.0	0.4	0.0	1.6	0.0	0.0	0.2	0.0	0.0	1.5	1.0	0.1	0.7	0.0	7.2	0.0	0.2	0.0	0.0	2.9
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112153-92134803	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 204.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 169.7;Early spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 481.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	19.4	58.2	22.3	20.6	24.9	30.3	30.6	39.8	32.3	26.4	21.0	52.7	86.6	21.2	35.8	43.7	16.7	24.3	20.7	24.2	39.0	38.7	204.7	53.2	13.1	60.1	42.3	29.0	48.7	59.6	17.1	21.9	50.6	43.8	41.5	31.4	20.3	17.5	7.9	26.5	40.0	20.4	46.6	13.4	45.1	86.4	31.8	6.6	33.6	11.7	16.6	21.3	26.2	57.0	113.7	54.3	134.0	86.4	92.0	149.6	18.7	37.7	112.7	47.1	128.8	131.8	201.7	98.1	57.9	65.3	481.6	96.2	118.1	237.0	55.3	40.3	82.6	27.9	51.1	99.7	125.7	56.0	39.4	109.1	105.7	185.6	194.0	42.2	49.4	19.8	108.2	217.8	56.4	115.6	12.5	53.8	100.7	45.9	53.4	40.3	27.8	222.8	216.7	187.9	94.1	62.5	80.0	156.3	117.2	60.6	56.9	69.5	59.5	65.0	70.6	95.2	49.8	72.8	70.5	88.1	49.8	75.5	85.2	2.8	11.1	3.9	11.6	16.3	7.7	15.6	8.0	8.9	16.3	12.3	7.1	9.6	1.5	7.8	10.3	14.3	6.7	8.2	22.3	24.9	39.8	32.3	24.2	39.0	60.1	42.3	50.6	46.6	31.8	57.0	3.1	67.3	169.7	35.9	24.0	2.5	1.6	4.6	48.9	2.6	6.7	3.7	1.6	7.2	44.5	1.8	2.1	1.5	8.9	20.3	1.9	10.7	74.4	10.7	8.1	7.7	10.8	11.6	34.3	19.8	1.0	9.1	43.3	16.4	28.5	4.1	5.3	45.2	1.5	0.0	39.6	13.1	2.0	5.6	1.9	34.4	3.7	9.2	0.0	15.9	1.3	2.4	0.0	39.2	53.1	14.2	11.7	1.5	34.3	1.4	9.6	1.5	15.7	1.9	0.0	4.0	6.5	7.8	4.2	51.4	5.4	4.4	12.2	9.3	11.9	2.5
DAB1		ENSG00000173406	"DAB adaptor protein 1"	O75553	1	56994778-58546734	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8;intestine: 22.3;seminal vesicle: 10.0"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 460.3;Inhibitory neurons: 1170.3;Oligodendrocyte precursor cells: 814.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 54.0;HeLa: 18.6;NTERA-2: 23.4;RT4: 32.0;WM-115: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	2.0	1.7	4.3	0.4	5.3	0.0	0.3	16.8	8.8	1.6	0.0	0.8	15.8	0.5	0.4	0.6	1.6	0.7	1.8	10.6	5.4	0.3	7.7	0.4	0.2	2.1	3.9	1.2	0.4	0.0	0.2	0.0	2.0	3.9	0.3	5.4	0.9	10.0	0.1	0.1	22.3	0.3	2.3	0.2	1.0	0.4	5.1	0.1	0.3	0.1	0.1	1.2	0.9	1.9	0.0	0.0	10.6	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.1	23.4	0.0	0.0	6.0	0.0	0.2	0.0	32.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.6	0.1	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	4.3	5.3	16.8	8.8	10.6	5.4	2.1	3.9	2.0	2.3	5.1	1.9	0.7	0.0	0.0	30.0	0.1	0.0	0.1	0.1	0.0	23.7	0.1	0.3	3.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.6	8.2	0.6	0.3	0.0	0.0	460.3	0.0	0.0	0.4	4.6	12.8	0.0	0.0	0.7	5.1	0.1	21.9	1170.3	1.9	6.1	0.3	0.0	4.7	3.4	0.1	0.0	22.5	0.0	1.0	1.0	814.8	26.5	0.0	0.0	2.6	0.0	0.1	101.1	0.2	0.0	0.8	0.0	0.1	0.9	0.2	0.5	0.0	0.0	0.7	0.6	0.0	2.1	0.0
DAB2	DOC-2	ENSG00000153071	"DAB adaptor protein 2"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 179.1;placenta: 226.6"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1756.4;Proximal tubular cells: 1653.7;Syncytiotrophoblasts: 1324.5"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"plasmacytoid DC: 48.7"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 48.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.1;ASC TERT1: 234.5;fHDF/TERT166: 356.8;TIME: 211.1;U-138 MG: 237.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"		NA	NA		130000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: AB_2672814"	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	76.9	113.6	7.3	33.1	8.3	4.1	48.2	13.4	13.1	48.4	26.2	33.2	13.5	32.5	116.8	16.8	21.6	50.1	20.0	7.5	7.7	179.1	27.3	53.3	33.2	14.6	10.0	34.0	22.8	10.1	7.9	226.6	12.6	13.0	54.5	11.6	24.2	19.8	11.4	21.2	25.6	47.8	7.8	58.5	16.6	10.6	20.1	20.9	23.5	16.4	19.0	44.6	20.6	10.8	0.2	8.3	12.9	27.9	220.1	234.5	16.0	145.7	149.5	56.3	92.5	108.1	0.5	0.1	8.8	356.8	54.8	0.3	2.0	5.2	78.9	0.2	4.2	19.9	191.1	35.5	52.4	0.2	24.3	146.5	0.2	91.7	16.5	87.2	172.4	9.9	0.0	5.0	95.2	0.6	2.1	0.3	8.9	4.1	15.8	5.4	32.7	0.0	37.8	3.2	0.1	0.4	17.4	9.3	79.2	20.4	0.6	4.9	211.1	237.9	26.1	27.7	11.9	0.2	0.1	0.3	82.6	18.1	31.5	5.8	2.3	0.5	2.1	4.6	0.1	0.1	0.3	1.4	6.3	0.2	0.2	1.7	3.2	1.7	1.3	48.7	0.4	12.7	7.3	8.3	13.4	13.1	7.5	7.7	14.6	10.0	12.6	7.8	20.1	10.8	100.2	38.5	42.2	0.0	14.5	14.5	1.2	15.3	3.4	1.1	38.3	26.7	55.1	70.1	9.9	95.6	70.9	170.8	83.8	29.6	197.6	75.7	1.4	31.7	161.0	116.9	9.7	10.1	11.0	2.0	20.1	139.5	3.6	36.4	25.3	50.6	187.4	3.7	1756.4	8.4	2.8	7.6	2.0	175.2	77.9	4.5	122.4	287.4	12.4	92.8	10.9	81.5	63.8	27.2	0.3	6.5	10.2	64.3	1.4	7.0	33.8	1653.7	7.5	3.5	6.6	62.4	50.4	0.5	4.8	3.5	13.4	1324.5	13.4	104.8	27.5	1.3
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	57.0	63.6	32.5	54.7	34.9	66.7	66.2	33.6	38.8	43.3	32.5	55.7	58.7	46.0	52.3	54.5	41.9	38.6	88.1	36.1	37.5	63.1	88.2	44.6	69.3	36.1	35.8	38.1	69.3	49.4	42.4	41.2	38.9	50.7	61.4	71.9	53.3	49.4	129.9	60.1	47.6	53.2	32.1	51.3	59.1	42.3	37.1	80.8	48.9	89.4	78.6	58.4	45.3	41.6	144.9	91.9	73.5	116.7	105.9	133.0	180.0	118.8	124.8	119.4	103.8	170.7	172.4	204.1	235.0	97.3	76.5	143.1	110.3	103.7	129.8	128.6	80.4	124.7	80.5	156.5	144.5	173.3	106.4	112.1	145.8	152.2	199.4	93.3	119.2	185.2	274.5	141.2	125.6	192.0	152.6	200.9	130.1	225.2	146.9	124.2	92.1	218.9	142.5	136.0	84.9	150.4	113.9	331.9	211.6	135.1	206.4	279.8	102.8	100.5	106.1	126.0	202.6	152.9	245.9	235.3	100.2	151.6	132.7	65.4	110.5	61.6	110.1	134.2	179.0	141.5	155.8	133.9	152.0	121.1	192.5	167.5	47.8	136.0	128.0	99.1	173.1	162.1	32.5	34.9	33.6	38.8	36.1	37.5	36.1	35.8	38.9	32.1	37.1	41.6	31.8	44.8	43.6	34.0	59.2	54.9	67.2	94.2	52.9	28.2	54.6	43.8	106.2	51.5	68.3	16.5	20.9	76.2	45.0	33.2	66.5	79.8	19.0	44.9	40.5	38.1	25.7	63.8	52.7	78.6	98.5	41.3	35.7	38.7	62.1	34.9	33.2	57.4	77.8	13.5	57.4	41.9	59.0	59.4	62.9	15.3	32.3	53.0	35.6	30.9	83.7	22.2	55.6	26.7	47.1	73.8	30.8	25.2	52.4	81.7	41.7	78.0	61.2	46.4	13.1	33.7	45.1	48.3	29.3	51.1	63.1	141.6	66.4	73.3	62.5	73.5
DARS1	DARS	ENSG00000115866	"Aspartyl-tRNA synthetase 1"	P14868	2	135905881-135986100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 85.1;Cytotrophoblasts: 115.4;Extravillous trophoblasts: 157.9;Hofbauer cells: 94.2;Syncytiotrophoblasts: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		210000	"Cluster 30: Non-specific - Translation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	37.5	42.1	30.1	41.2	31.2	34.0	48.7	33.3	52.1	34.7	28.0	38.5	23.5	38.4	22.8	46.0	37.8	25.8	42.3	29.5	35.2	47.3	44.2	27.8	48.3	32.6	31.2	47.2	36.1	38.4	24.6	44.4	35.6	33.6	26.6	87.1	32.5	36.5	82.8	40.2	28.0	39.3	34.0	32.3	33.3	17.8	30.7	63.1	43.4	60.1	55.4	40.0	36.4	35.3	201.6	77.0	73.4	66.3	61.0	78.1	141.6	99.8	92.6	92.2	91.1	163.0	84.0	210.0	159.8	78.4	86.6	111.7	94.9	114.9	170.3	95.6	86.0	134.0	76.8	185.6	83.9	188.3	90.8	84.5	75.6	109.1	99.8	122.9	46.8	106.3	131.6	66.0	66.6	87.3	139.2	117.4	77.8	85.3	66.9	179.3	157.9	139.0	91.8	76.9	40.3	89.6	75.0	63.5	74.8	72.2	66.8	118.2	38.2	86.0	87.4	64.5	92.8	194.9	123.3	250.2	144.1	132.3	51.0	33.7	85.4	51.2	115.2	82.6	174.7	219.9	172.6	151.4	133.7	198.8	175.2	154.2	31.7	171.9	67.4	130.4	168.9	153.3	30.1	31.2	33.3	52.1	29.5	35.2	32.6	31.2	35.6	34.0	30.7	35.3	29.4	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	115.4	20.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	157.9	18.2	0.0	0.0	0.0	0.0	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	136.4	4.4	0.0	0.0	0.0
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	27.5	33.6	6.4	4.0	6.2	8.1	25.3	5.0	12.0	28.4	2.9	27.9	8.1	27.8	18.9	30.8	28.6	7.2	22.3	6.8	5.8	23.2	25.0	24.0	8.7	6.9	5.9	23.8	23.1	19.3	22.1	7.9	5.5	25.1	10.8	5.2	24.2	9.3	35.4	28.8	30.4	10.6	4.8	44.3	25.0	36.7	6.7	23.5	24.2	12.5	27.3	27.2	25.9	9.0	20.8	0.1	38.0	15.6	16.0	16.0	30.1	27.4	76.7	61.5	43.6	1.6	11.8	58.5	14.8	33.3	65.5	11.8	0.3	46.1	62.5	29.9	39.6	52.0	29.9	39.9	26.5	37.0	17.0	27.0	32.5	25.8	31.0	22.7	15.5	16.2	39.1	21.2	32.1	23.2	29.7	54.1	1.2	0.2	9.1	35.2	5.6	41.8	11.7	1.6	49.7	20.2	0.0	0.9	22.7	14.8	17.5	0.5	22.9	26.3	29.1	0.5	0.3	35.4	58.3	66.4	23.3	23.0	27.7	24.1	22.5	47.3	55.6	28.9	54.9	58.8	48.3	61.3	28.2	56.8	44.5	49.6	22.9	62.9	35.1	27.0	59.0	70.5	6.4	6.2	5.0	12.0	6.8	5.8	6.9	5.9	5.5	4.8	6.7	9.0	18.4	6.4	22.8	5.2	45.3	58.5	23.5	36.2	48.3	19.2	25.8	19.4	7.9	18.6	27.6	12.9	18.8	25.2	41.3	23.3	23.5	38.5	15.7	14.5	54.8	23.9	21.0	27.1	3.7	38.3	35.9	25.2	16.8	23.6	37.9	12.9	16.4	14.5	24.3	15.2	3.8	21.2	12.2	17.2	42.5	7.6	17.7	19.7	24.9	6.5	48.8	29.9	52.5	5.0	4.6	45.4	21.8	23.3	38.7	31.8	20.3	14.4	15.6	111.1	13.1	18.7	19.9	63.8	41.5	45.9	60.9	24.8	42.8	24.1	22.0	35.7
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		1600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	44.2	34.7	20.5	55.9	21.4	69.3	37.2	22.8	23.5	31.9	23.1	45.1	45.3	33.5	10.5	64.7	32.1	13.3	55.0	19.7	20.7	40.6	51.2	37.0	49.8	23.6	21.2	32.3	48.0	20.3	22.6	22.2	22.3	33.0	23.6	20.1	32.4	17.1	65.2	42.3	46.9	19.5	18.2	49.3	39.0	77.5	25.2	47.7	32.1	21.4	34.4	42.2	36.7	27.0	275.7	98.0	64.3	117.9	27.8	33.5	183.9	120.7	59.6	95.7	78.2	98.0	132.3	320.8	72.1	58.7	47.4	151.2	84.9	114.5	80.7	225.9	135.2	165.4	95.2	101.3	64.3	203.1	136.1	33.7	73.8	65.4	119.0	41.1	85.0	133.7	251.5	164.1	60.6	111.9	357.5	178.3	198.7	99.6	97.1	254.3	102.4	199.3	72.9	91.7	127.3	114.2	79.9	124.0	149.3	83.1	113.1	266.8	93.7	79.0	107.5	139.7	267.9	192.9	212.2	256.0	95.6	194.4	123.8	1.5	2.3	1.9	2.7	3.4	2.9	3.1	2.4	2.9	2.2	2.1	2.4	2.6	1.0	3.0	2.4	2.7	2.7	1.3	20.5	21.4	22.8	23.5	19.7	20.7	23.6	21.2	22.3	18.2	25.2	27.0	57.1	9.6	27.6	29.7	50.3	69.3	90.9	37.6	34.1	55.7	46.9	33.3	40.0	38.6	28.8	25.8	35.5	43.5	68.7	60.0	23.5	44.4	49.8	26.3	37.0	45.0	33.0	96.6	17.1	55.1	108.6	39.7	46.9	34.0	26.6	58.0	36.0	41.6	47.7	26.9	16.8	71.6	28.5	49.2	54.9	65.7	28.0	50.3	40.9	16.9	36.0	35.1	34.0	18.6	45.2	63.5	49.4	23.7	73.6	110.3	50.4	48.2	23.5	45.4	26.3	50.5	58.9	111.6	41.0	67.0	74.9	69.0	53.0	41.8	81.5	107.9
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 272.7;brain: 236.6"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Region enriched"	"Detected in many"	8	"pons: 236.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	272.7	0.1	1.0	0.2	0.2	0.1	0.0	0.8	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.3	0.5	0.3	0.2	1.3	36.1	0.8	2.3	9.8	29.4	0.4	4.3	0.0	1.4	1.4	236.6	0.4	0.0	0.1	0.6	0.2	0.1	0.2	0.6	0.0	0.0	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.3	0.2	9.8	29.4	236.6	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138160988-138174921	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	6.6	6.7	4.4	6.7	5.1	15.3	7.6	5.4	4.8	6.2	5.8	6.4	5.3	7.4	8.2	6.6	6.5	5.6	6.0	4.2	5.1	7.2	6.1	7.7	9.0	5.1	4.8	8.2	7.3	7.4	5.6	5.6	5.4	6.7	6.2	5.1	7.0	6.1	6.7	7.6	7.2	6.9	5.4	9.6	11.3	3.0	4.8	9.7	8.2	6.5	9.0	6.2	5.5	5.9	24.5	9.9	17.7	19.7	9.6	9.0	18.4	14.2	10.4	15.1	18.2	16.9	10.6	22.3	26.4	12.9	22.8	17.8	20.6	7.0	19.7	19.2	17.1	24.2	12.3	13.9	11.8	31.5	20.5	12.4	11.6	14.0	13.1	8.9	12.6	19.1	16.0	4.7	15.4	18.9	31.2	18.5	20.4	18.9	11.4	19.3	20.1	20.4	13.2	23.6	17.1	22.0	38.0	13.1	21.1	14.4	24.6	25.5	11.9	12.6	8.8	23.6	16.7	7.1	10.5	46.6	8.2	22.4	16.8	4.2	7.1	13.3	8.4	9.7	11.1	7.0	9.6	8.1	8.6	7.4	9.6	10.7	2.9	8.4	8.4	5.2	8.4	6.2	4.4	5.1	5.4	4.8	4.2	5.1	5.1	4.8	5.4	5.4	4.8	5.9	7.5	6.4	12.9	6.5	8.2	5.2	3.4	6.2	6.2	5.9	6.9	11.9	6.1	7.2	5.9	9.2	0.0	11.3	14.7	4.7	9.8	10.8	0.1	6.1	9.8	6.7	6.0	16.2	4.2	9.0	8.6	8.6	9.2	9.5	5.7	8.7	6.1	6.9	10.4	6.7	4.8	6.6	6.1	16.7	4.8	0.5	8.7	10.2	3.6	8.4	9.0	8.0	6.2	8.5	7.8	8.2	5.6	8.2	7.0	3.7	3.9	5.3	5.5	5.1	0.0	10.0	8.7	4.3	2.1	5.6	4.1	4.5	12.9	6.5	7.3	2.9
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 201.2;Hepatocytes: 156.0;Proximal enterocytes: 147.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA003583: AB_2667001, HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favorable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	15.4	41.6	21.5	13.4	21.7	39.5	17.1	19.7	23.0	15.4	19.9	24.5	29.3	17.1	23.2	29.8	15.6	13.6	38.1	22.3	19.9	35.8	107.2	17.5	15.6	21.0	20.3	23.1	59.7	28.2	25.6	9.2	19.8	23.6	16.6	17.6	25.9	17.5	62.3	20.1	37.5	11.7	19.2	28.9	34.3	16.5	22.0	19.0	26.4	50.0	16.1	20.3	16.2	21.1	12.5	18.3	12.3	10.9	10.7	8.8	16.6	9.1	10.7	16.0	19.5	12.0	21.3	19.4	10.3	12.2	13.3	16.1	15.8	9.6	7.4	23.1	9.5	15.6	19.7	67.3	14.3	27.7	31.0	5.3	23.1	6.7	16.7	13.1	12.3	31.6	15.0	23.0	9.7	39.2	23.7	28.5	7.2	35.0	17.0	25.1	16.0	28.2	12.2	28.1	22.1	17.0	5.3	29.9	13.4	12.7	15.4	19.6	5.1	12.5	10.0	13.6	13.2	38.6	36.2	25.3	6.0	17.7	10.9	14.0	13.8	20.5	13.8	15.8	11.7	12.1	12.5	13.5	17.1	11.5	12.2	11.4	11.7	23.0	13.9	8.6	16.7	15.2	21.5	21.7	19.7	23.0	22.3	19.9	21.0	20.3	19.8	19.2	22.0	21.1	18.2	28.9	45.4	10.4	30.5	8.8	22.2	18.7	31.3	34.1	34.8	20.7	41.2	44.3	23.9	38.6	47.9	34.6	34.2	76.1	46.9	41.6	19.3	22.0	10.8	15.2	28.9	201.2	9.2	46.2	31.5	14.1	29.0	22.5	12.6	26.5	22.1	156.0	37.4	16.8	6.9	40.7	20.3	27.0	12.8	26.6	9.0	24.1	17.8	9.4	39.2	38.8	55.6	7.1	9.7	31.9	34.6	14.7	26.6	25.0	147.9	56.0	22.3	29.4	26.3	15.9	14.5	23.7	12.4	32.6	11.4	50.5	31.2	60.7	49.0	22.7
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	52.8	164.8	30.2	44.0	32.5	47.2	59.0	29.5	30.2	61.3	42.5	50.0	53.2	48.0	79.7	49.7	78.3	39.9	65.1	31.9	36.4	64.8	55.9	43.1	47.0	31.8	33.5	89.3	42.5	232.1	44.5	129.7	36.9	56.6	52.3	162.5	54.1	70.9	133.1	60.6	49.9	61.9	31.9	41.9	44.4	69.1	33.5	81.2	65.0	125.1	66.6	58.6	39.2	36.1	160.3	168.1	159.0	142.2	151.4	139.2	237.8	140.9	193.6	174.4	129.2	188.7	130.7	237.6	126.8	203.4	107.4	141.4	245.5	177.5	188.0	115.7	131.3	128.0	144.3	192.0	109.4	182.7	112.6	169.1	121.7	174.0	146.2	123.5	195.7	86.0	278.4	119.9	158.9	194.7	238.4	77.4	214.5	104.3	146.3	197.9	198.5	254.3	119.7	177.3	140.3	143.0	154.6	183.8	145.9	144.8	226.0	85.6	150.9	120.9	113.6	138.2	106.4	139.5	157.0	194.7	134.9	103.7	121.1	38.4	43.6	36.5	46.7	47.1	61.1	35.8	42.0	47.3	60.5	30.5	37.8	43.3	4.6	46.4	45.3	34.2	49.6	54.6	30.2	32.5	29.5	30.2	31.9	36.4	31.8	33.5	36.9	31.9	33.5	36.1	34.2	28.9	69.9	46.4	48.8	52.6	53.6	61.1	51.2	87.0	52.0	39.9	105.6	34.3	54.5	53.3	352.3	283.5	57.5	45.0	17.6	43.9	15.7	46.6	40.8	48.1	74.2	102.3	27.8	42.4	130.1	50.6	46.4	51.3	30.9	102.7	45.0	67.4	75.5	87.5	31.6	55.4	44.7	45.3	33.5	18.8	85.1	38.3	42.7	30.0	61.1	64.4	71.1	24.1	31.0	52.6	36.4	62.1	65.4	55.7	63.2	46.7	64.4	451.4	32.9	51.5	44.5	114.0	120.9	52.3	59.8	389.4	46.0	303.8	60.0	57.1
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617458-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 82.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	10.8	6.0	3.4	6.3	3.9	10.7	10.2	4.3	4.6	8.1	4.6	6.4	7.9	8.7	6.6	15.8	6.0	5.1	6.8	4.1	3.7	7.9	21.8	7.8	8.6	4.0	3.8	5.8	7.0	10.2	3.9	7.4	4.1	10.0	6.6	10.2	10.2	5.3	26.8	10.9	7.1	6.4	3.5	6.9	5.8	3.0	3.8	7.7	6.4	11.7	9.7	7.9	10.4	5.3	11.4	6.5	11.6	12.1	15.5	12.2	11.2	7.0	5.3	6.0	5.2	16.1	10.1	28.4	8.0	7.7	4.4	11.8	25.4	11.3	10.1	13.2	17.0	22.3	10.7	15.8	6.6	29.8	10.8	12.1	13.1	11.3	12.0	7.5	12.4	18.2	36.5	10.2	7.5	7.6	17.3	9.8	11.1	16.8	5.3	16.1	16.3	16.8	8.5	9.4	14.1	7.8	13.1	20.9	19.2	12.9	10.9	7.7	10.9	8.6	7.4	9.8	8.6	9.5	12.4	22.3	6.7	21.4	6.9	0.3	0.8	0.1	1.1	0.7	0.9	0.8	0.8	0.8	0.8	1.1	0.8	1.1	0.2	0.7	0.5	1.8	0.8	0.5	3.4	3.9	4.3	4.6	4.1	3.7	4.0	3.8	4.1	3.5	3.8	5.3	8.9	9.6	21.0	6.2	18.1	15.3	14.0	11.7	23.3	25.6	23.4	11.6	28.0	15.7	24.6	3.7	14.6	22.6	22.8	16.5	1.9	7.7	1.7	40.7	25.2	17.5	15.0	82.9	12.8	7.7	19.2	16.7	14.8	39.1	1.3	13.7	15.7	61.7	15.1	35.3	15.1	21.3	22.4	27.1	6.8	1.0	12.8	17.6	16.0	10.3	16.8	8.2	6.2	8.5	17.6	16.4	9.4	6.8	10.9	24.9	28.1	20.5	33.0	41.3	6.6	14.7	11.3	11.1	9.1	38.6	20.2	40.2	13.6	8.6	20.4	13.8
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.4;Muller glia cells: 8.2;Oligodendrocytes: 13.3;Paneth cells: 8.5;Proximal enterocytes: 8.5;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.3;myeloid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.5;RPMI-8226: 15.9;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	1.9	8.2	4.5	0.8	7.0	1.4	2.5	5.0	4.8	1.9	4.3	2.3	7.4	2.1	2.7	0.8	4.9	2.9	18.4	4.4	4.5	10.6	11.1	3.2	1.0	5.4	4.9	0.3	2.6	5.3	1.2	1.6	5.3	2.0	3.2	2.4	4.2	2.3	10.9	0.4	7.0	2.2	4.8	2.1	1.1	0.1	4.7	0.4	1.3	7.4	0.2	1.6	0.9	5.9	0.2	0.0	0.0	0.1	0.0	0.2	1.1	0.1	5.4	1.3	0.9	0.0	0.1	0.0	0.7	0.7	11.5	0.0	0.0	0.0	2.3	5.0	0.0	5.1	0.1	4.3	1.6	0.0	0.0	0.1	0.0	2.7	0.1	2.3	0.0	0.0	0.0	1.9	4.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.0	15.9	0.0	4.9	0.1	0.2	0.0	0.5	0.6	0.0	0.7	1.1	0.9	1.0	0.1	0.0	2.6	0.1	0.4	0.0	2.0	17.4	0.0	0.0	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	1.1	4.5	7.0	5.0	4.8	4.4	4.5	5.4	4.9	5.3	4.8	4.7	5.9	1.1	0.0	0.0	4.9	0.0	0.0	0.7	0.7	0.6	0.0	1.4	1.1	17.4	0.0	0.4	0.0	2.1	0.2	0.1	1.8	3.9	4.5	0.3	3.6	0.5	0.7	4.2	0.0	0.0	2.2	0.2	0.6	0.0	0.9	0.0	0.1	2.5	4.9	1.7	0.0	0.1	6.0	0.0	3.1	0.4	0.0	0.3	1.6	0.0	0.0	2.0	8.2	0.0	3.5	13.3	0.8	8.5	0.0	0.0	0.4	8.5	12.9	2.2	0.2	0.0	2.1	1.2	0.0	0.0	0.2	0.0	0.0	0.2	0.3	5.0	0.5
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814691-117832377	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 376.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	25.3	21.4	14.9	30.2	15.9	21.8	32.7	16.1	18.0	23.4	15.1	28.3	22.4	30.0	22.9	24.8	23.6	22.2	21.2	14.1	15.9	27.0	35.2	24.8	41.1	15.7	15.2	25.5	21.1	21.4	10.8	26.2	16.1	23.2	31.0	19.4	19.3	23.0	18.6	22.9	23.4	26.3	16.6	32.3	22.8	20.6	15.1	34.5	30.2	18.3	41.7	33.2	17.3	19.0	94.0	41.9	61.3	55.5	35.5	31.9	101.0	54.7	43.0	73.7	64.6	104.2	60.6	137.8	85.9	45.6	68.0	71.1	120.3	70.7	108.0	70.6	83.9	132.0	36.9	105.1	49.5	178.4	66.0	33.4	63.9	93.7	94.3	37.6	44.9	70.3	146.5	58.4	57.1	58.6	98.2	92.6	154.4	79.1	62.3	84.4	95.8	121.3	48.8	55.2	58.8	99.3	62.7	69.2	73.4	62.1	43.9	96.7	34.9	65.6	96.5	46.8	99.5	66.3	87.9	376.0	48.2	82.9	30.1	11.7	23.0	16.3	24.9	28.9	32.0	37.4	29.8	28.9	20.7	30.3	35.6	31.7	5.8	29.7	33.1	33.7	25.7	32.1	14.9	15.9	16.1	18.0	14.1	15.9	15.7	15.2	16.1	16.6	15.1	19.0	144.4	96.1	62.5	24.8	153.9	192.7	114.4	149.4	100.2	150.5	82.8	94.5	50.4	101.5	103.8	121.4	83.4	110.3	140.6	69.0	117.4	125.4	17.1	92.2	125.1	109.1	56.9	76.4	24.3	115.2	120.9	98.2	63.2	102.8	110.3	71.8	107.1	195.6	87.9	82.4	28.0	108.0	109.9	104.8	100.8	17.7	106.6	100.6	92.5	20.6	117.1	70.3	135.9	26.7	39.1	130.0	68.8	103.8	103.3	118.1	53.3	186.5	90.6	132.9	65.7	158.7	110.1	138.6	129.9	81.4	160.5	88.8	143.2	67.4	114.6	65.3
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	43.5	32.6	27.4	30.5	29.4	37.3	42.7	26.2	29.7	38.5	21.6	42.9	31.3	42.4	39.0	32.6	44.0	30.2	35.3	25.8	30.8	30.0	34.8	35.8	40.6	29.9	30.1	54.7	54.4	39.9	29.2	36.5	28.9	39.3	36.4	39.3	47.3	40.7	59.2	39.6	33.5	43.1	29.0	37.2	37.1	39.8	30.7	40.1	34.2	42.7	47.1	39.5	30.6	26.5	87.4	89.9	79.2	81.3	78.2	62.7	85.0	83.4	74.6	74.7	72.9	84.7	55.9	120.8	32.0	94.3	62.4	68.2	90.3	74.3	98.5	35.9	59.1	91.0	92.0	104.2	77.1	106.9	59.7	80.3	69.2	67.9	81.6	63.5	75.2	61.6	103.2	49.7	77.0	71.3	102.8	59.3	75.8	69.4	47.4	88.7	135.8	62.3	68.2	101.3	49.5	93.9	63.2	112.3	74.1	110.7	77.2	87.1	80.5	109.9	67.0	45.3	99.4	55.6	47.9	109.5	56.4	58.1	58.9	1.9	2.2	6.9	3.7	2.2	4.2	2.8	3.0	3.7	2.9	5.3	3.6	3.7	2.0	4.5	4.3	1.8	2.1	1.9	27.4	29.4	26.2	29.7	25.8	30.8	29.9	30.1	28.9	29.0	30.7	26.5	41.5	80.1	60.4	24.2	34.7	31.2	24.4	24.5	48.9	40.9	37.0	38.0	49.5	30.0	49.0	36.8	37.5	33.3	29.3	27.0	13.7	30.4	9.2	64.9	68.0	41.8	40.7	33.0	33.6	27.1	24.4	42.2	32.1	72.0	30.4	82.1	30.0	34.5	23.2	50.5	30.3	37.8	28.5	32.7	26.1	12.7	48.7	29.6	14.2	21.5	55.5	46.6	32.0	18.1	26.7	41.1	25.3	50.4	36.7	39.0	26.5	23.5	65.5	46.7	39.5	63.2	51.8	68.5	63.1	52.7	29.7	27.4	32.7	71.3	33.8	32.4
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620943	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	11.0	10.3	11.1	10.4	11.1	20.3	11.1	13.2	19.5	12.1	11.2	9.7	7.6	9.6	7.7	11.1	12.2	5.6	6.9	10.7	11.4	12.3	14.7	8.4	13.8	11.5	10.8	13.1	15.4	6.5	11.3	7.7	11.6	11.4	8.8	12.6	9.5	6.3	6.4	13.6	10.8	7.1	9.9	14.9	9.7	9.6	11.3	10.3	9.1	3.4	10.7	10.7	11.1	12.9	20.5	28.4	21.4	21.7	18.0	14.2	32.2	24.8	9.1	21.6	14.8	32.5	14.6	30.2	19.3	10.9	19.5	24.4	32.8	18.4	25.1	22.8	29.7	40.8	34.0	24.3	13.7	50.7	30.7	12.0	19.2	25.7	29.5	16.7	15.8	23.9	42.3	15.5	15.5	21.1	50.0	68.2	33.3	23.6	27.9	37.1	22.7	19.7	15.2	34.8	25.3	21.0	20.2	25.9	35.0	17.7	46.2	32.4	16.3	18.6	24.5	30.6	31.2	28.4	37.4	54.2	17.7	35.8	32.4	3.4	9.1	7.8	11.4	10.6	12.4	13.9	11.1	12.3	7.7	10.7	14.9	13.9	5.2	13.3	6.4	13.2	9.9	8.6	11.1	11.1	13.2	19.5	10.7	11.4	11.5	10.8	11.6	9.9	11.3	12.9	13.3	22.4	13.9	15.7	14.2	11.0	13.4	13.9	9.6	20.2	9.6	14.9	2.5	8.6	11.7	7.3	22.9	13.8	26.3	5.9	7.9	12.2	45.1	9.0	18.4	12.0	7.2	19.6	13.4	12.0	17.4	12.0	11.2	7.2	25.3	16.4	7.1	9.4	14.3	15.2	16.5	15.9	10.2	7.1	7.4	74.8	17.1	9.0	7.2	12.2	9.9	16.1	15.5	6.6	14.3	13.3	7.6	14.7	13.8	13.3	5.9	6.3	12.3	28.1	6.6	10.5	14.1	21.9	18.6	12.5	16.9	7.7	14.2	14.0	10.2	11.0
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.7;skeletal muscle: 41.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 11.8;U-266/70: 25.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	0.9	0.5	0.8	0.3	0.8	1.0	1.9	0.9	0.9	4.2	2.2	0.6	0.7	1.5	0.8	17.7	0.9	1.2	1.1	1.1	0.4	0.6	2.0	1.5	0.4	0.6	0.6	1.1	1.2	1.7	0.6	0.1	0.7	1.4	0.6	1.5	2.7	1.4	41.6	12.4	0.6	1.1	0.3	0.4	0.9	5.5	0.6	0.4	1.4	1.7	3.4	2.6	7.0	0.5	2.1	0.0	0.1	1.4	1.7	1.8	0.4	0.6	1.1	0.7	1.1	0.3	0.0	0.1	0.9	4.1	1.4	7.4	1.4	4.6	0.7	0.1	1.8	1.2	0.4	0.1	0.5	0.0	1.8	1.8	4.4	2.7	2.3	0.1	0.2	0.5	0.2	0.3	2.4	6.0	0.2	0.1	0.9	0.0	1.1	0.0	6.2	0.1	0.1	5.7	0.0	0.0	4.5	0.1	0.5	1.1	0.9	0.3	0.3	1.0	1.5	11.8	0.2	25.4	4.8	0.0	1.0	0.0	0.8	3.0	0.0	0.9	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.8	0.8	0.9	0.9	1.1	0.4	0.6	0.6	0.7	0.3	0.6	0.5	6.6	28.9	2.2	3.3	3.3	109.1	138.2	32.5	60.3	20.4	5.2	5.3	8.7	11.5	21.3	7.3	20.9	0.1	1.9	1.1	0.0	7.2	29.5	100.3	15.7	8.6	0.0	0.0	2.8	7.5	0.1	6.9	5.6	192.7	2.5	8.1	15.4	11.7	0.3	0.0	0.8	0.9	4.1	2.2	9.3	12.9	5.0	14.0	7.2	9.4	1.1	2.3	1.0	5.0	3.5	33.0	0.2	2.2	17.6	79.5	0.1	0.8	46.8	10.3	0.0	21.7	6.6	47.9	59.7	114.9	171.8	0.0	3.7	1.3	1.5	340.4
DERPC		ENSG00000286140	"DERPC proline and glycine rich nuclear protein"	P0CG12	16	69118010-69132151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 26: Non-specific - Cell cycle regulation"		Nucleoplasm		"HPA051872: AB_2681647, HPA065522: AB_2685503"																		6.7	10.6	13.3	15.3	12.7	9.3	13.3	12.1	14.2	11.7	13.1	10.2	6.6	8.8	25.9	11.6	16.0	10.8	8.9	12.4	12.4	10.4	10.5	9.0	17.8	13.6	12.5	16.3	10.2	11.7		18.8	12.4	10.2	10.6	9.8	9.5	13.7	2.1	13.2	7.2	11.3	13.2	10.2	6.1	11.0	13.3	17.6	10.0	10.1	18.4	13.0		13.1	15.9	13.1	50.5	39.4	29.0	27.4	24.8	15.3	25.8	54.2	37.6	23.2	50.3	15.8	19.1	27.4	30.5	22.9	62.0	44.9	34.4	7.4	10.8	25.3	8.3	14.4	27.4	16.3	28.7	22.0	41.3	33.1	23.4	35.1	44.2	25.2	25.9	13.1	41.0	11.9	36.5	39.8	51.6	43.8	12.1	65.0	14.6	40.3	35.7	8.6	31.2	28.9	21.8	19.8	38.5	37.3	34.3	69.6	10.9	34.5	20.3	17.2	22.3	9.6	15.3	46.2	31.4	27.6	45.4	2.4	5.3	3.2	2.8	6.0	4.0	2.6	2.7	2.6	5.5	3.1	2.6	3.3	1.3	4.0	6.3	5.1	4.0	4.2	13.3	12.7	12.1	14.2	12.4	12.4	13.6	12.5	12.4	13.2	13.3	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 105.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	7.4	4.8	3.1	4.2	3.6	3.9	5.8	3.7	3.7	4.0	3.7	5.4	3.9	5.4	2.8	4.2	6.1	2.3	13.8	2.9	2.5	8.0	105.9	3.9	4.2	3.4	3.3	4.9	4.2	6.2	2.5	2.7	3.3	4.0	5.8	3.2	5.4	4.5	10.0	4.5	3.1	5.7	2.1	4.1	4.1	3.6	3.4	3.9	4.1	8.1	5.5	3.9	3.4	5.2	12.5	25.7	6.9	12.1	3.8	5.0	13.9	10.5	4.2	15.6	11.6	20.4	11.1	27.8	13.6	5.7	8.6	12.5	13.7	11.4	18.2	6.0	13.3	15.4	12.6	20.3	10.6	21.4	10.8	4.9	11.3	18.6	19.7	4.7	11.3	18.3	23.9	4.4	9.7	32.7	20.2	17.0	15.9	21.1	10.0	24.9	9.6	29.4	9.4	7.8	8.5	10.2	14.1	14.8	6.8	8.7	13.0	10.3	5.1	14.1	8.3	13.1	15.2	8.8	18.7	46.3	7.1	22.4	12.8	6.1	8.4	1.0	9.4	8.8	12.9	12.0	8.5	9.3	14.5	11.7	11.7	12.6	2.1	10.1	6.3	13.5	8.0	7.2	3.1	3.6	3.7	3.7	2.9	2.5	3.4	3.3	3.3	2.1	3.4	5.2	6.3	3.2	13.1	1.6	7.1	5.6	7.8	11.2	6.8	5.6	6.6	7.1	14.8	15.7	5.5	7.3	4.2	12.3	6.9	1.6	5.9	10.3	2.9	3.8	6.3	9.1	1.2	7.8	2.0	5.1	12.4	7.4	2.6	3.2	8.2	10.2	5.3	124.1	7.9	3.3	2.3	6.6	10.2	6.0	3.1	3.6	2.8	3.3	12.4	1.0	3.8	5.2	8.2	4.0	4.4	5.9	2.4	2.2	4.6	11.2	1.0	20.8	8.1	5.2	0.0	9.7	9.1	6.8	8.1	5.0	3.8	2.9	4.3	13.5	6.7	4.2
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DNAJB2	"CMT2T, HSJ1, HSPF3"	ENSG00000135924	"DnaJ heat shock protein family (Hsp40) member B2"	P25686	2	219279342-219286898	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 366.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036268	Approved		Enhanced	"Nuclear membrane"		NA	NA		9900	"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA036268: AB_10670793"	"unprognostic (2.02e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.62e-3)"	41.9	106.9	264.5	17.7	290.6	26.6	45.7	276.0	323.5	63.8	232.0	48.9	23.2	46.2	45.2	54.1	48.2	26.6	85.4	266.6	270.7	81.0	72.1	45.8	26.0	281.8	281.8	65.0	84.8	54.3	112.1	27.1	279.7	73.9	15.8	63.9	62.3	35.5	135.6	108.1	36.0	15.8	269.7	46.7	54.8	86.0	280.5	28.4	71.0	56.5	20.5	52.8	59.0	366.0	34.9	14.2	21.9	20.7	45.6	22.1	29.3	32.8	27.2	29.0	24.2	66.2	21.3	21.4	39.7	31.6	66.3	49.1	27.9	36.3	16.3	45.3	12.2	41.7	28.0	32.0	30.8	7.1	36.5	21.3	103.3	31.8	38.4	51.3	12.9	23.5	7.4	23.7	21.4	18.0	13.0	8.4	12.9	30.2	26.4	13.4	17.9	13.5	31.7	24.5	20.6	26.0	38.0	38.4	64.9	57.5	28.6	14.9	17.5	41.6	82.3	12.0	28.6	26.2	8.4	35.0	42.8	6.5	31.1	0.0	0.4	2.1	0.7	0.4	0.6	0.5	0.7	0.6	0.2	1.7	1.0	0.9	0.4	1.3	1.2	0.6	1.0	0.4	264.5	290.6	276.0	323.5	266.6	270.7	281.8	281.8	279.7	269.7	280.5	366.0	24.6	19.2	31.4	35.6	30.9	28.6	40.9	17.1	9.1	97.9	61.9	33.9	77.4	25.8	18.0	38.6	56.3	36.1	24.0	41.5	78.2	60.0	43.8	43.5	16.2	22.3	53.7	69.9	17.9	33.5	34.7	27.5	22.4	27.9	24.8	22.1	20.7	20.5	28.2	80.8	26.5	47.5	10.2	19.7	28.2	70.9	36.4	28.0	32.0	11.2	21.6	84.8	15.5	16.6	144.2	68.9	23.6	39.1	28.5	39.8	31.7	56.5	39.0	87.3	19.7	27.3	28.3	56.5	20.6	18.9	50.4	69.0	30.2	23.1	25.5	25.8
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 181.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 119.0;HUVEC TERT2: 182.3;LHCN-M2: 312.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		9500	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	31.6	49.7	21.9	11.1	24.2	6.7	15.4	24.4	74.6	24.0	19.9	14.3	6.4	21.3	10.8	26.4	13.9	32.3	50.4	23.1	27.1	20.6	20.0	17.0	9.7	23.0	24.8	16.0	22.8	14.1	11.6	26.0	23.0	23.3	11.2	15.0	7.6	14.1	44.1	9.6	9.6	29.9	23.3	42.2	12.3	7.9	25.9	10.5	44.5	71.4	6.2	23.6	12.8	35.3	6.2	11.8	14.5	8.6	61.8	115.0	6.7	119.0	28.8	50.8	56.8	3.9	8.0	8.9	19.4	55.5	20.7	9.2	18.7	10.1	86.1	10.1	5.3	4.5	32.9	28.7	84.1	2.5	2.4	47.9	27.9	66.5	18.9	28.4	182.3	2.9	19.6	6.1	312.1	0.7	3.0	6.6	9.4	1.8	5.6	5.0	25.2	5.9	12.0	3.1	10.8	3.4	13.3	10.0	11.7	15.0	3.9	3.7	88.7	72.5	17.8	51.2	15.9	5.5	1.8	7.9	9.9	5.3	12.9	3.3	0.7	1.2	1.1	0.8	1.8	1.6	1.3	1.3	0.7	1.3	3.0	2.1	0.2	1.6	0.9	2.3	1.9	0.9	21.9	24.2	24.4	74.6	23.1	27.1	23.0	24.8	23.0	23.3	25.9	35.3	81.5	60.9	6.3	35.9	23.9	41.7	112.5	16.3	48.3	29.3	90.9	57.1	98.7	18.6	20.0	18.4	68.8	51.2	15.3	40.9	37.2	11.2	144.7	55.1	37.3	84.4	21.4	42.1	41.6	14.7	23.2	87.3	45.9	51.9	56.6	16.7	42.8	22.3	19.4	30.3	39.0	37.9	12.2	18.3	70.1	62.6	24.5	33.7	65.8	21.5	5.1	40.5	8.2	28.6	53.8	11.4	27.3	35.0	70.6	33.9	16.8	31.0	34.7	56.5	26.3	82.8	120.3	23.1	12.0	55.5	39.2	181.0	52.7	32.1	30.9	43.2
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 960.5;Urothelial cells: 876.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	82.7	66.0	112.4	55.9	119.0	183.2	87.0	124.0	219.8	76.0	125.6	103.7	43.5	81.5	109.4	117.0	73.8	50.5	121.0	119.5	122.2	73.3	49.8	69.9	54.8	122.8	122.8	76.6	43.6	57.6	65.2	73.7	123.7	58.1	49.2	87.4	74.8	70.5	328.3	132.7	56.9	73.3	120.3	59.3	62.1	118.2	118.5	81.1	52.6	177.5	68.0	92.7	90.8	139.5	179.8	106.7	127.0	130.9	126.3	113.1	117.6	196.2	159.8	179.1	194.4	146.4	176.0	68.7	359.2	146.9	162.4	111.9	87.3	137.8	275.3	138.3	119.6	123.1	61.7	104.6	116.1	92.4	99.4	100.2	130.7	136.1	64.2	178.9	135.6	72.2	203.8	66.9	232.5	121.7	232.4	181.0	255.7	126.1	141.2	122.7	91.1	96.0	148.9	108.1	76.5	201.2	153.5	119.3	151.2	259.6	87.2	129.8	170.0	113.0	85.4	270.6	172.0	126.1	193.1	80.9	160.1	208.7	146.4	345.1	160.8	201.9	133.8	168.2	135.2	134.8	120.8	138.4	120.2	124.0	152.0	141.7	287.8	148.0	206.3	109.9	159.6	247.0	112.4	119.0	124.0	219.8	119.5	122.2	122.8	122.8	123.7	120.3	118.5	139.5	225.2	48.1	62.7	41.1	150.9	756.7	640.9	632.6	182.7	100.4	281.8	175.9	115.0	62.9	206.8	97.5	81.3	276.9	287.0	143.0	193.7	134.9	105.8	225.6	125.2	178.8	193.5	131.1	49.4	69.4	241.8	159.8	66.8	296.3	212.7	70.5	101.4	46.7	164.7	94.2	56.4	149.8	223.8	133.7	803.5	126.4	151.0	339.2	282.8	60.9	313.6	122.7	173.0	37.2	73.5	138.5	132.4	202.3	132.9	413.2	82.4	196.1	253.8	104.0	98.6	146.0	198.8	319.4	504.8	204.1	960.5	508.1	288.0	111.4	155.1	876.8
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233029	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026275: AB_2671823, HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (4.84e-2)"	32.1	29.2	21.7	27.8	22.5	30.1	31.2	22.8	27.6	27.2	21.3	27.4	20.9	31.6	22.9	25.2	22.6	20.2	38.4	22.6	24.3	28.2	27.3	21.9	40.3	22.7	22.8	28.2	25.2	23.2	13.6	30.6	23.1	21.7	23.0	26.2	23.0	22.8	41.2	21.6	23.6	31.0	21.8	26.7	29.0	13.8	22.1	42.7	26.2	29.9	42.2	28.1	23.4	22.9	76.6	38.9	58.9	68.4	70.6	57.8	53.0	61.7	77.2	122.6	111.7	41.2	60.1	87.0	62.4	69.4	60.2	45.3	88.4	61.1	128.6	68.5	65.9	112.0	54.0	73.1	63.5	111.8	88.3	44.3	53.6	77.0	40.6	57.2	82.5	70.6	106.4	59.3	90.6	44.5	84.6	77.3	107.6	47.1	44.2	96.0	87.7	84.4	78.1	62.3	21.1	55.1	81.8	33.2	74.4	43.2	49.7	89.9	63.4	54.4	58.4	123.1	93.9	55.5	78.9	138.3	72.9	133.4	75.8	64.2	53.6	53.1	60.4	53.6	61.6	60.5	54.5	60.2	59.8	59.6	54.3	54.8	28.6	57.1	60.0	61.3	66.3	91.8	21.7	22.5	22.8	27.6	22.6	24.3	22.7	22.8	23.1	21.8	22.1	22.9	133.2	76.9	91.4	9.4	119.4	129.8	148.3	181.2	80.8	96.0	66.6	87.1	149.6	78.6	116.2	106.7	25.0	188.7	156.7	56.4	270.1	150.9	55.3	100.9	127.5	127.9	46.0	128.7	19.5	98.1	159.7	132.4	48.9	106.1	141.0	93.8	93.5	77.9	181.2	69.0	16.6	58.1	111.9	71.9	146.3	40.3	120.5	121.1	103.2	21.5	153.5	167.4	183.4	19.6	23.4	117.3	68.2	144.0	74.6	121.1	65.2	199.3	87.8	103.1	85.5	108.0	144.9	153.1	91.7	74.7	110.2	224.1	132.7	98.8	76.7	112.3
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866284-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	5.0	3.7	4.9	3.5	5.2	15.3	5.0	10.3	6.7	3.5	5.6	3.4	2.7	4.0	6.3	4.4	3.5	4.5	4.5	5.5	5.4	4.2	5.0	3.7	5.5	4.8	4.9	4.3	3.4	3.8	2.1	4.6	5.1	3.7	3.6	4.2	2.9	3.0	8.9	5.5	2.7	3.7	3.8	4.5	3.6	4.5	5.3	4.3	4.7	5.0	5.2	6.5	2.8	6.8	14.3	6.6	7.2	7.8	6.9	6.2	11.1	9.4	6.6	11.0	9.4	7.3	6.1	18.8	12.2	9.9	13.8	7.7	11.9	11.2	15.6	11.4	6.6	15.4	11.3	11.0	7.2	17.4	5.3	6.8	11.9	11.9	9.8	5.5	7.9	6.0	18.6	6.0	15.1	6.3	12.2	11.3	14.2	6.3	10.6	7.0	15.6	7.2	11.3	10.8	8.7	7.7	9.8	14.4	10.5	9.2	6.2	12.6	7.7	8.8	9.2	10.2	15.9	6.4	9.3	15.3	5.1	13.6	5.9	9.7	5.7	11.6	6.4	8.3	7.7	8.2	5.8	5.8	5.1	8.4	5.3	6.9	8.0	9.6	8.5	3.5	6.4	6.8	4.9	5.2	10.3	6.7	5.5	5.4	4.8	4.9	5.1	3.8	5.3	6.8	98.9	57.7	78.2	3.6	66.7	54.4	163.0	57.9	43.3	33.9	27.5	38.9	73.0	11.5	91.2	12.9	58.4	52.0	110.2	17.3	21.5	74.3	53.8	85.1	72.0	74.2	8.4	20.6	6.8	60.3	44.4	54.3	38.2	122.4	119.4	36.6	25.7	19.4	38.1	20.2	7.7	14.5	46.8	29.5	72.1	11.0	25.7	75.8	23.2	8.4	52.1	29.2	48.4	3.5	7.2	88.6	20.1	25.9	50.1	96.7	17.2	19.6	85.1	34.4	19.7	90.7	79.0	62.8	65.9	40.0	50.6	55.8	87.7	44.4	23.1	112.0
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 186.4;Oligodendrocyte precursor cells: 331.3;Oligodendrocytes: 429.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097"	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	19.9	8.2	38.1	7.3	54.3	0.7	19.9	39.1	34.6	23.3	22.5	17.7	13.4	19.6	15.5	16.1	18.1	17.2	14.2	29.9	37.2	19.3	9.6	13.7	4.6	44.7	51.8	24.7	14.1	25.6	5.6	19.6	44.5	16.5	13.8	2.3	17.7	18.4	5.2	33.4	15.1	19.2	35.6	9.9	13.3	6.9	45.3	8.5	26.6	10.6	5.7	16.5	18.9	50.1	16.1	29.8	57.2	41.2	29.2	38.7	12.6	31.5	66.2	21.9	23.1	18.8	18.0	0.0	10.3	47.4	19.8	18.0	18.4	23.8	25.4	0.3	17.9	10.0	18.8	22.7	28.9	0.0	14.2	31.8	7.0	22.7	49.3	53.0	51.3	0.0	0.0	0.1	33.1	16.4	0.0	0.0	14.1	12.4	13.5	0.0	37.3	0.4	22.1	17.5	3.4	24.5	32.9	18.6	28.9	40.6	4.7	0.1	54.2	39.7	15.3	9.8	30.7	0.0	0.1	0.0	31.3	0.0	25.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	38.1	54.3	39.1	34.6	29.9	37.2	44.7	51.8	44.5	35.6	45.3	50.1	55.9	32.1	20.3	186.4	0.4	17.2	15.5	9.5	43.9	0.5	18.5	17.3	11.8	12.8	17.9	22.0	0.0	14.1	3.2	28.0	0.0	14.7	11.3	20.2	36.8	35.2	5.4	1.7	2.4	7.1	11.5	27.7	16.8	17.1	0.0	33.3	26.4	7.8	5.7	0.0	4.8	15.3	6.1	4.6	5.9	24.5	32.6	5.1	7.2	105.9	2.8	6.6	0.0	331.3	429.1	13.6	9.4	36.5	0.1	13.7	17.5	11.5	20.6	1.2	13.1	30.5	24.1	2.0	6.7	21.5	16.2	12.6	1.1	35.4	12.3	10.3
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50674927-51384198	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.5;thyroid gland: 12.2"	"Group enriched"	"Detected in some"	11	"Astrocytes: 223.6;Excitatory neurons: 777.2;Inhibitory neurons: 837.1;Oligodendrocyte precursor cells: 445.4;Oligodendrocytes: 814.7"	"Group enriched"	"Detected in many"	4	"glioma: 2.7;thyroid cancer: 7.6"	"Group enriched"	"Detected in many"	8	"amygdala: 9.9;basal ganglia: 12.8;cerebral cortex: 17.5;hippocampal formation: 13.4;white matter: 17.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.1;GAMG: 5.9;HMC-1: 4.9;JURKAT: 5.8;U-87 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	0.8	3.3	9.9	0.2	12.8	0.2	0.3	0.9	17.5	0.9	0.0	3.1	0.2	0.7	0.7	2.1	0.8	0.3	2.9	13.4	0.8	0.8	0.1	0.5	0.3	1.3	0.4	0.4	0.4	5.3	6.4	0.1	1.2	2.0	0.3	10.1	1.5	1.9	1.9	2.4	0.8	1.0	0.0	0.5	1.4	5.9	1.7	0.0	12.2	1.8	0.3	2.0	0.6	17.2	0.1	0.2	0.2	6.1	0.0	0.0	2.6	0.1	0.1	0.3	0.2	0.1	0.4	0.0	0.5	1.9	5.9	0.4	4.1	0.0	0.1	3.7	4.3	0.1	1.2	0.1	0.0	0.1	4.9	0.0	0.1	0.2	0.0	0.3	0.0	5.8	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.3	1.9	0.0	0.6	0.0	0.3	0.6	3.7	0.0	0.3	3.4	0.0	4.1	0.1	0.0	0.4	0.2	1.6	0.2	2.2	0.3	0.0	0.0	7.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	9.9	12.8	0.9	17.5	13.4	0.8	1.3	0.4	1.2	0.0	1.7	17.2	0.0	0.0	0.6	223.6	0.0	0.0	0.2	0.0	0.0	22.0	0.3	0.4	7.5	0.0	0.7	0.0	2.1	0.1	0.4	0.1	1.9	0.0	11.4	0.3	0.2	0.4	0.0	0.0	777.2	0.0	0.2	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.5	33.7	837.1	0.0	0.0	0.0	0.0	6.0	0.0	0.4	0.0	52.5	0.0	3.1	1.0	445.4	814.7	0.3	0.0	0.0	0.5	0.1	0.0	0.2	0.1	5.1	0.0	1.1	1.2	6.0	4.1	0.4	0.1	0.0	1.1	0.1	0.0	0.1
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184689-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.0"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 789.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 30.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA017719: AB_1847820, HPA056837: AB_2683253"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	4.9	3.4	17.1	7.5	56.6	17.0	4.8	33.4	30.0	4.4	25.2	8.4	10.6	4.1	5.1	3.4	6.2	5.8	7.8	19.5	29.1	4.3	15.2	9.3	1.8	43.4	39.9	6.8	4.7	2.6	8.2	10.2	43.6	7.9	9.4	2.5	6.7	5.6	2.6	5.4	12.9	3.3	19.3	19.3	6.6	6.2	40.7	1.9	15.5	2.8	1.6	4.1	4.9	86.0	19.8	43.2	4.1	0.3	9.8	10.6	14.2	45.5	26.5	12.4	9.6	6.3	15.5	0.4	4.0	40.3	13.7	34.6	4.9	32.5	19.9	6.2	6.1	20.2	40.5	15.8	11.1	5.0	21.6	7.3	12.9	13.6	20.3	13.6	10.7	0.8	0.3	0.8	12.2	11.5	0.7	9.5	4.1	24.4	11.9	0.3	9.0	0.5	9.1	12.0	3.0	1.4	24.0	14.5	4.7	3.4	4.5	4.0	32.1	21.1	13.6	25.5	17.1	0.7	0.2	0.3	27.4	10.2	27.4	14.6	2.5	3.8	0.4	5.5	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.3	30.7	0.4	6.8	0.4	0.0	0.3	17.1	56.6	33.4	30.0	19.5	29.1	43.4	39.9	43.6	19.3	40.7	86.0	2.7	44.8	41.5	96.6	2.2	18.5	13.2	30.5	2.2	9.6	12.8	5.8	13.4	31.5	31.4	14.7	2.1	28.3	20.1	50.6	0.0	10.3	0.9	16.3	10.0	10.6	17.5	9.9	4.9	12.0	100.2	28.1	32.1	53.1	31.0	52.8	8.2	35.0	13.3	1.7	3.6	26.7	8.2	60.3	51.0	5.6	28.9	41.3	85.4	38.4	24.5	20.0	22.6	61.3	789.8	48.9	27.4	48.2	13.4	36.0	60.0	6.2	20.9	2.3	13.1	4.0	12.1	0.9	5.6	5.8	7.2	20.5	10.8	25.1	27.7	16.8
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Cell line enriched"	"Detected in some"	4	"MCF7: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	0.1	0.9	1.0	0.2	4.7	0.2	0.4	7.8	2.9	2.1	11.1	0.3	0.1	1.0	1.7	0.3	5.9	0.3	41.9	1.1	0.9	2.7	1.1	1.6	0.7	4.2	1.5	0.3	5.8	0.1	15.7	0.0	4.7	1.8	0.1	0.0	1.9	1.0	29.5	1.6	1.4	0.0	0.2	1.9	2.7	4.8	3.0	0.0	0.7	8.8	0.4	1.2	0.6	0.0	2.7	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.6	0.0	1.2	0.0	0.1	1.3	0.0	4.4	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	36.2	0.0	1.4	0.3	1.6	0.1	0.0	6.7	0.3	2.3	3.0	0.6	0.1	3.0	0.0	0.0	0.0	8.3	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	1.0	4.7	7.8	2.9	1.1	0.9	4.2	1.5	4.7	0.2	3.0	0.0	0.1	0.0	1.5	1.3	5.3	0.0	3.9	3.7	0.0	0.3	0.7	0.9	17.1	0.0	3.0	5.5	0.0	0.0	0.4	0.5	0.0	2.3	5.8	2.6	0.7	0.1	6.0	2.7	0.4	4.4	0.0	1.4	4.1	2.8	0.0	3.0	0.0	0.1	0.1	0.0	0.9	3.0	2.0	0.0	0.0	9.9	0.9	0.1	0.0	0.0	0.1	0.0	3.1	1.0	0.0	1.8	0.0	0.0	0.0	2.0	0.1	0.3	1.8	0.5	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.4	1.2
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2163933-2232578	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 99.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	11.4	12.9	3.7	10.5	7.6	22.1	8.9	9.9	9.1	8.8	4.9	12.1	12.5	10.0	1.1	14.7	8.6	5.2	9.7	5.1	3.7	19.7	15.1	18.3	8.0	7.5	4.9	10.5	15.4	2.0	13.9	5.4	6.2	9.7	3.9	8.5	9.9	1.9	12.2	14.5	17.6	3.4	1.7	17.3	12.7	99.7	7.9	7.0	15.6	2.8	5.0	7.2	9.8	11.2	27.7	14.4	48.4	26.5	3.5	5.2	63.5	15.2	3.4	8.3	6.6	18.4	10.1	31.6	7.3	10.0	7.0	24.0	16.1	8.6	3.9	16.4	20.0	29.6	26.7	18.3	5.5	42.8	52.6	5.0	6.3	15.9	8.1	6.8	6.7	17.8	36.2	32.7	6.6	15.6	34.1	46.4	37.4	17.4	25.2	34.8	13.6	21.8	4.6	12.9	31.9	24.7	10.7	31.8	20.2	12.7	14.3	32.4	9.6	22.9	20.7	34.2	30.1	29.9	42.8	22.0	22.6	28.6	13.7	0.1	0.1	0.8	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.2	3.7	7.6	9.9	9.1	5.1	3.7	7.5	4.9	6.2	1.7	7.9	11.2	9.3	32.1	16.3	12.4	9.5	17.7	14.7	4.7	10.2	27.2	12.7	8.4	7.1	11.5	7.2	9.2	66.7	6.1	15.9	29.1	3.9	11.5	37.6	14.2	10.7	10.2	20.8	8.6	7.8	12.2	13.8	11.0	27.5	28.2	6.3	15.9	5.3	14.4	9.9	13.5	6.8	12.0	4.1	12.3	30.4	18.2	3.1	19.0	12.4	10.3	8.5	5.5	8.2	10.6	15.0	13.9	28.6	3.4	8.6	12.9	35.6	3.1	7.6	28.1	0.0	14.2	10.3	32.4	23.0	12.2	19.9	16.3	6.3	15.3	15.9	15.3
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;retina: 18.0;skeletal muscle: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 49.5"	"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.3	1.4	2.8	0.5	6.7	2.6	0.4	35.5	5.1	0.4	0.0	2.0	0.2	0.2	0.0	0.6	0.3	0.3	14.2	10.2	3.8	1.4	3.0	0.2	0.8	12.0	5.9	13.7	0.3	5.1	0.6	0.3	12.6	0.1	1.5	18.0	0.4	0.2	26.5	0.5	1.3	0.5	4.4	1.0	0.5	3.5	5.7	0.3	0.4	9.1	1.0	0.2	0.2	7.7	2.1	0.0	1.6	0.1	0.2	2.9	17.7	5.4	5.1	12.2	4.7	0.1	0.2	0.2	0.3	1.7	0.2	0.1	1.7	0.8	7.4	0.3	0.6	31.5	0.2	0.0	0.5	0.2	0.5	0.7	0.3	2.8	2.0	2.0	4.0	3.4	2.8	12.4	3.9	0.1	2.7	0.3	0.0	0.0	1.8	6.9	0.8	0.4	2.1	0.0	1.2	0.7	0.0	0.1	0.0	0.5	0.0	0.0	8.7	6.0	0.0	2.2	0.6	4.3	1.2	0.4	0.5	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.7	35.5	5.1	10.2	3.8	12.0	5.9	12.6	4.4	5.7	7.7	0.8	0.0	0.0	104.5	6.0	0.6	0.1	0.0	0.0	10.5	1.1	0.9	38.4	1.5	0.0	0.0	108.4	2.6	2.6	7.5	1.9	0.1	58.5	0.1	0.8	2.9	0.0	8.6	17.7	0.4	1.3	2.8	0.0	0.1	4.5	43.2	1.1	4.4	0.4	6.7	21.7	3.4	0.0	0.8	0.7	34.3	0.3	1.7	0.0	8.4	0.1	8.6	2.1	123.1	115.7	0.7	5.1	4.9	2.6	0.1	2.7	10.7	0.0	85.5	0.0	2.6	3.5	4.5	1.2	0.3	0.3	0.1	3.8	14.5	7.4	0.0
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.7;Oligodendrocytes: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	8.6	7.5	3.7	4.9	4.7	5.4	10.8	4.6	5.0	6.8	3.6	6.7	6.1	7.9	10.7	9.6	8.1	6.0	10.2	3.6	4.7	10.4	8.1	5.3	5.3	4.6	4.4	9.7	14.3	8.7	5.9	8.1	4.8	5.8	7.0	8.9	6.7	6.1	10.8	9.7	6.6	6.4	4.3	6.3	6.8	5.9	3.9	7.0	10.8	6.9	7.4	8.0	7.1	5.7	16.9	8.9	14.7	12.5	2.6	11.7	14.3	6.2	10.8	14.7	7.6	11.9	15.5	5.2	14.8	5.7	17.9	19.0	17.2	17.9	17.5	4.1	10.7	19.6	9.9	18.9	15.3	10.6	12.1	9.9	22.2	5.9	28.5	9.0	14.4	11.0	21.8	20.6	13.6	6.6	13.0	9.8	13.0	25.4	8.1	16.0	13.7	7.2	12.9	21.0	10.7	10.4	11.6	12.8	10.7	8.5	44.6	14.4	4.4	14.2	13.8	14.4	10.0	18.2	31.3	13.4	12.3	17.7	13.9	0.0	6.7	0.3	6.0	6.7	7.7	8.9	8.1	8.4	6.7	6.3	10.3	9.3	0.3	14.7	6.2	5.8	5.8	4.5	3.7	4.7	4.6	5.0	3.6	4.7	4.6	4.4	4.8	4.3	3.9	5.7	15.9	16.0	7.5	91.7	18.7	31.0	20.0	19.8	24.5	29.2	12.0	16.6	15.8	18.6	17.2	9.2	39.6	26.7	9.3	7.5	13.7	16.3	2.2	10.7	13.7	10.0	5.4	16.8	28.0	24.1	23.5	12.0	21.4	13.3	3.8	21.1	5.7	7.4	17.5	18.5	47.0	7.4	14.2	10.3	12.9	3.3	14.0	9.8	16.0	44.0	14.3	15.0	11.3	71.9	101.5	18.7	7.1	6.8	6.9	8.9	13.4	19.9	7.6	24.2	0.0	18.9	14.0	9.8	14.0	21.2	23.2	22.6	9.9	21.9	10.5	13.4
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110546-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 997.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.0;THP-1: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	60.2	98.8	42.1	28.0	43.2	45.8	56.8	43.4	64.9	45.4	83.6	65.3	28.4	46.3	16.7	46.0	53.6	31.3	116.4	43.8	52.0	58.7	70.0	57.3	41.7	53.4	48.0	37.7	82.8	54.3	112.3	26.7	45.7	81.1	7.3	8.0	92.3	46.2	52.8	56.6	51.7	12.8	45.6	79.0	69.4	75.3	48.3	19.8	83.7	21.4	14.4	59.3	48.0	49.2	28.0	43.1	3.5	3.6	51.1	40.5	5.7	42.2	66.2	26.6	17.4	41.0	22.2	56.2	44.4	27.2	1.2	60.3	30.7	8.2	1.3	54.8	2.1	26.4	63.6	1.3	113.5	69.1	135.5	50.0	31.7	11.6	24.1	38.3	35.1	65.8	57.5	41.2	18.0	76.4	35.7	65.7	14.8	99.9	42.8	52.8	0.5	232.0	43.3	30.5	67.7	46.7	47.8	122.6	118.9	0.8	43.5	218.1	44.1	67.4	23.5	43.4	29.5	51.7	31.8	14.9	80.9	41.1	31.1	40.2	194.8	59.2	148.8	176.2	151.8	86.6	131.4	127.9	190.6	83.4	117.1	106.2	12.0	95.0	110.6	276.6	173.6	204.1	42.1	43.2	43.4	64.9	43.8	52.0	53.4	48.0	45.7	45.6	48.3	49.2	80.5	54.5	80.9	54.9	96.8	67.0	103.2	109.2	59.7	74.5	90.3	82.2	66.5	94.4	76.8	53.3	35.5	55.2	129.2	28.2	37.2	121.0	288.7	35.9	40.7	58.2	88.1	35.9	31.4	68.1	115.3	97.2	33.6	47.3	74.3	178.7	64.6	77.1	315.7	121.1	27.9	32.3	107.8	171.7	106.2	997.8	155.4	150.1	167.2	9.4	165.5	123.9	122.6	16.6	26.4	58.2	54.3	169.2	190.2	108.5	97.3	84.9	75.4	83.6	52.6	57.4	58.4	106.2	46.2	47.3	64.9	51.4	115.4	19.0	43.1	90.4
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	38.0	23.1	13.9	33.1	14.5	17.9	26.8	17.7	19.9	23.1	22.7	26.7	28.6	17.7	17.6	15.0	30.1	36.4	23.7	13.5	15.2	26.5	24.9	25.0	55.3	15.6	14.9	24.3	25.6	28.3	4.6	41.2	16.2	17.8	30.7	16.9	25.8	16.7	16.6	17.9	26.3	17.0	15.5	45.3	23.4	10.3	15.0	27.8	22.0	23.6	50.3	29.4	4.2	17.8	38.0	12.9	24.0	10.8	57.3	56.2	23.4	28.7	29.9	24.7	24.9	12.5	38.2	28.7	17.2	25.6	12.1	37.4	30.5	24.0	31.9	26.8	25.6	16.8	18.4	16.4	41.4	19.4	15.4	38.5	41.4	18.3	38.4	53.6	29.9	29.1	34.1	19.6	30.1	19.6	16.6	28.8	14.5	43.3	13.2	11.1	40.0	14.0	42.5	25.8	19.1	18.2	16.8	52.4	80.1	33.1	16.7	84.6	24.8	20.6	13.8	16.2	18.9	25.7	9.6	29.8	33.4	34.7	29.6	41.7	47.3	11.5	14.2	61.0	19.4	65.7	17.5	15.3	45.1	54.1	22.3	19.0	7.2	25.0	49.8	28.6	17.7	35.5	13.9	14.5	17.7	19.9	13.5	15.2	15.6	14.9	16.2	15.5	15.0	17.8	34.5	12.8	12.0	17.3	146.2	47.0	54.4	82.5	34.1	11.6	53.6	43.9	29.7	32.9	53.1	44.1	2.1	98.1	38.9	41.2	43.0	59.2	8.5	51.7	19.5	36.4	13.2	28.6	20.6	46.6	102.3	39.2	24.5	17.6	23.6	18.5	42.8	26.0	183.1	20.2	31.7	45.7	77.3	189.4	97.8	7.8	33.5	110.3	81.8	39.4	89.0	27.1	56.7	31.7	42.6	41.9	64.3	24.8	54.7	46.3	88.4	80.4	95.8	10.1	39.5	26.4	32.5	4.7	14.6	40.8	53.0	73.3	38.6	26.3	43.7	70.1
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30989365-31042815	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 99.2;skin 1: 372.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 500.7;Basal squamous epithelial cells: 214.5;Squamous epithelial cells: 419.6;Suprabasal keratinocytes: 688.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 246.2;HBEC3-KT: 54.6;hTCEpi: 156.7;hTERT-HME1: 103.6;REH: 44.8"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.3"					"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		6000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645"	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.04e-5)"	4.8	0.1	0.1	0.5	0.0	0.2	12.5	0.1	0.0	23.8	0.0	0.3	0.4	0.1	1.2	99.2	1.3	0.0	0.4	0.1	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.4	0.2	3.4	0.2	12.5	0.0	6.0	0.1	0.1	19.6	1.3	1.0	372.6	0.3	0.5	0.0	0.0	0.1	0.1	0.0	7.7	0.1	0.0	24.7	3.5	48.5	0.0	17.2	1.8	0.2	0.0	0.1	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	246.2	0.0	54.6	0.0	0.1	14.6	0.9	4.7	0.4	9.7	0.1	0.2	10.2	156.7	0.0	103.6	19.6	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.9	0.1	21.8	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.1	0.3	0.0	500.7	62.0	49.5	214.5	0.0	3.1	8.0	1.3	0.0	30.3	0.0	0.0	73.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.3	2.4	0.0	0.3	0.0	14.2	4.6	0.0	0.1	0.0	0.1	0.0	0.0	5.3	0.0	0.3	0.2	12.2	0.0	34.8	0.0	0.0	0.6	39.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	32.1	0.0	0.1	10.2	0.0	0.0	0.0	3.4	0.1	0.1	419.6	688.8	25.0	2.3	0.0	0.1	89.1
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.1;Late spermatids: 94.1;Spermatocytes: 53.1;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	5.8	6.8	5.2	12.6	5.8	9.6	5.8	6.8	7.5	6.1	4.6	8.6	5.7	5.3	4.9	12.2	5.1	5.5	6.1	5.3	6.1	5.9	9.2	6.8	18.8	6.8	5.8	4.8	4.4	7.5	4.9	9.9	6.6	5.4	8.4	5.3	5.9	5.0	9.6	10.8	10.4	7.9	5.0	15.9	6.4	27.5	6.4	7.6	5.4	8.9	20.2	7.0	7.4	7.8	17.1	25.5	11.0	17.1	8.8	14.8	20.4	16.1	15.6	33.4	23.7	27.5	29.9	39.7	14.3	17.0	9.8	22.8	26.6	28.5	25.5	6.1	16.0	13.4	15.6	20.6	14.9	15.1	18.4	14.5	21.9	27.5	26.8	12.8	21.3	29.9	16.1	6.5	16.0	24.9	16.0	22.5	12.2	16.9	13.5	26.8	12.5	28.3	18.4	11.8	13.0	11.3	31.8	12.3	7.1	14.1	25.1	8.4	11.7	14.8	13.3	12.9	13.6	18.4	24.5	36.6	10.6	19.7	8.8	12.1	29.2	89.9	9.5	25.8	9.2	56.9	6.5	10.3	21.9	48.4	9.4	8.5	27.8	21.3	37.7	8.6	13.5	17.2	5.2	5.8	6.8	7.5	5.3	6.1	6.8	5.8	6.6	5.0	6.4	7.8	2.5	9.6	4.6	6.8	17.1	2.7	2.0	12.8	4.6	3.9	2.4	2.2	2.6	4.3	6.2	7.3	8.4	29.2	6.0	5.7	5.9	10.4	118.1	1.7	3.5	5.3	4.2	3.0	7.2	5.4	17.3	3.8	4.6	2.6	7.0	7.2	9.3	7.9	13.4	15.2	8.0	5.5	6.1	11.9	2.3	94.1	3.7	6.2	3.6	2.8	13.5	4.5	9.2	5.5	7.3	9.5	3.6	7.9	7.7	3.4	4.2	10.8	4.1	2.9	6.6	3.4	4.7	53.1	15.0	5.2	2.6	61.4	4.2	10.0	6.0	2.1
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225342-7234517	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338"	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	18.2	20.7	15.1	11.4	17.2	14.8	18.1	15.6	17.9	31.7	15.2	22.6	12.9	29.6	10.5	23.0	22.3	14.1	13.8	14.7	14.9	16.3	10.6	15.0	16.7	17.1	16.3	33.9	12.8	17.6	26.0	14.7	16.2	24.7	8.6	14.4	17.8	18.0	16.5	28.8	16.7	18.1	15.0	16.1	14.4	16.4	16.1	22.2	20.1	11.5	13.0	22.1	25.9	19.0	31.0	43.9	52.2	52.0	39.0	35.0	22.5	21.1	38.1	50.0	63.7	37.5	25.6	43.8	31.3	23.5	39.0	43.5	43.5	28.6	19.0	43.6	50.3	28.5	46.0	40.0	68.0	16.0	23.7	52.5	48.2	47.2	25.7	35.0	20.9	50.5	24.6	20.0	30.6	28.9	61.6	16.1	17.8	20.7	17.1	89.5	33.8	26.8	27.8	26.9	22.9	46.4	38.3	18.9	46.7	23.5	27.4	22.1	17.6	28.0	25.1	52.8	39.6	31.1	28.0	20.4	32.6	23.8	44.4	13.5	4.2	10.2	10.0	4.9	8.3	8.5	7.0	9.0	5.0	9.3	8.0	8.5	1.9	7.2	4.9	7.0	4.5	6.2	15.1	17.2	15.6	17.9	14.7	14.9	17.1	16.3	16.2	15.0	16.1	19.0	11.7	9.6	12.1	12.4	13.1	17.5	22.6	20.9	21.6	15.7	13.2	14.4	7.7	5.7	15.0	18.4	25.0	21.3	11.8	11.2	5.9	11.3	0.9	8.8	12.9	10.5	13.2	6.5	11.2	10.4	15.9	15.7	7.7	13.5	14.7	18.4	9.7	4.9	14.6	10.1	9.4	14.3	24.4	6.0	9.4	1.9	26.1	7.6	10.6	2.8	9.3	13.1	14.4	10.6	10.4	7.2	9.9	22.2	5.9	17.1	10.8	5.5	9.3	30.0	13.1	16.0	14.9	18.4	34.2	21.7	19.2	36.5	11.5	18.4	19.6	15.0
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 392.2;Late spermatids: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	2.1	4.2	3.9	3.4	4.2	4.6	6.4	5.1	7.6	5.9	4.2	5.4	4.6	5.0	17.0	4.0	5.0	4.4	4.7	4.2	4.4	3.5	4.2	4.7	5.9	4.4	4.5	5.1	3.0	5.0	3.6	6.8	4.8	5.0	6.2	7.7	3.7	7.2	2.2	4.9	4.0	5.1	4.1	6.2	3.2	36.7	4.8	4.3	9.1	4.1	5.4	4.7	2.0	5.7	2.0	3.2	3.9	4.3	5.8	7.1	4.7	2.4	4.8	5.4	5.9	0.6	3.2	6.1	0.3	6.9	3.7	4.2	3.0	4.5	4.2	4.7	6.8	4.2	1.0	3.6	16.4	3.7	3.3	4.9	9.6	3.8	12.4	10.1	7.8	6.5	1.8	6.7	4.9	4.3	3.5	9.1	5.3	1.0	1.8	0.7	2.8	2.6	6.7	1.9	0.0	1.5	0.5	2.4	3.3	8.4	1.9	3.3	0.5	6.3	4.9	0.6	3.1	1.9	2.6	3.8	3.3	5.8	3.3	0.3	1.7	0.8	0.5	1.3	0.6	4.4	0.8	0.9	1.6	3.0	0.8	0.9	0.0	0.7	3.5	0.8	0.7	0.8	3.9	4.2	5.1	7.6	4.2	4.4	4.4	4.5	4.8	4.1	4.8	5.7	13.0	12.8	16.2	11.1	15.8	8.9	13.2	31.2	14.8	20.7	21.2	30.4	23.8	7.2	19.9	16.5	10.4	15.7	16.7	5.2	31.3	25.1	392.2	14.0	22.5	15.5	5.4	12.2	10.3	27.1	12.0	17.3	14.3	13.3	17.7	19.0	8.2	9.8	49.7	13.5	10.4	75.4	14.2	16.1	9.3	393.1	15.2	18.7	16.0	9.4	14.5	19.4	13.4	14.1	16.1	20.1	14.2	31.6	22.9	16.4	7.3	35.6	13.9	21.7	6.6	15.2	17.6	23.7	39.0	20.4	7.5	9.9	12.7	40.6	17.3	11.8
E4F1	E4F	ENSG00000167967	"E4F transcription factor 1"	Q66K89	16	2223580-2235742	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052042, HPA069007, HPA071325, HPA072309"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: "	"unprognostic (3.05e-1)"	"prognostic favorable (9.13e-4)"	"unprognostic (7.31e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (9.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.12e-1)"	"unprognostic (8.93e-3)"	13.5	16.0	7.9	6.6	8.6	11.3	15.1	10.2	13.5	17.5	4.8	16.5	6.2	18.7	1.9	16.1	15.2	3.3	15.3	8.1	7.0	16.1	19.0	13.4	6.8	10.2	8.1	15.9	15.2	4.4	19.0	5.3	10.0	21.3	1.8	3.0	16.0	5.5	19.0	23.6	15.0	2.7	6.1	20.5	14.8	14.4	8.3	6.4	22.6	4.3	2.8	16.1	16.4	9.4	10.9	20.2	8.3	16.4	4.8	4.4	20.0	14.8	6.6	10.0	6.7	32.7	16.2	15.8	15.8	5.7	5.6	14.6	6.8	7.6	1.8	17.2	25.6	11.2	36.1	18.0	9.3	14.2	19.1	6.6	8.5	9.0	4.1	5.6	6.9	13.5	26.7	10.6	3.8	30.1	18.8	30.6	18.7	6.6	18.8	34.7	9.1	27.9	6.2	7.6	21.4	15.5	18.4	21.9	10.7	3.0	19.4	20.0	12.3	12.0	15.7	12.0	12.4	20.7	10.9	32.0	5.0	10.0	12.3	6.8	8.1	11.7	10.2	9.8	8.8	8.2	8.4	9.7	8.8	8.0	9.0	8.4	11.4	6.9	11.8	5.2	11.4	7.5	7.9	8.6	10.2	13.5	8.1	7.0	10.2	8.1	10.0	6.1	8.3	9.4	9.1	16.0	8.2	8.5	14.4	7.1	7.9	12.2	9.1	13.8	12.3	10.8	4.9	5.7	13.9	11.0	37.5	20.4	18.5	26.5	11.7	11.1	19.6	12.6	10.2	10.3	25.8	6.5	8.1	10.5	17.2	8.7	31.1	11.6	2.5	12.3	6.8	10.5	12.6	30.3	7.2	19.8	20.3	7.3	7.8	5.0	11.5	7.3	7.2	10.3	9.1	11.3	13.4	5.0	5.5	11.1	14.5	16.1	13.2	9.7	15.4	8.0	12.0	15.7	13.1	9.6	11.2	19.0	16.1	7.6	8.9	13.4	11.8	12.6	15.3	6.4
EBAG9	"EB9, RCAS1"	ENSG00000147654	"Estrogen receptor binding site associated antigen 9"	O00559	8	109539711-109565996	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021153, HPA021154, CAB072810, CAB072811, CAB072812"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus"		"CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152"	"unprognostic (3.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.71e-2)"	23.3	28.4	18.6	17.6	19.9	16.9	32.4	23.4	26.3	36.1	19.8	28.6	23.5	22.8	44.7	17.0	27.6	19.4	24.7	19.1	20.5	37.0	45.2	28.1	25.4	18.9	19.0	22.2	36.7	34.9	20.5	18.1	19.0	23.3	31.2	32.5	42.9	27.6	53.2	17.9	21.0	17.0	19.1	20.7	27.2	25.3	19.3	20.6	57.4	42.3	27.0	17.2	15.3	20.2	36.7	25.2	25.3	17.3	15.3	24.9	19.7	19.5	14.6	27.0	25.4	25.7	38.1	51.7	33.0	13.8	21.8	25.2	24.4	31.3	28.5	57.6	26.9	56.9	15.8	39.6	34.3	20.0	16.1	19.9	60.1	23.4	47.2	21.9	25.7	45.8	59.8	37.0	24.0	55.8	58.2	31.5	15.8	70.1	25.2	30.9	20.1	43.7	31.4	23.7	27.6	22.1	21.3	22.6	27.6	18.4	44.7	25.6	17.5	20.9	15.0	19.1	14.4	54.9	38.3	48.7	21.2	52.7	19.6	5.8	13.4	14.7	19.3	19.5	34.1	40.7	27.1	27.0	22.5	40.3	33.5	30.4	2.8	29.4	17.3	23.8	33.4	14.7	18.6	19.9	23.4	26.3	19.1	20.5	18.9	19.0	19.0	19.1	19.3	20.2	32.0	121.8	102.4	12.7	40.2	21.7	28.6	51.8	44.9	34.5	36.8	46.0	37.6	54.3	65.1	29.5	6.2	50.2	24.0	33.6	64.6	47.3	134.7	42.9	26.7	34.5	31.8	36.0	16.1	65.8	34.0	28.8	22.4	33.0	46.9	16.0	23.2	48.8	32.7	50.5	16.1	39.4	50.8	24.7	22.1	115.0	29.2	27.9	19.6	11.2	25.3	53.4	27.8	18.1	16.1	38.5	41.3	23.0	53.8	36.8	50.5	58.5	61.8	34.7	32.9	35.1	32.1	101.6	50.4	40.5	19.9	22.2	28.5	34.7	46.0	31.7
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	35.1	38.8	30.3	35.2	31.1	34.3	39.5	28.8	33.5	30.0	32.5	35.4	23.6	35.5	55.7	46.5	43.5	21.7	37.1	31.1	31.0	55.7	126.6	27.7	35.9	29.3	28.5	27.3	36.1	45.6	48.9	33.1	30.0	29.0	36.5	19.6	34.5	31.0	51.9	36.8	24.5	35.0	29.6	24.8	33.4	44.4	31.8	30.5	41.4	28.6	39.8	52.5	34.5	31.1	325.0	180.2	66.0	192.7	52.1	58.3	142.6	219.4	107.8	338.7	210.5	215.2	192.5	211.0	167.9	157.0	157.2	218.2	144.5	200.9	360.5	101.2	146.5	144.8	160.9	188.5	95.7	248.7	106.8	47.6	197.4	248.6	197.3	64.2	185.5	145.2	220.3	67.8	165.1	172.8	190.0	152.0	290.8	209.5	165.0	139.2	150.4	235.5	123.7	135.0	132.0	139.9	127.3	228.6	219.0	105.6	94.5	136.1	147.6	128.7	248.9	211.4	360.7	102.9	219.7	262.7	107.6	258.7	265.2	19.7	45.4	24.9	52.3	54.1	55.2	61.5	52.8	54.5	68.7	68.5	48.3	48.3	3.9	59.6	53.3	65.6	60.5	43.6	30.3	31.1	28.8	33.5	31.1	31.0	29.3	28.5	30.0	29.6	31.8	31.1	38.0	35.3	39.5	5.9	36.9	123.0	91.6	78.0	40.5	26.3	50.6	62.1	32.0	52.9	52.5	31.3	6.2	102.2	23.3	34.0	90.1	144.5	163.5	56.8	47.3	51.0	24.1	45.0	5.6	124.4	135.1	51.5	33.1	31.6	50.7	35.1	27.8	148.3	63.3	15.2	3.8	49.7	48.8	22.5	24.7	94.9	33.2	28.9	55.2	3.7	41.4	55.7	35.0	6.0	4.9	135.3	25.8	38.4	53.1	179.3	29.4	135.9	81.3	29.5	39.5	55.0	68.1	92.6	97.8	54.2	99.4	84.3	26.8	57.8	66.2	95.3
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362485-133373354	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1128.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1476.3;Proximal tubular cells: 2336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	302.4	127.1	127.7	53.7	127.8	43.9	116.9	131.3	136.1	59.8	149.7	143.1	171.6	47.0	89.3	107.9	90.5	66.7	226.4	133.1	129.9	481.7	1128.7	48.5	52.4	129.4	129.9	71.3	96.8	98.7	74.3	73.6	128.8	102.0	104.6	39.8	163.4	123.2	294.3	68.2	153.6	59.4	130.3	48.4	84.5	52.6	134.6	40.0	88.5	271.6	59.0	87.4	57.8	136.0	185.1	229.2	120.4	303.4	173.0	111.4	110.5	132.2	175.9	183.2	154.1	509.5	174.0	139.2	111.9	151.4	94.4	167.7	160.2	136.1	132.0	107.4	281.2	138.5	128.1	367.2	145.0	180.4	93.5	124.5	115.9	121.2	153.6	160.8	165.1	98.3	127.8	117.4	181.6	443.9	90.7	352.0	84.4	289.8	272.1	152.8	146.4	74.6	227.8	236.0	78.1	123.4	137.0	224.1	178.9	69.4	174.8	171.5	132.1	81.3	115.9	169.9	177.4	87.0	58.8	159.8	192.4	98.8	68.7	96.1	184.7	86.8	105.5	212.2	137.6	178.7	117.8	115.8	242.6	148.9	119.3	115.8	19.8	166.0	168.1	104.9	123.0	233.0	127.7	127.8	131.3	136.1	133.1	129.9	129.4	129.9	128.8	130.3	134.6	136.0	99.2	44.8	82.7	16.3	60.5	68.2	86.9	271.8	62.6	57.0	98.5	119.6	255.2	210.1	161.5	174.7	6.2	470.2	34.0	298.6	565.4	162.8	29.9	148.9	92.7	71.4	131.7	72.2	11.6	101.1	163.5	92.5	87.7	226.4	91.2	120.0	88.5	1476.3	221.1	45.4	11.0	223.0	175.0	92.1	61.5	39.1	77.6	88.0	135.2	10.3	113.0	145.2	45.3	10.6	24.3	107.8	248.6	91.7	57.5	88.0	486.2	2336.5	93.2	55.2	85.5	57.0	98.8	52.9	66.1	125.2	76.3	299.1	62.5	220.0	317.2	127.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239402-2252300	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 301.3;Hepatocytes: 246.5;Proximal tubular cells: 272.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		7300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	51.5	57.3	35.9	12.7	39.2	19.6	52.0	38.6	45.9	46.2	61.6	74.0	59.9	44.9	10.6	57.0	50.7	11.3	189.7	32.1	38.0	123.2	235.7	37.2	13.8	39.1	37.8	38.6	74.7	43.8	50.4	14.6	35.0	56.6	15.0	12.8	78.7	24.2	220.6	49.7	58.8	9.3	37.3	35.3	69.5	18.2	42.0	13.4	105.0	87.8	9.5	50.3	43.6	36.5	29.5	68.0	25.7	107.4	9.6	13.6	96.6	29.5	19.1	23.1	33.7	120.0	88.0	42.3	71.2	17.7	16.9	71.6	29.6	27.5	3.2	74.2	157.1	12.9	61.7	151.7	87.3	38.6	6.0	25.2	63.1	18.9	41.7	16.4	23.6	1.1	71.7	87.1	8.0	119.1	4.0	57.8	60.1	46.8	68.8	134.3	27.7	207.1	45.5	32.5	88.8	56.2	70.0	131.4	92.7	12.6	84.7	67.7	19.6	18.4	68.0	19.9	33.0	95.8	61.0	72.2	23.9	35.4	26.2	1.7	3.6	1.6	1.9	3.8	3.1	4.4	2.8	1.6	3.0	4.9	3.4	2.9	2.0	3.6	2.5	3.6	4.0	0.8	35.9	39.2	38.6	45.9	32.1	38.0	39.1	37.8	35.0	37.3	42.0	36.5	47.1	3.2	28.2	13.4	28.0	21.3	115.6	11.3	21.1	53.2	77.2	95.1	92.3	94.4	15.0	77.3	43.8	179.6	20.5	151.7	301.3	35.1	10.9	128.2	54.8	28.2	45.5	61.7	4.2	36.9	80.7	33.1	33.1	122.8	5.7	62.2	34.2	246.5	47.9	21.9	6.7	105.9	20.3	31.0	23.8	5.3	24.5	29.8	39.2	4.7	17.5	89.9	5.2	13.0	10.0	33.2	91.1	24.0	36.8	72.8	176.1	272.3	14.6	77.6	0.0	73.4	42.7	6.3	19.6	32.9	22.3	109.9	21.7	50.2	104.7	110.5
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115693-4135597	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 422.7"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	53.6	123.6	43.9	21.0	47.7	21.5	65.0	46.5	63.7	60.0	50.5	53.3	64.0	44.9	102.1	26.7	49.2	40.1	150.9	42.4	47.8	236.0	422.7	28.6	20.0	45.0	45.6	71.4	159.8	53.2	52.6	37.7	44.2	45.2	55.4	31.8	29.9	36.3	198.4	22.7	59.6	35.5	45.3	30.1	103.5	30.9	49.0	33.5	37.0	236.4	21.8	31.6	26.8	45.5	82.8	45.1	72.8	161.0	89.7	131.4	8.8	114.0	116.7	122.1	107.7	34.0	12.4	3.6	139.6	126.0	111.0	41.6	83.6	67.4	179.5	30.4	95.8	44.0	59.7	186.8	51.3	40.4	20.7	90.6	40.6	106.2	58.4	166.0	262.9	136.2	146.2	31.1	118.6	33.4	113.9	100.7	49.5	8.1	158.7	108.8	90.8	1.5	67.2	16.8	1.8	33.7	6.8	48.2	107.6	131.0	109.8	18.9	268.6	92.4	49.8	82.7	69.8	46.8	88.7	8.4	47.9	34.7	73.0	19.2	36.4	17.4	41.5	28.4	57.1	45.8	48.8	58.3	58.9	51.9	59.8	59.2	1.2	66.0	43.3	45.3	57.9	41.1	43.9	47.7	46.5	63.7	42.4	47.8	45.0	45.6	44.2	45.3	49.0	45.5	61.0	28.9	25.2	17.0	24.4	18.2	48.6	50.3	22.2	14.3	33.3	41.0	165.8	78.6	40.1	36.8	12.5	293.6	29.3	32.0	428.4	53.2	63.1	60.8	43.1	48.0	52.1	77.6	10.7	175.5	29.0	55.2	34.7	57.0	23.4	68.6	53.9	162.2	64.3	18.5	11.9	41.6	20.3	22.0	19.2	50.6	63.3	23.5	35.6	14.0	34.7	77.7	21.6	8.5	18.2	80.4	37.5	50.8	28.3	24.7	120.6	577.0	83.6	46.4	26.3	46.8	33.9	46.5	35.6	24.9	12.8	101.9	41.2	224.0	60.8	22.3
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Spermatocytes: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			"Cluster 1: Neutrophils - Mixed function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	3.6	3.3	2.1	8.2	1.9	19.8	7.5	3.4	3.4	8.1	1.4	11.5	9.3	4.4	1.8	8.9	3.3	5.3	3.2	2.4	1.4	4.3	2.6	5.2	10.5	2.1	1.7	1.3	2.9	3.6	1.2	8.8	2.7	3.2	15.8	12.5	5.6	2.6	2.1	7.1	7.6	7.5	0.7	4.3	9.4	15.9	2.3	23.3	3.9	2.7	11.4	6.9	4.2	3.5	192.0	133.6	103.2	54.0	10.6	21.8	51.6	81.5	67.5	121.4	116.9	74.7	196.9	47.2	122.1	48.8	116.0	81.8	84.2	53.1	164.3	67.8	46.6	29.6	70.0	38.5	4.6	46.2	32.8	7.1	9.0	72.2	73.2	34.0	53.0	68.6	31.3	67.2	97.2	67.6	47.5	34.6	84.4	156.7	72.0	33.7	101.1	60.7	92.2	43.7	68.6	44.1	104.5	117.4	42.2	51.5	195.4	34.1	46.5	58.5	55.7	79.6	174.9	32.8	47.2	88.2	51.6	39.7	78.0	6.0	2.0	0.7	1.0	1.7	1.1	1.4	1.4	0.9	1.6	1.3	0.6	0.9	6.3	0.7	0.7	1.6	2.5	0.7	2.1	1.9	3.4	3.4	2.4	1.4	2.1	1.7	2.7	0.7	2.3	3.5	6.7	6.4	3.2	4.2	3.8	19.5	4.9	6.2	9.1	3.4	10.1	6.5	3.6	5.7	5.7	3.7	64.6	12.0	2.9	10.7	0.0	9.5	3.3	20.1	6.6	7.7	4.8	25.2	6.5	9.2	14.9	6.0	17.9	20.5	0.0	17.9	5.3	2.9	7.3	0.0	2.5	13.5	10.2	4.7	6.3	2.8	0.9	5.1	7.2	15.0	2.8	3.1	2.1	3.0	4.9	20.7	3.8	1.5	9.6	12.8	1.5	3.7	11.0	16.3	0.0	2.9	5.2	42.6	30.4	16.9	12.8	3.8	4.1	3.3	13.5	8.8
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039472	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	5	"monocytes: 1.2;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Secreted - unknown location"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Lipid droplets"	"HPA037972: AB_2675761, HPA037973: AB_2675762"	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	4.2	8.5	2.4	0.7	3.0	0.1	2.8	2.2	2.6	4.9	5.2	2.6	0.5	3.0	3.2	1.5	3.8	2.0	10.4	2.1	2.4	3.7	2.1	3.2	0.8	3.2	2.8	4.9	4.2	9.7	1.3	1.8	3.0	3.4	1.1	0.3	2.2	2.2	1.7	4.2	1.1	2.1	2.3	1.4	3.8	1.2	3.1	1.2	6.0	2.0	0.6	2.3	3.9	4.6	0.0	0.6	0.3	2.8	0.5	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	5.2	0.2	0.2	0.5	3.8	1.4	0.0	0.0	4.5	0.0	0.0	17.9	1.0	0.0	1.1	1.8	1.3	0.0	0.9	0.0	0.5	3.5	0.0	4.9	0.0	1.2	0.0	0.0	2.8	5.1	0.3	0.0	1.2	6.0	0.1	0.0	1.5	0.0	0.1	0.3	0.1	2.0	0.3	0.1	0.5	1.7	2.2	2.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.1	2.4	3.0	2.2	2.6	2.1	2.4	3.2	2.8	3.0	2.3	3.1	4.6	3.3	3.2	0.5	21.2	0.3	3.8	2.6	2.0	6.8	0.2	0.9	1.5	12.1	0.0	1.1	5.5	0.0	0.2	0.1	1.0	0.0	1.3	21.3	4.6	1.2	2.2	1.8	0.0	17.9	1.3	0.2	6.0	5.6	12.2	0.0	0.5	11.0	1.2	4.1	0.0	9.6	0.6	0.0	4.8	1.2	9.2	4.7	2.8	1.8	84.3	0.1	1.3	0.0	30.2	45.9	1.1	0.1	2.2	0.2	2.3	0.4	3.1	1.3	0.1	6.6	10.7	5.4	1.7	3.5	3.2	4.1	0.0	2.1	0.4	0.9	1.5
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873052-67884499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA		9700	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	10.1	11.8	36.3	11.9	36.2	24.4	10.6	36.0	42.2	11.6	34.0	15.5	13.7	12.9	9.6	12.1	13.2	12.1	17.0	34.7	34.8	12.2	10.9	10.8	16.3	34.3	34.5	15.8	18.1	13.6	14.0	10.8	34.4	11.3	11.2	8.5	11.3	10.2	21.9	16.1	14.1	9.7	33.0	13.7	15.8	18.3	34.1	20.6	10.9	11.3	16.0	13.1	10.5	37.0	23.8	33.6	22.0	19.9	19.6	14.8	43.6	21.1	17.8	42.4	33.9	55.2	22.4	38.2	22.6	29.1	17.9	32.4	43.1	17.2	21.3	14.8	54.6	27.2	21.9	29.5	23.7	33.2	29.8	20.3	23.2	42.7	19.8	24.9	32.8	28.3	48.2	7.1	25.4	36.5	44.9	83.6	21.8	15.9	18.4	66.1	26.1	42.3	17.0	17.7	38.5	20.8	56.0	15.9	15.8	17.3	29.4	45.2	21.5	17.7	24.7	16.3	28.6	34.9	22.2	94.7	13.6	39.4	16.3	0.7	5.8	4.2	8.9	6.2	7.9	5.6	7.6	8.4	6.0	4.1	7.5	5.4	2.6	8.3	10.9	4.2	11.2	6.6	36.3	36.2	36.0	42.2	34.7	34.8	34.3	34.5	34.4	33.0	34.1	37.0	0.6	22.4	24.8	8.5	4.8	0.0	0.3	0.2	7.4	1.2	0.3	0.4	1.5	0.0	3.2	0.0	4.2	0.2	1.1	1.6	0.0	0.4	0.0	1.0	1.1	2.1	1.2	8.8	14.2	0.0	0.4	2.6	15.3	1.3	3.8	0.8	1.4	0.2	0.4	0.0	12.6	0.4	0.0	0.3	0.3	0.2	0.3	4.5	0.0	11.2	0.0	0.7	1.0	8.5	13.6	0.3	1.2	0.0	8.3	0.2	2.0	0.1	4.4	1.2	6.6	1.0	0.9	0.2	0.2	8.3	0.1	0.0	5.5	0.8	0.4	0.1
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219958	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 184.4;U-698: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	11.2	11.3	5.5	31.3	6.6	66.5	14.4	3.7	6.2	11.6	4.4	15.6	14.1	11.9	12.6	16.7	10.7	12.2	7.2	5.2	5.6	12.5	59.3	29.8	41.4	6.5	5.2	13.1	24.9	17.2	9.4	14.0	4.9	12.4	16.9	5.6	13.3	10.7	5.7	17.2	18.7	12.5	5.4	24.4	17.7	10.5	6.7	79.1	17.6	5.4	42.5	16.7	13.2	6.4	18.0	17.8	11.1	11.1	14.3	31.6	35.1	28.8	38.8	19.5	25.5	8.2	23.4	95.9	15.2	28.6	42.3	13.9	12.1	39.8	29.6	184.4	7.1	32.7	16.9	18.7	66.2	39.0	91.8	28.7	47.4	41.6	45.5	26.4	39.2	122.1	8.7	128.2	24.4	10.6	78.9	14.9	5.6	8.2	13.4	113.2	19.6	90.0	22.4	37.0	1.4	14.5	20.8	29.6	44.4	9.8	15.2	123.3	38.7	37.2	25.7	32.1	33.6	75.1	49.4	162.3	61.8	37.1	31.8	2.9	2.6	3.1	4.0	3.7	5.7	6.7	5.9	4.4	3.3	4.4	5.2	4.1	3.0	2.1	4.6	7.5	6.7	2.0	5.5	6.6	3.7	6.2	5.2	5.6	6.5	5.2	4.9	5.4	6.7	6.4	11.8	60.9	100.7	10.7	51.1	20.6	7.0	15.5	10.2	5.3	17.2	11.0	3.1	20.0	19.9	16.5	10.4	10.0	29.1	23.8	0.0	7.0	14.4	11.4	14.8	12.6	8.4	12.6	17.4	12.2	32.8	11.3	20.9	20.0	23.5	8.1	12.8	76.2	17.0	1.7	15.4	26.4	14.2	32.9	194.0	63.1	8.4	44.3	16.0	14.0	43.1	3.3	12.3	11.1	10.3	15.2	4.7	9.1	135.5	12.5	16.1	8.5	11.0	4.0	0.0	9.4	13.6	7.8	5.5	23.1	27.3	40.9	25.5	5.1	12.3	20.7
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985463	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		17000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	1022.6	1037.0	771.8	507.3	755.2	920.3	946.7	737.2	1059.6	966.7	807.6	1122.4	821.4	887.6	563.7	1062.3	857.3	501.2	1396.6	740.9	729.1	843.2	1152.9	666.9	685.4	775.4	769.6	1627.6	3194.1	494.0	838.0	386.2	782.3	819.2	344.5	224.7	1276.4	500.3	2322.6	1142.7	798.9	385.4	758.3	721.6	1266.6	490.5	762.7	541.0	793.6	1112.4	499.0	927.8	797.7	745.1	1456.8	1018.4	579.3	1539.4	1515.6	2706.7	830.9	1110.4	1479.8	1036.7	1012.7	1618.1	652.7	3000.6	644.1	1032.3	461.1	1069.8	919.4	1719.4	544.2	755.0	1533.0	768.5	919.9	1677.0	2204.8	1668.0	1277.6	3515.5	1777.2	916.0	1404.1	1497.5	1086.6	1434.4	1526.7	2145.4	642.1	2095.7	1510.1	1266.3	1537.0	518.3	1015.7	1654.2	860.3	1938.3	871.2	1270.2	1575.4	1466.4	699.0	1377.1	2058.3	543.1	1344.7	1992.7	1321.8	738.2	765.7	1521.4	1738.7	2276.4	1644.3	1485.3	1100.4	2065.8	986.6	81.2	455.7	64.1	259.8	333.1	460.2	578.5	453.0	344.6	430.7	478.1	497.2	404.1	43.1	355.3	342.1	358.7	429.4	756.5	771.8	755.2	737.2	1059.6	740.9	729.1	775.4	769.6	782.3	758.3	762.7	745.1	323.1	221.2	392.2	24.5	1125.5	1321.1	1071.3	754.3	1269.7	212.6	981.3	694.3	627.9	597.7	448.3	255.6	77.2	958.1	535.9	556.9	986.1	716.0	799.2	318.2	675.4	568.2	744.2	934.8	23.2	1816.8	1305.0	679.7	619.3	428.5	373.4	596.1	656.8	690.6	610.1	203.6	28.9	982.1	411.0	885.4	859.5	1195.6	1008.4	514.2	645.7	36.5	907.5	429.1	614.8	27.2	42.2	868.2	815.5	832.8	992.8	1010.5	1562.7	1078.8	194.5	134.1	585.1	797.7	697.3	371.5	308.4	1343.0	1347.1	1243.1	727.1	1044.3	1168.4	1051.6
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 20.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 169.8;Late spermatids: 185.7;Spermatocytes: 64.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	3.2	2.6	1.3	3.2	2.3	3.9	4.2	3.7	2.0	3.8	0.9	2.9	4.8	6.0	4.0	1.6	3.5	2.9	2.5	1.1	2.9	5.4	3.5	3.1	4.5	2.9	2.5	3.8	1.8	3.2	2.5	3.6	3.3	2.7	3.3	3.9	2.3	1.9	0.8	2.2	3.3	2.4	1.7	4.4	3.6	20.5	2.8	1.8	14.2	0.4	3.2	2.6	2.4	4.3	0.9	3.7	1.5	0.2	1.8	6.4	2.8	2.1	0.4	0.6	1.0	1.7	5.2	0.3	5.8	0.7	0.0	1.0	0.0	0.4	3.5	0.1	0.5	4.9	3.4	0.5	1.8	3.8	0.5	1.2	1.7	2.4	0.0	4.4	4.1	3.8	1.5	9.0	2.2	0.1	1.7	2.1	0.8	2.6	2.9	4.5	1.1	1.8	8.3	3.0	1.1	0.5	1.1	0.1	2.5	1.1	6.0	4.5	1.5	0.2	1.1	0.3	1.0	9.4	6.9	0.9	5.5	7.3	3.8	2.8	1.0	0.3	0.5	0.6	0.4	2.2	0.4	0.3	0.5	2.6	1.2	0.7	0.0	0.5	0.4	0.3	0.1	0.3	1.3	2.3	3.7	2.0	1.1	2.9	2.9	2.5	3.3	1.7	2.8	4.3	5.3	9.6	2.2	7.2	7.9	0.8	1.8	0.9	0.6	2.5	2.3	2.4	6.2	1.5	1.3	0.0	0.0	0.3	1.3	0.4	0.0	1.0	169.8	1.9	2.5	6.0	3.0	1.3	8.0	0.9	0.1	4.1	2.6	5.4	6.3	1.3	4.6	0.5	1.9	3.3	10.1	0.4	2.0	2.9	2.0	185.7	1.8	2.6	0.0	32.8	2.7	1.0	0.0	13.0	19.5	1.1	0.3	3.8	1.4	1.1	1.2	1.6	3.3	2.9	0.0	3.2	4.0	64.1	24.5	0.0	0.6	0.0	2.3	1.2	0.7	1.3
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.7;Cytotrophoblasts: 1365.8;Fibroblasts: 309.7;Syncytiotrophoblasts: 889.6"	"Cancer enhanced"	"Detected in all"		"glioma: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 953.6;hTERT-RPE1: 2226.5;HUVEC TERT2: 4270.9;TIME: 3554.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1900000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	240.5	55.7	57.0	57.2	82.8	0.2	115.3	57.1	88.8	54.9	180.7	74.6	22.5	73.2	128.4	51.5	134.8	140.4	187.8	47.5	75.6	57.4	12.9	150.1	27.2	80.8	121.1	175.1	29.2	17.6	22.6	329.7	65.5	58.4	91.0	42.8	87.7	161.2	14.7	55.2	45.3	93.5	72.2	42.4	46.9	8.0	71.0	16.8	139.1	93.8	21.2	203.9	77.3	71.9	358.4	3.1	8.5	0.3	320.9	217.1	0.8	208.1	233.7	25.2	20.5	0.0	18.0	0.5	140.4	234.3	22.1	323.4	1.6	234.6	8.9	1.0	1.0	0.3	87.4	0.2	843.2	0.3	0.6	953.6	117.5	21.9	260.9	2226.5	4270.9	0.5	1.2	0.2	99.2	36.7	2.6	0.5	4.2	0.1	0.8	0.2	0.3	0.9	9.8	7.3	2.0	0.4	284.6	105.0	0.7	8.1	289.8	1.5	3554.3	1.5	107.5	397.9	138.5	13.7	0.5	1.4	73.1	0.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	82.8	57.1	88.8	47.5	75.6	80.8	121.1	65.5	72.2	71.0	71.9	26.6	250.0	109.1	234.1	0.1	79.4	79.1	367.7	42.1	2.8	6.2	78.2	12.5	12.8	98.2	27.6	0.0	1365.8	0.4	0.0	9.8	36.2	0.5	2.2	38.9	73.5	0.0	0.0	1.0	25.6	173.0	309.7	6.1	2.1	2.5	3.9	48.5	0.7	94.9	0.0	4.7	0.0	40.7	0.8	33.9	0.9	42.6	3.2	17.8	6.5	0.6	137.3	0.0	2.5	0.8	2.8	0.0	0.0	1.5	24.2	0.0	14.7	88.8	4.7	0.0	7.0	28.7	0.4	1.8	6.0	31.7	889.6	5.0	61.3	0.0	6.2
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849948-44899445	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		94000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	23.6	30.7	26.7	31.3	27.2	37.4	22.4	24.6	28.0	17.6	27.9	26.5	21.6	19.4	18.8	33.1	25.0	16.3	35.3	28.0	26.3	26.1	26.2	22.6	35.5	25.6	26.1	17.6	24.0	27.9	13.2	28.6	26.4	17.8	28.8	15.5	22.5	18.6	65.8	28.5	22.8	23.5	25.1	29.8	22.5	27.5	27.3	41.0	21.2	38.3	46.5	28.8	20.3	26.6	88.7	173.6	82.8	134.9	61.9	60.9	97.1	68.7	91.4	169.6	146.0	134.6	73.9	152.1	79.0	87.1	130.3	98.6	181.5	120.2	196.2	153.9	150.8	150.9	100.9	144.5	68.2	179.9	107.5	66.5	67.4	157.2	85.0	65.2	149.1	134.8	189.6	57.8	98.0	88.2	182.3	118.6	85.7	206.8	143.1	126.1	168.1	132.0	97.0	97.8	135.7	81.1	67.7	49.5	73.9	120.6	131.6	112.2	91.4	126.5	97.4	77.7	176.3	60.2	81.4	150.0	101.6	98.4	132.0	42.7	84.3	85.9	37.2	81.6	41.7	32.3	32.9	36.1	82.8	31.3	28.8	32.2	13.0	44.2	85.0	35.5	35.2	70.7	26.7	27.2	24.6	28.0	28.0	26.3	25.6	26.1	26.4	25.1	27.3	26.6	11.3	0.0	14.0	11.1	18.1	11.7	12.2	15.1	13.6	14.7	14.1	11.8	21.1	22.8	15.3	18.4	33.3	34.5	14.0	15.6	3.9	29.4	12.5	17.8	17.9	21.4	10.8	24.8	17.5	26.7	30.9	14.0	18.3	18.8	19.7	22.6	21.8	22.4	38.5	26.9	17.2	13.4	16.2	30.1	17.5	6.5	12.8	26.2	5.4	12.2	46.7	12.0	21.6	6.0	15.5	27.7	12.0	9.1	20.3	14.5	15.9	13.2	17.4	18.0	19.7	14.8	14.8	28.2	43.3	16.0	14.6	27.2	16.3	21.4	22.2	12.5
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019017-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 287.9;Skeletal myocytes: 251.2;Syncytiotrophoblasts: 376.8"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"A-431: 5282.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	88000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	27.9	11.4	12.6	4.0	18.3	0.0	20.0	16.6	9.7	20.4	10.5	12.2	5.7	11.4	10.3	23.5	13.9	9.0	7.1	6.3	10.3	11.6	35.3	14.9	2.5	10.4	19.0	15.1	15.8	3.5	2.9	67.9	8.9	16.2	10.7	10.2	22.1	15.0	10.9	51.0	9.5	9.3	7.5	5.1	11.1	4.2	22.6	12.8	20.6	20.6	8.3	14.7	24.1	6.3	5282.1	61.9	16.5	22.4	102.7	63.5	16.7	47.9	68.7	30.8	23.8	11.5	54.2	2.7	11.4	43.8	130.7	197.1	0.4	230.2	37.1	2.2	3.6	0.1	27.3	3.4	27.0	0.0	0.2	31.2	205.4	74.1	409.9	45.5	4.0	0.0	0.0	0.5	68.0	3.0	0.1	0.1	5.1	21.2	30.4	0.1	9.1	0.2	38.1	52.6	0.8	20.0	42.7	50.6	9.3	16.8	4.9	12.0	15.6	27.1	7.2	215.7	45.8	0.1	4.8	3.1	37.9	1.6	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	18.3	16.6	9.7	6.3	10.3	10.4	19.0	8.9	7.5	22.6	6.3	16.4	96.1	49.9	147.6	1.2	85.8	77.1	101.5	116.1	3.5	12.1	30.4	11.1	47.1	50.6	22.0	6.2	287.9	0.0	45.9	0.0	32.9	4.9	25.9	57.2	12.5	4.2	8.0	1.2	24.3	37.1	91.6	22.4	39.8	0.0	50.6	6.8	79.5	28.3	0.0	107.5	21.6	48.8	7.7	11.6	5.8	128.3	1.9	17.8	40.3	1.6	90.0	0.0	63.3	1.4	54.8	19.9	133.5	0.0	75.4	14.1	13.4	21.7	3.8	78.9	251.2	34.7	2.4	2.5	73.3	89.9	376.8	2.2	41.9	24.9	55.8
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465479-138469303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 1113.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 133.1"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 7.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.1;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 192.0;hTCEpi: 286.6;U-266/84: 478.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259"	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	565.5	354.0	7.5	135.4	15.9	176.7	173.9	133.1	70.1	302.5	10.0	246.5	54.8	197.6	13.5	370.9	911.7	345.2	258.8	20.7	30.4	173.2	149.5	173.4	145.2	9.9	13.2	974.6	137.0	93.5	243.3	54.2	12.9	309.7	161.1	56.0	140.9	84.4	66.0	363.1	107.2	474.3	4.4	77.5	254.5	26.9	10.4	301.5	584.4	354.9	19.1	191.4	115.9	19.5	21.8	0.9	45.0	67.6	119.6	192.0	5.1	36.7	22.7	48.4	39.0	26.4	18.9	1.1	5.9	80.2	165.8	10.1	2.6	74.5	22.2	1.1	3.3	3.0	11.5	7.6	15.5	8.0	57.8	15.2	286.6	43.2	9.8	37.6	4.2	53.9	112.5	26.0	14.3	108.2	3.2	34.1	4.1	80.3	0.1	0.8	6.7	4.1	36.8	13.1	56.5	6.4	44.7	120.1	106.6	43.3	1.5	6.6	1.8	17.5	22.6	8.7	14.2	60.1	478.8	8.6	20.3	103.5	5.2	0.0	2.6	0.3	0.1	3.6	0.0	0.7	0.1	0.0	0.7	0.2	0.1	0.1	7.1	0.1	1.2	0.0	0.2	0.5	7.5	15.9	133.1	70.1	20.7	30.4	9.9	13.2	12.9	4.4	10.4	19.5	920.4	275.7	485.6	6.8	116.4	181.8	719.6	207.4	816.1	43.5	550.0	459.0	652.4	420.4	124.0	29.5	64.6	159.5	46.2	645.2	7.9	255.4	1.4	356.0	836.5	383.1	960.5	27.3	20.3	101.7	110.1	989.9	736.0	645.4	354.0	274.8	347.0	183.1	131.4	3.3	2.7	747.6	93.6	218.6	109.7	3.8	164.7	300.7	106.7	20.6	8.6	191.6	0.0	1.5	2.4	135.3	380.8	53.0	67.2	405.1	224.8	5.7	127.4	101.3	223.5	1113.1	613.2	3.2	2.9	644.8	200.3	129.7	83.4	104.9	480.2	145.4
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 203.4;Early spermatids: 220.3;Excitatory neurons: 262.3;Inhibitory neurons: 245.4;Late spermatids: 495.6;Oligodendrocyte precursor cells: 226.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (1.95e-8)"	30.0	17.2	15.1	10.7	16.3	6.4	17.4	27.7	19.3	29.0	11.7	41.9	9.7	31.1	7.9	29.5	21.3	20.4	11.7	20.0	16.5	17.1	53.9	11.6	8.8	13.3	22.1	48.0	15.9	15.2	12.2	11.9	14.1	16.0	14.2	20.9	15.7	18.6	8.0	13.0	14.9	30.0	10.9	8.1	17.5	37.4	22.6	13.4	14.4	13.1	10.2	18.1	21.6	16.2	49.7	66.9	26.8	16.4	46.1	89.0	27.2	43.6	42.4	31.6	25.9	80.4	36.2	34.2	15.4	79.8	47.5	29.1	35.1	30.5	51.9	36.3	16.5	29.7	22.9	95.2	31.5	17.5	21.5	40.9	54.1	31.6	61.9	31.3	20.5	26.7	20.6	19.1	51.1	19.4	20.0	10.9	26.3	40.8	26.2	17.8	33.8	14.9	20.8	16.1	29.6	23.6	35.1	25.9	43.0	28.5	12.6	17.0	15.2	33.3	34.4	55.8	23.0	21.5	16.2	32.7	33.3	26.3	69.4	0.2	2.2	2.5	4.1	2.4	4.0	6.3	4.2	3.9	3.7	4.9	4.2	3.6	0.8	3.4	1.3	2.4	2.5	2.2	15.1	16.3	27.7	19.3	20.0	16.5	13.3	22.1	14.1	10.9	22.6	16.2	29.0	38.5	18.8	203.4	10.4	15.6	12.0	27.1	43.3	39.7	10.5	12.8	15.2	22.8	20.7	14.7	4.2	10.9	9.9	5.3	15.6	22.1	220.3	10.3	45.4	19.9	16.2	8.8	262.3	40.5	30.1	36.6	9.2	12.1	2.5	15.2	30.0	59.6	5.0	18.5	245.4	5.4	6.1	8.6	11.4	495.6	58.4	7.6	10.6	119.0	6.5	20.1	13.4	226.7	98.7	41.7	5.0	40.3	9.6	13.9	11.4	15.1	14.5	17.8	6.6	33.1	19.4	53.7	31.1	55.4	14.2	2.9	12.7	18.2	8.1	13.1
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157522	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA		44000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	11.1	9.0	7.2	10.5	8.1	30.1	8.6	7.4	9.5	9.8	8.6	8.8	7.6	10.5	8.0	6.3	8.3	9.5	6.3	7.8	11.1	8.5	7.7	8.9	8.0	10.9	8.1	10.8	7.4	11.1	6.6	11.2	10.9	10.1	8.6	6.6	17.7	8.4	4.5	4.6	9.9	11.1	15.6	11.9	9.5	3.3	13.0	11.7	10.0	5.8	7.1	8.0	5.9	8.7	38.4	22.1	16.7	17.4	21.5	28.3	20.1	21.2	29.1	56.3	41.1	23.0	23.2	27.4	27.0	29.8	66.2	27.4	24.2	27.1	29.5	45.7	12.0	33.8	19.2	18.7	17.9	32.2	0.2	22.5	13.1	23.7	19.3	17.7	18.0	10.7	19.1	23.6	20.3	13.4	35.5	17.0	15.8	8.4	10.8	27.6	40.9	12.1	15.3	18.7	14.1	20.4	32.0	24.0	50.7	12.7	9.2	9.0	31.4	25.7	24.9	15.1	36.2	19.0	30.8	0.3	15.9	20.0	23.1	10.7	5.3	6.3	5.4	7.9	5.2	5.3	4.5	5.2	4.8	4.2	3.0	4.3	15.7	6.5	8.0	3.1	6.5	2.1	7.2	8.1	7.4	9.5	7.8	11.1	10.9	8.1	10.9	15.6	13.0	8.7	94.5	67.3	34.0	25.1	35.9	19.5	42.3	33.0	31.3	38.8	26.6	26.0	29.9	32.9	46.0	22.0	14.6	47.8	44.8	32.2	21.5	40.2	2.4	55.8	68.7	76.3	15.0	36.0	39.6	48.5	89.2	52.6	22.4	41.7	41.1	93.5	33.5	21.9	38.2	47.1	42.9	24.0	16.2	29.9	20.8	4.2	57.2	50.7	21.4	48.7	47.1	50.9	45.3	51.3	16.8	54.7	21.8	84.2	46.0	39.5	33.6	33.0	48.9	24.8	39.5	60.5	45.9	2.4	5.5	22.5	10.1	40.8	40.0	61.3	28.6	40.5
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184146127	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	16.1	18.9	10.1	8.2	10.1	5.3	17.6	11.2	12.5	17.2	13.0	19.6	9.4	15.3	5.6	24.7	14.9	6.5	22.3	9.8	11.7	15.5	20.1	15.8	9.7	11.2	10.1	14.9	19.0	22.1	18.0	11.8	10.6	18.1	13.8	2.3	23.9	11.2	53.9	24.7	19.4	11.6	10.9	20.3	21.0	10.1	10.8	18.2	16.7	33.6	19.0	18.8	19.6	9.3	60.7	25.4	24.3	25.4	32.4	23.4	28.0	29.1	36.2	51.7	42.4	41.5	24.5	48.6	37.8	32.5	65.0	34.7	56.6	39.1	47.7	39.7	55.4	75.6	28.4	42.4	24.8	61.8	32.9	19.6	32.1	28.7	24.1	19.5	37.3	49.7	46.7	29.2	35.2	49.5	49.5	34.3	39.9	76.1	49.3	45.1	37.6	61.3	43.1	38.6	35.2	34.2	27.9	91.9	41.5	20.3	83.6	60.8	33.6	22.9	35.4	28.5	62.7	24.3	61.2	69.6	33.0	58.8	35.2	9.5	10.0	14.7	8.7	9.1	11.5	15.4	12.2	13.3	11.8	16.9	18.1	11.5	1.3	14.3	9.8	5.1	11.6	7.6	10.1	10.1	11.2	12.5	9.8	11.7	11.2	10.1	10.6	10.9	10.8	9.3	19.8	25.6	22.7	8.8	31.6	30.8	36.6	18.2	29.6	18.5	33.1	30.1	25.8	17.2	28.4	36.8	8.4	39.3	25.4	32.0	52.8	27.5	3.7	20.5	17.7	24.0	45.9	27.6	14.6	36.0	28.8	17.8	35.2	23.3	16.5	21.3	13.6	27.1	24.9	35.3	18.6	28.0	24.4	18.5	22.6	2.7	18.3	18.2	19.6	12.2	30.8	14.5	22.6	18.1	15.3	26.3	17.9	14.7	19.0	34.6	27.2	30.0	21.9	16.7	13.1	17.5	22.8	17.7	17.0	31.2	29.0	38.6	26.5	34.2	34.7	44.9
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67360328-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol		NA	NA		210000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011663: AB_2096478, HPA064885: AB_2685382"	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (7.11e-4)"	28.3	24.5	12.5	29.9	14.0	25.0	25.7	15.1	17.8	18.1	10.4	25.0	21.5	19.4	19.6	38.8	15.8	21.5	28.7	14.6	14.1	24.5	35.3	18.4	30.4	13.7	12.7	17.1	26.3	22.9	9.4	26.3	13.6	22.1	26.7	21.2	18.3	22.3	49.4	23.7	21.5	27.0	13.8	19.8	19.8	33.4	13.5	27.9	27.9	40.6	33.5	39.1	19.0	16.6	265.7	86.4	59.8	92.3	56.4	63.4	127.8	115.5	68.3	127.4	110.7	101.6	92.2	118.7	57.0	87.4	85.7	100.4	139.1	110.3	192.7	86.9	51.9	76.9	80.0	70.4	59.2	82.7	71.9	52.4	62.6	113.9	172.5	49.8	105.4	73.8	132.6	89.6	127.3	131.3	113.7	64.7	61.1	157.9	142.9	85.7	99.0	84.6	78.2	120.0	85.9	60.7	83.0	96.5	91.1	52.3	164.5	70.8	81.3	167.4	180.7	82.0	124.4	77.0	90.4	180.7	97.1	145.3	110.2	51.4	50.6	33.0	47.4	71.0	58.4	55.4	54.5	51.7	70.1	45.8	50.3	51.5	6.9	58.6	62.8	48.0	64.3	70.7	12.5	14.0	15.1	17.8	14.6	14.1	13.7	12.7	13.6	13.8	13.5	16.6	64.1	28.9	40.2	17.3	44.1	142.8	88.2	77.2	37.5	22.1	32.0	30.1	92.8	30.0	55.8	22.0	12.5	78.7	38.0	23.3	70.5	89.6	81.0	34.6	48.9	60.3	13.1	64.2	21.7	63.0	104.7	51.2	34.1	44.8	35.5	35.7	26.4	39.8	70.4	37.0	20.9	30.6	61.1	37.9	51.3	33.4	31.1	40.7	51.6	15.9	61.3	32.2	36.0	15.1	23.8	70.8	18.3	40.6	56.7	79.9	26.6	65.1	35.0	35.2	26.3	60.7	85.9	204.9	96.3	49.7	130.4	93.4	46.1	57.9	39.7	79.1
EIF3G	"eIF3-delta, eIF3-p44, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115014-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1509.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 1471.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol		NA	NA		64000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	193.6	153.1	91.9	97.0	98.6	127.9	188.0	97.9	110.3	211.3	91.2	219.0	94.9	190.6	61.3	144.2	189.7	68.1	212.6	88.1	93.5	152.7	134.3	135.4	125.4	100.6	94.6	280.0	324.5	116.2	119.6	90.8	99.9	172.0	54.3	24.8	182.2	102.2	529.8	212.4	148.0	73.8	98.4	168.9	207.6	176.3	96.8	124.9	139.2	221.1	98.8	183.5	171.9	103.1	211.5	175.5	130.1	174.9	170.8	216.6	169.2	175.6	242.3	269.0	247.7	289.2	111.1	214.9	245.1	210.8	121.9	158.4	159.7	265.0	111.1	196.0	491.8	379.8	179.0	293.2	283.7	303.8	192.7	262.7	191.0	191.6	181.0	172.2	195.7	263.1	349.2	249.6	164.3	282.3	333.2	1471.2	323.1	131.9	372.0	265.3	129.2	287.2	173.4	181.8	170.0	328.9	117.6	152.0	287.9	73.2	133.4	264.4	196.1	233.0	132.6	256.1	339.1	726.8	567.8	240.2	175.6	328.5	227.9	199.9	319.1	139.5	267.6	238.7	348.0	244.5	287.0	291.8	303.2	255.3	287.5	262.4	60.3	458.6	200.3	240.7	351.5	457.0	91.9	98.6	97.9	110.3	88.1	93.5	100.6	94.6	99.9	98.4	96.8	103.1	183.9	44.8	94.5	7.2	219.3	228.2	271.7	185.8	191.2	41.5	276.0	342.9	43.3	164.5	118.1	108.5	18.8	470.9	273.6	146.4	187.9	182.7	438.1	99.7	141.5	160.6	129.9	131.1	4.2	309.1	328.2	159.1	122.3	108.9	129.3	197.3	167.4	98.9	225.1	21.9	4.1	231.1	81.4	288.5	268.9	1509.3	237.9	198.9	145.9	4.7	351.7	85.5	557.1	6.6	10.8	205.3	198.8	177.1	192.6	241.0	277.0	320.1	100.6	56.6	164.3	189.9	243.8	221.1	142.4	152.9	238.7	527.2	261.5	209.6	235.4	263.2
EIF4B		ENSG00000063046	"Eukaryotic translation initiation factor 4B"	P23588	12	53006282-53042215	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039072, HPA046164"	Approved		Enhanced	Cytosol		NA	NA		340000	"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA039072: AB_2676333, HPA046164: AB_2679567"	"unprognostic (1.91e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.44e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.69e-1)"	"unprognostic (8.20e-3)"	181.5	173.3	92.3	137.5	110.4	226.6	251.5	117.5	100.2	222.2	111.1	167.1	192.4	251.8	135.3	165.1	270.5	165.7	179.4	79.9	103.3	200.1	218.2	135.3	233.6	108.0	95.4	637.4	278.8	202.8	90.7	155.5	112.3	152.5	173.0	114.5	262.7	142.3	510.5	178.1	161.6	177.2	120.4	177.9	163.1	80.2	103.2	287.9	233.9	361.4	293.2	186.8	148.3	116.4	214.9	341.1	233.9	296.6	416.3	787.8	300.6	204.0	492.1	188.9	170.8	352.0	340.4	1318.2	296.3	311.4	160.4	234.2	420.0	460.4	238.3	256.6	244.3	503.4	450.6	401.5	320.0	723.3	282.4	787.1	473.2	219.2	682.1	1144.5	377.1	385.9	561.1	515.8	319.6	468.0	443.5	488.4	438.3	232.9	178.6	447.7	321.9	558.8	267.8	347.1	238.8	326.7	213.7	456.4	432.2	298.9	521.9	485.3	339.6	128.6	272.0	142.8	184.6	450.2	529.3	330.0	219.3	318.7	180.7	40.8	76.2	40.8	105.0	79.0	152.5	96.1	126.9	116.3	94.9	69.9	159.2	148.3	19.7	100.0	97.9	61.3	114.2	146.9	92.3	110.4	117.5	100.2	79.9	103.3	108.0	95.4	112.3	120.4	103.2	116.4	140.5	147.4	227.1	20.2	283.6	207.9	244.9	179.3	270.4	86.8	246.1	177.4	144.2	215.9	166.5	93.8	31.3	139.7	220.6	108.7	181.9	131.7	242.5	120.6	186.1	168.5	186.3	209.4	33.0	174.6	244.5	145.4	154.5	124.8	235.5	201.5	208.1	211.3	109.4	63.9	35.5	188.0	71.2	276.1	185.3	638.6	202.3	182.9	140.5	18.7	254.0	127.0	178.2	22.6	37.7	129.2	117.6	195.6	227.5	214.8	204.1	257.6	121.6	85.5	111.7	205.1	160.7	79.6	48.6	281.3	235.8	178.7	243.3	203.7	234.0	244.0
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550674-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, RNA-mediated gene silencing, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	40.8	35.9	27.8	52.4	29.0	58.3	43.0	29.2	34.3	35.4	26.9	67.4	50.6	41.6	36.9	51.9	33.2	42.8	38.3	28.1	29.2	63.9	93.2	45.2	49.2	30.4	28.7	33.6	40.8	36.2	24.5	56.9	31.5	34.8	77.2	34.4	38.8	31.8	153.1	50.2	52.5	56.1	27.1	42.5	51.1	42.2	29.5	41.9	36.2	62.5	61.9	47.3	34.3	31.1	104.9	99.5	108.7	79.3	83.4	110.2	161.9	144.9	88.3	101.9	107.8	109.8	100.3	109.0	39.0	151.6	116.7	88.6	128.2	131.2	128.9	98.6	122.0	146.6	97.4	149.9	98.8	213.0	130.7	103.1	98.1	105.5	78.5	102.8	172.1	53.0	139.0	34.7	118.7	201.4	83.1	171.0	174.3	124.1	83.5	73.2	231.7	72.3	209.6	133.2	98.7	135.5	77.0	86.6	95.3	117.2	81.3	145.3	148.6	88.3	114.9	96.6	106.1	67.3	71.0	139.8	100.0	109.4	78.9	299.2	205.7	194.4	63.6	220.0	51.4	62.2	65.8	67.7	179.3	60.5	55.1	56.1	132.1	70.7	205.9	70.9	114.7	155.5	27.8	29.0	29.2	34.3	28.1	29.2	30.4	28.7	31.5	27.1	29.5	31.1	37.2	41.7	57.3	11.8	40.1	38.0	78.2	127.4	31.3	19.8	41.5	49.3	36.9	65.8	85.4	35.0	18.8	142.0	53.6	109.1	74.3	164.5	129.6	45.6	63.1	46.9	66.0	50.7	20.0	151.5	204.3	60.2	48.9	68.6	43.7	47.2	50.0	119.9	125.4	20.2	19.3	111.3	120.1	90.8	87.5	302.4	38.2	72.6	30.2	10.3	135.8	29.3	51.5	12.1	29.7	159.8	109.3	38.7	51.8	96.8	139.1	170.8	58.8	22.3	26.3	38.8	118.5	68.4	56.0	59.7	51.1	182.5	42.7	92.3	87.9	120.4
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 54.6;Late spermatids: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	12.5	11.9	14.3	10.4	14.8	14.3	11.9	19.7	17.3	15.9	11.4	19.4	11.4	15.0	13.0	14.0	13.8	7.8	13.2	15.3	15.0	12.3	8.4	12.1	12.6	13.6	14.7	15.0	10.5	16.7	10.8	13.6	14.3	13.5	11.5	18.0	12.1	13.2	20.2	15.7	11.8	12.1	11.6	12.3	12.3	34.7	13.8	12.9	13.5	14.5	14.9	15.6	14.3	17.3	19.8	11.6	29.4	16.0	16.1	14.2	11.7	13.7	16.8	21.4	19.8	13.4	7.0	25.3	7.9	20.7	14.3	19.1	26.9	12.5	19.7	20.2	27.0	10.3	20.0	15.4	16.7	41.0	17.9	16.6	16.9	15.8	17.8	19.5	18.4	14.8	25.4	27.0	20.3	22.4	27.8	20.3	13.5	18.3	9.5	31.1	24.5	26.0	21.7	14.7	22.6	20.9	18.9	15.4	14.5	19.4	16.4	16.1	20.5	14.3	18.6	14.4	15.5	19.3	20.4	25.1	13.7	14.8	17.1	1.3	2.4	1.2	3.4	3.0	3.5	4.8	1.8	3.3	2.2	2.0	1.8	3.2	2.0	1.0	8.1	4.4	1.4	1.9	14.3	14.8	19.7	17.3	15.3	15.0	13.6	14.7	14.3	11.6	13.8	17.3	8.4	12.8	15.2	23.2	10.6	7.4	7.3	6.2	15.4	18.0	9.6	8.9	22.7	10.0	8.5	12.9	12.5	9.8	13.8	8.6	9.8	8.9	54.6	8.0	12.8	10.2	12.0	12.4	21.0	6.4	5.5	8.1	12.2	13.0	6.3	23.1	11.0	8.9	8.0	18.5	20.5	10.8	8.2	9.5	6.2	98.9	14.6	7.5	7.2	13.1	14.5	8.1	14.4	20.1	20.2	10.2	3.6	15.4	10.3	10.7	5.7	9.4	6.3	13.7	6.6	11.8	11.0	38.7	13.3	10.7	10.5	6.7	8.2	9.0	8.1	8.0
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 348.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	86.2	91.8	24.8	75.7	22.2	84.0	69.0	17.9	22.2	66.6	34.1	81.8	62.0	71.3	32.7	126.8	59.6	50.9	90.8	23.3	29.8	53.9	113.0	74.2	55.7	38.5	36.1	57.5	96.2	99.3	57.4	59.4	32.4	62.2	56.5	22.3	93.1	59.2	348.3	116.7	67.2	74.7	24.4	58.2	79.9	64.8	37.4	49.1	71.3	177.0	63.2	76.0	85.3	16.6	559.0	232.3	173.1	205.7	196.9	192.5	322.5	298.6	204.1	315.4	238.8	486.5	173.7	348.4	381.9	367.6	358.5	292.7	322.6	365.8	230.5	375.1	345.8	321.3	226.1	206.4	173.4	321.4	212.2	199.6	206.8	292.4	268.8	152.8	278.3	128.8	239.6	267.2	205.7	403.4	219.7	105.3	368.9	241.3	180.8	221.7	183.4	281.9	156.8	331.8	197.7	174.6	258.1	415.6	187.6	144.6	445.2	206.5	364.1	227.2	228.9	297.3	567.9	203.8	263.2	629.0	260.5	271.4	258.3	8.3	16.0	6.7	11.7	14.4	10.8	7.7	7.8	9.6	12.8	9.2	6.9	7.6	5.6	8.7	21.0	18.1	6.0	12.7	24.8	22.2	17.9	22.2	23.3	29.8	38.5	36.1	32.4	24.4	37.4	16.6	63.9	76.9	72.6	23.8	41.7	59.1	78.2	58.0	70.6	24.2	69.3	46.2	109.4	50.1	72.3	62.5	14.6	64.0	37.6	135.5	13.7	98.8	151.6	53.0	67.1	69.3	55.7	82.7	10.8	135.3	74.8	64.5	75.4	85.6	48.0	163.8	43.5	152.8	66.8	21.9	12.9	97.2	50.8	40.8	39.9	202.7	73.0	48.9	33.8	14.0	53.0	23.2	30.9	4.0	10.1	149.0	69.0	56.1	112.9	96.8	77.0	45.4	51.4	23.2	78.9	81.6	78.9	24.8	41.4	120.7	91.8	79.6	46.0	94.8	108.4	95.6
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10808940	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol		NA	NA		48000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	307.1	259.9	177.4	278.4	178.0	516.4	213.7	182.9	197.9	281.1	260.2	329.2	217.0	310.5	310.1	372.0	265.0	290.0	377.9	165.0	195.9	321.8	288.7	312.8	286.6	190.0	226.5	247.1	259.6	368.6	160.2	406.4	196.9	276.2	318.6	258.5	231.1	305.5	456.4	299.5	216.3	395.9	186.5	249.5	245.4	226.4	193.0	384.8	349.7	372.4	369.3	430.0	203.0	191.1	933.5	715.1	958.4	527.9	668.2	712.0	668.4	848.9	841.7	713.1	483.6	790.1	1064.3	525.7	474.1	1029.4	545.2	537.8	1048.1	781.0	970.8	820.1	489.0	676.3	427.7	607.2	580.2	1041.8	545.9	582.3	601.0	444.6	577.3	657.1	830.2	483.5	527.8	570.5	935.1	481.8	691.7	377.9	702.1	646.8	756.0	690.3	563.8	336.1	630.7	1328.3	357.9	584.6	966.5	658.7	516.7	640.7	561.1	474.5	805.5	916.1	614.8	793.4	711.4	281.5	841.5	766.9	531.5	600.2	998.7	343.1	331.3	498.6	212.1	382.2	277.0	251.3	237.3	250.1	304.6	212.9	205.8	212.9	244.6	262.4	422.3	162.3	295.9	767.1	177.4	178.0	182.9	197.9	165.0	195.9	190.0	226.5	196.9	186.5	193.0	191.1	306.7	323.7	284.4	48.6	273.6	633.2	372.0	213.4	285.1	128.1	236.0	196.0	382.6	198.8	243.4	147.1	123.0	321.8	289.0	422.3	244.6	325.2	163.7	213.4	247.1	302.9	247.8	169.1	48.1	368.1	373.7	250.1	263.5	269.3	199.5	271.3	209.9	209.0	272.2	164.9	53.8	279.7	191.2	240.1	417.9	152.0	208.8	312.7	250.8	54.4	279.7	197.3	224.6	36.7	53.3	582.5	260.6	240.7	262.0	307.1	205.6	329.5	225.3	142.8	131.5	328.1	363.1	203.6	197.6	320.3	630.1	1056.1	267.7	281.2	289.0	518.3
EIF5		ENSG00000100664	"Eukaryotic translation initiation factor 5"	P55010	14	103333544-103345025	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 787.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000867, CAB004226"	Supported		Enhanced	Cytosol		NA	NA		77000	"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB004226: AB_627507, HPA000867: AB_1078731"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.47e-3)"	"unprognostic (6.33e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.70e-2)"	"prognostic favorable (5.67e-7)"	"unprognostic (2.76e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.14e-2)"	90.5	60.4	82.6	54.5	86.9	194.4	72.1	89.7	90.9	48.7	73.7	81.6	79.5	56.3	54.9	74.4	66.2	63.3	85.2	87.8	92.7	92.4	151.4	64.6	62.3	88.1	93.0	45.6	78.1	81.7	40.8	66.3	93.4	54.9	77.9	50.4	63.5	75.1	163.6	56.8	67.4	71.0	96.3	55.3	65.3	94.9	87.4	61.6	93.4	144.5	80.1	62.9	46.0	103.2	132.9	149.4	174.0	79.1	147.0	129.1	182.3	190.7	205.1	192.5	145.3	223.7	137.3	136.4	117.2	172.4	165.0	173.3	220.9	193.3	325.6	111.9	87.4	121.9	76.3	119.6	152.8	222.1	100.6	139.7	127.0	170.8	230.6	160.2	196.9	98.9	255.8	126.7	161.3	188.7	152.7	73.4	90.5	251.7	285.8	127.4	226.1	85.1	112.8	423.7	153.7	107.7	191.6	141.3	155.9	161.0	135.5	100.8	149.7	152.8	103.3	196.3	201.5	376.2	787.9	287.4	150.5	154.3	182.4	356.8	245.1	323.9	235.1	249.1	265.2	335.0	239.4	224.3	241.5	334.1	283.0	236.8	266.1	315.1	273.0	329.2	221.1	401.0	82.6	86.9	89.7	90.9	87.8	92.7	88.1	93.0	93.4	96.3	87.4	103.2	282.4	144.2	158.6	56.5	269.5	340.1	346.0	216.0	362.0	196.8	260.5	252.3	307.3	101.5	172.4	73.5	185.6	233.0	298.1	221.9	215.2	243.8	280.6	182.0	162.9	227.9	199.6	408.1	47.3	282.3	212.1	267.6	137.1	252.4	278.7	218.7	134.6	255.5	173.1	176.7	40.9	220.3	187.2	158.4	313.2	683.5	128.0	282.5	152.9	30.9	238.7	167.7	129.8	24.6	60.6	247.8	161.7	173.8	414.4	260.4	233.7	272.3	179.8	212.9	118.3	460.0	372.7	507.8	367.8	323.2	265.2	493.8	281.7	213.1	232.0	254.0
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017183	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	1.6	0.2	0.2	12.7	0.1	0.8	79.2	0.8	0.4	55.3	0.1	161.3	142.9	12.9	4.5	237.0	35.5	77.6	5.0	0.1	0.2	66.7	79.2	59.8	0.3	0.0	0.0	1.2	120.7	8.4	3.9	6.1	0.1	58.7	127.5	1.0	147.1	14.8	0.2	14.5	145.6	7.3	0.0	0.5	122.7	0.2	0.1	1.6	6.6	0.0	16.0	165.2	93.6	0.2	56.1	209.6	0.0	0.4	0.0	0.0	63.5	0.0	7.9	0.0	0.1	47.3	296.0	0.3	24.0	0.0	1.7	53.8	0.0	0.2	0.0	6.7	0.2	0.0	38.3	9.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.7	0.3	0.7	3.3	196.3	17.6	0.1	0.1	3.0	78.3	215.3	0.3	0.4	2.4	405.7	0.2	9.2	28.8	0.0	0.1	0.0	0.7	0.4	0.5	1.2	3.9	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	2.7	294.9	422.9	0.0	12.2	5.1	691.3	879.7	113.8	1.5	470.3	180.3	1.5	586.2	1130.0	329.2	18.8	76.6	9.5	1599.6	41.1	792.7	0.0	812.3	90.8	16.4	452.2	2.7	0.4	641.0	122.2	15.9	1390.9	1127.5	40.6	0.2	0.4	38.6	9.3	0.0	0.2	1225.3	1102.7	2.5	2.7	0.0	0.0	18.6	8.8	0.0	15.4	2.6	1.0	0.5	0.1	512.5	1506.1	0.0	6.0	1014.2	1476.3	147.1	888.2	67.3	0.0	0.8	46.3	0.0	0.3	418.5	8.4	257.2	18.7	0.3	983.0	1628.9
ELK1		ENSG00000126767	"ETS transcription factor ELK1"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 251.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	16.8	30.7	71.7	12.4	53.1	13.7	12.0	37.1	62.5	15.0	19.9	12.8	9.0	17.0	17.4	15.0	18.6	10.1	19.3	58.5	32.8	12.6	26.4	16.2	12.3	26.7	26.2	54.2	12.9	17.0	12.7	9.2	27.5	15.4	9.6	7.7	13.1	11.2	32.9	15.2	12.9	10.9	23.4	18.9	13.6	21.2	52.2	12.9	10.5	18.5	12.3	14.8	11.9	40.6	35.6	27.2	14.3	39.1	23.3	26.5	19.8	31.1	34.9	34.8	34.5	19.3	26.4	29.0	16.1	31.0	59.9	21.2	37.6	31.7	31.5	31.1	34.8	23.4	25.0	17.9	49.3	26.3	39.4	27.9	27.2	53.4	33.5	28.8	20.8	40.4	47.9	32.9	27.8	46.5	28.2	30.8	33.7	16.7	59.1	30.0	36.0	45.8	19.7	15.3	31.0	25.6	48.5	17.8	43.4	31.8	44.7	16.7	16.1	39.5	41.2	53.9	29.2	53.5	83.2	27.8	44.5	45.3	25.0	1.7	6.3	2.8	5.3	7.2	6.4	5.2	6.8	6.3	9.5	4.6	5.7	5.0	3.1	3.4	6.5	6.5	9.8	5.6	71.7	53.1	37.1	62.5	58.5	32.8	26.7	26.2	27.5	23.4	52.2	40.6	10.1	0.0	6.7	4.2	12.0	16.8	14.3	7.5	15.9	15.2	15.0	10.4	9.0	5.7	5.3	7.3	4.2	7.7	6.3	7.5	5.9	7.6	4.0	8.0	13.3	9.8	10.2	14.9	7.7	7.3	9.6	18.0	6.6	9.2	8.2	251.8	20.3	14.6	10.3	5.0	5.7	7.8	4.1	9.5	19.0	3.3	14.0	15.0	7.2	2.8	16.8	9.0	6.2	5.0	2.9	7.1	5.6	29.7	10.3	12.8	4.6	6.3	2.1	7.2	6.6	18.7	20.0	2.6	11.1	12.3	15.9	8.9	11.1	48.8	10.0	11.8
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	242.4	134.7	51.3	74.9	67.0	114.6	199.2	74.6	79.2	48.9	49.4	40.0	28.3	39.8	49.7	28.4	46.0	51.3	37.8	50.8	65.3	38.9	108.9	68.4	106.7	80.7	69.0	32.3	15.4	24.3	28.5	40.2	74.5	128.0	18.3	36.5	24.8	103.0	9.9	32.9	47.5	52.4	67.7	56.1	22.8	82.5	65.8	107.3	45.1	19.5	102.4	67.1	27.0	98.9	137.2	98.1	168.0	309.0	436.0	250.8	71.3	155.8	174.2	123.2	171.5	87.4	154.5	154.4	110.3	163.3	193.1	78.9	168.0	142.6	183.7	131.2	117.5	153.1	85.0	122.9	239.0	122.2	107.2	233.6	109.8	123.6	153.9	124.5	139.1	301.4	194.2	87.3	90.3	14.9	364.4	107.9	91.2	5.2	73.6	139.9	115.3	54.3	232.7	80.6	155.7	107.1	129.3	66.9	135.2	108.7	152.3	112.9	133.0	134.7	118.5	242.2	208.8	72.8	72.1	116.2	70.2	173.6	97.8	47.6	49.2	183.7	34.9	34.9	56.5	88.4	58.1	42.7	77.9	101.5	27.8	26.3	261.5	36.7	45.0	20.4	110.0	50.6	51.3	67.0	74.6	79.2	50.8	65.3	80.7	69.0	74.5	67.7	65.8	98.9	48.6	80.1	50.7	75.4	118.3	52.4	108.2	36.8	44.3	11.6	177.3	70.9	23.3	21.5	40.2	12.9	2.1	25.3	55.5	2.1	15.6	34.9	94.2	37.4	53.2	54.4	25.0	77.0	25.8	36.1	58.2	54.8	3.1	66.4	99.0	28.4	39.3	88.7	35.5	8.4	29.8	1.6	16.2	57.3	114.6	181.0	20.8	55.5	48.0	39.4	53.5	83.2	39.1	49.3	111.2	27.8	1.4	32.0	45.2	169.2	21.9	48.4	58.5	6.0	65.7	27.3	77.5	27.0	18.9	35.7	60.9	31.2	97.2	60.0	4.4	73.4
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 74.3;Glandular and luminal cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	13.6	13.0	17.3	11.0	19.0	6.6	16.6	19.0	20.3	26.1	14.1	13.8	9.7	22.6	11.3	12.2	16.1	15.4	16.3	19.2	19.8	17.5	21.0	12.1	16.3	18.2	17.4	16.1	10.9	16.8	11.6	12.0	18.5	13.4	15.6	12.4	9.8	19.2	27.9	12.0	11.1	14.9	18.0	13.7	10.7	14.2	20.1	14.6	18.3	26.5	19.5	13.6	10.6	19.6	34.5	36.3	26.1	21.7	28.9	27.8	17.6	17.7	26.6	31.9	31.2	23.9	14.7	60.0	24.6	27.7	31.3	21.5	26.3	34.3	41.2	11.2	12.4	38.0	21.9	41.3	27.7	21.4	27.5	32.7	48.4	24.4	36.5	26.2	32.4	41.3	46.2	34.8	32.9	20.9	47.3	30.1	28.9	29.5	12.0	34.4	24.4	24.2	33.8	25.5	13.6	25.5	18.1	14.4	28.4	21.3	29.2	24.2	25.7	23.6	35.2	26.8	26.5	14.4	25.9	45.2	26.7	24.7	26.8	20.2	16.1	12.9	25.0	22.2	28.7	17.9	21.8	26.0	18.3	21.2	18.7	22.1	3.8	25.0	27.0	17.3	23.5	19.1	17.3	19.0	19.0	20.3	19.2	19.8	18.2	17.4	18.5	18.0	20.1	19.6	8.8	3.2	12.7	26.4	14.4	2.7	7.1	10.2	10.8	8.5	6.8	8.9	16.6	7.2	11.1	7.3	22.9	15.1	12.5	6.3	7.9	12.5	7.4	74.3	25.0	10.1	1.2	9.4	32.2	9.9	14.8	9.5	9.7	125.2	8.2	12.8	10.4	19.0	14.9	15.2	38.7	7.0	0.0	13.2	4.0	4.8	8.4	9.6	1.8	31.9	9.6	8.7	24.7	49.3	45.9	9.3	11.3	10.1	11.0	7.6	9.9	13.1	10.6	12.2	0.0	9.5	8.4	20.2	17.7	6.9	2.4	10.4	13.7	15.6	10.5	5.4
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379273-154381523	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		240000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	"Endoplasmic reticulum"	"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	32.8	32.5	27.4	15.4	27.4	26.5	33.2	27.8	31.8	46.6	26.6	45.7	14.7	58.2	16.0	35.0	56.2	11.2	46.2	26.0	30.1	48.7	30.6	33.3	13.8	28.5	28.6	63.9	50.5	21.3	42.6	15.5	28.2	36.5	11.1	12.9	33.5	21.8	80.3	36.3	27.2	19.9	29.2	26.9	38.5	17.3	29.7	13.0	40.6	29.7	15.4	51.2	36.1	31.4	121.3	42.4	29.0	32.7	26.3	50.6	54.7	58.1	58.2	68.5	72.4	37.9	22.6	99.6	92.2	56.2	143.5	65.5	55.8	67.4	29.5	60.6	116.8	43.7	58.4	22.5	67.9	42.9	46.8	44.1	53.2	60.4	75.0	46.5	48.3	37.5	37.0	39.0	47.9	49.2	74.4	78.1	51.3	66.3	128.9	62.1	45.9	92.4	38.4	21.9	37.9	47.8	29.8	47.6	74.2	27.8	33.6	31.2	43.5	35.7	69.6	80.2	84.2	131.4	100.6	179.3	42.3	70.9	38.1	35.5	29.5	46.4	45.2	37.3	41.8	37.8	43.1	43.6	24.8	37.0	37.7	37.7	31.0	28.7	28.1	54.9	43.3	30.6	27.4	27.4	27.8	31.8	26.0	30.1	28.5	28.6	28.2	29.2	29.7	31.4	30.3	32.1	39.5	8.1	93.1	71.8	74.8	60.9	84.2	35.1	53.4	60.1	22.3	35.8	40.4	27.6	12.5	60.7	87.4	16.6	70.5	43.5	16.3	46.5	51.8	36.2	23.9	46.7	9.6	55.0	66.4	52.9	53.5	64.4	55.1	40.9	27.1	38.8	52.2	30.3	8.8	37.0	28.5	25.2	93.0	15.4	40.7	69.4	67.6	10.3	50.2	46.9	34.0	5.5	10.8	47.7	31.3	44.8	125.8	86.4	30.9	49.5	27.9	32.6	26.3	49.5	60.1	25.4	36.2	99.3	77.0	125.1	92.7	42.3	30.4	68.3
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		15000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	26.3	20.2	30.3	16.5	25.9	0.5	13.4	21.1	20.3	13.5	2.0	30.9	12.5	23.6	13.7	16.2	15.0	23.6	25.2	27.2	35.7	7.0	7.5	17.3	4.7	35.5	34.2	22.6	22.3	17.9	6.5	18.2	28.1	21.4	10.1	8.1	20.9	30.6	20.4	10.6	10.8	57.6	22.4	24.8	23.3	25.0	40.9	9.0	7.3	11.5	4.6	30.1	13.8	28.7	91.6	71.9	87.1	79.0	33.3	43.7	111.9	99.1	47.3	58.4	43.9	46.4	33.0	38.7	256.8	153.9	52.5	79.0	102.7	37.4	55.2	0.6	63.4	40.3	62.4	63.1	99.4	4.8	1.5	67.9	44.2	75.9	96.2	47.8	47.0	10.7	2.7	1.9	58.6	17.7	18.5	4.7	146.8	23.9	64.3	27.6	122.9	1.1	26.9	69.5	85.3	68.9	194.6	73.3	63.3	66.1	87.5	5.9	92.2	150.4	109.8	126.8	198.6	4.2	11.4	25.7	82.7	5.0	78.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.3	25.9	21.1	20.3	27.2	35.7	35.5	34.2	28.1	22.4	40.9	28.7	117.0	12.8	37.3	81.9	3.8	129.0	172.5	64.4	26.2	11.2	96.2	57.9	119.3	54.3	56.5	22.0	62.6	65.0	1.7	14.8	3.9	84.7	74.8	127.2	60.5	79.3	41.4	0.0	86.3	100.5	18.5	71.6	63.2	75.0	5.1	194.2	23.9	12.9	11.2	16.8	155.0	27.3	26.4	1.6	29.7	24.3	58.1	4.3	83.6	41.2	3.8	32.6	3.1	160.4	151.3	61.5	16.5	168.9	1.6	133.1	3.5	19.6	137.8	19.0	92.1	69.4	166.1	13.4	37.2	25.6	134.1	60.5	4.8	220.7	31.3	100.3
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879190	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394, CAB080034"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		310000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	463.4	418.4	552.9	553.3	591.7	792.8	409.1	679.7	749.9	370.7	585.6	382.6	401.2	321.7	125.7	1049.4	281.6	302.0	328.2	638.1	599.6	1063.6	612.2	453.2	492.4	624.1	607.7	295.0	220.8	347.2	245.7	362.7	602.9	279.2	358.3	741.5	581.3	354.2	231.0	548.1	382.3	471.3	583.4	394.9	321.6	217.7	585.3	455.6	271.4	146.5	695.4	485.9	519.7	571.5	3637.0	3088.4	1461.8	1258.6	1194.2	1323.8	1316.6	1919.1	2110.9	4044.1	3767.4	1986.9	2041.5	2586.5	2496.8	2328.5	1651.8	1736.8	2511.5	5127.7	4081.0	1780.5	2645.9	2191.3	2848.0	2511.0	1789.6	4421.6	1290.1	1377.4	1526.1	3208.9	4825.9	3045.2	2630.1	1294.6	2444.4	982.3	2664.2	1784.1	1685.2	2354.5	1600.3	1290.4	3063.4	1712.4	2172.9	4259.0	4815.0	843.6	1961.4	1211.1	2251.0	3232.5	2407.8	1748.4	1621.8	1302.1	2424.7	2774.5	2444.5	2402.3	3328.3	2771.0	2120.4	3906.9	4313.8	3556.1	2388.6	195.9	1198.7	232.3	528.4	822.7	597.3	411.2	552.5	543.2	1216.4	386.1	443.4	466.0	230.6	635.3	830.6	336.1	700.0	2171.2	552.9	591.7	679.7	749.9	638.1	599.6	624.1	607.7	602.9	583.4	585.3	571.5	140.0	278.9	499.1	99.6	222.3	416.5	570.9	1939.8	348.8	178.2	242.7	324.6	69.6	283.1	657.4	606.9	70.9	1045.4	194.0	455.9	925.4	2259.3	281.3	205.3	227.7	314.3	189.0	145.4	32.0	1399.1	2078.5	303.5	144.8	248.4	297.2	408.6	133.5	351.7	1147.4	482.9	33.2	297.3	787.3	356.4	524.5	699.6	171.5	454.2	448.2	30.9	1558.2	2624.9	279.1	28.6	26.9	1433.6	366.9	135.1	211.0	555.7	742.2	1005.4	245.7	216.6	151.2	156.1	402.5	215.1	154.3	468.1	349.6	1001.8	285.6	609.8	528.4	444.2
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41092592-41180077	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	15.7	13.7	6.8	17.7	8.9	65.1	14.2	20.5	10.8	16.0	6.1	16.6	13.6	17.2	13.5	16.3	16.4	14.2	11.5	7.1	9.4	13.1	15.5	14.7	17.6	10.6	7.8	23.9	18.0	23.2	13.4	19.3	7.7	15.0	14.5	17.8	15.0	15.6	20.4	18.9	16.0	16.4	5.3	17.0	14.5	19.6	8.6	27.2	20.2	23.4	17.9	15.4	14.8	11.2	31.6	21.7	35.4	23.0	22.2	23.3	32.3	15.0	21.8	21.0	21.0	27.8	12.0	32.7	12.2	28.4	18.7	24.1	48.1	20.8	23.5	30.5	32.2	24.4	25.4	22.3	26.9	59.3	26.5	24.8	22.2	30.0	27.0	19.3	24.9	18.7	26.3	43.9	18.3	12.5	16.2	18.9	27.5	38.3	15.2	33.7	16.7	21.3	20.3	40.4	11.3	11.9	51.1	26.0	25.6	29.5	17.8	33.9	31.3	20.3	24.8	16.3	20.8	28.5	14.1	47.9	16.3	17.4	21.5	3.6	1.7	1.6	1.6	1.9	1.5	2.2	1.7	1.7	2.1	1.4	1.4	1.1	4.9	2.7	1.0	1.6	1.4	1.2	6.8	8.9	20.5	10.8	7.1	9.4	10.6	7.8	7.7	5.3	8.6	11.2	45.4	67.3	49.2	58.1	53.8	24.6	22.9	11.6	40.9	44.6	35.1	25.8	31.6	38.6	15.8	25.8	35.5	18.4	63.2	37.0	3.9	16.1	15.3	55.1	56.4	36.2	24.7	60.4	71.8	18.7	17.9	32.0	27.5	72.5	25.3	36.1	32.9	29.2	18.4	25.2	73.6	24.2	2.0	60.7	25.7	6.4	28.9	60.5	8.8	45.9	52.0	27.7	40.2	81.4	80.3	25.8	28.9	30.5	51.2	30.8	20.2	10.8	22.8	30.9	26.3	47.6	36.7	22.8	31.2	35.3	25.9	30.2	46.0	36.7	23.7	36.3
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 171.9;Excitatory neurons: 306.8;Inhibitory neurons: 237.4;Late spermatids: 291.6;Oligodendrocytes: 159.2;Syncytiotrophoblasts: 214.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 12.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;HUVEC TERT2: 59.5;SCLC-21H: 65.5;TIME: 164.8;U-2 OS: 57.7;U-2197: 57.1;U-251 MG: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	27.6	28.1	5.8	27.4	5.3	4.1	11.7	17.9	49.9	6.4	0.0	17.7	49.6	7.8	5.6	10.7	13.6	9.3	6.5	7.1	24.8	33.9	4.8	13.9	7.9	59.6	14.7	11.4	6.9	59.6	10.4	21.1	53.3	5.8	13.1	45.8	4.0	7.3	6.1	4.0	47.7	13.4	7.7	12.2	3.2	62.3	29.1	6.5	4.6	10.7	3.9	10.3	5.7	29.8	0.3	0.9	3.9	0.0	54.5	62.8	43.7	12.8	0.0	0.0	0.0	0.7	0.1	0.1	0.1	39.8	23.2	0.2	38.6	0.0	0.0	0.0	34.2	0.1	0.4	0.0	0.2	0.1	4.6	33.3	0.0	12.3	0.1	16.2	59.5	0.0	0.4	0.4	0.1	0.0	0.5	0.7	7.9	0.2	12.5	0.3	0.0	0.2	0.4	4.8	65.5	0.5	0.1	0.5	25.9	31.2	0.7	4.8	164.8	0.3	57.7	57.1	71.6	0.1	0.1	0.0	0.2	5.4	6.8	0.0	4.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.7	0.0	12.4	0.0	0.0	0.7	5.8	5.3	17.9	49.9	7.1	24.8	59.6	14.7	53.3	7.7	29.1	29.8	18.2	19.2	6.4	28.7	1.3	15.9	4.1	0.0	3.4	75.6	5.3	1.7	3.5	2.8	1.9	7.3	77.2	98.6	0.2	44.0	15.6	0.4	171.9	2.2	10.1	21.9	9.1	3.2	306.8	0.7	44.2	27.7	0.0	2.1	0.0	0.0	7.1	0.8	58.8	3.3	237.4	10.0	0.0	82.2	66.7	291.6	22.4	81.9	10.6	103.0	50.9	3.3	2.1	44.2	159.2	0.8	8.3	7.9	1.6	3.8	91.2	68.4	1.6	14.7	0.0	3.0	13.1	2.7	11.5	2.3	8.4	214.0	2.6	0.2	12.3	1.7
EPB41L5	"BE37, FLJ12957, KIAA1548, LULU, LULU1, YMO1, YRT"	ENSG00000115109	"Erythrocyte membrane protein band 4.1 like 5"	Q9HCM4	2	120013077-120179119	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 55.5;MCF7: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037563, HPA037564"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA037563: AB_2675546, HPA037564: AB_2675547"	"unprognostic (1.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (5.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.20e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.61e-1)"	5.7	6.0	9.0	3.0	7.3	1.0	15.7	43.4	10.6	7.2	4.5	9.9	14.0	7.5	5.8	8.8	12.8	7.4	6.3	7.1	11.1	32.7	56.8	29.9	2.5	8.9	11.1	11.6	26.2	25.1	8.2	9.8	9.0	12.4	8.8	27.8	15.3	6.1	10.1	8.3	11.7	6.5	8.7	2.5	9.1	30.5	12.4	3.6	32.9	8.9	6.6	6.1	8.4	8.1	18.0	6.1	23.8	18.5	16.4	11.8	20.8	3.8	3.7	7.8	7.0	55.5	11.7	0.3	12.9	4.8	9.7	12.1	32.4	14.9	11.5	3.6	10.1	5.2	2.8	31.1	19.1	2.3	5.3	10.6	27.6	14.6	10.4	6.7	22.1	10.4	12.4	1.3	15.6	83.4	4.3	7.9	21.5	8.3	5.6	0.0	7.1	5.0	24.2	17.1	12.3	23.5	16.5	29.0	8.2	32.5	14.0	4.3	18.4	0.7	11.2	12.3	3.9	1.9	3.5	9.2	2.0	0.1	4.5	0.1	0.5	0.6	0.4	0.1	0.1	1.7	0.4	0.4	0.1	1.3	1.1	0.8	0.7	0.6	0.3	0.0	0.2	0.4	9.0	7.3	43.4	10.6	7.1	11.1	8.9	11.1	9.0	8.7	12.4	8.1	6.0	218.0	41.9	61.0	11.1	24.5	28.9	9.7	21.6	33.9	28.0	14.1	13.2	24.3	22.5	33.1	25.0	14.9	4.3	20.6	21.5	18.8	38.0	25.8	12.6	6.8	15.5	5.7	68.4	22.3	12.1	13.1	56.1	45.8	0.0	12.0	17.9	54.2	3.2	8.4	79.8	12.7	22.4	2.1	6.8	20.6	9.0	2.8	14.2	26.2	1.1	15.8	0.0	89.5	25.9	23.2	21.7	9.4	5.9	29.1	20.9	29.0	17.5	35.7	19.7	11.7	9.8	43.5	48.6	18.3	21.7	26.4	6.2	5.7	12.9	39.4
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 24.2;ovary: 6.3;testis: 8.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 24.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 9.3;U-266/70: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.2	0.0	6.5	0.0	12.7	0.0	0.2	24.2	10.9	0.8	0.0	3.2	0.1	0.9	0.3	0.8	1.9	0.9	0.3	11.4	0.0	0.4	0.0	0.1	0.0	0.0	0.2	6.3	0.5	0.1	0.1	0.0	1.1	1.0	0.7	1.1	0.1	0.6	0.0	0.0	0.3	1.4	0.1	0.0	0.6	8.4	3.5	0.2	2.0	0.1	0.1	1.4	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	9.3	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.4	0.0	0.9	28.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	12.7	24.2	10.9	11.4	0.0	0.0	0.2	1.1	0.1	3.5	0.0	0.0	0.0	0.0	421.5	0.1	0.3	0.3	0.0	5.2	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	401.8	0.1	1.4	0.1	0.0	0.0	423.8	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	879.2	0.0	0.0	0.0	0.0	208.7	3.1	0.2	0.0	30.0	0.0	1.0	0.0	31.2	9.0	0.1	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.3	0.0	0.2	0.1	14.7	2.7	6.0	0.0	0.1	0.0	0.4	0.0	0.1
EPHX2	ABHD20	ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490781-27545564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 333.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 106.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 139.4;K-562: 51.6;OE19: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	19.3	74.0	14.5	9.1	15.0	1.9	30.1	14.4	14.1	21.0	42.2	61.4	112.8	17.7	27.2	38.6	41.6	9.4	29.1	13.2	15.3	166.3	333.2	11.2	17.2	16.1	17.3	38.0	64.5	54.8	35.8	8.5	15.9	64.6	57.6	21.5	36.5	27.2	16.2	43.4	128.4	15.4	15.8	10.8	23.4	9.0	15.8	65.9	22.6	13.8	20.8	19.7	23.4	15.7	15.3	10.1	6.3	8.1	0.4	0.0	4.8	1.3	0.9	0.7	0.2	8.0	10.1	0.1	5.9	4.1	3.2	10.7	1.1	2.6	0.5	0.0	4.7	22.5	1.1	24.8	3.4	0.1	4.5	8.6	10.7	0.1	1.1	2.5	0.5	139.4	51.6	0.2	0.0	4.7	14.9	0.5	10.1	102.4	17.2	0.1	0.1	0.4	8.7	2.2	5.1	16.0	12.1	14.2	15.0	4.6	21.8	4.2	0.2	0.0	3.8	1.8	0.1	12.5	10.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	7.8	0.0	11.3	4.5	35.0	12.7	0.1	2.5	106.7	50.4	0.2	4.6	0.1	0.2	29.6	20.0	14.5	15.0	14.4	14.1	13.2	15.3	16.1	17.3	15.9	15.8	15.8	15.7	6.3	6.4	17.0	16.3	6.1	11.9	18.6	10.1	29.6	34.1	17.2	18.4	23.7	20.0	9.7	27.6	79.2	22.8	1.0	82.7	180.0	8.8	7.5	6.9	4.8	9.4	23.4	3.8	3.0	6.4	2.5	12.1	15.8	1.5	5.7	17.4	17.5	131.5	2.2	33.7	7.2	63.4	2.0	4.6	1.2	4.8	29.8	3.6	5.4	2.8	2.6	91.5	3.1	7.5	5.1	3.1	83.7	18.8	4.5	20.5	399.0	259.3	24.1	52.4	0.0	11.5	10.2	1.3	13.9	39.2	18.3	8.2	11.9	78.5	101.3	10.8
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A glucan phosphatase, laforin"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.8;tongue: 79.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.2"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.8	6.0	11.4	1.5	11.7	1.8	3.2	11.9	17.8	3.1	7.3	17.2	3.2	6.0	4.3	9.3	4.4	3.6	24.4	11.6	12.6	8.5	5.7	3.0	3.3	11.9	11.5	5.7	2.4	5.2	3.8	1.5	11.1	6.1	2.9	12.1	3.1	8.8	76.8	2.1	3.8	6.3	10.3	2.1	5.3	3.0	11.5	4.8	3.9	79.5	2.6	9.8	2.7	13.3	1.3	2.1	3.4	6.6	8.6	2.3	1.6	3.1	3.8	2.9	3.5	1.7	1.7	23.2	2.7	3.8	3.5	1.8	1.3	1.6	2.6	9.3	1.9	3.6	2.5	2.7	4.8	12.7	2.4	2.0	7.0	1.7	0.7	3.8	2.0	5.0	1.8	5.4	3.8	3.1	8.4	3.2	3.9	3.2	1.9	4.8	3.1	6.7	2.5	1.8	6.3	6.4	5.5	3.3	7.8	3.1	1.9	7.3	4.6	2.9	1.1	2.7	2.6	4.1	4.6	8.6	2.6	2.8	4.8	0.0	0.0	0.0	0.1	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.9	0.1	1.9	0.1	0.3	0.0	0.3	11.4	11.7	11.9	17.8	11.6	12.6	11.9	11.5	11.1	10.3	11.5	13.3	3.9	6.4	1.5	66.9	4.4	0.9	1.0	0.8	0.6	8.4	3.5	2.2	27.8	2.8	2.2	1.8	6.2	1.0	1.9	0.2	11.7	1.0	33.0	1.9	3.6	2.2	1.2	4.4	30.4	2.3	0.7	2.3	1.1	1.4	2.5	6.0	1.4	6.6	2.3	30.3	50.7	1.5	2.0	3.3	1.4	19.8	3.1	3.1	7.2	15.9	1.7	7.9	2.1	56.8	60.1	1.2	1.7	2.2	1.7	1.5	0.5	7.1	2.2	6.3	0.0	6.2	2.4	4.9	1.6	0.8	0.4	0.4	1.8	5.1	1.2	0.3
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"	P58107	8	143857324-143878467	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 16.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 137.1;Suprabasal keratinocytes: 274.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;EFO-21: 13.3;HaCaT: 13.8;HeLa: 26.8;MCF7: 20.2;SK-BR-3: 9.3"	"Not detected"	"Not detected"							"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"		NA	NA		1200000		"Cluster 61: Skin - Cornification"	"Cluster 20: HeLa - Mitochondria"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.2	0.0	0.4	0.3	0.4	0.1	0.9	3.9	0.5	0.5	1.3	3.3	2.1	2.4	0.3	1.7	2.0	0.2	0.1	0.8	0.6	1.2	0.3	0.9	0.1	2.5	2.7	0.0	0.7	0.2	0.2	0.2	1.7	1.4	0.6	0.0	2.2	1.4	0.2	16.1	2.7	0.9	1.6	1.2	2.1	1.8	0.7	0.1	0.2	0.0	0.2	1.8	0.9	0.4	7.9	0.1	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	7.4	0.5	0.0	13.3	0.0	0.0	13.8	1.4	0.1	0.0	0.0	3.4	0.0	26.8	4.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	20.2	0.0	0.0	1.4	1.8	0.0	0.0	0.1	0.0	0.0	4.9	2.3	0.0	2.2	9.3	0.0	1.2	7.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	3.9	0.5	0.8	0.6	2.5	2.7	1.7	1.6	0.7	0.4	0.7	19.2	9.2	1.0	1.1	137.1	20.3	8.2	8.0	0.6	32.7	25.0	27.9	11.5	4.4	14.7	0.0	2.5	0.0	48.1	0.0	11.3	0.5	12.6	0.5	3.2	6.0	0.0	0.3	14.7	0.3	2.4	12.2	10.1	0.0	0.6	0.7	4.4	0.3	0.0	0.0	14.5	12.2	0.0	8.2	0.3	0.0	0.4	16.0	0.0	0.0	0.6	0.0	0.0	0.1	31.9	21.7	0.0	0.2	8.6	28.2	7.0	24.2	0.2	0.0	0.0	5.2	1.5	1.0	10.6	274.3	6.2	1.2	0.1	28.4	31.5
EPRS1	"EARS, EPRS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase 1"	P07814	1	219968600-220046530	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	28.8	24.7	18.1	34.4	19.6	26.6	35.7	22.8	24.8	30.5	17.6	36.1	27.7	25.6	25.2	30.6	26.2	20.6	31.8	17.7	21.8	31.6	27.9	24.3	36.5	21.6	20.5	34.7	49.0	54.5	22.5	23.8	22.9	23.6	39.0	43.8	83.4	26.4	52.2	28.9	29.7	32.5	22.4	27.4	35.9	20.5	21.7	34.8	43.0	55.9	42.5	30.4	18.6	27.8	125.9	78.4	55.7	152.3	114.9	126.7	138.0	160.1	111.7	102.1	113.4	93.3	98.1	239.3	86.7	170.4	41.3	130.3	140.9	129.4	136.2	117.9	88.9	130.2	97.6	80.2	125.1	217.6	106.7	92.1	161.7	130.3	161.6	84.8	113.4	113.2	228.0	182.9	100.8	61.8	94.7	53.1	107.4	146.8	159.6	98.5	98.0	236.2	92.8	54.4	128.6	101.3	93.7	152.6	166.5	78.9	141.2	235.1	101.1	48.3	88.1	149.6	151.1	122.8	150.1	197.1	111.4	153.9	156.4	8.8	17.8	10.0	19.7	24.6	27.8	21.0	19.7	22.1	23.2	18.5	22.0	22.9	0.6	22.5	22.1	7.6	20.8	17.2	18.1	19.6	22.8	24.8	17.7	21.8	21.6	20.5	22.9	22.4	21.7	27.8	22.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.7	0.0	0.0	0.0	0.0	40.8	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	59.3	17.1	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	36.5	2.6	0.0	0.0	0.0
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519266	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	31.9	35.1	40.3	25.5	48.2	20.7	25.6	38.8	55.7	23.9	25.7	19.1	15.8	22.8	17.6	21.0	18.3	26.1	26.5	43.9	39.1	24.5	26.4	26.9	46.0	38.6	44.1	28.8	14.7	29.0	15.5	31.5	40.7	26.7	20.5	23.4	16.7	20.9	47.6	24.2	17.7	24.3	40.1	34.1	21.3	46.9	45.0	27.6	25.3	40.5	45.6	22.8	20.9	57.2	35.4	10.4	22.0	20.8	49.6	49.2	54.5	24.2	37.9	19.4	28.4	14.4	19.2	71.8	24.3	38.1	39.5	32.7	28.7	23.1	29.1	81.8	18.0	64.1	16.9	17.1	46.7	36.9	56.4	40.3	21.0	34.0	45.7	33.5	36.5	25.2	40.4	31.7	29.8	17.5	29.9	19.8	30.2	24.6	16.7	24.1	33.3	15.9	25.5	43.2	15.0	20.9	28.8	50.4	42.1	60.2	20.5	25.7	51.1	18.0	19.1	36.3	20.5	37.6	41.0	47.6	26.6	41.0	16.1	18.8	10.4	12.1	9.4	10.7	14.2	15.6	11.2	14.9	10.8	9.0	6.6	9.6	7.8	10.8	13.0	7.1	19.0	8.7	40.3	48.2	38.8	55.7	43.9	39.1	38.6	44.1	40.7	40.1	45.0	57.2	51.5	35.3	41.0	142.4	78.3	43.0	32.1	16.4	30.1	18.1	28.2	15.6	59.8	24.3	22.7	44.1	31.3	22.8	65.0	28.5	19.6	15.2	27.0	22.1	50.1	43.3	28.8	81.0	77.1	19.0	18.9	52.5	41.3	35.6	24.6	36.0	61.4	37.7	83.4	28.6	60.6	30.7	12.2	80.9	61.9	61.7	65.9	67.0	103.2	110.5	57.6	38.4	27.8	29.7	314.1	23.3	19.8	48.2	78.4	62.1	20.7	28.1	31.9	26.6	39.5	45.1	38.0	74.4	44.5	33.8	51.0	28.5	74.3	28.5	21.4	50.8
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28855010-28861061	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	20.3	32.5	47.6	17.5	47.7	18.5	23.4	48.4	61.7	20.9	44.7	25.8	22.0	22.1	22.7	28.8	26.2	15.1	41.0	48.0	48.0	29.2	41.2	18.3	22.0	47.9	47.3	25.6	23.6	36.2	18.9	24.5	48.1	21.0	28.1	16.9	22.6	23.9	52.7	26.3	19.9	26.5	47.7	21.0	26.3	17.9	48.4	23.8	19.2	51.8	29.6	22.1	20.6	48.9	50.4	96.2	55.9	63.1	59.1	40.6	53.4	40.1	56.2	117.1	95.9	94.5	31.7	64.1	47.0	68.8	87.9	55.2	102.0	90.0	97.5	63.6	119.8	52.2	60.6	95.8	75.5	63.0	45.7	53.5	78.1	95.3	89.3	46.1	97.2	80.4	104.4	39.9	66.4	78.7	66.1	98.4	50.6	91.8	46.0	59.7	87.6	83.4	71.3	56.1	58.6	47.1	64.5	155.6	51.6	82.2	110.0	71.8	39.7	48.1	53.1	52.9	84.6	32.0	62.3	69.9	51.4	54.4	49.1	25.5	34.2	14.4	32.2	44.6	24.2	38.9	26.9	23.5	54.9	36.3	30.8	32.2	2.6	42.8	31.6	28.7	32.1	30.8	47.6	47.7	48.4	61.7	48.0	48.0	47.9	47.3	48.1	47.7	48.4	48.9	12.4	6.4	2.8	5.9	14.0	8.0	12.7	33.9	12.0	10.9	14.9	18.3	8.0	17.2	13.9	11.0	6.2	69.1	9.9	13.4	37.2	28.1	1.0	11.1	14.0	14.4	21.6	20.4	7.2	21.6	55.2	15.8	19.9	13.3	5.1	24.8	14.3	21.7	35.6	11.8	7.8	15.0	26.4	8.5	6.7	5.4	14.3	12.4	10.6	3.7	66.6	16.4	9.2	5.5	4.3	21.1	12.9	15.8	29.2	15.1	20.0	33.3	9.7	9.0	19.7	11.0	15.6	22.3	21.7	25.4	11.6	51.7	10.4	25.0	26.6	9.9
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 136.1;Distal enterocytes: 111.0;Proximal enterocytes: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.0"	"Group enriched"	"Detected in many"	41	"OE19: 6565.0;SK-BR-3: 3115.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		980000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	13.0	5.4	16.1	12.1	20.5	1.6	56.0	14.3	13.1	37.6	23.3	68.2	63.6	25.2	26.6	102.4	64.2	31.0	57.0	13.3	16.0	73.5	31.1	36.2	4.8	22.4	22.7	23.9	37.6	81.7	17.3	27.0	17.1	55.6	48.5	8.1	68.7	50.5	20.7	91.0	67.3	25.0	18.5	6.9	49.7	11.7	15.4	7.4	56.5	15.0	28.0	40.0	52.9	16.4	38.7	45.7	50.4	31.7	59.3	41.2	67.7	27.2	44.9	58.6	48.9	34.4	102.7	2.9	54.6	62.7	31.5	117.6	2.8	61.2	26.9	5.2	38.6	1.8	36.0	56.3	35.3	0.9	1.0	41.0	56.6	36.2	21.9	56.2	24.4	1.9	6.2	2.4	43.3	59.4	7.1	3.0	90.7	6565.0	11.7	3.9	20.5	5.4	58.9	118.9	9.4	2.6	51.5	3115.9	16.9	62.2	88.1	2.2	2.9	30.2	37.7	37.7	17.6	5.3	3.3	3.6	3.0	0.9	98.5	1.1	0.2	0.4	5.0	0.1	0.3	0.6	0.2	1.4	0.2	0.6	0.5	1.4	1.2	0.4	0.1	0.1	0.2	1.7	16.1	20.5	14.3	13.1	13.3	16.0	22.4	22.7	17.1	18.5	15.4	16.4	3.9	41.7	40.1	12.7	2.2	14.0	19.0	37.1	17.6	4.6	62.7	34.9	20.7	32.9	43.8	136.1	12.5	12.0	5.1	111.0	7.9	30.9	0.3	48.7	13.9	6.1	15.6	1.3	0.9	25.5	84.8	15.7	53.5	61.3	0.0	20.3	11.7	10.7	4.0	6.7	1.0	47.5	42.7	2.2	3.1	1.0	18.3	1.7	10.6	1.0	1.2	24.1	26.8	2.0	1.0	32.5	54.8	23.0	1.1	34.9	121.7	19.5	42.0	5.8	0.0	13.1	12.7	6.8	5.7	43.5	18.9	22.7	2.8	4.4	75.4	31.3
ERCC1	RAD10	ENSG00000012061	"ERCC excision repair 1, endonuclease non-catalytic subunit"	P07992	19	45407334-45478828	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cataract"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004390, HPA029773, HPA050182, CAB072859, CAB072860"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044"	"unprognostic (1.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.57e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (9.00e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	47.0	49.8	34.7	28.0	33.9	31.4	50.7	37.6	42.6	50.5	44.8	45.1	26.2	47.9	40.2	43.1	43.7	30.3	109.1	35.9	37.2	57.8	38.3	40.4	30.0	38.7	35.5	54.2	57.1	48.9	56.9	22.9	37.3	55.2	20.8	23.2	70.6	29.2	84.0	63.3	40.1	33.4	35.4	43.1	42.9	27.8	36.2	24.1	46.9	83.1	30.5	41.5	44.3	36.6	61.1	104.0	84.2	125.8	57.8	108.1	27.3	90.1	119.1	106.4	141.4	12.0	58.8	34.5	24.9	94.2	57.2	45.0	26.0	277.7	65.1	79.1	28.6	57.9	39.3	36.2	120.2	55.9	96.8	81.0	60.3	111.7	99.5	89.0	117.3	40.8	33.8	69.8	167.9	40.3	50.9	44.4	20.9	54.4	42.4	77.7	40.5	46.3	78.5	36.7	36.6	76.2	58.4	47.3	79.6	27.7	55.0	103.7	70.3	97.7	91.4	59.2	93.8	49.5	43.2	39.5	105.3	45.8	296.6	30.7	131.9	26.3	61.3	142.8	41.7	75.8	37.3	48.6	134.7	84.1	29.4	47.4	17.8	60.6	107.9	315.8	49.8	90.2	34.7	33.9	37.6	42.6	35.9	37.2	38.7	35.5	37.3	35.4	36.2	36.6	43.2	22.4	36.3	13.1	53.4	70.9	109.7	82.7	41.5	0.0	73.9	76.8	39.1	37.1	43.9	20.2	0.0	36.1	67.8	26.9	90.1	54.5	27.1	50.4	43.5	37.5	39.6	20.2	32.9	65.9	33.3	62.4	22.4	24.5	50.0	103.4	38.9	29.6	96.2	0.0	21.9	41.2	34.6	61.5	71.7	107.1	79.2	69.6	67.6	17.8	49.0	0.0	38.1	16.6	13.8	85.3	33.5	57.2	49.1	94.9	69.2	73.1	67.5	0.0	46.0	60.5	60.0	37.0	37.1	51.4	52.8	35.6	36.0	98.6	43.2	89.0
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERF	"PE-2, PE2"	ENSG00000105722	"ETS2 repressor factor"	P50548	19	42247569-42255128	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 157.0;Suprabasal keratinocytes: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058532, HPA067952"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA058532: AB_2683744, HPA067952: AB_2685932"	"prognostic favorable (8.07e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.27e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.54e-2)"	38.2	31.8	21.1	21.9	23.7	15.2	35.1	16.5	24.3	35.8	10.4	37.1	34.4	48.2	17.4	25.6	49.9	50.1	37.8	19.5	23.9	37.5	43.4	41.6	20.0	22.3	22.5	43.0	29.1	21.0	40.3	18.5	19.5	30.9	10.0	14.6	26.4	17.2	11.6	33.5	34.4	19.9	17.5	31.4	29.8	32.8	21.9	24.2	38.7	18.0	15.6	29.7	31.3	37.7	57.6	136.4	57.7	65.8	12.7	32.4	16.4	53.3	37.4	53.5	54.0	63.2	65.1	47.4	32.9	49.3	48.0	61.7	42.1	124.4	39.2	23.5	29.1	28.5	82.9	80.1	34.3	33.2	45.5	37.1	41.3	41.4	45.5	69.6	45.0	37.9	62.0	38.4	29.8	115.8	38.0	25.0	48.5	54.4	29.3	46.6	21.0	20.1	33.5	49.1	26.6	54.2	59.4	43.4	61.8	39.1	43.6	58.7	54.2	78.4	112.9	27.4	100.0	43.2	53.1	39.0	76.9	35.3	108.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	21.1	23.7	16.5	24.3	19.5	23.9	22.3	22.5	19.5	17.5	21.9	37.7	63.3	3.2	1.7	7.8	25.0	157.0	30.2	19.8	77.4	14.1	95.0	57.9	7.3	25.8	6.3	9.2	22.9	7.2	21.7	21.6	7.9	19.1	9.4	35.1	20.5	43.7	26.4	7.8	4.2	15.8	4.9	27.2	13.7	23.4	11.4	10.0	41.4	30.2	11.7	10.1	1.5	22.9	2.0	14.5	58.6	4.1	11.1	22.9	55.2	7.5	7.3	19.0	3.1	3.5	8.5	15.3	27.2	10.1	11.2	18.8	34.6	23.3	11.9	12.3	13.1	61.0	39.8	3.0	16.2	37.9	109.7	14.8	25.5	10.2	21.7	17.6
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834251-172952683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 247.8;Intestinal goblet cells: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	67.3	147.8	33.4	49.1	31.2	44.9	60.3	47.4	35.4	127.2	26.7	97.7	79.5	67.4	75.3	55.0	72.4	50.2	60.9	35.8	31.8	66.1	193.2	77.8	40.8	41.4	36.4	56.9	80.6	50.7	48.5	47.9	38.1	146.8	102.7	21.6	97.6	69.8	92.3	46.7	79.4	64.1	33.0	69.2	107.1	25.3	41.3	83.1	75.2	91.9	55.0	58.3	54.3	34.0	120.2	112.8	95.0	211.6	353.3	262.0	51.9	239.5	179.3	105.5	97.4	159.5	120.4	114.8	166.9	406.4	181.7	43.2	68.5	316.8	123.3	92.0	67.5	70.7	156.1	86.1	258.9	33.3	21.6	223.8	128.6	155.8	143.8	173.8	171.0	117.8	42.6	156.8	177.1	150.4	96.5	57.6	56.0	283.7	101.4	327.4	62.9	358.5	245.2	68.6	52.9	96.0	82.7	234.7	120.6	91.1	98.0	37.4	132.4	171.3	69.1	165.9	99.2	246.8	294.0	47.5	236.9	78.3	76.2	3.7	7.5	19.2	3.1	10.5	5.2	9.3	1.6	2.1	6.1	6.2	1.0	2.3	30.6	14.3	14.3	3.1	1.0	5.1	33.4	31.2	47.4	35.4	35.8	31.8	41.4	36.4	38.1	33.0	41.3	34.0	41.9	57.7	29.5	22.9	62.0	22.8	32.1	22.7	14.8	37.2	51.2	35.1	32.9	68.6	29.4	49.7	16.7	20.7	44.3	83.6	21.5	101.9	11.5	36.2	48.0	33.5	26.0	25.9	35.4	60.8	90.3	47.2	49.5	77.9	23.5	64.4	37.5	247.8	41.1	21.9	41.8	202.9	36.7	77.0	105.2	33.8	65.0	54.8	7.2	30.0	91.1	39.0	36.0	47.7	30.6	86.9	59.3	58.3	96.2	74.2	95.0	38.5	28.4	12.6	39.5	56.1	41.1	1.9	10.5	27.2	26.9	9.0	25.1	103.5	73.3	47.8
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.2	0.0	0.0	5.2	0.0	0.0	24.2	0.0	0.0	15.5	0.0	57.1	25.2	3.4	29.6	64.2	21.3	8.5	0.1	0.0	0.0	8.5	0.4	15.8	0.0	0.0	0.1	0.1	42.6	28.4	7.2	12.2	0.0	19.9	62.8	0.0	25.9	10.0	0.1	60.6	22.0	2.5	0.0	0.0	38.6	0.6	0.4	5.2	36.6	0.0	15.3	22.5	28.8	0.0	138.3	0.0	0.0	0.2	0.0	0.0	101.1	0.0	0.0	0.0	0.0	44.6	140.8	0.0	3.8	0.0	0.1	81.6	3.8	70.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	226.5	0.0	1.4	0.0	0.0	10.7	0.0	0.0	0.0	67.3	1.9	0.4	12.4	142.6	3.4	0.0	0.0	18.3	17.4	99.1	35.1	0.3	0.0	21.0	14.0	21.4	108.0	0.9	0.0	0.1	0.2	0.1	0.3	12.0	13.8	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	38.5	36.7	0.0	0.6	44.6	18.9	30.4	35.9	0.0	29.4	18.0	1.0	21.5	32.4	27.6	0.0	55.1	0.5	76.2	13.7	19.6	12.9	47.1	3.7	0.9	33.1	0.0	2.6	27.5	69.1	0.9	58.1	46.5	1.3	0.0	0.4	0.1	6.0	0.0	0.4	107.2	16.2	0.0	3.2	10.3	0.0	0.5	24.9	0.0	0.6	0.0	0.0	0.5	0.4	21.7	48.1	0.7	1.8	25.1	25.5	0.3	35.0	0.0	0.0	0.0	1.2	0.6	0.9	71.3	79.1	62.1	0.8	0.0	73.9	40.1
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229033-68238102	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.3;Gastric mucus-secreting cells: 44.9;Late spermatids: 82.4;Syncytiotrophoblasts: 58.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.5;MCF7: 113.2;RT4: 60.4;SK-BR-3: 59.8;T-47d: 90.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.6	0.1	0.2	2.2	0.1	0.0	9.6	0.5	0.3	7.6	0.7	18.1	9.9	1.1	7.4	55.2	4.9	4.1	0.1	0.2	0.0	9.9	38.8	13.3	0.0	0.1	0.1	0.2	28.9	13.4	3.3	8.0	0.1	11.6	14.7	0.0	17.8	2.6	0.2	36.5	8.2	0.5	0.0	0.0	27.0	10.8	0.3	3.4	16.7	0.0	7.1	13.0	19.2	0.2	38.6	0.2	0.1	0.0	0.0	0.0	55.5	0.2	0.0	0.1	0.2	36.7	19.1	0.0	1.7	0.0	0.0	40.4	0.1	30.1	0.0	0.1	24.1	0.1	12.5	30.9	0.6	0.0	0.2	0.0	43.4	0.0	16.4	0.1	0.0	0.1	0.1	0.0	0.0	113.2	0.0	0.3	4.1	31.4	12.0	0.1	0.0	0.2	14.5	60.4	4.2	0.0	19.6	59.8	0.1	5.4	90.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	19.2	17.2	0.0	0.3	6.4	5.3	6.8	5.7	0.8	10.7	6.9	1.0	20.0	11.1	23.9	0.0	36.3	0.3	18.8	0.0	11.0	29.1	7.3	1.4	0.4	8.4	0.0	0.0	14.0	5.5	0.5	44.9	13.8	0.0	0.6	0.4	31.1	2.7	0.0	0.0	25.3	8.2	0.8	0.8	82.4	0.9	0.2	1.8	0.0	0.6	0.3	1.0	0.0	0.0	13.7	8.5	0.0	0.3	7.9	5.1	5.6	4.2	0.2	0.0	0.2	0.7	10.4	1.2	27.2	8.5	58.4	0.5	0.0	18.3	8.9
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein subunit alpha"	P13804	15	76215353-76311472	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 389.7;tongue: 493.5"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 402.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		680000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	93.0	112.3	33.8	55.0	36.0	63.0	70.4	36.0	54.6	38.7	40.3	131.4	135.6	27.0	30.6	85.1	30.1	44.7	243.0	34.2	37.6	180.0	389.7	39.0	60.9	35.6	35.7	25.6	81.6	71.0	13.9	70.9	36.0	42.2	123.5	34.3	49.3	38.2	300.8	40.1	116.3	65.7	35.5	38.8	67.7	28.4	38.2	54.5	38.7	493.5	65.9	74.0	33.1	36.9	122.4	196.7	128.2	134.8	141.7	149.1	201.0	144.4	166.2	183.0	162.8	175.3	221.3	203.5	141.3	144.3	138.5	304.6	502.7	200.2	211.9	245.8	98.0	222.2	131.4	205.2	114.7	214.5	158.7	112.7	185.9	93.1	153.5	100.0	187.8	64.7	214.1	205.2	190.3	191.2	44.9	178.2	99.9	225.3	58.4	192.8	158.6	272.8	202.1	386.9	133.3	67.2	218.2	492.2	205.0	294.4	254.1	223.4	111.4	178.2	119.5	157.0	177.4	99.0	221.0	255.9	127.8	281.1	128.5	50.0	120.3	82.7	65.4	110.3	61.7	77.3	60.6	67.6	159.4	67.3	48.8	60.1	30.2	122.9	96.1	63.4	95.8	141.9	33.8	36.0	36.0	54.6	34.2	37.6	35.6	35.7	36.0	35.5	38.2	36.9	65.7	57.7	41.6	45.1	54.3	53.4	110.8	151.5	44.9	13.1	47.2	46.4	352.9	65.8	84.5	36.8	22.9	277.4	61.1	250.9	209.4	106.5	11.7	29.5	45.1	51.8	65.4	117.8	26.0	84.1	180.8	66.8	90.2	37.0	38.6	53.1	48.9	348.8	132.3	53.8	31.5	141.6	89.5	79.0	84.5	7.9	59.4	103.0	56.9	28.1	129.0	26.7	85.5	37.2	46.9	92.1	176.2	58.3	87.8	92.4	231.1	402.9	50.2	20.4	46.0	44.0	113.7	66.4	40.5	79.5	57.1	300.2	55.5	123.4	187.3	162.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein subunit beta"	P38117	19	51345169-51366388	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 53.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1693.9;OE19: 770.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	159.1	171.5	121.1	44.0	134.4	70.2	115.3	134.8	145.5	55.7	123.0	97.6	136.3	48.9	16.9	140.7	53.3	62.7	387.8	112.8	120.6	144.5	493.6	50.4	58.2	129.8	124.8	55.2	81.9	106.3	73.1	39.0	125.7	55.2	41.2	24.1	172.2	37.9	280.7	79.0	129.7	31.7	119.9	64.5	90.0	53.6	132.4	81.4	70.3	280.3	36.9	65.6	69.0	137.0	118.9	304.3	41.3	113.9	129.4	150.4	65.6	82.4	61.0	63.5	63.1	257.3	192.1	121.5	80.2	129.8	33.8	104.0	83.3	171.1	19.2	182.0	323.3	98.1	188.9	1693.9	141.8	92.1	67.6	235.3	50.3	86.1	88.2	79.2	54.9	115.0	146.6	130.2	83.2	243.7	95.2	86.2	26.7	770.2	372.0	104.5	114.4	224.6	88.5	135.7	91.7	44.5	184.5	49.9	94.4	29.4	130.3	86.3	77.8	65.9	67.6	71.4	73.3	195.8	130.0	109.8	335.0	135.1	172.5	127.7	190.1	119.6	104.3	212.3	137.4	281.6	156.0	134.2	225.3	303.1	163.6	136.0	97.8	205.3	165.7	265.1	225.7	140.5	121.1	134.4	134.8	145.5	112.8	120.6	129.8	124.8	125.7	119.9	132.4	137.0	90.9	80.1	93.8	15.3	75.6	65.0	114.9	196.4	55.2	77.1	129.9	170.1	243.8	234.4	122.5	121.4	31.3	240.7	58.7	440.9	571.3	188.0	139.2	67.5	70.2	76.2	168.4	120.0	4.1	140.5	206.6	93.8	128.9	48.2	88.8	63.2	144.9	1105.3	217.5	43.7	4.2	335.2	158.7	147.7	73.4	354.4	107.5	86.9	286.4	5.6	95.2	158.8	50.4	7.1	18.9	155.4	339.4	114.3	69.9	74.9	710.7	1118.7	118.8	67.9	98.6	87.4	144.5	71.0	52.8	135.3	63.6	160.1	74.0	217.3	354.4	140.3
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1 persulfide dioxygenase"	O95571	19	43506719-43527230	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 256.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1037.7;Paneth cells: 788.4;Proximal enterocytes: 376.3;Undifferentiated cells: 447.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 222.6;OE19: 360.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	24.4	27.9	16.1	34.8	17.0	45.8	26.7	16.5	17.3	28.7	15.8	256.1	85.5	18.3	29.8	81.0	20.6	21.0	18.8	15.6	17.4	40.4	52.7	30.5	23.4	17.3	17.2	13.5	28.9	16.1	19.1	26.3	16.6	27.1	226.6	3.2	40.1	18.5	22.8	27.2	77.0	35.6	17.1	27.8	37.8	3.0	18.2	19.8	24.1	21.9	41.7	34.4	39.1	17.2	54.1	68.9	14.1	49.6	75.1	50.9	5.5	82.1	222.6	69.8	71.1	21.1	54.3	0.2	60.0	79.8	22.2	42.9	20.6	123.4	19.6	26.2	6.2	13.8	29.7	59.2	34.0	19.3	18.4	52.2	95.1	26.9	76.0	92.2	52.0	49.8	9.0	87.6	35.1	35.7	22.2	18.9	3.8	360.5	32.9	26.6	6.1	12.0	153.0	110.9	0.2	16.6	20.8	74.8	50.6	23.6	22.4	34.3	41.6	10.9	46.9	13.1	15.3	23.1	20.2	1.4	48.4	83.8	57.7	24.2	63.3	1.6	41.1	34.5	48.3	20.5	47.6	39.4	95.8	7.5	36.4	35.0	2.1	29.3	22.8	17.9	50.4	40.2	16.1	17.0	16.5	17.3	15.6	17.4	17.3	17.2	16.6	17.1	18.2	17.2	32.0	22.4	23.4	3.9	25.5	34.5	82.2	242.5	57.5	9.8	85.8	95.2	9.8	47.1	84.5	55.2	0.0	191.6	38.0	1037.7	54.8	71.7	0.9	31.0	41.2	44.9	63.7	17.4	6.2	63.6	95.7	42.1	53.5	68.2	38.0	12.6	42.1	89.2	115.1	5.0	6.8	324.2	79.3	105.0	78.5	2.1	17.7	74.6	80.0	3.7	78.5	11.7	63.8	4.0	5.6	102.7	788.4	16.1	34.9	75.0	376.3	136.4	23.1	5.8	19.7	32.0	45.1	2.1	6.2	82.8	23.2	92.5	50.4	15.8	447.5	146.5
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805183-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4"	"Cell line enhanced"	"Detected in many"		"HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	109.9	29.7	51.4	95.5	43.3	167.1	87.7	31.6	72.5	89.6	61.4	119.3	131.3	77.5	27.9	90.6	72.5	132.1	68.0	50.9	43.2	66.1	230.7	185.5	38.0	50.0	39.9	65.7	37.5	61.9	56.6	73.6	45.0	80.1	146.5	7.5	50.3	45.7	149.7	248.3	179.7	78.0	47.9	201.0	72.7	7.6	54.0	43.7	62.5	42.8	34.8	210.2	103.6	44.4	120.1	26.2	16.6	5.6	18.8	61.3	49.2	27.4	154.1	36.2	46.5	23.0	35.1	24.7	13.3	25.0	48.5	35.7	28.0	71.2	63.8	24.5	12.0	309.0	152.6	62.2	196.9	18.4	28.2	39.8	269.6	49.6	210.2	22.0	28.3	17.2	31.3	0.2	14.4	20.1	54.1	22.2	56.0	39.3	18.2	189.6	10.2	25.2	50.2	74.4	14.2	18.4	78.4	32.8	6.2	5.7	1.9	36.3	30.8	83.0	13.0	55.3	60.5	0.5	0.3	25.2	20.7	69.4	70.8	21.0	19.5	7.0	3.2	24.9	3.9	0.4	3.0	4.7	33.6	0.4	3.2	3.2	37.0	0.3	32.4	8.1	0.3	8.9	51.4	43.3	31.6	72.5	50.9	43.2	50.0	39.9	45.0	47.9	54.0	44.4	253.0	51.3	156.6	6.2	10.8	427.4	701.0	150.8	863.4	2.1	84.2	69.7	25.6	51.5	141.9	51.5	0.0	58.4	17.5	150.7	11.7	73.7	4.0	241.1	127.4	312.7	91.8	36.4	39.6	108.5	109.3	98.7	161.1	497.9	51.3	0.9	242.0	262.4	62.1	0.0	10.7	266.0	79.3	150.8	291.7	2.0	18.0	253.4	67.6	74.0	41.0	1.5	3.1	4.0	3.1	127.6	175.1	24.8	21.0	184.0	162.2	47.2	107.9	1.6	52.6	81.8	108.8	0.6	3.3	522.6	486.4	177.6	28.8	8.2	243.3	338.7
ETV5	ERM	ENSG00000244405	"ETS variant transcription factor 5"	P41161	3	186046314-186110318	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Oligodendrocyte precursor cells: 169.9;Syncytiotrophoblasts: 88.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 50.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 178.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009590, HPA063065, HPA073889"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: "	"unprognostic (3.85e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (7.85e-9)"	"unprognostic (3.52e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.84e-3)"	6.8	39.3	17.1	6.9	22.4	1.4	15.0	17.7	24.4	4.9	9.4	3.4	6.1	8.1	7.3	4.2	5.1	5.6	11.5	17.8	16.8	8.9	7.9	29.6	5.2	20.5	17.1	2.2	17.5	42.2	25.4	17.1	17.7	7.4	3.2	15.9	6.5	5.8	11.9	6.4	3.0	7.4	14.7	10.9	14.8	9.3	17.2	4.8	21.9	7.0	4.2	4.3	4.1	19.6	42.4	28.6	36.1	79.2	21.9	22.7	2.6	35.7	39.7	27.7	29.6	31.7	25.4	1.1	46.4	34.7	41.3	7.1	0.8	27.2	40.7	9.3	1.0	12.4	1.0	36.4	36.3	31.2	22.1	19.9	4.4	44.3	53.7	32.9	41.0	4.4	11.6	14.6	47.5	19.8	4.1	47.7	54.2	12.1	32.4	86.6	36.0	28.7	23.0	9.9	1.6	45.8	8.7	0.4	178.3	14.4	0.1	17.3	40.0	15.0	24.3	38.2	70.5	11.1	49.9	0.3	45.8	24.6	91.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.1	17.1	22.4	17.7	24.4	17.8	16.8	20.5	17.1	17.7	14.7	17.2	19.6	5.7	3.2	68.5	26.1	5.6	15.7	10.6	8.2	45.5	17.8	9.4	30.4	5.7	17.2	2.4	0.0	12.5	57.6	3.1	0.6	3.9	9.4	24.6	2.0	4.3	9.2	10.7	1.7	94.0	9.4	18.8	12.5	15.8	4.7	8.2	0.8	10.4	9.0	56.4	5.0	43.7	2.8	0.0	64.4	19.4	49.0	9.0	27.1	16.0	45.9	2.1	60.4	1.0	169.9	47.5	12.5	1.1	15.4	4.9	3.6	1.5	22.9	1.3	18.8	0.0	25.4	13.6	16.9	14.4	8.7	5.3	88.8	1.9	3.1	1.5	2.7
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	84.8	102.2	63.2	93.2	64.7	172.3	80.3	70.3	69.5	87.9	61.2	90.5	88.0	105.1	61.9	99.0	86.0	56.1	101.7	64.7	63.7	88.0	85.0	76.8	120.1	67.4	64.7	86.8	79.1	98.0	64.1	70.2	63.6	78.4	84.4	111.2	76.5	77.3	140.0	88.0	92.6	86.9	59.7	101.0	84.3	135.5	63.9	183.0	77.2	79.9	126.8	88.1	86.2	71.8	307.7	239.7	327.6	249.1	166.0	136.0	218.2	188.1	301.3	309.9	264.5	270.3	154.5	428.0	114.1	294.3	234.9	238.9	471.5	392.6	313.7	287.5	341.6	323.9	218.8	262.7	246.5	499.5	219.3	211.1	162.5	259.1	413.0	152.2	244.2	201.1	248.3	186.0	233.8	310.6	505.9	185.8	221.1	261.4	182.8	348.1	317.2	253.3	288.0	328.2	261.4	247.7	236.3	258.5	195.9	216.2	170.9	261.0	246.3	184.4	198.2	115.1	272.3	236.2	205.5	387.4	169.9	220.6	224.4	203.9	201.1	182.6	195.2	283.5	199.5	169.4	181.3	194.4	227.5	191.3	175.8	170.9	148.1	216.9	293.0	122.0	244.0	314.2	63.2	64.7	70.3	69.5	64.7	63.7	67.4	64.7	63.6	59.7	63.9	71.8	77.5	102.5	106.8	68.6	130.8	69.5	145.2	153.2	108.1	72.4	63.8	46.6	68.0	87.2	127.2	64.4	75.0	141.0	91.3	92.4	66.5	121.7	165.4	96.3	88.1	88.3	80.9	102.0	55.8	107.6	133.5	85.4	117.2	115.2	121.0	88.5	71.7	71.7	99.3	82.4	60.8	110.9	136.3	69.7	94.0	32.7	61.5	91.9	81.8	47.8	110.9	72.8	122.6	49.8	67.6	116.5	106.4	62.1	156.6	97.4	79.4	72.6	128.9	84.9	52.6	93.1	141.4	209.6	107.5	105.5	58.5	152.4	121.4	84.9	110.2	115.1
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.3;lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	0.5	0.3	0.2	3.3	0.2	17.3	1.2	0.1	0.7	0.5	0.1	3.2	2.9	0.8	0.0	2.5	0.3	0.4	0.2	0.3	0.1	0.3	0.5	0.6	5.8	0.1	0.2	0.2	0.3	0.7	0.1	3.3	0.2	0.2	3.7	0.0	0.5	0.2	0.1	1.8	2.5	1.2	0.2	1.5	1.6	5.7	0.3	11.1	0.4	0.0	6.4	1.2	0.8	0.4	41.3	26.8	43.4	28.6	2.7	6.7	36.5	53.4	17.7	46.7	50.5	33.9	22.5	44.3	25.3	12.6	25.1	40.0	55.5	22.5	54.8	69.5	48.4	41.5	28.8	17.3	1.0	59.8	29.4	1.7	1.1	46.8	12.5	5.7	14.7	43.4	84.6	57.0	37.8	19.0	65.9	33.6	60.4	49.7	26.0	46.2	40.5	47.5	9.6	25.6	48.1	60.9	34.8	27.9	19.5	20.2	25.8	36.6	5.5	44.9	39.5	42.7	72.9	41.5	59.0	71.3	15.6	48.1	54.9	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.2	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.4	0.2	0.0	0.0	0.3	0.7	0.8	0.1	0.7	0.0	0.0	0.3	0.5	2.3	0.0	0.1	0.0	0.0	5.3	0.2	1.2	0.0	0.1	9.3	0.3	0.4	0.7	0.0	7.4	1.0	0.0	16.7	0.9	1.1	0.5	0.0	4.6	0.4	0.0	3.3	0.0	2.9	0.5	0.0	0.3	0.8	2.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	11.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	9.3	9.8	2.7	0.1	4.0	0.8	0.8	1.9	0.3
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397359	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	12.9	19.4	18.6	14.1	20.2	17.4	14.0	18.9	26.1	12.5	15.1	13.3	11.4	11.3	4.2	21.4	15.1	6.6	16.8	18.8	17.8	9.9	21.7	7.3	22.0	20.8	18.4	14.3	28.6	5.9	7.2	7.4	19.2	11.0	7.2	2.3	16.4	8.4	41.7	23.0	10.8	7.2	19.0	14.3	13.6	11.4	18.3	14.8	11.6	23.1	11.8	14.7	13.9	22.1	58.2	123.5	15.1	48.8	10.7	13.5	39.4	24.5	13.1	44.6	37.0	72.5	47.5	92.9	64.8	12.9	22.8	25.1	33.1	31.3	12.2	66.7	117.3	42.7	45.5	55.7	32.1	76.7	41.8	16.3	69.0	35.6	33.8	12.1	21.1	57.7	57.5	70.2	14.2	88.1	70.2	58.6	56.6	85.2	59.9	66.9	40.9	94.8	17.6	43.1	64.4	47.8	34.6	62.4	68.2	10.5	31.1	95.6	16.2	45.9	37.4	30.1	76.9	109.6	138.5	106.3	34.9	116.0	39.0	15.2	68.2	1.9	41.3	77.7	47.9	66.0	43.3	40.9	110.1	74.0	63.2	55.4	5.0	62.1	48.6	118.7	37.0	48.6	18.6	20.2	18.9	26.1	18.8	17.8	20.8	18.4	19.2	19.0	18.3	22.1	16.1	3.2	4.8	2.3	21.3	30.5	29.0	29.6	44.9	5.5	30.1	44.2	8.4	22.8	16.9	18.4	4.2	28.4	23.5	12.7	37.2	21.7	9.1	5.5	16.7	11.1	8.5	28.0	5.0	21.4	124.0	13.1	16.3	9.1	5.1	24.7	7.1	20.3	28.8	6.7	4.8	18.4	20.3	11.8	13.3	8.5	16.8	18.9	14.2	2.8	18.9	7.0	18.6	4.0	4.3	17.2	15.3	12.4	21.3	28.0	6.6	34.9	12.7	4.1	6.6	17.8	16.0	17.0	33.1	47.4	33.2	21.2	17.0	31.5	34.2	23.8
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801318-121817021	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.0;Spermatocytes: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	14.7	14.3	9.2	16.7	9.9	37.9	14.4	10.5	15.3	11.9	8.4	11.7	9.3	12.9	14.4	12.3	12.9	8.1	15.7	9.4	9.9	11.8	16.0	13.6	25.8	9.3	9.2	12.9	11.2	14.7	11.0	14.1	9.3	10.4	12.6	9.9	11.9	9.3	21.6	13.9	12.0	10.2	9.0	15.8	11.7	43.4	9.2	32.8	10.1	18.6	21.1	14.8	11.9	10.4	66.3	29.9	76.7	44.4	10.7	20.6	39.2	83.7	45.4	114.6	84.5	32.5	53.2	113.9	20.1	50.5	35.7	23.2	83.1	38.1	95.6	51.1	39.9	56.8	43.4	43.0	26.0	98.5	51.1	16.1	20.1	77.8	20.3	23.7	56.0	72.6	102.2	42.3	110.0	38.9	154.6	78.6	42.7	25.2	34.7	80.6	134.4	52.4	41.4	21.0	51.3	53.7	28.8	45.5	52.3	38.9	38.2	64.2	35.2	50.4	76.5	44.4	80.9	63.0	49.7	132.5	52.4	67.8	34.2	15.8	14.5	23.4	17.6	21.1	18.5	20.7	20.9	25.4	17.9	22.4	22.1	22.6	3.8	14.4	21.3	15.9	24.9	14.0	9.2	9.9	10.5	15.3	9.4	9.9	9.3	9.2	9.3	9.0	9.2	10.4	20.4	44.8	19.1	4.9	20.8	12.7	15.5	31.7	18.8	10.7	6.7	10.7	13.2	17.2	25.4	3.7	10.4	31.4	21.5	5.7	1.9	23.7	154.0	10.9	15.6	17.6	6.0	27.0	10.4	30.5	31.3	15.8	7.7	11.8	31.0	25.4	10.0	5.5	24.5	16.8	8.8	9.8	28.5	11.9	10.1	21.8	13.1	16.3	8.8	11.2	22.2	15.3	16.5	6.6	10.9	20.2	9.2	10.9	22.9	8.4	6.5	8.5	16.8	17.7	6.6	23.4	21.8	170.4	62.8	14.1	14.8	10.9	26.2	16.5	11.6	12.1
EZHIP	"CATACOMB, CXorf67"	ENSG00000187690	"EZH inhibitory protein"	Q86X51	X	51406948-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 5.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 2.3;Extravillous trophoblasts: 2.5;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"U-2 OS: 32.8"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.0	0.2	0.7	0.0	0.7	0.0	0.0	0.6	0.6	0.2	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	1.4	0.2	0.0	0.1	0.0	0.5	0.3	0.4	0.1	0.0	1.0	0.9	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	5.9	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.6	0.6	0.2	1.4	0.5	0.3	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA		12000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636"	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	15.5	19.7	13.5	15.0	14.1	21.7	17.5	15.0	17.0	16.9	18.1	16.8	15.0	18.6	17.5	16.7	17.3	14.6	11.4	14.0	14.9	14.7	21.0	15.4	16.3	13.5	14.4	20.0	16.2	24.9	14.7	16.7	14.6	18.2	19.2	22.6	16.4	14.7	11.6	19.4	14.7	18.8	13.3	14.9	14.5	21.0	14.7	23.1	19.5	12.8	18.7	18.0	13.1	13.5	36.9	41.1	39.9	44.4	55.4	43.9	54.6	47.2	53.8	52.7	56.6	53.9	64.9	32.1	52.0	50.2	95.6	55.5	57.8	119.6	72.3	128.7	31.8	21.1	40.7	26.4	56.3	46.2	26.4	58.1	51.6	64.5	53.2	34.0	44.3	35.8	30.7	42.6	50.8	61.2	40.6	24.2	32.4	39.8	34.4	39.5	34.7	35.9	44.7	48.0	35.3	37.7	57.5	49.4	52.9	34.1	58.1	36.2	49.9	71.9	38.8	40.1	63.8	36.2	41.6	41.2	45.4	32.5	64.2	9.0	6.8	4.7	6.8	5.6	8.3	4.9	5.6	7.3	8.0	4.8	7.1	6.4	5.6	9.2	12.1	5.3	9.8	5.7	13.5	14.1	15.0	17.0	14.0	14.9	13.5	14.4	14.6	13.3	14.7	13.5	26.4	28.9	54.5	26.8	19.6	5.4	34.4	49.7	16.5	46.3	18.6	18.7	13.4	15.7	44.9	18.4	45.9	34.8	19.2	17.6	11.7	34.0	12.1	24.6	41.0	29.0	19.9	17.5	29.0	37.2	40.8	32.6	23.4	27.6	32.2	32.6	28.2	24.3	22.5	15.2	34.2	15.1	34.6	16.1	8.0	5.6	30.4	17.9	12.4	14.0	23.3	39.6	26.8	31.7	36.1	59.1	12.0	31.2	22.0	32.3	17.3	9.3	41.3	29.9	26.3	36.3	36.6	59.8	51.3	16.6	8.5	57.9	18.4	43.2	17.1	29.0
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.1"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 112.2;Proximal tubular cells: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	12.3	21.4	9.1	8.5	9.4	10.0	9.4	9.3	11.1	8.3	9.2	22.6	36.1	9.7	8.0	19.3	6.9	12.1	19.9	10.9	11.1	64.1	58.5	7.1	7.4	10.7	10.0	8.0	15.8	12.1	9.5	7.5	10.1	9.4	14.2	6.7	11.2	10.7	30.7	17.1	27.1	8.7	8.8	8.4	21.0	10.1	9.4	7.9	7.8	24.7	6.4	11.3	11.1	9.9	20.1	44.6	20.9	36.9	27.0	19.5	12.9	32.4	16.0	21.1	22.9	28.6	20.4	12.8	26.6	20.2	32.7	40.5	16.4	25.8	19.0	19.3	39.0	11.5	38.7	67.0	26.2	20.0	21.2	25.8	33.3	19.3	12.9	17.8	27.8	15.3	12.1	12.8	26.8	92.5	10.9	30.1	12.4	18.4	33.0	24.6	28.3	36.4	76.8	24.9	40.4	33.6	42.3	33.5	52.0	13.8	49.4	13.4	41.1	34.4	24.6	20.5	17.8	18.6	42.3	15.1	22.0	14.5	15.1	15.8	40.8	16.5	25.1	51.5	22.5	37.2	24.7	27.3	42.6	32.7	27.0	24.8	3.5	38.1	38.4	33.1	28.4	24.3	9.1	9.4	9.3	11.1	10.9	11.1	10.7	10.0	10.1	8.8	9.4	9.9	14.6	25.6	16.4	2.9	11.2	14.0	13.3	29.6	13.1	19.8	12.4	15.7	42.9	27.1	17.2	42.3	27.1	22.6	10.9	50.8	50.9	57.2	89.8	16.8	19.8	16.3	29.3	36.4	8.0	39.2	14.2	15.5	17.3	18.2	5.1	13.8	9.7	35.5	30.5	18.5	8.6	25.6	24.4	9.1	14.2	45.0	14.6	13.7	16.0	4.7	18.9	17.4	20.6	3.0	6.4	34.9	36.7	15.4	4.0	11.2	112.2	210.9	14.4	24.2	13.1	12.7	16.5	9.9	9.1	27.2	24.0	15.3	9.8	30.3	52.7	9.6
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 2.4;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 204.7;BJ hTERT+: 244.1;fHDF/TERT166: 273.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		96000	"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	28.4	48.1	7.9	23.6	11.8	2.0	20.2	7.8	9.2	48.4	23.7	34.6	22.9	29.2	17.8	35.1	19.5	36.4	23.7	9.9	11.4	11.8	54.2	21.2	8.9	13.7	12.5	41.5	25.6	22.4	18.5	35.6	11.2	35.5	33.7	3.1	61.2	27.8	16.6	15.6	24.4	61.7	9.0	8.8	34.4	12.5	12.1	4.3	17.6	22.7	19.5	35.6	26.4	13.4	43.5	30.7	18.5	21.9	197.4	204.7	6.1	167.9	244.1	69.7	105.8	8.1	33.0	0.0	23.0	273.8	118.8	11.9	0.1	53.7	80.1	0.2	4.6	3.1	30.3	40.6	70.6	0.1	5.8	122.1	17.0	101.2	23.3	157.2	101.4	0.1	3.4	0.2	102.9	11.0	0.1	2.3	3.8	18.3	15.6	0.8	90.9	3.2	23.4	8.7	0.7	9.4	33.8	0.7	33.8	42.8	20.8	3.8	156.3	75.4	34.8	95.3	39.5	0.7	0.2	0.3	123.3	3.3	63.0	0.6	3.2	0.0	0.1	3.6	0.0	0.4	0.1	0.1	2.6	0.1	0.1	0.1	2.4	0.0	1.4	0.3	0.0	0.9	7.9	11.8	7.8	9.2	9.9	11.4	13.7	12.5	11.2	9.0	12.1	13.4	28.1	16.0	13.2	5.9	2.2	12.2	47.4	43.7	15.4	0.3	29.9	21.2	17.2	14.3	56.0	7.3	0.0	2.2	0.2	46.8	9.8	45.6	1.0	17.5	88.6	35.2	15.7	3.6	1.0	61.0	47.0	94.9	35.7	39.1	1.3	30.4	31.1	68.3	16.1	0.0	1.8	78.7	83.4	7.2	15.0	6.3	110.9	8.7	21.4	17.8	6.4	12.2	0.0	14.6	31.0	47.6	41.6	116.2	8.5	92.6	39.0	11.7	47.8	1.2	19.7	49.4	44.3	1.2	5.5	23.6	10.2	3.4	3.1	94.1	32.0	82.7
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451685-93566112	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol		NA	NA		12000	"Cluster 35: T-regs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA019734: AB_1848369, HPA055800: AB_2682925"	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	48.1	47.8	26.7	59.7	30.8	49.9	37.8	25.8	27.0	45.0	55.0	74.4	59.0	39.2	36.0	46.6	50.8	42.3	60.9	26.0	24.2	47.7	55.7	42.0	56.5	32.6	29.3	39.1	57.9	87.3	26.8	60.3	28.8	42.7	69.1	30.6	56.2	40.8	81.7	41.9	58.4	50.9	25.3	49.0	69.3	17.4	30.3	45.5	49.0	71.4	45.6	53.4	33.0	28.7	179.7	145.4	32.0	92.8	93.7	116.6	100.3	123.2	107.8	92.9	68.0	47.5	108.2	116.1	68.9	156.2	73.7	188.8	86.5	144.3	71.1	117.0	62.8	63.8	126.1	75.3	104.6	109.0	83.5	114.3	87.2	105.7	166.3	90.9	133.7	81.0	74.4	94.9	101.3	202.8	108.2	61.4	41.2	212.7	134.3	62.1	85.6	97.4	112.3	107.2	85.8	52.5	139.5	166.4	86.0	31.4	91.0	70.6	140.6	99.6	71.6	123.8	136.4	74.2	78.6	44.8	107.9	96.6	90.9	3.1	6.6	5.2	4.9	7.5	4.1	4.4	4.3	4.8	6.1	3.5	3.0	4.4	13.1	4.3	9.3	3.9	8.3	4.1	26.7	30.8	25.8	27.0	26.0	24.2	32.6	29.3	28.8	25.3	30.3	28.7	64.0	44.8	93.9	67.9	42.7	102.2	49.6	56.6	70.6	30.0	86.5	49.0	112.3	77.2	75.2	75.4	50.1	73.8	49.2	164.3	21.5	50.1	26.1	77.5	76.2	64.9	91.8	60.2	92.1	74.7	104.9	60.5	123.8	92.3	48.8	66.1	63.1	186.6	71.0	40.4	62.5	176.8	36.7	146.4	78.6	9.8	66.8	103.4	53.4	80.6	111.0	35.7	35.0	64.3	80.9	86.4	92.0	65.5	60.8	125.8	81.0	75.7	87.8	33.7	39.5	63.5	68.6	12.3	12.4	91.1	114.2	103.4	49.3	94.4	177.2	109.0
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 36.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 18.6;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 33.6"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;hTERT-RPE1: 8.5;NTERA-2: 22.3;PC-3: 21.5;SCLC-21H: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	0.6	1.0	18.8	1.1	30.0	0.0	0.5	24.8	36.2	1.5	0.0	3.3	0.8	6.7	0.2	0.7	0.9	0.6	0.3	23.0	11.9	0.3	0.0	0.6	0.5	25.1	20.7	0.2	0.0	2.8	0.5	0.1	28.3	0.2	1.2	1.8	0.1	0.2	6.8	0.1	1.1	4.0	19.4	0.2	0.5	0.4	17.4	0.4	0.2	0.9	0.2	0.6	0.6	34.9	0.0	0.2	6.6	0.0	5.3	6.6	0.0	0.3	1.7	1.0	0.3	14.0	0.0	0.0	0.0	0.4	0.0	0.3	2.7	0.6	0.9	3.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.5	0.0	0.1	0.0	8.5	1.2	0.1	0.0	0.0	0.9	0.0	0.0	0.4	22.3	0.0	21.5	0.0	0.0	0.0	0.0	0.0	21.7	0.7	0.3	1.6	0.0	1.4	0.0	0.0	1.0	0.4	2.1	0.2	0.0	0.0	0.0	0.0	0.1	4.5	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.8	30.0	24.8	36.2	23.0	11.9	25.1	20.7	28.3	19.4	17.4	34.9	0.1	0.0	0.0	1.6	0.0	0.1	0.2	0.6	0.0	0.9	0.1	0.5	0.6	0.0	0.7	0.0	0.0	0.0	0.6	0.1	1.9	0.2	0.8	0.1	3.0	0.3	2.4	0.0	18.6	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	12.0	0.1	0.0	0.3	0.5	3.4	0.0	0.2	0.0	2.8	0.6	0.1	0.0	11.1	33.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.6
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560758-92590393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	14.4	13.7	21.5	12.7	23.5	35.5	16.2	25.6	43.1	15.8	20.5	13.6	13.4	14.3	22.4	13.6	13.2	9.8	11.1	21.5	20.6	13.0	16.6	11.1	16.6	22.1	21.8	16.7	15.8	11.8	12.5	10.6	23.1	13.7	11.9	9.5	13.2	11.1	16.2	14.4	13.2	10.8	21.1	14.0	13.1	8.2	23.3	17.3	14.0	15.1	14.6	13.6	14.3	26.8	24.5	12.1	34.5	55.4	20.8	22.8	20.0	29.1	29.9	26.4	32.5	21.1	27.6	43.5	26.5	19.0	22.7	19.9	28.5	17.5	40.0	22.4	37.5	35.2	20.6	43.9	20.5	36.8	27.6	14.6	17.8	20.4	24.5	21.0	16.1	31.6	46.0	50.4	29.9	30.8	58.8	59.2	50.0	22.6	16.8	42.9	36.9	34.0	26.7	27.5	35.1	31.7	26.3	29.3	32.1	32.9	27.7	26.6	19.8	28.7	46.6	37.4	30.5	12.1	14.4	76.3	18.8	48.5	39.6	15.9	13.8	14.0	12.7	15.0	18.5	30.3	16.4	17.2	13.7	23.4	19.5	17.3	5.8	15.2	11.4	31.2	21.0	7.7	21.5	23.5	25.6	43.1	21.5	20.6	22.1	21.8	23.1	21.1	23.3	26.8	157.6	57.7	64.3	23.8	146.2	114.3	196.1	130.7	84.2	83.7	120.3	113.2	27.8	184.5	87.9	88.3	75.0	61.7	258.3	126.9	99.7	93.3	47.8	174.1	167.5	89.3	137.3	119.5	28.0	87.0	62.0	99.6	59.1	294.0	87.0	76.3	109.9	120.9	72.4	55.5	27.1	118.7	95.6	121.2	155.1	19.2	102.6	116.5	76.5	27.2	112.5	104.8	121.5	27.6	57.8	89.2	122.3	88.8	139.3	126.1	84.2	98.1	55.1	73.8	52.6	207.3	107.0	100.9	115.7	75.4	104.8	70.6	151.7	78.5	113.3	137.9
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;retina: 71.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 138.0;Cone photoreceptor cells: 141.8;Excitatory neurons: 103.4;Horizontal cells: 85.8;Inhibitory neurons: 101.3;Muller glia cells: 191.3;Rod photoreceptor cells: 179.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.9;Hep G2: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.1	2.8	13.2	0.7	14.7	1.1	0.5	4.4	12.9	1.0	0.0	1.3	0.3	2.4	18.0	0.3	2.6	2.1	1.3	9.4	27.2	4.7	2.2	0.3	1.5	14.1	10.6	2.1	1.3	5.1	2.1	0.7	9.6	4.5	2.0	71.4	1.4	4.6	0.1	0.2	0.3	0.3	17.0	1.7	1.4	12.4	17.0	5.1	7.1	0.1	1.6	3.1	0.2	17.1	8.0	7.2	4.8	6.7	0.0	0.0	31.9	1.3	2.5	5.1	5.1	3.0	5.2	0.0	3.4	0.1	13.9	5.4	10.2	15.3	5.5	5.7	11.9	2.2	1.3	23.4	0.2	0.0	0.1	0.1	16.2	1.3	7.2	0.8	0.0	7.3	0.0	0.1	3.0	2.2	7.4	0.1	12.8	1.8	4.1	10.9	3.2	0.5	4.8	12.8	2.8	3.8	12.9	5.5	1.0	21.5	5.6	1.4	0.0	0.3	4.8	0.0	5.5	17.7	18.5	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.0	1.4	0.2	0.6	0.9	0.0	0.4	1.2	1.3	0.0	0.3	0.0	0.2	0.3	0.6	13.2	14.7	4.4	12.9	9.4	27.2	14.1	10.6	9.6	17.0	17.0	17.1	0.3	0.0	0.0	32.0	5.7	0.3	6.5	2.8	1.2	138.0	1.2	1.5	1.6	1.5	3.5	49.7	141.8	5.4	14.2	1.6	3.9	1.9	15.5	8.5	1.9	2.6	3.5	1.3	103.4	0.0	0.5	1.5	6.6	10.9	1.3	24.7	0.0	4.1	0.5	85.8	101.3	1.3	2.0	1.9	0.0	29.0	5.0	0.7	1.8	14.0	0.9	191.3	11.3	67.3	58.2	2.9	0.5	4.1	4.8	8.1	2.2	2.8	2.8	179.7	0.0	0.3	1.5	25.2	13.4	1.4	0.1	0.3	7.8	5.7	1.4	4.4
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519789-177554563	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	37.0	25.6	23.4	24.5	19.7	58.0	40.9	22.1	25.9	52.2	14.5	38.6	22.0	38.4	14.1	34.8	41.1	17.2	27.7	24.3	19.2	41.4	51.0	45.3	31.7	16.0	16.5	51.4	52.1	11.2	37.9	21.5	15.0	50.6	15.8	20.6	37.2	17.3	22.1	55.0	49.5	14.7	12.5	70.3	36.7	31.9	27.7	30.9	41.4	7.9	22.3	34.6	43.6	18.8	10.4	13.5	29.3	25.7	14.3	13.5	63.2	9.0	9.8	14.9	14.1	36.6	19.4	19.4	13.8	9.0	18.9	17.7	13.6	19.2	11.1	43.5	13.9	13.7	22.9	17.8	8.3	13.6	27.5	13.6	21.1	12.5	13.8	26.6	15.3	30.4	13.4	18.7	10.9	34.5	24.9	39.4	20.4	9.0	10.6	40.4	6.4	16.7	14.2	29.1	27.2	17.2	10.6	30.0	9.8	22.2	29.5	18.4	19.1	16.4	13.5	10.8	11.2	20.1	9.2	16.1	13.1	21.8	13.9	0.0	0.4	0.1	0.5	0.0	0.3	0.1	0.2	0.4	0.2	0.2	0.1	0.1	0.6	0.5	0.2	0.3	0.1	0.2	23.4	19.7	22.1	25.9	24.3	19.2	16.0	16.5	15.0	12.5	27.7	18.8	16.9	19.2	26.7	45.1	8.5	8.7	5.8	7.2	11.4	11.5	12.1	18.3	14.6	20.0	11.2	11.0	18.8	5.0	11.9	14.3	0.0	6.1	6.1	8.3	10.2	12.5	8.4	6.1	41.0	8.9	8.3	11.7	22.4	10.8	5.1	14.1	12.1	13.8	5.0	11.8	39.3	15.6	6.1	10.0	8.2	8.4	9.9	10.6	8.8	21.5	8.3	7.3	9.2	39.2	38.0	6.0	8.4	5.3	6.9	7.7	9.8	2.8	10.7	12.5	6.6	12.4	11.1	15.4	13.2	11.8	12.9	4.5	10.4	8.6	11.7	6.7
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041021: AB_10959734, HPA056698: AB_2683212"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	4.8	4.0	8.6	6.3	10.3	13.6	4.9	5.7	17.3	4.8	0.1	4.2	5.1	6.8	5.6	4.6	5.5	4.1	9.9	10.8	6.7	5.3	2.0	5.3	9.3	6.1	6.9	10.7	3.0	3.8	6.9	6.3	6.4	7.5	3.5	8.2	4.3	9.0	15.5	3.5	5.9	4.5	5.9	6.3	4.6	9.5	7.4	9.4	6.8	17.4	8.8	3.6	3.1	12.1	9.1	6.1	14.0	9.6	6.6	9.8	11.2	12.7	10.8	13.8	9.9	31.9	19.4	20.0	21.0	5.3	11.1	21.9	15.2	10.6	13.4	11.1	9.6	18.7	15.5	18.5	4.2	30.2	24.3	5.7	12.9	10.2	3.3	5.6	4.1	23.8	13.6	8.2	9.0	16.6	53.0	16.4	13.6	8.5	12.5	12.7	13.8	19.5	5.3	14.1	14.2	16.9	17.0	21.8	18.9	12.9	21.2	21.1	5.8	11.4	13.3	11.8	6.8	14.0	25.7	23.9	15.8	19.4	7.6	9.3	5.9	8.2	8.5	3.7	10.3	4.9	8.0	7.7	6.5	5.7	8.2	8.8	11.1	8.0	3.6	5.2	7.6	6.0	8.6	10.3	5.7	17.3	10.8	6.7	6.1	6.9	6.4	5.9	7.4	12.1	16.0	16.0	19.4	25.5	18.5	5.4	5.4	13.6	10.2	35.6	16.4	16.0	34.9	10.0	12.1	11.0	22.9	23.4	22.2	11.7	17.6	5.5	29.9	8.4	15.5	16.7	8.4	11.3	33.5	8.2	12.0	18.0	7.1	6.6	29.1	19.3	17.2	5.0	19.1	60.6	32.6	5.3	8.2	34.0	13.4	24.9	17.4	13.2	12.4	12.2	32.4	24.4	44.3	22.6	27.9	8.1	5.1	10.1	16.8	9.6	26.3	14.5	17.5	32.0	32.9	36.2	16.6	52.4	16.2	11.0	5.4	6.8	23.3	13.1	9.5	9.7
FAM222B	"C17orf63, FLJ10700"	ENSG00000173065	"Family with sequence similarity 222 member B"	Q8WU58	17	28755978-28855232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 73.8;Inhibitory neurons: 84.7;Oligodendrocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051840, HPA062239"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051840: AB_2681633, HPA062239: AB_2684722"	"unprognostic (4.11e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.18e-2)"	8.6	6.3	6.9	6.9	7.3	7.0	8.4	14.1	9.5	9.3	18.8	11.2	12.3	7.5	7.8	11.1	7.0	8.6	10.9	6.6	6.8	10.5	7.7	8.0	6.6	8.7	6.8	8.4	8.0	10.5	10.2	9.9	8.1	9.3	10.0	10.0	14.2	8.8	43.4	7.9	11.0	7.1	2.8	6.6	8.4	27.5	9.8	7.9	8.5	16.2	7.1	10.7	9.8	7.1	13.1	25.1	21.2	24.4	17.7	12.3	23.2	9.1	8.5	12.5	12.6	32.4	12.6	13.3	17.9	10.2	16.0	16.2	17.7	20.4	10.4	18.7	24.1	15.0	12.9	24.9	20.4	9.9	23.1	12.9	19.8	17.7	15.7	12.6	25.2	15.5	29.1	9.2	26.4	16.5	16.9	7.9	24.3	17.5	9.4	7.9	20.1	13.4	22.4	16.4	23.0	16.1	12.9	24.8	31.8	44.0	18.9	9.3	28.8	8.3	17.1	9.4	14.5	18.5	24.9	8.8	11.4	6.8	15.5	15.9	3.9	9.5	6.4	5.0	7.6	6.2	5.4	6.6	5.4	4.6	7.3	6.3	4.5	3.9	7.9	4.9	5.2	4.2	6.9	7.3	14.1	9.5	6.6	6.8	8.7	6.8	8.1	2.8	9.8	7.1	10.3	3.2	7.3	49.3	12.0	9.4	7.7	14.7	9.1	14.8	14.7	10.3	13.6	31.5	9.1	7.3	27.1	7.9	6.5	22.9	3.9	18.1	56.9	11.0	10.8	13.7	25.9	14.7	73.8	13.3	10.6	7.9	11.7	17.1	10.1	8.1	31.4	11.4	8.7	25.2	84.7	17.3	20.3	8.4	5.7	45.3	12.5	6.8	7.2	41.2	8.3	6.2	8.2	64.3	79.0	24.1	12.7	7.9	8.6	14.0	18.3	11.2	10.0	8.0	0.0	9.5	6.5	51.9	34.8	9.2	6.7	6.0	10.7	8.1	19.0	10.4
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145454-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 41.3;HUVEC TERT2: 28.0"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	16.7	4.1	7.7	5.3	8.6	7.2	11.2	16.6	15.5	2.8	0.5	2.8	2.9	3.8	3.8	4.3	2.3	5.1	7.2	6.7	1.7	4.5	4.6	5.1	5.2	1.6	2.3	2.8	2.2	3.9	1.5	10.8	2.9	3.8	2.8	10.5	8.8	2.9	6.0	6.3	3.4	5.1	0.4	5.0	7.3	6.0	3.9	3.2	4.2	5.0	4.1	5.1	2.5	13.7	6.3	2.4	2.5	2.1	12.5	7.1	3.7	5.3	1.2	1.0	1.6	1.9	7.9	41.3	4.9	2.9	3.5	3.1	3.9	5.5	1.8	19.7	6.6	4.4	6.4	3.4	7.4	10.3	2.7	7.8	8.7	1.5	9.1	2.0	28.0	5.8	8.4	19.6	3.1	6.5	3.8	7.4	3.2	10.3	5.9	8.6	4.2	8.5	4.2	6.1	4.6	3.8	5.0	9.0	2.7	3.6	6.5	4.4	17.9	3.2	9.7	2.1	1.9	8.2	11.3	19.1	7.3	5.1	4.1	2.8	0.6	0.6	0.5	0.5	0.4	0.6	0.5	0.4	0.3	0.9	0.5	0.6	1.5	0.6	0.6	1.0	0.6	0.3	7.7	8.6	16.6	15.5	6.7	1.7	1.6	2.3	2.9	0.4	3.9	13.7	272.0	60.9	69.9	0.0	4.9	0.0	0.0	0.0	0.0	0.0	87.0	42.2	0.0	0.0	36.5	33.1	0.0	1.6	9.2	0.0	7.9	12.0	0.0	4.6	3.9	44.0	0.0	0.0	0.0	17.3	2.8	13.8	0.0	12.0	32.8	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	28.2	0.0	0.0	4.0	0.0	0.0	3.5	42.3	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	2.5	9.8	1.3	0.0	0.0
FAM3C	"GS3876, ILEI"	ENSG00000196937	"FAM3 metabolism regulating signaling molecule C"	Q92520	7	121348878-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 415.8;Urothelial cells: 425.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"memory B-cell: 22.5;naive B-cell: 19.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 22.5"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 1257.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		48000000	"Cluster 37: B-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	40.4	45.9	23.8	38.5	26.8	9.6	42.1	20.4	46.5	96.5	15.9	46.5	177.0	51.4	57.5	32.0	34.5	35.3	64.0	33.8	22.6	62.9	49.5	34.5	44.6	29.3	20.7	36.7	74.0	57.3	29.6	44.5	30.4	31.7	54.0	47.8	38.1	32.3	19.0	32.2	158.2	44.3	19.1	47.4	61.8	24.5	21.8	17.1	111.1	24.5	44.8	56.6	31.3	25.4	133.1	33.2	60.7	64.9	100.3	164.2	55.6	139.7	61.5	41.2	52.1	26.4	1257.1	125.4	65.4	72.5	116.7	85.2	35.1	77.7	87.3	15.3	72.5	35.6	19.3	27.4	73.5	59.0	65.3	165.7	52.1	58.9	57.1	110.4	74.8	24.6	23.3	152.3	326.6	22.3	24.6	45.2	108.1	45.4	45.3	34.2	63.8	51.1	256.7	75.1	38.6	38.1	41.4	167.4	80.6	126.2	24.0	32.5	178.8	105.1	37.7	236.1	96.9	148.0	71.3	48.7	114.0	60.6	192.5	0.0	1.1	0.8	2.1	1.2	2.0	22.5	0.9	1.7	1.0	19.9	1.3	0.9	0.2	3.0	0.9	1.5	0.7	0.8	23.8	26.8	20.4	46.5	33.8	22.6	29.3	20.7	30.4	19.1	21.8	25.4	49.8	9.6	33.3	17.3	103.0	71.8	257.1	183.0	61.5	137.3	47.5	28.8	65.7	71.4	134.4	55.2	22.9	88.1	44.8	66.8	60.7	182.2	3.5	76.0	81.8	58.9	52.3	10.3	64.6	191.0	188.6	104.3	46.4	170.1	19.7	33.3	50.0	37.0	43.6	45.4	64.3	49.1	101.7	29.6	88.4	6.7	96.0	30.9	99.6	24.4	31.7	49.4	58.7	42.3	24.7	415.8	71.9	95.9	129.8	325.0	327.0	66.8	63.9	67.1	72.3	93.6	68.7	23.8	22.4	61.7	66.3	120.4	44.3	35.6	86.7	425.8
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444141-154450654	"Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favorable (2.05e-4)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	63.8	59.6	59.0	34.7	63.2	35.6	54.7	61.9	66.2	46.7	58.6	67.9	35.4	46.9	50.5	36.1	40.0	24.2	71.0	59.8	58.9	58.3	51.0	53.2	26.7	65.8	61.7	36.0	50.4	45.7	60.2	35.9	66.7	54.3	27.3	26.5	44.9	34.6	102.4	38.1	46.5	36.9	59.8	51.3	53.6	17.1	64.5	31.5	51.7	57.3	24.7	58.9	41.4	67.1	120.7	145.9	48.0	68.8	174.2	124.7	94.7	152.6	136.0	145.2	219.8	134.2	54.9	6.2	154.6	161.6	211.5	46.2	113.4	106.0	111.8	87.5	72.7	38.6	178.6	86.0	253.4	35.1	109.0	143.2	75.0	224.6	114.4	104.9	120.7	44.5	50.4	94.6	142.9	81.8	41.8	46.0	32.3	105.1	90.7	60.2	120.2	86.4	92.8	119.2	85.6	61.1	55.8	88.4	190.1	81.8	77.0	67.4	149.4	99.8	81.5	165.6	191.3	218.0	134.6	43.0	134.9	120.7	113.6	34.5	54.4	42.1	43.8	72.1	59.3	34.4	45.8	42.2	50.7	30.1	24.8	34.3	30.0	41.7	79.4	38.7	53.5	33.5	59.0	63.2	61.9	66.2	59.8	58.9	65.8	61.7	66.7	59.8	64.5	67.1	60.0	35.3	54.4	14.4	38.2	26.0	42.8	17.9	23.3	65.6	33.5	36.1	88.1	52.9	19.0	29.5	27.1	70.5	50.5	96.0	56.7	53.2	1.8	50.0	71.0	48.7	63.3	56.4	7.3	68.1	109.8	61.0	69.3	68.8	47.0	40.3	41.0	42.6	145.1	47.1	7.4	87.7	18.3	62.3	69.1	5.5	77.9	81.3	32.0	8.4	70.6	80.0	62.8	3.5	17.2	69.8	95.1	79.7	51.6	52.1	123.1	112.1	18.5	68.2	32.9	50.5	76.4	8.3	17.8	29.7	25.9	121.6	62.2	65.0	59.7	45.3
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"FA complementation group I"	Q9NVI1	15	89243945-89317261	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.2	2.1	1.6	13.0	1.3	31.4	6.0	3.8	2.5	3.3	0.0	10.5	6.0	4.7	1.1	8.1	3.4	3.0	1.7	1.7	0.7	1.7	2.9	3.4	23.9	1.2	0.9	3.8	3.0	3.0	0.6	11.3	1.7	3.6	12.4	5.4	2.8	2.0	0.8	8.0	7.3	6.9	0.6	6.0	6.7	32.6	1.3	44.2	2.0	0.8	26.6	5.4	3.7	1.7	108.2	122.4	127.8	86.1	10.8	16.0	78.5	101.4	58.3	123.6	150.5	96.8	95.4	198.8	53.4	33.8	79.3	143.9	196.8	69.0	116.2	127.8	123.5	197.2	176.7	45.8	1.7	146.0	96.3	8.6	6.8	87.1	44.4	17.6	51.7	120.2	139.2	142.3	83.5	61.5	150.9	49.6	101.1	70.3	44.5	130.6	187.1	84.6	28.5	196.8	93.9	80.8	105.2	73.3	46.7	85.7	81.2	64.8	35.4	103.2	103.8	94.9	155.8	93.3	209.5	151.9	38.5	125.7	104.7	23.4	2.3	3.0	4.7	3.0	2.8	3.5	4.7	6.5	2.2	3.6	3.3	5.6	3.1	5.1	4.3	4.1	11.8	3.1	1.6	1.3	3.8	2.5	1.7	0.7	1.2	0.9	1.7	0.6	1.3	1.7	2.6	3.2	1.5	3.6	3.8	4.2	2.6	4.0	0.6	2.4	2.9	2.7	3.9	0.0	3.3	1.8	0.0	17.0	3.9	4.2	0.0	2.0	7.9	5.0	3.7	3.0	1.2	48.6	7.0	2.9	18.3	3.9	5.6	4.5	2.5	14.9	6.8	0.8	8.1	1.7	5.8	5.9	0.0	3.0	3.8	7.9	3.4	4.8	1.8	1.9	3.3	11.6	1.0	9.0	6.9	2.5	1.2	1.5	13.9	2.0	1.3	1.0	6.3	1.9	6.6	3.6	4.0	69.5	60.2	9.2	2.4	12.4	8.1	2.5	9.1	2.8
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078338-82098294	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 372.8;breast: 271.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		3400000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	372.8	30.9	25.0	14.9	44.2	18.7	271.6	67.3	49.9	31.7	0.0	25.5	11.5	18.0	6.2	63.6	15.2	6.6	21.9	39.9	15.0	11.8	191.4	54.1	7.2	84.4	75.7	16.3	18.6	8.5	72.4	12.1	101.7	69.0	3.0	4.3	38.3	14.3	27.9	89.4	28.8	5.3	12.5	8.8	63.6	11.9	33.7	9.6	21.2	2.3	3.0	27.0	31.8	60.8	179.1	182.0	81.7	56.7	130.1	87.2	176.9	34.3	43.3	35.5	64.6	190.6	116.7	58.8	29.2	26.3	99.5	144.0	79.2	157.8	6.5	30.0	358.0	123.9	140.0	257.2	36.8	67.5	19.2	84.2	40.4	90.8	21.0	12.1	40.1	54.8	193.2	50.7	12.6	304.1	78.9	105.5	161.1	28.1	107.1	64.1	47.8	116.5	40.3	220.7	205.0	117.0	50.6	1109.2	93.6	29.5	199.4	123.4	71.1	52.3	107.0	45.2	88.4	68.5	17.1	60.6	31.2	71.1	79.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	25.0	44.2	67.3	49.9	39.9	15.0	84.4	75.7	101.7	12.5	33.7	60.8	9.6	25.6	126.0	28.4	7.4	7.8	12.7	33.2	8.0	28.7	442.9	165.4	5.9	21.5	28.4	11.0	6.2	32.0	12.8	35.7	3.9	19.2	1.5	19.6	19.8	10.8	18.1	20.6	11.9	29.2	77.7	13.4	33.6	17.1	12.7	29.9	10.8	244.1	13.9	30.3	12.5	22.3	22.4	9.8	6.2	3.4	16.4	7.0	17.8	4.7	6.2	14.1	8.2	11.6	17.6	19.1	23.6	11.3	9.7	60.4	6.5	5.9	23.7	13.1	0.0	9.0	14.9	1.8	11.7	34.1	13.8	29.6	10.6	27.9	27.4	19.6
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120630-65122177	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Cluster 30: Non-specific - Translation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	817.0	787.0	976.0	655.4	1009.0	1898.7	878.5	956.5	1212.5	1024.2	887.1	905.9	604.0	780.6	535.3	720.0	907.5	590.1	862.2	928.0	953.5	632.1	756.3	614.0	1342.5	982.1	958.7	1403.7	1167.7	395.0	521.6	482.7	989.8	649.3	438.8	228.2	854.7	532.3	1191.2	905.1	712.9	441.6	1010.2	784.5	796.3	336.6	1011.9	843.5	619.9	642.1	818.5	796.7	794.0	1017.9	1305.1	1040.6	658.8	1067.9	766.4	1142.2	1033.3	727.3	887.7	1327.5	832.4	1258.7	1232.1	1782.0	1782.3	744.2	701.5	1101.2	821.5	1287.2	419.3	1075.4	1494.0	1428.1	907.1	1607.8	1612.2	1546.9	1184.9	1583.3	1944.0	1106.3	1286.5	842.2	998.5	1416.3	1334.4	1578.6	644.9	2003.0	1579.6	2925.2	1850.4	1007.2	2027.5	1464.8	622.2	2980.1	1036.0	744.3	1054.4	949.2	663.8	1490.6	2131.0	399.1	1393.3	1829.5	771.2	868.6	954.8	1327.5	1150.0	1629.0	1943.6	2802.6	1042.6	1285.4	979.3	2638.2	2997.4	1808.3	2906.6	2694.0	3986.3	7025.5	4689.8	3729.6	3181.0	6502.9	5484.9	4364.5	1905.5	2994.7	2398.9	4141.8	3794.9	10270.4	976.0	1009.0	956.5	1212.5	928.0	953.5	982.1	958.7	989.8	1010.2	1011.9	1017.9	2252.8	641.0	1035.7	17.6	3768.6	3773.3	3059.7	1883.6	2632.2	351.8	3483.5	5942.5	507.2	1712.8	1280.4	958.2	196.0	2277.7	2670.7	1454.5	2050.4	1540.6	875.1	954.7	1569.4	1671.7	1226.4	1786.0	15.9	2689.2	2487.3	1531.1	923.5	1298.4	1370.0	1483.3	1755.9	2176.7	2188.0	190.1	18.2	2143.3	907.3	2643.8	3977.8	2397.4	2285.9	2349.4	2123.8	16.9	3121.9	935.5	2472.7	15.6	40.8	2042.7	2666.5	1229.2	2317.3	3295.5	2501.4	2615.9	826.4	513.6	1117.5	2227.4	2678.6	654.4	590.6	2506.0	4195.9	2793.0	2897.4	1470.6	2184.8	3518.0
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 207.3;Paneth cells: 153.6;Peritubular cells: 191.5;Proximal enterocytes: 145.9;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 255.9;TIME: 420.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	32.4	17.9	2.7	21.5	3.3	0.8	28.1	3.2	4.8	43.2	5.2	75.6	82.2	75.7	15.6	24.1	43.5	69.8	45.6	2.5	2.4	26.7	7.1	39.3	9.6	2.6	3.2	39.1	27.5	36.2	11.0	29.4	2.9	47.0	53.2	1.8	31.7	63.1	5.4	16.8	86.1	47.1	2.5	27.6	64.0	12.8	3.8	2.8	17.6	5.6	6.8	44.6	29.3	2.6	34.2	17.2	15.9	0.6	3.7	8.1	21.6	55.2	84.3	38.4	30.4	6.0	48.8	0.3	114.5	87.8	67.3	62.5	11.3	121.0	19.2	0.3	6.6	0.2	4.7	31.7	98.5	0.2	0.6	39.7	81.7	31.9	75.1	82.7	255.9	2.0	1.2	7.6	13.2	0.8	0.6	1.1	16.5	50.9	25.0	0.1	0.4	1.0	51.4	22.1	0.2	38.9	29.0	3.4	6.0	33.9	6.8	0.6	420.4	50.7	7.1	0.8	25.7	0.4	1.0	0.5	8.0	0.2	0.5	1.7	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	0.8	0.4	0.2	0.4	0.1	0.1	2.7	3.3	3.2	4.8	2.5	2.4	2.6	3.2	2.9	2.5	3.8	2.6	10.8	12.8	18.1	0.0	3.1	86.3	82.7	41.4	20.5	3.7	28.6	23.9	37.1	47.1	30.6	16.5	6.2	8.9	4.8	207.3	0.0	99.1	3.4	13.6	75.9	19.2	46.0	0.0	0.7	53.5	114.2	29.3	133.5	20.5	18.9	9.4	55.0	2.5	5.6	1.7	5.5	54.8	26.4	1.9	23.5	4.0	80.2	5.8	14.2	2.8	2.7	9.1	1.0	1.0	1.2	113.0	153.6	191.5	1.2	29.8	145.9	2.5	11.6	6.4	144.7	11.9	64.8	2.8	1.9	17.4	62.8	19.4	6.0	6.6	53.8	62.6
FBXL3	"FBL3, FBL3A, FBXL3A"	ENSG00000005812	"F-box and leucine rich repeat protein 3"	Q9UKT7	13	76992598-77027195	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"		"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053283, HPA065626"			Enhanced	"Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear bodies"		"HPA053283: AB_2682100, HPA065626: AB_2685523"	"unprognostic (3.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-1)"	45.7	25.0	17.9	24.0	20.4	69.1	42.6	23.5	26.1	31.7	12.4	27.4	24.0	31.4	23.1	27.9	27.4	24.2	25.1	17.1	17.5	37.8	31.4	29.8	32.7	17.6	17.4	44.6	20.8	29.7	9.7	32.5	18.3	29.9	25.1	21.1	22.9	26.2	30.0	30.5	25.0	27.8	18.5	31.3	22.2	30.0	17.0	36.2	48.0	37.9	31.4	25.4	23.1	28.1	43.4	11.1	21.4	14.8	50.7	50.1	17.0	48.6	39.6	28.3	36.0	16.0	30.1	27.9	31.6	43.1	17.1	31.9	21.4	26.1	40.4	55.7	56.8	36.2	32.9	14.3	33.6	46.7	26.9	42.5	34.2	22.6	31.0	33.1	37.7	15.3	14.0	20.8	34.0	15.8	33.7	25.0	8.2	37.0	20.1	27.3	24.3	17.0	30.2	22.7	25.2	20.5	31.0	30.0	28.4	14.5	16.6	51.1	46.7	27.1	17.8	18.6	23.9	26.5	32.9	25.6	46.9	33.1	30.0	8.0	1.9	4.6	2.1	2.9	2.9	2.6	3.8	2.2	1.9	2.8	4.5	3.1	5.2	2.1	3.1	2.0	5.1	1.4	17.9	20.4	23.5	26.1	17.1	17.5	17.6	17.4	18.3	18.5	17.0	28.1	35.9	44.8	22.2	31.6	48.9	67.3	38.0	17.0	50.1	25.1	36.5	21.6	21.6	12.8	15.4	22.0	10.4	33.0	42.4	54.8	41.1	17.9	41.2	26.8	29.0	38.3	23.9	50.7	30.4	18.8	41.7	42.8	17.3	34.7	28.5	20.4	32.2	28.5	23.3	37.0	29.8	23.9	22.4	36.1	41.5	24.6	74.6	33.3	42.7	37.5	36.5	45.4	20.6	33.7	58.1	19.1	25.7	74.9	33.6	40.2	38.3	29.2	19.9	24.3	59.2	46.1	52.7	52.5	58.9	40.9	56.1	28.5	44.9	22.7	23.1	38.5
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 649.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 247.5;Cardiomyocytes: 286.5;Prostatic glandular cells: 225.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 2.5;MAIT T-cell: 2.5;memory CD4 T-cell: 3.6;memory CD8 T-cell: 3.8;naive CD4 T-cell: 4.2;naive CD8 T-cell: 5.4;NK-cell: 3.2;T-reg: 3.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.9;NK-cells: 3.2;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.3;HDLM-2: 176.1;hTERT-RPE1: 58.3;U-251 MG: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	10.9	2.7	13.2	13.9	19.6	2.2	29.2	20.0	15.5	15.0	41.4	136.6	6.7	86.9	14.9	16.2	59.5	32.5	77.9	10.6	15.1	2.7	1.1	3.8	6.0	27.4	20.3	24.9	4.6	11.7	8.9	7.7	28.8	25.8	20.7	17.9	23.0	43.8	649.5	12.9	23.5	94.9	21.5	3.9	31.8	1.7	15.9	9.2	24.3	105.6	5.1	73.3	13.8	28.6	5.3	0.9	0.2	0.0	10.6	2.5	1.9	1.0	11.4	0.6	1.1	0.0	2.9	0.0	3.1	8.5	49.3	0.3	0.2	1.0	0.9	176.1	4.0	0.0	6.3	0.0	14.5	0.1	0.7	21.1	7.4	2.6	3.2	58.3	0.8	2.5	0.3	1.5	0.8	1.3	0.7	0.1	0.1	2.1	0.9	0.0	0.2	1.1	1.9	1.7	0.3	1.1	1.2	19.2	21.5	1.1	18.9	0.4	0.7	3.1	0.8	1.1	51.9	17.4	2.6	0.4	12.7	0.2	2.5	2.9	0.2	0.0	2.5	0.1	2.5	0.4	3.6	3.8	0.2	0.4	4.2	5.4	0.1	3.2	0.2	0.1	3.8	1.1	13.2	19.6	20.0	15.5	10.6	15.1	27.4	20.3	28.8	21.5	15.9	28.6	6.8	0.0	3.7	7.5	6.1	11.5	184.8	113.3	64.9	17.7	44.9	247.5	286.5	4.3	63.6	7.3	35.5	17.8	27.9	153.0	9.8	14.4	4.7	22.2	88.2	13.0	102.4	8.0	52.2	30.7	17.5	28.9	14.8	76.0	0.0	30.3	2.2	2.9	5.3	21.9	30.9	63.6	111.9	5.9	3.4	3.5	39.7	5.6	44.4	14.0	2.4	58.6	25.7	9.5	117.2	51.7	189.5	61.3	38.3	225.2	36.9	5.2	19.9	100.1	19.7	75.2	61.3	15.9	2.9	49.9	6.3	109.2	32.5	3.7	21.1	90.8
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429948-110464884	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"adrenal gland: 313.7"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1139.6;Theca cells: 745.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (3.58e-7)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	9.0	313.7	6.9	6.8	7.5	12.1	8.5	7.5	8.6	7.4	8.7	12.9	22.0	6.2	8.2	9.3	5.9	9.1	16.3	6.8	7.6	29.6	44.3	10.8	7.9	7.3	7.8	5.4	13.4	9.3	6.1	17.7	7.6	8.2	10.7	5.3	8.6	26.3	20.6	6.2	18.4	6.1	7.5	6.7	13.5	7.6	7.9	12.0	20.3	18.5	7.5	10.5	5.5	8.8	10.2	7.0	10.6	11.6	10.1	17.8	23.5	9.2	11.2	8.0	13.5	24.1	16.7	23.8	26.4	11.9	14.2	11.8	12.4	13.9	10.8	22.9	15.8	12.0	12.0	14.8	17.7	12.7	18.8	31.3	11.4	7.3	17.1	13.8	16.5	16.2	12.2	34.4	17.3	11.3	18.2	28.3	9.5	19.3	13.1	26.4	10.1	22.1	17.4	18.1	14.4	7.4	17.5	19.7	12.5	12.3	11.7	8.7	9.8	8.0	9.8	9.8	9.9	7.7	6.4	71.7	6.0	25.5	10.5	1.8	4.5	2.8	3.8	3.3	4.1	9.7	5.2	5.4	5.2	7.5	6.2	4.4	0.5	3.4	4.6	4.0	7.4	2.6	6.9	7.5	7.5	8.6	6.8	7.6	7.3	7.8	7.6	7.5	7.9	8.8	53.2	19.2	38.1	15.0	68.6	68.3	104.3	45.4	42.7	33.0	40.3	37.0	57.1	102.9	28.3	80.9	8.4	174.3	65.7	109.5	244.6	71.4	53.4	49.6	35.6	36.7	47.9	28.8	22.6	144.8	169.4	48.1	61.2	42.0	45.7	36.3	45.0	192.7	113.3	42.1	25.8	56.2	34.6	58.4	68.3	11.0	46.9	77.3	69.4	15.0	57.3	42.3	50.4	22.1	19.6	78.5	76.5	45.5	102.7	114.2	183.9	338.7	18.6	17.3	26.3	50.6	43.6	48.0	67.0	75.3	97.5	1139.6	74.0	745.1	96.4	149.6
FDXR	"ADR, ADXR"	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 343.1"	"Group enriched"	"Detected in many"	7	"Granulosa cells: 329.3;Theca cells: 794.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 89.5;Hep G2: 173.5"					"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	3.9	343.1	6.9	2.4	8.4	2.2	3.8	7.8	8.1	7.8	8.6	9.7	4.6	6.7	5.1	26.0	12.9	4.1	6.0	6.6	6.7	6.5	14.9	5.3	2.9	7.6	7.9	20.5	12.9	5.9	4.1	3.0	7.5	6.7	3.2	0.5	7.1	4.4	7.7	16.4	5.6	2.3	7.4	33.9	7.6	45.6	7.0	4.7	6.0	1.7	2.5	6.2	10.5	7.5	12.5	65.6	9.6	10.8	6.8	9.1	89.5	14.8	15.9	8.6	17.1	18.3	10.8	29.6	2.6	6.2	4.8	24.9	6.9	18.4	2.5	27.9	15.2	22.6	10.6	173.5	19.0	5.0	75.1	29.2	20.3	9.1	3.1	7.0	43.9	10.9	36.1	4.8	13.4	53.4	19.7	10.6	5.5	11.8	14.5	10.6	16.4	16.2	7.1	21.0	5.2	12.1	10.0	21.7	11.2	10.9	47.4	4.7	20.5	5.9	51.9	9.4	7.4	12.7	2.3	6.5	16.1	7.7	20.6	1.7	6.0	5.0	5.6	4.5	5.0	4.8	5.1	6.8	7.3	2.4	4.4	5.4	2.0	10.3	3.4	1.4	15.4	5.2	6.9	8.4	7.8	8.1	6.6	6.7	7.6	7.9	7.5	7.4	7.0	7.5	4.0	3.2	3.9	7.5	8.2	9.7	17.8	42.6	17.1	4.9	6.6	8.4	3.8	5.7	23.3	9.2	4.2	53.2	2.8	18.6	5.9	11.1	6.5	28.2	4.3	4.6	7.1	4.0	1.4	7.9	18.9	12.9	13.7	3.5	5.7	329.3	12.5	13.9	23.1	3.3	2.2	13.1	36.7	6.2	2.7	14.9	5.9	4.6	5.4	1.0	3.9	11.4	8.2	3.0	1.3	9.0	16.9	4.5	7.1	5.2	24.9	21.7	73.6	5.1	0.0	6.2	18.3	6.3	6.1	33.7	18.2	46.1	8.6	794.1	20.3	17.4
FEM1C	"EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785"	ENSG00000145780	"Fem-1 homolog C"	Q96JP0	5	115520908-115544775	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059919, HPA060977"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA059919: AB_2684161, HPA060977: AB_2684402"	"unprognostic (1.14e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	13.6	5.6	6.1	7.9	9.5	63.2	10.6	13.4	10.7	12.5	1.1	13.3	11.1	9.8	6.1	14.7	6.1	12.3	15.7	5.3	4.4	7.4	15.7	11.1	6.9	6.3	7.2	7.6	11.0	5.5	4.2	6.2	5.4	9.7	12.2	17.1	5.8	6.9	20.6	10.1	12.1	10.3	4.8	8.5	10.6	13.6	9.5	6.6	8.2	21.3	6.6	9.8	7.7	7.9	11.8	7.0	9.8	15.3	17.3	24.1	7.9	18.3	14.5	13.5	15.6	7.7	10.2	12.0	12.2	13.5	15.5	9.0	8.0	15.2	19.7	18.6	7.6	6.3	9.7	5.9	11.5	4.2	8.2	15.9	12.6	16.8	15.1	12.5	13.4	9.8	4.0	15.3	20.5	5.1	11.0	7.1	6.9	7.5	8.7	9.3	17.9	13.1	14.9	22.1	8.0	6.5	11.8	8.1	20.1	7.8	10.5	8.4	23.7	23.0	12.0	21.3	16.4	12.0	9.4	9.4	13.4	11.6	9.5	2.5	4.7	5.0	2.7	6.9	3.9	2.3	2.8	2.0	4.6	1.3	3.1	2.6	4.8	2.2	8.8	1.2	3.4	2.8	6.1	9.5	13.4	10.7	5.3	4.4	6.3	7.2	5.4	4.8	9.5	7.9	35.4	22.4	13.6	28.4	15.3	26.5	15.8	7.8	18.8	17.2	17.6	13.0	31.5	20.0	14.8	11.0	20.9	4.4	15.8	64.7	5.9	11.6	48.1	31.1	33.0	18.8	16.7	12.2	13.3	8.4	8.6	27.5	23.0	36.9	13.3	29.6	17.9	47.0	7.6	5.0	7.2	27.5	8.2	15.8	52.9	80.7	8.7	22.5	30.2	5.6	9.7	23.1	5.2	15.1	18.2	17.1	53.2	6.8	19.4	18.9	31.7	12.3	18.3	28.2	0.0	24.0	22.8	16.5	6.3	25.4	24.7	5.1	16.7	8.0	21.5	40.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792911-61797238	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		160000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	5.9	10.4	7.8	21.3	7.8	39.5	10.2	10.9	9.9	6.2	9.6	15.5	11.2	6.3	7.1	14.2	5.7	4.3	6.6	8.0	7.7	5.8	9.9	5.6	34.0	10.0	8.3	3.9	6.8	5.6	8.3	12.9	10.7	6.2	16.1	17.4	6.1	5.9	13.1	9.6	11.4	8.9	6.8	12.8	8.4	19.1	9.1	46.0	4.8	9.6	37.4	8.1	4.9	8.1	154.6	139.7	149.3	81.3	14.9	18.0	94.9	133.3	76.1	160.9	181.4	123.4	112.8	222.6	100.3	57.3	150.5	158.3	214.3	117.7	163.3	117.8	117.6	117.6	187.7	127.3	11.0	184.7	115.4	12.7	15.8	148.1	39.0	23.3	63.1	122.1	181.3	155.1	136.0	195.4	259.7	165.4	165.3	120.3	134.7	173.8	173.7	228.9	64.4	144.7	170.0	140.7	89.6	115.0	79.1	70.1	167.4	127.1	43.2	141.5	178.1	182.3	134.6	120.4	204.3	228.9	98.4	121.9	124.6	24.7	6.7	14.2	16.2	12.9	16.8	14.4	12.3	15.1	8.0	14.8	14.0	13.8	2.7	20.0	12.9	24.5	25.2	10.3	7.8	7.8	10.9	9.9	8.0	7.7	10.0	8.3	10.7	6.8	9.1	8.1	2.7	0.0	2.2	0.3	14.0	10.3	5.2	18.2	7.4	23.8	7.4	7.4	5.8	5.7	7.7	0.0	12.5	53.0	15.9	6.7	7.9	17.3	21.7	4.2	5.5	5.5	4.8	87.5	2.0	12.2	70.9	8.6	7.1	6.3	0.0	18.6	1.1	7.2	25.7	15.2	2.4	8.0	18.3	5.4	6.8	14.4	5.6	6.2	5.4	0.0	12.4	31.3	13.4	1.5	3.1	12.2	9.4	7.2	45.3	6.5	3.7	5.7	6.4	23.3	0.0	6.8	12.2	61.0	62.1	11.3	6.1	30.9	11.0	9.0	22.0	5.2
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			2.1	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.2	1.2	0.0	0.0	18.8	18396.9	5.3	0.1	0.0	0.0	0.7	18.8	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	9.9	47.4	3.7	0.0	0.1	0.4	0.0	0.1	0.6	0.7	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			2.0	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	1.3	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.4	0.0	0.0	48.0	17944.9	0.5	0.1	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.1	6.8	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
FH		ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519755	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 276.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.5;Early spermatids: 226.0;Syncytiotrophoblasts: 166.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		1800000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	43.4	75.2	30.4	31.0	33.3	31.4	37.3	33.5	42.0	28.9	43.9	66.8	68.2	36.9	26.1	51.1	27.9	23.7	179.0	33.9	33.1	101.8	276.4	26.4	30.0	31.8	31.0	24.9	38.1	95.0	31.1	32.1	32.1	33.5	69.0	58.8	42.0	38.4	213.4	40.3	59.1	42.0	32.4	30.1	53.6	44.4	32.7	31.3	34.6	229.3	40.4	37.5	33.7	33.0	129.2	105.6	97.9	89.0	93.9	110.0	154.9	155.7	121.1	171.6	107.1	152.2	78.0	81.1	100.3	119.9	75.0	178.4	151.7	115.8	148.4	93.5	48.9	76.3	102.2	131.4	84.1	180.2	66.7	80.2	70.7	96.6	108.0	60.2	107.2	175.8	236.3	101.7	126.9	64.3	156.6	120.1	104.5	186.2	223.6	127.4	107.2	365.7	167.4	107.6	125.4	108.4	131.1	153.3	104.0	67.2	117.1	120.9	106.5	76.6	98.9	137.0	264.0	90.3	103.7	97.3	85.7	203.5	112.6	11.9	22.8	4.9	16.1	33.3	21.0	27.2	18.8	15.1	46.7	25.1	22.3	21.1	1.3	18.3	29.1	23.1	23.8	16.7	30.4	33.3	33.5	42.0	33.9	33.1	31.8	31.0	32.1	32.4	32.7	33.0	17.1	38.5	30.2	9.4	25.0	20.0	24.6	69.5	17.1	24.7	19.9	17.5	173.5	35.8	40.0	23.9	14.6	101.6	13.7	44.0	78.2	60.4	226.0	25.4	23.5	18.6	18.0	37.7	12.7	45.0	58.7	25.5	26.5	25.4	19.0	24.9	13.6	80.4	50.7	35.3	14.9	40.6	48.8	18.5	14.4	37.4	23.9	23.9	24.9	8.4	27.9	35.0	10.3	8.0	14.4	29.4	35.7	26.7	41.3	19.0	66.1	86.0	29.2	39.1	39.5	27.7	67.9	84.7	47.1	32.1	18.6	166.1	14.9	48.4	74.2	22.8
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 1421.4;ovary: 535.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1077.5;Extravillous trophoblasts: 585.9;Granulosa cells: 851.4;Leydig cells: 567.0;Peritubular cells: 1049.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.7;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 534.6;RPTEC TERT1: 489.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes		14000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	68.3	70.2	10.4	28.9	13.2	17.0	65.4	7.6	18.2	101.9	15.0	75.2	48.5	105.1	33.8	55.4	55.8	81.5	1421.4	18.9	7.4	55.2	22.1	17.5	17.2	6.7	7.2	535.4	9.1	8.2	29.3	79.3	7.0	88.8	56.8	8.5	45.3	63.8	67.5	44.2	50.4	91.5	7.5	20.1	94.9	50.9	7.9	22.8	41.3	118.6	13.9	105.5	47.2	12.2	156.8	36.1	20.9	0.8	65.2	81.7	196.4	289.3	75.9	182.2	216.7	65.6	237.6	0.4	23.7	353.6	223.8	47.7	31.4	262.4	204.2	6.5	23.9	108.7	42.9	49.0	257.6	0.4	23.5	171.7	142.2	286.0	188.1	360.8	374.4	18.0	29.0	8.9	534.6	5.6	25.8	1.0	44.1	108.3	113.2	0.4	31.6	4.3	489.8	108.4	1.0	6.9	109.2	48.1	76.9	20.5	60.7	3.9	183.1	130.4	134.1	146.4	236.0	3.3	0.6	0.7	208.1	0.6	138.5	5.7	0.4	0.4	1.1	0.2	0.7	0.6	0.9	2.0	0.4	0.5	0.7	1.5	2.2	0.7	0.2	0.6	2.7	1.5	10.4	13.2	7.6	18.2	18.9	7.4	6.7	7.2	7.0	7.5	7.9	12.2	15.7	9.6	5.1	0.7	1.0	468.5	1077.5	342.5	389.9	9.5	59.8	126.2	362.1	15.7	91.0	29.5	2.1	220.4	1.7	212.6	3.9	100.7	5.7	44.8	40.4	27.4	58.2	63.5	46.3	117.9	585.9	96.1	186.1	32.5	10.2	851.4	17.2	9.2	25.3	0.0	4.9	169.8	73.2	0.6	31.8	17.3	567.0	10.4	23.2	25.3	2.7	1.6	0.0	0.5	1.6	234.5	258.2	1049.0	6.7	198.2	51.7	28.1	19.1	13.0	216.9	60.6	171.0	9.1	17.7	124.5	296.9	178.7	7.7	193.5	55.8	536.2
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377641-53460862	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	19.1	15.7	5.8	14.8	5.9	31.8	17.0	11.3	8.7	18.4	1.2	14.3	11.7	17.9	12.7	15.9	16.0	11.0	13.0	4.9	9.9	13.3	13.7	14.2	20.2	4.8	5.1	22.0	9.7	16.4	9.7	21.1	4.9	12.3	15.1	17.0	14.7	11.4	25.8	17.9	14.4	15.9	4.6	14.8	14.4	31.4	7.0	29.4	14.6	11.7	23.3	17.5	16.2	8.7	43.7	29.5	51.8	32.6	36.4	31.9	63.5	52.8	64.0	45.1	35.0	43.2	37.8	79.5	42.6	47.2	44.4	26.7	55.6	37.9	55.8	27.0	31.0	60.0	25.5	40.7	51.2	95.4	53.6	31.2	35.6	51.6	49.8	42.0	32.3	47.7	71.3	34.3	34.1	33.3	88.5	44.4	35.9	53.7	28.8	79.2	22.0	36.9	33.9	34.7	40.8	41.5	37.6	40.3	65.1	47.0	25.2	33.6	33.9	44.2	39.7	39.9	67.2	43.3	27.8	100.8	38.4	59.2	84.3	45.2	23.3	51.4	32.5	25.0	38.8	34.8	33.0	32.9	31.9	32.3	36.6	32.3	28.3	50.7	37.0	46.5	45.9	33.1	5.8	5.9	11.3	8.7	4.9	9.9	4.8	5.1	4.9	4.6	7.0	8.7	36.1	25.6	25.4	47.0	50.4	38.7	46.6	41.5	30.1	41.2	24.0	25.4	14.4	21.5	34.1	27.6	18.8	58.7	54.0	26.9	37.2	45.8	10.3	37.6	51.1	33.4	36.6	29.2	78.8	34.9	52.2	41.9	29.6	41.6	49.4	40.0	28.5	21.2	33.2	77.4	78.7	27.0	32.6	19.8	24.6	15.2	66.8	32.2	32.0	60.9	41.3	48.6	29.9	137.7	91.4	36.9	33.3	53.4	40.3	36.5	25.2	23.3	44.8	30.3	39.5	38.9	46.9	118.5	87.6	31.8	34.1	86.3	49.8	56.8	29.4	38.5
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FKBP prolyl isomerase 4"	Q02790	12	2794970-2805423	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 372.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		480000	"Cluster 44: Non-specific - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	35.4	38.1	92.1	22.3	95.9	24.2	53.1	127.7	372.1	41.7	89.6	35.7	20.3	32.2	44.6	69.3	38.2	24.8	42.7	96.6	104.4	68.1	57.5	38.0	19.8	101.0	101.4	50.4	52.0	47.8	36.1	50.6	106.2	44.4	37.8	52.2	48.1	44.9	69.4	49.8	25.6	40.0	97.8	24.3	58.0	58.4	103.0	25.1	44.4	48.5	29.9	44.6	46.0	141.7	91.6	198.6	56.2	94.9	68.5	40.1	268.3	87.5	31.2	141.2	95.0	199.1	108.3	120.9	24.5	56.6	98.2	121.9	353.3	118.5	168.2	222.6	226.1	133.2	141.8	71.4	52.6	105.5	35.0	36.5	106.6	167.2	165.9	84.0	83.5	119.8	124.9	166.4	57.6	261.5	186.2	94.9	480.0	266.5	141.2	110.0	98.7	72.4	119.5	114.2	80.7	116.0	101.6	272.7	45.3	348.8	368.0	70.3	44.9	69.1	216.4	78.6	224.1	40.9	67.9	177.0	61.4	154.7	72.2	17.0	11.5	6.7	12.5	10.5	13.9	14.0	11.0	11.9	6.4	14.3	11.3	13.5	1.5	9.2	15.5	5.6	11.0	11.1	92.1	95.9	127.7	372.1	96.6	104.4	101.0	101.4	106.2	97.8	103.0	141.7	31.9	6.4	11.5	10.1	39.1	143.9	261.5	38.5	80.8	60.3	133.9	96.3	13.1	54.3	26.8	53.3	75.0	186.1	27.2	111.0	154.6	82.0	125.4	49.7	47.4	43.5	106.1	77.8	12.9	25.9	117.3	42.6	41.8	74.5	38.2	45.3	20.7	49.3	62.0	97.6	15.5	124.9	63.1	17.5	102.1	40.9	34.8	67.7	92.5	4.7	40.2	48.3	25.7	10.1	17.6	60.3	100.1	38.7	47.3	272.4	77.3	141.7	21.1	63.4	85.5	28.3	117.2	149.4	74.4	111.5	132.8	223.3	74.0	38.6	148.7	147.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FLG		ENSG00000143631	Filaggrin	P20930	1	152302165-152325239	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"skin 1: 458.2"	"Cell type enriched"	"Detected in some"	13	"Suprabasal keratinocytes: 44.0"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 10.1;NTERA-2: 3.1;TIME: 2.1;U-2 OS: 2.4;U-2197: 2.6;WM-115: 2.0"	"Not detected"	"Not detected"							"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		NA	NA		3800000		"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.3	0.4	0.7	0.1	0.3	0.1	15.7	0.3	0.4	6.5	0.0	0.2	0.0	0.5	0.0	12.0	0.4	0.1	0.4	0.3	1.4	0.4	0.2	0.2	0.0	1.6	0.9	0.9	0.4	0.0	0.2	0.0	1.2	0.2	0.0	0.2	2.7	0.0	1.8	458.2	0.1	0.0	0.8	0.1	0.2	0.3	0.8	0.5	0.3	0.0	0.5	0.1	4.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	10.1	0.0	0.0	0.0	1.1	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.1	0.8	2.4	2.6	1.9	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.4	0.3	1.4	1.6	0.9	1.2	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.6	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.0	44.0	0.0	0.1	0.1	0.0	0.0
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII actin remodeling protein"	Q13045	17	18244815-18258738	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.4"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 134.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 198.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Enhanced		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		150000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	57.7	50.0	9.8	22.9	11.5	26.4	55.0	12.6	11.1	50.2	13.4	56.2	19.5	49.6	7.3	65.7	41.3	13.7	75.1	9.9	11.5	42.2	30.7	53.3	20.0	15.4	13.0	39.1	57.6	16.9	39.0	17.0	15.4	41.5	12.9	4.6	63.6	17.4	245.4	46.9	50.8	18.9	12.1	58.0	45.6	35.3	14.2	17.4	44.1	73.1	15.8	61.3	50.3	13.6	198.0	73.5	18.4	30.0	44.2	38.9	29.4	53.7	64.1	59.0	36.4	93.5	45.2	39.7	56.3	61.1	33.7	89.0	26.2	90.1	34.4	32.6	42.6	20.5	54.9	36.9	50.0	23.6	44.3	36.4	53.3	47.9	71.8	36.2	58.0	35.3	18.0	15.0	34.9	61.3	34.9	20.5	20.5	85.1	37.8	34.3	87.2	48.7	43.5	58.4	7.2	10.9	63.1	51.0	28.7	117.2	90.8	17.8	73.3	53.6	54.4	104.0	64.4	15.9	12.5	11.5	50.8	23.5	28.7	10.0	27.5	25.6	12.8	39.3	12.5	9.3	9.9	13.0	30.2	6.0	7.3	8.2	22.6	10.5	51.1	8.6	12.7	24.2	9.8	11.5	12.6	11.1	9.9	11.5	15.4	13.0	15.4	12.1	14.2	13.6	44.9	60.9	36.9	12.7	23.3	22.7	24.9	35.1	26.7	15.4	29.6	23.9	37.4	22.8	47.3	25.8	18.8	25.9	24.8	62.8	15.6	53.5	45.2	37.5	27.9	38.7	23.9	21.7	7.2	56.9	28.7	28.4	42.3	56.6	46.9	28.8	27.5	19.4	48.9	26.9	7.4	26.0	24.4	46.2	39.7	9.2	32.3	52.2	16.0	14.0	55.7	11.4	12.3	3.5	14.2	134.4	49.8	35.0	31.8	40.7	48.8	21.3	50.3	12.7	32.9	28.0	30.7	40.0	20.0	33.8	19.6	25.4	32.1	33.3	40.9	38.6
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911931-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	16.0	14.6	22.6	11.7	22.4	12.5	14.2	22.6	28.7	18.6	15.9	19.3	12.9	17.7	4.8	12.8	17.0	13.0	19.0	18.9	20.8	12.8	8.3	14.0	11.3	33.2	23.3	20.6	10.7	14.7	16.4	8.2	30.0	17.2	3.7	13.3	13.7	12.5	32.8	20.4	14.4	7.6	19.2	18.7	13.4	4.0	27.3	9.1	15.5	10.7	6.2	21.8	16.2	23.7	10.0	34.8	7.8	23.2	12.4	12.5	23.6	18.2	14.1	9.0	9.2	5.8	31.8	24.4	47.3	14.0	14.7	20.5	6.5	12.2	1.8	40.8	19.6	8.2	30.9	19.5	27.7	10.9	27.3	11.2	37.9	19.1	13.8	16.7	12.9	16.0	18.6	25.0	7.0	23.8	25.1	13.3	12.7	7.5	23.6	43.5	11.6	44.0	10.6	6.7	16.7	15.5	19.1	20.6	24.1	4.3	16.1	19.6	24.4	15.0	13.6	29.4	12.4	37.1	34.5	22.7	16.4	17.8	17.9	1.2	0.8	0.3	1.3	0.4	2.3	0.9	2.1	2.7	0.8	2.6	1.7	1.5	0.1	0.5	0.4	0.5	1.1	1.1	22.6	22.4	22.6	28.7	18.9	20.8	33.2	23.3	30.0	19.2	27.3	23.7	16.7	0.0	4.2	34.3	10.4	12.4	9.3	9.2	23.3	42.1	8.6	11.3	12.3	8.6	5.1	22.0	35.5	21.2	14.3	6.5	1.9	6.1	0.4	6.0	7.7	13.4	2.4	6.5	26.9	6.5	8.5	13.9	12.2	8.9	0.0	48.3	11.0	6.8	8.5	33.7	29.0	4.9	4.1	9.9	5.1	1.2	11.1	8.9	8.8	13.1	7.9	18.8	9.2	18.6	25.6	7.1	2.9	14.3	10.4	5.3	8.9	6.3	8.3	39.3	0.0	16.6	20.9	0.9	3.2	13.1	13.9	8.8	11.9	5.3	7.4	5.6
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"FMRP translational regulator 1"	Q06787	X	147911919-147951125	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	18.1	16.5	22.3	20.6	24.1	43.5	18.3	29.6	29.2	18.8	16.1	19.1	17.5	27.3	41.0	17.0	22.8	15.9	20.1	21.7	21.0	34.0	39.6	20.1	22.7	21.9	21.1	27.7	13.3	29.6	13.5	31.2	21.3	16.5	18.9	27.6	14.1	21.4	9.5	23.2	19.7	21.1	22.7	27.7	17.8	19.6	22.9	24.6	30.6	11.6	21.7	16.7	14.7	23.4	44.9	39.6	41.2	27.2	24.4	19.4	31.9	23.8	24.9	37.6	66.4	43.5	42.1	89.5	93.5	29.8	43.3	74.4	65.8	30.2	42.0	34.9	45.2	25.3	71.3	41.4	24.0	28.3	15.1	21.2	16.2	31.6	28.8	22.6	31.8	24.4	15.9	57.7	32.7	59.0	32.0	20.3	18.2	30.9	21.8	34.7	116.8	37.6	43.2	119.3	35.1	23.3	26.8	24.4	35.7	55.4	21.8	24.9	30.4	30.5	25.5	37.7	60.0	61.1	65.5	94.5	27.4	46.9	16.3	2.0	1.3	3.4	2.7	1.6	3.5	2.6	1.8	3.1	1.7	2.4	2.3	2.7	3.5	2.5	1.6	1.3	2.4	1.3	22.3	24.1	29.6	29.2	21.7	21.0	21.9	21.1	21.3	22.7	22.9	23.4	35.3	57.7	26.6	26.8	22.1	31.4	16.0	12.6	21.1	37.5	20.7	17.4	43.2	14.3	23.9	22.0	12.5	37.2	37.1	27.2	19.6	14.7	1.0	36.4	42.5	27.2	14.9	10.7	33.3	9.8	43.5	27.2	17.9	49.3	19.7	36.8	17.5	37.5	15.4	70.7	32.2	13.8	18.3	25.4	15.7	3.0	30.1	23.7	35.6	29.0	16.8	40.0	11.3	28.6	33.9	13.5	18.1	29.7	20.3	22.7	20.7	42.6	23.4	30.0	6.6	37.2	33.3	14.9	20.9	28.1	32.4	40.8	24.1	39.4	16.9	34.7
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716494-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA039485: AB_2676536, HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (6.35e-4)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (7.23e-5)"	38.0	34.4	5.8	12.1	6.1	19.6	36.6	9.9	7.4	46.7	8.4	35.4	8.9	38.9	9.4	33.8	40.6	8.2	29.9	5.7	6.8	29.5	31.3	39.1	15.9	5.9	6.2	48.8	39.2	7.5	29.2	9.6	5.8	36.3	8.8	14.9	32.7	8.2	51.0	40.5	42.8	9.0	5.3	50.6	31.6	16.5	6.4	14.0	42.8	7.0	14.2	34.2	40.2	7.8	10.6	8.5	17.7	12.5	10.0	11.6	12.0	12.3	12.7	11.1	12.9	8.4	14.0	23.2	6.0	14.0	9.3	21.2	15.8	10.0	16.4	18.2	24.1	17.5	28.1	14.3	14.1	19.5	16.6	14.2	16.4	9.7	22.0	16.2	13.1	14.1	19.2	19.2	10.7	9.7	30.0	22.6	16.7	9.4	7.8	21.2	16.8	12.9	10.9	12.8	7.9	13.1	18.5	15.2	10.5	13.2	12.3	9.1	14.4	13.1	13.8	19.0	17.3	18.6	13.4	26.1	9.5	11.9	9.1	3.8	2.1	3.4	3.7	1.5	2.9	5.1	2.6	2.6	1.3	5.4	2.7	2.9	2.0	1.8	2.2	5.6	3.9	0.9	5.8	6.1	9.9	7.4	5.7	6.8	5.9	6.2	5.8	5.3	6.4	7.8	65.0	51.3	71.7	82.6	114.7	70.9	112.5	45.9	112.7	95.1	57.0	49.0	38.2	27.1	63.6	25.8	108.4	48.9	122.0	46.1	5.9	39.9	5.5	94.3	121.9	59.7	36.5	59.1	86.7	37.8	37.4	70.6	89.2	165.4	57.6	95.5	48.2	27.0	28.4	67.3	93.6	46.5	34.6	37.2	58.3	8.0	89.5	59.2	39.2	71.2	62.1	28.1	83.4	100.5	108.3	50.8	39.4	62.1	102.4	120.8	36.6	11.3	60.5	103.2	46.0	70.5	61.6	37.3	28.1	96.0	69.9	82.9	105.7	93.4	42.6	168.0
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 287.6;Langerhans cells: 319.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 36.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	149.4	169.7	18.8	67.6	18.4	232.1	78.6	18.8	31.8	83.0	17.4	64.3	30.2	77.8	7.0	129.5	85.7	79.6	75.1	34.7	32.2	65.8	30.9	83.4	9.1	36.0	19.3	133.5	37.2	7.5	46.6	46.9	18.8	53.8	40.2	10.7	47.4	26.7	101.7	103.4	52.2	81.5	18.2	32.7	76.6	7.3	23.5	17.2	35.2	33.9	16.6	82.3	112.1	15.0	45.0	30.2	2.0	23.2	23.9	41.6	62.0	37.7	38.0	58.8	51.1	35.9	34.6	0.2	53.9	48.6	59.6	42.0	2.5	49.7	52.6	10.6	3.1	4.6	59.3	6.3	37.3	7.9	18.9	66.9	123.3	69.0	60.5	49.5	31.2	1.5	0.6	12.5	39.7	7.3	0.7	24.3	3.6	45.2	14.8	1.8	57.4	4.3	94.3	152.5	15.7	2.3	61.0	35.2	10.9	16.8	3.8	35.5	93.8	122.8	81.9	72.3	55.2	19.1	7.6	0.2	81.5	43.3	21.6	17.2	9.9	8.7	7.7	7.3	7.4	0.0	1.6	3.8	3.9	0.0	0.4	2.5	36.6	4.6	6.4	1.3	1.2	5.1	18.8	18.4	18.8	31.8	34.7	32.2	36.0	19.3	18.8	18.2	23.5	15.0	183.1	32.1	50.9	4.6	20.2	143.1	86.3	85.8	90.0	0.8	76.4	41.7	27.9	70.1	59.7	167.3	0.0	27.4	287.6	140.6	19.6	58.5	1.3	115.7	88.0	111.0	28.1	4.4	11.9	59.8	148.3	79.7	115.7	193.6	108.3	68.1	56.7	16.5	37.4	0.0	8.1	65.2	40.7	58.0	319.8	4.3	22.4	181.2	85.4	15.0	62.8	2.3	53.5	0.5	0.6	54.1	91.5	24.5	67.0	82.2	124.8	35.1	38.2	1.4	26.3	93.8	122.3	1.6	2.5	157.6	150.7	50.2	142.4	23.6	57.6	152.8
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947217-138953990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 50.1;parathyroid gland: 32.7"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.0;Granulosa cells: 3.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.4;fHDF/TERT166: 9.2;HEL: 8.7;hTCEpi: 4.4;SiHa: 6.6"									"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli fibrillar center"		"HPA061017: AB_2684415, HPA071790: AB_2686447"	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.8	1.2	0.3	1.0	0.8	0.2	2.0	1.6	16.4	0.6	0.2	0.2	17.9	2.0	0.4	14.9	0.2	0.1	1.1	1.0	0.1	0.1	0.1	0.7	0.9	0.9	50.1	0.9	32.7	8.4	0.4	1.2	0.2	0.2	0.6	0.2	1.1	0.3	0.8	0.2	4.2	0.3	0.4	0.2	0.8	1.2	0.1	0.2	0.1	0.5	0.0	3.4	1.2	1.8	1.1	0.5	4.4	0.2	0.1	2.0	0.1	0.0	0.2	0.0	0.2	0.4	0.2	0.9	9.2	0.1	0.5	0.2	0.0	0.2	0.1	0.2	8.7	3.0	0.2	0.0	0.2	0.3	0.1	4.4	0.1	0.1	0.4	0.0	0.2	3.4	0.3	2.5	0.3	0.1	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.4	1.2	0.2	0.1	6.6	0.2	0.1	0.7	0.2	2.6	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	1.2	1.0	2.0	1.6	1.1	1.0	0.9	0.9	1.2	0.3	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	46.7	11.4	14.7	13.4	15.1	68.5	43.1	34.0	19.6	28.1	19.3	21.7	12.4	23.5	15.3	35.4	25.4	28.2	18.6	14.3	9.8	16.3	23.1	30.3	12.8	17.4	15.5	43.0	86.9	30.2	8.6	21.3	13.3	20.0	17.0	28.7	25.1	11.5	84.1	30.6	16.9	21.1	11.5	18.8	22.2	11.9	17.1	18.5	18.0	51.4	15.8	23.2	27.4	17.0	21.6	6.8	9.1	20.4	41.2	48.4	16.1	17.0	17.7	13.5	19.9	11.9	19.5	11.7	14.8	20.0	22.3	15.0	12.1	20.8	20.4	12.9	18.3	32.5	6.2	9.8	47.4	8.6	24.8	56.0	43.2	29.3	40.4	19.8	10.3	10.2	21.8	94.5	26.9	12.2	9.4	12.6	6.1	10.1	11.6	12.1	32.4	48.7	30.7	16.5	23.4	59.9	12.7	11.8	16.6	18.1	12.1	27.7	18.3	24.9	12.9	13.8	20.6	0.9	16.8	13.5	13.4	16.2	16.4	7.8	2.8	6.1	3.2	1.5	3.8	0.8	1.7	2.6	1.7	1.7	1.4	2.0	15.6	3.7	5.3	2.7	1.9	1.1	14.7	15.1	34.0	19.6	14.3	9.8	17.4	15.5	13.3	11.5	17.1	17.0	88.2	44.8	46.0	112.6	41.2	67.7	73.3	34.4	91.6	63.4	64.1	46.9	31.6	71.4	44.4	25.8	70.9	25.4	41.4	86.9	17.6	50.4	19.9	91.2	41.8	55.6	66.9	246.9	102.7	30.9	36.9	105.8	46.9	105.6	15.2	46.2	84.6	77.7	46.4	52.2	99.9	55.0	20.3	85.2	83.3	17.7	106.6	96.6	56.9	160.2	55.9	78.9	22.6	108.6	133.2	73.3	44.2	100.4	83.3	122.2	28.3	21.1	57.7	68.6	32.9	236.6	81.6	9.1	17.8	61.1	46.5	41.2	37.6	30.6	34.5	184.2
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.8"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 186.8;Microglial cells: 288.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.0;RH-30: 37.3;THP-1: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.9	1.3	1.8	1.9	1.3	0.4	2.0	0.0	10.1	5.0	0.0	18.8	2.5	8.0	1.7	6.1	3.4	3.5	1.4	2.7	0.9	2.0	2.5	1.5	1.0	1.5	6.9	9.7	4.6	0.6	0.9	0.5	1.9	2.2	5.2	3.2	2.8	1.4	3.2	3.7	3.2	7.7	0.0	0.5	4.2	1.3	2.6	0.2	4.9	1.8	0.7	6.1	4.3	5.2	0.4	3.2	21.0	0.0	4.9	6.2	1.3	3.5	3.6	0.7	0.4	1.6	0.3	0.3	0.8	1.2	0.1	0.5	0.8	0.0	0.1	0.2	7.0	8.0	4.6	6.6	0.0	0.5	0.5	1.3	0.8	0.1	0.0	1.3	0.0	0.0	1.8	3.0	0.8	1.5	1.8	1.2	1.1	0.4	1.0	0.6	37.3	7.9	0.5	8.6	5.1	2.2	0.0	1.3	1.1	1.2	1.0	11.9	1.6	1.3	0.6	2.0	0.7	6.3	0.7	1.0	1.5	0.8	0.6	9.7	5.5	11.4	5.9	7.4	5.8	10.1	6.4	6.3	6.7	8.2	6.5	7.4	5.5	6.6	6.3	16.6	10.7	20.5	1.8	1.3	0.0	10.1	2.7	0.9	1.5	6.9	1.9	0.0	2.6	5.2	0.5	0.0	8.2	5.5	0.0	30.7	2.9	5.5	48.3	0.1	1.8	1.3	1.6	10.0	7.3	3.7	2.1	0.1	0.0	4.8	0.0	0.1	9.7	0.1	1.2	1.9	4.2	0.0	186.8	5.4	0.0	20.6	1.1	0.0	0.0	16.2	8.2	11.7	0.2	13.5	6.4	11.5	2.0	1.6	5.6	6.2	5.3	0.4	3.6	288.6	0.0	27.7	0.0	5.5	4.6	1.3	18.5	0.7	0.6	2.3	8.6	3.8	11.3	1.3	0.0	25.5	1.7	2.4	1.4	25.3	25.6	0.3	0.3	4.2	11.5	4.0
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA 2'-O-methyltransferase 3"	Q8IY81	17	63819433-63830012	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.7	20.7	11.8	18.2	12.4	15.8	18.0	12.3	12.7	20.4	12.0	20.5	14.2	20.2	17.2	19.0	18.8	15.1	20.8	11.3	12.0	23.3	18.8	14.8	20.9	12.6	12.1	22.3	15.7	20.6	12.4	13.1	12.5	18.7	18.0	8.8	17.7	18.1	28.8	23.9	18.4	22.6	12.3	21.0	17.8	15.2	12.3	21.0	17.2	14.6	23.8	20.1	18.7	12.7	63.0	97.0	36.8	52.5	57.9	49.5	57.0	61.4	44.7	68.8	54.2	81.4	40.9	83.4	24.7	36.2	36.0	42.6	69.3	58.4	87.8	14.4	69.2	75.0	68.6	76.6	42.2	95.9	52.5	35.1	45.3	106.9	51.2	34.9	58.2	50.2	75.9	33.1	46.5	105.5	84.9	31.1	99.4	70.2	97.7	74.6	100.9	58.6	44.8	56.3	33.9	132.5	72.3	60.9	43.1	72.7	58.0	31.8	52.7	50.9	71.6	57.4	115.1	79.5	120.9	81.4	45.6	62.6	50.3	4.5	11.4	7.0	11.0	13.0	14.5	9.6	11.6	14.5	13.6	8.6	9.2	11.5	2.5	13.9	10.1	10.3	15.1	10.0	11.8	12.4	12.3	12.7	11.3	12.0	12.6	12.1	12.5	12.3	12.3	12.7	16.2	32.1	30.2	4.2	17.3	13.8	13.6	16.1	26.7	6.6	10.6	12.6	27.7	18.6	25.7	14.7	10.4	16.0	19.4	15.7	13.7	28.0	8.8	23.5	27.5	25.1	12.7	20.8	2.0	33.8	17.0	18.4	11.2	24.1	24.1	17.5	14.3	19.9	14.2	3.3	2.0	12.0	16.2	13.8	9.3	17.8	24.2	16.3	8.8	1.9	19.3	16.0	15.5	1.5	3.8	30.6	14.0	19.2	18.6	10.6	15.5	29.8	24.3	9.3	46.0	21.0	20.5	11.7	15.7	20.8	12.8	16.3	18.6	15.7	21.1	9.5
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm		NA	NA		300000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	29.6	37.8	13.4	35.5	15.3	79.6	30.9	24.0	17.9	28.1	18.5	24.3	24.9	36.4	36.8	24.8	28.5	16.8	29.7	13.8	15.9	39.3	17.1	31.6	42.8	15.6	13.4	46.9	33.7	23.0	41.7	23.0	15.7	24.1	27.5	57.2	30.5	13.3	33.8	27.5	27.5	19.0	15.1	35.2	26.1	17.0	15.3	35.7	36.9	15.2	38.6	25.3	27.4	24.3	49.4	36.5	106.9	40.0	11.9	19.0	77.6	53.5	23.4	35.8	29.2	34.7	49.1	91.3	22.1	31.9	49.1	51.4	54.8	45.4	48.1	91.6	38.5	58.8	87.4	56.9	25.8	104.9	22.8	25.2	35.5	39.7	36.4	39.6	29.2	59.1	65.8	45.1	31.0	39.0	74.0	60.4	75.7	38.0	26.2	94.6	78.7	30.9	35.2	49.0	54.2	61.1	41.5	42.8	44.2	44.7	52.9	38.7	50.7	50.7	66.0	14.7	62.5	44.8	39.4	106.1	21.1	45.3	44.5	6.5	10.5	12.3	20.5	17.0	23.3	19.0	19.6	20.8	9.3	14.7	19.4	23.6	5.3	29.4	19.1	15.4	24.5	15.3	13.4	15.3	24.0	17.9	13.8	15.9	15.6	13.4	15.7	15.1	15.3	24.3	38.6	73.7	57.5	48.0	70.7	84.8	107.0	49.5	39.3	44.7	48.7	31.2	76.4	24.3	71.0	33.1	41.7	46.8	68.2	27.1	43.0	59.5	33.3	54.8	50.7	52.0	55.1	43.1	48.8	72.1	66.2	49.0	28.5	60.5	77.8	59.4	30.4	23.4	33.4	18.5	53.6	35.9	36.7	32.1	37.0	19.8	48.1	41.8	39.2	61.8	61.5	32.5	52.5	56.3	88.3	69.2	33.5	30.1	68.9	54.2	23.6	28.9	73.2	40.5	32.9	70.3	65.7	33.2	41.3	40.9	63.1	35.7	72.1	38.0	37.8	72.7
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 788.7;tongue: 451.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 986.2;Late spermatids: 1759.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA		15000	"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	35.8	40.1	54.8	22.4	65.0	48.1	31.9	62.9	76.0	36.6	54.2	49.1	21.2	41.4	26.3	40.0	33.3	25.6	118.9	51.5	66.1	26.8	33.9	24.6	30.0	63.7	60.6	49.2	34.3	32.5	25.5	39.0	64.9	38.0	20.1	42.2	29.7	32.6	788.7	21.9	22.4	36.2	60.5	23.1	32.3	132.4	60.8	50.5	31.4	451.3	30.5	38.5	28.3	93.2	144.2	65.8	138.8	108.5	104.6	118.4	62.7	111.9	114.0	123.1	120.5	97.5	70.9	73.3	179.8	77.7	193.9	67.6	113.3	68.8	171.0	97.4	76.1	74.3	88.9	112.7	110.8	46.6	58.5	125.7	77.0	62.3	147.8	183.7	126.1	70.5	60.7	86.0	157.1	52.2	89.4	78.3	156.8	88.8	71.2	61.0	177.5	78.6	95.4	44.6	58.4	74.6	96.8	110.9	149.9	193.7	154.7	88.5	101.3	92.0	102.3	58.1	223.3	79.0	108.9	86.9	96.0	65.9	120.2	9.4	12.6	10.0	11.7	13.7	12.2	12.9	12.3	10.6	14.4	9.1	15.5	12.9	10.9	11.6	10.4	10.2	22.2	9.6	54.8	65.0	62.9	76.0	51.5	66.1	63.7	60.6	64.9	60.5	60.8	93.2	89.1	64.1	75.0	58.1	81.1	78.4	97.6	68.5	78.6	72.6	67.7	72.3	224.6	48.6	74.8	35.0	56.3	96.8	93.5	28.9	58.7	84.5	986.2	158.2	132.1	78.1	53.8	105.6	75.6	75.8	99.5	78.6	33.6	114.8	126.6	106.3	62.4	70.2	67.9	87.5	87.8	36.1	40.7	76.6	58.7	1759.0	84.2	73.2	49.8	48.7	138.5	97.5	52.5	86.5	137.5	73.3	39.2	76.0	74.3	68.8	62.1	106.8	104.1	86.5	32.9	116.3	89.1	318.6	113.5	57.9	70.6	61.2	87.3	97.4	42.8	67.1
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain autophagy adaptor 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 263.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	16.7	13.0	10.5	9.7	12.0	6.5	13.4	9.6	9.4	23.1	11.3	42.0	8.0	25.6	10.3	21.3	15.4	18.7	66.8	8.6	10.3	10.7	10.8	14.7	8.6	15.5	10.8	23.1	12.7	20.3	7.6	8.2	14.8	19.3	10.7	33.0	14.9	22.9	263.3	19.3	14.4	28.2	15.1	10.2	20.4	3.3	11.9	10.5	16.5	104.6	8.2	39.6	16.9	15.1	10.8	10.3	3.0	13.0	27.9	21.8	4.9	10.2	23.7	13.1	14.6	5.6	9.3	7.9	5.6	14.2	12.7	7.9	8.5	17.0	15.7	3.3	9.0	11.4	8.7	6.3	19.0	8.8	7.9	24.3	16.7	21.1	20.5	20.3	26.7	13.4	7.4	11.3	9.5	6.7	9.0	5.5	4.5	8.8	9.8	3.1	8.3	4.4	15.9	37.2	2.2	3.4	6.4	20.0	17.6	4.4	9.7	5.7	20.8	5.0	5.9	17.0	5.7	6.4	4.4	2.7	17.2	11.1	9.6	0.7	0.5	0.3	2.0	0.5	2.7	0.2	1.2	2.1	0.2	0.2	0.5	0.7	0.4	1.5	0.3	1.3	1.2	0.7	10.5	12.0	9.6	9.4	8.6	10.3	15.5	10.8	14.8	15.1	11.9	15.1	9.5	28.9	13.7	12.4	4.8	4.1	4.8	5.6	3.4	11.2	8.5	4.8	89.3	8.6	13.0	16.5	35.5	4.3	8.7	6.8	3.9	8.8	0.1	6.4	8.9	9.3	9.6	6.9	0.8	8.3	2.2	14.0	12.8	11.2	2.5	14.9	11.4	9.2	4.1	0.0	0.8	7.6	2.0	5.8	4.6	1.6	12.8	5.1	10.6	10.3	4.0	20.0	6.2	8.0	21.2	11.0	2.5	17.7	3.0	17.3	8.7	6.2	18.6	37.1	6.6	20.8	12.8	2.3	0.8	8.4	4.1	2.9	12.7	6.1	6.2	7.9
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8"	"Cancer enhanced"	"Detected in all"		"glioma: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	16	"NK-cells: 69.0;T-cells: 174.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 538.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		820000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	76.6	10.8	117.1	52.4	106.4	32.3	46.8	83.8	104.3	45.5	33.3	32.9	16.4	45.6	33.8	16.0	51.4	32.1	40.5	102.1	121.5	23.9	20.4	63.5	108.9	136.3	104.9	28.8	8.5	18.7	22.9	29.7	107.0	17.6	15.6	26.9	12.9	12.5	12.3	41.5	47.1	38.0	109.9	71.9	29.3	16.5	105.7	86.1	45.7	18.3	67.6	48.4	33.4	109.8	10.4	1.5	178.6	30.2	133.4	81.4	3.2	29.1	90.8	24.2	42.9	1.3	1.6	21.0	18.3	56.1	21.0	1.3	25.8	39.9	46.8	0.7	66.5	57.0	13.6	2.7	78.7	19.5	19.0	78.8	59.1	90.5	76.8	62.9	99.5	99.6	4.9	140.3	86.8	1.5	92.7	17.9	26.0	3.3	18.0	29.1	24.0	1.4	0.0	9.1	124.6	50.7	5.7	2.4	124.7	39.6	1.3	57.0	63.9	72.3	13.5	538.7	18.5	20.0	19.7	32.5	136.0	44.3	128.9	1.1	6.4	0.2	137.0	5.6	174.8	4.8	83.9	152.7	7.4	6.4	27.9	72.3	3.0	69.0	4.2	4.3	79.2	51.5	117.1	106.4	83.8	104.3	102.1	121.5	136.3	104.9	107.0	109.9	105.7	109.8	87.8	0.0	8.3	382.6	26.0	17.1	2.5	0.6	1.8	57.2	2.9	6.9	11.3	14.3	2.1	7.3	0.0	2.7	291.6	1.2	17.6	9.3	3.7	5.6	51.7	70.3	13.2	20.9	118.7	1.0	2.4	61.9	17.9	4.9	52.0	20.9	76.4	60.3	3.0	47.1	127.6	3.8	2.0	35.8	96.1	3.2	26.4	42.7	37.4	88.1	64.5	89.1	228.6	342.8	162.3	9.7	0.1	7.2	96.2	3.9	17.7	212.2	4.4	8.3	13.1	48.8	32.9	3.9	8.6	0.7	13.4	52.0	275.8	71.1	2.9	1.1
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.7;skin 1: 9.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.4;Basal squamous epithelial cells: 12.5;Fibroblasts: 8.4;Skeletal myocytes: 13.1;Smooth muscle cells: 9.3;Squamous epithelial cells: 25.5;Suprabasal keratinocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.5;BEWO: 6.4;hTCEpi: 3.7;RPTEC TERT1: 1.9;RT4: 3.2"	"Region enhanced"	"Detected in many"		"thalamus: 6.9"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	0.7	0.1	0.7	0.1	0.6	0.0	0.8	1.2	0.6	6.5	0.2	0.3	0.1	2.8	0.9	16.7	1.4	1.6	0.2	0.6	0.6	0.6	0.0	0.8	0.4	1.2	1.0	2.9	0.1	0.0	0.9	2.3	1.1	2.9	0.2	0.4	4.2	1.5	1.0	9.4	0.4	0.4	0.7	0.0	0.4	0.1	2.7	0.3	1.0	0.8	0.7	2.6	6.8	1.1	0.0	0.0	5.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	1.0	0.5	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	3.2	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	1.2	0.6	0.6	0.6	1.2	1.0	1.1	0.7	2.7	1.1	0.4	0.0	0.5	0.0	0.0	8.4	4.7	0.1	12.5	0.1	0.6	0.8	0.6	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.5	2.1	2.1	0.0	0.0	0.0	0.2	0.6	8.4	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	13.1	9.3	0.0	0.4	25.5	8.5	0.8	0.1	0.0	0.0	1.8
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75641849-75724589	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol		NA	NA		47000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	37.6	41.5	32.6	50.9	35.6	69.2	50.3	24.2	48.5	47.2	12.9	61.7	52.4	45.1	32.1	49.5	55.2	49.7	47.8	33.7	51.7	67.5	65.3	46.0	60.2	26.0	28.8	32.0	42.2	56.0	28.2	38.4	32.4	77.8	58.0	46.8	37.0	49.2	115.1	25.5	62.6	55.0	24.0	48.0	47.5	60.5	40.0	66.5	74.6	119.5	61.2	65.8	25.8	30.0	96.8	96.6	160.5	131.1	134.8	136.6	54.1	141.6	144.6	96.2	101.5	128.5	137.1	197.1	125.5	120.1	87.0	68.8	170.1	176.0	136.6	111.4	66.2	185.7	95.7	141.7	119.8	188.4	146.2	109.9	144.4	114.6	122.8	129.1	172.1	114.9	140.9	139.2	150.7	63.0	218.4	63.1	154.1	140.3	36.3	159.8	199.2	96.3	112.3	125.8	124.1	141.1	105.7	151.0	201.9	165.7	75.1	90.9	178.5	95.3	76.5	107.7	81.7	136.2	133.9	195.2	135.5	122.9	122.7	83.1	36.2	62.4	50.0	47.8	76.4	35.1	48.1	55.8	41.1	28.2	46.9	51.5	30.8	59.6	64.1	18.5	44.1	64.1	32.6	35.6	24.2	48.5	33.7	51.7	26.0	28.8	32.4	24.0	40.0	30.0	72.8	54.5	100.7	26.1	126.3	89.0	81.7	53.2	114.4	61.4	71.8	55.2	79.1	20.0	81.0	53.3	50.1	36.4	133.0	92.2	41.1	59.0	213.8	84.7	57.8	69.8	135.4	43.9	70.6	68.9	49.3	56.7	65.2	80.0	105.7	76.7	51.0	77.7	45.7	70.7	74.9	107.9	50.8	75.9	131.3	228.8	26.4	86.1	60.5	30.9	85.3	29.3	53.5	36.7	59.1	94.8	66.6	39.9	117.7	84.5	88.3	104.1	85.8	69.1	19.7	57.2	91.9	63.2	74.8	79.8	77.7	41.3	186.2	99.5	75.6	88.3
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 412.7"	"Cell line enhanced"	"Detected in all"		"A549: 2333.8;MCF7: 883.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		2400000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	40.7	39.1	19.9	30.2	21.8	105.9	31.9	20.5	28.3	20.6	20.0	13.9	13.1	21.6	13.3	54.3	19.3	46.5	14.3	21.3	22.7	12.7	6.5	29.4	28.9	25.4	22.2	24.1	13.0	9.6	27.5	13.7	24.5	12.2	13.1	26.1	21.2	14.4	4.2	21.3	12.4	25.6	19.7	26.9	18.1	54.0	26.1	26.2	45.9	5.1	37.2	33.8	22.4	21.9	168.5	2333.8	49.7	189.7	207.2	281.7	43.5	116.0	341.7	120.0	205.8	111.2	61.9	110.9	174.1	274.3	475.9	146.3	79.3	202.5	60.3	111.4	55.0	116.8	517.2	244.6	401.6	117.8	373.5	136.6	58.5	233.9	49.8	185.6	252.5	79.8	69.6	46.3	218.4	883.9	77.5	93.0	35.3	549.5	172.2	74.9	28.4	120.5	357.1	210.9	49.6	62.0	115.9	444.5	99.9	65.0	67.1	99.4	289.8	73.1	250.0	102.5	181.8	58.2	80.0	189.8	200.6	77.5	150.9	166.1	84.9	412.7	50.3	72.1	32.1	16.0	13.7	36.7	40.1	17.0	16.5	28.2	137.4	69.3	63.5	18.9	18.7	72.8	19.9	21.8	20.5	28.3	21.3	22.7	25.4	22.2	24.5	19.7	26.1	21.9	7.9	0.0	17.0	4.6	21.5	12.5	24.3	46.6	8.6	6.2	14.6	8.6	1.1	14.3	22.9	11.0	18.8	29.6	58.9	25.5	29.4	39.3	10.3	7.7	13.7	13.2	9.5	37.7	2.9	29.3	41.2	19.6	23.4	10.7	37.5	26.1	18.2	1.6	45.6	33.7	2.3	11.5	24.4	58.2	26.0	20.8	26.1	56.6	19.6	5.6	112.3	13.6	83.4	3.5	3.7	31.0	11.4	16.1	21.6	23.9	18.5	18.3	10.9	32.5	6.6	7.5	23.6	10.9	32.8	34.4	13.8	36.3	33.8	11.6	13.5	30.5
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor subunit alpha"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	17.0	13.8	6.8	14.1	9.4	16.0	14.9	7.9	10.2	14.6	7.2	12.5	12.9	18.3	15.1	11.3	12.4	13.4	12.9	6.2	7.1	13.8	19.3	13.3	20.4	7.5	7.6	18.1	10.2	15.3	6.7	24.5	8.1	12.4	13.8	11.5	10.4	10.3	10.6	10.3	13.4	15.3	7.6	18.7	11.8	15.0	7.6	22.1	21.2	16.5	19.5	12.9	10.0	10.3	22.2	9.2	25.8	18.2	25.4	33.9	20.0	17.5	18.7	13.7	13.5	11.4	18.2	45.7	13.4	19.7	13.9	9.7	28.5	17.2	22.7	27.6	26.8	32.9	11.9	10.7	17.1	35.3	21.2	25.1	16.3	18.5	17.2	22.9	25.6	24.9	30.8	27.5	23.2	11.0	37.9	15.1	35.9	23.6	12.5	31.1	37.5	28.7	15.9	14.3	16.0	21.1	30.9	19.5	22.0	15.5	17.2	26.8	26.5	16.9	15.5	18.7	14.8	22.2	20.3	40.3	17.2	26.5	21.1	8.8	4.7	7.4	4.3	5.5	5.8	5.6	5.1	5.3	4.7	5.4	5.9	5.2	5.5	6.7	4.3	2.6	5.8	4.4	6.8	9.4	7.9	10.2	6.2	7.1	7.5	7.6	8.1	7.6	7.6	10.3	43.2	9.6	12.0	14.0	20.7	11.6	12.2	7.0	15.4	7.6	13.0	10.8	9.1	14.3	11.8	22.0	0.0	18.1	18.4	19.0	3.9	7.6	13.2	12.0	22.6	26.3	9.0	11.6	21.0	8.1	12.4	23.7	12.2	14.8	6.3	21.1	27.8	18.7	12.7	13.5	19.6	11.1	6.1	19.0	10.1	3.6	17.7	16.7	7.2	22.5	16.0	23.2	10.3	21.1	43.4	7.9	10.2	22.2	15.3	11.9	11.4	10.4	9.3	10.2	19.7	26.1	18.4	34.0	19.5	12.6	12.6	25.2	19.2	14.2	11.3	14.4
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6534512-6538374	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 27580.7;tongue: 18892.5"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 10357.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"CAB005197, CAB016392, HPA040067, HPA061280, CAB079968"	Supported		Enhanced	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	1219.9	1815.8	2605.9	1191.3	2589.5	4608.5	1042.3	2869.0	3067.8	1163.8	2419.2	1720.0	1480.8	1080.9	769.9	2973.8	1042.8	1161.3	5572.8	2630.1	2880.0	2323.2	2557.9	1137.9	1388.3	2845.2	2861.3	1087.0	652.0	1616.0	1338.7	1190.6	2828.4	1241.0	1586.6	2386.8	1835.8	1238.7	27580.7	1775.5	1457.5	1424.4	2670.8	1208.5	1215.5	693.0	2985.1	1570.9	1022.1	18892.5	1861.0	1889.0	1672.9	2741.6	6063.0	10247.9	3109.5	4709.2	3026.2	5018.7	6516.0	4716.2	7218.1	7172.8	7491.2	7211.3	4091.6	7540.8	878.2	5947.4	4904.2	3359.8	3372.7	10829.1	5432.4	6263.1	3229.5	4224.9	5857.5	6279.2	3890.9	6710.2	3046.1	4089.0	3521.7	6553.0	7609.7	15565.8	7762.7	5052.4	2215.9	1484.1	8670.0	11849.8	7303.1	3247.3	10995.7	7254.7	3950.7	5849.8	5505.7	3512.8	7909.6	7115.9	2088.3	3331.0	4243.1	10206.4	5984.0	8874.7	1657.2	4311.2	4794.3	5049.0	5907.2	2717.1	7931.5	3178.4	2544.6	9374.4	10632.2	4050.5	8040.5	2575.4	4295.8	737.9	1325.8	2011.2	1171.4	1046.9	1364.8	1333.1	3253.6	652.5	757.6	886.9	1981.4	1227.8	1900.6	474.6	2126.1	6812.0	2605.9	2589.5	2869.0	3067.8	2630.1	2880.0	2845.2	2861.3	2828.4	2670.8	2985.1	2741.6	1036.7	237.2	259.5	228.2	1086.9	1818.8	2223.4	7367.5	4070.9	1157.6	1794.6	3689.2	40.4	1263.9	2213.7	1022.5	417.0	4237.7	1032.7	2579.6	3463.0	5198.9	759.8	770.1	702.4	1597.4	1324.3	1180.6	112.1	3794.5	10357.8	1127.1	1068.8	1021.8	562.3	2063.7	1242.9	1742.3	3895.3	2348.7	145.8	2351.2	2543.1	2586.7	2494.4	2257.7	889.4	2134.0	4220.8	86.2	3422.3	6177.9	1045.4	98.5	196.2	5681.8	3001.4	1026.9	2668.2	1714.0	5714.0	7286.7	864.3	1435.2	1150.4	1744.7	2827.8	429.9	476.2	3605.2	1600.7	4694.0	1514.9	1839.0	3140.9	2882.4
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387, HPA074882"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		46000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Cytosol	"HPA029386: AB_10599604, HPA029387: AB_10600311, HPA074882: "	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	12.3	9.8	8.1	12.2	11.1	23.0	12.0	11.7	9.4	12.2	13.1	10.3	8.0	11.1	9.8	17.0	10.7	10.3	9.7	8.4	8.8	13.0	11.2	15.7	12.6	9.8	8.9	12.1	10.6	18.7	8.2	18.4	10.0	10.5	9.8	16.5	9.3	12.4	19.1	14.7	9.2	13.3	10.1	12.7	9.6	26.8	9.7	14.1	18.9	18.7	15.0	12.2	10.1	14.2	22.8	23.2	21.8	20.0	26.2	28.6	30.5	25.0	28.9	29.0	24.2	37.0	15.9	30.2	13.3	31.9	28.7	44.9	46.2	25.8	31.1	28.1	27.1	34.6	53.1	18.4	30.1	41.4	56.0	20.1	25.2	34.6	27.2	18.7	35.0	23.8	68.8	16.3	24.3	33.2	31.2	18.0	21.6	41.2	26.2	27.2	47.6	29.1	16.2	23.2	28.8	18.9	36.9	32.6	20.0	21.7	40.9	20.9	36.1	19.9	14.3	35.7	27.2	20.7	42.3	29.9	24.1	22.9	26.4	25.6	15.9	19.6	13.0	15.4	12.7	10.0	13.5	14.6	15.4	9.5	13.3	14.3	19.5	15.2	19.8	5.8	11.8	11.3	8.1	11.1	11.7	9.4	8.4	8.8	9.8	8.9	10.0	10.1	9.7	14.2	30.0	109.0	58.0	35.6	28.3	31.9	18.2	23.0	32.5	29.9	21.0	17.5	66.8	14.3	34.8	27.6	52.1	42.3	20.7	16.6	9.8	16.2	58.3	35.7	30.7	26.8	12.6	77.0	68.4	19.3	23.7	26.2	18.3	31.4	15.8	27.6	21.4	15.2	27.6	35.3	69.7	15.9	10.2	25.4	28.5	17.7	23.0	30.5	17.8	51.5	31.2	22.8	18.6	45.2	62.7	22.3	13.9	24.0	26.5	20.0	15.4	16.1	57.2	39.1	19.7	27.8	32.0	85.6	34.5	32.3	36.9	67.0	28.3	32.5	17.0	29.8
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447482-92460075	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 234.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	22.7	22.1	9.5	7.3	12.8	6.2	22.2	10.1	10.9	26.8	9.7	22.3	11.2	21.4	18.3	14.6	26.5	11.8	16.2	9.6	10.5	21.4	20.1	20.1	8.7	12.1	11.5	33.6	29.4	15.5	23.1	12.4	12.4	23.9	11.3	13.2	18.4	12.4	10.8	14.0	18.6	11.7	10.4	20.2	21.6	10.2	12.0	6.7	26.0	5.7	7.3	22.0	20.2	16.0	12.3	7.5	15.3	16.1	19.7	22.4	12.1	11.9	17.8	12.4	16.9	8.5	18.5	9.1	15.9	8.9	28.9	14.3	10.7	8.1	13.0	15.8	11.3	11.6	8.0	11.6	27.4	14.1	30.0	16.8	19.3	9.5	27.4	22.3	14.2	6.6	24.2	19.0	13.8	17.7	5.5	20.2	20.8	19.9	14.4	7.2	18.1	12.1	13.6	13.4	13.4	21.4	15.7	16.5	23.7	19.0	9.2	18.8	13.0	19.7	14.9	30.0	15.5	15.2	5.5	10.0	16.6	9.0	27.6	2.9	1.1	1.2	0.7	0.7	0.7	0.9	0.5	0.5	0.6	1.4	0.6	0.9	1.0	0.9	0.8	1.2	0.6	0.4	9.5	12.8	10.1	10.9	9.6	10.5	12.1	11.5	12.4	10.4	12.0	16.0	59.0	48.1	64.6	98.9	26.5	13.3	37.8	14.6	26.7	79.0	33.3	35.1	16.3	24.3	26.6	47.8	70.9	25.7	28.8	30.2	3.9	22.4	3.8	46.7	48.3	34.7	16.8	24.6	77.8	22.0	23.4	38.1	30.5	51.6	53.2	115.1	37.1	21.7	24.6	62.2	70.4	33.3	2.0	30.8	23.7	5.0	45.4	40.2	21.4	54.4	25.8	65.3	32.0	108.6	234.9	27.0	30.7	35.0	13.6	45.9	33.2	18.2	36.1	114.1	19.7	54.3	36.7	14.1	10.4	23.6	17.8	20.7	24.7	56.0	31.9	35.7
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	16.7	15.1	13.1	23.6	14.0	32.6	15.4	11.0	12.6	13.6	17.1	19.5	22.8	14.8	8.7	22.0	12.3	14.4	12.3	16.7	13.5	16.1	17.1	21.7	19.8	17.6	14.4	11.4	21.6	15.1	14.9	17.8	14.3	10.7	11.3	8.4	15.5	11.0	17.9	30.0	24.8	8.3	14.4	22.2	17.8	33.0	14.8	19.5	14.7	6.9	13.6	15.1	16.4	12.7	60.7	50.8	46.5	69.3	18.9	19.7	97.5	46.7	31.6	47.7	45.4	92.8	62.6	117.9	69.5	47.1	31.6	49.6	43.6	41.5	27.6	40.6	47.7	87.1	49.4	51.8	46.2	97.6	72.1	31.3	30.2	49.9	40.0	15.8	48.2	66.9	141.1	37.1	28.1	68.5	115.9	38.7	98.3	55.8	45.9	121.9	46.6	54.9	24.9	79.0	87.7	48.9	40.4	48.6	57.5	30.2	44.0	40.3	94.9	89.9	43.3	106.8	88.5	46.1	62.9	125.3	56.2	80.9	53.7	4.6	2.9	3.2	3.2	1.5	1.9	2.3	1.9	2.7	1.3	1.5	1.4	1.6	7.8	2.7	3.3	3.0	1.3	2.3	13.1	14.0	11.0	12.6	16.7	13.5	17.6	14.4	14.3	14.4	14.8	12.7	35.7	12.8	19.2	24.5	24.1	55.7	22.3	14.2	26.2	16.1	33.5	21.5	13.5	24.3	15.4	14.7	18.8	23.7	66.3	53.4	13.7	21.9	21.8	43.9	42.8	31.4	15.6	21.0	14.9	30.6	36.8	21.9	29.0	69.5	17.1	22.1	29.3	27.9	27.7	23.5	21.4	28.9	24.4	27.3	42.1	18.5	15.5	27.7	32.0	35.6	28.5	18.2	53.5	17.1	21.6	46.4	28.8	13.9	19.5	24.1	30.2	29.9	15.8	18.3	19.7	40.5	25.8	18.4	41.4	39.5	55.5	36.7	39.3	28.2	32.2	28.2
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	10.0	7.1	0.0	6.1	2.9	10.0	9.9	12.4	3.0	10.9	0.0	11.1	4.2	11.1	1.8	7.9	9.1	3.2	9.2	1.8	1.5	7.1	8.1	12.9	7.8	2.8	0.7	11.7	7.5	5.7	7.6	5.8	1.2	8.3	3.6	3.6	7.8	5.3	16.6	13.3	9.3	7.0	0.0	10.6	7.7	10.4	2.1	10.9	8.6	8.2	7.4	9.5	9.8	11.2	7.9	14.7	12.8	14.2	2.7	8.2	7.7	4.8	11.5	15.0	17.5	7.2	12.0	15.5	11.2	10.9	7.9	15.6	18.1	9.4	12.2	14.2	12.5	15.2	16.2	2.9	8.6	9.2	20.7	6.5	6.5	16.7	32.9	7.1	14.4	21.2	11.5	20.6	3.0	14.5	33.3	2.6	5.6	6.3	7.1	33.5	6.5	17.1	2.9	10.9	14.8	15.6	18.0	21.8	8.7	9.4	20.1	7.7	13.0	14.6	12.8	8.1	10.2	27.9	20.5	23.4	8.2	6.0	12.8	4.9	0.5	0.5	0.6	0.3	0.6	0.4	0.3	0.8	0.2	0.6	0.2	0.3	3.5	0.9	0.2	1.6	0.6	0.3	0.0	2.9	12.4	3.0	1.8	1.5	2.8	0.7	1.2	0.0	2.1	11.2	32.1	9.6	14.4	53.8	30.0	43.8	13.4	12.8	47.8	45.9	20.9	19.9	16.6	21.5	12.3	25.8	39.6	10.3	31.9	15.1	7.9	13.9	15.8	16.8	26.6	28.2	23.8	21.7	104.6	14.3	7.1	20.7	17.3	21.3	24.7	19.3	22.5	21.8	13.5	35.3	77.5	15.8	16.2	31.4	42.8	7.6	27.1	23.7	14.2	80.6	36.3	17.8	23.7	86.5	117.9	17.1	20.7	35.0	25.6	22.3	9.9	10.4	15.2	35.9	6.6	28.2	27.1	30.4	21.4	26.0	47.5	9.9	31.2	21.4	15.9	21.1
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580628-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 102.7;Late spermatids: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	6.6	6.6	5.4	7.8	6.3	13.5	9.2	6.4	5.7	7.0	6.2	6.9	6.5	6.1	6.5	7.0	5.9	6.3	4.8	5.2	5.9	6.2	10.6	6.9	8.6	6.3	6.3	8.0	6.9	9.4	4.5	7.5	6.1	7.3	6.2	3.6	8.2	6.7	6.6	7.8	6.5	5.1	6.2	8.3	7.7	11.0	6.1	8.3	7.7	6.7	9.9	7.1	4.7	7.2	15.7	20.8	9.0	19.5	19.7	13.5	12.4	13.4	15.5	13.2	16.5	17.5	10.5	14.4	8.0	12.6	29.7	17.0	13.1	14.7	14.1	20.3	11.9	10.6	11.4	9.2	29.2	18.5	16.9	12.7	39.7	14.1	27.8	12.4	12.6	14.2	17.6	16.1	15.0	15.6	18.0	16.0	18.8	17.2	16.1	12.7	9.8	16.5	11.4	12.0	14.2	20.6	14.4	67.9	27.5	16.1	11.6	13.2	16.4	19.5	6.3	17.0	15.6	43.6	20.6	9.1	19.3	18.6	20.2	5.3	7.1	13.2	7.1	6.9	9.1	6.6	6.4	7.0	6.6	6.3	5.1	5.2	13.1	8.7	8.2	3.8	6.5	8.1	5.4	6.3	6.4	5.7	5.2	5.9	6.3	6.3	6.1	6.2	6.1	7.2	4.8	12.8	7.7	0.0	9.6	10.6	5.0	2.7	12.0	4.1	11.5	6.1	3.6	4.3	3.7	3.7	4.2	7.2	7.3	10.0	5.9	5.1	102.7	4.3	5.5	6.7	7.2	8.2	0.0	6.4	4.6	5.0	8.6	6.8	1.3	5.9	5.0	7.4	5.2	11.8	0.0	8.2	2.0	10.1	8.3	131.7	5.3	7.6	12.4	0.0	6.9	4.9	5.2	0.0	0.0	5.9	6.6	3.8	6.3	5.4	6.0	4.5	2.4	5.9	6.6	5.9	6.5	7.8	4.6	6.3	10.4	10.4	8.8	5.8	5.8	5.4
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108449191-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	9.0	12.7	3.4	17.6	5.1	25.2	17.4	0.0	5.5	12.5	26.2	19.2	21.7	15.3	41.7	7.5	15.0	21.4	8.4	3.2	3.8	16.6	10.7	14.8	21.5	2.5	4.2	15.5	12.5	15.0	4.1	13.7	2.8	19.6	20.8	17.3	15.2	17.1	2.3	7.9	22.9	9.4	0.9	18.8	26.4	16.6	1.4	18.9	20.5	9.4	16.3	14.1	3.6	6.0	12.5	10.4	12.6	5.5	14.2	22.6	27.4	17.6	26.8	9.2	12.9	18.4	17.2	14.9	22.3	16.0	16.7	10.4	10.0	14.1	15.8	16.9	13.6	18.7	16.3	15.8	12.7	26.4	14.3	29.1	13.3	23.1	16.3	20.0	13.6	13.9	25.3	12.4	17.4	7.1	13.6	18.1	21.9	11.5	12.0	11.7	17.9	16.1	12.2	20.1	13.6	12.5	21.1	16.7	18.7	18.2	8.3	12.8	21.3	13.3	20.2	12.4	6.7	18.0	26.9	18.2	17.2	7.0	9.8	47.3	8.9	25.9	25.5	8.0	25.1	27.0	28.2	27.8	7.3	24.3	38.2	33.5	35.6	14.9	17.6	31.8	23.0	8.2	3.4	5.1	0.0	5.5	3.2	3.8	2.5	4.2	2.8	0.9	1.4	6.0	92.6	150.6	103.3	44.1	125.2	23.8	68.6	54.8	29.6	155.9	60.3	57.5	85.6	75.8	95.7	104.8	139.7	44.2	157.6	152.1	50.9	114.5	73.9	253.3	85.1	68.1	85.6	39.5	104.9	81.6	56.3	74.2	65.7	118.6	82.2	113.9	65.0	36.7	37.0	70.7	73.6	152.6	52.9	49.8	39.3	39.9	71.4	66.0	33.8	62.8	88.5	59.0	134.9	50.8	66.1	116.1	125.2	82.8	108.7	91.7	134.0	63.1	259.7	127.2	52.6	61.4	66.2	163.0	120.7	21.0	17.5	65.0	139.1	138.0	88.3	114.5
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1 activator of EIF2AK4"	Q92616	12	120127202-120194715	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	17.2	16.5	9.5	16.0	11.6	19.1	16.9	10.3	10.1	17.1	12.7	18.7	12.1	20.0	9.5	22.3	17.3	9.5	16.1	8.9	9.4	16.2	17.8	16.0	18.3	11.6	10.6	20.2	22.9	18.0	21.1	16.5	10.0	15.8	12.4	8.8	18.2	12.7	44.4	22.0	18.1	14.7	9.2	20.5	20.5	17.9	11.8	18.3	19.7	22.9	16.3	18.6	16.4	13.4	51.4	99.3	35.1	39.7	54.4	32.7	122.4	44.9	38.9	45.8	37.2	85.6	34.5	67.8	49.6	64.8	29.0	49.5	82.1	63.5	28.4	45.5	66.9	84.0	65.5	59.8	35.2	78.2	51.5	40.3	36.3	54.3	50.9	40.2	42.5	30.3	100.3	17.0	38.8	51.6	49.7	59.1	62.3	48.8	59.9	59.7	36.0	67.3	31.2	172.8	57.4	57.4	73.8	31.7	26.5	33.1	67.5	43.8	58.6	37.3	41.0	24.7	47.0	66.2	65.4	67.1	35.7	40.5	38.2	0.7	1.8	1.3	3.3	1.7	4.1	2.0	2.6	2.7	2.3	2.1	1.9	2.1	0.0	1.8	4.1	2.7	2.6	1.9	9.5	11.6	10.3	10.1	8.9	9.4	11.6	10.6	10.0	9.2	11.8	13.4	12.0	9.6	17.9	0.0	11.2	0.0	6.8	0.0	9.6	14.1	11.9	13.6	0.0	12.8	9.3	22.0	10.4	14.2	12.0	8.1	1.9	15.6	1.9	9.0	14.1	10.5	3.6	16.2	0.0	15.9	38.2	10.5	25.5	14.9	5.1	25.7	10.4	24.6	11.2	16.8	0.0	11.4	0.0	9.1	0.0	3.5	14.3	8.9	0.0	0.0	11.1	9.0	7.2	0.0	0.0	18.6	8.6	12.8	17.7	15.7	11.1	9.1	2.9	12.1	6.6	16.4	8.9	8.8	20.8	14.1	0.0	14.6	10.1	14.3	11.7	15.8
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 371.8;urinary bladder: 175.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 1160.8;Syncytiotrophoblasts: 4304.7;Urothelial cells: 3294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.7;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 416.5;Hep G2: 225.5;HHSteC: 564.9;TIME: 213.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	960000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	34.8	11.7	1.3	1.5	1.4	0.4	24.9	1.0	2.3	18.9	40.9	29.2	4.5	13.6	2.2	4.8	5.5	19.9	4.5	4.3	1.3	371.8	88.6	46.9	0.6	2.0	1.7	4.7	112.3	25.9	12.3	86.9	1.5	105.3	24.4	1.2	12.5	4.6	5.5	6.4	12.3	1.9	1.2	11.4	75.5	1.6	2.5	0.3	11.2	0.5	1.7	175.4	19.2	1.6	1.8	95.6	9.4	3.5	22.3	18.5	416.5	33.1	17.9	1.2	18.8	4.2	29.6	0.4	58.8	3.0	97.0	0.7	0.0	12.2	4.7	0.2	2.2	0.9	9.2	225.5	564.9	0.1	35.7	48.8	140.1	90.7	58.6	0.7	99.5	0.0	152.4	0.7	22.9	23.5	0.1	0.8	5.4	34.4	52.5	0.2	3.7	0.2	69.9	94.6	0.9	1.0	0.4	5.5	127.9	35.1	2.6	0.4	213.1	0.0	7.4	1.8	1.5	1.5	4.0	0.4	51.9	0.1	27.8	0.0	0.7	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	1.2	0.0	0.0	0.1	1.3	1.4	1.0	2.3	4.3	1.3	2.0	1.7	1.5	1.2	2.5	1.6	6.6	35.3	62.4	0.0	1.8	1.3	350.6	366.1	0.0	0.1	54.2	15.5	0.7	47.1	1160.8	259.3	0.0	60.6	0.4	176.0	33.2	316.9	0.0	166.8	35.4	31.9	84.8	0.0	0.1	381.9	263.4	52.9	224.8	261.8	29.2	0.2	2.5	7.0	33.8	0.0	0.1	357.6	453.7	1.6	3.7	0.0	0.9	14.1	3.6	0.0	9.9	0.5	1.0	0.0	0.0	440.4	146.6	1.5	1.3	780.2	22.9	85.7	681.4	0.6	0.0	9.5	46.7	0.7	0.5	1.3	1.7	4304.7	5.5	3.4	291.0	3294.2
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887411-154938211	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	8.3	4.4	5.0	5.0	5.9	3.3	8.2	5.4	5.6	5.9	5.0	5.4	3.3	6.2	4.6	5.3	6.1	3.4	6.7	5.1	5.4	4.7	6.0	4.3	6.5	5.2	5.2	8.4	5.5	6.4	4.4	4.8	5.4	5.8	4.6	4.1	4.6	5.9	12.3	7.3	4.0	6.9	5.2	5.6	4.3	6.0	5.4	7.5	5.3	10.2	7.3	6.8	5.0	6.9	17.2	25.0	15.9	37.0	16.8	14.2	20.4	16.4	9.9	28.0	20.6	41.6	15.0	45.0	20.2	15.7	28.8	17.8	47.7	29.8	38.0	9.0	22.3	27.3	15.6	25.2	9.3	48.0	15.2	10.7	13.6	38.9	23.2	10.1	23.2	10.7	43.9	10.7	21.2	23.6	26.0	19.2	22.3	13.4	19.4	33.3	31.2	37.4	11.6	11.6	20.9	14.4	18.9	20.7	13.3	15.7	24.6	11.0	14.2	25.1	18.0	19.1	37.2	10.7	17.5	34.5	10.7	38.8	22.6	0.0	1.9	1.7	2.4	2.3	3.9	3.4	2.2	2.2	2.6	2.7	3.2	3.5	0.1	2.8	2.2	1.9	2.2	2.1	5.0	5.9	5.4	5.6	5.1	5.4	5.2	5.2	5.4	5.2	5.4	6.9	6.7	0.0	6.4	6.8	8.4	10.3	6.7	5.3	10.2	6.3	5.2	5.0	15.0	1.5	12.3	3.7	0.0	4.4	5.0	1.9	0.0	5.7	3.4	4.3	9.5	8.4	1.2	8.8	19.1	4.2	4.4	11.1	5.1	4.8	1.3	15.6	4.6	9.2	4.5	16.8	20.5	3.9	0.0	14.4	2.6	4.1	10.8	4.5	7.2	11.2	6.0	7.0	5.2	15.1	19.3	3.4	1.1	13.2	4.5	7.0	2.6	4.5	2.5	4.3	0.0	11.5	8.6	11.7	16.1	8.2	15.9	2.1	5.6	15.6	4.7	4.9
GET3	"ARSA-I, ASNA1, TRC40"	ENSG00000198356	"Guided entry of tail-anchored proteins factor 3, ATPase"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	47.5	61.6	56.4	39.4	58.2	66.2	46.5	59.0	72.8	48.4	62.4	43.0	39.9	49.8	41.0	58.1	47.0	39.3	62.0	59.6	58.4	61.6	38.4	40.8	48.3	55.4	57.3	41.9	48.2	73.3	48.2	28.0	57.9	34.3	28.7	36.4	47.3	31.4	67.6	59.1	38.7	33.9	55.9	43.4	50.9	60.2	58.9	46.9	56.3	58.6	38.1	46.3	43.3	57.3	143.7	116.5	60.7	132.3	118.6	72.4	74.6	72.4	99.7	137.5	107.6	90.3	69.6	64.8	111.0	95.4	157.5	75.2	84.5	97.6	65.4	100.9	132.7	54.3	82.4	105.3	125.8	83.5	104.9	83.6	84.1	111.3	66.1	89.2	99.4	75.9	71.3	86.8	109.5	320.4	112.9	68.1	154.6	92.0	215.6	82.2	93.6	128.4	130.2	120.7	111.6	95.5	97.3	131.3	119.8	51.5	108.2	80.5	85.5	193.3	65.4	217.1	172.4	153.9	279.4	61.7	136.2	137.0	109.0	33.6	44.3	26.3	24.8	34.3	21.2	20.3	22.0	22.2	44.8	17.0	15.7	19.5	15.6	16.7	42.9	29.4	34.2	35.8	56.4	58.2	59.0	72.8	59.6	58.4	55.4	57.3	57.9	55.9	58.9	57.3	14.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	106.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	80.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	110.7	1.7	0.0	0.0	0.0
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984193-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 183.7;Early spermatids: 168.7;Proximal enterocytes: 371.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	17.7	21.2	19.6	13.8	19.0	18.2	17.8	21.6	23.1	14.2	17.9	32.8	42.7	16.6	6.6	17.5	16.0	13.5	29.8	19.0	19.7	21.9	45.9	15.3	20.9	21.5	21.1	11.3	53.7	29.6	18.1	12.2	20.9	19.6	25.4	7.7	28.8	13.1	40.9	14.5	45.2	10.9	18.8	21.9	24.7	38.5	20.6	10.5	15.9	30.4	16.9	19.4	12.8	20.6	27.2	44.1	35.6	29.2	14.7	28.9	43.5	28.6	31.2	44.2	35.6	63.7	46.1	15.2	39.7	24.2	25.7	39.8	27.3	42.4	27.9	44.7	46.6	20.9	44.3	73.4	26.6	32.1	37.9	18.9	32.5	38.8	34.6	27.8	21.1	32.7	33.0	51.3	32.6	66.1	34.9	33.9	54.9	23.9	39.7	74.5	26.8	50.7	45.5	21.9	30.5	28.9	39.3	91.2	34.5	18.2	43.4	33.6	19.1	42.8	45.0	24.0	54.3	79.1	48.3	45.7	14.2	21.5	36.7	3.8	16.2	13.4	11.2	13.9	11.4	23.5	14.9	18.5	11.6	17.8	13.6	9.5	1.4	10.7	17.4	5.1	24.9	10.6	19.6	19.0	21.6	23.1	19.0	19.7	21.5	21.1	20.9	18.8	20.6	20.6	18.0	3.2	6.7	2.3	32.5	15.9	19.9	21.1	17.6	10.8	32.7	27.6	17.4	27.1	16.6	9.2	0.0	43.4	23.0	183.7	35.2	44.0	168.7	24.0	11.4	17.9	27.2	17.0	3.4	80.8	57.8	17.7	16.8	18.7	12.7	22.8	20.7	59.1	45.9	8.4	3.2	60.3	26.4	39.3	24.8	123.7	17.4	24.7	23.2	1.0	39.6	12.6	39.1	1.5	3.3	57.3	100.3	12.4	39.6	21.7	371.7	84.6	33.3	11.5	13.1	15.8	18.5	41.9	26.7	17.3	14.8	37.5	27.4	26.7	68.7	26.0
GGA2	"KIAA1080, VEAR"	ENSG00000103365	"Golgi associated, gamma adaptin ear containing, ARF binding protein 2"	Q9UJY4	16	23463542-23521995	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 153.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 159.9;U-698: 170.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034422, HPA043313, HPA063634"	Approved		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"		"CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067"	"unprognostic (1.27e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (7.82e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.91e-5)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.08e-1)"	15.1	36.3	13.0	32.0	13.1	37.6	19.9	18.6	14.8	20.7	25.2	16.5	10.0	16.1	19.6	17.9	18.4	13.4	18.5	13.8	15.3	26.9	16.4	34.1	72.9	11.7	12.9	34.0	54.3	29.2	26.0	17.6	11.9	27.4	15.8	79.3	37.6	21.3	25.5	21.1	33.6	14.9	10.8	44.2	25.7	12.4	17.8	37.2	36.2	19.0	87.3	16.3	18.7	12.3	18.8	22.9	29.6	26.1	16.5	17.9	25.3	19.7	20.0	15.2	19.3	32.1	18.9	159.9	31.4	21.1	4.3	28.7	49.1	25.8	19.4	25.1	45.6	28.8	29.5	51.2	16.2	48.0	18.2	18.7	22.7	20.8	9.7	22.1	22.0	12.8	50.3	23.0	19.8	29.8	17.0	31.9	39.6	18.3	20.2	108.3	38.4	41.2	24.8	25.6	21.1	25.3	18.3	27.0	27.1	31.5	23.7	59.7	24.5	18.1	19.6	20.3	18.5	42.0	41.8	170.8	16.5	32.2	20.6	0.2	4.2	7.0	3.1	4.3	3.2	16.2	3.9	3.7	4.9	21.6	4.0	4.0	0.5	3.1	4.0	15.9	4.5	3.1	13.0	13.1	18.6	14.8	13.8	15.3	11.7	12.9	11.9	10.8	17.8	12.3	11.7	48.1	41.4	28.7	102.3	34.2	33.6	16.5	39.3	73.2	25.0	26.0	27.3	21.5	17.6	22.0	114.7	23.0	80.6	7.3	25.4	19.3	22.0	25.4	17.6	19.0	17.6	9.9	44.2	18.9	40.7	17.3	15.3	37.3	9.5	88.5	12.5	16.1	69.1	6.7	61.5	12.6	12.2	26.1	19.7	30.8	24.5	37.7	26.6	36.5	87.9	23.8	23.7	26.2	8.3	16.2	6.1	26.4	36.1	20.7	8.7	21.5	16.2	153.3	19.7	16.0	16.3	30.5	60.5	25.4	14.6	22.7	34.8	56.8	11.9	18.6
GIGYF2	"GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15"	ENSG00000204120	"GRB10 interacting GYF protein 2"	Q6Y7W6	2	232697299-232860605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 333.8;Late spermatids: 563.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050899, HPA054612, HPA059918, HPA065064"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA050899: AB_2681267, HPA054612: AB_2682542, HPA059918: AB_2684160, HPA065064: AB_2685417"	"unprognostic (7.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.61e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.40e-3)"	"unprognostic (8.01e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (7.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.66e-1)"	19.1	19.4	13.5	19.1	17.2	21.6	23.1	23.5	14.6	19.0	11.4	17.8	17.6	21.3	13.8	20.4	18.1	15.7	25.6	13.5	18.5	25.2	15.8	16.7	20.4	14.6	13.6	27.4	25.5	40.5	9.6	22.0	15.9	22.0	19.5	22.9	28.4	17.0	37.5	21.2	20.0	18.5	11.4	21.3	21.5	37.9	15.5	24.6	25.9	32.1	21.4	18.6	12.4	21.6	34.3	30.8	37.2	38.1	51.2	44.7	44.1	37.9	36.5	31.3	33.0	30.6	29.6	20.1	9.3	33.5	59.8	36.6	44.2	34.7	41.2	49.4	32.1	71.6	30.5	46.9	36.7	61.3	44.9	31.1	34.6	38.1	59.2	33.6	34.9	33.5	72.8	24.2	33.1	36.5	40.7	24.3	37.5	29.8	25.7	38.7	74.5	27.8	28.6	51.8	33.4	27.5	41.8	30.5	37.7	32.9	29.8	40.1	53.1	33.6	28.6	34.1	29.6	47.6	26.1	40.3	31.6	35.0	31.3	39.2	10.7	13.1	8.0	7.8	10.5	6.1	7.1	7.9	11.2	10.6	8.5	7.9	13.7	13.4	18.9	8.3	10.7	6.4	13.5	17.2	23.5	14.6	13.5	18.5	14.6	13.6	15.9	11.4	15.5	21.6	31.3	57.7	68.4	98.2	26.7	15.7	36.9	25.8	23.9	50.6	29.6	26.0	85.5	25.8	50.8	36.8	60.5	32.2	28.0	28.8	25.4	31.1	333.8	41.2	54.5	36.8	19.2	41.0	105.0	27.3	22.0	36.7	25.0	45.0	17.7	35.4	20.0	28.8	28.5	48.8	131.2	27.9	24.4	29.3	12.1	563.9	37.6	31.8	26.6	98.4	32.9	38.8	42.2	116.6	171.7	29.2	15.0	36.9	39.0	40.6	29.5	18.5	43.3	38.7	26.3	55.0	36.0	128.4	93.4	27.3	19.2	73.2	28.8	46.3	30.3	37.4
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406147	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 146.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041216: AB_10794989, HPA048209: AB_2680314"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	4.3	7.4	2.0	4.2	4.2	8.4	3.7	3.7	2.6	3.7	2.2	5.8	3.2	2.8	3.7	9.1	2.4	1.5	6.2	2.4	2.5	2.5	2.6	2.1	7.8	3.0	3.5	1.3	1.7	3.7	2.0	3.7	2.7	2.2	4.2	1.8	3.4	4.6	1.8	4.5	2.8	3.8	2.8	5.4	2.6	6.8	3.2	8.8	1.9	4.9	8.0	3.0	6.7	2.7	20.2	22.4	26.5	14.3	2.9	3.7	13.3	22.4	9.8	35.4	26.8	16.9	20.2	35.0	17.5	7.6	26.3	18.7	24.5	18.8	39.6	19.5	30.4	20.4	12.0	20.5	1.6	26.1	33.7	4.2	3.5	18.4	6.3	7.9	24.4	28.9	33.5	14.4	15.0	20.9	48.1	24.2	24.5	17.2	45.3	82.6	29.4	44.4	12.8	12.6	30.3	20.1	37.3	24.3	12.8	10.6	12.9	21.4	10.4	23.5	27.8	14.2	28.4	14.3	20.2	146.3	16.2	26.1	29.3	0.1	1.8	0.1	1.9	1.6	1.5	2.5	1.6	2.9	4.1	4.4	1.5	2.5	0.4	4.1	1.0	8.2	2.4	1.5	2.0	4.2	3.7	2.6	2.4	2.5	3.0	3.5	2.7	2.8	3.2	2.7	3.9	0.0	2.6	9.1	3.2	1.8	4.9	2.7	4.0	1.5	2.0	1.7	4.1	0.0	1.4	0.0	2.1	9.1	4.5	1.6	0.0	3.7	20.7	1.8	2.1	4.3	0.0	12.4	0.6	2.0	7.6	2.5	1.5	7.9	1.3	6.9	3.6	0.8	2.8	5.0	0.2	0.9	0.0	1.6	1.1	9.2	1.5	1.9	1.8	2.8	2.6	1.8	2.1	5.0	1.2	1.9	0.3	1.2	6.2	1.7	0.2	0.5	1.1	1.8	6.6	1.6	3.0	4.6	8.7	13.0	2.4	3.1	2.4	3.2	2.8	4.9
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57459785-57472268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 11.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	2.4	1.2	1.3	1.7	1.6	0.5	1.5	3.5	1.9	11.1	0.4	3.0	2.5	9.5	6.6	0.6	3.7	5.5	2.1	1.0	2.1	1.4	0.8	1.6	0.7	1.9	2.4	1.5	0.8	0.0	1.0	0.5	1.7	4.2	4.1	0.0	1.5	2.8	0.6	1.7	3.3	2.4	1.7	0.9	1.9	4.7	4.2	0.3	2.3	1.8	1.0	4.4	3.1	1.1	0.1	9.8	3.2	24.2	0.7	0.1	0.3	0.9	16.9	2.1	2.3	0.3	0.7	3.1	0.0	0.5	2.3	1.7	1.8	1.1	0.4	2.7	0.3	0.1	1.2	0.2	2.7	0.7	1.4	0.8	0.4	3.1	1.0	4.2	0.3	2.2	0.4	7.8	1.0	0.0	0.7	0.5	14.0	0.8	0.9	1.2	60.6	1.7	2.7	0.0	0.1	0.1	0.2	0.1	0.4	2.4	0.0	0.3	0.1	2.2	7.7	0.6	0.3	16.7	1.0	5.7	2.0	1.3	3.8	0.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.1	0.2	0.0	1.3	1.6	3.5	1.9	1.0	2.1	1.9	2.4	1.7	1.7	4.2	1.1	0.4	0.0	0.0	2.0	0.7	0.1	0.4	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.1	3.5	0.5	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	2.5	29.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.1	0.2	0.0	1.3	0.0	0.0	13.1	1.9	1.6	0.3	1.1	0.2	0.6	0.1	0.5	7.8	0.1	0.1
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 22.1;Peritubular cells: 33.8;Proximal tubular cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062755, HPA065406"			Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA062755: , HPA065406: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	16.3	23.4	4.4	2.5	4.1	0.1	11.4	5.2	3.9	22.3	3.3	19.2	1.5	20.9	0.7	4.9	17.3	5.6	30.9	3.1	3.8	41.5	3.2	30.6	1.6	5.6	5.6	27.5	13.2	2.3	18.9	4.4	4.3	21.7	0.4	0.7	9.8	4.0	3.0	7.1	7.4	3.3	4.4	4.5	11.9	5.3	5.5	0.2	19.4	0.4	0.5	20.2	11.4	2.5	6.1	12.3	2.0	4.8	1.5	7.2	4.3	6.1	5.3	2.3	1.6	3.2	5.1	0.0	10.8	6.0	2.2	3.7	1.2	5.6	0.1	8.9	0.3	0.0	10.9	1.9	6.9	0.0	0.9	4.1	1.2	1.9	0.9	2.6	1.9	0.1	0.5	2.0	1.3	4.0	0.0	1.2	4.6	0.7	2.2	11.7	2.6	6.7	0.4	0.0	0.9	4.6	6.1	2.9	1.7	0.6	8.2	1.0	3.2	3.2	6.0	36.8	1.9	1.4	0.9	1.5	1.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.1	5.2	3.9	3.1	3.8	5.6	5.6	4.3	4.4	5.5	2.5	4.8	16.0	9.8	8.5	0.0	5.6	5.4	8.7	1.8	10.6	3.5	2.4	5.9	15.7	5.6	12.9	4.2	0.9	0.1	0.0	19.6	11.8	0.2	1.8	9.0	6.9	0.0	0.0	2.1	8.3	0.9	18.3	0.5	2.1	0.0	2.6	6.8	0.7	0.4	6.7	3.2	0.2	2.0	0.3	6.1	0.9	22.1	0.8	3.6	5.6	1.0	10.4	0.0	4.0	1.3	10.3	0.0	33.8	0.0	5.1	0.0	21.7	3.1	7.3	0.0	8.2	14.6	0.2	3.4	0.7	2.8	1.1	0.7	0.1	0.0	2.8
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	17	"Early spermatids: 796.4;Late spermatids: 1841.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 240.2"					"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	16.1	22.3	16.0	7.9	16.5	9.5	12.4	17.0	28.7	10.2	15.4	14.4	11.7	8.2	10.7	16.7	7.2	6.9	37.0	16.5	18.2	16.2	25.9	9.8	5.2	17.3	15.8	6.2	9.6	5.5	8.4	7.5	17.9	17.9	9.0	2.5	11.1	8.4	37.6	12.9	10.6	8.7	15.9	9.8	12.9	30.2	16.8	3.8	7.2	24.8	7.3	13.9	11.7	17.2	47.2	57.8	14.6	32.8	52.2	33.9	24.0	67.2	29.8	55.6	45.9	36.3	44.2	20.0	36.1	28.6	67.1	44.4	17.5	39.4	56.7	45.6	30.4	40.4	39.0	42.6	55.9	32.8	39.0	23.1	33.8	76.5	38.4	21.6	35.7	13.7	60.8	21.9	68.4	66.3	26.9	60.6	16.8	75.6	38.2	23.7	22.9	48.3	53.7	31.4	13.8	12.4	26.9	81.2	240.2	21.6	35.2	37.5	21.6	42.8	11.2	93.7	70.5	42.6	48.7	41.4	40.8	38.1	61.2	13.6	18.8	26.6	12.7	23.1	14.2	13.2	13.4	11.7	22.5	10.8	11.7	13.4	9.6	16.1	30.0	9.2	18.6	14.5	16.0	16.5	17.0	28.7	16.5	18.2	17.3	15.8	17.9	15.9	16.8	17.2	24.2	9.6	10.1	5.5	14.8	18.2	21.1	39.1	14.2	7.2	21.7	23.6	62.8	12.8	21.5	16.5	6.2	39.2	19.5	25.8	29.4	41.1	796.4	16.1	24.2	18.7	13.8	15.6	11.3	41.4	41.6	25.2	14.8	17.7	46.9	16.4	11.0	30.3	44.2	1.7	10.1	26.5	32.6	15.0	26.9	1841.1	17.4	26.8	26.6	5.6	25.9	9.9	28.8	5.0	10.1	38.3	31.5	18.0	20.5	39.2	40.3	74.3	13.9	11.5	6.6	15.5	36.2	12.3	25.4	21.3	19.9	24.8	14.0	33.1	24.1	20.5
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;liver: 27.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.4"	"Group enriched"	"Detected in some"	7	"MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted to blood"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	2.5	0.2	7.0	6.8	7.3	28.1	0.2	1.5	9.8	2.4	5.6	0.4	0.1	3.6	1.0	0.5	3.0	1.7	0.8	7.1	11.1	0.8	27.6	2.8	0.3	2.9	2.6	0.2	0.8	0.6	1.4	0.7	3.1	0.8	0.3	5.7	0.2	1.5	9.0	1.1	0.3	3.1	1.2	12.7	0.3	15.5	4.3	0.9	1.7	9.6	0.4	1.4	0.5	6.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.5	3.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	36.4	0.0	2.0	2.3	0.0	1.6	7.0	7.3	1.5	9.8	7.1	11.1	2.9	2.6	3.1	1.2	4.3	6.8	0.0	0.0	0.0	1.6	0.4	0.9	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.0	4.7	0.0	0.0	0.1	14.6	0.6	2.3	0.1	0.0	0.0	37.6	0.0	0.0	0.4	0.0	4.8	0.0	0.1	1.1	10.4	1.4	0.0	30.2	0.0	0.0	8.5	0.0	41.7	0.3	9.4	1.8	6.5	12.4	10.4	1.0	34.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.3	0.0	0.2	0.2	4.0	0.6	0.0	0.3	0.1	0.2	0.0	0.0	0.0
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847288	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	34.4	35.0	26.9	43.4	27.9	43.4	27.7	21.2	27.7	31.7	35.9	46.0	43.3	30.1	24.6	37.7	45.4	30.4	41.7	29.3	26.5	46.9	38.3	32.8	41.7	24.2	26.1	24.9	35.8	60.4	31.5	33.7	22.8	40.2	43.9	41.9	43.5	37.5	44.1	33.6	40.4	37.2	22.5	39.2	44.7	20.3	26.6	45.7	40.2	37.8	43.2	36.5	26.9	22.4	43.2	47.5	76.4	47.9	66.1	52.5	73.4	80.0	59.0	59.6	50.7	66.7	75.5	69.8	74.0	74.2	49.0	47.3	96.4	67.0	53.4	114.0	59.4	72.4	57.7	47.7	37.3	117.6	129.6	50.2	52.3	56.3	41.5	57.6	77.2	65.0	122.8	58.8	65.6	69.8	96.6	64.8	91.0	65.0	35.2	123.5	59.9	86.5	73.4	64.0	93.1	47.1	86.4	80.7	37.1	83.1	90.3	123.9	86.1	41.1	46.0	186.2	50.3	49.0	73.1	145.5	29.3	57.9	85.5	10.3	14.1	7.8	9.0	12.7	8.0	6.2	6.0	8.9	9.7	9.6	6.2	5.6	28.1	7.0	20.8	10.8	6.5	8.2	26.9	27.9	21.2	27.7	29.3	26.5	24.2	26.1	22.8	22.5	26.6	22.4	28.6	38.5	47.3	35.6	29.9	19.1	18.7	17.1	19.4	36.8	30.3	23.6	42.3	28.6	37.3	31.3	29.2	28.0	31.1	54.9	66.5	24.4	11.3	58.2	36.7	28.1	46.3	45.6	43.6	19.4	31.6	23.0	26.0	43.0	31.6	27.4	26.7	53.0	32.0	45.4	37.0	41.2	18.3	39.3	23.9	10.3	24.2	35.9	21.4	32.8	54.5	25.0	28.8	28.6	35.8	29.2	38.8	16.1	26.5	29.0	38.9	54.7	73.3	42.6	19.7	24.6	36.1	21.9	24.5	23.4	24.2	35.7	26.1	28.1	38.8	21.3
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668778-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	4.7	3.0	2.3	5.7	2.2	13.6	4.3	5.9	3.1	5.1	3.1	4.4	2.9	4.9	3.0	5.2	4.4	4.2	3.1	2.5	1.9	3.6	3.4	4.3	6.7	2.5	2.2	5.6	4.1	3.3	3.7	5.7	2.5	3.5	4.4	5.6	3.4	3.1	5.3	5.0	4.4	4.8	1.9	5.5	4.1	6.0	2.6	10.6	3.5	4.4	8.0	4.3	4.4	3.1	12.1	8.5	14.1	12.9	4.6	8.5	10.0	12.5	9.0	7.9	11.7	2.7	9.4	22.1	6.5	11.7	4.7	4.6	12.7	9.7	10.2	25.4	7.9	20.4	8.9	5.2	6.9	17.1	10.2	6.8	6.8	19.2	12.3	6.9	11.1	10.8	12.6	17.1	9.6	10.5	10.7	5.7	18.9	8.0	5.7	7.2	9.7	10.3	6.0	9.6	10.4	8.6	12.1	8.0	8.1	9.4	6.1	8.7	11.2	5.4	13.1	9.3	17.0	7.6	13.8	12.1	6.6	15.8	8.7	8.1	5.4	9.9	6.7	7.0	5.1	4.0	6.5	7.9	6.3	6.0	5.3	5.5	7.6	7.5	9.0	4.6	6.0	4.6	2.3	2.2	5.9	3.1	2.5	1.9	2.5	2.2	2.5	1.9	2.6	3.1	12.9	6.4	20.0	3.9	20.5	17.0	19.9	8.6	8.6	23.6	9.0	10.2	4.0	10.0	11.0	14.7	12.5	14.1	17.7	12.7	5.9	10.9	13.3	10.1	12.5	13.2	7.8	26.7	7.0	11.1	16.6	10.0	9.2	16.3	28.5	12.8	16.8	6.1	10.7	25.2	5.9	13.1	10.2	13.4	7.9	2.8	9.6	12.2	1.8	4.7	14.8	17.5	29.9	5.0	9.2	11.5	14.1	7.9	11.5	12.4	8.5	5.7	7.1	24.7	19.7	18.3	13.0	34.8	28.6	8.3	16.8	32.3	19.5	13.2	11.0	19.6
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	7.5	8.0	6.2	5.0	5.9	19.3	7.4	6.3	6.7	8.7	5.5	8.5	5.0	9.0	2.5	9.3	10.3	3.1	7.9	6.1	5.3	8.5	9.0	8.2	6.7	6.2	5.8	9.5	9.8	5.6	8.3	3.6	5.6	9.0	2.4	2.1	8.8	3.5	9.2	9.3	9.3	3.3	5.2	10.7	8.2	13.4	6.2	8.1	15.5	3.4	4.4	8.0	7.1	5.6	13.8	8.3	9.9	8.6	4.7	4.3	13.2	9.3	5.9	14.7	7.7	25.9	10.1	10.9	9.5	8.1	10.6	19.2	7.8	13.7	6.5	5.8	8.8	8.5	12.7	12.6	6.4	8.1	13.6	6.2	12.9	9.5	11.8	6.2	6.5	13.6	12.6	7.7	5.1	14.9	19.8	17.8	7.1	16.3	13.1	21.3	10.1	10.1	6.1	12.1	14.8	12.2	17.0	14.8	10.0	4.5	18.1	13.3	8.3	16.0	8.7	9.7	10.4	14.7	12.8	17.2	9.7	7.5	10.7	0.0	0.8	1.4	1.7	1.0	1.5	0.7	1.5	1.5	0.8	1.0	1.6	1.4	1.7	0.8	2.5	1.0	1.1	1.0	6.2	5.9	6.3	6.7	6.1	5.3	6.2	5.8	5.6	5.2	6.2	5.6	5.6	3.2	5.6	9.1	7.3	6.0	11.2	3.8	5.2	5.2	6.4	5.6	3.2	4.3	5.0	3.7	0.0	4.1	6.3	9.3	1.9	4.3	29.3	6.9	5.2	6.8	9.6	2.5	5.3	5.4	6.9	4.2	5.6	10.3	2.5	6.0	4.6	6.6	4.5	8.4	4.2	7.6	2.0	3.5	3.8	6.9	4.1	4.5	1.8	4.7	3.2	2.4	4.1	2.5	4.8	6.1	8.2	5.7	7.8	12.0	5.5	3.5	4.2	5.9	6.6	5.0	4.6	22.2	9.5	5.1	5.4	11.5	8.9	3.5	6.1	12.1
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643657	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.6;Gastric mucus-secreting cells: 24.5;Hofbauer cells: 22.7;Kupffer cells: 33.3;Macrophages: 26.7;monocytes: 27.6;T-cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	7.5	3.3	2.9	32.0	2.4	50.9	5.4	2.5	6.1	3.7	2.5	9.6	10.4	3.3	1.4	8.6	5.4	6.0	2.9	3.8	4.0	4.3	4.7	16.9	29.4	6.5	4.4	2.6	6.0	8.9	3.6	4.6	5.7	5.4	6.5	0.4	6.9	2.8	1.1	6.9	22.6	4.3	4.5	54.3	16.7	2.9	6.6	19.1	8.5	1.9	22.9	8.3	5.3	7.4	9.9	4.5	5.9	6.5	6.4	3.3	23.5	6.1	5.2	3.6	3.4	3.6	13.0	24.1	12.1	4.3	4.7	11.5	3.9	6.7	2.3	8.3	6.1	7.6	7.1	4.0	1.9	21.7	92.0	4.2	4.5	3.9	2.0	4.2	8.2	21.1	5.3	8.5	3.9	14.6	13.7	35.8	3.5	12.7	8.1	23.3	2.6	14.0	6.9	23.3	5.1	15.2	8.4	8.7	3.7	4.5	8.0	30.7	15.0	6.6	3.8	7.6	4.6	4.3	1.9	19.8	4.2	28.0	4.6	7.0	19.5	51.9	13.2	23.7	12.3	12.6	8.4	11.9	15.1	12.8	8.9	9.7	71.8	9.7	33.1	13.5	10.0	12.5	2.9	2.4	2.5	6.1	3.8	4.0	6.5	4.4	5.7	4.5	6.6	7.4	1.7	0.0	10.2	0.3	26.6	1.1	1.7	2.5	1.2	0.0	1.9	1.3	0.9	2.8	3.1	0.0	0.0	0.6	14.9	21.2	0.0	4.1	0.1	1.4	0.9	1.8	0.0	1.3	2.1	4.7	5.3	0.9	24.5	4.0	7.0	3.5	2.5	1.6	22.7	0.0	2.1	6.6	0.0	33.3	6.6	0.4	0.6	26.7	1.8	6.5	27.6	0.4	20.6	0.5	0.2	12.9	20.2	0.7	13.9	2.0	9.3	0.7	1.5	0.1	0.0	0.4	1.6	0.6	1.3	3.5	1.1	0.8	25.8	0.9	6.0	4.1
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595937	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	27.8	22.4	11.1	24.8	12.1	49.9	30.4	12.5	13.5	21.7	13.1	22.8	17.8	22.8	24.4	26.4	20.1	19.4	21.6	10.9	12.1	19.2	31.6	22.7	26.5	13.0	12.0	20.4	20.8	20.9	19.3	23.5	12.7	18.2	25.5	11.7	23.2	14.2	50.6	29.5	18.7	24.4	12.1	19.6	21.9	30.2	13.5	26.1	16.0	29.0	32.7	35.2	21.2	14.1	66.5	33.5	63.9	66.4	49.8	57.1	102.9	98.6	68.5	89.3	90.4	92.6	75.2	107.8	62.7	73.5	50.8	60.6	105.1	80.5	121.1	62.6	83.5	108.4	66.4	74.5	66.5	143.3	73.7	36.2	72.6	122.4	144.3	42.7	65.2	47.1	146.8	74.6	87.3	58.2	77.7	85.9	165.8	48.2	65.9	81.8	114.7	121.8	75.0	70.7	76.9	71.1	74.2	73.4	73.1	93.8	52.7	82.5	53.0	59.1	83.9	127.2	138.6	69.9	67.8	185.8	68.3	113.2	77.3	23.2	28.1	24.4	22.5	36.3	26.0	28.1	21.0	24.6	39.8	21.1	21.9	21.2	2.8	33.5	35.3	29.0	28.2	21.7	11.1	12.1	12.5	13.5	10.9	12.1	13.0	12.0	12.7	12.1	13.5	14.1	18.5	16.0	48.1	6.5	29.7	63.3	84.3	37.2	27.3	8.8	17.5	14.5	21.9	12.8	63.3	7.3	10.4	37.2	27.8	18.2	27.4	52.9	54.0	27.2	31.0	28.1	17.3	17.7	6.4	62.3	49.4	40.8	23.9	29.7	48.1	29.5	11.0	18.3	32.0	6.7	5.3	27.3	24.4	17.9	29.6	13.5	23.9	27.7	8.8	8.4	31.7	21.1	25.7	3.5	5.7	51.5	21.9	19.2	32.4	68.3	15.7	18.8	54.4	9.6	0.0	44.8	34.8	46.7	45.6	29.5	52.8	46.1	28.3	20.6	27.5	56.5
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	47.2	47.1	17.1	42.1	17.0	27.4	68.8	18.4	24.4	38.8	18.7	40.0	38.8	33.8	25.6	65.0	28.2	28.0	29.6	17.9	19.4	33.4	50.3	29.7	51.5	17.9	17.7	35.8	60.7	27.1	35.9	36.4	17.8	46.7	46.0	16.0	46.4	26.3	78.2	39.1	29.6	32.2	16.9	34.0	41.0	26.8	17.9	35.9	28.6	42.9	64.9	92.3	41.3	19.1	110.4	79.1	114.4	125.3	105.6	105.1	178.1	133.0	101.5	135.4	100.6	121.3	80.8	255.4	42.2	100.1	104.6	78.2	189.1	125.1	180.5	156.3	134.6	196.8	139.0	189.3	218.1	283.7	138.0	96.1	216.5	147.8	224.1	90.3	107.8	99.7	214.8	136.2	93.8	77.7	170.6	162.1	195.6	153.4	151.2	99.3	93.0	315.0	108.9	153.9	81.4	105.6	82.1	190.5	193.6	101.7	74.7	155.8	86.6	92.8	100.0	139.2	281.7	147.6	252.0	387.0	96.9	203.5	148.4	1.2	15.2	3.3	19.9	16.7	34.1	28.7	26.8	24.1	26.1	23.9	30.4	29.4	1.8	26.1	12.9	40.7	18.8	20.2	17.1	17.0	18.4	24.4	17.9	19.4	17.9	17.7	17.8	16.9	17.9	19.1	34.6	22.4	48.2	5.2	84.3	163.7	146.0	111.9	77.4	19.0	72.6	46.4	51.3	25.8	144.9	12.9	10.4	73.2	78.5	42.8	41.1	105.1	54.4	44.7	76.5	53.4	47.8	51.5	11.6	104.6	117.5	92.9	47.9	53.0	63.1	47.5	23.2	41.9	40.9	21.9	11.1	71.7	67.1	24.2	77.6	28.2	51.9	43.0	78.2	5.6	59.5	17.7	38.1	7.1	9.4	99.9	34.4	34.3	122.3	126.1	19.1	47.2	56.5	14.8	6.6	106.2	79.1	37.9	74.4	59.4	153.7	90.3	63.0	74.5	85.8	135.7
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878275-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	8.7	9.4	5.4	8.7	7.0	5.9	7.8	5.8	6.3	8.0	7.1	10.8	10.1	8.8	5.9	9.9	7.7	7.6	10.2	5.1	5.9	6.8	9.5	7.5	7.6	6.1	6.4	8.0	10.8	9.1	8.0	5.6	6.9	8.3	9.3	37.7	8.4	8.3	13.2	10.8	9.6	8.6	6.1	8.5	8.7	15.2	6.8	5.3	8.2	9.6	7.4	10.4	8.1	9.0	8.4	14.7	8.6	9.1	14.7	13.0	11.0	13.5	14.3	14.0	10.2	9.7	9.6	5.6	6.5	15.0	10.8	21.2	7.1	11.4	10.2	8.0	7.0	5.9	20.5	12.9	16.9	7.1	13.7	8.8	8.1	13.5	16.3	9.9	12.7	7.0	9.8	9.4	10.0	17.5	5.1	8.0	3.2	19.7	13.5	3.2	12.7	12.3	7.0	11.3	5.0	9.5	16.2	13.0	8.5	7.6	25.1	5.0	14.8	13.0	7.2	16.8	12.6	11.4	19.6	6.5	16.3	7.4	13.8	8.1	3.4	4.3	4.2	3.5	3.4	3.0	2.6	4.5	3.3	3.5	2.7	2.5	7.6	3.2	2.8	4.6	2.7	1.3	5.4	7.0	5.8	6.3	5.1	5.9	6.1	6.4	6.9	6.1	6.8	9.0	11.8	6.4	14.4	32.3	8.1	2.0	4.2	5.8	6.2	16.3	10.2	10.2	21.0	7.2	10.8	5.5	64.6	6.8	11.5	11.7	3.9	9.5	16.2	10.4	13.6	10.0	5.4	5.0	31.7	8.9	4.9	7.8	10.7	8.8	15.8	14.6	10.8	14.8	6.6	18.5	31.4	9.7	12.2	7.3	4.2	9.8	5.9	9.3	8.8	20.6	10.1	15.2	9.2	27.2	34.3	9.0	2.7	9.1	11.1	4.5	7.8	6.1	17.8	38.0	6.6	15.4	12.3	50.1	21.4	11.0	4.3	8.6	9.1	10.9	8.8	4.0
GOLGA2	"GM130, golgin-95"	ENSG00000167110	"Golgin A2"	Q08379	9	128255829-128275995	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015421, HPA021178, HPA021230, HPA021799"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841"	"unprognostic (2.88e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (3.70e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (9.77e-5)"	"unprognostic (3.92e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.27e-2)"	51.8	44.2	31.5	31.3	31.8	33.4	49.6	30.4	31.5	73.5	44.1	48.2	28.9	57.0	59.7	75.0	49.9	42.2	63.9	30.9	36.2	42.3	50.3	47.3	24.5	34.0	36.3	57.4	65.3	77.4	122.4	56.9	36.7	54.4	44.5	31.4	65.1	54.9	57.2	73.4	38.0	58.1	28.7	33.4	51.7	35.8	33.0	23.3	53.3	51.1	32.1	48.6	66.3	31.8	49.1	48.1	52.8	54.9	130.4	148.3	46.3	93.6	129.2	79.4	71.1	60.7	44.7	23.1	34.4	154.3	84.4	94.4	30.3	47.4	74.2	34.1	28.9	25.5	114.0	48.3	85.2	38.2	71.4	95.4	74.0	79.1	81.9	124.9	64.3	55.1	83.8	58.6	77.6	99.8	33.0	33.9	16.2	92.0	86.2	32.9	58.1	40.0	63.4	42.5	29.3	34.9	62.5	52.1	43.2	53.3	117.0	32.2	86.3	102.9	51.8	66.9	50.8	40.7	51.1	29.7	89.8	20.0	65.6	32.4	6.6	12.2	6.2	5.3	3.8	6.0	4.1	3.4	2.7	7.3	4.4	6.1	30.2	7.4	8.2	13.2	3.6	2.9	31.5	31.8	30.4	31.5	30.9	36.2	34.0	36.3	36.7	28.7	33.0	31.8	33.9	44.8	66.8	20.9	27.0	31.7	27.7	45.1	41.5	68.0	53.8	34.8	88.1	45.8	57.8	42.3	41.7	37.9	32.6	69.6	43.0	47.6	41.5	62.9	82.2	35.5	46.1	18.7	15.1	60.8	35.6	67.1	59.7	94.3	65.9	33.6	44.6	72.3	28.3	25.2	20.4	90.9	40.7	24.9	23.1	7.7	68.3	34.2	24.9	10.3	19.5	33.4	28.8	15.6	15.5	57.7	45.1	64.7	55.6	43.7	42.6	35.4	73.2	51.7	13.1	59.6	43.3	99.5	51.1	71.4	45.5	102.3	28.1	29.5	42.6	44.2
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768914-132829078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	12.4	12.3	19.2	12.5	18.8	13.7	11.6	14.8	20.2	15.9	20.6	15.8	7.9	14.7	9.2	16.2	12.8	8.7	13.7	19.1	18.6	9.7	14.0	13.5	12.8	18.6	19.1	17.0	19.6	7.8	26.9	10.5	20.1	14.7	11.7	26.3	17.3	10.8	14.7	15.4	13.6	12.3	13.3	15.1	15.1	11.6	20.5	17.7	12.5	8.6	11.1	14.5	14.3	17.4	19.7	39.1	13.4	23.2	42.2	28.7	25.9	34.1	23.3	23.8	20.9	40.7	8.7	25.6	16.8	45.4	17.1	19.7	16.3	19.6	14.1	6.4	17.3	27.6	44.6	26.0	25.9	29.5	36.2	23.4	22.8	26.8	26.6	23.4	22.7	19.1	27.1	9.8	21.0	30.2	27.0	26.7	14.0	15.1	24.8	21.8	14.1	10.9	13.4	47.1	16.1	10.5	27.0	22.9	14.6	15.2	31.1	22.2	38.7	23.5	17.6	26.8	21.9	31.0	32.0	40.4	28.8	16.3	28.7	3.2	2.0	2.6	3.4	2.9	3.1	2.5	2.6	3.3	2.3	3.4	2.7	2.9	1.5	3.9	2.3	3.9	3.6	2.0	19.2	18.8	14.8	20.2	19.1	18.6	18.6	19.1	20.1	13.3	20.5	17.4	22.9	44.8	40.6	25.8	22.0	21.7	12.7	17.0	13.1	26.0	21.2	16.1	35.4	8.6	26.8	14.7	100.1	13.4	20.6	63.0	7.9	15.2	23.8	21.8	46.9	24.8	22.2	16.4	40.2	27.8	24.2	29.0	48.9	47.5	12.0	33.3	14.6	24.1	16.0	18.5	41.1	50.2	10.2	15.1	16.4	34.6	25.7	18.2	17.8	21.5	18.4	20.1	23.7	22.6	33.3	31.5	27.1	22.6	54.2	32.3	17.9	8.6	26.4	110.6	6.6	32.1	27.7	25.1	24.8	19.0	33.1	23.1	21.7	24.6	32.5	29.4
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	19.9	25.2	11.0	7.1	12.7	14.1	24.1	15.0	12.9	21.9	26.5	18.8	12.2	17.4	32.1	15.1	15.8	13.3	18.5	13.2	10.5	18.6	17.9	15.3	8.4	8.5	9.9	21.9	27.1	20.7	25.0	13.4	9.0	25.8	17.1	31.0	25.2	19.9	14.2	20.2	19.0	10.0	9.6	16.6	19.7	14.6	9.3	11.3	21.0	11.1	9.8	16.3	15.7	11.5	19.9	15.7	15.3	9.9	28.8	31.0	9.6	12.6	27.5	11.9	13.4	13.8	7.1	4.3	10.4	23.6	11.9	9.0	9.2	13.7	14.1	6.3	17.5	12.2	20.1	19.2	17.2	13.7	16.0	25.4	31.9	7.5	18.7	25.8	15.3	7.3	5.8	9.6	12.7	14.3	4.1	9.9	9.9	19.1	16.4	5.4	12.0	10.3	17.7	20.2	10.8	12.0	15.5	11.0	16.7	17.3	13.6	15.2	21.5	11.4	6.9	4.9	9.2	17.8	11.4	7.2	15.3	6.6	4.3	1.6	4.1	4.3	4.3	2.2	3.5	3.4	3.5	3.3	2.6	2.8	3.3	3.6	15.4	3.9	1.7	5.5	3.9	1.6	11.0	12.7	15.0	12.9	13.2	10.5	8.5	9.9	9.0	9.6	9.3	11.5	118.9	291.7	233.9	101.2	97.3	51.6	89.1	62.1	96.8	101.4	110.2	130.3	274.8	74.4	179.2	53.3	123.0	78.7	134.7	148.6	11.7	104.3	56.0	247.9	186.4	102.7	91.9	36.8	72.9	111.0	53.0	135.5	144.8	284.0	115.6	220.7	74.3	68.9	34.5	69.0	80.2	176.8	65.1	47.2	48.3	23.8	198.5	82.1	33.8	68.4	76.8	82.1	54.6	50.3	72.8	100.2	95.7	199.0	176.0	74.9	79.9	29.3	165.7	193.6	85.5	165.9	120.5	155.0	66.8	70.2	45.7	150.8	102.6	197.7	101.7	88.3
GOLIM4	"GIMPC, GOLPH4, GPP130, P138"	ENSG00000173905	"Golgi integral membrane protein 4"	O00461	3	168008689-168095924	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 370.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001677, HPA002315"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA001677: AB_1079017, HPA002315: AB_1079018"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-3)"	24.8	12.6	25.4	21.4	23.0	9.0	12.9	24.7	32.1	16.8	13.9	53.4	65.8	21.9	8.9	15.7	15.7	28.5	54.6	27.7	34.8	31.3	59.2	29.1	11.3	39.5	29.5	19.9	11.9	12.8	9.6	22.4	40.1	15.2	51.1	53.0	17.3	13.6	32.4	9.3	85.2	26.6	35.1	23.0	24.3	9.0	27.5	6.5	19.0	30.7	9.5	16.8	10.7	33.6	23.7	34.5	47.8	30.4	79.7	58.6	14.5	135.8	72.4	36.3	33.2	38.7	28.4	51.6	159.1	82.4	58.4	42.5	44.4	39.9	54.9	81.3	57.0	83.8	100.2	48.1	32.1	80.5	45.8	61.5	20.9	33.4	32.8	32.2	42.1	0.0	43.7	146.2	41.9	39.2	0.1	21.8	46.9	44.2	36.6	0.1	48.1	72.2	20.6	8.5	42.9	55.5	83.5	25.1	28.4	31.7	30.9	36.1	79.0	114.9	44.2	81.3	110.1	56.4	43.4	109.4	57.1	47.4	52.4	3.2	2.5	10.8	0.6	2.8	0.2	1.2	0.1	0.5	3.3	2.0	0.0	0.2	0.0	5.5	2.3	4.0	0.0	0.7	25.4	23.0	24.7	32.1	27.7	34.8	39.5	29.5	40.1	35.1	27.5	33.6	74.9	48.1	124.8	141.0	11.1	41.4	24.4	18.3	41.5	16.2	21.3	20.6	157.3	67.2	23.3	36.8	37.5	11.4	33.5	184.5	17.6	21.8	1.7	20.6	51.5	70.9	63.3	33.9	18.1	29.6	17.2	119.2	34.1	30.9	58.3	23.3	45.3	178.8	39.1	16.8	84.2	136.5	12.2	50.7	57.5	3.3	39.7	42.2	37.4	38.4	22.0	370.3	14.4	145.8	44.7	23.6	181.2	51.1	28.9	26.0	195.2	31.6	9.2	62.8	46.0	108.2	82.5	5.5	37.6	20.1	35.9	5.5	16.5	20.4	167.6	8.4
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 396.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 362.8;Early spermatids: 339.0;Gastric mucus-secreting cells: 245.6;Ionocytes: 325.5;Late spermatids: 391.6;Pancreatic endocrine cells: 282.9;Paneth cells: 265.2;Undifferentiated cells: 245.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.9;classical monocyte: 3.6;gdT-cell: 3.5;intermediate monocyte: 2.6;neutrophil: 4.2;non-classical monocyte: 4.2;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 372.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		81000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	22.2	159.8	72.5	33.8	78.8	6.6	39.5	69.2	84.5	70.0	99.0	195.7	235.1	40.1	15.7	13.6	38.1	131.0	12.7	72.1	93.8	74.7	19.0	14.7	9.7	73.4	76.1	36.9	41.6	37.6	36.4	17.2	69.9	143.2	163.9	25.5	173.4	10.5	9.4	14.9	61.3	28.4	80.1	41.7	396.2	17.4	108.0	45.4	68.1	4.8	5.6	38.3	14.9	79.2	146.0	139.5	102.4	116.7	129.3	74.3	108.0	64.8	46.6	99.9	80.5	69.4	282.9	2.7	62.6	126.2	96.6	109.4	63.7	64.1	71.9	5.0	101.2	45.3	89.1	3.4	76.8	67.3	34.9	113.4	34.2	94.1	34.0	124.9	172.9	21.2	28.7	4.2	57.3	68.4	8.3	49.6	161.9	188.9	99.6	42.9	116.9	21.8	166.0	61.2	115.1	72.0	88.2	189.0	73.8	66.1	106.7	68.1	110.5	25.9	72.6	79.3	78.3	372.3	37.4	0.9	112.2	29.8	57.8	1.9	3.6	0.4	3.5	2.6	0.4	0.6	0.2	0.5	0.4	0.6	0.4	0.7	4.2	0.7	4.2	1.5	0.1	1.8	72.5	78.8	69.2	84.5	72.1	93.8	73.4	76.1	69.9	80.1	108.0	79.2	13.8	9.6	15.3	30.3	1.7	2.3	10.8	11.3	4.6	20.1	41.4	21.1	4.9	80.1	80.9	35.0	8.4	8.4	10.7	362.8	25.4	168.4	339.0	78.0	49.8	20.5	73.1	11.2	47.0	222.2	35.0	30.4	245.6	56.8	1.3	65.9	8.6	11.1	11.8	67.3	43.2	95.5	325.5	5.0	2.6	391.6	18.3	6.6	23.2	6.5	6.9	16.9	12.3	82.0	19.3	282.9	265.2	13.2	3.2	72.6	71.8	16.0	78.6	6.7	0.0	13.5	19.5	10.3	38.7	2.9	1.0	6.4	5.2	60.7	245.6	29.1
GOLM2	"CASC4, DKFZp459F1927, H63"	ENSG00000166734	"Golgi membrane protein 2"	Q6P4E1	15	44288719-44415758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043015, HPA049488"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1200000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"		"HPA043015: AB_2678271, HPA049488: AB_2680790"	"unprognostic (2.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.45e-5)"	"unprognostic (2.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.12e-1)"	39.5	84.5	48.5	32.4	47.0	16.5	43.2	43.1	59.2	57.9	62.4	45.7	28.8	50.4	53.5	23.7	53.8	50.5	33.1	42.8	52.6	54.0	60.9	40.9	30.8	49.6	51.5	55.3	37.4	82.0	38.7	34.4	46.9	67.5	43.8	33.7	47.8	56.1	22.3	13.2	29.8	44.4	46.7	35.4	49.4	34.6	52.9	28.9	84.6	26.3	29.5	39.2	24.3	52.7	45.0	38.7	51.9	92.6	141.4	121.8	32.0	78.6	125.2	44.9	57.1	19.3	80.0	13.5	106.4	119.3	47.8	53.8	34.4	25.5	48.2	64.6	19.5	21.4	41.8	35.9	65.1	42.5	68.1	72.1	28.3	49.8	38.4	126.8	53.4	34.2	33.0	103.4	56.2	23.2	36.7	33.2	14.8	60.8	27.5	30.5	29.3	43.3	58.8	54.4	23.3	53.2	60.7	57.0	26.6	28.1	64.1	49.2	76.4	78.1	39.8	112.5	69.5	79.0	145.1	27.9	92.6	58.5	51.7	20.9	14.7	20.8	15.2	9.8	16.3	11.9	12.4	15.2	12.0	10.7	9.5	9.9	37.8	10.5	18.2	10.6	13.2	13.6	48.5	47.0	43.1	59.2	42.8	52.6	49.6	51.5	46.9	46.7	52.9	52.7	19.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	16.3	16.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	19.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	12.7	2.9	0.0	0.0	0.0
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749659-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 160.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	11.3	7.6	4.7	10.7	4.9	9.5	11.4	7.6	5.9	10.1	6.3	10.9	7.4	10.7	10.4	8.3	9.7	7.4	8.4	4.4	4.5	8.9	7.9	10.5	12.3	4.4	6.1	10.1	10.1	10.8	9.5	10.0	4.3	9.9	9.2	14.0	9.5	9.1	12.4	11.4	11.2	10.5	3.5	12.6	9.4	9.0	5.2	14.3	11.3	8.1	12.1	10.0	9.4	5.9	13.7	11.1	21.2	13.0	13.0	16.2	13.2	12.0	14.7	15.4	14.9	13.2	12.2	15.7	13.0	15.8	7.7	15.3	15.9	14.1	17.6	14.7	11.1	15.3	14.0	7.3	12.2	18.6	14.0	14.4	12.2	17.0	15.9	15.7	18.5	17.0	20.3	5.8	13.2	13.5	16.2	11.1	23.4	16.7	12.6	14.8	13.2	17.7	11.2	16.1	11.8	19.8	14.3	14.4	11.6	21.0	16.2	22.2	20.5	12.4	10.1	12.7	15.4	23.9	16.9	25.6	10.8	11.0	14.0	3.5	2.6	2.4	3.6	2.0	2.4	2.1	2.4	2.5	2.7	4.0	2.4	2.2	5.7	4.5	1.8	2.9	2.5	1.8	4.7	4.9	7.6	5.9	4.4	4.5	4.4	6.1	4.3	3.5	5.2	5.9	52.3	16.0	36.1	52.5	41.8	12.1	20.6	18.6	17.6	67.2	25.0	26.2	22.1	17.2	27.7	20.2	131.3	27.1	41.6	25.5	9.8	23.5	18.8	29.5	40.0	42.2	32.4	36.4	45.0	18.1	23.8	28.8	37.8	37.5	38.1	40.8	29.3	13.8	19.7	77.4	40.3	23.5	16.2	23.8	19.1	11.7	35.1	27.0	16.0	28.1	40.2	39.2	80.3	26.2	27.6	24.0	20.6	27.4	38.5	26.9	23.2	14.0	19.8	160.7	39.5	38.8	30.6	54.7	40.5	18.3	17.5	45.0	47.9	50.1	22.6	24.0
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GORASP2	"GOLPH6, GRASP55, GRS2"	ENSG00000115806	"Golgi reassembly stacking protein 2"	Q9H8Y8	2	170928464-170967130	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 380.7;Syncytiotrophoblasts: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035274, HPA035275, CAB075758"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		830000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.38e-8)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-1)"	32.1	43.1	32.6	32.0	34.6	33.7	40.5	35.8	36.7	62.6	34.1	43.5	38.3	43.2	60.4	46.8	34.3	37.2	57.6	32.5	35.9	33.6	45.6	34.3	39.9	34.2	34.5	37.3	67.1	47.3	40.0	55.5	34.8	40.7	43.6	37.0	68.4	52.6	39.7	38.6	36.7	46.1	34.6	31.1	42.0	32.0	34.4	41.8	50.8	38.1	44.2	53.3	24.0	37.0	66.1	51.7	72.2	54.9	137.5	103.2	83.0	101.5	113.9	89.6	113.8	132.8	84.2	97.0	59.7	143.2	61.0	75.9	82.3	96.0	102.2	57.8	81.2	107.5	41.2	198.8	138.4	90.2	62.9	79.2	102.9	90.0	148.3	95.7	98.9	64.5	92.4	72.4	80.3	103.2	85.5	87.0	74.3	109.9	49.3	68.4	64.5	115.0	112.9	91.8	59.3	54.3	58.4	91.6	95.9	59.0	60.8	73.6	93.5	82.8	56.2	79.5	55.7	81.1	56.2	112.4	86.6	58.3	95.6	48.3	38.3	27.0	53.0	40.6	81.7	44.8	59.1	63.4	48.3	40.7	58.0	48.5	9.6	64.5	46.8	63.9	57.0	62.8	32.6	34.6	35.8	36.7	32.5	35.9	34.2	34.5	34.8	34.6	34.4	37.0	28.7	41.7	36.6	15.0	46.7	37.2	39.6	83.4	38.1	30.6	33.0	22.5	40.9	27.1	64.2	20.2	31.3	114.4	49.3	39.2	56.7	69.1	196.6	16.2	34.4	32.1	31.3	35.1	20.1	78.1	112.1	48.4	48.4	32.7	20.3	25.7	38.9	45.0	46.4	42.1	23.0	63.9	48.8	22.7	29.7	380.7	58.7	23.9	48.0	22.5	46.3	39.3	35.0	27.2	31.7	69.7	41.9	49.7	171.9	62.1	31.7	43.7	23.1	34.8	59.2	27.5	40.3	39.6	39.6	47.1	36.1	229.7	43.4	44.9	48.2	67.7
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594301-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	24.5	19.5	12.1	16.7	12.4	10.6	18.9	8.7	17.3	14.9	8.0	19.8	8.9	19.9	9.1	21.7	16.6	6.8	23.0	11.5	12.4	26.5	21.4	14.9	16.8	12.5	13.0	15.0	19.6	15.6	10.1	9.6	12.8	19.2	13.0	2.9	16.3	10.6	79.0	17.3	16.2	14.3	9.9	18.6	19.3	13.1	11.7	11.8	14.4	31.9	19.0	22.8	16.1	14.7	54.6	67.6	31.2	46.3	28.1	20.4	44.0	66.0	27.8	53.3	30.7	74.9	44.8	131.6	55.0	47.8	34.3	38.7	68.9	59.4	54.5	38.2	65.2	82.1	65.2	57.3	26.2	174.9	48.3	25.0	51.1	96.9	79.3	13.1	36.6	44.0	135.5	31.8	40.7	96.2	82.0	39.8	138.9	92.5	71.4	72.9	52.1	96.3	35.0	58.4	50.4	75.8	59.6	146.7	41.6	31.9	46.2	89.3	52.8	50.7	66.0	53.4	121.1	57.8	69.5	169.9	45.7	89.7	79.7	0.1	9.4	0.1	20.9	17.9	20.4	29.1	21.2	24.0	17.5	30.7	24.1	25.1	0.4	19.0	22.0	11.1	15.7	12.6	12.1	12.4	8.7	17.3	11.5	12.4	12.5	13.0	12.8	9.9	11.7	14.7	17.0	32.1	38.3	5.2	36.0	73.7	65.9	32.5	26.2	7.7	23.8	25.4	27.2	25.8	33.4	16.5	8.4	35.6	19.5	26.5	25.4	51.9	12.9	19.1	53.7	32.5	37.0	42.9	6.4	57.1	53.0	29.0	23.0	20.1	57.7	24.3	18.5	46.9	37.4	8.4	4.6	26.1	10.2	13.6	21.3	11.4	26.8	19.0	23.2	2.8	18.8	6.9	23.7	1.5	3.3	53.0	17.5	26.7	23.8	92.5	7.8	34.3	14.9	6.4	32.9	66.0	45.4	47.4	44.3	33.5	62.7	15.5	26.3	38.6	43.6	51.5
GPKOW	"GPATC5, GPATCH5, Mos2, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113407-49123735	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	17.6	15.9	21.5	11.7	22.6	16.1	16.4	22.7	21.8	14.7	14.0	17.0	14.3	16.9	11.8	14.7	15.1	10.3	18.6	19.8	21.2	15.5	14.5	13.8	14.9	24.2	23.6	13.6	12.1	19.0	17.2	13.8	23.9	12.7	12.6	11.9	13.8	16.5	34.8	20.4	14.1	13.8	22.4	15.4	15.5	7.2	25.2	17.7	13.4	25.4	14.4	16.2	14.2	24.4	36.5	38.1	24.9	20.9	21.6	18.6	27.0	23.1	25.9	36.0	38.0	27.9	35.5	15.2	17.4	28.6	36.8	25.2	27.9	27.3	23.4	32.2	29.8	15.8	31.4	19.9	25.8	18.9	32.1	20.4	34.3	28.8	29.2	21.1	27.4	30.0	19.8	23.1	23.8	59.5	26.0	31.5	17.6	19.5	30.0	32.2	27.4	41.5	18.5	45.8	20.8	24.1	26.9	25.2	25.4	26.1	48.5	24.5	30.7	20.7	31.2	30.4	22.1	35.4	26.1	20.7	26.7	31.1	32.7	26.2	22.3	28.9	37.2	31.4	30.3	20.5	28.6	27.8	22.6	34.8	24.3	22.4	17.3	25.0	35.9	20.8	31.1	20.2	21.5	22.6	22.7	21.8	19.8	21.2	24.2	23.6	23.9	22.4	25.2	24.4	10.9	19.2	11.0	7.2	10.5	8.0	14.1	21.8	4.6	14.8	6.4	5.5	13.1	21.5	19.1	7.3	4.2	28.4	16.3	16.2	15.6	26.2	1.1	15.6	10.0	13.4	7.8	22.5	2.8	25.2	20.5	11.7	14.3	10.6	11.4	10.4	11.7	14.5	16.7	5.0	2.8	12.1	18.3	10.9	9.3	1.7	15.5	8.7	5.4	2.8	13.2	20.9	28.8	2.0	3.9	25.6	23.2	15.1	9.4	9.4	19.5	20.5	12.7	13.4	39.5	12.9	13.0	9.9	18.4	6.1	9.9	43.8	16.7	10.6	11.0	12.8
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12891559-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 201.9;urinary bladder: 130.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 939.1;Club cells: 357.8;Distal enterocytes: 477.9;Pancreatic endocrine cells: 600.7;Paneth cells: 359.8;Urothelial cells: 1252.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 355.6;A549: 285.7;CAPAN-2: 1347.4;HaCaT: 351.2;SiHa: 492.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	31.5	3.7	1.2	11.5	0.9	1.8	9.6	1.0	1.4	35.4	3.4	56.4	18.7	8.9	0.4	23.0	9.8	24.9	18.9	1.8	0.8	9.0	1.8	201.9	0.2	2.7	4.5	21.4	2.7	0.9	2.5	13.5	1.0	10.2	48.4	1.6	23.5	1.3	0.7	5.8	20.9	5.1	0.5	0.4	33.6	1.5	2.1	0.3	55.5	0.6	4.4	130.8	30.6	1.8	355.6	285.7	0.1	1.3	3.4	1.5	18.4	105.2	39.5	66.2	49.4	49.1	1347.4	0.1	8.6	83.3	67.2	351.2	1.0	50.1	101.7	0.4	4.3	0.2	105.4	2.2	23.8	0.1	0.3	1.8	66.5	27.5	6.7	82.3	40.9	0.0	0.5	0.3	2.9	251.7	0.2	0.3	1.6	130.0	43.5	0.2	6.7	0.3	133.6	69.6	0.5	0.6	492.0	36.8	15.9	52.3	10.9	1.0	4.0	2.6	83.9	156.1	4.3	0.2	0.3	0.3	34.6	0.3	2.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.2	0.9	1.0	1.4	1.8	0.8	2.7	4.5	1.0	0.5	2.1	1.8	10.0	939.1	200.2	0.0	1.0	12.5	329.6	202.8	4.6	0.1	80.6	41.7	1.9	11.5	357.8	46.0	0.0	3.8	1.5	477.9	0.0	46.9	0.1	91.8	54.1	15.8	8.3	0.0	0.2	72.1	11.7	108.5	176.9	288.1	10.1	0.2	8.6	0.2	1.6	0.0	0.4	43.5	61.1	0.3	18.0	0.4	13.4	9.6	51.6	0.0	0.6	3.5	0.0	0.0	0.1	600.7	359.8	10.1	0.5	320.1	114.0	0.2	86.3	0.4	0.0	23.0	38.8	1.5	0.3	22.7	9.1	1.1	4.9	0.7	110.4	1252.7
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol		NA	NA		78000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	55.6	64.4	55.9	32.0	56.7	42.7	54.6	59.2	80.5	53.3	53.7	58.8	35.0	56.3	30.9	50.9	49.5	28.1	91.1	59.2	57.6	81.9	101.7	48.6	37.5	60.1	59.2	56.4	69.8	48.4	62.6	29.7	60.0	64.5	18.1	20.5	58.8	40.7	148.5	56.6	46.8	25.5	55.1	54.9	65.5	70.6	56.5	37.3	58.7	63.7	24.9	53.7	48.0	59.2	112.5	204.9	74.7	98.0	51.7	49.5	105.4	73.6	58.2	114.1	93.9	180.7	68.1	55.0	64.5	74.1	83.1	83.1	71.6	94.2	38.7	37.0	256.7	93.5	112.2	203.5	85.5	102.9	86.8	71.2	67.9	101.3	60.0	45.9	120.4	93.4	89.1	62.0	64.3	220.8	176.8	116.4	95.3	107.2	151.3	107.0	102.5	89.5	71.1	114.8	127.6	199.8	74.9	136.6	110.0	56.7	155.1	91.7	69.3	113.3	133.3	88.6	120.5	112.6	51.4	58.9	88.7	65.5	104.5	57.6	85.7	65.9	77.5	81.0	81.8	64.5	80.9	78.3	93.4	64.2	56.9	71.8	13.2	81.6	78.1	64.2	115.2	98.7	55.9	56.7	59.2	80.5	59.2	57.6	60.1	59.2	60.0	55.1	56.5	59.2	24.0	12.8	24.8	27.1	24.9	25.1	22.5	37.1	17.6	30.6	31.0	27.6	53.7	30.0	30.7	20.2	25.0	71.1	22.7	78.6	60.7	50.7	33.0	22.7	22.4	30.0	41.3	21.7	12.1	69.4	67.6	31.0	35.7	23.3	24.7	45.2	28.5	50.6	60.9	48.8	14.2	42.7	52.9	37.3	31.5	76.7	30.1	32.0	33.8	7.5	42.4	46.3	29.9	10.6	16.4	48.1	56.1	31.6	50.1	25.4	58.4	100.9	33.9	27.2	6.6	28.3	36.3	50.9	50.3	27.1	30.0	54.0	31.1	41.9	57.2	23.2
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345246-44353106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1420.7;Kupffer cells: 892.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 2057.5;intermediate monocyte: 1122.4;myeloid DC: 1534.2;neutrophil: 851.2;non-classical monocyte: 548.1;plasmacytoid DC: 1331.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 1534.2;granulocytes: 851.2;monocytes: 2057.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	138000000	110000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	158.9	123.2	61.5	160.4	67.2	478.5	120.7	67.7	97.3	156.7	73.9	189.8	130.9	108.3	134.0	534.0	87.1	157.3	153.0	61.0	69.7	167.4	118.9	309.5	183.2	81.0	71.5	73.8	108.9	87.8	84.4	183.2	87.6	111.7	110.3	12.5	262.9	100.6	60.6	189.7	179.0	91.9	71.8	349.8	127.9	59.4	94.3	67.8	127.7	45.9	107.8	150.0	198.3	97.3	119.3	197.5	52.7	159.5	443.2	231.8	181.2	147.3	447.5	231.6	309.8	86.3	294.0	364.0	299.4	217.6	312.9	185.3	68.6	334.5	75.8	55.8	186.8	38.4	93.8	175.2	245.5	61.6	493.6	332.4	450.5	188.1	106.0	391.2	269.8	64.3	75.1	51.3	148.8	183.1	32.8	172.8	44.3	110.5	334.0	97.7	180.8	433.0	248.2	145.9	54.7	74.7	201.0	92.7	360.9	138.0	209.4	229.0	340.7	437.6	104.6	300.5	97.8	116.3	313.9	122.3	268.1	149.6	124.2	215.1	2057.5	176.5	35.1	1122.4	27.8	174.0	37.1	31.1	1534.2	112.2	27.8	26.5	851.2	30.6	548.1	1331.9	55.4	1613.4	61.5	67.2	67.7	97.3	61.0	69.7	81.0	71.5	87.6	71.8	94.3	97.3	113.0	86.6	83.3	12.7	82.8	112.7	151.1	574.2	97.9	23.6	85.7	69.7	90.7	133.0	332.7	218.8	18.8	429.1	195.7	494.8	9.8	447.7	2.1	103.8	83.8	170.9	124.3	38.7	6.8	307.3	324.1	149.4	83.6	372.5	75.5	90.0	207.8	84.7	1420.7	47.1	6.6	214.6	146.5	892.0	360.8	6.8	60.9	699.2	208.1	20.6	501.6	58.9	20.6	11.1	11.8	285.3	581.7	57.2	65.8	70.7	312.1	120.5	70.0	11.8	85.5	45.4	83.3	25.1	72.2	255.5	96.5	640.0	30.8	89.6	274.5	175.6
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 44.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.87e-5)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	6.8	4.2	4.6	5.9	5.0	5.0	5.1	8.8	6.2	13.4	2.8	4.1	4.8	4.3	4.1	44.9	3.8	3.5	8.2	4.8	6.1	6.2	4.7	9.3	7.2	6.3	5.5	5.4	3.7	6.5	3.0	7.5	6.6	3.9	3.9	5.6	7.2	4.0	8.8	4.5	5.0	3.6	5.3	4.8	5.5	4.6	6.0	5.3	6.5	5.1	11.0	4.9	11.0	5.9	16.3	9.5	12.5	44.2	7.9	8.1	25.2	14.8	11.9	13.5	19.1	22.7	10.6	17.5	15.0	7.6	18.0	12.4	20.3	20.8	18.8	9.0	18.0	21.1	16.0	11.9	22.1	21.2	11.1	12.4	24.5	16.3	26.8	5.9	9.7	22.1	18.5	39.4	9.9	11.2	13.4	17.1	16.0	9.9	34.5	17.3	17.0	22.0	8.8	15.7	25.3	20.7	14.7	25.9	44.5	9.3	23.0	24.5	11.2	14.6	16.3	10.4	21.3	14.7	21.6	16.6	14.3	28.9	14.5	9.9	2.5	3.6	5.1	2.4	6.1	3.9	7.6	5.6	3.9	1.8	9.9	7.5	2.0	3.8	2.8	1.1	15.1	4.8	4.6	5.0	8.8	6.2	4.8	6.1	6.3	5.5	6.6	5.3	6.0	5.9	20.9	9.6	6.4	2.3	3.3	17.8	5.3	9.9	9.6	6.1	7.0	6.0	8.8	4.3	9.3	9.2	8.4	9.2	3.5	5.1	1.9	5.3	11.6	2.3	4.9	36.0	6.0	11.4	4.3	6.0	18.2	6.0	3.6	5.6	2.5	6.6	20.3	7.1	6.0	3.3	5.1	4.5	10.2	9.7	7.4	5.4	4.1	2.7	7.2	5.6	4.5	5.4	2.1	3.0	4.9	7.5	3.1	5.3	4.4	7.1	6.5	6.2	5.0	6.7	0.0	6.1	6.0	22.6	12.0	10.0	19.6	5.6	9.2	5.2	7.2	8.2
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815783-70839897	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.2"	"Cell type enhanced"	"Detected in all"		"monocytes: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	38.0	61.2	38.4	36.9	37.7	23.7	37.7	42.5	47.1	36.3	58.9	54.6	43.1	32.5	34.0	42.0	43.0	35.2	80.7	41.0	44.5	55.8	54.4	35.5	47.4	40.3	42.3	38.4	62.0	48.8	21.5	43.8	41.6	39.9	62.7	25.4	83.9	35.3	275.2	32.0	41.3	40.0	40.7	34.6	50.8	32.8	40.9	76.0	45.7	155.0	53.7	50.3	25.8	46.1	116.9	78.1	90.0	94.5	93.5	108.1	128.3	138.2	87.3	102.3	83.5	80.5	117.1	167.6	102.9	143.7	53.0	43.4	161.3	108.6	135.9	91.3	52.8	88.4	75.2	112.4	115.1	130.8	48.7	91.9	102.2	103.6	71.6	123.0	106.9	91.9	102.6	94.7	144.2	124.9	217.4	92.0	96.3	127.1	80.9	88.2	139.8	71.6	126.1	144.0	93.4	84.0	65.3	183.6	234.3	104.7	79.8	63.3	98.4	95.1	99.7	79.4	88.7	78.1	66.2	106.4	78.6	83.6	94.5	12.7	17.4	7.7	10.1	12.3	12.2	7.4	14.6	15.5	28.1	6.1	14.4	12.6	2.0	20.0	15.2	27.2	13.3	8.4	38.4	37.7	42.5	47.1	41.0	44.5	40.3	42.3	41.6	40.7	40.9	46.1	27.8	32.1	36.6	19.6	38.0	50.0	53.7	32.9	48.3	18.2	37.7	28.3	135.5	40.0	30.4	27.6	25.0	106.2	57.4	52.9	74.3	70.3	7.6	53.8	40.4	33.0	69.0	41.2	35.1	61.3	141.3	41.2	65.2	44.5	17.2	60.2	35.0	50.9	63.2	28.6	30.5	73.5	36.7	66.3	53.7	6.7	34.8	45.4	62.2	24.4	301.5	23.8	41.2	21.6	28.0	60.1	46.7	39.1	58.7	65.9	47.1	74.1	27.6	19.6	19.7	38.4	46.2	35.0	61.8	69.7	50.4	77.2	45.1	99.0	89.3	67.0
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445841-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.0	13.7	6.3	14.0	5.8	14.0	14.4	7.0	6.9	13.7	7.2	11.5	13.1	16.1	4.2	18.2	13.0	8.6	13.6	6.2	6.7	13.0	16.3	10.9	16.0	6.9	7.4	13.7	18.6	13.0	8.6	11.4	7.4	12.2	6.5	3.7	12.7	8.9	28.4	17.5	10.9	8.6	5.6	14.1	13.8	7.4	8.7	11.5	11.8	14.5	10.6	14.6	13.5	7.3	58.3	148.9	25.0	47.3	20.2	19.8	21.6	44.9	20.8	62.2	51.8	84.0	42.4	83.4	37.8	28.7	35.0	48.8	62.7	67.9	24.9	63.8	86.5	78.2	48.6	60.4	23.0	71.9	47.8	23.8	37.0	58.9	29.4	14.3	31.5	43.8	107.3	50.1	27.0	59.1	75.1	180.1	68.1	63.8	43.2	92.9	28.3	58.5	26.4	70.4	56.2	32.1	51.3	71.0	22.4	15.4	34.6	36.5	35.2	57.9	49.1	25.9	107.1	50.6	126.8	78.3	19.7	64.8	69.0	0.3	24.8	3.3	41.5	40.7	46.4	44.4	37.1	41.0	40.9	44.8	42.6	40.3	2.0	41.6	32.4	29.7	36.3	37.4	6.3	5.8	7.0	6.9	6.2	6.7	6.9	7.4	7.4	5.6	8.7	7.3	17.3	3.2	17.5	1.0	26.8	46.3	31.7	18.6	23.3	13.4	16.0	13.7	7.1	14.3	14.3	12.9	0.0	41.4	15.1	14.4	23.5	29.0	3.8	13.1	20.5	19.1	19.2	28.8	1.6	18.2	39.7	18.1	13.3	14.3	19.7	16.8	13.6	18.5	24.4	21.9	3.9	14.5	14.2	11.1	14.3	19.4	17.1	11.4	28.4	2.8	25.3	6.1	19.6	3.0	2.6	22.4	6.5	12.4	28.5	24.2	6.8	18.8	16.8	15.7	19.7	22.7	20.4	9.4	34.3	20.5	40.6	35.0	17.9	26.3	17.1	24.0
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743442-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 95.5;Late spermatids: 189.0;Muller glia cells: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 47.6;PC-3: 53.8;SuSa: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol		NA	NA		130000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 21: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	6.2	6.5	6.8	5.8	7.1	2.8	6.2	5.6	7.5	4.4	5.3	5.0	3.2	5.4	7.5	2.7	5.6	5.1	6.8	6.9	10.7	6.3	11.2	5.5	9.2	5.1	7.1	9.9	4.8	6.1	6.5	2.4	6.1	6.8	3.5	7.7	6.3	6.1	5.9	2.7	5.0	5.3	5.3	5.8	3.9	13.3	9.5	10.4	6.0	5.3	8.6	4.8	2.3	4.7	0.0	9.9	19.7	0.0	13.6	11.8	0.0	11.3	1.9	8.0	10.0	6.3	10.0	29.3	0.0	9.7	24.6	3.2	0.0	5.3	9.1	0.0	12.7	0.4	0.0	0.0	10.1	0.0	12.3	15.7	2.5	7.0	7.1	13.6	11.7	13.4	7.9	2.2	14.2	0.0	2.6	1.8	47.6	0.0	53.8	14.0	18.6	0.0	14.5	10.6	0.0	16.6	0.0	0.0	10.5	38.9	0.0	9.5	7.5	7.9	16.0	7.4	7.5	0.0	17.3	0.0	10.5	1.9	8.9	2.9	2.5	1.6	4.5	3.6	4.5	7.9	3.9	4.3	8.2	8.1	6.3	5.5	0.3	6.5	2.7	6.9	5.6	3.6	6.8	7.1	5.6	7.5	6.9	10.7	5.1	7.1	6.1	5.3	9.5	4.7	6.4	12.8	11.8	3.6	10.1	1.8	5.3	8.9	3.4	17.0	4.2	7.0	17.9	14.3	8.0	14.7	8.4	9.6	11.5	2.0	5.9	14.2	95.5	1.4	10.7	8.3	3.0	4.2	3.9	8.7	4.3	11.2	3.1	1.3	10.8	6.3	6.1	20.3	6.2	11.8	4.3	3.5	2.0	7.6	2.1	189.0	12.8	4.9	3.6	1.9	9.8	61.4	14.4	3.5	2.6	5.6	5.5	18.8	7.6	6.5	0.8	11.5	10.0	10.4	26.3	8.2	7.6	11.6	10.4	2.5	1.4	3.4	7.5	15.7	3.2	3.9
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	5.2	7.7	4.2	6.6	4.9	4.4	5.1	4.6	5.5	4.9	7.9	5.0	4.6	4.6	4.5	4.2	4.2	3.7	5.1	4.4	4.8	4.3	5.0	4.9	9.1	5.0	4.7	5.7	4.5	4.6	2.9	6.6	4.9	4.6	5.8	5.6	4.2	5.6	7.0	3.6	4.2	5.7	4.5	7.7	4.7	9.9	4.9	8.3	5.5	9.3	9.0	5.5	4.2	5.4	13.7	18.7	23.0	14.1	16.9	7.8	20.0	9.0	8.2	13.8	14.7	22.5	9.6	22.3	15.3	6.8	10.7	16.1	21.4	11.8	19.2	15.6	5.0	28.7	12.8	19.0	13.1	26.1	16.8	10.4	12.6	10.3	14.5	9.4	21.4	18.9	20.4	11.3	14.8	15.6	21.6	13.2	22.0	13.1	17.2	17.7	27.0	16.6	13.8	8.6	4.9	15.1	13.5	11.6	12.6	20.6	14.7	19.8	18.9	12.9	14.0	4.1	10.2	9.9	11.8	31.5	13.5	26.0	12.5	18.0	7.2	11.6	6.6	11.2	8.3	9.3	8.1	9.5	8.7	7.3	8.6	8.4	5.0	10.8	10.5	4.1	10.2	7.6	4.2	4.9	4.6	5.5	4.4	4.8	5.0	4.7	4.9	4.5	4.9	5.4	4.1	3.2	4.4	3.3	6.8	1.9	3.0	4.1	3.4	5.3	4.6	1.8	4.9	8.6	6.3	7.3	0.0	9.0	4.7	3.8	5.9	5.1	7.7	8.1	6.0	5.4	1.2	5.5	3.8	4.4	8.4	3.8	3.1	6.1	12.7	9.1	7.5	5.3	9.2	16.8	4.0	3.2	6.1	8.3	2.2	2.9	2.1	7.0	3.6	8.4	12.5	5.5	14.4	4.5	7.2	4.9	2.5	4.9	5.3	3.3	3.4	5.9	5.1	4.4	0.0	3.5	3.9	14.3	22.8	2.8	2.6	8.8	5.7	9.7	3.9	3.1
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	24.5	29.1	14.9	17.8	16.1	9.4	19.9	19.9	19.3	25.1	16.9	20.9	19.5	19.4	17.2	26.4	16.4	13.2	16.2	15.9	17.3	21.4	28.1	17.8	25.9	14.8	15.1	30.3	51.8	15.4	20.1	16.8	15.0	18.7	16.0	11.6	15.9	14.6	13.4	20.6	17.5	18.5	14.7	20.4	24.4	32.7	16.5	22.4	17.4	11.0	26.6	24.1	24.1	15.8	53.7	43.7	29.2	31.2	77.4	68.2	22.0	57.7	52.4	46.5	58.6	26.2	38.2	70.0	48.0	51.9	67.0	37.8	49.1	53.8	61.5	31.8	28.2	34.9	28.9	63.0	75.4	17.1	29.5	50.6	70.7	49.7	50.7	46.3	65.3	51.2	68.7	42.1	74.5	37.3	83.7	42.9	33.1	66.0	51.9	43.2	31.6	35.4	50.9	36.7	22.4	29.1	32.1	21.5	46.5	38.3	20.8	20.9	49.9	30.6	31.4	25.9	39.8	42.6	62.7	77.0	48.2	28.8	41.3	4.3	4.2	6.4	3.6	3.5	4.1	18.8	5.7	7.6	7.3	11.7	5.6	5.5	2.2	9.7	3.7	8.2	7.0	2.8	14.9	16.1	19.9	19.3	15.9	17.3	14.8	15.1	15.0	14.7	16.5	15.8	20.2	0.0	8.4	16.6	48.7	47.9	48.1	44.3	48.3	9.2	19.1	17.5	9.9	17.2	28.2	14.7	10.4	43.0	32.3	26.5	19.6	31.5	96.7	42.2	33.8	22.9	13.2	14.1	30.2	33.1	51.4	30.0	31.1	29.0	11.4	17.7	26.4	27.0	34.1	5.0	30.1	24.2	22.4	21.6	39.3	58.9	39.4	28.4	21.4	13.1	58.8	9.0	46.4	17.1	21.8	43.3	23.4	70.7	35.9	72.7	46.5	48.2	40.0	14.9	26.3	17.5	28.0	74.3	87.9	38.3	46.5	62.1	36.9	26.1	24.5	91.8
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379572-6393981	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 228.3;Late spermatids: 391.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	35.0	38.1	36.7	34.0	38.4	71.0	34.2	43.6	43.0	48.8	30.2	41.2	40.5	48.5	25.9	46.0	44.8	36.1	32.8	39.1	35.8	37.6	30.0	31.5	43.5	34.4	34.3	73.6	57.5	42.6	49.8	26.8	34.6	39.5	23.3	24.9	43.8	31.7	36.8	36.8	39.2	25.1	30.1	36.4	43.9	68.3	36.1	37.1	49.6	22.6	29.8	37.3	41.0	36.1	115.6	97.1	62.0	100.9	46.5	73.1	47.3	81.7	84.7	112.0	106.0	104.4	48.5	76.3	111.9	67.2	73.5	109.9	69.3	65.6	57.1	106.6	90.1	97.2	60.7	86.9	78.6	107.1	79.5	82.8	78.2	85.5	64.1	86.4	69.0	72.9	115.9	91.7	63.9	96.2	115.4	79.7	108.2	59.7	124.3	101.5	68.0	94.6	67.5	74.2	76.1	99.8	83.0	64.5	95.6	36.4	84.0	94.0	79.8	78.5	62.6	134.0	110.1	153.9	197.2	79.7	98.1	124.9	91.0	10.2	29.7	20.8	26.1	28.4	29.7	32.9	23.5	24.9	23.3	31.6	27.0	24.6	40.1	27.6	30.2	30.3	25.4	19.8	36.7	38.4	43.6	43.0	39.1	35.8	34.4	34.3	34.6	30.1	36.1	36.1	29.2	48.1	56.6	5.2	51.9	24.3	50.2	40.5	53.5	27.6	43.1	34.7	28.9	32.9	58.4	25.8	8.4	46.1	51.6	88.2	21.5	48.5	228.3	70.5	70.7	41.0	30.5	51.7	6.9	50.8	43.0	43.3	51.0	57.4	63.8	32.7	58.9	26.0	60.2	25.2	7.0	53.4	24.4	54.8	25.9	391.6	44.4	42.1	33.8	5.6	66.0	35.6	49.4	3.5	4.9	47.4	66.0	49.7	55.4	29.9	65.3	48.8	83.6	33.5	32.9	44.8	52.9	71.8	38.3	44.9	21.0	54.0	48.3	41.8	54.4	40.6
GTF2H1	"BTF2, P62, TFIIH"	ENSG00000110768	"General transcription factor IIH subunit 1"	P32780	11	18322295-18367045	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004637, HPA046660"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB004637: AB_425470, HPA046660: AB_2679743"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.98e-9)"	"unprognostic (7.71e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.42e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.94e-1)"	19.0	18.2	6.0	7.6	6.4	4.7	18.2	7.6	7.2	16.5	10.0	17.9	7.5	15.6	8.2	19.4	14.6	9.4	14.9	6.7	6.0	16.2	17.2	13.9	10.9	5.5	5.8	19.2	17.9	8.2	13.8	10.0	5.6	15.8	8.2	13.1	18.7	10.0	16.6	20.0	14.7	8.4	5.8	17.2	15.2	26.5	6.1	8.8	16.0	8.3	11.1	17.7	16.9	7.6	14.7	13.3	11.0	15.5	25.1	20.1	13.7	21.8	23.6	19.0	21.9	13.9	5.6	24.9	8.4	22.4	27.2	19.8	19.1	20.1	24.1	11.0	18.5	15.9	13.4	14.1	35.8	30.7	16.5	22.4	23.8	11.7	37.3	15.7	17.3	12.8	25.2	12.6	27.7	13.6	15.6	23.3	9.8	24.7	19.8	16.1	23.4	11.3	15.3	19.6	12.5	13.5	17.8	17.1	27.0	9.4	8.8	17.5	12.6	24.9	12.2	45.3	17.8	6.3	16.0	17.7	21.5	24.0	24.4	11.0	5.0	5.4	3.8	5.0	4.2	5.4	4.8	4.3	5.4	5.7	5.8	4.7	3.5	7.5	6.0	2.9	5.2	4.2	6.0	6.4	7.6	7.2	6.7	6.0	5.5	5.8	5.6	5.8	6.1	7.6	27.8	16.0	18.2	19.2	26.1	48.3	22.7	22.2	39.9	17.3	23.4	20.6	28.3	22.8	21.9	11.0	20.9	26.1	26.8	14.7	7.9	25.2	50.2	19.0	17.7	21.6	7.7	26.1	32.1	30.5	27.5	27.1	21.4	20.2	18.3	20.0	22.1	13.9	25.2	21.9	29.9	12.9	14.2	20.8	27.2	46.1	17.1	28.8	23.2	20.6	25.9	23.4	25.7	24.1	29.4	28.8	10.5	16.1	25.7	23.4	18.6	25.1	23.6	21.2	6.6	23.4	23.2	84.8	30.1	37.6	51.7	28.2	20.4	29.2	16.8	26.8
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74650231-74760692	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA		55000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	61.2	75.3	32.5	48.2	36.4	32.7	52.2	36.7	35.7	57.5	64.7	41.9	52.8	57.5	41.3	54.9	66.9	47.0	51.2	32.3	31.5	70.9	57.6	52.3	56.7	31.2	33.7	64.4	49.8	106.0	42.9	56.1	31.6	64.2	39.9	82.8	69.4	54.1	84.2	62.9	48.0	61.5	31.0	47.6	67.6	25.4	35.1	70.6	118.0	56.8	68.8	49.4	38.8	46.4	136.4	110.4	222.6	219.9	120.6	106.7	46.3	83.7	76.9	90.5	89.6	76.9	161.6	165.4	33.7	104.1	121.6	116.3	221.1	101.3	116.2	126.4	115.9	85.6	128.0	107.7	72.3	159.5	126.9	98.8	84.7	68.8	70.0	132.6	123.3	55.2	165.3	80.0	110.9	126.8	133.7	147.5	243.6	286.9	67.1	146.0	77.5	133.1	118.7	232.2	185.5	236.3	153.0	226.5	78.7	185.8	116.4	105.2	111.7	123.6	66.8	62.8	108.8	90.2	83.3	256.2	70.9	95.8	126.6	20.4	10.0	17.4	11.3	7.3	16.6	22.1	14.6	16.7	14.6	24.1	17.8	17.4	4.1	21.3	6.6	23.0	8.7	9.7	32.5	36.4	36.7	35.7	32.3	31.5	31.2	33.7	31.6	31.0	35.1	46.4	118.5	80.1	60.6	55.8	80.3	60.2	83.3	136.3	125.7	276.4	140.7	113.7	30.3	210.1	106.3	119.5	283.5	112.6	101.5	46.0	56.7	155.4	37.1	368.7	201.3	98.2	112.5	91.7	68.6	83.0	64.4	78.8	117.8	321.8	13.3	246.1	115.3	101.0	80.3	250.7	74.1	71.0	73.2	106.7	53.7	39.8	152.8	76.0	55.2	46.9	122.3	200.9	101.0	102.5	98.1	132.5	70.6	193.0	81.4	117.6	150.6	110.2	233.3	184.3	85.5	96.8	87.8	34.1	51.9	145.8	91.9	72.2	60.5	172.7	63.9	124.3
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	26.5	33.6	26.3	20.6	30.4	42.4	29.1	35.1	35.8	36.2	23.9	28.8	26.4	31.7	22.3	39.0	32.0	17.5	39.1	26.9	27.5	27.5	32.9	23.7	27.7	28.1	28.6	44.6	33.6	24.5	36.0	24.6	29.0	34.3	19.2	13.7	29.1	20.7	47.9	38.6	30.3	21.6	26.2	32.1	28.5	29.4	28.5	44.5	28.6	32.3	25.3	29.2	33.2	36.6	44.1	77.5	67.3	63.3	35.9	32.5	93.2	42.0	45.4	78.6	55.4	83.5	71.8	72.7	38.7	47.1	63.2	103.9	79.8	76.3	40.2	74.9	69.1	86.8	90.3	78.7	55.9	66.2	176.0	45.0	49.9	83.5	57.7	38.0	69.1	235.1	112.5	66.0	42.1	142.1	107.9	92.4	87.5	100.6	79.7	113.9	69.5	89.2	52.4	50.2	80.4	59.7	71.2	73.4	43.8	38.1	96.5	95.6	46.0	92.0	71.3	59.1	71.8	25.8	57.3	78.0	44.8	49.8	62.4	54.2	16.0	22.5	15.8	18.9	23.0	14.6	16.3	20.7	17.2	13.6	18.1	16.4	9.5	20.7	16.3	16.6	19.4	17.8	26.3	30.4	35.1	35.8	26.9	27.5	28.1	28.6	29.0	26.2	28.5	36.6	16.0	9.6	19.0	17.3	21.0	12.4	16.5	21.7	30.7	14.2	25.2	21.6	29.3	14.3	17.2	16.5	8.4	42.1	20.0	30.4	29.4	25.5	3.4	16.2	15.4	16.4	14.4	22.3	9.0	30.3	38.4	19.7	18.3	19.9	16.5	50.1	18.5	17.2	22.5	15.2	7.9	15.9	34.6	15.7	9.9	4.3	17.4	15.8	16.0	8.4	14.8	18.8	15.5	6.0	16.6	27.2	25.4	21.4	17.4	13.9	27.3	11.7	14.6	20.8	46.0	17.2	19.4	20.5	31.9	26.1	16.6	41.6	17.6	34.0	25.7	19.4
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988434-1019932	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: AB_2683141"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	15.6	19.6	8.0	12.6	8.5	26.9	12.8	8.6	8.7	8.4	9.4	9.5	8.6	11.0	8.8	11.4	9.2	7.9	11.1	8.8	9.5	9.4	10.9	8.5	13.9	9.1	9.4	9.8	11.9	10.3	7.8	10.2	9.1	9.0	10.8	8.9	7.8	8.4	26.6	9.5	8.2	12.2	9.5	9.4	9.2	21.0	9.4	12.0	9.8	14.8	15.6	18.3	8.7	10.1	57.0	49.4	37.1	34.9	27.9	31.1	27.3	52.3	18.8	62.6	53.3	73.2	43.3	87.0	15.2	45.5	21.3	43.6	77.4	52.0	71.2	41.8	50.9	94.7	35.3	45.4	44.5	41.3	47.1	43.1	42.7	72.7	51.6	25.5	34.7	62.9	98.3	33.5	60.1	57.0	62.0	40.3	56.2	77.9	33.8	59.3	35.5	57.6	37.9	37.4	19.3	57.3	37.3	44.7	66.3	36.7	61.8	42.3	32.4	30.3	16.4	71.5	65.2	45.0	86.9	103.5	33.9	43.5	24.9	18.2	9.6	3.6	12.4	16.2	14.3	12.0	11.7	12.6	12.9	11.2	12.7	12.5	1.5	18.4	13.3	8.6	16.6	8.9	8.0	8.5	8.6	8.7	8.8	9.5	9.1	9.4	9.1	9.5	9.4	10.1	36.2	57.7	74.3	5.9	41.8	62.7	100.0	52.8	35.3	26.1	28.1	27.4	32.6	21.5	83.5	29.5	18.8	50.3	37.4	18.4	33.2	57.7	70.9	46.8	51.9	49.2	22.1	37.4	9.3	44.1	54.9	48.9	33.6	78.8	66.9	40.1	20.0	27.5	34.7	23.5	8.9	29.9	40.7	26.0	24.4	20.9	24.8	33.1	23.2	8.4	39.5	26.5	22.6	6.0	10.2	72.2	17.3	29.3	37.0	84.7	10.6	25.6	55.8	32.7	19.7	58.5	51.4	88.7	84.9	47.0	67.2	95.4	37.5	57.7	32.6	102.6
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990984-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.8;Spermatocytes: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	5.3	5.7	3.6	6.1	4.3	8.4	5.6	4.6	4.9	4.6	4.6	6.0	6.6	5.6	3.7	7.4	4.4	5.2	11.9	3.9	3.9	7.3	5.9	4.3	11.2	4.3	3.8	6.7	6.8	8.9	4.5	6.1	4.2	5.7	7.1	4.2	6.5	3.7	20.0	4.8	6.0	5.5	4.4	4.9	7.5	14.4	3.9	9.7	10.1	18.3	8.1	5.9	4.7	6.4	25.5	10.8	15.7	16.5	9.2	15.6	11.5	17.9	14.7	17.0	20.5	18.6	10.4	16.8	9.7	10.0	14.2	17.1	21.0	17.1	23.5	7.0	13.4	46.5	11.4	11.6	8.4	28.9	10.5	11.9	11.9	9.6	7.0	19.2	16.1	19.9	16.4	19.5	18.0	8.8	18.5	14.4	32.8	13.2	20.8	16.1	14.7	10.4	14.4	16.3	17.5	18.2	14.2	11.3	25.7	13.7	12.3	19.6	9.8	12.7	19.4	4.5	16.0	13.1	17.4	24.0	12.7	23.6	14.0	7.9	4.3	2.9	6.4	3.0	5.7	4.2	7.8	6.3	8.1	3.6	9.9	6.5	0.7	8.7	2.7	3.7	5.4	4.5	3.6	4.3	4.6	4.9	3.9	3.9	4.3	3.8	4.2	4.4	3.9	6.4	13.1	16.0	15.4	2.9	16.9	13.5	15.9	28.8	8.0	11.5	12.9	12.4	25.8	10.0	19.5	5.5	6.2	28.3	27.1	10.4	23.5	16.3	79.8	17.7	12.9	11.6	10.2	22.7	5.5	18.3	25.1	13.3	12.8	18.3	19.7	20.0	17.9	7.7	22.7	10.1	6.3	10.3	28.5	16.7	14.8	35.5	11.8	13.6	10.6	4.7	18.3	10.4	13.4	7.1	6.9	16.5	12.2	5.7	17.1	12.8	17.7	29.6	16.0	14.0	0.0	17.4	15.8	79.7	28.1	16.1	12.1	15.2	22.5	34.9	12.0	18.9
H1-10	"H1FX, H1X, MGC15959, MGC8350"	ENSG00000184897	"H1.10 linker histone"	Q92522	3	129314771-129316286	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1004.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 937.8"	"Low region specificity"	"Detected in all"							"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	121.4	54.7	39.9	42.6	43.9	1004.3	145.0	60.6	68.6	162.4	25.2	125.0	44.6	143.1	9.2	107.8	142.2	13.9	82.0	43.1	48.4	162.7	100.1	115.8	44.3	29.5	26.0	168.9	100.0	30.1	112.6	25.4	25.1	124.5	11.9	13.9	98.7	20.8	110.7	258.4	106.7	13.2	27.8	127.7	115.7	40.9	38.2	131.5	94.4	12.3	18.3	130.9	140.7	46.4	141.8	73.4	135.8	59.3	13.6	16.1	129.1	60.5	43.5	70.4	74.3	44.5	75.5	17.8	65.5	21.6	47.2	139.1	57.3	39.0	10.8	129.4	111.7	53.8	55.5	61.1	57.3	62.6	14.1	32.4	51.9	28.7	64.7	32.0	40.7	241.7	83.7	308.5	10.0	147.9	290.9	124.1	127.2	25.8	81.6	207.4	58.1	170.9	22.1	29.1	216.0	250.1	64.1	31.7	196.3	26.1	124.1	125.1	40.9	54.4	283.5	53.5	51.2	937.8	385.2	156.9	44.5	58.6	61.1	0.5	5.5	17.8	4.4	4.2	4.0	5.7	6.7	5.2	7.9	5.3	8.4	4.3	1.2	5.2	3.9	11.4	6.1	2.4	39.9	43.9	60.6	68.6	43.1	48.4	29.5	26.0	25.1	27.8	38.2	46.4	188.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	66.8	73.2	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	114.2	46.9	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	68.4	17.6	0.0	0.0	0.0
H3-3B	"H3.3B, H3F3B"	ENSG00000132475	"H3.3 histone B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 4220.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1321.3;Cytotrophoblasts: 1625.3;dendritic cells: 844.9;Extravillous trophoblasts: 1626.9;Hofbauer cells: 1908.9;Syncytiotrophoblasts: 3503.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 21089.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 21089.7"	"Low cell line specificity"	"Detected in all"											"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	607.2	369.9	223.8	532.5	262.6	4220.9	628.9	264.4	288.8	741.2	186.6	415.4	329.9	507.4	180.3	798.6	585.7	467.9	312.8	210.7	226.0	438.3	380.2	553.2	509.1	268.7	241.9	1166.0	578.0	341.1	357.5	427.1	242.8	348.2	223.1	299.8	519.2	237.1	332.5	1153.2	407.5	322.9	253.7	449.9	393.0	654.3	246.0	464.0	500.7	155.6	296.2	545.3	675.2	316.1	1386.5	1194.2	490.0	486.1	273.3	424.9	675.1	636.7	557.1	764.8	609.3	1290.7	952.6	683.6	593.1	373.2	539.5	530.0	390.5	881.0	432.0	375.9	883.0	612.8	668.2	1112.0	615.7	1029.2	755.0	467.3	534.2	785.6	1004.7	339.3	582.5	437.8	885.6	1193.0	399.4	2015.3	1492.3	859.5	394.8	442.8	1322.8	1091.7	894.2	746.6	607.3	803.5	988.1	1096.0	645.8	933.7	1402.2	259.3	734.2	1091.3	549.1	1359.7	1205.2	595.2	1721.1	1431.3	932.2	843.5	720.5	967.6	761.1	7991.0	3667.6	10060.5	2613.4	3365.8	2482.2	3199.5	2474.2	2478.9	3218.1	2813.7	2635.4	2173.4	21089.7	3240.7	3199.0	3294.6	2999.0	9615.0	223.8	262.6	264.4	288.8	210.7	226.0	268.7	241.9	242.8	253.7	246.0	316.1	1321.3	0.0	0.0	0.0	294.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	398.6	0.0	0.0	0.0	0.0	1625.3	844.9	0.0	0.0	0.0	0.0	0.0	0.0	172.3	0.0	0.0	0.0	0.0	1626.9	485.1	0.0	0.0	0.0	0.0	0.0	0.0	1908.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	257.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	314.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	377.9	0.0	0.0	0.0	0.0	3503.3	211.7	0.0	0.0	0.0
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578349	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	23.1	84.1	56.1	18.5	57.1	17.3	74.4	64.6	67.5	40.2	73.2	30.0	28.9	29.9	43.0	19.2	32.4	34.1	11.8	54.3	87.8	79.6	119.1	30.3	18.8	68.3	79.6	47.8	29.8	61.5	44.2	37.2	87.2	41.6	34.3	54.0	28.6	34.3	6.9	27.7	29.2	28.1	70.0	21.2	68.7	34.6	88.3	29.0	70.8	7.8	20.3	43.0	17.8	75.8	88.9	194.4	211.3	106.2	130.3	78.0	99.8	95.9	82.4	106.6	119.6	149.9	129.1	110.8	81.8	104.7	132.6	237.9	344.4	80.1	94.8	61.9	191.8	88.1	88.7	165.3	65.9	110.6	64.9	80.3	58.7	73.3	52.5	102.7	105.5	65.1	117.5	40.8	174.3	105.6	82.5	86.0	180.6	235.3	65.4	91.8	178.9	125.0	152.1	151.2	126.8	111.9	103.6	114.9	110.5	197.5	117.1	57.9	84.2	134.4	117.6	66.9	134.9	79.1	251.2	154.5	89.7	105.8	82.6	8.5	7.5	2.5	31.7	11.2	36.1	23.7	28.6	30.2	13.2	22.2	33.0	32.9	1.0	23.2	12.7	17.4	24.6	22.7	56.1	57.1	64.6	67.5	54.3	87.8	68.3	79.6	87.2	70.0	88.3	75.8	63.6	64.1	64.8	84.5	18.7	0.0	60.5	0.0	76.2	121.3	94.8	64.5	9.9	62.9	27.9	176.6	100.1	189.1	23.8	6.1	25.4	71.3	107.2	62.8	76.2	51.8	43.7	67.3	57.5	46.3	124.4	62.7	73.4	39.8	16.4	127.0	42.1	165.2	51.2	139.7	97.1	26.3	0.0	23.1	0.0	32.5	87.3	22.2	0.0	29.0	5.2	89.8	16.5	57.8	66.7	32.1	18.2	88.4	28.9	71.5	28.3	56.2	36.5	83.7	78.9	40.9	41.9	156.9	110.3	54.3	0.0	113.1	22.3	136.2	45.1	78.7
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 502.5"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 527.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		470000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	105.0	125.3	57.7	31.1	60.7	46.3	94.9	65.0	69.6	72.6	59.1	108.4	115.0	61.8	30.7	90.1	60.1	32.4	330.2	52.8	61.9	99.0	156.7	66.9	35.3	64.4	62.2	77.8	101.4	95.0	57.4	39.2	64.2	60.2	76.1	14.9	77.9	33.4	502.5	95.7	106.2	57.4	61.8	68.4	93.8	49.0	62.4	46.7	59.5	300.7	58.5	79.1	73.6	67.2	105.7	88.1	58.4	90.8	221.1	139.9	51.5	80.6	84.7	78.5	67.7	114.7	104.1	71.7	50.2	138.4	78.6	66.8	103.4	152.6	72.5	139.1	103.6	103.3	86.2	197.9	73.3	132.2	69.2	142.7	101.6	112.4	109.3	82.8	127.7	70.4	140.2	133.2	101.1	128.2	63.4	137.7	50.1	77.5	134.1	52.9	128.5	143.7	90.3	125.3	41.9	85.1	94.6	104.6	102.4	44.5	52.2	125.8	127.1	48.8	70.7	69.9	58.0	44.8	86.5	113.4	77.6	150.2	56.2	22.5	84.0	33.5	31.8	92.3	39.1	40.5	36.8	38.7	80.8	31.2	42.6	40.1	20.9	38.8	86.1	31.3	50.9	89.9	57.7	60.7	65.0	69.6	52.8	61.9	64.4	62.2	64.2	61.8	62.4	67.2	122.4	89.8	99.0	47.0	101.2	89.0	137.5	139.9	97.3	35.6	89.7	96.4	349.9	82.9	128.0	77.3	52.1	182.0	95.1	242.1	131.0	120.8	39.2	73.3	121.1	99.1	91.4	155.9	22.8	108.5	94.7	96.1	100.4	85.5	139.9	140.3	84.3	185.1	163.0	20.2	28.2	156.5	89.5	136.8	106.0	74.3	92.6	145.0	81.8	12.2	170.7	65.4	93.7	30.7	37.4	90.0	195.6	84.2	90.4	76.2	527.4	182.5	84.8	62.3	52.6	129.9	109.6	147.9	54.9	136.5	103.3	129.2	100.5	154.7	216.7	104.4
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 70.9;Late spermatids: 73.0;Spermatocytes: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: AB_2679332"	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	2.0	2.6	2.6	2.4	4.5	5.6	2.4	3.3	4.2	2.3	2.3	3.0	2.6	1.7	3.4	2.3	2.1	2.0	2.5	2.7	3.1	2.9	3.3	2.2	3.4	3.5	3.5	1.4	2.4	2.2	2.5	2.8	3.6	2.2	3.4	2.7	2.8	1.9	2.6	3.2	2.8	3.0	2.8	2.4	4.0	12.1	4.0	4.2	2.7	2.0	3.4	2.6	1.5	7.3	3.3	5.3	4.3	4.1	8.4	5.1	5.1	4.7	4.5	6.3	8.0	3.7	3.7	5.8	2.9	3.9	7.1	6.3	4.6	4.1	5.9	6.7	5.5	5.9	3.9	4.2	9.8	5.5	7.6	6.5	10.7	4.2	8.2	2.4	4.0	6.2	9.4	7.0	5.3	7.1	6.8	2.3	11.8	10.8	6.4	4.5	6.1	10.3	4.8	3.9	4.1	3.4	5.6	5.9	6.8	5.7	9.9	4.7	3.8	6.3	4.9	8.4	4.3	6.6	7.7	6.3	4.8	3.2	6.6	21.9	7.6	10.9	9.6	10.3	6.7	4.7	7.6	7.0	6.4	6.6	7.2	8.0	11.2	6.9	9.8	8.3	10.2	4.4	2.6	4.5	3.3	4.2	2.7	3.1	3.5	3.5	3.6	2.8	4.0	7.3	1.0	0.0	1.3	1.3	2.2	1.0	2.7	4.0	1.8	3.5	2.5	1.8	2.3	1.5	4.4	0.0	2.1	4.9	1.5	2.1	5.9	4.1	70.9	4.7	2.2	1.4	1.2	13.5	1.5	2.2	3.4	1.7	2.0	4.7	0.0	1.6	1.8	2.8	3.3	3.3	1.5	2.2	8.2	3.3	0.8	73.0	3.1	1.7	1.8	0.0	4.2	2.9	1.0	0.5	4.6	3.0	0.8	1.9	3.4	1.6	3.4	3.5	6.1	3.7	0.0	2.1	2.0	25.2	13.5	1.7	2.7	9.3	2.2	2.2	1.7	2.3
HARS1	"HARS, HisRS, USH3B"	ENSG00000170445	"Histidyl-tRNA synthetase 1"	P12081	5	140673035-140691537	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 41.4;dendritic cells: 11.5;Extravillous trophoblasts: 48.6;Hofbauer cells: 35.7;Syncytiotrophoblasts: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		190000	"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	31.6	39.9	64.8	27.1	67.0	24.3	29.3	64.9	88.7	32.9	57.9	39.2	21.8	34.5	27.1	42.9	30.8	21.0	38.3	67.8	72.2	30.7	47.3	27.2	29.6	71.2	69.9	31.3	40.8	37.1	60.0	18.5	72.8	33.0	29.6	18.5	29.2	32.0	56.7	53.9	28.6	35.2	62.1	32.2	36.0	25.6	77.4	32.2	27.1	33.4	36.8	34.3	32.0	71.9	66.8	94.3	55.5	120.5	68.9	74.9	57.9	104.8	75.0	118.6	109.4	174.8	54.1	88.4	90.3	118.3	94.3	66.6	85.9	169.2	111.6	74.5	105.0	63.7	115.4	111.8	86.3	101.1	49.8	80.4	51.5	129.0	72.6	69.5	122.1	52.2	56.5	68.6	125.6	111.0	71.8	100.6	43.3	52.3	60.9	65.4	82.0	70.9	97.0	82.2	86.5	83.7	86.1	121.5	84.2	54.9	89.5	55.5	100.3	107.8	41.6	61.5	144.7	68.5	90.5	89.4	82.8	83.1	76.1	16.2	31.2	24.0	61.0	46.3	54.2	34.9	54.1	57.6	48.5	34.6	58.1	55.4	8.1	59.3	54.9	34.3	51.3	56.7	64.8	67.0	64.9	88.7	67.8	72.2	71.2	69.9	72.8	62.1	77.4	71.9	9.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	41.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	48.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	36.0	1.7	0.0	0.0	0.0
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202522	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	58.4	49.8	13.2	15.0	18.3	49.0	52.4	17.1	14.8	50.1	15.2	45.9	16.3	53.1	20.0	54.4	40.0	19.9	39.8	13.0	14.7	26.7	37.8	40.1	17.3	19.2	16.1	51.1	34.9	29.0	24.2	24.6	19.2	35.4	17.8	16.5	46.6	22.5	86.4	70.9	34.9	22.1	15.0	34.0	38.0	57.1	14.9	23.6	36.8	39.6	19.9	43.4	51.5	25.7	9.0	10.1	18.8	12.2	38.7	36.1	8.8	15.6	35.1	11.2	19.6	3.6	23.5	8.7	20.4	21.8	23.3	11.4	7.7	9.7	13.9	6.5	7.0	6.0	16.7	6.9	22.1	4.3	17.3	42.3	28.3	10.9	13.3	37.7	37.0	8.8	11.3	21.2	14.5	14.8	7.3	13.6	11.8	12.8	11.5	6.9	13.8	22.4	19.9	11.1	7.3	22.0	18.4	26.7	25.9	25.9	8.3	13.2	35.8	14.7	11.4	22.7	4.7	24.6	31.9	9.0	14.4	9.2	15.3	142.1	59.5	80.0	37.5	61.7	35.8	35.6	39.5	36.5	40.3	34.6	45.2	38.5	146.2	53.8	64.1	20.5	55.6	91.8	13.2	18.3	17.1	14.8	13.0	14.7	19.2	16.1	19.2	15.0	14.9	25.7	67.9	22.4	39.7	37.2	72.9	108.2	77.6	56.2	91.6	29.7	83.1	54.7	22.1	31.5	51.6	33.1	8.4	46.1	95.5	56.1	45.0	50.5	175.9	56.8	45.8	51.8	54.2	59.5	32.6	32.3	26.1	76.8	50.4	93.3	50.7	25.7	35.3	36.8	28.9	42.1	35.2	41.3	85.5	49.8	81.8	332.7	54.0	67.8	74.7	49.6	46.3	33.4	37.0	40.2	91.4	33.7	46.6	57.9	70.2	82.8	55.1	45.3	37.6	29.2	46.0	91.4	70.0	53.0	38.0	55.3	133.0	210.4	94.8	42.6	28.1	89.9
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123086	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	13.9	16.1	6.2	13.7	6.7	20.5	12.6	7.0	8.4	8.4	8.4	21.6	23.1	9.6	7.6	19.3	8.5	10.8	39.0	7.4	6.8	17.6	22.9	11.5	15.6	6.7	6.2	8.3	9.9	25.1	8.3	13.1	6.4	9.5	21.6	13.5	15.2	10.0	64.4	17.6	20.2	12.5	6.2	14.5	15.3	10.2	6.7	13.0	10.8	57.0	17.1	22.3	11.6	6.1	54.3	60.5	31.8	28.5	25.6	25.2	29.2	52.0	43.0	67.8	57.5	70.7	38.5	34.3	26.3	46.1	80.8	49.8	63.2	51.8	70.5	30.8	48.0	34.1	80.8	38.6	47.3	40.9	39.4	24.2	37.4	67.9	46.5	37.9	49.1	26.1	63.1	41.1	46.3	72.5	28.0	31.4	51.5	36.6	70.1	27.3	59.9	65.4	44.0	44.8	20.9	24.2	54.8	58.7	38.2	66.7	45.6	27.1	48.7	42.4	23.6	110.4	47.0	26.9	29.0	47.8	35.5	28.8	42.7	25.6	47.8	30.1	20.2	66.4	19.0	39.0	19.6	18.2	62.2	34.7	17.1	22.1	13.1	19.1	57.4	56.2	23.5	19.0	6.2	6.7	7.0	8.4	7.4	6.8	6.7	6.2	6.4	6.2	6.7	6.1	15.5	6.4	4.8	2.3	20.8	54.8	53.2	57.0	22.8	5.3	16.1	13.7	49.3	17.2	33.3	16.5	0.0	32.9	12.4	44.6	50.9	34.9	13.7	19.0	10.4	21.0	10.8	32.8	3.8	29.3	37.9	17.1	12.8	16.7	13.3	10.4	15.7	18.5	41.8	8.4	4.5	19.2	67.1	21.0	44.1	2.3	13.4	23.5	24.9	1.9	27.9	13.0	7.2	2.0	2.7	68.4	31.9	10.5	18.4	63.5	46.4	36.0	28.9	7.1	6.6	12.5	20.1	24.4	28.4	21.8	46.0	40.9	12.0	15.6	30.2	88.6
HDAC1	"GON-10, HD1, KDAC1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292083-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	31.4	42.8	20.8	76.7	22.1	59.3	56.0	21.9	28.0	56.6	20.3	119.5	74.5	48.1	51.4	81.3	56.8	55.4	29.0	20.4	21.9	47.9	41.7	41.2	119.7	23.3	21.8	65.7	40.0	62.3	31.6	53.0	23.1	57.6	108.3	18.9	52.1	57.2	15.3	38.0	80.8	46.8	21.8	61.7	84.1	36.2	22.0	103.9	78.4	17.5	123.9	63.7	51.7	23.4	152.5	90.6	57.4	114.7	32.9	39.0	118.7	105.1	117.1	138.0	126.6	168.0	266.3	233.4	190.3	116.9	140.2	173.1	178.1	143.1	151.5	219.3	176.8	161.3	105.7	130.1	77.4	288.1	223.4	70.7	77.0	107.1	70.3	107.7	106.1	298.5	215.2	90.1	61.6	115.7	331.6	161.4	133.2	180.2	229.6	225.0	136.0	104.0	149.5	216.1	44.7	56.6	176.0	117.0	227.9	224.0	137.9	220.6	123.8	91.3	106.2	28.5	261.1	54.4	124.9	319.2	75.3	235.8	121.4	147.5	87.7	200.1	130.0	115.9	107.5	151.6	126.2	140.6	103.0	142.0	143.7	133.6	63.7	144.2	156.4	64.9	142.0	204.6	20.8	22.1	21.9	28.0	20.4	21.9	23.3	21.8	23.1	21.8	22.0	23.4	45.3	25.6	45.4	25.5	82.7	24.9	57.4	99.1	38.7	15.1	35.1	29.1	22.1	61.5	73.4	68.0	16.7	93.1	64.0	142.4	95.9	75.7	20.2	33.7	39.8	56.2	86.3	60.8	1.9	73.6	110.9	25.8	65.2	39.5	30.4	23.6	63.5	28.1	43.6	11.8	8.8	122.8	52.9	38.2	19.0	8.7	41.0	35.0	28.4	16.9	52.7	34.2	69.0	14.6	19.4	92.5	141.5	44.4	38.4	28.5	57.0	30.0	67.3	14.6	59.2	22.8	38.1	72.5	69.8	60.2	25.4	93.4	73.6	102.6	136.0	55.8
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742109-156766925	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm	"Secreted to blood"	NA	NA		790000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	96.3	89.7	95.9	72.8	98.8	305.3	90.6	98.4	113.4	91.4	98.0	109.2	130.2	77.6	70.0	186.3	112.8	62.5	119.0	92.8	95.1	135.4	222.3	113.5	64.6	106.3	99.7	86.8	93.2	92.8	67.8	71.8	98.8	81.7	118.1	68.9	96.6	56.8	234.9	155.3	128.4	70.5	100.8	77.2	99.1	42.6	99.6	157.2	90.7	132.5	114.9	106.7	102.7	105.7	491.5	249.1	258.2	125.6	150.0	203.0	296.8	158.4	406.3	366.8	234.4	279.4	500.9	335.5	310.6	325.0	158.6	338.8	408.9	365.0	356.0	276.1	299.9	278.1	339.4	241.2	202.0	411.9	227.4	152.4	335.7	292.8	560.4	278.6	272.4	249.6	387.0	260.4	293.7	369.3	345.5	459.2	472.1	755.4	347.7	384.8	156.9	435.1	401.0	162.6	396.9	432.0	380.4	480.3	199.3	319.8	387.6	621.9	242.4	181.1	286.5	230.3	408.9	364.0	486.0	555.6	238.9	318.4	235.2	6.2	9.9	9.2	6.6	8.8	4.9	5.6	5.6	5.9	11.6	6.6	5.0	4.7	5.6	5.2	10.0	11.9	8.2	6.8	95.9	98.8	98.4	113.4	92.8	95.1	106.3	99.7	98.8	100.8	99.6	105.7	51.9	70.5	99.2	12.1	35.3	147.3	185.1	90.5	76.2	66.7	89.9	66.0	91.0	98.7	75.3	71.7	27.1	44.1	72.4	121.4	80.3	112.2	48.4	144.0	79.2	66.1	124.6	217.8	12.0	132.0	107.3	66.7	62.7	91.8	30.4	67.4	35.0	164.5	52.7	53.8	12.4	104.3	48.8	45.6	89.1	47.0	40.7	71.0	39.2	14.0	57.3	71.4	25.7	5.5	16.1	165.7	59.5	45.9	59.0	281.3	138.2	118.1	126.8	34.9	19.7	70.9	57.8	27.7	28.3	108.6	159.4	54.9	50.5	83.2	114.9	228.6
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472297-4502208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 37.0;Endometrial stromal cells: 31.0;Extravillous trophoblasts: 30.1;Granulosa cells: 44.7;Theca cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	27.2	29.0	24.8	16.5	25.5	14.4	28.1	24.2	32.3	42.9	17.8	40.4	15.7	39.3	9.6	29.4	35.6	10.0	32.0	27.4	20.5	31.2	31.3	25.4	17.7	22.9	22.2	49.5	26.9	12.5	38.3	15.0	22.0	36.4	7.6	10.8	26.0	18.6	67.8	29.3	27.0	12.6	19.7	33.4	28.1	74.6	22.2	18.6	29.3	19.1	11.8	34.2	34.8	24.6	71.6	41.2	70.1	65.5	29.9	30.3	49.0	56.2	30.1	60.4	53.3	47.5	30.4	62.6	32.1	41.6	31.8	40.2	46.9	51.1	35.2	70.4	74.7	38.6	32.4	63.5	38.5	38.3	52.8	43.5	27.4	41.6	20.2	42.8	55.9	57.8	45.1	76.3	29.6	50.6	86.9	76.4	80.2	28.5	73.3	85.4	57.6	40.6	38.0	35.8	77.0	76.1	54.7	31.0	47.2	38.1	30.6	60.2	74.8	38.0	51.7	72.3	54.1	94.1	52.9	43.6	53.2	60.8	41.1	0.0	0.9	1.7	0.6	0.6	0.1	0.5	0.7	0.5	0.7	5.6	1.1	0.4	0.2	1.3	0.3	1.0	1.0	0.5	24.8	25.5	24.2	32.3	27.4	20.5	22.9	22.2	22.0	19.7	22.2	24.6	25.5	6.4	5.4	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.3	15.2	0.0	0.0	5.0	12.9	0.0	37.0	14.3	0.0	19.6	26.4	0.0	26.9	31.0	9.8	0.0	0.0	0.0	19.8	30.1	13.9	0.0	19.8	1.3	44.7	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	23.6	9.5	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	15.2	7.1	42.7	0.0	0.0
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	12.2	156.4	16.8	11.1	18.0	8.4	19.5	16.2	19.3	19.9	14.5	59.7	82.9	13.4	14.9	42.1	16.5	17.8	22.4	15.8	17.7	56.3	122.8	10.2	10.2	15.7	17.0	19.9	53.0	68.4	23.1	5.0	16.2	30.4	35.9	8.0	52.2	16.1	8.8	28.3	68.5	7.7	15.7	17.6	50.1	7.0	18.5	6.7	38.7	5.7	7.6	17.6	21.1	15.5	7.4	20.8	4.4	12.3	10.7	4.7	37.0	5.4	10.1	8.6	9.3	38.3	36.1	16.2	6.6	3.0	17.0	28.3	7.0	8.3	2.9	22.9	16.1	22.4	12.5	24.1	12.5	1.4	16.6	7.4	17.4	7.0	19.7	9.9	4.5	14.9	18.0	4.0	4.1	48.3	10.4	6.5	9.9	73.7	16.1	8.5	0.0	13.2	11.0	15.4	11.1	7.0	9.3	39.4	14.0	9.5	24.8	4.7	4.5	1.7	0.1	1.4	1.9	9.7	20.2	6.8	2.1	0.1	1.3	0.2	3.7	8.2	12.4	2.1	14.0	14.8	14.2	11.5	6.1	16.6	14.5	11.1	2.4	8.2	0.2	14.1	17.1	8.5	16.8	18.0	16.2	19.3	15.8	17.7	15.7	17.0	16.2	15.7	18.5	15.5	4.1	9.6	10.1	24.5	19.7	9.9	20.6	26.6	10.8	10.3	38.6	31.2	15.8	80.1	32.6	23.9	10.4	29.4	11.7	214.0	86.1	84.8	0.2	20.9	6.4	9.4	40.3	15.4	9.2	156.4	16.5	8.6	112.7	22.3	7.6	122.4	9.7	85.4	20.6	1.7	10.4	80.4	28.5	6.5	3.7	2.0	14.3	6.9	10.6	6.5	13.7	12.1	15.5	5.5	4.9	104.8	208.6	9.1	9.3	23.7	254.0	275.1	33.3	13.8	6.6	5.5	11.1	0.3	6.0	42.9	14.6	31.6	14.0	26.0	94.6	51.4
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604516	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		470000	"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	8.5	5.6	3.3	11.1	4.1	12.7	9.8	4.6	4.0	6.8	3.3	6.2	5.6	8.7	6.5	7.3	7.0	5.5	4.4	3.5	3.7	5.4	5.5	5.2	12.9	3.7	3.3	9.4	8.7	7.9	3.4	7.7	3.8	6.2	7.5	4.8	6.2	6.4	6.6	10.4	6.2	8.0	3.7	8.5	6.2	14.4	4.2	10.1	7.9	5.7	13.5	10.8	6.7	6.5	35.2	41.4	21.2	32.3	29.1	32.5	47.4	27.7	17.8	31.2	27.7	41.8	29.0	57.3	30.4	25.8	19.3	41.5	48.7	29.7	42.0	29.0	56.0	40.7	28.3	36.1	26.1	73.5	25.2	26.7	26.2	47.2	40.5	14.9	36.3	25.9	93.8	18.8	31.5	18.8	35.1	20.1	84.9	44.8	16.9	38.6	30.6	53.8	19.9	34.9	19.9	44.1	33.5	23.7	28.3	14.1	28.2	27.2	34.7	31.2	29.5	40.6	69.4	35.4	47.2	65.5	27.8	40.2	47.4	1.6	3.3	1.0	6.0	4.2	5.6	9.1	5.9	6.6	4.0	6.5	8.1	7.8	0.4	5.7	4.2	5.2	5.3	2.3	3.3	4.1	4.6	4.0	3.5	3.7	3.7	3.3	3.8	3.7	4.2	6.5	13.3	3.2	12.8	19.6	21.8	19.8	16.3	8.3	26.2	12.4	9.8	7.6	4.2	7.2	11.7	5.5	18.8	8.1	15.0	3.6	3.9	8.9	10.5	8.4	26.3	12.4	4.2	12.6	35.1	8.5	10.8	15.2	8.6	11.3	32.9	23.4	10.4	9.7	7.5	6.7	30.4	6.2	4.1	11.3	7.5	2.7	14.0	11.7	1.8	26.2	9.6	3.0	9.2	36.2	34.1	12.0	4.3	10.1	19.0	15.7	3.3	5.6	11.5	9.6	0.0	19.4	11.8	29.3	30.1	19.3	16.9	4.9	18.1	15.6	11.1	12.0
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065970-50107272	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	7.1	8.2	3.8	9.0	3.7	5.6	5.3	4.6	4.2	5.1	4.3	7.0	4.9	5.0	4.5	8.0	4.8	4.2	6.4	3.7	3.6	6.7	10.2	6.3	6.6	4.2	3.2	3.3	8.0	4.8	6.5	5.8	3.4	4.9	6.3	4.8	6.0	3.4	12.0	6.3	7.0	5.3	3.2	12.6	6.6	5.8	3.8	4.6	3.7	6.2	6.2	5.1	5.1	3.9	13.0	12.8	11.8	18.6	7.0	9.6	12.6	15.5	10.1	15.0	6.0	15.9	9.4	24.4	10.9	14.7	5.6	15.1	14.1	11.3	17.2	6.1	15.4	12.1	9.0	20.4	10.2	21.1	23.5	7.5	7.8	10.4	6.2	6.6	12.2	12.6	15.5	3.9	14.9	7.8	16.2	26.4	13.8	15.5	13.1	17.6	15.8	19.8	8.4	10.4	15.1	8.0	14.8	18.9	10.0	8.8	8.5	15.4	16.1	12.0	8.0	9.1	11.8	9.8	8.0	21.3	11.7	20.9	12.0	0.5	2.4	0.5	0.9	2.8	1.0	0.6	0.5	1.0	1.7	0.8	0.8	0.9	0.5	0.7	2.6	1.5	0.9	1.0	3.8	3.7	4.6	4.2	3.7	3.6	4.2	3.2	3.4	3.2	3.8	3.9	4.2	3.2	5.8	7.8	4.6	3.2	1.4	1.5	3.4	7.8	3.1	2.0	6.0	2.8	1.8	1.8	16.7	3.5	7.1	3.3	7.9	2.4	10.7	3.7	6.8	4.6	3.5	3.8	21.2	3.1	3.6	4.7	7.7	3.8	1.3	6.5	1.8	9.6	9.4	1.7	16.7	3.2	4.1	22.2	4.7	18.3	3.4	13.9	1.8	7.5	13.3	2.4	3.1	20.1	12.8	2.9	2.5	2.2	7.2	1.9	4.7	4.1	2.8	8.1	0.0	2.5	4.2	5.3	4.8	7.6	1.7	1.0	5.8	6.7	5.8	1.5
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 218.4"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 302.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	43.0	48.6	27.8	23.1	33.6	54.0	37.6	58.6	33.7	43.5	34.0	38.3	25.1	37.0	30.7	74.6	33.8	26.7	47.2	27.2	30.9	37.0	74.3	32.9	28.7	30.2	30.1	38.5	34.7	56.5	34.4	35.5	32.5	30.7	31.2	66.9	42.6	31.0	218.4	50.8	33.6	30.8	28.0	30.4	43.7	42.7	31.3	26.3	51.3	133.6	37.3	39.8	51.5	36.6	95.1	54.6	49.2	30.4	144.0	77.2	44.7	54.8	54.1	47.4	39.7	41.0	47.8	72.1	57.8	97.3	34.0	62.6	63.2	47.7	69.6	44.5	24.9	75.6	44.3	163.9	66.9	81.8	52.7	66.3	64.4	52.2	80.9	63.6	87.5	42.2	54.4	32.1	72.8	72.4	31.8	31.7	36.0	76.6	47.5	53.6	58.0	30.4	71.3	93.2	36.2	40.8	79.8	54.5	49.0	56.3	58.7	49.5	93.4	56.6	42.9	41.9	49.0	34.3	52.9	79.0	28.0	37.3	49.7	9.1	5.7	8.3	4.5	4.8	5.2	4.8	5.2	4.1	6.4	6.3	4.2	4.3	3.0	6.3	3.8	5.3	5.6	2.4	27.8	33.6	58.6	33.7	27.2	30.9	30.2	30.1	32.5	28.0	31.3	36.6	63.4	48.1	80.8	84.5	60.7	86.7	93.5	61.2	48.3	98.9	40.8	28.6	108.1	25.8	94.8	71.7	98.0	70.2	72.1	40.9	11.7	44.2	3.6	101.6	83.0	60.0	48.7	41.2	89.9	36.1	42.9	59.9	96.8	118.1	32.9	81.6	46.4	84.7	29.0	65.6	101.1	33.0	63.1	43.9	34.5	8.7	69.0	54.0	33.8	90.9	65.1	40.9	78.2	100.0	127.9	52.6	33.9	74.4	71.1	106.3	37.1	22.4	148.4	194.5	46.0	77.4	78.9	50.6	100.0	83.7	114.9	140.0	61.4	97.0	44.5	302.9
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 246.7"	"Group enriched"	"Detected in some"	27	"Early spermatids: 1329.5;Erythroid cells: 1206.7;Late spermatids: 1439.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.1"	"Group enriched"	"Detected in many"	28	"granulocytes: 2.2;NK-cells: 2.0;T-cells: 5.1"	"Cell line enriched"	"Detected in some"	5	"K-562: 290.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.1	0.0	0.1	0.8	0.1	246.7	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.9	1.5	0.4	0.0	0.0	0.2	0.0	0.1	5.9	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.1	0.0	0.0	3.2	0.2	50.5	0.1	12.6	0.2	0.1	1.5	0.1	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	64.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.2	290.9	0.3	0.0	0.0	7.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.2	0.0	1.5	0.5	1.8	0.0	0.0	0.1	2.2	0.1	0.0	0.2	0.0	0.5	0.0	1.5	0.7	0.1	0.0	5.1	2.1	0.6	2.0	0.0	0.0	0.9	2.7	0.1	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.2	0.4	0.1	0.0	0.0	1329.5	0.2	0.0	0.5	0.0	1206.7	0.4	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.7	0.7	1.0	0.0	0.2	0.0	0.0	1.6	0.0	1439.7	5.9	47.4	1.8	0.0	2.1	0.0	4.1	0.0	0.1	0.0	0.0	4.1	0.5	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.1	10.0	4.4	0.0	0.0	0.5	2.3	0.0	0.0	0.0
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"HEXIM P-TEFb complex subunit 1"	O94992	17	45148475-45152099	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	16.8	32.6	16.3	13.2	15.4	36.3	17.0	16.2	16.5	17.2	16.5	22.5	17.7	19.6	15.9	24.2	21.3	14.3	15.0	14.8	16.8	21.1	26.8	17.3	12.8	17.0	19.1	14.4	19.7	14.1	19.2	25.2	16.0	24.2	10.2	9.0	19.2	19.8	33.2	22.6	24.9	13.0	17.7	25.6	23.1	21.6	19.7	15.4	20.1	21.6	12.4	19.7	17.6	14.2	35.7	111.1	22.8	33.0	36.7	19.6	55.3	30.9	27.8	25.0	27.8	52.6	49.3	15.5	93.1	32.7	12.1	28.2	13.8	30.4	20.0	32.2	32.9	48.2	65.8	65.0	32.0	30.3	61.4	23.0	25.5	18.6	8.1	62.6	12.7	26.8	21.5	36.6	19.0	47.8	31.9	34.9	20.9	32.9	33.4	13.1	19.9	19.2	66.5	62.1	12.2	9.2	46.6	52.0	52.2	23.0	54.2	23.5	24.3	25.1	34.6	14.6	58.5	33.1	11.4	10.0	23.0	28.1	29.1	16.2	4.0	6.8	4.2	6.1	2.4	3.0	4.2	3.7	3.3	3.2	3.7	3.9	10.0	3.7	7.3	3.4	3.8	2.2	16.3	15.4	16.2	16.5	14.8	16.8	17.0	19.1	16.0	17.7	19.7	14.2	210.3	73.7	111.8	7.2	76.1	84.5	75.0	57.7	157.1	25.1	127.0	215.9	59.7	87.2	60.5	25.8	22.9	134.8	114.3	250.4	7.9	35.0	2.2	88.8	66.1	91.3	52.8	82.1	10.7	23.6	70.1	99.2	94.3	137.9	125.9	16.5	42.5	40.5	42.1	15.2	12.9	122.0	54.9	33.9	83.2	3.0	35.1	83.0	53.4	9.4	38.4	27.7	28.8	7.1	8.2	25.3	127.1	43.6	44.1	52.1	184.9	53.8	45.7	24.8	26.3	249.2	128.2	2.6	7.9	126.7	71.5	467.5	111.1	16.9	92.2	34.4
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol		NA	NA		45000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	73.3	95.6	101.5	24.8	102.2	54.5	69.7	98.9	127.1	81.4	98.2	75.7	29.3	66.7	32.7	118.8	70.2	27.0	82.1	103.3	99.3	100.8	85.7	80.1	30.6	105.9	103.2	74.4	85.1	28.1	81.7	24.8	104.3	86.3	25.3	15.7	72.4	29.6	93.7	95.2	81.2	28.5	98.1	100.6	84.6	105.9	102.7	35.3	68.5	18.5	24.8	81.1	83.9	104.1	104.2	93.1	47.8	66.6	56.0	59.8	57.3	65.5	86.6	99.6	76.8	72.6	65.0	23.4	47.2	106.4	88.6	63.2	43.7	100.6	45.8	19.7	76.0	58.8	98.8	117.5	92.8	47.1	55.4	78.1	100.9	93.9	121.9	82.7	120.9	44.5	54.8	30.4	92.1	77.9	58.1	71.4	43.8	75.9	88.9	51.3	48.6	41.0	94.5	87.7	54.9	86.1	54.6	114.9	78.3	48.3	82.3	98.6	87.3	119.5	82.4	69.6	123.3	41.6	17.6	21.8	96.9	53.3	89.4	48.8	28.7	38.9	24.5	32.3	16.6	16.4	18.5	19.4	23.5	15.8	14.1	16.0	44.7	27.1	33.6	19.3	22.3	35.9	101.5	102.2	98.9	127.1	103.3	99.3	105.9	103.2	104.3	98.1	102.7	104.1	20.8	25.6	28.7	17.6	22.0	27.9	23.8	27.7	29.6	30.6	27.0	25.9	3.1	17.2	27.6	22.0	35.5	34.0	27.4	60.9	1.9	43.3	72.3	45.6	28.7	26.3	11.4	23.4	14.2	42.6	36.5	21.8	68.8	66.1	23.4	26.3	16.1	20.7	29.5	23.5	12.6	32.4	22.4	22.9	26.6	137.8	28.9	30.3	23.2	15.9	28.1	20.6	25.7	6.6	16.1	68.2	42.7	23.0	27.6	53.9	41.1	14.6	32.3	35.5	13.1	17.8	24.0	36.9	32.5	37.0	30.3	50.2	23.5	22.1	36.2	50.8
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 subunit alpha"	Q16665	14	61695513-61748259	"Cancer-related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 448.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 155.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 155.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 941.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	64.9	133.7	22.1	146.6	24.0	448.3	36.2	28.2	26.1	132.9	24.7	42.8	33.6	52.4	74.8	62.1	41.1	145.4	36.5	21.1	28.4	104.2	51.6	75.7	71.4	29.7	29.7	35.3	36.0	91.7	30.7	77.6	33.3	46.9	41.7	35.5	45.3	67.2	12.1	34.2	37.3	59.1	27.2	72.4	37.6	32.4	38.5	55.8	49.5	17.6	88.2	169.9	43.1	26.5	313.6	123.6	112.7	344.7	185.2	297.1	161.5	253.8	270.1	288.7	258.9	54.1	100.3	75.8	186.2	293.0	73.6	71.8	71.0	416.1	352.5	33.7	41.0	46.5	105.3	93.1	414.8	20.1	49.3	523.4	129.2	216.5	225.6	408.6	198.1	44.4	32.3	0.4	941.4	65.6	59.2	24.3	108.9	49.6	159.7	4.3	269.1	22.8	400.2	204.3	100.3	111.9	472.5	67.0	170.7	148.9	70.6	36.3	119.2	700.2	157.3	235.9	215.2	39.1	61.2	84.1	369.9	38.5	194.7	43.8	22.3	155.0	11.5	18.0	14.4	19.5	15.0	13.3	19.6	19.0	22.6	15.6	56.3	19.7	19.4	9.2	11.0	18.4	22.1	24.0	28.2	26.1	21.1	28.4	29.7	29.7	33.3	27.2	38.5	26.5	93.3	70.5	116.0	69.2	157.3	106.4	101.8	102.6	97.9	54.1	38.5	30.1	43.5	87.2	69.0	261.1	50.1	24.8	65.1	44.1	103.7	278.5	3.6	95.6	131.3	152.3	66.4	35.3	45.6	251.6	67.1	81.4	49.5	272.3	223.6	339.7	176.0	30.7	136.4	156.5	39.3	39.0	57.0	145.9	111.7	6.2	24.2	240.2	103.2	53.4	87.1	134.0	26.8	78.9	35.8	236.9	21.9	48.5	60.0	59.3	20.2	192.1	37.7	54.8	52.6	75.8	136.9	80.5	44.2	128.7	87.9	25.4	91.6	92.2	51.8	116.0
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 633.9;Hepatocytes: 457.4;Proximal tubular cells: 578.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		110000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	50.8	79.5	41.7	15.5	43.9	27.0	48.5	44.9	46.8	23.2	40.3	42.6	34.9	25.9	48.6	27.5	29.9	14.9	87.4	39.8	43.1	91.1	169.2	30.2	21.0	43.8	42.5	19.2	65.9	72.6	41.2	17.6	42.0	33.9	34.2	20.4	39.7	26.1	80.1	33.4	34.2	20.1	43.9	33.8	56.9	29.8	47.3	38.8	38.4	85.5	23.8	30.6	24.2	44.0	30.3	76.1	47.1	45.6	29.0	24.3	33.2	27.8	39.2	42.3	46.1	49.9	31.1	39.9	31.7	25.3	59.8	29.3	21.2	40.9	44.1	87.8	40.7	42.2	64.1	45.8	68.1	25.1	40.0	27.3	36.8	40.2	64.8	16.7	33.2	91.4	25.5	117.4	34.0	60.3	61.3	31.3	21.4	70.0	138.7	60.8	33.1	53.6	61.5	21.5	38.4	46.4	36.0	42.7	49.6	27.5	45.9	44.6	16.5	22.0	37.7	30.4	35.7	107.0	127.3	57.4	49.8	32.2	36.2	41.0	77.5	4.7	68.9	58.5	62.4	98.9	73.7	69.8	113.4	96.7	56.4	58.6	7.6	66.8	56.9	246.1	107.3	81.2	41.7	43.9	44.9	46.8	39.8	43.1	43.8	42.5	42.0	43.9	47.3	44.0	49.3	22.4	17.5	5.2	57.9	45.4	63.4	137.6	49.5	39.8	99.1	105.8	115.1	130.1	68.3	80.9	20.9	154.9	69.3	148.2	633.9	115.5	67.3	83.9	28.6	47.8	96.0	100.8	1.7	172.1	71.7	53.2	52.5	44.6	18.4	43.5	63.1	457.4	113.9	20.2	2.5	127.4	126.1	61.1	51.4	128.0	40.4	47.7	120.9	1.9	74.1	123.7	87.6	1.5	4.5	85.6	157.5	44.8	77.7	40.7	181.4	578.1	105.1	45.5	46.0	54.2	72.6	38.4	77.4	64.7	45.9	56.8	51.0	85.1	126.7	84.8
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.7;Inhibitory neurons: 51.1;Oligodendrocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 253.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (8.11e-4)"	"prognostic favorable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	11.2	12.9	16.1	10.6	15.1	26.1	10.2	14.6	15.9	9.4	13.3	14.0	13.9	12.3	6.0	12.4	12.2	7.3	12.9	15.9	14.1	13.8	21.7	10.6	14.2	14.2	15.3	11.2	12.6	22.1	13.2	8.4	13.8	9.3	10.1	7.3	9.9	8.8	23.4	12.5	13.7	9.4	14.0	13.1	14.2	10.1	17.9	20.6	56.1	11.0	11.4	12.2	8.6	14.6	27.0	23.5	32.4	33.7	31.0	20.5	22.5	22.4	25.7	36.1	35.6	53.8	15.4	52.1	10.6	29.0	21.5	30.8	46.4	28.2	23.1	32.1	53.9	48.4	25.5	49.5	33.6	113.1	33.6	24.7	27.1	28.3	27.6	19.4	26.5	51.6	253.1	27.0	20.9	33.7	56.0	40.4	29.6	63.8	23.5	43.7	46.0	15.6	20.9	29.8	47.0	31.2	25.0	25.4	31.7	16.4	16.0	39.0	30.7	24.5	36.0	25.4	26.5	28.4	30.3	53.7	28.7	36.2	20.7	4.8	0.7	3.3	1.3	0.7	1.3	2.4	0.7	1.3	0.9	4.5	0.3	1.0	1.3	2.1	0.4	1.7	0.4	0.8	16.1	15.1	14.6	15.9	15.9	14.1	14.2	15.3	13.8	14.0	17.9	14.6	7.7	6.4	0.5	29.4	7.4	9.2	2.2	4.4	0.6	7.7	6.4	7.4	2.3	2.8	2.3	5.5	2.1	3.8	12.6	11.7	5.9	5.4	6.2	6.8	8.4	5.6	2.4	19.4	49.7	8.9	3.6	4.7	3.1	7.1	0.0	8.7	7.1	21.1	6.6	16.8	51.1	10.5	4.1	9.1	3.8	2.4	5.0	4.9	10.6	38.4	7.9	5.5	14.4	37.7	45.5	7.9	8.4	6.8	4.5	5.0	8.2	9.9	4.2	4.6	6.6	7.7	6.1	12.9	10.3	4.5	10.5	3.0	6.6	9.2	14.2	2.2
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992330-29996074	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 129.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	12.3	11.6	24.4	9.0	25.5	15.8	11.8	23.9	24.7	13.3	19.0	16.0	8.3	13.5	10.6	9.6	12.2	7.1	19.2	22.9	23.8	12.6	14.9	11.6	13.1	25.5	24.6	16.8	11.0	15.6	14.5	6.8	25.4	11.9	7.3	20.1	11.1	12.8	33.5	14.6	10.9	8.6	24.1	12.9	10.6	38.7	24.4	25.6	11.7	21.7	12.3	14.2	11.5	25.7	27.4	27.7	44.2	28.5	13.9	14.8	13.4	20.9	16.1	21.2	18.2	24.8	26.8	52.7	42.5	13.7	15.3	19.0	28.8	26.6	15.8	47.8	28.1	56.7	36.2	26.9	11.5	50.3	42.4	7.4	19.4	20.9	32.3	12.4	13.4	50.6	27.2	57.0	12.9	20.0	66.1	26.3	13.0	17.8	15.5	65.9	52.6	52.5	14.9	12.2	28.6	34.7	21.7	16.3	14.5	11.3	24.2	30.6	15.4	28.4	21.8	20.3	20.5	37.1	31.0	31.4	26.8	43.2	38.1	4.6	7.5	15.0	16.7	12.0	11.4	19.1	18.6	15.3	6.3	14.6	19.3	17.9	3.4	14.3	20.8	19.1	22.9	10.8	24.4	25.5	23.9	24.7	22.9	23.8	25.5	24.6	25.4	24.1	24.4	25.7	19.1	67.3	26.3	2.0	14.9	12.7	17.1	11.2	14.8	36.4	14.6	19.6	30.4	10.0	15.8	9.2	14.6	30.6	18.7	12.5	29.4	10.5	27.6	12.6	10.9	15.4	9.6	27.0	2.1	12.1	28.9	14.6	4.6	10.9	31.0	12.1	10.8	16.7	18.7	15.2	2.7	10.8	14.2	8.2	11.9	12.0	20.5	9.8	5.4	1.0	8.8	37.3	32.0	3.5	4.7	6.3	11.4	22.6	22.0	6.7	25.6	19.9	19.9	49.4	13.1	14.7	18.6	129.5	46.2	10.2	11.4	11.5	20.9	12.1	14.0	8.3
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220332-69267552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.5;retina: 46.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 31.5;Distal enterocytes: 29.0;Ductal cells: 32.6;Endometrial ciliated cells: 50.0;Glandular and luminal cells: 55.2;Muller glia cells: 126.9;Proximal enterocytes: 56.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 3.1;naive CD4 T-cell: 5.8;naive CD8 T-cell: 2.3;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	23	"T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;CACO-2: 57.5;CAPAN-2: 111.4;EFO-21: 33.9;GAMG: 45.4;Hep G2: 33.6;RPTEC TERT1: 81.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 11.9"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	1.1	2.7	1.3	0.0	0.0	1.4	1.0	1.1	1.4	6.8	53.5	0.9	0.0	0.1	4.6	6.8	0.0	1.0	1.1	13.3	4.6	1.5	1.0	1.3	2.1	0.0	6.2	0.0	0.3	0.0	1.7	0.0	4.2	46.8	0.1	0.0	0.0	0.1	48.0	0.5	1.4	0.3	1.1	1.0	1.0	5.2	9.3	0.0	0.2	0.0	0.1	1.2	1.2	40.1	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.1	57.5	111.4	0.0	33.9	0.3	45.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	33.6	2.7	0.0	0.0	0.0	0.3	0.4	3.2	0.6	0.0	11.3	0.0	0.0	0.7	0.1	0.2	0.1	0.0	11.9	1.3	0.0	1.2	0.1	81.9	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.4	1.6	0.2	0.8	0.0	0.1	0.0	8.1	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.5	0.0	3.1	1.0	0.0	0.0	5.8	2.3	0.0	0.2	0.0	0.0	5.4	1.0	1.1	1.3	1.4	1.0	1.0	1.1	1.3	2.1	1.7	1.4	1.0	1.2	0.0	3.2	4.8	11.8	0.7	0.0	0.0	0.3	0.0	1.9	0.0	0.0	1.0	31.5	1.0	16.5	0.0	0.0	0.2	29.0	1.9	32.6	0.6	50.0	4.5	0.5	0.0	0.0	0.4	7.3	0.0	0.2	1.5	55.2	0.0	0.0	0.0	0.4	0.1	3.3	0.5	5.6	0.0	0.3	0.0	0.2	0.3	0.4	0.0	0.0	0.0	126.9	0.0	0.0	0.5	25.5	12.7	0.0	0.3	0.0	56.3	15.7	0.3	5.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.1	5.6	0.3
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 122.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 53.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.1	21.5	9.8	1.9	23.1	0.4	15.4	0.0	53.3	14.4	0.0	18.0	1.4	14.4	11.0	26.3	12.2	7.8	24.1	17.6	0.0	12.7	122.4	13.4	2.2	0.0	0.6	50.0	2.9	4.0	9.9	1.0	0.0	13.2	3.4	43.2	24.1	12.4	7.7	16.7	4.3	12.3	0.0	8.2	6.1	4.1	3.9	3.4	34.3	9.9	7.7	12.3	7.8	17.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.8	23.1	0.0	53.3	17.6	0.0	0.0	0.6	0.0	0.0	3.9	17.2	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 143.4;Spermatogonia: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	12.2	23.6	10.3	7.4	11.9	11.5	13.8	20.7	12.0	11.1	17.6	9.9	5.3	13.6	10.2	7.5	11.5	9.3	19.0	10.3	13.4	16.9	18.5	7.8	11.9	13.1	12.6	18.8	13.6	17.2	12.4	8.2	13.9	15.7	7.5	27.6	11.1	11.6	11.6	5.6	6.8	12.1	15.1	8.7	9.9	44.7	12.2	15.8	21.0	11.4	11.2	8.3	6.0	17.5	66.7	31.8	44.3	34.6	29.0	37.3	4.3	44.1	26.2	32.0	37.0	25.8	45.1	42.7	52.3	20.6	62.3	1.9	60.1	17.5	52.9	23.7	29.1	102.6	23.6	10.5	18.1	27.2	40.7	23.7	9.3	23.9	13.9	48.4	18.7	68.1	36.5	26.9	44.2	33.5	56.4	40.9	33.5	33.3	39.3	64.2	49.8	6.6	26.2	21.1	43.5	25.6	66.9	30.4	60.8	23.3	91.5	25.9	13.2	37.1	22.4	53.1	48.5	39.3	23.5	55.4	36.2	36.3	14.6	8.2	1.0	3.5	4.3	1.7	8.0	6.9	3.8	5.8	3.4	4.9	5.6	5.7	0.0	4.7	1.9	7.8	3.9	2.8	10.3	11.9	20.7	12.0	10.3	13.4	13.1	12.6	13.9	15.1	12.2	17.5	19.5	25.6	20.4	56.8	15.6	5.6	8.5	12.9	10.8	99.3	20.1	16.5	46.4	18.6	18.5	31.3	41.7	10.2	29.9	1.9	35.2	10.1	9.9	36.7	31.1	14.3	4.9	71.5	67.5	8.4	10.1	27.6	12.8	11.7	55.7	55.8	13.2	17.2	8.7	47.1	88.7	6.9	18.3	4.6	3.1	12.3	33.8	11.9	5.4	28.1	5.2	35.4	12.3	66.4	68.7	7.4	3.6	32.4	19.3	8.2	2.0	19.2	26.2	76.2	13.1	37.5	23.8	143.4	113.2	11.5	4.3	1.6	22.1	100.6	7.5	6.6
HMG20B	"BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL"	ENSG00000064961	"High mobility group 20B"	Q9P0W2	19	3572777-3579088	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 265.7;Melanocytes: 229.5;Syncytiotrophoblasts: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 411.1;WM-115: 405.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050220, HPA053157, HPA069832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210"	"unprognostic (2.97e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.72e-7)"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.89e-5)"	50.4	41.4	27.3	18.2	29.3	30.1	49.9	29.1	33.7	50.9	29.4	59.0	28.1	54.5	15.6	48.1	44.7	16.8	36.8	26.0	27.5	56.0	54.4	38.3	20.1	32.6	28.4	38.0	38.1	30.3	18.1	22.7	31.8	68.9	17.2	8.8	49.9	25.6	25.9	58.3	47.6	19.9	29.6	39.2	54.2	36.0	30.3	48.2	39.3	12.0	15.9	49.0	43.8	34.1	93.1	39.0	34.6	83.0	42.2	38.1	64.1	58.7	42.4	52.6	40.0	14.1	33.5	50.5	53.7	42.6	47.5	44.4	20.3	40.0	31.3	45.1	46.6	24.8	132.2	37.7	27.2	33.9	117.5	32.5	47.0	30.2	20.0	53.4	53.4	44.8	42.0	81.9	35.0	126.3	64.7	62.0	39.7	78.5	78.4	42.3	60.4	69.5	39.0	58.4	21.7	66.0	81.7	141.3	411.1	32.4	106.8	90.5	77.4	27.7	62.1	99.3	50.8	76.4	43.0	36.2	72.0	85.6	405.1	44.9	68.1	66.2	40.1	70.1	35.8	35.2	34.1	43.6	66.1	30.2	36.3	35.3	37.9	59.5	77.0	59.5	41.4	51.8	27.3	29.3	29.1	33.7	26.0	27.5	32.6	28.4	31.8	29.6	30.3	34.1	50.1	28.9	19.3	9.8	27.9	70.5	52.1	67.4	47.8	3.4	75.0	70.9	8.7	28.6	40.0	18.4	10.4	122.9	34.1	50.0	92.0	65.0	26.7	39.7	41.4	42.5	66.8	24.4	0.7	45.5	265.7	35.4	32.6	44.4	37.5	58.1	38.6	20.9	81.9	8.4	0.7	170.8	57.0	29.6	93.4	49.6	37.3	47.1	229.5	3.7	86.2	41.2	42.2	0.5	11.7	58.6	68.5	44.8	34.9	62.8	74.7	76.2	29.5	18.7	32.9	22.4	53.4	39.9	17.4	53.0	79.8	303.7	30.8	49.6	68.7	62.9
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	0.8	0.7	0.2	10.1	0.3	20.6	2.1	0.3	0.4	1.1	0.1	6.6	7.4	0.8	0.2	4.0	0.5	0.9	0.8	0.2	0.2	0.7	1.7	0.9	18.1	0.5	0.3	0.2	0.3	0.9	0.2	6.2	0.4	0.5	8.8	0.8	0.8	0.2	1.2	4.2	6.5	2.9	0.3	2.9	3.6	27.5	0.7	27.3	0.7	0.4	17.7	2.2	1.4	0.5	77.0	47.2	94.5	50.8	5.0	9.0	70.3	71.4	34.9	88.0	78.9	96.8	145.1	127.5	66.0	22.2	118.5	86.3	112.4	69.0	148.6	116.1	34.4	76.7	32.3	48.4	1.4	68.7	67.3	2.4	4.1	82.8	64.0	14.7	50.6	85.7	73.2	101.0	93.2	28.5	72.3	38.8	81.9	51.2	51.6	78.0	126.3	63.9	34.8	20.4	78.8	43.8	106.3	32.8	38.6	45.1	97.3	54.5	32.9	63.2	52.4	50.6	97.2	53.7	96.3	102.4	41.4	104.2	61.1	0.2	0.2	0.0	0.1	0.1	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.6	1.5	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.3	0.7	0.5	0.4	0.0	1.1	1.3	6.0	2.5	1.8	4.5	2.8	0.6	3.2	3.7	2.5	4.3	3.2	0.0	0.0	37.3	2.3	5.3	0.0	0.8	86.2	3.8	3.1	3.1	1.2	133.3	0.6	0.2	55.1	4.6	11.7	5.7	0.0	21.6	5.3	3.8	22.2	0.0	0.4	7.8	6.1	8.8	2.7	60.9	2.1	7.6	0.0	0.0	2.3	0.1	1.0	0.5	1.2	0.2	0.3	0.7	22.9	1.5	1.3	2.6	2.8	1.0	6.6	0.6	3.8	100.9	23.3	14.1	1.4	4.5	5.2	1.6	15.6	3.0
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HNRNPA1	"ALS20, hnRNP-A1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		9300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	531.6	410.2	339.5	528.1	362.6	1087.9	640.6	348.2	424.9	750.3	326.5	542.3	447.5	625.3	474.8	510.3	589.2	214.7	391.4	320.7	363.0	501.4	277.0	380.6	685.7	363.3	348.2	1410.2	556.7	359.8	327.2	447.9	364.8	458.9	445.9	261.2	398.9	409.6	437.4	506.3	436.4	382.1	380.9	434.1	431.0	168.9	343.9	1010.9	396.3	174.4	824.8	513.7	580.9	372.6	1246.7	815.8	2072.5	1717.3	550.5	1057.0	1204.0	911.9	1405.6	1311.7	1153.1	1225.4	1306.6	3183.8	983.8	671.8	354.7	1045.9	1486.5	1393.4	1425.5	1216.4	1041.7	1700.0	1156.1	2250.0	320.4	2712.4	1078.2	845.2	568.3	642.9	1056.1	868.7	1408.6	1474.7	1930.7	1215.3	968.2	1244.6	2969.1	2880.9	2571.8	844.0	675.9	2911.7	1588.9	1574.1	1239.4	1395.0	1260.4	1739.0	758.0	1675.2	1392.3	1031.6	1010.9	1744.5	1063.1	781.6	1164.2	820.6	1395.1	1185.7	1349.3	2249.7	572.5	1646.7	744.0	140.4	423.5	165.9	572.8	513.1	893.3	576.5	746.2	657.5	704.5	501.8	851.2	810.1	41.0	823.3	437.7	556.5	683.4	1333.2	339.5	362.6	348.2	424.9	320.7	363.0	363.3	348.2	364.8	380.9	343.9	372.6	372.4	304.5	521.4	20.9	1018.9	1416.1	1039.8	1252.9	900.9	254.1	745.1	541.3	166.2	697.7	612.0	294.3	93.8	2076.2	900.8	407.3	739.6	1296.2	181.5	304.7	706.7	624.8	824.0	1032.4	16.5	2124.2	2894.5	600.5	458.7	400.7	528.9	790.7	562.2	183.1	1006.9	109.4	18.3	1130.9	459.8	863.9	1048.2	115.6	1050.7	609.2	588.7	21.5	1374.4	411.0	1304.9	23.1	34.1	1162.7	731.2	741.8	702.2	696.8	693.2	838.6	288.3	195.2	453.6	714.5	704.1	217.0	338.1	1030.6	1261.9	2178.8	958.6	690.9	1543.8	897.8
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26171151-26201529	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507"	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.12e-4)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	367.0	421.3	101.3	151.4	105.4	77.6	314.1	110.9	140.3	403.5	106.4	381.8	124.8	404.3	116.1	417.6	376.3	62.4	463.6	99.7	106.4	530.8	388.5	364.9	184.1	106.4	105.0	527.8	350.2	80.8	337.6	118.9	108.2	300.8	127.5	131.1	325.1	79.2	764.9	280.5	419.0	84.2	102.3	447.5	353.4	370.5	105.4	174.8	367.2	92.0	172.5	339.9	360.8	111.7	202.5	101.8	491.6	312.7	110.7	117.5	249.6	255.8	110.7	149.6	183.6	159.8	338.5	210.2	104.2	180.1	218.8	300.0	196.3	268.7	288.5	74.9	191.2	232.6	309.9	212.1	72.9	374.6	359.4	123.6	192.4	156.3	253.3	194.6	161.1	273.9	210.9	250.4	280.4	229.1	216.5	817.2	320.7	81.7	117.7	239.5	122.1	159.3	287.0	335.8	190.7	245.6	203.5	291.8	127.7	393.6	326.3	359.7	222.0	193.2	265.6	184.6	253.7	367.0	296.0	308.7	149.9	453.8	316.5	0.0	1.7	1.3	4.8	1.0	4.0	2.7	3.0	0.8	0.8	0.8	2.7	2.6	0.6	3.3	0.8	1.6	1.0	0.5	101.3	105.4	110.9	140.3	99.7	106.4	106.4	105.0	108.2	102.3	105.4	111.7	717.8	487.2	591.0	194.6	667.5	738.5	797.7	793.2	560.5	469.4	361.0	361.3	702.1	316.0	665.8	343.9	298.2	971.6	707.7	435.1	461.8	568.0	128.2	465.8	640.8	600.5	491.4	683.2	123.3	452.2	939.9	602.7	449.6	591.1	644.7	680.5	333.4	382.8	613.1	312.9	147.2	533.1	496.4	388.5	681.9	150.0	411.0	640.3	393.1	157.4	572.0	545.4	484.1	198.0	320.6	438.2	438.7	390.0	751.0	520.4	428.4	506.8	608.0	547.0	440.4	599.4	726.5	596.9	490.6	573.8	600.5	1082.8	701.7	652.2	541.4	632.1
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm		NA	NA		1800000	"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666"	"unprognostic (2.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	162.9	119.0	101.6	210.8	104.5	235.2	144.2	107.5	114.6	183.8	98.8	185.3	129.2	180.1	178.1	244.6	164.3	75.4	118.4	93.7	124.1	193.6	144.3	175.2	232.9	111.8	103.1	208.2	141.4	130.5	137.5	158.5	106.9	141.0	194.7	181.7	138.8	118.1	136.3	179.9	152.3	164.2	103.8	174.7	143.1	175.8	108.6	308.3	176.0	93.0	304.8	153.3	189.2	108.1	657.6	432.9	934.3	469.8	248.2	221.2	717.8	489.3	235.7	382.8	358.5	885.1	337.4	1315.9	366.5	388.4	518.3	370.6	944.2	616.7	712.9	609.6	556.2	996.1	620.3	1727.6	264.8	1064.7	584.0	249.8	288.3	569.9	422.1	217.9	537.3	587.4	723.1	414.3	492.1	891.1	746.9	444.4	507.3	762.5	405.0	947.2	790.1	414.2	547.9	1227.6	545.1	484.7	729.6	228.1	316.4	700.8	325.6	652.5	582.2	476.3	540.4	338.0	719.0	387.6	759.5	1117.2	305.4	699.5	320.0	8.9	21.2	10.8	25.0	22.6	20.2	21.2	20.0	22.0	23.4	20.4	17.5	18.1	8.2	23.5	23.0	37.8	25.9	14.5	101.6	104.5	107.5	114.6	93.7	124.1	111.8	103.1	106.9	103.8	108.6	108.1	274.8	166.7	255.1	84.5	277.4	351.8	429.6	442.1	224.8	192.8	155.2	135.1	64.2	114.4	302.7	160.0	98.0	512.7	368.9	200.7	121.3	257.2	47.2	296.5	387.2	289.7	275.0	288.6	56.9	273.8	563.0	231.4	184.0	343.0	278.1	222.6	196.7	165.0	342.7	148.0	70.5	315.0	193.3	221.0	372.5	44.0	204.7	258.3	192.1	73.1	311.1	187.1	232.8	65.9	88.6	276.1	184.0	209.5	336.6	288.9	136.8	156.7	257.8	164.4	151.2	319.3	461.9	362.8	208.3	331.1	330.5	496.0	307.9	214.1	310.7	382.6
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204533-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	86.7	103.2	33.2	92.5	34.9	139.7	63.9	35.6	37.0	66.0	37.3	144.7	98.2	75.5	43.8	122.0	64.4	51.1	83.1	32.4	39.1	91.9	88.3	69.1	95.7	36.9	35.4	56.7	55.4	76.2	46.2	64.0	36.9	59.8	119.0	27.1	68.1	54.0	119.0	115.4	88.9	74.4	35.5	79.9	85.5	38.2	36.9	117.0	52.0	58.7	102.7	122.3	72.7	38.5	347.4	282.5	424.1	414.7	153.8	134.6	613.2	378.5	174.3	296.9	317.2	525.4	251.8	555.2	340.3	204.7	361.1	223.2	373.1	516.7	363.8	865.9	439.5	349.8	223.7	325.1	153.7	446.1	285.6	134.0	239.2	267.3	266.8	122.3	270.3	218.4	290.1	245.7	302.0	934.2	542.6	429.7	389.5	354.0	401.7	436.3	255.6	329.8	254.2	364.8	389.5	302.4	295.2	407.9	278.8	264.0	244.7	270.7	244.0	359.7	305.2	256.2	527.8	285.4	360.2	649.3	145.2	488.2	298.8	3.2	4.4	15.7	5.1	7.0	5.7	5.9	4.1	6.0	4.4	5.2	3.9	4.7	0.8	5.8	7.5	10.9	4.8	2.2	33.2	34.9	35.6	37.0	32.4	39.1	36.9	35.4	36.9	35.5	36.9	38.5	124.7	32.1	41.0	4.6	115.4	281.6	212.1	42.7	243.0	26.5	129.6	141.3	45.9	41.5	42.7	49.7	18.8	106.3	148.5	251.2	50.9	118.9	9.3	112.4	225.6	107.1	119.2	273.2	3.5	151.7	208.9	110.1	167.7	124.7	44.5	102.0	53.6	101.2	101.0	16.8	4.3	219.0	48.8	67.0	129.9	11.1	74.0	109.9	67.6	8.4	56.2	34.7	76.2	3.5	6.1	204.2	138.2	88.0	179.6	275.0	90.5	116.8	25.8	28.3	78.9	149.7	173.6	81.6	122.4	362.5	339.8	114.4	129.7	238.1	247.9	235.5
HNRNPC	HNRPC	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1200000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	286.9	309.2	274.1	319.5	290.1	540.3	328.5	283.9	332.6	307.8	248.8	266.7	232.3	318.9	311.9	318.3	328.5	246.4	269.5	275.3	289.2	372.9	334.4	251.8	497.7	287.2	275.4	427.3	237.7	257.8	237.7	342.0	299.0	249.6	290.9	407.3	225.9	247.9	288.2	260.1	255.2	265.9	295.2	306.5	232.3	193.7	276.6	557.8	259.2	244.0	496.0	374.6	278.6	327.1	1076.2	832.7	1277.7	748.5	754.8	704.7	910.2	673.2	764.3	1034.3	900.6	799.4	787.6	1935.6	414.1	772.1	656.8	775.6	1611.4	1035.4	1389.0	1236.1	918.1	992.8	614.2	1241.4	920.6	1495.2	762.6	731.8	854.2	756.5	1781.1	897.8	1078.4	957.7	1483.6	787.1	829.5	1020.0	1713.7	1435.2	1351.4	990.3	770.1	1375.0	1073.9	925.3	1159.7	956.9	699.0	665.5	838.5	760.9	786.4	1057.3	725.2	1332.6	783.1	388.9	698.2	473.8	972.8	708.8	1144.4	1873.6	370.6	1215.3	794.1	480.2	515.1	516.9	419.0	450.9	544.5	531.4	494.0	451.2	716.3	467.0	552.1	478.2	810.8	471.0	439.4	460.5	575.7	1220.5	274.1	290.1	283.9	332.6	275.3	289.2	287.2	275.4	299.0	295.2	276.6	327.1	172.7	153.8	233.9	69.5	307.2	536.2	583.9	512.2	331.8	169.8	259.9	191.5	137.9	173.0	393.2	275.8	198.1	612.6	309.4	134.0	283.7	315.0	169.0	365.1	352.2	257.5	224.0	389.9	74.3	216.6	746.8	287.1	197.2	555.6	415.9	281.3	174.2	233.9	388.5	116.1	79.2	276.0	260.4	293.8	500.1	76.5	270.0	325.7	208.1	99.3	341.9	157.9	227.6	97.5	112.2	210.7	151.1	230.9	293.6	531.5	135.0	370.8	381.9	296.1	151.2	285.1	282.6	391.5	249.0	315.5	539.9	874.9	339.1	311.8	318.0	590.3
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	147.4	114.7	61.9	207.3	61.6	377.7	155.5	83.7	89.1	167.3	68.4	153.6	169.8	176.6	137.1	155.5	152.0	98.7	122.7	60.7	81.0	144.2	140.6	129.0	290.2	61.0	61.7	180.6	146.7	134.1	117.0	167.8	59.2	138.6	164.4	188.1	147.1	125.4	169.7	151.8	177.2	140.1	54.1	184.6	164.6	97.7	61.6	335.1	122.8	103.4	310.7	159.8	145.7	69.2	661.7	257.5	1073.5	344.2	138.9	179.1	508.9	506.2	384.6	566.7	484.9	461.1	565.7	1332.6	357.1	343.3	301.9	318.2	863.8	376.6	883.9	250.1	450.8	957.4	345.2	630.7	282.1	1283.9	475.2	221.0	164.7	459.6	459.5	290.2	521.2	637.3	1076.0	446.6	487.7	254.3	1569.2	887.2	897.8	487.2	236.1	1149.2	1089.0	556.7	478.0	394.8	540.9	583.3	496.5	426.0	262.2	497.0	319.7	504.9	443.7	435.3	595.3	339.7	661.7	472.5	403.1	1516.3	334.6	651.6	508.9	26.1	11.3	12.4	13.3	12.5	15.1	20.3	16.2	17.0	13.5	13.9	17.5	14.6	13.6	14.1	14.1	23.6	19.7	7.2	61.9	61.6	83.7	89.1	60.7	81.0	61.0	61.7	59.2	54.1	61.6	69.2	152.4	102.5	143.5	63.6	128.0	261.3	227.8	139.0	111.0	128.4	124.6	121.9	202.6	125.8	149.0	112.2	62.6	299.7	163.4	71.6	70.5	204.3	35.3	136.2	218.9	162.3	146.6	182.6	65.3	210.6	355.2	134.7	98.4	204.5	92.3	191.5	114.9	114.4	156.6	107.7	72.9	158.9	85.5	125.6	172.7	21.8	124.8	134.5	90.7	63.7	169.3	187.8	130.7	84.9	105.8	157.4	56.7	102.3	151.0	208.3	91.3	80.9	115.7	118.8	111.7	185.5	154.5	106.7	133.7	147.0	229.7	272.0	133.6	149.1	169.3	228.8
HNRNPDL	"HNRPDL, JKTBP, laAUF1, LGMD1G"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422565-82430462	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA		330000	"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	267.9	192.7	133.9	221.1	162.3	404.9	259.1	143.9	214.8	288.6	126.4	296.5	151.4	283.6	157.2	209.6	275.4	147.3	229.0	137.8	162.8	220.1	181.2	292.4	247.8	161.6	155.2	368.8	248.8	111.9	231.2	161.5	163.9	218.2	153.2	210.6	200.3	155.8	395.5	232.4	246.1	205.0	140.4	243.2	233.4	119.5	153.1	199.1	245.4	168.8	188.5	233.3	266.4	197.4	405.2	208.8	762.2	151.9	282.0	152.2	249.8	426.5	460.4	371.3	351.5	289.2	324.8	745.8	263.5	467.3	191.2	306.5	582.9	395.3	433.5	165.3	421.1	432.9	354.2	524.9	133.0	745.8	309.1	271.1	112.3	417.2	370.3	294.6	299.6	467.5	572.4	300.4	365.7	169.3	701.6	519.6	526.6	363.9	244.4	624.1	615.1	342.2	437.2	259.4	322.5	556.0	265.6	339.6	262.3	344.7	354.3	418.2	253.4	371.2	462.1	246.3	519.7	351.6	363.7	828.3	325.4	428.8	320.2	44.5	36.8	32.3	60.4	59.6	49.9	63.3	54.0	56.7	29.1	61.4	74.6	66.0	15.3	42.9	77.8	46.8	46.0	51.3	133.9	162.3	143.9	214.8	137.8	162.8	161.6	155.2	163.9	140.4	153.1	197.4	314.7	272.4	281.3	104.8	486.6	659.0	612.1	364.2	429.6	223.4	287.0	304.9	201.0	150.2	359.4	152.6	106.3	520.8	472.3	128.1	297.4	338.3	57.7	294.3	410.9	296.7	236.0	260.7	163.9	255.8	629.2	361.5	271.7	432.2	387.7	319.8	127.1	132.7	326.5	176.7	152.9	225.5	240.1	218.2	452.0	50.7	212.5	344.3	311.3	80.6	339.0	303.9	272.9	143.7	298.8	231.5	131.1	202.8	480.6	556.8	173.0	300.2	288.2	188.3	164.3	602.9	397.0	161.8	391.4	433.0	554.2	521.0	488.0	238.7	241.1	478.6
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm		NA	Yes		2500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: AB_2686166"	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	114.6	77.7	43.3	133.9	48.6	161.3	102.9	49.8	47.9	86.8	65.2	124.5	134.2	78.3	58.9	114.9	119.4	88.9	63.7	40.2	45.9	94.4	173.2	97.6	181.4	52.4	51.4	87.3	87.5	73.1	50.5	113.6	51.5	90.8	118.9	80.4	85.2	74.8	93.6	104.5	130.7	89.1	49.2	123.5	118.0	84.0	49.4	193.3	72.7	79.6	182.8	160.0	81.8	58.3	292.1	302.9	184.2	280.7	220.5	239.5	269.1	222.5	371.0	305.6	358.2	285.5	394.7	581.8	139.2	242.0	179.3	401.7	496.8	363.6	249.5	245.6	297.2	371.2	178.6	370.9	271.4	550.5	360.9	293.2	282.4	237.6	434.6	177.1	266.4	281.3	382.0	256.2	234.2	453.4	542.5	300.5	139.5	439.1	252.4	449.0	172.7	276.8	314.9	442.7	226.1	226.8	226.6	410.4	344.3	199.2	457.4	265.3	200.4	140.1	264.4	231.8	356.8	228.5	415.8	352.6	227.1	520.0	139.7	205.5	234.9	227.2	247.0	269.2	301.0	238.9	256.6	273.3	251.8	200.7	213.8	204.0	152.2	287.9	253.6	140.6	315.8	460.5	43.3	48.6	49.8	47.9	40.2	45.9	52.4	51.4	51.5	49.2	49.4	58.3	223.8	134.6	102.8	13.4	206.9	336.0	336.5	204.9	189.5	51.4	156.8	126.4	66.3	157.3	147.9	112.2	47.9	292.9	201.7	164.7	176.1	218.6	360.1	203.8	153.3	176.6	126.8	199.6	10.8	142.2	414.8	157.0	154.9	147.0	116.1	106.9	127.5	222.3	226.0	48.8	12.0	230.1	164.8	193.3	181.7	92.7	146.0	178.5	99.6	24.4	213.0	116.9	219.4	16.6	32.7	161.4	152.1	117.8	163.3	280.8	189.7	233.1	242.0	163.6	98.6	179.7	278.1	184.5	167.3	210.2	330.5	210.4	229.9	126.3	238.8	314.0
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2800000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	115.8	108.5	83.6	103.2	88.9	242.9	90.4	100.4	99.6	134.4	95.6	109.5	73.3	120.3	67.9	112.7	109.5	71.4	93.0	84.6	88.2	159.3	137.1	102.5	175.0	86.2	86.0	148.4	123.5	99.2	95.5	91.3	86.1	117.5	79.2	162.9	92.5	84.1	142.1	110.5	137.4	102.9	82.8	209.3	105.0	121.2	88.1	210.8	130.8	84.3	166.6	115.6	112.0	88.6	425.0	432.1	496.0	291.0	155.8	135.0	391.5	227.3	188.7	472.0	271.1	519.4	222.0	618.0	205.4	235.2	297.1	227.0	517.8	345.3	552.9	582.8	322.2	335.5	497.3	528.4	196.1	426.0	295.5	104.7	249.1	379.8	230.0	182.6	247.1	293.8	494.4	281.7	279.8	338.5	724.8	371.1	534.9	249.0	226.8	660.7	507.2	368.3	180.4	485.0	431.5	364.3	410.7	232.7	421.8	344.6	275.7	567.1	250.5	415.3	304.2	184.8	556.0	252.0	674.2	723.6	213.0	405.1	501.6	55.7	44.8	46.5	61.4	73.2	82.6	63.4	65.8	66.4	67.9	52.1	81.5	86.8	9.1	62.9	57.6	87.3	83.1	38.9	83.6	88.9	100.4	99.6	84.6	88.2	86.2	86.0	86.1	82.8	88.1	88.6	374.3	115.4	238.0	80.6	263.0	775.3	182.3	89.2	202.1	118.0	332.7	242.1	136.4	165.8	125.5	156.3	131.3	158.3	419.8	183.0	78.2	97.1	151.3	178.7	246.3	237.8	255.2	189.8	81.8	124.1	181.8	241.7	128.0	258.9	247.3	178.6	189.5	225.3	108.2	70.7	85.8	213.7	81.4	186.2	621.4	86.6	111.6	224.0	334.4	104.9	148.3	93.4	110.2	148.8	121.8	105.2	153.0	117.4	269.3	200.4	142.7	75.4	95.9	166.0	184.1	306.3	253.2	189.1	120.6	181.0	718.0	192.5	311.9	87.4	266.4	191.5
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408222-101414133	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 302.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	60.1	70.3	53.5	63.0	57.7	78.0	72.3	53.6	69.6	59.2	58.4	57.2	60.1	61.6	66.1	55.5	55.2	48.7	59.1	57.4	56.8	79.0	77.7	57.4	58.3	56.1	55.5	53.0	42.7	124.0	52.8	71.8	55.6	63.1	60.9	79.4	45.6	72.7	90.4	63.8	59.7	68.7	55.7	59.5	49.0	25.6	55.0	73.0	63.1	77.8	73.2	71.9	47.2	59.8	105.0	72.1	137.8	83.2	119.4	104.0	66.0	87.3	123.5	82.0	166.6	62.1	91.9	107.9	86.6	125.5	112.3	93.8	160.6	122.5	111.9	104.9	78.0	80.1	173.7	84.8	102.2	100.4	74.7	106.1	111.0	80.8	79.3	98.5	113.5	58.1	82.9	150.6	126.8	136.9	83.3	88.7	86.6	171.7	69.7	76.9	146.2	105.1	177.8	140.7	63.1	114.6	130.0	61.3	104.5	97.3	78.9	94.7	122.0	45.0	81.4	129.7	36.2	49.8	76.9	75.0	93.2	114.6	57.5	138.8	104.6	165.1	59.2	112.3	62.9	56.7	56.6	59.3	99.4	54.5	58.7	61.3	247.6	79.5	114.5	41.9	57.4	92.2	53.5	57.7	53.6	69.6	57.4	56.8	56.1	55.5	55.6	55.7	55.0	59.8	46.3	28.9	61.2	0.0	47.7	70.9	94.1	119.0	21.1	40.5	42.6	24.9	48.1	45.8	88.5	90.1	12.5	137.7	37.5	52.0	99.7	99.1	3.2	41.4	35.6	56.1	60.6	41.0	0.0	73.4	65.0	49.0	28.1	44.6	82.4	26.2	52.1	85.3	84.3	16.8	0.0	45.7	83.4	75.4	75.8	6.1	55.3	66.0	69.4	0.0	97.8	44.1	55.6	0.0	0.0	64.5	65.8	59.0	24.6	45.3	58.4	146.2	75.0	34.1	78.9	57.2	64.6	17.6	33.1	28.2	72.0	302.5	42.0	44.3	46.0	64.5
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		7100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	283.6	308.1	186.1	326.2	197.1	637.3	265.3	202.4	236.6	264.5	227.4	270.2	287.0	297.0	227.3	276.8	269.7	243.8	275.8	188.8	220.3	279.2	346.8	240.4	401.9	203.1	187.8	317.5	247.4	350.8	198.2	325.8	203.0	251.3	277.5	342.2	242.2	251.4	315.3	256.1	282.9	287.6	205.7	298.3	250.1	183.4	194.4	548.5	297.2	312.9	423.7	351.2	230.7	241.0	926.1	624.2	1048.4	625.7	492.2	540.7	840.0	634.1	785.0	778.2	726.4	527.0	641.2	1087.2	425.8	671.1	673.8	689.5	1061.5	772.9	941.8	753.7	624.2	765.1	511.9	754.6	648.7	958.6	726.5	554.6	577.4	665.6	876.1	583.7	806.1	605.5	792.8	541.4	776.4	809.0	1198.4	652.1	934.7	929.3	599.3	1030.2	835.0	727.6	760.3	747.6	677.1	802.6	669.6	703.8	645.5	721.8	698.6	801.6	665.8	537.9	631.7	552.7	844.2	564.7	795.5	784.6	514.3	762.6	779.5	582.0	438.9	559.2	302.2	419.8	378.9	347.8	346.6	348.7	457.5	324.4	354.8	327.2	546.1	477.9	429.1	270.8	457.4	1012.5	186.1	197.1	202.4	236.6	188.8	220.3	203.1	187.8	203.0	205.7	194.4	241.0	354.7	205.1	270.0	58.4	398.4	506.0	540.7	421.5	313.0	180.9	281.6	203.3	195.0	230.2	322.4	263.0	89.6	585.3	379.9	288.1	395.2	448.2	43.4	326.2	329.0	331.7	387.0	447.9	45.9	368.3	738.5	323.4	233.9	384.2	336.8	300.0	260.9	356.6	388.4	156.5	51.2	379.2	307.2	352.9	412.9	45.4	334.6	333.4	327.3	58.1	448.9	362.5	338.8	71.9	116.2	397.0	282.7	321.2	281.0	353.3	260.0	416.7	308.1	182.6	276.1	340.9	479.7	345.9	241.7	309.5	448.7	728.5	368.6	334.9	406.9	453.2
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	97.2	83.9	55.6	126.3	63.0	230.9	94.4	66.0	63.8	104.4	61.4	108.3	98.4	113.8	57.1	126.4	92.5	54.4	89.1	51.6	61.0	92.4	89.4	90.6	141.3	60.7	59.1	121.9	84.1	90.5	71.5	87.5	60.8	76.6	91.9	127.7	93.0	75.4	148.6	106.5	100.8	88.0	57.2	110.5	90.9	78.1	59.8	166.3	93.2	62.1	156.0	93.2	101.5	69.3	477.5	315.7	580.8	236.3	131.4	145.2	373.7	279.3	208.5	340.3	256.9	452.4	141.4	697.4	363.4	254.3	242.4	286.3	603.3	349.4	425.1	437.5	501.0	620.1	312.2	439.8	136.3	640.0	317.4	150.5	173.4	289.2	119.9	100.0	309.7	256.3	632.3	193.6	273.3	324.3	617.2	556.8	505.1	258.2	381.1	687.8	508.1	330.5	179.6	452.9	320.7	356.8	469.5	250.4	278.8	276.8	299.0	378.4	362.9	294.5	357.4	313.6	529.2	285.4	560.8	791.4	221.7	511.4	329.1	21.3	78.4	48.0	91.2	93.4	91.7	69.6	79.0	91.6	86.6	61.4	84.3	83.0	20.0	86.0	71.8	86.3	87.6	94.5	55.6	63.0	66.0	63.8	51.6	61.0	60.7	59.1	60.8	57.2	59.8	69.3	157.1	128.2	189.0	48.6	154.1	166.3	204.8	240.8	105.9	199.6	143.8	125.1	92.1	118.7	240.8	117.7	70.9	272.8	170.3	95.5	97.8	237.4	13.2	150.6	194.7	164.3	190.4	211.5	43.3	273.1	304.4	141.7	76.0	190.2	267.4	136.3	111.4	148.5	174.4	138.0	46.5	154.6	138.4	127.2	139.8	18.3	113.4	137.7	110.3	59.0	212.5	186.1	219.4	60.8	79.8	202.2	102.9	142.1	118.7	92.7	77.8	106.0	193.1	213.6	210.4	194.1	231.2	182.3	150.6	106.3	137.0	262.4	168.7	125.4	183.3	131.3
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		470000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	51.1	47.9	18.4	48.7	21.6	56.6	49.0	26.0	22.9	55.0	22.3	44.7	33.6	66.1	25.8	54.9	52.6	29.0	40.4	18.1	22.2	43.8	27.2	47.6	58.0	20.2	19.6	61.6	34.0	42.3	33.9	50.0	21.6	35.0	43.2	40.2	46.7	31.8	55.9	51.2	46.7	44.7	20.1	41.9	38.9	31.0	19.2	71.9	43.5	27.7	60.0	48.3	50.1	26.8	161.7	103.9	200.9	123.5	70.0	73.6	103.6	102.7	118.0	178.3	123.0	73.2	113.4	202.3	52.1	141.4	88.9	89.5	211.0	143.9	208.5	142.3	161.4	192.5	131.0	121.9	68.4	224.2	125.1	74.8	86.7	141.5	113.4	73.3	112.9	153.0	185.4	139.9	119.2	98.3	268.3	71.6	111.6	105.3	103.4	196.9	186.5	144.1	96.5	88.7	137.3	132.6	141.8	116.0	88.7	109.5	98.6	102.6	121.0	102.6	133.4	123.8	129.5	81.3	149.0	276.8	71.9	200.7	117.7	21.7	35.9	44.9	49.0	47.2	51.7	41.4	45.0	47.7	45.8	41.6	48.0	45.5	12.8	53.9	48.1	30.0	58.4	46.6	18.4	21.6	26.0	22.9	18.1	22.2	20.2	19.6	21.6	20.1	19.2	26.8	112.0	118.6	109.1	29.0	132.7	127.6	207.1	139.0	95.6	127.8	89.1	78.0	72.3	84.4	138.0	88.3	43.8	253.0	125.8	60.2	92.0	126.6	22.9	110.5	183.8	129.3	116.4	150.4	28.6	126.5	274.4	135.3	92.2	146.2	172.0	171.4	61.8	73.1	106.6	126.2	32.6	107.8	138.4	77.7	92.4	17.2	120.9	98.8	83.6	36.5	147.7	159.9	112.3	63.3	60.6	125.2	64.1	116.6	144.3	208.5	59.6	76.9	114.5	111.1	85.5	159.1	170.2	170.4	148.3	136.4	129.9	206.7	136.5	157.3	116.8	182.4
HNRNPU	"C1orf199, FLJ30202, FLJ37978, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		2100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	110.3	111.9	123.7	76.1	132.5	177.5	100.9	131.8	139.8	101.6	122.3	93.3	65.5	103.0	121.3	99.9	106.6	62.7	92.7	122.5	123.5	129.9	105.6	80.7	98.3	125.7	127.9	134.5	99.4	109.6	88.2	96.0	127.3	92.2	84.2	126.3	86.8	79.5	116.5	91.9	94.5	76.7	129.8	103.0	95.0	90.2	127.6	141.2	103.6	61.6	115.5	97.0	86.8	144.6	308.9	242.9	311.8	249.4	160.5	136.4	307.9	215.2	138.2	193.3	171.1	234.0	198.6	481.9	195.6	183.0	185.4	235.3	424.4	244.0	304.5	204.8	280.2	417.4	203.4	360.7	168.8	482.7	242.9	156.2	143.9	211.6	220.1	169.8	200.4	296.9	553.0	174.0	264.3	221.2	517.8	497.8	545.5	227.4	217.2	510.6	392.7	261.9	314.3	222.9	260.6	257.5	339.2	220.4	280.9	226.8	305.2	531.7	244.5	192.6	283.7	207.0	384.3	283.4	332.9	458.6	156.8	403.1	282.2	23.0	14.4	20.6	18.0	12.9	19.2	22.6	22.0	22.1	15.8	21.8	25.5	21.5	20.6	19.8	15.0	31.3	21.3	10.1	123.7	132.5	131.8	139.8	122.5	123.5	125.7	127.9	127.3	129.8	127.6	144.6	269.6	326.9	375.8	67.9	271.9	271.2	416.4	137.1	277.2	149.5	254.3	166.5	186.8	118.7	281.4	193.1	183.5	202.2	323.4	163.7	97.8	215.5	389.9	283.4	530.1	248.6	198.1	269.4	61.8	180.9	259.5	267.1	202.9	429.8	363.6	375.3	133.2	121.9	184.5	141.3	65.2	208.0	109.9	223.7	268.6	481.9	153.7	402.7	122.7	45.9	251.4	151.4	228.6	67.8	107.7	188.9	141.8	142.6	331.6	215.8	141.4	133.2	240.1	213.7	144.7	317.0	364.3	194.9	162.7	292.7	239.2	252.7	310.6	379.9	234.6	288.1
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307787	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm		NA	NA		26000	"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	85.7	65.9	53.2	89.1	62.4	176.2	75.0	64.3	63.8	78.0	58.9	85.7	81.3	85.0	49.1	81.4	82.8	58.0	75.7	52.9	58.9	48.3	52.5	75.0	102.4	63.9	56.3	116.3	71.7	64.7	58.3	48.8	60.6	59.6	73.1	91.2	84.7	66.7	92.7	93.2	78.7	79.0	53.1	86.4	73.5	79.8	56.1	140.0	69.9	75.6	109.6	75.2	72.1	66.0	284.3	371.2	216.5	200.4	104.3	124.0	82.2	163.1	194.1	207.1	187.8	218.7	213.2	250.1	112.3	206.4	116.8	91.2	208.1	191.3	234.6	248.5	172.9	272.9	168.8	170.4	121.0	259.5	244.3	132.9	116.8	185.8	171.6	186.5	195.7	187.1	203.1	233.8	185.9	217.0	341.0	151.8	165.0	270.8	126.7	219.0	171.6	142.3	149.0	298.8	171.2	154.2	363.3	212.6	95.4	147.7	163.7	290.2	188.4	231.6	218.6	105.4	318.3	264.3	184.5	238.4	147.5	210.8	311.6	13.2	6.2	11.0	11.9	6.7	18.1	8.8	14.4	12.4	7.3	9.0	9.9	7.9	13.5	12.6	7.9	13.7	10.9	5.7	53.2	62.4	64.3	63.8	52.9	58.9	63.9	56.3	60.6	53.1	56.1	66.0	57.0	80.1	69.6	14.7	105.4	56.2	42.9	35.9	71.7	63.2	69.0	58.5	64.1	52.9	36.1	31.3	73.0	50.1	151.9	51.4	45.0	65.1	51.6	52.7	76.8	57.7	76.7	129.4	13.9	62.2	58.8	67.7	55.5	54.2	58.9	78.8	60.3	43.0	63.6	48.8	16.2	66.4	30.5	102.4	76.5	73.9	86.3	92.3	35.6	16.9	81.1	70.8	93.7	21.6	22.2	68.6	39.4	71.5	152.2	48.6	49.5	29.5	49.9	97.3	78.9	74.7	70.3	113.6	108.9	99.1	60.2	53.4	134.2	60.3	73.6	43.6
HNRNPUL2	"DKFZp762N1910, HNRPUL2"	ENSG00000214753	"Heterogeneous nuclear ribonucleoprotein U like 2"	Q1KMD3	11	62712630-62727457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA041632, HPA056696, HPA067699"	Supported		Enhanced	Nucleoplasm		NA	NA		88000	"Cluster 6: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891"	"unprognostic (3.06e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.48e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.45e-2)"	30.4	20.9	44.3	28.6	45.4	27.3	26.2	47.3	52.3	28.7	37.2	40.5	29.0	32.5	36.3	37.2	29.1	17.1	33.1	45.0	43.1	26.8	21.1	25.8	35.1	42.3	43.8	26.5	32.5	24.7	20.9	25.1	43.0	26.6	28.0	37.5	30.6	30.2	48.6	39.8	35.2	28.3	42.4	34.1	31.3	16.7	45.5	47.4	24.3	35.9	37.6	34.2	28.2	44.2	110.9	49.8	83.5	50.3	45.1	55.3	14.4	70.2	41.5	52.1	40.2	34.4	37.5	129.1	36.5	57.9	45.0	62.2	51.2	66.3	69.1	59.1	27.8	123.0	64.9	39.1	41.2	127.8	78.1	43.8	50.7	50.2	61.4	41.0	64.8	33.5	46.6	47.8	61.0	63.5	128.1	114.1	39.8	41.4	42.9	88.6	77.0	62.3	65.4	65.2	48.4	56.3	71.7	57.8	75.3	39.3	43.5	55.6	72.8	61.0	28.2	77.4	74.4	60.8	54.3	124.6	55.3	62.1	57.5	1.1	0.8	1.3	1.4	0.6	1.0	1.0	1.0	1.2	0.5	1.3	0.8	0.9	1.0	0.8	1.4	1.4	1.0	0.5	44.3	45.4	47.3	52.3	45.0	43.1	42.3	43.8	43.0	42.4	45.5	44.2	21.1	28.9	12.1	0.0	19.0	29.4	15.0	20.2	13.6	31.3	25.0	18.7	43.8	30.0	17.5	53.3	10.4	27.9	32.4	68.8	5.9	27.4	9.9	20.8	26.3	30.6	38.4	23.5	0.0	36.0	26.9	23.0	19.4	29.7	15.2	28.0	37.5	40.7	37.9	42.1	0.0	48.3	22.4	54.1	29.4	6.9	42.0	27.6	14.2	0.0	38.0	18.2	24.7	0.0	0.0	35.0	42.7	45.9	12.5	24.1	59.6	25.6	16.1	19.7	32.9	22.8	27.5	15.6	20.1	19.6	32.1	25.2	19.8	20.6	58.6	17.4
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162438-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Endometrial stromal cells: 31.1;Enteroendocrine cells: 39.4;Proximal tubular cells: 75.1;Suprabasal keratinocytes: 27.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 6.7;myeloid DC: 5.6;NK-cell: 11.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;granulocytes: 6.7;NK-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 124.4;PC-3: 43.9;RPTEC TERT1: 42.0;SCLC-21H: 113.4;U-937: 42.3"	"Not detected"	"Not detected"							"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	4.7	5.9	0.0	2.8	0.0	2.5	6.9	0.0	0.2	12.7	0.0	22.0	0.0	17.0	5.6	1.0	19.6	0.0	0.0	0.0	0.0	28.4	0.0	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.1	14.1	3.9	0.0	0.0	4.5	16.1	25.7	14.8	1.9	0.2	0.9	0.2	0.0	0.0	1.9	0.1	0.0	0.0	16.8	13.8	0.2	37.7	0.0	0.0	18.4	6.0	4.4	0.0	14.6	11.7	1.2	1.2	2.4	1.4	0.3	1.4	7.9	0.0	34.7	23.5	0.0	1.2	0.0	124.4	0.3	1.1	0.0	0.6	0.0	0.5	6.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	43.9	8.1	0.0	0.0	42.0	0.7	113.4	0.0	15.6	0.0	0.3	0.6	0.0	31.3	1.4	0.0	11.4	14.0	0.2	0.0	0.0	0.0	0.0	42.3	0.0	6.7	0.8	0.0	1.3	0.2	0.2	0.1	0.0	0.1	5.6	0.9	0.2	0.0	0.8	11.5	0.3	1.8	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	6.2	0.0	0.0	0.0	2.0	25.1	14.9	0.0	3.4	0.0	12.2	14.7	0.5	0.0	0.0	18.4	0.0	0.2	2.9	10.5	54.8	0.0	0.0	1.0	31.1	4.3	39.4	16.6	0.0	0.0	0.3	4.8	0.0	0.6	0.0	0.0	0.7	0.0	0.3	0.0	0.0	21.7	0.0	3.4	4.2	0.0	0.0	1.9	5.4	0.0	0.8	0.0	2.1	0.0	0.0	0.0	20.2	0.0	0.9	19.4	13.3	75.1	0.0	0.0	0.0	3.0	4.6	0.0	1.0	2.6	27.6	0.3	2.2	0.3	21.4	14.2
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48728750	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 41.1;prostate: 82.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 144.7;Enteroendocrine cells: 195.2;Intestinal goblet cells: 77.0;Paneth cells: 71.3;Prostatic glandular cells: 61.9;Undifferentiated cells: 81.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	13	"PC-3: 173.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	82.3	41.1	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	4.6	0.0	1.9	6.0	0.0	13.2	0.0	0.0	0.5	0.6	0.0	0.2	0.0	2.5	3.0	0.0	3.0	0.0	1.4	0.0	8.7	0.0	0.1	1.0	4.2	2.5	1.5	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.7	0.0	0.0	0.3	0.0	2.2	173.0	0.0	1.4	0.1	0.0	0.4	0.0	0.0	2.7	0.0	4.4	0.5	0.0	0.5	0.0	0.5	4.7	4.7	1.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	144.7	0.0	0.0	0.6	0.0	0.0	0.2	195.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	77.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.3	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.1	0.2	0.1	81.6	14.6
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.0;skeletal muscle: 25.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 41.1;Fibroblasts: 20.1;Granulosa cells: 26.7;Melanocytes: 39.2;Proximal tubular cells: 22.0;Skeletal myocytes: 28.3;Smooth muscle cells: 19.6;Spermatogonia: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;HDLM-2: 28.4;HEK 293: 33.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 7.7"	"HPA063965, HPA072160"			Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA063965: AB_2685162, HPA072160: AB_2686491"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	11.0	1.7	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.3	0.0	1.0	1.3	0.4	8.1	0.0	0.0	0.0	0.0	9.8	0.0	0.1	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	25.9	7.8	6.2	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.5	0.5	0.0	0.8	3.3	0.0	21.5	8.5	7.0	1.5	2.3	2.0	2.8	1.8	0.9	3.3	0.0	1.7	8.8	0.5	3.9	0.5	2.3	2.4	28.4	33.7	0.7	5.9	0.9	0.9	0.1	5.1	7.9	3.6	4.2	1.9	0.0	2.7	0.1	7.1	0.0	5.8	2.5	0.0	2.0	0.0	1.7	0.3	0.4	4.1	0.0	6.5	2.1	0.0	6.2	7.9	4.1	9.5	0.5	6.5	0.3	0.0	5.1	9.0	1.5	2.7	0.0	0.0	0.0	0.1	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	6.5	7.9	0.5	0.0	0.0	1.8	0.0	0.3	0.2	0.0	41.1	0.0	3.7	0.1	0.2	2.1	0.0	0.0	0.0	0.4	11.5	20.1	0.0	0.0	0.0	26.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.9	4.1	4.7	0.5	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.9	0.0	0.1	0.6	22.0	0.0	0.0	6.6	28.3	19.6	9.3	21.2	0.7	9.5	0.4	0.5	7.2	0.1	0.0
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188668-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.9;epididymis: 7.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 18.5;Distal enterocytes: 20.3;Distal tubular cells: 25.4;Endothelial cells: 18.8;Intestinal goblet cells: 20.6;Oligodendrocytes: 28.0;Proximal enterocytes: 22.0;Undifferentiated cells: 28.6"	"Cancer enriched"	"Detected in many"	5	"ovarian cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.6;Hep G2: 7.2;RPTEC TERT1: 21.3;RT4: 16.9;SCLC-21H: 5.7"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.1"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.0	0.2	1.7	0.5	5.2	0.0	1.6	6.1	5.0	0.3	0.8	2.9	0.3	0.4	7.5	0.5	4.8	0.7	0.1	1.6	3.3	6.5	0.0	3.2	0.4	19.9	5.8	0.4	0.2	0.0	0.0	0.0	8.2	1.0	2.0	0.0	0.2	2.6	0.1	0.6	3.3	0.3	6.5	1.1	0.4	1.7	5.3	0.1	0.1	0.3	0.1	2.2	0.4	10.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	6.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	21.3	16.9	5.7	1.0	0.0	0.0	1.2	0.8	0.0	0.0	3.9	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.2	6.1	5.0	1.6	3.3	19.9	5.8	8.2	6.5	5.3	10.1	14.2	3.2	18.5	0.0	0.1	4.2	0.2	0.0	0.0	0.0	0.9	1.3	0.1	0.0	2.5	7.3	0.0	0.0	0.1	20.3	25.4	0.0	0.1	0.2	0.2	18.8	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	5.6	0.4	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	28.0	0.1	13.2	0.4	0.9	0.7	22.0	3.2	0.0	0.0	0.0	0.6	1.1	3.4	9.5	0.3	2.6	0.0	0.5	0.5	28.6	2.7
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452473-119637199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 320.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.1;Oligodendrocytes: 221.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 75.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		450000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	74.4	85.0	37.2	41.9	50.2	19.7	44.4	51.1	50.0	68.8	47.2	64.5	79.3	34.1	53.0	50.9	39.1	52.5	68.6	34.9	50.7	84.4	320.0	75.6	33.2	50.6	49.5	34.8	55.2	75.5	26.5	53.4	49.2	56.8	65.9	27.2	44.9	79.0	59.8	51.8	87.6	39.5	44.7	36.6	53.8	20.9	49.9	31.9	133.9	52.8	39.7	57.7	31.5	56.3	68.8	59.8	104.1	143.7	261.8	120.3	57.9	63.4	80.3	57.3	103.0	49.4	112.8	84.4	128.0	70.6	81.0	68.7	77.0	144.4	84.3	94.6	79.8	118.1	62.0	96.9	65.8	38.0	169.9	110.0	56.3	64.9	54.7	69.3	103.9	59.4	41.0	48.9	64.2	64.0	59.2	23.6	82.1	161.1	43.1	68.7	103.0	104.8	92.2	192.7	81.1	70.6	149.0	23.4	78.7	93.3	88.7	68.2	67.6	52.7	38.1	66.5	53.1	26.3	55.3	32.6	63.7	104.4	56.7	75.5	27.3	49.9	6.5	15.5	7.3	11.1	5.8	5.3	21.3	10.3	5.5	5.2	4.9	6.9	17.1	13.8	4.1	12.2	37.2	50.2	51.1	50.0	34.9	50.7	50.6	49.5	49.2	44.7	49.9	56.3	38.9	73.7	125.2	47.3	28.2	14.9	42.5	43.2	24.5	19.7	31.1	22.1	76.4	64.3	52.3	36.8	14.6	64.3	19.1	40.0	84.1	39.9	8.8	29.0	48.9	32.3	33.0	42.1	92.9	35.8	29.3	35.6	48.4	35.8	68.4	25.3	32.2	225.1	77.9	15.2	102.8	45.8	22.4	51.8	13.8	13.4	34.5	46.7	8.8	49.6	85.7	47.3	9.2	78.4	221.5	20.5	29.6	51.1	23.1	24.8	85.7	65.4	33.8	18.6	6.6	29.2	32.2	30.6	22.7	34.7	17.2	65.0	15.7	57.2	55.3	39.7
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989147	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 42.5;Hepatocytes: 68.9;Hofbauer cells: 53.9;Proximal enterocytes: 45.3;Proximal tubular cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"basophil: 61.8;eosinophil: 27.3"	"Lineage enriched"	"Detected in many"	38	"granulocytes: 61.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 91.0;Hep G2: 66.2;HMC-1: 98.1;U-2197: 96.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Approved		Enhanced	"Lipid droplets"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	27.3	25.7	5.7	10.9	6.2	4.4	17.1	14.7	9.1	8.5	3.5	15.9	19.5	9.5	2.1	12.3	9.4	11.5	11.7	5.9	5.9	27.7	136.5	11.2	8.4	6.3	5.4	8.6	25.6	8.0	5.4	4.5	6.6	8.2	5.8	1.6	10.0	4.5	7.0	18.5	18.4	9.8	5.6	16.3	11.1	6.0	7.1	2.8	6.3	4.5	5.5	13.9	8.7	6.9	20.3	23.2	2.4	11.5	7.9	28.5	1.4	24.8	38.7	4.8	10.0	1.7	34.4	1.2	8.1	30.3	0.8	6.1	2.2	3.6	2.4	91.0	5.4	1.6	18.6	66.2	7.4	0.5	98.1	13.7	6.0	23.1	4.6	11.2	2.2	1.2	4.9	1.0	18.3	43.6	0.6	14.4	1.9	8.5	3.2	2.5	7.8	22.3	15.1	1.3	8.4	4.1	3.2	15.9	2.2	1.1	31.1	1.6	11.5	10.0	2.8	96.1	2.7	1.6	15.4	1.1	39.1	2.5	0.8	61.8	1.4	27.3	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.2	0.0	0.1	1.2	0.5	0.0	0.6	0.0	0.7	5.7	6.2	14.7	9.1	5.9	5.9	6.3	5.4	6.6	5.6	7.1	6.9	7.6	3.2	4.2	3.3	1.2	7.9	2.6	4.1	4.0	0.7	13.6	9.8	1.7	27.1	2.2	14.7	0.0	2.0	0.5	10.8	15.6	42.5	37.5	1.9	7.1	11.1	7.8	4.8	0.2	30.3	3.5	26.0	8.2	4.2	9.5	9.0	6.8	68.9	53.9	1.7	0.4	11.4	6.1	7.3	15.9	2.2	6.5	11.4	14.2	0.0	12.8	2.1	0.0	0.5	1.2	20.7	14.0	5.3	1.9	1.8	45.3	46.7	1.3	0.5	13.1	9.4	6.3	0.8	1.2	4.9	12.6	1.4	1.7	6.5	23.5	2.8
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112380080-112472405	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 181.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 214.8;Early spermatids: 153.9;Granulosa cells: 187.2;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	76.3	63.6	28.1	13.3	30.1	11.6	22.8	25.1	29.5	23.3	27.6	31.7	38.9	22.8	11.5	29.8	21.2	19.0	89.9	24.8	33.1	69.0	149.0	28.7	13.9	25.4	33.2	50.8	20.0	21.8	8.8	16.8	27.1	20.3	26.9	12.6	18.8	15.9	151.7	31.1	32.2	20.5	26.6	18.6	24.6	14.0	32.0	19.6	30.4	181.3	15.8	29.2	15.0	28.5	45.0	39.4	29.0	14.8	49.0	48.4	33.4	30.1	18.6	21.1	17.7	77.0	49.4	28.5	16.2	44.4	26.9	50.6	31.9	42.2	25.8	120.9	21.0	30.0	58.5	76.1	30.7	17.1	18.5	52.0	29.9	31.3	22.8	30.5	24.8	34.7	42.3	18.9	58.2	29.6	42.5	15.3	17.2	106.9	50.3	27.1	87.4	42.7	44.5	40.4	20.7	14.5	75.8	49.5	26.0	23.7	70.0	20.0	28.3	30.2	27.9	85.2	29.6	21.5	57.3	13.5	37.0	24.8	18.2	54.3	8.4	32.8	4.6	8.1	6.8	6.9	4.8	5.0	9.5	8.4	5.6	5.9	48.0	5.9	11.5	9.4	8.7	4.9	28.1	30.1	25.1	29.5	24.8	33.1	25.4	33.2	27.1	26.6	32.0	28.5	32.0	99.3	84.3	48.6	14.1	13.3	17.5	21.6	29.6	9.3	12.0	13.3	214.8	14.3	32.2	14.7	6.2	26.5	18.3	23.7	64.6	15.5	153.9	38.6	38.3	19.1	14.9	32.8	10.8	18.7	30.9	31.1	29.0	27.8	30.4	187.2	17.2	124.2	35.7	6.7	12.2	32.2	8.2	23.6	12.5	163.0	27.4	27.5	8.8	15.9	47.3	24.1	6.2	16.1	19.3	13.2	23.5	47.0	20.9	16.0	52.4	111.1	37.7	14.5	46.0	18.1	46.9	12.9	16.4	34.2	16.2	31.7	16.2	108.9	36.2	29.5
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080742-102139699	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2527.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 12150.7;Urothelial cells: 5781.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		71000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	362.9	439.5	1188.2	299.3	1221.3	459.2	438.6	1272.5	2527.6	282.1	1284.0	289.7	191.3	239.6	318.6	262.0	560.3	363.7	460.6	1213.8	1334.7	452.4	380.5	376.1	321.9	1283.8	1324.0	350.4	273.5	421.8	355.5	420.6	1351.6	348.4	311.1	1127.6	371.1	319.5	405.8	224.8	244.2	306.2	1216.2	217.6	297.5	541.9	1274.3	404.8	223.3	434.9	376.7	406.5	232.8	1639.1	1348.6	1832.2	1142.0	794.2	678.0	567.7	1512.1	1466.0	709.0	1779.5	994.1	1123.6	1245.6	1671.5	1323.1	960.7	1164.7	1471.2	3319.0	1452.5	3215.8	1227.4	1091.9	1291.8	1029.3	1444.3	334.9	1936.9	950.0	539.4	604.6	1140.3	416.2	1107.1	998.6	1764.9	1818.9	838.8	1634.1	1850.8	2087.7	891.1	1191.0	2500.5	1709.3	1968.2	1550.2	715.1	1030.3	1738.2	1497.0	1077.2	1860.4	1389.6	848.2	1903.9	1790.2	765.2	708.2	1234.6	786.5	1860.0	2826.4	783.5	2534.1	2402.7	1167.3	1182.5	1521.0	184.4	87.6	112.1	195.4	128.5	254.9	128.4	162.4	202.2	104.9	127.8	119.2	174.8	57.5	252.6	124.9	208.0	177.8	113.5	1188.2	1221.3	1272.5	2527.6	1213.8	1334.7	1283.8	1324.0	1351.6	1216.2	1274.3	1639.1	1571.4	1137.8	696.7	255.6	934.0	1340.7	12150.7	814.1	748.4	1185.6	1215.2	1173.1	2257.3	684.9	1020.6	513.1	2103.8	1415.1	1091.2	905.8	342.4	1210.5	662.9	2972.0	1350.8	1163.8	947.3	1502.3	158.9	867.6	1909.7	1632.5	788.5	2209.5	916.4	1026.8	341.3	554.4	1348.0	723.5	216.2	992.2	703.9	618.8	3110.7	442.6	732.0	2305.3	1300.2	267.0	773.6	1548.1	356.3	96.5	435.3	779.9	1021.6	722.9	1227.4	3791.1	552.2	896.4	2827.3	3623.6	618.0	1112.4	1974.9	3800.9	2142.4	830.1	1113.7	2050.2	3196.2	972.6	1028.8	5781.1
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953931	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Plasma cells: 4874.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		330000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 12: NES - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	330.4	340.6	166.0	423.5	183.7	438.9	341.8	185.3	234.2	363.2	225.6	340.5	261.4	302.2	1032.5	157.5	305.5	218.9	309.5	164.4	206.2	317.1	736.4	271.1	245.9	205.0	191.3	302.6	397.1	336.0	247.2	521.1	201.6	360.2	387.5	185.6	254.9	382.8	87.5	120.0	269.5	385.7	188.8	322.4	297.6	180.7	196.5	228.2	1411.8	91.2	328.0	356.6	164.6	237.3	856.5	459.9	926.2	940.0	960.1	897.5	1229.9	1449.4	1133.4	776.0	1038.1	839.1	805.3	243.8	1102.2	1579.2	995.1	583.2	934.6	1578.9	1063.2	607.3	307.4	684.5	447.6	861.0	1457.4	702.1	514.6	519.6	690.9	920.0	1342.8	2643.7	1513.9	293.8	560.0	914.8	1039.9	314.7	409.2	768.3	756.9	925.5	544.5	372.2	597.1	1079.2	1064.3	527.1	271.5	645.7	889.2	912.0	932.7	1468.4	743.9	1016.2	854.4	566.1	476.0	462.8	607.9	945.5	949.0	455.6	1106.9	494.7	904.5	113.8	81.3	30.3	199.7	88.6	244.9	108.5	118.5	187.8	111.8	71.1	75.9	133.8	18.7	199.3	83.3	322.7	81.1	188.5	166.0	183.7	185.3	234.2	164.4	206.2	205.0	191.3	201.6	188.8	196.5	237.3	507.5	237.2	373.8	28.7	646.0	309.3	905.1	743.6	196.9	50.3	261.4	334.0	687.8	235.9	475.3	257.5	156.4	568.4	480.6	424.0	56.7	471.2	89.6	570.8	751.1	439.6	406.6	213.5	34.0	250.4	1081.0	714.0	390.9	690.9	405.3	500.6	446.9	891.9	553.1	77.4	41.9	631.5	238.0	300.1	309.8	47.0	563.2	378.4	421.6	52.5	240.5	141.0	199.8	30.2	61.3	321.8	419.1	337.7	4874.6	760.6	246.1	271.4	404.2	111.6	216.9	325.7	569.3	489.0	154.4	196.3	260.7	921.0	316.0	542.6	494.6	620.0
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302673-76304295	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 5909.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 16589.4;Exocrine glandular cells: 6539.7;Squamous epithelial cells: 6300.1;Urothelial cells: 13091.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 2482.8;MCF7: 3979.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	964.4	856.4	810.6	329.6	835.1	52.3	560.5	821.6	1798.8	2123.4	864.3	2043.6	208.7	2824.2	131.7	5909.6	993.8	217.2	2981.9	776.6	944.5	986.4	554.9	790.9	99.0	894.1	838.7	731.6	751.7	221.1	303.3	324.3	870.8	979.0	73.8	10.2	1075.3	522.5	3669.8	2258.3	523.8	1066.9	808.2	224.5	770.3	99.8	840.0	218.7	627.1	628.1	279.3	1579.4	3398.4	869.5	1251.1	902.4	79.5	576.8	487.3	447.5	5.1	514.9	249.8	260.9	325.8	84.8	660.7	8.5	389.1	599.1	514.1	1094.2	359.0	279.6	76.5	690.9	106.4	41.5	611.4	345.5	267.9	69.9	466.5	542.8	2482.8	370.0	50.5	436.6	831.3	169.5	459.4	1079.7	276.5	3979.7	117.1	508.9	407.4	212.7	800.6	417.3	195.8	974.5	342.8	423.2	7.6	529.1	363.8	1323.3	456.0	224.5	1674.9	551.6	504.2	778.8	1200.3	221.7	1310.1	85.7	145.9	10.7	575.9	247.2	579.5	19.7	13.6	10.9	58.8	78.2	28.1	115.0	92.4	62.1	31.5	105.5	102.1	88.2	5.8	79.7	112.8	56.5	64.5	46.7	810.6	835.1	821.6	1798.8	776.6	944.5	894.1	838.7	870.8	808.2	840.0	869.5	708.2	272.4	186.4	78.4	145.4	1849.8	16589.4	3603.0	1728.4	243.4	312.5	174.4	822.3	264.5	1899.4	1144.0	323.2	161.7	62.0	824.2	1500.7	2021.4	11.9	1181.8	1060.9	1038.7	422.0	136.1	4.3	6539.7	399.4	998.5	219.2	1227.1	216.7	136.3	725.7	234.7	1199.8	70.7	2.2	433.0	1245.1	147.7	2828.9	30.8	299.5	1024.8	2056.2	35.6	188.0	171.4	50.4	8.0	2.7	2719.4	1417.1	534.5	296.9	3854.8	95.3	2324.4	1253.9	29.2	611.4	551.2	2129.1	20.3	105.5	6300.1	2241.7	2432.7	758.2	68.2	390.5	13091.2
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486584-197516737	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 790.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1737.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		18000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	179.4	790.6	188.6	128.3	191.6	110.6	168.8	204.9	401.9	96.9	217.8	170.0	158.1	90.8	89.3	124.5	132.6	69.1	145.0	184.3	198.6	374.9	462.6	136.6	149.2	199.6	198.5	167.6	219.0	159.2	116.0	148.6	205.3	104.5	195.1	71.8	93.9	93.6	162.7	83.3	148.7	104.5	195.1	94.6	155.4	57.6	198.6	99.3	138.7	176.7	172.7	144.6	92.3	201.4	559.7	650.1	541.3	496.9	373.6	389.2	786.5	573.2	304.7	686.1	495.6	2219.1	326.2	1724.4	730.0	304.1	834.2	538.4	2232.9	633.2	943.0	417.0	888.2	1209.8	984.8	2562.8	353.2	1331.4	349.1	445.5	717.1	599.5	1053.2	471.4	542.6	919.1	1535.3	606.8	501.7	690.4	853.6	1304.2	1086.4	735.2	1424.9	1000.1	679.7	1235.5	709.5	539.7	716.5	400.8	582.0	608.5	771.0	1116.3	425.0	789.4	242.2	405.8	570.4	532.8	910.0	331.1	861.4	1399.5	485.7	795.3	456.7	12.1	52.3	11.4	36.4	81.8	71.7	63.8	59.6	54.3	84.6	54.0	81.0	70.3	11.0	62.6	72.1	49.4	51.8	70.6	188.6	191.6	204.9	401.9	184.3	198.6	199.6	198.5	205.3	195.1	198.6	201.4	216.4	166.7	172.5	38.8	220.4	246.6	1737.2	247.5	264.0	75.8	216.0	263.1	239.2	195.9	287.9	79.1	256.5	825.7	197.7	213.7	375.6	235.0	6.2	322.2	304.5	233.9	274.6	241.6	31.9	145.9	419.8	356.0	215.6	445.2	299.5	407.1	63.1	312.5	328.0	95.9	47.2	302.2	166.8	88.6	479.3	12.8	130.5	381.9	163.7	30.0	138.5	125.7	68.0	20.6	35.6	171.4	163.2	113.6	322.9	705.9	160.1	797.1	328.6	117.1	85.5	199.0	471.7	88.5	106.0	262.4	207.1	1001.2	467.2	1017.4	512.1	861.5
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134973-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1251.1"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1316.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 1251.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	52.2	42.1	175.9	23.5	193.6	20.7	27.9	175.2	1251.1	25.0	182.5	29.3	11.3	25.9	37.6	35.8	54.8	32.3	57.3	184.9	189.3	73.5	47.6	66.6	34.9	172.7	180.7	56.3	28.6	30.3	63.8	37.8	180.9	28.4	25.3	26.7	20.1	29.3	36.6	21.7	20.4	28.0	177.2	32.3	53.1	67.8	190.2	37.4	32.2	32.6	45.1	58.8	35.4	227.4	69.9	130.7	105.1	10.2	99.1	56.0	70.0	117.8	104.6	179.0	82.8	154.9	105.4	179.6	71.9	82.4	253.7	131.2	411.7	104.8	229.2	141.6	51.7	155.7	69.3	137.2	32.3	109.1	118.8	35.5	236.5	119.6	68.3	93.0	105.4	62.0	132.7	27.8	127.4	94.7	158.1	124.2	150.3	338.6	96.6	122.5	85.8	58.9	135.0	83.5	108.5	90.1	107.4	104.0	56.6	160.6	35.0	104.7	64.4	61.3	77.4	89.2	132.4	21.8	76.0	150.6	51.0	129.8	104.7	1.4	5.0	2.7	7.6	12.2	9.4	11.1	9.7	11.8	8.4	10.6	14.7	13.8	0.5	16.7	19.6	6.6	7.0	7.7	175.9	193.6	175.2	1251.1	184.9	189.3	172.7	180.7	180.9	177.2	190.2	227.4	171.1	131.4	87.7	36.6	130.8	214.6	1316.2	44.7	175.2	38.7	152.2	143.3	163.6	40.0	123.3	46.0	417.0	23.2	78.9	153.2	29.4	49.8	100.0	346.1	140.1	132.3	227.7	58.9	121.0	35.9	64.2	249.6	94.3	250.6	248.6	61.7	26.4	25.7	90.6	30.3	77.7	159.0	65.1	38.6	452.1	36.5	33.8	281.3	163.7	55.3	42.6	28.2	26.8	30.7	53.2	45.5	154.0	39.1	142.0	426.3	18.2	31.6	290.5	79.0	39.5	98.1	153.1	161.3	164.6	151.1	143.3	42.5	363.8	58.5	166.1	511.8
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	38.9	99.7	53.4	31.0	54.1	54.7	35.7	56.0	60.6	33.5	45.9	34.8	25.4	39.4	59.1	30.3	35.1	28.6	65.4	51.5	74.1	43.3	30.8	26.9	34.5	60.8	56.4	60.2	27.7	52.8	144.7	36.4	56.7	35.3	35.3	56.1	28.4	39.6	181.8	35.1	26.0	34.6	56.1	28.5	32.5	41.5	79.9	43.0	47.6	109.2	35.7	35.1	27.8	55.3	151.4	79.3	99.9	70.5	72.1	54.0	87.1	71.5	60.4	57.2	55.5	47.6	66.0	114.1	163.1	68.1	66.3	66.0	120.5	52.3	75.0	86.5	106.9	70.9	99.9	59.2	40.8	138.1	57.7	48.4	66.1	63.2	39.3	40.8	60.3	166.3	67.4	81.0	76.5	114.3	135.7	115.4	58.7	139.4	115.7	104.2	123.7	103.3	62.0	105.9	69.0	106.9	66.7	54.4	56.4	83.9	39.8	96.5	57.4	69.2	52.2	79.5	126.1	47.6	69.1	92.7	44.4	192.4	50.3	48.4	20.6	33.2	41.0	21.5	44.5	33.9	44.4	42.2	28.5	33.3	44.8	40.7	6.7	49.7	35.3	20.6	47.9	27.9	53.4	54.1	56.0	60.6	51.5	74.1	60.8	56.4	56.7	56.1	79.9	55.3	28.2	51.3	42.9	11.4	36.8	29.6	38.0	28.0	38.7	52.5	25.8	23.5	173.3	20.0	53.1	49.7	10.4	95.3	37.6	26.2	49.0	36.7	6.8	51.0	39.3	29.8	81.2	55.5	10.2	34.3	69.8	42.1	42.3	32.9	34.8	48.4	10.4	22.8	38.2	42.1	12.1	37.8	28.5	19.5	19.2	11.7	45.1	30.3	32.0	7.5	34.4	78.0	25.7	8.0	13.6	32.5	18.5	53.8	54.3	37.2	20.4	32.1	44.4	56.7	46.0	46.9	41.0	29.4	92.2	42.7	26.6	116.8	51.6	45.8	32.6	36.8
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1"	Q7Z6Z7	X	53532096-53686728	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Granulosa cells: 507.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		73000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	37.7	46.1	55.6	21.1	57.4	26.7	37.4	57.6	69.6	39.8	42.0	49.4	17.6	45.6	52.6	48.4	40.7	18.5	57.1	62.6	61.3	45.2	41.8	36.1	26.6	58.7	67.8	54.0	45.9	43.2	54.2	24.0	73.2	38.4	22.7	40.0	38.9	28.6	101.0	59.3	40.2	28.8	49.1	42.5	45.5	43.0	65.1	41.2	42.9	58.1	30.3	44.6	40.2	57.2	166.8	100.4	64.0	45.4	109.2	64.8	78.5	48.8	62.6	50.2	52.3	77.0	52.2	86.6	32.3	89.4	90.4	77.8	145.6	81.8	68.3	125.6	64.6	69.1	91.9	60.5	100.2	104.5	40.6	62.4	59.8	120.8	137.6	49.7	88.3	66.4	70.3	54.5	66.3	102.4	57.0	58.2	87.7	45.4	71.3	52.0	87.9	52.8	84.0	113.3	53.1	38.4	137.7	60.5	44.1	118.7	87.0	50.1	113.8	46.0	65.8	66.5	62.9	47.3	50.2	73.1	49.2	100.1	67.6	2.8	2.3	4.3	3.3	1.9	4.0	2.4	3.1	3.5	3.3	2.4	2.2	2.2	1.9	3.5	3.8	3.5	2.9	1.9	55.6	57.4	57.6	69.6	62.6	61.3	58.7	67.8	73.2	49.1	65.1	57.2	41.4	51.3	46.1	70.2	41.9	30.1	32.6	30.4	44.9	57.8	37.0	35.6	110.4	37.1	35.4	40.5	50.1	31.0	40.0	29.2	1.9	42.8	28.6	45.6	59.8	38.3	47.6	47.7	94.4	35.4	34.8	38.6	57.1	69.6	22.1	507.7	32.9	48.1	24.8	82.4	85.8	28.1	18.3	31.4	30.8	32.8	28.3	34.1	26.6	59.0	43.7	22.6	35.0	83.9	95.3	49.3	20.5	39.1	50.9	44.1	27.1	14.7	35.7	33.3	13.1	69.6	56.4	34.5	44.6	53.3	41.6	37.9	46.7	114.1	31.7	42.0
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094132-220148041	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		35000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	55.8	49.8	19.9	33.3	21.1	18.3	41.8	23.5	25.4	35.3	37.8	54.2	43.4	31.8	31.4	47.9	41.4	30.5	60.0	20.0	21.8	65.5	83.8	31.0	38.8	22.7	22.2	39.0	33.6	80.5	16.0	40.7	25.0	36.1	54.8	34.8	40.0	37.5	92.9	40.5	40.4	39.4	21.6	28.4	39.1	30.1	22.3	31.8	39.7	85.7	43.1	35.6	30.0	22.9	137.2	125.6	70.7	69.9	104.2	104.4	169.6	81.4	86.9	87.9	70.7	121.7	138.8	125.6	107.1	101.4	68.0	129.3	99.0	101.5	100.9	87.5	119.3	62.6	94.6	137.8	64.6	100.4	64.9	76.0	101.3	95.4	97.6	84.7	86.9	79.9	156.9	70.7	116.7	75.9	79.8	72.0	92.1	106.2	82.1	69.5	140.7	202.2	126.2	90.4	38.0	106.6	123.2	188.2	130.3	80.6	218.5	111.9	89.8	86.1	71.6	117.0	138.4	60.0	98.9	90.8	91.3	77.3	97.6	33.8	24.6	22.8	23.0	27.7	30.8	23.6	24.9	30.3	29.2	18.3	27.8	25.6	4.7	28.3	22.3	10.6	29.9	26.7	19.9	21.1	23.5	25.4	20.0	21.8	22.7	22.2	25.0	21.6	22.3	22.9	66.4	35.3	38.0	15.7	30.7	20.1	28.6	44.1	34.7	28.6	40.1	39.4	144.3	22.8	42.9	29.5	25.0	79.0	31.5	54.2	11.7	47.7	20.0	63.8	48.3	43.7	36.2	29.6	17.3	65.4	55.5	37.0	32.1	44.3	19.6	41.3	37.5	99.6	45.9	20.2	22.7	55.4	28.5	51.0	11.2	6.8	37.3	35.9	19.6	15.0	46.1	34.6	27.8	16.6	31.5	67.4	44.9	42.5	33.1	34.1	38.4	36.1	62.0	35.5	46.0	46.3	39.0	44.6	44.1	63.5	26.6	71.7	31.0	54.4	69.9	27.6
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1667.3;Basal respiratory cells: 1443.4;Hepatic stellate cells: 2131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 509.6;HaCaT: 500.2;Hep G2: 425.3;PC-3: 515.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	242.2	88.5	53.0	20.2	43.1	9.0	141.3	50.1	57.1	125.7	60.9	136.7	78.4	116.0	4.7	340.4	146.3	35.0	291.9	45.3	56.8	218.1	154.1	204.7	14.0	69.3	56.0	66.8	42.4	8.1	167.8	45.7	62.3	202.5	26.4	5.1	58.5	149.6	53.8	129.6	154.3	12.2	53.3	79.7	162.5	16.4	79.1	5.9	266.8	37.8	6.2	351.1	206.9	47.1	76.1	245.3	2.7	49.3	31.2	14.1	187.6	314.1	12.6	56.9	6.2	130.5	111.4	0.6	509.6	84.3	67.2	500.2	40.1	17.9	8.6	6.2	25.6	41.5	229.2	425.3	42.3	0.9	2.2	57.4	69.7	0.3	4.3	93.5	35.0	27.6	94.0	2.3	110.4	99.8	11.4	1.8	172.7	336.5	515.3	0.9	200.8	4.2	11.1	206.1	93.5	87.4	261.3	91.9	2.4	128.8	57.0	7.6	188.5	151.3	300.0	49.0	216.1	5.6	6.3	5.2	176.2	39.5	21.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	0.1	53.0	43.1	50.1	57.1	45.3	56.8	69.3	56.0	62.3	53.3	79.1	47.1	1667.3	237.2	171.7	88.2	25.1	102.3	992.2	1443.4	406.3	2.7	98.6	114.3	35.1	112.9	685.1	228.1	4.2	129.9	46.3	594.3	37.2	584.1	5.7	794.1	450.1	907.7	572.7	49.9	0.6	535.5	493.7	195.3	675.3	707.6	22.2	8.9	2131.4	109.1	25.6	0.0	0.5	557.4	321.4	72.2	52.4	8.7	28.6	38.9	90.7	92.8	8.2	85.0	1.0	4.0	0.3	257.4	924.9	0.4	26.7	519.7	579.8	7.1	168.1	8.3	13.1	229.7	206.1	3.2	53.7	455.8	87.9	89.1	39.8	15.9	389.1	591.6
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	22.6	25.1	11.5	19.9	12.6	9.7	9.6	17.0	14.7	12.4	21.4	26.2	36.6	13.7	7.8	17.0	11.0	9.0	62.5	14.8	13.2	16.8	14.2	11.9	17.1	13.0	13.1	10.8	13.0	54.7	6.9	12.1	15.2	13.9	26.7	26.2	16.2	16.1	79.4	15.8	36.0	17.1	10.1	15.3	11.9	16.9	14.3	35.0	11.2	99.7	24.8	17.7	11.1	14.8	43.8	58.5	10.4	36.5	25.5	26.1	22.6	50.8	24.5	40.6	30.5	41.6	25.8	91.6	36.8	29.9	59.9	64.2	98.2	39.3	37.0	40.7	32.2	35.7	62.4	19.2	21.8	69.8	48.8	19.9	23.6	39.4	41.2	19.3	25.7	32.0	46.4	35.9	26.0	41.4	51.4	17.4	12.9	25.2	21.8	29.3	44.4	28.1	33.4	58.3	41.4	15.8	58.2	82.1	47.1	19.1	32.7	37.4	26.4	47.6	43.9	63.1	83.1	41.5	99.9	48.8	33.2	64.9	37.7	16.9	27.9	8.3	15.1	52.9	16.4	27.7	14.7	13.5	43.5	32.6	15.2	16.4	15.5	17.3	54.8	144.4	17.7	23.2	11.5	12.6	17.0	14.7	14.8	13.2	13.0	13.1	15.2	10.1	14.3	14.8	18.0	9.6	16.5	22.9	30.6	56.0	58.7	51.4	33.0	35.1	10.9	12.6	17.5	14.3	22.6	25.8	37.5	38.3	63.0	69.0	82.2	26.1	52.2	19.9	13.4	17.5	19.2	9.4	45.9	17.9	40.4	21.2	11.7	9.2	27.3	14.5	10.8	22.4	26.5	26.9	53.3	37.6	69.2	24.9	28.6	23.4	20.8	26.4	26.6	12.2	16.0	29.3	12.3	19.6	17.9	21.5	37.9	23.7	33.2	40.6	49.6	48.1	38.2	34.6	13.1	23.8	25.5	45.7	26.2	28.4	41.2	68.4	17.7	37.2	56.0	42.0
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA		8300	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	55.6	61.3	51.8	33.4	53.0	57.9	54.7	60.8	57.9	56.6	49.4	70.8	73.9	57.3	35.9	62.4	49.8	29.6	185.8	53.8	56.3	71.0	60.5	43.9	41.9	58.0	54.0	57.7	46.0	75.3	36.8	41.1	60.0	45.7	59.7	46.1	49.1	43.1	204.0	61.9	59.9	44.7	50.6	53.1	63.7	36.6	56.6	59.5	49.4	236.6	56.5	55.5	53.4	56.0	111.6	147.4	66.0	57.9	71.3	55.9	76.0	58.2	74.0	134.5	106.7	191.4	113.4	124.5	52.2	80.4	123.7	152.7	122.9	189.0	122.6	34.7	96.7	151.2	58.4	200.6	69.7	166.5	31.8	74.4	71.5	125.9	65.7	59.2	80.4	105.6	194.9	67.7	83.0	61.1	146.1	190.4	128.3	113.4	137.9	117.7	120.2	140.2	77.7	102.5	118.5	85.5	71.9	235.0	127.3	50.8	118.1	73.0	72.4	104.2	65.4	35.8	136.3	91.2	225.3	129.8	49.1	169.9	101.2	76.0	111.7	72.2	84.9	120.8	64.5	96.3	72.8	77.7	131.9	84.6	84.6	73.1	31.4	84.8	110.9	61.2	108.1	102.1	51.8	53.0	60.8	57.9	53.8	56.3	58.0	54.0	60.0	50.6	56.6	56.0	50.7	38.5	28.2	10.4	52.1	56.7	60.2	103.8	48.9	37.9	38.5	38.2	186.0	52.9	49.5	23.9	33.3	133.9	71.3	81.7	156.5	88.5	59.3	28.2	36.0	53.7	50.7	41.6	7.0	102.1	86.3	49.2	37.2	35.9	48.2	54.1	41.7	55.4	97.6	13.5	7.6	68.4	71.2	57.7	60.9	115.1	45.1	51.7	69.4	10.3	78.7	49.3	56.7	6.6	8.9	70.8	72.5	47.4	38.1	37.5	121.7	174.9	33.4	33.4	78.9	50.0	64.1	52.8	55.3	48.4	60.0	108.5	49.1	63.4	113.7	54.3
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928790	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.7;placenta: 110.9"	"Cell type enriched"	"Detected in many"	11	"monocytes: 2612.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"eosinophil: 465.0"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 465.0"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 61.8"	"Region enriched"	"Detected in many"	12	"basal ganglia: 34.1"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	9.8	0.7	0.6	40.5	0.4	0.7	2.0	0.4	0.8	7.2	1.0	5.3	10.3	10.2	1.2	1.3	2.6	6.2	1.8	0.4	0.6	1.7	2.4	25.9	58.7	0.7	0.3	1.2	1.2	0.2	0.1	110.9	0.5	2.0	8.2	1.3	1.9	3.0	8.1	1.3	8.4	2.4	0.4	23.0	5.8	1.1	0.8	31.2	4.0	0.6	31.5	9.1	0.5	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	7.6	4.8	0.3	0.8	0.0	61.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.1	0.2	0.2	0.0	0.3	0.0	32.5	1.3	465.0	0.1	1.4	0.1	0.2	0.1	0.0	26.4	0.3	0.1	0.2	4.9	0.1	0.1	0.3	0.1	1.2	0.6	0.4	0.4	0.8	0.4	0.6	0.7	0.3	0.5	0.4	0.8	0.6	24.9	0.0	0.5	0.7	4.4	0.4	0.2	18.3	0.0	0.0	0.5	0.1	0.3	0.0	76.0	0.0	0.0	0.0	0.3	8.3	0.0	4.4	3.7	70.1	23.0	6.9	0.0	0.0	0.2	8.1	0.0	0.3	0.0	223.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	2.0	3.7	28.1	1.8	0.0	13.6	0.0	0.0	2612.3	3.0	0.0	0.0	0.1	0.4	0.0	0.4	2.4	0.5	0.0	0.0	33.3	0.2	0.0	1.2	8.4	0.0	0.1	0.1	0.6	0.0	1.3	0.0	1.3	2.0
IER2	ETR101	ENSG00000160888	"Immediate early response 2"	Q9BTL4	19	13150411-13154911	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5;U-266/84: 338.3"	"Low region specificity"	"Detected in all"							"HPA055387, HPA060574"			Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055387: AB_2682802, HPA060574: AB_2684324"	"unprognostic (3.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	193.3	74.8	26.8	44.2	20.3	239.8	103.8	50.0	28.5	53.8	20.7	115.7	39.6	65.1	7.3	128.6	298.3	36.8	90.7	20.0	23.3	117.8	118.5	136.4	47.3	30.0	27.1	107.5	119.3	31.0	87.8	33.9	30.3	83.8	29.9	16.7	104.8	27.9	26.4	276.3	78.3	45.4	26.4	95.4	139.7	13.7	28.9	45.2	107.7	49.5	20.8	90.7	78.4	25.7	62.4	36.3	28.2	43.0	18.3	24.5	62.2	47.4	25.6	32.0	18.8	31.4	36.9	36.7	46.7	34.5	53.8	41.4	13.1	27.4	15.9	22.2	24.6	48.2	67.9	26.5	22.4	61.2	51.9	12.7	66.3	34.5	21.4	38.9	37.9	37.4	123.6	48.1	12.5	102.4	37.1	255.5	53.5	66.9	155.8	71.8	28.4	45.0	29.5	36.2	34.7	49.7	53.0	160.0	114.5	22.1	19.1	36.6	68.8	67.0	46.2	56.1	138.6	139.9	338.3	37.9	36.3	120.4	53.0	363.9	167.4	273.7	249.7	191.3	214.5	139.9	175.1	202.5	100.5	155.3	114.7	146.8	833.3	215.0	183.7	45.1	178.2	275.5	26.8	20.3	50.0	28.5	20.0	23.3	30.0	27.1	30.3	26.4	28.9	25.7	1678.3	176.3	492.4	31.3	636.9	319.0	1201.7	587.9	659.0	82.2	977.1	1651.1	61.3	571.9	330.0	95.6	35.5	539.9	974.9	807.5	52.8	873.6	14.0	714.9	1302.8	718.1	977.5	75.6	6.7	380.3	541.6	721.1	1071.4	1261.4	489.2	279.8	427.3	83.5	593.9	15.2	7.5	973.4	553.4	316.8	366.4	11.9	137.9	714.3	236.5	48.7	144.7	453.1	185.3	7.5	6.7	494.4	691.5	38.7	484.3	779.5	680.9	44.5	221.7	141.9	644.2	591.4	730.3	6.6	10.1	720.1	441.6	915.6	671.4	313.4	652.7	418.5
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406487	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 63.3;Distal tubular cells: 64.6;Muller glia cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 66.7"	"Group enriched"	"Detected in all"	8	"granulocytes: 66.7;monocytes: 21.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 325.3;BJ hTERT+ SV40 Large T+ RasG12V: 318.1"									"CAB045980, HPA053890, HPA055380"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.5	38.0	12.6	4.5	12.4	9.9	14.3	15.2	17.8	17.2	13.0	14.6	3.9	6.9	6.6	5.0	9.5	13.8	22.7	12.4	12.7	23.7	24.9	14.1	3.4	15.1	14.2	9.1	6.1	11.9	20.3	9.9	13.5	6.7	5.0	8.0	42.0	6.2	17.4	4.9	7.5	7.9	29.4	18.7	6.9	5.4	13.9	13.3	9.1	20.6	2.4	7.6	9.4	14.4	10.0	1.2	2.6	17.2	8.1	16.5	0.2	11.7	68.9	325.3	318.1	1.0	10.4	0.7	3.8	14.6	63.4	8.2	1.0	1.0	15.6	0.6	1.1	1.7	8.4	0.9	9.2	1.4	1.7	13.5	0.3	6.2	0.1	6.4	0.4	1.7	0.2	7.7	3.5	0.3	2.3	6.8	0.3	0.1	6.3	3.1	0.8	2.0	7.9	1.2	0.1	0.6	3.1	2.4	69.6	2.4	1.3	1.5	0.5	1.7	1.9	2.5	1.4	1.0	1.3	0.6	2.2	2.3	0.9	9.9	12.6	15.4	1.6	15.6	2.9	3.0	4.1	2.9	3.7	3.2	5.7	3.5	66.7	1.9	21.7	0.2	4.9	6.6	12.6	12.4	15.2	17.8	12.4	12.7	15.1	14.2	13.5	29.4	13.9	14.4	63.3	35.3	5.8	7.2	2.5	2.9	3.3	12.9	3.4	26.4	2.4	5.2	19.1	4.3	7.6	9.2	18.8	4.8	4.7	6.3	64.6	12.6	0.4	21.1	3.2	41.4	0.0	4.0	13.8	5.1	20.8	22.8	0.5	7.2	2.5	11.0	9.3	12.1	36.9	32.0	13.3	1.4	4.1	14.5	3.3	3.0	19.3	13.3	1.8	16.9	13.5	77.9	1.0	12.1	14.4	3.6	4.7	43.6	0.7	1.1	9.8	26.7	17.8	13.4	39.5	18.1	11.4	0.5	3.0	1.0	1.7	1.4	3.1	15.4	0.2	1.2
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643130-185825042	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.6;Glandular and luminal cells: 117.7;Rod photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 263.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	8.0	9.0	0.9	4.1	1.1	11.9	5.3	6.4	2.0	7.2	1.3	12.6	15.0	5.0	0.7	3.3	11.2	7.5	9.0	1.0	2.1	8.2	1.6	11.7	1.3	2.2	2.1	6.6	4.9	6.4	1.4	15.1	1.3	1.9	14.9	22.3	9.3	1.1	2.0	4.4	16.0	4.6	1.5	4.4	13.2	6.1	1.9	2.2	7.3	3.4	1.8	3.8	5.5	1.2	129.4	11.0	124.2	22.5	64.8	102.5	73.2	68.5	94.2	102.2	121.6	94.1	36.2	0.0	98.2	56.9	130.1	57.7	58.4	97.3	163.9	0.2	58.2	37.7	0.6	64.1	140.2	1.2	0.2	75.0	50.4	67.6	263.9	53.2	95.3	10.1	37.6	0.1	75.2	1.1	0.3	27.8	87.3	22.1	45.7	13.5	48.1	38.8	63.7	0.4	7.7	1.2	5.0	0.2	113.5	120.5	10.1	82.1	144.8	34.8	74.8	44.6	78.2	0.4	0.2	0.3	34.7	0.1	50.3	0.4	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.7	1.7	0.4	0.0	0.6	0.9	1.1	6.4	2.0	1.0	2.1	2.2	2.1	1.3	1.5	1.9	1.2	6.2	12.8	11.6	2.3	0.6	19.8	20.1	48.1	1.2	5.2	18.4	6.2	15.7	44.3	49.2	25.8	16.7	2.8	0.9	82.0	3.9	38.9	126.6	86.4	13.8	18.9	35.6	46.9	0.7	25.4	18.0	25.3	20.9	117.7	2.5	64.5	39.7	0.5	16.4	1.7	1.1	44.7	46.8	8.8	16.9	81.7	5.3	10.5	14.2	13.1	11.3	21.2	6.2	4.5	0.2	61.1	80.1	0.4	1.5	63.0	68.8	11.4	74.8	176.7	0.0	2.0	18.8	4.7	14.4	1.2	14.6	6.3	1.1	0.8	45.9	77.8
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
IK	"RED, RER"	ENSG00000113141	"IK cytokine"	Q13123	5	140647058-140662480	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 438.7;Endometrial ciliated cells: 510.8;Respiratory ciliated cells: 732.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048798	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"		"HPA048798: AB_2680525"	"unprognostic (9.90e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.83e-1)"	73.9	64.0	53.4	68.7	56.6	135.4	66.9	64.4	70.8	70.0	62.3	76.1	55.4	73.9	74.4	77.0	143.5	53.4	74.2	54.2	68.6	67.0	68.6	69.5	89.9	60.6	60.6	78.8	48.3	74.3	55.8	64.9	59.9	60.3	70.3	90.4	65.2	66.2	136.5	73.4	67.9	64.6	57.0	71.6	60.5	107.7	57.6	114.0	72.6	83.0	96.0	69.6	68.1	62.3	119.1	132.5	114.4	163.2	125.7	106.4	133.4	139.0	146.7	151.6	153.2	184.1	133.4	138.9	167.4	145.4	172.3	120.9	168.2	190.1	175.4	198.1	136.6	130.4	213.2	117.8	129.6	214.6	136.9	117.2	124.4	151.5	136.8	112.0	132.7	114.9	144.3	121.1	137.3	110.0	184.1	216.8	74.5	100.3	134.2	145.5	160.7	141.4	117.7	109.2	103.6	112.3	171.5	155.6	172.9	97.9	181.3	171.8	141.2	126.2	87.9	106.2	167.8	181.8	294.1	188.4	141.8	162.4	94.5	353.1	136.5	240.3	188.3	157.1	168.9	197.4	202.7	194.3	139.0	191.5	212.7	199.1	229.4	198.8	193.0	131.2	284.4	247.0	53.4	56.6	64.4	70.8	54.2	68.6	60.6	60.6	59.9	57.0	57.6	62.3	110.7	163.5	134.9	10.1	102.8	46.1	86.4	127.5	61.5	75.3	40.0	57.7	126.7	80.1	177.1	86.5	29.2	115.2	139.9	69.2	121.3	106.4	438.7	510.8	124.9	91.4	34.1	137.6	7.6	99.6	99.6	82.6	50.0	107.2	132.2	68.0	54.3	74.7	70.6	53.8	8.2	66.4	97.6	56.8	58.8	55.0	98.2	80.2	56.9	8.4	107.4	116.1	151.4	8.5	7.4	110.1	67.3	83.8	76.9	50.5	80.4	120.8	732.0	97.3	72.3	96.0	115.7	311.3	145.0	65.3	45.5	132.8	128.5	93.0	65.5	66.9
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 28.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in all"		"BJ: 206.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	14.0	7.1	2.3	15.3	2.8	5.1	10.1	2.3	3.1	12.6	5.0	6.6	4.1	10.3	5.8	4.8	6.7	12.9	9.3	2.3	2.9	8.3	10.3	11.0	12.6	3.2	2.7	5.9	5.8	4.2	7.7	26.8	3.2	6.8	7.0	1.2	6.1	7.4	2.6	3.1	5.7	16.0	2.9	11.8	5.6	4.6	3.1	11.6	9.3	4.8	9.6	17.1	7.4	3.7	13.0	39.8	43.5	28.4	102.8	105.8	39.4	206.0	124.7	53.3	67.2	8.8	12.4	42.4	35.5	128.7	37.1	26.7	17.5	80.5	90.1	12.4	26.7	16.2	23.9	59.8	39.3	30.2	31.1	81.1	16.6	62.4	54.5	95.3	75.3	7.8	25.5	16.0	133.3	11.8	14.0	68.7	16.9	10.2	33.5	11.9	64.0	21.7	88.9	14.6	6.6	20.8	58.9	4.1	34.1	73.6	13.1	37.0	71.6	115.7	41.3	50.5	53.9	17.2	20.1	31.8	33.3	27.2	85.1	11.4	6.4	19.3	2.8	4.9	3.3	5.9	1.8	2.9	5.4	3.8	2.0	2.0	28.1	5.0	5.7	3.7	2.6	1.8	2.3	2.8	2.3	3.1	2.3	2.9	3.2	2.7	3.2	2.9	3.1	3.7	44.9	12.8	15.7	1.6	34.4	7.6	15.5	55.6	21.6	2.8	7.9	22.4	3.0	0.0	18.7	3.7	4.2	35.5	32.5	2.3	11.7	10.5	2.8	7.9	47.4	47.7	0.0	19.8	5.9	5.8	65.3	47.0	2.6	4.4	20.8	32.7	44.3	8.4	45.7	3.3	3.3	4.8	12.2	31.2	34.1	3.6	30.7	35.4	14.2	14.0	40.4	2.0	37.0	11.6	2.2	5.1	3.1	17.0	74.8	7.6	1.0	10.1	6.3	2.6	39.5	27.8	46.8	32.1	16.0	9.0	7.2	10.1	23.6	25.3	2.9	6.5
IKBKG	"FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9"	ENSG00000269335	"Inhibitor of nuclear factor kappa B kinase regulatory subunit gamma"	Q9Y6K9	X	154541199-154565046	"Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"		"Disease variant, Ectodermal dysplasia, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000426, CAB010373"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB010373: AB_2124846, HPA000426: AB_1851572"	"unprognostic (7.53e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.37e-3)"	"unprognostic (9.77e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.36e-2)"	24.4	32.1	18.0	27.6	19.2	42.5	21.7	18.1	23.8	18.9	16.6	22.1	21.2	24.3	6.2	25.5	19.4	16.0	21.5	17.9	17.3	20.7	62.5	29.7	29.0	22.7	19.3	18.3	18.7	10.8	20.2	11.9	21.6	19.9	10.7	6.3	19.8	13.3	20.0	28.4	26.6	14.1	17.9	41.8	22.6	18.8	20.6	19.7	22.9	9.8	18.7	24.8	21.1	23.6	45.8	46.6	11.2	37.1	22.2	18.2	29.7	28.2	35.1	29.4	43.9	32.2	26.5	35.6	73.5	32.6	79.6	39.8	15.0	27.3	12.0	39.6	25.2	27.5	65.4	54.9	37.4	29.3	92.7	23.4	25.6	39.9	15.8	19.4	33.2	34.6	16.6	34.3	23.5	43.1	29.7	52.9	10.4	32.5	69.2	35.4	16.7	38.4	27.6	27.4	19.5	19.9	32.7	32.9	23.0	8.7	19.4	33.4	36.4	29.8	33.9	70.6	69.9	67.5	49.0	69.2	41.4	50.6	41.3	24.9	34.2	61.3	35.3	42.2	24.1	21.3	21.4	26.5	29.8	20.9	17.1	21.3	50.4	30.7	51.1	25.4	26.8	31.0	18.0	19.2	18.1	23.8	17.9	17.3	22.7	19.3	21.6	17.9	20.6	23.6	16.0	3.2	14.3	8.5	22.3	12.4	12.1	20.6	6.2	6.1	8.0	9.8	6.9	10.0	13.6	12.9	10.4	23.3	27.3	14.0	1.9	18.7	0.9	8.0	10.8	15.3	4.9	9.9	5.5	16.9	16.8	12.6	12.8	9.5	29.2	12.0	10.8	36.4	28.3	25.2	4.8	7.7	14.2	17.2	15.9	2.0	14.3	29.4	12.4	4.7	44.5	11.1	48.4	3.0	11.4	23.4	12.8	13.9	13.7	12.5	10.9	7.6	8.3	10.2	6.6	9.6	13.7	4.6	12.8	10.6	10.5	38.0	24.6	10.2	8.5	14.2
ILF3	"DRBP76, MPHOSPH4, MPP4, MPP4110, NF110, NF110b, NF90, NF90a, NF90c, NF90ctv, NFAR-1, NFAR-2, NFAR110, NFAR90, TCP110"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1600000	"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	49.2	58.5	31.6	79.4	31.5	179.5	49.8	44.2	37.5	60.8	38.5	56.0	52.0	64.5	40.9	60.4	61.1	31.9	49.0	31.4	37.9	43.1	32.1	50.5	82.9	30.6	32.8	76.5	52.6	55.5	53.8	47.8	29.7	52.4	44.8	69.5	54.0	48.8	83.6	58.7	56.1	49.8	29.4	61.7	47.8	78.9	35.4	97.3	61.6	58.2	72.3	56.1	52.1	42.8	285.9	226.7	359.5	330.9	76.5	104.0	208.9	178.1	149.6	291.8	226.5	261.8	160.8	353.2	172.1	160.8	178.0	248.9	392.5	240.7	260.9	227.2	349.5	459.3	206.9	247.5	109.2	334.8	219.5	99.0	105.0	232.1	257.4	111.1	253.1	201.7	400.0	269.4	172.3	233.8	558.1	534.0	433.3	149.2	246.2	405.2	342.2	244.2	116.3	297.1	395.1	286.7	229.0	179.4	131.6	161.6	152.2	212.0	205.2	237.6	224.2	249.3	356.5	228.9	339.7	431.4	132.8	351.6	262.2	20.2	18.1	10.2	24.4	14.1	20.6	19.3	20.2	22.3	22.8	22.9	19.5	20.2	2.7	21.3	21.2	25.1	20.6	11.8	31.6	31.5	44.2	37.5	31.4	37.9	30.6	32.8	29.7	29.4	35.4	42.8	63.6	99.3	133.9	34.3	106.2	86.2	110.0	64.2	104.7	95.4	77.5	64.3	69.7	60.1	98.8	42.3	85.5	90.0	100.0	78.4	27.4	89.0	21.2	89.8	105.7	77.4	114.0	124.3	24.4	80.4	111.1	94.8	101.9	121.4	96.8	145.9	36.8	47.9	71.4	94.2	34.0	85.6	50.8	55.0	68.3	21.0	76.4	75.8	39.2	24.4	66.0	69.2	92.7	31.7	28.9	88.2	55.6	62.4	124.9	144.6	38.8	47.2	82.9	103.6	32.9	100.3	80.1	137.2	120.6	113.8	77.0	70.9	103.5	140.8	111.7	94.9
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	11.7	15.6	42.8	6.4	43.7	11.1	19.3	45.5	66.4	13.5	41.8	12.7	8.6	11.5	29.8	11.7	10.4	5.1	26.2	42.8	42.3	27.2	18.6	8.9	9.5	42.4	42.0	17.5	16.4	17.9	23.3	6.9	42.3	14.3	10.0	37.7	11.8	14.1	50.0	12.5	9.5	10.7	42.9	10.8	15.1	16.7	43.0	24.8	13.2	42.1	13.1	10.9	12.6	43.5	22.9	26.9	95.6	21.0	14.9	9.9	15.3	19.9	8.7	16.2	11.7	21.0	17.5	20.7	18.7	15.9	32.5	25.8	37.6	28.8	23.8	24.9	52.6	29.4	45.5	32.3	15.8	29.6	19.9	8.0	27.1	8.7	19.2	29.5	17.5	48.8	38.0	23.2	15.9	28.2	48.5	48.9	15.8	114.6	26.3	41.1	72.2	20.6	54.6	26.2	22.5	27.0	32.5	11.6	32.5	61.9	37.1	35.1	2.6	15.3	27.2	16.2	42.2	17.2	58.2	47.5	24.9	24.9	18.5	21.9	3.0	32.2	28.9	3.4	26.3	34.1	25.3	29.5	8.1	32.1	32.0	39.8	0.8	37.3	3.0	40.2	35.4	13.6	42.8	43.7	45.5	66.4	42.8	42.3	42.4	42.0	42.3	42.9	43.0	43.5	29.2	35.3	14.6	30.7	22.4	18.2	26.8	60.5	12.0	30.6	44.6	55.1	56.8	18.6	26.8	60.7	33.3	36.3	17.6	21.7	119.3	17.0	39.8	30.2	16.9	19.4	56.5	47.4	40.6	24.5	32.5	19.7	20.9	33.8	22.7	22.7	18.2	45.0	21.3	43.7	48.0	30.6	52.9	7.7	11.4	10.5	13.4	9.4	8.8	24.4	10.3	85.3	30.9	51.3	60.7	15.8	26.7	20.7	22.0	26.0	18.6	98.4	28.9	38.5	32.9	19.1	51.0	61.6	23.0	19.6	27.3	23.7	24.2	16.2	34.7	26.2
IMMT	"HMP, Mic60, MICOS60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195472	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 288.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	41.3	82.4	30.3	34.9	31.8	40.3	36.5	33.1	39.0	30.2	41.9	57.4	57.4	35.0	27.6	43.4	30.9	27.1	174.8	31.9	34.5	80.9	65.0	32.5	44.3	35.3	34.2	28.1	48.5	90.2	36.0	36.7	35.1	29.4	58.1	42.4	37.9	35.1	200.9	38.0	46.6	38.9	29.8	44.8	56.0	49.2	32.6	52.3	35.5	288.9	47.1	41.5	33.8	32.8	115.6	111.2	99.2	45.6	93.7	88.3	101.5	80.5	85.6	108.0	98.7	160.7	89.1	175.7	78.9	87.7	87.7	83.4	128.9	118.4	131.8	71.4	105.9	139.0	65.6	192.0	95.7	135.9	91.1	100.6	84.0	101.7	119.5	67.2	124.7	99.7	138.4	96.7	105.1	99.0	135.6	140.8	117.8	175.1	88.2	89.9	211.2	158.7	122.5	128.3	119.3	89.0	82.9	124.0	126.3	77.4	70.7	94.6	93.6	76.0	83.6	112.0	101.8	76.6	104.1	119.9	86.9	158.8	94.4	12.1	29.2	12.2	23.5	34.0	20.7	15.9	20.6	19.3	32.9	13.7	18.3	22.3	3.8	20.8	33.2	17.2	23.2	25.4	30.3	31.8	33.1	39.0	31.9	34.5	35.3	34.2	35.1	29.8	32.6	32.8	29.3	54.5	49.2	31.3	42.1	23.3	34.9	51.6	30.1	40.9	21.6	19.7	223.0	24.3	57.3	40.5	33.3	94.9	49.6	57.9	133.1	59.9	152.4	26.5	34.0	38.3	56.0	76.1	41.6	52.8	73.9	36.3	39.8	26.8	48.0	55.6	35.7	64.2	70.9	23.5	46.5	46.2	38.7	49.4	28.3	158.9	27.7	48.9	17.8	26.2	80.6	30.2	52.5	29.1	44.1	43.3	36.3	36.9	56.4	28.6	59.8	92.6	41.8	42.5	6.6	39.7	58.2	100.7	54.6	41.1	24.9	98.5	45.6	118.6	68.0	33.6
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP U3 small nucleolar ribonucleoprotein 3"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"	"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	45.8	61.8	37.1	26.4	38.7	29.3	43.9	39.3	49.1	36.9	46.6	43.4	36.6	30.1	30.4	79.8	32.7	14.2	53.1	38.3	41.6	49.6	90.4	33.9	34.9	38.7	36.7	33.3	50.6	23.2	40.1	21.1	39.5	39.7	24.4	17.8	44.8	22.2	71.5	71.6	51.6	14.0	40.0	63.0	50.9	16.8	38.7	34.7	36.1	33.1	38.4	35.1	47.4	41.2	75.1	82.9	39.5	68.8	68.6	39.0	58.5	61.6	48.8	49.3	56.6	64.1	64.3	88.7	65.5	32.2	54.5	121.7	131.1	100.0	43.4	67.2	157.3	93.6	64.9	112.8	50.6	95.9	62.5	36.1	81.0	39.8	48.8	36.6	32.8	71.3	122.8	70.4	45.4	89.9	76.3	232.9	106.4	75.7	86.4	82.1	48.4	98.3	68.1	100.2	67.1	69.4	52.2	89.8	119.4	56.8	78.5	87.9	37.6	64.0	51.9	46.4	84.6	95.4	188.5	100.3	70.7	153.2	43.0	80.6	109.0	85.2	137.4	87.3	148.8	143.2	131.5	133.8	117.4	127.3	150.7	144.3	13.7	126.4	87.4	119.3	140.9	192.2	37.1	38.7	39.3	49.1	38.3	41.6	38.7	36.7	39.5	40.0	38.7	41.2	85.9	38.5	41.6	6.5	81.4	228.5	93.1	177.0	149.7	22.4	72.1	79.4	12.1	77.2	89.7	40.5	14.6	106.8	79.0	47.5	144.8	105.2	1.6	71.7	54.9	74.0	43.9	56.8	6.8	105.9	106.5	63.0	78.0	70.9	48.7	50.8	76.4	114.1	94.2	21.9	7.1	71.2	93.6	54.3	106.6	6.6	60.9	51.0	97.8	8.4	118.0	58.2	152.4	6.0	10.2	113.7	56.0	44.0	66.5	107.0	113.8	209.5	65.2	23.7	26.3	46.1	50.7	13.9	38.2	144.4	237.4	54.9	83.3	77.2	98.8	86.9
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP U3 small nucleolar ribonucleoprotein 4"	Q96G21	2	130342877-130347967	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 303.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066222: AB_2685638, HPA066673: AB_2685701"	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	29.2	25.4	14.3	20.6	16.1	20.8	25.6	15.3	16.8	14.8	11.4	22.4	19.9	18.0	6.3	20.5	13.9	12.4	37.5	13.7	16.5	19.9	47.7	17.7	24.5	18.5	18.3	12.1	45.4	12.9	11.4	11.5	16.6	15.4	7.2	3.6	31.8	12.0	70.1	18.7	18.5	11.7	15.9	17.3	24.5	11.8	18.1	7.2	11.4	25.5	12.2	23.3	15.7	16.9	88.7	87.1	11.1	59.2	13.5	22.7	61.5	60.8	30.2	54.1	39.8	184.5	55.0	303.2	71.5	30.2	36.0	56.6	64.5	66.5	25.9	64.2	66.0	100.3	33.2	143.8	70.7	99.7	51.8	28.1	48.0	71.9	37.6	10.9	38.5	68.7	103.1	58.8	26.5	157.0	63.2	57.1	85.4	53.0	106.3	73.1	39.4	134.4	27.0	61.0	57.9	51.8	41.3	124.0	62.9	7.2	52.7	47.0	47.5	69.8	74.3	75.2	109.0	77.5	87.8	235.4	56.5	56.5	98.9	12.3	72.7	23.9	71.5	82.6	66.1	115.9	62.7	62.6	84.1	99.7	64.8	64.6	8.0	90.8	79.4	91.5	68.9	89.2	14.3	16.1	15.3	16.8	13.7	16.5	18.5	18.3	16.6	15.9	18.1	16.9	41.4	16.0	24.8	3.3	65.5	106.6	79.3	67.0	58.6	21.9	49.5	46.4	53.7	58.6	46.5	44.1	4.2	63.6	52.3	43.4	101.8	96.4	24.2	19.6	27.3	48.6	54.5	32.6	4.2	110.3	100.5	43.2	45.9	22.3	46.3	26.8	29.6	89.1	76.5	16.8	4.8	49.8	52.9	36.5	54.0	69.9	30.7	37.5	78.2	1.0	66.1	18.9	33.0	4.5	5.0	83.7	54.2	25.6	82.4	148.6	55.5	144.6	22.9	25.5	26.3	43.7	51.6	32.7	48.3	57.6	110.4	49.3	45.9	62.1	77.5	79.2
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950763-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 80.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863"	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.3	7.7	3.8	9.9	4.5	80.5	10.1	11.3	5.5	8.3	3.3	9.1	8.2	10.8	10.5	7.4	9.7	8.5	8.5	3.5	4.5	9.7	9.2	10.9	14.9	4.2	4.7	8.9	8.5	7.7	6.0	15.1	4.7	8.0	11.8	7.6	8.6	7.7	4.7	4.6	7.6	13.0	4.8	15.5	9.7	8.1	4.2	18.6	11.5	8.4	13.5	8.5	5.0	5.7	19.3	5.6	24.8	14.0	9.2	7.3	8.3	12.9	10.1	18.1	21.1	7.3	21.6	31.3	5.7	11.3	19.0	9.2	24.1	9.9	20.7	22.1	42.2	22.5	21.2	4.3	12.6	43.8	25.5	5.4	5.0	16.0	11.3	8.7	28.7	19.1	51.0	48.4	17.5	6.7	36.0	26.0	29.9	10.9	10.4	17.6	17.7	25.7	18.4	19.4	22.4	24.1	13.3	26.9	14.0	15.3	6.1	17.0	10.4	18.5	6.8	40.0	23.7	22.2	15.1	46.0	9.3	28.9	15.6	44.0	28.0	26.4	20.1	30.8	19.9	21.7	20.3	18.7	23.4	24.3	20.4	18.6	50.7	30.6	32.3	17.7	27.1	14.8	3.8	4.5	11.3	5.5	3.5	4.5	4.2	4.7	4.7	4.8	4.2	5.7	27.1	19.2	18.4	24.5	37.7	7.6	20.4	17.6	9.1	23.3	16.3	14.4	14.2	11.5	14.0	7.3	4.2	38.8	31.7	19.6	21.5	12.6	7.2	21.5	20.1	24.7	12.0	27.0	14.5	18.0	22.0	19.5	16.8	28.3	33.7	21.8	21.4	14.3	17.9	26.9	21.5	18.7	22.4	35.8	16.6	4.3	13.7	23.4	16.0	18.7	24.3	17.6	27.8	22.6	24.3	15.5	17.7	9.8	26.8	14.0	17.7	12.8	13.5	19.8	19.7	26.9	25.9	16.6	15.3	12.0	11.2	45.7	28.6	25.7	15.4	18.7
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Endometrial stromal cells: 16.7;Extravillous trophoblasts: 16.1;Theca cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	9.9	21.4	9.3	11.3	13.4	17.2	11.7	13.2	14.3	10.4	8.1	9.7	9.9	10.0	10.3	14.6	8.5	8.2	12.2	9.5	11.6	13.2	15.1	7.9	16.7	15.4	12.0	8.0	11.5	8.0	8.1	10.0	14.8	8.5	10.7	21.8	9.0	7.0	19.0	11.8	8.5	11.9	13.9	12.9	15.4	12.1	12.2	18.6	9.9	18.1	16.8	12.8	10.6	20.0	33.4	38.1	21.5	46.4	30.5	48.9	30.9	44.9	27.4	43.3	48.1	58.4	43.1	82.7	45.0	25.1	40.6	46.2	56.1	43.6	72.8	39.5	37.4	66.7	44.5	44.9	53.9	110.6	38.4	26.3	32.2	69.5	147.0	53.5	56.8	35.6	71.5	31.9	46.7	40.9	57.9	197.8	94.6	45.6	68.9	40.8	62.3	114.0	36.4	31.0	17.8	16.7	39.1	30.6	47.4	72.8	42.6	23.4	36.5	50.1	36.2	85.6	55.1	15.6	19.6	119.4	33.1	75.8	36.2	7.8	8.1	7.8	14.6	5.7	22.1	9.7	18.2	18.2	9.9	11.3	12.7	15.7	2.5	25.9	5.2	6.7	28.1	10.5	9.3	13.4	13.2	14.3	9.5	11.6	15.4	12.0	14.8	13.9	12.2	20.0	7.2	22.4	7.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	7.9	8.3	0.0	0.0	2.5	5.5	0.0	11.8	8.8	0.0	3.9	13.7	0.0	8.7	16.7	3.9	0.0	0.0	0.0	11.9	16.1	8.3	0.0	8.2	7.6	13.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.6	0.0	0.0	11.6	2.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	13.1	6.5	18.5	0.0	0.0
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520659-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Breast myoepithelial cells: 14.0;dendritic cells: 15.9;Endometrial ciliated cells: 16.0;Glandular and luminal cells: 11.1;granulocytes: 25.2;Theca cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.7;U-937: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	3.4	7.5	3.3	6.3	2.9	13.1	3.8	8.7	3.7	6.7	2.6	7.7	2.6	4.6	2.8	4.7	6.5	3.8	4.4	3.0	3.0	3.8	1.1	4.4	12.6	3.5	3.6	8.2	2.1	1.8	6.7	3.3	3.4	5.0	7.1	5.1	12.0	3.6	1.1	6.1	7.3	3.7	3.3	10.2	3.4	6.3	3.4	8.4	3.3	0.8	11.3	5.7	5.1	3.7	0.1	0.0	7.5	8.9	2.2	2.5	0.0	1.9	4.0	2.2	6.6	0.7	3.2	7.5	6.3	1.6	5.4	5.6	8.4	2.5	1.5	5.8	3.0	6.5	0.7	0.0	1.9	6.8	0.5	3.3	2.4	2.5	2.5	3.8	2.8	4.9	4.3	11.8	1.6	5.5	6.5	20.7	3.5	8.0	3.1	5.3	2.4	6.4	1.8	3.0	1.2	2.7	2.6	2.6	0.2	3.2	2.8	12.5	1.6	5.6	3.2	0.0	2.2	13.5	11.2	11.3	1.9	19.0	1.1	0.0	1.6	1.4	2.9	1.4	3.8	3.3	3.4	3.5	2.3	3.5	5.2	3.4	0.8	1.9	1.8	2.2	2.0	2.5	3.3	2.9	8.7	3.7	3.0	3.0	3.5	3.6	3.4	3.3	3.4	3.7	6.8	12.8	5.8	0.0	7.3	0.0	0.0	0.0	0.0	0.0	7.2	14.0	0.0	0.0	3.7	3.7	0.0	2.1	15.9	0.0	0.0	1.3	0.0	16.0	5.3	3.3	0.0	0.0	0.0	1.6	0.3	3.3	0.0	11.1	25.2	7.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.3	0.0	0.0	1.0	6.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	6.9	11.1	0.0	0.0
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051615: AB_2681552, HPA066822: AB_2685729"	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favorable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	8.6	22.0	7.9	11.1	8.9	6.8	8.3	8.7	9.4	9.1	10.5	8.8	6.9	9.2	11.3	11.1	9.7	6.7	12.2	7.9	8.6	10.7	5.9	8.8	14.6	8.5	8.8	8.2	9.7	9.5	12.5	7.9	8.6	9.1	9.3	10.5	8.9	7.2	11.6	9.9	9.6	9.0	8.6	15.7	9.4	12.8	8.9	17.5	10.6	6.9	17.9	11.0	8.7	9.4	24.7	17.0	20.1	21.4	24.3	11.3	8.8	11.1	15.1	19.0	20.9	11.9	13.4	24.4	15.2	11.4	17.0	20.1	39.2	22.7	26.1	10.3	16.1	24.4	9.5	21.0	17.6	12.3	18.2	13.0	16.0	22.9	16.3	10.2	23.8	34.5	52.2	13.7	12.8	13.5	57.5	22.3	27.4	28.8	10.9	36.5	23.3	12.8	13.4	16.8	14.4	26.4	11.5	14.8	20.5	16.0	14.4	13.8	14.1	10.9	27.6	18.7	14.2	7.0	5.3	29.8	16.8	20.3	15.8	17.0	20.6	19.0	17.3	23.0	16.1	18.0	15.1	19.3	29.1	19.5	13.4	14.5	8.3	25.1	17.4	15.4	20.3	12.0	7.9	8.9	8.7	9.4	7.9	8.6	8.5	8.8	8.6	8.6	8.9	9.4	3.6	6.4	4.2	28.7	10.9	2.3	2.4	4.7	1.8	2.1	2.7	2.3	5.8	5.7	3.7	3.7	6.2	7.7	6.1	2.8	1.9	3.7	8.3	4.8	6.2	4.6	6.0	4.2	29.5	5.1	4.8	4.7	9.2	5.9	0.0	6.7	3.9	2.5	7.5	1.7	31.3	3.6	4.1	3.8	6.1	4.1	7.8	4.1	3.6	23.4	5.4	2.4	4.1	32.2	39.9	4.9	1.7	4.5	4.3	1.9	3.3	4.3	3.4	6.1	0.0	4.2	4.0	5.1	3.5	7.7	3.0	4.8	5.4	11.2	3.5	1.7
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267894	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.0;monocytes: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	4.9	3.1	3.1	5.8	3.1	2.4	4.7	4.1	4.5	4.4	2.3	7.1	7.9	2.3	3.4	5.2	2.9	6.9	1.8	2.9	3.2	4.1	18.1	3.3	4.6	3.6	3.6	1.8	3.8	12.1	1.9	8.7	3.2	3.4	6.0	4.7	2.7	1.7	2.7	5.1	10.4	1.9	3.2	6.4	3.5	2.2	3.5	4.5	4.1	3.2	4.4	5.2	2.5	3.2	16.3	4.1	5.9	5.8	5.7	6.6	5.1	4.2	9.0	3.5	7.1	8.3	10.1	13.0	8.3	5.0	3.4	4.9	5.0	5.6	11.2	5.9	3.8	3.2	3.9	7.9	3.4	5.1	7.1	7.3	4.9	6.0	12.0	4.0	7.7	3.7	2.1	6.5	6.3	4.1	7.0	9.8	3.8	6.6	3.8	0.5	12.8	6.0	6.6	4.1	4.1	7.1	5.5	14.4	4.3	9.6	12.0	6.1	6.7	3.8	7.4	8.1	5.4	13.8	8.7	10.1	7.2	5.3	1.5	1.7	0.7	1.6	0.1	0.7	0.1	0.3	0.1	0.1	0.4	0.2	0.4	0.1	3.0	0.2	1.0	0.2	0.0	0.1	3.1	3.1	4.1	4.5	2.9	3.2	3.6	3.6	3.2	3.2	3.5	3.2	8.9	6.4	4.2	16.6	16.9	54.0	10.0	8.4	26.2	10.0	11.6	8.3	2.8	4.3	13.3	1.8	6.2	10.5	8.1	29.3	3.9	4.2	3.0	24.3	9.7	9.9	8.4	3.0	21.8	4.9	22.5	15.7	8.2	22.8	7.0	2.5	8.2	13.2	10.0	13.5	27.8	10.6	10.2	22.8	40.7	1.4	2.8	29.1	26.6	24.4	16.6	5.4	2.1	30.7	23.6	6.2	21.7	1.9	8.5	9.6	28.6	9.1	29.1	5.8	6.6	10.2	8.5	10.0	5.1	20.1	58.1	9.4	10.1	4.1	11.1	17.5
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234610178	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 440.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 277.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA027815: AB_10609994, HPA062269: AB_2684732"	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	35.6	39.6	43.3	25.6	50.2	157.2	45.0	48.5	49.1	50.0	43.3	42.5	39.6	55.8	26.5	47.0	45.1	40.7	45.0	40.5	45.4	34.2	53.6	43.7	36.3	55.2	49.0	54.8	49.5	45.5	24.1	29.6	51.1	39.2	49.3	26.9	55.0	33.5	47.4	64.2	42.2	31.7	48.9	28.4	44.4	18.0	44.7	29.6	57.3	40.5	30.3	38.7	43.7	61.1	28.0	41.5	29.8	45.7	61.2	48.1	35.1	21.8	18.4	12.7	14.2	24.5	33.5	0.0	49.4	21.2	43.3	37.4	16.2	28.3	20.2	45.2	36.8	26.7	32.9	72.3	49.4	101.0	91.0	57.0	65.8	28.3	53.4	74.4	33.0	24.5	23.0	55.6	33.2	8.4	25.5	107.2	27.1	65.1	15.7	49.6	13.8	66.8	25.1	22.9	58.8	41.8	35.2	46.7	72.7	29.8	45.1	277.5	36.8	45.5	19.0	34.7	41.6	122.9	33.8	9.1	23.1	89.6	63.4	10.1	4.5	8.5	3.9	3.6	4.0	4.3	4.8	4.6	4.7	4.0	4.9	4.1	2.3	3.0	1.9	17.8	4.0	2.5	43.3	50.2	48.5	49.1	40.5	45.4	55.2	49.0	51.1	48.9	44.7	61.1	96.0	134.6	191.3	28.1	75.6	325.9	440.4	142.3	139.5	34.6	126.6	109.7	63.6	133.0	143.8	51.5	10.4	44.6	168.3	84.2	13.7	65.8	24.9	180.8	126.2	101.9	145.5	76.6	14.3	50.0	58.0	97.3	47.4	285.2	107.5	39.6	117.4	185.7	88.9	58.9	22.9	117.1	71.2	131.8	271.2	27.1	69.6	159.7	110.3	30.9	83.2	87.7	38.1	20.6	64.2	68.9	92.0	81.3	39.2	138.2	81.7	40.2	95.1	19.5	78.9	117.1	102.9	29.5	24.1	182.1	396.2	79.4	91.3	15.5	162.7	370.6
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028708	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	26.1	25.3	12.2	9.2	13.9	5.6	28.5	13.4	12.0	20.1	12.8	32.4	6.9	25.8	5.1	13.3	33.7	6.5	22.6	14.1	21.1	28.7	19.1	20.9	6.2	15.2	14.8	32.4	17.5	19.8	22.6	7.9	10.9	18.4	3.3	7.3	19.2	10.1	16.8	25.2	15.1	8.0	12.6	19.0	18.8	13.5	19.0	9.7	18.7	4.2	3.3	26.4	18.2	9.4	15.4	13.2	32.2	36.3	9.6	8.8	45.8	15.9	13.0	4.4	5.9	6.2	24.8	5.4	11.3	13.6	12.4	23.6	5.6	11.8	3.7	25.8	19.1	6.9	13.0	8.5	12.5	1.9	29.7	11.8	9.1	7.8	6.8	34.8	6.0	10.9	10.4	59.4	5.7	42.2	21.0	14.5	14.5	6.6	68.2	4.4	9.1	13.0	15.6	22.4	24.9	36.0	22.5	23.2	42.5	8.6	16.1	3.4	10.4	20.2	19.5	6.8	10.3	22.9	26.3	9.0	31.3	4.7	25.8	1.7	1.4	1.3	2.8	1.9	2.7	1.4	2.5	2.6	1.3	1.6	2.0	2.3	9.0	5.9	2.3	10.7	2.6	0.8	12.2	13.9	13.4	12.0	14.1	21.1	15.2	14.8	10.9	12.6	19.0	9.4	71.4	22.4	14.3	5.9	40.2	73.7	32.5	22.5	115.5	57.1	54.6	41.5	19.5	32.9	11.6	64.4	29.2	22.8	58.9	10.8	37.2	19.6	1.3	25.3	26.0	44.0	47.6	10.8	8.2	19.0	49.7	47.8	12.2	25.6	26.6	15.2	55.6	60.5	33.3	10.1	8.6	14.7	16.2	54.7	78.9	4.0	30.1	26.6	35.6	9.4	10.0	57.8	38.1	8.5	4.8	17.8	7.0	34.3	21.1	30.0	6.7	23.1	13.8	10.4	39.5	56.4	83.2	1.6	50.5	54.2	50.6	46.0	39.0	27.5	12.8	20.6
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785617-209806175	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 95.4;skin 1: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 10.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.6	11.4	1.6	3.2	1.5	2.8	35.9	10.9	1.8	21.6	5.2	27.1	26.9	5.9	49.3	95.4	21.7	10.8	29.7	1.7	1.4	17.0	33.3	8.8	0.9	1.9	2.9	1.9	19.7	26.4	6.5	20.4	1.9	32.4	31.5	2.4	39.0	26.4	0.5	114.0	25.0	2.0	2.1	2.1	24.8	2.9	2.3	20.3	17.1	2.7	23.0	40.5	46.8	1.2	61.9	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.5	0.1	0.3	13.6	20.7	0.0	0.1	0.1	0.0	210.7	0.0	80.5	0.0	0.0	1.3	0.1	0.2	0.0	0.2	0.0	0.2	0.1	170.1	0.1	82.2	0.0	3.7	0.0	0.1	0.2	0.0	8.3	0.0	0.3	1.2	17.0	0.2	0.0	0.0	0.3	7.7	78.8	18.7	6.1	1.4	34.1	1.9	3.8	24.1	0.3	0.0	0.0	0.1	0.0	0.3	0.8	15.8	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.6	1.5	10.9	1.8	1.7	1.4	1.9	2.9	1.9	2.1	2.3	1.2	1.9	16.0	10.4	0.3	1.0	387.2	253.9	154.0	217.9	0.1	47.2	33.3	26.0	32.9	70.4	35.0	0.0	94.2	1.3	95.5	27.4	36.7	1.1	120.2	9.5	6.0	59.9	0.4	0.0	19.2	25.4	4.5	53.0	121.7	2.5	0.0	1.1	35.9	8.3	0.0	0.1	74.9	38.7	1.0	30.1	0.7	0.6	2.3	35.6	1.9	1.0	6.5	0.0	0.0	0.0	49.2	43.8	0.0	2.5	153.9	49.5	11.9	82.1	0.6	0.0	0.4	7.4	8.2	3.7	251.9	552.4	161.6	2.5	0.7	44.5	290.3
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85899162-85922606	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;lymphoid tissue: 244.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 2477.4"	"Lineage enriched"	"Detected in all"	7	"dendritic cells: 2477.4"	"Group enriched"	"Detected in some"	4	"Daudi: 240.7;THP-1: 382.3;U-698: 928.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	25.9	7.6	4.7	81.4	5.6	85.5	9.3	7.0	6.2	5.6	5.4	27.1	47.1	8.0	3.1	6.7	6.5	19.7	3.8	6.3	5.4	6.1	36.9	27.4	244.1	9.5	8.5	2.5	3.4	1.7	1.7	10.1	10.0	7.7	33.5	0.8	7.1	8.9	2.0	5.0	56.2	13.5	11.3	137.3	22.9	4.8	12.6	61.5	4.1	1.7	224.9	21.8	1.6	14.0	0.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	26.0	0.0	240.7	1.5	0.0	0.0	0.1	1.4	0.0	0.2	0.2	2.7	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.5	0.0	0.0	0.6	21.3	0.2	20.6	0.0	7.5	1.1	27.2	0.0	0.0	0.1	0.1	1.0	0.0	0.2	1.4	0.0	382.3	0.6	0.0	10.9	0.2	0.9	0.3	0.3	928.2	0.0	128.4	0.0	9.1	137.1	3.4	3.3	134.3	4.5	347.0	1.8	2.1	291.2	361.3	3.5	2.8	8.4	111.5	97.3	2477.4	0.7	150.1	4.7	5.6	7.0	6.2	6.3	5.4	9.5	8.5	10.0	11.3	12.6	14.0	3.7	0.0	4.2	0.0	225.8	10.5	0.8	0.0	0.6	0.0	2.4	3.4	1.5	2.8	1.3	0.0	0.0	0.8	492.3	13.0	1.9	0.5	1.5	7.3	7.6	7.6	28.7	7.4	0.6	1.4	5.7	10.8	15.3	12.5	2.5	0.4	1.8	6.5	64.1	0.0	0.2	11.8	0.0	105.1	366.0	4.6	0.3	122.2	44.4	33.7	35.3	0.4	23.7	1.0	0.4	0.1	10.7	0.0	14.1	2.3	34.2	3.5	0.0	0.2	6.6	0.7	6.7	0.7	6.7	0.4	9.2	1.1	23.1	48.8	25.6	2.5
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161063	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	18.7	13.7	9.1	19.0	9.0	51.6	17.0	9.8	9.6	20.2	7.5	21.6	15.4	19.5	15.1	22.2	15.5	17.4	21.4	8.8	9.1	15.0	10.8	14.1	32.0	9.2	9.3	19.7	15.8	11.2	8.8	22.1	8.9	13.3	16.9	10.4	15.0	12.3	34.9	20.3	16.2	20.3	8.2	18.2	14.9	12.4	8.8	22.7	14.9	21.3	30.1	18.3	19.4	8.9	53.7	20.5	29.6	41.6	35.1	36.4	34.5	39.3	35.0	46.1	44.2	40.6	39.3	67.3	41.3	32.6	40.0	44.8	56.3	31.8	64.9	65.0	26.5	78.0	35.2	32.8	32.7	121.2	53.4	22.9	21.7	40.6	62.3	28.7	37.7	43.2	57.1	33.5	25.2	54.2	73.8	67.1	32.3	55.9	31.3	64.9	67.3	47.5	17.3	33.5	46.8	35.3	72.7	15.7	41.9	16.0	30.3	99.1	45.2	33.5	33.4	49.8	41.6	40.1	26.1	131.9	30.8	69.4	39.0	79.8	57.6	94.2	54.8	56.4	61.4	56.1	55.8	58.7	62.8	50.7	61.0	55.0	90.7	84.8	51.2	54.5	73.5	56.5	9.1	9.0	9.8	9.6	8.8	9.1	9.2	9.3	8.9	8.2	8.8	8.9	26.5	25.6	23.4	0.0	27.4	27.4	16.5	21.3	20.5	19.7	17.0	15.6	19.7	21.5	21.8	9.2	22.9	44.1	38.5	15.8	23.5	26.7	2.8	11.9	23.0	25.3	9.0	29.0	0.0	28.0	41.2	21.8	12.8	21.0	45.6	25.8	26.0	12.3	34.8	20.2	0.0	16.7	16.2	21.1	25.6	1.8	16.1	23.9	10.6	0.0	43.7	20.7	46.4	0.0	0.0	24.4	15.3	16.1	24.1	17.4	18.8	23.2	14.8	19.0	19.7	18.8	20.9	57.4	42.6	20.0	35.8	45.8	32.9	18.7	20.5	16.9
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	7.6	7.2	2.4	10.1	2.8	7.1	7.5	2.4	5.7	7.3	2.5	7.6	3.9	8.1	4.4	5.2	6.9	4.2	5.7	2.3	2.9	7.8	9.6	9.4	8.1	2.5	2.6	9.4	7.2	8.8	5.6	6.5	3.2	7.6	7.4	2.7	6.6	8.3	3.9	5.5	6.7	7.7	2.1	9.2	6.8	5.1	2.7	16.7	7.6	3.7	9.0	7.6	4.6	3.5	26.1	5.7	12.9	11.9	15.8	9.3	5.6	12.2	28.5	19.4	23.6	3.0	13.1	0.9	17.7	22.0	22.2	9.8	5.1	20.4	11.9	9.9	1.0	2.4	2.5	10.2	27.1	10.8	12.9	21.5	10.7	12.1	7.7	19.2	25.4	23.7	4.2	9.9	16.9	10.8	16.3	7.7	9.1	27.7	6.7	13.7	5.6	9.1	20.8	9.9	0.9	5.8	5.8	13.1	18.9	10.7	6.5	10.3	21.0	9.4	7.9	13.5	5.6	14.3	7.0	4.4	10.7	1.1	13.3	0.1	0.5	0.1	0.6	0.2	0.6	0.0	0.6	0.8	0.2	0.1	0.8	0.7	0.6	0.6	0.4	0.2	0.4	0.6	2.4	2.8	2.4	5.7	2.3	2.9	2.5	2.6	3.2	2.1	2.7	3.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363241-34540748	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 139.7;Oligodendrocytes: 260.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	19.5	16.2	13.7	18.1	27.1	27.3	20.0	19.6	17.7	24.5	17.7	21.6	20.2	19.4	16.6	42.8	15.7	17.0	20.2	14.7	15.9	23.3	55.6	18.7	21.4	19.8	20.0	18.8	16.5	23.1	7.8	25.6	21.0	19.6	23.5	25.6	18.7	19.9	17.2	14.0	20.9	21.5	15.9	20.4	20.9	38.5	20.2	23.2	26.3	21.7	25.7	30.6	14.8	45.7	55.5	34.6	35.2	25.9	38.3	57.4	42.7	43.5	52.0	56.2	54.0	101.5	83.8	26.7	42.1	55.6	73.9	66.2	54.9	92.3	66.2	20.8	17.9	78.3	28.2	59.3	43.9	32.6	34.4	31.7	46.2	44.4	72.2	49.8	41.7	40.6	45.5	45.7	46.2	26.5	49.2	18.8	16.9	35.6	44.2	40.9	76.3	63.6	34.7	91.2	21.4	16.4	82.0	32.7	51.0	33.9	38.3	31.1	39.5	61.5	36.0	42.8	33.3	36.2	40.5	40.0	41.0	21.6	38.0	4.6	6.7	7.0	12.0	7.0	12.5	9.2	4.2	6.1	4.9	7.8	3.7	5.7	20.2	7.6	4.9	14.3	5.8	4.3	13.7	27.1	19.6	17.7	14.7	15.9	19.8	20.0	21.0	15.9	20.2	45.7	26.1	12.8	21.8	56.5	33.1	15.0	23.9	11.7	25.6	19.5	15.1	8.5	25.0	12.8	25.6	31.3	25.0	17.5	46.1	28.8	5.9	12.8	59.0	26.5	34.6	20.7	12.0	26.5	85.0	16.3	21.2	24.2	33.1	36.1	19.0	17.9	18.2	53.0	15.8	15.2	72.3	16.9	10.2	24.3	26.7	139.7	22.4	31.4	26.6	68.4	30.0	38.2	43.3	79.4	260.0	22.6	23.7	15.4	50.3	25.8	21.1	26.8	23.5	26.0	13.1	21.4	22.0	40.6	25.5	30.4	16.2	46.9	30.8	12.3	11.9	40.6
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
IWS1	"DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319"	ENSG00000163166	"Interacts with SUPT6H, CTD assembly factor 1"	Q96ST2	2	127436207-127526886	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035719, HPA061866"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA035719: AB_10669527, HPA061866: AB_2684628"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.81e-2)"	24.2	18.5	26.7	23.2	32.3	31.5	22.2	30.3	37.8	23.1	30.1	24.8	23.4	22.9	23.8	22.9	21.3	18.9	48.4	26.8	32.2	30.1	40.2	22.5	28.8	30.7	32.1	18.0	21.6	23.8	24.8	26.5	32.0	23.3	23.8	26.5	22.7	19.3	76.0	21.6	24.4	21.9	27.7	27.6	23.1	23.2	31.5	31.2	20.7	62.0	28.4	25.8	23.4	40.4	52.0	34.5	68.4	45.0	51.0	42.4	71.4	73.9	50.0	67.2	55.9	81.6	38.8	48.7	38.2	59.3	51.4	41.9	66.7	58.2	79.4	50.7	45.4	68.1	50.6	92.9	60.2	78.2	54.5	42.0	43.6	71.5	64.0	35.7	58.0	60.3	72.8	37.0	64.3	48.3	77.7	63.4	92.2	43.0	46.8	68.9	53.5	44.9	67.6	62.0	53.4	34.7	52.9	65.9	60.3	73.4	29.6	53.5	66.4	66.3	50.4	40.4	43.8	28.6	33.6	64.5	36.6	54.2	45.0	3.6	13.2	18.5	9.7	14.8	11.8	11.4	11.1	11.8	13.0	15.1	10.5	11.0	13.9	15.0	17.3	11.8	11.0	9.5	26.7	32.3	30.3	37.8	26.8	32.2	30.7	32.1	32.0	27.7	31.5	40.4	23.1	112.2	74.3	35.3	36.6	15.7	55.3	22.8	23.9	27.9	16.9	15.7	77.4	21.5	53.5	16.5	27.1	40.0	33.5	35.1	19.6	38.6	13.2	38.5	39.8	28.9	28.1	30.7	21.9	25.5	56.3	41.9	32.1	36.8	42.3	42.3	20.7	25.7	27.1	21.9	27.8	25.7	30.5	16.4	25.4	8.5	39.1	29.2	10.6	25.3	40.1	26.4	46.4	25.6	105.0	41.9	28.0	31.6	37.5	53.8	25.1	19.1	44.6	44.7	32.9	29.3	35.6	69.8	52.0	24.1	17.0	92.8	37.4	34.6	26.9	77.2
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA025959: AB_1855289, HPA055789: AB_2682922"	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	16.1	20.1	11.8	15.2	16.5	9.8	13.7	10.3	14.0	16.3	1.1	14.5	10.2	12.9	6.4	9.7	16.1	10.7	12.1	11.2	16.0	11.9	5.5	13.8	26.8	14.4	12.8	23.9	13.3	20.4	13.1	7.1	13.9	13.0	6.2	8.9	14.5	14.1	12.7	12.0	18.4	9.8	9.8	21.8	12.7	6.8	13.9	15.8	16.2	8.5	16.2	17.9	11.6	15.7	66.6	46.2	1.3	2.0	13.8	18.5	19.6	10.7	28.9	21.0	26.4	35.2	50.4	75.2	24.7	13.4	21.3	13.0	6.4	60.8	8.2	44.2	2.3	18.0	30.0	7.7	17.5	19.2	2.5	11.8	27.3	26.3	29.5	14.5	15.1	21.4	10.5	24.4	13.1	26.4	35.6	18.5	14.7	19.5	23.9	29.9	1.2	29.8	19.9	18.1	9.0	5.6	30.2	0.8	42.2	11.4	12.1	25.3	22.5	13.9	12.7	43.2	30.1	10.6	49.7	68.3	24.1	34.1	22.6	0.9	0.6	2.0	3.2	0.6	3.4	3.8	3.1	3.1	1.1	2.3	3.0	3.1	0.7	1.9	1.6	0.5	3.1	1.3	11.8	16.5	10.3	14.0	11.2	16.0	14.4	12.8	13.9	9.8	13.9	15.7	13.6	9.6	11.2	4.2	35.1	4.2	7.0	6.5	21.6	24.4	10.3	7.1	13.3	12.8	6.0	7.3	35.5	7.3	41.0	7.7	7.9	5.5	0.6	4.6	5.4	12.5	11.5	4.6	15.3	16.9	9.7	10.2	5.6	3.6	2.5	16.0	18.2	3.5	4.2	10.1	16.0	8.8	6.1	30.5	15.7	0.8	20.5	12.1	1.8	5.6	19.4	7.4	42.2	9.0	16.5	8.8	4.9	19.2	22.4	4.6	13.8	10.4	9.5	22.9	0.0	6.7	11.6	0.3	3.3	6.0	3.7	7.3	35.0	4.2	10.7	4.3
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134069071-134152001	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 342.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 5.3"	"Group enriched"	"Detected in many"	7	"B-cells: 5.3;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 99.5;RH-30: 122.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA		44000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	23.6	18.7	53.4	10.1	86.3	1.3	19.2	68.7	73.4	33.4	52.9	54.6	6.6	40.8	17.5	21.5	28.7	24.5	31.0	56.5	61.3	11.4	3.2	29.6	7.8	73.5	76.8	48.7	5.1	17.7	33.3	102.7	71.0	32.5	12.9	47.3	13.3	44.5	7.0	13.0	22.5	42.8	59.7	13.5	22.4	35.7	73.3	17.6	15.8	14.6	7.5	41.7	23.4	115.2	0.0	1.0	87.9	42.5	85.3	62.7	75.4	37.0	49.1	15.1	14.8	0.3	0.6	0.0	38.7	53.3	56.2	0.5	70.0	0.7	28.2	0.2	29.6	0.3	0.0	6.9	24.9	0.4	36.2	43.2	0.0	10.7	9.6	35.8	99.5	40.8	0.3	0.2	64.5	1.0	27.5	0.2	18.9	0.6	2.9	0.5	122.8	0.0	0.9	0.2	57.5	32.2	0.0	0.2	1.0	35.3	0.2	0.2	0.6	25.1	18.4	40.3	24.7	0.1	0.1	0.4	27.6	1.2	48.0	0.0	0.0	0.1	1.3	0.0	1.6	5.3	1.6	0.9	0.0	3.1	2.3	1.7	0.5	0.0	0.0	0.0	0.0	1.8	53.4	86.3	68.7	73.4	56.5	61.3	73.5	76.8	71.0	59.7	73.3	115.2	22.2	0.0	6.0	12.7	10.9	5.1	5.6	0.9	0.0	21.7	0.3	9.3	15.7	0.0	0.7	5.5	8.4	6.0	1.2	0.1	1.9	0.4	2.1	0.8	23.3	35.5	0.0	0.4	84.3	0.2	71.2	29.6	1.5	0.5	1.3	11.7	12.5	0.0	8.6	8.4	44.2	0.0	12.2	0.6	4.2	4.9	42.9	10.9	17.8	24.4	0.2	20.2	1.0	76.4	342.8	0.3	0.0	64.3	0.9	2.2	0.0	0.2	1.5	75.6	26.3	19.0	24.3	15.5	19.2	0.2	3.8	6.2	3.5	9.7	0.0	1.0
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 295.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	331.1	92.7	34.4	36.3	37.0	129.1	308.2	41.6	38.1	172.0	28.0	154.7	34.7	116.4	15.8	100.2	314.1	89.6	158.4	39.1	37.2	94.0	205.2	202.8	52.1	32.7	30.7	197.0	192.2	59.8	75.0	40.1	30.5	153.4	55.0	29.7	154.5	71.7	114.3	286.6	79.1	113.3	34.3	62.0	239.5	20.2	33.8	71.5	189.5	158.8	5.4	156.4	164.5	36.9	49.8	2.8	22.4	2.6	35.3	40.0	0.2	69.4	27.0	57.1	34.3	10.1	3.5	1.7	23.8	57.4	133.6	12.9	2.0	27.7	40.6	29.8	128.9	0.5	1.9	16.9	29.4	5.3	10.2	42.0	74.0	78.1	34.0	27.7	47.2	2.4	15.6	29.6	24.9	8.0	2.5	32.5	13.5	34.6	32.2	1.1	295.6	7.0	60.7	5.8	43.7	12.8	49.9	62.3	26.4	24.5	17.2	3.0	61.6	127.5	37.3	35.3	96.8	37.9	9.8	4.4	133.9	8.4	35.2	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.6	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	34.4	37.0	41.6	38.1	39.1	37.2	32.7	30.7	30.5	34.3	33.8	36.9	2721.4	538.5	543.8	187.7	1018.8	1235.5	2850.5	772.6	2825.1	103.4	1647.1	2067.3	1487.5	1315.4	449.3	104.8	262.7	675.8	651.1	1653.6	50.9	987.0	49.3	1337.1	2845.2	1443.8	1497.4	174.3	12.2	516.4	93.9	2730.7	2663.1	1822.2	541.9	333.4	737.2	158.6	650.5	87.5	4.9	1909.1	836.2	584.9	632.0	48.2	1227.4	1034.9	757.7	65.6	140.1	1234.2	8.2	17.6	10.0	562.8	1529.6	258.8	1540.3	1489.1	1654.1	48.6	216.3	453.5	1538.3	1892.9	2392.5	17.4	20.9	2146.3	964.4	415.6	1065.5	846.5	1199.5	545.7
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040446-20154404	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	17.9	9.9	38.7	15.4	46.5	48.0	10.3	39.1	40.3	14.9	33.8	13.8	17.7	12.3	8.1	27.4	11.7	12.6	35.9	34.4	42.2	16.6	39.3	16.2	22.4	41.7	44.9	27.7	18.7	51.0	10.2	13.7	43.0	14.5	12.5	33.9	37.6	13.0	60.2	14.3	21.5	13.6	37.1	19.8	13.9	2.7	42.2	23.6	14.4	56.1	20.1	11.9	15.1	45.1	2.7	6.9	3.8	6.2	15.1	14.2	8.8	8.8	13.0	9.1	13.3	2.1	4.5	24.0	3.6	16.7	11.5	2.0	9.4	2.8	7.6	21.8	9.0	21.0	10.7	0.7	7.1	3.2	26.2	6.1	5.0	7.9	5.1	16.0	8.8	5.8	13.7	32.9	13.0	3.3	7.0	6.4	1.6	6.7	6.8	9.1	7.1	5.1	12.4	14.2	1.9	4.1	4.9	7.9	30.5	5.9	8.2	14.2	8.5	15.3	6.1	5.8	10.1	12.3	27.6	5.7	13.9	13.8	33.0	0.6	0.4	1.3	1.5	0.7	1.5	0.4	1.3	1.1	0.4	0.8	0.4	0.8	2.4	0.5	0.5	1.2	2.2	0.3	38.7	46.5	39.1	40.3	34.4	42.2	41.7	44.9	43.0	37.1	42.2	45.1	15.5	32.1	20.8	165.2	11.9	8.5	11.3	2.2	3.4	14.6	5.5	5.0	64.1	4.3	10.4	5.5	4.2	7.3	19.5	16.6	11.7	3.8	3.8	6.4	5.7	14.6	11.5	52.2	22.4	4.4	1.1	11.7	3.6	13.1	10.8	12.3	20.7	33.6	7.7	15.2	32.1	7.3	4.1	22.8	23.3	1.8	6.5	16.0	17.8	52.5	11.1	14.8	14.4	418.2	175.4	3.3	2.4	5.3	19.9	7.1	24.7	6.2	12.7	11.9	6.6	25.2	9.0	0.8	1.4	10.0	12.9	9.9	23.5	2.9	3.8	8.0
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	39.7	24.0	23.4	34.0	22.2	60.8	33.8	21.3	30.2	28.1	20.4	46.7	34.8	29.2	39.7	58.3	27.6	29.5	44.1	25.6	24.1	33.1	45.0	31.9	36.1	25.2	26.5	24.7	80.0	39.2	20.8	33.0	24.8	27.9	46.4	32.4	36.8	31.8	140.0	35.2	36.2	40.5	24.8	28.3	33.5	69.0	27.3	37.0	40.4	71.7	52.3	37.7	36.1	22.1	102.3	76.4	66.7	51.8	69.0	66.2	114.5	106.0	96.0	97.4	64.6	93.8	104.5	110.9	107.2	141.6	97.0	65.1	52.7	100.6	127.8	87.6	37.9	69.8	55.9	97.3	134.7	77.9	63.9	69.0	155.7	95.7	262.5	86.4	74.7	57.2	71.3	83.1	98.4	91.5	76.9	42.6	74.9	125.5	64.1	55.4	94.7	68.5	88.3	85.8	64.8	48.9	61.0	76.0	101.8	76.4	35.3	48.1	66.2	98.9	99.2	93.5	111.8	99.1	130.9	110.4	74.5	55.7	75.8	3.1	1.6	5.4	2.7	1.4	2.1	2.3	1.9	2.0	1.4	3.1	1.6	1.8	4.5	1.9	2.2	2.6	6.0	1.0	23.4	22.2	21.3	30.2	25.6	24.1	25.2	26.5	24.8	24.8	27.3	22.1	45.5	32.1	26.6	25.5	29.6	70.9	92.9	32.7	24.5	31.8	42.8	34.3	51.4	21.5	33.2	12.9	14.6	23.6	42.0	56.2	25.4	34.8	85.2	55.3	33.8	33.1	19.2	29.0	47.9	53.4	32.0	31.9	18.8	80.5	17.7	30.9	24.3	32.9	20.1	72.3	47.4	29.0	20.3	33.3	61.1	127.7	25.7	34.7	26.6	51.5	36.8	37.5	21.6	45.8	36.6	61.2	40.8	29.0	27.6	107.6	44.8	30.7	22.5	27.5	26.3	48.2	47.2	44.9	24.6	34.4	79.0	40.8	32.1	27.1	33.7	135.5
KDM3A	"JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA"	ENSG00000115548	"Lysine demethylase 3A"	Q9Y4C1	2	86440647-86492716	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055543, HPA065162"			Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055543: AB_2682842, HPA065162: AB_2685424"	"unprognostic (1.97e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.32e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.15e-6)"	"unprognostic (2.01e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.50e-3)"	"unprognostic (4.44e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-2)"	21.2	12.9	17.9	13.1	19.0	70.3	19.9	17.5	18.9	18.0	18.6	25.0	18.9	20.7	18.2	20.8	18.4	15.9	21.7	15.3	18.1	15.4	12.9	16.7	17.9	18.1	17.4	21.5	16.1	14.6	12.8	22.1	17.8	16.6	15.9	54.7	19.8	19.7	21.5	38.6	20.1	15.0	16.6	18.4	14.9	50.9	18.7	27.4	20.0	21.4	19.6	20.8	20.2	20.1	34.7	13.5	31.5	8.3	15.9	16.1	29.4	16.5	16.2	15.1	18.5	17.3	14.3	20.1	30.4	13.8	31.1	21.5	23.7	16.6	29.2	27.1	19.7	32.4	12.6	24.8	11.9	26.1	19.9	17.8	24.5	13.6	24.9	51.9	19.0	18.5	21.1	31.9	16.1	8.9	36.2	36.4	28.3	20.6	20.4	24.5	42.6	44.0	13.6	19.2	24.4	25.9	21.7	15.5	30.2	27.5	9.0	16.8	21.2	30.6	12.6	31.8	19.1	33.3	33.9	29.6	38.8	26.6	38.2	16.9	3.0	5.8	6.7	3.3	7.1	4.2	7.5	6.6	4.6	3.6	7.9	7.0	13.4	5.0	2.2	4.2	8.3	3.9	17.9	19.0	17.5	18.9	15.3	18.1	18.1	17.4	17.8	16.6	18.7	20.1	26.0	35.3	17.0	56.8	19.7	30.5	23.2	19.5	43.3	24.0	18.9	14.6	30.3	7.2	24.8	5.5	52.1	5.2	29.2	24.2	0.0	12.1	82.0	36.6	15.6	23.4	15.6	21.0	28.7	9.8	8.5	19.1	23.0	35.5	38.6	11.9	15.4	7.6	10.4	55.5	27.4	13.7	26.4	10.9	18.2	29.7	17.4	17.5	21.4	28.1	8.6	36.0	21.6	26.2	23.5	11.3	8.0	17.3	21.4	16.0	23.0	5.6	44.1	34.4	6.6	21.3	20.4	38.7	14.1	35.5	40.1	11.6	27.4	15.2	10.7	13.6
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352685-138437028	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	21.7	19.4	22.6	16.9	23.0	25.4	25.3	22.2	22.8	22.7	21.1	23.9	18.6	23.0	28.3	21.2	24.2	14.2	20.0	21.3	20.7	21.4	14.5	19.3	23.0	23.4	22.7	30.8	20.3	34.2	16.5	20.5	21.5	21.8	24.0	36.3	22.2	25.9	41.5	28.1	23.4	20.8	21.9	26.0	21.6	19.4	23.9	35.9	23.2	27.1	29.4	24.8	19.9	21.8	24.3	32.4	65.0	58.7	27.2	23.3	47.0	15.6	27.1	30.0	33.5	35.7	27.2	46.3	27.9	30.3	41.0	24.3	53.2	37.8	32.6	30.3	29.3	39.2	28.6	27.1	25.4	32.2	43.3	26.9	39.0	22.1	26.7	23.2	34.6	29.3	31.8	26.1	34.3	30.3	46.4	41.0	31.0	34.1	13.7	53.1	48.5	30.9	40.4	31.6	32.7	35.9	27.0	28.0	25.7	93.2	27.3	43.5	31.9	17.9	17.4	19.3	28.8	32.8	16.7	40.2	12.5	45.6	25.6	0.2	2.9	4.2	2.3	2.2	3.2	2.3	2.7	3.0	2.5	2.0	2.5	2.3	5.5	4.2	2.3	3.0	1.7	1.3	22.6	23.0	22.2	22.8	21.3	20.7	23.4	22.7	21.5	21.9	23.9	21.8	22.8	16.0	15.7	43.1	22.1	15.9	13.7	15.1	20.5	21.3	29.1	29.5	33.2	17.2	17.0	22.0	29.2	13.4	24.0	26.8	0.0	16.0	6.1	22.8	19.9	18.9	21.0	25.4	40.9	16.8	10.7	18.5	17.9	24.2	13.3	26.3	18.2	23.0	17.6	23.5	39.1	26.4	18.3	39.2	18.3	2.8	21.1	27.9	16.0	50.6	27.0	17.3	16.5	41.7	56.9	19.9	28.0	23.0	16.2	21.2	20.9	16.1	25.6	31.9	26.3	21.8	18.7	13.0	15.5	26.2	21.6	10.9	19.1	17.1	24.6	21.0
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013868-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	59.8	47.4	36.3	67.0	38.8	93.3	61.7	44.7	37.4	59.5	34.8	62.9	62.3	82.6	47.2	57.3	70.3	48.6	56.8	36.6	39.7	54.0	50.6	52.1	94.1	40.7	38.7	110.6	50.9	61.7	38.3	63.7	38.1	55.1	57.3	58.5	45.2	55.8	45.9	57.3	59.2	65.6	44.1	64.0	52.3	42.2	37.2	112.2	63.8	40.6	96.7	62.2	47.6	46.7	204.6	121.0	272.6	201.6	92.5	115.4	159.5	120.7	152.1	221.5	185.5	136.2	178.1	302.9	131.5	153.5	128.4	139.2	221.9	165.1	225.6	181.7	188.8	191.1	111.8	188.0	121.5	256.2	123.8	127.6	92.7	168.9	132.8	145.6	212.6	183.1	251.0	136.5	172.6	132.6	379.2	218.7	277.0	127.3	144.3	300.1	230.2	257.7	156.0	203.7	185.7	241.7	175.7	148.8	157.2	192.9	177.3	183.7	160.5	143.9	154.5	155.3	205.9	140.3	163.5	296.0	149.2	202.3	112.1	5.8	5.7	5.9	7.8	8.9	11.7	9.9	9.2	8.2	7.8	8.0	9.8	9.5	5.0	8.0	7.5	8.9	9.3	3.0	36.3	38.8	44.7	37.4	36.6	39.7	40.7	38.7	38.1	44.1	37.2	46.7	130.6	38.5	77.4	40.8	181.9	147.6	200.3	58.8	183.2	94.8	111.1	109.9	104.4	97.2	89.8	69.9	50.1	192.7	131.9	87.9	84.1	96.2	24.7	122.5	154.4	125.7	117.8	131.6	46.0	103.1	234.5	132.4	103.5	127.0	128.1	224.5	99.6	64.6	120.8	63.9	48.1	101.1	28.5	141.9	148.4	21.7	111.2	139.2	108.5	36.5	142.6	142.6	105.0	43.7	59.6	107.1	76.2	124.1	141.8	136.4	74.5	123.8	93.3	89.3	92.1	140.4	157.9	198.2	122.7	173.8	130.6	173.5	161.7	138.7	152.0	167.1
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413102-6424811	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm		NA	NA		710000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: AB_2683162"	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	78.3	90.9	39.2	44.8	37.0	63.9	73.6	35.0	44.6	109.8	14.0	90.2	53.8	121.7	17.0	111.3	105.3	27.5	62.5	39.3	32.0	66.8	89.9	73.5	52.1	35.8	34.4	120.7	89.5	24.7	77.5	44.0	32.6	75.7	34.2	41.0	75.1	33.1	100.5	93.7	88.4	36.3	31.1	79.6	81.8	106.5	35.5	53.8	83.4	26.0	45.7	94.5	91.5	44.1	302.1	128.6	148.0	139.2	62.0	67.0	216.8	103.7	84.0	147.2	148.3	259.2	77.2	286.8	187.3	76.7	82.8	162.6	203.5	104.5	162.2	2.6	240.3	209.2	94.9	158.2	86.0	204.9	186.2	74.9	47.6	108.3	117.0	65.8	124.0	138.6	328.7	142.5	95.7	146.9	290.7	182.3	264.3	78.9	187.9	284.3	124.5	206.5	73.0	143.9	152.5	160.7	133.8	119.7	144.3	121.7	118.5	222.4	111.4	108.0	160.9	230.4	230.9	257.1	306.8	279.8	107.3	298.1	130.9	1.6	2.7	2.1	2.2	3.1	2.5	2.4	2.6	2.9	2.9	3.2	1.5	1.6	1.9	1.3	2.8	4.8	1.9	1.7	39.2	37.0	35.0	44.6	39.3	32.0	35.8	34.4	32.6	31.1	35.5	44.1	39.8	9.6	17.5	9.1	27.9	58.8	23.6	18.7	33.6	44.6	50.9	49.7	12.8	41.5	23.5	31.3	50.1	41.8	35.7	46.5	5.9	28.0	84.2	38.5	52.4	32.7	57.6	41.8	12.3	30.9	47.5	33.8	21.9	51.9	18.4	41.8	41.4	44.0	38.9	50.5	12.9	50.5	10.2	42.9	44.2	24.4	50.7	32.0	26.6	12.2	26.7	37.9	15.5	11.1	19.1	32.9	34.9	46.3	33.8	36.9	36.0	23.0	17.4	57.4	26.3	39.7	29.9	92.1	57.3	48.8	72.5	40.0	22.9	34.6	60.4	32.1
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KIF21A	"FEOM1, FLJ20052"	ENSG00000139116	"Kinesin family member 21A"	Q7Z4S6	12	39293228-39443390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.3;retina: 77.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 308.6;Cone photoreceptor cells: 308.6;Inhibitory neurons: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.1;MAIT T-cell: 3.4;memory CD4 T-cell: 4.4;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.8;NK-cell: 3.0;T-reg: 2.2"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.0;T-cells: 7.3"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 187.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022079, HPA058432"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Cytosol	"CAB022079: , HPA058432: AB_2683717"	"unprognostic (1.08e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (8.07e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.34e-2)"	6.5	12.1	37.4	3.9	40.0	0.9	6.2	41.4	51.2	12.3	8.0	11.9	9.0	9.2	5.5	20.9	33.7	6.1	19.2	38.2	55.7	26.5	20.5	5.9	2.9	67.4	46.6	4.5	13.2	16.6	16.0	5.7	70.3	11.2	13.1	77.6	23.9	3.1	15.3	12.7	10.3	8.7	39.3	6.5	12.5	12.5	46.5	2.2	8.8	9.5	5.3	5.9	11.4	44.3	18.5	23.2	31.8	13.7	6.0	3.0	25.4	4.5	2.2	5.9	4.1	42.2	22.4	0.0	14.1	1.9	9.4	16.0	18.5	11.2	5.4	36.1	14.7	0.2	40.6	38.6	4.6	31.0	0.1	2.0	24.4	7.4	35.3	13.4	7.7	7.8	35.4	36.9	4.8	11.1	4.0	0.0	42.8	0.0	20.0	0.1	0.0	21.1	22.3	30.1	43.0	187.6	17.7	27.7	10.8	32.1	32.2	3.9	5.6	3.4	13.7	1.1	13.1	16.7	6.1	0.0	8.1	4.4	2.9	0.0	0.0	0.0	7.1	0.0	3.4	0.5	4.4	7.3	0.0	0.0	1.0	4.8	0.1	3.0	0.0	0.0	2.2	1.0	37.4	40.0	41.4	51.2	38.2	55.7	67.4	46.6	70.3	39.3	46.5	44.3	4.1	38.5	17.5	205.7	5.3	18.5	25.1	25.9	4.6	308.6	10.9	11.0	121.9	22.8	53.9	12.9	308.6	15.3	36.2	30.0	9.8	27.8	108.4	78.1	30.2	5.5	24.0	2.5	189.9	41.3	100.8	17.2	36.2	27.7	13.4	92.7	12.8	44.2	3.8	138.0	221.0	28.7	22.4	2.5	2.2	79.9	3.1	2.4	14.2	23.4	7.8	112.3	25.7	124.1	160.3	37.2	20.0	2.6	30.7	37.5	20.7	53.3	193.9	186.1	0.0	26.1	17.4	57.2	24.0	30.5	30.7	59.1	33.5	17.7	29.3	21.7
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	13	"granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.0	1.5	0.3	5.7	0.2	21.6	1.4	0.2	0.3	1.5	1.4	4.1	3.9	2.0	0.1	5.3	0.9	1.3	0.6	0.3	0.2	4.6	0.5	1.5	7.9	0.2	0.3	0.7	0.5	0.4	0.1	6.4	0.3	0.9	5.0	0.2	1.1	1.2	0.1	3.7	3.8	4.2	0.2	2.2	2.0	10.6	0.3	15.9	0.3	0.2	9.8	1.8	2.1	0.2	100.7	81.5	64.2	59.0	3.7	7.3	36.3	105.3	57.0	154.8	120.6	50.2	72.4	56.8	31.4	53.1	78.6	110.5	121.6	39.5	158.7	52.9	60.2	55.3	78.8	30.7	2.1	55.6	48.3	3.3	4.2	71.8	60.5	19.4	52.0	46.9	36.0	70.2	95.4	44.1	31.2	28.2	71.6	35.5	33.2	37.0	133.8	31.2	39.3	49.7	32.5	25.3	120.4	51.9	44.9	74.5	50.6	25.3	34.5	90.0	120.8	62.0	157.6	26.3	74.3	48.4	31.5	72.2	78.0	0.0	1.2	4.6	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.4	0.0	0.5	0.0	2.3	1.9	3.7	4.2	0.0	0.2	1.8	2.8	0.8	5.7	4.7	7.3	2.1	24.2	1.4	3.3	3.9	1.8	13.3	13.1	3.6	2.2	1.8	42.3	1.8	0.0	32.4	5.8	3.6	8.7	2.5	22.4	3.9	0.3	8.1	0.0	1.0	3.1	0.0	2.8	3.4	4.8	0.9	3.2	0.0	1.0	8.1	0.2	0.0	0.0	0.2	0.4	0.4	1.9	6.8	1.6	0.8	0.9	3.6	0.1	6.6	0.4	8.2	70.8	20.9	11.3	1.0	2.5	4.2	3.6	8.6	3.3
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62391025	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		300000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.9	7.7	15.6	23.2	20.7	12.8	10.8	15.5	17.7	19.5	0.0	13.8	11.5	12.0	6.3	12.5	17.6	12.9	6.2	17.4	23.0	8.0	5.3	9.8	32.8	17.9	17.5	12.9	10.2	12.3	8.5	16.9	18.4	9.9	14.7	42.7	6.9	11.4	4.8	5.9	15.9	13.1	14.6	18.4	9.6	49.1	16.1	43.6	12.6	6.8	28.9	20.2	7.2	28.0	47.3	46.9	81.4	67.3	28.8	39.6	65.2	51.2	38.5	54.6	67.5	53.1	49.6	111.9	53.3	41.9	67.2	29.1	61.3	37.7	72.5	116.8	44.2	113.8	41.2	27.8	34.7	65.3	42.9	30.5	26.6	50.1	47.5	33.1	49.1	66.5	86.6	66.7	46.9	36.1	104.4	33.1	42.6	12.0	31.9	78.3	59.6	65.3	25.4	55.4	68.0	55.9	67.0	27.9	34.7	55.3	37.6	38.5	39.8	31.9	52.2	40.5	51.3	64.8	94.9	114.1	36.4	74.5	39.8	10.4	4.6	4.7	29.2	5.0	35.3	13.5	29.8	32.7	6.2	10.5	26.3	29.0	7.8	23.2	3.3	9.6	42.3	17.7	15.6	20.7	15.5	17.7	17.4	23.0	17.9	17.5	18.4	14.6	16.1	28.0	30.8	16.0	14.1	54.5	44.1	16.8	41.4	20.1	39.3	45.5	17.9	23.9	9.4	4.3	20.5	20.2	104.3	20.3	73.4	23.1	13.7	37.5	113.8	103.3	47.2	21.4	21.0	42.3	56.7	30.9	22.6	28.2	20.4	43.4	17.7	25.6	19.6	4.4	15.4	52.2	64.5	7.9	14.2	12.9	22.1	130.7	13.1	83.6	12.4	26.2	104.9	28.0	76.2	119.6	156.0	26.6	26.1	13.2	47.8	42.7	13.5	18.7	49.2	92.9	26.3	33.1	25.4	118.9	42.8	34.3	9.5	43.9	77.9	48.9	11.0	56.1
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009015-32056425	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		97000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	59.7	41.8	110.0	46.7	128.2	84.9	45.3	107.7	149.7	47.3	75.6	66.4	52.0	54.1	30.3	52.7	39.2	59.8	87.4	85.8	100.2	44.7	31.9	52.5	39.9	121.9	123.8	27.6	41.8	91.6	22.9	54.4	120.6	65.9	63.6	45.1	39.1	52.0	65.0	38.9	54.7	81.3	128.1	48.1	51.4	64.4	116.8	44.0	50.5	67.3	36.6	60.8	29.8	143.4	115.8	96.4	127.3	89.9	89.2	97.7	54.4	155.6	73.3	117.6	99.6	106.6	124.0	78.7	65.8	185.8	66.9	93.3	117.6	99.4	156.4	68.4	64.1	100.2	87.9	104.5	102.5	70.5	105.6	79.9	138.0	135.8	94.0	93.4	152.8	68.2	122.9	80.5	164.7	69.7	74.0	39.7	20.7	110.1	43.4	95.7	237.2	32.6	90.6	79.5	123.3	89.9	120.4	47.5	117.3	88.0	57.5	99.4	128.4	118.7	111.0	139.3	117.2	24.2	29.8	90.9	113.2	142.2	114.1	41.8	25.9	44.0	19.1	33.0	18.7	23.7	24.0	20.6	24.7	24.3	21.1	20.8	51.1	24.3	35.7	47.9	29.4	18.4	110.0	128.2	107.7	149.7	85.8	100.2	121.9	123.8	120.6	128.1	116.8	143.4	160.3	182.7	206.8	49.3	86.3	213.1	177.7	200.6	66.0	181.9	119.0	103.8	396.0	115.8	198.4	104.8	100.1	121.0	125.5	145.0	45.0	209.4	185.5	167.8	171.4	181.0	132.3	69.2	44.6	176.0	134.9	141.2	85.6	158.9	91.2	159.7	88.5	46.2	132.7	151.4	56.0	227.3	213.6	111.8	129.1	51.8	59.0	137.2	101.4	84.3	169.3	160.5	82.4	61.9	83.3	202.2	164.9	130.9	84.2	254.1	120.2	59.5	206.1	123.8	85.5	176.0	244.8	566.0	195.6	87.6	236.7	331.9	116.0	137.4	208.1	246.8
KIN	"KIN17, Rts2"	ENSG00000151657	"Kin17 DNA and RNA binding protein"	O60870	10	7750962-7787993	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016339, HPA038700"			Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016339: AB_627860, HPA038700: AB_2676159"	"unprognostic (4.33e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (3.23e-5)"	2.1	2.4	1.9	2.6	1.9	3.1	2.6	4.4	2.5	2.8	1.8	2.2	2.4	3.3	2.8	2.0	2.4	2.1	2.1	1.8	1.8	2.3	3.3	2.2	3.4	1.7	1.8	3.0	2.7	2.0	2.6	3.0	1.9	2.5	2.2	3.4	2.5	2.1	2.8	3.4	2.4	2.1	1.4	2.8	2.5	2.1	2.0	2.4	2.9	2.2	2.7	2.1	2.4	2.6	4.3	2.7	4.1	2.5	3.3	3.9	3.3	3.8	1.7	4.5	4.8	5.2	4.2	3.3	1.9	2.3	1.4	4.0	3.5	2.3	5.1	3.8	4.0	5.2	2.7	5.1	4.6	1.9	4.1	3.3	2.5	3.4	2.2	3.7	3.4	4.1	5.3	3.1	3.5	3.9	3.8	2.9	3.9	4.5	1.6	4.8	2.9	3.1	3.8	2.3	1.7	3.8	3.0	2.9	6.2	3.8	5.5	3.8	2.5	2.9	3.2	5.1	3.1	4.0	4.7	4.1	3.6	2.9	2.0	15.9	3.9	7.1	3.7	4.3	3.7	5.9	3.3	3.1	3.0	5.4	3.6	3.8	8.8	4.9	4.1	5.8	3.0	1.5	1.9	1.9	4.4	2.5	1.8	1.8	1.7	1.8	1.9	1.4	2.0	2.6	31.5	35.3	27.2	12.1	20.7	17.3	14.6	31.3	13.6	54.8	17.2	20.1	13.0	20.0	24.8	18.4	39.6	36.7	32.0	20.4	13.7	32.9	5.7	21.7	28.4	25.6	23.3	30.3	17.4	21.5	23.8	24.0	14.3	27.9	16.4	22.9	21.0	11.9	32.1	63.9	14.8	20.3	18.3	16.9	22.8	6.2	27.7	21.8	16.0	11.2	30.7	28.7	38.1	13.0	19.4	21.2	23.6	30.9	18.1	18.9	18.2	16.9	26.0	54.7	13.1	27.8	29.7	29.1	19.0	12.1	14.3	38.4	25.7	30.1	14.7	17.3
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	15.2	18.0	18.8	9.5	25.4	3.6	15.9	33.0	78.1	27.3	0.0	28.5	9.8	27.1	6.3	18.2	21.6	8.9	32.1	26.6	12.7	22.4	8.2	18.9	9.1	39.8	10.8	24.6	15.5	15.2	48.3	7.2	37.0	28.7	4.7	28.4	15.9	16.0	57.8	18.3	16.3	11.2	5.7	13.7	20.2	32.2	23.1	25.1	17.7	14.2	6.4	27.2	21.7	35.8	49.4	58.2	28.3	16.9	16.9	13.5	21.9	34.1	24.2	34.2	26.1	31.9	14.3	21.3	31.9	25.6	43.9	40.7	29.3	33.2	11.4	35.7	37.2	4.4	48.0	22.4	32.1	9.9	22.7	13.5	42.7	40.1	32.8	22.0	16.1	26.2	24.1	29.0	27.8	69.2	56.8	15.0	27.8	14.2	49.2	21.4	14.6	30.1	27.2	27.4	76.3	37.5	24.6	22.1	41.3	15.7	36.3	6.7	26.8	55.5	49.8	68.2	45.5	30.7	27.4	11.9	39.3	6.7	22.9	0.0	0.2	0.5	2.4	0.1	3.1	1.9	1.1	1.6	0.3	3.2	1.1	1.4	0.3	1.3	0.2	2.1	0.3	1.1	18.8	25.4	33.0	78.1	26.6	12.7	39.8	10.8	37.0	5.7	23.1	35.8	4.0	3.2	1.5	8.8	8.9	8.9	9.2	11.1	7.4	34.4	10.1	7.2	2.4	7.2	5.5	12.9	12.5	9.9	5.1	3.1	13.7	14.8	10.1	7.7	6.2	5.2	37.1	0.8	20.7	8.2	18.2	6.5	13.7	9.7	0.0	8.6	3.9	2.3	3.1	55.5	19.0	7.2	18.3	3.2	4.0	4.6	8.7	2.8	12.4	5.6	6.3	14.6	4.1	4.0	6.2	19.1	4.9	13.9	9.1	18.2	3.9	10.3	7.3	35.2	0.0	9.5	13.3	26.2	29.8	8.9	9.7	12.7	8.2	3.4	4.9	8.5
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664197-38701517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA049512: AB_2680799, HPA065054: AB_2685415"	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	27.9	23.8	13.8	22.1	18.4	95.0	20.8	16.5	14.9	30.1	14.1	44.5	38.0	28.0	14.1	56.3	20.2	33.5	14.8	14.6	14.1	16.1	44.2	23.9	16.4	19.8	17.9	44.7	33.4	31.0	11.3	31.5	18.4	23.3	47.4	16.6	31.2	19.7	14.5	65.4	38.7	25.7	15.7	29.2	46.0	5.2	16.1	13.1	28.1	17.9	19.6	42.1	39.2	21.3	21.1	14.1	51.8	10.6	23.3	34.5	16.8	11.3	32.5	7.4	9.2	13.3	37.3	0.0	15.7	24.4	21.6	22.3	14.9	19.8	11.9	0.3	11.5	20.1	20.7	28.5	23.8	5.0	0.2	31.3	53.3	10.8	20.0	14.0	29.0	7.6	58.0	9.7	12.0	4.7	5.4	8.8	12.2	42.6	10.1	7.2	25.2	22.8	26.4	49.1	14.9	19.4	12.3	9.6	24.4	20.8	6.0	6.9	46.2	24.6	14.4	42.2	12.4	13.7	4.6	0.1	10.2	14.9	10.7	10.8	4.4	17.0	6.3	7.6	4.5	5.3	7.0	5.7	3.4	4.2	9.7	5.6	13.4	3.0	12.5	0.8	8.3	2.4	13.8	18.4	16.5	14.9	14.6	14.1	19.8	17.9	18.4	15.7	16.1	21.3	108.7	22.4	29.5	20.9	78.6	121.5	150.9	82.2	99.0	42.8	38.5	29.7	16.2	77.2	76.6	31.3	31.3	27.4	137.3	219.5	11.7	88.3	1.1	87.3	70.8	86.7	86.5	239.3	11.6	86.2	21.8	70.0	230.4	168.2	19.7	35.0	65.7	57.2	56.3	35.3	27.9	170.3	91.6	87.9	78.6	4.1	51.9	94.9	49.8	45.0	64.4	46.7	143.2	36.2	47.8	113.6	145.5	48.2	105.2	143.9	124.6	24.3	39.4	38.1	26.3	55.5	42.6	1.1	5.0	191.6	222.5	27.4	84.3	62.4	128.4	308.7
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 395.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 552.0;Late spermatids: 1588.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	52.5	64.9	161.4	33.9	170.8	48.6	52.7	144.2	203.3	48.5	139.0	75.0	40.1	44.5	56.3	49.5	53.0	37.4	105.7	178.2	143.8	53.2	73.0	43.2	45.4	150.6	153.9	55.6	51.1	54.6	68.8	59.2	156.5	56.8	40.7	48.2	60.6	47.8	395.9	51.4	48.6	43.3	140.5	54.0	64.8	192.2	158.6	67.1	49.7	203.9	44.8	49.8	46.2	157.1	119.1	36.0	117.1	197.3	79.0	59.4	83.8	52.6	67.7	100.7	109.4	104.5	60.6	117.0	58.7	77.3	37.8	61.6	126.1	67.8	68.5	62.8	171.3	146.0	102.1	109.7	77.4	86.5	99.7	95.8	67.1	77.6	45.2	77.9	98.7	131.1	180.7	80.9	38.4	147.3	142.3	148.9	153.4	297.3	38.0	137.2	86.0	141.4	62.3	67.9	216.1	168.8	55.8	63.2	93.1	75.7	109.8	247.6	58.8	45.7	83.9	50.8	52.9	88.0	118.8	170.9	19.9	122.7	39.4	42.3	83.5	100.3	62.0	78.9	51.9	41.6	50.8	56.0	90.7	39.6	65.6	51.8	40.4	54.7	63.3	49.8	59.5	76.5	161.4	170.8	144.2	203.3	178.2	143.8	150.6	153.9	156.5	140.5	158.6	157.1	21.3	12.8	17.0	10.4	26.7	18.7	32.9	33.5	14.8	31.9	37.8	33.7	40.3	37.1	19.1	18.4	14.6	99.6	32.7	34.8	86.1	61.7	552.0	19.2	19.0	30.4	52.3	59.3	29.1	54.7	115.1	36.2	20.9	18.8	13.4	50.7	32.5	28.4	63.8	32.0	22.0	43.7	34.6	47.0	22.7	1588.3	44.7	31.8	33.8	11.2	54.7	55.4	55.6	11.6	14.8	46.3	44.3	59.0	31.7	44.4	72.6	55.3	16.9	25.9	52.6	30.4	32.2	180.8	35.6	22.8	20.6	107.0	28.3	71.4	53.7	36.7
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171598-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 128.7"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 28.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 28.8;monocytes: 8.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	29.1	128.7	13.5	5.6	14.0	6.1	24.9	9.4	14.8	20.2	24.8	56.1	7.2	26.2	10.6	31.1	26.5	16.7	70.5	12.4	21.2	16.3	12.6	17.3	9.9	12.4	14.2	70.1	9.4	10.4	10.1	12.3	16.1	16.9	3.6	2.3	14.1	13.5	29.6	28.1	14.0	14.2	11.6	13.2	16.7	15.5	19.1	4.3	26.6	13.4	6.8	29.4	22.5	10.3	2.5	5.5	22.4	11.4	13.5	8.0	6.9	8.4	4.7	8.2	6.6	3.6	7.4	0.0	4.6	14.0	2.3	0.1	5.6	5.1	2.1	4.6	1.5	15.1	15.2	9.6	25.6	0.0	8.5	13.3	23.9	10.6	0.8	18.4	21.2	5.3	23.7	0.2	6.3	0.7	1.6	16.7	7.4	1.3	13.1	2.3	2.1	0.7	6.1	1.3	0.9	25.2	6.7	0.2	17.0	4.7	6.8	7.3	9.3	6.2	17.1	11.2	2.6	2.1	0.7	0.3	4.5	0.0	3.1	0.0	5.4	28.8	1.0	8.0	0.4	0.0	0.5	0.7	0.5	0.1	1.8	1.0	9.7	0.0	8.3	0.8	0.2	2.4	13.5	14.0	9.4	14.8	12.4	21.2	12.4	14.2	16.1	11.6	19.1	10.3	14.1	9.6	10.9	5.9	0.9	7.6	11.5	16.4	10.8	2.2	10.8	9.0	60.7	11.5	14.3	7.3	2.1	10.9	2.4	1.0	17.6	14.3	7.2	6.8	6.9	20.5	6.7	6.5	3.8	5.9	8.5	22.3	2.6	3.3	1.3	7.7	37.1	7.5	41.7	0.0	4.6	3.0	18.3	12.0	2.2	7.7	15.2	10.5	12.4	6.5	2.5	29.4	0.0	3.5	0.7	8.6	1.7	14.3	0.6	8.3	0.7	13.4	4.0	2.7	98.6	28.3	31.1	9.2	8.6	15.5	9.8	49.8	1.5	55.5	1.7	7.9
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 50.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 560.6;Late spermatids: 242.7;Oligodendrocyte precursor cells: 168.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	9.5	18.8	12.8	7.0	13.3	12.4	13.0	16.3	15.9	10.5	12.1	9.2	7.8	11.5	12.2	9.0	9.7	9.7	50.8	12.5	13.1	11.9	10.4	7.7	8.3	12.6	12.7	11.8	7.7	10.8	7.3	8.6	12.3	10.1	7.9	14.9	8.5	8.1	9.1	10.9	6.9	10.5	12.2	8.0	6.3	42.2	13.4	12.4	9.2	9.7	9.1	8.7	9.4	14.7	24.7	20.7	55.7	66.3	26.8	23.2	20.3	21.3	31.5	30.7	35.6	25.3	17.5	24.1	16.8	26.2	50.5	26.2	21.5	15.0	25.8	6.4	15.5	15.9	16.7	32.9	20.0	32.5	12.0	20.7	19.1	35.2	28.8	24.2	39.6	29.4	28.3	25.5	50.7	28.4	27.3	51.3	77.0	16.7	24.5	23.7	31.2	22.2	29.2	21.0	33.5	32.5	46.2	22.7	23.3	33.9	18.9	16.9	17.0	25.7	26.6	56.9	25.7	39.9	35.3	58.6	17.0	33.8	31.5	44.1	15.3	67.2	13.0	17.9	13.7	9.2	13.8	12.3	11.1	11.9	10.1	10.0	14.4	9.5	15.8	8.0	16.7	12.6	12.8	13.3	16.3	15.9	12.5	13.1	12.6	12.7	12.3	12.2	13.4	14.7	12.1	22.4	5.5	45.7	13.0	23.6	18.2	13.0	18.2	23.7	12.3	13.5	101.2	8.6	11.3	9.2	29.2	20.7	14.4	5.7	11.7	17.7	560.6	18.3	16.7	15.8	10.8	25.6	74.5	17.6	27.1	19.8	10.2	13.2	21.5	16.3	13.2	7.0	19.7	37.0	75.2	7.6	14.2	16.0	17.2	242.7	16.8	12.6	12.4	35.6	13.4	30.3	8.2	168.9	45.6	19.4	1.9	20.7	12.3	11.5	7.4	13.5	18.8	16.3	6.6	14.3	17.9	83.7	19.7	24.6	33.8	23.7	17.2	12.1	7.0	24.0
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 60.4"	"Cell type enriched"	"Detected in all"	4	"Muller glia cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.7	7.3	4.6	6.1	4.7	3.1	9.4	7.0	4.8	8.7	1.9	8.0	7.8	6.8	60.4	4.8	5.4	4.9	4.6	4.1	5.6	12.0	11.2	5.2	5.8	4.1	5.4	6.0	5.2	8.5	3.6	4.2	3.6	5.5	8.9	27.2	7.1	7.4	13.7	4.0	7.6	6.6	4.7	6.3	4.2	4.3	5.9	8.5	18.9	9.7	4.8	6.0	4.2	5.0	9.9	8.5	15.1	6.8	13.5	9.8	8.1	12.4	6.6	8.1	9.5	13.8	7.3	14.3	9.8	9.2	6.6	4.1	16.2	12.2	17.4	13.7	10.1	17.4	6.0	8.1	11.5	28.9	10.5	12.4	8.6	12.4	12.4	7.9	9.7	10.6	22.8	12.7	8.5	10.9	34.8	14.4	3.8	22.1	3.4	12.9	12.9	8.7	13.7	10.1	31.6	11.0	8.1	19.6	9.2	5.6	6.8	21.0	9.2	10.2	12.6	10.9	10.4	18.7	13.1	25.1	7.7	13.5	11.4	2.0	12.2	7.6	2.9	9.2	4.6	3.2	2.2	2.4	10.4	3.5	4.0	4.0	8.6	8.4	9.8	2.6	0.9	5.0	4.6	4.7	7.0	4.8	4.1	5.6	4.1	5.4	3.6	4.7	5.9	5.0	9.5	3.2	22.9	29.4	14.3	13.8	10.8	10.1	13.6	22.8	11.1	7.7	15.4	5.7	11.6	44.1	41.7	4.1	12.1	21.4	11.7	5.2	4.0	8.3	21.4	12.8	9.0	12.4	44.6	4.5	6.9	10.4	3.1	9.8	7.6	16.8	8.6	20.0	9.7	23.5	41.5	10.8	4.1	38.8	12.0	3.5	9.6	23.3	10.6	24.4	22.1	216.0	11.3	47.3	35.7	4.9	12.2	8.2	6.4	13.8	14.5	19.2	10.1	47.0	13.1	20.1	9.2	32.5	22.5	12.9	14.8	23.8	9.9	4.4	15.2	11.4
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 390.9;MAIT T-cell: 461.3"	"Lineage enriched"	"Detected in all"	22	"T-cells: 461.3"	"Cell line enhanced"	"Detected in many"		"HEL: 25.1;NTERA-2: 22.1;U-937: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051403, HPA076494"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA051403: , HPA076494: AB_2686800"	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	4.1	1.7	2.4	3.8	2.6	3.0	2.5	4.3	2.9	1.3	1.4	1.5	1.0	1.2	2.1	1.0	1.0	3.3	2.0	2.1	3.2	1.4	3.0	2.2	10.4	2.5	3.4	1.0	0.5	0.4	1.1	0.6	2.3	1.1	1.9	1.3	1.6	0.7	1.7	1.0	2.2	1.6	1.7	8.8	1.6	1.1	2.6	2.5	1.0	1.8	5.0	2.4	0.8	3.8	0.2	3.1	1.6	2.3	3.0	0.7	1.4	0.5	0.3	0.4	1.1	1.1	1.1	4.9	0.1	0.4	2.1	0.2	3.3	0.5	0.4	3.6	1.9	25.1	0.4	1.6	0.8	1.1	1.6	1.4	0.4	0.5	0.0	0.4	7.6	2.5	1.4	0.4	0.2	0.7	1.0	2.0	22.1	1.0	1.7	1.2	1.0	0.0	0.5	0.4	0.4	4.4	1.1	0.5	1.6	4.3	0.3	1.7	0.8	0.7	1.0	0.6	1.4	1.4	4.1	2.6	1.8	17.3	0.2	17.5	2.6	1.5	390.9	2.9	461.3	4.2	85.1	237.7	8.2	5.0	23.5	147.7	5.7	20.9	5.4	3.9	8.7	99.7	2.4	2.6	4.3	2.9	2.1	3.2	2.5	3.4	2.3	1.7	2.6	3.8	12.7	0.0	4.3	2.9	4.7	0.4	0.4	0.0	4.0	5.0	1.0	0.9	2.8	1.5	0.1	0.0	8.4	1.0	93.7	0.1	1.9	0.7	1.6	0.8	0.6	2.9	1.2	24.6	3.8	0.2	0.5	1.3	0.5	0.5	118.9	0.9	25.7	2.0	3.4	5.0	3.6	0.1	0.0	9.1	1.4	3.1	0.6	3.7	1.8	2.8	5.4	1.8	164.8	9.5	6.2	0.3	0.1	0.0	16.9	0.2	0.3	3.1	0.1	3.9	0.0	2.1	1.0	7.8	7.3	1.3	0.0	0.3	109.3	0.7	0.6	0.1
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701937-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 166.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041079, HPA066169"	Uncertain		Enhanced	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA041079: AB_10962350, HPA066169: AB_2685628"	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	7.5	6.8	14.3	6.9	16.9	4.0	11.5	14.6	22.5	9.1	9.7	8.3	7.1	7.0	8.8	10.4	7.4	6.3	7.3	15.5	15.1	9.9	7.9	5.7	9.0	15.9	15.8	11.4	8.6	13.5	6.4	8.8	17.3	7.3	9.1	8.8	12.5	6.8	14.4	13.0	7.3	4.8	13.2	6.4	8.1	8.9	15.6	5.9	6.2	5.4	6.7	7.2	8.8	22.9	30.2	45.4	49.7	37.9	12.1	11.3	25.5	18.3	9.9	17.1	17.2	32.2	25.5	35.7	72.6	11.1	15.0	27.4	38.9	25.1	16.6	24.2	27.2	21.1	25.3	42.7	21.9	33.5	15.9	7.2	35.1	22.4	18.4	15.0	18.3	25.0	66.1	15.6	16.2	39.3	29.7	27.6	96.8	29.7	17.9	63.0	26.7	41.4	18.0	28.4	44.4	37.4	22.7	29.0	31.2	28.1	33.8	22.4	21.3	26.7	27.4	16.5	24.5	23.0	51.3	44.7	14.4	25.2	26.6	0.4	3.0	1.5	4.0	7.1	5.9	5.8	5.6	3.9	3.6	7.1	10.1	5.7	0.8	4.4	6.7	4.6	3.8	3.5	14.3	16.9	14.6	22.5	15.5	15.1	15.9	15.8	17.3	13.2	15.6	22.9	40.3	6.4	17.8	108.7	19.8	12.2	29.9	47.9	17.6	39.2	37.9	31.9	8.9	38.6	29.5	38.6	87.6	57.1	13.6	43.0	46.9	98.2	2.8	33.8	79.8	47.2	15.0	21.7	9.7	66.3	45.4	26.0	26.5	42.1	6.3	66.9	26.0	53.4	36.5	35.3	12.7	41.7	61.1	24.9	12.6	8.5	60.6	17.9	12.4	16.9	27.2	25.8	33.0	15.1	166.6	77.8	19.0	53.8	14.8	46.4	32.3	34.5	21.3	64.1	46.0	18.7	38.9	67.8	125.3	31.5	16.1	24.6	16.8	53.6	64.4	23.3
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin (SPAG5) binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.6;thyroid gland: 53.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	8.0	6.2	6.3	8.1	7.1	14.1	14.3	7.7	8.6	5.1	4.5	7.9	9.2	6.4	12.3	9.1	5.7	4.4	7.4	7.2	6.2	7.2	12.0	5.8	14.5	6.2	6.2	5.1	5.0	8.4	5.6	10.7	6.5	6.8	10.4	9.0	10.3	7.2	12.2	6.7	6.2	10.2	5.9	7.1	10.2	63.6	6.1	25.6	53.1	12.4	16.1	5.6	5.6	7.7	103.4	47.5	92.7	61.0	20.1	30.9	48.1	69.9	54.0	141.0	123.3	102.6	44.2	39.7	34.8	47.3	112.1	115.7	100.0	64.8	126.5	70.8	48.8	117.7	107.4	65.2	18.9	63.8	58.6	16.1	36.5	71.3	70.6	34.5	80.3	97.6	86.3	66.8	120.0	52.2	55.6	51.2	58.6	87.7	71.2	56.4	69.7	45.7	49.7	42.3	89.9	62.5	58.3	63.3	15.1	55.8	66.5	45.3	41.6	67.5	68.8	69.7	98.3	56.5	98.6	70.5	41.8	84.0	56.5	13.2	17.6	17.4	7.9	24.3	6.8	9.5	5.7	7.0	18.4	11.2	5.4	5.5	9.7	9.8	47.8	12.7	9.4	7.1	6.3	7.1	7.7	8.6	7.2	6.2	6.2	6.2	6.5	5.9	6.1	7.7	2.4	9.6	1.1	2.6	4.1	2.2	2.9	7.6	3.4	8.2	4.2	3.4	7.3	1.5	5.4	0.0	8.4	25.2	2.5	1.9	3.9	8.5	328.2	5.9	4.9	3.7	2.4	34.3	5.1	9.3	40.8	5.2	5.6	4.4	1.3	16.9	3.6	8.0	21.6	5.0	4.9	5.3	14.2	9.8	2.0	600.1	9.0	8.2	3.6	4.7	8.0	8.5	6.2	2.0	4.3	12.3	0.5	7.2	12.6	4.9	2.8	5.8	7.2	8.5	0.0	3.7	6.5	145.7	19.2	7.0	1.4	21.1	5.1	8.5	6.4	3.0
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421902-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	20.2	18.4	10.0	19.8	10.6	11.4	11.9	10.6	15.0	14.1	6.7	15.5	13.0	13.6	15.1	21.8	12.9	12.1	20.3	11.6	10.7	16.1	32.0	13.0	15.7	11.2	10.2	10.6	18.8	19.2	9.0	15.9	11.2	15.1	15.4	28.6	12.4	16.3	74.4	13.5	13.6	23.0	11.6	12.3	14.5	20.6	10.7	15.5	17.9	41.0	20.6	22.1	11.4	12.6	75.1	43.4	73.2	37.2	46.6	51.2	23.2	56.5	47.5	60.4	54.4	52.6	35.6	54.1	50.6	62.4	47.8	38.3	58.2	48.2	88.9	14.8	22.1	66.6	37.1	29.5	27.3	59.8	29.5	35.7	61.0	43.7	60.9	29.5	67.3	28.8	47.6	30.5	55.8	34.6	43.7	14.1	31.8	52.5	46.2	44.1	60.8	34.8	26.2	51.8	50.4	30.3	60.5	32.6	50.1	56.9	43.2	34.8	57.9	37.7	41.2	18.7	44.1	29.1	31.8	99.9	52.7	40.9	39.1	27.1	19.3	18.8	17.4	19.5	18.6	15.8	15.2	19.3	25.4	12.7	15.4	15.8	41.5	21.2	29.3	7.9	17.6	18.2	10.0	10.6	10.6	15.0	11.6	10.7	11.2	10.2	11.2	11.6	10.7	12.6	27.9	16.0	31.8	53.5	31.9	41.4	22.2	15.8	28.5	30.1	24.2	12.3	31.1	22.8	32.9	14.7	31.3	21.2	31.5	18.6	13.7	23.2	120.1	35.0	26.1	27.6	16.3	49.2	107.2	33.4	25.9	26.1	19.4	29.5	38.7	18.6	22.5	50.2	23.3	20.2	81.7	19.7	18.3	27.9	47.4	221.8	22.4	30.0	17.8	61.8	31.5	22.2	26.8	59.8	91.7	35.1	19.8	24.8	36.6	34.5	18.6	23.1	44.8	47.4	13.1	25.4	32.1	42.1	18.0	27.1	45.5	24.9	31.3	19.6	14.0	27.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160495007-160565571	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	20.2	8.1	4.4	12.0	5.4	15.2	11.1	7.2	10.8	11.1	2.7	16.9	8.8	12.7	8.5	16.5	9.0	9.7	23.3	5.8	7.3	11.1	12.2	11.0	10.4	6.2	5.5	9.0	13.2	11.0	6.3	11.9	6.5	11.6	8.5	13.2	10.5	12.4	124.6	11.3	9.8	13.5	5.9	11.2	12.1	12.2	5.5	11.2	10.3	59.8	12.0	14.3	11.8	6.9	103.4	29.9	20.0	32.7	30.3	27.8	39.7	70.7	39.6	41.0	33.0	38.5	32.1	52.6	73.8	59.9	52.5	45.8	27.4	38.2	50.2	77.0	20.5	52.8	15.2	9.0	37.7	49.3	33.8	22.0	18.5	38.5	76.6	27.5	53.9	26.5	44.2	33.5	45.5	13.8	38.0	17.7	53.9	33.7	31.4	33.9	41.6	50.4	21.9	22.9	23.3	24.8	60.8	29.7	55.7	22.8	33.7	14.4	72.9	39.4	36.0	37.3	87.9	80.4	50.4	96.3	30.9	45.4	31.6	7.7	2.3	2.9	1.8	3.5	2.5	2.3	1.6	2.6	1.7	1.5	1.3	2.0	4.2	4.0	5.7	1.5	2.7	1.8	4.4	5.4	7.2	10.8	5.8	7.3	6.2	5.5	6.5	5.9	5.5	6.9	70.5	38.5	25.1	40.1	62.8	123.6	87.3	24.3	60.3	58.6	59.4	48.1	158.8	30.0	38.4	11.0	79.2	26.1	54.5	65.0	35.2	36.5	24.3	71.2	63.2	60.7	28.7	38.1	48.5	37.7	25.3	55.1	45.9	92.1	31.6	57.6	37.5	34.7	39.2	53.8	52.9	38.1	28.5	47.9	97.2	18.4	33.8	80.0	44.4	49.6	43.2	57.5	28.8	45.8	69.2	77.4	44.3	34.6	65.2	86.5	32.0	40.2	40.6	69.6	32.9	102.4	67.4	38.2	25.3	85.3	126.0	40.6	60.6	36.1	43.7	104.4
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553085-10566031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 177.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	12.3	11.5	10.6	20.0	11.3	17.1	12.6	11.0	11.8	16.6	11.6	14.3	10.0	13.8	7.6	16.8	14.4	7.1	12.1	10.2	12.0	12.7	13.6	11.2	22.3	11.3	11.0	14.8	15.6	10.3	13.4	8.7	11.1	15.6	7.5	33.8	13.0	8.7	22.3	20.9	17.4	7.3	10.3	22.3	12.5	16.1	11.2	30.6	14.6	9.7	15.1	15.9	15.9	11.9	37.7	17.6	23.6	35.0	13.2	14.3	16.6	34.0	16.1	21.6	20.2	27.1	13.6	55.7	39.2	14.1	18.4	29.1	30.3	27.3	23.9	60.2	67.1	177.2	39.6	18.1	23.4	69.6	61.7	17.7	21.7	31.8	31.4	18.4	13.9	33.2	50.4	56.4	18.7	33.5	72.7	104.3	38.2	30.3	45.0	30.0	30.7	28.4	18.1	32.6	39.2	18.2	40.2	23.4	25.7	20.7	29.5	50.0	16.8	27.9	23.0	74.4	71.9	38.7	48.5	39.7	23.2	56.3	41.6	2.2	4.9	2.9	11.9	5.7	11.0	7.4	7.9	9.7	6.8	8.3	8.7	9.5	0.8	10.3	3.0	16.0	6.5	4.8	10.6	11.3	11.0	11.8	10.2	12.0	11.3	11.0	11.1	10.3	11.2	11.9	8.9	16.0	25.5	6.2	20.4	13.5	11.4	12.2	40.9	15.4	6.4	9.5	8.6	8.6	17.5	14.7	39.6	11.4	15.0	9.5	1.9	8.5	4.6	9.0	17.6	11.0	9.6	26.1	4.0	7.5	8.9	11.0	16.3	10.4	19.6	12.3	10.4	9.0	8.0	11.8	3.7	10.1	8.2	12.5	6.1	5.8	8.4	10.5	8.8	5.6	9.2	11.6	24.7	6.0	7.7	5.6	7.6	9.1	17.4	10.8	9.0	5.0	16.0	55.0	0.0	13.5	9.3	25.3	16.8	28.1	13.8	4.5	26.8	9.0	12.7	8.2
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1 small subunit processome component homolog"	Q13601	12	75490863-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	15.2	14.2	6.5	15.6	7.0	43.9	16.7	9.3	10.4	11.6	7.6	12.5	12.1	15.0	9.0	16.0	9.8	10.0	11.8	6.9	8.2	16.2	20.4	11.5	19.0	6.6	7.3	15.0	10.7	20.3	8.0	14.5	7.0	13.2	10.9	16.0	19.3	9.8	23.5	12.7	10.3	10.9	7.4	12.6	12.7	12.0	7.5	17.9	14.9	22.7	18.0	15.9	9.8	8.2	59.4	48.1	29.2	27.1	21.8	20.1	54.1	51.0	31.7	38.5	24.8	35.7	30.7	62.2	40.3	23.9	39.0	30.5	39.1	43.0	42.4	52.0	39.9	60.9	25.0	41.8	26.4	107.0	37.1	21.3	35.8	44.8	41.7	39.1	26.6	57.4	67.7	19.8	38.2	39.2	63.1	30.8	43.6	32.4	42.4	49.9	56.1	37.4	42.6	73.6	35.4	29.6	48.0	33.7	59.5	27.9	56.2	42.9	34.4	36.2	24.1	37.7	53.2	38.8	52.3	39.0	19.6	37.0	66.2	13.3	3.2	13.2	13.1	6.5	16.4	23.0	18.3	15.0	5.5	20.6	18.6	17.9	1.5	12.9	5.5	15.3	18.2	7.6	6.5	7.0	9.3	10.4	6.9	8.2	6.6	7.3	7.0	7.4	7.5	8.2	62.9	70.5	49.2	13.4	64.0	49.1	104.3	70.3	48.9	56.4	41.1	50.5	25.6	24.3	55.7	40.5	33.3	68.5	86.4	18.7	58.7	50.9	5.4	52.5	63.8	46.7	18.0	55.8	25.3	49.0	55.7	48.2	21.4	62.6	38.0	41.3	31.1	40.9	29.5	74.0	24.3	25.7	46.8	24.2	21.3	7.6	52.5	30.0	12.4	6.5	42.4	66.4	66.9	19.1	16.3	42.8	28.1	53.4	37.9	45.6	19.2	47.0	42.3	55.5	13.1	79.2	50.2	72.6	61.1	46.8	44.3	70.5	65.4	59.6	29.3	63.2
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40925.1;vagina: 13409.3"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 16844.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	93	"A-431: 2462.5;HaCaT: 1626.2"									"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		680000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	7.7	7.5	0.0	0.0	0.1	6.8	5.1	0.0	0.0	6884.6	0.0	5.6	0.1	10.2	0.0	40925.1	7.0	8.8	9.2	0.0	0.1	5.6	12.8	6.0	0.3	0.0	0.0	9.9	17.2	0.0	26.9	0.0	0.0	115.2	0.0	0.0	6881.1	3.8	9.8	20.5	8.5	14.2	0.0	7.7	31.3	6.9	0.0	13.6	6.1	0.0	1855.2	924.7	13409.3	0.0	2462.5	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.8	7.1	0.6	0.0	0.0	1626.2	0.0	0.4	0.0	1.4	0.0	4.5	21.8	0.0	0.0	1.7	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	5.4	1.2	0.0	1.3	0.1	0.1	0.1	14.8	0.3	0.2	1.2	0.3	0.0	10.7	0.0	0.0	1.9	2.0	7.7	0.0	2.3	6.4	5.1	0.0	0.4	0.0	6.6	0.3	6.3	5.8	1.9	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.0	1.1	0.0	0.9	2.8	545.6	17.1	146.8	0.0	2.3	4.6	0.6	1.5	94.5	0.0	0.0	0.1	0.2	0.6	0.0	0.0	1.2	2.7	0.2	11.4	1.2	5.5	0.0	0.0	0.5	12.6	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	8.2	0.0	0.0	3.2	55.9	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.7	286.6	27.1	227.9	0.1	0.1	3.3	0.0	0.0	0.0	16.9	0.2	0.6	16844.0	1.6	0.4	8.8	0.0	0.4	3645.4
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586895	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6940.5"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 5910.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"spinal cord: 36.3"	"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1600000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	15.8	1.2	0.0	0.0	0.0	2.7	332.7	0.0	0.0	412.0	0.0	1.7	0.0	0.9	0.0	1304.2	1.7	0.0	3.5	0.0	0.0	0.8	2.5	1.7	0.0	0.0	0.0	1.3	2.9	0.0	4.3	2.2	0.1	29.1	0.0	0.0	702.1	3.8	15.9	6940.5	2.1	0.1	0.0	0.9	1.7	1.5	0.0	186.7	2.3	0.0	262.3	0.7	846.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.7	0.0	4065.2	0.0	2003.9	0.2	0.0	0.0	0.1	1.6	0.0	0.1	0.2	2.5	0.1	2448.6	3.0	794.2	0.0	0.1	0.0	0.5	3.6	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.3	9.1	1.7	696.0	0.0	0.9	0.0	0.0	3.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.5	35588.3	1072.7	181.5	2407.4	0.0	103.5	740.9	0.3	0.0	6.0	0.0	0.0	17.9	3.2	7.3	0.0	0.1	0.0	0.1	0.0	129.0	0.0	0.0	0.0	0.0	127.0	116.5	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.4	0.0	0.0	1833.4	0.0	0.0	9.3	1990.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.5	0.0	9.9	702.0	96.8	0.0	2.3	0.0	0.0	0.0	96.3	0.0	0.1	83.2	11677.1	2.5	62.1	0.1	2.3	100.0
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619442-41624842	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 382.1;skin 1: 949.4;urinary bladder: 632.2"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 13196.1;Prostatic glandular cells: 5931.6;Urothelial cells: 8499.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"hTCEpi: 20287.9;SiHa: 8539.7"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		610000000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	5.1	0.4	4.9	0.8	5.3	2.8	382.1	3.5	5.8	102.2	3.5	2.0	0.8	4.3	14.1	320.4	6.9	1.9	2.7	6.3	3.3	3.1	0.6	9.8	0.3	3.5	3.4	0.9	2.6	0.5	6.6	7.0	3.5	132.4	0.3	0.3	263.2	116.1	0.9	949.4	0.6	1.0	3.4	0.4	2.3	4.5	3.3	142.7	1.6	0.0	97.8	632.2	212.3	4.7	212.5	0.2	0.0	0.0	0.8	0.9	48.8	1.9	0.4	2.8	2.7	16.8	1.9	1.0	14.7	0.2	0.4	2101.7	0.1	2129.1	1.9	0.3	1.6	2.0	910.8	2.0	0.5	1.9	2.2	0.4	20287.9	1.3	1539.9	0.0	1.0	0.0	1.0	1.5	0.4	0.7	0.7	0.3	0.4	237.2	0.0	0.7	3.1	1.7	0.8	770.5	0.3	0.2	8539.7	3.8	0.9	4.8	0.3	1.4	0.8	0.0	401.5	0.2	1.0	0.9	0.4	3.1	1.4	77.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	3.5	5.8	6.3	3.3	3.5	3.4	3.5	3.4	3.3	4.7	5.6	22.4	7.2	0.3	0.5	139.6	13196.1	338.0	327.8	0.2	158.4	792.8	0.1	0.0	415.8	36.8	0.0	21.5	3.8	0.9	0.0	567.7	0.4	116.9	13.5	54.5	1.8	0.0	3.2	202.1	148.5	87.9	0.0	134.1	3.8	0.0	0.0	0.0	3.8	20.2	0.5	0.6	36.7	0.0	14.1	1.6	2.1	37.5	10.6	3.7	6.7	0.0	0.0	0.5	1.4	1754.5	2.5	212.5	0.0	5931.6	0.1	0.4	100.1	0.0	0.0	0.9	101.0	0.3	0.4	48.2	124.3	5.7	60.8	3.1	0.8	8499.3
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487176-52493257	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease variant, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 2523.3;esophagus: 7338.5;vagina: 4945.4"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 674.0;Club cells: 200.5;Squamous epithelial cells: 876.0;Suprabasal keratinocytes: 151.4;Urothelial cells: 306.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 9761.7"									"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		NA	NA		4500000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavorable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	3.1	1.5	0.0	1.9	0.0	0.1	6.9	0.0	0.0	2523.3	0.0	1.2	0.0	1.3	0.0	7338.5	9.1	0.9	1.8	0.0	0.0	1.1	2.6	3.4	0.0	0.0	0.0	2.3	3.3	0.0	3.1	8.8	0.0	5.0	0.0	0.0	1025.5	0.0	1.9	480.0	1.3	0.4	0.0	1.4	4.9	1.0	0.0	33.6	1.5	0.0	628.6	19.7	4945.4	0.0	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.9	0.0	0.0	1143.8	0.0	2414.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.6	0.3	9761.7	0.2	306.7	0.0	0.3	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	14.0	0.3	0.1	0.5	0.0	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.2	0.2	0.4	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.5	79.0	674.0	12.0	0.0	0.6	1.7	0.0	0.0	200.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	2.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	5.5	0.0	0.0	0.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	100.4	0.0	0.0	24.5	0.0	0.0	0.0	11.8	0.0	0.0	876.0	151.4	0.0	1.7	0.0	0.1	306.8
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 219.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.9;Ductal cells: 63.0;Endometrial ciliated cells: 33.0;Glandular and luminal cells: 33.5;Pancreatic endocrine cells: 48.4;Suprabasal keratinocytes: 37.4;Syncytiotrophoblasts: 58.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 202.5;MCF7: 287.3;SK-BR-3: 127.7;U-2 OS: 174.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		No	No		230000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Intermediate filaments"		"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavorable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.4	5.3	0.0	0.3	0.0	0.1	8.7	0.3	0.6	18.5	0.0	0.1	0.5	1.2	0.9	51.0	3.4	2.7	0.3	0.1	0.0	2.7	0.7	3.4	0.0	0.0	0.0	0.2	11.6	7.0	0.4	7.3	0.0	1.5	0.1	0.5	24.8	3.4	1.3	219.1	0.3	0.1	0.0	0.1	0.5	0.3	0.0	0.8	0.8	0.0	41.1	9.9	36.5	0.0	202.5	66.7	0.0	0.0	0.0	0.0	54.2	2.9	1.8	15.3	4.6	4.5	85.9	0.0	94.4	2.3	99.4	98.5	0.0	1.3	5.3	0.4	0.0	0.0	99.4	2.4	10.1	0.1	0.1	1.1	11.9	3.5	23.0	70.2	23.2	0.0	0.0	0.1	5.4	287.3	0.2	0.1	0.4	58.5	10.1	0.2	79.4	3.0	87.1	35.7	24.5	1.3	50.1	127.7	1.2	5.6	24.1	1.0	13.5	0.3	174.4	0.2	71.6	0.1	0.3	0.5	18.0	7.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.2	3.9	4.4	0.0	0.0	14.7	4.6	0.4	10.0	9.4	11.0	0.0	25.9	0.1	0.3	0.0	63.0	0.9	33.0	3.7	0.5	0.0	0.0	0.1	20.4	3.4	0.4	0.0	33.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	12.2	0.0	1.6	0.5	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	4.8	0.1	1.8	21.7	0.0	0.0	0.4	2.2	0.1	0.0	2.9	37.4	58.3	0.3	0.3	0.3	8.5
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		55000	"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	81.6	77.7	90.8	52.8	98.9	36.1	81.6	92.8	106.3	61.4	165.0	97.4	43.4	58.1	97.1	72.7	53.2	58.6	134.6	81.0	94.2	104.0	106.6	67.0	61.8	100.2	95.3	63.9	67.2	143.0	67.4	69.4	100.7	77.5	90.8	127.9	73.5	73.5	378.2	137.6	53.2	60.3	95.2	53.4	61.1	145.1	99.4	54.7	107.7	281.6	61.0	113.1	55.2	110.3	200.5	133.4	100.3	106.5	132.8	127.3	140.2	159.7	127.3	97.2	85.2	89.4	233.9	152.8	213.4	166.7	102.7	347.2	122.5	138.2	162.7	251.9	65.2	109.1	223.0	174.4	126.3	160.3	83.3	119.1	124.6	122.1	208.4	208.3	161.9	122.2	107.4	88.1	189.0	154.6	141.3	95.0	76.8	91.1	194.3	109.6	258.2	73.5	244.8	307.0	122.4	100.0	245.8	113.2	143.2	201.7	115.3	101.7	230.0	193.9	250.4	100.0	151.2	38.9	55.9	110.4	229.4	93.4	109.5	117.0	42.7	48.0	56.2	40.3	54.7	95.6	69.4	65.8	44.0	106.6	71.1	62.1	29.6	64.9	52.6	185.8	48.4	16.0	90.8	98.9	92.8	106.3	81.0	94.2	100.2	95.3	100.7	95.2	99.4	110.3	363.1	307.7	239.8	72.5	171.7	654.5	285.8	215.6	270.9	206.5	460.6	348.7	852.7	270.2	214.7	428.6	360.7	155.1	194.9	575.2	31.3	249.7	721.9	351.3	186.6	345.0	224.0	165.3	93.9	304.0	199.1	211.9	95.3	298.1	134.9	384.5	295.9	401.7	116.8	326.4	112.1	226.4	207.5	181.3	261.6	377.9	248.5	168.9	172.5	104.9	194.3	449.2	142.2	90.0	139.8	341.2	325.7	441.6	184.6	283.5	152.6	109.3	319.3	400.9	335.2	333.5	292.1	694.3	386.4	217.8	723.0	164.7	168.3	162.4	282.4	328.0
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194849-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.5;intestine: 5.3;lymphoid tissue: 4.7;placenta: 11.6;testis: 5.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 110.2;Extravillous trophoblasts: 26.2;Intestinal goblet cells: 37.5;Spermatogonia: 53.1;Syncytiotrophoblasts: 28.2"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Region enriched"	"Detected in some"	4	"cerebellum: 5.5"	"Immune cell enriched"	"Detected in single"	13	"non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in single"	21	"monocytes: 5.0"	"Group enriched"	"Detected in some"	22	"NTERA-2: 255.7;SuSa: 191.2"	"Not detected"	"Not detected"							"HPA028501, HPA030064"			Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA028501: AB_10599287, HPA030064: AB_10600538"	"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.2	0.3	0.1	4.7	0.5	0.0	0.2	5.5	1.3	0.3	0.0	5.3	0.1	0.1	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.0	1.5	0.2	0.2	0.1	0.2	0.0	0.0	0.1	11.6	0.3	0.1	1.2	0.0	0.4	0.1	0.0	0.1	0.3	0.3	0.0	0.9	0.1	5.8	0.0	0.2	0.4	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	10.1	0.1	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	191.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.0	0.1	0.5	5.5	1.3	0.3	0.0	0.2	0.1	0.3	0.0	0.0	0.6	0.5	6.4	13.0	0.0	1.8	0.4	0.7	0.1	0.0	2.5	1.0	2.2	0.3	0.0	7.5	0.0	6.2	110.2	2.1	3.6	0.0	0.0	0.5	0.8	0.5	2.3	10.7	0.0	0.6	0.4	26.2	3.6	0.0	1.7	1.3	2.2	0.0	0.1	7.6	3.3	0.4	37.5	0.0	1.4	1.2	1.0	1.8	4.3	0.0	0.0	0.5	0.4	1.0	0.0	0.1	0.3	1.6	18.4	1.1	0.6	0.1	0.1	6.0	3.7	0.0	1.1	2.7	0.7	53.1	0.0	0.1	28.2	1.9	2.3	9.2	0.3
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201380833-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 362.1;skin 1: 215.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 174.7;Ductal cells: 178.0;monocytes: 248.6;Pancreatic endocrine cells: 227.0;Proximal enterocytes: 214.7;Squamous epithelial cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 159.9;CAPAN-2: 158.5;HaCaT: 220.4;HBEC3-KT: 190.3;hTCEpi: 181.5;MCF7: 218.3;OE19: 246.5;RT4: 164.7;SK-BR-3: 250.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.5	0.1	0.0	15.9	0.1	0.1	15.8	0.0	0.2	65.4	0.0	67.6	75.6	5.0	11.0	362.1	14.7	50.2	8.4	0.2	0.6	38.6	21.6	10.6	2.9	0.0	0.0	0.4	50.7	2.4	0.7	4.1	0.0	15.7	51.0	0.0	51.9	22.6	5.1	215.4	74.5	2.9	0.0	1.4	66.9	0.3	0.0	6.2	3.5	0.2	47.7	71.4	135.2	0.0	159.9	1.3	0.0	0.3	0.0	0.0	57.0	0.0	0.0	0.1	0.1	127.3	158.5	0.0	8.9	0.0	0.0	220.4	0.0	190.3	0.1	0.2	0.0	0.0	0.1	79.3	0.0	0.1	0.2	0.1	181.5	0.1	36.8	0.0	0.1	0.0	0.1	0.7	0.1	218.3	0.2	0.4	3.7	246.5	2.6	0.2	7.4	2.3	126.0	164.7	9.1	0.2	0.1	250.6	3.1	5.4	37.6	0.4	0.0	0.1	0.5	0.5	0.6	0.1	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	35.4	0.0	0.9	88.5	112.1	47.2	46.7	0.0	15.4	14.1	2.1	110.1	31.3	31.3	0.0	3.8	0.5	174.7	45.0	178.0	1.1	26.2	2.6	1.6	18.1	0.0	0.0	121.9	5.9	2.6	85.1	34.5	0.0	0.0	0.4	9.0	0.5	0.0	0.0	53.8	18.3	0.6	16.0	3.6	0.0	2.6	10.6	0.0	248.6	0.0	0.0	0.0	0.0	227.0	109.6	0.4	2.9	77.1	214.7	71.8	4.8	0.0	0.0	0.0	3.2	0.0	0.3	265.6	152.7	10.4	1.5	0.0	136.2	150.2
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122215-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lung: 219.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 486.7;monocytes: 339.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 27.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.6;T-cells: 4.8"	"Group enriched"	"Detected in many"	4	"EFO-21: 169.5;HDLM-2: 46.6;HHSteC: 60.4;hTCEpi: 59.1;JURKAT: 52.7"									"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		NA	NA		59000	"Cluster 13: T-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.7	0.6	0.2	33.1	0.4	0.8	1.3	0.3	0.2	1.4	0.0	3.2	2.7	0.7	2.6	4.4	1.1	3.9	0.3	0.2	0.1	0.6	0.9	219.7	16.1	0.2	0.1	0.3	7.8	1.9	0.5	1.9	0.1	2.7	6.8	0.6	27.2	2.5	0.2	7.0	3.1	4.3	0.2	9.0	4.1	22.7	0.3	28.1	7.5	0.2	21.5	11.2	0.9	0.0	10.7	0.3	0.2	1.7	0.1	0.1	8.7	0.2	2.8	1.8	0.5	2.8	5.3	0.1	169.5	0.9	18.9	1.5	3.7	6.4	0.2	46.6	5.9	0.0	0.3	0.4	60.4	0.0	1.4	0.9	59.1	0.1	7.4	0.0	7.6	52.7	0.4	9.9	0.2	0.2	2.5	0.4	0.3	0.9	2.7	0.0	0.0	0.8	0.2	3.4	0.7	0.4	0.8	0.3	5.0	2.1	3.4	0.4	8.3	0.0	3.0	0.4	0.2	3.5	13.2	0.5	0.0	0.1	0.1	0.3	0.0	5.6	0.2	0.0	2.4	0.1	1.8	1.1	0.0	0.2	2.3	1.3	1.3	0.6	0.0	0.0	4.8	0.7	0.2	0.4	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.3	0.0	0.2	64.1	486.7	0.0	2.0	6.0	2.9	2.4	8.6	0.0	0.3	0.6	1.2	1.5	9.5	1.8	0.0	2.9	0.1	0.1	0.0	0.6	34.3	1.3	0.2	0.5	0.0	0.4	0.7	6.1	0.4	1.0	1.5	0.8	18.9	0.4	0.0	0.0	1.3	0.0	0.6	0.2	0.0	0.0	41.1	84.9	0.6	4.8	1.8	0.0	339.6	0.0	0.0	0.0	0.1	0.6	0.0	0.0	4.1	1.6	0.1	0.0	11.5	0.0	0.0	0.4	0.3	14.0	0.5	4.0	5.7	1.2	2.3	0.0	0.5	2.2
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	17.4	27.7	9.5	16.2	12.6	14.0	14.6	16.4	10.8	14.1	23.8	15.3	16.7	10.5	11.7	18.9	9.3	12.9	16.3	8.8	13.9	29.0	62.1	13.5	15.6	13.2	14.4	9.4	16.5	21.8	8.8	18.3	14.0	13.9	14.4	20.3	15.9	11.3	26.4	11.2	13.1	11.7	12.2	12.5	17.2	14.9	13.0	15.9	20.0	37.0	15.5	21.5	9.0	17.3	43.9	61.0	40.1	29.6	36.6	30.2	67.9	52.9	31.5	51.3	40.8	120.5	50.2	102.9	63.9	33.2	47.5	41.1	88.2	36.1	67.3	64.3	35.9	83.9	56.1	43.6	34.0	93.9	47.5	27.6	33.9	60.9	65.1	33.9	45.9	37.2	122.8	47.4	48.0	39.3	77.7	31.6	58.2	28.5	52.9	56.6	63.6	61.0	27.8	65.1	47.2	27.7	94.0	48.3	54.9	37.0	42.1	37.4	66.9	34.0	50.2	39.7	50.4	45.9	134.7	90.3	47.0	37.9	28.9	8.2	8.7	6.0	8.1	9.6	7.5	8.6	7.0	4.5	11.7	8.6	8.2	6.7	4.4	8.2	12.1	10.0	7.6	7.7	9.5	12.6	16.4	10.8	8.8	13.9	13.2	14.4	14.0	12.2	13.0	17.3	35.9	48.1	44.7	31.0	26.8	71.0	33.8	23.1	59.7	41.0	34.0	25.1	47.8	22.8	27.7	29.5	87.6	27.4	22.0	29.1	9.8	19.7	8.6	52.9	50.4	28.6	24.0	33.0	38.9	24.0	17.3	31.0	38.7	57.5	19.7	27.9	21.0	129.0	27.3	18.5	45.5	25.8	20.3	33.0	26.6	25.4	14.9	23.0	26.6	24.4	27.6	18.4	13.4	26.7	40.4	27.0	16.1	19.2	56.4	44.3	20.3	54.7	33.0	54.0	6.6	42.2	36.8	37.4	42.5	52.2	74.3	34.2	22.0	34.4	27.5	33.2
LARP4B	"KIAA0217, LARP5"	ENSG00000107929	"La ribonucleoprotein 4B"	Q92615	10	806914-931705	"Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036566, HPA042738"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036566: AB_10673624, HPA042738: AB_2678137"	"unprognostic (3.02e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.13e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.95e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.54e-2)"	14.3	19.9	13.1	17.2	13.3	18.5	13.6	15.3	17.4	13.4	20.9	17.0	19.4	13.1	10.3	25.2	13.3	12.8	22.2	16.4	14.9	13.8	13.0	20.2	22.1	16.0	12.0	13.0	16.5	17.1	12.7	15.1	15.6	16.2	15.6	14.5	16.8	12.3	38.7	22.3	18.5	10.9	12.1	19.4	21.9	18.9	13.2	16.0	22.2	22.3	19.7	15.9	16.7	14.1	50.0	42.7	21.7	24.5	19.0	19.1	32.2	33.0	15.7	35.6	34.2	58.1	56.4	59.9	12.0	33.0	10.6	51.6	38.5	28.0	30.5	38.1	27.9	51.6	29.5	33.9	31.3	37.3	42.5	21.2	31.7	36.8	20.4	19.9	24.8	28.8	65.5	39.3	28.9	50.9	53.0	33.8	23.2	49.5	16.5	36.1	18.7	41.5	28.6	38.5	21.4	30.2	32.5	62.5	25.4	21.1	59.3	35.6	34.4	27.6	7.2	87.8	34.2	39.2	51.2	58.3	30.5	30.0	17.6	11.4	8.2	9.7	5.4	9.0	5.7	4.2	6.0	6.2	7.3	5.2	5.7	6.0	8.0	5.4	7.9	8.3	6.1	3.9	13.1	13.3	15.3	17.4	16.4	14.9	16.0	12.0	15.6	12.1	13.2	14.1	23.7	51.3	62.1	59.4	22.4	30.3	15.6	16.2	23.9	20.5	21.6	15.4	43.5	28.6	30.7	23.9	27.1	17.2	24.6	38.5	5.9	17.4	14.7	42.0	24.5	21.2	13.8	22.7	87.7	16.3	13.2	19.4	44.9	43.4	7.6	31.0	14.6	19.1	21.5	23.5	84.1	35.1	18.3	34.7	25.3	7.1	17.4	30.3	17.8	83.4	33.4	15.7	14.4	65.9	71.6	33.2	27.2	24.0	25.5	27.0	32.5	16.2	33.4	22.4	26.3	23.4	18.3	27.8	23.8	28.8	42.6	46.2	20.7	26.1	34.7	35.6
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765177-203776372	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 23.2;granulocytes: 82.2;NK-cells: 30.9;Plasma cells: 65.1;T-cells: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	14	"B-cells: 7.5;NK-cells: 5.2;T-cells: 12.0"	"Group enriched"	"Detected in some"	4	"Karpas-707: 22.8;U-266/70: 28.2;U-266/84: 71.9;U-698: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	0.5	0.6	0.2	8.8	0.3	1.6	1.7	0.4	0.4	1.4	0.3	3.7	3.1	0.3	0.3	0.9	0.4	2.6	0.3	0.3	0.2	0.2	0.9	2.7	11.8	0.5	0.2	0.2	0.4	0.1	0.0	0.1	0.5	0.7	3.4	0.1	1.2	0.4	0.1	0.2	2.0	0.7	0.2	7.2	4.5	0.3	0.3	11.1	0.2	0.3	21.2	5.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	8.0	0.2	22.8	0.0	0.0	8.7	0.0	0.1	0.0	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	28.2	71.9	24.9	0.0	1.9	0.0	0.3	0.0	0.5	12.0	0.0	9.1	7.5	7.1	9.4	0.0	2.5	5.5	7.1	0.3	5.2	0.0	0.0	8.1	3.5	0.2	0.3	0.4	0.4	0.3	0.2	0.5	0.2	0.5	0.2	0.3	0.7	0.9	0.0	1.9	0.0	14.6	1.1	0.4	0.0	0.0	0.0	0.3	0.1	2.6	0.0	0.6	0.0	0.0	0.1	23.2	0.1	0.0	0.2	0.0	0.4	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.6	1.5	0.4	82.2	0.0	2.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	1.9	10.6	0.0	0.4	0.0	30.9	0.5	0.0	0.1	0.0	0.0	65.1	0.4	0.6	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.2	0.4	0.0	29.2	0.1	0.3	0.5
LCOR	"C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2"	ENSG00000196233	"Ligand dependent nuclear receptor corepressor"	Q96JN0	10	96832254-96995956	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031429, HPA057621, HPA077000"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824"	"unprognostic (5.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.16e-4)"	3.7	3.1	7.1	6.2	6.4	25.5	5.0	21.8	6.6	4.3	3.3	8.7	11.2	4.2	4.6	7.0	3.9	3.9	3.7	4.8	15.6	5.3	5.9	4.8	6.3	6.9	5.6	6.4	8.2	4.3	5.3	4.9	6.7	4.7	8.5	15.8	5.6	3.5	9.2	4.1	10.7	3.4	4.8	5.5	8.3	4.6	7.5	6.0	5.4	5.1	6.0	6.8	4.7	15.8	14.7	9.3	16.5	8.9	4.4	6.2	7.9	6.2	6.0	7.5	8.5	12.0	10.0	15.4	7.3	6.4	7.0	12.2	16.5	8.6	13.3	7.4	8.0	17.7	6.0	15.2	8.4	22.1	8.8	4.9	7.5	11.5	20.4	7.7	8.1	7.8	12.7	7.2	11.9	6.7	9.2	8.4	6.3	7.9	4.0	11.2	12.7	4.3	8.6	30.7	7.5	6.6	7.0	4.4	8.8	7.1	8.3	6.9	12.5	5.8	13.0	5.2	11.6	9.4	6.7	17.9	6.1	13.9	3.1	1.7	5.0	8.0	5.8	4.1	4.7	4.6	4.4	5.3	3.7	8.6	4.7	3.7	16.7	5.0	2.0	5.4	3.6	2.5	7.1	6.4	21.8	6.6	4.8	15.6	6.9	5.6	6.7	4.8	7.5	15.8	26.4	19.2	26.8	72.1	36.1	15.4	16.7	31.3	25.6	45.2	37.0	20.3	17.8	37.1	38.2	31.3	77.2	18.8	46.5	85.3	11.7	27.0	0.8	34.6	26.8	23.1	46.9	17.7	138.3	33.9	8.2	17.1	28.1	35.9	26.6	67.1	20.3	22.2	14.1	40.4	151.6	31.2	52.9	30.5	29.7	2.3	10.2	40.0	21.4	103.0	28.1	11.7	24.7	143.2	264.9	41.5	62.0	13.9	36.8	26.9	67.1	25.4	54.1	58.9	19.7	21.6	26.8	21.7	26.3	29.2	12.9	38.6	34.0	22.0	33.6	34.4
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971778	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"granulocytes: 272.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.2	11.4	8.1	13.8	8.8	9.0	15.5	14.7	12.9	11.6	6.4	17.0	13.3	10.4	10.0	19.8	8.7	13.2	8.1	8.0	10.0	13.7	22.2	9.7	18.0	8.0	8.1	8.5	8.1	18.8	9.1	12.1	7.7	12.3	19.2	12.0	18.5	8.6	13.9	20.8	14.5	11.7	6.9	10.5	13.2	9.3	8.3	22.1	11.1	11.7	17.9	19.3	14.0	10.0	28.0	63.9	40.3	32.6	40.7	35.0	28.8	44.4	36.6	37.3	33.9	44.3	17.9	56.2	25.3	45.8	41.3	53.2	54.2	39.6	35.8	37.5	24.5	88.5	50.6	78.5	32.0	80.7	118.2	37.9	30.5	29.2	37.6	35.2	37.0	46.5	54.6	30.1	44.9	118.7	43.0	61.1	17.4	82.6	27.0	47.6	69.7	58.9	32.8	77.0	28.5	43.4	33.9	51.5	36.5	43.8	42.8	72.6	44.4	36.8	25.5	34.3	53.7	23.4	78.2	50.7	32.2	113.1	40.0	11.5	14.5	15.7	27.4	23.3	25.7	18.7	27.2	22.3	23.8	16.4	27.9	25.2	3.3	30.9	26.0	17.8	31.7	16.3	8.1	8.8	14.7	12.9	8.0	10.0	8.0	8.1	7.7	6.9	8.3	10.0	16.2	35.3	24.6	10.1	15.2	26.1	16.8	33.4	18.2	38.2	11.8	10.2	21.2	17.2	37.0	7.3	10.4	24.9	24.8	24.6	15.6	26.3	2.4	19.5	38.8	18.0	7.7	12.4	16.5	24.2	26.7	19.9	15.8	29.8	272.8	16.2	10.0	18.0	19.5	26.9	16.9	17.9	26.4	14.8	6.0	2.7	8.1	13.0	3.6	5.6	12.8	23.1	22.6	13.0	13.3	18.2	14.7	13.5	11.0	9.0	20.5	23.3	31.4	23.2	6.6	18.5	29.3	21.5	11.0	19.5	24.7	17.6	25.0	23.8	17.0	21.2
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 553.9;Basal prostatic cells: 646.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 523.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		90000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	122.2	47.1	11.9	39.9	13.6	4.2	89.4	40.3	16.4	63.3	12.3	125.6	112.1	56.8	33.2	37.1	47.9	69.3	31.9	11.7	13.1	48.7	20.7	62.5	32.6	15.4	13.8	38.6	31.1	31.0	24.0	50.6	17.3	45.7	130.5	32.2	47.2	42.2	21.9	47.3	121.8	48.6	13.3	40.8	96.8	16.2	13.1	38.1	33.3	28.3	33.8	96.7	53.2	16.3	154.3	4.5	47.2	69.7	211.9	211.0	177.7	377.2	264.4	296.9	235.8	57.7	220.2	6.8	34.1	523.4	99.7	170.8	42.8	348.7	258.1	98.1	45.1	64.2	16.2	20.5	135.3	23.2	87.5	142.2	100.8	104.6	297.8	89.0	106.2	28.3	45.6	30.3	96.9	26.5	29.0	7.1	24.3	81.0	20.5	28.7	115.2	2.4	68.7	180.3	35.2	75.4	51.5	102.7	166.6	50.0	49.0	14.1	166.7	126.5	98.0	118.4	62.1	16.5	2.0	28.0	137.6	25.3	55.6	0.2	0.2	1.5	6.6	1.1	2.6	0.2	8.2	8.1	4.9	0.6	3.3	6.0	0.1	5.9	2.7	1.2	15.3	3.0	11.9	13.6	40.3	16.4	11.7	13.1	15.4	13.8	17.3	13.3	13.1	16.3	123.2	44.8	91.2	13.4	4.8	553.9	646.1	175.4	283.4	14.6	62.2	73.0	7.3	61.5	179.1	119.5	160.6	128.1	15.5	413.7	15.6	145.6	67.1	75.7	183.9	91.8	122.8	17.5	12.9	307.6	376.9	170.9	126.9	132.6	24.7	15.9	117.8	19.8	34.4	6.7	30.1	138.0	187.2	11.7	59.3	11.7	75.5	19.3	90.7	41.2	9.9	22.7	28.8	78.9	48.4	219.0	244.5	77.5	6.9	221.6	214.8	22.3	67.8	95.4	65.7	54.9	118.0	30.8	10.4	100.0	291.5	64.0	33.3	62.4	244.3	385.1
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation factor"	Q9BRT6	12	66116555-66130750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	21.6	34.4	12.3	24.4	13.5	50.3	18.6	12.7	16.0	13.2	11.2	20.1	19.2	15.2	18.6	19.5	13.2	14.7	23.2	12.8	13.7	20.9	21.2	15.5	26.3	13.5	14.3	17.6	17.2	17.0	10.7	17.5	13.7	15.3	20.3	7.4	14.5	14.1	29.7	13.8	18.2	19.4	13.0	18.2	19.1	22.1	13.5	22.1	17.3	25.3	25.6	27.3	14.0	14.2	77.0	61.1	36.4	44.2	42.6	40.8	44.5	87.0	56.4	63.9	53.6	52.8	31.0	87.0	70.6	58.6	50.7	63.6	57.2	52.9	85.7	78.4	48.8	94.5	41.7	47.3	49.8	162.5	61.8	41.9	53.6	53.7	58.3	50.1	56.6	44.1	81.5	60.9	76.1	81.3	74.1	110.4	77.9	61.6	63.0	61.9	67.2	62.7	63.3	90.8	36.3	45.1	57.0	58.3	97.4	38.0	77.4	89.5	60.5	48.3	71.3	60.9	80.4	45.7	77.6	130.2	65.4	76.0	76.8	34.3	32.0	35.5	27.8	38.0	32.0	29.2	32.3	30.6	31.3	27.5	27.4	29.2	43.8	27.4	48.4	27.0	38.9	28.8	12.3	13.5	12.7	16.0	12.8	13.7	13.5	14.3	13.7	13.0	13.5	14.2	34.2	12.8	33.9	2.9	47.6	27.1	53.9	86.3	30.1	15.9	24.5	28.4	25.1	41.5	64.3	31.3	4.2	66.3	49.4	34.1	66.5	68.3	63.3	40.5	45.4	32.5	13.8	33.4	5.0	71.3	70.4	34.8	35.7	46.6	89.4	61.2	35.7	60.2	64.2	21.9	4.4	31.1	85.5	50.4	26.5	17.0	43.8	45.6	35.6	3.7	84.1	30.8	59.8	3.0	5.8	96.3	43.3	30.1	27.3	46.3	44.0	86.5	35.8	15.2	26.3	29.7	36.8	126.6	48.6	30.6	30.5	72.7	43.8	126.4	36.1	60.6
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892076	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6"	"Cancer enhanced"	"Detected in all"		"glioma: 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	15.0	5.9	14.9	11.4	13.0	27.7	12.5	14.2	16.6	8.4	13.4	5.0	4.6	6.5	0.7	6.8	8.3	5.4	4.4	14.7	16.0	13.1	2.3	18.2	19.4	19.9	16.3	3.5	2.6	2.3	8.6	6.5	18.5	5.7	1.5	0.6	5.3	2.4	23.4	4.9	6.6	4.8	18.7	19.0	3.9	1.7	19.0	1.8	12.3	4.6	8.4	5.8	7.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	2.2	1.3	12.8	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	71.8	0.0	0.0	0.3	72.7	18.5	0.0	0.0	0.0	0.0	0.0	10.2	0.0	60.9	0.0	0.0	0.3	5.1	27.3	0.9	0.0	0.0	15.3	0.8	0.2	0.0	0.8	4.3	0.0	0.3	0.5	0.1	0.2	0.0	81.6	0.9	0.0	0.2	1.7	0.0	0.0	0.2	0.6	4.7	29.2	0.3	0.6	0.5	1.5	0.0	1.4	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	0.2	14.9	13.0	14.2	16.6	14.7	16.0	19.9	16.3	18.5	18.7	19.0	13.3	109.2	3.2	7.1	8.5	6.6	8.4	7.9	8.0	0.6	1.6	2.8	9.5	2.8	8.6	1.7	5.5	2.1	0.4	1.0	0.8	0.0	3.0	0.5	40.5	11.0	144.6	0.0	103.7	1.3	2.0	3.2	9.8	0.0	39.6	7.6	0.9	167.4	1.7	39.1	0.0	3.8	0.2	2.0	65.0	56.8	1.2	4.1	54.1	10.6	64.6	47.5	1.1	4.1	5.0	1.0	1.0	1.9	0.0	3.0	5.4	0.0	8.8	5.0	2.6	0.0	17.3	3.6	0.3	7.9	0.8	6.0	21.5	1.9	12.4	0.5	25.1
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 196.2"	"Cell type enhanced"	"Detected in all"		"Theca cells: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No		7900	"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	30.4	196.2	31.5	22.2	32.7	23.7	27.2	34.6	42.8	24.4	39.9	27.9	22.6	25.2	14.1	27.7	22.6	15.4	76.0	30.8	35.7	43.2	79.1	25.6	24.1	37.6	35.8	26.6	38.2	35.2	41.5	18.5	37.9	26.4	13.2	13.0	30.8	16.6	69.3	28.9	25.5	14.7	30.8	29.5	33.7	24.2	37.2	17.5	34.6	40.7	14.5	28.2	22.4	33.0	108.4	111.0	35.6	114.0	41.4	29.2	110.4	67.2	52.7	71.0	86.0	96.3	37.7	134.3	91.4	70.6	68.0	45.0	92.1	81.1	34.2	80.0	78.0	74.5	97.5	127.6	190.4	169.7	74.9	55.0	114.6	67.5	132.6	34.1	57.5	183.9	200.9	259.4	33.0	71.8	85.5	101.6	127.6	43.6	143.1	89.4	50.9	146.6	39.3	63.9	94.2	94.1	59.4	85.2	242.2	24.9	50.3	211.9	41.2	36.0	39.2	100.7	99.2	272.3	182.6	121.4	161.7	185.0	66.2	4.5	2.4	0.5	3.4	3.7	2.3	4.0	3.1	3.4	2.6	3.7	3.8	2.6	0.3	2.7	1.5	3.9	2.7	1.7	31.5	32.7	34.6	42.8	30.8	35.7	37.6	35.8	37.9	30.8	37.2	33.0	12.6	6.4	13.1	18.3	14.1	8.3	11.1	14.9	11.4	26.9	14.2	12.7	19.8	15.7	14.3	27.6	6.2	28.8	8.4	40.1	46.9	33.9	6.5	24.0	16.3	15.3	11.4	17.1	13.5	28.0	31.9	13.3	29.6	25.6	5.7	51.1	11.4	47.0	30.8	21.9	17.4	26.4	22.4	14.6	8.6	6.3	12.8	16.4	14.2	9.4	17.8	24.9	8.2	10.6	15.7	26.0	16.8	17.3	17.6	16.8	27.5	50.2	17.0	26.5	19.7	17.9	24.7	12.0	14.4	11.0	10.7	35.0	10.7	85.0	35.1	11.4
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23296897-23425328	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 41.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 26.9;Endometrial stromal cells: 26.9;Endothelial cells: 33.1;Extravillous trophoblasts: 22.0;Fibroblasts: 22.9;Hepatic stellate cells: 19.6;Sertoli cells: 26.3;Smooth muscle cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 935.5;BJ hTERT+ SV40 Large T+ RasG12V: 517.3;fHDF/TERT166: 602.7;TIME: 510.7;U-87 MG: 905.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	30.4	3.3	1.9	15.9	2.7	1.2	18.8	4.7	3.0	10.6	0.8	25.3	9.3	12.0	0.9	3.8	4.9	8.0	10.7	1.8	3.2	6.1	3.9	8.3	11.7	7.7	8.1	12.9	6.5	2.5	2.6	36.2	7.0	7.5	5.4	3.0	4.1	13.0	4.5	5.4	10.3	41.3	4.5	5.0	9.0	2.3	4.5	1.8	5.2	2.6	9.5	12.0	7.3	3.7	58.2	147.7	42.7	35.8	112.4	183.8	19.4	935.5	295.9	415.6	517.3	1.1	4.4	10.7	7.5	602.7	193.2	47.6	2.1	79.0	215.3	1.8	8.5	0.9	19.4	1.0	226.8	0.5	3.8	164.6	3.9	155.0	20.8	274.0	350.7	2.4	0.5	2.0	138.1	32.3	0.6	1.4	29.1	0.4	24.5	1.9	36.7	0.4	120.1	0.3	0.9	13.7	122.9	6.1	8.6	131.3	0.8	1.2	510.7	384.6	103.3	163.8	127.3	4.1	0.8	29.9	905.4	1.4	413.5	0.1	0.2	0.8	0.4	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.2	0.6	0.3	0.1	0.2	0.2	0.1	0.2	1.9	2.7	4.7	3.0	1.8	3.2	7.7	8.1	7.0	4.5	4.5	3.7	12.9	0.0	3.0	6.8	0.6	2.5	0.3	26.9	0.6	1.5	0.6	9.7	2.6	1.5	4.1	0.0	0.0	2.7	0.4	0.0	0.0	1.9	0.6	1.7	26.9	33.1	0.0	0.0	8.1	1.5	22.0	22.9	1.5	2.1	0.0	2.0	19.6	0.2	1.3	1.7	3.2	0.1	0.0	0.3	5.7	0.4	0.9	0.9	3.6	6.5	0.0	1.2	0.0	7.1	11.9	2.3	0.1	0.4	0.9	0.6	0.2	0.2	1.6	3.2	26.3	2.7	48.1	1.3	1.6	0.5	3.1	1.0	1.0	3.1	0.4	0.2
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 38.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 38.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	13.1	10.2	7.7	12.0	11.9	8.0	11.4	18.7	9.1	16.2	7.3	16.3	7.0	15.5	7.7	10.7	13.7	10.2	14.6	7.7	12.5	8.2	10.3	11.9	17.0	9.8	8.1	18.8	9.5	12.2	12.3	10.1	8.5	13.9	10.2	19.2	12.0	12.1	19.3	10.8	12.8	14.8	6.0	13.9	11.2	13.1	10.1	15.5	9.7	11.5	18.7	14.8	13.8	15.7	30.5	10.0	28.8	17.5	28.9	35.2	11.0	21.5	25.6	25.3	31.5	26.0	15.5	16.1	33.5	24.9	40.7	19.1	25.7	21.2	34.5	13.3	14.4	29.8	16.2	19.2	18.9	21.4	19.3	25.0	10.9	24.7	31.9	23.0	30.7	14.7	18.1	27.5	23.4	25.1	15.9	7.8	19.3	15.8	22.3	16.0	17.6	10.6	11.3	19.4	14.2	14.4	28.5	18.5	20.1	26.4	39.0	17.1	30.1	19.4	12.0	24.4	22.2	24.5	26.9	15.2	19.8	28.0	20.3	38.9	4.7	10.1	7.4	6.9	6.0	9.3	5.8	6.3	4.1	6.6	5.3	7.5	2.3	7.1	6.9	3.5	6.1	5.4	7.7	11.9	18.7	9.1	7.7	12.5	9.8	8.1	8.5	6.0	10.1	15.7	19.2	32.1	27.0	64.6	29.7	10.6	18.1	11.4	8.0	56.0	11.6	8.5	15.4	14.3	17.0	9.2	56.3	8.5	25.8	10.4	1.9	10.1	12.8	12.2	22.9	20.8	6.0	11.1	69.8	9.9	6.6	23.8	10.7	16.4	11.4	23.0	34.6	14.2	9.0	38.7	86.1	11.0	8.2	17.6	17.9	9.6	25.1	14.6	17.8	66.5	30.8	19.8	27.8	102.1	139.2	14.1	9.5	28.6	15.1	15.9	7.1	5.2	15.1	43.1	19.7	31.7	22.8	18.0	17.2	9.4	10.5	6.0	19.9	17.0	11.0	14.7
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886224-43995989	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease variant, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria		No	No		210000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favorable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	32.2	33.2	30.1	23.8	31.3	49.6	41.6	39.3	35.4	23.9	49.2	50.6	33.4	32.5	28.4	28.4	27.6	18.2	47.0	30.8	31.8	63.5	48.3	19.6	31.2	33.0	30.4	34.1	30.4	48.7	19.2	27.2	35.2	27.7	48.9	40.4	27.8	25.3	100.9	30.2	30.3	27.6	30.2	24.3	27.1	33.2	32.1	29.3	31.2	93.5	31.7	27.0	22.5	36.3	127.8	101.9	62.3	80.0	58.1	79.9	108.0	82.7	59.4	88.0	67.3	164.4	65.7	181.7	78.4	50.8	58.8	105.2	118.8	86.3	116.8	110.2	75.2	164.2	76.5	217.9	85.5	239.9	71.4	77.3	73.8	81.6	130.4	49.2	71.2	53.6	246.5	71.5	75.8	68.5	126.8	273.7	104.0	123.8	71.8	139.7	140.7	147.6	95.3	115.3	111.0	107.3	93.6	120.6	154.5	79.2	90.1	140.6	62.6	63.2	86.4	66.9	89.2	72.5	87.4	156.2	60.0	144.1	55.6	10.5	16.5	2.9	13.3	16.2	25.5	22.5	18.0	17.9	23.5	24.5	24.8	21.9	1.2	20.3	18.9	9.6	16.3	20.2	30.1	31.3	39.3	35.4	30.8	31.8	33.0	30.4	35.2	30.2	32.1	36.3	29.2	22.4	34.1	56.8	46.2	46.3	27.2	34.6	46.1	66.4	37.6	30.4	97.2	32.9	35.4	46.0	31.3	37.1	22.5	33.1	21.5	25.6	5.3	31.2	48.2	30.4	27.5	58.4	91.6	17.7	23.6	32.4	40.2	40.1	29.2	51.0	22.1	55.1	25.2	65.6	96.5	49.2	20.3	38.8	25.9	6.3	25.1	28.9	21.4	38.4	36.8	24.5	23.7	55.3	94.9	20.0	33.0	23.7	34.4	31.9	36.6	62.3	25.8	57.0	13.1	45.8	32.6	27.2	33.3	53.9	44.3	33.2	32.2	63.7	76.0	31.9
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 78.0;Endothelial cells: 88.3;Extravillous trophoblasts: 164.2;Hepatic stellate cells: 95.3;Sertoli cells: 39.5;Smooth muscle cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 115.0;ASC TERT1: 70.3;HSkMC: 44.0;HUVEC TERT2: 51.4;U-2197: 108.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		98000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055775: AB_2732600, HPA058434: AB_2732622"	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (2.64e-4)"	104.5	34.3	12.6	10.5	12.6	2.4	63.6	11.2	11.8	56.2	8.4	23.2	8.9	36.4	6.2	10.3	31.6	29.0	55.7	9.6	10.6	64.7	11.3	109.0	4.3	12.2	13.8	13.5	12.0	7.5	16.7	53.0	13.0	24.9	6.1	1.3	12.8	11.0	23.6	26.6	21.4	15.2	10.9	28.9	21.3	3.6	15.0	2.0	42.3	6.2	1.5	36.7	28.8	11.5	0.0	0.0	1.3	0.0	115.0	70.3	1.4	0.4	0.8	0.1	0.1	0.0	0.0	0.2	3.1	1.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	11.8	0.6	0.0	2.2	0.0	0.1	44.0	0.0	4.1	0.2	0.9	51.4	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	7.6	0.2	0.0	13.8	7.5	0.8	108.3	0.0	0.1	0.0	1.9	5.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	4.3	12.6	12.6	11.2	11.8	9.6	10.6	12.2	13.8	13.0	10.9	15.0	11.5	78.0	0.0	4.3	0.0	1.7	14.5	0.3	0.0	1.8	0.0	0.6	0.6	10.4	0.0	1.3	0.0	0.0	1.9	0.1	0.2	0.0	0.3	1.3	0.1	1.9	88.3	0.0	5.3	0.0	0.0	164.2	26.4	0.5	0.3	2.5	0.5	95.3	0.6	3.6	0.0	0.1	0.4	0.0	3.1	19.0	1.9	9.0	2.9	17.8	14.0	0.0	0.4	0.0	0.0	0.1	0.0	2.2	9.1	0.2	1.4	0.0	0.4	0.7	0.1	39.5	2.1	47.6	0.4	4.7	0.6	12.5	8.3	1.6	0.4	0.1	1.2
LRRC42	MGC8974	ENSG00000116212	"Leucine rich repeat containing 42"	Q9Y546	1	53946085-53968168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047458, HPA050537, HPA064581"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.88e-5)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.67e-2)"	15.6	29.0	10.5	9.7	10.7	11.8	14.8	9.7	13.6	16.2	14.9	16.4	12.3	18.7	15.3	21.8	16.6	12.5	14.7	10.4	11.7	15.2	24.3	15.3	11.4	10.8	10.4	17.2	13.2	15.4	24.1	22.4	10.0	15.1	13.2	8.6	16.7	14.8	17.6	21.9	11.8	18.1	10.4	9.2	16.7	19.4	12.2	16.4	23.6	15.7	14.4	18.7	18.3	10.8	73.3	26.9	66.0	38.9	34.0	45.9	45.2	56.7	78.7	74.4	100.4	90.8	48.0	41.4	44.4	70.6	88.0	63.5	57.0	81.4	85.4	32.7	35.5	38.2	40.4	57.9	61.7	23.9	35.2	41.8	110.6	64.5	69.5	54.1	47.6	37.7	48.8	10.6	73.2	25.5	45.1	33.1	56.6	53.5	42.0	75.9	70.2	28.8	53.1	54.1	39.3	42.3	76.5	42.7	63.4	103.1	63.4	28.3	39.6	56.1	71.7	50.1	35.9	29.4	36.4	61.7	54.3	24.8	30.4	0.0	3.1	5.7	4.9	3.1	4.3	4.2	4.2	5.9	3.9	2.3	4.2	3.2	4.8	4.9	2.3	6.9	4.8	2.9	10.5	10.7	9.7	13.6	10.4	11.7	10.8	10.4	10.0	10.4	12.2	10.8	7.8	12.8	5.8	3.6	6.7	51.6	36.4	46.6	29.6	4.4	15.9	14.1	10.5	30.0	24.2	11.0	4.2	43.8	5.4	14.9	19.6	35.0	2.9	16.2	17.0	11.1	68.2	16.0	8.0	16.7	31.4	22.6	17.3	16.8	0.0	19.8	8.2	15.0	17.8	10.1	4.9	9.6	30.5	5.7	11.7	3.5	23.9	8.5	10.6	7.5	10.6	28.7	9.2	5.5	8.4	32.6	13.3	17.7	16.7	46.4	9.9	17.6	19.2	3.6	13.1	15.5	22.7	21.9	48.5	25.5	39.1	57.5	7.9	75.7	14.6	41.0
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397523	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		740000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	49.6	82.6	18.5	54.1	20.5	79.3	34.1	18.4	21.7	60.4	19.0	72.1	46.8	32.2	55.5	47.9	29.4	32.2	33.0	19.1	18.6	41.1	75.0	45.8	30.9	18.2	19.3	21.7	119.4	34.8	21.8	51.7	18.6	35.3	72.0	21.7	56.2	35.7	32.6	24.3	46.0	52.3	18.3	33.0	73.8	29.2	22.0	29.3	36.0	17.0	42.8	56.6	30.1	19.9	390.5	289.9	81.8	123.6	135.3	158.7	146.2	310.7	172.3	284.5	249.4	668.8	109.0	168.8	207.8	356.4	174.3	138.1	205.2	265.2	336.3	90.4	298.6	295.9	154.8	361.8	283.7	294.1	134.8	140.8	211.3	305.2	351.7	82.6	213.3	95.7	278.9	155.6	189.4	264.3	209.0	139.0	92.5	364.2	419.1	175.9	261.9	323.6	156.0	194.9	199.1	165.4	107.5	119.3	161.9	120.4	201.1	157.9	229.6	327.4	135.5	306.2	410.4	232.3	205.1	213.6	222.2	195.9	210.8	22.8	21.9	19.8	9.4	26.9	11.7	11.0	9.5	11.5	20.3	8.5	6.1	7.9	10.9	8.6	27.8	16.5	10.3	13.0	18.5	20.5	18.4	21.7	19.1	18.6	18.2	19.3	18.6	18.3	22.0	19.9	33.1	22.4	23.7	5.2	61.2	139.4	102.1	54.7	43.9	20.4	55.0	30.9	4.1	40.0	50.0	20.2	2.1	90.8	38.4	101.6	29.4	165.0	67.1	53.6	53.8	45.6	38.3	36.6	5.5	187.0	272.2	64.5	104.5	96.3	30.4	28.9	27.1	69.1	103.3	21.9	5.5	178.3	26.4	29.0	111.1	18.7	35.4	45.1	65.8	3.7	45.6	26.5	30.9	2.0	6.8	187.7	75.7	29.0	211.3	164.8	63.5	48.0	26.5	15.5	13.1	59.1	92.8	61.3	27.7	66.1	132.7	236.0	33.2	38.3	127.1	146.7
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.9;retina: 41.3"	"Group enriched"	"Detected in many"	9	"Astrocytes: 3381.0;Excitatory neurons: 1001.8;Inhibitory neurons: 2137.4;Oligodendrocyte precursor cells: 2480.6;Oligodendrocytes: 933.9"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.0;SH-SY5Y: 22.5;WM-115: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol		NA	NA		150000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA054051: AB_2682358, HPA076122: AB_2686779"	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	3.1	15.7	47.8	5.6	45.4	1.0	1.7	22.6	73.9	21.8	0.0	9.9	2.0	5.0	3.1	3.9	3.1	13.5	2.3	64.2	36.3	2.6	0.8	10.6	4.9	37.5	32.2	5.5	14.4	8.9	3.8	1.0	37.8	26.1	3.8	41.3	1.2	7.3	0.2	5.1	2.6	3.8	28.5	1.9	3.8	4.6	56.4	1.2	5.0	0.2	6.7	6.5	4.8	31.9	0.2	3.2	11.0	0.3	1.1	3.4	1.1	1.0	0.5	0.4	1.1	0.2	0.7	0.8	0.2	6.0	0.3	0.2	0.2	0.1	0.5	0.5	0.1	0.3	1.0	0.3	0.2	0.8	0.5	2.8	0.0	1.3	0.1	0.2	0.1	1.3	0.4	1.2	0.0	0.3	1.3	0.8	4.1	0.1	0.9	0.2	0.2	0.2	2.8	1.1	2.4	22.5	0.0	0.2	3.5	4.5	0.3	0.8	0.0	2.0	1.5	2.7	0.6	1.3	1.2	0.3	0.4	0.3	55.9	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.4	0.0	0.1	0.1	0.1	0.0	47.8	45.4	22.6	73.9	64.2	36.3	37.5	32.2	37.8	28.5	56.4	31.9	0.5	0.0	1.1	3381.0	0.6	7.6	0.3	0.0	0.0	54.2	1.2	0.4	25.5	4.3	0.6	0.0	2.1	0.2	0.0	0.0	0.0	0.0	22.5	0.9	26.5	5.8	0.0	0.0	1001.8	3.6	0.0	25.0	2.6	1.1	0.0	20.1	4.2	0.0	0.3	220.4	2137.4	0.0	0.0	0.0	3.2	22.2	126.2	1.9	56.9	111.5	0.0	126.9	0.0	2480.6	933.9	0.4	0.0	91.7	1.0	18.3	0.0	0.2	0.0	11.3	0.0	0.1	4.0	0.9	0.5	0.6	5.1	0.0	0.4	4.9	0.0	0.6
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806966	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		97000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	38.6	34.3	19.0	19.3	21.8	32.7	37.9	20.6	21.4	44.8	17.4	43.0	23.6	45.0	19.3	39.0	36.9	18.1	32.3	19.4	19.1	43.8	27.6	31.6	36.6	22.8	19.6	37.6	37.2	20.5	30.1	22.5	21.7	29.7	27.8	7.2	25.2	16.3	43.9	37.0	33.6	27.7	24.5	43.5	34.6	26.7	22.9	45.1	30.1	20.9	39.3	39.9	35.6	23.7	91.1	42.5	84.9	103.7	43.8	61.9	58.4	50.1	38.5	85.2	75.1	56.9	37.6	50.3	66.8	50.1	79.8	36.2	109.3	101.1	76.9	72.4	85.0	83.6	27.3	60.1	55.7	80.6	39.7	47.1	47.3	78.6	80.4	40.6	90.3	102.0	127.5	63.0	60.7	73.3	132.3	168.4	56.8	75.0	77.6	73.4	40.5	123.4	69.5	31.6	66.6	55.6	56.0	58.8	101.7	44.7	61.6	68.7	20.1	47.6	74.5	54.1	85.1	53.2	109.9	88.2	26.8	123.3	76.7	29.1	31.3	15.9	36.9	37.7	45.2	3.7	51.6	33.6	35.4	4.1	45.6	30.1	8.7	13.8	25.1	30.9	29.9	57.5	19.0	21.8	20.6	21.4	19.4	19.1	22.8	19.6	21.7	24.5	22.9	23.7	82.9	22.4	23.6	4.6	95.2	58.2	63.7	104.9	56.3	30.9	108.2	177.2	14.9	60.1	48.5	55.2	6.2	143.5	58.5	36.5	113.5	104.5	20.1	38.8	61.2	90.2	54.0	121.8	5.9	137.1	218.8	58.0	46.9	49.2	82.6	119.9	72.8	59.7	143.2	30.3	6.0	93.9	73.2	67.9	76.8	26.0	49.7	56.6	92.5	3.7	99.3	53.3	109.2	9.5	19.8	94.0	55.7	49.2	91.5	78.2	40.8	113.3	24.2	28.3	46.0	70.7	71.4	66.9	176.5	90.8	64.2	69.0	77.8	101.3	113.6	58.6
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 213.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859"	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	7.7	8.4	4.5	9.3	7.8	16.5	12.4	7.0	6.2	9.3	5.3	9.2	8.8	10.7	10.2	9.1	7.0	7.4	7.7	4.1	6.6	8.3	11.0	7.4	12.0	6.1	5.9	10.1	9.4	9.9	3.9	18.6	6.7	12.7	10.6	11.6	10.1	8.1	9.5	9.4	9.0	9.1	6.2	10.3	11.0	13.6	6.1	11.3	12.1	11.2	10.5	8.3	5.9	13.1	20.4	8.6	17.5	7.9	14.6	19.9	17.7	16.8	13.6	14.2	19.4	12.1	16.5	13.3	8.0	15.1	12.2	10.2	18.8	13.8	25.5	15.7	13.0	39.8	11.9	9.7	11.0	13.3	14.8	13.9	12.1	20.1	16.6	13.9	15.2	9.5	33.0	31.0	16.4	6.3	8.6	12.9	25.1	16.8	10.1	11.4	34.9	28.0	16.0	17.3	9.5	19.7	19.3	14.5	17.0	16.3	14.8	18.6	20.2	12.4	22.9	16.8	14.3	25.1	25.1	18.5	19.3	28.3	15.0	12.6	4.9	7.9	6.3	7.6	5.2	5.8	4.2	4.2	4.9	5.1	4.5	3.4	8.6	7.0	10.7	3.1	5.0	2.6	4.5	7.8	7.0	6.2	4.1	6.6	6.1	5.9	6.7	6.2	6.1	13.1	42.1	16.0	22.6	36.6	30.7	30.2	26.3	22.8	30.7	28.4	22.8	17.4	25.8	12.8	24.0	11.0	33.3	19.3	26.8	18.4	1.9	14.4	213.7	21.6	45.9	27.5	22.7	18.7	47.1	14.0	18.8	30.3	38.2	36.2	27.8	24.2	14.3	19.7	13.2	42.1	54.8	18.9	22.4	18.1	13.2	73.1	26.8	23.5	12.4	25.3	28.2	44.9	18.6	53.8	90.8	20.2	14.2	21.1	43.9	31.5	16.6	16.9	22.6	30.5	13.1	29.3	28.6	46.8	23.9	30.1	32.0	29.8	30.5	34.3	20.8	29.8
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843338-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	26.3	22.6	12.2	22.4	13.2	52.5	24.1	13.4	16.3	18.8	12.9	20.3	15.7	22.2	15.6	23.3	19.4	12.4	18.7	12.6	13.7	18.5	24.6	19.0	26.2	13.0	12.9	21.2	23.5	14.1	14.0	19.6	13.0	17.5	20.5	10.3	18.0	17.4	36.9	29.3	20.0	21.0	12.6	22.2	20.6	20.7	13.5	16.8	17.0	18.5	25.6	23.1	19.4	14.7	42.5	39.0	45.3	101.4	32.9	39.7	52.5	64.5	47.2	69.7	55.2	63.6	21.6	88.7	50.6	58.7	76.5	46.8	76.3	63.2	96.8	51.2	74.4	175.8	45.1	98.4	57.9	219.0	97.8	45.1	45.5	77.7	84.4	28.7	49.0	51.1	170.3	57.2	54.4	71.7	75.2	92.8	53.6	48.5	42.5	64.1	85.6	40.1	51.9	58.1	40.0	48.2	65.8	53.8	62.3	41.1	30.2	138.1	44.7	44.4	51.6	100.0	120.0	70.9	93.6	118.9	44.5	112.3	63.8	2.0	16.7	7.3	18.9	21.8	20.6	28.6	19.6	20.5	25.3	24.5	21.5	24.9	0.5	36.0	19.5	30.7	18.7	14.2	12.2	13.2	13.4	16.3	12.6	13.7	13.0	12.9	13.0	12.6	13.5	14.7	19.8	6.4	34.1	9.1	22.1	25.6	22.3	28.8	13.1	9.9	10.8	15.7	25.6	10.0	28.3	7.3	2.1	25.5	22.1	9.0	13.7	29.4	25.0	11.5	29.0	20.6	19.7	18.3	13.7	28.7	30.5	27.6	12.8	14.0	24.7	17.6	11.4	18.0	27.9	11.8	14.2	13.3	38.7	13.1	14.8	10.7	25.7	17.0	5.4	10.3	33.6	9.9	23.7	13.6	13.7	29.9	10.4	27.4	17.6	21.9	6.9	17.3	24.1	10.2	6.6	29.0	24.5	57.5	62.5	18.9	32.1	16.3	16.2	57.8	19.7	16.3
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719565-50756219	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		15000	"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	86.8	108.2	128.2	91.1	134.2	75.9	96.4	165.6	193.2	172.2	131.4	163.3	99.4	144.8	88.1	98.3	157.5	63.8	102.8	126.1	138.7	112.7	90.8	119.0	132.4	131.3	128.4	223.5	111.6	63.6	172.0	78.5	132.5	141.3	75.1	175.8	94.8	73.4	151.9	105.3	131.2	65.8	124.6	133.6	113.7	73.7	133.5	84.1	144.0	43.2	88.4	130.1	136.5	148.4	176.7	114.3	222.8	143.1	91.5	87.9	105.5	162.8	63.0	77.0	92.1	214.5	132.4	212.5	171.1	65.2	87.5	148.8	149.4	67.5	132.2	226.6	242.5	251.5	445.3	174.9	50.5	223.4	136.0	84.2	94.5	84.2	48.7	193.7	79.9	164.9	202.9	188.0	99.1	99.1	221.4	218.0	146.2	125.3	83.4	238.2	208.4	224.0	105.5	109.8	158.1	163.2	96.8	121.5	179.3	192.6	196.3	164.9	113.7	170.9	146.3	72.8	171.5	167.8	191.7	265.1	108.1	152.5	123.9	49.1	32.3	32.6	32.0	24.0	28.2	67.3	35.7	27.6	21.2	55.4	37.1	30.5	47.8	23.3	19.8	64.7	29.6	12.1	128.2	134.2	165.6	193.2	126.1	138.7	131.3	128.4	132.5	124.6	133.5	148.4	129.7	150.6	194.2	231.8	177.8	216.2	200.9	99.4	200.3	512.3	121.1	129.5	111.5	70.1	148.3	93.8	229.4	104.8	237.1	130.8	74.3	102.6	18.9	111.1	171.8	151.9	207.8	191.2	121.5	85.3	108.5	149.8	99.4	144.8	148.0	364.8	94.2	83.1	76.4	380.2	145.9	151.8	81.4	87.4	122.5	48.4	394.5	105.1	96.0	107.7	184.2	207.8	197.8	181.5	239.1	86.5	158.0	355.0	134.5	151.2	157.8	56.2	130.1	402.2	236.7	204.5	172.3	122.2	159.3	135.7	177.0	99.9	162.8	253.1	141.7	191.7
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290154	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 223.1;NK-cells: 197.8;Spermatocytes: 718.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	14.8	8.4	7.8	19.8	8.4	20.4	11.2	8.2	13.0	10.0	7.1	10.8	8.8	9.1	5.7	15.9	10.4	8.2	15.6	8.0	9.0	8.8	10.4	11.8	24.3	9.0	8.6	12.4	9.6	5.3	8.4	11.1	8.9	7.8	10.1	11.1	7.3	6.7	21.2	9.2	9.3	9.0	7.9	18.7	7.9	102.1	8.5	12.8	6.7	11.7	17.8	18.8	10.8	9.3	59.9	30.8	26.7	39.3	22.9	26.0	46.1	53.2	18.1	53.7	37.1	97.1	75.6	158.9	37.5	23.0	86.2	37.0	100.6	55.4	69.8	28.6	74.8	159.2	29.5	109.0	38.7	184.4	41.4	20.5	34.4	61.8	103.9	13.9	47.2	89.1	217.9	51.2	37.8	60.5	63.4	236.6	134.0	62.1	99.2	96.2	48.6	76.4	24.4	40.7	63.4	27.4	29.0	31.0	55.8	34.0	32.3	54.4	44.7	53.3	42.7	70.2	169.1	36.2	59.1	250.4	36.5	154.7	44.2	37.3	26.4	24.4	73.5	26.8	85.5	21.7	48.2	80.3	19.5	15.0	22.1	47.9	7.6	30.3	39.2	14.3	25.4	30.2	7.8	8.4	8.2	13.0	8.0	9.0	9.0	8.6	8.9	7.9	8.5	9.3	29.1	16.0	23.5	6.8	26.9	120.1	59.2	19.9	27.9	10.1	15.7	32.9	20.9	14.3	25.6	1.8	8.4	47.7	128.9	11.5	9.8	24.9	223.1	17.7	29.4	32.3	10.7	46.3	3.6	19.8	55.6	31.9	9.7	12.7	21.5	31.5	14.3	11.2	35.8	15.2	4.2	16.1	4.1	30.4	34.0	113.4	34.2	44.7	21.4	2.8	35.2	14.1	197.8	6.0	9.3	30.0	11.4	26.7	36.1	117.5	3.0	7.4	19.2	30.2	39.5	34.4	27.9	718.6	36.6	36.0	115.8	20.2	135.3	46.8	28.9	64.1
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA028055: AB_10601912, HPA064537: AB_2685281"	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	4.9	7.0	7.4	2.7	7.6	1.1	5.6	9.5	10.1	7.2	6.9	6.8	6.1	6.2	4.2	5.0	7.1	3.4	8.6	7.4	7.4	5.4	6.5	3.3	3.2	7.5	7.0	10.9	4.9	9.8	5.5	7.4	7.7	5.6	5.4	9.6	4.9	6.3	13.8	6.5	4.2	5.9	6.6	4.2	5.8	4.2	7.3	6.2	6.2	13.5	3.3	7.2	6.1	7.8	5.0	5.3	11.4	8.9	6.5	7.2	8.9	7.2	6.2	8.4	7.5	3.4	5.9	6.6	8.6	4.6	4.3	8.6	8.9	5.1	6.2	12.8	9.8	3.8	8.7	3.6	10.2	4.0	6.0	10.1	10.9	7.9	11.2	11.3	3.5	14.9	7.7	6.2	5.8	7.9	10.3	5.0	7.2	5.0	6.8	7.2	8.3	3.9	6.1	2.3	13.6	16.6	5.4	16.4	9.5	14.3	10.0	13.4	3.6	6.4	3.5	4.1	9.6	19.6	16.0	3.1	5.5	1.6	6.2	1.6	0.8	1.4	0.8	0.5	0.9	0.7	1.0	0.5	0.7	1.7	1.3	1.4	3.1	1.3	0.8	1.4	1.5	0.3	7.4	7.6	9.5	10.1	7.4	7.4	7.5	7.0	7.7	6.6	7.3	7.8	2.2	0.0	0.5	3.3	0.3	0.9	0.9	0.8	1.8	4.0	4.1	2.0	8.8	0.0	2.8	5.5	6.2	4.6	0.1	3.4	3.9	1.8	0.3	2.9	5.1	2.0	4.2	3.2	3.1	0.6	3.1	3.0	0.0	2.1	0.0	5.0	3.9	4.2	0.6	1.7	3.4	1.7	2.0	0.0	0.8	0.4	4.4	0.2	1.8	1.0	0.1	3.7	0.0	2.5	4.3	2.2	1.1	6.0	0.3	1.1	3.8	8.2	2.4	8.0	0.0	2.5	3.9	2.0	2.7	1.3	1.1	2.9	0.5	3.0	2.7	1.0
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.3;retina: 27.9"	"Cell type enhanced"	"Detected in all"		"monocytes: 277.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.2;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 30.8;SK-MEL-30: 27.1;THP-1: 99.5;U-937: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	5.2	2.7	2.0	8.5	2.7	31.3	6.4	10.1	3.3	7.1	9.1	4.5	3.0	4.3	2.7	4.2	3.9	5.1	2.2	2.0	2.5	3.6	5.5	5.5	7.5	2.2	2.6	4.5	2.2	6.2	1.8	4.6	2.5	3.4	4.3	27.9	4.3	3.3	1.7	9.7	3.3	4.4	1.1	10.8	7.7	6.1	3.3	25.7	6.4	3.8	6.5	5.7	5.2	3.4	8.6	1.9	0.9	2.0	12.7	14.4	1.3	3.1	12.5	3.3	3.1	0.0	2.3	1.1	1.2	6.8	7.7	4.1	1.2	1.6	2.9	30.8	2.7	2.8	1.9	0.6	2.3	4.2	3.7	4.8	7.8	4.0	10.0	4.8	2.8	1.3	0.2	1.7	2.6	0.4	5.3	8.7	0.2	1.6	0.9	0.4	1.2	0.0	9.2	9.2	5.4	1.1	3.4	0.2	27.1	1.0	1.2	99.5	5.8	2.4	1.1	2.8	2.8	2.1	0.1	0.2	4.1	38.0	7.0	0.4	2.9	5.7	0.6	3.4	0.8	1.0	0.2	0.7	1.7	1.4	0.2	0.4	12.2	1.7	6.1	0.2	0.2	0.7	2.0	2.7	10.1	3.3	2.0	2.5	2.2	2.6	2.5	1.1	3.3	3.4	66.3	19.2	41.1	71.2	70.9	71.0	89.8	14.6	18.8	67.4	17.6	15.6	11.6	15.7	28.4	11.0	93.8	6.7	77.3	25.0	11.7	6.6	24.6	22.6	23.8	51.2	9.6	21.0	151.5	12.3	5.0	27.0	41.3	22.4	112.5	9.4	26.0	15.4	31.9	52.2	155.9	14.3	28.5	65.6	81.3	17.7	28.0	111.4	120.9	159.3	277.4	25.6	88.6	112.1	81.6	39.6	24.2	21.8	37.3	56.0	12.7	10.9	26.7	162.5	13.1	31.2	22.7	93.3	28.0	18.7	65.1	8.8	71.3	13.6	7.6	98.5
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150582151-150584693	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 174.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.0;Cholangiocytes: 28.6;Horizontal cells: 25.2;Muller glia cells: 7.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3;pancreatic cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTERT-RPE1: 101.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.9	4.1	0.7	8.7	0.7	0.0	0.1	1.0	1.0	0.0	7.5	174.2	9.0	0.1	1.3	1.4	0.1	1.0	1.1	0.5	1.8	0.0	0.9	0.0	0.0	16.8	10.4	0.0	0.1	0.0	0.2	0.0	17.0	0.1	10.2	7.4	5.8	0.3	0.2	0.2	38.7	20.3	5.7	0.0	0.5	0.0	2.0	0.7	3.3	0.0	0.0	0.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.5	0.0	0.0	0.0	101.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	1.0	1.0	0.5	1.8	16.8	10.4	17.0	5.7	2.0	3.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	1.4	28.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	25.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MAEA	"EMP, GID9, HLC-10, p44EMLP"	ENSG00000090316	"Macrophage erythroblast attacher, E3 ubiquitin ligase"	Q7L5Y9	4	1289887-1340147	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	28.5	44.2	21.9	23.5	21.3	18.3	28.8	19.8	24.0	32.6	25.9	39.7	33.5	34.4	10.9	46.7	29.2	17.5	38.6	21.1	27.2	40.9	32.3	24.0	24.3	25.7	23.0	34.9	35.4	30.7	38.9	17.2	26.3	29.2	14.2	8.8	35.7	21.5	37.1	41.2	35.7	14.9	18.1	40.0	37.1	26.8	23.2	20.7	33.9	19.2	15.7	30.7	33.5	20.0	58.1	66.9	47.6	47.7	31.5	31.1	61.4	57.4	30.6	47.1	42.2	70.5	73.5	52.5	43.6	42.4	85.5	42.0	46.1	72.2	19.1	42.4	52.2	49.2	74.1	68.1	37.1	55.8	50.9	38.8	38.6	37.8	23.6	31.8	38.0	50.4	70.4	41.6	41.3	61.5	84.2	86.5	62.2	63.4	72.9	81.0	38.1	47.8	50.3	68.2	84.7	57.8	51.1	39.3	41.5	26.3	71.5	48.4	52.8	85.9	36.0	39.0	96.1	50.5	83.4	58.1	59.0	51.3	48.2	74.9	49.9	70.9	59.2	52.6	83.5	47.6	47.1	56.4	47.1	38.1	41.4	42.5	117.9	45.5	77.3	33.0	59.8	59.1	21.9	21.3	19.8	24.0	21.1	27.2	25.7	23.0	26.3	18.1	23.2	20.0	22.0	19.2	25.0	28.4	21.6	18.7	15.7	33.9	8.0	28.1	22.5	25.3	35.5	14.3	24.3	16.5	20.9	48.2	29.7	41.2	46.9	43.4	8.0	21.9	25.2	24.4	20.4	26.3	19.6	30.3	46.4	25.0	25.5	25.0	10.8	30.4	19.6	15.0	39.6	21.9	23.2	33.1	30.5	29.2	15.9	9.8	35.4	23.2	28.4	14.0	46.3	22.3	28.8	22.6	20.0	40.3	31.3	37.2	23.5	22.7	30.4	36.4	17.9	19.1	13.1	24.9	27.9	36.6	44.0	19.3	19.9	95.2	29.7	59.6	38.1	21.8
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530702-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	40.9	31.0	37.0	13.0	34.8	19.5	34.4	26.8	34.8	30.9	38.2	61.1	18.2	34.7	1.8	30.1	33.6	11.6	80.5	26.8	28.0	50.3	32.8	60.0	9.4	35.5	33.3	21.7	39.7	4.2	25.6	25.4	32.2	49.2	4.7	2.4	25.6	10.7	78.6	38.6	31.1	6.7	30.2	21.0	37.2	9.7	35.6	22.9	27.3	13.1	4.9	39.4	35.7	43.2	50.0	35.0	1.2	5.2	3.9	4.8	26.2	32.3	18.3	7.7	5.4	25.2	13.4	11.6	11.7	8.2	51.8	38.1	2.9	9.2	3.3	17.9	25.2	6.8	50.8	18.7	8.7	16.2	20.7	4.8	11.8	12.9	9.6	9.5	7.1	35.7	17.8	6.2	3.6	32.7	18.2	57.6	11.2	12.2	35.2	27.1	1.2	19.5	7.3	20.2	14.8	5.4	19.5	56.4	14.6	7.5	22.0	21.3	16.8	11.8	82.3	59.5	17.9	11.8	3.9	19.8	15.5	22.0	17.1	0.5	0.4	1.2	0.6	0.2	0.6	0.3	0.3	0.7	0.2	0.5	0.7	0.5	0.6	0.5	0.5	1.5	0.7	0.4	37.0	34.8	26.8	34.8	26.8	28.0	35.5	33.3	32.2	30.2	35.6	43.2	33.0	41.7	17.6	2.0	8.8	63.9	52.2	21.3	37.0	2.2	33.7	20.2	2.8	11.5	25.7	31.3	2.1	11.0	13.2	45.8	1.9	15.2	2.9	57.3	13.3	24.6	23.2	8.2	8.8	14.9	9.0	16.6	20.4	94.3	9.5	6.6	9.7	14.8	10.9	11.8	3.7	24.4	16.2	13.2	27.9	6.0	4.7	18.0	19.6	9.4	8.7	7.1	8.2	0.5	3.1	46.2	38.9	3.0	6.0	60.8	27.4	2.5	29.6	1.6	13.1	33.2	27.1	0.9	4.0	25.8	57.7	78.0	11.0	2.0	19.8	73.5
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816015	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Granulosa cells: 1684.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	81.6	125.1	102.3	52.8	97.8	31.8	162.6	104.9	112.2	174.5	111.7	106.8	54.3	134.3	101.9	67.4	149.0	94.3	142.2	95.5	121.9	141.0	57.5	85.9	48.0	125.4	118.4	255.9	75.5	148.0	195.3	177.1	128.8	208.8	53.5	74.4	103.3	169.9	88.9	60.5	62.5	140.6	108.5	60.8	77.6	63.1	110.1	68.8	149.2	91.4	46.2	111.7	95.7	108.9	34.0	61.4	373.7	111.0	171.6	229.5	66.8	137.9	243.7	106.4	187.5	62.3	84.4	47.1	361.2	279.0	88.5	45.2	106.5	104.2	76.1	84.5	87.0	100.0	68.6	122.1	145.5	25.4	71.8	310.4	43.0	109.3	55.5	223.6	209.9	55.2	24.5	55.7	207.6	94.0	57.0	41.9	134.7	59.1	72.4	37.4	132.9	68.2	148.5	25.3	56.6	149.5	54.7	62.4	330.6	437.5	263.1	42.9	185.0	90.4	141.3	135.9	39.5	35.7	32.7	34.5	132.0	66.7	477.6	178.5	31.9	132.1	119.1	80.0	91.7	59.2	98.1	112.1	41.1	63.9	97.3	112.0	11.8	108.6	140.8	25.8	108.9	127.4	102.3	97.8	104.9	112.2	95.5	121.9	125.4	118.4	128.8	108.5	110.1	108.9	77.9	44.8	42.8	17.6	37.4	42.4	96.4	198.6	43.3	69.8	123.3	97.8	60.5	44.3	175.4	77.3	29.2	231.5	36.9	11.9	246.5	107.4	3.4	42.4	96.8	116.4	58.3	10.3	12.9	53.7	133.7	151.7	20.9	57.1	102.1	1684.0	79.9	16.2	69.1	138.0	20.3	48.8	173.0	19.5	47.4	17.4	233.3	41.1	158.3	21.5	42.1	175.9	44.3	17.6	20.4	47.9	33.7	320.4	46.7	75.2	25.5	149.3	119.9	66.0	157.8	77.7	236.3	12.8	13.7	15.3	34.9	169.2	51.4	58.6	25.3	76.6
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048801-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 31.1"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Oligodendrocyte precursor cells: 76.4;Proximal enterocytes: 69.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9;stomach cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Karpas-707: 44.2"	"Not detected"	"Not detected"							"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.7	1.9	0.2	1.9	0.4	0.6	1.0	1.6	0.7	1.3	0.5	30.6	0.6	2.2	0.2	0.2	0.4	1.4	1.8	2.1	1.5	0.1	0.9	0.1	1.5	1.7	1.2	0.1	0.0	1.5	0.4	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.2	31.1	0.4	1.7	0.2	0.3	2.1	1.9	1.9	0.5	0.1	0.0	0.6	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.2	0.0	4.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.9	1.9	1.0	1.6	1.8	2.1	1.5	1.7	1.5	1.7	1.9	1.5	0.0	0.0	1.8	37.9	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.8	1.3	0.0	1.9	0.1	7.9	0.1	0.3	0.1	0.0	4.2	11.6	0.0	0.8	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	11.0	9.5	0.0	0.0	0.3	1.8	0.0	0.0	0.0	5.6	0.0	1.4	0.0	76.4	4.9	0.0	13.8	0.7	0.0	0.2	69.3	0.2	0.0	0.0	0.0	0.1	0.2	9.0	4.1	0.1	0.1	0.3	0.0	1.9	9.7	0.0
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA020487: AB_1845757, HPA052210: AB_2681762"	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	2.6	3.2	2.8	1.6	2.9	2.0	2.2	3.3	3.7	1.9	3.7	2.7	1.0	1.8	2.3	3.9	2.3	1.4	5.1	2.7	2.7	3.1	5.6	2.0	2.9	2.5	2.5	2.6	2.9	2.3	2.0	3.4	2.5	1.6	1.7	1.8	1.9	2.3	6.3	1.8	1.8	1.8	2.4	1.8	2.2	4.9	2.9	1.5	3.3	6.4	1.9	2.1	1.9	3.0	9.2	11.4	8.8	47.8	7.8	5.4	7.6	6.1	5.0	6.2	5.7	19.7	8.1	8.8	7.0	4.4	27.5	8.7	7.9	4.3	7.6	4.2	12.9	5.2	15.0	30.4	5.0	12.2	3.2	4.6	6.5	5.3	5.8	41.5	5.8	8.5	16.5	2.3	7.9	6.4	8.4	37.2	15.1	18.0	29.0	6.5	6.7	12.4	6.1	8.1	7.0	8.5	5.0	8.9	16.1	17.2	4.5	7.3	9.8	5.2	4.0	10.0	12.5	2.6	8.6	14.7	20.6	15.0	17.3	0.7	1.0	0.7	0.8	0.8	1.0	1.0	1.2	1.0	1.0	1.0	1.4	0.9	0.7	0.9	0.7	0.9	1.2	1.0	2.8	2.9	3.3	3.7	2.7	2.7	2.5	2.5	2.5	2.4	2.9	3.0	40.5	38.5	41.7	12.7	32.1	43.7	54.8	58.3	30.1	29.1	38.6	60.8	97.1	37.1	40.0	44.1	16.7	77.6	25.7	22.3	115.4	90.6	168.5	50.2	31.9	38.9	19.2	35.3	14.7	96.3	68.7	44.9	16.3	31.7	14.5	41.5	44.3	106.8	54.0	18.5	16.6	32.5	50.8	26.3	15.1	33.6	49.4	22.3	35.6	8.4	44.5	46.8	30.9	18.6	20.2	73.2	28.2	49.2	34.9	61.2	38.1	117.6	44.6	35.8	32.9	35.6	65.6	82.2	75.2	42.4	44.2	49.8	25.2	61.7	44.4	49.2
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		2000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	15.6	11.7	6.7	13.0	12.0	6.3	12.9	8.8	11.6	17.5	7.7	12.5	11.1	16.4	13.7	15.2	14.2	12.3	11.0	7.2	8.5	15.3	21.1	10.8	14.1	1.6	5.0	14.3	36.2	32.9	6.7	21.7	1.6	14.4	12.5	18.2	14.0	13.1	8.4	10.3	11.6	18.0	1.0	12.2	14.2	10.8	6.2	14.7	25.4	10.1	13.8	17.8	7.7	9.8	32.4	13.8	23.2	20.1	29.8	35.7	74.2	26.3	40.9	11.6	10.9	10.7	18.2	24.2	47.4	33.9	10.8	18.7	11.0	22.3	26.0	30.3	16.4	14.4	18.5	11.8	18.1	22.7	31.6	24.2	23.5	17.8	15.5	21.3	35.0	16.7	23.5	36.1	24.5	62.6	14.0	7.2	11.9	16.4	14.4	12.5	50.5	16.7	15.9	43.3	12.6	18.4	26.2	27.6	21.1	30.1	13.8	14.2	33.6	26.0	21.4	18.6	27.2	24.4	18.0	15.9	34.4	17.8	63.1	0.9	1.5	2.6	3.0	1.2	3.6	1.9	2.4	2.5	1.4	1.9	2.0	2.9	1.2	3.8	1.1	2.7	6.3	1.5	6.7	12.0	8.8	11.6	7.2	8.5	1.6	5.0	1.6	1.0	6.2	9.8	40.3	38.5	33.4	71.5	45.1	31.0	34.8	26.7	39.3	63.5	43.3	46.0	101.8	35.8	39.1	44.1	22.9	55.1	52.6	24.7	17.6	32.3	33.1	43.2	52.0	40.6	21.7	43.8	188.5	60.4	236.1	50.7	28.5	54.7	16.4	32.3	42.1	88.7	29.4	43.7	238.0	37.1	20.3	36.2	22.0	22.5	53.7	37.2	40.9	101.2	39.2	51.3	55.6	136.7	149.1	37.5	25.1	65.5	120.2	43.0	28.6	22.1	40.9	42.2	39.5	69.1	53.5	72.9	56.2	53.0	34.5	380.5	45.8	68.3	30.8	47.3
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368612	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	49.3	66.1	20.2	23.9	21.1	37.6	49.3	17.7	28.8	52.1	18.6	41.8	25.5	49.3	12.1	29.9	50.5	16.4	55.6	20.0	17.8	52.8	50.0	50.3	20.3	22.8	18.1	58.5	49.1	26.3	56.6	21.1	20.9	49.4	14.9	14.8	37.3	19.5	58.5	36.8	41.6	18.6	17.5	54.7	46.0	34.8	19.8	17.1	64.8	24.5	12.7	45.7	41.5	22.0	11.0	25.5	21.3	15.7	23.8	20.4	27.1	25.3	23.5	12.9	10.9	20.3	38.3	5.7	14.6	18.6	11.8	33.0	11.7	17.1	8.4	30.8	26.1	34.0	58.5	18.1	35.3	23.1	5.7	25.3	17.0	12.3	15.3	27.3	30.9	16.9	20.5	27.4	10.7	22.1	11.9	25.2	9.0	13.2	11.8	16.0	11.0	34.6	16.8	49.8	13.2	22.7	16.4	23.9	11.5	15.6	26.1	26.1	61.5	27.1	18.7	19.0	25.5	27.9	7.1	9.3	17.6	25.9	27.6	4.0	19.8	3.5	9.2	23.0	9.1	3.2	6.9	6.8	22.6	2.6	9.5	6.9	2.2	6.0	18.9	9.2	10.2	14.3	20.2	21.1	17.7	28.8	20.0	17.8	22.8	18.1	20.9	17.5	19.8	22.0	34.1	22.4	51.7	29.0	12.5	13.5	15.2	13.0	11.4	30.7	18.2	16.3	2.8	5.7	19.2	9.2	54.2	17.2	17.2	22.4	3.9	11.4	10.4	10.1	18.3	23.2	34.2	7.6	28.9	8.7	10.9	20.4	39.3	12.7	31.7	46.8	32.5	22.4	20.4	28.6	23.8	19.5	12.2	29.8	20.2	14.0	23.3	26.3	16.0	15.0	31.4	17.3	19.6	18.1	19.5	11.2	20.0	12.4	12.9	16.0	27.9	15.9	19.3	52.4	26.3	25.6	16.3	21.1	10.4	14.9	8.5	21.2	16.2	17.0	24.0	15.3
MAP11	"C7orf43, FLJ10925, TRAPPC14"	ENSG00000146826	"Microtubule associated protein 11"	Q8WVR3	7	100154420-100158723	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 7.0;Extravillous trophoblasts: 7.2;Hofbauer cells: 7.7;Syncytiotrophoblasts: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.5	13.3	9.4	16.7	9.6	11.9	8.4	9.6	10.7	9.7	7.4	20.0	14.2	11.8	6.4	15.9	9.5	7.1	7.3	10.4	12.1	16.6	17.2	10.7	20.7	11.5	11.4	6.7	13.8	17.6	17.9	7.3	12.3	12.8	11.5	4.9	15.3	8.4	5.6	25.0	22.5	5.7	7.0	32.2	17.8	30.3	12.0	13.9	15.5	3.8	12.4	9.4	10.9	9.4	7.6	9.7	11.1	18.8	6.8	3.7	12.5	13.9	10.8	9.4	6.8	7.6	8.8	9.6	12.4	10.5	14.6	14.4	5.3	11.0	3.6	18.1	10.6	7.3	13.5	6.7	8.1	9.0	32.1	7.5	7.4	9.1	7.0	6.8	8.3	9.7	15.9	16.9	12.4	23.6	20.7	19.3	12.4	14.0	13.9	12.3	5.1	10.7	8.2	8.6	14.0	14.8	12.5	35.7	7.6	7.3	7.2	10.7	11.5	18.6	15.7	24.7	10.9	24.8	25.4	9.7	10.5	12.3	20.2	0.6	0.3	1.4	0.6	0.6	0.5	0.2	0.8	0.6	0.2	0.6	0.4	0.7	1.9	0.2	0.6	0.2	0.0	0.2	9.4	9.6	9.6	10.7	10.4	12.1	11.5	11.4	12.3	7.0	12.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209565	"Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 431.3;retina: 154.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 717.2;Excitatory neurons: 571.8;Horizontal cells: 647.8;Rod photoreceptor cells: 562.1;Sertoli cells: 769.2;Smooth muscle cells: 461.2"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 301.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		180000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	30.2	19.4	135.6	10.9	127.6	0.1	17.8	181.9	299.9	14.9	0.0	16.9	2.1	16.6	9.5	13.0	11.5	11.0	25.8	138.9	310.5	4.0	2.2	7.1	2.2	392.1	297.1	7.0	3.6	2.5	16.4	10.0	431.3	20.1	5.3	154.9	7.7	25.4	6.0	13.3	7.1	26.4	222.4	1.3	15.3	12.0	332.9	1.5	8.3	9.6	1.3	26.7	11.4	272.0	1.4	62.8	133.5	48.7	80.9	140.1	0.2	32.6	22.7	29.0	34.5	0.5	1.7	0.1	71.8	108.2	87.9	0.6	73.2	2.8	43.3	0.2	12.3	6.7	22.3	18.3	43.6	0.0	5.1	142.1	9.3	116.7	42.8	25.9	91.6	0.2	10.6	0.3	49.5	0.6	0.1	0.0	36.5	0.0	21.3	0.4	16.4	0.1	2.5	0.1	89.9	63.0	28.9	0.3	14.9	109.7	0.2	6.1	301.6	90.7	44.6	69.4	140.3	8.0	0.4	0.2	98.5	0.1	72.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	135.6	127.6	181.9	299.9	138.9	310.5	392.1	297.1	431.3	222.4	332.9	272.0	45.6	0.0	2.0	85.5	1.5	31.6	71.3	2.3	5.2	240.3	14.3	34.3	366.0	2.8	11.5	9.2	717.2	1.6	0.6	0.0	0.0	12.9	13.2	75.4	116.8	97.8	77.6	0.0	571.8	3.4	1.4	220.6	6.6	27.7	1.3	25.3	42.1	0.8	6.4	647.8	350.7	0.7	18.3	1.3	28.4	23.4	309.7	10.1	80.0	91.8	0.0	406.1	0.0	131.2	269.3	7.1	0.0	384.8	0.5	22.1	0.1	0.9	48.6	562.1	769.2	85.4	461.2	8.9	8.0	1.9	50.6	4.0	4.2	269.9	0.2	20.0
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386837-66491544	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.5;Langerhans cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	57.9	31.0	47.6	38.3	79.7	63.7	32.5	30.2	61.3	31.1	22.5	26.5	19.4	26.3	29.6	51.8	23.7	27.0	40.7	69.4	44.3	31.2	105.3	34.7	49.5	31.6	32.6	25.7	22.4	38.5	26.8	29.6	40.1	26.2	23.6	34.1	29.3	21.8	85.5	23.7	27.0	31.9	35.7	32.6	24.1	15.2	42.8	33.8	22.8	51.3	55.4	31.2	33.7	49.9	105.8	55.3	94.4	39.0	55.3	41.3	53.8	83.6	61.6	76.6	68.1	79.0	82.1	96.8	93.2	59.9	58.2	93.3	88.8	106.4	89.8	79.1	56.8	30.9	50.4	40.7	45.1	41.0	45.3	32.3	64.0	55.9	81.6	81.5	60.7	48.0	54.3	116.7	113.4	40.3	33.5	51.9	47.9	93.9	42.9	39.2	58.1	84.7	74.8	48.5	58.3	31.7	60.8	45.5	63.0	74.9	41.0	33.7	90.8	99.5	63.8	71.1	112.4	74.0	143.1	60.6	105.1	69.9	48.4	3.0	7.5	5.4	6.4	7.7	5.8	2.8	5.6	6.1	7.7	4.6	6.9	4.2	3.5	8.3	7.7	15.1	4.6	2.8	47.6	79.7	30.2	61.3	69.4	44.3	31.6	32.6	40.1	35.7	42.8	49.9	24.5	28.9	24.8	24.2	40.0	82.8	45.9	32.3	21.1	10.0	22.2	10.2	21.5	40.0	24.9	25.8	14.6	48.1	45.0	25.1	46.9	69.4	12.1	16.3	13.9	34.6	21.7	19.0	69.7	23.1	48.8	30.3	17.9	35.4	8.9	19.8	18.9	172.5	51.4	10.1	46.4	15.4	20.3	90.7	265.3	23.6	22.4	115.1	53.4	48.7	87.9	34.9	35.0	28.1	31.7	103.9	23.5	21.8	49.1	87.7	22.2	35.9	17.7	7.8	6.6	16.3	52.4	35.6	42.7	30.3	67.3	51.7	54.0	5.9	19.1	65.4
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 43.1;SuSa: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	8.3	13.7	4.0	4.0	4.4	5.2	7.7	4.0	5.9	14.3	4.4	10.6	5.5	11.1	3.3	16.3	8.7	4.5	6.2	3.9	4.5	7.7	3.9	8.7	3.7	5.3	6.1	12.5	3.4	2.9	6.1	6.7	4.4	8.9	3.5	2.2	6.7	6.1	5.0	12.5	7.3	6.7	3.3	9.4	6.7	11.8	5.0	3.5	7.4	3.4	3.6	10.1	15.2	4.1	6.9	11.0	9.9	7.7	43.1	17.2	10.4	9.0	8.3	13.0	12.4	12.2	1.4	4.1	7.3	16.5	10.4	8.2	10.4	9.4	7.8	7.2	8.3	1.9	8.4	5.4	21.2	1.9	7.8	21.6	6.2	18.2	7.2	12.0	9.5	7.5	3.7	1.4	13.2	4.8	13.0	7.4	10.7	8.4	6.7	8.6	12.9	3.0	5.4	3.7	4.4	12.3	9.7	1.0	5.0	53.7	6.1	3.1	6.0	14.6	10.8	15.5	6.7	2.6	4.0	1.2	16.5	1.6	9.2	0.8	3.4	10.7	3.7	6.5	2.0	1.8	1.8	3.2	2.3	1.0	1.6	2.0	1.1	4.9	6.0	1.4	1.0	3.1	4.0	4.4	4.0	5.9	3.9	4.5	5.3	6.1	4.4	3.3	5.0	4.1	10.7	6.4	3.3	2.6	7.8	5.5	6.1	9.5	13.6	2.4	5.8	4.6	5.3	2.8	5.6	5.5	2.1	5.7	6.7	16.2	5.9	8.1	8.7	3.0	7.9	8.5	10.7	1.7	2.0	6.2	8.0	9.6	12.2	5.2	2.5	7.7	7.5	1.1	7.7	0.0	2.1	6.9	10.2	6.9	6.1	5.7	11.5	14.4	3.6	6.5	3.4	13.1	17.5	1.0	2.0	8.0	20.8	11.7	9.3	6.3	9.0	3.5	3.2	2.1	26.3	8.4	11.1	33.2	16.4	9.8	4.3	5.1	6.2	7.7	6.7	5.3
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.8;pituitary gland: 118.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332, HPA079657"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	4.8	23.3	127.9	2.3	131.0	1.3	4.8	122.0	147.7	8.2	29.6	8.3	1.4	10.9	3.5	2.2	11.3	3.5	5.5	166.8	120.6	11.5	5.6	4.0	0.6	154.9	130.9	9.1	43.1	19.2	118.2	1.4	142.6	11.6	1.2	11.5	11.4	6.1	2.4	4.0	3.7	5.7	124.6	2.3	9.0	27.7	139.3	1.0	7.0	2.5	0.4	6.7	4.8	164.4	0.0	7.1	9.4	26.2	3.4	1.8	0.3	5.1	4.6	9.9	7.2	6.3	1.1	0.4	2.5	5.9	16.8	5.8	10.2	4.8	4.4	4.0	13.1	0.1	8.6	4.1	3.1	0.6	4.4	2.4	1.0	6.4	1.3	6.6	2.2	0.9	11.5	1.6	2.8	3.9	0.4	0.6	24.9	3.3	10.5	0.6	15.4	0.3	4.6	0.2	76.4	28.5	8.4	6.8	10.0	3.6	11.0	0.4	2.1	12.5	19.1	19.0	9.3	1.1	1.3	0.5	7.9	0.2	3.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	127.9	131.0	122.0	147.7	166.8	120.6	154.9	130.9	142.6	124.6	139.3	164.4	1.7	6.4	4.1	7.2	0.9	2.4	5.8	2.0	2.8	34.4	6.1	5.3	1.1	5.7	3.3	11.0	22.9	1.6	0.4	2.2	13.7	6.9	43.8	23.9	15.9	2.9	40.2	0.0	10.3	28.9	0.6	6.5	4.1	19.9	0.0	2.8	0.4	4.6	0.5	67.3	11.6	1.6	4.1	0.8	3.5	39.2	6.2	1.1	3.6	1.0	1.6	41.3	0.0	3.5	48.7	11.6	0.5	6.4	0.1	6.3	1.4	8.9	10.9	18.3	0.0	14.2	6.0	10.6	8.2	0.9	1.0	5.7	1.3	7.7	0.9	5.5
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819954-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"		NA	NA		11000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	66.7	44.5	41.2	69.7	46.7	192.7	48.3	45.3	45.5	45.9	41.9	69.0	39.7	61.0	52.9	62.7	44.8	57.4	58.2	37.0	50.0	54.1	30.4	50.6	75.8	48.0	52.5	37.8	40.4	38.3	24.3	66.8	47.9	56.0	58.0	16.1	32.7	70.6	34.1	34.7	41.2	91.3	47.7	57.7	43.9	54.4	47.5	88.0	74.1	39.7	69.3	83.1	37.8	47.0	179.7	161.4	176.6	102.0	93.5	84.3	250.7	171.3	106.3	261.0	191.0	470.0	161.9	271.2	167.4	154.8	265.6	159.9	213.1	191.6	283.7	92.4	83.1	523.3	105.0	253.2	98.7	190.6	222.8	91.6	94.1	213.8	141.7	89.3	165.0	151.4	240.0	150.6	232.4	111.0	263.0	166.2	127.6	182.7	147.5	174.4	312.8	145.9	143.0	121.8	109.7	115.3	307.2	134.3	179.4	160.6	194.3	140.0	147.5	291.9	157.7	147.3	224.7	131.5	194.5	289.6	154.9	428.3	166.0	256.8	125.8	262.1	100.1	150.8	104.0	75.1	94.1	92.9	97.4	81.8	94.6	104.3	139.7	111.1	170.6	89.5	107.1	185.6	41.2	46.7	45.3	45.5	37.0	50.0	48.0	52.5	47.9	47.7	47.5	47.0	71.6	19.2	30.2	8.1	67.0	132.8	194.4	48.1	62.0	11.1	54.7	42.3	36.5	25.8	44.5	55.2	8.4	108.0	82.0	67.6	84.1	68.8	90.2	43.5	44.7	64.8	71.5	52.8	7.8	78.3	130.0	61.4	40.8	60.9	115.4	45.7	39.3	14.9	107.0	10.1	8.5	43.6	36.7	94.6	121.2	76.6	35.8	99.5	71.2	12.2	120.5	36.5	92.7	7.5	12.6	75.0	40.5	64.3	71.1	115.3	32.6	74.3	39.4	11.5	65.7	61.5	102.8	72.1	62.1	65.2	110.8	169.2	89.8	76.6	44.4	123.1
MARS1	"CMT2U, MARS, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase 1"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.9;Cytotrophoblasts: 29.5;Extravillous trophoblasts: 22.0;Hofbauer cells: 19.3;Syncytiotrophoblasts: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 738.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		NA	NA		23000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	35.9	47.2	63.1	35.9	65.2	31.6	31.5	62.0	83.6	30.8	61.6	47.6	21.5	40.7	39.0	54.3	30.1	19.3	50.5	67.5	67.5	55.7	60.6	42.7	34.5	64.2	65.5	24.2	64.4	40.7	58.9	27.3	68.1	38.7	29.6	39.6	39.6	34.0	48.5	33.0	37.3	41.3	63.5	53.9	53.2	50.7	65.6	32.6	40.0	33.1	44.4	44.8	33.6	67.9	110.6	149.6	99.7	171.9	107.1	64.6	180.2	149.0	178.4	158.1	168.6	162.9	119.0	192.3	97.6	187.2	98.3	119.4	226.0	196.4	166.2	167.4	96.9	136.7	52.8	89.4	238.1	207.7	147.5	96.2	302.9	181.5	467.5	76.6	114.8	238.1	212.9	400.3	112.1	150.4	187.9	148.1	184.8	173.0	162.3	155.5	738.3	200.0	117.0	86.4	131.6	134.0	79.8	120.9	215.8	109.6	161.0	260.7	86.9	57.5	162.8	82.8	91.6	357.5	395.8	232.5	139.7	154.8	199.1	29.9	29.8	39.3	35.1	53.6	31.7	24.4	23.4	32.0	57.9	14.7	20.0	27.4	14.5	30.0	45.6	55.9	26.3	34.2	63.1	65.2	62.0	83.6	67.5	67.5	64.2	65.5	68.1	63.5	65.6	67.9	5.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	29.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	22.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	38.0	1.2	0.0	0.0	0.0
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 120.0;heart muscle: 116.1;liver: 183.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000		"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.6	9.4	1.3	9.4	0.0	2.8	12.9	7.0	120.0	4.9	57.5	1.9	88.4	3.3	11.1	17.7	5.1	116.1	10.4	27.0	4.8	183.4	6.0	1.0	19.2	16.5	2.7	0.2	0.3	1.0	9.0	15.3	46.0	5.6	0.0	2.3	52.2	37.5	6.3	7.5	44.4	22.2	0.8	1.6	0.5	14.6	0.2	3.2	18.9	4.3	9.9	61.5	32.0	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.4	12.9	7.0	10.4	27.0	19.2	16.5	15.3	22.2	14.6	32.0	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27187953	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	5.0	3.9	1.7	6.2	1.9	18.7	5.3	2.3	2.3	3.8	2.1	4.1	4.4	3.9	4.5	5.9	3.0	3.9	2.5	1.9	2.0	3.9	4.9	4.0	8.9	2.0	2.0	3.4	3.3	6.0	3.1	6.5	2.1	3.1	5.2	2.7	4.1	3.0	2.3	6.0	4.3	4.5	1.6	4.6	4.7	6.5	2.0	10.4	4.7	2.2	7.1	4.5	4.3	2.3	29.4	22.0	43.8	15.5	6.2	9.1	25.4	43.3	18.0	68.4	83.8	26.7	27.2	22.4	16.1	18.4	33.5	26.8	27.9	16.0	48.2	20.2	26.5	26.9	14.5	15.5	3.8	10.4	19.8	5.6	7.5	41.6	7.9	9.0	14.7	18.2	21.1	49.9	41.5	17.9	34.8	11.2	32.0	15.9	8.9	22.2	71.9	18.9	17.4	10.6	19.2	26.8	26.0	17.6	19.1	28.1	17.2	21.4	12.6	17.0	36.3	44.0	37.4	5.9	10.3	34.7	18.3	31.1	14.8	0.2	1.8	1.7	0.7	1.7	1.1	1.1	0.9	0.7	1.0	1.6	0.9	0.8	2.3	1.0	1.8	1.1	1.6	0.8	1.7	1.9	2.3	2.3	1.9	2.0	2.0	2.0	2.1	1.6	2.0	2.3	4.3	6.4	7.8	2.6	7.4	11.0	4.9	4.4	4.0	1.7	4.2	4.8	3.0	2.8	7.0	1.8	0.0	8.6	10.1	7.0	0.0	4.0	3.0	9.7	5.3	4.6	4.2	7.8	4.3	2.5	24.9	7.3	6.1	17.9	12.7	6.9	2.5	2.5	5.8	3.3	4.3	3.7	4.1	7.8	19.3	1.7	3.1	11.3	0.0	3.7	5.1	1.8	3.1	3.5	4.9	4.4	2.9	2.6	7.1	5.0	2.8	1.9	4.0	1.0	0.0	3.8	5.3	14.9	14.1	10.9	9.9	6.2	11.6	5.4	4.5	6.6
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		600000	"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	14.2	12.5	13.0	11.5	16.0	10.3	13.0	13.9	13.6	11.6	14.1	19.4	14.8	12.0	8.4	14.9	13.2	6.7	21.3	12.1	11.5	15.8	15.5	13.3	9.9	18.6	15.7	16.8	17.6	15.4	12.1	9.4	15.9	14.2	15.4	8.1	13.0	10.3	37.5	18.9	16.9	9.6	14.0	14.3	15.4	4.9	16.1	10.4	14.0	29.2	10.8	14.3	11.0	16.6	31.6	36.0	14.3	17.9	38.8	26.2	11.2	18.7	23.8	19.5	14.2	28.4	19.9	13.6	11.1	26.4	55.6	38.7	17.3	28.0	19.9	8.4	8.4	26.3	14.6	45.5	21.4	16.6	10.6	26.7	23.4	33.2	19.6	19.4	20.1	17.6	30.2	10.1	19.3	28.5	25.3	14.1	9.2	15.7	19.6	18.8	19.9	13.7	20.8	31.2	10.7	11.2	21.3	41.0	18.1	20.3	21.9	15.3	30.5	26.5	9.7	31.7	22.1	20.7	26.6	9.4	10.5	20.1	13.7	1.7	2.1	2.0	1.4	1.6	1.0	1.1	1.1	1.1	1.4	1.3	1.2	1.2	1.9	1.8	1.9	1.7	0.9	1.6	13.0	16.0	13.9	13.6	12.1	11.5	18.6	15.7	15.9	14.0	16.1	16.6	16.6	57.7	48.5	24.8	17.3	2.2	13.9	3.7	19.4	34.0	19.9	13.2	61.0	58.6	21.7	29.5	16.7	33.6	22.5	100.0	13.7	25.9	1.1	16.1	27.5	26.8	34.7	17.1	13.6	30.5	27.5	22.8	25.0	16.6	8.8	36.5	44.3	45.7	25.5	45.4	15.9	32.6	2.0	37.7	2.9	3.2	30.7	20.7	1.8	15.9	32.4	20.7	20.6	12.5	19.9	32.7	29.5	28.2	14.2	18.1	42.8	19.6	16.2	33.7	32.9	26.2	17.5	6.2	4.1	15.6	2.0	18.1	16.7	27.5	57.9	16.6
MAZ	"Pur-1, ZF87, Zif87, ZNF801"	ENSG00000103495	"MYC associated zinc finger protein"	P56270	16	29806106-29811164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048315, HPA059495, HPA065930"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579"	"unprognostic (1.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (7.08e-2)"	71.0	91.7	156.7	92.1	153.0	270.3	65.5	147.4	179.9	87.4	125.2	139.4	92.7	90.1	51.4	92.6	88.6	73.6	74.4	158.9	134.8	63.6	101.2	73.2	123.9	140.4	144.6	96.7	105.4	113.3	83.0	61.8	136.6	122.9	101.0	50.8	86.2	75.4	126.2	96.3	87.7	75.8	134.8	97.8	85.5	89.9	143.9	256.0	79.5	93.1	111.2	94.4	68.4	145.2	227.2	294.8	298.8	326.9	158.4	149.6	268.4	161.0	130.6	246.0	177.4	378.5	316.5	402.4	205.2	316.9	121.6	201.3	494.2	210.9	87.5	329.9	792.4	267.7	641.3	526.2	222.1	668.7	318.8	160.7	292.1	207.2	232.5	228.7	249.4	556.7	398.5	343.3	118.3	927.1	644.8	566.3	303.7	246.1	227.6	627.9	281.3	468.5	202.3	242.2	456.1	355.1	153.8	330.1	204.6	190.5	284.3	633.7	172.8	269.8	215.4	103.6	256.1	249.3	344.4	448.5	131.9	435.4	227.9	18.1	14.7	23.9	58.8	24.0	63.6	13.5	39.1	56.5	19.4	10.2	31.6	47.3	11.9	40.1	16.4	19.9	45.8	21.3	156.7	153.0	147.4	179.9	158.9	134.8	140.4	144.6	136.6	134.8	143.9	145.2	52.1	6.4	5.4	9.4	35.3	32.9	14.7	26.7	35.3	61.6	77.8	66.9	0.3	31.5	14.5	11.0	12.5	26.8	106.7	111.5	29.4	31.6	2.5	58.5	59.0	41.0	133.3	90.3	12.8	41.9	55.6	46.3	34.7	39.6	33.0	103.1	30.7	37.7	57.5	47.1	13.0	103.6	32.6	47.8	47.8	6.6	28.0	47.6	46.2	8.4	26.4	35.6	50.4	9.5	14.2	36.3	68.5	36.9	41.6	32.8	37.8	21.9	25.6	35.1	32.9	30.1	49.1	22.2	24.5	38.6	35.5	16.7	67.5	70.9	126.8	14.9
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 97.4;Spermatocytes: 136.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	28.5	39.8	23.9	26.2	25.9	44.2	29.1	24.8	28.2	32.3	19.3	35.7	24.8	32.1	20.5	39.2	31.6	19.6	35.7	26.7	22.2	32.5	35.7	29.9	30.2	23.1	22.0	34.8	34.5	32.4	42.8	24.6	21.1	33.0	17.7	24.0	30.5	23.5	51.0	43.4	33.7	20.4	19.5	41.0	33.6	88.1	23.1	29.6	35.4	28.6	24.2	35.3	32.2	25.6	30.9	28.6	31.5	35.9	33.2	26.9	33.9	36.2	41.4	49.2	37.7	21.6	23.9	48.5	25.8	35.3	28.8	54.4	36.3	63.4	28.4	54.7	23.2	30.6	43.8	23.1	63.9	74.8	62.1	31.5	100.4	56.2	127.2	31.1	40.9	47.4	39.3	73.8	38.3	28.5	63.3	38.9	29.8	16.1	22.7	57.8	23.3	53.2	24.4	13.8	41.5	39.5	27.0	25.5	33.2	25.4	32.4	67.4	44.7	53.0	24.1	17.3	37.2	135.8	62.2	51.6	34.3	56.8	49.0	16.0	11.2	22.7	15.3	9.7	14.6	11.6	13.5	12.9	11.2	11.4	13.8	11.4	14.5	14.3	7.8	10.2	13.8	12.6	23.9	25.9	24.8	28.2	26.7	22.2	23.1	22.0	21.1	19.5	23.1	25.6	17.7	9.6	24.6	19.6	20.1	22.7	13.9	18.2	23.3	15.1	16.5	14.5	28.1	14.3	20.5	16.5	18.8	31.1	25.0	24.5	13.7	15.7	85.1	17.1	16.1	17.6	13.1	9.7	20.4	13.8	24.2	16.5	28.1	17.3	8.8	17.7	13.9	18.1	18.7	15.2	17.3	19.5	24.4	15.8	11.1	97.4	15.5	17.5	16.0	9.4	15.7	17.4	14.4	12.1	16.4	21.1	24.5	19.2	34.6	14.4	21.3	9.7	16.9	20.3	13.1	14.8	18.9	136.0	32.5	21.6	29.3	51.4	20.0	28.1	18.6	17.0
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151606-54224669	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	26.9	10.5	6.5	19.2	8.9	20.3	19.9	9.5	9.4	16.0	6.5	17.3	12.0	11.3	15.8	29.5	11.3	11.5	14.9	6.8	8.9	16.7	16.9	16.4	32.1	7.6	8.3	11.4	17.4	16.5	9.2	18.8	7.7	13.4	16.4	14.3	19.4	15.1	15.4	25.4	15.5	11.9	7.0	21.2	13.9	31.5	7.9	20.1	31.0	16.8	35.2	21.0	20.1	8.2	29.1	13.2	23.2	11.7	27.3	23.0	22.5	26.5	33.9	30.6	26.6	8.5	15.8	68.7	13.1	42.1	13.5	45.1	20.1	36.6	33.4	50.2	11.1	10.2	20.4	18.3	28.2	32.7	17.7	20.2	40.3	23.5	34.1	20.3	35.9	20.7	8.0	62.0	28.0	14.0	33.1	18.1	24.2	11.3	17.2	21.8	13.9	27.9	44.5	29.9	25.6	10.8	21.0	21.1	14.7	30.3	10.9	16.3	31.2	31.1	14.1	10.9	24.4	65.1	38.3	52.5	27.4	27.4	19.0	0.0	1.4	0.7	0.6	2.6	0.9	0.7	0.7	1.0	0.8	1.3	0.3	0.6	1.2	0.2	5.0	0.7	1.5	0.4	6.5	8.9	9.5	9.4	6.8	8.9	7.6	8.3	7.7	7.0	7.9	8.2	71.1	28.9	21.0	30.3	44.9	49.3	37.3	21.2	13.1	19.3	46.0	35.3	35.8	24.3	23.0	33.1	16.7	14.3	57.6	51.2	7.9	26.3	1.9	62.1	48.9	38.0	16.3	22.7	42.5	58.4	49.4	32.7	21.9	103.3	8.2	32.0	32.2	25.2	30.3	21.9	38.3	35.9	10.2	142.6	38.7	4.8	25.1	82.2	26.6	43.1	69.3	45.9	8.2	32.2	49.5	54.3	28.0	26.4	53.7	51.5	35.7	23.5	30.0	27.0	26.3	39.0	35.2	6.5	6.1	54.6	62.5	18.3	47.7	43.0	38.7	79.5
MBD6	KIAA1887	ENSG00000166987	"Methyl-CpG binding domain protein 6"	Q96DN6	12	57520710-57530148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in all"		"RH-30: 116.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038948, HPA038949"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA038948: AB_2676285, HPA038949: AB_10671868"	"unprognostic (2.56e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.01e-2)"	32.8	40.0	18.7	34.5	22.1	57.1	36.5	19.5	21.3	43.3	21.9	38.8	41.6	46.9	17.9	35.8	40.7	19.1	25.8	17.7	22.8	38.8	44.2	34.4	26.1	24.1	20.8	43.8	44.5	23.0	105.0	25.6	20.0	38.6	20.7	38.5	46.9	27.1	34.1	37.8	44.9	19.8	17.2	64.9	42.6	57.5	25.0	27.9	110.2	18.8	18.8	34.3	35.0	26.8	22.7	31.7	24.2	26.0	16.6	11.9	33.9	25.7	15.8	16.6	12.3	33.0	35.3	22.8	19.3	14.0	16.2	31.3	22.3	19.4	11.6	45.2	22.5	40.2	33.4	22.8	20.3	24.2	99.7	20.8	33.7	17.8	24.8	25.1	22.3	19.3	26.1	58.7	13.5	23.3	25.3	23.9	23.3	16.7	23.2	24.6	116.7	17.7	14.3	44.4	33.3	20.2	20.5	40.6	25.0	14.2	45.7	38.7	21.9	17.8	29.0	18.2	17.4	60.5	22.4	15.7	23.2	15.1	30.6	0.0	1.0	0.4	1.3	0.9	0.5	1.3	0.2	0.4	0.5	0.8	0.5	0.5	13.6	0.7	0.4	0.3	0.2	0.6	18.7	22.1	19.5	21.3	17.7	22.8	24.1	20.8	20.0	17.2	25.0	26.8	24.7	6.4	17.8	12.4	14.1	11.0	13.4	11.9	22.2	55.5	27.5	22.4	6.2	25.8	13.0	9.2	27.1	12.4	12.6	20.6	5.9	9.4	13.3	18.9	19.7	16.7	15.6	18.7	5.4	12.0	8.8	12.2	29.0	32.8	19.0	21.7	14.6	24.3	14.0	25.2	6.6	20.5	8.2	23.8	11.0	9.4	14.6	23.1	12.4	15.0	9.1	30.4	11.3	6.6	8.1	9.2	20.7	12.8	14.8	12.3	20.8	4.4	16.3	69.4	19.7	14.9	17.3	51.7	30.8	23.7	12.4	22.6	16.8	16.9	16.8	15.8
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 537.7;Oligodendrocytes: 471.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	116.4	35.8	18.2	105.0	24.9	90.4	48.1	22.9	22.3	76.9	18.9	69.0	43.6	68.0	30.1	65.3	38.4	75.2	63.2	18.7	23.0	31.5	47.6	78.1	138.4	25.5	20.1	45.1	24.3	26.5	11.8	29.9	26.0	55.1	71.1	17.7	32.3	66.0	188.8	61.5	58.3	116.5	25.0	92.3	40.5	14.9	25.2	108.4	31.8	131.0	135.1	78.4	32.7	32.5	133.8	107.8	17.3	38.9	132.5	135.8	12.7	163.3	131.5	105.6	87.8	48.0	76.3	136.3	81.3	230.8	32.8	59.7	32.1	94.5	155.0	106.9	43.7	149.3	52.2	22.7	73.8	180.5	104.5	63.8	50.2	121.9	94.0	80.8	219.5	54.1	77.3	180.5	103.6	45.9	169.0	66.0	7.2	38.9	85.4	170.5	53.0	171.6	53.7	66.3	13.8	15.7	71.1	38.2	69.8	6.2	53.1	270.5	186.6	143.6	55.1	96.4	142.7	186.9	115.9	154.6	83.8	220.6	79.1	95.3	53.7	90.1	79.4	61.7	84.4	56.2	64.5	66.5	70.1	49.7	80.6	70.7	78.4	79.6	54.7	24.9	62.6	104.3	18.2	24.9	22.9	22.3	18.7	23.0	25.5	20.1	26.0	25.0	25.2	32.5	175.5	150.6	193.7	179.2	252.1	213.6	49.0	25.9	156.0	28.5	51.8	48.0	179.8	52.9	89.5	38.6	64.6	26.1	266.0	164.7	21.5	36.0	2.6	64.0	92.2	142.9	47.3	160.2	258.6	63.6	9.2	122.9	78.0	68.5	162.6	31.5	90.0	91.5	60.9	32.0	185.5	68.8	14.2	216.4	195.5	9.7	89.5	235.0	103.2	537.7	249.4	18.2	230.7	224.7	471.9	57.3	90.3	71.5	181.3	61.2	121.4	42.2	63.1	84.1	98.6	102.7	145.6	4.3	12.7	149.4	243.6	14.8	340.1	46.8	80.7	50.1
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658706	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.5"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 107.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 81.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	21.3	47.6	13.4	13.5	13.7	6.0	60.0	12.4	15.5	21.3	24.9	30.5	27.2	14.4	38.9	25.4	17.2	15.2	54.9	12.0	13.1	73.3	120.5	13.4	17.8	14.8	13.4	14.2	24.6	32.8	14.1	14.2	14.8	48.2	35.9	12.2	28.2	20.6	34.4	19.8	20.7	11.7	16.3	15.6	25.8	8.6	16.0	14.2	44.6	35.4	21.5	27.0	15.0	18.4	38.5	52.4	21.4	82.5	22.4	23.0	36.9	16.4	29.4	35.7	25.7	91.1	46.9	90.4	62.8	25.9	28.0	30.8	37.8	58.8	44.3	47.6	45.6	48.2	24.7	100.5	39.2	24.4	42.8	29.5	30.1	32.6	25.8	15.8	31.7	24.9	63.2	31.6	24.9	103.0	0.3	42.9	29.0	33.2	27.2	46.3	64.5	130.9	92.5	66.9	32.9	36.7	80.1	111.8	38.8	10.1	92.7	59.6	22.7	14.4	22.1	26.1	49.9	22.4	46.2	54.6	23.7	66.3	36.6	2.0	8.4	1.9	6.5	13.5	8.5	9.7	8.4	7.4	19.4	9.9	8.3	9.1	1.3	14.7	8.1	8.1	12.1	8.3	13.4	13.7	12.4	15.5	12.0	13.1	14.8	13.4	14.8	16.3	16.0	18.4	9.1	16.0	23.6	27.4	26.8	13.3	17.5	20.2	22.2	12.6	54.9	28.3	61.5	20.0	22.3	16.5	6.2	48.5	17.6	26.3	21.5	20.6	4.3	94.0	24.0	15.1	29.5	13.9	22.2	18.2	23.0	13.1	30.1	107.0	12.7	22.7	9.7	93.1	18.0	3.3	21.6	22.8	8.2	12.1	11.2	9.8	13.7	14.0	12.4	11.2	17.9	15.4	20.6	30.2	28.0	15.3	17.0	20.3	27.2	29.6	23.6	59.1	17.7	10.8	6.6	15.2	9.0	4.2	12.0	35.9	13.8	63.6	17.9	30.9	33.9	20.9
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1 apoptosis regulator, BCL2 family member"	Q07820	1	150560895-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 685.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 106.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 4726.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Enhanced		Enhanced	Mitochondria		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	297.8	149.2	72.9	264.9	75.0	685.1	175.0	77.0	84.2	143.4	85.0	137.1	99.4	98.5	41.8	199.3	190.7	278.8	139.1	65.3	81.5	125.2	404.6	237.1	161.2	86.4	77.8	105.3	161.7	89.2	82.8	146.9	79.4	96.3	120.1	90.1	124.7	56.4	153.8	189.2	133.6	171.4	80.6	171.5	167.0	41.3	91.4	128.9	133.3	160.1	157.1	302.6	124.6	75.8	140.2	74.8	131.9	73.3	262.9	262.2	175.8	164.8	174.5	173.0	139.4	91.9	112.3	184.9	102.2	120.2	80.3	187.7	101.7	203.3	166.7	154.8	68.3	76.4	109.9	106.2	204.7	130.6	151.3	147.3	221.3	170.6	330.0	159.5	192.7	49.4	168.1	225.3	234.2	160.3	64.6	80.7	242.0	122.9	131.9	94.7	111.1	85.9	195.2	103.7	95.9	134.2	125.6	135.9	232.4	191.2	100.4	195.2	251.6	109.2	119.4	55.5	212.8	310.2	409.5	4726.7	189.5	95.1	141.9	23.3	19.8	51.8	15.0	17.4	17.4	12.6	19.0	16.6	16.6	14.0	22.8	17.6	106.3	10.6	16.2	9.4	30.1	11.2	72.9	75.0	77.0	84.2	65.3	81.5	86.4	77.8	79.4	80.6	91.4	75.8	366.0	198.7	295.5	12.4	339.2	489.2	394.7	142.6	434.2	38.7	339.3	229.9	84.8	228.8	148.8	33.1	60.5	108.6	398.5	491.8	41.1	196.4	209.2	187.5	310.8	241.9	259.6	61.8	6.5	174.7	203.4	278.4	228.3	365.7	343.8	209.0	229.2	218.8	262.7	11.8	5.5	309.0	107.8	453.6	930.9	347.0	72.7	614.2	273.9	30.0	250.6	101.2	94.7	10.1	6.8	183.4	345.1	60.9	831.8	293.4	233.1	68.9	110.3	78.0	78.9	350.3	217.4	47.4	35.4	372.2	572.0	270.4	499.8	126.0	205.7	401.1
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 180.8;lymphoid tissue: 156.4"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 132.9;Erythroid cells: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	22.9	14.2	56.4	50.2	61.7	180.8	32.0	51.4	70.4	17.4	45.8	45.3	38.7	29.7	13.1	31.2	25.6	18.2	17.0	48.8	50.5	13.7	26.3	23.0	82.4	58.5	59.8	37.0	24.1	15.1	8.9	35.0	55.1	20.4	50.8	10.6	21.3	22.2	25.7	44.9	41.3	32.3	55.1	29.4	27.4	49.4	55.6	156.4	20.4	28.5	88.5	21.6	11.9	60.8	310.1	359.5	399.9	306.7	28.7	35.5	214.4	195.7	165.5	374.9	407.7	281.9	335.2	469.2	184.6	112.0	321.6	252.5	439.3	241.6	303.9	238.6	498.1	274.7	251.9	248.9	18.9	553.6	226.2	30.1	43.4	306.9	179.6	61.8	154.0	295.1	542.2	444.6	200.8	786.2	940.1	442.9	361.9	295.2	236.4	572.5	517.7	651.6	92.3	221.5	253.4	397.0	264.9	294.3	104.9	217.9	126.2	314.4	81.0	198.1	346.7	379.8	411.1	200.3	311.8	875.0	135.9	463.1	354.3	3.7	4.0	4.3	14.1	7.5	10.9	9.1	10.3	13.2	9.3	15.0	11.2	10.5	1.4	15.9	13.3	11.3	17.2	11.6	56.4	61.7	51.4	70.4	48.8	50.5	58.5	59.8	55.1	55.1	55.6	60.8	23.2	9.6	17.9	6.2	34.5	46.7	28.5	25.7	37.0	9.4	30.8	36.3	9.6	11.5	13.3	3.7	14.6	132.9	32.5	42.3	9.8	28.2	54.7	11.8	16.3	23.8	17.4	173.6	4.0	26.2	102.7	22.8	40.8	19.8	24.1	67.3	10.4	10.3	40.4	6.7	4.0	48.8	18.3	10.4	22.2	32.0	21.1	17.6	19.6	3.7	14.1	11.1	18.6	12.1	11.7	16.7	22.8	15.4	59.8	20.8	19.0	11.5	18.0	12.5	13.1	30.7	46.0	90.0	79.8	41.3	35.4	72.0	29.4	14.9	79.0	22.9
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	30.5	14.2	9.1	16.7	10.5	10.0	26.1	12.9	11.9	23.8	9.7	25.9	13.3	26.7	10.8	25.0	23.7	12.1	18.2	9.4	10.4	16.1	18.6	24.9	18.9	11.3	10.2	22.2	17.0	16.1	11.0	25.3	11.5	15.2	16.6	12.3	20.5	13.7	30.1	25.6	19.6	18.3	11.5	19.5	20.3	11.8	9.9	20.7	17.5	15.9	19.7	25.1	24.1	12.4	54.4	28.6	49.6	40.3	24.0	27.1	27.0	49.2	55.9	62.2	63.3	42.5	32.9	69.7	20.3	34.8	20.7	46.8	65.1	46.8	74.1	46.0	50.3	34.7	20.8	38.3	35.7	71.3	80.6	24.1	25.8	47.4	60.7	27.6	38.9	37.5	35.3	43.9	41.7	28.5	77.4	52.6	33.3	34.7	26.5	49.8	104.0	30.8	29.0	30.0	25.0	28.7	32.9	33.1	39.3	33.0	20.4	50.2	34.3	26.5	24.1	29.8	56.3	36.1	37.7	71.1	35.5	46.1	16.2	9.8	2.3	1.4	2.0	4.2	2.0	2.0	2.0	1.9	3.2	0.9	2.0	2.2	3.0	1.8	2.5	1.5	1.9	1.1	9.1	10.5	12.9	11.9	9.4	10.4	11.3	10.2	11.5	11.5	9.9	12.4	39.0	16.0	16.5	11.8	26.2	42.8	35.0	12.3	24.5	11.4	18.1	14.2	18.6	25.8	15.6	20.2	4.2	40.5	35.4	23.7	13.7	11.7	4.6	18.8	31.7	38.3	10.8	25.0	14.0	13.7	52.6	27.4	12.2	26.2	18.3	18.2	26.7	25.6	38.5	32.0	17.3	20.8	12.2	35.5	35.0	6.2	30.1	35.9	23.2	15.0	34.2	18.3	26.8	17.6	25.3	15.8	11.9	22.6	28.0	32.8	15.6	18.7	12.5	18.3	19.7	32.8	27.4	42.5	68.7	29.9	42.8	39.7	31.6	12.7	29.1	29.1
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
MED10	"L6, MGC5309, NUT2, TRG20"	ENSG00000133398	"Mediator complex subunit 10"	Q9BTT4	5	6371874-6378571	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042795, HPA054188"			Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA042795: AB_10796679, HPA054188: AB_2682410"	"unprognostic (2.33e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.14e-1)"	26.3	20.6	33.3	22.3	34.8	55.5	23.8	32.5	39.2	19.0	28.6	35.5	19.6	20.3	24.1	27.0	19.9	20.5	31.3	36.5	38.7	21.9	22.7	20.4	35.5	33.8	35.2	20.5	27.1	22.2	18.2	20.9	37.4	21.0	12.6	8.5	21.6	22.3	34.0	27.0	23.9	20.2	33.8	23.4	24.4	17.6	36.1	26.7	20.0	20.2	22.8	26.4	22.3	36.1	55.0	59.8	23.5	43.9	36.3	40.2	66.7	67.9	61.1	70.6	51.7	91.4	43.5	70.8	53.3	57.5	101.7	40.3	40.7	50.3	63.6	116.6	46.6	47.0	94.0	46.5	111.9	56.7	39.8	46.1	65.1	66.7	95.4	43.6	57.5	39.9	69.8	41.3	55.3	68.7	84.2	86.2	40.2	38.0	154.4	47.6	41.6	29.6	48.6	57.3	44.7	66.3	128.8	53.1	106.2	29.2	36.9	50.6	63.5	70.6	77.7	65.5	73.5	65.5	70.1	102.4	63.4	89.5	53.8	127.4	42.3	94.6	75.0	47.1	92.6	98.2	93.9	81.8	36.5	88.6	101.7	85.7	31.6	76.1	52.0	67.5	93.1	109.2	33.3	34.8	32.5	39.2	36.5	38.7	33.8	35.2	37.4	33.8	36.1	36.1	108.3	22.4	21.7	11.1	96.7	92.0	87.8	142.0	58.1	68.0	49.8	68.8	46.9	34.3	56.3	46.0	29.2	81.9	116.2	38.6	58.7	103.2	5.5	43.5	50.5	74.7	44.2	46.3	28.3	92.0	78.5	67.9	35.2	50.8	51.4	58.0	75.7	23.0	64.5	74.0	18.8	56.2	95.6	30.7	61.9	11.8	70.2	44.4	62.2	13.1	96.9	55.1	133.9	12.5	21.0	148.4	52.2	45.1	72.5	108.0	68.7	51.9	53.1	49.1	32.9	51.1	71.5	63.7	83.8	53.4	70.5	79.4	105.8	68.0	45.8	88.6
MED19	LCMR1	ENSG00000156603	"Mediator complex subunit 19"	A0JLT2	11	57703714-57712323	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039912, HPA040860"	Uncertain		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"		"HPA039912: AB_10795262, HPA040860: AB_10794153"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.40e-1)"	"unprognostic (4.87e-3)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.38e-2)"	11.3	18.1	22.7	6.2	23.7	6.8	11.6	20.7	41.5	11.0	21.0	10.0	9.6	11.6	13.4	15.5	9.2	6.1	11.3	23.4	22.6	14.7	13.2	8.9	7.5	21.4	22.9	9.6	11.6	9.8	16.0	10.2	22.2	12.5	7.8	12.0	12.1	8.9	10.6	15.5	9.7	8.1	22.2	10.8	11.1	22.8	26.0	8.2	13.6	9.2	9.4	10.1	11.9	23.7	30.3	19.1	22.7	21.0	23.6	21.4	27.0	25.4	19.7	23.9	24.0	13.6	23.0	16.6	38.5	24.4	21.0	22.6	17.1	16.1	21.0	21.8	18.6	14.3	11.3	12.7	35.5	15.7	16.4	17.5	28.9	23.8	46.6	16.7	31.1	13.3	15.9	16.1	29.1	14.5	22.3	29.2	19.8	21.4	37.7	21.1	32.2	20.2	15.9	12.6	17.6	24.7	20.5	20.7	47.2	19.1	43.8	16.0	25.7	20.7	24.8	49.2	22.6	19.9	20.5	15.7	28.3	11.5	22.1	27.9	25.8	31.3	29.2	37.2	31.6	45.0	32.8	31.4	25.6	39.4	34.0	32.0	16.4	24.6	39.2	36.9	33.9	26.0	22.7	23.7	20.7	41.5	23.4	22.6	21.4	22.9	22.2	22.2	26.0	23.7	40.7	9.6	27.1	4.6	32.5	87.6	60.9	72.0	62.0	38.6	37.4	39.8	14.7	30.0	40.2	51.5	35.5	58.2	32.2	36.2	39.2	44.1	12.2	33.3	37.8	39.3	23.3	21.4	9.2	45.4	48.6	38.1	20.9	34.0	22.2	39.2	36.0	26.3	29.3	37.0	8.3	38.3	54.9	17.6	31.4	15.4	28.3	18.6	37.4	2.8	26.3	37.4	24.7	5.5	7.2	40.6	33.2	29.7	22.9	53.6	32.9	47.2	42.1	59.7	19.7	31.3	50.5	111.7	97.9	42.7	82.3	73.1	35.8	37.5	31.8	52.8
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500779	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 170.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 211.3;U-266/70: 193.0;U-266/84: 214.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	33.3	32.6	15.7	24.4	22.6	79.8	27.5	21.8	24.9	43.5	0.0	43.6	16.0	48.9	14.3	19.2	39.1	20.2	54.9	24.1	4.8	17.8	19.6	37.0	21.1	1.3	3.2	44.5	31.6	27.9	26.1	22.9	1.0	31.1	13.9	50.0	21.6	24.1	170.9	32.8	27.0	25.6	1.5	29.4	28.2	14.7	2.7	27.5	25.2	69.2	14.8	33.8	32.8	14.0	19.7	32.2	7.2	10.7	15.6	22.2	12.4	26.1	29.6	12.0	12.5	10.4	24.1	42.5	30.3	31.4	12.7	18.8	8.2	13.2	7.1	65.7	11.6	10.8	42.1	6.2	19.2	25.6	32.8	24.5	21.6	21.0	27.9	24.8	22.5	13.5	8.6	72.7	19.1	16.6	18.6	56.4	10.6	10.2	20.5	80.6	16.5	48.3	10.4	8.7	12.0	19.2	24.1	48.2	39.6	13.4	13.7	211.3	40.2	29.1	29.3	22.1	19.7	193.0	214.3	81.3	24.5	19.2	15.9	1.1	1.4	1.7	1.3	0.7	1.5	1.1	0.9	1.2	1.0	1.0	0.5	0.8	5.3	1.1	1.4	5.8	1.3	0.7	15.7	22.6	21.8	24.9	24.1	4.8	1.3	3.2	1.0	1.5	2.7	14.0	21.8	6.4	18.6	21.9	29.8	37.2	10.9	10.6	25.6	82.3	25.2	19.7	42.0	17.2	16.2	1.8	173.0	5.0	72.5	60.6	0.0	7.7	2.5	26.4	26.0	24.0	21.5	11.0	28.7	11.1	4.9	25.1	25.0	43.1	3.8	9.0	22.9	13.2	18.0	70.7	18.8	32.2	8.2	25.4	64.1	4.4	31.4	35.5	14.2	20.6	17.7	19.0	33.0	13.0	20.2	25.8	46.3	32.4	44.6	19.7	17.2	3.4	9.1	85.3	98.6	48.8	46.1	5.1	10.7	16.6	38.1	15.3	33.1	11.0	14.0	19.3
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772119	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	13.6	23.2	8.9	9.8	9.2	11.0	12.8	8.7	11.9	9.8	9.9	8.4	4.0	10.8	20.8	13.1	10.2	5.5	10.3	9.2	9.4	22.0	17.5	9.3	8.1	9.2	9.3	11.3	28.0	9.1	12.7	8.7	9.0	13.4	10.8	3.7	10.6	7.1	15.5	11.7	6.9	12.3	8.9	9.0	9.8	9.9	9.6	4.8	14.3	6.9	9.3	16.5	9.4	9.0	24.7	44.1	17.7	14.9	22.6	15.7	23.4	24.8	23.1	41.9	24.7	32.0	32.6	28.8	45.7	33.0	23.1	27.9	27.4	39.8	38.0	17.2	32.6	34.9	17.4	35.0	17.9	39.0	17.4	14.7	32.7	47.8	33.5	18.9	22.2	17.8	34.1	28.2	23.1	47.0	26.1	39.6	40.6	29.1	41.5	23.0	293.1	43.1	33.6	29.8	18.7	16.2	26.9	29.6	22.9	16.0	38.5	32.0	17.1	17.4	18.0	29.6	34.0	13.2	9.3	32.6	24.4	25.3	34.5	0.0	7.1	0.0	8.0	10.8	27.4	6.9	10.0	9.6	16.3	10.5	13.4	13.2	1.1	12.9	1.8	19.3	5.1	7.5	8.9	9.2	8.7	11.9	9.2	9.4	9.2	9.3	9.0	8.9	9.6	9.0	6.3	9.6	3.3	0.7	8.3	10.5	17.1	14.8	13.6	3.7	12.2	12.4	4.3	10.0	14.1	5.5	0.0	18.7	3.1	6.3	25.4	16.8	12.1	5.3	13.2	8.2	6.6	6.3	0.8	24.1	25.3	11.3	10.2	8.9	12.7	8.7	3.3	7.9	22.7	3.3	0.6	8.4	12.2	2.2	9.8	10.9	11.1	6.4	7.2	0.0	16.7	2.6	3.1	3.5	1.1	12.3	2.3	4.9	14.9	15.4	1.1	60.4	2.6	5.4	0.0	9.7	13.0	8.0	17.7	12.1	10.4	9.7	4.1	14.0	10.7	11.3
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989973-20997035	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.9	32.2	11.0	11.1	11.5	26.6	12.2	12.3	16.1	14.1	13.2	20.6	17.6	12.8	11.2	22.4	13.0	10.3	23.7	10.7	11.1	20.0	19.7	11.7	18.0	12.0	10.9	13.8	18.8	19.4	9.6	12.2	11.6	12.3	21.7	8.0	15.6	13.8	21.3	16.1	21.5	14.2	12.0	23.3	17.6	18.6	12.0	21.7	13.6	29.2	19.3	12.2	14.6	12.3	37.5	48.0	41.8	16.1	25.3	12.2	32.0	22.3	32.8	69.1	58.2	34.3	44.9	85.8	24.4	29.1	43.7	54.0	57.5	48.5	49.6	32.5	44.7	41.8	27.5	56.6	31.5	71.5	42.8	23.4	41.7	35.1	27.8	23.0	27.9	70.5	40.4	38.6	33.8	24.9	48.9	72.2	49.6	62.7	56.2	56.8	42.9	48.2	37.5	34.4	30.2	36.5	30.0	43.9	24.8	31.1	29.4	60.0	15.5	22.4	72.0	25.1	30.2	28.7	49.8	62.1	15.5	46.0	29.3	28.8	8.1	8.6	11.7	9.8	7.0	13.9	12.7	13.2	16.8	10.8	12.4	11.7	0.1	10.7	5.5	11.1	11.5	6.9	11.0	11.5	12.3	16.1	10.7	11.1	12.0	10.9	11.6	12.0	12.0	12.3	11.2	9.6	17.7	21.9	33.6	18.9	17.9	21.2	46.1	37.5	16.5	16.4	5.4	21.5	17.9	11.0	43.8	30.8	23.0	19.3	5.9	20.4	49.2	11.8	16.2	13.5	12.2	26.9	9.7	15.4	17.4	17.7	36.2	11.1	29.7	22.0	11.7	24.2	18.1	21.9	9.3	24.0	16.2	11.3	12.4	10.2	33.5	16.3	3.6	6.5	19.8	23.4	26.8	8.5	11.0	13.8	32.5	21.4	33.6	11.0	27.9	18.0	21.4	53.1	13.1	14.6	17.0	23.4	17.3	40.6	17.8	12.7	27.6	29.0	35.6	24.8
MGLL	"HU-K5, MAGL, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-128052190	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 84.7;plasmacytoid DC: 89.8"	"Group enriched"	"Detected in all"	14	"dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7"	"Cell line enhanced"	"Detected in many"		"BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	174.8	16.1	100.8	22.9	91.0	18.9	92.0	87.2	123.4	26.8	48.0	81.9	36.9	17.7	9.9	139.9	34.3	44.8	101.9	96.9	75.9	71.0	106.9	72.0	13.5	72.5	86.6	6.1	7.8	3.6	12.5	41.6	70.9	25.8	60.4	6.2	102.1	27.5	66.0	38.1	50.3	27.8	63.0	44.9	38.2	6.2	107.2	10.0	18.9	64.9	21.3	42.5	39.4	88.6	52.4	46.2	0.1	0.5	76.8	90.0	6.2	209.1	238.6	45.3	72.2	1.2	21.0	14.0	56.9	71.3	13.7	2.1	0.4	27.9	25.2	23.5	0.9	1.6	31.4	0.4	27.7	0.3	1.7	34.2	16.1	85.0	92.4	25.6	97.5	1.0	0.3	3.0	191.3	5.6	0.5	0.9	0.5	33.6	71.5	0.2	24.6	109.4	170.4	5.9	26.5	2.1	36.3	70.4	12.6	2.0	3.5	2.1	125.9	49.5	14.8	121.0	29.1	0.5	0.4	43.4	102.4	3.4	156.6	20.6	8.3	36.0	0.5	84.7	2.8	4.9	0.5	1.1	9.2	0.5	0.2	0.2	1.5	2.0	57.2	89.8	0.0	17.1	100.8	91.0	87.2	123.4	96.9	75.9	72.5	86.6	70.9	63.0	107.2	88.6	565.4	195.5	108.6	83.2	8.5	22.8	11.9	14.1	5.7	22.8	25.2	19.9	53.7	118.7	32.2	42.3	0.0	84.6	16.1	398.7	168.3	99.4	4.1	100.0	36.4	207.7	88.6	30.7	39.0	160.7	154.6	71.5	47.9	132.1	8.8	0.1	17.2	148.7	123.9	0.0	48.9	239.1	63.1	32.8	86.3	5.8	32.6	77.8	21.4	52.5	235.2	54.5	2.1	43.2	5.8	535.2	201.0	69.6	36.2	18.5	134.2	102.0	48.0	7.8	85.5	22.3	141.4	0.7	1.7	64.7	22.3	72.7	9.3	1.1	74.0	6.0
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467190-129770983	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 465.7;Proximal tubular cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 60.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	21.5	17.0	14.7	10.3	15.1	12.7	20.4	14.8	18.6	13.9	16.6	14.7	16.9	13.3	8.1	15.9	23.7	19.6	18.5	14.1	14.5	23.5	89.3	11.7	19.4	15.9	15.4	16.9	26.5	12.3	9.5	6.8	16.0	15.0	5.0	3.9	22.7	7.8	25.5	17.1	15.3	8.0	14.7	14.3	18.2	15.2	15.0	23.2	16.3	16.0	11.1	18.4	13.8	15.2	0.0	7.0	7.1	35.2	14.9	30.9	27.1	15.6	17.0	10.9	10.7	44.0	45.6	33.0	24.6	20.2	0.0	20.8	4.5	16.4	4.6	0.0	2.7	6.6	16.2	28.6	22.7	0.7	17.8	19.7	0.0	6.6	0.0	0.0	0.1	53.5	0.1	22.0	14.0	60.0	26.1	34.0	1.6	29.9	27.8	29.3	0.1	12.7	20.7	16.0	7.2	18.0	18.3	7.7	0.0	5.5	29.8	25.3	0.0	14.6	7.1	0.1	0.0	0.0	0.0	17.1	0.0	10.8	0.0	9.6	37.2	17.1	43.9	39.2	43.6	49.7	40.4	42.0	39.0	48.2	39.6	42.8	4.6	49.5	37.2	43.7	54.0	42.1	14.7	15.1	14.8	18.6	14.1	14.5	15.9	15.4	16.0	14.7	15.0	15.2	106.0	12.8	19.0	32.0	59.2	51.2	80.6	91.5	49.5	17.4	69.0	112.9	49.3	94.4	48.7	103.0	8.4	51.3	51.1	55.6	127.2	50.0	107.6	138.0	29.6	70.4	54.5	48.2	28.5	58.7	67.0	59.2	31.1	34.1	64.7	93.9	108.1	465.7	89.7	15.2	16.9	73.1	50.8	75.0	48.7	140.6	67.4	44.6	65.8	62.8	56.4	37.2	78.2	23.1	30.7	82.4	57.9	55.3	37.0	47.1	108.4	340.3	102.5	45.6	46.0	48.6	70.6	45.3	81.4	46.9	42.6	26.8	52.5	87.4	63.8	75.2
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA SH3 domain ER export factor 3"	Q5JRA6	1	222618097-222668007	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA055922, HPA056816"	Supported		Enhanced	Vesicles		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	25.6	22.0	11.0	23.4	13.1	33.2	21.4	12.9	14.9	23.9	13.2	24.3	23.9	23.7	29.2	13.7	16.0	20.6	20.6	10.9	13.6	21.1	74.5	21.5	26.9	10.8	12.3	25.4	38.7	30.1	15.2	23.1	11.7	39.3	29.5	24.4	33.2	22.1	23.7	17.4	25.9	23.8	10.7	27.3	45.0	36.5	11.5	25.7	31.7	20.5	26.2	21.0	14.1	12.8	24.8	18.8	26.5	42.5	92.8	47.1	46.5	34.8	49.4	36.2	43.1	16.6	26.2	24.0	33.0	41.8	20.5	39.9	28.5	31.3	37.8	38.1	21.6	27.7	21.5	31.5	88.6	50.7	34.7	45.2	35.0	35.9	60.8	44.8	41.4	28.9	34.8	44.4	30.7	15.9	34.3	33.8	33.2	76.8	27.5	24.4	70.8	47.8	23.1	22.8	30.4	31.3	38.6	36.2	30.4	36.2	38.2	37.5	31.7	27.5	17.9	44.5	41.3	48.4	30.9	23.8	36.7	25.4	37.5	26.8	15.6	36.5	17.6	22.4	17.7	20.7	14.7	17.5	11.7	18.6	16.4	17.8	27.1	22.5	26.0	13.2	19.2	13.5	11.0	13.1	12.9	14.9	10.9	13.6	10.8	12.3	11.7	10.7	11.5	12.8	48.5	70.5	49.6	31.3	46.9	18.7	26.8	20.4	29.0	60.9	24.3	35.3	65.0	25.8	47.1	5.5	31.3	28.6	73.8	35.2	0.0	25.1	37.0	34.9	72.5	36.4	60.4	26.3	51.4	34.8	17.0	53.0	79.5	42.0	17.7	44.2	25.4	63.3	20.4	45.4	58.0	95.3	32.6	22.0	14.0	24.9	37.0	32.9	19.6	35.6	32.1	31.8	44.3	41.2	29.1	26.4	25.8	48.9	54.4	39.0	41.3	19.4	44.7	41.5	19.7	57.9	46.6	55.7	42.1	21.9	16.1	35.8	47.8	70.2	24.6	29.4
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024561	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.5;Inhibitory neurons: 164.6;Oligodendrocytes: 216.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 104.9"	"Immune cell enriched"	"Detected in some"	4	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in all"		"WM-115: 131.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	15.9	12.0	18.3	14.9	20.3	17.3	11.2	104.9	34.5	16.5	3.6	28.1	11.0	31.0	17.0	19.6	38.6	13.4	35.6	14.3	13.7	10.9	18.8	8.3	23.0	13.2	6.4	26.5	14.0	38.5	7.2	16.7	15.6	16.4	20.6	14.1	10.9	19.8	48.2	18.9	14.5	37.3	1.9	17.8	10.7	24.4	12.7	6.0	14.7	20.8	20.3	15.9	12.0	45.9	34.0	39.6	20.2	33.7	15.6	19.2	25.6	32.6	33.1	43.6	34.5	36.1	4.8	35.1	15.5	39.3	51.2	38.7	30.1	31.9	43.0	35.6	25.2	35.9	44.6	11.9	9.6	17.1	20.2	14.4	25.9	46.9	43.7	25.2	24.9	9.7	47.6	22.8	16.9	26.6	16.9	10.7	13.0	27.3	26.4	23.2	30.3	1.9	32.1	24.8	53.5	21.1	40.6	26.0	65.2	31.5	10.8	7.0	43.9	46.0	28.4	29.7	63.6	16.4	30.2	50.8	40.0	7.7	131.6	11.1	0.0	0.1	0.3	0.0	0.6	2.5	0.3	0.3	0.0	2.6	0.2	0.1	0.1	0.9	0.0	0.2	0.7	0.2	18.3	20.3	104.9	34.5	14.3	13.7	13.2	6.4	15.6	1.9	12.7	45.9	19.6	3.2	10.2	57.1	32.1	11.2	15.2	17.9	13.1	20.9	13.7	15.5	16.5	12.8	13.2	12.9	52.1	14.1	6.2	43.5	0.0	23.9	10.5	36.4	10.2	16.4	10.2	19.3	176.5	9.8	40.3	10.5	13.3	38.8	19.0	9.7	8.9	37.3	3.1	1.7	164.6	20.8	8.2	3.2	9.6	13.9	4.1	4.2	8.8	23.4	6.0	38.2	5.2	71.9	216.0	24.6	23.6	6.4	12.5	14.4	19.8	5.5	27.8	12.2	0.0	11.0	12.1	19.8	13.8	11.2	11.8	11.2	9.1	24.2	21.5	10.1
MIDEAS	"C14orf117, C14orf43, ELMSAN1, LSR68"	ENSG00000156030	"Mitotic deacetylase associated SANT domain protein"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 59.4;Cardiomyocytes: 21.0;Cytotrophoblasts: 41.3;dendritic cells: 15.8;Extravillous trophoblasts: 32.5;Hofbauer cells: 25.8;Syncytiotrophoblasts: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	9.0	5.0	4.1	9.3	4.2	14.5	6.6	5.1	5.2	6.4	0.4	7.1	7.7	7.3	1.3	9.3	6.7	9.2	6.7	2.6	4.0	3.0	4.7	6.9	9.3	5.3	2.3	11.3	5.9	9.7	2.6	8.8	1.6	5.7	3.9	2.9	7.8	5.8	10.1	11.8	8.8	6.5	0.4	13.7	7.5	5.4	5.5	5.8	6.2	5.9	5.6	5.7	6.2	7.9	12.8	14.1	5.0	9.4	4.6	7.8	9.6	5.1	8.7	7.0	6.3	12.5	14.8	18.5	5.6	7.0	7.3	19.3	8.3	14.5	2.8	24.6	5.1	29.7	12.8	4.5	7.4	5.2	61.9	10.4	8.8	6.1	7.6	6.1	11.2	6.4	15.5	16.7	3.4	29.7	12.0	8.3	1.6	6.4	11.7	13.8	27.0	4.9	10.4	13.5	6.4	5.3	19.3	26.4	10.3	2.8	20.3	10.8	22.6	14.3	16.3	10.8	5.6	13.0	6.7	20.4	11.7	6.3	17.0	0.6	0.5	0.2	0.3	0.2	0.4	0.4	0.1	0.3	0.6	0.7	0.2	0.2	0.8	0.5	0.3	1.2	0.4	0.4	4.1	4.2	5.1	5.2	2.6	4.0	5.3	2.3	1.6	0.4	5.5	7.9	59.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	41.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	32.5	9.4	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	29.4	3.6	0.0	0.0	0.0
MIER1	"hMI-ER1, KIAA1610, MI-ER1"	ENSG00000198160	"MIER1 transcriptional regulator"	Q8N108	1	66924895-66988619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 97.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019589, HPA050306"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019589: AB_1853953, HPA050306: AB_2681080"	"unprognostic (3.38e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.44e-8)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.45e-2)"	18.6	20.8	10.7	18.4	12.4	97.9	16.5	12.8	13.8	19.7	10.4	27.5	15.5	18.7	13.5	16.6	13.1	18.8	11.4	8.9	11.6	16.2	24.6	16.3	20.7	11.4	10.8	20.7	9.1	12.3	7.8	20.2	12.1	14.4	23.5	18.9	11.3	17.1	8.2	12.6	16.1	17.9	11.0	20.0	18.8	18.2	10.9	24.4	14.1	13.1	19.6	18.5	11.8	14.8	29.7	16.8	20.4	36.8	41.9	27.2	22.7	30.3	33.5	29.7	32.1	13.7	17.7	29.8	11.1	34.3	26.7	19.2	24.9	33.1	42.5	34.6	19.3	65.2	44.0	21.8	33.2	52.5	36.9	28.2	24.5	33.3	34.3	34.5	32.9	35.6	34.6	25.6	35.6	9.4	76.0	18.8	29.2	13.4	10.8	32.7	49.1	20.4	25.5	32.6	12.0	23.7	45.5	27.9	29.8	19.3	14.4	34.2	39.7	34.5	24.2	33.7	28.4	31.8	31.6	42.5	28.1	22.5	21.2	43.7	10.9	26.8	18.5	12.4	21.5	11.2	16.4	16.5	8.6	13.1	16.6	16.3	37.1	15.8	20.8	11.7	15.1	8.7	10.7	12.4	12.8	13.8	8.9	11.6	11.4	10.8	12.1	11.0	10.9	14.8	77.4	16.0	45.7	40.8	65.7	48.3	40.5	37.3	51.2	37.7	45.9	44.7	32.9	35.8	35.0	27.6	25.0	41.6	92.1	125.7	45.0	36.8	55.3	54.3	56.8	54.7	42.1	50.1	50.6	40.6	26.8	62.8	34.1	70.6	92.4	48.9	40.4	50.3	22.2	40.4	48.6	54.6	34.6	45.6	38.3	49.3	81.4	56.1	14.2	46.9	69.8	68.7	86.5	40.7	83.8	54.1	77.7	93.3	48.1	52.4	41.3	34.1	35.2	48.5	78.9	64.7	77.5	53.0	62.9	42.0	34.7	34.3	97.1	35.7	53.5	60.4
MIER3	"DKFZp686L09111, DKFZp781I1119, FLJ35954"	ENSG00000155545	"MIER family member 3"	Q7Z3K6	5	56919602-56971675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Distal enterocytes: 128.8;Paneth cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058349, HPA065946"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA058349: AB_2683688, HPA065946: AB_2685583"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.31e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-3)"	6.8	6.8	4.5	7.4	5.7	11.0	8.8	12.7	6.4	8.0	4.4	30.6	22.8	10.1	8.8	6.3	7.4	6.3	5.1	3.7	5.2	7.5	11.1	5.2	8.5	4.9	4.9	11.7	8.2	12.5	4.7	6.9	5.2	8.1	22.0	16.9	5.9	6.6	6.3	6.5	15.5	9.1	4.7	6.8	7.2	15.8	4.6	10.0	9.1	10.7	7.9	7.5	6.0	8.1	10.0	14.2	19.5	36.9	12.8	10.0	26.9	9.2	11.9	17.1	19.0	22.9	8.3	10.7	10.8	10.8	15.6	12.3	24.9	9.8	18.3	5.7	11.4	9.2	17.6	11.0	9.6	12.6	18.3	11.7	12.2	12.7	10.6	10.5	11.3	13.0	12.2	17.9	10.0	11.0	19.3	14.5	15.5	4.5	8.3	31.9	18.4	11.1	8.2	19.7	16.2	25.8	28.0	10.2	14.2	15.5	14.8	12.0	10.9	4.9	15.2	8.8	16.8	11.1	16.0	26.7	9.3	9.6	10.9	0.2	0.9	1.6	1.1	1.6	1.6	1.3	0.9	2.0	1.3	1.3	1.5	1.1	0.8	1.5	1.2	1.6	0.9	1.3	4.5	5.7	12.7	6.4	3.7	5.2	4.9	4.9	5.2	4.7	4.6	8.1	7.7	16.0	5.4	14.0	7.8	13.5	4.7	4.6	13.1	8.0	11.1	5.8	8.2	11.5	6.7	3.7	14.6	3.9	8.5	128.8	5.9	4.0	15.4	12.0	13.6	7.5	12.0	1.7	11.5	5.9	3.6	8.8	5.1	15.5	4.5	8.3	7.5	9.1	4.1	10.1	12.1	17.4	10.2	5.5	10.7	8.5	5.9	6.2	1.8	14.0	8.6	7.1	5.2	17.6	18.1	7.1	78.7	8.6	9.0	9.4	18.1	6.1	5.9	13.9	13.1	10.8	10.7	11.3	6.0	6.6	9.8	6.8	8.4	4.8	14.0	8.0
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894383-23895227	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 2032.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 4974.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	No	13800000	5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	233.3	467.9	195.8	119.5	200.0	146.0	223.3	209.3	450.0	235.0	204.3	194.3	98.9	205.3	49.8	514.2	219.4	20.9	290.8	245.2	289.7	530.3	484.6	208.2	61.5	225.2	224.7	223.7	255.7	127.8	368.0	100.4	217.2	318.7	35.2	23.8	233.6	132.8	99.3	302.5	171.7	43.4	250.8	204.5	230.7	113.5	204.2	65.0	274.0	19.5	46.2	255.8	316.7	369.4	1698.3	605.3	122.2	499.0	58.9	111.3	590.7	581.2	154.7	298.9	382.1	526.4	364.4	761.3	499.8	83.1	115.2	788.1	155.0	546.8	51.5	642.2	4974.4	286.2	534.6	1126.5	225.3	1077.2	758.6	230.9	354.9	173.8	103.5	248.8	241.3	589.4	466.9	540.1	122.2	1476.0	827.0	2345.5	532.8	488.6	2365.8	1040.4	127.9	2398.8	294.7	179.6	1080.9	1290.4	380.3	531.9	1374.7	37.6	671.2	442.6	424.7	232.5	1227.9	127.3	9.9	1647.2	732.5	1020.9	967.5	484.6	477.9	484.2	543.5	443.5	872.4	579.5	1250.8	1527.9	1221.7	983.3	796.9	1378.9	1040.4	928.4	166.8	1158.9	383.3	977.1	1258.3	1803.3	195.8	200.0	209.3	450.0	245.2	289.7	225.2	224.7	217.2	250.8	204.2	369.4	161.2	157.0	199.4	21.5	433.4	672.2	295.5	1134.8	1027.2	28.3	856.0	778.2	0.3	479.0	489.1	693.4	2.1	462.7	171.3	317.9	1649.4	859.0	190.5	733.7	485.3	248.5	348.9	455.7	17.1	377.7	885.0	336.2	606.5	844.3	180.3	192.2	261.6	885.2	278.8	21.9	24.1	432.5	697.8	207.7	505.2	153.9	336.1	232.6	773.7	19.7	217.0	59.5	155.5	17.6	52.8	649.9	360.4	302.8	1337.1	269.8	476.8	2032.7	404.6	33.2	138.1	338.1	349.7	21.3	124.2	1511.3	758.8	686.0	386.3	227.6	473.0	256.1
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 98.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		220000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	13.8	13.0	24.9	8.2	49.9	7.2	15.0	42.7	33.7	19.0	30.9	18.4	16.8	18.1	7.0	37.1	17.4	14.0	33.5	22.2	30.7	30.4	19.0	12.9	6.4	58.7	43.9	21.7	47.6	30.1	15.1	6.8	53.4	14.3	17.2	13.3	29.6	13.7	16.7	20.6	14.8	15.6	33.3	15.1	25.9	23.6	43.1	3.6	47.3	18.0	8.7	15.0	20.1	75.6	11.3	7.3	7.7	10.8	13.4	11.1	6.4	3.6	9.1	5.0	7.9	15.6	26.3	0.7	8.4	4.7	1.5	5.5	6.1	6.8	2.2	8.6	9.2	11.0	13.8	13.5	3.0	3.3	4.3	9.1	5.9	9.0	2.5	16.8	12.9	3.8	7.0	27.5	5.3	17.4	0.6	7.4	3.5	3.5	2.5	8.3	1.4	34.8	23.4	22.1	13.1	9.7	6.9	12.4	7.4	3.6	49.5	11.1	12.0	4.3	5.5	2.2	3.1	10.1	9.9	37.5	10.2	7.2	20.4	98.4	9.3	56.2	0.4	4.1	0.3	0.8	3.5	1.0	11.5	1.5	5.8	2.0	85.4	4.7	2.8	1.7	4.8	9.9	24.9	49.9	42.7	33.7	22.2	30.7	58.7	43.9	53.4	33.3	43.1	75.6	4.5	9.6	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.8	5.8	0.0	0.0	3.7	3.7	0.0	3.8	1.4	0.0	39.2	11.6	0.0	3.4	3.7	3.7	0.0	0.0	0.0	7.0	0.8	2.9	0.0	4.5	3.8	6.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	12.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.8	5.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 72.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	9.4	5.4	9.3	5.7	9.6	3.8	6.6	15.0	10.4	7.0	8.9	5.4	3.5	7.1	4.6	7.1	6.8	6.3	10.8	8.0	11.6	10.1	3.5	7.7	4.1	10.5	11.0	6.8	3.3	7.3	4.9	9.0	10.0	8.9	3.9	16.3	4.9	6.1	3.4	7.1	3.6	8.5	9.2	6.1	4.8	3.9	11.2	5.9	9.6	8.9	3.7	8.0	5.2	10.3	10.9	5.3	7.3	4.4	10.7	19.7	11.5	9.8	20.8	3.0	4.3	8.4	5.4	5.6	10.5	11.8	5.3	10.3	13.4	7.9	4.6	5.6	4.9	7.8	5.7	7.6	6.6	5.9	6.9	8.7	12.9	3.5	8.0	11.3	7.4	5.9	13.7	6.1	7.1	1.4	7.4	4.4	15.7	1.4	2.7	3.3	21.0	6.0	8.9	12.1	6.7	4.9	7.1	10.0	17.9	15.3	3.0	12.5	8.7	4.2	3.7	72.5	4.3	5.4	8.3	5.4	9.4	9.5	10.2	3.0	0.7	1.3	1.1	0.6	2.1	0.9	1.0	1.3	0.2	1.6	0.8	1.2	1.4	0.8	1.4	1.1	0.9	0.5	9.3	9.6	15.0	10.4	8.0	11.6	10.5	11.0	10.0	9.2	11.2	10.3	65.2	147.4	39.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	43.8	44.8	0.0	0.0	18.0	82.8	0.0	65.2	27.5	0.0	46.9	44.4	0.0	66.4	46.8	19.8	0.0	0.0	0.0	21.2	108.7	21.7	0.0	73.2	11.4	11.6	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	32.4	0.0	0.0	7.5	0.0	0.0	14.2	28.4	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	53.2	11.3	17.6	0.0	0.0
MIOS	"FLJ20323, MIO, Sea4, Yulink"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566875-7608932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	10.0	9.5	7.0	15.2	6.6	18.8	14.5	12.1	8.7	12.3	26.8	11.3	8.8	9.9	10.4	22.9	10.8	9.9	11.9	5.7	9.3	12.6	17.3	11.7	22.4	6.7	7.4	13.3	17.3	28.1	8.9	11.6	6.1	21.7	13.0	18.8	13.5	11.2	85.5	18.1	9.3	12.2	6.7	15.3	13.4	19.2	7.2	16.2	9.3	51.1	29.9	13.9	14.3	8.2	42.4	18.8	21.8	26.4	17.1	35.9	18.3	32.9	26.8	20.6	20.6	23.2	16.5	37.1	9.9	19.7	55.3	37.6	23.1	24.2	27.0	14.8	19.5	9.5	22.5	16.1	24.3	40.1	10.2	30.9	29.0	18.3	46.2	20.1	18.2	12.4	47.2	29.4	88.0	29.1	9.2	17.0	45.3	21.3	19.8	27.4	33.4	36.3	19.0	21.3	23.0	37.2	17.7	49.1	19.3	40.5	26.7	35.1	15.7	31.3	33.2	17.4	27.7	25.9	30.9	33.2	27.6	23.0	37.2	0.0	5.4	8.8	4.3	9.9	3.6	10.1	4.6	4.2	7.6	8.8	6.0	4.9	0.6	5.4	5.0	4.5	5.1	4.0	7.0	6.6	12.1	8.7	5.7	9.3	6.7	7.4	6.1	6.7	7.2	8.2	8.2	9.6	11.9	18.6	30.3	12.1	14.8	6.6	15.4	8.2	13.2	10.8	18.2	12.8	9.2	7.3	12.5	16.8	12.2	9.0	17.6	11.7	38.5	22.7	11.4	7.5	4.2	15.6	22.9	17.5	8.7	9.3	16.3	18.6	9.5	15.4	6.8	17.0	15.5	11.8	21.0	7.2	4.1	22.7	12.2	57.9	5.9	18.4	7.2	27.2	10.1	9.4	13.4	23.1	18.2	14.1	11.3	7.5	19.4	24.9	6.7	11.3	11.0	17.0	13.1	13.1	9.3	36.0	30.4	24.8	18.9	21.2	15.3	15.3	11.1	19.7
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751112-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 196.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	1.3	0.0	0.3	12.1	0.3	0.0	0.9	0.5	0.4	4.4	0.1	95.5	171.0	0.7	0.0	0.3	9.8	11.3	0.0	0.4	0.3	8.8	0.1	9.3	0.1	0.5	0.5	0.3	1.7	0.0	8.1	1.2	0.5	5.6	48.4	0.0	1.0	0.5	0.0	0.6	196.6	3.3	0.2	0.0	22.9	0.5	0.3	0.3	0.1	0.0	0.0	9.0	0.6	0.2	30.4	121.4	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	42.1	44.2	10.8	11.5	0.0	0.1	90.2	0.0	37.7	0.0	0.0	0.1	0.0	47.0	13.3	0.0	0.0	1.9	0.0	82.6	0.3	4.5	0.0	0.0	0.0	0.0	0.4	0.2	63.2	0.1	0.7	0.1	76.9	24.6	0.2	0.4	1.0	30.1	33.7	1.4	0.4	42.9	134.3	0.1	0.1	29.3	0.0	0.0	0.0	14.8	1.8	0.2	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.4	0.4	0.3	0.5	0.5	0.5	0.2	0.3	0.2	0.1	38.5	8.0	0.3	2.9	0.1	4.5	22.5	0.0	0.0	4.7	2.3	0.5	10.0	39.7	11.0	0.0	0.6	0.0	793.4	1.9	39.9	0.6	40.5	1.5	0.8	58.0	0.0	0.2	46.0	6.0	2.4	56.6	14.3	8.9	0.0	0.0	0.0	0.1	0.0	0.3	230.9	28.5	0.0	0.0	0.9	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.2	157.7	646.7	0.0	0.1	41.6	1115.2	27.5	41.3	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.3	2.1	1.6	0.0	220.7	62.1
MITD1	LOC129531	ENSG00000158411	"Microtubule interacting and trafficking domain containing 1"	Q8WV92	2	99161427-99181058	"Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036162, HPA036163"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA036162: AB_10672236, HPA036163: AB_2674978"	"prognostic favorable (5.96e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.39e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.32e-11)"	"unprognostic (2.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.91e-2)"	"prognostic favorable (5.46e-8)"	17.9	16.8	12.3	25.1	12.9	13.2	17.1	12.3	15.5	17.2	11.8	17.5	15.4	16.8	14.3	17.9	15.8	12.7	13.6	11.9	12.9	18.7	17.3	14.2	36.5	13.0	12.7	17.0	11.7	9.1	11.0	16.6	12.9	13.5	20.0	22.1	13.5	11.9	10.7	15.8	19.1	17.0	12.4	22.3	17.4	7.0	12.7	27.0	15.1	11.2	29.1	16.8	16.2	13.7	58.0	15.3	30.5	11.8	35.1	45.2	41.9	27.1	37.8	37.2	50.3	18.8	47.6	40.0	30.4	22.2	84.9	43.0	30.0	29.9	61.7	57.2	20.6	35.4	22.3	40.4	52.2	60.2	20.1	35.9	25.4	32.6	31.2	34.3	42.4	37.8	29.6	24.1	34.0	13.8	57.8	88.5	25.8	37.1	30.0	32.4	43.8	34.7	47.2	32.1	10.0	14.7	26.5	24.3	35.0	52.8	12.9	47.1	32.1	23.0	30.2	24.3	34.1	28.2	23.6	55.5	41.7	50.2	23.4	19.2	24.7	18.2	17.5	22.8	19.7	30.6	24.8	20.8	22.0	28.4	23.6	19.3	28.0	26.0	21.8	29.8	23.1	12.8	12.3	12.9	12.3	15.5	11.9	12.9	13.0	12.7	12.9	12.4	12.7	13.7	31.0	25.6	19.9	22.9	51.2	18.9	30.3	78.2	22.2	13.4	19.5	22.9	12.3	31.5	41.6	35.0	14.6	48.2	39.1	28.1	45.0	46.9	18.8	28.2	34.8	33.1	15.7	27.3	18.3	61.2	34.9	27.6	19.9	24.7	30.4	20.2	30.0	31.2	51.0	11.8	16.9	25.5	40.7	24.5	22.3	6.2	51.0	31.0	23.2	11.2	50.5	26.2	40.2	15.6	38.4	57.3	33.5	39.5	23.3	20.2	32.9	63.4	34.5	55.4	39.5	22.4	24.4	14.4	15.5	20.0	17.5	22.6	42.4	26.4	27.5	19.6
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993350-37050846	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	15.6	17.9	7.3	17.4	8.0	22.1	15.4	7.1	9.1	17.4	7.6	17.4	12.0	16.3	14.0	14.3	14.9	11.1	35.4	6.9	8.3	16.0	19.1	15.8	21.9	8.6	7.4	15.1	16.6	22.4	22.7	14.8	7.6	16.2	14.5	9.6	12.1	14.0	49.1	13.4	13.4	19.2	7.1	18.8	15.5	25.4	7.7	28.4	19.2	42.2	24.3	17.2	14.0	9.0	37.1	56.7	66.7	0.2	25.9	34.5	30.7	54.7	44.4	64.1	62.3	43.4	40.1	92.2	25.0	44.1	33.6	24.7	65.2	45.8	68.5	42.2	32.1	68.1	42.3	54.9	23.2	81.9	40.5	28.4	29.0	54.8	57.8	21.9	37.6	55.0	86.0	32.0	66.2	27.6	81.0	22.2	49.4	38.4	31.6	4.6	90.6	40.2	35.1	39.3	14.2	36.1	52.1	56.9	32.7	33.3	79.9	55.6	28.8	46.0	50.5	44.0	65.9	29.1	93.7	88.1	37.8	71.9	45.7	12.6	12.5	15.1	12.7	22.6	9.8	11.3	7.7	11.4	14.3	9.7	8.4	9.6	2.6	7.8	29.2	5.9	15.0	11.0	7.3	8.0	7.1	9.1	6.9	8.3	8.6	7.4	7.6	7.1	7.7	9.0	10.8	25.6	15.8	22.9	18.5	7.1	12.4	18.7	7.4	18.5	9.6	9.7	41.8	12.8	15.8	11.0	10.4	33.4	16.0	6.1	19.6	14.6	31.3	12.5	11.3	10.7	5.4	19.0	18.5	14.7	26.9	14.4	12.2	9.5	7.6	13.0	13.6	14.9	20.1	3.3	21.6	8.6	16.2	16.3	8.9	13.2	11.1	13.8	8.8	10.3	18.2	15.9	11.3	27.2	31.3	9.3	7.4	13.9	22.1	6.4	5.3	12.9	16.5	18.1	13.1	10.0	14.0	58.6	29.3	9.3	5.5	20.0	15.9	14.8	8.4	6.5
MMS19	"CIAO4, hMMS19, MET18, MMS19L"	ENSG00000155229	"MMS19 homolog, cytosolic iron-sulfur assembly component"	Q96T76	10	97458324-97498794	"Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051936, HPA056299"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051936: AB_2681668, HPA056299: AB_2683091"	"unprognostic (8.57e-2)"	"unprognostic (2.38e-3)"	"unprognostic (9.34e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (4.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.39e-4)"	25.9	23.3	45.1	14.9	47.1	16.4	27.0	45.7	66.4	27.7	45.3	26.1	14.2	24.6	18.3	32.8	24.8	13.1	39.3	47.6	44.0	37.3	24.0	25.1	22.3	44.7	44.2	30.3	30.6	17.1	35.7	20.6	45.2	23.5	17.5	28.8	26.7	15.8	38.0	44.4	28.4	17.8	43.4	33.4	27.9	47.2	45.8	25.8	23.5	29.2	22.7	25.6	30.3	44.9	39.1	36.5	43.3	61.1	41.4	49.9	26.3	30.7	61.6	45.8	53.5	48.9	49.7	59.9	32.5	42.1	30.4	43.5	71.5	82.7	43.1	26.3	54.5	32.0	30.5	51.8	31.3	42.7	29.9	41.5	35.7	40.7	86.3	88.8	78.2	44.7	45.5	32.8	45.1	35.1	40.5	77.3	24.6	39.0	29.8	32.1	33.0	27.1	55.0	27.9	17.8	29.5	17.8	23.4	48.3	53.7	47.9	37.8	45.0	21.1	26.0	14.2	35.6	29.5	35.0	34.6	31.5	62.3	17.3	10.5	6.1	4.6	5.4	6.6	9.3	6.0	7.2	6.8	8.5	5.0	8.7	7.1	1.2	5.7	5.2	6.3	7.2	6.3	45.1	47.1	45.7	66.4	47.6	44.0	44.7	44.2	45.2	43.4	45.8	44.9	9.4	22.4	16.0	21.2	10.0	10.5	6.2	11.3	12.5	10.6	9.2	11.2	18.0	12.8	8.2	5.5	18.8	13.7	13.4	8.7	11.7	11.1	9.6	5.6	12.1	13.0	10.2	11.6	32.8	8.1	18.8	9.9	16.8	9.0	3.8	12.8	15.4	14.4	12.4	10.1	29.7	14.6	4.1	12.6	9.6	7.4	15.5	9.0	14.2	7.5	15.6	6.4	6.2	27.6	38.6	9.7	4.1	11.3	10.7	6.1	9.1	6.7	7.6	22.2	13.1	9.1	8.8	22.2	28.5	12.7	11.5	8.8	9.7	9.7	13.1	4.9
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1 component of CDK activating kinase"	P51948	14	60734742-60969965	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 365.2;Inhibitory neurons: 223.4;Oligodendrocyte precursor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212"	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	21.5	20.4	25.0	9.5	26.9	14.0	25.8	27.8	31.6	21.0	16.7	18.5	8.8	18.1	18.9	16.8	24.7	14.1	21.0	25.3	26.0	27.0	23.5	14.3	13.5	22.9	22.9	22.4	14.7	55.3	22.2	16.0	22.2	20.8	12.7	29.2	25.7	15.7	79.9	13.0	10.7	19.3	21.3	11.6	16.8	12.2	27.2	26.1	18.3	65.3	17.3	19.8	16.4	28.7	203.9	38.5	47.0	33.3	53.5	58.6	51.3	73.1	78.4	87.5	70.2	30.9	69.4	48.6	53.9	53.9	47.3	63.2	53.0	84.1	124.7	61.0	55.0	32.9	36.2	45.9	66.4	77.0	16.8	36.0	60.5	56.5	62.1	84.1	84.6	69.6	49.6	45.3	98.5	69.5	48.2	48.2	25.8	38.3	85.1	49.4	127.9	30.9	102.9	94.3	41.9	28.5	56.0	46.6	71.7	54.0	72.2	37.0	64.9	66.8	70.7	31.8	55.6	19.7	17.8	70.4	53.9	12.9	49.4	12.2	6.1	22.3	14.3	8.6	14.7	26.9	15.3	15.3	11.9	19.8	17.6	17.8	0.5	34.6	10.1	46.6	13.6	6.6	25.0	26.9	27.8	31.6	25.3	26.0	22.9	22.9	22.2	21.3	27.2	28.7	30.1	32.1	25.5	91.1	31.1	24.9	59.4	88.3	23.3	43.0	28.0	35.6	58.4	22.8	50.8	29.5	31.3	50.6	51.1	6.1	80.3	35.2	6.1	85.6	34.6	28.9	17.4	14.5	365.2	44.5	36.3	33.9	25.5	60.4	32.9	23.3	18.5	23.3	20.2	23.5	223.4	13.8	52.9	6.9	10.7	6.9	30.1	13.3	14.2	119.9	12.6	50.3	44.3	196.6	148.1	59.3	9.3	30.5	30.1	48.1	4.3	74.3	81.4	59.2	52.6	77.5	52.2	50.9	41.2	26.6	18.2	36.0	35.3	26.9	16.0	44.2
MNT	"bHLHd3, lncRNA-HAL, MAD6, MXD6, ROX"	ENSG00000070444	"MAX network transcriptional repressor"	Q99583	17	2384073-2401104	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059532, HPA067578"			Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA059532: AB_2684053, HPA067578: AB_2685864"	"unprognostic (3.72e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.98e-2)"	11.8	11.1	10.1	7.0	7.2	15.4	9.8	1.2	10.1	11.8	0.3	15.7	6.5	13.4	4.0	16.7	13.4	5.1	7.4	10.1	4.8	9.2	7.1	10.0	5.1	4.8	6.2	13.8	7.9	6.8	15.3	4.7	4.1	11.1	3.3	3.9	8.7	6.8	5.8	14.8	10.1	5.2	2.0	11.3	10.6	13.6	6.9	4.6	10.7	2.8	3.3	12.8	11.7	7.3	8.9	10.4	8.8	11.2	10.8	12.1	8.3	6.2	7.5	3.1	3.4	7.5	8.1	12.4	6.0	8.5	6.8	13.4	6.4	12.2	2.3	6.8	10.4	8.6	19.3	6.1	7.4	3.5	15.4	19.6	11.4	6.6	9.0	9.8	5.4	9.2	7.7	10.4	3.5	6.1	8.7	6.3	4.1	6.3	7.9	9.6	4.4	7.8	5.7	12.7	9.5	13.7	6.8	6.4	15.2	4.5	5.2	6.8	10.3	7.6	5.4	12.3	4.7	9.4	5.0	4.7	15.2	7.8	5.2	0.4	0.4	0.9	0.1	0.5	0.3	0.3	0.2	0.3	0.1	0.1	0.2	0.2	1.3	0.2	0.4	0.3	0.0	0.2	10.1	7.2	1.2	10.1	10.1	4.8	4.8	6.2	4.1	2.0	6.9	7.3	9.6	6.4	19.1	11.4	10.3	18.6	20.2	15.8	13.1	16.1	11.6	9.7	6.6	14.3	20.3	14.7	22.9	6.8	16.4	25.7	1.9	10.2	8.3	33.5	24.7	13.5	19.8	5.0	9.4	10.2	9.8	12.8	19.9	51.8	13.9	12.4	14.6	9.9	14.3	26.9	6.7	25.1	14.2	26.0	9.5	20.7	11.1	17.2	10.6	7.5	13.9	13.0	13.4	1.0	4.7	12.3	18.7	13.2	8.2	25.4	18.2	2.7	14.7	12.1	6.6	15.5	14.2	34.6	26.4	19.4	25.7	9.3	10.9	10.3	28.4	65.5
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;JURKAT: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	33.7	9.5	14.6	3.2	17.9	0.0	26.8	16.8	14.7	8.8	11.2	11.7	16.2	10.0	10.1	6.7	10.3	5.5	22.0	12.7	16.0	20.4	40.3	22.9	4.5	17.4	18.8	9.0	11.9	9.6	5.3	35.6	16.2	5.3	5.6	3.0	6.1	7.5	25.7	7.3	12.7	9.2	15.6	2.6	7.6	3.2	17.3	3.3	16.0	45.0	3.4	10.0	6.6	16.4	0.0	2.1	7.0	11.4	19.3	7.2	15.2	8.7	15.0	12.1	10.0	40.4	0.1	0.0	8.4	7.4	7.0	0.4	8.2	9.8	8.7	0.0	8.6	0.0	0.0	13.7	12.2	0.0	3.1	12.0	3.7	7.9	4.2	7.2	10.1	51.1	8.4	0.7	11.7	5.0	16.0	0.0	7.9	0.1	4.6	0.0	6.3	1.1	7.6	8.2	6.1	8.5	0.0	4.2	7.0	6.3	5.2	1.4	16.2	12.2	9.8	7.7	4.1	0.0	1.7	0.0	1.3	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.2	14.6	17.9	16.8	14.7	12.7	16.0	17.4	18.8	16.2	15.6	17.3	16.4	5.7	6.4	1.5	6.2	0.1	0.6	0.6	0.7	1.2	1.6	9.3	6.5	11.6	8.6	0.3	9.2	12.5	33.7	0.5	3.6	5.9	4.4	0.8	0.9	1.6	3.3	0.0	0.0	3.2	4.1	2.3	4.3	1.1	1.4	1.3	6.3	3.3	36.2	2.9	3.3	2.6	3.5	0.0	2.8	1.0	1.8	3.7	0.4	1.8	2.8	0.0	4.6	0.0	1.0	4.4	1.0	9.1	3.0	1.3	0.2	13.2	17.8	0.0	2.2	78.9	3.9	20.3	1.6	1.9	1.2	1.1	6.2	0.3	0.8	5.5	0.6
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	11.2	7.5	6.3	17.3	7.9	34.5	13.9	13.6	7.7	14.6	4.7	10.9	10.9	17.3	9.4	17.7	12.0	12.6	11.6	6.4	6.6	9.4	14.1	12.9	20.3	7.2	6.2	23.8	11.1	10.4	6.5	17.2	8.0	13.6	11.6	7.7	11.5	11.8	17.7	14.9	11.0	13.9	8.6	18.6	13.0	10.8	7.2	19.4	11.7	15.8	20.0	15.4	13.8	11.8	19.7	7.8	19.1	12.8	16.5	16.3	25.1	17.9	30.0	20.3	17.5	12.8	12.9	9.4	7.0	19.9	21.0	9.8	12.9	16.9	18.8	18.7	10.3	37.2	8.2	7.2	11.4	23.4	34.7	12.0	21.3	18.3	26.5	22.2	14.5	14.6	31.0	24.3	14.9	5.8	14.1	9.8	14.2	24.9	7.9	16.4	7.5	17.8	6.6	20.1	7.1	17.4	22.2	12.3	22.8	14.3	14.9	16.3	23.3	17.7	4.9	14.3	15.2	10.9	9.8	8.9	12.7	32.3	13.2	32.5	8.9	19.5	9.1	10.9	9.0	11.3	9.9	8.6	8.8	12.6	12.6	9.1	13.5	9.9	13.6	5.7	13.4	7.9	6.3	7.9	13.6	7.7	6.4	6.6	7.2	6.2	8.0	8.6	7.2	11.8	29.0	28.9	24.1	44.4	49.6	68.3	65.7	33.1	36.5	19.4	19.6	17.4	20.4	14.3	28.9	22.0	8.4	16.1	44.3	14.7	3.9	17.8	51.7	20.9	30.1	24.1	11.4	63.3	36.4	12.5	19.7	31.0	19.4	28.0	47.5	22.4	16.8	16.5	17.5	16.8	37.1	17.1	18.3	26.8	56.8	18.3	18.6	35.8	24.9	52.5	41.4	12.2	40.2	41.7	55.3	23.3	14.5	26.7	17.1	42.0	9.5	7.1	33.5	12.2	13.1	44.8	41.5	33.5	31.4	45.8	81.7	25.2	44.6	16.7	11.1	68.1
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000212	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 79.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	13.4	30.9	24.8	7.8	35.5	11.8	12.2	47.8	51.0	12.1	17.8	8.5	10.4	11.5	16.3	9.6	10.4	10.1	7.0	32.4	22.4	10.8	21.1	8.8	5.6	11.1	11.4	17.4	15.1	11.7	6.2	79.9	16.6	12.4	10.8	22.3	10.9	11.5	20.2	18.7	10.0	11.4	3.9	6.0	8.4	20.2	16.6	5.6	10.2	10.3	7.0	7.5	11.1	55.7	29.8	121.0	11.4	26.4	35.0	40.3	60.5	28.7	30.8	14.6	18.3	64.6	13.1	3.7	14.2	30.5	23.9	22.5	39.8	25.5	17.1	4.6	23.0	6.4	40.7	27.1	25.6	4.7	13.9	20.8	24.3	19.6	28.6	85.7	13.1	4.1	3.9	41.4	32.7	26.7	10.7	6.4	8.9	82.0	45.2	4.2	22.9	4.3	47.0	23.3	9.2	11.5	35.4	33.9	23.0	15.9	19.7	5.0	12.6	22.5	21.4	44.7	15.7	11.1	16.2	11.5	24.0	3.8	16.2	8.3	1.5	1.8	1.9	1.3	1.7	1.7	1.9	1.5	0.7	2.7	2.1	1.7	3.7	1.5	1.7	2.5	1.5	0.4	24.8	35.5	47.8	51.0	32.4	22.4	11.1	11.4	16.6	3.9	16.6	55.7	8.6	131.4	130.4	6.2	5.1	17.5	19.1	4.9	21.1	5.4	11.5	9.5	3.0	10.0	61.8	5.5	4.2	329.8	10.4	3.6	21.5	9.9	0.9	6.2	11.5	13.6	1.8	0.4	4.2	7.4	28.2	33.4	10.2	15.5	66.3	10.3	7.5	24.0	23.4	1.7	6.5	10.5	6.1	2.1	5.0	1.8	11.1	8.2	12.4	3.7	0.3	6.7	3.1	15.1	8.7	7.5	6.7	11.7	5.8	16.4	4.4	12.7	62.2	7.2	26.3	16.9	12.0	9.9	26.6	19.7	16.1	257.8	11.9	10.1	10.1	11.8
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA031872: AB_2674081, HPA054102: AB_2682379"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	142.9	184.7	173.9	97.3	180.9	99.0	179.3	156.9	261.5	249.3	183.1	113.4	89.5	262.5	217.7	121.1	209.8	129.2	138.4	180.9	210.1	130.2	204.9	132.6	72.5	170.8	180.3	358.2	137.2	137.2	198.8	242.6	191.2	161.9	140.1	94.1	121.2	191.6	175.6	103.9	99.6	328.5	166.9	90.6	118.0	90.1	183.6	79.3	159.2	130.7	109.6	172.1	143.1	179.1	404.7	257.2	372.6	167.3	541.7	388.2	486.6	533.0	479.4	437.1	462.2	259.6	369.5	289.1	401.4	533.5	522.0	272.0	477.1	406.9	535.6	120.9	219.0	157.5	413.9	308.9	602.7	212.2	141.6	449.6	351.2	380.8	489.6	389.2	478.9	142.2	249.5	383.0	551.5	403.7	188.0	207.6	355.5	512.0	322.3	186.9	340.9	292.1	456.5	221.4	347.3	275.5	425.7	310.1	418.5	385.2	203.3	198.1	433.8	263.2	171.2	459.1	289.3	179.3	221.3	241.2	472.1	420.1	403.8	54.1	40.9	32.9	41.2	44.0	46.9	37.0	38.9	38.2	41.8	32.3	41.7	37.0	16.1	46.0	47.3	70.2	36.1	40.3	173.9	180.9	156.9	261.5	180.9	210.1	170.8	180.3	191.2	166.9	183.6	179.1	102.5	125.0	160.1	39.8	75.8	363.5	572.5	292.0	75.1	46.9	198.6	103.6	130.1	123.0	242.0	110.3	10.4	443.3	106.2	103.2	246.5	269.1	46.9	231.7	235.5	146.6	178.6	68.5	109.6	129.9	1214.1	266.0	90.7	187.2	155.8	153.5	118.5	196.8	163.6	58.9	104.4	202.0	219.7	61.7	254.9	34.2	330.9	90.8	188.5	32.8	68.7	117.0	40.2	59.3	78.2	176.8	118.9	574.8	120.9	332.7	105.1	282.9	429.7	38.8	144.7	164.9	287.9	37.2	48.0	112.7	317.8	583.5	118.2	171.5	134.4	396.8
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130632-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	22.6	18.4	15.2	20.4	16.4	26.5	25.0	17.7	21.4	19.9	15.4	17.6	17.7	22.1	27.5	28.6	16.6	18.4	23.2	15.3	17.7	17.8	30.8	16.9	25.2	17.1	17.0	25.9	19.7	22.9	15.8	20.3	17.0	24.6	19.1	15.1	21.0	16.7	33.1	26.7	15.5	16.8	15.6	19.6	17.8	15.4	16.3	22.5	21.7	24.0	27.5	23.8	18.1	17.6	45.8	33.7	42.7	51.3	39.1	36.7	58.3	49.8	39.6	40.6	29.7	60.7	32.9	64.3	30.5	35.3	31.0	41.1	54.8	35.3	54.1	44.7	43.2	77.3	26.3	139.1	34.1	101.0	58.2	32.0	44.4	33.4	44.4	27.4	34.8	39.1	113.5	49.1	41.0	49.1	81.6	101.5	71.0	63.5	38.1	66.6	66.7	75.4	33.1	49.0	51.8	40.0	33.6	75.0	49.9	36.1	38.2	44.5	36.0	47.2	51.1	45.3	64.0	41.0	50.6	104.1	40.5	82.8	49.1	17.6	12.4	9.8	15.2	17.8	20.2	18.0	19.6	18.8	15.3	15.0	21.4	19.2	1.9	17.1	26.1	16.3	18.3	11.3	15.2	16.4	17.7	21.4	15.3	17.7	17.1	17.0	17.0	15.6	16.3	17.6	38.6	35.3	55.5	8.1	36.8	33.4	42.7	37.8	30.7	37.2	26.0	36.8	44.5	30.0	53.0	18.4	4.2	50.5	47.7	17.9	25.4	47.8	6.0	40.4	52.4	40.4	18.0	26.9	9.8	41.8	48.1	43.2	19.9	65.4	48.1	31.2	21.8	33.2	27.2	18.5	11.4	21.6	26.4	17.7	20.8	6.3	48.7	19.0	12.4	15.0	39.2	25.5	47.4	12.1	15.9	33.1	15.0	43.6	25.6	40.6	14.2	22.7	29.2	53.2	39.5	62.2	49.1	70.2	84.5	35.6	33.5	32.4	39.9	42.8	28.2	31.9
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415570-94493885	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Cytotrophoblasts: 39.2;Granulosa cells: 34.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	9.1	6.1	3.4	11.7	3.7	22.6	13.9	6.8	3.4	8.8	6.0	7.6	6.8	11.7	8.9	7.1	7.9	7.3	5.0	3.3	3.5	6.0	6.4	7.7	12.6	5.1	4.4	11.1	7.5	5.6	3.1	12.1	3.8	9.3	11.5	6.3	7.8	7.3	5.0	15.6	7.7	9.9	4.0	12.7	7.3	8.3	4.4	14.3	7.4	5.4	16.1	8.5	7.4	6.7	21.5	21.5	39.9	5.0	13.1	18.2	22.8	29.4	19.0	25.9	30.6	39.4	43.3	55.8	47.0	15.3	32.5	40.1	33.7	22.1	34.1	37.5	20.0	48.7	31.5	22.7	6.0	32.7	33.6	12.8	13.4	33.7	21.0	11.7	23.0	26.8	34.9	35.6	20.9	15.5	33.2	30.5	13.0	49.3	23.3	29.0	35.3	28.1	16.8	29.6	14.1	19.8	40.6	26.0	8.6	33.2	43.4	19.3	16.9	38.7	28.6	33.9	21.5	8.8	33.2	54.4	10.4	50.3	31.5	5.7	8.0	6.5	8.2	10.0	8.3	6.4	6.0	8.9	11.6	6.9	5.1	8.4	3.8	8.6	8.4	8.7	8.8	6.7	3.4	3.7	6.8	3.4	3.3	3.5	5.1	4.4	3.8	4.0	4.4	6.7	23.6	28.9	14.3	0.0	6.3	0.0	0.0	0.0	0.0	0.0	12.5	13.7	0.0	0.0	9.3	9.2	0.0	39.2	20.8	0.0	3.9	11.4	0.0	19.5	22.2	8.4	0.0	0.0	0.0	8.1	15.8	8.9	0.0	16.3	17.7	34.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	8.8	0.0	0.0	6.1	0.0	0.0	6.5	11.7	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	28.0	7.2	16.8	0.0	0.0
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831541	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	32.1	32.8	35.6	14.4	36.6	24.7	29.7	36.9	39.7	30.1	33.2	40.9	25.6	31.4	22.8	27.1	29.8	21.9	58.1	34.9	36.7	31.2	29.9	20.1	26.2	36.5	36.0	48.8	41.0	28.9	17.3	23.2	36.2	24.8	23.1	21.7	22.1	25.5	64.2	23.8	26.7	26.5	35.7	28.2	36.2	20.1	37.4	25.9	23.1	52.4	26.9	37.9	25.4	36.8	36.8	80.0	33.4	33.0	78.3	71.3	61.6	32.2	54.0	54.2	46.4	155.7	49.2	59.1	71.9	42.0	36.0	33.6	48.3	62.6	48.0	57.6	76.4	47.2	41.7	110.0	67.4	42.8	25.5	80.8	53.2	64.4	90.7	63.7	52.9	58.4	64.8	56.6	42.3	73.3	43.2	55.0	55.1	64.0	76.5	34.7	63.7	66.5	59.9	35.8	39.2	63.2	23.9	26.9	68.7	62.9	81.2	45.5	32.3	47.5	39.0	32.3	45.1	100.1	82.4	48.0	41.4	32.3	32.4	29.8	37.3	18.5	61.6	39.6	59.1	31.8	42.4	55.3	43.0	36.6	35.6	42.2	14.5	26.6	32.9	26.0	52.5	42.0	35.6	36.6	36.9	39.7	34.9	36.7	36.5	36.0	36.2	35.7	37.4	36.8	17.1	6.4	13.6	4.2	19.2	12.5	20.8	42.5	27.9	15.3	25.3	31.5	31.5	20.0	19.5	14.7	6.2	90.5	50.9	17.9	46.9	43.8	22.0	7.9	16.3	21.7	8.5	30.3	5.4	54.7	60.0	23.3	20.4	11.0	8.8	31.8	20.7	15.6	41.7	32.0	6.6	20.7	32.6	31.4	10.8	30.5	24.5	17.3	16.0	2.8	31.8	24.4	44.3	7.1	8.2	40.4	14.7	24.0	22.8	18.4	30.8	47.5	6.1	13.7	6.6	17.5	28.0	23.2	29.2	24.1	12.5	77.3	48.5	49.4	31.9	18.8
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 8.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 35.7;Daudi: 80.9;K-562: 57.0;REH: 43.2;RPMI-8226: 34.4;RT4: 33.9;U-266/84: 52.1;U-698: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	24.0	26.7	1.5	2.2	1.9	1.9	24.1	1.6	8.4	21.1	2.2	24.6	0.0	21.4	0.0	25.3	19.8	4.0	32.1	1.6	1.6	26.0	30.7	15.2	8.0	1.7	1.6	28.3	36.8	9.0	13.1	1.7	1.7	18.0	5.7	1.3	22.4	0.0	61.8	26.5	19.6	0.7	1.5	16.3	30.0	9.5	1.6	2.6	18.2	0.0	6.9	22.1	20.1	1.6	0.0	0.5	35.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	26.8	80.9	0.2	0.0	24.2	0.5	0.2	0.0	0.1	0.0	0.3	31.1	0.0	2.1	12.7	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	57.0	0.0	0.2	0.0	23.1	0.0	0.3	0.1	0.0	43.2	0.2	34.4	0.0	33.9	0.1	0.2	0.2	0.6	0.2	0.1	0.1	0.2	0.5	15.1	0.1	0.0	0.3	23.2	52.1	56.9	0.1	0.0	0.4	0.6	6.7	2.2	5.3	8.2	6.4	7.6	7.7	4.1	11.3	6.8	9.8	6.6	0.2	9.8	2.3	4.8	6.6	6.3	1.5	1.9	1.6	8.4	1.6	1.6	1.7	1.6	1.7	1.5	1.6	1.6	20.4	12.8	12.1	6.8	23.8	30.2	39.3	54.6	42.7	10.9	41.3	37.7	46.5	32.9	23.9	25.8	8.4	69.3	16.3	11.3	60.7	41.5	18.3	21.6	25.6	26.9	16.3	45.9	10.4	37.5	67.7	25.1	24.5	21.1	23.5	31.4	22.5	30.4	42.6	16.8	12.0	27.4	34.6	39.1	21.1	15.0	20.8	22.2	19.6	1.9	43.8	13.0	22.6	7.5	9.2	29.6	15.5	16.6	23.7	28.8	32.0	64.0	21.6	11.1	6.6	28.4	25.2	30.6	18.0	31.9	32.4	71.1	19.3	42.6	41.8	33.3
MRPS36	"DC47, MRP-S36"	ENSG00000134056	"Mitochondrial ribosomal protein S36"	P82909	5	69217760-69230158	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 546.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035802, HPA056795"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA035802: AB_10600933, HPA056795: AB_2683237"	"unprognostic (1.19e-1)"	"unprognostic (6.78e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.84e-3)"	20.3	18.4	20.1	12.7	20.3	21.0	16.5	21.3	26.3	12.7	20.2	23.6	24.1	12.8	15.4	20.3	12.7	10.4	67.3	20.1	21.5	49.2	38.0	14.7	15.1	20.3	20.6	12.4	14.7	31.3	9.8	13.0	20.6	14.4	24.3	18.9	13.7	12.1	47.0	12.6	24.0	12.4	20.3	11.6	21.8	8.6	20.8	15.7	17.2	67.7	16.7	16.6	14.0	20.5	29.2	27.6	19.1	26.4	32.8	33.1	50.3	25.6	24.5	32.1	39.4	38.6	31.8	31.2	51.9	21.8	71.8	29.3	32.1	38.8	31.7	36.8	33.6	21.3	31.4	43.4	38.7	22.9	27.9	34.6	27.3	30.7	14.5	33.4	24.0	31.9	25.7	22.9	28.7	31.8	35.3	34.9	14.2	26.8	31.9	20.6	33.2	47.9	56.4	32.5	26.6	25.9	26.2	37.9	46.3	30.9	29.0	32.9	17.6	14.3	24.5	32.0	44.5	23.9	41.9	41.6	25.0	42.1	19.1	36.3	22.1	29.3	22.7	32.0	25.4	31.1	25.7	25.8	27.9	25.0	22.8	24.7	25.1	26.5	30.2	27.4	40.3	17.7	20.1	20.3	21.3	26.3	20.1	21.5	20.3	20.6	20.6	20.3	20.8	20.5	64.5	115.4	83.6	16.3	76.5	81.4	101.1	204.0	83.1	26.3	72.4	109.3	333.1	97.2	104.3	88.3	14.6	126.8	67.5	220.5	401.1	118.4	127.7	123.3	79.5	57.2	92.8	97.2	20.4	139.5	192.4	68.6	67.2	113.0	56.4	41.4	52.1	216.1	127.1	28.6	21.4	162.8	120.1	102.4	67.5	45.2	64.7	72.9	106.7	10.3	142.0	61.8	56.7	10.6	17.1	137.1	190.1	69.2	60.5	100.5	256.6	546.3	86.4	45.9	72.3	78.7	92.3	66.1	37.9	86.9	76.9	123.3	64.2	76.9	168.1	114.6
MSL1	"DKFZp686P24239, hMSL1, MSL-1"	ENSG00000188895	"MSL complex subunit 1"	Q68DK7	17	40121971-40136917	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 8.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 358.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022800, HPA023567"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA022800: AB_1853057, HPA023567: AB_1853059"	"unprognostic (1.94e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (2.92e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.61e-2)"	60.2	52.0	34.3	48.0	33.6	56.7	56.7	26.1	39.6	76.6	16.1	62.7	51.7	75.1	55.9	48.1	77.5	38.6	46.8	32.1	26.5	57.1	43.9	61.5	50.8	24.1	25.7	58.3	59.3	47.8	78.8	48.5	22.2	59.8	46.8	41.1	56.5	51.9	63.6	60.8	61.6	53.7	21.8	88.2	57.1	66.2	27.9	62.3	79.8	51.6	51.6	53.3	62.0	27.7	35.9	42.2	88.3	57.9	78.5	67.6	45.0	61.6	65.3	76.1	68.4	42.4	37.8	78.8	45.6	65.0	48.4	65.2	74.7	40.5	78.2	68.0	59.6	43.6	60.5	50.6	40.9	59.7	81.6	56.9	63.6	56.1	46.5	77.4	71.0	47.2	69.3	62.8	61.4	22.8	95.0	64.8	37.6	39.4	27.2	77.1	48.7	72.1	55.4	38.9	80.9	48.0	57.5	358.8	46.5	80.1	83.5	81.0	58.7	51.0	56.4	37.8	52.3	98.5	58.5	77.7	52.0	43.7	60.7	0.0	1.0	0.8	1.7	0.6	0.8	1.1	0.9	1.3	0.7	0.9	0.9	0.8	8.7	0.7	0.8	1.4	0.6	0.5	34.3	33.6	26.1	39.6	32.1	26.5	24.1	25.7	22.2	21.8	27.9	27.7	44.1	28.9	40.7	42.7	22.7	50.0	37.8	21.7	69.4	55.2	41.6	32.3	29.5	25.8	25.8	11.0	12.5	15.4	43.8	36.4	3.9	17.2	16.1	35.8	53.9	43.3	31.2	22.3	39.8	20.7	15.4	37.4	20.4	48.1	3.8	24.8	36.4	35.9	25.2	52.2	33.4	29.1	8.2	36.4	42.8	28.5	58.4	34.2	32.0	33.7	30.6	31.3	30.9	25.1	32.4	24.7	32.1	39.9	26.8	72.7	35.4	9.0	32.7	28.4	39.5	29.2	40.7	71.8	49.2	57.5	65.8	17.0	29.9	27.5	31.4	58.7
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 337.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		130000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	213.3	83.3	66.6	259.8	71.4	269.8	144.6	80.0	70.9	113.9	79.6	116.0	43.9	155.8	45.0	87.9	110.0	123.1	130.2	64.8	95.9	139.7	91.8	281.5	207.5	101.9	79.6	91.9	41.0	39.2	48.2	150.6	98.8	72.5	78.4	24.0	76.0	126.6	56.2	100.7	96.6	251.6	91.8	200.0	78.4	21.9	87.3	177.0	152.5	75.7	242.2	154.8	98.0	95.5	298.3	223.2	214.0	177.9	250.6	328.9	1.9	733.9	472.2	397.3	305.5	0.6	50.9	247.7	638.8	654.4	210.3	199.4	228.5	523.4	514.1	461.7	63.0	687.5	355.0	0.6	236.0	845.3	1063.8	248.1	110.7	733.1	641.5	384.2	892.3	338.5	339.5	747.1	638.4	0.6	503.0	631.0	266.1	0.3	418.9	259.8	384.0	189.0	426.5	0.2	1.7	0.8	590.6	4.4	231.5	239.7	2.7	453.8	1426.9	449.5	285.3	613.2	494.6	268.6	438.4	262.5	328.9	1053.3	513.0	219.9	312.4	194.0	214.8	359.3	160.4	91.9	116.9	170.6	225.3	76.9	78.3	121.9	334.3	177.5	460.3	31.9	97.0	673.8	66.6	71.4	80.0	70.9	64.8	95.9	101.9	79.6	98.8	91.8	87.3	95.5	243.4	179.5	163.0	19.9	140.8	205.5	62.2	56.5	38.7	0.7	27.9	30.9	27.5	11.5	45.4	68.0	4.2	6.0	227.3	7.5	29.4	177.3	1.4	35.7	64.9	256.2	0.0	71.9	2.2	170.0	16.0	85.7	16.3	62.9	164.6	22.6	100.3	51.2	167.2	5.0	3.8	3.2	2.0	255.3	206.2	5.3	73.7	251.9	69.4	67.5	291.9	43.6	337.8	7.1	14.7	327.7	3.3	109.4	105.7	102.2	0.0	113.6	25.6	2.4	72.3	85.0	131.0	1.9	3.6	24.3	149.5	4.2	206.9	24.4	2.2	54.0
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MSTO1	"FLJ10504, LST005, misato, MST"	ENSG00000125459	"Misato mitochondrial distribution and morphology regulator 1"	Q9BUK6	1	155610205-155614951	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1482.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005899, HPA005914, HPA006075"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA005899: AB_2667460, HPA005914: AB_2667466, HPA006075: "	"unprognostic (1.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.28e-1)"	18.5	18.2	7.9	10.2	8.2	7.3	18.9	9.0	9.4	18.0	7.6	11.7	8.7	16.1	18.0	14.7	16.7	7.2	14.1	9.0	8.8	17.8	31.7	12.7	11.5	10.0	9.4	17.0	25.1	14.9	24.3	8.6	10.3	20.7	9.0	7.8	14.4	14.8	6.8	11.9	15.7	11.8	7.9	21.2	14.6	23.1	10.0	8.6	18.5	4.7	10.7	15.9	12.8	8.4	23.0	31.1	26.7	41.1	21.9	18.5	33.3	28.8	24.5	35.1	27.9	30.8	14.3	39.5	26.1	25.9	22.6	24.7	40.2	38.8	24.2	15.3	33.6	34.1	29.5	17.8	34.8	36.7	26.4	19.2	19.4	38.8	55.7	15.6	29.2	28.5	28.4	17.3	29.3	37.7	24.7	24.9	35.4	38.6	40.8	21.2	25.0	35.4	29.6	23.1	22.0	26.7	20.2	60.6	26.3	31.2	33.5	49.2	19.5	22.2	24.3	24.0	44.9	36.4	33.8	29.3	25.0	35.6	30.9	3.5	5.9	0.4	10.0	8.3	11.2	7.4	9.4	9.1	8.4	5.5	9.8	6.2	0.7	9.6	5.5	8.4	7.5	6.8	7.9	8.2	9.0	9.4	9.0	8.8	10.0	9.4	10.3	7.9	10.0	8.4	4.6	6.4	6.0	3.9	8.8	2.7	6.1	8.6	5.2	9.1	6.6	4.4	9.7	2.8	7.2	7.3	22.9	7.9	5.8	2.9	3.9	9.6	324.5	4.2	8.2	6.1	5.4	3.8	2.0	13.4	23.7	6.3	12.8	4.7	14.5	9.5	2.2	7.1	8.7	11.8	2.1	4.9	2.0	2.6	3.5	1482.8	9.0	5.5	3.6	1.0	6.3	4.6	3.1	2.5	2.2	8.0	0.9	11.3	17.0	5.5	2.8	9.9	10.9	9.7	0.0	6.7	6.4	23.0	12.6	6.3	1.4	6.6	7.2	7.1	4.6	2.8
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.1	23.8	24.1	10.8	23.4	15.4	24.6	23.7	31.0	31.7	19.4	31.2	13.1	29.9	11.6	22.6	31.8	6.2	39.2	24.1	20.1	24.7	24.1	19.6	12.1	22.2	21.5	38.6	30.1	9.4	36.9	9.2	20.1	31.8	5.6	8.3	23.6	12.7	25.6	21.1	22.1	9.0	20.0	26.7	22.5	37.6	22.5	16.5	30.4	7.7	9.1	29.2	24.4	22.3	33.6	26.3	47.9	48.2	18.0	30.5	42.3	26.2	19.9	25.4	24.3	34.4	44.1	65.4	26.7	19.3	17.9	45.3	35.1	25.0	17.1	43.2	59.0	34.1	25.2	35.5	39.6	43.2	25.3	34.4	30.9	18.0	41.1	35.5	36.4	48.0	39.3	27.7	13.4	60.4	78.3	85.2	69.1	47.7	55.1	73.1	29.1	21.5	20.6	26.0	76.9	80.1	35.5	40.5	40.8	24.3	36.7	40.7	26.6	20.4	21.6	34.1	27.8	55.9	28.9	41.3	25.6	28.7	36.6	0.1	0.2	0.8	0.3	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.3	0.4	0.0	0.4	0.1	0.9	0.2	0.2	24.1	23.4	23.7	31.0	24.1	20.1	22.2	21.5	20.1	20.0	22.5	22.3	32.1	3.2	16.0	37.9	20.9	15.6	28.8	14.6	13.1	0.0	64.8	38.6	9.2	27.1	15.2	35.0	0.0	11.6	17.7	17.2	17.6	13.2	32.8	25.0	28.4	20.4	18.6	25.4	17.2	19.6	8.0	21.8	28.1	23.9	5.7	47.6	18.2	15.5	11.0	0.0	16.1	21.6	10.2	18.5	13.5	11.3	36.1	15.7	12.4	21.5	13.8	0.0	20.6	32.6	27.0	16.3	11.5	32.0	17.8	45.4	18.5	8.8	27.0	0.0	19.7	30.5	25.4	21.5	13.3	16.8	19.0	9.3	18.7	27.1	24.9	46.2
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	41.6	34.4	44.4	46.2	46.7	60.7	35.7	45.7	45.3	40.2	38.2	40.0	31.0	37.2	28.7	79.3	33.4	32.6	29.7	44.3	44.1	31.9	30.3	37.8	70.1	49.0	46.1	37.8	23.0	30.2	31.8	39.1	49.4	37.0	47.4	119.8	37.3	36.7	21.2	74.7	40.1	43.8	46.1	60.7	33.9	30.4	45.8	90.2	26.8	24.1	91.8	51.7	47.2	52.7	97.1	83.4	129.8	171.1	57.0	53.2	88.8	80.0	112.3	157.5	114.7	79.7	82.7	137.0	84.0	106.3	84.3	127.2	177.2	222.1	132.8	136.4	87.9	146.4	91.2	81.0	88.3	167.2	180.0	59.6	122.6	111.3	164.1	74.8	148.3	140.4	164.2	106.1	114.6	189.0	213.9	212.1	112.3	91.7	95.1	201.5	92.4	160.6	112.1	143.4	102.9	94.2	83.5	118.2	67.6	102.4	138.9	113.2	104.5	87.9	80.4	100.4	94.0	78.3	109.4	191.8	64.4	120.4	86.9	7.3	7.2	9.9	18.6	12.6	15.6	13.9	15.2	13.5	11.8	10.0	14.0	14.3	3.1	12.1	16.4	13.8	13.5	6.7	44.4	46.7	45.7	45.3	44.3	44.1	49.0	46.1	49.4	46.1	45.8	52.7	22.9	3.2	3.9	2.3	16.9	13.4	4.2	4.2	34.1	0.0	11.3	7.9	3.7	1.5	4.9	1.8	0.0	15.3	16.5	12.1	5.9	5.1	0.8	5.2	10.0	12.0	12.0	20.8	1.5	9.5	8.3	8.6	15.3	9.5	10.8	7.5	13.2	8.2	8.9	0.0	1.6	11.9	4.1	12.8	7.6	0.7	5.0	8.9	1.8	2.8	8.9	0.0	9.2	2.0	2.7	9.7	8.2	4.1	24.1	4.2	6.6	2.7	0.9	0.0	0.0	8.2	11.7	5.9	5.2	32.5	11.2	18.9	18.1	13.6	12.2	4.5
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644184-97730260	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	53.3	41.4	18.6	56.0	26.7	109.9	39.0	26.2	24.5	52.6	27.2	51.3	51.2	50.1	33.7	52.2	41.1	41.2	35.7	17.2	21.2	40.8	89.6	40.7	59.3	28.3	23.2	50.7	30.4	53.4	13.4	28.9	28.6	44.7	47.5	44.8	29.3	41.4	60.2	27.0	52.2	62.5	25.9	41.6	48.1	39.6	23.3	65.9	62.7	50.6	61.0	56.3	22.7	37.1	191.5	96.4	61.1	84.7	97.3	102.7	30.7	167.8	139.0	104.2	79.4	59.9	137.0	173.5	181.5	164.6	114.1	121.6	150.3	115.2	143.6	189.5	79.9	320.0	97.5	69.6	118.2	170.5	142.4	78.6	109.3	128.1	282.2	97.3	119.3	126.2	215.5	300.2	108.4	77.6	286.0	43.2	38.9	160.9	113.0	187.2	73.0	255.4	64.5	108.6	92.3	69.2	118.3	101.3	132.0	58.6	158.0	105.1	126.8	146.7	52.7	135.8	123.6	166.1	196.4	174.5	134.3	194.5	130.9	57.0	71.5	38.1	35.7	49.2	49.7	71.6	51.1	52.8	87.0	51.4	51.9	45.7	10.1	51.4	54.6	112.2	33.3	31.9	18.6	26.7	26.2	24.5	17.2	21.2	28.3	23.2	28.6	25.9	23.3	37.1	185.1	128.2	109.2	69.2	294.6	261.7	233.0	178.9	194.1	0.0	166.1	150.7	109.9	201.6	146.1	141.6	0.0	10.0	231.7	140.5	25.4	230.9	267.4	156.0	269.9	185.1	121.8	205.7	96.4	231.7	98.6	227.2	156.5	178.5	137.1	183.1	164.6	438.0	267.5	0.0	97.0	249.9	146.5	258.7	273.9	163.5	195.4	266.5	184.9	86.2	258.2	0.0	195.7	110.6	141.8	241.8	137.8	216.3	675.9	374.7	160.8	99.2	87.2	0.0	223.5	237.8	334.5	162.1	129.6	249.8	314.8	13.7	200.3	285.6	251.6	315.0
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139079	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 117.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	5.5	6.5	5.6	10.4	6.2	23.5	9.3	10.0	7.9	7.5	5.0	7.5	7.6	8.1	7.3	5.7	6.7	6.2	4.4	5.7	5.7	7.4	6.7	7.2	20.1	4.9	5.0	10.1	5.4	5.5	5.8	12.3	5.2	5.5	7.6	8.8	5.2	4.1	7.2	7.5	7.9	5.9	5.3	11.5	6.8	16.9	5.8	29.2	7.1	5.9	18.8	6.7	6.6	6.5	20.8	9.8	33.7	22.8	5.7	5.5	38.8	12.8	10.3	21.9	27.3	17.3	11.0	66.9	23.3	8.2	19.2	10.4	31.1	13.4	32.5	25.8	22.7	45.7	15.7	22.4	8.5	61.4	19.4	7.0	7.2	21.2	12.4	10.1	21.3	50.9	53.2	20.0	13.9	9.2	88.1	49.5	57.4	8.9	13.0	70.4	40.8	17.9	20.5	22.1	20.8	24.8	21.1	25.1	26.5	34.8	15.2	42.1	12.1	14.7	21.4	14.1	19.8	15.3	19.2	117.7	2.8	35.4	9.8	9.1	7.3	11.8	7.9	8.1	9.3	7.2	8.3	10.3	9.4	8.6	9.8	8.9	5.4	10.6	5.1	8.7	10.1	4.9	5.6	6.2	10.0	7.9	5.7	5.7	4.9	5.0	5.2	5.3	5.8	6.5	36.4	28.9	29.7	52.2	53.8	46.5	28.5	37.0	26.2	0.0	33.2	25.0	13.6	18.6	32.6	38.6	0.0	68.3	64.5	26.2	7.9	33.8	5.0	24.7	29.2	40.2	32.2	51.6	70.3	19.3	67.4	23.9	23.4	36.0	60.1	56.4	43.5	15.0	34.1	0.0	58.0	31.1	40.7	27.4	54.0	7.4	32.6	34.5	17.8	54.4	50.4	0.0	90.6	68.9	68.1	30.9	28.5	23.7	39.6	41.2	39.2	15.5	21.0	0.0	39.5	24.2	39.4	125.5	89.3	24.1	43.2	60.7	54.0	45.8	33.7	48.1
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 365.5;Late spermatids: 792.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	9.9	15.2	4.4	6.2	6.1	4.9	10.0	4.7	6.9	9.8	4.6	11.3	12.4	8.4	12.0	10.2	6.3	6.6	7.6	4.3	4.9	31.8	34.9	5.9	4.7	5.2	5.5	6.2	8.8	11.6	3.9	7.6	5.1	7.3	12.0	34.0	8.4	8.5	9.7	8.2	12.5	9.5	4.5	4.0	14.7	19.7	5.3	4.6	11.5	7.3	6.8	8.9	7.6	6.6	34.3	25.1	19.7	22.7	25.7	25.6	15.7	22.3	20.3	26.8	27.9	21.5	34.5	19.0	7.0	21.7	26.6	21.9	44.3	30.0	35.6	6.9	24.0	23.6	16.8	43.1	32.7	6.2	10.9	17.5	31.1	34.7	107.9	15.2	33.1	13.8	32.8	19.0	30.8	30.9	21.1	14.2	20.5	74.9	22.5	10.7	26.9	15.9	32.5	30.2	8.6	12.9	21.9	36.7	29.6	19.6	40.5	13.3	25.8	15.9	22.4	38.8	19.6	18.4	12.9	13.6	19.8	25.0	21.6	1.3	0.8	0.3	0.5	0.6	0.7	0.4	0.7	0.6	0.8	0.3	0.6	0.7	0.2	0.2	0.3	0.5	0.7	0.4	4.4	6.1	4.7	6.9	4.3	4.9	5.2	5.5	5.1	4.5	5.3	6.6	6.8	19.2	9.8	5.9	6.1	16.8	12.3	13.5	10.2	0.0	9.7	4.8	7.4	18.6	12.2	11.0	0.0	25.0	6.9	11.9	56.7	22.6	365.5	7.5	10.0	10.0	4.8	12.6	13.1	24.1	29.0	10.1	14.3	8.2	5.1	9.2	8.9	39.9	9.7	0.0	16.4	12.6	20.3	6.3	7.0	792.9	16.8	6.5	14.2	11.2	3.8	0.0	4.1	18.6	42.4	20.0	9.6	12.0	10.7	20.6	20.0	112.7	16.1	0.0	6.6	7.5	13.1	93.0	35.9	18.4	19.5	39.1	4.5	20.6	15.7	16.6
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"		14	64388031-64463457	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in all"	6	"liver: 356.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 142.9;Proximal tubular cells: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998"	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	56.4	18.0	8.6	20.0	17.4	27.0	29.8	8.3	12.3	16.9	15.0	23.3	19.7	16.1	9.9	25.1	16.0	13.1	28.1	12.9	8.1	55.3	356.9	15.4	23.6	7.5	7.8	24.9	23.8	27.5	9.2	13.3	7.0	12.9	27.5	3.6	15.6	13.8	64.1	17.1	18.9	20.0	7.2	14.5	17.9	4.7	8.9	30.2	20.5	61.9	27.7	18.6	16.6	8.3	294.1	164.9	58.5	143.6	70.5	53.4	95.7	106.4	83.3	148.1	147.4	161.2	144.2	103.3	49.6	67.1	68.3	146.0	177.6	111.2	160.4	107.3	117.9	122.2	143.5	131.8	50.6	104.5	81.2	43.0	37.3	124.3	66.4	57.5	93.1	98.1	108.5	98.7	114.7	270.1	179.9	62.3	118.0	186.5	160.4	138.3	201.2	114.4	110.5	160.9	128.7	49.0	183.7	111.4	58.3	54.0	164.4	58.6	51.5	115.1	184.1	102.2	134.2	58.8	65.6	177.9	107.4	125.2	134.8	0.4	11.7	0.1	9.7	19.5	13.0	27.0	10.1	12.3	17.7	15.3	7.8	10.7	0.9	17.8	16.7	4.0	19.5	12.2	8.6	17.4	8.3	12.3	12.9	8.1	7.5	7.8	7.0	7.2	8.9	8.3	8.1	19.2	23.5	15.0	16.2	13.8	14.2	14.7	13.6	0.0	9.8	8.1	43.9	15.7	19.5	16.5	0.0	30.6	10.8	7.9	41.1	16.9	1.4	6.8	11.7	12.3	3.0	42.3	19.5	10.3	30.9	14.9	15.3	8.7	50.7	27.2	12.8	142.9	25.3	0.0	15.6	14.3	2.0	13.0	11.0	1.5	13.1	12.3	14.2	8.4	13.3	0.0	8.2	14.1	10.9	11.7	6.3	13.2	24.1	10.2	8.2	75.3	11.5	0.0	19.7	13.1	19.3	0.9	8.9	19.5	10.7	9.9	16.6	21.4	24.6	12.7
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865679-151101887	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Extravillous trophoblasts: 166.5;Granulosa cells: 86.9;Microglial cells: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA		89000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	12.5	12.2	7.1	11.4	6.7	13.2	7.9	25.1	7.4	7.1	8.3	7.4	3.2	8.4	6.2	6.7	7.1	5.9	11.5	6.4	9.8	12.7	5.6	19.5	11.1	11.5	10.1	14.6	10.7	6.8	9.2	14.3	11.0	5.5	7.9	7.5	3.2	7.0	1.3	6.0	5.2	10.0	11.6	9.2	6.0	9.9	8.4	8.6	10.9	0.5	10.8	12.8	4.2	15.4	40.6	35.1	44.9	110.0	11.5	40.0	108.4	63.0	68.3	62.1	75.7	71.8	37.4	152.3	41.1	96.9	36.8	42.7	72.4	61.8	76.8	63.4	65.3	62.7	60.4	66.1	72.4	115.7	9.8	47.7	76.9	60.6	109.8	55.5	105.5	81.6	150.9	76.2	65.0	86.1	57.1	23.9	45.5	40.7	32.1	67.2	33.2	67.1	42.1	19.6	44.1	32.5	83.9	36.7	53.0	40.6	11.5	79.5	80.6	41.4	90.6	91.9	90.5	62.3	63.5	154.0	68.8	105.7	54.0	0.0	0.2	0.0	0.2	0.3	0.4	0.2	0.6	0.7	1.1	0.3	0.5	0.6	0.0	0.3	0.3	0.5	1.8	0.2	7.1	6.7	25.1	7.4	6.4	9.8	11.5	10.1	11.0	11.6	8.4	15.4	6.9	0.0	1.7	47.7	6.9	6.5	8.0	15.7	1.8	0.0	3.3	4.1	2.4	1.5	9.8	14.7	0.0	25.8	1.4	2.6	7.9	9.0	44.9	11.3	18.4	10.7	1.2	5.0	84.0	18.1	166.5	14.4	8.2	22.2	0.0	86.9	6.1	1.7	24.9	0.0	73.8	3.0	46.8	3.0	13.3	6.2	0.6	13.8	35.6	126.5	2.4	0.0	2.1	60.8	59.3	19.2	1.4	7.9	14.0	31.3	0.9	15.2	5.3	0.0	0.0	8.7	13.1	0.5	6.8	2.3	3.4	73.6	4.0	42.9	4.0	35.1
MTIF2	IF-2mt	ENSG00000085760	"Mitochondrial translational initiation factor 2"	P46199	2	55236595-55269347	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006021, HPA061422"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA006021: AB_2147687, HPA061422: AB_2684514"	"unprognostic (2.91e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.86e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.85e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.33e-1)"	17.5	18.2	14.8	16.7	16.6	14.2	19.6	17.0	18.0	14.4	19.1	27.7	27.2	10.8	17.8	18.7	13.0	11.6	31.9	15.0	17.4	24.8	33.0	12.3	20.6	16.8	16.1	11.4	26.7	24.2	10.9	13.4	17.0	14.4	31.5	15.5	18.5	14.0	44.2	16.1	22.0	12.4	16.4	17.4	20.7	12.2	16.8	16.8	20.5	48.8	20.3	15.0	13.2	18.1	42.4	39.8	23.2	40.2	27.8	37.7	53.1	37.8	29.9	35.5	30.9	48.0	39.8	69.1	69.6	34.5	39.7	36.7	55.2	54.5	58.3	77.1	42.6	63.3	30.9	89.4	53.4	101.6	36.4	41.7	54.9	49.1	101.9	31.4	29.1	37.8	114.4	38.4	37.0	35.2	31.5	68.2	49.3	52.2	48.5	32.7	74.3	67.1	34.4	36.8	41.3	26.2	33.7	54.8	71.0	27.8	28.9	33.6	28.5	37.0	42.5	44.6	62.8	71.3	68.3	18.8	39.3	74.3	29.7	5.6	10.3	9.7	9.0	12.7	11.7	7.5	9.2	8.6	13.5	9.5	11.2	11.5	4.0	16.7	10.8	6.6	12.2	6.8	14.8	16.6	17.0	18.0	15.0	17.4	16.8	16.1	17.0	16.4	16.8	18.1	10.9	22.4	23.6	9.8	16.6	7.6	19.1	18.8	13.6	0.0	15.5	14.2	80.7	22.8	16.9	7.3	0.0	32.1	22.2	18.7	29.4	33.6	16.9	24.0	17.6	13.5	19.2	22.1	8.9	33.5	31.1	14.0	17.3	15.6	21.5	26.7	10.4	29.9	23.8	0.0	9.7	19.3	18.3	25.1	7.0	18.2	9.0	19.0	8.8	12.2	35.5	0.0	21.6	8.5	13.6	29.8	15.3	10.5	21.5	11.8	26.3	25.7	22.5	0.0	6.6	14.0	20.6	30.1	17.8	20.3	7.4	16.3	13.3	29.0	33.3	15.1
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	52.9	39.0	65.6	13.4	100.4	0.3	45.0	97.4	81.7	34.5	59.3	36.6	32.6	31.4	22.6	38.0	28.7	37.9	85.6	66.0	76.9	26.2	56.8	40.4	9.0	106.4	90.8	51.4	98.2	65.2	22.9	70.0	104.2	31.9	39.1	56.9	49.9	24.7	106.2	26.0	33.4	38.2	75.7	16.1	42.2	12.2	87.6	22.8	27.3	167.4	14.5	35.8	31.0	151.1	21.9	115.7	18.5	100.1	0.1	0.6	33.2	1.1	7.8	0.6	2.3	8.7	7.8	2.8	8.5	0.0	4.8	22.2	30.8	10.9	1.1	15.8	13.2	0.0	19.2	55.8	6.6	0.0	0.4	9.1	16.4	2.4	33.3	0.0	296.8	7.7	0.0	43.3	0.1	5.7	4.4	5.7	26.5	44.1	2.9	0.1	17.0	11.5	5.9	44.4	9.2	2.2	14.8	26.6	84.7	11.0	19.2	0.3	61.4	0.1	24.0	0.1	0.2	5.9	3.5	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	65.6	100.4	97.4	81.7	66.0	76.9	106.4	90.8	104.2	75.7	87.6	151.1	408.9	70.5	281.0	139.1	2.9	21.0	56.4	38.9	58.1	0.0	42.7	31.6	141.6	55.8	88.4	20.2	0.0	23.8	1.6	58.5	11.7	50.1	18.5	71.4	53.8	154.5	15.0	0.0	6.1	174.2	40.0	83.8	94.8	144.2	9.5	7.6	29.3	71.2	58.2	0.0	81.8	47.3	22.4	4.1	16.1	24.5	76.4	9.0	28.4	174.3	2.7	0.0	2.1	39.2	469.2	56.5	19.1	57.2	15.3	77.9	52.4	10.4	49.4	0.0	19.7	69.7	60.1	2.4	8.3	45.3	20.3	54.0	7.1	79.8	49.3	81.3
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 663.8"									"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	189.2	244.3	111.9	53.4	175.1	13.5	133.5	114.5	136.5	149.4	263.7	310.7	37.5	268.3	208.8	157.0	181.0	103.6	526.4	123.4	118.4	83.0	29.9	124.9	31.8	130.3	122.7	185.4	90.3	235.7	48.8	102.8	125.3	154.3	76.1	514.6	62.0	314.8	68.8	73.0	89.4	284.4	122.1	149.7	124.0	115.7	115.4	44.6	272.1	75.9	33.3	250.5	123.1	120.4	19.1	56.1	82.4	155.3	424.0	384.4	41.0	263.8	212.8	188.8	182.8	75.1	2.9	0.5	116.8	368.0	196.8	75.7	92.5	146.5	306.4	1.4	91.7	48.7	39.2	126.8	258.4	22.9	5.9	241.1	171.2	219.3	178.7	421.8	282.0	12.3	35.2	1.2	440.8	5.3	2.9	15.9	26.5	30.0	156.7	43.2	322.2	16.5	153.1	4.8	28.8	207.3	78.5	1.0	152.6	231.6	51.5	29.3	348.5	422.7	90.1	174.3	282.6	24.5	4.9	1.4	663.8	9.9	62.5	1.3	2.8	0.5	4.0	0.8	3.1	2.3	2.1	4.5	2.1	0.4	1.3	2.9	1.1	5.4	0.3	2.4	0.5	3.4	111.9	175.1	114.5	136.5	123.4	118.4	130.3	122.7	125.3	122.1	115.4	120.4	128.3	16.0	14.6	8.5	2.0	10.3	27.0	15.0	13.6	142.0	9.4	42.5	117.3	2.8	10.3	31.3	95.9	1.4	62.6	1.3	1.9	25.5	3.5	48.7	203.7	56.1	6.7	0.8	19.3	4.1	8.1	97.2	2.0	63.9	2.5	64.7	52.5	4.2	3.5	111.0	27.9	7.5	10.2	5.0	13.3	12.4	101.2	7.4	14.2	10.3	1.3	365.7	6.2	15.1	8.9	6.5	0.3	143.3	11.0	21.2	1.6	8.1	10.2	163.8	13.1	132.1	83.6	2.3	10.7	6.0	8.8	0.8	19.7	218.5	1.5	21.1
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127742951	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 254.6;skin 1: 289.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1013.3;Basal prostatic cells: 1080.5;Basal squamous epithelial cells: 1270.8;Squamous epithelial cells: 768.8;Suprabasal keratinocytes: 1070.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 1069.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691"	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (4.96e-5)"	254.6	59.8	2.6	62.3	2.2	53.7	115.8	3.7	3.3	54.4	3.0	57.9	30.6	53.8	3.8	99.5	167.5	83.3	45.5	2.3	6.3	20.0	64.9	47.0	49.4	9.2	5.0	100.0	103.1	7.0	12.3	33.4	6.0	32.7	36.8	0.7	42.2	14.1	50.6	289.1	48.6	54.8	4.5	60.1	70.6	12.5	5.5	47.2	27.0	15.7	39.2	63.2	96.3	4.4	56.8	89.3	9.3	100.9	166.6	209.8	28.4	72.2	31.6	87.5	72.7	137.0	150.2	587.3	86.4	43.0	82.4	122.2	383.8	226.5	67.8	128.9	167.0	370.7	189.5	203.6	150.0	282.0	52.0	138.8	560.4	55.5	490.8	74.8	104.3	217.3	549.8	315.5	49.7	151.9	394.4	616.9	27.4	273.2	204.0	203.7	46.1	1069.6	79.2	61.9	660.7	64.9	32.6	270.7	195.9	17.5	106.4	172.2	120.5	63.4	71.6	49.7	87.2	5.5	8.7	275.9	55.3	286.2	30.8	3.0	39.5	0.7	31.5	36.0	161.5	92.0	114.3	67.4	33.5	71.4	195.2	128.0	4.1	85.5	26.9	1.4	95.6	88.9	2.6	2.2	3.7	3.3	2.3	6.3	9.2	5.0	6.0	4.5	5.5	4.4	218.0	57.7	70.4	0.7	108.0	1013.3	1080.5	278.9	1270.8	0.6	251.3	207.3	10.9	44.3	98.4	12.9	0.0	20.6	20.9	23.0	1.9	78.3	1.0	43.9	224.5	158.0	12.5	189.1	1.6	43.6	61.2	337.9	46.4	72.0	57.0	47.6	141.0	25.8	26.9	0.0	1.1	67.8	97.6	43.7	133.1	3.9	98.8	23.3	168.9	1.0	17.0	1.4	5.2	0.0	0.2	66.5	40.4	67.4	45.7	364.8	4.8	13.3	21.5	0.3	46.0	458.5	349.1	0.6	0.6	768.8	1070.1	5.9	75.0	56.0	117.7	409.4
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 67.8;skin 1: 41.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 34.9;Hepatocytes: 24.3;Intestinal goblet cells: 25.0;monocytes: 27.4;Squamous epithelial cells: 34.2;Urothelial cells: 27.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 17.3;intermediate monocyte: 8.2;myeloid DC: 18.7;plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	72	"dendritic cells: 22.8;monocytes: 17.3"	"Group enriched"	"Detected in many"	7	"U-266/70: 444.0;U-266/84: 364.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.8	0.3	1.8	4.7	2.0	0.6	3.3	1.2	2.0	5.2	1.8	6.1	4.8	0.9	7.2	22.1	3.1	1.5	0.5	2.2	1.7	1.5	11.4	3.3	6.4	1.5	1.5	0.3	67.8	0.3	2.9	6.7	1.6	4.2	6.7	0.2	6.4	7.5	0.5	41.5	5.7	1.1	1.9	7.6	6.2	1.3	2.0	6.5	5.3	0.5	9.5	15.9	12.8	1.6	1.2	0.4	14.4	3.5	0.2	0.1	31.8	0.5	0.2	1.0	0.7	0.4	0.8	2.2	1.4	0.1	0.4	3.3	10.4	2.7	0.8	2.0	4.9	0.5	0.3	0.5	0.4	0.3	7.5	1.0	12.1	0.4	1.3	0.2	1.2	5.4	3.2	0.4	0.6	1.2	0.2	0.3	13.4	2.2	0.4	1.3	15.5	2.9	1.1	58.0	2.5	3.1	1.4	2.1	0.8	5.5	3.7	18.7	0.0	0.0	4.6	6.2	0.5	444.0	364.6	1.0	0.1	2.3	0.3	0.0	17.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.2	0.0	3.4	22.8	0.0	6.7	1.8	2.0	1.2	2.0	2.2	1.7	1.5	1.5	1.6	1.9	2.0	1.6	0.4	0.0	1.1	0.0	0.8	6.6	10.0	2.1	13.1	0.4	3.8	6.0	3.7	0.0	5.5	9.2	0.0	34.9	20.1	13.4	0.0	1.5	0.1	5.1	0.6	0.5	17.3	0.0	0.2	5.8	15.4	0.9	5.1	6.3	0.0	0.0	1.4	24.3	5.1	0.0	0.3	25.0	8.2	8.3	13.1	0.4	0.0	10.6	1.8	0.0	27.4	0.8	0.0	1.0	0.0	2.9	6.5	0.0	3.6	5.3	6.4	0.1	4.9	0.1	0.0	1.4	0.7	0.0	1.2	34.2	11.8	17.5	0.3	0.0	10.8	27.1
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	172.9	38.6	5.0	109.1	17.2	0.2	78.4	5.5	14.5	372.3	11.1	3322.6	95.4	1074.6	219.7	759.7	606.1	250.6	74.8	5.3	5.2	27.9	9.2	108.9	9.5	9.0	7.0	144.0	10.7	2.8	11.6	68.2	7.1	762.7	293.2	0.4	83.3	1665.5	41.2	68.5	487.4	1053.2	5.8	46.0	832.5	60.9	7.2	2.9	46.0	34.6	5.3	2048.3	314.2	6.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	17.2	5.5	14.5	5.3	5.2	9.0	7.0	7.1	5.8	7.2	6.3	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495636-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	7.8	5.5	2.3	7.1	2.6	13.1	8.0	2.3	3.0	11.3	3.5	11.7	13.0	7.3	5.2	22.1	7.5	4.9	5.6	2.3	2.4	13.5	11.1	7.8	5.7	3.0	2.4	6.8	13.2	17.0	9.5	6.4	3.2	7.9	14.6	2.1	15.4	3.9	8.5	24.2	13.0	7.2	2.2	8.4	14.4	9.6	2.9	6.4	9.4	4.5	10.0	7.3	14.5	3.1	41.6	47.3	21.7	25.1	10.1	12.5	32.5	34.0	27.0	53.2	57.9	42.6	46.4	21.9	15.6	23.3	20.0	66.5	48.0	38.3	36.8	18.9	24.0	30.6	58.8	29.4	8.4	36.5	40.0	6.9	20.2	41.6	40.8	13.5	22.2	29.7	46.5	24.2	28.2	28.9	25.3	29.4	23.9	44.1	20.4	32.8	30.7	28.4	27.7	32.3	37.9	18.5	44.9	31.7	15.4	30.3	55.2	17.6	15.9	32.8	41.1	47.5	65.3	19.8	41.4	21.3	22.8	24.7	44.5	0.5	0.6	0.4	1.1	0.4	0.9	0.6	0.7	1.1	1.2	0.5	0.6	1.2	0.0	1.4	0.2	0.6	0.6	0.4	2.3	2.6	2.3	3.0	2.3	2.4	3.0	2.4	3.2	2.2	2.9	3.1	13.1	9.6	12.0	23.8	12.3	29.6	12.3	14.4	23.9	18.4	11.0	12.3	4.4	17.2	8.6	5.5	35.5	12.0	9.6	24.4	1.9	10.7	81.4	10.6	12.7	10.6	10.8	24.6	25.8	13.3	21.6	9.6	23.9	16.7	2.5	20.4	6.8	9.5	10.9	3.3	36.4	23.5	14.2	7.9	10.1	20.8	12.5	7.8	3.6	10.3	11.0	3.9	15.5	22.6	24.4	16.4	13.9	9.8	19.4	26.4	23.0	4.4	6.4	24.8	0.0	13.3	9.0	19.7	19.4	29.1	23.4	7.3	13.0	9.9	32.5	16.3
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 255.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 330.2;Hepatocytes: 414.2;Sertoli cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	42.9	7.3	9.2	15.4	7.8	0.6	27.4	3.5	11.4	13.3	5.8	23.7	13.2	16.2	16.6	15.9	9.2	26.7	19.1	7.1	5.3	25.6	255.5	74.9	11.3	4.2	8.9	14.0	49.3	34.6	5.8	48.4	6.0	15.1	22.0	21.5	12.8	17.7	9.2	15.3	13.4	20.1	3.9	8.2	12.2	9.6	13.2	17.4	19.3	13.6	10.5	25.4	14.3	6.7	102.5	51.7	82.6	24.9	22.4	95.0	74.6	190.8	93.9	129.0	127.4	63.9	8.9	0.1	31.0	220.5	52.1	221.0	27.4	164.3	161.1	0.3	23.9	0.2	22.6	82.3	52.1	2.2	0.6	38.6	111.1	135.0	360.0	47.6	23.8	42.4	0.2	0.4	120.7	43.5	39.7	12.4	53.9	6.7	81.2	50.5	52.6	7.7	51.0	42.8	41.8	109.0	64.5	11.1	57.9	70.2	10.1	3.1	29.1	122.7	61.5	75.0	22.7	0.9	0.5	1.1	74.4	0.4	69.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	7.8	3.5	11.4	7.1	5.3	4.2	8.9	6.0	3.9	13.2	6.7	95.8	330.2	112.5	1.6	3.6	76.7	58.2	78.7	31.9	1.4	29.0	22.9	7.9	45.8	84.3	69.9	0.0	5.2	0.8	30.4	0.0	120.4	2.9	13.0	20.2	60.5	58.5	10.7	22.3	44.6	26.5	40.3	18.3	18.1	3.8	129.1	5.0	414.2	4.2	0.0	38.0	24.6	34.6	10.5	10.0	3.8	5.0	2.3	26.6	70.3	1.0	72.2	0.0	1.0	0.8	38.1	54.1	9.1	0.4	112.2	4.5	1.2	48.2	2.7	203.8	32.6	160.1	2.4	21.0	13.9	28.1	3.4	3.3	44.9	38.0	47.1
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492686	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		3800000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	169.3	27.0	12.4	34.4	11.8	4.9	115.9	13.3	12.7	77.4	17.1	104.9	47.4	97.1	21.5	64.7	66.4	46.1	97.5	10.2	14.7	56.8	39.5	87.2	24.1	14.8	11.2	43.6	69.3	34.3	22.9	56.9	14.6	69.9	41.7	2.1	91.7	58.2	49.5	57.7	65.6	65.7	11.9	30.8	76.3	17.1	13.7	21.3	60.6	35.8	25.1	86.3	67.8	10.8	169.8	182.1	19.3	79.5	88.8	87.6	74.2	168.6	138.9	108.7	91.0	122.3	90.7	16.9	118.7	261.1	72.7	139.9	29.2	117.2	56.3	75.2	74.5	16.2	96.4	46.2	131.7	1.6	81.5	68.7	57.3	100.2	57.3	99.5	141.7	10.5	13.1	13.7	93.5	129.5	1.9	1.4	12.4	105.8	34.0	6.9	26.4	30.7	100.5	86.9	7.8	43.0	105.9	152.6	67.4	47.5	125.3	8.7	187.9	156.6	119.1	77.7	147.8	10.7	9.1	7.2	124.7	4.1	138.8	0.1	0.9	0.0	0.9	2.0	0.4	4.8	2.1	0.9	1.1	3.8	0.7	0.4	0.5	0.0	1.7	1.0	1.9	1.5	12.4	11.8	13.3	12.7	10.2	14.7	14.8	11.2	14.6	11.9	13.7	10.8	133.7	125.0	35.9	5.5	20.8	39.8	38.2	27.8	31.9	4.1	44.0	33.0	75.4	48.6	36.3	86.5	0.0	57.8	2.5	159.0	21.5	62.3	17.4	26.3	44.4	78.0	39.5	13.5	2.5	52.0	28.4	51.8	66.3	75.5	12.0	25.4	83.6	38.5	20.0	5.0	3.8	111.8	14.2	14.5	43.4	11.4	42.3	16.7	64.0	15.0	20.3	5.6	0.0	2.5	1.0	92.8	88.7	48.5	12.8	64.7	92.8	15.4	12.9	2.1	118.3	37.7	90.6	9.4	7.5	39.5	42.6	47.6	10.0	10.6	88.1	39.2
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520778-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 96.0;lung: 24.4;lymphoid tissue: 78.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.2;Kupffer cells: 235.4;Macrophages: 122.7;monocytes: 195.5;NK-cells: 616.9;T-cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 263.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.4;HL-60: 52.3;HMC-1: 87.9;NB-4: 210.2;THP-1: 154.3;U-937: 84.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	9.6	4.5	5.1	38.9	5.2	96.0	3.5	5.7	7.2	2.7	6.3	5.0	7.4	2.0	0.7	3.3	6.5	10.5	4.6	4.7	5.9	3.8	7.8	24.4	20.7	9.2	7.6	1.2	2.4	1.2	2.2	7.1	8.7	3.7	3.4	0.2	3.7	1.8	1.5	2.7	12.2	6.4	7.5	78.1	6.5	1.4	8.6	5.4	3.0	4.2	8.5	10.2	2.8	10.1	0.1	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	6.1	0.4	0.0	0.4	0.0	0.0	0.0	52.4	0.2	38.1	0.0	0.0	0.1	52.3	87.9	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.5	23.8	0.1	0.3	0.1	210.2	0.0	0.1	0.3	1.0	0.0	5.6	0.1	0.0	0.1	0.3	0.0	0.1	0.3	0.1	0.8	154.3	12.3	0.1	0.2	0.2	0.1	0.1	1.9	0.3	0.3	84.3	0.0	64.5	107.6	105.7	56.6	78.7	44.5	5.9	22.3	39.7	62.8	2.8	1.6	17.0	263.2	32.3	98.8	8.1	34.0	101.3	5.1	5.2	5.7	7.2	4.7	5.9	9.2	7.6	8.7	7.5	8.6	10.1	1.9	3.2	12.3	2.0	26.5	3.3	2.4	0.8	1.2	0.7	3.1	4.3	2.6	5.7	2.9	1.8	2.1	5.0	110.2	2.0	1.9	1.7	6.0	0.6	2.9	4.1	1.2	14.3	2.3	0.9	8.2	2.7	3.6	1.2	31.6	2.2	10.8	6.7	75.8	6.7	1.5	2.1	0.0	235.4	49.3	6.8	2.5	122.7	7.2	64.6	195.5	1.5	616.9	1.5	3.4	1.3	3.2	1.2	30.0	1.8	3.0	2.9	0.2	0.8	0.0	3.4	2.2	6.0	3.4	3.6	5.4	5.1	100.1	3.9	2.7	1.9
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719571-17722136	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 36.1"	"Group enriched"	"Detected in some"	9	"Skeletal myocytes: 10.0;Spermatogonia: 3.8"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 461.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA055436, HPA078647"			Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	461.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAA16	"FLJ22054, MGC40612, NARG1L, PRO2435"	ENSG00000172766	"N-alpha-acetyltransferase 16, NatA auxiliary subunit"	Q6N069	13	41311267-41377030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 23.5;pancreas: 20.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039761, HPA040157"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA039761: AB_10795112, HPA040157: AB_10793917"	"unprognostic (2.09e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-2)"	3.2	2.7	1.8	5.0	2.1	23.5	3.9	4.9	2.2	5.0	1.6	2.8	4.3	6.3	2.7	4.2	4.3	3.5	2.4	1.5	2.4	3.1	2.9	3.7	6.5	1.8	2.0	5.9	20.5	3.5	1.9	3.8	2.0	4.7	3.2	5.9	3.9	3.8	4.4	4.1	4.1	3.7	1.1	4.5	4.8	7.5	2.2	5.9	3.7	4.5	4.0	3.9	3.5	3.4	7.3	6.0	14.9	10.8	5.1	6.5	5.7	8.9	7.4	8.6	7.5	7.1	5.6	12.1	4.1	7.2	3.5	10.0	7.7	5.7	10.5	7.5	15.5	15.0	6.3	7.2	5.5	16.8	9.7	4.5	4.2	3.6	6.8	5.8	8.6	11.7	6.8	6.5	5.6	6.0	17.5	4.8	12.6	10.1	8.1	12.9	6.1	10.1	6.8	6.6	5.0	11.6	8.0	7.7	3.3	8.6	4.7	9.3	6.2	5.8	4.9	9.3	7.0	4.5	5.4	14.0	7.5	7.2	7.1	4.4	1.5	3.1	2.3	0.8	2.1	1.0	2.6	2.4	0.8	1.6	4.5	4.7	0.8	3.4	1.2	1.6	2.0	1.3	1.8	2.1	4.9	2.2	1.5	2.4	1.8	2.0	2.0	1.1	2.2	3.4	15.0	9.6	16.7	34.0	19.6	17.7	21.9	9.5	18.8	27.9	10.3	10.2	12.0	10.0	12.4	9.2	14.6	8.8	20.2	5.6	1.9	12.5	17.9	17.2	26.7	16.7	7.7	15.4	53.5	20.5	7.8	18.8	19.9	22.1	3.8	18.9	13.6	8.7	19.1	38.7	66.9	5.5	4.1	8.5	11.7	26.3	30.1	14.3	14.2	45.0	12.0	11.3	21.6	68.9	57.1	13.1	6.9	19.9	28.3	20.0	7.3	7.0	17.3	33.6	19.7	17.0	24.7	39.2	28.8	17.0	14.6	2.9	31.7	17.1	9.7	21.2
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810548	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 311.5;Inhibitory neurons: 135.1;Microglial cells: 155.5;Oligodendrocyte precursor cells: 468.0;Oligodendrocytes: 532.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.5;BJ hTERT+: 5.4;fHDF/TERT166: 6.4;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	2.4	1.1	1.1	1.0	2.3	0.2	5.8	1.2	1.4	6.3	1.1	3.0	1.7	3.7	5.5	1.5	3.8	4.2	2.6	1.4	0.6	3.3	2.9	2.0	0.5	2.2	1.3	3.9	2.2	10.2	0.5	1.2	1.8	4.9	2.4	1.6	5.8	3.7	1.0	0.8	1.6	3.5	1.4	1.9	2.7	0.9	1.5	1.2	2.3	1.7	0.5	3.8	1.2	3.3	0.0	0.0	0.3	0.0	4.4	14.5	0.1	3.1	5.4	0.7	0.9	0.2	1.7	0.0	0.6	6.4	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	4.1	0.8	0.1	0.0	3.8	0.5	0.0	0.0	0.1	3.1	0.6	0.2	0.0	0.0	2.2	0.0	0.0	0.2	0.1	2.2	0.3	0.1	0.1	0.3	0.3	1.2	0.3	4.0	0.2	0.7	2.9	0.1	0.1	0.6	0.0	0.0	0.0	1.9	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	2.3	1.2	1.4	1.4	0.6	2.2	1.3	1.8	1.4	1.5	3.3	5.1	0.0	11.5	311.5	0.1	2.3	8.9	2.7	1.2	7.7	35.1	13.7	3.0	12.8	9.1	12.9	12.5	19.6	0.3	11.1	7.9	10.1	74.9	23.7	8.7	2.8	9.0	2.7	113.4	2.5	1.4	15.0	23.9	30.2	4.5	3.4	2.9	4.5	1.8	0.0	135.1	2.6	10.2	0.3	3.0	39.6	15.2	1.1	3.6	155.5	0.0	6.7	0.0	468.0	532.9	3.6	4.4	12.0	0.0	13.6	13.2	2.4	21.9	6.2	0.0	23.4	4.9	3.2	2.8	5.3	1.8	12.3	0.8	5.7	16.4	16.0
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191741097	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 452.0;Langerhans cells: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA054978: AB_2682660, HPA067802: AB_2685899"	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	22.0	5.3	2.3	23.2	1.8	5.5	9.8	1.5	2.4	4.7	4.9	5.2	10.0	4.6	0.6	13.2	5.4	7.4	3.9	2.5	2.5	10.5	9.8	21.1	12.4	2.7	2.7	4.5	3.8	0.8	4.3	7.6	2.5	4.4	3.8	1.0	5.2	3.2	2.8	4.4	18.8	3.7	2.2	36.7	4.7	9.2	5.1	6.3	3.2	3.3	11.6	18.4	7.6	3.6	36.2	5.5	1.5	1.6	15.7	16.4	10.2	53.4	31.3	28.6	15.1	30.9	18.7	2.6	43.1	26.3	23.9	11.5	5.7	22.1	29.0	21.2	5.5	18.4	10.8	5.6	14.3	9.8	16.5	22.5	20.3	47.9	23.4	13.8	8.3	4.8	28.7	76.3	31.8	3.3	3.5	10.8	3.6	6.8	31.4	7.1	6.1	16.8	30.2	22.2	2.0	1.3	21.3	7.7	14.1	18.7	2.7	4.7	31.4	28.2	24.6	15.4	33.6	25.2	12.7	9.1	25.1	9.7	6.4	20.0	10.4	8.8	13.2	17.1	19.1	10.8	17.3	13.7	7.3	3.5	8.0	10.7	38.8	6.6	21.5	6.9	28.5	8.5	2.3	1.8	1.5	2.4	2.5	2.5	2.7	2.7	2.5	2.2	5.1	3.6	42.2	214.7	452.0	2.0	66.5	53.0	141.0	15.7	32.5	3.3	33.1	34.3	9.3	8.6	106.2	11.0	2.1	23.6	46.9	79.0	3.9	16.7	212.8	64.9	28.1	34.0	4.2	9.1	3.5	5.7	43.5	62.2	32.1	179.6	139.6	2.2	10.8	8.6	54.9	3.3	3.6	20.2	8.2	113.8	301.8	69.9	10.2	151.3	40.9	18.7	108.8	1.9	18.6	1.5	1.7	30.7	85.7	3.8	43.9	44.8	109.2	22.4	57.6	3.6	6.6	101.5	46.3	25.7	18.4	35.6	45.3	146.3	111.6	12.2	31.7	112.8
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 243.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044615: AB_10795884, HPA057213: AB_2683371"	"unprognostic (1.45e-1)"	"prognostic favorable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	21.7	39.4	31.6	17.9	34.3	18.8	20.7	33.5	39.5	21.2	28.9	27.1	23.0	23.6	19.0	21.7	21.2	14.9	23.3	31.8	33.4	25.8	23.1	15.4	20.1	33.2	33.2	24.5	34.6	21.8	24.9	8.4	33.0	20.5	19.4	24.8	17.3	18.0	59.2	21.1	23.0	16.2	32.2	18.0	23.5	24.4	35.4	17.5	19.6	32.2	19.6	25.5	18.5	34.5	74.8	75.9	70.3	78.4	30.8	33.1	13.8	43.5	36.6	63.0	37.9	45.8	65.7	56.3	85.8	41.1	44.6	57.8	66.5	56.1	48.0	107.1	64.1	94.7	49.2	36.0	32.4	67.9	89.0	28.6	44.5	75.4	60.3	53.5	41.9	69.0	50.1	94.9	46.2	67.4	94.1	78.6	51.8	45.0	74.3	83.2	65.2	84.9	31.3	30.4	89.1	65.6	69.0	86.3	62.5	11.2	98.9	60.8	29.8	43.8	41.3	92.0	81.2	64.2	104.5	36.1	81.0	63.9	82.9	33.0	15.6	14.9	26.5	22.7	29.6	26.4	21.9	23.9	21.4	21.2	13.4	22.4	3.0	42.7	25.9	21.6	34.3	16.6	31.6	34.3	33.5	39.5	31.8	33.4	33.2	33.2	33.0	32.2	35.4	34.5	17.2	16.0	18.9	5.2	17.5	18.6	18.5	25.0	21.1	15.3	22.5	27.1	9.6	31.5	12.0	23.9	2.1	28.4	13.6	27.3	49.0	36.7	88.4	11.3	17.1	20.7	18.0	30.3	6.7	70.8	40.0	20.6	13.7	13.4	17.7	17.6	22.9	22.5	31.2	15.2	6.6	27.5	16.2	17.7	20.3	243.5	23.6	16.0	32.0	1.9	27.6	35.8	33.0	2.5	6.4	38.4	22.7	34.3	30.9	13.3	41.6	43.1	11.6	14.8	19.7	23.2	22.9	20.2	25.0	22.1	17.0	15.2	20.1	23.0	37.9	15.1
NACC1	"BEND8, BTBD14B, BTBD30, NAC-1, NAC1"	ENSG00000160877	"Nucleus accumbens associated 1"	Q96RE7	19	13116862-13141147	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021238, HPA062245, CAB069927"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724"	"unprognostic (2.19e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.74e-2)"	12.6	19.5	31.0	14.6	19.2	8.8	10.3	7.1	26.6	9.7	0.0	17.3	13.3	18.4	7.9	27.6	11.9	6.4	20.9	25.7	7.4	14.8	20.5	16.7	12.1	13.4	15.9	7.7	12.2	10.7	14.8	12.4	15.1	14.6	6.6	3.7	15.8	11.2	24.2	17.4	16.0	7.7	8.9	15.9	16.0	17.0	20.6	11.3	14.0	7.9	8.8	15.0	12.6	16.4	98.8	110.0	28.0	59.6	15.0	17.7	74.9	47.4	34.2	42.4	32.4	114.8	40.4	50.9	104.1	39.8	37.3	49.0	34.8	80.7	16.2	89.1	52.5	32.4	87.9	84.7	35.5	52.0	82.3	28.8	28.0	46.1	24.7	36.5	50.2	46.4	72.5	19.8	22.9	206.1	82.9	39.6	123.6	28.9	101.7	47.8	32.9	49.5	28.2	101.1	58.2	37.7	49.6	64.9	39.1	29.8	59.3	46.4	76.7	94.6	58.8	67.2	87.0	53.4	88.1	42.4	99.7	52.8	58.9	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	31.0	19.2	7.1	26.6	25.7	7.4	13.4	15.9	15.1	8.9	20.6	16.4	4.9	0.0	1.7	6.2	5.6	12.1	7.5	11.8	2.8	16.6	11.5	7.5	2.1	12.8	8.5	16.5	2.1	19.0	12.9	22.7	7.9	12.3	2.3	10.9	8.9	8.1	4.9	12.2	7.2	8.8	20.0	5.2	10.7	17.6	10.2	13.3	8.6	18.0	21.1	26.9	5.9	16.2	14.2	9.6	9.6	2.0	4.4	8.8	5.4	3.7	10.5	12.0	10.3	5.5	5.4	21.7	11.1	9.4	5.6	16.5	14.0	15.0	5.9	7.7	6.6	7.5	7.0	11.1	15.6	8.4	13.9	27.1	7.9	15.2	15.4	17.2
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166890	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	9.5	8.1	4.7	7.6	5.9	7.6	8.3	3.9	7.1	8.7	9.2	7.2	4.7	10.4	6.1	7.0	12.3	7.0	6.5	6.2	3.5	6.8	7.1	7.0	8.7	2.4	3.7	10.9	7.7	10.7	4.8	6.6	1.8	8.5	8.1	13.5	7.6	8.6	19.4	8.3	4.9	8.7	3.1	7.3	6.0	13.3	2.5	7.1	10.2	10.3	7.9	9.5	4.8	4.0	15.2	12.7	16.0	16.4	9.2	14.5	18.8	17.6	11.7	15.1	15.0	14.4	17.8	39.4	5.0	10.9	12.2	12.5	32.7	18.9	19.7	17.5	20.2	41.7	11.4	12.3	16.1	27.2	14.3	13.7	16.5	18.5	14.9	15.6	13.6	12.5	47.7	20.3	20.4	15.0	31.8	15.5	20.9	11.5	12.5	26.1	11.8	20.7	15.0	6.9	17.3	13.1	11.6	20.9	13.0	13.9	11.3	11.8	14.4	18.0	15.6	14.1	20.2	12.7	19.1	30.2	17.1	15.6	18.2	0.0	0.5	0.0	0.7	0.5	0.2	0.6	0.7	1.0	0.8	0.7	1.0	0.7	0.0	0.4	0.5	0.8	0.2	0.5	4.7	5.9	3.9	7.1	6.2	3.5	2.4	3.7	1.8	3.1	2.5	4.0	15.2	6.4	16.7	24.8	25.9	32.4	23.6	10.5	19.4	10.9	10.7	12.8	4.0	11.5	8.0	9.2	18.8	14.3	19.0	4.2	3.9	9.8	48.0	35.7	13.3	9.2	19.2	11.1	44.8	6.8	15.6	25.1	9.2	22.1	10.8	10.2	12.1	5.0	11.7	8.4	30.9	8.2	4.1	17.9	13.3	19.1	6.8	32.8	8.8	19.7	6.0	10.3	4.1	31.7	29.8	7.8	4.0	5.3	16.4	14.4	2.8	8.9	30.3	14.7	32.9	29.8	24.7	23.6	16.2	14.8	41.1	21.3	24.9	13.0	8.0	13.1
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056732-98083077	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		410000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	39.4	28.9	16.2	49.3	15.0	67.8	36.5	13.8	18.2	49.9	29.8	133.5	52.2	28.5	33.5	51.4	29.4	34.2	46.3	15.1	17.0	32.8	67.0	45.9	59.5	16.2	17.2	26.2	67.6	20.4	42.5	31.7	18.4	106.4	129.2	8.3	120.0	19.7	34.2	29.2	47.8	29.0	15.1	53.3	76.1	27.2	17.2	18.8	27.3	17.4	60.5	47.5	41.5	17.2	387.9	111.8	32.5	94.5	64.0	68.8	70.5	120.9	93.7	96.3	78.3	134.8	53.6	118.1	57.2	133.3	101.9	134.1	61.0	103.6	80.0	95.7	91.0	70.3	128.4	271.9	176.3	80.3	55.3	58.4	69.1	102.9	116.4	111.8	104.3	57.9	129.9	119.8	71.2	265.0	54.1	114.9	56.2	277.5	143.3	103.4	89.0	121.5	78.2	116.6	65.7	34.4	77.8	414.4	107.2	35.8	137.6	85.3	274.2	74.8	72.5	193.4	125.8	110.7	99.3	45.7	88.4	95.9	59.6	30.9	190.9	29.5	34.9	237.6	53.4	55.6	45.5	36.8	194.7	54.9	48.8	33.7	77.4	38.9	217.0	178.8	58.3	91.4	16.2	15.0	13.8	18.2	15.1	17.0	16.2	17.2	18.4	15.1	17.2	17.2	46.7	28.9	54.9	3.6	57.0	70.1	134.0	183.0	30.7	11.4	61.6	45.5	25.3	42.9	206.3	22.0	18.8	86.7	50.2	234.3	70.5	49.4	42.8	63.4	37.9	63.4	64.9	18.7	6.7	100.7	159.2	50.6	99.4	55.8	43.8	29.5	34.2	33.6	160.0	10.1	7.2	362.7	95.6	67.7	107.6	71.5	32.3	89.8	129.9	6.5	53.1	14.1	14.4	2.0	3.1	70.9	181.0	26.4	141.1	213.6	66.5	68.3	204.5	8.0	13.1	32.9	91.3	10.5	21.9	42.0	61.7	150.8	50.6	44.6	260.1	223.3
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214851	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.4;Excitatory neurons: 34.3;Horizontal cells: 18.5;Inhibitory neurons: 33.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.6;Karpas-707: 14.1;NTERA-2: 18.1;U-2197: 14.6;U-266/84: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA054050: AB_2682357, HPA057065: AB_2797258"	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.1	6.0	22.7	2.2	24.4	0.5	3.1	28.4	60.4	4.2	4.6	3.4	0.9	5.1	8.2	2.6	4.0	2.3	7.9	28.8	27.0	8.3	1.0	2.3	3.2	18.5	15.4	8.9	2.5	12.1	14.5	0.0	17.9	11.0	2.9	19.1	3.2	5.8	1.3	5.2	2.2	4.7	12.1	4.2	2.2	2.1	15.7	1.7	8.5	2.9	1.6	2.9	2.6	25.7	0.0	4.8	0.1	9.4	0.6	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.3	0.0	16.6	0.0	8.9	1.0	3.4	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.8	0.4	1.3	0.2	2.4	0.1	0.3	6.6	0.4	14.1	0.0	1.7	5.9	0.0	18.1	0.0	8.4	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	1.1	0.0	3.5	1.8	0.0	0.1	0.0	10.3	14.6	1.2	6.6	31.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.3	1.2	0.8	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.0	1.0	0.5	22.7	24.4	28.4	60.4	28.8	27.0	18.5	15.4	17.9	12.1	15.7	25.7	1.0	0.0	3.0	8.5	0.9	6.4	6.2	1.0	8.0	24.4	0.7	2.9	11.1	2.8	0.8	12.9	0.0	0.0	2.9	1.8	13.7	1.1	0.0	0.0	0.2	3.1	7.2	0.0	34.3	0.2	0.0	4.1	1.1	0.1	4.5	0.2	3.6	0.7	0.1	18.5	33.7	0.4	0.0	0.3	0.0	0.4	0.3	0.1	0.0	9.4	0.0	13.7	0.0	9.5	9.1	0.8	0.5	0.4	1.9	3.3	0.0	3.3	0.0	9.9	0.0	5.5	4.0	0.2	0.1	2.6	3.0	0.0	3.5	0.2	0.5	1.0
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 476.2;Spermatogonia: 514.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		170000	"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	66.2	39.6	57.4	55.9	62.6	165.0	58.8	60.6	95.7	67.4	57.1	52.7	34.6	54.6	29.9	55.2	65.6	26.7	51.0	57.2	68.0	48.6	52.0	50.4	91.5	65.0	61.6	72.4	34.9	41.1	40.9	61.9	63.0	54.1	51.5	38.2	43.5	43.4	41.7	46.7	58.3	45.1	56.0	83.3	47.3	108.9	62.4	100.7	48.1	22.2	97.7	51.1	56.0	65.3	191.3	110.8	520.2	184.6	85.8	44.9	243.8	150.9	112.4	230.5	286.5	205.7	134.4	357.9	103.5	65.8	251.9	180.2	351.9	161.0	291.5	164.0	222.9	462.7	201.6	326.9	30.2	489.3	186.4	52.5	38.3	254.0	87.6	60.1	159.5	294.8	396.3	204.1	157.6	131.4	559.6	445.0	755.5	189.5	93.1	697.4	454.0	343.8	115.3	189.4	198.3	239.8	248.7	140.4	159.7	389.2	100.8	377.0	86.7	105.5	322.8	204.4	250.0	124.5	251.2	616.2	107.6	306.7	107.3	6.4	9.4	10.9	14.1	12.1	16.4	16.1	16.1	16.3	14.3	22.3	13.9	13.7	4.0	9.7	7.3	14.7	22.0	9.1	57.4	62.6	60.6	95.7	57.2	68.0	65.0	61.6	63.0	56.0	62.4	65.3	196.5	57.7	106.7	70.8	136.1	78.1	135.2	72.4	133.7	45.3	77.4	87.4	58.4	37.1	99.1	36.8	37.5	319.3	150.8	64.8	31.3	55.0	16.6	119.6	138.1	138.4	51.3	142.8	32.7	37.4	223.2	100.6	81.1	137.9	115.2	134.2	90.3	38.6	108.1	43.7	34.8	68.1	44.7	43.7	62.6	26.6	94.8	82.7	40.9	31.9	52.3	60.9	62.8	63.8	160.3	29.8	44.9	78.2	107.4	88.6	28.9	36.6	109.1	77.3	85.5	148.1	106.6	476.2	514.5	92.1	57.0	268.2	142.2	90.7	101.7	85.3
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 290.1;heart muscle: 145.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"NK-cell: 53.7"	"Lineage enriched"	"Detected in many"	15	"NK-cells: 53.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA	1200000	2300000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	4.6	65.7	124.0	3.9	169.1	1.5	2.7	118.1	140.3	35.1	0.0	47.8	4.6	62.7	3.5	7.0	40.4	4.8	145.5	135.6	179.1	3.2	2.9	1.8	1.3	140.4	134.2	43.8	2.6	0.0	22.2	0.5	147.4	14.9	6.6	117.7	3.6	17.7	31.2	2.1	18.3	46.9	129.7	4.7	23.0	5.0	137.0	0.4	30.2	29.5	1.0	34.8	24.3	290.1	0.1	0.0	20.8	0.3	0.2	0.5	0.3	1.0	0.0	0.7	1.2	0.3	0.3	3.1	18.2	20.1	0.8	0.3	0.1	0.0	0.0	0.4	12.1	61.3	0.1	0.0	2.1	0.0	9.5	12.4	0.1	0.1	18.6	0.1	0.0	0.1	0.0	1.0	20.8	0.0	0.2	5.2	1.8	0.0	0.4	0.1	132.5	10.0	0.0	0.0	107.4	52.7	0.1	0.5	0.1	2.0	0.2	0.8	0.2	72.8	33.4	0.3	31.8	0.1	0.5	0.1	8.3	28.4	79.0	0.0	0.2	0.0	3.6	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	1.4	0.7	53.7	0.0	0.0	0.2	1.9	124.0	169.1	118.1	140.3	135.6	179.1	140.4	134.2	147.4	129.7	137.0	290.1	13.7	0.0	0.0	530.8	0.4	1.7	0.5	0.0	0.0	123.5	5.7	0.6	131.7	0.0	0.0	0.0	37.5	0.6	27.7	0.1	1.9	18.3	6.7	0.3	2.4	2.8	5.4	0.0	461.4	0.0	0.2	12.8	5.1	0.5	1.3	11.7	7.1	0.7	0.4	175.0	441.2	0.0	8.2	4.7	3.8	5.9	15.2	1.8	0.0	35.6	1.2	216.6	59.8	939.0	1013.5	1.3	0.0	10.1	5.6	0.4	0.0	0.2	0.7	98.0	0.0	107.5	4.8	1.0	2.8	0.4	1.7	0.1	13.4	5.6	0.0	0.2
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942594	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	38.3	44.0	40.3	38.7	41.4	17.2	36.0	39.7	46.6	34.5	38.6	35.4	29.4	32.6	41.1	29.0	30.1	28.8	31.3	41.5	45.8	41.7	30.1	27.1	43.5	42.7	42.1	35.7	25.7	38.2	26.0	33.9	42.3	36.4	35.2	46.2	24.4	35.5	38.6	27.2	27.8	33.8	43.6	34.2	29.6	25.8	43.8	49.9	37.7	38.6	42.2	45.6	26.1	43.1	144.3	44.6	105.5	131.8	118.6	102.8	74.1	106.1	80.9	66.4	69.7	99.5	51.2	97.0	229.7	76.3	85.4	84.6	136.1	113.0	104.7	50.8	85.0	125.2	55.3	87.5	103.9	146.4	85.3	84.1	101.2	48.7	134.1	99.5	104.3	103.2	71.6	99.7	113.7	165.5	111.3	88.4	134.5	137.2	139.5	86.9	78.6	92.9	99.3	101.9	57.3	153.1	63.8	126.4	189.4	85.4	279.1	112.4	97.5	67.1	71.4	85.0	193.0	155.6	149.4	162.1	93.8	162.5	103.2	9.9	37.7	20.9	37.5	44.5	56.6	53.2	46.2	44.8	40.1	43.5	52.8	48.1	4.0	43.1	47.0	32.2	45.0	40.4	40.3	41.4	39.7	46.6	41.5	45.8	42.7	42.1	42.3	43.6	43.8	43.1	38.5	25.6	43.5	9.1	71.1	52.5	83.6	55.9	36.5	55.7	48.9	36.8	40.5	25.8	51.6	42.3	58.4	59.1	58.9	44.0	97.8	64.3	116.2	39.5	66.6	50.2	45.0	35.1	12.8	49.8	81.8	47.1	30.5	35.9	52.6	54.7	30.0	31.1	65.4	45.4	14.0	44.9	54.9	54.1	60.7	66.2	37.6	38.6	32.0	2.8	68.2	91.0	51.5	10.6	10.4	69.1	45.9	51.6	42.0	81.9	37.0	82.5	44.6	60.3	26.3	40.9	51.3	52.9	59.5	33.5	44.8	53.2	49.8	58.8	52.1	84.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878017	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.2;lymphoid tissue: 162.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 70.9;granulocytes: 74.1;Hofbauer cells: 198.4;Kupffer cells: 85.3;Langerhans cells: 55.8;Macrophages: 85.7;Plasma cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 657.3;eosinophil: 750.1;neutrophil: 1235.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1235.8"	"Cell line enhanced"	"Detected in some"		"HEL: 78.3;HMC-1: 396.0;NB-4: 148.7;REH: 76.5;RPMI-8226: 144.0;THP-1: 137.9;U-937: 76.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA		7800	"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	29.5	14.4	4.8	43.1	5.0	180.2	12.7	4.9	7.5	4.6	6.4	19.2	11.7	4.5	1.0	7.2	13.9	13.0	9.4	4.9	5.4	8.9	10.1	45.1	39.8	6.8	5.9	3.3	4.1	1.4	5.3	24.3	6.4	7.4	11.8	0.1	10.7	4.5	3.6	4.9	42.6	10.5	5.8	162.3	9.3	1.8	8.6	12.9	8.1	7.1	33.5	18.7	7.2	7.1	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	78.3	0.0	0.0	0.0	12.8	396.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	26.8	0.0	0.8	0.0	148.7	0.0	0.0	0.0	76.5	0.0	144.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	137.9	0.0	0.0	0.2	0.1	0.2	0.5	0.1	23.7	0.1	76.8	0.1	657.3	184.6	750.1	2.3	92.5	9.8	108.2	32.0	6.9	86.1	85.9	1.9	2.1	1235.8	4.4	62.0	100.7	96.3	106.3	4.8	5.0	4.9	7.5	4.9	5.4	6.8	5.9	6.4	5.8	8.6	7.1	1.5	3.2	18.7	0.0	70.9	2.8	2.2	1.3	0.6	0.0	3.1	2.5	2.1	0.0	5.8	1.8	0.0	3.2	21.1	1.3	0.0	0.6	0.2	0.2	0.1	3.6	0.0	28.8	0.0	3.1	16.0	1.8	2.0	0.4	74.1	0.0	1.4	0.7	198.4	0.0	0.0	0.5	2.0	85.3	55.8	1.0	0.6	85.7	14.2	3.7	38.5	0.0	3.1	0.0	0.1	0.9	22.5	0.0	68.2	0.3	0.2	0.2	0.9	0.3	0.0	0.5	1.6	0.0	0.4	0.5	2.3	13.0	17.5	0.7	1.7	4.3
NCKIPSD	"AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH"	ENSG00000213672	"NCK interacting protein with SH3 domain"	Q9NZQ3	3	48673844-48686364	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 121.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019267, HPA050005"			Enhanced	"Plasma membrane"		NA	NA		110000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"CAB019267: , HPA050005: AB_2680988"	"unprognostic (1.55e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"	18.6	17.7	25.5	6.3	28.5	5.9	17.0	16.4	47.6	14.9	2.4	13.7	10.0	12.9	11.4	11.1	16.3	12.4	37.5	26.3	23.0	19.3	14.3	16.5	8.5	23.1	16.4	31.1	11.8	121.9	20.1	11.1	22.5	17.5	9.8	11.3	14.1	15.8	12.6	19.8	12.5	11.7	13.1	11.5	11.6	16.4	23.7	6.3	13.6	10.0	7.0	12.6	14.6	29.3	20.9	18.0	18.0	18.6	24.0	14.5	25.0	20.5	22.8	22.2	28.2	26.6	12.4	15.3	10.9	12.2	25.4	13.8	23.2	27.1	12.7	17.3	28.3	27.4	73.2	21.5	20.9	18.8	29.6	14.0	23.3	30.9	19.3	25.2	12.8	19.1	9.5	19.8	18.1	15.3	17.1	15.8	21.0	20.6	31.5	8.6	8.3	25.8	12.3	21.2	18.7	15.1	21.4	19.9	17.4	16.3	17.7	22.7	7.2	19.0	21.3	22.8	27.5	17.7	14.1	17.0	21.7	24.6	29.8	0.6	2.9	0.1	2.1	3.4	1.5	2.9	2.4	2.4	3.6	1.4	3.5	2.4	0.2	3.4	1.8	5.2	2.9	2.9	25.5	28.5	16.4	47.6	26.3	23.0	23.1	16.4	22.5	13.1	23.7	29.3	15.9	0.0	6.9	7.2	2.9	2.5	3.7	8.1	1.8	9.2	3.8	5.5	17.0	5.7	4.0	1.8	12.5	9.6	4.5	10.8	5.9	7.0	2.4	4.7	5.5	8.1	8.4	4.8	11.8	4.6	10.5	5.4	6.6	5.8	5.7	7.6	23.6	6.4	8.6	11.8	10.9	6.0	6.1	6.5	6.1	2.5	18.3	6.4	1.8	1.9	4.5	3.5	0.0	2.5	8.3	7.5	6.2	47.4	3.9	2.3	13.8	7.6	3.9	6.3	13.1	4.0	6.4	5.6	18.4	2.8	1.7	8.2	3.3	8.6	8.7	2.3
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	212.0	192.8	128.8	226.0	146.3	301.4	228.7	129.1	139.6	180.0	114.1	183.6	160.7	205.2	150.2	228.8	173.2	132.2	164.3	115.9	152.3	166.2	218.5	147.4	289.7	148.8	141.5	258.2	209.0	258.9	115.9	203.4	140.4	155.4	219.2	147.1	157.0	160.9	350.9	197.1	157.4	201.0	137.9	176.3	164.7	126.2	142.1	347.0	198.4	228.2	329.0	271.1	169.1	143.9	718.3	691.8	715.7	640.1	485.7	592.0	823.0	790.4	497.2	690.8	628.2	1227.4	521.4	1083.7	608.6	651.0	892.6	719.5	1614.4	1059.9	1284.7	554.6	644.0	1587.3	605.9	1749.5	544.0	1930.4	632.7	513.5	613.2	872.3	1019.6	394.9	834.2	770.5	1745.4	378.6	760.5	1176.4	1443.2	1086.7	1202.0	728.7	435.9	1290.8	1452.0	918.4	583.8	959.9	749.0	502.0	555.8	704.5	706.9	625.7	476.8	985.3	686.3	611.4	626.7	714.5	1063.7	624.3	554.5	1885.9	467.2	1173.1	685.2	27.3	95.6	62.5	136.5	100.3	152.8	113.5	118.4	121.9	130.6	111.9	130.3	114.2	16.8	177.8	121.7	102.0	102.3	151.0	128.8	146.3	129.1	139.6	115.9	152.3	148.8	141.5	140.4	137.9	142.1	143.9	286.2	291.7	411.7	8.1	468.9	459.9	633.8	241.0	644.9	145.0	315.2	303.8	320.9	147.3	401.6	195.0	47.9	386.9	596.2	215.0	230.9	294.4	20.6	348.7	669.8	291.1	200.0	419.2	9.3	254.4	444.6	370.9	292.0	421.8	451.7	262.7	130.6	242.0	239.5	80.8	10.4	319.6	156.6	133.7	231.1	32.2	217.2	281.8	165.4	10.3	268.9	199.6	346.1	14.1	14.9	268.0	153.9	159.9	543.5	651.1	120.1	277.6	250.3	141.0	151.2	548.9	442.0	433.3	532.4	707.9	441.4	379.0	454.0	442.6	380.6	449.1
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 467.5;Excitatory neurons: 313.0;Inhibitory neurons: 421.8;Microglial cells: 341.9;Oligodendrocyte precursor cells: 459.4;Oligodendrocytes: 305.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 81.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	16.6	15.1	24.0	13.3	25.4	17.3	17.3	24.6	28.2	18.6	13.6	15.9	20.9	19.0	12.8	17.6	15.7	14.0	15.3	29.6	19.5	18.9	15.0	16.0	15.3	17.7	19.2	26.6	17.4	30.0	16.6	17.1	16.0	15.2	16.6	47.3	16.0	20.2	33.4	15.7	18.9	19.0	19.5	16.3	12.5	19.9	21.8	26.1	11.8	36.1	16.3	14.9	15.5	22.3	14.1	10.3	17.7	9.2	19.2	17.3	26.9	7.4	14.7	9.1	8.1	9.6	5.9	10.2	3.1	13.5	17.4	3.4	10.7	6.3	9.8	48.6	15.5	36.5	4.1	4.1	12.0	16.9	29.1	27.9	9.4	8.8	7.1	11.3	9.4	12.9	22.6	16.5	14.0	9.4	15.1	6.0	8.5	8.2	6.8	11.8	81.5	5.1	9.9	18.9	16.2	12.8	17.1	10.2	7.4	9.3	12.3	8.6	10.2	15.2	11.9	10.5	7.5	18.8	17.5	17.2	8.6	10.5	7.7	10.6	3.3	7.0	3.4	2.6	3.8	1.6	3.0	3.8	2.5	2.4	2.9	3.5	13.8	3.5	2.9	5.2	3.7	2.0	24.0	25.4	24.6	28.2	29.6	19.5	17.7	19.2	16.0	19.5	21.8	22.3	41.0	38.5	31.5	467.5	16.7	30.5	11.6	7.8	14.2	96.5	32.3	26.7	41.9	17.2	22.8	14.7	52.1	13.1	47.0	39.0	7.9	16.5	29.7	14.6	37.6	34.9	25.2	29.9	313.0	26.6	18.1	39.8	19.9	28.4	20.2	52.9	36.8	22.8	17.9	62.2	421.8	20.7	20.3	29.8	30.3	7.4	47.2	37.7	19.6	341.9	34.7	66.7	78.2	459.4	305.8	20.1	33.5	43.2	14.3	15.7	30.4	12.5	16.9	71.6	39.5	116.9	34.4	37.7	37.6	16.6	31.0	5.3	33.4	27.2	24.1	21.7
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	22.1	18.3	37.8	28.1	39.7	42.8	29.0	60.8	84.7	27.3	41.0	44.0	47.1	30.7	20.3	30.6	25.1	26.4	23.4	39.3	34.7	33.6	46.2	26.9	29.9	32.7	35.7	33.5	34.2	42.3	17.1	28.3	31.0	27.6	40.6	41.4	22.4	31.4	42.0	31.6	38.2	29.7	28.2	29.3	42.7	32.4	35.4	51.9	34.8	39.9	34.7	28.8	18.3	43.4	68.0	110.6	77.7	65.1	62.4	47.1	38.6	48.9	54.8	52.4	47.1	59.8	30.3	70.9	33.6	85.9	39.3	50.4	96.4	59.2	77.3	95.6	71.1	70.7	96.3	71.1	60.8	45.3	80.7	48.5	60.6	81.2	94.4	45.2	73.9	98.0	63.0	28.8	52.3	44.3	79.3	29.1	38.6	118.6	29.9	78.1	78.5	33.5	54.9	76.0	26.5	43.8	80.7	34.7	37.7	197.5	33.5	50.3	65.5	53.7	32.6	39.9	68.3	19.7	25.0	40.4	51.0	52.4	47.0	408.4	104.8	240.4	126.9	86.0	106.7	188.4	144.0	141.0	76.3	191.4	139.8	139.0	205.2	139.9	112.3	130.3	144.7	98.8	37.8	39.7	60.8	84.7	39.3	34.7	32.7	35.7	31.0	28.2	35.4	43.4	90.9	80.1	113.2	116.2	130.0	67.8	106.2	91.3	86.0	150.3	76.8	60.8	91.5	82.9	86.9	53.3	158.4	102.1	121.7	198.1	35.2	95.5	69.7	75.7	109.5	88.4	87.9	132.1	127.0	96.5	101.7	77.1	149.4	103.7	87.3	88.9	67.5	126.4	76.1	129.5	122.2	118.8	81.4	81.9	76.7	43.6	101.5	96.7	37.4	107.7	172.8	83.1	197.8	123.1	151.4	111.7	148.3	121.5	88.5	95.6	194.4	46.7	63.8	167.1	92.1	106.0	106.2	98.7	90.2	78.0	68.2	87.6	142.1	89.5	153.0	122.9
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172404-130237303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 272.0;intestine: 123.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.9;Horizontal cells: 112.7;Inhibitory neurons: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		10000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.65e-1)"	8.3	26.2	183.3	13.4	96.0	8.4	5.1	0.0	227.7	22.6	0.0	123.6	5.2	70.7	5.7	40.6	29.3	13.9	12.6	272.0	20.8	17.6	2.8	9.5	1.9	17.0	23.4	10.8	4.9	2.3	14.5	1.7	16.6	36.1	10.1	8.5	8.1	65.1	3.1	18.3	19.8	58.6	2.3	1.2	25.1	3.1	75.5	4.2	32.8	1.9	3.8	63.8	20.8	85.8	25.6	50.8	25.9	51.9	15.9	35.3	12.3	64.3	29.6	48.2	32.0	24.3	12.8	0.1	22.8	81.6	56.5	45.2	42.5	56.3	21.5	75.3	13.0	0.1	32.3	26.5	24.4	2.2	30.2	41.2	28.0	54.7	34.4	42.9	46.2	9.9	18.8	0.3	70.8	73.1	4.9	25.6	39.6	13.7	21.2	0.1	81.5	17.3	47.4	15.9	67.9	63.9	39.5	18.7	37.7	19.4	34.8	16.2	36.7	92.9	75.4	75.5	84.1	0.1	0.1	0.2	108.7	7.1	102.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.3	96.0	0.0	227.7	272.0	20.8	17.0	23.4	16.6	2.3	75.5	85.8	0.5	0.0	0.0	26.1	0.1	9.7	10.5	16.6	15.4	7.7	3.0	10.0	2.9	1.5	6.3	11.0	4.2	0.1	5.3	0.8	5.9	7.9	0.4	27.8	10.5	1.0	1.2	14.7	40.9	2.9	1.6	9.1	1.1	12.4	3.8	4.4	0.7	0.5	3.7	112.7	42.5	1.0	0.0	0.6	5.8	0.9	1.2	2.5	5.4	2.8	9.8	19.2	0.0	8.0	7.8	5.3	0.1	1.5	1.3	11.0	0.2	17.3	9.7	4.3	0.0	4.2	19.0	0.0	1.9	6.0	7.0	0.5	2.6	1.2	0.5	3.3
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945177-61154531	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	42.7	39.2	34.8	23.3	35.7	18.0	38.5	34.6	56.0	34.7	33.0	48.3	21.0	31.6	17.5	36.4	31.3	17.0	57.7	34.8	37.5	37.4	32.2	24.9	19.7	36.2	37.9	37.7	35.7	31.2	45.1	14.5	37.3	31.9	26.2	22.0	25.8	23.0	80.2	22.6	24.9	25.9	34.4	18.3	35.9	31.2	35.4	13.0	23.0	46.5	18.8	43.4	33.4	35.0	109.0	51.9	41.6	129.1	80.7	113.8	70.3	129.8	71.1	85.2	103.7	99.4	84.0	150.8	127.5	91.2	141.2	44.2	72.6	113.8	103.6	66.0	104.3	52.1	95.7	99.4	115.6	72.5	26.2	59.7	119.2	74.9	226.0	53.9	74.7	64.0	79.5	76.3	90.9	89.6	64.2	108.0	35.3	41.2	135.0	77.3	115.1	192.7	83.1	46.1	84.8	33.0	74.7	72.7	136.0	35.8	86.1	40.4	68.6	55.5	82.8	125.3	134.2	46.0	73.2	170.8	75.9	123.2	66.3	0.4	18.3	2.4	17.3	19.1	21.1	23.0	22.3	21.1	32.1	15.2	18.6	20.1	0.8	27.1	15.8	11.0	31.7	12.2	34.8	35.7	34.6	56.0	34.8	37.5	36.2	37.9	37.3	34.4	35.4	35.0	40.8	12.8	28.0	23.8	32.8	60.5	64.6	62.2	34.1	27.9	47.9	59.8	87.6	45.8	39.6	38.6	12.5	20.8	18.7	29.8	93.9	55.1	175.7	41.8	95.1	35.8	24.7	28.8	62.2	56.6	49.2	60.4	28.5	40.3	20.3	27.2	31.8	94.6	51.4	42.1	68.8	59.3	40.7	29.5	59.1	22.2	76.7	29.0	44.4	40.3	24.7	34.0	22.6	61.9	71.3	69.8	52.2	62.1	29.0	144.1	32.2	151.4	25.9	29.1	26.3	55.2	60.1	108.4	73.9	63.0	63.6	14.2	34.0	48.5	65.7	71.1
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32553001-32573184	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 583.9;Distal tubular cells: 534.1;Early spermatids: 889.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	38.6	50.8	42.7	30.7	45.3	31.0	35.9	47.1	48.1	34.1	42.8	41.8	44.6	38.1	26.8	43.8	36.0	17.6	144.9	44.5	46.5	73.6	66.7	30.5	26.9	44.5	42.9	29.7	31.0	41.8	40.3	22.5	44.6	28.5	29.1	30.7	37.0	22.0	168.0	28.2	43.6	26.7	45.9	28.8	43.5	53.5	44.3	28.7	33.2	101.8	24.5	34.1	33.4	47.1	106.4	63.7	69.6	80.1	46.7	43.0	44.5	69.5	56.5	62.8	68.8	62.8	46.5	78.4	70.5	48.2	65.1	58.8	66.5	76.8	47.0	108.6	106.0	187.2	88.8	65.9	45.2	94.4	46.3	44.8	36.7	56.8	42.9	47.5	57.6	118.4	61.0	86.1	71.9	61.2	128.1	221.2	73.6	90.7	140.1	86.7	58.4	73.1	72.0	39.3	69.7	78.4	80.2	91.1	50.7	52.0	86.3	72.0	51.4	67.9	103.8	75.7	103.8	38.0	77.0	131.5	113.7	65.6	32.7	126.3	97.6	136.1	76.9	94.3	74.5	106.0	81.4	80.0	108.8	89.0	82.3	87.4	302.1	91.9	116.3	152.7	112.4	110.2	42.7	45.3	47.1	48.1	44.5	46.5	44.5	42.9	44.6	45.9	44.3	47.1	69.5	125.0	111.6	15.3	76.2	94.2	106.2	222.9	90.0	44.1	64.6	72.6	583.9	101.5	141.4	108.5	6.2	191.8	69.4	115.8	534.1	172.5	889.5	106.9	86.1	101.0	64.6	196.7	21.8	166.7	143.0	109.5	83.6	86.4	90.5	64.3	74.3	182.2	160.8	18.5	23.8	152.5	209.5	55.0	96.4	146.9	91.6	78.4	160.1	3.7	108.6	115.3	90.6	18.1	21.3	144.4	124.9	89.9	165.7	80.0	201.0	520.3	152.3	56.5	105.2	94.8	151.3	182.0	125.9	139.7	96.7	104.1	81.0	95.6	167.3	103.8
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 876.5;Proximal tubular cells: 881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	152.6	199.3	431.2	103.4	439.3	171.5	135.8	427.1	606.3	127.3	416.7	237.8	161.0	145.8	163.0	170.2	132.4	88.0	482.4	444.8	441.9	249.9	262.0	108.6	132.0	438.5	439.4	130.4	115.5	331.0	186.7	83.0	441.9	132.2	145.0	127.1	163.6	135.8	408.9	128.2	147.8	125.5	411.8	133.3	201.0	66.2	442.5	140.6	130.1	512.8	119.9	162.9	132.9	448.3	250.2	419.6	222.3	383.1	159.6	158.8	238.5	168.1	370.9	259.3	278.8	575.4	278.1	260.7	146.4	185.6	189.1	289.5	162.9	269.7	194.5	172.9	417.8	183.9	350.3	465.7	217.6	379.3	302.6	191.6	240.7	249.2	329.3	180.4	283.7	361.1	194.5	159.3	218.4	304.1	369.7	472.9	144.7	324.3	377.9	252.4	237.6	346.1	298.8	281.3	147.9	209.7	122.0	227.4	250.9	147.3	338.2	332.8	185.5	139.5	158.7	151.5	296.8	288.4	286.4	334.8	277.6	398.2	159.3	299.4	530.8	478.1	406.0	558.8	483.1	616.1	498.0	468.1	589.7	546.7	538.1	514.0	122.7	478.0	489.6	655.0	817.6	1113.4	431.2	439.3	427.1	606.3	444.8	441.9	438.5	439.4	441.9	411.8	442.5	448.3	184.8	76.9	132.7	41.8	107.6	0.0	187.1	0.0	12.5	186.4	162.2	210.2	392.9	204.5	48.3	198.6	58.4	333.1	175.8	109.0	876.5	268.1	24.9	105.8	86.3	142.7	105.6	114.3	72.6	264.7	305.1	128.8	35.2	87.1	109.7	112.0	153.8	346.5	399.1	153.1	82.6	171.6	0.0	184.4	0.0	56.0	218.1	142.2	0.0	33.7	231.0	219.5	158.6	40.2	62.3	250.6	191.7	217.4	59.3	203.2	560.2	881.6	85.2	183.5	170.9	117.2	176.0	85.5	83.1	31.5	0.0	307.7	112.9	225.5	237.6	221.5
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 770.8;Early spermatids: 502.9;Late spermatids: 1712.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	20.5	18.1	9.2	3.2	9.3	6.8	17.5	9.5	8.9	16.6	7.5	24.2	5.1	19.1	7.9	18.9	17.3	2.4	47.2	7.6	8.0	18.0	26.9	13.7	3.1	9.5	9.7	19.1	24.0	7.5	16.6	3.0	9.2	16.3	4.1	7.7	17.3	4.0	88.0	19.0	16.1	3.6	8.4	17.0	19.7	20.9	9.2	2.5	14.9	21.1	3.2	18.4	15.9	10.1	3.3	4.9	9.1	8.1	7.9	5.0	10.4	6.6	4.2	5.2	3.4	10.6	6.2	4.9	4.2	4.1	11.7	5.4	8.8	8.1	3.5	2.8	7.4	20.1	8.7	9.0	9.4	6.0	7.8	8.0	8.2	6.9	12.0	4.2	6.1	5.6	13.5	7.3	5.6	10.5	3.7	6.2	10.2	15.7	6.9	4.6	5.3	12.3	9.5	7.5	5.8	4.7	9.0	10.3	4.8	4.4	10.2	4.6	8.9	3.2	3.0	4.4	4.8	12.1	7.1	3.5	5.7	7.7	4.6	3.1	5.7	3.8	2.8	7.1	2.4	2.9	2.4	2.2	5.0	3.5	2.9	2.8	3.3	4.4	6.6	4.4	2.7	2.8	9.2	9.3	9.5	8.9	7.6	8.0	9.5	9.7	9.2	8.4	9.2	10.1	42.8	54.5	46.7	14.4	36.5	19.9	53.7	97.7	24.5	81.2	64.9	65.7	770.8	92.9	58.6	90.1	68.8	57.5	32.5	89.3	230.9	86.5	502.9	84.5	64.9	48.1	78.3	112.4	19.4	101.5	59.5	57.2	55.5	56.9	31.6	45.5	68.2	334.5	114.4	57.2	22.1	114.8	87.5	88.3	38.1	1712.0	66.5	62.3	37.4	17.8	86.4	88.7	49.4	15.6	19.5	98.6	80.9	62.4	39.0	109.3	176.4	372.6	85.9	104.7	72.3	54.0	66.1	243.5	77.1	50.0	23.4	89.9	29.9	83.8	95.4	65.3
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791741-90959393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 59.4;choroid plexus: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 374.6;Oligodendrocytes: 307.8"	"Cancer enhanced"	"Detected in many"		"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 4.0;MOLT-4: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.2	3.5	20.5	0.9	28.2	2.4	1.6	6.7	59.4	3.3	24.3	8.3	0.6	5.5	3.1	2.2	3.4	1.8	9.0	33.2	20.0	2.3	0.2	5.4	0.4	8.4	12.7	3.2	0.3	0.5	3.8	1.7	7.2	3.3	0.1	0.9	1.3	0.8	0.3	1.7	1.6	0.2	12.4	1.4	2.9	4.8	27.1	0.0	2.0	0.1	0.0	4.5	2.4	41.2	0.1	0.1	1.4	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.7	4.0	1.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	3.9	0.0	1.0	2.8	2.8	0.0	3.7	4.2	2.2	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	2.8	0.1	0.0	1.4	1.7	0.0	0.1	1.0	2.5	2.4	0.0	1.0	3.8	2.4	2.0	2.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	20.5	28.2	6.7	59.4	33.2	20.0	8.4	12.7	7.2	12.4	27.1	41.2	0.8	19.2	69.7	20.9	0.0	0.5	0.2	0.1	0.0	4.8	0.2	0.8	64.0	0.0	2.5	12.9	0.0	0.0	0.4	0.1	0.0	0.0	4.4	0.4	2.2	3.4	0.0	12.2	374.6	0.2	0.0	6.4	0.0	0.2	1.3	0.2	0.7	0.0	0.1	0.0	63.5	0.0	0.0	0.0	0.6	1.4	2.5	0.3	3.6	38.4	0.0	0.4	0.0	17.6	307.8	0.1	0.0	2.2	0.1	0.1	0.0	9.0	0.0	0.5	6.6	1.0	6.1	4.6	2.2	0.1	0.9	0.0	0.2	0.5	0.0	0.0
NEDD8	Nedd-8	ENSG00000129559	"NEDD8 ubiquitin like modifier"	Q15843	14	24216857-24232367	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		990000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	169.0	224.3	156.9	71.5	162.3	91.0	156.7	158.6	219.1	152.4	152.5	172.9	55.9	147.6	132.6	202.1	131.3	51.0	299.8	163.1	168.6	195.8	175.7	147.7	81.2	163.7	158.7	138.1	110.9	289.1	143.9	84.3	162.4	133.7	88.7	74.6	139.3	85.5	294.3	182.2	128.8	97.7	157.5	164.6	146.8	77.9	162.1	125.7	132.8	197.1	113.1	152.0	157.5	162.0	166.9	292.7	223.8	159.9	255.2	223.2	165.6	218.7	237.4	259.5	237.5	204.6	196.1	142.1	126.9	317.1	212.3	169.2	230.8	349.5	365.6	201.9	139.7	150.2	272.9	710.7	220.8	251.8	151.6	237.0	231.8	217.2	172.0	239.1	317.3	162.3	139.3	161.5	409.4	380.3	203.4	241.1	166.1	303.7	335.8	141.3	176.9	146.1	302.7	322.1	96.7	221.7	188.3	192.6	168.4	229.5	117.6	199.2	230.3	145.4	144.9	184.9	198.5	187.9	322.7	210.6	102.6	146.2	139.6	461.6	277.3	459.9	214.7	302.8	235.5	311.9	246.0	241.0	276.3	273.4	229.8	233.1	299.8	233.7	310.5	369.7	327.3	526.6	156.9	162.3	158.6	219.1	163.1	168.6	163.7	158.7	162.4	157.5	162.1	162.0	276.4	144.2	156.8	0.0	182.1	277.9	227.5	644.7	166.8	101.0	263.4	301.5	464.7	215.9	301.5	310.8	47.9	525.7	237.0	267.8	594.8	344.9	72.6	201.8	189.4	259.5	212.4	220.7	0.0	406.9	625.0	246.0	108.1	195.4	218.6	228.7	222.0	431.5	576.3	106.0	0.0	286.4	362.2	288.7	345.5	77.3	272.1	255.4	268.6	0.0	394.0	275.0	346.1	0.0	0.0	449.8	311.5	275.7	161.3	254.4	340.2	845.8	279.7	95.9	210.4	178.7	318.4	150.0	196.9	252.1	386.6	419.5	216.0	289.8	291.8	275.5
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913758-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 689.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	25	"HEK 293: 3890.8"									"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA		220000		"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	0.3	19.5	61.1	0.9	27.9	0.0	0.1	150.0	689.9	9.6	0.0	2.8	0.1	4.0	0.0	4.0	5.3	0.2	0.2	57.7	54.0	1.9	0.1	0.2	0.1	610.3	89.1	1.7	2.0	0.0	17.9	0.2	487.1	1.5	0.7	90.8	0.3	27.6	1.7	0.6	1.3	2.5	86.8	0.1	0.9	18.9	430.5	1.7	0.1	0.7	0.5	0.4	6.5	203.6	0.0	0.0	154.3	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3890.8	0.0	0.0	0.0	79.4	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.2	5.9	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.7	32.6	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	27.9	150.0	689.9	57.7	54.0	610.3	89.1	487.1	86.8	430.5	203.6	3.1	0.0	0.0	12.4	0.0	1.3	0.2	0.1	9.1	30.9	1.1	21.2	2.4	0.0	0.6	0.0	6.2	0.0	3.2	0.1	0.0	0.1	92.6	0.7	19.5	2.9	3.5	0.0	46.6	0.2	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	20.2	17.5	0.0	0.0	0.0	0.7	114.6	0.9	0.7	1.8	13.1	0.0	22.8	0.0	9.5	13.6	0.0	0.0	4.5	0.4	0.3	0.0	0.4	0.0	69.1	0.0	3.3	5.7	43.8	1.0	14.0	0.3	0.0	4.1	0.0	0.1	0.4
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787345	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	9.5	27.8	29.2	5.9	28.8	2.3	9.5	27.7	27.9	13.1	23.8	8.6	2.8	9.5	12.5	6.9	15.0	5.7	14.6	29.6	35.6	12.8	16.3	7.4	7.1	32.0	34.3	11.1	11.2	9.0	17.9	6.4	36.8	11.3	4.8	13.4	10.0	8.1	24.5	15.8	6.8	8.5	31.9	12.4	6.9	26.1	36.1	4.7	11.8	13.7	6.9	9.8	8.8	28.3	8.2	22.9	14.1	27.7	6.6	12.2	6.3	13.0	10.6	12.2	8.4	7.1	8.8	3.2	4.9	15.7	26.3	7.1	13.5	14.1	16.7	9.7	6.7	11.3	5.7	13.9	5.3	5.0	8.2	10.8	20.7	10.7	9.9	11.8	11.6	3.7	16.1	10.8	15.0	8.6	0.9	5.2	12.6	33.9	12.1	14.4	18.1	8.8	14.4	12.3	21.5	17.0	10.2	5.3	19.1	11.2	8.4	0.7	14.3	13.9	19.8	3.8	18.4	10.0	22.3	5.7	36.6	16.7	28.8	0.7	2.2	0.2	12.7	3.9	17.5	21.9	12.9	15.3	4.6	16.9	18.7	16.8	1.3	15.1	2.0	8.3	9.3	7.0	29.2	28.8	27.7	27.9	29.6	35.6	32.0	34.3	36.8	31.9	36.1	28.3	7.2	0.0	5.8	6.2	14.0	8.5	17.1	8.0	13.6	32.3	13.1	7.7	19.6	14.3	7.0	7.3	16.7	18.6	5.6	1.5	33.2	21.1	1.1	6.9	8.4	8.9	10.1	10.3	6.3	23.3	15.8	10.3	3.1	3.8	2.5	14.9	7.9	23.6	15.1	8.4	6.9	6.1	14.2	6.9	6.6	2.1	14.0	6.8	14.2	0.0	6.6	38.9	11.3	6.0	3.7	15.1	1.0	24.5	3.8	15.3	0.8	32.2	6.8	17.1	6.6	11.8	10.2	19.0	68.1	8.3	12.8	5.3	9.7	8.9	6.2	12.0
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309874-177362936	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.6;lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	HPA065761			Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.1	0.0	0.0	1.7	0.0	6.6	0.3	0.0	0.1	0.2	0.0	1.1	1.1	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	2.3	1.3	0.5	0.0	0.4	0.6	1.5	0.1	23.6	0.0	0.0	3.5	0.4	0.4	0.0	19.3	15.8	16.4	8.2	1.8	3.3	8.0	23.4	8.6	25.3	14.9	5.8	16.5	21.2	3.4	6.2	25.1	8.8	17.4	9.3	36.6	72.1	11.4	14.7	11.9	15.2	0.5	79.1	9.7	0.3	0.5	26.2	5.6	5.2	9.9	53.9	15.3	99.1	16.7	8.4	80.7	30.2	7.5	5.7	11.5	16.2	11.2	6.8	6.8	2.6	12.8	8.9	11.7	13.4	6.3	7.2	10.9	20.4	4.7	15.2	11.8	7.8	24.0	6.8	4.8	33.5	10.1	27.8	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.4	1.2	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	2.6	1.6	0.5	0.0	0.0	0.1	0.1	0.6	0.3	0.0	14.7	0.1	0.2	3.3	0.9	0.0	0.5	0.0	4.8	0.4	0.0	1.5	0.0	0.1	1.0	0.0	1.3	0.4	0.2	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	6.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.5	2.7	2.4	4.5	1.3	0.3	1.0	0.5	1.2	0.2
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982717-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	9.3	7.8	7.5	10.8	8.6	14.2	6.0	8.0	11.5	7.1	6.1	9.4	13.4	11.3	6.3	9.5	12.4	5.7	6.3	8.0	6.9	6.8	5.8	6.6	10.8	8.7	8.9	15.5	16.7	10.1	3.0	10.3	6.8	8.9	4.7	7.0	18.2	8.4	12.0	12.8	13.4	5.7	8.1	12.1	12.7	16.5	7.4	9.4	7.4	4.6	7.4	6.8	1.8	9.5	27.2	24.6	21.0	38.8	8.5	8.9	41.6	14.3	10.1	16.9	13.4	41.1	45.7	47.8	20.1	9.3	21.0	25.2	21.3	17.9	8.2	24.5	33.2	31.5	18.0	39.4	12.4	33.1	30.9	7.6	15.6	11.3	12.0	12.5	13.0	26.6	60.5	22.3	7.4	31.7	63.8	94.4	60.8	23.2	36.5	57.6	18.3	30.2	12.1	22.5	57.1	35.7	16.4	19.3	24.4	13.0	37.1	24.5	14.7	17.0	19.2	19.8	31.9	47.2	52.7	53.6	19.4	34.5	21.4	7.0	14.4	14.9	15.4	16.9	18.5	16.3	17.9	13.9	13.9	24.0	15.0	12.0	5.3	15.4	14.0	17.3	22.1	13.1	7.5	8.6	8.0	11.5	8.0	6.9	8.7	8.9	6.8	8.1	7.4	9.5	11.1	12.8	17.9	30.7	18.5	32.6	18.6	20.3	17.6	19.2	17.6	19.3	4.6	14.3	19.1	12.9	39.6	27.9	16.2	14.6	9.8	18.7	24.0	25.2	17.7	13.2	16.2	17.2	55.9	13.6	28.1	14.7	13.3	28.5	9.5	23.3	11.4	8.3	16.4	37.0	40.9	17.8	14.2	10.1	12.1	7.4	15.5	11.3	14.2	13.1	19.6	18.1	19.6	31.7	30.2	16.2	18.7	13.2	14.0	23.6	17.5	8.9	17.3	21.9	0.0	15.4	15.2	32.9	39.4	29.8	38.2	28.5	18.8	15.8	20.1	27.0
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959038	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 635.4;Late spermatids: 1699.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	51.9	48.5	37.4	15.2	38.2	23.5	49.4	38.6	40.3	47.9	36.6	45.9	12.7	50.1	26.9	51.7	46.9	11.9	57.1	35.8	39.2	50.0	24.5	43.6	16.9	39.1	38.3	47.4	52.4	41.1	42.5	20.5	37.4	35.4	24.2	6.3	40.5	26.7	58.2	51.3	37.2	27.7	38.7	38.7	46.6	166.2	39.2	36.8	39.6	30.8	25.4	44.1	43.5	39.6	51.8	59.9	55.5	48.4	54.7	59.9	50.9	40.3	73.8	90.1	74.6	69.5	35.7	49.0	41.3	79.0	117.1	44.0	47.4	85.7	64.5	39.4	63.2	35.9	41.9	80.5	110.6	43.4	29.0	63.2	119.2	96.2	113.5	75.6	84.2	87.6	51.6	56.6	90.2	89.6	77.1	44.6	22.9	79.6	68.1	63.0	49.1	95.2	61.0	49.8	42.3	52.8	30.4	44.4	80.1	48.4	66.0	89.6	37.1	39.7	63.5	34.5	67.8	65.9	77.8	47.6	26.0	36.4	69.8	44.9	60.4	58.7	49.4	68.8	46.2	50.9	45.4	47.2	56.9	49.9	41.9	41.0	31.4	48.8	67.8	45.4	49.0	55.4	37.4	38.2	38.6	40.3	35.8	39.2	39.1	38.3	37.4	38.7	39.2	39.6	49.0	16.0	27.9	4.6	42.8	47.2	69.0	61.5	40.5	15.5	55.1	62.5	47.2	72.9	43.1	33.1	12.5	98.4	37.7	84.6	133.1	93.3	635.4	68.4	40.8	49.8	34.2	52.2	6.2	136.5	112.1	47.7	31.1	45.6	45.6	46.7	45.3	34.8	82.8	11.8	6.2	71.1	46.8	55.3	42.6	1699.6	71.1	45.0	49.8	3.7	73.2	65.5	51.5	6.6	9.9	113.1	99.1	45.1	68.6	79.6	124.8	107.7	112.5	25.6	32.9	48.7	84.9	224.7	91.0	54.2	41.8	114.4	41.7	41.0	72.4	64.6
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677407	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 161.6"	"Group enriched"	"Detected in many"	4	"Adipocytes: 102.2;Cardiomyocytes: 279.9;Endothelial cells: 105.5;Sertoli cells: 105.2;Smooth muscle cells: 70.5"	"Cancer enhanced"	"Detected in all"		"glioma: 147.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 627.3;HUVEC TERT2: 321.5;LHCN-M2: 512.6;RH-30: 518.3;SuSa: 340.7;WM-115: 247.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No		100000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	40.0	8.5	24.4	13.8	24.8	0.0	28.2	27.2	22.7	27.1	16.5	16.8	5.3	41.1	12.9	8.2	30.3	11.3	161.6	21.1	26.5	35.2	4.8	42.1	4.8	32.8	27.1	10.1	5.6	10.4	12.8	16.7	25.8	21.2	6.6	8.2	9.7	36.1	55.7	8.6	12.5	30.3	30.0	49.1	10.8	6.2	26.4	2.7	19.9	47.3	2.3	24.2	19.0	30.9	0.2	2.5	627.3	134.7	1.3	33.4	0.6	154.7	120.7	2.3	3.4	102.5	1.9	0.6	35.8	14.9	0.1	2.8	63.9	0.0	1.8	0.0	1.1	0.9	9.7	47.3	5.5	0.3	37.1	28.5	0.0	5.7	0.0	5.3	321.5	0.1	4.9	0.2	512.6	4.3	0.0	0.3	102.3	6.0	88.1	0.7	518.3	0.4	0.6	0.0	1.6	100.4	3.6	4.5	124.9	340.7	1.3	0.9	235.1	0.8	34.5	4.1	8.8	0.2	24.0	0.2	13.4	0.1	247.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	24.8	27.2	22.7	21.1	26.5	32.8	27.1	25.8	30.0	26.4	30.9	102.2	0.0	4.4	0.0	0.7	2.4	0.4	0.2	0.6	0.5	9.4	32.9	279.9	0.0	0.6	18.4	0.0	0.2	1.0	0.6	0.0	2.1	0.4	2.1	31.9	105.5	0.0	0.0	0.3	0.0	1.9	29.4	0.5	2.7	0.0	0.2	26.7	0.1	1.8	0.0	0.6	0.2	0.0	0.8	3.1	0.1	8.1	1.7	1.8	12.2	1.0	17.4	0.0	3.0	2.2	0.3	0.1	4.1	0.1	0.5	0.0	0.1	0.0	1.5	105.2	10.9	70.5	0.5	5.0	1.2	2.4	0.1	1.1	1.4	0.3	0.5
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.1;Late spermatids: 121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	8.8	13.6	19.7	8.4	17.2	8.0	7.6	13.6	28.7	8.9	10.7	10.8	6.2	11.1	6.2	13.4	8.6	5.3	21.4	27.3	13.9	17.2	10.5	9.3	6.4	14.4	18.1	8.5	12.7	27.4	9.5	4.6	14.3	9.9	5.4	7.3	8.5	6.7	22.8	10.2	8.8	8.0	14.3	9.9	10.0	20.9	17.6	9.3	11.1	19.1	7.1	9.3	7.7	16.6	75.8	36.7	12.2	74.3	21.5	22.0	7.7	57.3	37.9	74.1	53.7	32.7	18.4	21.1	50.4	69.9	48.9	27.1	25.1	37.8	52.0	31.9	12.5	26.8	24.4	26.4	22.4	35.1	28.6	20.1	16.4	53.3	51.0	21.8	47.7	13.7	12.0	18.7	64.5	35.1	21.4	16.6	8.3	16.9	20.4	24.2	56.8	18.8	68.5	37.3	17.0	11.6	36.0	24.5	14.0	9.4	14.9	15.4	92.7	101.1	109.6	44.8	112.5	30.0	26.7	25.5	27.0	14.5	68.5	10.0	10.0	4.2	15.5	14.7	13.1	8.3	11.5	10.4	15.1	8.6	9.7	9.2	2.3	13.2	21.0	10.2	10.7	12.2	19.7	17.2	13.6	28.7	27.3	13.9	14.4	18.1	14.3	14.3	17.6	16.6	8.1	6.4	20.1	14.7	9.4	14.1	11.6	9.8	8.6	16.3	14.5	9.0	23.1	18.6	10.0	14.7	10.4	11.7	12.7	9.0	21.5	40.0	77.1	14.5	17.7	13.2	13.1	13.9	27.5	24.9	6.7	12.5	7.7	15.2	22.9	12.2	11.7	14.4	13.5	30.3	27.1	7.9	6.1	14.7	7.5	121.4	7.2	10.2	8.8	18.7	8.6	19.1	14.4	17.6	16.7	40.1	14.5	12.4	14.7	13.6	10.5	30.1	8.6	9.6	6.6	13.7	15.6	29.5	8.1	15.5	14.3	3.8	12.9	17.4	11.2	9.5
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462788	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 777.3;Oligodendrocyte precursor cells: 606.7;Peritubular cells: 438.5;Skeletal myocytes: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.03e-4)"	23.0	12.4	28.4	5.2	37.7	10.0	15.1	75.9	24.6	18.3	31.8	14.2	7.2	8.9	11.7	18.8	15.6	14.3	16.9	28.4	31.3	10.8	40.5	8.4	5.1	51.5	33.4	15.7	13.5	10.9	5.4	4.3	34.9	15.0	9.1	4.2	17.5	11.6	13.8	8.7	6.4	13.2	37.3	9.4	9.7	5.8	33.6	8.6	27.4	15.8	6.8	13.8	10.3	27.1	5.0	6.8	1.0	74.2	31.8	20.2	0.2	1.6	5.1	1.6	2.4	0.4	4.8	10.9	4.8	2.7	0.7	7.2	3.1	15.4	0.9	23.4	6.6	0.4	15.2	4.8	7.3	1.2	1.8	25.7	14.9	6.8	27.6	5.5	19.1	3.0	5.1	16.9	1.5	3.6	0.3	0.3	2.9	6.9	6.6	1.1	6.9	18.2	4.3	13.1	4.8	5.7	4.1	28.2	10.3	0.8	30.2	0.5	15.5	1.3	8.5	15.2	3.1	1.2	3.1	0.1	1.7	0.2	1.7	3.2	2.7	1.5	1.9	1.9	2.9	0.6	2.3	3.0	1.3	0.3	2.2	2.7	0.1	0.5	2.5	1.0	0.1	1.8	28.4	37.7	75.9	24.6	28.4	31.3	51.5	33.4	34.9	37.3	33.6	27.1	232.1	35.3	44.7	777.3	4.4	85.0	68.8	72.1	220.9	42.6	140.7	107.4	192.9	148.7	68.1	47.8	2.1	5.7	8.1	28.4	27.4	38.0	28.9	85.8	69.8	132.7	25.2	163.7	142.3	47.8	1.1	265.6	30.5	68.2	27.3	11.6	197.0	304.5	14.8	42.1	125.7	46.8	36.7	60.8	42.6	26.4	408.8	19.2	46.2	259.5	14.9	150.2	5.2	606.7	431.3	20.8	37.6	438.5	8.0	53.0	19.1	109.9	82.6	6.9	144.7	513.1	133.7	5.0	13.5	148.4	76.3	1.6	15.0	34.9	69.7	57.1
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401513-35404749	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1114.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 4056.6;Langerhans cells: 4828.7;Suprabasal keratinocytes: 3420.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 391.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favorable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	281.0	171.3	75.6	150.7	78.0	1114.7	171.4	75.4	92.5	123.8	78.3	121.0	61.2	95.5	29.6	151.8	141.2	130.4	145.5	71.4	75.9	104.5	208.1	366.0	122.6	90.1	76.2	255.7	101.9	68.8	92.4	92.7	81.6	112.6	80.9	18.7	118.3	110.0	139.7	260.5	148.5	92.7	77.0	226.2	130.7	31.7	84.9	123.2	111.9	138.3	181.4	366.2	166.8	79.8	62.5	54.1	20.1	18.2	114.7	75.9	71.1	25.2	240.7	53.3	47.3	16.9	36.5	37.5	66.1	40.2	125.2	79.5	38.3	104.9	76.1	229.2	14.9	18.6	39.9	101.4	68.6	29.9	15.0	83.1	103.5	36.4	92.2	35.5	48.6	18.4	15.9	58.4	38.6	73.0	39.2	71.0	18.6	60.0	33.1	87.8	23.1	31.6	92.8	391.7	17.9	31.2	67.2	115.9	29.7	41.0	66.1	62.2	91.7	72.8	26.5	21.3	41.0	70.9	77.7	64.5	60.8	22.0	15.3	322.0	444.9	301.4	175.3	267.2	264.0	258.4	207.1	182.5	428.9	329.7	178.1	153.0	942.9	285.9	183.7	233.0	154.9	506.4	75.6	78.0	75.4	92.5	71.4	75.9	90.1	76.2	81.6	77.0	84.9	79.8	802.9	535.2	914.0	14.4	505.6	4056.6	1862.8	2061.4	1729.6	27.0	430.7	414.0	188.6	367.4	719.2	62.5	12.5	196.4	762.2	447.8	195.6	875.0	4.3	703.8	935.6	1079.8	203.5	87.8	7.1	394.8	174.9	1145.1	333.8	1440.1	906.1	68.2	313.4	147.2	791.2	48.8	5.1	453.0	634.7	491.4	4828.7	14.7	153.1	1609.0	1085.1	39.4	428.1	95.2	97.9	6.6	8.6	383.5	511.5	116.2	1039.4	1412.0	1051.6	115.9	298.2	37.4	203.8	956.9	847.2	3.3	26.4	1544.6	3420.6	660.0	838.4	91.8	346.0	1004.6
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290512-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	16.8	16.8	13.7	15.6	14.5	21.9	20.6	20.4	17.6	15.5	15.9	17.1	16.9	17.4	15.7	18.3	15.4	12.4	23.4	13.8	15.0	14.6	27.7	16.0	22.3	13.7	12.8	21.9	15.8	23.4	13.5	13.5	13.5	16.5	19.1	19.4	17.9	16.0	37.7	25.5	17.5	15.7	10.9	18.2	15.8	12.2	14.0	26.3	22.9	26.5	25.2	16.8	15.7	18.2	29.8	24.0	21.4	20.3	31.3	35.1	21.5	27.6	27.4	30.6	30.5	21.7	11.9	46.0	17.0	32.0	20.5	16.3	38.8	29.8	28.4	33.9	18.9	24.1	58.2	24.5	38.1	43.3	25.6	32.7	48.9	26.1	65.4	27.3	18.9	25.6	37.6	38.3	32.2	20.9	28.3	40.7	34.7	21.9	26.8	30.0	23.3	25.2	20.7	28.1	29.3	20.6	27.5	29.3	15.9	25.1	17.0	42.7	23.8	24.8	20.6	18.1	30.4	20.4	19.9	44.6	27.3	21.5	14.4	35.9	5.5	10.4	9.8	8.9	10.5	13.0	10.7	10.8	9.0	10.3	11.8	11.9	3.5	9.3	7.4	15.4	7.6	6.7	13.7	14.5	20.4	17.6	13.8	15.0	13.7	12.8	13.5	10.9	14.0	18.2	16.0	60.9	42.5	35.3	41.9	8.4	24.6	12.5	21.6	29.3	13.2	13.5	36.9	22.8	35.4	27.6	54.2	12.5	17.2	20.6	7.9	16.1	65.9	16.7	19.0	14.9	9.1	25.2	59.7	13.2	11.8	18.5	26.5	19.8	18.9	15.7	17.5	32.4	15.0	21.9	59.0	23.9	12.2	19.4	10.2	17.0	18.3	19.0	3.6	47.8	16.4	13.7	16.5	37.7	55.0	12.4	21.6	23.0	47.1	25.3	23.3	8.2	43.7	32.2	13.1	27.3	17.5	16.1	14.8	20.9	11.2	18.1	20.9	19.2	16.7	21.0
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NIBAN2	"bA356B19.6, C9orf88, DKFZP434H0820, FAM129B, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Niban apoptosis regulator 2"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 606.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 73.6;Extravillous trophoblasts: 40.5;Hofbauer cells: 23.0;Syncytiotrophoblasts: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	48.7	107.5	26.7	36.6	24.7	27.3	42.0	25.2	24.5	96.0	45.3	74.6	50.8	38.9	12.6	606.7	39.4	39.6	39.4	22.7	35.0	72.3	16.7	121.9	6.6	48.9	34.3	31.6	142.6	26.2	34.0	84.8	36.3	66.5	30.3	2.7	142.1	32.2	13.6	111.3	53.9	22.0	39.7	32.2	83.3	11.0	34.7	5.6	110.6	11.3	53.6	68.4	189.6	31.9	134.0	149.8	29.9	39.3	87.9	170.1	138.2	259.1	238.5	140.1	86.4	48.2	143.7	0.4	100.4	295.5	172.9	217.5	25.9	192.2	45.9	25.2	27.5	22.8	218.9	50.4	173.1	1.0	62.0	187.3	118.3	231.4	80.8	256.8	213.6	8.4	43.5	1.2	269.8	157.3	1.6	37.6	30.9	228.0	194.4	16.0	99.9	70.1	120.5	105.6	47.4	22.1	212.3	149.0	93.4	42.1	98.2	7.5	279.9	143.1	62.4	182.2	218.0	2.5	5.1	0.6	403.3	21.6	271.1	0.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	26.7	24.7	25.2	24.5	22.7	35.0	48.9	34.3	36.3	39.7	34.7	31.9	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	73.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	40.5	4.2	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	120.9	0.1	0.0	0.0	0.0
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 31.0;Endothelial cells: 19.7;Fibroblasts: 46.0;Microglial cells: 19.7;Smooth muscle cells: 22.6;Theca cells: 19.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 285.4;ASC TERT1: 113.0;BJ: 152.1;BJ hTERT+: 131.8;HHSteC: 158.1;HSkMC: 591.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		6300000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.78e-4)"	28.3	5.2	0.9	9.2	1.2	0.7	9.6	0.6	1.4	7.5	44.0	8.8	2.3	17.4	5.8	5.4	6.7	19.0	15.6	1.4	0.5	4.8	5.9	6.1	3.5	1.8	0.6	18.9	3.4	13.2	2.5	60.8	0.5	8.4	6.8	0.1	3.6	10.4	4.3	1.7	3.5	11.4	1.1	1.9	6.8	1.4	0.9	2.1	31.6	5.5	1.4	15.4	5.4	1.6	0.0	3.4	76.6	0.0	285.4	113.0	0.2	152.1	131.8	14.5	15.0	0.4	0.0	0.0	22.2	17.3	0.0	10.7	9.9	0.1	3.9	0.1	2.0	0.0	3.0	0.0	158.1	0.0	0.0	591.5	0.0	59.6	0.1	82.5	8.1	0.1	0.0	0.0	8.6	0.0	0.0	0.4	3.3	0.0	5.1	23.5	0.2	0.1	19.9	0.0	0.0	1.8	0.0	0.1	0.0	10.0	0.0	0.0	0.9	54.4	0.6	33.0	0.0	0.0	0.0	0.1	17.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.6	1.4	1.4	0.5	1.8	0.6	0.5	1.1	0.9	1.6	31.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.6	1.4	0.2	0.3	2.1	0.0	0.0	1.8	0.0	0.7	0.7	3.7	0.0	0.1	14.0	1.5	11.3	19.7	0.0	0.0	0.8	0.0	1.1	46.0	1.1	0.4	1.3	0.4	8.6	0.0	1.6	0.0	1.7	2.0	0.0	0.3	1.2	4.4	6.2	0.3	3.6	19.7	1.0	0.0	0.0	2.0	4.8	0.2	1.3	8.6	0.1	0.2	1.7	0.4	0.0	0.8	6.6	6.1	22.6	0.2	0.1	0.1	1.0	0.8	0.4	19.1	3.0	0.2
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736911	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	29.3	24.8	18.1	31.9	18.6	31.5	37.3	18.7	21.8	25.4	17.9	24.8	25.1	28.5	21.9	34.6	27.5	25.1	22.9	19.3	18.7	25.7	34.1	17.9	47.2	18.5	17.8	36.5	32.6	17.9	16.7	25.6	18.4	24.6	25.6	23.0	17.9	17.8	38.3	34.5	20.1	24.8	19.1	22.3	22.5	21.8	18.3	32.9	25.2	18.3	42.4	43.3	24.5	20.1	118.4	37.6	68.8	68.3	57.9	80.6	90.2	90.6	75.2	105.0	113.2	105.9	55.0	152.4	111.4	66.9	93.1	72.9	149.4	116.4	153.4	101.3	85.7	155.0	44.5	92.9	82.6	141.1	81.7	80.6	126.7	137.4	184.4	48.7	75.9	60.3	174.5	73.9	90.5	58.2	109.5	140.9	175.3	132.4	122.5	102.5	80.7	191.2	92.1	72.4	88.1	91.8	56.6	105.1	200.7	62.2	52.0	123.1	45.7	72.8	123.5	85.6	129.3	87.5	150.6	182.1	55.7	143.9	101.5	41.8	54.2	28.8	59.2	65.3	83.4	73.6	72.3	68.6	72.1	74.8	84.5	79.4	4.0	81.5	62.5	64.0	68.9	75.1	18.1	18.6	18.7	21.8	19.3	18.7	18.5	17.8	18.4	19.1	18.3	20.1	51.1	44.8	25.9	8.1	56.3	98.4	128.9	87.0	81.4	25.8	51.2	88.8	21.5	24.3	62.2	14.7	12.5	74.9	62.7	18.9	46.9	64.2	23.7	43.8	126.9	47.7	28.1	41.8	8.2	45.2	90.6	68.7	32.6	39.9	54.5	47.9	26.0	33.2	54.4	13.5	7.2	41.3	42.7	34.5	32.8	8.0	57.5	39.0	23.2	10.3	59.1	48.0	54.6	13.0	8.0	51.5	28.4	45.1	33.3	107.0	18.4	58.4	41.9	45.8	39.5	72.7	54.3	81.1	83.9	79.3	101.4	48.8	52.5	97.7	60.5	125.2
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600655-42648735	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	17.4	19.2	16.4	17.6	18.7	46.5	19.3	22.3	17.1	28.4	17.9	17.7	13.2	18.4	22.4	17.0	23.0	11.4	17.8	15.0	20.3	18.2	21.1	23.9	22.1	20.5	16.4	29.0	22.1	10.6	36.5	11.1	17.6	23.2	13.4	41.3	17.5	10.5	19.5	32.6	25.4	10.7	14.0	36.7	16.3	18.0	18.2	15.4	25.4	10.4	20.0	18.3	22.6	27.8	15.1	7.7	32.3	15.6	16.6	19.3	14.9	22.8	6.8	9.9	12.9	14.7	13.3	25.9	10.7	9.1	9.0	12.6	16.1	8.4	19.2	11.0	13.1	31.4	30.5	24.6	7.3	25.4	19.9	9.6	12.2	18.4	10.5	19.1	17.4	7.1	30.3	20.2	18.6	6.9	17.8	35.5	23.1	7.6	12.3	17.3	12.0	10.5	15.7	12.7	9.4	8.5	24.1	11.1	4.8	16.3	17.5	17.8	28.0	18.0	13.1	21.4	23.2	17.2	21.7	17.7	10.1	30.0	11.3	7.8	3.6	7.5	5.7	4.6	5.3	5.5	5.6	4.9	2.9	5.3	5.6	4.9	5.3	7.0	6.8	5.1	5.3	2.3	16.4	18.7	22.3	17.1	15.0	20.3	20.5	16.4	17.6	14.0	18.2	27.8	221.8	109.0	141.4	169.4	129.5	59.0	60.3	57.8	66.0	200.0	76.3	69.8	68.7	65.8	73.2	88.3	246.0	72.5	156.0	60.3	17.6	47.3	23.9	114.4	125.5	166.2	71.8	76.6	143.5	38.8	51.1	83.3	86.6	132.4	96.8	210.0	110.7	58.6	45.9	132.9	170.0	70.2	61.1	53.8	70.2	21.8	167.7	78.9	51.6	194.9	97.4	101.9	163.7	180.0	267.2	47.6	59.2	134.3	131.3	77.5	106.8	17.0	53.3	279.9	92.1	103.5	88.9	246.2	186.1	42.4	57.3	31.3	164.4	104.5	75.0	54.2
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153559-51162428	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	63.6	84.4	79.3	74.7	81.6	77.0	63.1	78.7	102.2	38.2	79.0	60.1	38.8	49.7	46.8	91.0	48.6	20.8	37.7	88.0	92.0	65.4	83.2	41.3	73.9	83.9	78.4	33.6	67.8	52.8	47.4	39.2	82.4	38.7	77.6	218.4	50.7	30.4	35.6	57.5	33.1	66.3	76.5	48.5	41.8	25.3	81.0	61.1	41.3	20.9	95.8	72.2	48.9	80.1	483.6	833.1	285.9	444.8	118.6	183.7	479.7	355.3	227.3	652.2	489.7	656.9	288.1	754.2	372.4	304.1	272.4	252.1	542.5	553.3	553.4	398.4	729.3	504.9	605.8	975.9	237.1	575.8	243.8	177.8	341.7	493.1	458.6	120.6	404.6	247.8	739.0	270.0	392.8	720.4	715.2	647.1	390.7	957.5	739.3	446.9	587.6	751.3	511.5	320.2	418.6	461.1	188.1	521.0	385.3	246.2	554.0	419.6	279.5	476.9	452.2	307.0	774.4	374.0	840.9	956.3	286.2	480.4	385.8	1.1	55.0	2.1	47.2	77.1	69.3	96.4	50.3	53.8	134.0	67.6	54.3	60.4	1.7	69.6	48.6	84.8	49.1	68.4	79.3	81.6	78.7	102.2	88.0	92.0	83.9	78.4	82.4	76.5	81.0	80.1	53.1	32.1	30.5	0.0	71.3	132.4	97.5	198.8	88.8	283.3	98.8	118.1	34.2	65.8	92.3	71.7	285.7	180.0	25.4	54.2	150.6	211.3	34.2	40.2	107.2	85.1	89.7	81.8	0.0	201.5	269.7	85.0	64.2	37.2	45.7	113.5	27.8	123.3	207.1	40.4	0.0	107.4	101.7	25.7	88.9	93.7	61.2	48.9	129.9	0.0	47.2	105.6	27.8	0.0	0.0	194.0	50.5	58.6	113.8	170.6	12.2	195.2	42.0	323.7	13.1	83.0	182.9	22.7	98.8	139.4	133.1	88.5	38.0	215.5	157.7	98.2
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461691-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	20.8	39.6	40.2	8.8	42.5	13.4	25.5	41.2	49.4	25.5	36.7	23.3	16.1	24.0	24.7	27.4	23.8	16.1	25.3	41.0	40.4	36.7	57.3	19.9	18.1	42.5	40.4	30.3	44.1	16.2	27.3	13.9	42.4	36.7	11.5	5.0	32.8	19.3	5.2	34.3	23.6	13.6	39.6	26.2	41.4	11.5	41.2	18.6	27.3	4.3	14.8	22.2	24.0	43.5	36.7	47.6	10.3	28.5	26.1	23.7	34.9	26.5	12.0	32.9	25.3	44.3	69.2	0.8	46.2	41.8	9.9	35.3	26.3	43.7	15.7	28.5	10.5	31.1	38.0	24.5	50.5	36.5	22.2	32.4	54.4	41.5	16.7	28.6	39.8	116.3	32.7	0.9	19.2	116.0	81.7	39.2	31.4	55.8	39.7	73.7	0.7	42.4	42.1	21.2	12.9	26.6	50.4	78.1	27.4	6.5	66.5	39.4	17.9	17.5	0.8	14.9	0.3	0.9	0.6	57.1	8.9	35.6	31.5	13.1	59.3	6.1	61.1	35.9	45.6	38.9	42.6	57.2	53.9	35.0	43.2	44.3	32.5	27.9	26.6	52.7	42.3	53.7	40.2	42.5	41.2	49.4	41.0	40.4	42.5	40.4	42.4	39.6	41.2	43.5	16.2	25.6	26.0	11.1	19.3	27.3	38.1	48.8	43.3	11.7	48.7	46.4	22.6	40.0	38.7	42.3	0.0	105.8	30.6	29.1	52.8	34.6	12.5	24.9	21.8	19.0	20.4	20.8	9.1	49.8	102.5	23.8	46.4	34.4	20.8	41.3	26.4	78.7	67.1	5.0	11.1	38.2	30.5	29.5	18.7	35.7	29.2	23.1	35.6	8.4	30.9	45.5	54.6	7.5	19.0	37.4	36.5	30.5	27.8	29.0	46.3	114.5	35.7	10.0	26.3	10.6	24.0	5.4	37.3	29.6	30.5	64.2	32.9	37.9	38.5	32.8
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	116	"heart muscle: 1438.4;skeletal muscle: 634.8;tongue: 722.1"	"Cell type enriched"	"Detected in some"	36	"Cardiomyocytes: 995.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8;testis cancer: 13.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 29.2;NTERA-2: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.7	1.7	0.2	0.0	0.2	0.0	0.8	0.2	0.8	0.2	0.2	0.5	0.0	0.4	0.1	5.7	0.6	0.0	1438.4	0.2	0.4	1.9	0.3	2.1	0.0	0.3	0.4	0.5	0.6	0.0	1.7	0.1	0.1	2.6	0.1	0.0	8.0	0.8	634.8	0.7	0.5	0.0	0.2	0.1	0.6	0.5	0.2	0.0	0.6	722.1	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.8	0.2	0.4	0.3	0.4	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	995.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.4	0.0	0.0	0.2	0.0	0.6	26.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	24.6	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944203-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	26.7	23.6	17.1	23.0	17.1	30.1	26.4	16.8	21.2	29.5	14.3	28.0	17.9	30.3	10.3	47.3	27.7	14.1	32.8	18.1	18.5	27.1	33.7	23.6	23.1	18.5	17.0	26.0	35.6	21.2	24.4	15.8	19.5	26.8	11.6	9.6	26.5	16.0	73.0	45.0	25.2	15.0	15.1	28.0	28.4	36.0	17.6	20.1	24.3	26.4	15.9	32.7	31.7	18.5	112.8	110.4	19.8	129.5	34.5	31.0	70.2	82.3	38.9	114.4	62.1	148.5	110.5	126.3	113.3	56.0	94.0	102.2	147.6	122.8	49.2	79.2	161.5	67.0	141.2	132.0	77.4	151.1	63.8	50.3	35.0	125.3	84.3	35.3	56.4	44.6	190.8	58.2	51.6	182.1	98.7	92.6	112.0	82.3	128.8	120.0	81.5	155.9	53.6	47.4	136.0	133.0	109.3	166.3	105.1	30.3	74.8	81.1	64.1	68.3	95.9	75.2	143.0	97.6	112.5	225.7	84.3	209.1	57.7	21.3	30.9	22.2	23.9	46.4	31.3	23.9	23.3	23.4	36.8	19.3	23.3	18.6	2.8	34.5	57.5	23.6	19.9	31.7	17.1	17.1	16.8	21.2	18.1	18.5	18.5	17.0	19.5	15.1	17.6	18.5	21.5	16.0	23.1	12.4	42.7	69.3	90.8	42.9	47.8	54.6	33.4	34.7	4.5	28.6	29.8	36.8	62.6	63.7	24.7	27.4	17.6	49.9	10.2	34.8	40.9	27.8	30.0	23.8	12.6	46.2	65.5	29.9	28.1	36.9	13.9	36.4	24.7	24.0	39.6	45.4	12.4	27.6	36.7	24.6	29.2	10.3	29.5	24.4	24.9	12.2	35.7	20.6	60.8	9.5	10.6	39.2	21.4	21.4	42.6	71.9	22.9	19.6	27.1	77.0	32.9	41.2	34.6	43.0	83.9	47.4	82.0	58.8	36.6	51.8	53.1	69.3
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	8.6	9.0	5.1	9.5	6.5	3.6	11.2	5.9	5.9	6.7	5.9	5.2	5.4	8.5	6.4	9.0	6.2	5.7	5.3	4.6	5.8	7.2	9.9	5.2	13.1	6.5	6.4	8.2	5.3	9.1	4.3	8.9	6.5	7.4	6.3	6.2	5.3	6.5	9.4	9.3	5.4	7.1	6.4	11.4	5.5	10.4	5.8	7.5	11.1	10.4	13.2	10.3	6.4	7.1	38.4	20.6	13.6	44.1	13.9	22.4	16.1	29.9	23.6	40.2	46.3	35.1	26.4	41.3	21.4	15.0	20.6	26.9	39.2	18.0	64.6	28.3	29.3	28.1	16.6	22.6	27.8	45.0	12.2	13.0	17.3	42.5	42.2	26.2	18.1	15.1	44.2	20.3	40.0	12.9	28.5	33.2	28.9	22.3	22.4	12.5	31.3	22.8	23.7	11.7	9.7	24.1	21.4	10.7	33.9	15.2	27.6	17.1	17.7	25.6	25.9	23.4	50.9	19.1	40.8	56.8	23.4	42.6	19.5	0.1	2.6	0.6	4.3	4.3	5.4	14.4	4.4	5.5	4.6	12.8	5.7	5.2	0.1	8.2	5.0	4.1	4.3	3.3	5.1	6.5	5.9	5.9	4.6	5.8	6.5	6.4	6.5	6.4	5.8	7.1	33.5	19.2	13.7	11.4	38.0	23.7	32.7	17.0	33.0	20.7	16.4	20.7	22.5	14.3	31.8	22.0	8.4	21.1	17.7	5.1	25.4	20.6	3.9	20.3	50.1	26.1	5.4	26.7	11.7	13.8	15.1	27.0	10.2	17.0	29.2	26.9	11.7	12.9	13.2	13.5	15.5	8.1	12.2	17.0	11.9	5.0	18.3	15.0	12.4	11.2	23.3	20.5	20.6	19.6	23.6	15.3	3.4	24.8	26.3	34.1	1.7	22.7	21.1	20.9	13.1	37.8	23.7	64.0	64.5	25.5	21.7	15.2	17.3	44.5	10.7	19.1
NOL4L	"C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424"	ENSG00000197183	"Nucleolar protein 4 like"	Q96MY1	20	32443059-32585074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 49.3;testis: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 107.4;Late spermatids: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 73.4;HEL: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041768, HPA043600"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA041768: AB_10964172, HPA043600: AB_10961001"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.10e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (2.63e-4)"	10.4	9.1	12.8	8.7	17.5	20.8	10.2	20.8	19.9	8.7	3.1	17.2	18.7	6.6	12.0	2.5	8.6	8.6	5.6	13.2	14.7	14.5	7.0	13.4	8.0	14.5	13.5	4.0	11.1	4.3	22.3	11.1	14.8	8.7	13.6	49.3	9.7	8.2	1.6	3.5	19.8	6.5	10.3	12.9	13.2	50.0	13.1	15.1	9.7	1.7	5.8	9.7	5.2	19.5	9.1	27.4	16.9	11.6	3.6	5.4	2.3	5.7	4.6	7.1	4.9	73.4	20.8	0.6	16.6	7.5	11.0	2.5	5.4	15.9	3.2	2.1	4.3	58.2	14.5	53.2	9.3	0.9	3.3	13.6	2.2	5.2	3.4	16.1	43.1	12.5	17.7	7.6	3.4	5.1	19.3	17.8	9.9	27.7	25.3	8.2	2.1	3.0	12.0	1.6	22.3	18.1	17.9	0.4	9.8	17.4	3.7	17.8	45.5	6.6	22.6	6.1	5.9	5.6	2.1	4.0	7.2	31.4	20.3	2.9	2.0	1.2	5.8	4.5	5.1	1.6	3.8	3.4	2.1	1.1	7.6	6.4	6.5	8.3	12.1	0.2	6.9	4.9	12.8	17.5	20.8	19.9	13.2	14.7	14.5	13.5	14.8	10.3	13.1	19.5	23.1	6.4	3.3	7.2	4.1	0.0	10.8	0.0	2.2	49.9	20.8	18.3	8.8	11.5	1.3	12.9	66.7	0.3	29.5	57.9	9.8	8.0	107.4	9.4	2.9	25.3	17.5	4.6	29.7	7.8	2.1	5.8	20.4	8.7	12.0	11.1	21.8	4.7	9.8	8.4	22.0	36.6	0.0	3.3	0.0	171.5	5.6	8.6	0.0	33.7	6.1	17.2	24.7	14.1	51.2	14.0	36.6	4.9	9.0	15.2	59.4	24.0	2.2	57.3	19.7	1.7	5.0	75.3	3.8	0.8	0.0	0.4	16.5	16.9	29.5	28.7
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461353-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	19.0	22.0	15.6	13.5	15.5	19.9	17.8	14.3	17.6	19.8	14.5	15.3	8.7	19.5	9.3	29.7	17.1	8.0	20.5	16.5	14.4	21.4	27.0	18.1	14.3	15.2	14.6	19.3	28.4	13.6	24.3	12.1	15.1	23.5	11.8	6.8	17.3	10.1	31.0	27.9	16.2	13.7	13.9	23.5	18.0	28.8	15.8	13.8	17.3	12.0	16.0	22.9	20.6	15.6	37.5	52.3	20.0	45.6	30.5	20.6	33.6	41.2	30.8	46.7	39.3	57.8	13.5	65.3	18.3	46.4	20.7	25.7	58.8	59.1	49.5	41.5	23.9	33.8	62.9	33.1	29.8	78.2	47.0	23.7	48.0	62.9	60.9	19.7	31.6	23.5	54.8	24.5	38.1	33.1	43.3	77.1	71.4	42.0	47.6	36.9	19.9	33.5	36.7	44.1	23.3	31.8	34.0	43.9	14.9	21.3	17.7	44.1	34.7	28.2	38.5	36.6	72.7	22.9	34.4	54.5	25.3	40.6	33.4	0.0	3.0	0.2	3.6	5.9	4.1	2.8	2.7	3.6	5.0	2.2	3.3	3.2	0.1	2.8	6.3	2.7	3.0	2.7	15.6	15.5	14.3	17.6	16.5	14.4	15.2	14.6	15.1	13.9	15.8	15.6	4.8	3.2	12.9	5.2	5.7	20.0	6.6	3.7	4.0	6.5	6.7	6.5	6.6	4.3	8.6	3.7	6.2	4.2	5.4	3.8	3.9	6.3	30.4	7.1	7.7	6.5	10.2	5.7	11.6	4.0	6.1	4.8	9.2	13.6	3.8	7.3	4.2	8.8	5.0	3.3	7.3	5.6	2.0	1.6	4.0	22.0	5.9	3.4	5.4	4.7	3.8	4.2	4.1	6.0	5.9	5.7	2.1	6.0	4.8	10.6	2.4	3.0	6.0	3.8	0.0	6.9	4.5	2.7	5.6	9.5	25.9	3.0	4.9	7.0	7.2	9.5
NOLC1	"KIAA0035, NOPP130, NOPP140, P130, Srp40"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"		No	Yes		44000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109"	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (7.68e-2)"	36.5	23.9	10.7	41.9	12.3	37.2	32.3	14.6	20.5	27.1	4.5	31.8	21.8	30.3	18.7	33.3	34.4	29.0	24.0	12.6	18.2	21.4	37.5	24.9	43.1	10.9	14.4	34.4	38.4	42.9	14.6	38.3	11.9	31.5	39.1	38.0	26.3	26.6	45.3	21.9	22.8	33.8	10.8	27.6	27.4	19.3	12.2	54.2	37.6	46.4	55.7	64.2	19.6	18.3	202.1	175.1	98.2	209.0	84.7	66.0	166.6	108.5	87.8	150.1	130.5	302.1	132.4	401.5	118.1	69.5	73.9	225.1	285.0	236.1	173.3	127.0	194.8	267.9	143.6	200.3	112.0	389.8	122.8	86.3	169.8	158.3	328.7	94.5	96.5	194.3	286.6	172.6	102.6	170.3	373.7	95.0	196.5	150.7	137.1	277.3	261.6	233.3	100.2	123.5	148.3	141.9	103.5	124.1	144.5	95.6	207.5	99.3	79.3	67.7	93.5	81.3	256.9	165.5	254.4	442.4	110.5	422.7	60.7	2.4	12.5	11.6	20.4	14.4	24.9	16.6	16.1	19.2	16.2	12.1	18.5	22.6	1.3	17.3	17.2	12.4	13.0	17.9	10.7	12.3	14.6	20.5	12.6	18.2	10.9	14.4	11.9	10.8	12.2	18.3	47.8	60.9	74.7	6.2	47.6	120.4	112.6	37.7	101.9	20.8	52.6	48.0	35.3	20.0	68.2	16.5	14.6	49.2	29.1	28.3	25.4	42.2	29.0	38.5	56.3	47.3	27.6	56.8	8.8	23.1	62.7	63.9	43.3	73.1	44.2	28.6	16.8	23.4	27.1	10.1	7.9	38.3	18.3	11.2	46.0	9.7	23.0	26.8	26.6	4.7	22.9	15.1	32.0	2.5	6.8	48.8	21.0	21.1	62.3	89.5	10.2	19.9	56.6	20.0	6.6	85.8	58.9	32.1	53.5	103.3	117.5	48.6	44.5	40.1	49.1	100.5
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949712-156973176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	5.0	4.4	2.5	4.7	2.6	6.8	4.4	2.7	3.3	4.7	2.5	5.1	3.4	4.8	3.3	5.2	4.6	2.7	3.7	2.5	2.4	3.7	5.0	3.9	5.7	3.2	2.3	5.2	5.9	4.3	3.1	4.0	3.1	3.8	3.7	3.2	4.2	3.0	7.5	6.1	4.4	4.6	1.8	4.7	4.3	4.1	2.8	4.2	3.8	4.3	5.0	4.8	4.7	3.1	13.5	11.4	8.2	12.3	8.1	8.4	11.3	13.2	6.5	10.5	8.5	12.4	11.1	23.4	12.9	10.8	10.7	10.7	14.9	15.9	12.8	10.7	12.9	19.6	9.9	11.5	6.5	34.7	11.6	6.0	7.7	9.4	12.1	6.1	8.9	12.9	30.3	12.2	9.6	17.7	22.1	28.9	19.9	11.9	12.2	15.7	12.4	18.1	6.8	15.8	10.0	12.3	12.0	9.4	9.2	9.2	4.6	18.5	14.5	11.2	3.7	21.1	17.2	15.7	12.1	21.1	14.4	24.4	10.8	0.8	0.8	0.4	0.6	0.5	0.3	1.3	0.7	0.8	0.8	1.8	0.9	0.5	0.2	0.7	0.7	0.8	0.3	0.3	2.5	2.6	2.7	3.3	2.5	2.4	3.2	2.3	3.1	1.8	2.8	3.1	15.3	9.6	18.3	7.2	16.1	39.4	46.9	10.5	12.0	16.8	9.5	7.9	11.7	8.6	15.5	5.5	20.9	16.2	19.3	20.0	3.9	19.2	9.6	17.9	20.7	16.0	7.8	19.1	9.6	13.6	20.5	16.9	13.3	18.6	21.5	21.2	6.8	13.6	14.3	11.8	10.8	16.2	6.1	10.4	26.0	4.4	17.4	13.3	24.9	13.1	18.3	7.5	21.6	7.1	10.2	15.9	14.1	13.2	15.3	36.3	8.7	6.3	15.3	29.8	0.0	28.9	18.0	33.5	37.6	20.0	42.5	7.3	21.0	26.6	21.8	37.3
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71254814-71301522	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		450000	"Cluster 44: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	106.4	147.2	58.6	96.4	57.7	115.3	109.2	71.5	64.9	116.8	64.4	101.3	86.2	130.2	107.9	111.9	115.4	100.7	81.2	55.3	69.9	103.3	121.5	103.2	136.5	60.3	61.5	197.9	164.8	114.8	97.1	99.1	60.5	97.0	101.2	70.2	106.8	89.6	99.1	112.2	102.0	113.5	59.2	109.5	114.3	55.2	68.5	255.5	116.0	86.1	165.2	116.8	102.6	61.0	421.2	539.7	595.3	344.4	251.2	238.5	345.3	330.9	319.2	459.3	388.5	413.4	312.9	481.4	379.9	320.5	309.7	310.5	949.5	299.4	488.1	383.9	605.7	394.8	498.4	398.0	212.3	547.7	338.7	272.0	206.0	473.1	305.7	370.5	382.0	342.1	535.3	509.0	406.2	413.9	756.0	466.8	771.3	433.9	365.2	660.0	657.3	414.0	345.9	426.1	431.7	519.4	467.8	299.1	392.5	354.9	271.4	354.0	343.9	268.0	438.6	402.9	400.1	297.3	503.2	516.0	216.8	627.1	433.8	107.5	117.3	91.1	107.9	120.0	119.9	107.4	107.9	106.4	118.7	107.2	115.1	115.6	50.8	119.6	140.7	101.1	128.0	178.1	58.6	57.7	71.5	64.9	55.3	69.9	60.3	61.5	60.5	59.2	68.5	61.0	72.9	76.9	81.1	16.3	97.2	126.3	99.9	105.8	116.7	62.3	111.4	83.6	63.5	90.1	99.8	44.1	41.7	132.3	103.6	52.0	56.7	147.8	11.8	81.6	137.8	95.4	139.8	144.6	16.2	111.4	179.9	93.9	71.4	104.8	88.0	135.9	83.9	128.3	112.6	53.8	20.7	105.6	95.6	153.2	107.7	15.9	106.6	95.0	56.9	13.1	132.0	84.8	96.8	19.6	22.8	110.7	75.4	127.9	115.2	94.9	89.0	121.0	71.1	50.3	65.7	78.7	127.8	45.7	66.5	137.3	122.3	130.1	108.5	163.7	117.2	103.0
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 202.1;Suprabasal keratinocytes: 205.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	32.9	24.3	17.6	23.7	17.4	24.8	21.6	17.4	18.1	15.2	15.0	22.1	18.0	14.0	10.7	43.6	15.5	12.5	29.0	17.9	17.2	25.1	31.7	14.1	26.8	17.1	16.9	15.6	21.5	15.3	10.6	15.7	17.4	14.1	18.8	4.8	14.8	12.0	70.9	29.8	16.3	14.5	16.3	17.3	19.9	15.1	17.6	16.6	11.6	30.6	29.9	44.6	21.1	18.2	85.2	135.1	30.3	134.2	49.6	53.3	122.1	70.2	42.4	103.1	89.4	190.7	85.6	145.6	91.6	53.4	101.0	76.5	162.7	242.7	74.5	184.5	115.8	77.7	103.5	159.5	98.7	156.5	80.4	51.8	113.5	98.3	126.1	31.5	79.2	64.4	155.5	69.6	78.9	261.2	121.8	208.7	111.9	127.9	170.3	95.5	44.7	152.1	101.2	75.9	96.0	76.5	41.1	165.1	94.3	28.8	71.9	110.8	68.4	76.9	75.9	68.8	177.1	85.7	122.4	165.1	58.0	218.7	67.2	7.6	51.9	9.5	52.9	86.5	69.4	81.9	58.5	56.7	78.9	85.4	62.6	65.2	4.4	80.0	45.9	97.1	44.1	44.7	17.6	17.4	17.4	18.1	17.9	17.2	17.1	16.9	17.4	16.3	17.6	18.2	21.8	6.4	19.6	2.3	34.4	202.1	145.6	66.4	114.4	3.7	37.2	35.3	35.6	25.8	48.8	1.8	4.2	46.2	17.3	31.8	37.2	53.6	11.0	13.8	30.6	37.6	20.9	20.8	3.1	53.6	60.3	43.3	53.0	20.2	26.6	15.1	12.1	36.9	38.1	0.0	2.9	32.3	32.6	8.3	46.4	5.5	19.6	17.1	56.9	1.9	20.8	4.9	4.1	3.0	1.7	56.4	18.0	14.7	23.8	134.2	20.1	72.6	16.5	3.0	6.6	90.5	46.1	38.4	32.1	112.9	205.3	38.3	22.2	35.9	57.7	116.6
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040119	Supported		Enhanced	Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	28.4	22.6	14.6	22.6	15.1	34.6	19.8	15.2	18.5	20.5	14.7	20.8	14.2	20.8	10.2	28.6	21.2	10.9	18.8	15.0	15.1	21.7	26.7	20.6	28.3	14.9	14.6	20.2	21.6	9.9	21.2	12.2	15.0	25.0	14.2	6.6	19.2	8.6	42.2	25.7	24.5	14.7	14.4	32.3	20.6	23.1	15.3	22.8	23.5	12.2	28.7	21.7	21.0	15.4	69.0	107.2	29.5	101.8	37.4	32.1	159.8	61.4	40.4	71.8	61.6	130.5	69.0	144.7	16.7	30.8	75.5	84.9	113.9	69.6	68.0	175.3	105.2	143.7	110.8	78.5	49.0	141.2	79.9	33.0	67.3	87.9	135.8	31.3	50.2	76.9	102.7	22.8	58.1	83.7	77.1	124.7	247.6	93.6	59.9	108.4	84.1	72.8	53.1	92.1	22.7	44.5	94.1	102.5	50.2	116.2	17.1	70.4	47.6	49.1	64.1	63.7	143.2	31.2	49.7	217.9	45.0	81.3	88.6	2.4	14.0	1.5	23.6	19.5	32.7	21.0	22.4	27.1	28.7	15.8	27.2	28.2	5.1	22.2	19.0	24.8	16.8	19.9	14.6	15.1	15.2	18.5	15.0	15.1	14.9	14.6	15.0	14.4	15.3	15.4	3.9	12.8	6.8	7.8	20.5	23.8	17.7	12.9	47.8	5.8	6.0	4.4	6.8	5.7	6.4	3.7	2.1	12.6	6.6	13.1	1.9	12.0	17.9	4.2	4.4	11.4	7.2	19.4	9.1	11.8	13.4	10.3	26.0	4.3	7.6	1.4	7.9	8.3	11.8	6.7	7.3	11.1	16.2	7.7	15.7	7.3	9.3	11.7	8.8	2.8	7.7	3.0	18.6	5.5	5.7	13.5	5.3	4.9	19.2	19.2	2.1	1.3	5.2	2.9	13.1	22.7	9.7	11.3	21.4	43.4	21.3	7.3	16.2	1.2	16.4	16.7
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652593-2658393	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB075757: AB_2665763, HPA049918: AB_2680952"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	41.4	31.3	39.9	42.6	39.7	60.4	37.1	38.8	59.7	30.9	35.3	33.8	28.8	39.9	34.7	37.1	50.7	26.3	30.9	41.1	45.8	29.8	30.5	25.9	53.5	40.4	40.6	49.7	38.6	27.1	31.5	37.4	43.4	31.1	39.9	21.0	27.1	35.6	43.2	38.4	28.1	52.0	39.9	37.7	25.9	28.3	45.4	51.9	33.4	29.2	62.2	52.4	28.4	44.4	152.8	147.3	108.4	108.0	122.8	89.8	184.2	150.4	97.3	198.3	134.9	204.3	122.2	330.5	82.7	104.2	117.7	253.3	287.5	221.4	196.6	93.5	171.4	195.0	76.0	225.3	125.9	179.4	91.3	123.6	137.2	254.8	260.4	78.2	117.4	153.1	215.7	151.2	138.1	103.1	317.8	214.1	233.8	270.9	180.9	257.2	156.2	188.5	120.8	146.7	115.5	101.1	171.0	193.4	302.8	115.7	167.6	152.7	91.6	170.2	115.9	132.6	227.2	91.9	186.0	274.0	45.9	209.4	128.5	5.1	23.2	18.9	33.0	26.4	41.1	35.8	35.9	36.6	23.6	32.4	34.0	34.0	1.8	33.6	19.8	41.1	33.4	24.8	39.9	39.7	38.8	59.7	41.1	45.8	40.4	40.6	43.4	39.9	45.4	44.4	75.0	44.8	59.8	14.0	89.3	96.4	103.6	76.4	88.2	39.5	62.9	78.6	39.0	42.9	100.1	23.9	62.6	117.5	132.2	71.8	25.4	78.2	8.0	64.6	100.6	73.3	72.3	93.2	24.6	86.5	124.2	87.5	44.4	48.5	79.1	97.5	52.5	40.9	86.9	50.5	24.1	81.2	54.9	46.8	45.9	14.0	57.2	57.5	30.2	12.2	64.9	32.8	80.3	18.1	21.5	75.6	34.6	54.9	79.6	92.0	38.7	53.8	81.2	37.6	26.3	110.0	141.5	50.3	185.9	89.1	81.7	56.5	102.6	99.4	110.0	58.0
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265736-202303661	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	36.0	35.1	33.5	43.9	33.6	76.3	43.7	38.8	58.4	29.5	33.4	30.4	28.2	32.2	33.4	37.8	31.6	23.6	25.1	33.4	36.3	32.8	40.7	26.4	60.3	32.3	33.3	37.4	37.8	24.8	30.2	32.6	32.6	29.5	35.8	28.1	26.5	23.1	41.8	30.7	29.7	27.3	32.6	33.9	29.6	24.9	34.8	41.9	27.1	21.5	59.8	43.3	30.2	35.3	126.4	86.0	85.1	106.8	62.0	55.6	199.2	118.5	62.9	89.1	82.9	191.5	110.9	193.1	95.4	72.5	111.6	114.0	170.1	144.7	158.4	75.0	152.5	233.6	133.3	193.7	91.5	234.7	108.6	72.1	85.3	124.6	284.6	48.6	81.2	112.3	260.4	144.1	113.4	131.4	215.1	258.7	212.9	139.4	146.5	179.5	128.3	257.1	107.1	148.5	130.5	95.8	109.0	156.6	140.8	136.2	106.4	181.8	70.3	113.5	133.8	102.5	206.0	115.7	226.1	274.8	84.2	163.7	138.5	13.4	24.0	7.4	37.2	35.6	55.0	56.1	53.1	51.2	37.4	45.0	57.5	58.9	2.3	52.1	28.3	53.1	58.0	32.5	33.5	33.6	38.8	58.4	33.4	36.3	32.3	33.3	32.6	32.6	34.8	35.3	56.3	109.0	116.2	22.2	111.6	85.8	150.5	98.0	78.0	28.1	53.8	70.2	82.7	37.1	116.8	40.5	41.7	78.1	87.1	35.7	29.4	59.9	39.2	59.6	75.9	62.3	35.2	65.2	39.0	67.8	96.9	82.6	51.0	97.0	137.3	47.7	32.2	46.1	47.7	25.2	47.5	61.5	61.1	23.2	43.5	11.1	43.2	51.5	24.9	20.6	59.6	18.8	35.0	20.6	27.0	50.3	17.3	29.7	118.6	89.9	18.3	37.8	70.6	44.2	26.3	112.2	116.8	70.4	58.4	77.5	74.7	68.0	124.1	45.4	79.6	94.6
NOSIP	CGI-25	ENSG00000142546	"Nitric oxide synthase interacting protein"	Q9Y314	19	49555468-49590262	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.8;Late spermatids: 844.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043464, HPA062132"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA043464: AB_10794284, HPA062132: AB_2684693"	"unprognostic (2.27e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-3)"	42.4	48.0	33.2	27.1	37.0	31.7	42.8	37.2	45.1	50.0	29.4	49.0	29.1	49.3	10.0	47.8	45.1	15.4	60.9	31.9	35.0	48.1	48.6	39.5	51.8	36.2	34.9	44.5	125.1	24.0	40.8	21.6	36.9	44.0	14.6	10.1	38.3	20.6	134.7	46.7	50.8	16.2	34.7	63.2	44.8	143.5	36.0	40.0	40.9	65.2	26.5	41.3	41.7	38.0	239.7	114.5	49.6	113.1	43.5	32.7	44.5	54.8	50.0	90.9	85.3	84.9	43.1	63.4	93.5	48.2	37.0	51.0	47.8	98.4	40.3	74.1	126.0	81.3	67.9	96.6	66.6	67.8	64.6	43.4	66.5	71.4	37.7	38.0	54.4	101.8	90.7	46.0	50.3	59.7	66.2	127.0	65.9	89.3	100.4	89.3	74.0	58.3	43.5	70.6	57.4	71.2	74.9	59.1	50.2	21.8	53.9	72.6	83.5	83.6	64.4	27.0	99.3	87.8	186.7	86.6	31.2	90.7	65.2	261.9	129.1	192.3	257.3	126.1	328.8	161.8	519.8	294.6	127.8	157.2	841.3	466.7	244.1	244.5	117.6	168.8	303.6	579.4	33.2	37.0	37.2	45.1	31.9	35.0	36.2	34.9	36.9	34.7	36.0	38.0	78.3	19.2	34.9	13.1	67.3	72.8	54.8	109.8	40.9	25.4	45.5	49.5	38.4	62.9	59.3	51.5	22.9	94.2	74.7	171.6	86.1	84.5	364.8	56.3	44.9	73.0	58.7	58.5	9.2	283.6	85.0	51.7	57.6	68.6	68.4	57.0	93.9	49.5	72.2	11.8	9.1	108.9	91.6	63.8	67.0	844.8	71.7	55.5	62.2	13.1	100.5	45.5	120.5	9.0	12.3	219.2	138.2	72.2	55.4	43.2	129.6	133.8	58.4	37.2	59.2	85.1	66.1	268.7	50.9	39.6	76.3	136.3	154.2	73.1	108.5	54.4
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222638	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA045908: AB_2679493, HPA066370: AB_2685665"	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	4.6	4.2	1.6	8.1	2.1	4.5	6.9	7.4	2.8	6.4	3.9	5.4	4.1	6.7	5.9	4.6	4.6	4.7	4.3	1.4	2.4	5.6	5.6	5.4	14.9	2.6	3.0	7.6	3.1	6.8	3.2	6.6	2.4	5.6	6.2	6.6	4.4	4.4	3.1	5.2	4.9	5.1	2.2	9.9	5.9	7.0	2.3	12.0	8.3	5.3	13.3	7.0	3.8	3.0	7.9	6.3	9.7	12.1	11.7	8.5	7.9	11.6	14.6	10.0	14.9	13.0	16.8	13.5	15.2	7.3	11.2	14.6	13.4	11.7	17.8	12.2	5.3	22.5	6.8	6.7	5.0	17.0	14.3	8.1	6.7	17.6	11.2	7.8	14.3	15.5	21.2	6.5	14.1	3.9	21.0	9.1	8.0	12.6	8.7	14.3	13.6	18.5	6.4	11.3	10.3	9.5	14.9	8.8	11.3	10.1	10.0	8.3	11.8	17.3	9.3	10.3	10.5	4.5	6.1	51.9	4.3	12.4	13.7	6.8	1.6	2.9	4.9	2.6	5.5	4.1	5.7	6.3	1.8	4.3	8.9	7.5	1.9	5.3	2.9	1.5	4.6	3.2	1.6	2.1	7.4	2.8	1.4	2.4	2.6	3.0	2.4	2.2	2.3	3.0	23.1	19.2	13.2	24.2	40.8	16.3	16.4	10.5	27.3	16.5	12.0	7.6	15.2	4.3	13.2	12.9	29.2	10.3	32.8	5.6	1.9	8.4	4.9	11.1	15.0	21.1	10.3	29.5	25.5	6.8	8.2	15.9	12.2	14.2	19.6	16.7	22.9	9.1	7.4	10.1	32.2	7.9	8.2	13.0	12.8	3.2	15.8	13.8	8.8	19.7	14.5	11.8	27.8	19.6	24.3	6.8	6.5	17.0	37.8	14.1	7.1	5.6	10.9	16.9	6.6	19.8	13.1	26.2	32.5	14.0	13.2	14.1	35.3	14.9	8.7	15.9
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411810	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	"Nucleoplasm,Nucleoli rim"		NA	Yes		2000000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim"	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (7.48e-4)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	515.1	370.6	180.7	468.4	190.3	789.2	597.1	188.6	233.5	759.2	195.9	486.6	347.1	656.6	421.5	623.0	596.1	355.4	336.7	169.0	210.7	375.3	370.3	364.5	777.0	196.2	188.6	1384.6	810.6	278.0	314.4	423.7	207.5	386.2	421.2	161.3	385.2	318.5	450.9	386.6	374.1	436.0	213.9	358.1	467.8	284.7	202.6	683.3	510.1	282.4	761.7	524.9	565.4	204.5	2476.2	1522.7	1864.0	2663.1	1073.3	1915.6	2736.9	2111.3	1826.0	2678.1	2387.2	3640.2	1622.2	6243.9	1683.2	1194.5	1927.6	1386.6	2552.2	4639.2	3423.4	2027.9	2027.3	2149.1	1361.9	2740.2	1593.2	4556.3	1790.7	1732.2	1559.7	1845.8	3572.3	2184.3	2019.4	1460.9	2712.8	1406.5	1945.5	2826.5	3071.1	3087.4	2400.7	1280.7	1857.2	2695.2	2051.7	3241.9	2306.9	1583.1	1433.8	1167.4	1210.6	2084.4	4091.0	1288.7	2513.8	2000.7	1289.5	916.7	2114.4	1082.5	3705.3	1161.5	2139.6	3702.2	1403.3	3561.5	1897.0	153.6	287.1	92.3	443.1	311.4	834.2	847.9	832.8	654.3	564.2	634.9	1189.9	973.4	38.0	656.2	264.4	516.8	782.6	1076.1	180.7	190.3	188.6	233.5	169.0	210.7	196.2	188.6	207.5	213.9	202.6	204.5	462.2	346.1	461.1	12.4	911.0	1400.1	1224.1	1692.5	993.1	177.2	779.0	1045.4	243.5	514.8	764.5	323.7	43.8	1647.8	615.9	175.3	743.4	1073.6	135.8	466.3	707.3	568.2	362.1	865.5	15.6	919.2	2021.0	685.9	489.8	544.6	443.8	688.8	383.8	254.1	1071.0	127.9	20.3	656.0	679.5	629.2	817.6	98.6	974.9	557.2	610.1	19.7	862.8	339.2	476.8	14.6	21.2	922.5	370.1	649.9	671.6	1051.5	404.2	911.0	357.4	144.1	433.9	617.8	1074.1	855.7	578.6	907.2	1019.1	1538.8	865.1	1019.5	866.2	967.3
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284188-24291862	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Neuropeptide	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 122.6;brain: 423.9;prostate: 332.8"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 56.7;Prostatic glandular cells: 100.6"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Region enriched"	"Detected in all"	7	"hypothalamus: 423.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	34	"SH-SY5Y: 700.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	30700000	21000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.8	122.6	32.8	12.8	59.0	5.6	2.2	11.0	39.1	1.3	11.3	2.9	9.7	0.3	0.3	2.3	0.5	1.1	0.8	31.7	423.9	0.5	0.2	0.3	0.0	24.2	25.1	0.5	8.8	0.1	4.7	0.0	15.2	332.8	1.9	4.4	0.3	3.9	0.2	0.2	13.1	1.2	18.8	0.0	8.8	1.1	29.2	0.2	0.9	0.2	0.0	1.4	23.8	33.1	0.0	0.0	2.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	2.0	0.0	0.2	20.5	0.0	0.6	0.0	0.0	0.8	700.2	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	59.0	11.0	39.1	31.7	423.9	24.2	25.1	15.2	18.8	29.2	33.1	0.0	0.0	0.0	2.0	0.5	0.1	1.3	0.0	0.0	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	13.4	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	56.7	0.0	0.0	0.0	0.0	16.1	0.3	0.7	1.8	1.0	0.0	0.8	0.0	2.0	1.9	0.3	0.0	0.4	0.0	100.6	0.0	0.0	0.0	0.7	0.0	15.6	0.3	2.4	2.8	0.0	0.0	5.1	0.3	0.0	0.0	2.0
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309390	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 32.7;testis: 19.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 62.5;RT4: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.2	32.7	1.4	0.0	1.3	0.0	0.2	1.0	1.5	2.4	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	1.4	1.3	3.6	2.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.1	0.7	19.3	5.9	0.0	0.0	0.0	0.0	0.0	2.0	1.4	0.0	62.5	0.0	0.0	2.3	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	8.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.0	1.5	1.3	1.8	1.4	1.3	1.3	1.2	5.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	8.2	0.0	0.0	1.9	1.2	0.1	1.8	0.0	2.6	0.0	0.0	10.6	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.8	0.0	0.1	0.0	0.0	4.9	0.0	0.1
NR1H2	"LXR-b, LXRb, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50383388	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234"	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	59.6	61.4	43.2	37.1	45.6	143.4	57.9	43.1	53.3	61.1	41.3	78.7	43.1	67.3	10.8	56.0	63.6	28.4	89.6	40.7	45.0	63.9	61.0	66.4	33.9	55.8	47.3	56.9	49.8	32.1	40.6	26.3	48.5	63.7	11.9	9.4	46.9	37.9	132.1	60.7	55.1	20.3	44.4	56.7	60.2	31.8	48.4	21.4	56.5	36.7	16.7	77.1	58.3	47.8	56.2	124.1	12.1	32.4	34.5	36.4	42.0	75.8	53.4	38.4	41.7	25.8	48.9	34.8	67.1	39.4	31.7	46.8	7.8	34.1	9.5	89.9	57.6	32.5	41.8	26.4	63.7	58.2	84.0	34.8	45.2	39.3	27.3	37.7	33.4	24.7	51.7	65.4	20.8	53.2	39.3	40.5	25.5	32.2	94.4	22.8	35.8	57.2	30.4	54.3	14.9	50.6	50.9	54.0	46.7	6.6	37.9	42.5	53.9	54.3	45.3	58.4	66.8	82.5	79.3	26.4	108.6	36.5	53.8	159.1	123.9	232.4	90.4	125.4	89.3	112.3	89.9	86.2	121.3	117.7	90.8	81.4	194.8	85.9	146.4	103.9	89.0	129.3	43.2	45.6	43.1	53.3	40.7	45.0	55.8	47.3	48.5	44.4	48.4	47.8	50.7	28.9	30.7	3.6	70.7	43.0	89.3	53.2	32.5	37.9	33.4	27.3	29.6	37.1	31.1	31.3	14.6	64.5	57.0	82.1	64.6	63.6	15.5	31.9	19.5	50.0	20.8	58.9	5.9	72.6	53.3	40.2	37.2	33.8	50.2	25.1	36.8	20.7	51.3	37.0	5.5	45.5	46.8	37.0	48.3	9.5	45.4	54.5	60.5	4.7	65.2	46.8	65.9	0.5	6.9	74.3	89.6	53.4	47.5	91.0	93.5	61.8	21.7	25.4	39.5	45.5	50.2	34.6	25.9	27.9	45.7	140.0	54.8	27.7	35.7	109.0
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.2;liver: 47.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	12.3	28.2	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.4	0.0	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.2	0.0	0.1	0.0	0.0	31.2	0.6	0.1	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	14.1	12.4	11.4	18.0	12.0	19.1	13.6	21.6	13.3	15.7	2.5	16.9	18.4	17.1	9.8	12.4	15.3	11.3	15.7	12.4	9.0	13.9	13.0	16.8	18.0	7.6	6.1	18.6	14.2	14.2	19.2	9.7	4.6	13.7	11.7	36.2	13.5	11.5	20.1	19.5	18.8	12.8	4.7	19.9	14.8	20.7	8.7	22.4	24.3	17.9	15.7	14.4	13.7	13.5	18.3	20.2	22.8	17.7	15.8	18.8	52.0	25.8	20.7	20.5	21.0	13.0	17.4	28.0	13.2	23.3	17.9	17.9	21.2	13.3	21.2	37.1	30.0	36.8	45.8	12.0	13.4	27.3	27.3	15.0	17.2	25.9	13.4	17.1	23.5	27.2	26.6	18.7	18.3	16.2	41.9	21.3	15.1	8.6	20.7	33.4	27.1	18.8	9.9	27.1	14.5	36.1	23.5	19.4	23.2	17.9	19.5	26.7	30.5	31.6	37.2	29.1	35.6	28.4	40.0	30.4	22.7	25.6	28.2	2.7	0.9	0.7	1.6	1.2	1.5	0.8	0.9	1.0	0.9	1.8	1.2	1.1	1.2	1.0	1.1	1.5	0.9	0.6	11.4	12.0	21.6	13.3	12.4	9.0	7.6	6.1	4.6	4.7	8.7	13.5	14.0	22.4	12.2	35.9	15.7	3.7	11.1	1.0	17.1	17.4	15.1	9.7	6.2	11.5	4.7	7.3	14.6	7.8	15.2	16.5	5.9	6.6	58.8	8.0	10.3	13.4	25.1	20.4	35.5	7.2	7.3	11.5	14.3	9.1	9.5	17.2	18.9	8.2	7.8	13.5	39.9	10.2	0.0	20.1	2.3	65.4	19.3	14.2	5.4	52.5	13.6	13.9	9.2	50.8	92.2	12.3	12.4	20.7	14.2	19.6	13.0	6.8	13.7	17.2	0.0	18.8	10.3	33.9	22.2	13.3	3.1	14.9	15.3	17.0	10.4	18.4
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 411.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	35.3	11.8	15.2	22.6	18.1	49.4	25.5	34.0	24.7	19.7	18.2	13.7	19.2	18.8	13.6	25.7	18.8	21.1	24.2	14.9	25.0	19.2	39.8	31.9	25.6	18.1	14.9	21.1	14.7	33.8	16.2	46.9	16.1	19.7	14.5	9.5	16.1	20.0	45.0	20.4	18.0	23.8	15.0	24.5	16.0	11.1	21.6	40.0	25.6	40.1	27.3	18.2	16.0	28.5	30.4	60.6	4.4	0.1	38.2	42.3	5.2	46.5	55.3	39.3	45.1	4.5	39.7	26.8	20.8	68.6	46.0	28.1	0.3	36.6	48.3	15.2	21.0	6.9	77.0	13.5	35.7	28.1	20.6	30.8	46.3	64.7	62.5	49.0	15.0	12.1	10.3	98.8	35.1	10.9	16.7	20.0	11.9	5.1	13.0	6.0	41.4	58.0	11.5	2.1	8.0	6.1	81.3	11.7	19.4	4.9	5.3	39.8	35.8	94.7	18.7	45.7	35.9	20.1	19.7	41.5	49.7	28.5	33.6	67.4	21.3	38.9	18.3	24.2	15.1	15.9	18.6	17.9	28.5	22.3	17.8	17.2	68.4	23.1	23.6	25.9	12.8	17.3	15.2	18.1	34.0	24.7	14.9	25.0	18.1	14.9	16.1	15.0	21.6	28.5	152.3	67.3	69.1	71.2	134.1	58.8	35.9	37.9	79.6	13.1	39.0	55.8	43.4	57.2	41.2	25.8	16.7	48.9	158.3	22.9	17.6	30.8	165.6	8.1	30.1	82.3	28.1	55.9	411.4	33.3	39.5	112.2	23.9	10.4	89.3	7.5	63.5	193.9	53.2	37.0	169.5	4.1	10.2	66.3	99.2	144.1	63.0	97.4	53.4	241.7	87.6	34.6	83.4	240.3	237.5	35.9	17.9	71.5	115.1	46.2	25.3	67.9	37.9	65.0	151.2	181.9	105.0	24.5	40.1	57.4	56.3	36.5	204.5	12.6	12.9	14.3
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771311	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 22.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.5;Extravillous trophoblasts: 160.0;Inhibitory neurons: 114.7;Oligodendrocyte precursor cells: 112.6;Spermatogonia: 111.1"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 110.7;CACO-2: 26.5;Hep G2: 25.8;K-562: 34.1;NTERA-2: 39.2;U-266/84: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.3	0.8	1.8	0.9	1.9	4.4	0.9	2.2	1.9	0.8	4.5	2.2	1.7	0.5	0.5	1.9	0.5	0.4	1.0	1.8	1.5	1.7	2.7	1.5	0.3	2.0	1.5	0.3	2.9	0.8	1.4	2.3	1.5	1.4	1.5	3.1	1.2	0.5	1.4	2.2	2.5	0.4	1.4	0.8	0.4	22.9	3.4	0.1	5.4	0.8	0.7	0.7	1.3	1.6	1.2	3.0	14.7	2.0	0.3	0.2	110.7	0.2	1.1	0.8	1.3	26.5	2.9	5.0	1.0	0.1	3.8	2.8	1.6	1.3	1.7	1.1	4.6	4.1	4.8	25.8	0.1	2.3	7.2	0.1	1.3	1.2	1.6	0.3	0.2	1.2	34.1	0.7	0.6	0.6	0.1	3.2	39.2	1.3	1.1	1.2	1.5	2.2	0.5	2.0	2.2	0.8	0.2	0.7	0.9	21.7	2.6	1.3	0.0	1.4	3.1	0.9	0.7	3.3	25.0	4.3	0.9	2.3	0.8	0.0	0.6	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	4.9	0.0	0.3	0.1	0.0	0.1	1.8	1.9	2.2	1.9	1.8	1.5	2.0	1.5	1.5	1.4	3.4	1.6	0.8	0.0	7.7	47.0	0.6	37.3	17.4	4.2	13.6	3.8	6.8	3.7	2.0	7.2	5.9	5.5	29.2	36.7	1.6	8.9	1.9	10.1	53.5	4.1	0.9	3.2	4.8	6.1	105.5	3.5	160.0	2.0	2.0	3.7	1.3	16.1	1.4	6.0	8.2	1.7	114.7	6.9	8.2	2.2	30.6	30.3	1.2	3.2	8.8	54.4	5.2	7.0	0.0	112.6	73.0	1.9	6.0	1.9	0.5	19.4	24.5	3.3	8.6	10.7	0.0	1.5	3.5	72.7	111.1	8.6	39.8	30.6	0.3	8.1	11.9	15.5
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 60.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	7.6	4.7	0.4	0.6	0.4	1.7	6.1	0.4	0.4	13.0	0.3	6.7	0.2	13.5	0.3	8.8	8.2	0.3	5.3	0.4	0.4	4.4	2.9	7.8	1.0	0.5	0.4	8.1	5.2	0.3	1.7	0.9	0.4	4.8	0.5	0.3	4.2	0.9	2.1	8.1	6.5	1.1	0.4	7.3	3.9	10.9	0.5	1.5	4.8	0.5	1.1	6.9	9.1	0.4	3.0	2.8	5.2	3.7	0.8	2.8	0.6	1.5	2.9	4.7	4.2	3.1	2.1	5.1	1.0	3.1	2.1	4.6	2.9	5.0	1.3	7.1	1.5	3.1	4.0	4.0	1.0	2.4	4.6	1.7	1.8	4.6	1.7	1.6	3.7	4.1	2.8	4.5	3.2	2.7	3.9	2.6	1.1	3.3	1.7	9.2	3.5	6.2	2.1	1.5	1.9	1.7	1.7	2.1	1.0	1.6	3.4	2.4	1.5	4.3	2.3	2.4	2.8	1.6	3.3	1.8	0.6	6.5	5.6	0.3	1.6	0.1	0.4	0.5	0.3	1.8	0.4	0.6	1.4	1.7	0.2	0.2	0.6	0.4	0.2	1.6	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	12.1	3.2	2.0	0.7	12.9	9.8	6.3	9.6	5.7	1.7	3.0	7.5	1.9	12.8	4.9	1.8	2.1	23.0	5.1	1.6	3.9	12.2	13.5	1.0	8.4	12.3	1.2	9.2	0.3	5.6	28.1	9.0	1.5	2.7	12.7	5.0	4.6	1.0	17.6	3.3	0.4	3.4	2.0	20.5	18.9	60.1	5.6	12.8	3.6	1.0	25.6	1.2	7.2	0.5	0.3	4.8	0.5	6.0	5.5	1.7	0.5	1.0	0.4	1.9	6.6	7.3	11.6	4.4	2.1	14.6	6.3	5.1	9.9	3.9	6.3	4.3
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2 ribosome biogenesis factor"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	32.0	36.5	17.1	33.2	18.9	39.3	28.7	19.3	22.2	43.7	15.6	36.4	30.4	29.9	25.0	26.7	35.0	12.2	28.3	17.4	19.0	30.9	26.6	20.3	36.9	19.1	17.9	60.4	37.7	20.6	28.1	17.3	19.2	28.5	22.8	22.6	28.1	11.5	67.9	22.2	26.0	16.9	19.9	25.8	31.2	31.8	18.2	23.5	22.1	19.0	32.0	35.9	30.6	20.4	65.2	35.4	42.5	57.6	26.6	48.9	64.8	45.8	24.5	29.5	24.9	61.2	62.3	53.0	94.0	27.3	70.2	39.6	34.6	51.9	41.9	36.1	53.7	27.9	65.8	68.3	24.8	47.9	61.7	32.4	48.2	39.8	29.6	46.5	25.5	47.3	28.0	42.8	32.2	50.1	81.4	120.4	28.3	27.8	29.9	58.4	49.8	100.5	37.7	70.9	45.3	58.5	27.8	52.8	135.7	32.6	49.5	135.8	28.0	22.0	67.4	41.8	133.3	42.7	61.1	90.0	54.6	84.3	33.3	9.3	12.1	7.5	16.3	20.6	23.5	27.1	24.6	24.7	18.5	19.5	28.7	29.8	2.2	21.4	15.9	17.2	26.4	10.3	17.1	18.9	19.3	22.2	17.4	19.0	19.1	17.9	19.2	19.9	18.2	20.4	125.8	80.1	95.9	6.5	237.4	94.1	162.1	95.9	215.1	34.6	164.2	218.3	83.7	140.2	94.5	62.5	14.6	142.3	183.7	122.9	150.6	143.1	418.6	145.2	303.6	101.1	139.6	129.2	13.1	237.9	196.2	107.6	112.1	192.8	119.2	165.4	129.2	207.7	137.4	50.5	13.2	234.6	52.9	233.2	100.2	159.1	278.4	161.9	83.6	7.5	229.6	85.8	188.4	10.1	13.4	181.2	147.9	171.5	139.4	144.4	147.5	281.7	55.9	37.7	138.1	132.8	138.0	250.2	96.3	171.7	86.0	135.4	176.1	176.8	246.1	192.5
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.0;Hepatocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	24.0	38.8	13.2	10.2	12.6	8.9	20.2	14.2	13.3	20.3	13.7	13.9	17.6	13.6	44.5	51.7	14.9	7.9	22.4	13.7	14.3	14.9	50.4	12.9	9.1	16.8	15.4	10.3	10.6	12.9	8.8	10.3	18.5	14.8	13.5	10.4	16.7	21.3	10.1	22.6	24.2	12.5	13.4	9.5	13.8	8.9	15.2	9.9	13.3	10.9	18.1	12.1	24.1	15.1	135.6	48.9	65.5	33.8	54.9	41.5	36.2	26.3	35.2	46.9	59.3	68.5	71.7	67.0	86.0	35.9	174.2	67.6	85.5	122.1	41.3	22.0	49.5	27.9	44.7	70.3	39.8	27.6	21.1	51.1	46.3	92.2	23.0	20.2	44.2	28.7	46.4	29.1	36.1	60.1	27.3	35.8	26.0	67.4	58.1	19.9	47.4	54.6	98.9	55.7	23.4	26.5	23.4	34.6	28.4	44.9	23.1	35.0	38.7	21.6	35.4	52.3	51.0	40.9	29.4	114.9	40.0	42.4	20.8	21.0	19.6	18.7	16.3	18.7	16.4	19.1	16.1	14.1	19.4	15.1	11.6	12.7	2.2	19.7	14.2	17.4	20.4	15.2	13.2	12.6	14.2	13.3	13.7	14.3	16.8	15.4	18.5	13.4	15.2	15.1	7.1	12.8	16.7	5.9	6.3	10.8	12.8	53.0	10.8	4.3	11.7	6.1	25.0	15.7	29.0	12.9	0.0	21.5	6.1	9.6	9.8	20.1	13.3	15.5	6.6	9.2	6.0	13.0	2.2	20.3	22.0	9.0	8.2	15.5	8.2	14.0	7.5	55.0	18.6	1.7	2.2	10.2	26.4	8.7	9.6	8.0	8.4	7.9	5.4	1.0	11.0	10.6	7.2	2.5	5.7	21.4	11.9	9.1	11.3	10.4	25.2	16.5	25.4	6.2	0.0	5.9	12.5	3.7	7.8	19.4	12.1	18.6	5.3	25.1	11.2	16.4
NSG2	"CALY3, HMP19"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045706-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 198.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"SCLC-21H: 39.5;SH-SY5Y: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	0.5	33.3	115.8	2.6	198.5	0.0	0.1	43.8	152.8	0.0	1.7	6.9	2.3	0.0	0.4	0.1	0.0	0.3	1.0	125.2	171.9	0.7	0.4	0.3	0.0	54.5	82.1	0.1	0.9	0.0	7.0	0.0	101.1	0.2	3.9	39.2	0.1	0.1	0.3	0.1	3.8	1.8	52.4	0.2	3.0	14.7	100.3	0.0	0.6	0.0	0.0	0.1	1.2	47.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	64.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.8	198.5	43.8	152.8	125.2	171.9	54.5	82.1	101.1	52.4	100.3	47.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NSMCE4A	"bA500G22.3, C10orf86, FLJ20003, NSE4A"	ENSG00000107672	"NSE4 homolog A, SMC5-SMC6 complex component"	Q9NXX6	10	121957091-121975217	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037459, HPA038412, HPA044872"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 4: Stomach - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124"	"unprognostic (1.16e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.64e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.01e-3)"	27.3	20.6	9.3	14.6	11.8	20.2	27.4	10.8	13.3	23.0	9.3	37.0	24.7	23.4	12.4	19.2	22.8	14.4	21.2	9.5	10.0	15.6	25.2	16.9	23.8	10.9	10.8	22.7	30.0	15.1	11.2	14.1	10.9	24.8	21.0	10.7	24.4	16.5	20.6	19.4	26.8	17.7	10.4	23.3	29.5	4.9	10.6	21.5	21.1	8.4	19.7	30.0	20.8	13.2	43.4	51.9	55.0	49.0	18.9	24.7	40.3	23.7	42.3	40.0	55.2	40.5	32.8	57.2	17.9	18.9	22.0	36.7	32.5	26.0	31.5	69.0	76.3	37.5	17.0	76.5	16.0	43.2	25.5	16.9	19.4	23.5	37.9	22.4	42.8	51.5	35.1	40.3	22.6	35.1	78.2	62.8	28.7	30.7	40.4	66.9	42.4	61.2	27.7	35.4	14.9	29.1	27.0	18.1	38.2	22.0	20.0	40.3	35.3	15.8	28.0	26.8	49.6	53.0	60.6	88.0	19.7	57.5	17.3	0.3	31.5	19.5	29.6	38.3	34.4	50.6	39.5	38.7	33.1	46.6	41.4	33.6	2.9	41.7	38.5	51.5	48.3	36.5	9.3	11.8	10.8	13.3	9.5	10.0	10.9	10.8	10.9	10.4	10.6	13.2	49.3	22.4	33.1	9.4	35.5	17.0	45.0	47.0	23.9	20.3	30.4	34.3	23.1	30.0	31.8	12.9	33.3	56.4	40.0	35.8	35.2	28.0	0.7	16.8	15.4	33.9	21.6	26.1	5.3	61.2	38.0	25.9	28.5	17.0	11.4	34.6	18.5	33.3	35.6	26.9	5.4	35.1	46.8	20.0	19.2	1.6	35.4	22.4	21.4	7.5	48.6	33.3	40.2	7.5	17.4	30.4	37.0	33.4	36.3	41.9	36.8	39.2	21.6	37.4	26.3	27.1	31.3	6.7	16.6	35.5	21.6	66.2	29.3	39.6	44.8	47.9
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase 5"	Q96P11	7	73302516-73308826	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	13.9	11.6	9.8	9.7	11.3	33.4	14.1	11.7	12.9	15.3	9.1	18.6	8.9	18.7	3.2	17.7	15.5	4.2	17.7	9.8	10.9	17.4	16.2	12.1	14.2	12.8	10.8	13.0	24.0	6.6	12.8	6.1	11.7	15.5	4.3	3.2	14.6	6.3	37.9	19.7	17.7	6.2	11.6	24.4	16.3	20.7	11.0	13.0	13.6	8.1	9.4	18.6	14.7	13.3	34.7	46.4	12.3	29.3	4.8	6.3	48.4	15.3	9.1	23.6	25.3	63.0	24.3	55.3	10.6	7.7	34.6	28.9	23.7	15.2	8.1	36.6	57.0	20.7	35.8	36.4	20.0	45.9	26.0	8.3	25.7	20.0	17.3	5.2	3.1	40.4	71.0	12.7	10.8	83.2	39.3	91.6	52.1	24.9	34.9	48.9	9.5	79.8	10.1	17.1	33.2	54.6	27.9	72.5	36.4	12.8	47.9	37.1	5.3	0.2	34.8	34.7	11.1	49.6	73.8	80.8	0.5	65.6	2.5	23.7	21.5	24.0	19.6	19.6	15.7	32.2	22.3	20.4	25.0	46.2	31.0	26.5	27.4	26.8	14.8	31.5	26.9	23.2	9.8	11.3	11.7	12.9	9.8	10.9	12.8	10.8	11.7	11.6	11.0	13.3	11.1	6.4	7.4	14.4	38.2	17.0	20.0	32.8	14.8	27.5	23.0	25.0	20.4	27.1	21.3	36.8	12.5	37.7	27.3	18.3	37.2	35.8	17.4	18.1	12.7	8.9	3.6	19.1	9.2	33.0	48.9	17.2	21.4	15.5	26.6	50.5	5.3	21.0	36.6	32.0	9.3	18.3	26.4	21.0	10.8	21.6	29.2	20.2	21.4	3.7	39.9	13.2	36.0	10.1	12.1	29.1	20.5	20.7	24.9	12.6	28.4	25.1	21.8	23.1	6.6	20.8	16.8	64.2	56.7	15.1	21.3	21.8	24.9	16.2	23.1	14.3
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636135	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 391.4;Late spermatids: 761.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	26.4	68.6	20.6	19.3	21.7	24.5	22.1	23.6	27.0	22.5	22.4	23.2	18.3	19.6	15.9	20.2	18.9	19.9	67.9	21.0	23.1	31.5	41.6	22.8	20.2	22.5	23.8	19.8	31.1	22.4	23.4	19.6	22.5	22.7	11.2	6.3	22.4	16.7	98.9	25.1	19.5	13.7	21.3	29.7	24.9	93.3	22.9	16.1	17.9	84.3	16.0	23.9	20.0	24.1	57.8	117.2	47.9	82.2	30.0	44.6	50.2	107.6	63.5	108.1	92.8	96.6	74.0	74.8	53.7	78.5	76.7	110.1	101.8	96.4	66.8	56.3	50.9	31.2	106.3	100.4	96.3	63.3	45.0	47.0	48.6	113.5	56.0	34.2	60.1	64.1	116.5	54.2	57.5	194.1	72.0	85.6	62.6	105.4	96.6	66.8	55.8	150.4	43.7	32.4	96.5	48.5	53.1	97.3	74.7	30.2	81.4	32.4	41.8	129.1	64.5	118.7	115.3	41.2	53.7	115.2	59.0	64.4	75.0	32.9	49.7	39.2	43.7	55.1	43.7	43.2	43.5	46.5	49.2	50.4	43.9	36.3	13.6	30.6	70.9	52.8	44.5	36.4	20.6	21.7	23.6	27.0	21.0	23.1	22.5	23.8	22.5	21.3	22.9	24.1	35.6	3.2	13.9	5.9	45.9	99.8	85.7	50.3	16.5	18.3	33.4	33.8	4.1	20.0	35.7	22.0	22.9	72.6	23.1	49.7	97.8	60.5	391.4	21.4	29.8	38.3	20.3	23.4	6.4	55.9	86.8	41.1	21.9	23.2	30.4	20.5	20.0	52.7	67.0	42.1	6.5	44.0	42.7	27.6	80.3	761.6	35.1	34.3	55.2	3.7	33.1	23.3	25.7	4.5	9.2	69.2	29.9	24.8	41.0	105.7	84.5	89.6	22.5	23.6	26.3	34.1	58.8	129.2	43.2	19.2	99.3	135.6	38.3	39.2	48.4	70.7
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341772-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.4;monocytes: 559.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	36.7	33.2	23.5	47.0	24.3	30.7	31.3	24.5	23.0	32.5	23.2	36.0	62.1	32.7	18.1	27.7	31.6	33.8	33.6	21.1	24.1	28.9	35.5	36.4	62.8	25.9	24.8	35.2	40.1	40.7	25.8	30.7	25.3	31.4	30.2	31.7	41.8	28.5	52.8	29.3	56.9	21.1	24.2	54.7	36.6	52.0	24.5	46.2	47.3	32.4	40.6	30.2	28.0	26.7	78.0	34.8	45.9	26.9	47.0	56.6	38.7	61.2	55.8	45.5	52.2	34.2	67.3	84.5	78.5	38.8	58.3	38.0	27.9	40.0	29.2	74.2	46.4	30.8	32.1	21.9	65.2	72.0	38.0	36.4	46.4	32.9	31.3	56.4	30.6	41.4	81.5	2.5	37.3	42.0	126.9	55.0	73.0	79.4	45.6	69.4	47.9	12.8	33.3	37.9	42.9	71.8	116.3	48.7	60.4	31.7	33.9	40.6	62.7	38.2	13.7	51.8	58.9	78.5	64.0	73.7	77.9	60.6	64.4	18.2	20.5	28.5	25.9	27.1	30.8	26.9	22.6	26.6	18.1	26.0	24.5	23.5	37.6	33.6	34.9	25.2	19.8	23.8	23.5	24.3	24.5	23.0	21.1	24.1	25.9	24.8	25.3	24.2	24.5	26.7	61.0	73.7	66.4	14.0	52.7	24.9	33.8	36.4	39.9	38.4	31.0	32.3	57.4	34.3	51.4	25.8	12.5	49.3	91.8	53.4	60.7	52.1	249.4	59.5	46.5	45.8	29.3	17.1	13.6	69.8	43.0	42.3	29.0	47.9	72.2	45.1	33.2	40.5	30.0	48.8	19.4	40.9	18.3	37.1	45.8	34.2	44.1	46.7	16.0	18.7	559.4	57.7	74.2	11.1	23.0	52.3	20.5	41.0	22.3	48.7	56.5	37.8	55.7	41.4	26.3	39.5	43.3	160.4	12.5	25.8	29.0	50.1	60.0	40.2	26.0	33.1
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"	P80303	11	17208153-17349980	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 758.3;salivary gland: 771.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 1867.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000	690000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	56.2	75.7	23.9	62.1	27.8	619.9	141.1	28.8	32.1	137.2	58.0	68.3	57.3	60.8	458.2	146.3	107.2	60.8	95.7	22.8	34.7	43.2	102.2	49.8	60.2	25.7	28.2	56.0	758.3	479.1	113.0	90.9	26.8	70.9	68.4	64.5	771.4	190.9	38.5	21.1	40.7	78.5	26.2	42.2	92.9	119.2	28.4	334.2	153.9	30.4	78.5	61.8	44.9	26.6	119.9	49.0	53.7	163.4	118.9	162.3	65.0	260.5	381.0	115.1	203.0	48.7	26.8	182.9	63.5	250.7	107.1	50.1	34.4	66.8	178.7	126.7	76.3	135.8	57.8	85.2	340.5	1867.0	238.6	71.1	86.8	82.9	200.9	284.9	143.3	672.1	120.1	361.1	114.9	105.9	656.2	670.3	12.9	194.0	50.5	239.8	130.4	15.1	51.9	37.5	63.5	35.4	114.6	114.2	61.4	78.0	93.5	498.1	128.1	120.9	110.9	369.1	112.1	70.3	41.3	101.1	140.5	646.1	106.4	210.5	43.5	168.2	94.1	30.5	122.9	22.7	88.5	173.7	40.6	14.5	246.7	271.2	39.3	277.9	25.6	426.0	42.7	119.8	23.9	27.8	28.8	32.1	22.8	34.7	25.7	28.2	26.8	26.2	28.4	26.6	118.7	44.8	70.4	16.3	54.8	27.5	60.2	156.3	14.8	71.0	152.8	87.0	193.8	55.8	176.5	42.3	54.2	127.1	136.5	17.6	27.4	91.1	690.6	112.4	92.9	94.7	42.4	137.8	21.9	132.6	319.1	148.8	40.2	97.0	67.6	80.0	108.5	141.8	70.7	35.3	23.5	189.0	189.2	29.4	40.0	508.5	149.8	37.6	69.4	18.7	24.1	111.2	95.8	13.6	10.8	75.2	13.2	114.3	256.5	108.7	3.9	28.5	618.8	99.3	46.0	50.8	75.4	174.9	61.3	87.7	30.1	1158.2	92.3	88.3	45.3	61.2
NUDC		ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946871	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 642.2;Respiratory ciliated cells: 635.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol		NA	NA		140000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	62.6	140.1	108.3	37.7	111.2	51.7	64.2	113.6	124.2	69.3	118.7	97.8	35.8	70.1	70.0	59.7	93.9	28.4	106.7	110.1	115.8	79.8	116.0	63.7	42.3	109.5	110.5	74.5	81.4	53.1	75.4	40.8	110.7	72.1	31.5	48.6	54.5	57.0	126.1	67.1	52.7	41.8	108.6	63.3	85.3	86.7	110.5	47.5	63.2	60.6	42.3	80.0	61.7	120.2	204.2	208.1	106.9	149.2	83.5	74.6	121.2	159.2	97.3	209.4	153.5	192.3	137.8	169.5	137.1	109.6	154.2	156.2	229.5	209.8	160.7	132.1	238.0	210.9	207.7	333.7	147.2	224.9	149.2	80.6	134.5	252.7	161.8	90.9	156.4	194.9	306.1	92.3	143.5	175.9	227.3	289.9	281.2	264.8	266.4	234.7	135.5	172.4	180.1	79.2	177.4	133.1	173.3	109.0	149.1	99.8	106.5	137.0	155.5	148.7	178.1	188.3	207.4	184.0	311.9	202.0	160.4	312.7	170.9	184.4	138.8	141.1	152.7	150.2	154.5	176.7	154.1	145.4	140.7	185.9	150.7	154.9	95.4	147.4	155.1	163.2	163.5	168.0	108.3	111.2	113.6	124.2	110.1	115.8	109.5	110.5	110.7	108.6	110.5	120.2	111.8	134.6	116.1	12.4	93.6	154.1	329.0	187.2	82.0	93.3	85.1	85.9	166.5	137.2	169.8	110.3	52.1	203.3	89.2	91.3	262.2	285.0	85.6	473.8	105.4	120.6	131.4	99.3	16.1	317.4	206.7	128.9	105.5	113.4	147.6	104.5	95.3	642.2	147.5	111.0	16.5	123.1	128.1	70.2	132.1	132.7	135.8	83.7	151.2	11.2	115.3	181.1	86.5	10.1	19.2	309.7	79.7	153.1	77.5	277.7	76.3	200.1	635.8	105.7	111.7	129.1	174.6	246.4	249.7	70.9	148.5	162.7	128.9	91.1	129.1	200.1
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	21.0	34.7	12.2	12.6	13.2	16.2	21.7	14.0	18.1	19.1	15.4	39.2	30.2	18.5	4.6	34.2	18.5	9.0	52.0	12.2	14.0	43.8	48.8	22.0	17.3	14.1	13.3	15.7	45.4	14.1	24.9	10.3	13.0	26.1	8.3	1.1	30.6	14.8	42.4	27.2	36.3	6.0	13.4	41.9	38.1	10.8	14.8	12.9	31.6	19.7	10.4	26.0	21.5	12.7	35.5	22.7	5.4	22.6	8.1	9.7	20.1	15.0	15.1	10.3	9.5	14.8	29.1	16.6	38.4	14.6	15.5	36.1	3.2	23.0	1.3	21.6	9.2	22.6	15.6	15.4	24.2	14.9	35.5	15.2	16.9	10.8	11.7	7.9	16.9	19.5	11.1	17.7	12.2	53.1	20.4	27.1	8.5	21.5	47.0	25.1	9.2	62.4	17.9	19.4	12.6	19.9	12.8	47.8	58.8	2.1	48.9	16.3	15.9	17.0	16.2	54.5	12.6	66.2	28.5	10.6	58.7	17.0	20.4	40.6	69.1	52.5	53.4	88.7	48.1	63.4	47.0	52.8	72.7	77.3	40.8	44.7	42.7	52.1	86.2	121.4	64.9	52.1	12.2	13.2	14.0	18.1	12.2	14.0	14.1	13.3	13.0	13.4	14.8	12.7	18.8	3.2	14.6	5.5	42.6	12.0	28.9	78.8	19.4	14.7	34.6	30.1	3.7	48.6	36.6	40.5	12.5	107.9	51.5	94.1	164.4	61.8	15.5	19.0	27.2	20.3	37.2	14.5	4.8	87.4	50.9	20.1	47.4	27.8	15.2	15.5	23.2	54.3	57.7	30.3	5.6	98.1	61.1	50.1	21.8	9.6	20.2	40.0	33.8	4.7	70.8	26.5	49.4	1.5	3.5	68.0	93.0	19.5	65.8	33.6	133.5	144.8	13.6	18.0	13.1	20.2	45.0	6.6	8.2	34.3	17.5	67.5	37.5	43.6	73.6	33.0
NUFIP1	"NUFIP, Rsa1"	ENSG00000083635	"Nuclear FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989471	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	3.2	3.7	3.2	2.8	3.4	7.9	4.6	2.9	4.6	3.6	2.1	2.6	2.8	4.5	5.5	3.3	3.5	2.4	2.5	3.3	3.0	4.0	4.1	2.3	3.7	2.6	3.2	4.3	3.8	4.0	1.8	3.0	2.9	3.4	3.0	2.6	3.3	3.2	4.8	3.4	2.4	4.0	2.9	3.0	2.8	5.5	3.1	3.6	3.9	3.9	3.8	4.2	2.6	3.9	7.4	5.7	9.5	7.9	6.4	6.6	11.3	8.6	7.4	15.6	9.9	15.6	11.5	21.5	7.0	8.0	9.4	11.3	17.9	12.2	20.2	6.6	14.0	16.4	3.7	14.0	10.5	21.3	6.4	6.9	11.0	10.5	15.8	6.0	7.9	10.9	13.3	3.5	11.1	8.5	17.8	13.4	22.5	19.5	9.3	17.3	9.0	13.1	9.5	6.3	5.2	11.5	7.3	9.9	9.6	8.9	7.5	11.8	6.0	7.9	6.8	10.3	11.9	4.8	7.9	26.7	8.9	14.8	11.4	0.0	2.6	0.8	2.5	2.6	4.7	4.0	2.9	2.8	3.4	4.1	4.5	3.4	0.2	5.9	1.8	4.5	1.7	1.8	3.2	3.4	2.9	4.6	3.3	3.0	2.6	3.2	2.9	2.9	3.1	3.9	11.3	6.4	12.2	6.2	10.5	15.4	11.8	16.7	23.9	7.8	9.8	16.3	4.5	4.3	15.4	5.5	12.5	15.7	11.7	4.2	17.6	14.0	37.2	14.0	21.7	10.9	5.4	14.5	19.2	16.7	15.9	11.9	7.7	18.6	17.7	14.1	7.1	9.7	10.8	8.4	16.9	5.3	12.2	3.4	5.5	63.2	10.8	7.9	8.8	7.5	6.9	9.7	7.2	16.6	14.4	10.8	1.6	11.3	5.0	8.6	3.2	14.8	6.6	6.8	6.6	20.3	15.6	27.1	31.6	14.3	16.6	8.8	9.9	15.7	8.4	7.1
NUMB	C14orf41	ENSG00000133961	"NUMB endocytic adaptor protein"	P49757	14	73275107-73458617	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 290.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002874, CAB011478"	Approved		Enhanced	"Cell Junctions"		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"CAB011478: AB_443023, HPA002874: "	"unprognostic (5.28e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.32e-6)"	"unprognostic (9.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.87e-1)"	35.6	25.9	17.3	37.7	19.2	35.5	33.0	20.4	23.4	34.3	22.0	46.3	46.6	35.6	25.9	40.0	39.0	41.7	28.8	20.9	17.6	41.3	52.1	52.8	24.7	20.3	19.5	33.9	37.3	40.5	20.2	44.4	19.7	29.5	42.2	20.4	36.8	31.6	21.1	32.6	47.4	37.6	18.1	40.4	36.8	20.3	19.4	27.6	39.0	24.1	30.9	40.5	34.0	18.2	70.2	46.9	33.3	30.2	65.8	99.6	45.3	64.9	87.2	51.2	54.1	57.0	86.0	31.9	39.7	80.7	37.8	45.2	39.8	66.6	77.2	48.9	22.2	25.5	28.2	37.3	69.7	23.7	57.5	56.0	70.3	126.2	74.8	56.2	112.3	49.2	47.0	37.1	65.6	62.9	43.3	32.8	15.4	78.9	50.1	27.6	46.7	21.6	71.2	105.3	13.6	35.3	81.0	54.2	33.4	55.9	81.3	34.5	108.8	76.2	42.7	49.3	28.2	30.9	38.9	29.2	153.1	27.4	34.3	91.9	93.3	96.8	12.6	76.4	13.2	22.6	12.7	14.0	68.7	21.4	12.9	11.8	290.3	12.8	102.8	12.8	17.9	64.5	17.3	19.2	20.4	23.4	20.9	17.6	20.3	19.5	19.7	18.1	19.4	18.2	54.4	64.1	49.0	108.4	53.6	42.8	27.7	38.6	42.1	30.7	38.4	26.0	22.0	44.3	50.0	55.2	81.3	26.0	29.9	59.3	25.4	27.9	11.9	68.2	35.0	59.2	40.7	22.9	151.1	26.4	31.0	37.5	43.8	56.6	24.1	26.3	52.1	51.0	42.6	15.2	78.8	39.4	36.7	91.5	109.7	8.1	45.1	94.1	46.2	141.5	117.3	42.6	39.1	62.4	81.8	46.9	39.3	36.9	40.9	37.1	64.7	43.2	56.9	46.4	26.3	22.8	29.7	59.2	32.7	35.6	46.5	34.3	25.6	16.7	37.5	44.6
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706925	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	16.5	10.3	5.4	18.2	6.1	45.6	16.7	12.5	7.4	15.2	10.1	12.8	10.1	17.0	11.6	16.2	15.0	14.9	11.2	6.2	6.3	13.1	23.4	13.9	23.9	6.1	7.1	18.6	13.2	17.9	9.2	18.9	6.4	12.0	13.1	15.7	12.0	13.1	25.1	15.9	12.8	14.4	6.3	17.8	11.6	26.7	6.8	25.2	13.8	19.5	27.6	18.7	14.5	9.7	55.6	27.2	57.7	50.8	24.9	29.3	57.8	42.3	39.3	61.8	65.7	45.5	24.9	104.3	69.7	37.7	51.9	39.4	68.1	41.0	99.0	56.2	52.7	55.6	29.4	47.0	18.6	81.0	50.2	31.0	32.5	64.9	46.5	23.6	37.0	34.5	131.7	32.5	41.9	29.5	60.5	50.1	45.6	20.8	29.5	80.1	74.2	97.9	27.3	53.1	64.6	37.5	36.0	58.3	36.2	90.5	37.8	29.0	34.8	63.2	36.2	30.2	66.7	41.8	63.8	102.8	15.6	36.8	76.1	1.2	1.3	3.2	2.8	1.2	3.7	1.7	3.5	3.4	1.9	2.1	2.1	2.1	3.4	3.0	1.8	1.1	1.7	1.3	5.4	6.1	12.5	7.4	6.2	6.3	6.1	7.1	6.4	6.3	6.8	9.7	28.9	19.2	23.2	39.8	31.4	76.3	37.9	11.1	51.2	14.2	32.5	18.7	14.3	11.5	11.9	16.5	16.7	20.9	24.0	19.4	1.9	8.8	27.3	69.3	56.8	23.3	20.9	44.0	53.0	6.0	21.7	31.8	23.4	91.0	3.8	17.7	13.6	30.7	17.5	16.8	48.8	13.6	12.2	15.6	36.7	19.6	17.4	27.5	21.4	47.8	12.7	7.2	20.6	37.2	50.5	13.4	7.0	14.7	27.9	41.7	10.1	9.8	23.4	12.7	13.1	55.1	26.4	30.4	22.3	51.8	79.3	23.9	35.8	11.7	16.8	35.1
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NVL	NVL2	ENSG00000143748	"Nuclear VCP like"	O15381	1	224227334-224330189	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	7.0	7.7	5.5	8.7	5.7	9.8	10.7	7.8	7.5	9.5	6.5	9.1	6.3	9.0	7.7	7.2	8.8	5.6	5.9	5.3	6.4	8.7	6.1	8.0	12.5	5.4	5.3	10.6	8.8	9.5	10.3	13.0	5.6	9.0	10.6	12.8	7.4	7.9	6.5	15.7	8.2	8.1	4.7	10.4	7.2	6.6	5.6	13.0	10.2	5.2	12.1	8.8	8.9	7.5	28.8	15.8	31.2	25.2	11.5	16.6	31.6	22.0	16.5	30.6	27.0	23.4	23.4	39.6	22.5	14.7	11.7	26.1	37.3	22.2	31.5	30.5	47.0	16.4	25.5	11.3	20.3	39.1	28.8	13.5	16.9	26.8	28.5	14.3	19.2	23.0	48.9	23.8	19.1	21.3	30.6	18.3	47.5	20.0	26.1	34.2	37.3	24.8	17.8	19.2	27.5	22.9	34.2	53.1	31.9	25.6	24.3	32.1	19.8	23.2	14.9	27.1	42.9	15.6	33.3	39.3	15.1	30.2	24.8	13.9	7.8	8.4	11.5	11.8	11.7	13.5	11.8	9.1	8.7	9.0	9.9	10.0	0.8	11.9	16.4	9.0	9.3	7.8	5.5	5.7	7.8	7.5	5.3	6.4	5.4	5.3	5.6	4.7	5.6	7.5	10.2	22.4	23.1	21.2	14.3	5.2	4.6	7.8	4.0	14.5	7.9	8.3	10.5	7.2	12.2	1.8	10.4	21.5	12.6	26.9	13.7	9.5	10.1	10.0	11.6	9.3	4.2	7.2	32.1	8.4	14.0	9.3	5.6	7.3	16.4	13.4	4.6	4.5	10.7	10.1	31.0	12.6	10.2	6.5	5.7	3.1	9.6	8.1	5.4	26.2	8.7	9.7	15.5	24.6	43.0	7.0	23.4	10.9	12.3	3.7	7.0	8.1	16.7	20.4	0.0	8.5	10.1	17.5	11.3	7.3	4.5	18.3	12.9	11.4	14.7	3.7
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 244.7"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 12007.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030136, HPA045808"			Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030136: AB_2673331, HPA045808: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	1.5	1.6	2.3	1.6	2.3	0.6	2.4	4.2	2.7	0.6	1.5	1.3	0.7	0.5	2.6	1.7	0.9	0.8	1.1	2.6	2.3	1.6	2.8	1.4	1.5	2.7	2.2	0.3	2.1	4.3	2.7	0.6	2.8	15.3	1.6	2.7	8.2	1.3	2.9	1.2	1.2	0.5	1.9	1.3	1.4	244.7	2.3	0.6	3.3	0.9	0.6	1.1	1.0	2.3	0.9	1.8	1.0	2.5	0.8	2.4	2.3	1.9	0.4	1.7	0.7	1.0	2.3	0.8	1.5	0.6	1.2	0.9	1.0	1.7	0.5	5.8	5.3	0.8	3.2	1.5	1.0	0.4	0.9	3.8	1.0	1.9	2.3	1.1	2.6	2.3	1.2	2.8	1.9	7.7	0.7	1.3	2.5	3.6	1.9	0.4	0.8	1.3	0.3	2.3	1.2	2.8	0.8	3.7	3.6	2.3	8.2	2.1	2.3	1.0	0.5	1.9	1.0	4.0	7.5	2.0	1.3	1.2	2.7	0.6	0.8	0.1	0.3	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.3	0.6	0.4	0.7	1.5	0.3	0.7	0.4	2.3	2.3	4.2	2.7	2.6	2.3	2.7	2.2	2.8	1.9	2.3	2.3	2.3	0.0	1.7	0.3	0.3	0.8	2.6	1.8	1.8	0.5	16.0	6.2	1.4	0.0	2.2	0.0	2.1	1.7	0.9	4.2	1.9	2.4	2386.5	3.4	0.6	5.3	3.6	0.4	0.4	3.1	3.0	1.0	1.5	1.5	1.3	0.5	1.8	3.1	4.8	0.0	0.3	7.4	2.0	4.2	1.6	12007.9	46.0	5.1	1.8	0.0	1.8	1.7	0.0	0.0	0.3	3.3	4.9	42.5	1.6	20.4	5.7	7.4	3.2	1.6	0.0	0.4	0.8	67.6	31.8	1.2	0.6	1.5	0.6	1.4	2.7	3.2
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 155.4"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 325.2;U-251 MG: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	9.2	20.4	14.1	22.1	13.1	16.3	23.4	10.3	15.3	19.8	14.1	54.7	122.3	20.7	46.9	25.8	22.4	32.4	14.3	17.8	15.6	155.4	129.5	19.0	34.6	13.1	13.2	8.7	26.9	44.4	33.6	8.6	11.7	23.8	49.9	26.9	40.2	29.2	4.4	20.0	88.4	15.0	11.6	12.6	85.0	6.3	13.7	53.6	37.4	3.9	40.3	28.1	12.0	12.7	208.9	108.5	1.6	0.0	0.0	0.0	2.7	53.3	23.9	28.4	26.9	0.0	249.4	35.7	230.1	30.5	248.0	65.5	29.7	325.2	29.1	83.8	22.6	0.1	78.6	0.1	25.6	101.7	0.3	14.7	150.8	0.1	61.1	81.4	115.5	140.2	0.1	17.6	30.3	78.3	172.2	70.2	102.5	234.2	145.2	38.5	0.1	59.4	288.7	135.0	230.3	69.5	75.4	25.5	5.4	0.8	26.2	25.2	195.6	0.2	215.1	1.2	399.5	49.5	59.6	113.3	163.0	0.3	0.4	208.4	3.5	69.1	101.6	1.5	136.9	168.0	191.0	147.3	18.1	156.7	247.2	165.0	11.2	156.0	1.3	122.4	338.7	137.7	14.1	13.1	10.3	15.3	17.8	15.6	13.1	13.2	11.7	11.6	13.7	12.7	135.9	28.9	70.6	2.0	102.5	109.0	146.6	401.4	81.4	17.6	152.7	190.6	39.2	194.5	224.2	176.6	29.2	46.2	66.3	359.7	217.2	510.5	1.4	197.5	22.9	103.3	306.4	38.9	10.1	570.2	11.4	14.9	157.5	190.8	36.8	75.3	31.1	193.9	44.3	1.7	11.6	301.3	341.8	6.4	27.0	2.5	5.0	21.7	65.8	5.6	15.9	49.9	82.4	2.5	1.8	1277.4	311.6	21.4	53.5	180.1	702.0	1384.9	171.4	77.6	0.0	3.7	41.8	2.6	3.2	105.2	131.4	15.3	129.8	52.1	188.6	239.2
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 324.0;skeletal muscle: 363.6;tongue: 374.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	64.9	67.4	35.0	39.2	39.4	32.1	32.0	42.8	45.4	33.8	119.6	56.3	95.6	40.9	16.6	61.6	34.0	26.9	324.0	34.4	50.6	89.7	39.8	43.4	40.0	44.6	44.4	24.8	27.5	99.9	34.9	33.1	44.2	37.9	41.5	25.9	43.0	46.9	363.6	56.4	87.5	51.0	35.7	39.0	52.5	36.2	43.6	32.1	54.9	374.7	41.5	42.5	37.7	35.6	35.8	73.5	42.2	66.0	63.4	69.8	41.9	54.2	51.3	59.5	50.9	67.2	71.7	156.0	63.0	79.2	119.2	108.2	85.7	81.4	58.4	92.0	22.8	47.4	140.6	33.5	32.8	59.4	51.2	66.0	60.5	85.4	60.9	43.0	82.4	50.7	55.8	45.4	63.7	50.1	59.2	34.1	39.8	97.7	81.8	55.9	30.1	175.9	68.5	104.4	73.2	35.0	78.8	107.6	34.4	75.8	64.2	58.7	66.4	43.4	38.5	76.3	64.0	40.9	84.0	85.9	78.4	65.7	80.4	9.9	21.8	12.6	17.9	28.5	19.5	11.1	20.7	18.1	22.0	9.3	8.5	10.8	12.2	19.3	35.4	10.8	42.1	23.2	35.0	39.4	42.8	45.4	34.4	50.6	44.6	44.4	44.2	35.7	43.6	35.6	19.6	6.4	22.5	49.3	23.1	19.5	12.3	15.9	22.8	21.4	14.4	18.2	114.3	12.8	14.2	47.8	18.8	24.0	20.0	64.5	31.3	14.9	51.0	26.1	15.6	16.0	23.4	32.0	43.3	16.9	16.4	20.6	35.2	38.9	21.5	15.5	17.9	22.6	33.8	62.2	53.1	32.6	12.2	24.5	43.4	24.5	11.8	33.8	21.4	29.0	22.7	14.3	16.5	22.1	36.6	20.9	38.0	17.3	27.8	16.4	82.0	51.8	17.0	24.0	19.7	24.7	20.2	10.6	19.9	28.1	26.3	36.7	27.7	30.3	33.5	18.1
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	12.6	13.8	18.6	13.2	18.3	12.2	12.8	20.5	19.6	18.2	12.5	14.8	18.9	17.1	10.3	9.6	16.9	8.4	11.8	19.6	15.8	30.3	20.7	10.7	26.2	18.8	16.7	22.5	10.6	6.6	10.8	8.6	17.9	15.7	8.1	12.1	12.2	10.1	7.2	9.6	17.2	9.8	16.2	15.2	12.4	8.6	17.5	13.5	13.1	8.0	21.2	15.3	14.3	17.4	11.3	20.7	20.3	13.1	19.9	22.3	38.4	14.5	14.8	21.6	25.6	19.9	10.8	68.5	9.5	18.3	34.1	10.8	12.1	15.9	9.0	25.1	17.6	33.9	32.5	29.3	20.7	13.3	20.9	22.3	20.0	37.4	16.0	17.4	27.3	9.6	11.0	10.9	20.9	21.3	10.7	13.2	11.0	10.3	29.3	7.8	13.7	22.4	12.4	5.7	9.0	15.9	18.4	15.2	11.5	10.4	23.7	22.9	17.5	21.9	22.7	17.2	24.0	10.7	16.9	35.9	17.4	37.9	13.7	15.1	10.9	20.7	18.7	9.0	18.4	13.9	15.8	15.3	9.8	16.5	12.1	11.5	2.9	27.0	7.3	15.9	21.0	10.9	18.6	18.3	20.5	19.6	19.6	15.8	18.8	16.7	17.9	16.2	17.5	17.4	9.5	0.0	3.4	15.3	16.7	5.5	8.9	8.3	9.1	20.9	6.7	7.4	2.3	10.0	4.9	9.2	35.5	6.4	16.5	9.0	11.7	7.7	0.9	5.0	12.2	10.4	18.0	22.3	11.2	6.7	10.1	11.7	6.1	4.4	2.5	10.0	10.0	11.8	18.0	8.4	9.2	8.8	6.1	9.0	5.8	1.8	14.3	9.3	7.2	10.3	15.8	11.3	27.8	13.0	9.9	8.8	11.0	13.5	10.0	5.2	47.1	86.3	4.1	34.7	26.3	11.1	10.3	10.2	21.5	5.0	4.5	4.0	12.9	12.0	14.0	5.4
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248599	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol		NA	NA		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	42.2	44.3	39.7	38.2	42.7	53.7	57.3	42.5	48.9	34.3	30.0	48.0	50.1	34.7	38.8	58.1	38.0	35.1	57.4	44.5	43.8	56.4	43.0	23.5	47.9	38.0	36.6	31.1	56.3	44.1	27.4	42.0	40.1	41.1	52.7	42.5	36.3	33.6	105.6	52.0	45.7	37.0	38.0	24.6	35.2	48.8	40.7	58.3	59.7	93.1	53.3	48.3	31.0	39.1	181.4	84.1	134.9	225.5	70.1	152.2	243.0	142.1	142.8	194.2	147.1	200.9	104.4	246.5	138.9	114.5	143.9	139.9	165.3	164.6	227.3	113.7	142.5	231.3	76.4	209.9	135.3	264.3	90.2	134.8	200.6	206.3	217.4	177.4	174.5	88.0	256.8	82.3	170.3	116.6	241.4	272.9	159.1	193.9	273.0	180.4	217.8	170.7	245.1	192.0	218.3	124.7	96.8	141.6	206.2	142.2	101.2	220.6	127.5	127.1	161.4	128.5	210.8	76.2	207.3	190.5	124.6	180.0	115.4	18.1	24.9	7.4	16.2	24.2	23.4	17.9	18.6	20.8	37.1	16.4	21.5	21.2	2.1	26.1	20.0	22.5	25.3	22.7	39.7	42.7	42.5	48.9	44.5	43.8	38.0	36.6	40.1	38.0	40.7	39.1	43.2	35.3	33.0	57.5	49.0	62.7	73.5	92.4	76.8	47.3	86.0	83.8	68.3	47.1	57.0	31.3	35.5	153.7	47.7	44.6	103.7	145.1	267.8	37.1	55.2	47.8	70.7	92.5	132.6	105.3	112.8	53.0	60.1	43.1	41.2	73.3	29.3	25.8	97.3	33.7	129.8	79.6	65.1	59.6	54.4	99.5	40.4	55.9	32.0	65.6	83.1	60.3	52.5	101.6	101.8	112.8	51.8	51.1	56.3	84.2	78.4	141.7	36.1	35.9	26.3	69.7	92.3	104.8	35.9	113.7	64.1	105.9	55.9	94.6	107.6	79.3
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 879.4;tongue: 394.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 933.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol		NA	NA		370000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	92.7	90.4	45.7	35.8	53.5	50.1	64.0	45.9	55.9	52.3	36.8	55.4	63.2	39.7	21.9	61.8	37.7	41.6	105.7	54.9	49.2	72.3	73.8	58.9	45.7	48.0	53.9	92.1	35.4	33.1	33.8	57.5	52.9	34.1	57.2	48.8	46.3	41.4	879.4	77.9	69.6	43.4	44.3	57.3	56.1	72.8	45.4	30.1	27.1	394.5	37.6	43.8	56.3	49.0	83.3	23.1	12.8	17.8	171.4	175.6	15.2	97.6	110.7	72.1	119.0	41.1	108.1	0.7	37.6	134.3	113.2	75.6	17.3	93.5	54.8	192.9	9.2	17.2	32.1	22.0	175.4	0.6	59.5	94.6	72.6	69.2	71.8	177.9	62.4	23.8	21.5	123.7	98.7	17.6	8.3	2.3	5.2	22.4	10.3	1.4	25.5	8.5	87.9	57.6	2.8	13.6	84.9	25.0	64.3	49.9	54.6	11.4	171.6	58.8	28.9	81.0	27.5	63.3	23.5	0.6	88.3	14.3	11.4	47.9	2.5	0.3	56.1	1.5	43.3	18.0	71.2	65.8	0.5	11.7	28.0	34.5	1.7	51.2	3.8	5.2	109.6	30.2	45.7	53.5	45.9	55.9	54.9	49.2	48.0	53.9	52.9	44.3	45.4	49.0	68.2	67.3	29.4	18.6	25.9	74.4	46.6	104.5	67.2	38.7	30.5	32.9	237.7	68.6	81.3	31.3	18.8	112.8	89.8	199.8	33.2	135.5	281.9	36.0	38.6	82.4	42.6	126.5	48.9	114.0	39.8	91.6	88.7	37.4	70.8	92.8	47.8	30.9	31.6	90.9	26.6	106.4	65.1	15.1	26.0	933.6	95.7	14.5	90.7	25.3	36.6	36.4	119.4	13.6	28.1	166.3	186.9	103.4	86.3	92.3	209.9	162.4	73.7	103.4	111.7	63.1	106.6	102.0	13.7	58.1	77.9	75.4	107.5	166.3	44.1	75.0
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59615774	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		70000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	19.6	41.7	14.1	15.5	15.2	27.2	27.4	15.3	18.9	24.7	18.4	26.8	29.4	20.0	31.6	19.6	22.4	19.5	25.5	15.0	15.6	42.8	57.6	18.5	17.8	15.4	16.7	22.4	37.3	44.9	16.1	22.9	16.7	25.9	28.3	15.9	30.1	27.0	57.7	26.6	25.5	21.2	14.0	15.6	27.8	18.0	15.7	24.0	32.3	43.8	23.7	19.6	17.1	15.1	40.9	33.6	24.7	33.2	56.5	52.4	26.8	32.9	42.3	38.4	34.4	38.1	40.2	41.1	42.7	37.9	47.2	41.4	45.4	43.5	43.0	40.0	20.9	28.1	25.1	25.8	60.2	36.2	52.9	40.4	52.8	36.2	94.4	40.0	41.7	38.3	48.6	37.3	34.5	19.0	34.0	26.2	28.0	59.5	32.7	32.5	39.8	28.6	45.6	47.0	28.5	20.3	38.6	47.7	46.0	33.6	66.9	22.7	45.8	32.7	22.8	49.5	22.3	51.9	45.2	41.4	37.0	25.6	26.8	1.7	1.6	1.5	2.8	1.4	2.6	2.2	2.9	2.3	1.6	1.6	2.6	2.1	1.5	2.2	1.3	4.0	1.3	1.1	14.1	15.2	15.3	18.9	15.0	15.6	15.4	16.7	16.7	14.0	15.7	15.1	29.2	25.6	9.0	14.7	18.9	39.6	16.4	13.7	29.6	23.8	38.0	27.1	34.1	32.9	19.0	27.6	22.9	14.2	31.1	34.0	7.9	14.0	8.8	37.9	52.7	21.8	30.0	10.5	25.6	18.6	14.7	21.1	22.4	43.8	27.9	21.8	15.4	67.1	16.0	26.9	22.9	40.0	8.2	12.9	16.9	14.5	15.8	17.9	14.2	12.2	9.6	15.7	18.6	18.1	23.3	20.2	20.5	19.9	32.2	31.2	34.6	21.0	27.8	21.7	6.6	28.4	19.3	25.1	14.5	27.0	47.3	30.8	20.0	43.5	28.4	26.4
OSBPL5	"KIAA1534, OBPH1, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087107-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	22.0	8.0	7.1	7.2	7.7	13.6	19.2	7.8	11.5	42.2	2.1	28.2	5.9	26.6	2.9	12.5	22.3	5.0	14.9	5.2	6.4	13.5	3.1	17.5	2.4	50.3	13.3	14.5	10.4	2.3	10.3	5.0	56.0	25.6	3.2	1.8	16.4	9.9	9.9	25.9	16.6	7.6	5.4	24.9	15.5	3.3	19.8	22.0	14.9	5.9	1.4	24.6	28.3	10.5	3.7	5.6	6.6	7.6	18.9	8.8	0.1	17.9	8.8	7.1	5.0	0.0	10.4	0.0	5.3	10.1	4.9	13.3	1.3	5.0	1.1	3.5	6.0	15.1	19.2	0.0	15.9	13.6	2.3	13.9	5.7	2.5	2.6	5.2	4.8	26.7	5.5	0.0	3.5	10.3	30.7	75.5	4.8	2.4	11.5	15.9	9.0	2.2	3.0	3.3	10.8	1.3	7.6	26.1	7.0	3.7	10.8	35.9	16.4	8.8	12.1	21.2	3.1	3.8	0.0	0.5	9.5	25.3	11.5	0.2	3.6	1.2	9.0	4.7	1.2	0.0	0.9	3.3	3.0	0.0	0.6	3.4	0.4	11.0	11.5	1.3	0.1	5.2	7.1	7.7	7.8	11.5	5.2	6.4	50.3	13.3	56.0	5.4	19.8	10.5	19.5	0.0	5.5	8.1	0.5	4.8	2.6	4.2	5.2	11.5	7.7	5.2	6.9	2.8	4.8	3.7	8.4	0.4	34.6	8.3	1.9	3.0	0.1	2.2	22.1	12.1	0.0	5.7	25.6	2.0	0.6	12.3	5.1	2.5	1.3	3.5	3.9	0.5	1.7	62.2	20.6	8.0	2.0	8.7	3.1	1.2	9.0	3.9	3.6	17.8	2.3	4.1	56.7	20.1	28.2	2.2	8.5	17.0	4.9	3.2	6.1	3.2	5.5	1.2	13.1	7.4	11.4	0.1	0.6	3.8	6.8	0.0	9.1	2.5	8.2	2.5
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 245.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 243.7;Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 238.7;SiHa: 319.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		440000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	52.7	15.8	30.4	16.6	34.9	13.3	18.5	23.9	32.7	13.5	15.9	19.2	8.3	14.9	17.6	26.8	12.4	15.2	245.9	36.2	27.1	53.1	1.3	8.0	21.7	19.5	21.4	13.8	5.3	48.6	14.7	5.0	20.0	25.5	21.1	23.6	18.9	29.8	28.5	23.1	12.8	36.6	19.3	11.0	34.2	13.2	25.7	76.8	27.3	42.6	25.9	15.1	13.8	24.5	35.3	1.6	27.9	33.6	84.7	45.0	0.1	62.1	38.9	50.3	30.4	5.7	23.5	91.2	15.0	47.5	25.8	20.5	77.5	55.9	58.5	78.5	9.1	63.9	238.7	11.9	36.8	125.8	20.9	42.7	15.3	49.3	82.2	24.6	46.4	81.6	13.3	114.0	58.1	4.5	105.5	6.1	6.4	0.0	24.5	82.8	78.9	68.7	41.7	2.9	27.9	28.8	319.5	0.3	38.3	2.5	0.4	27.4	28.3	39.7	51.9	68.6	50.6	18.6	16.5	3.6	59.9	90.9	30.9	1.4	1.4	4.7	11.6	1.5	13.8	10.0	11.5	12.7	6.3	7.5	13.6	10.9	0.4	11.3	2.5	2.4	21.5	6.6	30.4	34.9	23.9	32.7	36.2	27.1	19.5	21.4	20.0	19.3	25.7	24.5	8.4	6.4	9.2	37.5	19.2	14.8	11.7	12.4	17.6	14.1	18.8	14.2	243.7	7.2	14.3	11.0	2.1	7.0	18.3	5.0	187.9	5.4	19.1	11.7	18.8	9.8	13.2	23.1	71.5	0.7	11.9	21.3	20.4	31.2	9.5	8.7	6.8	0.3	38.2	13.5	84.2	18.6	12.2	1.3	7.0	8.6	6.2	5.2	16.0	26.2	4.4	11.8	10.3	66.4	46.8	4.8	5.3	7.5	31.3	12.1	2.9	27.4	5.6	21.6	13.1	9.7	24.6	35.6	19.7	27.6	21.6	6.8	26.6	8.6	18.1	9.0
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive kinase 1"	O95747	3	38165089-38255484	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		300000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	18.4	17.2	9.7	15.7	10.0	33.8	15.6	13.6	12.5	17.8	13.0	18.3	15.2	14.8	15.6	34.1	12.8	15.1	16.9	9.9	10.8	21.5	18.6	15.5	18.5	11.0	11.0	16.1	12.1	26.3	11.5	16.5	11.1	16.5	19.7	13.0	15.2	16.3	36.7	19.5	15.7	17.6	10.2	15.0	16.8	14.1	11.0	25.1	14.8	35.4	23.4	26.7	21.1	11.2	48.5	21.9	42.5	29.8	29.0	33.3	48.2	41.9	57.1	59.2	63.8	28.3	30.8	53.4	20.8	50.5	25.4	29.4	57.8	43.1	77.5	57.6	24.5	58.6	46.1	31.1	34.6	36.6	34.2	26.6	49.6	54.8	87.8	55.7	37.5	67.7	45.2	29.9	102.7	13.7	71.1	26.4	44.8	31.2	26.1	24.2	35.7	41.4	36.4	36.4	22.0	34.0	45.9	114.2	29.0	46.3	37.7	23.7	34.4	37.0	36.6	56.8	63.0	22.7	29.0	38.7	50.7	44.6	75.3	6.8	1.6	3.9	1.8	2.8	1.9	1.0	2.2	1.7	2.6	1.2	1.7	2.1	3.2	3.1	2.5	1.4	2.8	0.9	9.7	10.0	13.6	12.5	9.9	10.8	11.0	11.0	11.1	10.2	11.0	11.2	19.0	12.8	25.8	46.7	27.3	44.1	35.5	25.3	26.7	13.3	19.4	16.5	32.6	4.3	27.6	27.6	20.9	12.1	27.4	44.0	19.6	28.4	3.9	39.9	32.1	19.0	24.1	29.7	59.6	14.5	21.0	18.4	90.7	91.2	15.8	24.9	14.6	20.5	14.9	21.9	51.9	24.5	10.2	29.8	79.0	2.3	9.6	58.0	7.2	29.0	35.2	8.0	18.6	44.7	42.8	46.5	29.4	12.8	19.5	56.5	27.0	22.5	16.1	7.0	13.1	23.7	22.6	15.1	18.5	41.9	51.9	33.0	29.6	19.6	21.6	115.3
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132190147-132295315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 324.2;U-87 MG: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		13000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	17.4	11.7	11.9	16.1	12.1	2.4	12.3	11.4	28.4	29.5	42.2	28.7	22.6	31.1	76.7	19.6	29.6	19.9	40.6	14.4	17.2	80.0	10.5	31.5	2.5	11.4	14.3	8.6	70.7	10.9	19.9	35.1	19.1	10.8	32.7	7.8	32.5	17.1	13.0	16.7	26.8	52.6	10.0	8.7	20.5	9.7	16.8	11.3	20.7	22.9	8.3	22.9	22.3	12.2	57.0	34.9	11.2	57.2	149.2	173.7	61.1	261.9	223.7	108.9	265.0	78.9	50.3	1.5	71.8	283.3	120.5	70.2	33.2	136.5	172.7	41.5	11.9	0.6	48.1	49.0	324.2	0.0	33.9	104.6	193.1	128.8	117.4	162.7	59.1	0.1	21.2	3.6	134.0	23.2	0.2	0.5	3.0	53.7	27.2	0.9	3.6	9.8	31.1	11.0	5.4	15.8	67.7	22.3	47.9	84.1	28.4	3.7	88.9	171.7	63.5	51.0	57.1	24.4	28.1	11.8	323.4	0.4	48.3	0.0	0.4	0.0	0.8	0.3	0.7	0.0	0.4	0.1	0.2	0.0	0.0	0.1	1.0	0.9	0.0	0.3	0.0	0.2	11.9	12.1	11.4	28.4	14.4	17.2	11.4	14.3	19.1	10.0	16.8	12.2	13.0	35.3	10.3	7.5	1.1	16.8	43.6	115.6	23.9	11.6	9.5	9.5	13.3	8.6	36.9	11.0	22.9	2.6	0.3	43.2	5.9	68.3	1.4	26.7	96.9	12.2	15.0	0.0	7.7	71.8	70.2	61.6	12.8	28.0	5.7	11.1	9.3	7.8	7.6	0.0	7.7	18.6	32.6	1.3	5.5	2.0	8.1	4.4	30.2	2.8	2.6	6.8	0.0	1.5	1.2	81.9	41.0	5.3	3.0	19.6	41.4	44.6	71.9	5.2	26.3	109.4	47.6	23.0	29.1	6.8	9.8	7.5	4.8	10.4	13.8	15.3
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560709-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 469.7;skeletal muscle: 557.5"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 460.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Supported		Enhanced	Cytosol		NA	NA		850000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	98.4	95.9	26.1	51.2	27.5	76.8	76.1	24.7	28.6	68.8	31.5	83.6	36.8	87.2	41.1	72.1	67.8	39.8	151.9	25.8	24.4	57.0	82.0	72.9	65.1	33.6	25.6	124.8	469.7	27.9	37.4	49.6	30.4	59.3	32.7	22.7	75.5	36.9	557.5	65.0	66.7	46.2	30.4	71.2	153.1	99.4	32.7	32.7	55.0	244.6	65.1	91.9	69.2	36.1	280.8	90.3	75.7	143.3	223.0	441.9	250.7	161.6	135.2	143.5	103.6	175.0	142.2	239.7	150.3	238.5	58.0	131.5	161.2	197.8	175.8	120.6	128.7	200.2	94.1	194.7	234.5	146.5	122.5	392.7	234.3	164.0	252.6	180.0	179.4	174.9	211.3	126.6	231.5	131.5	135.3	132.8	268.9	95.4	98.0	105.4	274.6	194.9	138.4	343.0	63.9	106.9	118.3	106.1	266.1	137.3	115.8	388.9	146.2	118.6	161.8	308.1	201.3	315.1	423.3	202.5	181.7	130.8	78.6	9.8	18.2	4.8	14.2	22.9	13.3	16.0	20.6	13.0	19.0	19.9	25.3	17.6	1.9	11.8	33.0	18.2	14.9	7.9	26.1	27.5	24.7	28.6	25.8	24.4	33.6	25.6	30.4	30.4	32.7	36.1	55.0	19.2	48.9	8.8	120.6	55.8	80.7	36.5	45.5	25.9	104.4	77.5	145.3	90.1	47.7	47.8	81.3	85.2	82.0	115.5	41.1	44.4	70.7	49.0	95.7	50.5	59.3	75.3	9.4	92.3	154.1	69.1	88.7	78.9	53.2	83.0	69.9	152.7	100.5	33.7	10.3	87.5	26.4	460.9	104.6	25.6	69.0	162.4	56.9	13.1	78.6	29.1	30.9	6.0	13.7	57.0	83.2	46.3	212.5	103.5	96.4	46.5	17.5	110.5	6.6	85.3	75.2	37.4	186.3	77.5	41.8	107.1	66.7	86.2	81.7	114.9
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 169.6;granulocytes: 124.5;Melanocytes: 140.5;Microglial cells: 166.8;Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 35.4;HMC-1: 45.5;SK-MEL-30: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: AB_2685685"	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	3.9	3.1	3.4	9.0	3.5	12.3	2.0	14.8	4.0	1.8	4.3	9.2	7.6	1.9	2.2	1.6	1.8	7.1	4.7	2.8	3.7	1.7	4.7	14.9	14.5	4.5	4.5	1.2	14.9	0.9	2.0	16.0	4.9	2.6	8.7	5.0	3.7	2.1	1.3	4.3	9.0	3.0	4.9	9.1	4.4	0.7	5.2	10.4	1.8	2.1	14.0	4.8	2.6	5.6	0.1	0.1	4.8	0.2	8.9	8.5	0.1	2.0	15.5	1.0	1.9	0.3	0.1	35.4	0.2	0.5	7.6	1.5	0.1	1.8	0.9	0.9	4.5	20.8	0.3	0.0	9.1	3.4	45.5	4.1	1.2	8.9	8.2	0.9	0.0	6.2	0.2	0.1	14.8	0.3	12.6	0.3	0.4	8.1	1.4	9.5	2.4	0.1	1.6	7.6	1.0	1.7	0.0	0.3	36.1	0.8	1.2	3.5	0.3	1.1	0.6	0.0	1.2	5.7	1.6	12.3	9.7	11.7	8.5	13.1	1.4	2.0	2.5	6.4	6.1	2.0	6.2	4.4	1.9	1.6	4.9	3.8	2.3	1.7	14.6	4.1	7.2	2.7	3.4	3.5	14.8	4.0	2.8	3.7	4.5	4.5	4.9	4.9	5.2	5.6	6.2	0.0	12.4	40.8	37.0	31.5	3.9	5.2	0.6	39.7	2.2	2.2	15.4	10.0	14.0	3.7	0.0	0.8	39.0	169.6	0.0	4.0	3.5	0.6	4.4	10.9	3.6	3.8	57.5	6.5	26.2	24.3	8.2	1.1	124.5	97.0	12.5	10.3	27.1	63.9	60.0	23.2	6.1	73.6	26.2	2.1	2.5	79.1	140.5	166.8	40.8	34.9	19.6	82.4	75.3	2.0	62.1	7.9	38.4	7.7	109.3	0.4	0.8	3.2	124.9	32.3	37.1	0.2	3.0	3.8	22.6	2.3	78.1	11.8	27.4	13.7
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No		60000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"HPA073653: AB_2732234, HPA076187: AB_2686784"	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	69.5	54.3	47.8	36.6	50.8	56.6	67.4	52.0	64.2	65.1	52.0	57.1	43.3	61.6	57.3	52.0	51.2	53.3	92.5	51.2	52.0	78.0	90.9	50.3	39.4	49.5	49.5	53.7	54.8	74.3	29.3	68.1	50.8	69.1	54.8	95.2	51.3	68.5	155.3	31.1	40.2	65.3	54.3	34.2	46.9	83.6	49.0	47.6	73.6	122.9	45.3	70.1	39.9	56.5	94.5	82.2	158.0	153.7	161.8	127.1	129.1	81.2	180.0	151.5	130.9	77.2	112.8	62.5	136.9	115.5	227.3	60.4	249.3	98.0	153.5	52.2	96.7	49.2	157.1	122.6	142.3	74.2	74.3	135.8	186.1	102.5	191.7	153.1	146.8	45.9	115.9	82.1	153.0	101.7	82.4	101.8	78.5	89.4	104.8	63.8	119.2	88.1	188.8	114.3	89.4	135.3	260.3	99.2	190.0	144.0	141.4	106.3	82.4	136.6	112.5	68.8	103.7	61.7	112.6	94.3	79.7	113.1	120.4	40.4	24.1	46.2	18.9	20.7	25.2	26.4	23.2	26.2	23.7	26.7	28.9	23.2	8.6	24.9	22.5	66.8	23.0	22.1	47.8	50.8	52.0	64.2	51.2	52.0	49.5	49.5	50.8	54.3	49.0	56.5	66.4	32.1	52.2	15.0	39.4	73.3	74.0	78.5	52.3	48.8	78.8	53.1	122.4	78.6	52.7	44.1	20.9	76.3	66.0	33.1	158.5	120.3	182.6	73.8	56.4	71.2	44.9	54.9	30.0	91.6	89.2	64.2	39.3	55.9	24.6	47.4	50.0	49.2	59.4	35.3	25.3	52.1	103.7	40.9	39.7	58.0	76.4	42.0	83.6	20.6	53.8	86.6	24.7	26.7	35.1	116.4	43.8	66.5	43.3	106.4	45.1	148.8	40.9	67.7	26.3	70.2	71.4	171.2	76.6	56.0	66.3	68.1	35.1	49.7	47.7	84.3
PALM	"KIAA0270, PALM1"	ENSG00000099864	Paralemmin	O75781	19	708935-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 257.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 85.2;Distal tubular cells: 52.8;Hepatic stellate cells: 63.1;Leydig cells: 48.4;Muller glia cells: 92.8;Proximal tubular cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.6;EFO-21: 20.7;REH: 34.3;SH-SY5Y: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	89.0	23.1	158.4	2.0	140.7	0.7	66.0	86.1	257.8	60.3	54.5	54.4	7.4	43.3	3.3	14.4	47.0	2.8	41.1	165.1	97.0	52.7	7.3	30.0	0.6	106.4	103.6	65.7	5.8	1.2	62.5	6.6	96.9	42.6	0.6	4.6	12.9	8.3	9.6	33.4	20.8	2.4	95.0	23.4	18.0	19.6	112.1	0.6	21.0	1.7	0.2	29.4	41.8	110.5	0.0	7.6	14.6	16.6	0.6	0.2	2.2	0.9	0.0	1.0	0.2	1.9	0.1	0.0	20.7	0.0	0.0	2.7	8.0	0.0	0.4	0.0	14.1	0.0	4.3	9.3	9.4	0.0	0.3	3.0	0.0	0.9	0.0	0.4	0.4	1.6	4.6	0.1	1.1	15.9	1.1	9.4	5.9	1.0	3.2	34.3	0.0	0.2	0.6	0.0	1.7	28.0	7.5	0.1	0.2	4.6	1.8	4.5	0.0	0.0	13.4	16.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	158.4	140.7	86.1	257.8	165.1	97.0	106.4	103.6	96.9	95.0	112.1	110.5	27.2	0.0	1.7	85.2	2.7	7.1	7.2	6.3	1.8	11.4	5.7	5.3	5.8	1.5	4.9	5.5	12.5	0.9	0.2	1.3	52.8	1.4	1.4	3.8	27.0	25.6	0.0	1.3	26.9	0.2	7.2	37.6	1.1	5.9	0.0	1.4	63.1	0.4	1.0	25.2	15.1	0.1	12.2	2.4	5.4	6.6	48.4	1.1	17.8	10.3	0.1	92.8	0.0	16.6	9.8	0.2	1.4	45.1	0.1	10.1	7.2	57.9	0.5	5.7	0.0	2.3	14.1	0.8	7.3	1.1	7.0	1.9	1.1	0.1	0.4	7.2
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128841-94181968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	11.4	7.2	5.1	12.1	5.2	4.1	6.4	1.2	5.5	7.9	2.7	8.4	5.4	8.5	5.2	7.9	5.2	11.5	9.9	5.0	7.1	6.9	16.8	10.2	6.4	2.1	2.9	7.1	7.4	4.4	4.7	9.7	3.3	7.7	7.2	3.1	6.0	7.0	20.8	8.3	5.8	12.8	2.8	5.8	7.4	9.9	4.9	8.1	8.7	10.8	7.0	21.9	6.5	2.7	24.6	10.2	26.2	16.0	23.9	32.3	17.1	29.8	63.0	25.1	30.7	26.2	37.6	7.8	27.3	30.5	46.1	50.5	20.9	49.2	25.2	33.6	10.9	36.0	10.2	13.5	23.1	18.7	31.0	25.7	33.9	32.8	29.2	16.1	21.2	20.1	23.8	27.5	28.3	7.8	31.3	4.4	21.0	19.7	18.2	36.7	35.0	9.7	16.3	24.0	11.0	31.9	20.9	11.9	14.4	13.3	25.2	9.5	15.4	49.5	25.5	16.4	29.9	4.5	18.2	12.6	20.6	19.0	32.2	3.2	4.0	0.3	2.1	2.2	2.4	1.3	1.7	2.3	2.7	1.2	1.6	1.7	0.2	2.6	1.4	0.4	2.9	3.2	5.1	5.2	1.2	5.5	5.0	7.1	2.1	2.9	3.3	2.8	4.9	2.7	3.8	0.0	8.7	4.6	6.6	102.0	12.3	14.9	13.6	1.3	4.5	2.0	4.7	4.3	4.7	1.8	0.0	12.8	5.3	4.7	0.0	15.7	5.3	9.1	13.0	6.8	2.4	5.2	8.9	18.2	32.4	17.5	7.1	13.9	9.5	4.0	2.2	8.1	20.5	0.0	15.4	4.1	0.0	3.1	21.6	3.9	4.4	11.5	17.8	8.4	3.7	1.1	1.0	9.5	5.8	26.1	3.4	3.8	7.4	10.2	2.6	2.1	6.2	1.1	0.0	16.9	10.6	1.7	8.2	8.3	72.2	23.8	6.6	10.1	4.2	12.7
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756253-60802086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	3.7	3.0	2.2	2.2	2.3	1.4	3.4	3.2	3.1	4.2	1.7	3.2	1.3	4.1	1.2	3.5	3.2	1.4	3.1	2.3	2.3	2.5	2.3	3.2	3.0	2.5	2.1	4.9	3.5	1.7	3.1	2.0	2.5	2.6	1.5	4.0	3.8	1.2	4.2	3.7	3.6	1.5	1.9	4.1	3.4	3.5	2.6	3.7	6.2	1.7	2.5	3.2	4.1	3.0	1.8	1.5	3.4	2.0	3.1	3.7	2.4	1.5	1.9	1.4	1.2	2.4	1.3	2.6	1.7	1.3	1.4	2.8	3.7	1.8	2.3	4.0	2.1	4.0	1.7	1.7	1.9	4.4	2.4	2.2	2.5	1.7	3.7	2.9	2.6	2.6	3.2	1.9	1.4	1.4	5.0	3.6	5.3	2.9	1.1	3.4	4.9	2.7	1.9	1.4	1.6	2.4	2.2	2.7	1.9	3.2	1.3	2.7	2.4	1.8	1.8	1.3	1.7	2.4	1.5	5.4	2.2	4.8	1.4	3.7	0.8	1.5	1.3	1.0	1.7	1.1	1.2	1.2	0.7	1.4	1.7	1.5	2.2	1.4	1.2	0.8	2.2	0.8	2.2	2.3	3.2	3.1	2.3	2.3	2.5	2.1	2.5	1.9	2.6	3.0	11.5	12.8	12.2	13.1	13.9	12.5	13.5	4.6	12.0	6.8	8.4	8.6	7.9	7.2	8.8	9.2	25.0	6.0	21.0	6.9	3.9	4.8	4.7	6.1	13.2	10.9	2.4	13.3	29.5	4.3	4.6	11.0	6.6	6.6	13.3	14.6	11.7	5.0	7.4	5.0	24.8	5.7	10.2	10.4	22.7	4.3	7.5	17.8	12.4	25.3	12.0	5.1	8.2	19.1	22.1	4.9	6.0	8.6	12.7	15.4	4.3	3.5	7.1	10.3	26.3	9.3	11.3	30.3	17.3	13.2	15.9	8.8	20.8	10.6	4.0	16.2
PARP1	"ADPRT, ARTD1, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 469.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		150000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	32.0	26.4	33.9	63.9	41.9	29.4	29.5	46.2	33.2	26.2	20.6	43.5	29.3	30.2	19.8	31.3	28.9	20.4	55.1	30.3	36.2	22.4	37.1	27.4	125.5	48.4	39.7	27.5	50.8	94.7	38.0	58.2	47.7	40.7	37.2	44.9	28.9	46.4	94.5	21.1	36.8	45.6	41.9	57.7	29.6	40.5	40.9	64.6	28.4	70.2	150.8	38.7	24.6	58.1	182.4	108.9	295.4	209.3	75.9	61.3	137.1	101.3	119.1	178.2	144.9	175.4	98.1	559.3	147.2	80.9	77.9	135.1	411.6	132.4	144.4	204.1	396.6	216.2	135.9	114.5	44.6	372.2	93.3	61.7	50.5	144.2	101.3	49.3	140.5	132.2	346.9	291.8	94.1	99.6	114.7	110.0	476.2	290.5	165.1	334.2	484.5	533.4	76.4	144.5	264.0	229.2	165.2	190.3	100.1	205.3	159.6	225.8	99.3	93.3	140.9	120.6	235.1	110.9	151.8	472.6	78.2	125.7	214.3	11.1	11.7	12.3	31.2	20.5	45.3	72.2	37.3	36.7	28.2	69.9	28.2	32.5	2.2	22.0	42.3	16.2	49.3	25.7	33.9	41.9	46.2	33.2	30.3	36.2	48.4	39.7	47.7	41.9	40.9	58.1	33.4	54.5	73.6	13.7	169.1	72.3	83.9	56.4	51.2	96.1	58.8	43.3	115.0	44.3	69.8	57.0	141.8	469.2	53.8	27.7	72.4	88.9	34.1	53.3	66.5	62.0	75.0	100.5	16.5	107.0	111.7	49.8	37.8	55.2	122.1	116.2	34.2	69.4	139.6	90.9	17.5	50.0	57.0	47.8	35.7	20.5	40.0	48.3	62.2	16.9	76.9	80.1	95.8	10.1	31.9	48.5	24.2	35.0	186.9	82.8	25.6	48.5	56.4	118.1	46.0	58.7	48.0	88.8	199.6	77.2	48.2	137.6	85.0	103.5	61.9	41.7
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563675-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 16.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 19.3;Spermatogonia: 57.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 0.7;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8"	"Not detected"	"Not detected"							"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	19.3	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX3	"HUP2, WS1"	ENSG00000135903	"Paired box 3"	P23760	2	222199887-222298998	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Deafness, Disease variant, Proto-oncogene, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;salivary gland: 4.8;skeletal muscle: 3.6;skin 1: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.4;Late spermatids: 34.8;Melanocytes: 33.8;Skeletal myocytes: 12.8"	"Cancer enriched"	"Detected in some"	24	"melanoma: 20.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 9.0;BJ hTERT+ SV40 Large T+ RasG12V: 10.6;HBF TERT88: 8.0;RH-30: 17.5;SK-MEL-30: 29.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.4;midbrain: 1.4;pons and medulla: 1.3"	"Region enhanced"	"Detected in many"		"midbrain: 7.7"	"HPA063659, HPA069000"			Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA063659: AB_2685080, HPA069000: AB_2686067"	"unprognostic (2.57e-2)"				"unprognostic (1.48e-2)"	"unprognostic (1.27e-2)"		"unprognostic (1.65e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.70e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.26e-1)"		"unprognostic (9.70e-2)"	0.5	0.0	0.4	0.0	0.1	0.0	1.0	4.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.3	1.9	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	4.8	0.0	3.6	2.9	0.0	0.0	2.0	0.0	0.0	1.1	1.2	0.0	0.0	0.8	0.1	0.0	0.1	5.5	0.0	0.0	4.9	0.0	0.0	0.0	0.0	6.0	6.5	9.0	10.6	0.0	0.7	0.0	0.0	4.4	0.2	0.0	0.0	0.0	8.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	6.9	0.1	0.0	0.0	0.0	17.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	29.1	7.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.1	0.0	0.1	3.3	1.9	2.8	2.0	1.2	5.5	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	34.8	0.9	0.1	33.8	1.9	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.4	5.6	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0
PAX6	"AN, AN1, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31817961	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 61.6;retina: 68.9"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 264.2;Muller glia cells: 462.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;AN3-CA: 20.1;HEK 293: 18.0;HeLa: 14.9;hTERT-RPE1: 50.6;U-251 MG: 16.5"	"Region enhanced"	"Detected in all"		"cerebellum: 54.3"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.0	0.6	21.7	0.0	22.9	0.2	0.1	61.6	34.1	0.0	16.5	0.2	1.7	0.0	0.6	0.0	0.0	0.0	0.0	23.6	20.7	0.8	0.1	0.0	0.0	22.0	18.1	0.0	9.2	0.0	4.3	0.0	21.7	0.0	0.3	68.9	0.1	0.0	0.8	0.5	0.9	0.0	21.4	0.0	9.4	1.6	19.6	0.4	0.0	0.0	0.1	0.1	0.1	25.8	0.0	0.2	15.1	20.1	4.6	6.6	5.9	0.0	0.0	0.2	0.0	1.3	3.7	0.1	6.3	2.3	9.0	0.4	1.8	0.0	0.3	0.0	18.0	8.9	14.9	8.4	0.0	0.5	0.0	0.1	0.7	0.1	0.5	50.6	0.0	5.2	7.6	0.0	0.2	0.0	3.7	0.6	0.3	0.0	10.1	0.0	7.3	0.1	0.8	0.6	0.7	0.0	0.4	0.1	0.0	0.0	4.7	0.0	0.0	5.3	0.4	0.0	16.5	0.1	0.2	0.1	8.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.7	22.9	61.6	34.1	23.6	20.7	22.0	18.1	21.7	21.4	19.6	25.8	0.2	0.0	0.0	76.7	0.1	0.5	0.0	0.0	0.0	78.8	0.5	0.0	3.8	0.0	0.0	0.0	12.5	0.1	0.1	0.2	0.0	0.0	0.7	0.2	0.5	1.0	74.6	0.0	3.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	264.2	1.6	3.1	0.0	0.0	0.4	0.6	0.0	0.2	0.0	3.7	0.6	462.6	0.0	3.5	0.6	2.5	1.3	0.0	0.0	0.0	0.1	0.2	0.0	30.6	0.0	0.9	0.5	21.4	7.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278921	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 267.9;thyroid gland: 565.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 246.5;Endometrial ciliated cells: 114.0;Glandular and luminal cells: 228.2;Proximal tubular cells: 128.1"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"EFO-21: 79.7;GAMG: 50.0;RPTEC TERT1: 193.2"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.5"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	2.0	6.0	1.4	0.6	0.9	0.5	1.7	0.1	1.1	14.5	1.7	1.8	0.6	8.8	32.9	2.2	37.5	3.6	2.1	1.0	1.9	267.9	1.2	1.6	1.7	5.2	1.3	1.7	1.0	1.4	1.4	1.9	3.0	1.1	0.9	1.5	1.9	26.1	0.5	1.8	2.4	0.8	3.7	0.8	1.4	2.4	2.3	0.5	565.5	0.3	1.0	2.1	1.0	1.9	9.4	0.8	0.4	0.0	0.4	0.2	3.0	2.6	8.0	0.7	1.2	5.7	1.6	1.7	79.7	0.6	50.0	0.1	1.6	2.6	0.7	3.9	0.0	1.5	0.7	3.4	0.9	0.0	0.0	2.3	0.3	0.6	1.9	9.9	0.1	0.0	1.3	6.2	2.5	1.8	1.0	3.8	0.5	2.2	5.5	0.0	0.6	2.1	193.2	14.4	1.5	0.0	10.4	0.1	5.6	0.0	0.0	3.5	2.7	13.8	0.5	2.6	7.2	1.2	4.6	0.6	11.9	2.0	0.0	0.7	1.0	0.0	0.1	0.6	0.4	1.3	0.4	0.3	0.9	0.5	0.7	0.4	0.2	0.6	0.4	0.3	0.2	0.4	1.4	0.9	0.1	1.1	1.0	1.9	5.2	1.3	3.0	3.7	2.3	1.9	1.3	3.2	2.0	0.7	4.1	0.6	1.9	1.8	7.4	0.6	2.0	1.4	0.9	5.7	3.4	246.5	0.0	2.4	1.6	9.5	46.9	8.5	1.6	114.0	21.8	1.4	4.8	3.0	0.8	2.9	2.4	1.6	4.1	228.2	0.0	1.0	1.1	0.3	5.2	0.0	0.8	3.2	2.0	2.6	2.1	3.9	5.0	5.6	0.0	0.0	2.0	4.0	1.0	0.5	0.2	29.2	7.4	0.4	0.5	1.6	6.3	128.1	0.6	0.9	6.6	3.6	1.7	6.2	7.3	12.5	0.9	0.8	3.1	0.4	3.7	2.2
PBRM1	"BAF180, PB1"	ENSG00000163939	"Polybromo 1"	Q86U86	3	52545352-52685917	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015629, HPA059373"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA015629: AB_1855012, HPA059373: AB_2683994"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.06e-1)"	21.4	12.9	6.4	20.8	11.0	24.6	16.6	18.5	8.9	21.1	13.2	17.9	15.4	22.1	16.4	22.5	19.4	16.9	18.5	6.0	11.9	11.2	18.2	17.6	22.1	10.7	9.9	29.4	12.0	14.3	8.7	20.9	11.8	18.6	18.5	20.2	13.1	17.4	15.5	17.3	14.2	25.4	8.6	18.9	16.0	14.1	10.3	42.0	26.7	22.8	22.0	20.0	12.0	19.8	32.5	20.5	71.9	35.4	34.7	35.0	50.4	44.5	29.9	49.5	43.0	23.3	21.5	78.7	6.2	51.8	40.8	21.8	63.1	33.1	59.6	85.5	34.6	74.6	38.1	18.1	49.6	62.7	54.6	33.2	37.3	55.4	35.4	38.9	48.4	60.6	43.7	41.7	50.3	11.0	103.9	18.8	43.8	22.0	34.4	53.8	45.1	40.1	20.4	62.5	48.7	53.8	52.7	12.4	41.6	43.4	23.4	35.7	56.5	46.1	34.8	40.1	54.4	30.0	51.3	73.6	28.5	49.8	46.9	9.0	4.0	9.9	3.6	2.6	3.8	2.9	3.6	4.0	4.0	5.3	5.7	3.6	2.3	3.6	8.0	8.7	3.9	1.6	6.4	11.0	18.5	8.9	6.0	11.9	10.7	9.9	11.8	8.6	10.3	19.8	49.1	41.7	61.3	95.3	44.0	40.5	35.8	28.3	43.9	45.6	40.7	30.4	61.7	30.0	39.8	23.9	47.9	36.0	67.7	36.8	19.6	37.7	39.1	61.4	54.5	47.7	35.2	82.9	76.4	46.2	36.9	39.8	42.8	46.8	29.1	61.9	33.5	47.9	53.0	30.3	84.5	35.3	28.5	61.7	47.7	17.1	34.2	65.6	48.0	80.6	67.6	29.1	49.4	87.9	135.5	49.7	29.2	58.3	76.9	37.5	18.7	18.4	58.2	44.3	26.3	54.3	69.2	48.6	35.8	43.7	51.6	50.9	50.4	45.8	39.8	37.0
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	24.3	32.1	16.5	11.8	22.3	3.1	36.1	10.7	18.0	88.3	1.9	52.3	22.4	136.8	21.6	30.1	74.6	37.6	24.0	15.3	14.1	29.4	7.7	20.7	4.5	8.8	32.7	52.1	48.1	29.5	14.3	19.5	6.7	38.0	19.8	17.1	43.8	53.8	36.3	10.2	19.9	125.2	13.7	10.2	21.9	6.8	12.6	10.9	35.1	26.5	8.1	40.2	41.5	12.1	2.9	74.4	82.4	19.1	50.8	23.3	3.4	25.2	20.9	8.4	6.1	14.2	11.8	0.0	5.5	47.8	4.3	22.8	31.7	8.1	3.6	3.1	31.3	93.0	56.5	0.3	34.7	0.0	22.2	24.4	0.0	5.4	2.1	19.2	0.3	0.0	0.2	0.0	2.2	47.1	0.2	0.6	111.5	3.8	4.5	0.0	21.6	27.0	6.3	44.1	2.5	39.6	27.8	186.1	0.1	71.4	73.2	0.0	0.5	3.7	8.6	24.2	8.1	8.5	61.2	0.1	0.4	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	16.5	22.3	10.7	18.0	15.3	14.1	8.8	32.7	6.7	13.7	12.6	12.1	28.6	22.4	18.6	382.3	2.8	22.8	115.0	39.8	70.6	39.9	129.9	87.8	50.0	98.7	25.3	33.1	110.5	101.3	1.5	29.2	33.2	47.9	91.3	47.7	144.3	47.0	90.9	30.3	475.9	68.7	7.3	126.7	32.1	38.5	71.7	57.6	68.9	18.7	9.7	5.0	405.0	38.2	50.8	1.9	17.5	124.4	63.6	12.1	16.0	125.5	1.6	33.5	1.0	327.2	227.4	31.7	72.5	103.8	2.8	41.5	40.4	57.9	37.3	30.6	39.5	142.0	70.9	2.3	17.5	83.6	28.1	104.7	7.6	168.0	43.7	75.9
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 429.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 527.8;Hep G2: 527.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	77.3	102.9	115.0	31.0	111.8	21.8	67.9	111.9	140.7	58.0	114.1	83.9	54.4	48.2	91.2	54.3	111.5	47.4	152.3	109.3	136.9	165.1	429.5	57.9	31.1	125.4	138.5	64.2	174.9	135.1	61.5	33.4	139.4	73.8	88.3	48.6	49.9	78.4	109.7	25.7	64.0	75.6	119.7	25.6	84.8	20.0	131.8	25.8	86.3	109.1	35.8	69.3	39.2	118.9	158.3	374.3	21.4	223.8	80.9	76.0	29.4	50.0	84.5	77.7	61.6	527.8	270.3	32.2	141.4	56.3	57.9	101.7	138.9	81.3	53.2	86.2	251.9	28.6	57.5	527.1	84.9	28.5	99.2	74.1	88.5	76.5	35.8	114.1	212.3	19.9	57.1	2.8	55.2	270.2	3.5	94.7	30.1	420.5	346.0	15.1	29.7	103.6	328.6	164.7	94.0	158.8	41.5	277.1	111.5	59.9	81.1	53.8	86.2	12.7	102.9	18.9	123.8	1.1	6.7	1.1	68.3	93.1	19.5	0.2	24.8	8.7	19.6	47.1	15.3	25.7	25.8	28.3	49.6	10.9	8.4	17.1	1.6	19.6	34.4	35.8	41.1	18.7	115.0	111.8	111.9	140.7	109.3	136.9	125.4	138.5	139.4	119.7	131.8	118.9	25.5	41.7	91.5	8.5	25.9	49.8	169.1	88.2	103.0	39.0	197.9	249.6	151.5	138.7	86.0	187.6	6.2	124.6	18.5	113.8	453.9	185.0	2.3	138.7	49.3	40.8	176.4	36.2	4.9	169.9	81.6	82.2	86.6	175.3	31.1	64.6	37.9	603.7	180.3	35.3	8.5	313.3	65.1	79.9	55.7	11.2	67.4	73.1	78.2	5.6	68.0	153.0	22.6	9.0	4.6	154.8	164.7	95.5	35.1	212.7	232.1	877.7	78.4	33.2	85.5	57.2	63.3	4.4	12.3	147.8	45.7	77.6	32.6	95.9	230.2	187.5
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087477-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		1600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	278.3	276.3	145.5	199.8	155.0	390.0	240.4	168.5	203.5	209.3	159.1	259.9	172.8	253.9	142.6	278.4	193.8	134.9	223.2	142.1	155.6	218.1	304.3	233.6	227.1	163.7	146.9	186.0	249.9	174.6	140.2	194.8	159.2	143.9	125.8	90.5	185.0	139.5	782.3	216.6	203.1	172.4	163.8	241.3	214.5	95.2	150.4	301.0	170.8	308.3	209.6	233.8	206.0	190.9	384.9	387.5	327.1	257.5	345.1	262.4	525.9	280.5	257.2	272.0	227.0	453.0	250.6	522.9	140.9	320.7	293.7	334.7	388.4	408.6	276.5	376.2	299.9	419.2	219.5	701.3	388.0	350.8	385.8	230.3	261.6	224.5	310.5	203.4	350.7	138.9	437.2	375.6	346.2	475.7	454.7	524.7	331.5	361.1	253.2	362.9	358.0	527.1	375.5	389.6	309.7	249.1	230.3	465.8	342.1	229.8	277.6	314.2	325.1	253.5	317.6	217.6	359.4	495.7	551.2	531.7	268.6	480.4	319.5	42.6	89.7	141.5	80.3	92.5	73.8	41.1	62.1	69.3	82.9	36.4	62.8	71.2	138.2	95.4	80.5	58.9	81.7	100.5	145.5	155.0	168.5	203.5	142.1	155.6	163.7	146.9	159.2	163.8	150.4	190.9	241.0	153.8	132.7	27.4	312.7	484.0	296.0	192.1	196.9	64.9	270.8	212.6	0.6	208.8	134.5	196.8	22.9	372.4	208.7	401.7	272.0	196.0	34.4	187.6	220.8	242.8	178.6	485.3	19.1	199.2	470.1	196.9	227.9	284.8	114.2	129.6	227.0	392.7	385.7	58.9	18.0	239.8	138.4	509.2	795.9	34.4	186.1	382.4	300.6	30.0	422.9	122.3	347.1	14.1	49.1	211.7	311.7	186.5	357.1	278.5	338.4	481.0	128.6	56.1	170.9	222.9	241.9	131.0	65.5	267.0	545.8	703.4	291.2	148.4	232.9	366.6
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.1"	"Group enriched"	"Detected in many"	8	"Astrocytes: 311.8;Excitatory neurons: 1152.0;Inhibitory neurons: 882.3;Oligodendrocyte precursor cells: 917.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.4;RH-30: 120.4;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		340000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	1.8	3.2	10.5	5.2	14.6	0.0	3.0	0.0	33.7	23.9	0.0	19.2	3.2	16.9	25.1	14.3	9.7	8.1	19.1	23.7	50.1	2.0	1.0	2.9	1.4	13.0	14.3	4.7	0.9	1.1	0.2	0.2	14.3	10.6	7.8	3.4	0.8	18.2	0.6	11.6	5.0	22.1	3.9	18.6	11.4	1.0	46.3	1.4	4.1	0.4	1.2	16.3	5.9	11.8	0.0	1.1	14.4	20.1	29.5	28.5	0.0	3.8	0.0	1.9	0.9	1.9	26.5	0.0	0.1	0.2	0.0	15.3	1.3	38.5	3.4	0.0	43.4	0.1	26.8	0.0	30.4	0.6	0.0	17.2	8.8	1.0	10.7	17.5	7.5	0.0	0.0	0.0	9.0	0.1	0.0	0.1	8.8	9.3	4.0	0.0	120.4	0.0	0.9	65.2	0.9	0.2	0.4	1.2	1.3	8.2	1.8	6.9	0.0	24.1	6.2	6.7	0.0	0.0	0.0	0.0	18.8	0.1	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	14.6	0.0	33.7	23.7	50.1	13.0	14.3	14.3	3.9	46.3	11.8	1.1	0.0	0.0	311.8	0.3	85.0	92.4	25.7	46.7	46.8	0.7	9.0	83.2	0.0	13.7	64.4	0.0	0.1	0.0	0.3	0.0	0.6	16.9	66.8	8.4	7.6	0.0	0.0	1152.0	0.7	0.1	24.0	20.9	60.4	1.3	0.8	19.2	0.1	0.3	10.1	882.3	0.5	4.1	1.0	3.5	10.4	0.3	1.3	21.4	43.1	0.0	1.3	0.0	917.3	26.4	26.5	0.0	28.6	1.3	26.1	0.0	0.2	27.0	3.4	0.0	51.3	11.0	1.1	2.7	18.5	38.6	0.1	1.8	1.7	0.3	50.3
PCGF1	"MGC10882, NSPC1, RNF68"	ENSG00000115289	"Polycomb group ring finger 1"	Q9BSM1	2	74505043-74507695	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011356, HPA069156"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA011356: AB_1855063, HPA069156: AB_2686095"	"unprognostic (2.41e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.13e-1)"	9.9	10.4	13.7	8.6	14.5	17.8	15.2	14.6	17.3	12.8	13.0	11.5	11.2	12.5	14.4	9.7	14.4	10.0	12.3	14.1	13.9	10.9	13.0	12.3	14.1	13.9	13.8	14.8	11.0	17.6	2.3	11.4	14.7	9.3	12.3	18.1	11.0	8.8	12.1	14.8	10.8	11.2	13.7	8.5	11.7	11.0	14.5	14.4	14.2	17.6	14.7	10.7	2.1	15.1	18.9	11.6	12.3	19.0	15.4	19.0	19.0	17.8	23.8	16.2	10.9	25.5	12.8	16.9	7.6	16.5	38.0	11.4	20.7	23.5	14.6	16.3	24.7	12.0	15.7	25.6	24.9	31.7	16.5	25.5	33.3	10.5	57.4	26.0	12.8	21.8	25.0	23.0	17.8	27.8	22.6	42.0	16.3	23.5	12.3	18.0	27.3	14.1	24.8	21.0	14.0	27.8	13.8	27.1	30.1	12.1	10.1	21.4	11.7	26.2	17.5	14.5	24.1	12.5	9.7	18.3	22.1	22.6	16.3	11.1	24.2	10.4	15.5	20.1	18.3	18.1	20.7	19.8	26.9	17.9	16.3	16.8	8.7	14.4	23.3	13.1	24.2	14.2	13.7	14.5	14.6	17.3	14.1	13.9	13.9	13.8	14.7	13.7	14.5	15.1	7.0	3.2	1.8	2.3	8.7	12.5	9.0	23.8	31.3	5.0	10.5	10.9	3.5	12.8	10.6	3.7	4.2	12.2	6.5	9.5	31.3	11.0	19.0	11.3	11.5	8.5	1.2	10.3	1.7	10.4	19.5	13.1	6.1	10.4	10.2	2.9	7.1	6.2	13.6	5.0	1.6	12.8	18.3	9.9	14.0	4.9	7.8	10.8	7.2	0.0	15.0	6.7	19.6	0.5	2.3	11.3	15.9	4.9	11.4	9.4	14.2	17.5	9.5	9.5	6.6	10.4	14.0	19.3	8.0	24.3	18.9	18.3	9.6	5.0	9.4	8.5
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 196.1;kidney: 99.1;liver: 374.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.5	10.7	3.2	8.0	3.9	4.5	21.1	3.8	3.3	6.8	3.4	44.8	196.1	5.8	3.1	20.0	5.9	4.5	5.8	3.1	3.9	99.1	374.1	16.5	8.7	4.6	4.2	3.0	34.8	17.4	8.0	2.8	4.1	9.1	19.2	2.7	18.6	7.1	2.6	12.6	136.3	3.8	4.0	21.7	16.0	19.7	3.9	3.7	18.9	1.2	7.5	10.8	10.0	4.3	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.2	3.9	3.8	3.3	3.1	3.9	4.6	4.2	4.1	4.0	3.9	4.3	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease variant, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 383.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes		170000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	31.2	47.2	23.2	85.2	26.0	383.2	51.0	26.8	29.7	41.5	26.8	89.0	70.7	38.1	30.9	81.2	39.1	34.8	30.6	23.0	24.4	43.7	55.3	37.5	168.8	25.1	24.0	37.7	32.8	42.4	25.1	69.8	26.0	32.2	93.7	94.1	40.3	38.3	27.9	62.8	72.9	47.9	26.8	54.0	53.9	62.3	23.3	219.9	42.0	26.8	137.3	51.0	42.3	30.0	769.1	591.4	585.0	253.7	136.1	126.6	409.5	491.6	288.3	453.7	640.0	465.3	594.2	773.4	155.7	177.5	395.2	558.8	350.7	594.4	413.2	231.7	386.8	543.7	207.8	1098.3	57.8	753.7	233.0	92.6	138.2	387.2	91.7	95.3	263.3	503.6	493.9	631.2	449.7	278.3	1450.6	829.3	439.9	592.0	322.9	787.9	514.1	622.5	208.5	441.1	500.8	339.4	345.1	524.6	351.9	213.9	371.2	378.0	177.2	324.3	373.3	461.5	572.0	317.2	981.6	1313.9	145.9	707.4	426.2	5.0	23.2	18.5	36.5	23.3	45.7	33.5	45.7	37.1	32.6	29.2	41.6	37.3	7.7	43.6	24.7	29.9	48.1	36.7	23.2	26.0	26.8	29.7	23.0	24.4	25.1	24.0	26.0	26.8	23.3	30.0	32.4	44.8	26.0	2.9	40.6	67.7	44.4	121.4	44.3	42.1	27.5	45.2	14.5	21.5	60.5	58.8	27.1	171.5	44.3	42.9	60.7	51.6	176.0	30.2	21.4	34.8	19.9	189.0	4.3	39.6	175.6	38.7	21.9	27.7	22.7	53.1	29.6	27.1	96.7	32.0	5.9	53.9	75.3	24.2	33.4	109.1	36.1	32.7	37.4	3.7	47.6	74.0	23.7	4.0	13.5	28.3	20.3	40.3	56.6	23.3	33.3	46.1	44.1	97.1	52.6	29.2	46.1	149.1	101.1	65.5	49.7	66.4	48.6	29.6	84.5	40.4
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574180-101594465	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No		38000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	47.0	47.6	42.6	43.5	45.3	58.7	53.5	48.6	69.1	48.2	54.5	47.8	38.8	53.8	52.6	48.1	43.8	41.0	57.7	43.1	50.6	51.9	49.6	41.0	57.3	43.7	43.9	69.7	33.3	50.0	39.3	50.5	44.0	47.6	45.2	58.3	42.5	49.1	66.5	39.0	36.1	53.4	45.8	39.8	34.8	28.4	45.8	58.0	49.8	66.4	57.5	50.7	40.0	52.9	135.0	71.1	105.2	82.9	96.1	136.8	113.4	90.0	126.3	94.1	105.1	85.8	73.1	139.4	66.5	100.0	92.8	71.4	138.0	119.6	196.9	102.6	76.6	151.1	84.9	103.4	73.6	141.1	72.1	82.4	115.5	78.0	109.6	134.8	129.6	64.1	143.7	82.6	117.2	55.8	123.8	120.2	162.4	110.8	113.9	71.8	93.2	110.0	123.7	76.7	136.1	108.0	83.4	82.0	132.6	119.3	76.7	105.4	81.5	86.5	113.8	44.1	97.1	62.1	100.2	174.0	84.1	150.9	107.4	58.3	22.4	38.6	22.1	27.0	29.1	29.8	28.9	26.9	23.9	24.1	29.1	27.3	20.2	36.4	36.0	18.9	35.9	40.9	42.6	45.3	48.6	69.1	43.1	50.6	43.7	43.9	44.0	45.8	45.8	52.9	94.9	60.9	101.4	25.5	124.2	232.6	235.2	171.7	126.9	89.5	90.3	65.8	111.5	75.8	106.2	64.4	39.6	120.3	75.0	46.6	266.1	130.3	30.1	89.1	80.4	111.0	81.9	195.9	50.4	95.0	205.7	126.9	55.5	114.6	102.6	53.8	90.3	51.7	90.3	97.6	51.3	70.8	187.2	87.3	242.1	15.0	130.8	105.0	250.8	39.4	131.0	128.4	102.0	36.2	49.1	111.2	51.6	134.6	77.8	207.5	72.2	182.6	85.8	90.5	131.5	110.8	170.3	105.7	70.1	100.6	238.5	235.9	125.1	60.9	78.8	196.3
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408597	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		410000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	25.7	29.6	35.8	22.6	36.2	23.2	24.4	36.5	39.3	26.2	34.1	32.4	17.9	26.9	17.5	37.2	22.6	11.9	40.2	34.4	36.1	28.5	31.3	24.0	18.9	37.3	37.9	25.7	26.6	22.5	21.9	19.2	37.4	26.0	18.0	22.9	26.2	20.9	105.0	27.9	23.3	21.1	37.6	23.8	26.3	19.7	37.0	25.5	24.3	59.7	22.4	29.3	26.4	36.6	96.9	82.4	54.6	71.0	41.5	43.2	34.7	76.7	44.9	61.6	51.8	83.9	47.4	41.3	67.2	74.7	78.4	50.2	66.3	78.4	60.5	59.8	74.4	43.6	80.8	74.1	60.8	80.1	40.5	45.6	58.5	68.1	110.3	56.3	62.7	67.5	103.0	75.6	61.4	200.3	110.4	111.2	68.7	98.1	88.3	50.5	54.3	73.6	63.6	73.0	54.8	110.6	58.0	92.4	43.4	61.3	41.1	42.5	57.6	83.6	91.4	100.8	123.6	71.4	87.5	91.0	67.7	72.2	89.1	13.4	12.1	12.5	15.4	16.6	13.9	15.7	14.2	11.2	10.2	14.9	9.8	13.2	31.6	28.0	15.6	21.1	20.9	6.6	35.8	36.2	36.5	39.3	34.4	36.1	37.3	37.9	37.4	37.6	37.0	36.6	82.9	86.6	94.7	6.2	73.6	62.2	110.6	104.6	57.5	97.4	84.3	76.6	63.6	72.9	86.7	42.3	33.3	213.1	84.7	101.6	168.3	176.1	60.3	91.3	118.6	99.1	117.9	151.7	10.1	171.0	223.0	87.4	59.7	88.3	72.2	83.4	61.8	80.8	114.9	77.4	11.6	116.5	75.3	38.3	63.3	78.3	83.6	66.1	103.2	5.6	102.1	166.4	119.4	8.0	17.4	177.4	92.2	92.2	102.5	184.3	100.0	134.5	96.8	101.0	52.6	85.6	127.2	132.5	123.0	131.9	65.6	184.4	79.5	115.2	114.0	122.5
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562993-100576739	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	20.8	22.0	19.1	27.1	21.6	22.9	23.0	21.6	24.3	18.9	16.6	27.3	17.0	24.1	37.2	36.8	22.5	21.3	30.6	18.4	21.3	28.4	18.5	18.4	25.3	21.8	24.7	21.1	11.4	23.4	10.5	23.4	21.7	27.0	28.9	21.1	16.9	23.2	58.8	36.8	17.3	38.6	20.8	17.0	17.6	22.8	22.1	22.4	21.4	34.3	34.0	33.1	17.5	22.2	41.8	58.7	59.9	52.2	19.3	27.4	67.5	51.3	32.5	92.9	58.1	74.2	25.5	68.6	74.0	62.3	122.3	34.2	76.0	50.2	74.0	110.6	65.8	72.0	31.8	89.7	50.8	77.3	73.2	29.8	92.0	82.0	52.3	24.2	58.9	52.8	61.1	43.8	70.7	74.6	75.8	117.7	77.9	45.6	86.6	72.5	63.2	48.0	58.2	98.7	55.9	49.6	41.0	54.7	59.0	48.6	42.3	53.0	45.8	56.4	60.1	44.8	72.2	26.4	54.1	68.3	34.4	90.5	45.7	82.3	64.8	80.2	63.1	124.4	72.8	92.5	95.0	70.4	114.9	78.1	97.7	75.4	7.0	93.9	161.7	64.0	113.6	87.3	19.1	21.6	21.6	24.3	18.4	21.3	21.8	24.7	21.7	20.8	22.1	22.2	37.4	19.2	25.2	1.6	39.5	65.6	36.6	79.2	52.9	13.0	24.8	36.2	40.9	18.6	46.1	14.7	6.2	70.8	61.5	16.0	60.7	50.6	37.0	38.9	26.6	30.2	19.8	21.7	2.3	39.1	51.2	22.6	19.4	34.6	92.9	25.4	12.5	17.0	59.7	11.8	2.0	24.0	89.5	17.8	80.7	14.3	14.6	54.4	35.6	3.7	104.3	19.7	40.2	2.0	4.5	31.8	18.6	33.4	27.7	33.2	19.7	77.9	28.1	16.5	52.6	23.8	54.1	5.5	66.9	63.2	57.5	52.4	91.8	24.5	31.3	32.4
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746410-43773278	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1048.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		200000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	17.0	16.6	7.5	16.5	8.0	27.1	15.6	9.2	7.6	24.7	13.9	20.6	23.6	16.4	44.7	18.9	15.4	13.5	17.3	7.7	9.8	15.3	34.5	16.8	18.7	9.3	8.2	16.5	36.0	22.6	16.2	23.8	9.1	25.2	22.5	8.4	21.6	19.1	7.6	17.3	21.4	17.0	9.0	12.5	20.4	10.8	9.3	9.6	56.0	4.1	12.3	15.6	15.2	9.8	29.4	11.9	24.6	55.1	48.9	51.9	70.8	58.6	62.1	46.0	56.7	33.6	32.1	33.8	37.4	72.9	30.8	47.8	31.8	61.5	39.7	24.3	44.7	47.2	17.6	30.9	80.1	26.0	33.8	33.6	49.8	35.0	58.5	54.0	81.3	11.1	27.7	17.4	45.5	11.1	9.1	30.4	24.4	48.5	44.0	17.9	36.7	26.2	39.3	26.0	22.9	25.4	48.7	49.0	19.4	25.0	33.1	28.1	50.9	37.7	18.9	29.7	29.1	7.1	8.6	33.9	48.1	41.2	28.8	11.6	8.8	13.3	12.1	9.2	12.8	5.4	6.8	9.5	8.3	6.1	6.0	7.1	2.4	12.7	9.9	17.6	5.8	15.8	7.5	8.0	9.2	7.6	7.7	9.8	9.3	8.2	9.1	9.0	9.3	9.8	224.9	192.3	183.9	31.6	177.8	192.2	313.7	665.2	114.4	56.5	137.9	95.5	58.3	124.4	427.7	167.3	41.7	655.2	319.6	228.7	70.5	401.2	24.3	178.8	300.3	223.7	186.1	95.3	29.2	390.4	807.8	350.7	261.0	328.5	261.6	255.1	233.1	342.2	426.0	70.7	38.3	523.1	231.9	157.3	292.2	26.7	253.5	246.5	243.7	36.5	258.0	128.3	279.1	29.7	38.8	279.9	196.8	276.8	341.1	286.5	234.3	129.1	245.6	61.9	124.9	138.4	389.7	186.4	147.6	138.9	148.5	1048.8	237.8	390.8	335.4	291.7
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 570.3;skeletal muscle: 661.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 164.8;Exocrine glandular cells: 242.1;Pancreatic endocrine cells: 320.1;Peritubular cells: 223.0;Sertoli cells: 164.3;Smooth muscle cells: 157.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 177.1;eosinophil: 121.2;neutrophil: 438.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 438.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	74.3	26.7	23.0	74.5	27.2	50.3	58.2	18.8	39.8	183.7	30.2	570.3	31.5	489.5	28.8	64.5	236.0	45.0	79.9	22.3	27.6	52.8	16.0	84.7	15.1	23.9	23.4	94.2	15.1	9.6	66.3	33.2	24.9	245.3	24.9	5.7	42.3	200.7	661.5	38.0	111.7	177.6	20.8	84.5	156.1	37.6	28.5	11.5	37.1	70.5	7.6	315.4	125.0	20.5	115.8	25.8	120.7	89.4	32.5	59.9	118.9	232.4	132.8	128.9	89.0	50.9	109.6	20.4	220.4	156.4	69.5	59.5	19.7	160.6	30.3	27.5	27.6	73.6	92.2	52.6	83.6	38.8	237.3	132.0	29.1	115.6	51.5	191.9	85.4	18.3	52.4	15.3	102.5	103.9	7.0	88.6	75.7	23.2	108.8	144.4	101.3	14.0	89.1	29.6	17.5	35.8	91.5	16.9	44.6	39.9	24.3	31.3	292.9	153.8	168.1	60.5	211.7	4.0	4.7	24.1	73.3	44.2	35.7	177.1	46.7	121.2	5.3	22.9	6.3	9.6	3.1	7.2	26.7	5.3	3.0	4.0	438.7	2.3	29.3	1.9	7.0	23.9	23.0	27.2	18.8	39.8	22.3	27.6	23.9	23.4	24.9	20.8	28.5	20.5	36.6	0.0	0.6	11.1	7.5	14.5	47.1	106.8	6.2	6.3	7.6	65.3	21.0	4.3	20.9	25.8	14.6	12.5	4.4	5.5	25.4	164.8	27.0	7.5	44.8	51.0	3.5	9.4	13.9	242.1	53.3	65.0	9.7	7.3	17.2	18.6	51.0	1.6	64.0	8.4	7.4	2.1	36.7	16.6	18.3	49.3	44.7	44.9	10.6	5.6	31.0	16.2	1.0	2.0	1.7	320.1	33.6	223.0	3.2	30.4	1.0	15.7	13.2	22.6	164.3	24.6	157.7	11.6	38.7	12.2	15.8	14.1	10.8	18.2	3.1	25.3
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	19.4	16.2	13.3	23.2	15.0	29.4	24.3	19.7	18.1	20.6	17.0	23.0	19.7	19.9	20.2	25.8	15.9	16.5	14.5	13.4	13.9	22.0	33.4	22.7	33.2	15.1	13.6	23.6	21.0	29.7	10.6	22.9	15.5	18.5	23.9	20.9	20.1	15.9	17.7	24.3	19.4	19.4	14.2	21.4	20.6	14.0	14.2	42.0	28.5	19.6	34.7	22.8	15.9	23.5	54.8	40.0	50.3	53.4	47.5	47.5	40.2	43.4	40.9	50.1	49.6	39.2	60.2	106.6	46.5	51.6	79.5	29.4	86.9	50.5	71.7	36.1	33.2	73.1	47.6	41.3	47.5	90.2	60.1	31.5	55.9	53.3	78.2	44.5	64.7	62.1	88.0	43.8	52.0	38.5	113.2	78.8	28.6	51.4	26.7	104.3	89.6	38.9	48.2	54.6	69.5	41.2	59.9	40.7	39.0	37.5	41.4	78.7	61.5	56.4	58.6	41.2	74.3	37.0	69.7	112.3	40.1	90.6	45.3	2.3	1.2	1.9	2.3	1.6	3.0	2.0	2.2	2.5	1.8	2.5	2.6	2.1	0.4	3.0	1.1	2.2	2.0	1.0	13.3	15.0	19.7	18.1	13.4	13.9	15.1	13.6	15.5	14.2	14.2	23.5	36.2	86.6	70.3	75.7	52.3	56.6	37.0	29.3	51.8	32.7	42.6	30.1	40.5	32.9	45.8	22.0	60.5	32.4	50.8	39.2	7.9	22.0	9.7	34.9	50.0	40.7	30.5	69.6	120.5	25.8	39.1	36.8	41.3	52.8	29.1	45.1	40.0	58.2	30.9	13.5	115.3	36.3	28.5	46.6	54.5	10.0	32.9	44.6	46.2	119.9	38.7	13.3	42.2	98.5	138.0	38.9	28.2	33.1	52.8	53.7	28.5	27.4	25.5	27.9	32.9	36.3	31.1	44.2	48.5	66.9	68.2	38.7	49.9	30.9	40.4	59.6
PDS5B	"APRIN, AS3, CG008, FLJ23236, KIAA0979"	ENSG00000083642	"PDS5 cohesin associated factor B"	Q9NTI5	13	32586452-32778019	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039513, HPA040015"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039513: AB_10671999, HPA040015: AB_10671047"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.91e-2)"	11.8	8.1	3.8	9.4	6.2	23.3	12.6	7.6	14.3	18.5	0.0	13.5	6.1	19.0	13.2	7.1	12.8	7.8	7.4	7.5	8.3	9.8	9.6	10.9	13.3	0.7	0.4	15.9	7.5	9.3	9.8	10.1	0.0	12.8	8.2	11.1	8.5	9.8	11.4	10.4	10.6	11.7	0.3	13.4	9.8	12.1	0.9	20.9	10.4	8.0	10.7	10.2	11.4	10.5	12.4	7.3	32.7	17.6	15.3	11.0	9.2	20.5	13.7	17.1	17.1	10.1	20.2	45.0	7.2	10.1	17.2	16.1	23.9	12.9	20.2	36.1	9.0	40.7	13.1	14.2	9.0	37.6	24.0	8.6	6.4	14.3	12.8	11.2	13.1	17.8	14.4	29.6	15.8	15.9	45.3	28.2	24.2	25.9	8.9	45.7	45.2	15.5	11.0	10.2	8.5	20.4	23.6	23.0	9.2	19.7	22.2	24.8	26.0	16.3	15.7	11.8	12.4	9.0	10.7	37.4	7.0	25.1	24.1	3.0	2.7	4.0	3.0	2.4	3.5	3.4	3.5	3.2	3.5	4.5	3.4	3.3	3.3	2.8	3.3	2.3	2.8	1.6	3.8	6.2	7.6	14.3	7.5	8.3	0.7	0.4	0.0	0.3	0.9	10.5	50.3	16.0	30.2	86.8	33.9	28.9	23.8	14.6	34.1	42.3	24.3	17.0	26.7	21.5	24.6	27.6	25.0	24.9	35.9	17.4	5.9	14.8	14.5	24.2	79.7	42.2	31.8	22.9	185.5	16.0	18.5	46.4	19.4	19.9	23.5	55.3	23.9	28.0	18.5	47.1	222.6	21.8	16.2	39.0	38.1	13.7	67.1	31.3	35.6	131.2	39.4	15.8	34.0	154.8	155.1	14.7	17.9	62.4	43.8	23.4	15.9	12.9	31.3	20.8	72.3	46.9	51.4	49.5	60.6	17.0	29.3	6.2	37.1	41.8	21.1	17.0
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.6;Late spermatids: 733.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		9600	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"		"HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502"	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	33.3	37.9	4.9	20.9	5.0	12.9	33.1	14.7	6.5	35.7	7.9	61.3	52.5	31.9	17.0	43.4	29.2	20.8	39.1	6.0	4.1	47.6	104.5	34.6	13.4	6.2	4.7	31.1	70.4	27.1	63.2	23.5	7.5	55.8	47.8	13.4	80.5	25.2	52.0	27.8	61.1	18.5	1.2	31.8	56.7	113.2	7.2	11.7	42.9	16.5	15.0	39.1	34.7	5.7	21.4	30.9	31.1	26.1	16.9	20.4	51.4	19.6	17.4	14.3	19.7	38.0	45.3	40.7	42.0	26.5	20.5	34.0	22.1	20.1	20.5	25.0	30.2	24.7	51.8	100.2	44.3	19.7	56.4	21.5	20.4	25.0	20.9	28.0	15.3	21.6	18.5	26.0	34.1	52.2	12.9	10.4	15.3	20.8	11.7	19.9	12.9	48.6	22.7	33.9	31.9	22.8	52.6	30.0	50.9	19.7	121.0	30.3	23.8	11.0	10.0	12.3	25.7	24.2	25.1	39.3	22.7	16.4	35.8	2.9	7.8	11.6	9.4	7.7	10.8	8.3	6.8	7.7	11.7	9.0	8.2	8.1	1.0	7.5	6.2	5.4	6.6	8.2	4.9	5.0	14.7	6.5	6.0	4.1	6.2	4.7	7.5	1.2	7.2	5.7	29.6	38.5	64.6	32.7	33.0	38.2	42.2	21.6	18.8	32.1	57.9	27.8	45.7	58.6	52.9	29.5	31.3	51.7	30.6	149.8	27.4	38.2	483.6	48.1	41.7	35.1	161.2	33.2	80.7	58.3	56.5	36.0	71.9	75.3	39.3	42.1	27.5	123.6	30.5	40.4	68.3	216.7	24.4	33.1	16.8	733.8	49.0	30.9	26.6	31.9	27.5	19.7	39.1	55.8	45.0	46.5	114.4	45.5	45.4	58.1	115.6	53.4	48.3	47.4	46.0	24.0	28.0	142.3	72.7	24.6	42.6	80.7	33.9	21.2	127.2	76.5
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 87.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 1717.4;Late spermatids: 4366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		830000	"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	25.6	21.8	79.4	7.6	62.2	12.9	18.4	23.9	87.0	14.3	17.5	17.1	14.1	12.3	10.2	19.7	14.0	7.0	15.5	62.5	51.7	50.4	21.5	20.9	7.0	48.8	59.7	19.1	21.3	17.8	37.3	7.8	54.7	17.2	9.4	10.0	22.7	10.6	6.7	13.9	19.7	6.9	34.4	12.5	16.6	23.9	70.5	10.2	19.1	5.4	9.3	10.9	12.6	57.6	43.4	51.9	8.1	15.5	19.4	27.3	9.9	15.2	23.8	14.5	12.1	42.5	65.7	14.4	15.7	21.9	20.0	31.9	15.8	43.4	9.5	16.2	13.4	14.7	60.9	31.7	38.1	14.0	20.6	38.9	40.7	15.3	16.9	23.6	6.9	6.3	26.2	31.9	13.8	29.1	2.0	24.9	22.3	41.9	19.7	16.7	4.8	40.4	62.9	51.9	7.8	9.3	63.3	57.7	23.2	3.3	19.0	19.4	12.5	10.5	20.3	14.2	14.4	19.3	9.8	8.4	43.2	39.9	10.3	0.6	2.4	0.1	0.8	2.2	1.5	0.6	0.8	0.9	1.3	1.7	0.8	0.6	0.6	0.9	4.3	0.6	0.7	1.4	79.4	62.2	23.9	87.0	62.5	51.7	48.8	59.7	54.7	34.4	70.5	57.6	15.8	80.1	66.6	44.1	37.7	28.4	142.4	72.2	27.3	46.3	74.8	53.5	48.0	34.3	73.2	101.2	22.9	42.9	23.6	97.6	180.0	146.4	1717.4	66.9	28.3	36.1	30.1	15.8	49.3	196.6	86.3	39.4	63.2	73.2	31.8	23.8	17.2	54.2	207.6	52.2	48.7	55.4	12.2	58.2	101.0	4366.5	50.1	118.7	42.7	61.8	38.4	14.9	20.6	16.6	13.5	223.4	36.4	54.2	146.4	184.7	108.4	95.7	71.1	43.3	6.6	17.0	35.0	678.1	30.4	60.7	28.4	124.1	27.3	22.1	57.5	239.8
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.2	17.8	34.9	13.4	34.1	10.9	14.9	29.9	33.1	19.9	21.2	18.3	11.8	21.5	6.2	19.5	19.8	8.8	23.1	33.4	30.7	16.8	17.7	13.1	16.3	34.2	33.3	21.9	17.5	15.5	23.5	11.4	33.8	20.5	7.5	8.7	15.3	12.2	46.8	18.7	17.4	10.8	31.8	20.5	17.5	32.8	33.6	12.5	17.2	18.1	12.0	19.5	17.0	33.9	41.8	89.8	34.8	55.3	26.5	19.5	77.9	29.6	20.5	40.1	42.7	88.1	30.0	100.0	44.4	23.4	28.5	62.6	65.1	46.3	22.6	52.1	93.2	44.6	45.1	72.0	34.2	36.4	57.5	23.9	28.2	49.5	41.3	20.7	30.2	52.9	54.7	42.6	22.4	57.2	68.9	42.7	57.3	40.2	29.7	71.7	30.8	49.3	28.2	31.2	34.8	46.5	50.8	36.9	39.4	33.1	44.6	24.3	30.7	30.9	43.5	47.3	57.9	22.7	42.5	41.6	34.9	37.1	40.6	0.2	0.7	2.0	0.9	1.0	0.9	0.8	0.9	0.7	0.8	1.3	0.9	1.3	0.2	1.3	1.2	1.1	0.6	0.7	34.9	34.1	29.9	33.1	33.4	30.7	34.2	33.3	33.8	31.8	33.6	33.9	10.4	22.4	30.1	11.1	18.5	14.8	14.8	15.7	21.1	24.0	13.5	12.4	22.6	8.6	20.9	9.2	16.7	30.9	15.3	11.8	1.9	15.9	64.7	16.6	17.3	13.7	12.6	14.1	10.6	14.6	28.3	16.6	16.8	17.6	30.9	21.1	5.0	10.6	16.9	35.3	13.0	18.6	12.2	6.0	20.4	27.0	9.3	10.4	10.6	5.6	65.1	10.7	5.2	5.0	11.5	11.4	11.7	19.2	23.6	19.3	8.3	4.7	22.3	17.8	6.6	16.8	14.8	31.3	67.5	20.0	16.3	21.2	17.4	16.6	21.9	13.0
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	33.3	41.0	26.3	29.2	28.6	35.5	32.2	26.7	30.5	31.8	27.1	29.6	21.7	35.5	21.2	43.6	29.4	20.2	28.8	26.9	26.2	38.7	48.2	26.2	32.3	27.1	27.2	34.2	57.3	30.1	21.8	21.5	27.6	32.9	19.6	9.2	29.3	21.5	48.8	45.3	28.2	22.5	25.8	34.4	35.7	40.0	27.0	23.8	27.1	20.0	27.3	35.0	31.9	30.0	132.2	146.6	53.0	113.7	59.9	58.4	81.6	84.7	69.6	141.6	110.0	170.6	55.2	177.2	74.4	97.0	110.3	89.4	163.9	153.5	103.1	76.4	159.8	85.9	80.8	149.0	149.3	209.6	86.8	82.7	94.7	148.3	147.3	68.3	93.0	62.4	144.6	69.9	87.7	164.3	102.6	209.8	103.1	128.3	106.7	129.0	91.7	173.3	78.9	88.7	91.4	94.6	84.2	94.6	117.8	42.0	66.8	106.1	74.2	165.9	126.1	85.3	145.1	88.1	81.0	178.6	116.2	94.9	109.0	7.5	24.9	6.4	18.9	29.8	23.2	20.2	17.4	18.1	26.8	20.0	19.4	18.0	0.9	20.0	22.3	23.2	14.3	29.3	26.3	28.6	26.7	30.5	26.9	26.2	27.1	27.2	27.6	25.8	27.0	30.0	23.6	3.2	18.9	4.9	17.4	22.6	23.4	32.7	22.2	6.5	14.1	12.2	3.8	24.3	22.1	25.8	8.4	34.9	7.8	19.6	25.4	48.0	44.4	11.7	13.8	23.2	23.4	24.6	4.3	43.9	40.0	15.4	22.4	10.6	18.3	24.4	27.8	22.8	38.4	3.3	4.3	22.4	22.4	27.8	12.6	14.3	19.9	21.2	21.4	2.8	29.0	13.5	16.5	6.6	5.1	38.7	16.2	20.3	28.3	26.4	31.3	55.1	24.6	8.9	19.7	23.2	20.7	28.7	20.9	25.9	22.9	28.5	13.5	19.9	29.7	15.1
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.3;Syncytiotrophoblasts: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	15.9	13.9	15.5	9.5	15.3	7.8	16.2	11.7	21.8	15.5	10.7	16.8	15.1	17.1	6.4	20.9	13.7	9.3	19.6	15.8	13.6	15.8	33.0	14.3	10.5	14.1	13.1	14.9	11.2	11.8	14.1	11.8	13.8	26.4	8.2	28.1	16.8	23.8	22.6	18.6	16.2	8.5	12.2	12.6	13.8	14.0	14.3	9.7	14.0	11.3	8.6	48.8	17.6	16.0	22.5	21.1	17.2	19.2	12.3	11.6	11.2	25.2	20.8	27.4	26.1	22.4	40.1	16.4	24.9	19.4	16.3	26.3	17.9	24.6	12.9	23.1	30.3	20.4	22.6	31.2	18.8	23.0	27.3	14.2	19.2	20.7	19.0	16.3	17.9	21.2	32.2	16.3	12.4	18.7	21.9	30.4	17.7	17.2	24.6	23.5	14.5	23.3	21.7	14.8	20.5	23.5	24.4	20.2	23.9	13.2	18.4	16.2	17.7	19.9	21.5	19.6	22.0	23.3	20.4	32.3	21.8	31.2	21.7	1.4	2.2	4.6	4.5	1.6	2.8	2.2	2.3	3.4	2.7	2.0	2.9	2.8	0.3	2.6	1.5	2.8	3.0	2.4	15.5	15.3	11.7	21.8	15.8	13.6	14.1	13.1	13.8	12.2	14.3	16.0	5.9	9.6	2.0	32.0	9.2	7.1	13.9	29.2	4.0	15.1	8.3	6.9	8.4	4.3	12.3	9.2	27.1	49.7	11.3	14.1	7.9	17.2	5.9	10.6	4.9	7.8	9.0	4.6	42.0	14.7	18.7	8.1	4.1	7.4	6.3	7.8	8.2	51.1	22.7	18.5	48.4	9.7	14.2	9.0	3.1	3.1	8.1	8.0	12.4	28.1	19.9	21.2	10.3	29.7	29.9	18.2	12.3	5.7	14.7	10.8	29.7	18.5	23.5	67.3	6.6	4.5	11.0	7.1	12.8	7.1	8.1	64.7	9.8	8.3	12.0	13.5
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118055	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 641.9;Suprabasal keratinocytes: 642.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol		NA	NA		85000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA028700: AB_10603983, HPA058304: AB_2683673"	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	99.3	80.2	157.9	55.4	167.4	110.5	71.6	168.7	195.3	59.5	144.7	65.7	43.9	59.2	67.2	73.9	57.7	39.7	103.1	159.4	180.9	95.5	103.2	71.0	64.0	171.8	173.3	60.0	49.8	53.5	100.5	57.0	171.8	54.3	41.9	53.6	50.9	45.6	183.3	54.0	46.8	46.3	165.8	54.5	52.8	58.6	169.4	67.1	48.5	114.5	61.3	82.6	59.9	176.0	305.9	205.3	154.0	201.1	141.3	134.1	167.2	218.4	205.1	190.9	150.6	274.2	228.4	204.6	252.4	148.1	185.6	220.0	241.6	279.1	235.2	224.6	236.3	226.1	322.4	394.9	405.9	314.5	217.1	149.0	362.8	305.6	877.0	144.1	222.4	208.9	343.6	142.6	177.8	316.4	237.2	372.6	300.1	359.7	495.8	200.4	154.9	249.8	212.1	186.7	202.5	334.1	168.3	224.3	367.6	200.5	184.9	394.3	188.9	195.4	283.8	245.1	472.2	211.6	226.3	403.5	236.7	214.2	273.1	112.6	104.8	115.5	58.5	107.5	66.9	116.6	72.5	72.1	129.2	120.0	74.7	72.1	54.1	66.1	135.1	201.5	98.8	73.5	157.9	167.4	168.7	195.3	159.4	180.9	171.8	173.3	171.8	165.8	169.4	176.0	178.2	32.1	39.7	13.1	94.6	641.9	320.5	407.2	124.7	76.3	105.5	140.2	125.2	62.9	163.9	115.8	16.7	183.1	114.3	83.6	342.4	168.0	36.1	152.7	140.4	162.3	101.3	93.0	21.5	150.6	242.9	157.2	55.5	176.1	99.5	116.8	97.5	143.5	175.0	21.9	21.8	97.3	248.2	64.2	399.6	26.9	126.5	120.0	184.9	7.5	123.8	94.8	80.3	11.6	62.4	230.3	78.9	110.2	79.1	426.2	86.2	281.2	135.0	77.6	78.9	135.7	298.2	142.7	269.8	153.3	642.6	179.6	113.8	137.3	95.9	355.6
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 83.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 20.8;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 23.8;granulocytes: 20.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	4.3	6.8	13.2	8.3	14.5	23.5	6.4	8.6	15.2	9.1	42.5	22.2	32.2	5.0	11.6	9.6	5.7	5.8	36.0	13.9	11.4	29.7	4.0	13.3	7.0	13.3	13.8	5.2	16.0	15.3	23.1	3.9	12.2	4.8	24.1	83.3	7.6	4.1	49.5	8.1	22.2	5.0	9.7	15.0	15.5	7.0	19.3	20.2	51.7	42.7	6.7	4.2	4.2	18.4	15.0	6.5	4.2	7.3	8.4	4.1	6.9	2.1	2.5	3.6	2.0	16.0	21.1	2.7	3.3	3.3	10.8	20.8	3.1	7.9	2.1	0.6	3.2	21.1	17.4	5.9	7.0	0.0	14.2	5.9	11.7	3.5	19.1	4.3	0.8	8.7	14.6	0.1	2.0	4.5	3.6	0.6	5.8	7.2	9.7	0.0	0.0	0.4	4.9	15.3	6.6	4.0	13.7	22.8	17.4	4.5	15.6	1.8	0.4	0.0	7.6	11.0	1.9	6.6	7.0	1.4	8.8	0.0	3.9	1.6	1.2	20.8	0.3	2.6	0.4	1.9	0.2	0.4	1.1	2.3	0.5	0.6	3.5	1.6	1.9	23.8	0.0	0.7	13.2	14.5	8.6	15.2	13.9	11.4	13.3	13.8	12.2	9.7	19.3	18.4	1.0	6.4	54.8	105.1	5.0	15.2	3.8	5.0	10.2	7.0	3.7	4.2	79.0	4.3	8.7	16.5	0.0	0.7	24.6	53.8	25.4	5.0	51.0	18.0	3.7	4.2	6.0	0.8	14.5	7.6	0.4	4.6	14.8	21.3	9.5	2.3	2.5	5.8	5.6	3.3	13.0	20.1	8.2	13.6	4.9	158.2	2.8	8.5	21.4	11.2	5.4	9.8	5.2	4.5	10.6	16.6	26.2	3.0	3.8	13.5	45.4	32.8	15.3	110.5	0.0	3.3	3.1	5.1	3.2	9.9	11.6	1.5	1.6	7.5	36.9	11.5
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289126-296107	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 657.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 160.3;Alveolar cells type 2: 81.8;Breast glandular cells: 35.1;Club cells: 31.6;Collecting duct cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 132.8;U-266/70: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	25.3	5.6	5.8	41.6	5.8	16.3	41.9	5.5	25.6	56.0	6.8	25.2	50.5	21.6	32.7	14.1	34.6	18.9	18.8	5.4	5.8	116.4	77.8	67.0	63.5	6.9	6.4	8.7	657.7	2.9	12.5	7.3	8.2	34.6	6.3	0.6	36.2	46.1	4.5	8.6	103.0	3.0	5.7	101.9	18.5	6.3	7.1	37.4	74.4	3.2	17.6	21.5	22.6	6.3	5.4	5.8	10.5	11.7	4.2	3.7	8.2	4.2	3.4	2.4	2.1	5.0	15.0	0.0	5.3	5.1	5.1	3.3	0.9	1.9	0.3	13.3	4.0	2.5	4.2	6.8	5.3	0.3	22.8	13.8	1.5	0.9	0.7	8.9	8.1	132.8	10.5	15.9	1.3	7.7	24.0	12.1	8.3	1.8	1.0	21.5	2.1	7.8	5.6	1.8	0.1	2.4	1.5	7.8	7.2	4.6	5.7	2.9	7.5	4.9	7.0	1.5	0.5	34.8	1.0	6.0	0.8	4.3	5.8	1.2	0.7	1.0	6.1	3.2	5.1	1.5	1.0	3.3	0.5	1.5	2.1	4.5	3.7	5.6	2.5	2.0	0.1	2.2	5.8	5.8	5.5	25.6	5.4	5.8	6.9	6.4	8.2	5.7	7.1	6.3	17.8	160.3	81.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	35.1	26.8	0.0	0.0	31.6	33.1	0.0	0.3	29.8	0.0	0.0	4.9	0.0	12.5	12.0	4.5	0.0	0.0	0.0	8.3	3.3	4.2	0.0	17.6	6.3	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	16.1	0.0	0.0	2.9	10.2	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	14.4	0.9	0.0	0.0
PHACTR3	"C20orf101, PPP1R123"	ENSG00000087495	"Phosphatase and actin regulator 3"	Q96KR7	20	59577509-59847711	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 104.4;choroid plexus: 36.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.7;Excitatory neurons: 100.4;Inhibitory neurons: 88.7;Oligodendrocyte precursor cells: 218.1;Oligodendrocytes: 241.1"	"Group enriched"	"Detected in some"	5	"glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 85.4;HBEC3-KT: 64.6;PC-3: 113.2;THP-1: 131.3;U-937: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051834, HPA054847"			Enhanced	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051834: AB_2681629, HPA054847: "	"unprognostic (7.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.43e-7)"	"unprognostic (1.99e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.83e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.32e-1)"	0.9	1.2	90.4	0.5	92.4	0.5	0.4	82.0	93.4	0.3	36.5	0.8	0.7	1.0	0.7	1.1	8.6	1.9	4.0	82.3	75.4	2.2	0.6	5.9	0.1	78.5	82.4	6.2	0.2	0.0	1.7	0.6	76.1	0.1	0.8	3.3	0.1	0.0	0.2	1.1	1.0	0.3	74.7	5.5	0.5	0.5	93.7	1.9	0.1	1.0	0.1	0.5	0.1	104.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	85.4	0.0	6.2	1.3	0.0	0.2	0.3	64.6	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	1.4	0.1	10.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	17.9	0.3	0.4	113.2	0.0	0.0	0.7	25.1	1.4	2.1	6.5	0.5	0.0	0.1	0.0	0.5	131.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	90.4	92.4	82.0	93.4	82.3	75.4	78.5	82.4	76.1	74.7	93.7	104.4	0.3	12.8	0.5	205.7	0.3	0.6	1.3	2.1	0.0	13.8	0.2	0.0	8.9	10.0	8.4	3.7	0.0	0.0	0.0	0.0	1.9	1.1	1.0	7.1	3.7	0.3	1.2	0.0	100.4	0.0	0.0	4.2	0.0	2.1	0.0	0.5	3.3	0.0	0.2	5.0	88.7	0.9	44.7	0.3	1.1	0.9	0.0	3.7	0.0	7.5	0.0	0.8	0.0	218.1	241.1	2.9	0.1	0.0	0.9	2.9	4.3	0.1	1.3	1.9	0.0	2.9	0.9	0.3	1.0	0.1	0.4	0.0	0.1	0.9	4.5	3.2
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600925-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	8.2	8.9	9.5	7.1	9.5	4.4	8.1	11.8	10.3	6.9	7.9	6.3	5.0	9.1	7.5	9.0	7.9	7.1	9.7	9.8	8.9	7.6	8.2	6.4	10.9	8.8	9.0	11.4	7.1	8.8	5.1	7.3	9.1	8.4	6.2	8.4	7.3	6.2	12.1	10.6	5.4	8.3	9.0	7.1	6.3	5.6	9.8	7.2	8.7	10.0	10.4	7.7	5.5	10.9	15.5	15.9	13.5	25.6	19.0	18.3	14.9	21.4	16.0	17.6	16.4	21.8	15.1	15.2	19.0	27.7	21.2	12.2	19.1	29.7	25.7	24.7	20.4	13.0	18.5	8.8	11.3	10.8	13.5	18.6	16.4	17.2	15.6	16.5	15.0	8.7	10.4	17.2	27.4	13.3	15.2	13.4	16.9	10.3	12.4	12.1	19.1	12.4	16.4	18.1	17.3	19.9	19.3	16.4	22.7	13.0	22.0	14.7	23.2	29.0	16.1	16.3	32.7	13.3	13.6	17.0	20.8	17.4	21.3	8.7	4.8	6.6	7.1	5.7	8.1	8.2	7.1	7.4	4.8	7.1	7.9	8.3	3.8	10.7	6.1	6.4	6.5	5.5	9.5	9.5	11.8	10.3	9.8	8.9	8.8	9.0	9.1	9.0	9.8	10.9	34.6	25.6	40.2	10.7	36.1	28.6	31.6	72.1	26.7	60.0	27.7	42.2	56.6	20.0	47.3	35.0	39.6	51.5	42.4	29.5	74.3	53.6	37.2	32.8	44.6	36.8	27.5	26.9	14.2	33.3	50.3	41.8	16.3	28.3	46.9	35.0	28.2	28.5	30.1	75.7	14.8	26.9	65.1	17.2	17.6	9.7	42.0	21.9	21.4	5.6	43.4	86.9	37.0	8.0	11.8	40.3	23.1	41.3	29.7	31.9	16.5	56.1	63.3	72.3	46.0	50.3	51.7	64.5	86.4	32.3	25.9	51.4	34.2	43.2	27.7	27.8
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970780	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria		NA	NA		77000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 32: Non-specific - Translation"	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	134.3	166.6	75.6	95.2	75.6	149.4	138.7	76.7	81.3	152.2	78.8	162.3	149.8	134.0	122.6	168.7	137.0	80.3	157.0	72.9	75.1	112.7	233.4	88.0	141.9	74.8	75.2	244.3	199.5	130.9	76.3	84.9	75.8	114.0	145.4	48.2	138.1	97.8	303.5	150.6	127.4	102.3	75.5	113.6	141.8	36.1	77.5	144.5	103.4	231.1	162.8	135.8	125.4	75.9	270.5	261.1	214.1	295.8	170.6	295.0	469.2	183.6	245.6	329.7	259.8	420.5	283.0	567.8	78.8	187.4	200.6	225.0	395.9	337.5	267.2	306.9	316.1	296.4	146.3	409.2	284.1	488.8	212.4	307.2	229.2	208.0	452.5	331.8	331.4	157.0	270.1	127.1	238.5	277.2	449.0	452.9	813.3	236.8	224.7	307.4	338.3	356.7	270.0	312.8	111.7	372.9	152.2	434.9	503.8	440.1	67.6	379.3	191.8	141.5	227.4	115.2	402.2	128.1	166.3	586.7	186.7	251.0	207.6	78.5	88.3	43.8	84.2	107.2	103.8	102.8	96.2	98.1	138.5	98.1	85.0	85.1	35.4	117.8	94.8	129.0	123.6	114.2	75.6	75.6	76.7	81.3	72.9	75.1	74.8	75.2	75.8	75.5	77.5	75.9	114.1	48.1	54.8	14.7	155.0	74.4	106.8	110.1	191.8	42.9	155.1	230.8	45.1	91.5	62.1	35.0	39.6	212.9	99.8	104.6	115.4	134.1	2.8	68.2	124.8	86.0	100.6	143.7	10.0	162.3	282.2	97.7	100.4	88.0	63.5	177.2	92.1	172.5	163.0	18.5	11.4	142.7	77.3	125.0	70.4	7.2	97.3	105.0	72.9	8.4	131.0	87.3	102.0	12.5	12.9	119.8	90.3	68.8	145.9	99.4	197.3	142.4	40.1	46.8	72.3	109.1	128.7	33.3	57.0	245.3	76.3	170.1	102.9	218.5	268.5	113.4
PHF12	"KIAA1523, PF1"	ENSG00000109118	"PHD finger protein 12"	Q96QT6	17	28905250-28951771	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 40.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021410, HPA021452"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021410: AB_1855287, HPA021452: AB_2670708"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.16e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-3)"	13.7	11.0	11.6	15.6	12.6	39.9	14.4	14.1	12.1	17.9	7.2	18.2	11.5	18.7	14.0	10.6	17.2	11.0	11.0	10.7	11.9	12.3	14.7	16.7	18.2	11.5	11.1	17.9	19.1	13.8	16.9	10.9	9.1	21.8	11.4	14.9	15.7	17.0	15.7	15.2	17.7	14.6	7.2	22.9	14.8	9.9	11.3	25.3	17.0	14.2	17.2	16.8	13.8	14.0	15.0	24.4	33.1	19.8	18.6	13.8	15.0	14.6	22.0	23.0	21.2	16.9	14.3	17.3	17.9	17.4	19.0	15.9	21.5	13.0	21.8	27.9	22.5	18.8	27.2	13.2	16.8	20.5	22.7	15.8	13.8	20.9	19.0	21.3	16.7	23.0	16.0	18.6	14.2	16.6	38.3	26.7	19.0	33.6	10.4	38.2	26.8	17.6	15.2	19.3	22.8	18.7	22.6	35.7	17.6	17.5	19.6	26.6	9.9	18.9	16.8	18.2	18.4	21.9	19.9	20.2	14.7	15.2	19.5	25.2	4.4	7.2	6.3	3.6	6.1	4.4	4.9	6.6	2.5	6.5	4.4	5.2	40.1	6.3	4.3	8.2	3.1	2.9	11.6	12.6	14.1	12.1	10.7	11.9	11.5	11.1	9.1	7.2	11.3	14.0	13.1	16.0	8.6	27.1	24.7	15.3	8.5	7.5	26.7	22.7	17.6	15.1	6.9	8.6	12.2	3.7	14.6	7.9	24.5	12.0	1.9	9.1	9.5	17.5	16.4	14.4	10.7	27.0	16.3	10.4	7.6	11.9	12.8	23.8	14.5	14.4	14.3	11.7	9.2	25.2	18.6	16.5	12.2	15.7	18.9	7.4	17.1	16.5	12.4	27.2	20.0	12.9	17.5	30.2	31.3	9.7	6.5	16.6	31.4	27.1	8.9	5.9	8.1	21.3	26.3	11.2	17.2	13.5	12.6	22.2	16.3	6.0	35.3	11.4	10.8	14.0
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PHF23	"FLJ16355, MGC2941"	ENSG00000040633	"PHD finger protein 23"	Q9BUL5	17	7235029-7239722	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052410	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm		"HPA052410: AB_2681822"	"unprognostic (1.76e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	22.0	39.6	21.3	24.5	21.0	10.1	19.1	21.6	25.1	22.3	20.7	24.2	22.8	23.6	23.3	35.3	20.2	20.2	18.0	22.7	23.1	22.5	26.3	18.3	30.4	25.4	30.3	19.0	17.9	24.3	20.8	23.0	25.1	24.0	17.7	15.2	19.1	22.8	22.6	19.3	21.4	22.9	21.8	28.4	19.7	24.8	23.1	36.7	24.3	21.9	34.2	29.1	23.3	22.9	49.6	78.1	85.2	56.0	54.4	54.7	33.4	65.8	72.2	78.5	66.7	42.5	34.2	72.5	39.7	71.2	55.4	46.6	81.1	54.1	64.6	73.7	67.4	54.6	51.5	47.8	87.5	26.4	82.7	75.9	51.5	68.4	45.6	82.3	75.6	34.8	61.1	17.4	92.7	37.9	45.7	53.5	80.7	35.7	34.3	61.5	41.5	35.4	83.9	27.4	28.0	89.0	47.0	37.9	75.2	50.9	46.0	30.7	69.5	69.0	47.9	41.2	82.8	32.0	35.2	37.6	62.0	42.9	60.6	23.1	8.2	15.5	16.2	6.6	13.9	12.0	12.3	17.9	9.3	15.6	10.0	12.5	15.9	10.7	9.5	16.7	11.2	7.9	21.3	21.0	21.6	25.1	22.7	23.1	25.4	30.3	25.1	21.8	23.1	22.9	22.3	6.4	9.2	2.0	21.9	84.1	22.7	21.6	56.9	13.6	36.5	17.7	18.7	15.7	17.2	22.0	6.2	32.1	31.2	24.0	39.2	39.2	19.8	20.2	25.7	26.0	18.6	33.6	3.7	21.5	21.0	20.0	8.6	22.1	17.7	15.2	17.5	13.8	37.0	16.8	2.8	18.5	26.4	20.9	40.3	24.8	24.8	20.8	33.8	4.7	37.3	14.5	35.0	3.5	2.5	35.1	26.0	17.3	23.7	28.9	16.6	30.1	11.4	11.0	39.5	14.8	29.1	30.9	22.4	39.2	83.3	76.8	21.3	30.5	16.5	27.1
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468692	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	26.0	21.1	26.5	23.0	29.7	58.2	27.7	30.0	30.6	23.3	28.9	25.1	22.7	22.9	26.0	29.0	22.8	19.6	20.9	26.7	28.5	25.5	30.9	20.1	35.5	28.9	28.5	20.7	26.2	25.1	21.5	25.6	29.7	19.7	28.8	24.5	21.0	19.1	35.8	27.7	22.4	22.6	28.8	26.4	26.0	18.8	28.2	52.2	19.7	29.0	41.9	30.6	23.7	33.9	80.5	56.8	95.0	62.8	68.7	51.7	65.9	80.1	65.5	102.9	86.4	78.4	46.5	115.4	45.7	60.1	72.1	60.7	130.2	95.3	115.6	71.7	136.5	71.8	86.9	92.2	71.9	190.3	54.9	50.4	72.9	81.3	100.5	41.7	73.8	80.6	97.5	71.8	74.9	107.5	154.8	124.3	96.1	220.8	82.2	115.4	84.9	81.5	68.6	63.1	46.6	38.9	87.9	57.4	90.0	66.6	45.9	96.8	50.7	54.0	95.6	44.1	97.9	58.9	112.3	194.9	52.2	82.6	59.0	32.8	47.0	57.9	36.0	45.2	47.2	47.6	41.1	45.6	49.2	42.6	40.2	39.5	55.6	47.6	44.1	41.7	47.8	59.3	26.5	29.7	30.0	30.6	26.7	28.5	28.9	28.5	29.7	28.8	28.2	33.9	36.4	22.4	13.9	2.3	52.3	77.2	78.1	81.1	58.1	24.6	35.1	35.4	10.6	41.5	33.5	11.0	4.2	93.0	42.3	27.2	46.9	58.5	14.7	26.6	20.7	43.7	15.0	56.1	3.5	56.2	115.0	36.2	20.4	25.5	33.7	20.9	37.5	24.7	58.7	13.5	3.7	32.1	63.1	38.8	55.9	9.1	42.3	37.3	33.8	2.8	67.5	47.3	59.8	5.5	8.2	64.5	32.5	41.8	41.6	84.4	41.1	42.1	24.3	28.2	98.6	32.3	38.6	63.5	88.1	59.0	91.6	109.2	42.3	20.2	41.9	95.7
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744218	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 135.0;Exocrine glandular cells: 136.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 25.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 975.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	51.4	3.0	113.6	9.4	125.3	11.4	30.1	130.7	125.9	46.1	89.1	27.2	7.6	25.4	79.6	56.6	49.3	7.6	22.4	108.8	128.8	40.9	126.0	18.0	14.9	121.8	113.9	46.1	171.1	103.9	23.7	13.2	122.4	52.6	7.0	7.5	156.2	33.5	2.6	92.5	13.3	15.0	117.0	6.5	41.7	40.3	115.8	34.0	29.5	4.3	13.3	35.8	62.9	153.6	156.8	35.2	148.0	444.6	64.9	82.8	286.1	101.0	209.3	132.9	257.6	195.7	28.6	0.1	58.1	270.5	16.6	205.6	216.8	224.6	83.9	1.1	162.1	29.1	151.3	153.3	135.7	214.3	1.7	147.6	338.6	146.8	142.2	83.0	100.1	519.7	71.4	443.9	66.8	380.9	222.8	90.1	440.0	93.3	274.6	228.0	181.1	24.8	9.6	120.4	160.8	146.0	65.9	63.9	975.9	103.9	164.8	505.7	0.9	38.3	172.1	207.3	134.8	294.0	79.9	246.1	456.9	328.2	302.7	5.3	1.1	0.2	4.7	0.3	0.2	11.1	2.4	8.2	5.3	4.0	13.0	25.2	2.2	1.8	0.3	2.6	4.5	6.3	113.6	125.3	130.7	125.9	108.8	128.8	121.8	113.9	122.4	117.0	115.8	153.6	5.3	3.2	12.6	31.6	10.0	51.9	118.1	24.2	42.7	0.7	29.7	38.0	2.1	128.7	12.5	20.2	2.1	49.9	2.2	1.6	135.0	60.2	51.2	15.6	3.8	6.9	1.8	5.5	0.3	136.1	54.0	58.7	8.6	12.2	5.7	30.9	3.6	96.1	9.2	0.0	0.6	3.6	18.3	2.2	4.3	116.9	67.7	6.5	56.9	2.8	11.0	82.4	0.0	14.1	32.3	35.6	2.0	127.9	27.4	62.1	0.2	118.4	24.7	3.4	13.1	11.2	48.8	20.0	19.4	57.5	77.1	25.3	5.9	71.4	3.2	56.8
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.6;brain: 15.2"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 10.1;pons: 15.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	15.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PICALM	"CALM, CLTH"	ENSG00000073921	"Phosphatidylinositol binding clathrin assembly protein"	Q13492	11	85957175-86069882	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 500.3;Oligodendrocytes: 709.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019053, HPA019061"	Enhanced		Enhanced	Vesicles		NA	NA		40000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA019053: AB_1855361, HPA019061: AB_1855362"	"unprognostic (9.27e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.36e-3)"	"unprognostic (9.02e-3)"	"unprognostic (9.80e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.31e-1)"	"prognostic favorable (2.02e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-1)"	183.5	62.5	97.1	120.4	162.1	111.4	111.5	119.3	118.7	86.4	43.8	86.3	106.3	79.3	52.4	109.1	66.1	127.0	87.9	91.7	110.8	168.5	147.0	99.4	82.7	125.2	130.7	94.4	80.6	120.6	36.5	157.2	131.6	73.1	83.1	71.5	62.3	93.6	75.8	74.2	115.5	135.3	106.0	126.5	73.0	64.9	120.7	93.1	75.7	101.9	96.7	139.5	73.5	194.7	167.0	78.4	121.1	85.9	185.5	188.8	228.5	211.7	274.7	164.4	143.0	310.7	222.4	126.0	210.8	342.6	171.1	134.6	129.4	154.2	232.8	38.6	45.0	364.9	101.5	98.9	185.6	87.2	158.3	166.6	161.7	308.7	253.3	275.1	178.7	85.9	239.1	103.0	305.2	98.2	103.9	76.8	66.9	269.0	42.7	69.8	182.2	91.1	312.5	139.2	72.9	58.7	258.4	85.4	68.7	156.5	115.6	67.0	196.9	298.6	104.1	355.0	170.2	36.7	107.1	118.4	70.8	64.6	206.6	6.4	13.5	7.5	5.7	11.7	4.9	3.1	4.2	8.0	11.4	2.1	4.2	4.0	40.6	7.1	12.5	3.9	6.4	5.3	97.1	162.1	119.3	118.7	91.7	110.8	125.2	130.7	131.6	106.0	120.7	194.7	147.1	35.3	58.9	134.5	33.3	116.0	44.4	33.0	30.1	20.8	34.8	28.6	46.4	42.9	34.3	71.7	12.5	42.9	43.9	64.2	31.3	57.7	59.3	32.3	32.8	98.7	25.1	88.8	144.7	37.6	127.1	44.6	34.1	50.9	48.2	23.2	71.4	52.3	85.0	40.4	140.7	30.1	30.5	142.8	229.2	95.4	35.8	127.4	60.5	500.3	92.1	22.6	32.0	188.0	709.3	90.2	55.3	43.6	39.1	49.5	71.4	84.0	41.0	16.3	78.9	36.4	92.7	17.3	14.1	34.4	96.5	41.3	38.9	23.6	30.6	77.7
PIGN	"MCD4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 323.7;Alveolar cells type 2: 372.2;Club cells: 138.4;granulocytes: 159.0;Oligodendrocytes: 123.2;Respiratory ciliated cells: 145.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	10.0	10.3	9.8	10.9	14.3	16.9	15.9	49.4	47.1	11.8	3.2	16.2	14.0	11.1	11.9	22.7	8.9	12.6	13.5	13.1	9.6	11.9	18.1	9.9	10.5	4.1	0.1	12.1	15.8	16.0	4.3	17.5	9.6	17.3	18.4	38.9	14.8	7.5	13.4	20.1	13.3	8.9	0.0	10.0	21.1	19.8	11.4	12.3	16.9	10.8	12.8	14.9	7.7	49.7	31.6	19.0	18.4	23.0	23.1	31.4	24.3	32.3	25.7	21.2	24.9	24.4	31.9	36.0	44.0	25.0	18.3	44.6	26.0	27.8	32.9	30.3	16.9	21.6	29.6	19.7	16.8	46.0	24.6	18.5	18.1	21.0	24.5	22.3	27.0	25.3	26.1	50.8	23.3	28.2	22.8	13.5	29.9	25.3	17.3	24.1	35.1	35.7	25.5	48.5	20.8	21.4	42.5	29.0	13.6	50.9	46.1	28.6	29.8	41.0	28.2	15.4	23.5	54.3	53.8	17.4	22.5	25.7	40.9	10.1	7.5	6.1	6.9	6.6	7.2	7.9	7.1	6.9	8.9	8.8	8.0	8.4	9.6	12.1	7.8	10.2	6.5	3.7	9.8	14.3	49.4	47.1	13.1	9.6	4.1	0.1	9.6	0.0	11.4	49.7	8.9	323.7	372.2	52.5	9.7	8.0	8.9	8.4	10.2	7.2	16.3	9.4	10.4	12.8	138.4	11.0	4.2	9.6	14.1	11.6	1.9	11.0	6.4	9.1	16.2	24.7	6.7	16.6	54.5	9.5	11.5	26.6	10.2	11.5	159.0	19.3	10.0	12.0	10.1	6.7	41.3	11.6	10.2	9.2	4.0	6.5	7.2	26.9	3.6	44.0	7.9	7.3	3.1	57.8	123.2	10.9	9.4	3.8	8.2	11.7	5.6	5.0	145.5	6.6	6.6	6.8	6.7	20.7	7.3	17.4	17.0	10.4	18.5	10.5	12.3	12.1
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444441-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.9"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 161.8"	"Region enhanced"	"Detected in many"		"white matter: 5.7"	"Low region specificity"	"Detected in single"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	0.5	2.5	0.3	1.3	0.0	2.5	0.8	1.1	0.4	0.9	0.0	3.3	3.0	0.8	0.0	3.3	0.3	0.7	0.3	0.1	0.1	0.3	0.3	0.7	1.5	0.2	0.0	0.8	0.2	0.1	0.1	0.6	0.0	0.3	4.1	0.4	0.7	0.1	0.0	2.7	3.1	2.0	0.0	6.0	1.2	0.3	0.1	13.9	0.4	0.0	2.1	1.3	1.3	0.2	42.1	54.1	161.8	73.1	1.5	4.5	12.6	47.9	29.8	78.6	52.5	32.8	17.9	0.0	18.8	39.8	39.9	29.9	82.6	21.6	41.9	64.6	33.9	0.1	33.8	41.2	0.2	1.7	48.9	2.4	1.5	32.2	12.4	8.0	24.8	36.8	10.1	23.0	49.9	30.5	9.2	0.5	70.9	34.0	37.8	74.9	64.8	29.6	12.9	6.4	36.5	51.3	41.7	42.5	39.1	20.4	19.9	4.0	11.9	59.9	48.4	36.0	80.7	8.2	31.5	0.2	23.6	20.4	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	1.0	0.1	0.0	0.3	0.3	0.3	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.4	1.2	0.6	0.0	0.0	0.0	0.0	0.6	5.5	0.0	0.7	1.3	21.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.0	0.0
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849689	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 782.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	55.3	90.1	130.7	31.2	140.6	48.1	52.3	132.5	201.4	59.4	99.9	83.2	36.4	61.7	7.2	59.5	63.7	13.0	105.5	149.6	141.4	70.1	63.2	49.0	26.4	152.6	134.4	54.6	43.5	28.2	69.2	20.5	156.7	74.7	9.3	20.6	39.6	22.0	90.4	54.3	49.0	16.7	113.9	53.8	61.1	98.4	133.8	42.3	44.8	33.4	12.4	67.4	52.4	132.7	116.8	104.5	75.4	70.8	25.8	22.9	45.1	85.3	35.7	60.9	58.3	97.5	36.1	72.0	132.0	31.7	63.8	58.4	52.2	49.6	19.3	153.9	223.5	187.0	137.2	85.5	41.9	88.0	105.0	31.5	33.5	39.5	18.7	45.7	49.9	124.1	86.1	105.4	37.3	81.0	133.7	338.6	72.8	47.8	156.8	120.6	79.4	121.2	44.5	56.4	95.1	112.4	82.0	40.5	96.6	30.8	51.9	104.3	87.3	85.6	68.3	133.6	139.1	135.0	137.0	97.1	90.9	111.3	107.2	280.9	181.0	397.6	170.1	202.0	159.8	165.5	165.5	171.8	171.4	176.5	130.5	146.0	114.0	192.2	195.8	316.9	245.5	214.7	130.7	140.6	132.5	201.4	149.6	141.4	152.6	134.4	156.7	113.9	133.8	132.7	73.8	28.9	20.5	11.1	48.8	48.3	65.7	153.9	23.3	77.3	56.1	62.0	79.6	44.3	67.4	62.5	12.5	119.4	81.3	82.3	164.4	101.5	270.5	75.9	57.6	65.6	99.9	78.9	41.3	108.6	98.1	66.5	38.7	40.6	63.5	83.6	56.4	45.8	140.7	60.6	39.2	70.6	160.7	54.7	75.2	782.4	90.1	60.6	124.5	20.6	131.6	87.9	138.0	11.6	24.3	113.7	81.2	129.8	74.3	68.9	97.0	143.8	104.5	76.0	65.7	52.3	98.6	186.7	94.7	54.0	65.9	55.0	77.8	81.8	69.2	58.5
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.1	14.8	23.5	10.4	24.0	8.7	16.9	25.2	36.3	15.2	24.0	16.2	11.5	14.7	21.5	14.4	12.9	7.3	19.0	23.6	24.8	19.7	28.6	10.6	10.5	24.4	24.2	16.1	13.1	20.4	13.9	11.8	24.2	15.6	12.7	18.3	16.1	10.1	19.4	10.6	12.7	10.8	24.0	13.9	15.8	5.7	23.8	17.5	16.5	20.4	11.1	13.2	14.9	25.4	36.8	41.2	42.5	29.9	28.1	23.4	23.1	24.6	26.8	28.7	29.1	20.8	26.4	11.2	68.6	25.2	39.2	25.8	38.6	43.0	35.6	26.9	83.3	18.8	51.1	55.3	14.9	29.9	14.8	15.7	22.5	32.0	11.1	32.4	29.1	32.5	32.1	46.6	20.4	43.4	25.3	49.9	30.3	42.4	36.7	25.8	34.7	32.3	37.1	24.7	27.0	48.1	28.5	13.3	27.0	32.0	20.3	25.9	30.7	13.4	19.9	36.8	17.7	15.4	18.5	17.9	38.5	28.3	14.7	42.7	37.1	40.6	41.8	41.1	41.7	49.2	43.7	40.3	38.0	45.6	44.1	44.8	15.7	41.1	39.4	44.6	58.1	39.6	23.5	24.0	25.2	36.3	23.6	24.8	24.4	24.2	24.2	24.0	23.8	25.4	68.3	67.3	48.2	14.0	44.4	43.2	63.3	167.9	36.5	26.7	67.2	94.5	84.9	78.6	89.4	119.5	8.4	162.8	44.5	99.2	181.9	125.0	13.5	78.6	66.7	71.5	92.7	71.7	17.8	117.9	89.0	59.9	45.3	56.6	57.6	46.3	92.4	288.5	110.3	28.6	17.8	93.7	128.1	72.9	44.9	9.3	74.6	50.7	60.5	7.5	69.6	90.7	80.3	16.6	27.3	136.3	114.9	81.3	38.7	51.5	162.0	296.1	95.9	42.9	85.5	65.9	94.6	19.6	42.6	51.3	46.9	120.7	44.8	53.9	88.5	54.8
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.0;skeletal muscle: 43.2;urinary bladder: 29.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 19.2;Fibroblasts: 69.6;Paneth cells: 20.6;Proximal enterocytes: 39.7;Skeletal myocytes: 49.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"hypothalamus: 17.8;thalamus: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.8;HEK 293: 10.5;LHCN-M2: 25.1;RH-30: 20.5"					"Group enriched"	"Detected in some"	25	"hypothalamus: 5.4;midbrain: 1.5"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.2	0.0	0.0	7.8	0.2	0.0	0.4	0.0	0.0	1.6	0.0	3.8	0.0	0.1	0.0	2.6	0.2	1.1	2.0	0.0	17.8	0.2	0.0	0.0	0.0	0.1	2.8	0.0	0.5	0.0	16.1	42.0	0.2	0.9	0.2	0.0	13.5	0.1	43.2	1.5	3.1	0.5	0.2	0.0	0.5	0.5	6.8	0.0	0.0	12.3	0.0	29.8	3.8	0.0	1.4	2.6	0.0	1.0	2.4	2.1	4.0	0.8	0.4	2.6	2.0	24.8	0.0	0.0	5.2	5.1	3.2	0.4	0.1	0.0	1.4	0.0	10.5	0.0	2.0	0.0	8.8	0.0	5.0	2.5	0.2	0.5	0.0	0.8	0.0	2.7	0.6	0.0	25.1	0.7	2.7	0.0	0.4	0.0	0.5	0.0	20.5	0.0	0.4	3.4	0.0	0.0	2.0	3.3	0.3	0.4	0.2	0.0	0.0	3.1	7.5	0.0	4.1	0.1	0.1	1.0	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.8	0.1	2.8	0.2	0.2	6.8	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.2	0.0	0.1	0.3	19.2	0.0	0.1	0.0	0.0	5.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.4	5.7	69.6	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	9.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.2	39.7	2.3	0.0	0.0	0.0	49.8	5.4	2.3	7.0	1.7	0.1	10.5	0.0	0.0	14.1	0.1
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334713-109409974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	59.3	67.9	63.3	44.4	72.9	87.9	57.0	44.9	89.8	68.9	22.1	56.1	33.4	74.5	62.2	50.8	46.2	48.3	65.8	78.6	77.0	61.1	77.3	51.4	41.4	52.6	52.1	87.8	38.8	88.1	36.8	58.2	56.2	78.4	52.5	64.2	49.2	91.9	39.0	30.6	40.6	77.1	58.9	54.7	33.1	47.0	58.6	53.8	92.1	54.2	44.6	53.7	36.9	68.9	36.0	24.6	96.2	74.6	93.4	101.3	52.4	57.9	86.5	44.6	72.6	22.9	47.6	46.0	78.1	111.8	71.8	20.5	57.0	71.3	81.1	39.5	21.7	53.5	47.4	31.1	66.2	40.2	75.8	70.4	58.1	59.7	85.1	80.0	72.4	40.8	37.2	84.0	73.0	21.9	48.8	36.9	19.2	21.9	16.3	31.1	84.6	77.5	69.5	31.9	18.4	47.1	59.8	21.5	70.5	64.2	48.6	58.7	84.6	63.4	30.7	58.8	27.5	56.4	51.6	53.5	66.8	54.8	42.6	32.9	19.2	29.3	14.4	19.7	14.4	16.5	14.1	13.4	19.3	11.7	18.0	13.4	49.0	17.8	27.7	8.0	20.5	18.5	63.3	72.9	44.9	89.8	78.6	77.0	52.6	52.1	56.2	58.9	58.6	68.9	85.2	67.3	58.4	71.2	76.9	63.5	56.2	59.8	58.1	102.1	53.0	58.5	127.5	51.5	51.7	57.0	62.6	24.1	78.2	85.9	49.0	40.8	22.5	42.8	97.5	70.3	67.6	32.1	159.0	33.3	31.0	86.7	32.1	68.2	47.5	99.3	70.6	94.8	54.5	77.4	126.0	53.1	36.7	91.5	78.5	20.7	85.1	77.1	60.5	66.5	73.4	93.0	68.0	60.8	111.6	30.9	30.4	92.6	72.0	59.2	46.8	58.7	48.4	91.3	78.9	105.0	110.1	73.4	42.9	43.7	58.2	26.3	68.7	61.6	39.3	44.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 4207.6;tongue: 2900.8"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 2065.2;Late spermatids: 1763.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		310000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	190.5	600.9	539.0	341.4	552.3	439.0	190.5	586.8	629.9	406.8	755.0	225.0	170.8	202.8	205.7	658.3	240.0	212.0	779.6	549.1	561.6	549.5	32.2	236.9	284.1	640.0	559.1	169.4	112.6	269.6	224.1	168.6	636.2	252.6	206.2	1266.7	389.8	291.6	4207.6	350.5	218.0	298.9	522.3	239.2	228.6	235.1	677.1	203.5	174.6	2900.8	429.2	578.5	374.9	530.6	1584.6	3937.1	788.9	938.8	914.3	1009.4	638.7	1684.6	3878.2	2619.1	2623.6	1094.4	1931.2	1184.5	1627.3	3157.6	1937.8	2253.9	2480.9	3383.2	2051.7	2134.0	1126.5	727.7	1809.1	929.7	637.1	955.2	1525.1	926.4	1559.2	2025.1	810.9	3403.0	1558.6	587.3	182.8	933.3	4267.0	965.1	359.4	419.6	966.2	2438.6	1433.3	1046.5	2560.0	2301.7	3557.2	1973.8	804.4	871.5	2226.3	1344.7	1755.4	1291.4	932.0	675.7	1247.3	3003.7	1622.0	2928.7	3110.3	1170.0	1762.1	1037.2	3720.5	1534.4	3002.3	131.9	836.3	138.6	192.6	466.7	187.9	205.2	254.1	190.4	685.6	142.9	215.8	162.5	100.7	108.4	380.1	140.5	334.0	1261.7	539.0	552.3	586.8	629.9	549.1	561.6	640.0	559.1	636.2	522.3	677.1	530.6	95.9	118.6	88.1	107.7	169.6	565.5	708.9	2065.2	307.9	480.7	157.8	174.7	313.2	87.2	759.4	829.4	369.1	566.1	100.2	358.9	802.2	1395.6	315.0	169.2	77.3	207.7	282.2	44.8	90.2	597.0	1416.7	220.1	138.1	188.0	206.7	144.0	73.2	4.3	750.0	1065.0	97.6	166.8	925.7	297.7	532.9	1763.1	157.2	558.8	355.8	38.4	1255.0	784.1	78.2	53.3	33.4	1213.2	264.5	268.1	209.9	431.4	389.1	208.7	396.9	708.6	124.9	160.9	398.2	43.4	98.6	341.6	389.0	575.7	192.7	157.4	380.7	860.7
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 80.5"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 80.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	19.3	16.5	9.3	17.6	14.2	48.7	24.1	20.7	10.9	16.4	17.0	23.9	30.5	23.6	25.0	24.7	18.1	17.1	14.1	9.5	9.7	16.9	20.5	20.4	18.2	12.3	10.4	31.2	15.5	22.3	10.1	24.7	12.7	20.3	30.0	26.7	16.3	15.4	9.8	20.3	30.8	18.5	10.1	19.0	20.9	10.5	12.6	17.8	26.1	13.4	17.4	21.3	15.4	17.6	61.1	23.8	45.2	27.3	29.8	33.6	29.6	35.3	32.2	38.5	39.8	25.3	42.5	23.9	41.0	33.6	47.3	46.7	44.7	26.6	52.4	8.6	33.0	17.7	49.3	21.4	26.2	17.6	5.1	27.7	27.1	30.2	36.3	30.6	44.7	18.6	29.9	16.8	42.2	12.2	20.5	15.2	22.8	23.1	27.1	19.3	68.8	9.8	34.3	117.9	22.0	14.5	52.7	29.8	45.7	33.9	22.5	15.7	42.2	32.5	29.2	42.1	37.2	9.2	8.6	16.6	13.6	17.1	12.6	15.3	9.9	16.6	5.7	5.9	5.1	8.0	5.1	5.3	5.0	9.3	6.6	5.6	80.5	3.5	8.0	8.6	4.6	2.7	9.3	14.2	20.7	10.9	9.5	9.7	12.3	10.4	12.7	10.1	12.6	17.6	104.7	41.7	57.8	102.5	52.5	48.4	44.3	33.3	75.1	85.4	60.2	67.9	50.8	38.6	47.9	69.9	89.6	42.9	48.1	101.5	11.7	61.2	2.6	63.7	68.7	59.5	44.3	57.7	134.2	60.7	33.1	53.1	85.6	84.6	15.8	107.0	47.5	39.4	24.2	65.6	130.8	64.3	32.6	35.8	27.9	6.6	54.3	44.9	32.0	178.0	57.3	50.5	22.6	117.1	146.4	77.6	98.1	48.2	54.8	64.7	84.0	26.7	49.1	150.5	39.5	62.8	55.5	43.6	34.6	83.0	52.4	37.4	44.8	90.2	65.0	124.2
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790755-32896777	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 188.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 393.9;Distal enterocytes: 105.5;Extravillous trophoblasts: 185.9;Undifferentiated cells: 135.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 198.8;OE19: 72.7;SuSa: 149.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 20.2"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	5.5	2.6	1.6	6.5	2.0	5.8	11.2	3.1	3.8	20.3	8.2	49.8	23.6	5.0	3.9	5.3	73.0	7.4	188.2	8.7	1.0	7.8	25.9	1.3	4.5	1.4	0.3	15.1	16.4	33.6	9.9	20.5	0.6	9.1	45.2	2.6	58.5	6.9	6.0	2.9	26.5	5.5	0.7	2.0	17.8	6.4	1.6	12.4	0.3	1.7	10.6	5.3	3.4	1.6	56.5	10.8	0.4	0.3	0.2	0.0	0.5	0.0	0.0	0.2	0.1	198.8	49.6	0.0	32.9	0.0	7.1	48.8	6.8	43.3	0.0	0.2	15.7	0.3	2.3	52.6	29.5	3.1	0.6	0.2	40.2	0.1	46.2	21.4	1.8	0.1	10.4	15.3	4.8	14.9	0.2	0.4	29.7	72.7	9.5	0.0	23.6	16.8	14.3	26.3	5.9	5.3	2.3	11.4	0.1	149.0	24.7	0.7	0.3	0.1	21.1	0.0	13.5	12.6	0.2	0.4	0.1	0.2	2.6	5.8	0.9	8.1	0.2	1.1	0.6	0.1	0.4	0.3	2.9	0.3	0.5	0.3	0.6	1.0	1.7	0.5	0.4	0.4	1.6	2.0	3.1	3.8	8.7	1.0	1.4	0.3	0.6	0.7	1.6	1.6	0.4	0.0	0.0	0.3	2.2	7.0	48.1	20.7	32.5	3.2	22.1	13.1	393.9	21.5	17.7	1.8	4.2	57.9	0.9	105.5	3.9	12.7	4.0	61.2	11.6	3.7	27.1	2.1	1.3	10.1	185.9	12.9	43.3	52.1	4.5	23.2	5.0	46.0	8.6	1.7	58.8	67.0	26.4	17.0	20.4	1.8	11.8	28.6	10.6	4.7	1.4	14.3	0.0	2.0	1.0	23.6	65.5	2.2	1.6	32.8	30.8	11.0	14.2	1.1	0.0	13.0	9.8	6.9	5.7	12.1	3.3	41.5	2.7	1.0	135.6	28.2
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456952-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 256.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 261.0;Inhibitory neurons: 260.9;Oligodendrocyte precursor cells: 235.3;Oligodendrocytes: 864.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	13.4	6.5	165.2	6.7	229.0	8.3	26.2	186.6	212.7	31.9	89.3	12.6	12.4	14.0	14.2	17.8	19.6	15.3	22.1	130.2	179.5	57.0	16.8	12.6	6.0	256.9	217.1	13.3	15.1	18.1	9.6	6.2	213.7	12.9	13.4	18.5	34.0	20.9	8.2	16.1	11.3	14.3	222.9	6.1	13.8	10.3	194.1	16.1	30.4	9.8	10.1	16.5	12.4	239.5	36.9	21.8	26.7	30.4	12.1	13.4	25.7	29.1	15.9	44.5	38.4	72.4	32.5	23.4	21.5	35.4	16.0	29.0	35.2	29.8	74.1	35.4	19.2	21.2	23.5	56.3	20.9	34.4	4.6	5.7	28.1	30.0	46.3	26.7	23.0	28.9	30.1	33.3	34.7	42.6	15.2	14.3	28.8	51.4	15.9	20.6	40.2	19.3	64.6	26.6	46.2	8.2	20.3	30.4	24.5	24.9	34.7	31.3	10.6	25.9	29.2	19.3	38.2	19.8	18.0	17.0	14.8	19.2	25.4	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.5	0.2	0.1	0.0	0.4	0.1	0.4	0.0	2.0	0.2	0.7	0.2	165.2	229.0	186.6	212.7	130.2	179.5	256.9	217.1	213.7	222.9	194.1	239.5	59.8	41.7	18.9	28.7	3.1	27.0	21.3	23.5	34.1	44.5	44.3	35.9	49.7	38.6	28.7	47.8	29.2	0.2	3.5	17.7	23.5	21.3	14.6	21.0	12.2	71.1	9.0	24.6	261.0	18.1	0.3	15.3	26.0	38.5	10.1	11.8	23.2	28.6	3.1	5.0	260.9	16.6	16.2	7.6	10.0	9.2	10.8	6.2	7.2	163.9	4.5	8.6	2.1	235.3	864.7	17.4	16.7	17.0	5.2	44.6	12.4	33.1	29.0	19.2	13.1	11.4	13.9	15.4	6.3	30.4	30.4	0.3	5.0	15.5	19.4	26.8
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.4;T-cells: 6.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	33.3	22.4	36.2	21.7	37.3	10.0	31.8	43.8	41.3	42.5	27.8	25.2	17.8	36.1	13.7	18.9	31.9	19.9	31.9	35.6	32.9	23.2	9.7	32.4	36.4	34.8	36.2	42.6	11.4	13.3	21.6	23.8	34.2	30.2	13.7	10.9	20.2	20.5	18.5	31.5	28.8	22.9	32.0	30.0	19.4	26.3	39.5	60.5	45.0	20.3	24.0	30.4	32.0	38.6	16.6	20.8	97.2	71.6	38.0	26.5	30.9	26.7	34.1	52.4	44.3	50.1	5.4	37.0	31.9	29.1	55.0	30.2	42.7	47.8	30.4	10.5	22.7	2.6	36.4	59.6	28.9	14.7	9.7	34.1	26.3	38.8	30.0	47.2	59.4	77.3	28.0	23.6	48.0	123.8	90.7	11.5	36.2	21.3	37.6	71.1	70.8	18.2	28.7	30.1	34.4	65.7	47.8	22.1	48.4	54.1	25.8	17.0	64.6	124.4	40.3	40.2	32.9	26.1	12.4	30.3	29.7	15.6	52.9	0.0	0.0	0.0	4.7	0.0	6.4	0.2	4.1	3.9	0.0	0.5	4.3	4.3	0.0	3.4	0.0	0.0	3.8	3.0	36.2	37.3	43.8	41.3	35.6	32.9	34.8	36.2	34.2	32.0	39.5	38.6	33.4	16.0	7.0	69.2	5.1	5.6	1.8	5.3	14.8	4.3	4.7	5.8	9.6	1.5	3.8	3.7	10.4	1.9	7.4	9.4	0.0	3.3	7.0	5.4	16.9	24.2	1.8	2.1	9.7	1.6	2.0	11.5	10.2	10.3	1.3	19.8	11.7	3.1	4.0	3.3	9.1	9.5	4.1	2.9	4.3	7.2	15.2	1.7	3.6	16.9	1.2	6.7	2.1	13.0	16.4	3.3	4.8	18.4	6.3	2.3	7.8	3.0	1.8	5.1	13.1	8.5	10.2	15.9	13.0	6.1	7.0	0.8	17.0	5.7	6.4	0.9
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745071	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.6;retina: 12.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 93.7;Early spermatids: 206.2;Excitatory neurons: 126.0;Inhibitory neurons: 131.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.3;AF22: 39.0;HEL: 10.1;NTERA-2: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.0	0.0	5.5	0.3	4.8	0.2	2.6	4.5	6.0	1.2	9.3	2.5	2.5	0.7	8.2	0.1	8.1	1.5	1.8	3.8	1.4	1.2	0.1	4.0	0.0	1.3	4.6	0.1	1.4	0.4	1.5	0.4	1.5	0.3	2.4	12.4	1.3	1.9	0.2	0.1	2.5	0.1	1.6	0.0	3.8	11.3	1.3	16.6	5.7	0.0	0.0	0.4	0.1	2.0	0.0	12.3	39.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.4	9.8	0.0	0.8	0.0	0.1	0.0	7.0	0.0	0.0	0.0	3.6	10.1	0.0	1.4	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.3	0.0	0.0	4.4	2.4	9.4	20.8	1.3	1.6	0.9	0.0	0.0	2.4	0.2	3.6	0.9	0.0	9.4	0.0	5.7	4.2	0.0	0.0	0.0	0.2	0.0	1.7	0.4	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	4.8	4.5	6.0	3.8	1.4	1.3	4.6	1.5	1.6	1.3	2.0	0.0	3.2	13.6	93.7	0.3	0.0	0.4	0.5	0.6	10.5	4.0	5.0	0.8	4.3	2.3	1.8	4.2	0.0	0.1	2.7	0.0	2.2	206.2	34.6	1.3	0.6	3.0	0.0	126.0	2.3	0.3	0.3	15.3	13.6	0.0	0.1	0.0	0.0	0.2	25.2	131.5	4.0	0.0	0.3	0.4	21.4	1.2	0.4	0.0	12.2	0.1	16.1	0.0	5.5	5.7	1.5	4.6	0.4	0.0	0.4	2.8	2.1	23.4	3.0	0.0	0.0	0.2	2.4	1.2	0.7	0.1	0.0	0.3	0.1	4.4	0.4
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 10.3;NK-cells: 21.3;T-cells: 27.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 203.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	18.0	10.4	21.2	13.9	25.5	4.4	19.6	10.7	42.0	18.6	5.0	21.4	25.9	25.9	20.5	39.4	12.7	24.0	29.2	25.9	14.8	39.1	38.7	36.6	14.9	12.4	14.9	19.2	27.3	27.6	21.8	37.3	13.3	17.9	20.1	19.8	25.2	18.8	31.8	66.5	25.1	23.6	13.2	13.7	21.2	40.7	13.7	15.6	27.3	57.4	18.0	24.9	21.7	36.9	25.9	23.5	23.3	16.1	33.1	37.5	28.0	28.2	49.1	16.8	18.0	20.0	31.8	16.1	13.3	25.6	17.0	55.4	22.3	86.1	15.4	11.4	21.8	0.0	22.6	23.6	21.8	2.9	7.3	20.5	69.7	13.9	58.3	27.5	56.8	33.2	24.3	0.1	15.6	9.9	14.8	2.5	18.1	39.3	15.5	4.0	33.1	3.2	203.2	28.3	31.6	15.5	36.4	26.8	28.9	32.7	14.9	0.3	54.6	14.1	11.5	15.4	14.3	0.1	0.0	5.4	21.6	0.1	8.8	0.3	2.7	2.3	27.1	2.4	17.5	5.1	16.3	21.9	3.2	10.3	25.4	21.9	0.8	21.3	2.9	1.6	11.9	11.6	21.2	25.5	10.7	42.0	25.9	14.8	12.4	14.9	13.3	13.2	13.7	36.9	48.6	144.2	42.0	19.9	28.0	72.8	54.7	51.6	97.9	46.5	25.6	19.2	55.9	55.8	46.0	57.0	75.0	58.4	47.6	39.1	41.1	63.1	202.0	50.2	30.6	70.8	22.3	6.9	133.8	85.3	53.9	34.3	28.1	83.7	5.1	20.8	32.5	45.1	37.2	26.9	92.9	19.6	22.4	23.7	23.6	336.5	44.1	20.4	24.9	35.6	28.5	20.2	147.2	35.2	161.9	71.4	26.9	36.1	7.4	91.4	64.4	118.1	29.1	49.5	26.3	32.2	28.9	119.4	86.1	71.6	84.8	39.7	39.7	14.7	27.5	83.5
PLEKHA3	FAPP1	ENSG00000116095	"Pleckstrin homology domain containing A3"	Q9HB20	2	178480457-178516463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 196.2;Late spermatids: 413.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034496, HPA034497"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA034496: AB_2674189, HPA034497: AB_10603126"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.02e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.52e-2)"	3.6	6.6	4.1	3.9	4.7	5.4	3.0	7.1	5.9	3.4	5.9	4.0	4.6	3.5	6.2	3.2	3.5	3.0	6.3	4.2	4.2	4.7	4.1	3.2	3.6	3.8	4.2	3.8	2.7	4.6	4.2	2.7	4.1	3.6	2.6	8.0	2.7	4.3	2.7	1.7	3.4	3.4	4.0	3.4	3.9	10.0	4.3	1.3	3.7	3.2	2.8	3.7	2.5	5.1	4.1	2.7	3.1	4.0	6.0	3.2	5.9	6.6	5.0	3.2	3.5	1.1	2.7	3.5	8.3	4.7	9.0	2.8	2.9	1.7	6.0	10.8	2.8	5.5	2.7	3.2	4.2	3.5	6.0	2.9	5.6	5.9	3.7	5.7	2.9	3.1	2.6	5.4	4.3	1.3	4.7	5.1	5.2	2.9	3.9	2.5	4.6	6.1	4.1	2.4	3.2	4.5	3.3	2.4	10.4	4.3	2.8	6.1	3.3	6.3	6.1	8.0	7.4	6.7	14.2	3.5	8.2	2.9	3.7	0.5	0.2	0.3	0.4	0.2	0.4	0.5	0.7	0.5	0.2	1.5	0.4	0.5	0.6	0.8	0.4	0.6	0.3	0.1	4.1	4.7	7.1	5.9	4.2	4.2	3.8	4.2	4.1	4.0	4.3	5.1	56.7	16.0	14.6	9.8	32.7	43.2	48.4	12.6	50.7	90.3	39.6	35.2	56.1	32.9	13.4	27.6	41.7	29.2	53.6	15.3	78.2	36.9	196.2	44.9	39.5	44.9	25.8	35.3	15.8	47.3	18.6	43.0	21.4	38.0	10.8	23.7	39.3	42.8	15.8	132.9	20.4	23.3	12.2	28.3	44.9	413.6	34.8	33.1	30.2	18.7	28.6	56.7	40.2	11.6	18.5	45.0	11.3	52.3	39.9	91.7	20.0	67.9	17.9	64.0	78.9	54.2	54.4	66.0	41.5	28.6	30.4	30.5	44.0	44.8	19.0	79.7
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777297-17014414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.7;MAIT T-cell: 2.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	10.3	1.7	10.0	5.5	11.9	0.6	13.3	9.6	7.0	11.2	26.5	18.3	27.3	4.1	3.8	46.0	9.1	7.3	24.0	7.5	14.3	26.4	16.7	8.0	2.3	11.5	17.9	12.7	15.2	17.6	4.2	9.0	11.8	7.0	16.9	27.4	21.5	5.3	2.2	14.1	25.4	3.6	7.3	1.8	23.7	10.1	21.2	4.0	10.9	2.2	6.6	14.0	18.3	10.3	14.2	12.7	11.9	5.5	0.7	0.0	20.7	0.1	0.4	4.9	9.0	22.6	116.4	0.2	5.4	1.9	0.7	75.2	16.9	0.2	3.5	4.2	16.2	39.7	11.2	13.5	0.3	0.1	0.5	0.6	6.4	0.0	0.4	10.7	0.0	14.3	1.7	0.4	2.0	8.7	8.8	0.3	6.1	58.6	12.4	11.5	0.0	3.0	10.9	109.9	8.3	0.9	16.7	44.3	0.6	22.3	11.3	4.1	3.3	0.2	4.1	3.2	2.8	7.6	2.4	16.2	0.1	0.8	0.1	0.1	0.1	3.7	0.3	0.0	2.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	10.0	11.9	9.6	7.0	7.5	14.3	11.5	17.9	11.8	7.3	21.2	10.3	8.2	3.2	17.0	111.0	0.6	0.6	1.1	1.4	0.6	2.3	6.9	6.1	8.7	7.2	8.6	11.0	25.0	6.7	0.2	12.0	3.9	6.1	16.3	20.5	2.3	4.7	0.0	1.3	19.3	6.0	0.9	1.0	40.8	22.9	2.5	16.1	2.2	2.9	1.8	0.0	26.2	6.5	0.0	1.0	1.4	6.1	0.6	2.7	0.0	48.7	0.8	4.3	1.0	15.6	37.9	10.7	4.1	0.4	1.8	0.8	9.2	10.6	8.0	9.7	0.0	1.0	1.2	0.5	0.5	12.3	0.4	6.0	1.2	2.1	3.1	6.4
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 764.9;breast: 316.5;skeletal muscle: 249.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.3;Astrocytes: 12.1;Cardiomyocytes: 35.9;Hepatocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"ASC diff: 249.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Enhanced	"Lipid droplets,Plasma membrane,Cytosol"		NA	NA		55000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Lipid droplets"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (8.31e-4)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	764.9	3.9	8.5	6.4	9.4	2.7	316.5	8.0	5.1	8.8	2.5	70.7	2.3	28.7	2.0	9.6	18.5	8.5	112.8	5.0	6.7	7.6	87.1	3.4	0.8	9.8	9.7	21.8	24.7	0.1	4.4	0.1	7.3	13.4	3.9	0.2	22.6	15.1	249.9	16.3	18.9	20.4	8.5	4.9	25.1	2.7	11.1	0.9	4.1	163.4	0.2	34.3	7.2	7.1	0.1	0.4	0.1	0.7	249.6	1.6	8.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.4	0.0	1.2	0.1	0.0	1.8	0.0	0.6	0.3	0.0	0.1	1.4	3.6	0.1	0.1	8.1	4.7	0.0	0.4	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.2	0.3	0.1	5.7	0.3	0.0	0.2	0.0	29.7	0.1	0.4	0.3	0.0	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	9.4	8.0	5.1	5.0	6.7	9.8	9.7	7.3	8.5	11.1	7.1	12.3	0.0	7.2	12.1	0.2	0.3	1.2	0.4	0.6	0.3	0.9	3.9	35.9	7.2	2.1	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.3	1.6	0.4	1.0	0.0	0.0	0.3	1.5	0.3	1.7	3.6	0.6	0.0	1.0	7.5	30.6	0.1	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.5	0.0	0.6	0.0	4.1	0.0	0.4	0.0	0.9	0.9	0.0	6.6	5.9	1.8	0.5	0.4	0.3	0.3	0.4	0.1	0.3	0.3	1.9
PLPBP	PROSC	ENSG00000147471	"Pyridoxal phosphate binding protein"	O94903	8	37762595-37779768	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 101.8;Exocrine glandular cells: 49.8;Hofbauer cells: 47.3;Proximal tubular cells: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017033, HPA023646, HPA023733"	Approved		Enhanced	Cytosol		NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.85e-2)"	34.2	23.1	22.2	21.2	24.3	14.6	23.3	25.3	27.1	22.1	26.8	47.2	34.5	19.2	23.3	20.2	27.5	19.1	39.2	24.0	25.0	58.5	78.2	25.7	25.0	22.8	24.9	24.7	40.3	37.4	16.2	20.1	23.7	20.2	37.9	10.9	28.3	27.8	46.4	17.0	37.3	25.9	23.7	25.0	33.5	8.4	24.5	27.4	31.8	42.1	29.0	22.9	16.1	28.6	50.3	45.4	35.1	32.0	25.9	31.1	31.6	55.2	45.8	34.7	38.9	51.6	24.3	58.4	61.9	39.9	55.5	41.4	65.4	52.5	56.6	49.9	34.3	79.4	16.4	51.7	51.6	36.8	52.5	22.9	49.8	33.0	52.0	37.6	52.3	78.3	42.8	42.1	28.7	34.8	116.4	32.4	43.0	92.8	41.9	73.6	46.6	34.8	56.5	60.0	21.5	25.1	45.4	20.0	56.8	25.4	44.2	48.6	52.1	19.1	60.7	69.8	38.1	43.3	90.9	43.0	27.4	51.8	35.0	164.3	109.6	136.1	85.6	130.0	90.0	77.8	87.8	83.6	115.2	61.9	77.0	74.3	46.9	75.9	147.4	66.5	116.7	110.2	22.2	24.3	25.3	27.1	24.0	25.0	22.8	24.9	23.7	23.7	24.5	28.6	35.9	9.6	26.5	0.0	6.7	0.0	0.0	0.0	0.0	0.0	27.8	23.0	0.0	0.0	8.1	31.3	0.0	21.2	20.0	0.0	101.8	38.2	0.0	12.8	20.7	13.5	0.0	0.0	0.0	49.8	31.6	13.9	0.0	19.6	12.6	14.8	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	11.9	0.0	0.0	0.0	0.0	33.2	0.0	0.0	1.8	0.0	0.0	82.2	13.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	12.9	9.8	17.1	0.0	0.0
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535005-154550400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	29.4	21.9	22.8	24.9	26.3	31.1	38.7	26.0	24.3	32.8	20.8	30.9	24.8	34.0	28.6	33.9	34.2	24.8	25.9	22.6	32.6	38.1	43.8	27.3	35.2	30.5	26.8	34.0	19.6	41.1	16.0	28.3	30.7	27.4	34.2	26.4	25.8	33.7	31.7	26.4	25.8	44.6	33.5	27.7	26.4	21.4	25.3	40.4	38.0	39.5	51.2	34.8	22.7	39.2	73.2	58.6	73.7	79.4	85.1	73.5	62.3	91.6	111.2	121.9	98.9	69.3	62.7	79.1	45.7	109.1	80.3	52.4	97.2	122.1	134.5	80.2	48.7	95.1	45.1	67.8	87.0	96.0	76.4	79.7	110.8	144.6	112.6	73.0	106.1	85.3	98.9	98.2	107.2	52.3	73.9	45.7	56.1	57.5	62.7	72.2	38.5	48.2	84.8	46.1	43.0	48.6	55.9	59.3	91.7	69.4	57.1	66.4	69.3	72.4	81.9	64.6	82.9	50.9	72.0	100.6	68.1	45.6	98.8	53.0	37.0	29.7	41.6	43.3	49.9	47.0	43.5	45.7	47.6	36.2	45.9	43.2	9.4	67.6	63.9	46.4	55.7	49.4	22.8	26.3	26.0	24.3	22.6	32.6	30.5	26.8	30.7	33.5	25.3	39.2	26.9	25.6	18.1	29.0	26.9	16.3	31.2	98.7	18.2	26.2	19.6	22.9	24.7	20.0	50.7	22.0	12.5	49.1	23.6	18.0	15.6	48.0	31.7	22.7	33.0	27.5	27.1	30.5	23.6	34.7	37.9	30.9	17.9	20.3	45.7	27.0	16.1	26.8	34.2	62.2	21.7	15.9	73.2	19.3	12.0	5.8	28.0	17.2	14.2	17.8	36.8	31.2	28.8	14.1	25.0	32.6	20.9	35.0	21.8	14.9	33.7	35.0	45.2	21.4	19.7	31.2	40.8	36.4	30.2	25.0	17.3	44.3	26.9	36.8	22.3	20.6
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146055-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	5.4	6.0	4.5	8.6	4.8	9.2	9.4	7.3	5.2	9.4	10.1	13.6	8.8	11.8	8.2	8.9	12.9	6.5	8.2	4.5	6.1	9.2	4.8	4.9	11.2	4.6	4.0	22.3	10.7	9.2	8.2	4.8	3.3	25.4	10.1	14.1	7.8	8.5	29.1	12.6	8.9	10.4	3.4	6.1	8.5	3.0	5.9	13.6	12.5	16.3	10.8	10.9	8.1	3.9	30.7	13.4	11.8	18.3	3.8	2.3	0.8	15.1	15.0	22.1	28.2	15.7	14.6	88.3	18.0	3.3	18.8	11.5	24.3	12.1	49.9	27.8	30.8	18.0	8.0	14.9	4.2	52.4	13.9	3.8	8.8	8.4	17.7	18.0	5.4	26.2	7.0	46.3	6.9	4.7	33.3	41.3	4.8	26.4	13.2	54.5	58.5	65.1	24.8	5.7	33.1	23.0	9.1	14.5	15.1	15.3	0.1	45.5	8.8	0.4	13.3	4.6	32.0	24.5	38.3	19.0	6.1	44.3	2.1	0.8	0.3	1.2	0.7	0.2	1.2	1.5	0.9	1.3	0.6	1.0	1.4	1.2	1.0	1.9	0.2	0.9	0.1	0.6	4.5	4.8	7.3	5.2	4.5	6.1	4.6	4.0	3.3	3.4	5.9	3.9	7.3	9.6	10.3	21.5	14.3	30.2	23.8	7.4	17.1	28.5	21.6	16.5	23.4	27.1	11.5	16.5	31.3	2.8	7.1	6.8	5.9	11.9	5.5	15.1	13.6	8.8	10.8	18.3	29.5	10.4	2.4	12.0	15.3	20.6	6.3	17.3	8.9	9.2	3.4	8.4	38.9	21.4	6.1	6.7	17.9	9.0	24.5	6.8	17.8	26.2	14.6	11.1	4.1	32.2	27.3	18.1	7.9	19.2	15.5	44.4	5.2	15.6	12.2	24.3	6.6	26.9	20.3	5.3	6.6	24.4	31.7	1.2	10.5	5.3	28.4	17.4
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"PML nuclear body scaffold"	P29590	15	73994673-74047827	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	84.4	29.4	14.4	25.6	13.8	38.1	77.0	11.8	16.4	53.7	11.6	46.7	18.4	47.1	7.5	38.3	44.6	21.6	39.3	13.8	13.1	35.4	25.4	75.2	25.6	18.2	13.8	37.5	20.3	8.3	26.8	23.7	14.8	41.5	8.5	3.9	44.2	17.2	22.5	47.4	39.0	19.5	14.6	48.6	35.3	11.3	15.2	17.0	48.1	7.9	15.2	42.7	44.5	13.1	37.2	13.8	11.8	11.4	30.2	43.2	40.6	18.5	31.6	55.9	63.3	14.6	64.2	16.4	63.7	31.6	53.3	66.6	16.3	37.1	7.6	58.0	25.1	35.8	21.3	16.3	36.9	33.9	31.1	83.7	24.8	37.5	19.2	39.3	38.3	26.1	30.6	28.3	32.7	17.3	28.3	52.6	12.8	7.7	25.0	21.6	13.4	30.8	60.3	59.5	10.1	11.1	29.7	16.3	44.8	10.3	12.8	28.7	66.1	56.6	15.5	28.5	38.1	29.4	20.0	8.0	38.9	42.2	18.2	7.4	14.7	23.4	13.0	20.2	9.8	12.4	10.4	14.1	14.5	10.2	8.2	8.5	12.0	14.5	22.6	9.2	14.3	10.1	14.4	13.8	11.8	16.4	13.8	13.1	18.2	13.8	14.8	14.6	15.2	13.1	127.8	16.0	12.2	8.8	24.9	22.9	14.3	30.4	37.5	8.1	13.5	12.8	10.0	5.7	16.7	5.5	2.1	9.4	18.8	13.1	7.9	25.8	3.4	16.0	16.7	48.0	14.3	29.3	4.7	19.1	15.0	20.7	58.1	26.0	12.0	11.5	32.2	11.3	30.8	8.4	4.8	14.3	14.2	20.1	18.5	4.0	27.7	19.6	7.2	7.5	24.6	8.5	20.6	4.5	6.0	62.8	15.5	24.0	21.6	26.2	22.8	10.4	18.3	5.4	39.5	7.7	20.4	1.1	4.0	27.1	19.6	4.9	20.4	16.8	12.1	26.0
PMPCA	"Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2"	ENSG00000165688	"Peptidase, mitochondrial processing subunit alpha"	Q10713	9	136410641-136423761	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	29.2	58.1	27.0	20.6	27.6	31.4	27.1	27.0	34.6	29.2	36.8	32.2	24.8	26.8	10.4	34.5	27.5	17.9	73.2	28.0	27.3	37.3	110.8	25.4	27.1	27.1	27.6	29.3	28.8	26.9	38.8	20.8	27.9	31.8	15.3	8.8	28.4	16.1	69.2	37.6	30.6	15.3	25.6	38.2	35.3	37.8	27.9	21.4	29.4	50.0	17.0	28.0	27.8	26.7	48.7	87.7	41.8	84.5	30.8	45.0	63.2	49.3	39.6	67.2	48.9	101.1	56.5	67.4	50.5	50.3	36.2	110.2	77.9	72.0	30.0	97.2	92.8	54.6	113.2	123.6	53.9	71.7	44.9	66.3	48.9	52.6	27.0	38.2	58.0	61.2	140.2	43.4	42.6	132.1	68.1	90.1	85.4	86.2	82.2	83.0	59.1	149.9	46.3	33.9	85.4	56.1	66.6	92.9	58.6	28.6	127.6	95.5	48.2	47.8	50.7	39.8	63.8	26.2	37.4	73.5	62.9	61.3	43.9	37.4	50.5	36.5	53.2	51.9	51.4	52.5	49.0	57.2	61.7	48.8	57.9	50.2	11.9	67.2	51.5	31.4	52.7	62.2	27.0	27.6	27.0	34.6	28.0	27.3	27.1	27.6	27.9	25.6	27.9	26.7	17.3	16.0	26.7	14.7	24.2	27.5	40.2	65.0	27.9	24.7	19.3	15.2	35.9	15.7	32.8	22.0	22.9	103.1	22.5	28.0	49.0	32.9	24.6	25.6	23.5	21.7	20.8	23.5	13.8	30.7	50.4	23.7	21.9	26.2	24.7	44.2	19.6	57.2	37.8	18.5	11.4	24.2	44.7	19.2	14.6	15.8	19.0	17.4	16.0	6.5	21.0	22.9	14.4	8.5	8.0	31.6	20.9	22.6	26.6	22.6	25.6	46.9	22.6	27.4	39.5	22.4	27.9	37.7	42.4	23.2	26.9	103.8	21.7	77.0	38.6	28.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing subunit beta"	O75439	7	103297435-103329511	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		19000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	30.8	42.0	16.9	22.3	18.2	53.5	32.5	18.9	22.1	33.3	24.7	33.4	38.0	29.9	26.2	27.7	29.3	25.1	44.9	18.8	18.1	47.4	46.1	22.6	36.4	16.5	16.6	35.4	41.1	39.7	22.4	25.8	17.6	31.5	33.2	25.4	30.6	28.1	34.8	33.2	32.4	26.3	17.2	28.2	35.8	26.7	17.4	30.2	33.4	38.2	33.9	29.3	28.4	19.9	30.2	42.8	49.9	69.4	28.5	57.1	38.0	26.7	45.6	54.3	62.8	47.7	33.7	76.9	41.7	47.9	58.0	37.5	59.7	43.2	49.2	26.4	69.4	26.4	74.0	61.6	35.0	35.0	30.6	53.4	40.5	41.8	39.6	51.3	28.8	55.9	52.5	77.9	48.5	71.1	59.2	82.0	59.2	60.4	52.4	42.7	34.3	79.4	50.3	54.2	62.2	76.5	37.3	108.6	55.8	49.5	45.3	49.1	24.9	48.3	57.9	85.1	52.3	57.4	79.9	61.8	35.7	59.3	38.2	16.7	19.3	13.2	18.3	21.4	20.1	25.9	21.1	18.5	24.7	19.3	26.1	21.7	5.7	17.9	19.7	12.6	30.2	22.3	16.9	18.2	18.9	22.1	18.8	18.1	16.5	16.6	17.6	17.2	17.4	19.9	32.0	32.1	36.9	27.1	54.5	36.7	68.2	123.2	51.8	31.6	41.3	37.3	70.4	41.5	70.7	27.6	22.9	125.6	55.9	35.8	72.4	75.6	106.3	38.4	37.0	37.1	27.1	65.8	36.8	73.2	61.3	42.5	35.7	35.0	60.2	49.9	31.1	53.7	54.6	23.5	33.9	48.1	75.3	49.4	30.7	24.0	51.9	42.4	26.6	18.7	92.5	35.8	58.7	35.7	44.4	59.7	45.4	49.7	56.1	35.2	60.4	127.5	58.2	37.9	65.7	48.6	73.5	125.4	56.4	47.1	37.5	124.9	55.9	63.3	59.1	62.2
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5970925-6009106	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	5.3	5.1	6.7	5.3	7.2	5.8	6.5	6.3	7.6	4.8	2.8	4.8	5.7	4.9	5.0	5.3	5.7	4.0	4.1	7.4	5.8	10.4	4.7	4.4	8.4	5.3	5.6	5.7	3.9	11.0	4.6	4.8	5.5	5.2	4.7	8.4	5.7	5.5	4.5	11.9	5.3	5.3	4.4	5.9	5.0	4.0	5.2	8.8	9.2	3.5	8.9	5.1	4.9	7.0	15.1	16.7	12.9	32.2	9.0	13.6	10.9	7.8	5.8	6.6	5.6	14.0	9.9	28.2	8.7	10.9	17.2	19.6	19.2	6.6	8.0	11.3	7.2	12.0	12.5	10.1	15.9	15.8	9.4	15.1	14.8	5.4	22.3	11.4	13.7	15.2	22.9	12.6	11.9	15.5	5.2	17.1	13.3	7.6	9.6	16.3	15.3	14.0	16.4	11.0	11.9	25.7	13.3	23.0	16.2	18.0	27.1	11.8	12.4	9.3	21.2	14.2	14.6	19.8	32.8	27.5	7.2	15.3	22.9	5.0	2.9	1.9	4.5	4.1	4.9	3.4	3.5	3.8	3.0	3.4	4.4	3.4	1.4	2.3	1.8	3.1	3.4	3.4	6.7	7.2	6.3	7.6	7.4	5.8	5.3	5.6	5.5	4.4	5.2	7.0	12.2	12.8	8.2	11.4	13.6	5.0	9.3	10.9	15.9	13.2	10.7	11.3	3.2	12.8	9.7	11.0	22.9	9.4	15.2	1.8	35.2	5.5	9.9	11.0	14.6	10.1	5.4	8.4	14.0	3.3	6.3	6.6	8.2	11.8	5.1	11.4	7.9	7.6	5.2	30.3	12.2	2.2	10.2	7.1	5.9	6.6	12.8	6.3	7.2	5.6	8.7	7.8	20.6	3.5	8.3	4.7	2.6	10.1	9.6	12.6	2.2	39.5	9.3	14.3	26.3	10.0	8.0	34.5	11.7	10.5	8.1	12.7	11.4	11.9	2.6	11.1
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, MR-1S, PDC, PKND1, TAHCCP2"	ENSG00000127838	"PNKD metallo-beta-lactamase domain containing"	Q8N490	2	218270392-218346793	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	50.9	88.9	127.6	33.3	134.7	35.4	49.7	131.2	168.4	62.8	129.3	74.7	40.6	45.6	77.3	40.5	60.6	41.6	98.4	127.8	137.5	106.5	191.5	55.5	40.9	133.9	130.9	47.1	46.1	93.4	49.5	46.9	134.1	87.4	54.7	26.7	60.6	55.3	85.1	44.9	51.1	36.4	128.7	58.7	81.6	45.6	137.8	45.8	90.0	93.6	37.6	64.2	45.4	134.7	53.2	68.3	49.1	77.0	72.2	60.6	90.0	32.7	70.3	76.1	85.0	112.9	51.2	61.7	63.7	55.0	83.5	53.6	95.4	61.4	52.9	128.0	119.4	90.0	119.5	169.4	78.7	58.9	38.6	83.0	59.8	51.9	15.0	51.0	83.2	48.0	67.8	78.3	68.4	152.2	77.6	139.5	49.0	121.3	69.3	75.1	49.5	51.8	88.3	79.2	47.4	39.9	23.6	156.9	94.6	52.0	52.4	56.4	51.5	31.4	53.7	37.5	45.5	32.4	35.7	69.0	79.9	95.8	38.8	142.4	111.4	151.9	97.7	114.3	94.2	223.1	105.7	117.7	106.4	187.2	116.4	111.2	31.3	136.2	109.4	99.0	150.0	132.2	127.6	134.7	131.2	168.4	127.8	137.5	133.9	130.9	134.1	128.7	137.8	134.7	84.5	70.5	91.2	30.0	58.2	55.2	91.5	179.2	82.6	54.5	130.1	162.4	154.5	128.7	127.8	196.8	6.2	172.9	48.2	292.0	508.7	70.6	13.5	125.9	116.5	66.9	121.3	56.3	44.9	49.8	105.3	88.5	99.9	114.1	57.1	97.0	83.2	250.4	136.7	35.3	47.4	186.3	187.2	85.3	59.6	16.5	103.2	66.2	136.9	20.6	79.6	168.8	51.5	19.6	32.8	37.7	143.6	124.1	74.6	93.4	162.7	326.7	148.5	41.6	92.1	60.0	128.6	42.5	50.6	113.9	62.4	77.3	52.5	97.2	228.1	117.5
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818914-825573	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 508.1;breast: 361.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	508.1	75.3	11.9	9.2	14.0	43.1	361.4	13.6	18.8	42.2	13.4	58.1	19.3	49.2	2.8	39.9	50.8	9.5	171.3	11.9	14.0	61.9	58.4	57.3	8.1	17.5	11.8	50.5	75.4	9.6	46.3	8.4	16.8	46.6	4.8	1.3	81.1	16.7	194.6	71.8	74.7	6.4	12.6	51.2	71.3	32.1	12.8	10.9	55.3	64.3	4.1	64.8	44.5	15.3	33.9	26.0	5.3	14.0	194.4	17.2	34.1	35.3	28.1	21.6	19.1	22.3	33.3	19.9	20.4	26.7	13.6	30.0	8.1	14.6	6.6	25.9	71.5	27.6	11.2	36.3	63.3	19.2	33.4	33.9	18.7	14.5	16.7	22.3	17.7	14.5	23.8	19.9	19.5	20.0	25.8	42.3	15.2	34.3	55.1	24.6	11.5	45.7	21.4	7.7	19.6	26.0	65.3	55.0	21.9	3.4	23.7	22.0	32.5	19.3	15.0	12.7	16.3	75.2	49.8	16.7	48.4	27.0	13.8	11.5	9.5	22.1	3.7	6.1	3.6	4.7	4.8	5.4	6.1	4.1	5.4	4.4	8.2	4.0	7.1	7.0	4.2	4.7	11.9	14.0	13.6	18.8	11.9	14.0	17.5	11.8	16.8	12.6	12.8	15.3	78.1	6.4	11.8	12.7	63.5	44.2	69.2	34.2	42.1	14.0	79.5	67.1	45.5	61.5	65.2	51.5	8.4	70.2	50.8	151.8	33.2	65.1	22.1	58.0	31.8	51.8	51.5	52.6	8.9	65.3	32.0	37.4	204.4	114.3	11.4	42.2	100.6	50.6	29.2	11.8	7.5	96.1	20.3	27.6	29.0	6.2	48.4	46.6	42.7	16.9	29.6	32.2	21.6	5.5	13.8	142.2	170.7	39.1	92.0	78.5	166.8	45.0	31.3	9.0	65.7	64.4	50.7	33.5	23.9	53.7	41.2	169.4	53.3	182.2	43.6	195.5
POC5	"C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444"	ENSG00000152359	"POC5 centriolar protein"	Q8NA72	5	75674124-75717448	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 102.7;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037509, HPA037510, HPA061521"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263"	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.60e-7)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.62e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.09e-4)"	5.8	6.1	5.3	6.1	7.6	10.2	9.5	6.9	8.1	7.6	4.3	5.1	4.6	7.6	8.3	3.8	8.9	4.4	3.8	5.2	5.8	5.2	4.5	6.0	11.4	6.8	6.5	11.2	5.1	5.7	3.3	5.9	6.9	6.9	6.3	29.2	4.3	5.2	3.8	6.0	5.9	7.3	5.9	9.7	5.5	20.1	6.1	14.3	5.7	3.5	11.0	5.6	5.5	10.5	16.1	12.4	20.5	20.4	8.7	7.0	15.0	14.9	8.9	25.9	19.4	18.3	14.3	21.5	27.9	8.4	34.8	14.8	18.3	14.8	19.3	23.3	12.7	14.1	9.3	10.2	11.7	16.2	26.3	7.8	14.3	19.6	32.4	8.7	10.5	21.6	13.8	38.1	12.2	19.1	26.3	20.5	8.9	3.6	10.9	16.5	17.0	25.8	11.9	7.8	16.1	17.7	14.0	7.6	15.7	10.3	14.5	18.5	4.5	8.7	19.2	15.3	30.5	23.4	53.1	31.6	13.2	21.3	21.1	8.1	10.0	23.1	14.6	11.2	12.9	15.1	14.5	15.5	15.2	18.0	14.8	14.4	10.0	18.5	9.0	17.1	21.5	8.7	5.3	7.6	6.9	8.1	5.2	5.8	6.8	6.5	6.9	5.9	6.1	10.5	5.9	6.4	11.1	6.2	8.3	2.7	3.0	8.2	5.2	12.3	5.2	6.2	3.9	8.6	6.3	7.3	12.5	7.4	12.2	3.6	9.8	7.7	102.7	12.3	8.4	5.8	4.9	13.5	18.4	6.9	7.7	6.1	6.1	5.7	2.5	8.1	6.1	3.6	6.3	10.1	9.4	4.0	10.2	5.4	4.8	53.3	6.2	6.0	3.6	14.0	4.0	5.9	10.3	9.0	32.1	5.5	2.5	7.2	10.5	2.5	3.2	5.1	19.9	39.0	6.6	3.8	6.0	36.8	15.7	6.4	2.8	4.1	10.8	9.6	5.5	1.7
POGK	"BASS2, KIAA15131, KRBOX2, LST003"	ENSG00000143157	"Pogo transposable element derived with KRAB domain"	Q9P215	1	166839447-166856359	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007838, HPA031630, HPA075919"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: "	"unprognostic (3.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (4.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	11.3	9.1	33.8	13.5	38.4	11.0	14.2	32.4	39.2	14.9	25.0	12.3	9.5	15.7	10.9	14.7	11.9	11.2	10.5	30.4	30.8	13.9	11.1	19.5	13.5	34.2	36.5	17.3	13.7	19.5	8.3	14.1	34.8	10.5	13.7	26.5	11.6	13.0	6.8	18.8	11.3	15.2	34.2	14.3	14.0	6.3	34.7	12.3	11.7	9.5	16.9	17.5	11.5	43.4	33.4	27.4	29.5	36.5	30.5	25.2	17.1	22.6	22.7	28.1	21.2	21.0	27.4	37.3	33.1	23.3	23.8	32.6	37.1	29.7	25.6	46.3	25.4	14.9	25.2	15.0	26.0	52.8	39.7	19.2	46.1	31.7	44.9	24.8	25.4	33.9	51.0	24.3	27.0	15.7	33.0	13.2	48.5	38.5	32.2	37.2	16.5	32.9	29.4	79.4	38.4	46.5	32.1	43.6	41.7	43.5	41.7	48.3	24.1	29.7	29.7	23.9	41.2	34.2	47.7	47.8	16.7	25.9	28.7	2.2	6.0	5.1	4.7	7.5	5.1	6.7	4.6	5.1	7.8	3.9	4.2	4.6	0.8	7.5	9.0	3.7	4.3	4.9	33.8	38.4	32.4	39.2	30.4	30.8	34.2	36.5	34.8	34.2	34.7	43.4	11.7	54.5	19.5	12.4	20.2	21.9	26.2	13.0	18.8	30.7	17.8	12.8	10.1	11.5	19.4	12.9	10.4	10.8	15.3	9.8	1.9	16.9	2.8	9.8	19.9	16.0	9.0	5.9	14.7	16.3	12.3	15.4	13.3	15.2	24.1	23.4	15.0	13.4	16.0	48.8	15.7	11.9	4.1	20.1	17.5	1.6	10.8	18.7	8.8	8.4	21.6	16.5	10.3	23.1	27.8	15.0	11.9	18.0	11.6	31.9	9.2	7.3	11.1	29.5	13.1	19.8	17.1	1.0	3.3	25.4	24.0	9.0	13.7	7.8	15.6	28.0
POGZ	"KIAA0461, ZNF280E, ZNF635"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459494	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 347.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (4.40e-4)"	27.0	32.4	29.4	15.6	42.8	40.2	29.0	51.0	42.9	42.7	20.9	45.4	15.2	36.5	56.2	22.5	45.5	23.7	26.9	27.3	27.9	36.3	29.1	26.4	21.1	44.5	29.0	66.5	29.2	34.5	61.6	16.0	36.2	40.4	21.4	55.3	27.3	25.0	26.1	36.7	29.1	28.2	23.6	32.5	29.8	33.6	34.9	27.3	46.9	20.1	21.7	35.8	32.5	79.1	22.1	28.0	68.4	38.8	29.8	28.7	23.3	18.9	17.3	21.1	21.9	31.3	22.2	45.4	31.5	23.6	16.7	18.6	40.9	20.0	27.5	38.4	22.4	27.8	41.1	18.4	21.8	38.5	26.9	25.7	16.0	23.4	27.8	39.3	34.2	33.4	26.3	42.2	21.5	55.7	42.7	24.4	48.4	22.8	16.5	41.2	33.1	22.8	22.9	34.8	36.6	37.8	31.5	26.3	31.2	56.0	34.3	49.9	28.3	25.2	29.8	21.0	27.2	30.6	27.6	86.1	18.0	20.3	21.7	3.3	1.0	2.5	1.8	0.9	1.5	2.1	1.7	2.4	1.0	2.0	1.8	1.8	2.1	1.3	1.2	1.8	1.4	0.8	29.4	42.8	51.0	42.9	27.3	27.9	44.5	29.0	36.2	23.6	34.9	79.1	42.7	60.9	41.6	167.8	60.6	45.2	26.8	25.2	54.1	83.7	48.4	34.9	18.8	37.1	30.0	64.4	83.4	17.1	34.4	31.8	3.9	22.3	17.0	31.5	40.9	45.0	58.2	29.3	147.8	14.7	11.3	40.2	34.7	43.6	27.8	87.6	47.2	44.4	21.3	79.1	142.4	32.4	20.3	30.0	49.2	12.2	53.7	32.8	51.6	112.4	30.7	37.8	26.8	155.8	347.4	23.7	26.3	73.7	58.9	31.4	29.3	13.7	29.7	60.1	65.7	55.8	41.3	32.3	49.9	40.3	34.1	11.5	39.9	44.0	36.4	28.8
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114680-44124358	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	48.4	58.8	48.9	35.0	46.7	44.6	44.4	46.4	53.8	53.4	52.0	39.0	32.4	47.3	14.0	86.6	75.8	18.5	86.8	46.5	47.6	51.6	113.5	36.2	36.9	49.0	49.3	59.3	73.4	62.0	53.0	27.1	49.3	46.8	28.9	22.6	46.6	30.1	118.8	59.9	32.9	32.4	46.9	35.9	48.0	48.7	56.7	46.2	40.6	77.5	33.4	48.2	54.3	45.6	162.2	209.3	114.1	240.5	99.5	105.5	112.9	97.2	97.5	130.6	97.4	178.0	151.4	371.1	121.2	141.1	261.0	218.3	188.9	265.6	84.4	105.9	222.1	82.2	216.3	152.3	112.8	253.4	96.1	96.8	159.6	202.4	195.1	136.3	110.7	245.8	305.4	173.2	146.3	262.7	310.5	476.0	180.0	231.0	203.0	206.4	153.4	528.9	114.0	102.7	225.0	176.2	121.5	430.6	83.7	73.5	249.7	321.6	88.0	171.7	215.8	213.3	310.5	269.3	430.3	359.1	154.1	252.7	248.6	1.7	41.2	10.4	51.6	38.9	77.3	82.2	61.7	52.5	70.8	80.2	81.4	60.5	3.3	44.9	38.8	112.7	54.1	69.7	48.9	46.7	46.4	53.8	46.5	47.6	49.0	49.3	49.3	46.9	56.7	45.6	25.6	6.4	31.8	11.8	35.3	49.3	83.0	111.8	42.7	41.6	57.1	62.7	58.2	44.3	54.1	29.5	31.3	69.9	24.3	31.0	103.7	71.9	108.9	53.5	52.4	33.6	41.9	52.2	5.0	59.5	84.1	49.3	40.2	24.9	26.6	65.6	19.2	95.6	46.8	53.8	5.1	53.6	30.5	14.4	26.6	288.0	41.7	15.0	49.8	4.7	13.0	58.1	18.6	5.0	7.8	44.5	25.0	53.4	38.0	127.6	10.0	95.2	69.7	52.0	19.7	55.4	78.6	48.2	52.4	70.5	60.5	35.4	25.7	103.9	81.5	71.3
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 129.3;Late spermatids: 469.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: AB_2680522"	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	25.9	36.5	51.7	26.3	56.0	68.2	33.3	52.5	54.9	43.2	45.5	36.7	25.8	40.5	34.7	42.6	53.2	24.0	34.4	50.2	51.1	40.6	33.2	36.3	36.2	59.2	54.1	91.1	35.9	34.4	35.6	32.6	53.3	41.3	29.3	30.1	37.7	33.4	34.9	39.1	31.8	35.4	50.6	38.6	44.4	30.8	54.1	48.6	37.6	34.5	46.4	34.8	34.3	58.1	43.7	43.7	96.3	45.4	42.7	48.7	61.7	49.0	41.1	73.6	54.6	51.6	29.5	73.3	30.8	58.2	34.9	49.5	101.0	55.8	57.1	35.6	74.9	58.4	50.8	53.6	39.5	91.9	57.5	33.8	62.5	54.1	56.0	61.4	52.5	54.1	63.7	47.0	58.8	48.5	76.3	65.3	53.5	56.4	40.5	96.5	87.7	49.5	61.4	27.9	31.5	27.2	59.6	51.1	53.0	56.2	47.4	67.4	48.3	46.7	56.0	31.8	50.1	45.3	59.5	67.1	37.8	56.0	67.4	23.3	36.9	29.8	30.9	34.8	32.0	26.9	27.3	26.3	41.9	26.2	29.7	27.1	21.2	28.6	30.9	21.5	31.0	38.7	51.7	56.0	52.5	54.9	50.2	51.1	59.2	54.1	53.3	50.6	54.1	58.1	15.8	19.2	15.1	10.4	28.6	19.6	23.7	13.1	22.2	30.1	23.0	20.6	13.3	17.2	16.0	20.2	20.9	36.5	23.1	22.9	21.5	29.1	129.3	22.9	20.7	18.9	19.2	25.6	7.1	24.9	39.7	23.2	21.4	23.4	24.1	18.8	16.1	19.0	22.2	25.2	8.8	15.8	16.2	25.7	17.9	469.0	21.8	19.9	19.6	18.7	40.3	23.6	22.6	11.6	17.4	26.4	21.2	24.8	24.5	37.2	19.2	20.3	19.5	17.1	46.0	19.3	18.5	33.0	34.5	22.9	17.6	52.1	23.0	22.6	19.0	28.6
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576185-43620523	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	5.0	3.8	2.3	6.9	2.7	4.2	4.8	5.1	2.9	5.9	5.3	7.0	4.6	4.2	3.6	5.5	5.5	4.3	3.7	2.2	2.2	4.7	5.6	5.7	12.9	2.7	2.2	4.7	5.4	3.7	3.2	4.0	2.7	4.7	7.2	7.4	4.0	3.8	8.5	8.5	4.4	6.3	1.8	5.6	4.6	10.6	2.5	12.9	6.8	4.7	14.2	4.8	4.3	3.6	46.7	9.7	13.5	19.9	17.6	29.1	33.0	48.6	13.9	26.2	29.2	12.0	7.9	48.9	12.0	17.6	7.6	11.4	13.1	28.6	31.5	25.9	10.0	15.3	31.6	35.5	13.4	26.8	19.2	19.5	33.4	21.5	11.3	10.6	24.3	14.5	24.0	29.6	33.0	15.0	23.9	6.4	4.2	33.2	7.2	25.1	14.3	11.8	9.9	34.6	15.1	5.4	14.5	12.9	7.3	15.4	17.9	10.8	36.2	23.6	24.4	12.2	25.2	28.0	21.3	91.1	11.8	14.5	27.3	4.1	1.7	2.7	4.2	1.6	3.8	5.0	3.5	3.1	1.3	4.9	2.8	3.0	1.7	4.2	1.6	2.6	4.6	2.0	2.3	2.7	5.1	2.9	2.2	2.2	2.7	2.2	2.7	1.8	2.5	3.6	3.1	12.8	8.2	12.1	15.1	4.7	3.2	4.8	19.4	6.3	3.4	3.3	2.3	5.7	6.5	3.7	10.4	2.4	5.2	6.3	5.9	2.1	11.4	10.2	4.8	2.8	5.4	5.7	14.8	0.9	2.8	5.3	8.2	9.0	0.0	6.1	1.4	2.4	1.7	0.0	15.3	2.2	4.1	2.2	2.2	7.3	3.4	3.0	1.8	6.5	3.2	2.6	2.1	10.1	13.4	1.9	4.5	3.0	12.7	2.2	3.1	2.3	5.4	9.4	0.0	7.0	5.0	25.9	6.7	13.0	3.0	1.9	8.8	5.6	3.0	2.3
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 236.8;Oligodendrocytes: 159.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	4.7	4.3	2.3	3.7	5.0	2.7	5.4	7.0	4.5	6.8	1.9	3.2	2.4	6.3	4.6	3.4	4.0	3.7	4.6	3.1	5.4	4.7	4.9	4.9	4.0	5.6	4.2	6.0	4.3	5.5	3.2	6.3	5.7	4.3	3.1	5.2	4.2	3.9	4.6	4.1	3.1	4.1	3.6	5.6	3.7	3.1	4.7	3.9	7.6	3.3	3.6	3.2	3.9	10.5	6.7	6.7	4.1	5.3	5.3	10.5	3.5	12.5	8.8	9.5	9.8	4.3	5.2	6.9	10.0	8.3	6.2	2.5	3.8	4.3	11.4	7.6	4.5	6.3	5.7	2.1	10.1	4.0	4.9	5.0	5.1	7.7	5.3	7.6	8.0	4.4	5.6	3.9	9.1	0.5	7.9	3.2	1.5	0.7	3.9	3.3	10.6	4.8	5.7	2.2	4.1	4.6	9.4	2.5	3.4	2.8	3.7	3.8	10.4	6.9	3.6	3.3	7.2	4.5	4.4	6.0	4.6	6.2	12.2	5.8	5.3	2.7	2.4	6.0	2.0	5.1	2.6	3.0	4.8	4.1	3.2	2.2	4.6	3.9	11.5	5.8	3.4	2.0	2.3	5.0	7.0	4.5	3.1	5.4	5.6	4.2	5.7	3.6	4.7	10.5	45.8	32.1	44.6	65.6	36.3	14.7	21.8	22.1	20.5	32.9	19.5	15.0	21.8	24.3	26.1	29.5	20.9	17.3	37.5	8.3	23.5	20.3	236.8	19.5	32.1	34.4	14.9	29.2	63.5	15.8	13.0	33.7	17.3	21.0	51.9	33.8	57.1	25.0	21.8	65.6	60.0	11.3	24.4	39.2	25.0	58.7	37.6	33.3	23.2	73.1	55.8	19.6	25.7	84.4	159.6	19.1	15.1	38.4	26.4	14.6	17.8	21.2	20.8	38.8	6.6	38.5	27.8	61.3	23.6	14.5	12.9	6.7	27.6	48.8	12.2	11.6
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;testis: 2.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.3;Excitatory neurons: 77.7;Inhibitory neurons: 42.7;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 26.8;Spermatocytes: 23.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	2.4	0.6	0.3	0.0	0.4	0.0	1.0	0.2	0.5	0.3	0.0	0.3	0.1	0.3	0.7	0.1	0.4	0.3	0.3	0.3	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.2	0.4	0.1	0.4	0.1	0.0	0.6	0.0	0.2	0.5	0.2	0.4	0.3	0.3	0.1	0.0	0.3	0.3	2.6	0.1	0.1	0.3	0.1	0.1	0.2	0.2	0.4	0.0	0.6	0.0	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	32.3	1.0	0.9	1.0	0.6	0.6	4.2	3.0	1.5	3.6	1.5	1.7	0.0	0.0	0.2	0.6	0.2	3.9	0.4	8.3	4.2	2.0	1.9	4.8	0.8	77.7	1.0	0.3	2.0	1.5	2.1	0.0	5.5	3.3	1.1	0.7	3.3	42.7	0.0	2.0	1.3	1.0	14.1	4.4	1.3	0.0	15.0	0.7	2.5	1.0	22.1	26.8	0.5	1.1	3.8	1.5	1.0	0.3	0.8	1.9	3.8	0.0	2.9	1.1	23.4	10.4	0.5	1.6	0.0	1.8	4.1	0.3	1.3
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR1F	"A43, RPA43, TWISTNB"	ENSG00000105849	"RNA polymerase I subunit F"	Q3B726	7	19695461-19709037	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.6;Cardiomyocytes: 23.1;Cytotrophoblasts: 40.3;dendritic cells: 24.9;Extravillous trophoblasts: 34.1;Hofbauer cells: 34.7;Macrophages: 16.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	8.6	7.9	5.8	8.0	6.4	17.2	10.2	6.1	9.2	8.9	5.6	7.3	5.6	11.9	5.1	9.5	6.6	6.2	7.8	6.2	6.8	8.0	8.7	6.3	10.5	6.1	6.8	8.8	7.5	9.1	2.7	10.8	6.1	9.7	7.0	3.2	6.1	8.9	7.1	7.6	5.3	11.8	6.6	7.8	5.8	6.2	6.5	8.6	8.7	8.3	12.9	12.2	4.6	7.6	28.0	20.9	15.1	22.6	17.1	21.1	11.7	15.7	11.8	17.9	20.7	17.2	23.9	31.0	44.6	19.6	22.7	24.6	30.9	29.2	33.3	9.9	23.7	28.8	15.9	13.3	26.2	59.4	20.0	19.2	20.3	19.7	23.4	12.1	29.7	21.3	45.0	27.2	26.1	10.1	32.9	55.3	39.3	28.9	23.4	26.3	26.0	32.6	29.7	14.2	10.9	16.4	14.3	38.3	20.0	24.6	15.5	52.5	25.0	37.0	19.8	34.5	38.4	34.4	22.8	77.5	25.0	86.9	55.5	5.7	4.5	1.4	7.9	6.0	12.0	12.5	9.4	10.5	7.0	13.0	10.7	12.6	0.4	17.4	5.9	9.0	9.3	5.8	5.8	6.4	6.1	9.2	6.2	6.8	6.1	6.8	6.1	6.6	6.5	7.6	21.6	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	40.3	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	34.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	16.6	3.0	0.0	0.0	0.0
POLR1G	"A34.5, ASE-1, CAST, CD3EAP, PAF49, RPA34"	ENSG00000117877	"RNA polymerase I subunit G"	O15446	19	45406644-45410737	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.8;Extravillous trophoblasts: 26.3;Hofbauer cells: 11.5;Syncytiotrophoblasts: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 14.5"	"Cell line enhanced"	"Detected in all"		"U-251 MG: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	3.2	2.4	2.9	3.3	3.0	2.1	3.1	4.1	4.3	2.4	1.1	2.5	2.4	2.7	1.4	4.3	3.0	2.8	3.5	2.9	2.4	2.7	2.6	2.0	3.5	3.4	2.6	3.5	3.8	2.9	1.9	2.2	3.6	2.2	2.1	2.7	2.8	1.9	6.7	4.4	1.9	3.0	1.1	2.1	1.8	1.8	3.4	2.1	2.3	4.5	4.0	4.1	2.4	3.8	31.4	29.0	5.3	20.6	7.5	6.5	20.3	15.3	5.2	26.2	15.1	32.5	21.5	48.3	14.8	11.3	20.6	29.5	46.4	43.0	18.4	22.1	28.7	24.3	11.0	23.9	12.8	25.3	8.9	9.4	27.3	38.2	20.7	7.0	19.2	16.0	63.0	8.9	25.6	37.0	18.7	9.3	37.0	34.6	27.3	25.1	19.5	32.2	10.5	22.7	30.8	9.6	30.9	40.6	6.4	10.6	19.9	15.4	18.2	36.5	36.7	20.4	200.5	16.1	74.0	51.6	16.8	37.6	25.9	1.5	2.7	0.3	1.4	3.5	3.1	2.7	2.0	2.2	4.2	3.0	2.9	3.5	1.3	3.3	2.8	14.5	1.3	2.0	2.9	3.0	4.1	4.3	2.9	2.4	3.4	2.6	3.6	1.1	3.4	3.8	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	15.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	26.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0
POLR2A	"POLR2, POLRA, RPB1"	ENSG00000181222	"RNA polymerase II subunit A"		17	7484366-7514616	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 2.4;lymphoid tissue: 1.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012226, CAB016388, HPA021563, HPA053012"			Enhanced	Nucleoplasm,Cytosol		NA	Yes			"Cluster 27: Non-specific - Gene expression"		"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.70e-2)"	0.1	0.7	0.4	1.6	0.2	0.2	0.1	0.3	1.9	0.0	0.8	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.1	0.7	0.4	0.1	0.0	0.2	0.2	2.4	0.7	0.1	0.0	0.1		0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.5	0.1	0.4	0.0	0.4	0.2	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0		1.6	1.0	1.7	0.5	1.5	0.4	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.4	0.0	0.6	1.0	2.1	0.0	0.0	0.3	0.0	0.5	0.0	0.9	0.0	1.6	2.9	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	1.0	0.4	2.1	0.0	0.0	2.5	2.3	1.0	0.0	2.7	3.5	2.8	1.2	0.8	0.0	0.0	0.8	1.6	0.0	1.0	0.5	1.1	2.0	0.4	0.2	1.6	1.1	0.8	1.0	0.0	2.2	0.8	2.0	0.9	2.5	1.1	0.3	0.8	2.2	0.5	1.3	1.0	0.0	2.0	4.2	0.0	3.2	10.1	0.4	0.2	0.3	1.9	0.7	0.4	2.4	0.7	1.1	0.4	1.1	1.6	124.2	22.4	41.6	13.4	68.0	42.8	40.7	33.8	64.3	90.4	56.5	187.1	26.9	38.6	30.3	23.9	110.5	35.9	153.5	55.0	3.9	27.0	25.0	74.9	64.4	57.7	76.7	43.3	18.1	30.2	28.7	53.3	103.0	67.3	42.5	46.0	40.4	29.9	45.4	55.5	14.9	43.9	26.4	42.1	38.3	7.4	37.0	65.7	37.4	19.7	38.2	27.3	26.8	17.6	17.8	32.0	35.9	41.8	62.0	27.9	42.5	13.2	38.4	90.5	6.6	94.4	53.9	58.5	120.2	73.8	41.2	53.8	89.2	49.8	32.6	30.8
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113709-36115213	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1145.8;Late spermatids: 2796.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035632: AB_2674711, HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	32.6	41.0	97.6	23.3	104.3	44.4	34.8	104.2	118.6	30.6	85.8	35.0	28.9	28.4	39.7	40.2	55.7	27.2	78.9	94.6	100.8	32.9	40.2	25.5	31.5	98.5	98.6	50.0	83.9	61.3	26.1	21.8	101.0	30.2	20.2	25.9	66.9	35.9	195.2	41.5	29.9	21.7	98.5	29.7	31.5	66.8	97.4	30.4	37.2	119.7	24.2	28.3	15.7	120.6	96.7	364.7	61.9	103.8	38.5	44.6	67.7	35.5	47.5	80.5	67.5	179.0	62.0	61.6	80.4	38.2	46.8	49.6	60.4	82.5	42.1	107.8	115.5	59.1	88.8	180.9	70.0	88.7	53.1	47.5	71.4	51.7	75.1	51.1	52.8	112.2	66.6	117.1	48.5	292.1	124.6	111.0	74.5	201.6	151.7	130.4	51.6	114.0	94.0	121.3	145.0	74.0	60.1	172.5	59.5	53.7	81.3	92.7	35.7	88.6	91.6	60.3	128.2	83.2	88.4	99.6	102.3	88.0	94.7	130.7	109.5	128.4	113.9	115.2	130.6	168.7	148.3	134.1	90.2	134.8	150.4	117.2	72.5	111.0	113.0	223.8	176.5	114.0	97.6	104.3	104.2	118.6	94.6	100.8	98.5	98.6	101.0	98.5	97.4	120.6	108.2	83.3	66.3	2.9	62.9	79.0	94.9	156.4	75.1	63.1	203.5	279.4	253.5	133.0	124.7	163.7	25.0	144.5	76.3	141.5	352.1	178.2	1145.8	380.4	114.9	101.6	106.2	199.9	2.9	240.5	166.2	96.9	71.4	126.0	82.4	150.0	111.0	282.5	124.3	33.7	3.2	163.3	126.1	72.9	63.8	2796.6	139.1	68.7	168.9	0.0	122.5	183.2	77.2	1.5	7.9	196.8	196.8	154.2	88.5	127.9	221.4	528.2	386.6	73.6	111.7	111.1	125.1	378.2	183.1	155.9	109.0	103.8	68.1	133.7	167.7	90.1
POLR3C	"C82, RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145844402	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	16	"Early spermatids: 288.2;Late spermatids: 574.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	16.9	8.5	5.0	10.5	5.3	14.7	15.1	8.7	6.5	14.1	4.6	12.0	8.0	13.4	9.3	11.1	12.3	10.9	10.1	5.5	4.9	10.3	10.7	9.7	14.1	4.6	4.6	16.0	14.6	11.9	6.3	10.4	5.1	9.6	11.2	7.9	12.4	8.3	14.7	15.9	11.8	13.1	4.7	12.6	11.3	24.8	5.3	15.3	11.4	10.3	15.6	13.0	12.2	6.5	29.9	23.7	19.0	17.6	23.0	29.3	19.8	30.6	31.5	36.2	34.9	32.6	16.4	51.6	28.9	37.2	19.5	31.6	30.6	30.5	34.9	22.7	24.9	27.9	26.5	17.6	42.1	58.4	35.2	29.3	18.9	42.4	61.7	20.8	21.8	22.0	36.3	30.9	35.6	37.2	27.7	22.1	29.0	29.3	29.7	30.1	23.6	34.1	19.7	20.6	18.2	26.4	26.0	37.5	36.7	28.5	29.5	49.6	26.7	34.0	27.4	19.6	41.9	42.9	48.1	58.8	12.4	28.4	28.3	63.0	31.7	31.9	22.5	36.9	29.5	30.4	24.2	23.3	33.9	33.8	25.1	22.7	2.7	34.0	27.0	35.6	23.3	26.1	5.0	5.3	8.7	6.5	5.5	4.9	4.6	4.6	5.1	4.7	5.3	6.5	12.6	6.4	10.8	12.1	15.6	5.0	8.3	8.8	13.1	3.6	5.5	5.2	23.8	2.8	10.1	3.7	4.2	11.7	18.5	3.5	11.7	14.8	288.2	7.8	7.3	11.2	4.2	19.1	13.0	21.3	12.5	11.0	9.2	7.5	8.2	6.9	9.3	5.2	14.3	1.7	12.4	7.5	8.2	12.6	6.2	574.5	10.2	9.4	1.8	10.3	13.3	5.1	10.3	14.1	12.9	16.5	6.8	14.7	12.2	8.4	8.9	12.8	8.1	3.8	19.7	11.0	9.9	26.1	22.5	10.9	4.3	9.6	13.4	11.1	8.5	9.5
POLR3D	"BN51T, C53, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245133-22254601	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	15.0	11.9	3.4	4.4	3.3	6.5	10.6	3.0	3.9	14.1	3.8	11.3	2.5	10.4	3.3	15.2	11.3	4.1	14.1	3.0	3.6	11.7	10.0	11.1	4.7	3.7	3.6	14.9	17.5	4.0	13.7	6.6	3.6	12.8	4.5	4.0	10.6	3.8	32.8	11.2	8.6	5.8	3.5	11.4	10.6	19.3	3.9	3.4	10.6	8.3	4.3	15.1	14.4	4.3	5.1	10.7	11.0	7.8	10.0	16.6	11.3	18.9	9.1	10.7	8.7	10.5	3.6	27.8	10.2	12.5	8.9	9.1	16.9	9.2	11.0	6.9	9.4	20.7	10.5	11.2	13.6	5.0	9.5	13.8	12.9	13.4	21.8	13.1	8.9	14.9	28.9	9.5	8.7	7.2	22.2	10.4	18.9	13.0	9.0	14.7	12.2	18.0	6.1	6.0	7.8	24.2	8.5	5.9	17.7	11.9	5.4	8.0	13.0	9.4	9.1	18.8	11.4	17.0	22.7	18.9	9.2	10.1	14.0	0.1	1.4	0.3	1.8	1.1	2.5	2.4	2.3	2.6	1.6	2.2	3.0	1.9	0.1	2.9	1.6	3.5	1.8	1.3	3.4	3.3	3.0	3.9	3.0	3.6	3.7	3.6	3.6	3.5	3.9	4.3	15.0	9.6	6.5	4.6	15.8	19.5	43.6	21.2	13.6	12.8	15.2	14.5	10.9	4.3	13.3	11.0	16.7	16.2	18.5	6.9	11.7	20.2	42.7	11.6	37.7	15.6	21.5	10.3	2.4	11.8	33.2	21.3	12.8	14.8	18.4	18.7	11.7	3.8	13.7	3.3	2.8	19.1	12.2	8.8	8.2	40.5	15.8	8.6	8.8	1.0	13.4	4.5	14.4	2.5	3.5	22.5	6.7	12.8	20.5	52.3	6.7	12.6	11.2	12.2	19.7	22.1	21.3	44.2	52.0	12.1	19.2	27.0	15.0	25.1	12.3	41.8
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	25.4	20.4	10.3	18.8	10.1	44.7	21.0	7.2	14.3	18.3	3.4	19.5	21.6	19.6	9.4	20.1	18.7	13.6	16.0	11.9	9.7	16.6	23.5	17.4	21.3	6.8	8.5	23.8	25.5	16.1	21.4	17.0	6.4	19.2	12.1	17.5	19.3	11.2	25.7	21.6	22.8	13.0	2.3	22.9	21.8	18.7	8.8	17.8	20.0	16.0	17.1	18.8	18.1	9.1	49.6	35.4	43.5	98.0	23.0	18.8	36.0	34.6	29.2	33.8	29.3	63.0	30.6	67.7	11.0	30.1	37.5	37.0	43.5	33.6	37.6	59.2	86.5	50.6	36.6	42.4	23.5	106.1	61.8	24.8	23.3	44.9	41.0	21.9	25.5	38.5	141.2	49.3	33.7	37.8	63.7	67.0	45.5	27.4	42.3	57.4	33.8	57.1	17.2	42.8	61.7	54.3	30.3	57.3	31.1	28.8	48.1	55.0	36.2	60.2	36.8	48.0	70.5	58.8	58.8	96.0	35.2	66.6	61.0	0.0	0.8	1.4	1.7	0.5	1.0	1.0	1.1	1.3	0.9	1.1	0.9	1.4	0.9	1.6	1.4	1.5	0.6	1.1	10.3	10.1	7.2	14.3	11.9	9.7	6.8	8.5	6.4	2.3	8.8	9.1	31.8	38.5	28.9	33.0	28.6	25.2	10.1	17.5	29.0	34.6	19.5	19.7	4.4	20.0	19.9	18.4	98.0	17.1	30.6	19.7	5.9	12.3	13.2	14.6	24.7	18.3	18.0	30.7	55.6	17.1	13.2	19.2	32.1	21.3	16.5	31.1	17.2	24.9	16.2	40.4	58.9	21.7	16.2	18.9	21.7	6.3	14.9	23.3	19.6	23.4	13.8	18.2	32.0	30.2	38.6	21.8	14.1	17.7	37.6	22.2	19.1	8.4	17.6	26.6	13.1	27.0	17.6	19.2	13.1	29.6	31.0	19.4	27.9	24.7	23.2	21.9
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.5;Kupffer cells: 119.6;Langerhans cells: 104.4;Macrophages: 105.0;monocytes: 137.6;Plasma cells: 96.7;Spermatocytes: 75.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 94.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.3;Daudi: 113.0;hTEC/SVTERT24-B: 42.7;U-266/70: 75.5;U-266/84: 80.2;U-698: 88.4;U-87 MG: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	2.6	2.8	6.1	28.0	5.9	8.4	1.7	15.5	10.6	1.1	3.8	4.3	3.1	1.2	1.5	2.0	1.6	3.4	0.8	5.8	15.4	1.4	2.0	3.8	52.1	8.0	9.1	0.8	1.7	0.3	2.0	3.8	9.4	3.0	3.0	1.9	2.6	3.1	1.1	1.4	14.0	2.9	5.8	27.5	5.0	9.2	14.0	6.5	1.5	0.5	48.3	7.1	1.2	6.7	0.9	1.5	1.8	0.1	0.0	2.9	0.5	8.2	52.3	5.1	10.0	0.5	1.4	113.0	2.8	2.9	0.9	1.0	0.6	8.6	23.2	0.3	0.5	2.7	0.3	0.1	0.6	1.1	2.2	2.2	1.6	42.7	2.8	0.4	3.2	2.4	1.3	25.4	1.1	0.8	0.3	6.1	0.4	0.2	0.6	1.3	0.2	0.4	0.2	0.5	1.8	0.8	0.4	0.7	0.8	0.7	0.1	14.1	3.9	22.0	2.3	0.2	1.1	75.5	80.2	88.4	41.3	2.8	3.1	2.6	28.3	0.5	3.1	51.5	2.7	29.3	4.4	4.0	20.9	33.0	2.3	3.3	4.3	1.7	94.9	3.4	7.2	14.4	6.1	5.9	15.5	10.6	5.8	15.4	8.0	9.1	9.4	5.8	14.0	6.7	2.7	0.0	7.0	0.7	225.5	7.8	8.3	14.1	4.6	63.5	7.2	7.6	3.7	2.8	3.2	0.0	6.2	0.9	29.3	2.8	0.0	1.4	15.2	4.0	1.1	7.3	9.5	10.7	19.7	2.8	0.8	2.7	1.5	8.5	6.3	0.5	4.2	1.1	49.5	1.7	10.0	1.6	4.1	119.6	104.4	9.8	0.9	105.0	8.8	32.8	137.6	1.9	37.0	4.5	1.0	3.5	0.1	0.4	96.7	3.8	2.8	0.4	2.4	6.6	0.0	1.7	5.0	75.1	28.8	13.3	8.8	3.7	31.7	0.6	1.0	5.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 48.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 20.9;Pancreatic endocrine cells: 20.8;Suprabasal keratinocytes: 37.6;Urothelial cells: 14.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.4;CAPAN-2: 3.6;EFO-21: 1.3;SK-BR-3: 2.5;T-47d: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.1	0.1	0.2	0.1	0.1	0.2	2.0	0.3	0.4	0.8	0.0	0.6	0.9	0.0	1.7	1.3	0.5	0.7	0.1	0.1	0.1	0.3	0.1	1.0	0.2	0.1	0.1	0.1	0.2	6.3	0.4	0.3	0.1	0.6	0.2	0.1	1.1	2.0	0.2	48.0	0.7	0.3	0.0	0.2	0.7	0.1	0.1	0.2	0.7	0.0	0.5	0.4	2.1	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	3.6	0.1	1.3	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	2.5	0.0	0.3	3.9	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	8.2	0.3	0.0	20.9	10.6	5.0	1.8	0.0	3.0	1.5	0.8	0.0	3.9	11.0	0.0	1.5	0.1	0.9	0.0	5.3	2.2	1.3	0.7	0.3	3.0	0.0	0.4	1.3	0.4	0.6	10.2	4.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.2	8.2	0.0	2.2	5.5	0.0	0.1	5.4	0.0	0.0	0.4	0.0	0.0	0.5	20.8	1.1	0.0	0.0	5.0	0.4	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.1	7.0	37.6	7.9	0.5	0.2	0.6	14.2
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38043829-38046793	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.3;skin 1: 32.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.2	1.5	2.3	0.2	7.0	0.0	0.3	0.9	10.3	0.2	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	9.7	1.9	0.0	0.0	0.0	1.0	1.4	2.6	0.1	0.1	0.2	0.0	0.0	1.3	0.2	0.0	0.3	0.3	0.1	0.9	32.6	0.0	0.0	0.6	0.1	0.1	0.8	2.0	0.3	0.0	0.5	1.0	0.8	0.3	2.5	0.0	0.0	24.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.7	0.0	0.1	0.0	28.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.0	0.9	10.3	9.7	1.9	1.4	2.6	1.3	0.6	2.0	2.5	12.2	0.0	0.0	2.3	8.3	27.3	2.9	1.4	20.5	7.8	9.9	39.1	5.2	0.0	0.2	0.0	22.9	0.2	13.4	13.8	0.0	0.0	0.2	0.5	2.3	1.9	1.8	2.7	6.4	0.0	0.1	5.2	7.1	1.4	0.0	0.5	0.0	0.0	0.3	1.7	1.1	11.0	0.0	0.0	1.3	0.0	0.3	4.3	7.2	1.0	0.0	14.0	0.0	0.5	0.2	0.0	0.1	0.0	2.7	0.7	0.3	0.1	0.0	21.1	0.0	8.5	7.2	0.2	4.1	20.2	55.8	0.1	5.2	8.3	5.7	3.2
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104853287-104858574	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 45.6;epididymis: 32.4;kidney: 58.8;seminal vesicle: 15.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal tubular cells: 27.4;Proximal tubular cells: 13.2"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 59.6;AN3-CA: 53.9;HEK 293: 21.2;RPTEC TERT1: 57.3;SH-SY5Y: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			1.5	0.1	22.5	0.1	36.9	0.0	0.3	34.6	36.2	0.0	0.0	0.7	0.0	0.0	32.4	0.0	0.0	0.0	0.1	26.3	18.9	58.8	0.0	0.0	0.0	31.0	35.5	0.1	0.0	0.0	0.1	0.0	25.3	0.2	0.2	0.3	1.3	15.2	0.0	1.7	0.1	0.0	22.7	0.0	0.6	0.2	30.6	0.2	0.0	0.0	0.1	0.0	0.0	45.6	0.0	0.0	59.6	53.9	0.6	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.4	0.0	0.0	0.0	6.5	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	1.8	1.7	0.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.1	0.0	6.4	1.4	0.0	57.3	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	36.9	34.6	36.2	26.3	18.9	31.0	35.5	25.3	22.7	30.6	45.6	0.0	0.0	0.0	1.0	0.5	0.8	0.1	0.0	0.0	3.8	0.0	0.6	1.0	0.0	0.0	58.8	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.2	5.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	13.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 44.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 99.4;Hepatocytes: 144.5;Proximal enterocytes: 93.2;Rod photoreceptor cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 10.3;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 10.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	7.9	6.3	9.6	4.5	12.7	6.6	3.8	9.5	6.9	4.1	23.5	11.8	18.4	3.8	3.6	7.7	4.1	4.4	26.3	7.7	8.8	22.4	33.2	4.0	3.4	11.0	11.2	11.2	8.2	7.4	2.6	4.3	10.0	6.2	9.1	18.2	7.8	5.7	26.2	7.7	18.4	4.3	8.6	4.4	6.1	1.3	11.7	3.7	7.0	44.6	3.9	5.1	4.0	10.5	7.8	1.9	2.4	8.4	13.0	8.3	5.3	6.7	13.2	7.0	7.2	3.8	3.7	2.8	3.3	15.6	6.5	3.5	7.1	8.7	6.3	8.1	8.9	8.7	4.8	8.0	8.1	6.0	14.3	6.6	6.9	5.2	11.8	6.0	1.5	6.3	3.2	6.4	6.6	2.0	6.8	2.2	0.3	6.5	1.9	8.0	8.6	3.6	4.7	4.6	2.4	7.0	2.6	2.4	8.0	3.2	2.7	4.6	2.6	7.3	7.7	6.7	2.9	6.3	4.0	1.2	11.4	6.6	2.3	1.4	0.8	10.3	1.0	1.0	0.8	0.8	0.5	0.5	0.6	1.0	0.6	0.4	0.7	0.7	0.7	3.1	1.4	0.2	9.6	12.7	9.5	6.9	7.7	8.8	11.0	11.2	10.0	8.6	11.7	10.5	15.0	3.2	13.6	49.6	8.0	23.3	15.0	7.8	9.1	15.0	14.3	11.4	99.4	22.8	8.9	7.3	62.6	8.0	18.4	58.8	9.8	10.3	0.6	9.4	26.4	15.5	19.9	32.0	1.4	16.6	6.7	16.0	14.8	18.4	5.1	19.1	22.5	144.5	8.8	5.0	13.8	31.4	0.0	24.8	10.2	1.1	19.6	10.4	3.6	10.3	12.2	16.0	8.2	19.6	27.2	13.0	24.5	30.1	10.6	19.1	93.2	40.8	5.0	148.0	6.6	31.0	15.8	0.7	1.7	19.3	34.2	3.0	9.6	14.6	37.9	19.9
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 165.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	165.1	3.9	4.0	8.7	3.0	3.0	74.3	3.2	4.7	9.7	0.6	48.7	23.6	7.0	1.2	6.2	7.0	10.5	14.6	4.0	2.7	14.3	17.1	28.5	4.9	3.7	3.5	14.5	2.8	7.9	0.5	43.6	3.4	5.5	40.6	1.0	5.7	1.7	5.2	6.2	15.1	8.7	3.2	12.0	35.5	6.9	3.5	4.1	13.2	8.1	2.1	67.7	9.1	5.0	44.0	38.6	0.0	0.2	198.7	113.7	247.5	3.7	44.7	5.4	2.1	7.8	111.6	0.0	0.1	4.0	72.9	17.3	14.4	0.7	1.0	106.4	20.3	0.0	8.1	10.3	51.8	0.2	0.1	118.9	9.7	9.8	37.5	20.6	0.7	1.0	0.0	0.0	8.3	11.0	0.1	0.8	0.7	99.2	112.0	0.0	0.0	0.2	30.6	157.5	0.1	1.2	18.8	6.7	2.2	6.7	0.0	34.2	35.0	7.8	10.6	4.6	0.2	0.0	0.1	0.3	3.2	0.5	1.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	3.0	3.2	4.7	4.0	2.7	3.7	3.5	3.4	3.2	3.5	5.0	284.1	3.2	7.2	1.6	0.6	1.0	50.5	0.4	4.6	0.9	1.9	2.8	9.2	1.5	2.5	5.5	0.0	110.4	1.8	93.4	1.9	1.1	4.9	5.2	1.4	26.1	8.4	0.0	39.3	0.7	217.8	12.3	83.1	20.8	8.9	232.9	25.7	3.4	49.9	0.0	74.1	21.3	0.0	19.4	4.8	2.2	4.1	19.1	3.6	38.4	1.8	0.6	0.0	6.6	1.2	17.3	84.1	0.0	1.6	42.1	17.0	14.3	1.5	0.2	13.1	1.9	31.3	10.9	22.8	4.6	1.1	88.9	2.2	0.8	24.5	239.6
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 201.3;Endothelial cells: 189.5;Excitatory neurons: 206.1;Oligodendrocytes: 202.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001924, HPA071162"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001924: AB_1079665, HPA071162: "	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	32.4	27.0	22.5	13.7	33.6	3.3	37.9	0.3	29.5	24.0	18.3	25.0	11.9	27.7	11.4	28.6	26.6	20.1	77.0	29.0	10.0	36.3	26.7	39.6	9.3	7.0	14.9	85.2	21.3	17.1	19.6	60.2	11.2	24.7	18.2	5.1	21.6	29.3	25.9	30.4	15.0	31.3	5.9	29.9	25.5	11.9	31.6	18.5	39.0	44.3	10.5	24.4	29.5	22.9	18.8	37.1	29.7	25.5	48.4	133.3	52.9	67.0	75.2	38.6	55.4	98.0	55.9	14.2	75.6	135.7	51.5	46.0	16.3	61.0	69.1	32.3	9.0	31.3	28.3	14.6	21.0	9.8	16.9	104.8	41.3	112.1	114.0	75.2	134.0	18.9	16.7	13.9	138.5	14.4	9.1	2.8	53.4	26.8	28.5	14.6	74.0	5.5	56.6	41.0	2.4	12.1	33.4	17.6	91.3	206.5	22.7	14.3	131.3	107.7	36.0	59.8	68.8	0.2	0.4	1.2	119.7	13.7	173.7	0.9	0.2	0.1	0.3	0.0	0.6	0.3	0.5	0.3	0.3	2.7	0.5	0.5	0.6	0.1	0.1	0.9	0.8	0.2	22.5	33.6	0.3	29.5	29.0	10.0	7.0	14.9	11.2	5.9	31.6	22.9	201.3	99.3	19.8	7.5	9.4	41.0	76.5	42.8	68.3	15.5	19.6	40.3	164.0	10.0	18.3	80.9	4.2	37.2	2.5	8.0	11.7	42.2	3.5	40.2	12.7	189.5	18.6	8.6	206.1	24.8	23.2	74.6	46.9	73.3	3.8	132.8	157.8	14.0	8.9	45.4	68.4	15.9	10.2	16.7	30.9	5.4	21.1	6.2	62.2	174.3	3.1	6.3	0.0	116.6	202.9	33.9	19.7	42.2	4.6	45.0	8.6	48.7	9.0	1.8	19.7	71.7	78.9	2.4	8.6	48.2	27.6	91.9	5.9	25.4	12.5	84.5
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 337.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	26.0	30.5	21.9	34.9	23.2	51.9	33.2	23.4	26.6	27.7	22.1	29.0	23.2	31.0	31.9	28.2	28.3	28.6	35.7	23.3	22.9	30.1	30.5	28.0	58.4	17.7	19.7	34.1	19.2	25.9	22.9	29.8	20.4	26.0	31.7	25.8	25.9	28.3	34.1	25.9	28.8	33.9	18.9	36.2	25.7	56.1	23.5	52.8	27.4	31.2	59.1	37.0	22.4	23.3	60.7	54.7	63.5	53.4	56.0	61.3	55.8	68.3	79.1	71.8	59.1	89.1	74.3	99.0	86.4	74.6	33.9	53.6	66.2	72.4	87.6	87.3	68.9	159.5	53.8	81.9	58.8	190.4	88.0	74.4	71.9	57.5	54.6	80.3	89.5	87.3	79.2	76.0	78.9	46.3	107.8	111.7	55.0	166.0	54.2	90.4	73.7	93.3	111.7	50.7	44.7	66.0	61.1	48.7	60.1	60.7	75.1	90.7	63.1	41.5	74.5	39.9	60.7	87.4	129.9	163.3	69.8	337.5	27.7	51.7	23.9	44.1	32.7	26.7	39.4	44.3	41.9	44.5	43.8	35.8	37.9	38.1	14.9	44.6	25.9	41.5	61.5	22.6	21.9	23.2	23.4	26.6	23.3	22.9	17.7	19.7	20.4	18.9	23.5	23.3	28.9	41.7	51.8	46.0	78.4	75.8	68.1	116.9	44.9	60.2	30.8	31.0	32.5	40.0	70.7	42.3	29.2	88.1	77.4	31.8	37.2	62.3	243.3	47.5	56.1	48.1	33.6	58.5	128.7	68.3	75.4	47.0	24.5	60.7	57.0	238.1	36.0	35.5	52.9	37.0	93.2	35.8	71.2	40.6	65.4	76.7	58.4	49.1	64.0	49.6	92.9	46.3	72.1	64.3	85.0	71.4	42.1	52.3	63.4	46.4	45.8	55.6	58.6	60.5	52.6	44.6	47.9	120.3	58.8	50.3	59.1	44.2	81.8	84.0	42.4	50.7
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666000-21700015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 190.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	8.9	14.2	4.7	12.8	5.7	6.3	9.5	4.0	7.0	11.6	2.1	12.1	8.1	12.0	9.3	16.4	10.7	9.5	13.9	5.8	4.8	12.6	15.0	10.1	16.4	3.5	2.9	10.7	19.2	16.4	14.3	9.1	3.9	12.4	10.6	9.0	14.7	9.5	18.8	12.3	13.3	9.9	3.6	14.0	13.9	10.1	3.1	15.8	18.8	13.0	16.4	11.7	12.1	4.8	20.4	17.1	18.1	20.1	19.2	17.6	15.8	19.3	17.9	28.0	24.5	21.3	10.3	34.0	12.7	27.2	13.9	22.9	28.6	23.6	16.2	19.2	28.2	26.7	14.2	32.4	14.7	42.5	21.5	17.4	21.2	19.4	14.0	15.1	25.1	18.5	190.3	17.9	19.6	28.6	20.5	13.7	20.2	35.7	14.9	23.7	31.1	5.7	14.2	14.1	30.8	18.4	21.2	32.7	9.7	11.3	27.1	20.3	27.5	15.8	25.1	17.5	12.7	19.2	17.5	24.7	21.6	22.6	24.9	1.5	9.7	5.1	9.6	15.3	12.2	7.2	11.5	12.6	13.7	8.3	10.5	9.4	2.3	14.1	22.6	11.9	15.6	12.1	4.7	5.7	4.0	7.0	5.8	4.8	3.5	2.9	3.9	3.6	3.1	4.8	9.8	9.6	29.5	15.0	21.5	3.2	7.9	10.9	10.8	26.3	13.4	10.2	5.7	27.1	16.6	14.7	33.3	15.8	39.4	23.9	13.7	12.8	66.8	15.4	14.8	8.0	11.4	17.7	19.9	16.7	13.3	10.3	39.3	19.5	17.1	16.6	10.4	18.9	15.3	18.5	24.2	20.6	14.2	21.0	5.3	90.9	12.2	15.5	1.8	8.4	16.6	11.5	52.5	12.5	17.4	18.5	17.4	13.5	23.8	10.9	14.2	9.1	11.9	31.4	0.0	11.2	9.4	23.6	17.3	12.3	5.7	22.2	24.5	14.8	20.8	12.6
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504495-149546043	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	19.6	19.2	12.3	15.6	15.0	36.4	20.3	19.8	18.3	18.1	9.6	15.4	14.2	20.1	25.7	13.7	16.5	18.9	15.9	13.1	18.0	17.9	22.9	16.1	17.2	10.6	12.8	27.3	14.8	18.8	18.8	22.7	10.9	19.2	16.0	13.1	15.8	15.2	10.7	14.4	14.6	14.7	11.1	17.4	16.4	16.3	17.0	18.5	25.7	11.5	17.1	20.9	16.9	15.8	22.7	12.0	41.0	34.7	23.8	30.9	38.1	43.8	41.1	46.4	49.2	25.1	22.8	23.8	29.4	33.9	27.9	20.1	31.5	16.5	73.1	34.7	29.7	26.4	27.0	43.9	37.3	49.2	21.6	24.3	27.8	47.6	39.7	26.2	25.7	17.1	58.1	14.0	36.5	24.2	28.1	41.8	32.6	22.6	18.5	37.2	37.7	11.9	35.6	17.0	24.1	18.4	52.0	22.4	31.7	28.2	26.5	35.1	31.0	30.8	24.3	55.1	42.3	18.4	9.9	37.0	26.3	38.7	45.5	34.1	17.1	20.4	15.1	19.9	21.0	23.7	19.5	17.5	18.2	17.9	24.5	18.8	14.5	32.0	19.3	17.9	23.7	16.5	12.3	15.0	19.8	18.3	13.1	18.0	10.6	12.8	10.9	11.1	17.0	15.8	54.8	67.3	70.7	25.1	49.7	48.8	56.4	49.0	30.7	46.2	29.5	34.9	45.6	18.6	59.7	46.0	8.4	50.4	48.4	16.9	43.0	42.0	24.4	57.6	55.7	43.2	23.3	25.4	37.3	26.3	46.2	76.2	20.9	48.2	77.1	30.9	33.5	21.3	37.3	28.6	34.7	22.9	48.8	25.2	43.8	12.0	61.8	38.3	40.9	21.5	45.5	42.0	28.8	27.2	41.1	32.2	21.9	56.1	29.4	33.8	19.7	37.6	71.9	37.1	52.6	66.1	70.5	75.9	59.3	22.5	45.3	65.3	53.4	47.7	22.3	43.0
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381195-27409591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 233.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	46.0	49.6	34.7	45.1	35.1	73.5	43.6	35.4	37.8	38.4	36.9	48.3	39.9	45.6	26.1	62.6	39.0	28.0	44.9	35.0	37.0	40.7	45.3	40.6	59.6	35.4	36.0	34.9	53.0	41.4	43.4	37.6	35.3	36.0	51.3	20.0	45.1	38.8	95.7	41.2	43.0	44.9	35.1	47.1	47.8	233.9	36.0	64.9	36.8	53.0	75.3	47.0	39.6	35.3	302.0	243.1	174.0	134.8	108.7	88.0	160.6	182.8	119.8	214.8	170.9	377.7	154.4	352.7	130.9	130.9	181.8	160.3	296.4	205.6	191.4	148.4	241.1	343.6	172.9	404.0	97.9	343.5	139.2	95.7	116.9	219.2	175.1	101.7	209.1	171.1	293.3	106.0	165.5	269.4	256.7	370.5	254.1	207.1	173.1	261.1	365.0	185.3	145.9	206.4	233.2	264.0	164.4	178.9	135.9	137.4	99.4	111.3	169.5	159.3	192.6	141.6	281.8	229.0	277.0	545.5	124.8	275.6	122.5	67.3	41.5	59.0	57.5	52.3	56.8	44.7	61.1	60.3	65.4	37.9	45.1	47.4	20.9	55.0	71.4	91.9	88.9	48.0	34.7	35.1	35.4	37.8	35.0	37.0	35.4	36.0	35.3	35.1	36.0	35.3	72.9	64.1	51.3	9.8	76.7	81.1	88.7	71.9	83.6	40.8	63.1	59.3	37.9	52.9	63.7	69.9	29.2	93.9	114.2	81.0	33.2	135.7	1540.4	102.7	75.8	80.8	80.7	119.6	19.5	139.3	163.8	56.6	69.3	89.8	59.1	76.1	40.4	44.7	85.4	48.8	21.1	78.9	54.9	59.7	75.7	3492.8	70.2	68.2	24.9	17.8	127.3	69.7	112.3	17.1	15.9	156.7	52.7	71.1	137.8	152.1	52.6	61.4	61.8	41.7	46.0	54.9	80.5	793.3	298.9	108.7	80.6	53.1	89.7	123.7	106.4	122.6
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600413-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	20.9	27.5	0.2	12.0	0.1	1.0	15.8	0.2	1.3	23.3	0.1	21.8	8.9	21.2	1.1	23.1	22.0	10.7	14.6	0.5	0.4	22.8	33.6	17.4	5.0	1.2	1.3	22.8	28.0	4.8	26.3	5.0	0.6	22.8	6.4	5.2	20.1	7.9	23.0	21.1	21.0	7.0	0.3	25.1	25.2	21.7	0.3	10.1	22.9	1.2	5.6	22.5	21.8	0.2	9.1	20.0	30.9	16.8	17.0	2.2	8.9	15.9	7.0	5.6	23.3	5.0	9.7	11.5	9.6	16.0	10.5	23.6	24.3	35.7	9.7	13.1	0.0	19.8	14.1	0.2	7.6	16.3	27.3	14.2	4.0	28.0	30.9	13.2	9.7	3.9	18.4	3.7	14.4	5.4	5.5	2.4	9.1	1.9	2.3	25.4	39.3	19.8	1.4	8.0	19.3	9.1	29.5	28.3	8.8	13.0	13.8	21.8	2.6	12.7	9.0	18.5	10.7	26.9	5.1	11.3	15.8	19.9	15.8	7.9	1.2	2.0	0.9	2.1	1.6	2.9	0.4	1.7	3.3	0.7	0.5	1.1	1.0	1.0	0.8	1.2	1.9	0.4	0.2	0.1	0.2	1.3	0.5	0.4	1.2	1.3	0.6	0.3	0.3	0.2	243.9	32.1	40.3	20.5	152.7	69.8	64.9	41.1	167.9	72.7	165.1	163.8	59.1	28.6	34.2	27.6	131.3	44.0	178.9	120.5	35.2	27.2	32.0	138.2	103.8	102.6	71.3	30.5	26.1	23.0	21.8	103.2	107.0	151.4	44.9	143.0	38.2	33.6	33.1	35.3	27.0	102.2	54.9	35.5	70.6	11.3	46.3	123.4	37.4	30.0	46.4	59.0	72.1	21.1	29.7	29.8	58.3	30.1	140.1	51.9	88.1	40.3	46.9	102.2	32.9	211.5	114.9	45.9	23.4	125.7	77.9	88.5	144.1	99.9	77.0	34.5
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379638-45406349	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.4;heart muscle: 139.4;skin 1: 219.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 85.6;Granulosa cells: 118.3;Syncytiotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 130.1;hTCEpi: 189.0;hTERT-HME1: 131.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151"	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavorable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	20.4	20.1	11.7	2.9	11.7	0.6	29.6	11.5	14.0	44.9	9.5	11.1	5.0	8.2	15.2	179.4	9.6	6.0	139.4	10.8	14.3	24.8	12.6	20.3	2.6	11.9	11.1	8.8	31.5	12.2	11.8	26.6	11.7	30.8	6.8	13.6	55.6	13.3	5.8	219.8	9.1	5.4	10.0	6.4	12.0	3.1	12.7	4.0	17.7	4.4	18.8	23.6	84.9	12.4	72.3	10.7	4.6	3.8	4.7	2.9	61.5	14.5	2.5	17.5	24.3	23.1	70.6	9.5	5.9	11.9	36.5	97.2	4.0	130.1	16.0	24.0	5.9	1.4	36.3	8.7	10.0	1.0	3.4	4.0	189.0	27.9	131.9	79.2	33.2	7.9	8.1	3.6	1.2	64.7	1.8	1.9	5.3	36.9	18.3	7.4	5.6	1.7	22.9	95.0	2.4	7.6	64.5	68.4	1.6	30.0	58.2	1.9	46.3	23.1	60.9	1.8	76.2	35.1	42.1	6.5	3.3	2.9	5.6	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	11.7	11.7	11.5	14.0	10.8	14.3	11.9	11.1	11.7	10.0	12.7	12.4	14.3	35.3	13.0	9.4	2.0	68.7	85.6	38.4	67.2	1.7	21.9	28.6	38.8	20.0	27.8	20.2	10.4	83.2	2.5	17.8	5.9	34.9	0.7	8.7	3.0	13.4	7.2	10.1	0.8	15.8	37.7	5.6	8.6	17.1	4.5	118.3	11.7	2.5	7.6	0.0	0.9	6.9	14.2	1.6	5.0	0.5	5.9	2.2	12.4	9.4	1.9	2.4	2.1	2.5	1.6	50.4	17.2	12.4	6.1	44.2	22.6	3.9	16.3	26.8	6.6	8.4	14.1	2.7	2.1	81.2	71.0	128.5	2.5	2.8	9.0	63.4
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavorable (3.98e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favorable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.0	8.2	10.3	2.4	9.9	0.8	6.0	6.2	12.8	6.8	8.2	8.9	6.2	6.3	3.3	7.0	7.2	3.6	12.8	10.7	10.3	11.9	10.2	9.3	1.7	8.8	9.6	7.2	12.9	14.4	15.6	4.1	8.4	9.5	3.3	4.6	10.5	7.1	6.1	4.5	6.4	2.5	7.6	5.6	11.5	7.4	11.2	1.4	10.6	5.1	2.1	9.0	5.7	7.8	12.0	17.9	9.2	9.6	3.9	3.3	0.1	6.5	8.7	8.6	5.6	17.5	20.3	0.0	12.0	6.3	21.9	43.7	8.5	8.3	2.7	0.6	9.7	0.2	28.0	13.0	9.1	5.8	21.3	2.4	15.3	4.3	10.2	9.3	5.4	0.0	12.2	0.1	4.9	27.5	0.2	1.9	13.6	24.4	24.3	0.0	16.3	19.9	8.1	15.8	14.2	20.8	11.4	15.7	12.2	7.0	12.1	5.3	6.7	3.2	14.4	15.5	7.4	8.8	22.3	0.4	6.7	1.2	8.3	0.0	0.3	0.8	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	10.3	9.9	6.2	12.8	10.7	10.3	8.8	9.6	8.4	7.6	11.2	7.8	3.1	3.2	7.7	10.1	0.7	2.2	1.9	4.9	2.8	10.0	8.4	5.7	10.4	15.7	3.8	7.3	8.4	0.6	0.3	8.9	5.9	5.7	0.3	7.5	2.9	3.1	6.6	1.7	3.5	3.3	0.9	2.2	4.1	9.0	2.5	13.6	3.9	5.9	6.0	1.7	4.8	8.9	4.1	3.5	1.6	0.9	1.2	2.3	3.6	1.0	0.9	8.3	2.1	3.5	1.4	7.4	7.1	1.9	1.0	4.7	6.4	5.1	5.8	7.1	0.0	3.4	3.6	0.5	4.0	4.6	1.7	0.3	0.4	5.1	8.3	2.6
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830782-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	24.0	17.1	23.7	23.8	26.3	38.8	27.2	26.0	27.8	25.1	20.8	23.3	19.6	28.4	21.3	26.1	26.7	20.8	23.8	22.9	25.1	19.6	21.5	21.1	35.5	25.0	25.0	33.0	20.7	25.2	15.8	25.2	25.7	21.0	25.1	28.0	18.9	25.7	25.3	23.2	21.4	30.6	26.0	25.9	19.7	24.0	24.2	41.0	25.2	37.0	36.4	29.5	20.5	30.5	57.8	40.0	85.3	55.8	52.6	54.7	48.9	60.5	63.3	101.5	81.6	45.2	64.5	81.9	41.6	69.3	39.5	50.9	101.3	56.6	73.2	69.3	61.7	107.2	53.3	67.2	52.9	99.9	73.0	48.0	60.7	92.4	81.8	45.4	61.3	68.9	92.4	54.3	61.2	37.6	109.6	58.6	105.9	50.7	46.2	88.4	70.5	78.2	54.9	52.2	59.5	54.0	74.5	57.5	73.4	43.5	50.5	61.7	50.9	49.6	45.3	78.9	57.2	50.0	82.2	102.8	48.5	127.6	65.0	17.2	9.1	8.5	12.4	9.5	14.3	9.8	9.7	13.7	8.8	9.9	10.5	10.2	5.4	14.3	11.4	6.7	10.8	13.2	23.7	26.3	26.0	27.8	22.9	25.1	25.0	25.0	25.7	26.0	24.2	30.5	11.3	16.0	10.0	2.9	21.3	17.3	21.4	33.4	7.4	22.0	12.0	9.8	13.4	8.6	24.2	5.5	2.1	47.6	19.6	15.4	31.3	30.6	33.7	9.8	15.2	17.8	11.5	20.6	8.4	25.9	41.2	17.1	12.2	11.1	26.0	16.8	19.6	20.2	26.3	8.4	8.6	15.0	28.5	18.0	11.5	30.0	23.9	14.1	10.6	4.7	35.6	21.5	25.7	10.6	16.0	31.9	14.7	17.0	14.3	24.6	14.3	25.7	18.1	16.9	26.3	16.2	20.0	35.4	43.2	16.5	14.1	43.9	17.4	28.8	16.2	21.2
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996803-73069198	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632"	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	27.2	23.2	16.9	26.8	22.9	101.2	22.7	22.6	25.3	27.9	21.7	26.9	24.7	24.7	19.0	23.0	27.7	23.3	25.8	17.3	17.7	23.6	53.6	18.0	26.3	19.7	19.1	22.9	23.0	25.4	11.0	28.6	21.5	18.3	23.8	24.4	20.7	15.7	25.8	16.7	22.3	18.8	18.9	21.6	21.4	27.1	20.1	36.2	24.8	24.8	25.8	24.0	15.3	38.7	33.6	38.5	80.9	48.2	41.7	35.9	48.8	66.2	46.7	59.0	61.3	56.1	39.8	63.3	37.3	39.7	56.0	23.6	63.6	36.8	76.0	96.6	23.8	71.1	43.6	67.8	45.8	105.7	70.6	40.9	53.6	71.3	58.3	40.9	41.4	62.9	63.6	70.6	49.5	49.3	88.3	45.8	74.8	50.0	31.8	82.0	45.9	58.9	50.0	89.4	18.1	47.7	77.3	49.9	62.1	57.9	45.9	58.7	47.0	52.4	62.4	61.3	57.3	43.1	97.4	125.5	36.9	79.9	60.4	7.9	5.9	14.8	12.5	3.4	13.8	6.9	12.9	13.1	5.1	7.8	11.1	10.0	21.3	11.3	5.7	18.0	17.6	4.3	16.9	22.9	22.6	25.3	17.3	17.7	19.7	19.1	21.5	18.9	20.1	38.7	56.8	57.7	32.4	19.2	58.5	117.1	110.1	115.8	69.4	50.1	53.2	55.5	54.7	47.1	74.0	27.6	14.6	74.8	62.8	72.4	19.6	63.4	58.1	86.3	76.0	61.9	53.8	61.0	45.6	53.1	72.0	61.6	38.2	142.7	30.9	49.1	40.4	76.4	43.1	50.5	34.8	55.5	77.3	39.2	78.1	12.7	53.4	61.6	56.9	41.2	52.6	53.9	54.6	42.3	101.8	71.4	58.3	48.5	69.7	115.7	44.3	45.8	64.0	39.0	39.5	73.9	60.4	100.6	77.1	54.6	109.1	138.3	69.4	59.1	54.5	128.1
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229779-55259017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol		No	No		19000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA043989: AB_10987309, HPA063681: AB_2685087"	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	21.8	36.8	31.6	52.7	35.4	96.4	20.3	8.0	35.7	22.0	19.4	28.3	38.1	25.7	5.1	35.2	26.6	23.8	28.3	41.7	12.8	23.8	25.5	28.3	82.4	15.0	13.2	21.1	20.3	22.6	29.7	21.2	15.6	23.5	12.2	8.8	24.1	21.4	38.7	28.5	42.4	18.4	8.3	61.5	42.6	89.7	20.6	62.2	27.3	20.2	49.3	33.4	23.4	18.1	101.2	143.4	28.7	46.1	33.5	30.8	73.1	63.1	54.7	64.8	55.2	95.4	67.9	261.0	33.7	56.6	48.2	48.2	10.3	65.9	25.1	98.2	241.8	198.5	71.8	71.0	57.5	295.9	187.6	45.4	37.4	64.5	43.4	34.7	42.2	178.7	105.5	112.1	42.5	64.5	218.1	105.5	39.3	82.2	116.5	131.8	56.4	216.0	45.9	126.6	81.8	45.5	58.7	69.7	62.2	24.6	38.3	219.7	55.3	101.3	49.7	39.4	96.4	55.4	108.7	184.1	92.4	240.5	79.1	0.0	2.8	6.5	11.7	3.9	6.6	3.3	4.8	9.3	4.0	2.7	4.9	7.5	3.1	7.8	3.4	28.6	3.6	6.8	31.6	35.4	8.0	35.7	41.7	12.8	15.0	13.2	15.6	8.3	20.6	18.1	14.7	12.8	19.8	11.1	27.2	2.8	8.9	1.0	11.4	16.3	14.2	10.4	2.6	18.6	6.2	18.4	10.4	11.1	66.2	21.7	0.0	21.2	237.3	36.3	13.6	15.8	15.1	41.4	14.4	28.7	9.3	9.7	50.4	19.7	7.6	19.7	16.1	22.3	32.4	30.3	10.6	15.7	2.0	31.2	4.8	55.3	18.6	34.0	0.0	9.4	21.9	14.7	51.5	6.0	11.3	47.3	18.8	19.5	27.0	22.1	34.2	12.3	12.6	15.3	19.7	12.5	10.7	38.5	41.0	13.9	3.4	11.4	39.6	31.3	14.2	50.7
PPP6R3	"C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3"	ENSG00000110075	"Protein phosphatase 6 regulatory subunit 3"	Q5H9R7	11	68460731-68615334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 186.0;Oligodendrocytes: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017183, HPA038467, HPA038468"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		6600	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030"	"unprognostic (9.46e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.54e-2)"	"unprognostic (6.43e-2)"	28.7	28.0	20.4	31.1	26.7	53.0	31.1	35.0	23.1	27.2	29.4	33.4	27.3	30.9	23.3	32.6	26.2	30.7	32.9	20.0	21.9	29.2	31.9	28.1	37.0	24.2	23.4	38.4	22.7	42.9	24.1	34.7	24.8	32.4	33.5	33.8	28.3	26.1	48.8	29.9	31.0	34.5	21.8	32.9	30.0	36.9	23.1	44.4	43.9	49.0	36.6	32.7	26.4	34.6	72.8	83.6	85.0	59.6	44.5	44.9	66.3	62.0	59.7	70.7	64.2	148.3	71.3	83.4	59.4	58.1	74.3	66.6	94.6	70.2	92.3	81.4	40.6	96.1	83.0	49.8	42.6	92.3	82.5	44.8	46.1	72.6	78.0	39.6	65.3	65.4	83.1	59.7	51.1	96.5	92.8	70.8	42.9	142.1	49.5	86.1	116.0	80.9	46.9	103.8	47.8	57.4	88.5	68.8	128.7	70.4	102.4	48.5	65.3	69.1	65.0	74.4	53.4	47.1	71.2	107.0	50.1	40.1	75.1	14.5	9.9	13.2	11.8	13.3	11.4	11.3	12.6	11.7	6.4	12.8	13.7	12.8	14.1	10.1	15.8	13.2	13.2	6.8	20.4	26.7	35.0	23.1	20.0	21.9	24.2	23.4	24.8	21.8	23.1	34.6	41.5	44.8	37.6	134.8	39.6	33.1	25.4	17.6	25.6	49.8	32.1	24.9	42.3	25.8	33.1	27.6	56.3	19.4	36.6	40.9	15.6	15.4	65.8	33.3	33.1	31.0	30.5	35.6	133.3	16.7	17.0	29.8	36.7	43.1	27.8	31.6	29.6	25.3	17.5	26.9	155.0	29.6	16.2	24.9	27.6	24.8	31.1	29.4	21.4	163.9	22.1	28.6	17.5	186.0	213.6	23.9	36.2	31.6	35.9	37.9	29.4	16.1	25.9	50.2	19.7	29.0	30.2	33.8	31.0	29.2	35.5	32.8	38.6	28.6	26.5	42.2
PPRC1	"KIAA0595, MGC74642, PRC"	ENSG00000148840	"PPARG related coactivator 1"	Q5VV67	10	102132994-102150333	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038511, HPA057571"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA038511: AB_10672521, HPA057571: AB_2683472"	"unprognostic (2.27e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.29e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (8.65e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.93e-2)"	31.0	19.2	10.3	13.1	10.9	19.0	19.3	9.8	10.7	20.3	12.0	23.2	8.1	21.8	8.1	25.2	21.7	11.9	19.2	10.2	12.0	21.2	19.4	26.3	13.7	11.7	11.4	25.0	24.9	9.4	17.9	13.4	11.2	19.2	8.2	5.1	16.3	8.0	28.8	29.2	16.1	14.2	10.3	19.8	20.4	14.2	11.2	11.0	16.0	12.1	13.7	21.0	20.2	11.5	30.7	44.3	27.0	54.5	23.6	24.2	34.7	26.7	35.9	37.9	31.2	51.1	34.1	66.4	21.8	40.5	23.8	56.7	55.4	52.8	32.6	27.5	43.4	63.5	33.9	48.7	31.4	50.6	26.3	31.9	46.9	44.3	82.8	24.9	23.9	26.5	48.0	38.4	29.9	52.4	40.5	70.0	46.6	29.0	26.7	55.9	38.6	28.2	32.7	30.1	18.6	26.9	23.3	25.2	32.7	25.9	40.8	26.4	26.1	30.1	38.0	30.9	61.2	31.8	24.3	59.6	33.8	61.7	15.4	0.0	1.2	0.1	1.8	1.3	2.3	1.5	1.4	2.3	2.6	1.8	1.7	2.1	0.0	4.1	1.3	1.0	0.9	1.3	10.3	10.9	9.8	10.7	10.2	12.0	11.7	11.4	11.2	10.3	11.2	11.5	16.4	28.9	13.2	6.5	13.4	44.4	33.1	6.1	48.9	4.7	17.5	12.4	9.1	8.6	9.5	5.5	4.2	7.6	9.2	7.9	1.9	8.0	1.1	16.3	16.1	15.6	8.4	10.7	6.8	9.6	12.9	13.7	32.1	31.3	10.8	9.5	6.8	7.2	8.7	1.7	6.2	11.2	6.1	5.3	15.9	2.4	6.2	9.7	8.8	2.8	3.9	2.2	9.2	5.5	5.3	14.0	5.8	6.4	21.4	26.0	2.8	2.4	3.8	4.1	6.6	35.6	18.2	6.3	14.8	36.0	43.5	5.1	10.8	7.8	11.4	30.0
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48890197-48903143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	38.8	50.6	35.5	25.6	36.9	46.0	39.3	38.1	44.2	47.9	31.1	50.0	39.2	42.5	22.7	48.6	41.0	24.2	43.0	36.7	40.2	41.7	61.0	35.6	31.1	38.8	37.3	58.4	62.8	28.1	50.5	18.2	38.6	42.2	20.4	21.5	43.2	28.3	65.0	52.0	42.2	25.3	38.4	45.2	52.1	13.8	39.0	38.6	38.6	32.3	29.0	39.2	43.2	40.0	100.6	124.3	64.5	63.2	58.2	40.8	48.8	57.3	67.1	116.8	70.7	146.3	45.0	91.8	46.2	40.0	88.1	79.9	110.6	42.6	43.5	80.8	95.2	78.1	94.6	109.5	55.9	95.5	69.8	50.7	81.4	96.8	95.5	46.5	67.0	35.9	75.7	169.0	50.1	167.5	41.5	94.3	60.3	69.3	139.6	66.7	63.0	209.4	75.5	66.2	95.7	49.4	75.3	82.6	66.5	48.0	103.5	68.9	58.6	51.1	92.2	65.6	77.4	99.9	106.5	69.5	29.0	88.0	53.8	41.8	81.9	53.1	56.4	79.1	74.7	83.9	78.2	56.2	96.9	70.4	81.5	74.9	23.4	76.1	73.0	86.9	114.3	84.5	35.5	36.9	38.1	44.2	36.7	40.2	38.8	37.3	38.6	38.4	39.0	40.0	37.0	41.7	65.9	6.2	65.4	111.8	86.1	99.5	85.4	36.7	76.9	97.2	39.0	54.3	68.6	31.3	12.5	58.5	53.4	85.1	49.0	59.9	6.2	37.5	38.6	54.5	70.1	38.7	4.4	95.8	56.1	53.9	39.8	54.3	70.5	36.6	43.5	45.0	70.2	18.5	3.9	68.2	77.3	72.2	113.5	4.9	69.9	56.2	88.9	3.7	96.6	47.4	55.6	3.5	4.8	73.7	123.6	43.6	105.9	54.2	151.1	108.5	51.6	27.7	39.5	64.4	69.8	2.7	17.7	69.5	117.3	54.6	62.9	67.0	67.9	69.3
PRCC	RCCP1	ENSG00000143294	"Proline rich mitotic checkpoint control factor"	Q92733	1	156750610-156800815	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.9	31.8	43.4	29.7	45.2	41.9	31.4	44.5	50.4	32.4	42.3	36.6	27.0	34.5	23.1	39.7	29.7	23.0	37.6	45.7	42.0	36.7	34.2	29.6	36.3	43.3	42.8	30.9	29.0	34.7	28.1	29.0	43.7	33.5	22.5	26.6	30.4	24.1	63.4	43.2	30.9	27.3	41.3	37.4	31.8	27.0	43.3	37.5	31.0	34.4	30.7	32.6	32.2	46.9	79.1	67.3	51.6	59.5	42.5	33.8	89.8	53.8	52.8	59.3	50.8	106.2	65.0	80.6	90.4	43.1	34.1	80.3	74.7	57.0	45.3	101.6	97.4	59.1	47.4	68.4	52.5	81.9	66.6	48.1	64.7	51.5	46.6	45.7	55.2	52.5	99.7	72.1	41.8	140.2	94.1	94.6	124.9	108.9	82.0	81.6	45.7	108.7	62.5	74.0	91.6	163.4	57.0	140.6	92.4	84.4	102.7	129.8	51.1	59.3	61.9	66.0	89.6	184.6	298.5	124.1	58.7	52.2	56.1	46.9	28.6	57.4	27.5	29.9	26.5	24.0	24.7	30.0	32.5	27.6	24.0	25.2	27.7	30.2	37.1	38.9	27.1	26.0	43.4	45.2	44.5	50.4	45.7	42.0	43.3	42.8	43.7	41.3	43.3	46.9	22.2	9.6	16.4	12.7	32.0	52.4	38.2	52.1	46.1	19.8	31.1	24.4	13.0	18.6	29.4	20.2	22.9	63.1	36.0	27.2	21.5	39.4	13.5	21.4	21.9	30.2	34.3	16.6	15.9	32.2	63.4	28.7	24.5	23.2	17.1	28.9	25.4	16.0	44.0	28.6	14.4	26.9	40.7	22.6	27.4	10.4	30.4	28.4	21.4	9.4	44.9	16.9	30.9	18.1	25.4	35.5	34.2	28.6	48.8	43.8	29.8	29.9	21.5	19.8	32.9	32.2	29.2	43.3	46.2	39.6	51.3	101.1	30.3	32.4	29.4	39.2
PRKCA	"PKCA, PKCα"	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302613-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 564.8;Excitatory neurons: 247.6;Inhibitory neurons: 400.0;Microglial cells: 281.1;Oligodendrocyte precursor cells: 849.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 157.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	3.1	21.1	37.0	6.9	35.0	1.8	2.3	20.8	51.4	7.5	11.8	18.5	11.9	11.7	4.8	3.2	4.6	7.5	4.4	76.8	32.8	12.8	7.3	4.5	4.9	37.3	36.1	15.7	5.1	0.9	6.3	5.0	25.3	13.0	8.6	30.1	2.3	16.9	5.8	3.0	10.6	10.7	30.1	6.5	8.4	2.6	36.9	3.1	3.2	4.3	4.6	8.9	5.6	27.3	7.3	38.0	7.7	7.8	18.2	46.0	1.0	40.8	26.4	28.8	24.3	4.5	4.6	9.6	10.9	65.9	48.1	0.9	3.9	4.8	61.9	16.4	9.3	0.0	22.2	20.2	24.9	12.2	62.8	20.2	1.8	36.0	30.5	41.8	25.0	45.6	25.8	0.2	44.8	2.3	24.9	7.4	3.1	18.9	20.2	4.5	56.5	0.2	10.2	6.4	4.6	25.6	13.5	7.7	0.4	8.0	0.8	17.0	75.1	49.6	28.6	31.4	25.8	0.1	0.0	1.2	157.6	0.1	25.1	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.8	0.4	0.3	0.0	1.2	0.7	0.0	0.0	1.1	0.4	0.1	0.3	37.0	35.0	20.8	51.4	76.8	32.8	37.3	36.1	25.3	30.1	36.9	27.3	10.0	0.0	8.4	564.8	5.7	10.6	15.0	10.3	13.6	198.3	7.9	11.2	9.8	45.8	7.2	40.5	2.1	4.1	24.6	27.1	7.9	16.1	3.2	5.5	40.1	5.6	8.4	5.7	247.6	6.8	3.4	17.5	23.9	6.3	20.3	39.9	27.8	14.7	25.4	10.1	400.0	38.4	2.0	11.9	7.6	3.0	53.4	20.9	10.6	281.1	6.8	34.3	12.3	849.0	198.3	8.8	21.0	48.5	11.8	12.8	27.0	21.3	7.0	77.1	26.3	6.5	41.4	1.3	3.9	6.1	10.4	15.2	36.9	47.1	26.4	17.2
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 267.7;THP-1: 194.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 121.4;thalamus: 334.6"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		30000	"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	46.1	59.7	10.4	45.4	11.1	90.3	28.9	4.4	11.7	25.9	7.3	43.5	54.8	9.1	39.1	32.7	42.3	32.8	19.6	12.8	11.0	25.6	8.8	44.3	46.8	9.9	8.5	13.6	33.2	20.7	8.2	20.5	7.5	39.3	41.5	2.2	25.9	31.9	6.8	34.0	55.7	16.2	9.5	54.2	65.1	20.8	9.0	16.3	41.8	9.2	62.1	44.2	23.2	12.3	33.5	14.4	5.2	8.7	35.9	21.6	46.2	20.4	25.7	24.5	23.7	34.4	31.9	86.5	8.3	45.6	42.9	14.5	34.1	49.8	20.6	75.2	23.6	50.1	18.3	32.0	23.6	64.8	103.4	17.1	35.8	25.6	23.2	21.8	22.4	9.3	9.7	11.8	36.1	85.0	7.0	81.0	13.0	51.5	23.0	7.6	13.6	20.6	25.5	72.8	8.3	6.5	15.4	267.7	39.6	24.0	22.6	194.0	31.5	11.7	14.4	15.4	19.2	18.1	33.6	45.9	27.6	116.4	22.6	51.8	73.7	50.1	3.6	71.3	2.2	6.2	2.1	2.5	57.0	8.2	2.2	2.0	52.9	6.9	47.7	16.3	2.6	24.1	10.4	11.1	4.4	11.7	12.8	11.0	9.9	8.5	7.5	9.5	9.0	12.3	4.3	3.2	23.5	2.0	25.7	29.2	26.3	8.0	23.9	0.3	11.8	4.3	6.4	14.3	16.1	14.7	0.0	3.1	24.7	61.8	3.9	8.9	34.5	18.5	4.4	2.7	26.5	5.2	3.4	10.7	16.0	6.7	54.0	17.8	5.7	8.9	3.3	2.3	44.8	1.7	4.2	37.1	4.1	47.4	43.0	75.6	9.0	41.5	10.6	20.6	44.9	2.0	8.2	1.0	0.5	13.2	55.4	6.8	25.8	19.7	64.5	13.1	16.5	0.2	6.6	6.5	12.1	23.1	3.7	23.9	27.8	8.8	10.0	10.4	23.0	34.6
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;dendritic cells: 22.4;NK-cells: 32.0;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 75.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.7"	"Cell line enhanced"	"Detected in many"		"HEL: 57.8;JURKAT: 40.0;MOLT-4: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.8	0.7	5.3	5.2	8.5	5.7	0.9	6.1	6.3	1.6	12.1	1.4	1.5	2.5	8.3	2.2	3.9	1.5	0.3	5.5	8.2	10.9	1.0	5.3	12.3	6.5	8.6	1.3	3.4	0.7	0.8	0.2	6.4	1.8	1.7	1.5	1.4	1.1	124.5	0.3	3.3	0.7	5.5	5.0	2.1	1.1	7.2	33.6	14.9	112.6	9.4	2.2	0.6	9.8	0.1	5.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.2	0.4	3.4	0.3	0.0	0.0	0.0	0.0	3.3	6.0	0.0	0.0	3.9	57.8	0.0	0.4	0.7	2.8	0.6	0.3	3.5	0.1	0.2	0.0	0.5	40.0	12.8	0.1	0.0	0.0	43.9	8.0	5.8	0.5	0.0	8.5	1.3	0.0	11.6	2.9	0.4	2.1	0.0	0.0	0.0	3.4	0.0	5.8	0.0	0.0	5.6	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	2.4	0.1	0.3	23.0	0.4	18.0	0.1	24.5	24.5	0.2	0.0	19.1	17.9	1.6	13.3	0.0	0.0	39.7	10.5	5.3	8.5	6.1	6.3	5.5	8.2	6.5	8.6	6.4	5.5	7.2	9.8	0.2	3.2	7.0	22.9	0.8	0.0	0.3	0.3	0.6	1.6	0.3	0.3	0.4	0.0	0.7	1.8	0.0	0.0	22.4	0.0	7.9	0.3	2.1	0.5	1.2	0.2	1.8	8.0	13.7	0.8	0.1	0.7	1.5	3.0	1.3	8.2	1.1	0.0	0.5	0.0	14.7	0.5	0.0	1.3	0.5	5.6	0.0	1.7	0.0	7.5	0.8	1.2	32.0	24.6	75.2	0.1	0.1	0.0	10.2	0.2	0.0	0.3	0.9	0.4	0.0	4.2	0.4	1.0	2.2	0.5	0.0	0.0	31.7	0.3	0.4	0.1
PRKDC	"DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic subunit"	P78527	8	47773111-47960178	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	17.3	16.8	8.6	14.1	10.7	19.2	16.1	9.8	11.9	18.2	10.8	16.2	7.0	20.1	8.0	24.0	18.3	7.4	16.7	10.6	9.3	14.8	14.0	14.8	17.9	10.4	10.0	19.8	18.0	14.0	16.3	10.9	9.8	13.5	11.6	23.8	16.0	9.2	26.4	19.8	17.2	12.1	10.6	18.8	16.6	18.3	9.6	27.8	13.4	15.0	17.1	18.7	17.5	14.3	123.5	103.4	98.4	93.9	59.9	63.0	41.6	51.2	49.9	70.3	68.9	68.0	39.6	117.1	43.1	63.3	52.3	68.5	131.3	70.2	109.3	26.3	81.8	230.2	92.1	83.7	25.8	88.6	46.0	45.9	22.5	111.3	115.3	27.1	73.4	79.5	156.6	48.0	78.8	57.7	125.8	72.3	108.6	85.6	31.2	60.8	77.3	41.2	35.5	104.4	49.2	62.5	158.1	50.6	51.1	60.2	72.6	60.1	86.2	91.5	78.0	73.0	104.2	41.3	56.7	162.8	51.7	97.9	75.6	11.4	8.1	4.1	8.7	6.8	11.0	13.1	10.8	9.2	6.5	16.7	11.2	10.3	7.7	12.8	13.7	15.3	8.3	2.9	8.6	10.7	9.8	11.9	10.6	9.3	10.4	10.0	9.8	10.6	9.6	14.3	73.4	38.5	36.1	56.8	67.9	38.4	48.3	59.7	77.4	103.4	63.1	64.0	82.1	22.8	44.1	42.3	125.1	61.1	81.9	17.5	17.6	41.9	29.0	66.0	166.5	59.7	25.8	147.6	85.5	36.0	60.6	73.2	55.0	72.6	45.6	105.1	32.5	41.2	35.9	104.3	77.1	31.2	38.7	45.5	20.1	15.5	56.8	54.6	19.6	61.8	63.6	73.1	57.7	82.0	76.0	34.9	16.6	69.6	69.3	57.1	13.2	23.5	50.1	111.6	52.6	91.2	69.3	100.7	106.3	85.3	40.6	33.0	71.0	143.2	55.2	36.4
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358584	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	9.7	11.9	8.1	6.2	8.3	4.7	10.5	8.4	10.2	9.8	12.0	10.8	3.2	9.4	3.3	7.5	10.7	4.3	13.2	8.3	8.3	8.6	10.2	5.9	9.4	8.9	8.4	12.1	9.7	4.8	11.1	6.3	8.8	10.5	3.0	4.6	10.0	7.0	21.8	9.8	8.8	4.5	8.3	9.7	8.8	9.8	8.4	14.4	8.6	13.5	5.8	9.7	8.3	8.4	18.1	24.7	13.2	36.1	7.1	7.0	50.8	13.8	6.8	19.5	15.6	79.4	16.1	42.4	29.8	14.0	8.4	22.6	20.4	13.8	12.6	12.7	24.5	8.6	30.8	36.8	7.8	24.3	15.8	11.3	4.9	15.2	14.0	9.3	11.8	18.7	28.1	0.8	10.3	28.2	25.8	36.3	25.3	16.5	18.8	43.7	19.3	25.7	10.7	17.7	19.8	13.2	53.5	16.2	15.7	11.9	25.2	22.2	16.0	14.7	12.9	19.9	17.6	9.6	22.5	41.6	17.1	23.4	16.8	12.3	8.2	7.1	17.4	10.6	20.2	10.9	11.6	14.9	11.8	12.8	16.7	15.4	0.8	21.4	9.5	32.9	14.7	14.3	8.1	8.3	8.4	10.2	8.3	8.3	8.9	8.4	8.8	8.3	8.4	8.4	7.1	19.2	10.6	16.6	12.1	6.9	8.9	12.8	9.1	21.2	10.8	8.8	13.3	8.6	10.0	9.2	54.2	25.4	12.6	28.3	5.9	12.3	4.4	12.9	8.7	7.6	13.2	7.8	25.0	16.1	8.4	10.5	23.4	5.9	7.0	24.9	6.8	8.4	12.2	30.3	25.9	32.4	10.2	7.7	20.6	4.3	11.8	6.2	8.8	12.2	9.1	9.7	13.4	18.6	20.4	23.6	29.8	13.2	6.9	6.7	24.7	7.7	14.5	18.2	13.1	9.9	8.6	6.9	19.3	6.1	6.0	11.6	16.5	10.0	24.1	12.7
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395104	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.3;skeletal muscle: 81.0"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"HDLM-2: 104.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053354, HPA060103"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA053354: , HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	1.4	4.8	4.2	0.9	3.3	0.4	1.5	3.5	2.5	1.4	2.2	1.9	1.2	1.7	0.4	1.0	2.1	0.4	23.3	3.3	4.5	1.7	0.6	0.9	1.0	6.4	7.8	0.6	0.4	2.3	2.9	0.6	4.9	3.3	0.1	0.3	2.4	1.3	81.0	0.7	1.6	0.5	6.1	1.6	1.2	0.8	5.0	0.7	1.0	18.4	0.6	1.6	1.0	2.9	1.5	0.6	0.3	0.3	0.1	0.3	0.5	1.2	0.3	1.3	1.1	4.3	2.6	5.7	1.1	3.9	0.1	0.7	0.5	0.1	0.3	104.7	1.4	1.4	2.7	0.5	3.0	0.0	3.2	0.9	0.7	2.8	0.6	0.7	0.1	3.7	0.5	5.7	4.1	1.2	4.9	2.6	1.4	0.6	2.7	15.4	0.4	12.5	0.2	0.1	1.3	0.7	6.0	4.5	0.2	1.3	2.1	3.0	0.4	0.1	0.4	0.2	0.4	1.0	1.8	9.2	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	3.3	3.5	2.5	3.3	4.5	6.4	7.8	4.9	6.1	5.0	2.9	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.2	0.0	0.4	0.1	29.7	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.2	2.4	1.5	2.5	0.0	0.4	0.0	0.0	0.3	1.2	1.1	0.9	0.0	0.7	2.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	0.1	1.2	3.0	0.3	0.0	2.4	0.0	0.2	6.6	5.6	2.9	0.4	0.8	0.3	0.0	2.6	0.4	2.4	0.6	0.3
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890547-60906585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA		71000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	46.1	70.6	89.8	49.8	87.9	67.0	48.8	73.7	100.2	57.4	60.2	54.5	42.9	55.4	34.2	81.7	57.3	29.4	47.9	91.3	94.1	50.4	77.2	34.6	64.1	92.0	80.7	66.6	69.4	79.8	79.3	42.9	92.9	62.1	51.8	46.1	56.5	48.2	75.2	80.3	49.5	47.9	75.6	54.3	54.3	30.5	81.1	78.5	43.4	38.9	73.7	58.7	55.9	84.5	197.5	147.0	161.8	116.2	92.7	80.8	155.6	102.4	137.5	200.2	149.0	162.7	141.1	280.5	145.2	98.2	120.2	179.0	229.2	184.6	153.4	207.0	153.4	232.4	111.3	184.9	134.2	308.6	161.1	86.3	137.0	154.4	171.9	58.7	158.7	167.4	248.2	155.3	99.5	270.6	328.9	249.5	292.6	150.5	197.7	285.8	165.5	227.5	101.7	127.5	142.3	172.9	126.6	208.3	178.0	73.1	225.8	170.2	101.9	89.6	147.2	161.8	171.2	147.2	223.3	287.9	111.6	208.6	138.6	4.2	7.8	2.0	2.4	3.8	1.7	0.9	1.8	1.7	3.6	2.4	2.2	2.0	0.5	1.8	2.3	3.9	1.7	1.0	89.8	87.9	73.7	100.2	91.3	94.1	92.0	80.7	92.9	75.6	81.1	84.5	15.8	19.2	23.7	10.1	26.7	42.1	35.2	40.2	33.0	32.0	24.6	19.4	17.6	20.0	28.6	27.6	10.4	94.7	16.2	20.4	27.4	48.5	21.6	21.4	19.7	27.3	39.0	45.2	19.8	51.6	90.2	24.9	23.4	28.4	22.8	25.4	20.0	46.1	46.3	62.2	22.2	40.0	32.6	23.0	21.6	3.6	37.0	19.3	26.6	11.2	41.2	25.4	21.6	10.1	11.8	33.4	27.7	38.7	31.9	40.4	27.8	27.9	17.8	25.3	46.0	22.4	22.6	25.2	38.0	37.4	41.6	40.6	24.8	24.8	55.1	26.3
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321479-150353233	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	26.0	24.7	18.1	22.3	20.2	44.8	27.0	23.2	23.1	27.5	22.8	25.2	16.9	25.0	26.7	22.2	25.7	13.8	19.5	17.8	21.4	29.0	30.4	24.3	28.6	19.7	18.9	34.1	23.8	17.6	27.0	20.9	19.3	27.5	19.6	43.5	21.7	19.5	22.2	23.8	24.6	18.7	17.3	33.8	19.1	20.1	19.7	30.9	32.0	14.9	28.5	24.3	24.3	21.6	44.8	47.5	47.1	30.3	31.0	33.5	63.8	45.6	31.9	69.1	47.5	36.6	40.8	58.7	29.7	37.6	64.4	51.5	86.1	32.2	61.7	29.7	38.3	50.7	72.1	35.2	30.7	62.5	31.6	24.6	43.7	59.0	50.5	32.9	42.7	39.0	61.3	34.8	50.0	66.5	52.3	55.0	67.6	114.3	41.9	75.1	38.5	38.8	28.5	26.7	40.3	35.7	37.9	44.2	34.9	63.3	52.9	150.5	34.3	43.2	33.3	36.7	75.8	33.1	62.8	64.7	28.8	56.2	45.9	9.3	9.0	13.3	14.9	11.8	14.6	13.0	10.8	9.8	9.5	10.0	11.0	11.4	5.3	11.5	21.8	7.6	9.1	8.3	18.1	20.2	23.2	23.1	17.8	21.4	19.7	18.9	19.3	17.3	19.7	21.6	26.1	35.3	23.4	31.6	26.1	11.7	13.1	13.0	10.8	30.4	10.8	10.8	13.2	11.5	19.7	11.0	18.8	16.1	22.9	15.8	13.7	15.6	11.5	13.2	20.0	22.5	2.4	19.0	19.5	11.9	16.0	16.3	17.9	17.8	22.8	25.5	14.6	11.0	12.1	32.0	17.5	17.5	4.1	8.6	11.8	5.3	20.2	14.5	10.6	15.0	14.2	27.8	17.5	18.1	28.4	13.4	9.5	18.4	12.4	12.6	12.6	5.0	20.6	42.6	13.1	19.1	21.2	44.3	23.5	11.6	10.1	20.0	24.0	11.3	11.6	10.0
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404602-52420836	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	9.0	8.1	11.8	10.7	12.2	19.3	13.3	16.2	14.2	12.1	10.5	11.2	8.4	14.1	9.8	9.5	11.4	7.1	7.4	11.3	12.3	10.4	7.9	9.7	15.7	12.2	12.5	17.3	7.9	8.9	9.6	9.9	12.1	10.1	12.1	17.6	8.4	9.0	6.7	11.4	10.7	9.0	11.6	11.2	8.2	8.9	11.8	21.1	12.2	8.1	15.0	8.7	10.3	13.5	17.6	8.5	29.8	14.3	11.5	11.3	17.6	11.8	8.0	19.1	18.3	15.5	8.5	36.2	12.0	8.1	14.8	12.8	42.6	12.8	24.7	19.8	32.4	48.7	31.1	16.3	14.2	54.8	17.2	8.7	11.2	20.9	20.0	14.5	16.3	25.9	45.4	9.2	11.5	9.9	42.5	32.8	36.6	18.6	19.7	41.3	44.8	30.3	16.9	10.4	19.7	24.0	23.8	19.3	23.8	20.0	13.6	43.8	12.9	10.8	16.2	16.3	23.5	17.4	26.6	35.7	15.9	47.0	14.0	12.3	6.2	8.9	7.4	7.1	10.2	7.2	8.3	9.1	7.9	6.5	11.3	8.8	4.8	11.1	7.5	4.3	8.9	5.7	11.8	12.2	16.2	14.2	11.3	12.3	12.2	12.5	12.1	11.6	11.8	13.5	37.5	41.7	32.1	8.5	49.1	53.0	92.7	48.8	33.6	35.9	34.4	32.1	29.9	22.8	41.1	16.5	93.8	60.5	52.6	69.9	35.2	36.9	84.6	36.8	34.3	47.6	35.8	44.6	6.7	29.4	77.9	33.8	20.4	31.6	60.1	43.1	34.6	19.3	40.0	25.2	7.2	42.7	32.6	35.8	40.0	18.6	25.7	34.4	30.2	1.9	40.4	49.4	70.0	7.1	7.4	27.0	49.1	33.4	47.3	47.0	61.2	34.9	28.3	47.8	52.6	53.8	33.2	109.8	55.1	38.1	56.0	103.4	57.6	44.7	62.2	67.9
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275642-113294009	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	11.6	14.7	9.2	15.2	9.5	15.1	13.4	10.3	10.9	11.2	8.6	11.1	9.9	13.5	19.4	14.9	12.3	10.3	11.0	9.4	9.5	15.4	16.2	9.4	15.6	8.9	8.9	14.8	14.4	25.4	12.2	12.5	9.2	13.3	12.3	13.1	11.2	11.1	18.1	14.6	9.8	13.2	9.0	11.6	10.3	11.6	9.1	16.9	10.2	15.2	17.6	16.7	11.3	9.6	36.6	61.3	40.3	44.4	27.8	28.6	40.4	56.1	28.1	60.2	44.2	60.4	33.4	76.5	32.5	30.3	62.2	81.8	84.9	48.8	66.2	54.2	32.1	39.1	50.4	43.7	25.2	68.0	34.2	20.7	32.7	63.1	59.9	22.6	28.9	41.8	67.5	40.9	51.2	57.3	65.1	47.9	63.9	94.2	66.5	59.4	95.9	51.4	26.0	28.9	52.7	35.5	82.9	44.0	26.0	32.0	68.3	35.0	29.8	49.1	37.3	63.0	72.4	52.1	153.1	73.3	37.6	42.9	63.8	27.4	16.2	16.1	14.7	19.4	17.1	17.1	14.4	13.3	20.4	17.4	14.5	14.6	5.2	18.4	24.6	13.4	14.6	14.8	9.2	9.5	10.3	10.9	9.4	9.5	8.9	8.9	9.2	9.0	9.1	9.6	15.7	9.6	18.4	6.8	23.7	15.7	17.6	10.4	18.8	22.9	12.7	14.6	12.9	12.8	15.2	18.4	18.8	27.7	26.6	5.8	25.4	18.6	17.2	17.5	24.7	12.6	17.5	20.0	8.6	16.9	34.5	16.4	10.2	21.9	19.0	21.5	6.4	9.9	18.4	28.6	8.3	13.0	10.2	13.5	17.8	13.0	11.5	20.5	5.4	2.8	27.3	22.7	18.6	4.0	5.7	15.5	9.6	10.9	15.7	20.6	8.1	16.9	14.3	24.1	0.0	16.9	17.5	28.6	21.0	21.4	18.8	21.5	20.0	24.7	14.0	16.9
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA038272: AB_2675923, HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	16.7	16.7	9.0	24.7	9.8	45.0	21.5	14.3	10.4	16.8	9.4	24.2	23.0	18.6	15.7	27.6	18.0	17.4	15.3	8.7	10.3	18.9	21.7	17.4	30.4	10.4	8.7	18.9	19.7	24.0	10.5	22.2	10.9	18.4	20.9	16.7	16.6	15.0	22.8	21.0	23.0	17.4	9.9	20.7	22.2	25.5	8.7	31.5	24.6	20.0	28.1	27.1	15.1	12.3	63.4	62.9	68.9	70.8	39.1	51.8	95.5	61.8	55.2	86.0	78.9	120.0	57.8	130.9	88.0	62.7	49.2	63.8	90.8	74.3	91.6	72.4	78.6	121.8	55.7	79.9	50.7	135.4	81.6	41.7	61.9	113.8	127.3	52.4	67.5	60.8	133.2	60.6	52.9	38.4	57.2	63.4	102.9	41.2	75.8	110.4	73.3	86.9	43.7	99.8	82.2	56.0	73.9	53.5	67.6	50.6	46.8	85.4	79.1	90.3	56.6	51.9	81.4	38.8	67.7	130.6	57.9	78.2	56.1	87.6	70.1	91.7	66.7	86.5	62.3	65.5	62.1	60.7	79.4	70.3	65.5	58.8	61.1	70.4	101.1	84.8	58.8	80.1	9.0	9.8	14.3	10.4	8.7	10.3	10.4	8.7	10.9	9.9	8.7	12.3	98.5	112.2	118.5	48.3	120.3	141.0	120.0	117.9	101.3	65.0	73.6	70.6	64.4	55.8	122.1	53.3	73.0	123.1	123.7	67.2	49.0	110.0	150.3	101.0	126.6	97.4	78.3	105.6	56.4	111.5	155.9	96.4	74.9	121.0	123.4	111.0	53.9	72.5	109.2	60.6	53.3	81.5	87.5	95.7	114.5	36.4	69.3	125.5	55.2	44.0	184.1	62.7	107.1	44.7	71.3	128.3	86.8	79.7	112.1	131.7	69.5	75.7	152.6	75.2	98.6	104.8	132.1	239.0	121.4	141.6	151.7	132.2	119.9	164.9	103.7	148.4
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684867	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 252.3;Rod photoreceptor cells: 293.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm		NA	NA		120000	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	78.5	128.7	82.6	45.7	85.0	70.5	78.6	93.2	121.3	98.5	98.7	93.5	33.0	94.5	44.1	85.3	94.2	30.8	100.9	84.4	84.0	78.2	91.2	84.2	52.8	83.6	82.1	131.6	78.3	82.7	130.4	44.7	86.2	89.7	44.5	115.6	78.1	49.1	146.7	92.6	84.2	51.7	80.9	98.2	80.5	100.1	81.5	83.9	89.0	80.1	61.6	96.9	84.3	88.0	104.0	240.7	149.0	116.1	120.8	90.4	107.9	78.2	109.5	160.3	122.4	208.2	50.0	150.0	73.2	150.5	113.4	152.9	356.3	139.5	181.6	99.4	170.0	124.3	187.1	161.0	73.5	145.4	138.9	86.0	91.2	194.8	146.7	84.5	146.1	106.2	121.1	126.6	117.9	112.7	114.4	117.4	97.0	97.7	74.4	218.4	82.3	80.7	63.1	121.1	71.0	103.8	145.0	61.5	69.3	121.6	87.4	91.3	122.1	91.7	78.3	130.2	176.1	46.6	46.7	101.9	81.6	108.1	121.6	23.1	8.9	10.1	19.1	14.4	23.6	17.5	17.7	20.9	15.7	18.3	16.7	20.0	9.0	14.2	21.7	25.2	23.2	11.2	82.6	85.0	93.2	121.3	84.4	84.0	83.6	82.1	86.2	80.9	81.5	88.0	45.7	60.9	84.3	24.5	72.8	30.1	30.0	42.5	56.9	128.0	31.8	34.4	39.4	42.9	53.9	47.8	252.3	43.3	66.6	42.9	7.9	35.5	11.8	45.4	38.8	46.3	36.5	73.0	23.6	40.9	26.7	48.3	56.1	40.3	52.6	55.9	37.9	38.7	39.8	72.3	29.3	40.2	32.6	40.1	26.5	11.2	73.3	42.6	19.6	19.7	48.3	55.9	46.4	21.6	19.0	42.7	36.5	52.3	70.0	31.4	48.7	18.3	51.3	293.2	72.3	65.4	44.8	100.4	99.1	57.3	27.8	39.5	62.8	50.2	50.3	31.5
PRR14	MGC3121	ENSG00000156858	"Proline rich 14"	Q9BWN1	16	30650717-30656413	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052022, HPA060265, HPA075914"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: "	"unprognostic (1.57e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (3.74e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.54e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.31e-3)"	20.5	20.2	17.1	13.9	16.8	23.6	20.3	19.0	21.7	26.6	12.8	30.8	13.8	29.8	7.1	22.4	26.1	6.6	16.4	16.0	15.3	22.1	21.3	24.1	14.1	18.5	16.6	25.1	24.9	13.0	21.2	8.3	16.1	26.2	7.8	9.4	19.1	13.7	15.1	26.2	25.6	10.9	15.0	32.5	26.0	12.6	18.3	18.7	23.4	9.6	10.6	24.5	22.7	17.9	18.2	20.3	17.1	18.2	15.2	11.7	11.9	17.6	11.8	18.1	17.2	9.3	17.3	30.5	15.3	12.9	8.4	17.7	14.4	20.4	9.8	41.5	36.0	17.9	19.6	21.4	23.6	16.1	43.3	9.8	23.1	13.0	13.7	18.9	23.1	8.2	22.8	24.3	10.0	42.2	36.7	28.4	6.2	12.4	10.3	29.4	8.4	44.2	13.7	7.3	14.5	32.4	7.1	26.8	18.2	5.3	29.9	13.1	18.1	16.3	17.7	17.0	18.4	44.1	29.4	21.3	11.0	33.0	14.7	11.4	6.0	23.7	9.6	6.5	7.4	7.0	8.0	9.7	5.7	10.5	7.3	7.2	22.5	8.6	10.9	7.6	10.3	5.5	17.1	16.8	19.0	21.7	16.0	15.3	18.5	16.6	16.1	15.0	18.3	17.9	18.1	9.6	10.4	13.7	23.2	22.8	26.1	28.8	33.6	13.9	19.1	18.7	6.6	25.8	13.2	12.9	14.6	15.8	31.9	24.1	15.6	22.3	6.7	8.8	13.0	20.9	12.6	15.4	7.5	22.2	15.3	15.3	27.5	15.1	12.0	15.4	18.9	10.1	18.2	1.7	7.7	18.3	20.3	16.0	34.1	2.5	19.3	20.2	8.8	8.4	30.2	13.1	33.0	5.5	8.7	20.4	14.6	21.1	17.3	23.6	23.6	15.1	10.0	14.2	19.7	12.8	19.9	17.2	27.2	28.5	23.0	14.1	26.5	11.7	19.8	17.3
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	30.9	21.0	26.8	33.3	25.8	72.5	32.7	32.1	35.0	34.0	19.0	27.0	21.6	30.2	37.5	36.7	29.7	26.2	22.7	22.9	34.2	28.8	31.1	35.8	44.8	27.5	27.1	34.3	28.9	33.8	25.7	34.2	27.6	28.2	31.9	34.5	30.3	27.1	25.7	39.7	34.0	25.4	20.3	36.0	28.9	29.3	26.4	49.6	27.8	23.7	43.4	38.5	34.4	30.7	84.9	64.3	88.1	58.4	61.0	70.5	65.2	47.8	67.7	54.8	49.7	99.1	59.0	123.9	73.1	70.4	44.3	73.8	96.5	76.1	83.8	70.1	51.4	94.2	51.2	69.5	63.3	154.4	73.8	68.6	57.1	92.7	137.3	49.3	80.9	66.6	126.8	66.6	63.0	40.3	92.8	65.2	116.8	67.5	110.5	69.3	65.5	60.7	77.8	93.3	56.7	58.3	72.6	85.4	56.0	115.8	58.2	107.0	101.6	61.9	57.0	60.7	100.4	55.5	63.4	175.3	39.4	74.7	56.7	2.2	1.3	0.7	1.3	1.2	1.3	1.7	1.2	1.2	0.6	2.0	1.1	1.3	3.4	2.5	1.4	2.0	1.0	0.6	26.8	25.8	32.1	35.0	22.9	34.2	27.5	27.1	27.6	20.3	26.4	30.7	233.8	298.1	224.7	81.0	272.5	167.0	270.8	107.5	198.6	164.6	105.4	104.6	115.7	133.0	198.3	86.5	139.7	204.0	325.0	190.0	25.4	174.0	63.9	228.0	246.7	214.5	165.1	139.0	101.5	151.3	210.1	189.1	157.0	378.3	263.2	132.8	130.3	119.0	128.9	138.0	108.6	162.3	57.0	142.8	183.0	36.5	139.1	211.0	96.0	91.8	227.9	120.4	269.8	87.9	143.2	223.1	145.2	96.3	281.8	294.3	99.6	40.1	132.1	170.4	78.9	218.1	184.2	247.7	160.8	178.0	145.9	476.8	317.3	178.5	168.5	335.5
PSAPL1		ENSG00000178597	"Prosaposin like 1"	Q6NUJ1	4	7430285-7434930	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"skin 1: 98.5;stomach 1: 38.6"	"Cell type enriched"	"Detected in some"	13	"Gastric mucus-secreting cells: 41.8"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.7;melanoma: 2.5;pancreatic cancer: 2.0;stomach cancer: 3.0;urothelial cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 16.6;OE19: 32.2;RPMI-8226: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA		31000		"Cluster 61: Skin - Cornification"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.3	0.0	0.0	0.0	0.3	0.0	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	98.5	0.0	0.0	0.0	0.0	38.6	3.4	0.1	0.2	0.0	0.0	3.1	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297125-78330093	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 175.0;liver: 267.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1170.1;SK-MEL-30: 752.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	7.8	65.8	123.3	7.3	124.6	2.0	5.1	130.5	175.0	5.1	92.8	5.9	5.4	4.3	61.6	33.2	34.7	1.7	2.7	122.4	126.5	136.7	267.9	5.1	9.3	130.2	122.4	5.6	129.1	9.7	7.6	3.0	129.9	10.0	5.5	6.2	19.2	4.0	0.6	57.2	4.5	3.3	133.6	6.0	19.4	10.4	120.3	30.0	30.3	0.5	12.4	7.3	11.2	161.6	222.8	146.0	121.1	215.6	35.1	41.2	284.7	184.3	130.4	91.8	170.6	38.2	41.9	143.2	79.8	416.9	82.9	215.3	209.1	203.6	136.4	141.2	73.9	49.2	60.8	293.3	322.0	277.6	84.6	131.1	1170.1	122.0	322.9	22.6	85.0	548.3	53.8	358.2	77.1	83.2	95.8	44.3	278.2	415.1	158.4	46.5	78.6	173.4	126.6	50.9	54.9	127.0	51.1	87.7	752.3	75.9	42.0	344.1	19.9	23.2	73.5	85.9	151.5	242.0	242.7	0.8	268.9	215.6	112.1	0.0	0.0	0.0	5.2	0.0	5.9	3.1	5.0	7.0	0.3	1.3	8.1	7.5	0.3	0.0	0.1	0.0	15.1	3.3	123.3	124.6	130.5	175.0	122.4	126.5	130.2	122.4	129.9	133.6	120.3	161.6	0.4	0.0	0.0	70.2	11.0	41.9	8.8	18.9	115.5	0.9	1.8	3.9	0.6	1.5	4.7	11.0	0.0	32.0	2.2	2.0	62.6	11.5	1.7	77.7	10.3	3.7	3.6	29.9	7.3	48.4	13.7	4.2	6.6	145.9	0.0	0.5	3.6	161.7	5.3	5.0	6.0	4.8	18.3	4.4	2.9	3.8	5.0	3.4	19.6	5.6	3.8	26.7	0.0	48.2	78.8	22.7	0.1	1.9	29.1	16.0	0.3	304.1	3.8	1.1	0.0	33.5	14.3	1.6	3.7	35.5	50.7	9.3	8.6	68.2	4.2	11.8
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15510995	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	32.9	40.9	67.8	46.9	72.1	62.0	27.4	83.9	89.1	45.8	52.6	40.8	23.1	57.5	36.0	26.2	42.9	30.8	34.4	71.5	79.2	32.6	22.3	32.8	80.7	65.2	66.4	86.0	17.1	30.3	52.2	39.5	64.4	36.3	30.9	154.4	19.1	41.0	38.6	26.0	34.4	43.2	65.1	54.7	28.5	81.6	68.1	129.7	37.1	29.5	69.3	31.2	32.3	72.2	117.5	76.5	254.7	187.4	54.0	65.2	56.7	138.3	98.1	121.7	143.6	32.1	59.5	248.1	31.4	73.5	68.2	32.0	160.1	75.0	174.9	164.8	96.6	860.4	194.9	60.8	65.1	101.7	91.7	54.8	21.0	102.1	74.4	121.0	108.0	115.2	144.4	134.1	80.2	42.8	211.5	250.9	395.2	2.7	117.2	194.7	138.8	50.7	68.3	40.5	161.1	176.7	123.7	54.0	67.1	157.5	54.5	134.9	76.7	88.0	88.6	66.7	133.2	57.1	85.3	221.8	70.2	100.8	51.6	13.7	2.6	5.4	6.1	2.0	7.7	11.0	12.5	8.8	3.0	17.5	18.7	11.6	8.4	9.5	5.7	3.1	12.9	2.4	67.8	72.1	83.9	89.1	71.5	79.2	65.2	66.4	64.4	65.1	68.1	72.2	93.7	54.5	31.9	27.4	98.1	31.9	49.1	8.1	48.9	231.0	22.0	35.6	57.8	31.5	23.1	47.8	66.7	122.7	82.1	24.7	62.6	9.5	95.5	92.9	62.5	84.8	38.1	160.1	73.4	8.5	76.2	74.8	23.0	35.1	15.2	104.2	65.3	18.0	32.1	138.0	76.9	34.1	2.0	36.5	45.9	58.5	125.9	45.8	40.9	20.6	47.9	162.2	83.4	49.8	67.6	3.6	20.6	134.3	60.4	19.6	14.1	54.5	42.1	279.1	124.9	85.2	89.8	217.9	243.8	34.5	21.2	41.3	111.6	68.6	45.8	20.3
PSMB2	HC7-I	ENSG00000126067	"Proteasome 20S subunit beta 2"	P49721	1	35599541-35641526	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		9700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.4	29.3	10.0	13.9	10.3	21.7	25.0	9.7	11.6	23.6	9.4	24.3	12.9	26.9	11.5	31.8	21.9	9.1	27.3	10.6	10.4	22.6	45.9	25.6	15.8	9.9	9.7	21.0	25.2	11.3	19.6	15.2	11.0	20.0	12.7	12.1	22.3	10.8	63.1	30.9	23.2	13.4	9.9	25.4	24.2	15.6	9.5	20.5	18.7	14.8	16.7	22.9	23.9	11.8	68.8	42.4	45.5	32.2	23.3	27.9	55.5	31.8	36.6	63.2	51.1	51.6	79.3	68.8	71.3	37.6	38.6	41.2	59.3	53.4	54.5	54.5	54.1	63.4	44.5	50.1	41.4	66.1	34.7	30.4	33.4	77.0	36.8	25.9	50.8	54.1	76.6	37.7	41.9	30.7	85.5	50.1	59.3	29.7	44.0	52.3	47.5	48.7	45.3	35.9	39.8	30.1	36.0	34.5	52.1	50.3	24.9	29.3	35.2	32.0	37.5	30.9	76.5	31.8	55.0	66.9	49.9	70.4	55.6	20.5	23.6	18.2	19.6	30.3	19.9	22.3	19.3	20.6	26.4	18.5	14.0	17.3	8.8	23.6	35.4	27.4	26.3	26.1	10.0	10.3	9.7	11.6	10.6	10.4	9.9	9.7	11.0	9.9	9.5	11.8	110.8	64.1	68.9	6.2	80.4	111.1	145.2	298.5	50.7	48.0	65.8	95.1	59.8	67.2	145.0	66.2	16.7	406.6	83.6	72.4	144.8	286.2	118.0	95.4	78.8	115.9	98.3	78.7	20.8	227.3	341.0	101.3	61.2	75.9	35.4	109.6	85.6	158.1	222.6	58.9	20.9	96.9	187.2	92.7	70.3	22.8	100.6	94.1	76.5	15.9	184.1	68.4	87.6	17.1	23.4	252.0	76.6	91.4	141.7	186.0	108.5	221.7	126.8	50.4	92.1	66.8	291.4	224.4	144.0	80.4	111.5	442.1	81.4	123.9	111.7	178.9
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256527-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 308.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 593.2;Late spermatids: 549.5;Syncytiotrophoblasts: 469.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000872, HPA016885"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705, HPA016885: "	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	76.7	61.3	47.6	48.0	50.3	86.3	64.9	50.8	63.3	51.7	47.6	72.4	35.7	67.3	71.6	71.5	53.4	37.5	114.9	49.5	53.6	62.2	83.3	55.0	49.5	50.5	51.3	45.6	52.7	69.3	37.0	69.6	53.0	49.7	60.4	40.1	55.3	57.5	308.0	74.1	54.5	61.5	49.4	57.5	61.1	82.2	50.3	62.5	48.1	142.5	72.2	64.7	54.1	50.8	141.6	131.1	147.5	154.8	126.6	115.4	154.9	133.5	185.7	287.9	215.4	122.3	154.7	119.4	198.4	162.3	132.2	142.8	182.2	155.8	334.2	143.9	80.0	93.8	84.6	105.9	109.1	143.7	120.4	104.3	120.7	187.9	137.1	120.2	176.2	130.3	134.8	69.9	200.6	267.9	108.0	186.7	130.6	180.7	160.4	127.5	190.8	97.6	163.0	144.6	154.6	103.2	109.0	279.6	118.0	121.8	175.9	125.2	134.9	110.1	98.8	119.6	196.3	120.0	204.3	178.3	159.8	129.1	172.1	95.1	101.4	160.1	67.1	93.7	66.4	57.7	68.5	69.0	101.1	56.8	62.5	60.7	109.9	82.0	110.7	70.8	101.2	116.5	47.6	50.3	50.8	63.3	49.5	53.6	50.5	51.3	53.0	49.4	50.3	50.8	63.1	102.5	80.4	11.4	51.4	65.0	90.3	175.3	30.1	51.3	48.6	45.7	39.2	88.6	136.0	55.2	52.1	304.2	48.2	91.2	119.3	180.8	593.2	68.9	56.1	90.1	57.0	80.6	21.0	197.7	178.9	71.4	30.1	70.1	98.2	82.4	75.7	196.6	150.2	79.1	21.2	68.7	111.9	91.8	82.2	549.5	76.4	74.7	67.6	14.0	146.0	88.1	72.1	10.6	22.3	210.3	71.5	82.0	50.7	75.5	104.2	160.4	123.9	65.8	85.5	67.5	139.5	198.1	48.7	44.1	50.2	469.4	55.4	82.5	74.4	92.7
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980807-39997959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 252.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 247.0;Syncytiotrophoblasts: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 842.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: AB_2680579"	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	56.5	64.2	44.5	47.6	45.4	48.1	53.6	44.1	50.0	54.6	40.7	60.3	43.3	61.8	35.0	69.6	51.6	25.3	76.5	47.4	47.0	47.8	93.6	51.0	45.7	45.9	43.0	52.7	57.1	55.4	48.3	47.4	48.0	47.7	46.1	31.3	54.2	37.2	252.5	86.1	48.9	45.2	42.9	49.3	52.7	52.9	44.2	56.9	45.9	103.3	51.1	53.6	53.2	46.6	203.7	247.8	133.2	192.9	106.3	68.2	158.3	146.2	150.7	257.3	198.3	206.4	170.0	242.3	357.7	157.6	172.5	310.2	238.6	190.7	172.9	245.5	266.2	140.4	120.5	207.2	96.5	191.3	151.0	91.5	160.0	272.7	118.8	86.4	147.6	166.0	291.5	146.9	121.2	148.0	298.2	131.2	185.5	130.9	145.2	216.2	184.7	227.7	130.5	135.3	174.9	132.5	139.7	842.6	124.3	160.9	190.2	162.7	132.9	110.7	195.8	165.6	266.2	158.2	217.2	269.3	169.4	142.2	182.6	8.1	22.4	19.0	17.6	21.3	17.2	16.6	17.0	20.4	29.8	17.7	15.3	19.1	6.3	16.6	18.3	20.4	16.3	17.9	44.5	45.4	44.1	50.0	47.4	47.0	45.9	43.0	48.0	42.9	44.2	46.6	32.4	44.8	40.1	16.6	43.3	46.7	57.2	71.5	33.0	70.8	31.7	25.7	21.3	15.7	48.6	16.5	20.9	165.3	38.0	98.3	46.9	101.4	247.0	30.7	35.9	46.5	26.4	44.6	18.0	106.3	131.6	50.6	34.7	28.5	25.3	70.2	32.2	50.9	96.3	60.6	17.6	59.2	69.2	27.4	37.0	51.8	62.7	39.1	65.8	4.7	57.4	89.9	35.0	11.1	16.5	101.4	68.3	54.2	57.2	76.3	75.3	54.8	32.0	56.9	26.3	51.1	50.7	87.3	54.0	38.7	44.6	271.7	32.4	78.8	77.2	53.7
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254709-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	108.8	118.0	198.8	77.8	203.8	89.4	97.9	203.0	288.1	88.7	195.2	136.9	68.9	99.5	114.3	115.5	91.0	58.2	191.2	202.8	205.8	110.2	170.5	81.7	95.7	208.5	215.3	85.8	114.0	91.6	79.4	91.1	209.3	91.3	82.1	64.5	83.9	86.4	404.1	103.3	91.3	91.0	204.2	109.6	115.4	152.0	203.7	114.3	76.7	188.0	114.0	118.6	88.2	203.4	251.4	294.8	213.4	175.2	227.4	167.0	231.9	166.0	202.1	258.6	205.1	388.3	278.2	202.2	396.2	235.4	178.7	255.4	277.1	250.6	219.6	331.9	236.6	197.8	256.2	396.6	250.8	234.7	220.5	182.5	204.2	296.3	271.4	193.3	229.5	222.4	313.6	247.9	220.2	723.5	217.4	276.7	406.0	384.3	293.4	181.6	207.7	364.7	252.7	210.6	166.7	283.8	184.5	266.3	222.7	313.0	278.9	452.3	203.4	128.1	201.2	159.2	288.2	295.1	397.7	430.3	212.6	218.1	238.7	439.4	439.0	713.9	247.3	478.1	281.2	399.0	287.4	274.4	398.4	426.1	261.0	258.1	580.2	351.2	502.3	240.3	476.6	651.0	198.8	203.8	203.0	288.1	202.8	205.8	208.5	215.3	209.3	204.2	203.7	203.4	90.1	57.7	62.9	15.7	78.5	88.6	111.9	249.0	58.1	50.9	60.9	69.3	245.2	82.9	125.0	60.7	27.1	328.6	74.0	104.1	168.3	177.3	279.1	91.5	63.0	95.8	84.2	107.3	25.3	186.9	234.1	88.5	46.9	59.1	83.6	88.8	83.2	116.0	184.5	33.7	24.2	94.1	156.6	104.0	98.0	243.2	105.3	90.3	104.9	11.2	256.6	91.9	115.4	16.1	23.2	172.2	129.1	98.6	67.0	121.4	168.6	206.6	148.3	54.6	118.3	79.0	221.1	234.8	83.5	66.7	86.5	414.6	77.7	105.6	114.5	107.2
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296814-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 596.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	68.9	78.8	51.6	52.1	52.9	126.7	57.5	54.5	69.3	50.1	50.9	75.8	47.3	59.5	59.3	85.8	44.0	41.2	124.8	53.0	54.2	57.3	75.1	52.6	62.3	54.3	54.1	37.8	49.0	49.0	41.7	70.2	55.6	68.3	65.4	47.3	59.7	59.2	265.8	85.5	55.6	62.4	54.3	56.5	58.0	42.0	55.0	71.9	42.0	159.5	71.2	73.1	62.2	56.7	140.1	226.2	170.6	89.0	120.1	122.1	209.8	191.6	166.2	236.2	212.7	301.9	189.8	190.1	207.7	156.7	103.2	176.3	135.0	175.1	215.4	113.3	146.3	147.2	169.1	235.9	156.0	241.3	241.3	112.4	176.3	213.4	213.0	106.0	207.0	119.2	222.2	82.1	153.5	345.4	147.0	232.1	184.9	145.0	113.8	198.8	106.9	251.6	125.1	207.3	106.9	119.3	185.7	70.4	114.9	130.5	148.7	166.6	187.5	137.5	116.0	152.5	146.5	174.6	241.4	560.2	186.6	174.1	145.2	152.4	163.6	193.4	133.2	176.2	130.5	149.7	131.8	141.2	201.9	110.5	126.6	131.2	98.7	139.5	187.4	172.2	168.2	187.8	51.6	52.9	54.5	69.3	53.0	54.2	54.3	54.1	55.6	54.3	55.0	56.7	74.4	67.3	59.4	16.6	84.2	104.4	183.5	167.8	64.3	59.6	47.0	47.5	53.3	57.2	114.9	46.0	8.4	337.1	69.5	120.4	80.3	158.5	153.8	76.3	80.6	96.2	85.5	121.0	22.7	190.9	229.8	87.7	67.8	80.3	103.9	76.7	66.0	147.6	188.5	57.2	21.3	100.1	122.1	75.1	91.2	25.3	56.5	95.1	99.6	9.4	119.5	86.0	81.4	15.6	25.7	164.0	104.1	65.5	121.4	259.6	93.9	109.4	88.1	59.9	92.1	68.4	186.1	184.2	88.7	103.6	129.3	596.1	86.2	114.0	110.3	197.8
PSME3	"Ki, PA28-gamma, PA28G, REG-GAMMA"	ENSG00000131467	"Proteasome activator subunit 3"	P61289	17	42824385-42843760	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 253.8;Late spermatids: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008388, HPA012510"	Supported		Enhanced	Nucleoplasm		NA	NA		460000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB008388: AB_592552, HPA012510: AB_1855752"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (6.02e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	46.9	45.2	27.9	43.4	29.1	51.7	40.3	27.9	32.1	32.6	27.0	43.6	38.0	39.8	28.1	67.3	33.8	29.3	52.0	30.2	29.7	49.7	41.8	36.2	49.2	28.2	35.0	25.4	43.8	49.9	25.2	36.2	29.2	31.2	45.3	34.6	42.1	35.7	80.8	50.7	39.6	41.6	27.9	37.5	46.7	46.4	30.6	43.1	39.5	50.1	57.8	61.9	39.0	26.7	153.1	211.4	124.3	125.3	97.6	101.7	158.6	199.6	134.3	238.7	168.6	180.7	116.5	224.8	137.0	155.3	134.9	142.1	186.2	180.9	268.2	114.6	159.0	131.1	114.8	151.1	111.0	306.1	139.6	97.4	116.1	187.5	175.8	66.3	140.4	123.8	220.7	75.3	154.4	75.8	268.0	101.1	166.0	227.8	114.1	171.4	228.0	173.8	115.4	217.8	140.4	139.5	113.5	92.2	140.6	174.1	193.2	111.0	131.2	187.0	132.9	156.0	259.8	119.7	217.5	316.3	133.6	156.9	181.9	52.0	78.1	73.6	55.2	86.6	59.6	51.4	44.2	54.4	75.7	49.4	41.5	47.6	101.5	66.3	74.9	41.6	59.4	87.5	27.9	29.1	27.9	32.1	30.2	29.7	28.2	35.0	29.2	27.9	30.6	26.7	15.1	19.2	19.3	5.9	29.2	30.2	38.1	34.6	35.3	13.2	26.9	18.4	35.1	22.8	28.2	29.5	14.6	43.6	21.2	31.1	27.4	58.7	253.8	24.4	24.5	21.1	24.7	30.3	10.5	52.9	71.4	21.6	31.6	31.1	22.2	19.2	18.9	28.0	49.5	13.5	10.6	25.2	44.7	30.8	21.3	143.8	15.5	29.6	16.0	4.7	42.6	17.0	24.7	11.1	7.3	63.6	26.8	19.9	38.5	58.8	28.5	43.3	23.9	18.5	19.7	17.7	35.9	43.8	41.5	49.0	47.2	76.2	22.6	25.3	30.7	52.7
PSMF1	PI31	ENSG00000125818	"Proteasome inhibitor subunit 1"	Q92530	20	1113240-1189415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 1242.7;Late spermatids: 4603.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041122, HPA041300"	Approved		Enhanced	Cytosol		NA	NA		160000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041122: AB_10805838, HPA041300: AB_10794370"	"unprognostic (1.79e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.03e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.32e-2)"	49.7	37.8	32.8	41.8	33.8	53.7	43.4	33.5	35.7	44.3	33.2	46.0	44.2	42.5	27.8	47.7	37.8	26.8	52.0	31.5	33.0	42.4	72.6	43.4	40.9	35.7	33.2	43.8	56.8	43.1	35.2	26.3	34.2	33.3	31.7	32.9	38.8	32.5	128.3	47.2	42.9	36.9	32.8	38.3	44.0	107.6	36.7	41.2	37.7	83.6	39.9	42.3	39.1	35.5	141.5	126.4	29.7	70.3	63.8	66.5	50.8	83.8	64.9	76.1	67.2	118.2	96.4	71.2	56.1	90.3	79.3	123.8	78.9	143.3	95.1	42.3	47.0	99.1	20.8	217.0	83.7	120.6	33.2	67.9	82.3	85.3	132.7	45.9	83.2	55.3	101.5	138.8	62.9	75.4	156.3	107.9	42.6	81.4	79.2	74.5	62.2	118.6	67.7	117.9	75.4	52.4	92.3	159.1	77.3	28.5	108.8	43.3	96.8	95.3	63.8	111.3	115.6	85.9	185.5	77.5	41.8	81.3	74.7	123.8	65.2	123.3	49.8	80.2	57.8	73.2	66.2	54.4	66.3	69.0	59.7	52.8	71.7	58.5	83.0	37.8	81.6	69.4	32.8	33.8	33.5	35.7	31.5	33.0	35.7	33.2	34.2	32.8	36.7	35.5	48.7	35.3	44.2	34.0	58.3	41.2	59.1	81.0	33.0	32.7	40.5	41.5	55.4	31.5	44.8	40.5	4.2	68.0	48.8	51.9	82.2	102.5	1242.7	27.3	38.4	47.4	67.4	190.1	25.2	103.8	88.9	50.2	48.4	28.1	49.5	46.5	50.0	70.0	100.3	21.9	25.4	57.9	34.6	56.3	56.7	4603.4	77.3	58.2	51.6	34.7	76.1	64.3	55.6	22.1	38.1	99.4	75.3	88.8	66.8	69.0	103.3	80.7	32.4	33.1	118.3	36.7	65.0	97.4	90.7	52.1	48.6	74.0	55.0	73.0	62.6	68.8
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183488	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 673.8;Spermatocytes: 544.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.5	9.8	4.0	9.1	4.0	17.3	6.8	2.7	5.5	7.3	2.5	10.5	8.9	7.8	4.8	11.8	6.4	5.4	8.3	4.6	3.8	9.7	15.9	5.7	8.9	2.2	2.4	7.2	10.8	5.1	8.0	7.7	3.2	5.5	9.9	4.9	7.3	3.2	13.8	7.1	8.2	5.1	2.1	6.3	7.1	40.3	3.7	6.3	10.8	5.6	6.2	7.8	7.4	4.0	104.0	34.7	23.5	32.9	12.3	15.1	65.0	55.3	25.9	44.8	28.2	66.6	26.9	113.7	28.9	17.1	38.1	28.5	40.3	30.3	30.2	48.9	61.6	209.6	52.4	83.6	21.9	101.0	40.4	18.9	24.6	46.2	46.5	9.8	24.9	47.0	160.4	61.9	27.2	58.2	63.0	54.7	82.2	38.9	53.5	99.6	29.8	115.8	19.1	30.4	77.6	22.7	70.4	39.1	57.4	4.0	36.6	51.4	26.7	50.1	16.8	66.7	79.9	46.4	79.3	96.8	42.0	170.4	38.6	10.6	6.8	3.9	10.5	9.0	12.3	12.0	14.7	12.4	12.2	10.6	11.5	10.3	0.6	7.5	9.1	11.3	13.7	7.9	4.0	4.0	2.7	5.5	4.6	3.8	2.2	2.4	3.2	2.1	3.7	4.0	23.7	6.4	17.6	5.2	17.8	136.0	44.1	68.6	43.9	14.2	31.3	39.0	24.8	22.8	39.9	20.2	4.2	108.9	12.6	14.7	66.5	50.8	673.8	20.8	36.5	26.3	29.9	63.3	7.5	49.7	118.6	31.8	18.8	21.6	36.1	26.2	18.9	32.7	59.5	8.4	8.0	45.7	69.2	17.7	35.5	88.4	31.7	25.0	46.2	3.7	24.4	18.0	12.3	3.5	5.9	32.4	20.0	33.1	31.7	41.5	30.6	89.4	20.8	19.7	26.3	29.5	31.3	544.1	98.7	51.7	97.7	54.5	20.1	54.7	56.9	27.9
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 173.4;Inhibitory neurons: 164.7;Spermatocytes: 171.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.9	13.0	11.5	13.2	11.5	53.7	16.2	12.8	13.9	12.5	9.9	14.9	12.4	14.8	21.7	14.0	16.2	12.1	11.1	11.8	10.6	12.2	8.9	9.9	20.8	12.1	9.0	13.7	9.5	9.5	10.3	13.8	10.6	11.0	15.5	17.4	10.0	8.3	20.9	14.4	12.4	12.6	8.7	11.1	12.0	25.0	10.5	23.1	12.2	12.7	21.9	20.4	10.0	15.8	50.5	20.4	46.6	23.3	18.9	19.8	60.3	26.1	34.0	48.3	43.6	68.4	27.8	67.8	27.7	27.9	25.4	24.6	54.7	32.2	50.0	28.9	27.3	76.4	14.1	83.1	37.4	55.3	46.7	31.6	6.5	29.8	32.9	19.2	41.7	65.9	42.8	26.1	43.2	54.1	65.5	52.8	65.5	27.3	28.0	43.7	46.8	34.6	50.8	74.6	42.7	22.0	35.8	59.1	23.1	44.9	34.5	56.6	25.1	28.9	27.7	28.0	25.4	22.5	14.5	115.1	13.2	32.7	35.2	14.8	21.3	14.5	11.8	22.7	12.0	23.3	15.1	11.0	19.1	22.5	15.4	11.2	16.9	11.9	18.1	20.9	21.8	15.7	11.5	11.5	12.8	13.9	11.8	10.6	12.1	9.0	10.6	8.7	10.5	15.8	21.0	19.2	29.5	79.3	36.4	33.3	24.9	16.4	23.3	43.2	24.6	21.0	28.6	21.5	18.9	16.5	58.4	70.0	41.0	16.4	21.5	31.3	17.4	40.0	33.9	24.0	25.2	23.1	173.4	34.1	104.7	25.1	25.5	39.4	9.5	28.0	23.9	11.1	27.2	30.3	164.7	20.0	12.2	25.7	25.3	21.4	31.4	27.7	19.6	92.8	45.2	25.5	27.8	115.6	156.4	26.8	22.2	26.7	31.8	16.5	16.1	23.8	25.9	69.1	32.9	27.2	27.4	171.5	75.4	24.0	34.1	80.4	38.9	48.1	27.2	26.2
PTCD3	"DKFZp666K071, FLJ20758"	ENSG00000132300	"Pentatricopeptide repeat domain 3"	Q96EY7	2	86106223-86142157	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041154, HPA041382"	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA041154: AB_10795488, HPA041382: AB_10795695"	"unprognostic (1.16e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.77e-4)"	"unprognostic (3.69e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (6.86e-4)"	10.0	15.8	13.1	7.6	14.2	14.7	9.9	15.2	15.9	11.6	16.3	12.6	10.1	11.7	10.2	10.7	11.7	6.4	26.2	13.3	14.5	12.4	16.5	9.6	11.8	13.6	14.0	15.1	10.7	13.1	14.8	9.2	14.7	10.4	13.5	13.2	9.8	7.5	32.8	10.3	11.9	9.0	13.7	12.0	11.8	16.6	13.5	10.5	12.0	36.3	11.1	10.3	10.7	16.7	16.2	37.6	22.0	18.5	16.1	16.6	26.2	32.6	13.8	18.0	18.0	69.9	15.1	39.7	11.8	17.1	18.6	28.9	44.7	17.7	22.9	17.8	37.0	31.8	23.0	59.2	16.3	26.0	23.1	19.8	12.8	13.7	24.4	18.8	15.7	28.6	33.5	14.8	16.0	15.0	21.7	31.0	20.2	31.5	23.9	28.8	30.9	30.6	24.6	31.7	23.9	14.7	15.2	25.0	30.4	20.6	13.2	15.7	11.3	14.2	15.1	14.6	19.2	33.7	47.6	31.6	13.8	29.4	11.1	4.4	9.6	7.6	12.4	7.0	14.6	15.3	11.2	13.2	10.6	16.4	15.1	11.3	0.3	14.3	14.1	10.7	13.9	8.8	13.1	14.2	15.2	15.9	13.3	14.5	13.6	14.0	14.7	13.7	13.5	16.7	17.1	57.7	33.5	50.3	31.0	26.0	26.3	27.7	34.7	61.7	19.2	16.8	105.7	18.6	37.4	23.9	66.7	53.0	30.6	21.7	25.4	18.8	34.8	27.5	33.3	23.5	31.1	39.5	52.9	11.9	27.0	30.5	30.1	24.2	33.6	47.5	21.4	41.7	21.7	37.0	53.1	25.3	20.3	19.6	13.3	22.4	27.1	17.7	8.8	21.5	22.7	49.8	28.8	48.7	53.4	15.0	19.2	19.5	26.4	23.7	23.2	30.1	26.2	65.3	13.1	36.3	21.3	98.3	62.4	28.7	24.7	36.7	31.8	47.9	38.5	20.4
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713551	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	1203.7	522.8	832.1	1028.5	1020.8	2322.6	1026.6	865.2	1035.4	1185.1	644.5	1045.1	703.0	1110.9	698.4	1186.1	1022.9	565.9	541.0	779.9	898.4	1203.7	652.1	933.2	1396.2	952.9	933.7	1078.5	1090.3	481.3	398.6	688.1	919.2	722.6	985.0	437.1	765.6	604.7	305.9	1425.4	935.1	699.4	875.4	896.2	873.2	237.1	929.1	2059.3	1002.8	246.4	1523.2	896.5	999.1	1137.2	2436.8	1416.4	1990.8	1788.7	592.5	783.4	2037.5	1614.2	1346.2	1379.8	1436.6	1380.8	2759.6	3811.5	1795.4	1271.0	948.1	1252.2	2830.6	1992.5	1738.6	3027.0	2228.9	4906.7	1096.2	2266.8	732.6	5621.1	2018.0	1143.7	733.1	1226.2	1002.6	1307.0	2286.8	3049.7	2910.9	1573.5	1222.0	3433.7	7998.5	7671.0	3004.9	2381.4	1180.4	5426.1	1408.4	2601.9	1719.2	2116.3	4041.8	2483.3	1851.0	1833.5	1507.1	1552.9	1383.9	4430.2	1704.1	1154.2	2052.5	1429.4	1769.7	1887.9	999.3	7614.4	790.8	3401.9	1897.3	2067.1	1713.8	1146.7	1346.2	1695.8	1945.2	2776.6	1928.5	1640.8	1828.0	2438.2	2109.4	1808.0	321.7	1782.3	1957.1	1944.4	2506.6	4661.6	832.1	1020.8	865.2	1035.4	779.9	898.4	952.9	933.7	919.2	875.4	929.1	1137.2	3907.5	971.2	1529.2	49.6	4518.0	7745.0	3851.3	5347.3	5459.5	703.1	3534.0	3673.7	259.7	1974.5	2483.8	2273.2	294.0	2599.4	4054.7	1741.3	3785.9	3474.2	103.3	2713.9	3364.3	4186.4	1695.3	3942.3	37.4	4190.1	5153.9	2404.0	2340.5	3092.6	2928.1	2349.3	1940.1	1347.6	3134.5	812.6	40.9	3178.6	3733.2	3492.4	8474.1	201.4	1306.3	3470.5	3689.1	78.7	3334.5	2195.9	2988.7	40.7	282.0	3669.3	2492.8	1404.5	3523.3	4524.2	1624.2	3136.2	1925.7	934.2	1926.2	2766.5	4571.8	1157.6	2467.8	5778.6	7944.4	2734.1	4276.7	1312.4	3381.3	4052.2
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	47.2	118.0	157.8	56.2	154.0	52.9	60.9	136.2	185.0	73.5	124.6	105.2	49.6	87.4	55.8	116.8	77.3	49.3	176.7	158.5	141.6	125.5	154.2	72.6	49.9	151.3	148.8	63.8	70.4	146.7	73.1	49.8	147.6	119.0	51.3	43.4	97.1	86.8	340.8	73.7	57.1	92.1	143.2	82.8	83.5	124.5	162.7	59.1	75.3	206.2	54.9	71.1	62.2	148.5	108.9	183.9	111.0	219.9	74.4	94.5	118.3	115.5	120.2	144.8	100.1	103.4	135.4	113.9	83.3	187.3	173.1	184.1	110.9	138.2	100.6	198.6	68.1	64.6	193.6	101.7	229.1	113.1	147.2	114.6	133.1	109.8	101.8	230.9	146.5	120.3	102.0	124.7	117.1	293.8	103.0	76.6	186.8	301.0	193.0	108.3	93.7	216.2	159.0	119.8	120.6	86.9	220.4	237.3	147.3	99.4	253.4	55.0	101.7	127.6	113.8	129.9	165.2	114.9	284.1	96.8	153.2	79.1	180.7	7.6	19.2	9.8	20.8	18.4	19.9	10.8	15.8	18.5	23.0	13.4	13.8	13.9	6.1	20.4	18.3	16.4	16.9	20.4	157.8	154.0	136.2	185.0	158.5	141.6	151.3	148.8	147.6	143.2	162.7	148.5	19.8	3.2	8.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	51.9	38.6	0.0	0.0	3.1	53.3	0.0	49.5	9.2	0.0	54.8	70.3	0.0	33.7	21.8	19.0	0.0	0.0	0.0	62.3	44.2	12.2	0.0	32.9	8.8	24.8	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.9	0.0	0.0	41.9	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	37.9	4.0	31.8	0.0	0.0
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.1;Oligodendrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	3.7	5.7	7.8	2.2	14.1	0.7	3.1	9.7	12.4	3.1	2.5	4.3	1.4	3.1	2.2	2.0	3.3	2.2	7.0	8.0	8.9	3.3	1.5	4.4	1.9	10.9	11.5	3.0	5.9	3.6	6.7	1.7	10.8	3.2	2.8	4.4	2.9	2.0	4.8	3.1	2.3	4.1	6.7	1.8	4.3	7.8	10.2	1.8	3.3	6.7	1.9	2.5	2.7	18.3	6.1	2.7	4.7	6.1	5.8	7.9	6.2	4.4	3.0	4.4	3.7	2.6	5.0	5.1	2.9	3.4	10.1	4.7	4.9	2.8	4.3	6.8	1.3	1.2	7.7	2.8	7.4	1.4	3.8	7.9	10.0	6.7	9.2	2.6	4.7	8.3	3.0	0.0	8.4	3.3	5.2	2.2	3.3	5.0	4.8	5.6	9.3	0.0	2.4	1.5	4.1	5.1	6.1	5.7	9.5	6.2	3.1	2.5	6.7	5.8	3.5	9.1	5.4	7.2	8.4	0.7	4.3	2.5	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	14.1	9.7	12.4	8.0	8.9	10.9	11.5	10.8	6.7	10.2	18.3	5.7	0.0	7.7	19.2	4.7	4.8	3.0	2.2	5.7	10.7	2.3	3.3	11.3	5.7	1.4	5.5	10.4	0.4	2.6	2.1	3.9	3.1	11.7	2.3	7.3	5.8	3.5	0.8	36.1	2.9	2.0	8.1	14.3	3.1	5.7	6.7	4.2	1.0	3.1	5.0	27.0	2.6	4.1	1.0	4.6	6.2	3.7	3.6	3.6	14.0	0.5	2.2	0.0	18.6	82.6	6.1	2.9	14.3	2.0	1.4	1.1	1.7	2.1	9.8	19.7	7.4	5.5	21.0	20.8	4.7	4.3	0.3	4.0	2.3	2.3	1.8
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 235.1;Late spermatids: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	38.8	56.5	15.0	5.3	16.1	9.0	37.4	15.8	17.4	31.1	16.6	31.0	7.6	32.8	7.8	34.8	29.5	4.2	27.7	14.4	16.5	37.6	40.6	36.5	6.1	15.6	16.3	28.0	44.7	9.6	41.9	6.7	15.8	32.7	3.9	4.2	37.1	5.9	41.0	28.1	23.4	4.7	16.0	28.9	39.2	105.4	17.0	4.3	30.6	5.8	4.9	27.5	28.1	16.0	34.5	19.4	2.3	17.8	17.5	11.4	7.0	20.1	17.1	19.4	16.8	27.9	17.6	27.9	22.1	14.7	16.8	30.6	16.9	20.4	16.6	31.4	57.3	12.9	43.8	43.4	25.7	25.2	17.1	12.7	21.9	8.8	24.0	11.2	13.7	26.2	32.6	19.5	14.2	65.4	21.4	41.0	18.8	3.9	37.7	38.6	16.7	22.3	22.5	23.3	15.5	21.4	33.8	11.1	23.2	7.2	53.1	32.7	16.6	13.6	23.3	28.6	33.1	27.1	22.6	18.6	13.6	23.3	10.0	11.2	38.0	38.2	24.8	36.8	23.0	33.7	22.7	26.2	44.9	30.3	22.3	21.0	3.1	26.1	34.6	64.6	28.5	28.8	15.0	16.1	15.8	17.4	14.4	16.5	15.6	16.3	15.8	16.0	17.0	16.0	26.8	22.4	35.0	14.4	31.8	17.8	15.8	58.5	34.1	14.4	64.9	78.4	5.8	45.8	38.6	40.5	4.2	72.2	34.7	19.9	72.4	95.3	235.1	48.0	23.9	24.6	31.3	30.1	8.2	85.8	66.3	23.9	28.1	25.6	17.1	16.5	29.6	39.8	62.4	5.0	10.8	45.7	48.8	32.6	21.2	640.8	46.6	45.6	46.2	6.5	56.2	74.9	41.2	9.5	14.6	106.2	38.8	46.6	61.0	26.0	37.9	72.8	57.2	15.7	19.7	17.3	28.1	179.8	28.6	55.0	17.3	76.8	25.9	21.3	62.7	22.0
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;monocytes: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	26.3	30.8	13.0	44.5	14.0	55.4	22.1	12.3	14.7	23.2	28.6	24.8	13.9	23.0	18.7	29.6	22.0	23.1	31.9	17.5	13.0	46.7	21.0	55.2	52.9	16.1	14.4	25.6	15.9	48.3	19.7	34.2	13.7	25.0	18.8	9.9	18.9	18.2	35.4	23.9	28.3	21.9	13.7	46.5	21.0	18.3	14.2	35.5	18.7	21.6	52.6	35.8	23.5	14.1	66.1	32.4	38.4	26.6	24.6	33.6	54.5	43.2	40.8	123.8	44.9	96.1	134.3	32.5	74.8	40.0	48.7	56.9	30.8	123.8	78.2	48.5	27.6	45.9	30.9	51.3	49.0	48.2	60.2	39.6	84.9	55.9	68.2	54.3	72.3	38.5	81.5	28.9	68.3	36.5	52.1	38.1	20.4	36.2	44.2	45.6	44.6	31.1	71.2	48.4	30.8	35.3	62.0	77.6	71.3	32.1	50.4	50.9	108.2	107.3	43.1	48.8	54.2	31.4	27.3	38.9	67.1	32.3	40.6	19.8	7.1	25.2	12.9	12.1	9.5	19.2	10.8	10.0	7.1	17.4	8.9	9.8	15.4	5.3	22.8	11.8	9.4	8.7	13.0	14.0	12.3	14.7	17.5	13.0	16.1	14.4	13.7	13.7	14.2	14.1	34.0	227.6	83.6	22.9	147.8	86.0	61.7	37.1	56.3	25.1	23.9	24.4	30.0	11.5	40.0	36.8	47.9	54.0	68.7	26.1	23.5	26.2	67.7	45.0	44.0	36.3	18.6	32.0	61.6	19.3	20.9	52.1	32.1	65.9	70.8	14.2	41.4	20.8	37.4	43.7	43.3	16.4	20.3	40.6	169.5	37.4	14.0	100.7	37.4	32.8	207.8	12.1	38.1	27.6	42.1	41.7	14.5	12.0	178.7	26.6	8.9	65.2	30.2	27.5	19.7	55.5	57.7	20.8	24.5	48.7	47.2	54.3	83.8	44.3	14.6	53.5
PUF60	"FIR, RoBPI, SIAHBP1"	ENSG00000179950	"Poly(U) binding splicing factor 60"	Q9UHX1	8	143816344-143829352	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 332.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045733, HPA052096, HPA059714"	Enhanced		Enhanced	Nucleoplasm		NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110"	"unprognostic (3.49e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-2)"	71.6	73.5	7.9	11.0	7.6	39.6	75.5	8.1	22.9	71.4	5.3	84.8	22.3	84.9	5.9	84.9	76.3	7.3	88.5	7.8	15.4	82.8	124.3	64.0	17.7	12.2	11.6	57.2	62.9	11.7	71.0	19.2	14.1	67.2	5.8	1.3	63.3	17.8	125.5	108.7	69.5	10.5	7.3	72.3	73.2	70.8	14.5	15.9	59.8	9.0	9.7	74.5	68.6	12.4	95.7	211.5	36.7	31.3	16.6	15.6	62.7	74.4	27.4	70.3	75.1	95.4	103.9	89.4	71.2	58.9	52.8	83.0	86.5	91.4	3.6	91.4	147.7	110.2	117.0	106.3	60.4	38.5	70.0	45.4	61.8	89.8	26.9	21.1	69.0	92.1	88.7	37.4	20.5	332.5	156.1	26.4	77.8	63.3	191.6	84.2	42.9	91.8	19.5	91.8	71.5	80.3	101.6	40.4	77.7	9.1	116.7	21.4	79.0	72.9	176.2	85.7	98.6	66.7	103.9	109.7	70.7	73.3	71.9	90.8	112.6	99.8	129.0	133.7	139.3	116.8	103.1	128.6	127.1	135.9	98.6	113.1	58.8	132.6	137.6	76.8	139.0	193.9	7.9	7.6	8.1	22.9	7.8	15.4	12.2	11.6	14.1	7.3	14.5	12.4	70.2	38.5	46.4	21.5	64.7	107.7	102.1	197.4	65.4	62.8	51.3	67.9	63.7	51.5	103.0	29.5	29.2	146.6	56.4	98.0	92.0	110.7	20.5	65.6	55.3	67.3	66.9	65.0	8.2	89.8	134.3	68.4	74.9	60.3	55.8	75.0	41.7	76.8	101.1	43.7	8.3	75.9	118.0	44.0	62.3	47.8	64.0	52.3	90.7	6.5	105.2	182.6	81.4	9.5	23.7	98.2	91.4	59.0	52.7	83.0	91.9	118.1	85.4	64.8	65.7	57.1	122.9	104.2	128.5	63.1	107.1	173.3	74.2	99.3	97.7	81.2
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	27.8	26.0	33.4	22.5	34.3	52.0	31.9	37.5	37.8	28.0	28.5	26.7	22.5	32.2	29.3	25.7	35.0	22.7	28.6	33.7	42.5	28.7	25.9	25.6	26.2	27.0	30.0	40.3	27.5	39.3	19.2	32.4	28.0	27.3	29.4	38.4	30.3	28.0	46.1	32.7	22.6	31.6	27.8	25.7	26.3	18.4	45.5	35.1	34.9	38.3	26.1	27.1	26.0	31.5	33.7	43.7	70.4	44.7	54.1	46.5	48.2	39.3	47.9	40.3	45.5	46.0	56.6	39.3	40.2	53.8	25.2	48.2	58.3	43.4	51.4	33.2	50.8	42.8	50.7	56.0	37.9	52.6	39.2	50.0	53.3	53.5	56.1	52.8	55.6	36.9	60.0	36.1	46.5	28.1	51.6	37.8	72.2	42.0	30.2	53.1	48.0	42.3	58.7	50.0	58.0	44.0	54.5	41.7	47.6	77.6	42.1	39.3	58.5	33.2	29.8	44.7	39.7	28.8	28.3	42.5	29.7	38.3	43.0	44.1	31.3	24.8	31.0	30.3	31.7	23.9	27.5	30.3	32.0	21.1	31.0	32.0	19.6	37.9	34.5	18.5	35.9	31.0	33.4	34.3	37.5	37.8	33.7	42.5	27.0	30.0	28.0	27.8	45.5	31.5	66.6	73.7	58.8	85.2	56.9	90.2	53.8	41.2	56.3	54.6	63.2	58.7	80.7	61.5	46.3	36.8	79.2	52.6	66.4	56.4	23.5	44.0	32.2	139.8	98.0	61.5	104.7	34.3	87.0	36.4	42.4	56.8	55.0	154.6	18.3	105.1	43.2	61.0	34.0	33.7	87.5	65.6	24.4	78.3	49.8	21.5	72.1	50.4	17.8	102.1	56.6	41.6	69.0	111.6	101.7	58.1	45.0	80.5	41.7	84.6	28.8	49.2	42.7	59.2	32.9	81.6	65.5	36.4	24.4	62.9	93.6	78.0	50.5	63.6	75.8	95.5
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA030316: AB_10610289, HPA049670: AB_2680845"	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	27.6	29.8	29.7	33.4	31.7	33.4	41.7	42.5	32.7	36.2	32.4	36.5	34.4	36.3	32.8	39.2	29.7	27.1	33.1	31.1	30.9	36.8	43.1	33.2	48.6	26.0	29.3	44.6	27.4	41.4	8.3	40.3	26.1	37.3	37.0	66.8	33.0	33.1	21.5	47.2	35.6	32.3	29.1	42.6	35.8	24.9	31.6	70.5	57.6	32.6	47.6	38.0	18.3	37.6	72.4	50.0	65.3	46.1	40.2	40.5	65.9	49.2	53.6	48.4	42.2	43.5	33.0	96.3	11.0	44.9	58.2	38.9	61.4	35.6	71.2	87.0	38.2	105.0	35.3	62.2	43.4	107.2	93.3	29.7	79.7	42.1	77.4	45.5	53.1	57.1	75.0	82.9	57.3	35.5	93.6	65.9	55.8	68.3	31.5	80.6	110.9	73.8	45.0	68.1	55.9	76.6	42.2	58.3	48.1	43.4	33.0	61.5	52.5	58.6	58.5	38.3	64.6	93.3	123.0	181.8	35.3	75.8	51.4	11.5	4.0	5.8	6.0	5.2	7.1	4.8	6.7	7.5	4.2	5.3	7.3	6.0	11.6	7.7	7.3	3.7	5.8	3.7	29.7	31.7	42.5	32.7	31.1	30.9	26.0	29.3	26.1	29.1	31.6	37.6	43.6	35.3	51.6	89.5	57.6	79.7	32.2	26.4	74.0	94.6	46.9	30.5	46.5	32.9	33.8	47.8	62.6	36.3	43.6	44.0	11.7	16.6	10.1	33.9	35.6	45.0	34.6	41.0	134.7	15.5	16.9	36.5	43.8	45.9	20.3	53.0	41.4	56.3	29.1	58.9	153.5	43.2	38.7	70.7	44.2	5.8	34.2	44.9	32.0	144.3	42.7	26.8	43.3	155.3	186.0	22.6	28.1	26.4	54.7	57.8	33.9	29.7	39.5	72.3	32.9	40.5	47.6	16.8	16.6	75.2	106.3	52.0	50.1	31.2	40.2	56.6
PUSL1	FLJ90811	ENSG00000169972	"Pseudouridine synthase like 1"	Q8N0Z8	1	1308597-1311677	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032057, HPA039999"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA032057: AB_10601251, HPA039999: AB_2676792"	"unprognostic (2.04e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (7.55e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (1.62e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-1)"	8.1	14.0	6.9	3.3	6.5	4.5	8.7	6.3	9.1	12.7	8.2	9.1	4.5	11.0	4.0	21.0	10.6	2.6	9.8	6.7	6.1	9.4	14.4	8.3	3.9	7.9	6.2	9.1	14.9	3.3	14.9	3.2	6.7	11.7	2.0	2.0	13.7	4.3	7.9	18.1	8.9	2.6	6.2	10.2	10.8	10.9	6.2	4.2	7.5	2.3	3.5	10.4	12.3	7.6	21.9	9.8	9.7	16.6	4.6	7.4	13.1	19.4	10.7	18.8	12.6	33.9	14.1	13.3	15.4	9.6	8.0	17.8	10.8	17.8	3.3	15.1	71.0	18.5	17.7	20.5	17.4	22.2	17.1	7.2	9.2	10.4	7.9	5.1	8.6	18.3	24.1	6.0	8.8	18.2	21.1	28.9	13.2	18.4	42.6	19.2	7.3	32.0	14.8	8.3	44.3	16.2	15.3	45.1	16.1	4.5	12.7	14.6	10.2	12.1	12.5	19.9	18.8	23.4	8.1	57.4	15.0	20.0	7.4	3.7	12.5	6.2	10.2	17.5	10.3	8.5	11.1	8.6	11.7	9.2	7.2	7.3	4.9	9.0	15.9	7.3	14.4	8.4	6.9	6.5	6.3	9.1	6.7	6.1	7.9	6.2	6.7	6.2	6.2	7.6	5.7	0.0	5.3	1.0	8.9	22.0	12.0	19.9	11.4	8.1	16.3	14.0	2.5	8.6	13.5	7.3	6.2	27.0	8.4	15.0	11.7	20.9	11.5	7.7	9.3	6.6	5.3	3.4	2.4	23.1	41.9	9.3	12.2	5.2	7.0	6.3	4.6	10.5	20.9	3.3	2.4	12.5	16.2	8.8	17.4	18.2	8.7	7.4	7.2	0.0	7.7	5.9	10.3	1.5	2.2	26.1	9.9	11.3	14.2	16.8	13.4	18.9	12.0	7.9	0.0	5.2	9.3	17.1	18.5	13.4	19.2	34.5	9.7	18.3	13.2	25.6
PWWP2B	"bA432J24.1, FLJ46823, PWWP2"	ENSG00000171813	"PWWP domain containing 2B"	Q6NUJ5	10	132397168-132417859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 56.2;MCF7: 44.5;SK-BR-3: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038056, HPA038502, HPA078118"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: "	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-2)"	10.4	31.0	9.5	3.2	15.1	2.4	10.1	3.6	10.8	9.8	9.1	19.1	4.8	10.4	1.0	22.1	9.3	2.0	14.0	10.6	7.1	11.6	5.9	11.0	2.9	8.5	7.2	8.3	38.1	6.5	14.5	4.2	7.9	11.3	2.3	1.9	15.4	3.9	22.3	16.1	10.6	1.2	4.7	27.2	16.3	17.4	7.8	1.0	13.5	5.1	1.6	12.1	12.2	5.2	21.9	12.9	1.6	8.2	1.2	1.0	56.2	2.6	2.6	1.5	1.4	5.8	12.4	0.0	8.8	1.6	3.2	22.9	2.3	3.1	0.2	16.5	6.4	2.5	12.4	5.7	5.8	7.2	9.3	0.8	8.0	0.9	2.3	1.3	1.2	2.9	4.3	1.8	1.0	44.5	0.2	27.0	2.5	8.5	9.5	5.2	0.1	5.0	0.7	16.3	10.4	12.9	1.7	33.1	6.9	1.6	10.2	17.5	4.3	0.8	4.4	4.0	1.8	0.4	0.2	4.5	5.0	6.4	1.6	0.0	1.6	2.6	1.3	3.5	1.0	0.9	0.7	0.8	1.5	3.3	0.5	0.5	0.3	5.4	5.3	0.9	0.0	0.8	9.5	15.1	3.6	10.8	10.6	7.1	8.5	7.2	7.9	4.7	7.8	5.2	5.8	22.4	11.0	2.3	18.0	17.6	14.0	5.8	9.1	7.3	13.5	11.0	5.4	14.3	10.2	9.2	8.4	31.8	12.1	33.5	13.7	15.0	33.0	29.5	4.7	7.1	25.3	2.1	4.3	22.0	47.4	4.1	16.3	19.9	2.5	13.6	13.2	1.6	13.1	15.2	3.8	29.1	10.2	12.6	17.2	70.8	3.7	13.3	14.2	5.6	7.3	3.1	6.2	2.0	0.2	10.6	25.5	2.2	2.2	16.3	5.5	1.5	29.4	14.9	0.0	3.9	5.0	1.2	1.6	8.8	20.3	52.9	7.8	17.4	19.4	31.8
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	83.1	60.9	28.7	49.1	30.8	81.4	74.4	27.6	30.5	64.5	33.7	69.0	55.7	56.3	18.7	30.9	72.3	38.2	84.2	28.0	28.5	70.2	29.5	84.6	29.3	37.1	30.8	28.5	34.5	27.8	29.5	73.3	30.3	58.9	49.9	61.8	49.4	40.6	119.2	45.6	61.1	44.5	31.8	72.5	47.5	26.5	36.6	25.9	58.1	46.1	18.4	75.8	53.2	29.2	182.4	87.5	31.3	30.1	60.4	158.1	206.1	151.8	128.6	118.9	61.5	102.5	108.9	12.2	94.6	154.9	115.1	126.0	21.7	272.0	93.0	9.9	18.6	2.3	63.8	37.9	86.8	2.7	3.6	76.5	176.2	125.3	143.9	139.7	211.6	32.2	32.4	19.5	239.3	119.6	11.1	4.1	43.5	77.1	300.8	26.2	51.0	10.8	121.4	171.9	48.7	14.5	133.2	40.3	81.7	72.1	96.1	14.8	289.9	78.9	86.7	103.6	183.9	20.4	12.3	4.6	228.9	27.0	159.2	40.8	44.2	49.2	84.5	15.7	45.3	1.7	38.4	56.0	26.2	1.1	29.5	40.3	169.6	51.8	0.8	4.1	31.4	60.6	28.7	30.8	27.6	30.5	28.0	28.5	37.1	30.8	30.3	31.8	36.6	29.2	93.6	57.7	27.9	11.8	3.0	42.3	40.6	32.8	15.4	7.8	20.3	22.9	14.7	22.8	33.3	42.3	33.3	40.8	61.6	83.1	19.6	31.6	2.1	26.0	16.7	71.0	54.6	6.1	5.1	40.2	152.4	29.7	37.2	28.8	18.3	6.2	62.2	17.2	34.2	11.8	7.7	52.7	24.4	42.3	23.7	2.8	24.2	23.5	26.6	19.7	36.8	9.1	99.9	13.0	9.2	84.8	51.6	18.8	14.5	41.7	56.6	14.6	40.0	33.6	6.6	16.7	12.1	3.5	9.1	8.1	19.5	25.0	34.4	11.3	35.8	42.6
QARS1	QARS	ENSG00000172053	"Glutaminyl-tRNA synthetase 1"	P47897	3	49095932-49105130	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		58000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	61.1	58.8	20.0	57.2	21.3	96.6	89.5	23.5	18.5	58.3	34.2	104.8	101.6	45.5	58.5	102.5	71.0	48.3	72.0	18.4	21.1	57.1	51.1	52.3	75.8	23.8	21.0	69.0	73.9	78.1	33.0	76.7	23.0	60.4	121.0	21.4	103.2	61.1	156.1	105.0	84.6	60.2	22.7	60.1	75.0	30.0	23.0	92.3	53.2	146.2	118.8	72.8	58.1	24.6	95.9	97.8	128.0	197.4	146.4	180.8	159.2	90.5	188.2	160.5	152.9	123.0	113.5	257.1	61.4	136.7	95.3	119.9	166.3	137.8	111.4	78.2	148.0	206.4	156.0	216.1	91.2	187.2	130.9	184.8	123.1	127.4	108.1	175.3	184.7	144.6	95.3	112.4	118.0	89.2	130.7	154.9	116.1	159.0	122.9	76.0	123.7	200.6	108.5	163.9	48.7	161.6	85.4	211.0	147.8	122.7	184.4	205.5	137.6	82.8	127.3	131.7	117.9	111.9	176.5	142.9	88.4	156.3	60.3	30.7	84.3	25.8	44.5	104.1	57.4	62.2	54.1	47.0	127.0	49.9	46.6	49.0	8.0	71.8	94.5	57.4	82.1	81.2	20.0	21.3	23.5	18.5	18.4	21.1	23.8	21.0	23.0	22.7	23.0	24.6	15.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	0.0	0.0	0.0	0.0	193.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	156.7	14.7	0.0	0.0	0.0	0.0	0.0	0.0	96.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	187.0	2.0	0.0	0.0	0.0
QRICH1	"AB-DIP, FLJ20259, VERBRAS"	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Unfolded protein response"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	29.8	27.9	15.4	30.5	17.0	61.0	27.8	25.3	20.2	25.8	16.0	25.9	26.3	28.6	25.9	30.0	27.6	25.2	26.0	16.9	14.8	21.3	23.5	27.8	40.1	14.7	13.2	34.0	26.0	33.2	24.8	27.0	14.6	25.8	25.2	30.4	28.3	26.3	34.8	35.4	31.0	28.9	13.2	35.8	25.9	44.5	13.3	51.9	25.7	32.4	41.9	26.8	23.7	16.9	41.4	39.6	78.6	35.6	48.2	45.8	48.2	48.4	60.3	75.6	70.7	44.3	50.8	65.6	29.1	58.9	62.8	33.5	69.0	63.0	64.8	57.8	45.1	65.5	52.9	37.8	43.1	57.9	75.0	53.3	47.4	74.8	46.6	46.2	60.3	62.7	45.0	58.6	51.6	31.8	84.9	41.4	62.3	43.7	48.9	43.3	40.3	55.4	47.6	63.2	29.9	58.9	54.9	47.7	39.7	59.3	42.4	65.5	52.5	49.0	55.1	43.7	69.8	54.2	66.6	82.2	44.0	55.2	57.2	21.3	15.6	19.1	18.1	18.9	21.5	16.6	17.3	20.6	18.5	16.6	18.3	22.0	11.7	18.1	33.0	13.5	19.8	14.3	15.4	17.0	25.3	20.2	16.9	14.8	14.7	13.2	14.6	13.2	13.3	16.9	21.8	9.6	18.9	19.6	30.5	22.2	13.7	16.0	17.1	13.6	20.6	17.7	21.1	14.3	17.9	20.2	22.9	25.7	28.2	16.6	1.9	15.9	15.8	19.8	20.7	19.6	25.9	22.5	37.9	14.0	27.8	20.3	23.9	27.5	16.5	20.0	18.9	20.4	19.7	11.8	39.1	20.6	10.2	25.3	18.3	10.9	22.4	19.5	12.4	14.0	22.3	12.5	15.5	24.6	25.5	18.6	10.5	30.9	39.7	18.0	14.4	10.1	15.2	17.6	6.6	21.9	25.3	52.4	27.8	24.5	22.6	36.8	28.5	17.0	16.8	15.5
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.5	7.6	7.3	11.2	7.6	15.9	5.9	12.9	8.1	7.3	5.9	6.7	5.1	8.3	10.6	5.3	8.6	4.6	7.6	7.3	7.6	7.5	8.6	7.0	17.5	7.3	7.6	9.5	18.8	8.1	32.3	4.9	6.9	6.4	5.4	12.3	5.9	3.7	5.6	11.1	11.8	6.7	6.0	15.7	7.1	10.8	8.0	8.1	11.7	3.4	14.6	6.3	5.8	7.3	14.7	35.0	28.6	38.2	15.8	19.0	35.9	18.3	20.4	34.9	31.9	26.4	31.1	22.6	29.5	24.7	64.1	46.7	34.2	26.5	28.0	33.5	17.2	12.1	59.8	29.3	22.5	36.4	17.8	15.3	26.3	34.8	41.8	15.4	25.9	23.3	29.8	59.1	18.8	25.0	13.6	24.2	34.0	44.2	22.3	24.8	37.1	37.2	12.0	13.1	30.5	23.1	28.9	22.6	15.9	18.5	16.3	21.1	15.0	42.2	30.4	35.1	42.6	20.9	29.9	49.7	28.3	18.9	40.5	0.4	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	7.3	7.6	12.9	8.1	7.3	7.6	7.3	7.6	6.9	6.0	8.0	7.3	8.8	9.6	7.9	13.7	17.7	5.7	2.8	2.2	1.8	24.4	2.3	2.9	4.3	0.0	4.4	5.5	18.8	1.3	5.8	1.6	1.9	3.4	6.7	5.7	7.4	6.6	16.3	14.5	10.1	4.0	2.8	5.2	4.1	5.6	1.3	7.1	2.9	4.4	2.3	5.0	11.1	3.8	0.0	3.7	8.2	7.3	5.9	3.3	0.0	8.4	4.3	2.6	4.1	6.0	10.7	3.4	0.7	7.2	5.4	7.9	0.9	2.3	9.0	8.8	6.6	9.2	4.7	19.4	24.2	1.8	11.5	1.0	5.1	7.3	3.9	3.6
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891989	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 969.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342"	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	140.0	231.6	79.7	123.9	86.4	126.0	150.1	83.4	105.0	159.3	78.5	223.8	139.8	117.4	130.9	480.0	146.1	185.1	156.3	86.1	97.4	162.9	124.1	148.1	141.2	87.0	83.0	104.9	107.6	192.5	106.8	214.4	101.3	150.3	224.2	99.0	195.1	126.2	119.6	288.5	158.9	149.2	87.2	183.9	216.2	201.8	86.0	143.6	155.3	109.6	246.0	269.8	232.2	86.7	285.2	330.3	330.1	240.8	294.7	275.0	431.1	297.0	300.4	264.4	313.0	305.8	497.4	370.7	295.8	342.6	262.3	429.0	525.0	393.2	248.2	243.7	314.9	445.3	219.9	274.1	224.7	211.5	254.0	282.8	438.1	260.2	214.7	281.7	595.2	197.8	364.5	214.3	378.1	283.7	209.9	167.3	275.9	1057.4	185.9	176.3	250.5	346.3	716.1	734.7	237.4	251.9	214.0	335.6	286.5	387.8	445.0	243.0	453.7	208.4	296.4	203.1	267.8	112.2	289.5	288.8	193.7	353.5	228.8	183.5	154.8	235.2	56.7	133.9	58.8	78.8	85.3	68.6	137.1	64.1	78.9	63.6	232.8	71.3	154.6	87.6	109.5	340.2	79.7	86.4	83.4	105.0	86.1	97.4	87.0	83.0	101.3	87.2	86.0	86.7	155.7	57.7	57.8	15.3	90.2	192.2	180.2	375.2	134.3	42.3	107.5	69.6	89.5	105.8	245.4	187.6	33.3	326.4	76.0	313.4	346.3	360.6	413.1	119.3	72.7	260.7	206.2	91.1	31.3	337.0	340.4	96.9	149.9	194.5	74.9	75.9	235.2	88.4	239.2	57.2	27.7	227.4	244.1	114.8	214.2	80.9	97.3	148.1	186.7	42.2	217.8	137.9	65.9	25.6	21.9	391.1	277.0	86.5	72.1	187.6	205.8	271.5	240.0	36.1	46.0	45.2	161.5	407.5	95.3	225.5	284.4	969.3	96.6	97.6	209.2	360.8
RAB11FIP1	"FLJ22524, FLJ22622, Rab11-FIP1, RCP"	ENSG00000156675	"RAB11 family interacting protein 1"	Q6WKZ4	8	37858618-37899497	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 798.0;Endometrial ciliated cells: 622.9;Glandular and luminal cells: 969.7;Urothelial cells: 613.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 101.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 101.9"	"Cell line enhanced"	"Detected in many"		"K-562: 73.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017037, HPA023904, HPA024010, HPA025960"	Enhanced		Enhanced	Vesicles		No	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992"	"unprognostic (1.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.32e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (4.94e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.50e-1)"	7.5	5.7	3.8	17.7	2.7	58.5	21.8	3.8	3.8	14.5	39.3	40.7	41.3	5.9	14.8	47.1	16.9	21.7	12.0	4.4	4.3	13.7	7.2	74.0	17.2	3.4	2.7	4.6	42.5	12.0	8.6	25.8	2.1	8.7	47.0	6.1	23.8	13.5	4.6	18.9	53.5	7.1	2.3	12.0	45.5	6.4	4.0	15.4	13.0	2.7	31.1	23.6	14.9	2.2	41.8	18.1	1.9	8.0	0.4	0.1	54.1	4.2	6.6	7.5	9.6	40.6	23.2	17.0	12.7	5.1	0.4	31.6	14.5	9.4	11.3	44.2	13.5	3.3	9.0	11.9	20.9	7.3	36.3	4.8	12.2	2.8	7.9	11.1	0.1	22.2	73.1	8.2	3.8	9.9	12.4	10.7	12.0	40.9	5.3	3.9	9.7	13.2	39.4	42.2	7.4	8.5	10.6	52.3	13.0	36.8	35.2	14.0	0.6	0.2	23.1	0.6	0.7	16.5	20.7	4.5	0.3	9.8	5.7	24.0	20.5	38.1	4.4	9.4	9.9	6.0	3.2	3.1	18.3	3.8	2.0	2.2	101.9	10.9	20.2	11.0	7.7	10.7	3.8	2.7	3.8	3.8	4.4	4.3	3.4	2.7	2.1	2.3	4.0	2.2	7.6	798.0	112.9	1.0	128.5	15.9	113.5	49.5	24.5	5.4	113.6	58.5	15.8	84.4	228.0	64.4	16.7	44.9	123.6	385.5	15.6	170.2	0.9	622.9	71.4	25.3	243.7	3.8	7.9	248.9	8.1	28.7	272.7	969.7	30.4	2.8	32.2	15.3	32.1	6.7	8.6	312.3	95.6	59.1	174.7	1.8	1.8	121.1	16.0	2.8	95.2	18.6	120.5	0.0	1.0	364.6	299.1	1.5	48.2	192.7	331.9	16.5	348.8	21.0	6.6	9.0	23.3	2.4	5.2	124.2	30.5	96.0	83.8	2.8	256.6	613.9
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 44.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Late spermatids: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Vesicles, Centriolar satellite"		"HPA036406: AB_2675105, HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.0	5.3	5.2	2.3	4.7	0.5	7.5	2.3	19.8	6.9	0.0	6.5	2.0	10.6	1.5	5.8	7.5	3.7	6.6	6.0	6.2	11.7	2.3	6.8	1.0	17.4	6.2	6.9	7.4	12.2	5.4	1.7	16.1	5.1	0.8	0.8	7.5	3.3	11.5	8.2	3.4	3.2	4.2	14.3	5.9	44.7	11.6	0.4	5.1	3.0	0.9	6.7	5.8	6.0	20.0	8.8	0.6	6.2	6.7	7.9	11.1	28.6	15.9	10.1	8.0	6.9	4.4	0.0	15.3	16.3	10.7	8.1	4.1	8.6	4.4	38.1	11.1	7.8	4.0	4.2	7.8	0.0	1.4	9.5	8.9	12.5	8.3	9.3	13.5	3.6	6.0	3.6	7.1	0.6	0.1	0.2	4.8	3.2	15.0	7.1	7.8	18.3	8.7	2.7	2.8	2.9	10.0	3.3	4.3	2.1	2.2	0.5	35.4	24.4	13.2	17.3	15.0	13.8	4.3	0.1	18.0	8.5	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	5.2	4.7	2.3	19.8	6.0	6.2	17.4	6.2	16.1	4.2	11.6	6.0	12.1	6.4	3.6	4.6	1.3	25.5	8.3	6.7	12.5	4.4	13.0	6.9	12.0	12.8	3.7	20.2	0.0	1.2	5.5	7.7	27.4	12.1	86.2	6.1	3.2	20.4	1.8	0.0	11.1	18.4	12.2	9.0	3.1	12.8	0.0	34.5	16.8	6.1	2.1	6.7	11.5	2.5	2.0	1.3	8.1	171.6	14.3	1.9	8.8	7.5	1.0	7.4	1.0	1.0	1.3	22.7	2.7	8.6	6.1	13.4	0.4	46.9	5.0	2.6	26.3	7.2	6.2	39.8	6.6	5.1	17.6	14.8	4.5	6.4	4.6	16.4
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 22.3;Peritubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 97.2;U-2197: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	9.6	6.1	8.6	13.2	9.0	0.8	7.8	10.9	9.6	45.9	6.1	59.7	7.0	52.6	14.1	19.9	14.5	26.9	12.3	8.5	15.2	7.3	4.1	10.6	4.5	8.7	8.7	10.8	2.9	5.7	3.4	27.6	9.5	38.7	15.9	3.9	3.9	55.7	6.1	4.8	10.8	75.0	9.2	2.2	11.6	5.1	9.7	3.2	32.6	10.4	4.1	46.7	14.7	11.5	15.6	6.1	21.6	15.3	32.3	97.2	19.8	44.9	77.4	38.6	39.7	13.4	7.3	3.1	13.6	72.3	19.3	5.5	22.7	16.4	45.6	11.6	10.5	11.3	9.4	10.6	19.8	5.9	1.6	36.5	18.6	48.1	44.7	18.7	20.3	6.6	17.6	9.3	43.4	13.2	5.2	6.3	8.1	10.3	8.2	5.7	31.7	4.7	26.8	10.7	11.2	7.6	22.5	10.6	11.6	26.8	9.7	6.8	27.4	59.6	18.5	177.4	26.6	8.0	9.3	7.6	33.5	12.5	30.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.0	8.6	9.0	10.9	9.6	8.5	15.2	8.7	8.7	9.5	9.2	9.7	11.5	2.9	12.8	5.0	6.8	0.7	4.1	1.6	2.0	5.7	2.5	4.0	3.0	3.4	1.5	1.6	0.0	2.1	11.5	1.7	2.4	0.0	3.4	2.4	6.5	15.5	2.6	1.2	4.8	13.0	2.9	10.7	22.3	1.1	6.2	0.0	3.7	4.6	3.4	4.2	1.7	12.3	1.4	2.0	0.8	3.1	2.5	19.9	1.4	5.4	11.2	7.7	4.4	0.0	8.0	5.3	2.6	0.1	30.5	0.5	3.5	0.6	6.1	5.3	0.9	0.0	17.2	14.5	6.6	7.8	4.1	5.1	13.7	0.8	4.0	1.6	1.8
RAB30		ENSG00000137502	"RAB30, member RAS oncogene family"	Q15771	11	82973133-83071923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.8;Oligodendrocytes: 243.1;Plasma cells: 260.9"	"Cancer enhanced"	"Detected in all"		"breast cancer: 6.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 54.4;naive B-cell: 55.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 55.7;HDLM-2: 57.6;U-698: 164.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054514, HPA060565"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA054514: AB_2682512, HPA060565: AB_2684320"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.85e-1)"	11.2	11.0	12.3	13.9	28.0	14.5	12.4	20.5	12.9	8.3	0.0	13.1	17.8	8.4	5.8	6.9	5.5	5.7	9.3	10.5	24.2	3.7	7.7	6.5	19.8	28.0	19.1	14.0	4.3	2.9	4.4	8.5	28.6	7.2	13.8	11.2	6.1	5.2	12.9	7.4	21.3	10.2	20.3	10.1	11.6	4.0	21.8	10.4	5.8	11.8	28.4	8.9	4.4	39.7	4.1	5.6	5.8	2.9	11.1	16.7	6.8	9.8	9.1	19.0	7.9	8.7	1.8	55.7	10.0	14.9	4.9	4.8	8.3	6.4	11.3	57.6	1.6	12.6	16.4	5.1	2.6	2.0	2.5	9.5	4.4	8.5	6.5	7.2	14.0	5.0	1.9	15.0	9.8	7.9	2.1	0.6	7.7	5.5	10.0	4.8	15.2	23.7	9.5	3.4	6.7	4.6	22.6	5.3	2.7	8.6	12.4	0.2	17.9	8.1	19.1	8.0	2.7	24.0	14.3	164.6	3.1	1.4	5.7	1.4	0.7	1.0	4.9	0.3	3.6	54.4	4.8	4.8	2.0	55.0	11.2	10.0	0.9	2.3	0.8	5.8	9.5	6.2	12.3	28.0	20.5	12.9	10.5	24.2	28.0	19.1	28.6	20.3	21.8	39.7	15.2	9.6	3.3	87.8	80.5	24.9	10.7	9.9	73.4	8.3	11.7	13.0	14.5	0.0	2.7	3.7	16.7	7.0	6.8	5.4	1.9	2.4	0.7	3.3	6.1	10.5	10.1	3.2	60.7	4.0	30.8	23.5	5.1	4.2	0.0	0.9	18.2	6.4	1.9	11.8	78.2	1.5	8.2	1.6	15.2	1.3	14.3	6.4	42.7	67.5	24.8	13.9	3.1	80.4	243.1	4.3	3.5	18.0	260.9	8.9	9.3	4.6	2.3	10.5	6.6	20.3	13.5	0.7	2.2	11.0	11.5	2.9	12.9	24.0	1.8	2.0
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947097-19985175	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	35.7	27.3	39.2	27.0	39.9	41.4	33.2	42.1	49.5	30.5	36.6	29.7	29.6	22.7	42.4	42.3	21.1	32.2	36.3	38.6	43.1	33.6	42.8	29.5	24.3	42.7	42.5	19.9	27.2	53.8	20.5	49.2	42.2	30.7	30.5	35.4	35.8	28.8	29.1	36.0	28.2	28.0	44.0	24.2	32.6	18.0	41.1	28.9	41.1	30.3	29.1	35.4	29.7	46.1	29.8	26.8	38.5	26.4	65.8	57.8	38.9	51.3	59.7	47.8	55.0	31.9	45.7	21.8	30.3	56.7	27.6	18.4	29.0	38.2	55.7	37.9	24.1	31.9	24.9	31.1	82.2	45.0	38.1	53.6	71.0	56.1	81.9	59.9	61.6	28.5	37.1	34.1	57.9	46.2	34.8	31.9	48.4	40.8	42.6	25.8	27.2	32.2	98.9	38.8	12.0	39.6	36.9	45.3	60.3	57.0	35.4	35.8	61.6	34.5	30.1	44.4	44.2	42.0	73.5	28.6	55.0	40.4	57.1	28.7	18.0	31.3	7.9	19.6	10.6	7.9	9.3	9.6	18.1	5.8	8.5	8.1	36.0	20.3	26.3	11.8	10.9	11.5	39.2	39.9	42.1	49.5	38.6	43.1	42.7	42.5	42.2	44.0	41.1	46.1	114.8	60.9	45.1	33.0	43.6	170.0	129.5	48.8	62.0	34.0	57.0	35.9	57.0	27.1	52.6	42.3	31.3	74.7	44.2	68.7	103.7	52.2	21.2	45.9	44.4	72.4	62.0	55.3	33.7	45.3	67.2	65.2	66.3	72.0	85.0	39.1	41.7	39.3	54.2	15.2	31.4	59.4	65.1	44.4	158.8	15.9	36.7	60.9	83.6	28.1	43.1	86.1	41.2	65.9	44.1	65.2	55.9	35.3	50.7	109.7	49.4	62.3	48.1	36.8	52.6	86.5	72.4	24.6	27.1	65.0	188.0	164.3	60.6	37.1	41.5	151.0
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124978-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003426, HPA004167"	Approved		Enhanced	Endosomes		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Endosomes		"HPA003426: AB_1079735, HPA004167: AB_2667156"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	133.5	118.1	91.7	113.7	99.2	203.5	119.4	97.4	107.9	90.9	77.1	106.9	135.7	103.1	67.3	92.3	87.3	88.6	69.7	89.0	101.9	145.9	99.7	120.1	94.6	98.5	98.1	82.4	76.4	102.6	48.7	106.8	98.5	70.6	86.3	40.5	84.5	84.3	46.7	91.5	124.1	97.6	96.7	116.4	118.0	41.7	104.3	87.1	109.7	54.6	79.2	115.1	83.0	100.6	169.5	311.3	96.2	140.1	210.7	144.8	184.7	201.6	212.5	273.9	238.1	223.5	163.5	81.5	172.9	254.4	194.8	231.8	179.1	197.9	175.7	104.9	232.6	124.8	120.6	326.1	206.4	165.8	195.6	187.3	204.7	208.1	144.6	143.1	292.6	110.2	145.8	123.6	189.7	154.7	170.3	148.6	95.2	294.7	0.9	110.0	165.2	139.4	209.0	246.1	53.6	136.2	103.7	651.5	220.6	149.5	288.7	159.9	276.6	279.8	155.0	237.9	218.5	113.0	157.1	104.1	185.1	127.6	290.4	56.9	119.7	129.5	45.7	103.4	40.6	42.8	44.5	46.2	83.4	43.6	36.5	37.2	194.5	56.8	110.0	55.1	56.0	99.2	91.7	99.2	97.4	107.9	89.0	101.9	98.5	98.1	98.5	96.7	104.3	100.6	185.1	6.4	9.7	23.5	83.7	111.3	89.6	139.6	62.0	51.0	86.8	80.0	5.4	77.2	66.3	106.7	12.5	189.6	95.3	198.8	252.4	207.0	63.7	43.5	51.3	146.6	78.6	64.6	12.0	173.8	210.6	81.8	78.0	51.1	44.4	59.1	165.2	63.9	443.6	38.7	12.6	115.2	142.4	204.1	213.8	100.4	108.7	171.2	158.3	24.4	207.5	105.7	133.9	18.6	21.2	247.2	189.9	155.7	64.3	105.0	243.3	408.8	33.7	43.1	131.5	57.5	137.3	28.9	60.8	74.8	130.8	274.9	83.0	65.0	99.9	145.1
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 179.1;Oligodendrocytes: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA064860: AB_2685372, HPA072273: AB_2686504"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	22.5	15.5	27.3	16.9	28.8	7.3	21.6	23.8	31.6	21.9	19.4	39.7	12.2	28.8	25.4	31.7	21.9	19.0	26.3	28.0	27.8	19.9	11.7	19.3	19.5	27.3	29.8	23.8	16.3	31.3	16.8	21.4	28.0	29.4	22.7	24.9	24.3	30.2	34.5	23.6	17.2	31.7	26.1	18.4	21.6	21.8	27.1	19.6	39.2	30.7	19.4	26.0	21.8	30.2	19.5	25.7	39.6	33.0	44.8	36.2	24.5	20.0	35.8	30.3	28.2	29.9	18.6	26.6	15.6	31.3	40.4	64.7	25.6	25.0	32.4	25.1	15.4	20.8	40.4	22.9	38.3	17.2	17.5	35.2	37.6	26.1	29.3	43.5	34.8	26.2	18.3	19.9	36.9	43.3	22.5	13.5	14.6	55.7	19.6	36.7	72.3	23.0	25.2	21.3	22.3	17.2	35.7	31.9	18.6	29.5	60.7	9.4	26.9	25.6	15.1	28.3	20.3	19.3	33.9	27.7	24.0	8.7	22.9	3.4	1.3	1.8	0.9	2.1	0.7	1.1	0.9	0.9	1.1	1.4	1.6	1.1	2.1	0.8	1.0	1.5	1.2	0.5	27.3	28.8	23.8	31.6	28.0	27.8	27.3	29.8	28.0	26.1	27.1	30.2	47.2	25.6	50.8	115.2	26.6	18.0	23.0	20.8	40.5	44.9	26.7	26.4	46.9	11.5	31.9	11.0	50.1	25.5	26.0	24.9	3.9	11.8	15.4	31.5	30.3	33.1	16.9	17.0	179.1	14.5	8.7	22.9	18.3	47.7	14.0	34.2	27.1	15.4	15.9	57.2	129.7	16.7	24.4	28.6	14.4	17.5	40.7	25.1	14.2	78.7	35.9	33.6	33.0	101.0	147.7	13.0	18.6	51.6	11.9	39.7	11.7	10.1	30.6	34.6	85.5	31.0	51.4	73.8	37.4	27.6	17.3	41.6	16.4	22.5	21.6	27.8
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.9;lymphoid tissue: 43.0;testis: 45.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 55.7;Extravillous trophoblasts: 49.4;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	5.0	2.5	5.5	13.7	8.2	38.9	7.1	6.9	6.3	5.2	3.2	16.7	10.5	5.3	1.5	21.3	4.4	6.4	2.8	5.0	6.0	9.2	4.7	6.2	23.9	6.7	7.1	2.4	2.7	5.8	1.4	14.0	6.5	3.3	18.7	5.3	4.8	3.4	4.9	14.4	11.6	12.5	5.5	6.5	9.8	45.5	7.6	43.0	3.3	4.8	30.2	7.7	8.0	7.0	193.0	174.5	135.8	86.8	24.8	29.7	113.0	195.0	97.0	207.3	140.3	174.6	144.7	107.5	86.0	108.3	99.9	127.1	137.7	93.6	219.9	203.0	85.4	137.9	165.8	58.1	8.4	146.1	109.0	16.2	17.2	140.7	111.4	60.3	71.7	96.4	101.6	159.6	197.0	136.8	122.5	72.6	96.2	108.9	112.9	113.9	163.5	78.3	54.9	95.7	113.9	97.5	161.7	102.7	53.0	68.8	199.7	64.8	64.9	136.2	119.1	86.8	144.7	83.3	225.2	126.6	67.7	97.0	81.1	24.1	3.2	4.7	6.5	4.1	5.7	8.2	7.9	9.2	2.8	4.3	4.6	6.1	0.7	11.0	2.6	1.8	19.1	5.8	5.5	8.2	6.9	6.3	5.0	6.0	6.7	7.1	6.5	5.5	7.6	7.0	2.0	6.4	6.4	2.9	4.2	12.9	2.5	4.9	6.2	1.5	4.8	5.1	1.5	2.8	3.3	5.5	4.2	21.8	4.4	3.1	19.6	1.9	15.2	2.2	3.1	2.7	0.0	55.7	7.5	2.2	49.4	5.9	7.7	4.0	2.5	14.2	5.3	2.7	13.1	1.7	8.0	5.7	20.3	11.3	8.0	17.7	1.5	7.1	1.8	1.0	4.5	2.7	6.2	6.0	12.3	2.0	1.0	3.8	10.9	2.8	1.1	2.1	2.3	0.8	13.1	3.1	5.5	79.6	32.2	19.5	12.9	8.6	6.9	2.2	11.6	2.9
RAD17	"CCYC, RAD17Sp, Rad24"	ENSG00000152942	"RAD17 checkpoint clamp loader component"	O75943	5	69369293-69414801	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 121.6;Spermatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004551, HPA005448"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004551: AB_628195, HPA005448: AB_1079738"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.74e-2)"	"prognostic favorable (5.79e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-2)"	9.6	11.5	6.3	8.5	6.8	8.0	11.7	7.3	8.8	9.7	7.2	10.8	4.8	10.1	8.1	9.5	9.1	5.4	12.5	7.1	7.9	16.1	13.4	8.2	19.4	6.8	7.3	10.3	16.5	12.9	16.2	8.2	6.9	9.6	9.3	16.5	10.7	8.5	13.3	9.9	11.7	5.6	6.5	13.3	11.8	41.2	7.2	14.8	11.1	8.3	13.0	9.5	8.9	7.9	16.2	7.0	21.7	25.7	0.0	0.2	26.5	15.7	19.8	21.0	29.5	16.9	17.3	70.7	16.6	9.1	41.9	7.4	21.8	9.1	32.3	0.0	11.8	17.3	17.0	16.9	25.3	0.5	21.7	15.1	14.9	15.6	15.2	0.0	18.4	18.3	16.9	21.0	26.7	0.0	32.2	11.8	13.4	6.7	8.8	27.7	19.8	15.9	25.1	14.5	22.7	15.8	14.4	4.5	0.6	22.8	21.2	21.1	5.6	0.0	19.1	9.8	10.3	26.9	44.6	24.4	21.3	33.7	14.2	1.4	2.3	4.0	4.3	2.9	4.2	7.5	3.9	4.6	3.4	5.5	5.4	4.7	0.9	6.5	1.4	1.7	5.8	2.5	6.3	6.8	7.3	8.8	7.1	7.9	6.8	7.3	6.9	6.5	7.2	7.9	17.5	32.1	17.9	20.2	20.2	5.5	6.5	10.3	12.0	17.9	13.6	15.1	33.5	8.6	19.9	5.5	20.9	18.0	20.5	9.5	25.4	12.8	121.6	19.4	23.7	13.9	15.1	24.4	16.5	12.9	17.3	11.5	12.8	16.0	30.9	20.2	10.8	12.6	10.1	6.7	17.8	11.1	14.2	10.4	4.3	72.3	14.3	11.9	5.4	11.2	15.6	20.8	16.5	23.1	28.1	12.2	7.5	10.9	31.7	9.3	11.1	24.3	29.3	45.4	6.6	20.1	16.5	172.7	70.1	12.5	5.8	14.1	17.2	16.7	10.8	6.4
RAD18	RNF73	ENSG00000070950	"RAD18 E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	2.7	2.3	1.2	3.3	1.5	5.2	5.3	1.3	1.7	3.2	0.5	3.8	10.1	2.8	1.9	3.4	2.3	3.1	1.8	1.5	0.9	1.6	2.7	2.7	4.6	1.6	1.0	2.8	1.7	2.0	1.3	3.0	1.5	3.2	4.9	2.6	3.2	1.6	1.3	4.5	6.5	2.8	1.2	3.5	2.2	2.9	1.1	5.8	3.7	1.0	4.4	2.5	2.9	2.3	16.2	15.2	12.3	7.4	3.0	6.4	14.9	25.0	8.5	23.5	16.1	13.7	10.1	19.8	4.7	14.2	13.8	5.6	13.1	13.0	23.8	12.2	17.2	16.9	16.1	8.2	1.9	22.7	13.9	2.4	4.6	23.3	15.7	6.3	7.7	17.1	18.2	19.0	20.9	18.6	22.9	15.9	17.2	12.7	28.5	18.0	13.6	15.6	6.9	12.2	5.1	11.5	11.2	10.5	8.2	9.7	11.0	9.8	6.4	19.4	10.5	16.8	21.7	9.6	16.1	43.7	14.3	24.5	14.6	6.4	1.6	5.1	1.5	1.7	2.8	1.9	2.1	2.7	2.0	1.9	2.2	1.6	0.7	2.8	1.1	3.6	3.0	0.8	1.2	1.5	1.3	1.7	1.5	0.9	1.6	1.0	1.5	1.2	1.1	2.3	5.7	16.0	9.8	6.2	7.7	11.1	7.5	6.4	5.7	4.6	7.3	11.7	2.2	4.3	7.5	3.7	2.1	9.0	8.6	5.2	1.9	9.6	4.2	4.0	5.8	4.6	1.8	7.2	20.9	8.2	12.4	6.8	3.6	4.9	13.9	14.8	6.1	3.1	7.1	3.3	15.7	6.5	2.0	5.2	5.6	3.0	4.1	4.6	3.6	14.0	7.1	3.2	8.2	16.1	14.3	10.2	4.3	2.6	8.7	6.4	4.0	3.1	4.1	2.3	6.6	4.3	6.9	26.2	14.0	6.0	11.8	6.7	7.5	9.3	6.3	3.6
RAD21	"hHR21, KIAA0078, SCC1"	ENSG00000164754	"RAD21 cohesin complex component"	O60216	8	116845934-116874776	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 424.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020044, CAB022065, HPA073277"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB022065: , HPA020044: AB_1856035, HPA073277: "	"unprognostic (7.85e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.43e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.86e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.58e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	75.4	80.5	62.9	74.0	74.5	206.0	71.9	74.7	75.7	50.5	56.7	73.1	57.3	67.6	54.6	71.2	50.6	49.4	89.8	58.1	74.3	68.2	64.7	67.9	122.8	70.0	69.3	67.8	41.9	82.3	33.8	90.1	75.2	57.5	82.5	114.2	56.9	65.0	76.6	54.0	60.4	60.2	71.9	75.5	56.4	88.7	67.2	177.2	80.9	95.5	119.5	59.7	44.5	97.1	301.6	143.9	277.3	156.7	136.5	117.0	124.2	202.1	191.4	220.8	202.4	119.8	275.2	438.6	109.4	146.0	117.4	162.4	238.5	132.1	257.6	589.1	153.1	447.6	167.2	153.7	85.5	145.7	253.1	100.2	106.0	129.4	156.0	146.1	176.4	625.8	183.6	595.6	193.1	181.1	665.4	86.2	163.6	385.4	179.2	241.8	201.5	223.4	133.5	173.3	348.2	179.1	212.2	569.4	140.6	144.5	238.3	178.5	128.5	154.6	223.5	164.4	217.1	313.3	383.9	391.9	132.8	206.7	189.7	35.3	7.9	28.0	17.4	8.7	17.5	14.4	20.3	20.6	9.0	12.8	20.8	20.6	29.7	14.3	12.7	7.6	43.7	11.4	62.9	74.5	74.7	75.7	58.1	74.3	70.0	69.3	75.2	71.9	67.2	97.1	115.7	256.4	157.1	24.5	111.2	95.6	77.5	62.5	78.0	75.4	65.8	53.0	155.2	51.5	101.0	55.2	31.3	142.4	118.1	90.4	43.0	54.0	258.0	67.0	86.7	97.0	84.4	249.8	39.3	44.9	157.0	89.4	57.1	88.2	153.5	112.9	75.0	72.1	67.9	67.3	48.1	72.7	69.2	93.1	100.0	424.9	116.5	93.4	69.4	45.9	110.8	112.5	77.2	41.2	58.3	63.5	66.3	106.5	124.0	100.0	35.7	59.4	70.5	67.9	72.3	88.6	85.3	33.2	88.6	103.7	100.4	113.7	134.1	85.5	94.1	95.5
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46246461-46278480	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	0.5	0.7	3.0	4.1	3.8	8.7	1.0	4.3	3.9	1.3	2.1	3.2	2.0	0.7	0.1	5.4	0.4	0.5	0.7	2.9	2.5	1.4	0.5	1.2	5.5	3.2	3.0	0.5	0.5	0.3	0.4	3.4	3.8	1.0	4.6	0.4	0.9	0.4	1.2	2.3	2.8	1.7	2.8	2.8	1.5	15.6	3.1	15.4	1.8	0.0	8.3	0.8	1.8	3.7	22.2	16.1	46.8	29.1	3.3	2.4	43.9	25.8	11.3	42.8	43.3	33.3	14.2	42.5	19.1	11.0	38.5	22.2	44.6	14.5	36.8	23.7	43.0	53.0	49.7	32.1	0.1	54.0	29.3	1.6	1.2	42.1	12.5	6.9	13.5	49.7	38.2	41.7	23.1	20.4	68.9	60.0	42.5	19.4	25.2	52.8	26.8	19.0	9.4	17.5	22.4	16.3	18.4	25.2	5.7	38.0	9.1	37.7	5.7	43.9	26.1	23.6	43.7	17.6	10.6	46.9	11.5	35.1	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	3.0	3.8	4.3	3.9	2.9	2.5	3.2	3.0	3.8	2.8	3.1	3.7	0.0	0.0	0.0	1.0	0.7	0.3	0.7	0.5	1.8	0.0	0.5	0.5	0.8	0.0	0.1	0.0	0.0	4.3	0.4	1.8	0.0	0.3	2.7	2.3	0.8	0.5	0.0	7.2	2.8	0.0	9.4	1.1	0.5	8.0	4.5	5.6	0.4	0.0	2.6	0.0	1.1	1.3	0.0	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	1.0	1.0	2.9	0.3	0.1	0.0	4.7	0.4	0.4	0.0	0.1	0.0	0.0	0.4	4.0	12.4	5.6	3.1	0.3	1.6	1.1	0.2	2.9	1.0
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155, CAB079979"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.8	5.0	3.3	6.9	3.6	10.2	6.9	2.1	6.0	9.2	2.9	7.3	10.9	7.4	2.1	9.0	10.9	5.7	4.2	3.8	2.4	7.1	6.6	6.7	8.3	2.9	3.6	8.0	8.0	3.4	10.1	4.4	2.2	10.8	3.0	1.8	9.8	6.1	5.2	11.4	11.1	2.4	2.2	9.4	8.4	8.6	2.5	6.1	9.7	2.1	3.7	6.5	8.5	2.2	10.8	15.8	9.5	13.8	2.8	1.1	12.0	5.7	4.9	8.0	7.1	23.2	20.9	11.1	12.4	1.8	13.0	18.7	6.0	5.5	0.9	13.0	16.3	16.8	8.5	10.4	3.8	12.3	20.3	3.2	5.3	7.2	3.5	6.1	5.5	23.2	14.7	15.6	2.3	33.2	21.9	21.8	13.2	15.9	12.1	18.8	12.5	13.6	2.2	9.0	9.8	10.6	9.9	27.2	21.1	2.4	19.1	10.9	4.2	11.7	14.3	23.3	8.7	14.6	14.2	11.5	7.5	11.6	9.6	5.3	1.8	6.0	5.2	2.3	3.8	4.3	4.1	4.3	1.2	3.1	2.9	3.2	2.8	3.1	2.5	3.4	2.4	1.5	3.3	3.6	2.1	6.0	3.8	2.4	2.9	3.6	2.2	2.2	2.5	2.2	16.0	22.4	17.1	10.1	31.0	17.1	17.7	17.9	23.3	19.6	19.7	18.4	1.1	12.8	22.2	20.2	70.9	27.9	31.3	54.2	13.7	11.3	27.3	32.1	13.4	16.3	14.3	17.7	8.5	13.1	22.4	13.8	27.0	14.9	20.3	26.0	11.0	6.6	15.1	21.9	6.0	48.9	10.2	10.3	31.4	13.2	10.5	14.0	19.6	11.2	8.9	15.0	56.7	2.5	5.3	11.6	31.6	12.4	38.5	16.6	61.8	10.9	44.0	32.1	13.1	10.5	14.5	32.0	17.6	18.3	17.3	40.6	30.3	15.3	38.7	18.0
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681458-17811453	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	6.8	10.5	5.9	7.4	5.2	4.9	9.3	5.7	13.0	17.2	1.4	13.1	6.3	16.4	3.4	11.6	15.1	7.4	12.7	3.9	2.4	9.2	5.3	10.8	5.8	4.9	0.4	15.9	10.1	10.2	18.0	4.6	1.2	16.1	2.7	8.9	15.3	9.5	5.7	12.5	8.4	6.3	0.1	11.8	10.9	6.4	0.8	7.1	14.5	1.8	4.3	15.6	14.4	4.3	29.3	39.0	24.2	20.0	3.2	6.5	4.2	9.9	10.5	8.1	7.9	20.4	12.1	9.4	13.3	12.9	6.9	33.8	8.5	19.7	3.4	9.3	19.0	17.2	24.4	10.4	10.5	6.9	10.4	7.5	9.4	7.4	11.0	9.6	10.1	11.8	7.5	7.5	4.2	25.9	14.7	6.7	1.7	15.1	11.4	34.2	18.9	13.4	6.6	34.6	16.8	30.0	15.6	13.6	32.2	27.8	18.3	8.6	19.6	12.8	16.3	20.7	14.1	6.6	1.6	5.9	12.5	8.4	35.7	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.6	0.3	0.7	0.0	0.2	5.9	5.2	5.7	13.0	3.9	2.4	4.9	0.4	1.2	0.1	0.8	4.3	6.1	12.8	20.5	24.8	4.7	12.1	10.8	11.7	12.0	28.7	14.1	10.2	4.0	11.5	14.0	14.7	22.9	0.1	10.0	4.8	0.0	18.4	2.5	9.4	9.6	11.0	11.4	4.6	37.3	9.0	0.8	8.0	12.8	10.5	14.0	7.7	15.4	6.2	2.4	23.5	35.9	7.1	4.1	3.5	8.7	4.9	6.8	4.5	8.8	14.0	5.9	6.8	7.2	26.2	17.1	13.5	2.5	6.0	1.7	11.6	2.2	1.8	7.3	13.1	6.6	5.0	7.6	1.2	11.7	10.5	8.8	0.4	6.8	12.4	8.5	12.9
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		9400	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	109.7	65.4	72.1	90.4	83.2	189.2	98.2	82.6	79.3	108.9	81.8	127.2	109.8	96.9	41.6	119.6	84.8	70.7	143.2	67.6	77.4	104.4	68.3	117.4	116.9	87.8	81.9	101.2	78.2	62.1	55.6	77.6	84.2	88.3	87.6	55.0	105.3	64.3	178.4	114.6	117.7	70.1	83.7	109.6	101.9	116.5	80.9	161.7	125.5	106.0	99.9	99.3	98.4	100.7	250.4	138.1	247.6	193.9	115.3	110.3	210.1	172.9	136.0	215.1	183.0	375.8	204.0	204.3	238.7	140.6	290.9	259.4	135.8	252.7	119.2	132.2	119.3	468.3	81.4	375.4	147.8	236.2	215.0	122.4	141.6	161.9	175.4	160.7	203.0	245.6	201.7	300.9	135.8	185.9	589.3	266.6	137.5	306.0	277.2	344.4	360.6	250.7	126.7	135.4	235.8	266.6	271.8	248.4	376.6	125.8	256.2	234.4	167.5	414.4	270.7	212.3	206.6	310.7	308.3	353.5	213.0	169.9	201.3	139.3	110.7	221.3	138.8	137.1	100.2	96.5	122.2	150.4	135.3	99.6	107.8	104.0	173.3	186.1	195.5	110.0	141.4	165.3	72.1	83.2	82.6	79.3	67.6	77.4	87.8	81.9	84.2	83.7	80.9	100.7	91.8	54.5	61.3	23.2	98.3	79.2	126.9	102.3	74.6	24.2	74.9	67.8	63.4	58.6	61.7	55.2	18.8	161.3	118.3	287.4	127.2	149.1	48.1	36.4	48.5	92.1	93.0	87.9	19.3	160.5	227.7	78.2	70.8	66.9	59.7	69.7	76.8	39.8	159.6	8.4	14.6	143.2	95.6	112.2	118.1	46.7	65.6	96.9	115.6	50.6	151.3	62.6	163.7	15.6	57.1	190.3	270.7	62.1	206.4	157.5	220.7	107.3	38.8	36.3	111.7	47.7	97.7	106.6	121.1	103.7	80.7	171.4	117.2	51.6	178.6	176.2
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130872037-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	285.3	333.2	207.7	340.1	222.3	406.0	220.5	212.1	265.0	193.6	204.5	269.1	177.8	207.6	238.1	445.6	180.6	148.9	256.9	220.6	260.3	249.0	208.2	225.9	416.4	207.2	213.3	180.7	192.9	210.6	180.1	243.0	231.0	149.7	266.6	213.3	200.4	155.5	415.0	231.2	220.0	250.1	228.5	255.9	223.4	308.6	236.5	577.6	166.8	383.7	480.6	380.9	244.7	230.2	1391.5	1850.5	1580.8	921.6	707.0	868.2	1219.5	1770.2	926.2	1695.1	1163.1	2003.5	1434.2	2260.7	1169.3	1290.0	1067.9	877.0	2327.1	1854.5	1830.8	766.9	1831.5	1331.9	1318.9	2068.9	864.1	2347.9	1100.3	821.9	1129.3	1470.6	2111.6	1119.9	1671.0	1593.5	2013.6	656.5	1686.3	1688.2	2306.9	2810.1	1857.8	1429.2	2936.2	1773.9	1347.2	1274.4	1608.2	2377.1	1441.5	875.0	1018.5	920.7	1334.4	1299.9	1817.9	1666.5	1157.6	975.6	1495.0	998.8	1694.1	905.2	1605.1	3245.4	1002.2	1410.7	1390.4	285.0	398.0	275.5	501.5	489.3	614.6	726.4	682.5	581.4	531.7	593.3	611.5	585.9	80.7	500.4	481.0	506.9	768.0	1005.0	207.7	222.3	212.1	265.0	220.6	260.3	207.2	213.3	231.0	228.5	236.5	230.2	321.3	182.7	141.5	18.6	337.4	635.3	693.4	702.0	406.3	155.3	239.0	316.0	112.6	165.8	310.5	169.2	37.5	734.2	273.6	157.0	387.4	642.1	90.2	212.9	280.8	306.2	201.9	540.9	27.8	452.8	1266.0	379.6	181.0	201.3	194.0	273.1	143.8	181.6	624.5	139.7	25.8	300.5	349.9	171.7	424.1	148.1	213.4	239.7	332.6	9.4	417.0	287.5	219.4	19.6	23.5	596.4	189.1	230.9	418.2	954.8	167.2	423.2	214.3	141.6	164.3	286.0	600.8	746.4	571.6	578.0	547.0	613.1	332.3	451.9	403.6	621.0
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127355	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 754.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 2431.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol		NA	NA		1400000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA065868: AB_2685572, HPA065931: AB_2685580"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	65.5	68.0	37.6	63.3	38.6	117.5	60.7	40.2	47.9	67.1	28.8	63.9	52.9	66.7	21.4	94.7	61.2	30.0	47.5	39.7	40.5	64.8	86.7	53.5	94.7	41.1	39.1	61.0	54.0	35.9	50.3	46.2	41.4	49.8	42.9	35.3	51.8	34.3	54.9	61.8	60.6	36.2	40.8	71.1	55.5	117.8	39.6	104.0	46.5	34.8	72.6	61.9	64.7	43.7	434.6	218.5	479.7	263.2	79.1	93.8	403.7	388.7	169.3	494.6	356.4	401.5	150.8	669.8	169.7	157.8	224.9	394.2	449.4	340.4	269.6	290.1	1071.3	562.6	218.5	426.6	120.3	913.7	294.4	103.9	158.7	393.0	139.2	114.3	227.1	300.2	2431.9	261.1	226.8	339.2	665.5	622.0	547.2	553.8	380.8	667.4	674.7	172.6	171.6	233.9	478.6	354.7	356.6	196.4	236.6	210.3	137.1	378.9	176.4	341.5	668.1	258.7	438.3	260.9	383.6	1066.0	186.9	405.9	292.7	21.1	94.7	75.8	71.3	101.6	78.8	123.1	101.6	91.1	111.5	119.1	101.8	77.0	9.5	90.8	93.6	103.6	115.4	102.5	37.6	38.6	40.2	47.9	39.7	40.5	41.1	39.1	41.4	40.8	39.6	43.7	133.1	35.3	37.1	14.7	135.0	274.4	195.0	260.6	109.3	44.4	142.3	175.6	47.1	104.4	104.8	90.1	6.2	409.2	103.8	106.4	277.8	188.5	394.2	104.6	131.1	143.5	117.6	259.2	22.2	112.3	754.9	156.7	72.4	86.7	64.7	187.2	93.5	169.5	268.7	37.0	21.4	194.0	209.5	85.5	223.3	236.1	145.1	95.3	177.9	6.5	140.6	103.5	87.6	7.5	23.9	150.0	109.3	136.9	179.6	338.0	107.3	213.7	93.8	39.0	98.6	110.9	289.5	505.1	435.2	220.1	294.9	194.7	119.2	176.5	273.6	218.2
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.06e-2)"	25.1	40.3	30.0	24.0	30.6	21.5	24.7	30.4	33.7	30.5	25.0	43.1	22.2	35.1	10.6	26.6	29.0	17.8	35.3	30.0	30.3	24.6	24.4	25.2	26.5	33.0	34.9	28.2	29.6	20.7	32.0	16.7	31.7	32.2	12.1	19.3	25.6	22.9	36.6	29.2	27.6	19.0	30.5	30.1	32.0	44.7	31.5	26.2	25.8	21.3	17.9	36.6	27.9	31.1	73.8	50.4	42.3	47.6	31.2	31.3	30.0	45.9	43.1	52.7	56.7	64.9	25.4	69.0	50.4	35.8	33.1	44.8	38.2	44.8	32.0	71.0	62.3	37.1	38.8	77.6	33.7	54.9	52.2	30.9	30.4	33.0	37.3	24.5	38.9	37.0	68.4	63.6	30.3	30.7	91.8	26.6	77.6	31.8	64.3	67.0	40.6	63.3	34.3	56.3	46.4	52.1	41.1	42.9	41.1	24.7	32.7	41.0	40.6	44.2	32.2	78.2	68.4	65.4	72.1	59.2	55.9	68.0	55.6	14.5	23.1	29.2	23.2	23.2	24.1	17.6	22.7	23.5	23.4	24.5	19.5	25.8	26.0	17.9	24.3	22.3	32.1	24.5	30.0	30.6	30.4	33.7	30.0	30.3	33.0	34.9	31.7	30.5	31.5	31.1	14.0	25.6	26.6	9.8	18.4	12.2	20.5	27.1	9.6	16.7	12.0	10.2	16.4	18.6	19.9	7.3	25.0	29.2	18.6	16.9	43.0	28.8	59.5	14.3	12.6	19.2	13.2	8.6	9.4	20.8	29.5	17.1	17.3	15.4	17.7	14.1	9.3	10.8	25.0	23.5	11.7	20.2	32.6	14.9	16.8	73.3	16.8	16.5	21.4	8.4	31.5	21.9	25.7	13.6	17.5	22.7	11.4	24.8	21.7	18.8	20.2	21.0	21.4	20.8	19.7	13.5	15.8	86.8	40.8	10.4	11.8	35.4	20.6	19.1	15.1	23.0
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 41.4;Excitatory neurons: 66.8;Inhibitory neurons: 92.6;Microglial cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;HEK 293: 16.0;hTERT-RPE1: 82.3;WM-115: 36.5"	"Region enriched"	"Detected in all"	9	"basal ganglia: 109.2"					"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	4.1	7.0	3.5	2.6	15.0	0.0	6.9	2.2	6.6	9.3	7.2	6.0	1.7	7.4	6.7	7.9	6.0	5.3	14.0	3.5	1.4	15.1	6.5	5.3	6.7	3.4	1.7	11.5	1.3	6.0	7.5	14.4	0.9	12.5	2.2	13.6	13.1	11.2	2.4	1.1	2.0	5.9	1.4	4.9	3.9	0.6	2.4	1.2	9.1	5.3	4.2	7.2	6.1	3.7	0.0	1.9	1.2	6.4	13.7	3.6	0.0	1.6	0.8	0.0	0.6	0.3	0.1	0.1	0.2	2.5	0.3	0.4	0.0	0.3	0.0	0.1	16.0	0.1	0.1	1.1	0.3	0.2	0.1	7.1	0.0	0.0	0.0	82.3	13.4	0.1	0.1	5.6	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.6	8.3	0.0	0.2	0.1	9.1	0.0	0.1	0.0	1.1	0.1	2.1	7.0	0.2	0.0	0.1	5.6	0.2	36.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	15.0	2.2	6.6	3.5	1.4	3.4	1.7	0.9	1.4	2.4	3.7	2.4	0.0	0.5	41.4	0.3	0.1	18.0	6.4	1.8	4.5	1.7	7.5	12.0	12.8	14.9	11.0	25.0	0.2	0.8	0.0	0.0	1.6	1.5	8.3	4.2	10.5	0.0	0.0	66.8	0.9	0.1	6.8	7.7	3.0	0.0	0.1	22.1	2.1	0.4	5.0	92.6	0.0	2.0	1.9	0.4	1.2	0.0	0.3	0.0	29.0	0.0	24.8	0.0	19.6	2.9	1.4	0.0	0.0	0.2	10.2	0.6	0.6	9.2	6.3	0.0	2.9	9.7	0.2	1.0	6.6	0.1	0.3	0.5	0.2	0.2	9.7
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA replication, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 143.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	27.1	25.0	22.9	21.1	23.8	143.6	25.9	33.1	29.9	27.8	21.7	31.5	15.0	33.6	26.3	23.2	32.4	25.5	23.9	22.8	23.5	24.3	26.8	27.9	29.7	24.2	22.8	38.8	22.2	21.8	28.1	31.7	24.4	26.0	20.4	51.1	21.4	19.9	29.7	34.6	26.0	24.1	23.9	29.4	25.6	45.5	24.4	26.6	27.2	25.7	23.5	25.3	24.7	27.7	35.4	18.4	42.5	44.4	31.9	32.9	45.9	28.1	26.1	25.1	27.3	20.5	28.3	49.6	20.3	24.4	28.7	33.3	46.2	24.8	41.9	26.9	35.7	41.9	57.1	58.6	24.7	57.5	23.7	28.8	33.7	33.2	38.9	28.6	36.9	42.2	54.5	43.8	29.7	36.5	45.5	51.2	48.7	24.0	17.3	62.8	42.5	43.3	24.7	31.7	33.4	28.5	39.7	35.1	52.3	47.0	27.4	49.7	32.3	31.0	22.8	27.0	30.8	37.7	40.9	60.9	25.1	36.5	26.1	7.1	1.2	2.0	2.0	2.0	2.2	2.0	2.1	1.5	0.9	1.7	1.8	2.0	2.5	3.5	1.1	3.7	1.7	0.6	22.9	23.8	33.1	29.9	22.8	23.5	24.2	22.8	24.4	23.9	24.4	27.7	139.1	86.6	115.3	47.3	125.7	100.7	103.5	40.8	223.1	67.1	145.6	160.8	147.0	44.3	56.5	27.6	100.1	46.3	88.9	71.5	25.4	48.8	307.5	109.8	123.7	93.7	82.0	83.1	52.5	47.6	57.6	127.1	121.8	203.1	51.3	127.8	64.2	59.5	38.4	62.2	53.4	76.0	28.5	53.5	70.2	41.9	72.4	101.5	62.2	54.4	54.0	53.1	52.5	61.3	58.7	56.4	32.8	58.6	173.7	99.9	54.5	23.9	52.0	61.4	52.6	247.0	112.9	100.3	45.8	161.0	101.7	101.5	110.2	105.3	69.3	111.9
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713340	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Group enriched"	"Detected in many"	10	"basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		0.3	1.5	3.7	0.4	28.1	0.5	0.1	2.5	73.9	0.6	0.0	0.8	0.2	0.2	3.1	1.1	1.1	0.1	25.2	26.6	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	1.7	0.5	5.7	2.2	4.1	95.3	0.3	0.2	0.0	2.7	0.0	0.2	1.1	2.2	0.2	0.1	45.3	0.0	0.4	0.4	22.6	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	25.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.7	0.1	0.4	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.7	0.2	0.1	0.1	0.2	0.0	3.7	28.1	2.5	73.9	26.6	0.0	0.0	0.0	0.0	2.7	2.2	22.6	0.0	0.0	0.5	97.9	0.0	0.0	0.0	0.0	0.0	10.9	0.4	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	6.6	0.3	1.8	0.9	0.0	0.0	5800.8	0.2	0.0	3.5	0.0	0.1	0.0	47.8	0.0	0.0	0.1	0.0	5921.8	0.5	0.0	0.0	0.3	4.9	1.2	0.5	1.8	132.1	0.6	6.6	0.0	597.6	689.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	2.8	0.0	17.0	1.2	0.6	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0
RBIS	C8orf59	ENSG00000176731	"Ribosomal biogenesis factor"	Q8N0T1	8	85214048-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 56.0;Cytotrophoblasts: 105.8;dendritic cells: 39.1;Extravillous trophoblasts: 123.8;Hofbauer cells: 102.1;Syncytiotrophoblasts: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	74.4	69.3	55.7	51.0	56.1	83.2	95.2	57.4	72.4	85.3	57.0	81.0	60.6	67.0	91.1	90.2	72.2	42.8	101.1	54.6	58.2	88.5	86.2	52.3	70.8	56.9	55.6	82.7	103.1	60.6	68.9	45.6	57.5	71.6	56.8	45.8	75.2	41.4	78.0	63.9	66.3	48.8	58.5	75.4	99.0	41.5	56.1	75.1	61.3	68.6	71.3	73.9	73.5	59.8	166.6	83.1	122.6	79.4	73.4	140.2	94.8	107.6	102.7	123.1	120.5	97.2	140.0	42.1	86.8	71.8	116.2	112.9	84.8	118.2	138.1	116.6	92.5	242.1	74.2	145.8	87.0	92.5	105.7	120.0	137.0	79.4	99.7	133.3	106.4	145.3	111.9	97.8	103.7	131.0	205.8	173.1	36.1	372.8	143.3	86.9	100.6	188.2	121.2	104.7	40.7	87.1	81.7	132.8	161.0	145.5	154.4	135.9	81.8	78.1	164.9	87.5	104.2	114.1	144.8	197.4	155.8	116.8	88.9	76.6	55.2	39.2	63.5	71.7	76.7	89.3	83.7	78.9	96.9	77.7	95.8	95.0	14.1	104.7	64.4	118.7	90.8	71.0	55.7	56.1	57.4	72.4	54.6	58.2	56.9	55.6	57.5	58.5	56.1	59.8	56.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	105.8	39.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	123.8	27.8	0.0	0.0	0.0	0.0	0.0	0.0	102.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	76.9	7.6	0.0	0.0	0.0
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, S1-1, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47145221-47186813	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: AB_2683421"	"unprognostic (9.07e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	23.7	31.1	28.5	19.9	28.8	32.5	23.9	32.6	36.4	33.3	26.6	28.8	18.1	29.5	12.4	34.2	31.5	12.1	30.8	28.5	28.4	30.0	32.2	23.9	25.1	28.2	27.9	40.6	32.2	15.9	38.0	17.3	28.3	33.8	11.3	14.8	23.6	15.6	26.5	27.1	27.8	12.5	26.6	33.9	26.4	12.8	29.3	23.6	33.1	12.4	15.9	28.3	29.9	31.9	50.1	52.5	48.9	58.8	25.7	21.0	57.3	36.8	21.4	37.2	35.8	46.4	39.8	60.1	22.0	25.6	47.5	47.7	64.9	46.1	20.4	61.6	59.0	45.1	65.1	48.8	37.5	46.0	52.1	27.7	22.0	61.2	49.8	26.5	40.4	56.5	38.3	47.0	23.0	74.9	84.8	78.2	81.9	37.1	58.0	74.0	41.0	62.2	27.7	42.9	58.6	44.5	56.0	41.6	35.6	29.3	50.9	45.7	35.8	43.7	54.9	47.8	39.5	48.4	42.9	49.5	38.8	32.8	62.3	13.5	8.1	11.4	12.7	10.7	12.0	11.2	10.2	10.8	9.2	11.1	10.0	9.7	7.5	9.9	15.8	10.7	12.7	9.3	28.5	28.8	32.6	36.4	28.5	28.4	28.2	27.9	28.3	26.6	29.3	31.9	17.4	41.7	36.9	22.5	21.6	11.1	22.4	15.0	22.8	26.7	16.5	16.8	36.6	21.5	28.8	9.2	14.6	34.2	21.3	32.2	11.7	20.5	1.3	23.6	20.1	19.6	35.8	14.9	14.8	17.7	28.5	20.2	31.6	31.5	24.1	29.1	16.8	23.3	19.7	21.9	15.4	31.5	10.2	14.2	10.0	2.7	18.0	15.4	16.0	8.4	19.9	14.7	20.6	15.1	18.1	19.8	20.8	25.6	22.5	18.7	23.1	14.3	28.8	27.0	0.0	21.4	21.8	10.7	8.7	23.4	10.5	46.1	23.8	19.7	34.2	18.1
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	24.5	20.2	2.6	28.7	3.5	30.2	22.6	23.2	8.0	18.2	7.6	24.5	20.3	28.6	12.4	23.4	26.6	23.7	18.4	2.9	9.6	17.7	18.5	22.9	39.9	4.1	4.1	39.0	19.9	25.2	13.9	30.2	3.7	23.4	24.1	27.4	19.3	19.3	19.2	17.6	20.2	28.5	0.9	27.0	22.2	23.0	6.2	50.6	23.0	17.2	44.8	36.4	17.0	10.4	87.9	57.6	121.3	74.5	29.1	57.0	74.5	47.7	56.1	65.5	64.0	80.4	60.3	157.5	51.8	96.0	68.3	60.7	144.8	121.9	83.3	74.8	52.2	132.0	56.6	54.2	50.0	145.1	67.9	82.0	61.7	75.2	49.7	41.8	73.9	84.0	128.1	73.9	58.0	64.3	172.8	40.8	88.4	56.7	59.2	104.2	149.0	77.0	47.0	142.2	63.9	82.9	85.1	66.0	64.3	99.2	85.1	52.4	104.9	54.8	81.0	54.3	71.7	79.7	93.4	165.3	48.3	55.3	72.9	6.7	10.5	8.9	11.7	11.6	13.6	12.2	10.4	13.7	12.7	11.5	10.7	9.8	7.5	9.9	9.8	8.1	10.1	11.5	2.6	3.5	23.2	8.0	2.9	9.6	4.1	4.1	3.7	0.9	6.2	10.4	22.6	25.6	24.1	0.0	28.7	29.6	23.8	17.4	19.4	15.8	19.4	19.3	22.5	17.2	19.2	3.7	27.1	21.5	35.8	17.1	1.9	14.9	4.8	20.7	24.0	18.7	24.6	25.2	0.0	17.8	18.5	22.6	11.2	24.9	26.6	31.5	20.0	14.0	18.5	8.4	0.0	20.4	20.3	24.6	20.6	4.8	14.6	25.7	16.0	0.0	23.7	13.5	21.6	0.0	0.0	21.0	14.6	16.6	22.9	18.5	15.0	9.8	25.3	14.4	6.6	28.0	22.6	15.1	17.4	21.8	29.5	17.5	29.7	18.7	19.8	27.8
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.37e-4)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	4.7	4.0	3.3	7.0	4.0	44.7	4.2	10.9	4.1	3.2	4.5	4.3	5.3	3.4	3.4	3.2	3.8	4.2	4.6	4.5	2.5	3.2	7.2	4.2	11.3	3.1	3.0	5.9	4.3	3.7	1.6	5.0	3.3	3.6	3.8	4.9	4.6	2.6	7.0	2.9	4.8	3.6	2.7	7.2	5.4	8.6	3.4	8.6	4.6	6.6	9.6	4.5	2.2	5.6	11.8	12.7	11.2	11.6	7.0	7.2	17.6	6.2	8.1	9.5	12.4	15.7	10.6	22.4	9.7	7.0	7.8	16.4	17.6	15.5	13.9	23.4	16.3	18.1	21.0	11.4	9.6	19.9	18.4	6.6	10.5	13.2	12.3	5.0	10.2	16.6	26.1	38.0	9.6	12.1	18.0	15.4	24.0	10.4	7.1	21.1	17.0	15.3	7.8	11.8	13.4	6.8	13.5	16.7	13.1	11.9	11.6	23.5	7.2	9.1	16.2	9.9	11.4	28.8	15.9	48.0	13.6	19.7	11.4	6.3	3.9	5.6	3.7	3.4	5.3	6.1	4.2	3.3	2.8	5.1	3.5	4.3	5.4	3.1	3.9	2.7	4.5	3.3	3.3	4.0	10.9	4.1	4.5	2.5	3.1	3.0	3.3	2.7	3.4	5.6	9.1	6.4	3.7	21.5	18.3	33.1	9.3	7.3	6.2	5.7	10.8	5.0	12.3	5.7	4.8	3.7	14.6	8.7	12.8	9.1	0.0	4.1	9.6	15.9	14.5	8.4	9.6	10.7	30.0	3.5	7.9	8.1	10.2	18.8	28.6	10.6	11.0	18.5	6.5	0.0	26.2	8.4	0.0	6.8	11.4	6.7	4.1	7.7	8.8	39.4	6.1	3.9	7.2	29.1	31.2	4.3	3.9	5.3	15.5	9.6	8.8	4.5	10.6	7.3	0.0	11.2	12.4	30.6	13.9	9.4	33.8	4.7	14.3	6.5	9.9	8.6
RBM15B	"HUMAGCGB, OTT3"	ENSG00000259956	"RNA binding motif protein 15B"	Q8NDT2	3	51391285-51397908	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036645, HPA058136"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA036645: AB_10671965, HPA058136: AB_2683618"	"unprognostic (2.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.84e-1)"	13.0	10.3	10.2	10.6	9.5	11.1	12.3	8.8	10.5	12.0	7.4	14.4	10.4	16.9	10.6	17.0	12.0	9.3	10.4	9.9	9.5	9.7	9.9	11.5	11.2	9.9	10.1	14.6	17.8	13.8	10.7	8.0	8.9	10.9	11.9	8.2	12.3	11.0	6.1	16.5	13.0	12.2	9.3	11.4	14.6	11.4	9.7	19.7	10.8	7.0	12.2	13.0	10.5	9.6	19.2	16.7	38.2	40.1	33.7	26.2	23.3	17.4	32.2	27.2	22.3	20.8	13.6	27.5	14.1	31.5	30.0	17.3	22.0	31.3	13.1	22.2	17.3	23.9	26.2	17.9	19.7	31.4	13.0	28.6	38.2	25.0	29.5	29.6	28.5	44.3	18.1	18.2	23.6	20.4	54.8	19.8	30.5	17.6	25.9	19.4	16.8	23.5	24.5	45.5	24.7	35.5	22.4	29.5	20.6	25.2	23.4	36.7	26.0	27.7	24.1	23.6	33.3	26.6	25.9	30.3	22.6	24.8	30.2	0.0	1.9	0.7	1.8	2.7	1.9	1.0	2.2	1.9	2.1	2.4	2.2	1.3	0.4	1.7	2.7	2.3	1.1	1.6	10.2	9.5	8.8	10.5	9.9	9.5	9.9	10.1	8.9	9.3	9.7	9.6	16.7	3.2	5.4	4.2	15.2	25.4	38.9	12.6	16.5	18.2	24.9	20.2	17.3	20.0	12.5	14.7	10.4	15.2	19.8	19.9	11.7	19.4	22.4	17.6	17.2	19.1	12.6	19.0	4.4	23.2	20.7	16.7	21.4	19.6	5.1	31.0	17.9	20.5	18.4	15.2	5.1	21.0	12.2	33.1	20.9	10.6	15.8	15.1	7.2	2.8	16.3	14.2	22.6	3.5	5.0	28.2	13.4	15.1	16.4	32.8	15.2	16.5	11.2	15.5	26.3	26.0	21.1	14.9	7.9	28.0	28.1	19.7	16.3	21.0	24.4	36.7
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237622-122264840	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	9.0	9.5	7.4	6.4	7.9	11.7	16.4	8.0	10.1	8.9	7.3	7.5	7.0	8.8	10.3	7.7	7.4	7.6	13.5	7.8	8.8	11.4	8.4	7.2	8.1	8.2	7.9	9.5	6.9	11.9	5.7	10.4	8.6	11.1	8.1	11.5	7.9	8.3	20.7	6.8	6.1	8.7	8.0	8.0	8.5	3.6	8.0	9.5	10.0	23.1	7.6	8.7	5.4	8.4	8.1	8.3	11.2	12.4	16.1	19.8	9.7	18.0	14.7	12.1	11.2	9.6	7.8	14.1	7.7	11.8	13.3	18.5	17.6	18.7	15.1	14.5	8.0	10.5	12.6	8.2	18.1	21.1	14.0	17.0	20.8	12.7	25.8	12.1	17.6	11.3	14.6	10.7	18.3	8.8	11.1	13.0	8.7	27.2	13.7	9.7	23.2	19.3	16.9	9.0	23.3	12.3	13.6	18.9	21.3	8.8	11.0	11.8	9.8	11.3	6.4	18.3	18.0	15.5	30.7	11.7	18.6	12.9	13.8	4.5	6.2	11.4	6.3	7.2	6.1	5.8	5.5	6.2	6.5	4.0	5.7	6.0	6.5	5.4	9.7	4.6	6.4	5.8	7.4	7.9	8.0	10.1	7.8	8.8	8.2	7.9	8.6	8.0	8.0	8.4	19.7	32.1	12.8	2.0	18.3	21.7	11.7	28.5	19.9	12.4	27.2	20.7	51.6	10.0	23.1	25.8	2.1	32.8	23.3	17.2	27.4	23.2	75.0	14.7	19.9	21.6	19.7	28.4	9.1	16.2	44.7	15.9	13.3	16.4	17.7	14.1	13.6	13.7	27.7	3.3	12.9	16.5	34.6	21.0	17.2	76.9	13.4	18.4	19.6	4.7	20.6	16.9	27.8	6.0	10.7	23.0	18.7	17.0	16.4	20.8	14.8	26.6	19.8	14.7	19.7	15.2	25.4	19.7	22.1	16.5	25.9	56.9	23.5	16.7	14.2	20.7
RBM22	"Cwc2, FLJ10290, fSAP47, ZC3H16"	ENSG00000086589	"RNA binding motif protein 22"	Q9NW64	5	150690792-150701077	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001634	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA001634: AB_1079746"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.50e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (7.29e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.87e-3)"	20.3	15.8	18.8	19.3	21.1	64.5	22.2	21.8	28.5	21.3	17.4	22.5	19.7	23.5	19.8	16.8	25.4	22.7	20.9	18.9	19.7	21.8	21.3	22.7	29.2	21.0	18.9	30.7	18.1	23.9	10.9	22.6	20.6	17.7	23.4	23.6	16.4	19.6	27.3	18.8	19.0	21.3	20.3	26.7	19.1	11.6	19.6	41.6	22.2	34.3	32.3	26.1	16.0	26.0	34.9	37.3	56.0	66.2	37.2	34.3	79.4	35.0	39.1	68.4	75.7	61.3	50.7	51.7	54.5	33.6	65.1	36.1	73.0	63.3	71.0	57.6	55.6	41.4	35.1	26.3	35.4	74.4	47.0	29.1	50.1	56.5	37.0	30.2	48.9	41.7	44.3	50.7	43.2	41.3	68.4	50.6	33.8	42.2	37.6	69.8	46.4	45.9	34.0	35.6	52.4	39.1	39.3	64.4	65.2	33.4	67.2	64.9	33.0	55.5	43.7	24.3	64.4	46.8	56.0	74.2	44.0	66.3	42.6	27.0	30.6	51.8	33.9	36.7	38.2	37.9	31.4	32.5	36.5	35.9	33.2	31.8	52.8	43.8	46.9	19.7	37.4	33.4	18.8	21.1	21.8	28.5	18.9	19.7	21.0	18.9	20.6	20.3	19.6	26.0	69.4	28.9	28.2	8.5	51.3	26.0	52.9	33.9	42.1	33.3	29.3	25.9	28.2	27.1	35.9	16.5	25.0	54.9	56.6	34.2	25.4	36.3	8.4	48.4	44.1	50.5	25.9	34.9	7.4	34.3	43.6	39.3	24.5	101.6	63.4	37.3	27.8	16.6	44.3	30.3	7.6	33.2	44.7	31.1	30.3	3.6	43.2	45.8	23.2	6.5	48.5	35.9	58.7	7.5	13.7	29.1	37.1	45.5	32.1	25.6	29.4	22.5	23.1	19.0	32.9	40.2	37.6	32.0	28.5	22.8	21.7	72.7	56.9	34.4	33.4	39.4
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058532-73123899	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	31.4	23.2	14.7	36.0	16.2	72.6	30.7	21.5	20.9	28.7	17.2	28.9	23.4	31.4	22.7	28.9	29.5	21.2	22.2	14.5	19.3	20.8	21.2	30.3	40.0	14.9	13.7	31.1	33.2	22.7	25.3	26.7	16.1	22.5	24.0	41.9	31.4	19.8	41.1	33.3	29.9	23.2	12.5	29.7	27.7	28.5	15.9	36.4	29.3	21.9	33.4	28.1	29.8	20.7	97.8	55.6	86.9	66.6	38.1	44.6	76.5	78.4	54.6	59.5	65.2	74.5	61.2	116.7	40.5	54.0	45.1	72.3	100.9	47.2	101.6	73.8	53.3	98.2	43.2	57.7	24.1	87.5	60.0	32.4	33.3	69.7	56.7	51.1	60.0	42.4	102.7	47.6	65.2	73.3	114.4	51.1	73.8	59.6	60.1	97.4	94.8	57.1	49.0	67.4	58.5	55.8	98.5	64.4	35.0	52.2	92.7	37.9	77.2	87.5	85.5	47.3	79.7	50.2	96.0	141.5	39.1	61.3	61.2	17.4	17.2	16.6	19.9	19.2	18.7	22.3	15.8	16.9	18.2	23.7	16.6	17.6	20.3	27.2	17.5	28.7	19.2	11.7	14.7	16.2	21.5	20.9	14.5	19.3	14.9	13.7	16.1	12.5	15.9	20.7	177.8	230.8	319.9	94.7	226.2	227.4	194.3	109.8	198.6	253.8	136.2	139.2	131.5	77.2	191.8	92.0	268.9	151.8	268.4	137.5	17.6	111.0	71.1	160.4	295.6	170.2	155.2	149.3	115.4	122.6	183.5	185.1	146.8	223.2	247.8	183.3	95.3	98.3	113.1	180.0	99.3	146.3	54.9	110.8	180.8	29.2	157.8	169.9	81.8	71.2	176.9	131.2	155.5	84.9	134.1	132.9	111.0	137.7	233.2	236.5	86.3	32.9	137.0	263.0	72.3	234.2	213.4	213.8	212.9	196.7	236.7	185.4	242.9	161.0	162.5	235.1
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		NA	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	17.6	13.0	6.1	14.9	9.2	12.2	14.6	7.6	8.6	12.5	7.2	12.2	10.3	12.8	6.3	11.8	11.4	8.2	20.3	6.6	9.2	8.5	15.2	10.6	14.9	7.6	7.7	14.9	12.4	10.5	13.5	11.2	7.9	10.3	9.3	10.4	10.1	7.7	29.6	13.6	9.2	10.7	6.1	10.8	11.9	16.3	8.7	11.3	12.6	17.6	12.5	12.2	11.6	13.1	56.2	60.5	35.9	103.0	25.1	15.9	49.0	50.3	20.7	44.6	48.0	50.7	47.9	74.0	26.8	23.0	64.8	37.0	53.2	42.6	57.4	37.1	51.0	74.4	43.0	47.1	22.3	94.7	63.9	18.1	27.4	59.4	35.5	16.8	41.9	40.3	141.6	42.0	35.1	45.2	68.3	54.0	68.5	38.5	47.0	53.4	42.8	70.7	21.8	37.5	40.0	48.4	65.0	107.2	34.8	42.6	27.6	28.7	40.4	64.4	33.6	57.7	61.9	42.8	39.5	126.0	42.4	78.2	70.8	3.8	11.0	4.6	12.6	9.2	8.7	12.8	10.7	11.6	11.5	13.4	9.7	11.1	9.7	12.3	8.1	14.1	7.4	5.8	6.1	9.2	7.6	8.6	6.6	9.2	7.6	7.7	7.9	6.1	8.7	13.1	22.7	16.0	31.4	33.3	23.2	16.2	17.1	16.2	24.5	54.9	16.3	17.8	28.8	10.0	27.7	12.9	93.8	20.8	27.5	9.1	25.4	22.3	2.5	21.3	50.3	25.3	11.4	20.4	13.1	22.9	26.5	25.7	21.4	22.5	36.7	30.3	9.7	14.8	19.1	40.4	17.6	14.9	14.2	12.9	10.2	3.3	27.7	17.9	5.4	7.5	18.9	18.6	37.0	18.6	15.3	18.7	8.2	20.7	17.7	19.0	8.1	16.7	17.1	56.1	6.6	51.3	26.4	42.6	44.7	19.1	14.5	18.6	24.4	34.6	16.4	14.8
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48581162	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Exocrine glandular cells: 1442.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm		NA	NA		130000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"CAB062559: AB_2665621, HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	246.8	129.7	21.7	143.2	23.7	301.8	200.9	23.0	33.2	82.3	27.5	122.4	102.1	118.2	89.4	147.1	101.7	71.9	100.7	22.3	27.9	89.2	71.1	130.5	158.5	27.9	24.0	99.3	167.2	94.2	80.1	104.0	26.5	75.7	146.0	51.4	126.0	81.8	112.3	195.3	102.6	114.9	28.7	128.5	114.2	55.9	23.4	156.9	90.1	38.3	206.1	135.0	101.7	29.3	128.2	168.7	172.5	187.3	42.4	226.3	117.2	156.0	272.3	381.6	273.6	173.7	322.5	241.4	50.0	302.3	75.9	107.1	153.2	209.1	304.1	236.5	206.7	126.2	270.5	164.0	153.0	360.8	248.0	168.1	143.8	129.7	124.3	46.2	320.4	131.7	69.8	194.6	268.6	215.9	304.9	209.3	100.5	33.3	230.1	280.7	181.4	196.5	177.7	201.8	70.1	179.1	152.2	206.9	187.5	83.7	272.2	363.6	440.7	127.0	213.0	425.8	278.2	93.7	114.0	279.1	176.5	208.0	263.0	33.0	187.0	30.7	118.4	211.9	141.7	147.5	120.6	119.7	264.1	101.5	120.6	119.5	28.7	150.9	187.0	185.0	137.5	256.3	21.7	23.7	23.0	33.2	22.3	27.9	27.9	24.0	26.5	28.7	23.4	29.3	336.2	166.7	172.1	18.6	391.7	519.4	182.9	379.4	157.6	58.9	326.1	260.5	76.8	154.4	196.7	53.3	47.9	459.9	392.1	165.8	176.1	482.2	6.0	114.6	193.8	292.9	247.4	287.0	18.4	1442.0	726.9	274.2	164.1	234.3	265.2	144.9	195.9	74.6	433.2	42.1	17.7	360.2	136.3	439.5	783.6	17.1	245.7	339.3	522.9	18.7	571.7	181.8	358.4	15.1	18.0	915.3	235.9	147.4	317.7	119.0	143.3	164.3	84.6	87.0	131.5	378.4	299.4	43.6	200.8	285.2	507.8	489.3	352.5	178.2	368.0	202.6
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92540481	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	8.3	8.6	8.2	5.6	9.4	14.1	8.2	10.1	12.1	9.0	6.5	8.0	5.3	8.2	4.8	7.6	8.4	3.8	10.0	8.5	7.5	7.4	9.0	6.4	8.4	9.0	7.7	9.8	8.5	4.6	7.5	4.6	9.1	8.2	4.6	6.5	8.3	3.3	13.5	8.0	9.0	3.7	7.3	11.3	8.0	8.9	8.5	6.5	8.4	7.0	6.4	7.3	8.3	12.1	5.5	4.0	6.8	11.1	6.5	7.3	5.4	6.5	5.2	6.4	6.1	4.9	6.9	8.0	11.8	4.4	9.9	6.2	6.6	4.6	7.9	7.8	9.4	5.3	12.0	5.8	5.2	10.2	7.1	5.2	8.5	7.2	6.5	8.9	6.9	10.1	11.5	13.1	6.9	5.6	12.1	10.1	6.1	6.9	5.8	6.5	6.1	9.8	5.9	5.9	7.6	9.9	5.7	11.6	8.6	8.3	3.7	8.5	4.4	11.7	6.3	9.1	8.9	8.6	11.1	13.3	5.3	8.6	11.0	67.8	12.4	30.3	23.2	16.3	25.7	28.5	25.1	23.7	12.3	28.7	32.1	27.3	19.2	26.2	13.3	14.3	25.7	16.0	8.2	9.4	10.1	12.1	8.5	7.5	9.0	7.7	9.1	7.3	8.5	12.1	13.5	12.8	7.5	8.1	23.5	8.5	13.2	11.9	12.5	12.7	8.7	7.7	16.7	5.7	10.9	3.7	0.0	10.9	18.8	6.9	7.9	9.2	9.4	9.5	12.3	13.8	0.0	8.6	20.5	6.0	5.8	11.7	6.6	12.9	30.4	11.9	7.9	3.7	6.2	11.8	15.8	4.0	14.2	6.8	6.4	5.9	5.9	8.1	5.4	5.6	9.8	11.5	26.8	11.1	34.3	5.5	6.2	6.4	16.6	10.5	7.0	9.6	7.8	13.2	13.1	15.0	13.7	24.0	15.5	9.9	11.4	15.3	18.9	8.4	5.7	11.8
RBM5	"H37, LUCA-15, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088919-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	70.6	53.9	42.2	44.2	45.4	63.5	69.8	48.4	49.6	96.2	47.9	74.8	37.4	74.6	64.0	57.5	85.8	40.1	58.0	41.1	52.5	66.2	58.1	61.8	66.8	46.5	42.5	120.2	73.1	45.2	84.7	60.1	46.2	85.2	47.7	90.5	63.9	47.2	63.6	81.6	72.1	53.7	40.9	95.2	64.8	62.9	44.1	62.5	80.8	36.4	69.5	66.6	73.2	62.5	31.1	37.3	132.6	58.2	54.3	78.1	31.3	91.9	54.8	67.0	46.9	37.6	34.7	72.4	31.0	60.3	65.6	26.8	90.4	44.5	71.5	67.5	33.2	91.0	136.5	34.2	66.7	84.1	71.0	70.1	49.8	72.7	71.3	114.5	71.9	72.5	63.3	47.4	63.7	27.3	85.6	56.9	47.9	52.3	42.3	46.3	57.9	37.6	48.7	152.1	19.0	43.8	75.6	32.8	46.2	89.5	30.2	79.9	82.0	44.3	45.9	61.7	53.7	64.8	103.2	76.4	32.9	50.8	52.3	54.3	21.4	29.2	24.8	22.2	23.3	20.5	22.2	25.9	18.4	19.6	27.9	22.3	39.0	22.9	22.6	13.9	28.5	17.0	42.2	45.4	48.4	49.6	41.1	52.5	46.5	42.5	46.2	40.9	44.1	62.5	70.1	70.5	103.3	108.7	69.9	32.0	39.8	31.1	27.3	94.4	43.9	44.2	44.5	25.8	68.2	38.6	183.5	52.5	77.0	51.3	11.7	27.3	128.2	52.4	67.9	67.9	73.5	40.2	100.8	20.9	26.2	54.4	74.5	47.8	68.9	85.1	60.3	40.0	32.4	94.2	107.1	53.7	50.8	42.2	48.4	246.2	64.3	56.4	44.4	96.5	66.9	43.2	75.2	117.6	136.0	30.8	45.8	57.9	64.5	49.5	42.4	11.3	84.0	126.1	32.9	62.4	57.1	57.8	33.0	31.1	34.0	81.7	68.1	52.2	44.7	55.5
RBM7		ENSG00000076053	"RNA binding motif protein 7"	Q9Y580	11	114400030-114414203	"Predicted intracellular proteins"	Meiosis	RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 196.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013993, HPA048003"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA013993: AB_1856137, HPA048003: AB_2680231"	"unprognostic (2.90e-3)"	"unprognostic (8.21e-3)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.38e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	18.5	9.1	3.4	6.5	5.3	39.8	15.3	7.6	7.8	12.9	3.6	13.1	6.2	13.9	4.9	13.3	13.9	10.5	9.9	4.0	5.1	12.7	18.0	13.7	6.8	6.3	5.0	16.4	10.0	9.6	7.2	11.3	5.0	10.1	11.2	6.8	12.7	8.7	12.2	10.8	11.3	10.9	5.2	10.1	12.1	11.5	4.0	15.2	10.4	14.6	9.3	12.6	13.2	6.6	13.1	13.4	17.0	11.5	21.9	27.6	11.3	31.1	43.5	34.6	37.8	30.7	28.1	24.2	34.5	28.0	26.0	11.0	19.7	23.6	40.4	15.3	8.4	27.5	14.5	27.3	36.7	18.9	15.3	32.2	25.0	31.2	41.7	32.6	30.1	17.1	19.8	2.9	20.8	6.4	23.0	9.5	13.9	13.1	19.7	14.5	29.5	18.2	26.1	22.2	13.1	12.5	18.8	10.4	8.9	27.5	6.8	5.0	26.6	9.1	17.2	10.2	22.8	10.8	12.4	18.8	7.3	22.7	14.9	53.0	15.3	17.8	11.5	13.7	15.2	11.9	11.6	10.5	15.2	9.7	14.8	11.6	14.0	17.3	16.5	14.0	14.7	10.6	3.4	5.3	7.6	7.8	4.0	5.1	6.3	5.0	5.0	5.2	4.0	6.6	49.4	16.0	25.7	2.0	44.0	67.4	78.4	48.4	41.5	11.5	47.4	31.9	15.1	30.0	34.2	29.5	12.5	51.0	52.4	30.8	66.5	49.8	196.4	37.6	38.8	45.0	47.4	26.1	5.4	35.1	78.0	51.7	26.0	51.3	40.0	20.1	37.9	27.5	29.8	8.4	5.6	30.9	40.7	27.4	55.3	29.5	31.4	30.8	42.7	7.5	32.2	24.5	28.8	8.5	10.2	39.0	37.6	17.0	18.0	71.2	38.1	46.5	27.8	13.0	0.0	49.1	47.6	35.3	16.9	32.8	68.6	92.5	46.6	18.7	38.4	82.6
RBMS1	"C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1"	ENSG00000153250	"RNA binding motif single stranded interacting protein 1"	P29558	2	160272151-160493807	"Predicted intracellular proteins"	"DNA replication"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 398.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047943, HPA061791"			Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA047943: AB_2797235, HPA061791: AB_2684611"	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.16e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (1.33e-7)"	"unprognostic (1.84e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.32e-1)"	58.2	22.6	8.7	43.3	13.3	35.8	34.5	9.7	11.9	36.6	17.2	38.9	12.8	51.7	12.6	28.9	31.6	34.1	41.0	7.2	10.7	36.5	22.3	47.7	28.3	13.8	12.3	44.1	10.2	50.4	16.0	83.8	15.0	24.0	15.8	6.8	19.2	28.6	16.4	29.4	20.5	56.9	10.9	40.7	20.1	10.4	13.4	26.1	23.0	23.8	22.0	57.0	31.6	10.2	50.5	18.2	63.9	8.4	90.2	155.6	77.1	62.7	89.1	42.4	43.8	50.9	36.9	0.4	76.3	106.6	20.0	30.0	31.1	46.0	69.2	40.9	23.2	18.9	44.2	41.0	82.3	30.8	1.1	187.9	35.6	73.7	32.8	56.7	67.5	15.1	1.2	23.0	103.2	39.4	28.8	31.2	39.3	8.3	40.1	21.6	55.7	25.5	64.9	61.1	8.3	21.7	39.1	22.9	60.2	78.8	11.7	47.9	81.7	75.3	47.7	69.7	57.5	12.2	0.7	21.2	60.7	46.2	49.2	4.0	20.5	26.2	8.6	12.0	29.5	0.9	14.9	13.3	13.7	1.9	24.1	10.9	44.4	13.7	6.9	7.6	2.7	11.0	8.7	13.3	9.7	11.9	7.2	10.7	13.8	12.3	15.0	10.9	13.4	10.2	102.8	112.2	97.8	12.1	37.3	91.1	110.0	59.1	55.2	3.0	44.7	43.2	62.3	18.6	48.1	69.9	0.0	99.1	83.9	0.4	25.4	24.5	59.2	39.8	141.4	126.0	0.0	38.3	132.7	47.3	112.6	161.8	36.7	42.0	20.3	40.8	162.8	29.1	126.3	1.7	136.1	0.5	22.4	123.4	80.2	15.5	88.9	103.8	55.2	153.6	81.2	20.8	93.7	116.1	19.7	96.4	1.3	98.9	23.3	107.0	0.3	36.4	54.1	1.4	78.9	113.6	185.9	6.7	14.5	47.3	82.5	398.3	113.0	53.4	0.5	175.5
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905359	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA042863: AB_2678204, HPA062144: AB_2732677"	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	11.9	8.9	8.8	12.1	10.8	32.5	10.4	14.0	10.0	13.5	4.4	10.4	9.9	11.9	8.1	13.0	9.7	11.0	13.8	10.9	7.9	12.7	13.4	11.5	18.5	7.1	7.4	11.2	6.8	15.8	9.6	14.6	7.6	9.7	11.2	16.0	9.0	9.1	11.8	10.0	9.4	13.9	7.1	14.1	11.8	11.6	8.0	18.8	12.9	15.3	17.2	14.4	9.0	10.5	17.3	26.2	33.5	18.2	17.4	19.8	17.8	22.0	24.4	25.2	21.8	31.2	18.8	28.8	16.7	29.8	30.1	40.9	35.4	25.1	27.7	13.4	13.5	16.4	44.4	21.3	23.1	19.9	26.5	19.9	25.5	24.3	34.6	22.0	35.6	25.4	24.1	21.6	32.9	23.9	20.2	14.7	17.7	24.9	21.8	19.7	54.8	19.4	25.8	13.9	38.3	25.8	39.2	24.9	21.2	22.8	29.2	17.2	33.9	20.5	17.3	27.7	39.8	14.0	25.4	32.1	22.3	18.2	23.1	10.0	4.6	6.0	6.1	7.3	5.1	4.3	4.8	6.0	4.1	5.8	4.5	4.5	8.0	4.0	6.7	6.5	5.1	2.8	8.8	10.8	14.0	10.0	10.9	7.9	7.1	7.4	7.6	7.1	8.0	10.5	33.8	41.7	32.8	20.9	27.7	11.0	13.6	20.0	20.5	19.2	15.6	10.5	34.8	12.8	17.3	9.2	37.5	15.7	26.6	18.9	3.9	12.0	5.9	27.6	30.9	28.3	23.3	22.7	38.4	11.4	15.2	18.4	23.9	40.1	17.1	21.9	29.6	19.5	9.6	28.6	35.1	19.8	12.2	27.4	19.4	9.5	13.4	21.4	14.2	30.9	26.1	16.9	24.7	35.2	39.3	23.5	9.0	18.0	22.5	24.3	14.8	12.0	17.7	20.2	19.7	16.3	24.1	30.7	17.9	23.3	14.8	23.0	28.8	15.4	14.7	27.3
RCCD1	MGC14386	ENSG00000166965	"RCC1 domain containing 1"	A6NED2	15	90954870-90963125	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039683, HPA040776"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"HPA039683: AB_10794752, HPA040776: AB_10795478"	"unprognostic (1.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.63e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	3.9	8.8	4.1	3.0	4.3	4.6	3.5	5.5	5.2	6.9	5.0	6.3	5.1	5.5	3.5	6.6	6.0	2.0	5.9	4.0	3.6	6.2	6.7	2.6	3.9	3.3	3.2	7.3	9.2	5.2	2.9	2.2	3.7	5.4	4.5	3.1	5.0	2.8	3.8	7.4	4.8	2.8	2.9	4.3	6.7	5.8	3.5	4.7	4.5	1.0	4.7	5.5	5.7	3.4	8.0	11.7	2.7	5.7	6.6	7.8	20.2	9.1	1.6	2.6	2.7	5.6	14.9	28.0	14.2	5.6	0.2	16.8	8.9	2.4	4.3	23.7	18.2	20.3	21.2	8.0	5.5	9.8	7.7	5.8	8.0	2.6	3.6	10.3	4.3	16.2	15.7	18.0	7.8	2.7	11.8	10.2	10.4	9.6	4.8	14.0	13.6	30.4	12.0	3.6	8.8	10.1	15.8	10.0	11.6	14.2	11.5	18.7	6.9	1.6	11.2	6.6	0.4	31.9	14.1	16.9	3.0	21.4	7.7	0.0	0.2	0.0	0.2	0.6	0.5	0.8	0.4	0.7	0.4	0.5	0.8	0.2	0.0	0.5	0.3	0.6	0.6	0.2	4.1	4.3	5.5	5.2	4.0	3.6	3.3	3.2	3.7	2.9	3.5	3.4	6.0	0.0	2.2	7.5	9.7	7.4	11.3	9.0	7.4	6.2	9.9	10.9	8.5	4.3	5.3	7.3	4.2	20.9	5.0	14.9	3.9	8.0	3.1	3.2	8.2	5.0	22.1	56.8	9.6	4.9	18.4	8.0	8.2	5.7	0.0	12.5	4.2	8.5	12.0	0.0	11.3	20.5	6.1	8.1	4.0	6.5	8.7	5.7	5.4	3.7	4.3	11.1	10.3	8.5	2.0	5.0	11.7	7.9	9.4	9.8	17.4	13.7	2.9	2.9	26.3	9.7	9.2	22.2	20.1	17.2	8.9	9.0	4.6	10.2	25.7	7.3
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931738-76954393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 321.5"	"Cell type enhanced"	"Detected in all"		"Spermatocytes: 528.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		92000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	31.3	30.8	42.5	24.9	43.9	24.6	35.8	35.8	57.8	34.1	41.4	33.1	22.2	44.0	321.5	28.5	54.3	32.6	38.8	44.0	55.0	49.3	19.8	28.8	30.0	38.0	45.1	34.2	21.5	80.6	30.8	49.2	46.9	41.2	36.5	43.9	22.7	41.1	56.9	22.6	23.3	39.6	40.0	25.4	26.9	93.4	51.4	40.3	48.0	60.4	32.4	39.0	25.2	40.8	93.9	65.3	284.1	134.9	120.1	135.6	177.3	109.1	147.5	138.7	115.1	81.2	78.2	58.3	154.3	119.3	149.5	139.9	217.4	94.0	176.0	45.3	170.8	28.9	91.4	135.0	143.0	105.4	42.9	123.6	126.8	68.2	87.5	146.1	148.9	98.3	74.2	56.3	146.6	60.3	104.9	71.9	216.6	98.0	72.1	109.4	187.0	37.3	91.6	123.8	161.8	161.1	178.8	98.6	220.5	251.1	96.0	115.0	80.5	162.8	131.2	104.8	228.0	80.4	266.6	69.6	92.8	87.6	151.1	7.5	7.6	16.2	21.7	7.4	24.9	23.4	23.0	28.1	16.1	22.9	25.5	25.1	3.9	23.5	12.3	19.1	18.1	20.0	42.5	43.9	35.8	57.8	44.0	55.0	38.0	45.1	46.9	40.0	51.4	40.8	87.3	25.6	36.8	56.8	111.2	82.1	125.0	85.5	96.2	87.1	75.9	74.8	94.9	62.9	52.5	99.3	37.5	183.1	76.3	23.3	49.0	116.0	44.8	87.0	101.6	64.8	73.5	91.5	48.4	45.1	296.8	106.0	54.6	85.6	28.6	120.9	60.0	32.8	57.3	127.9	72.0	55.0	101.7	30.5	38.3	81.7	61.8	30.0	92.5	19.7	34.1	99.7	89.6	149.8	63.3	56.9	43.2	93.6	85.6	127.5	25.8	56.2	48.7	58.9	59.2	78.9	126.3	528.6	140.8	109.3	70.8	163.6	76.7	131.8	84.4	117.0
RCOR1	"COREST, KIAA0071, RCOR"	ENSG00000089902	"REST corepressor 1"	Q9UKL0	14	102592649-102730561	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001956, HPA049327, HPA054241"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.05e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.72e-4)"	11.2	5.8	3.3	11.2	3.1	46.1	9.0	4.6	4.1	14.2	3.3	11.0	12.0	9.5	13.3	33.2	9.5	8.7	6.7	5.0	3.6	6.7	9.4	12.9	11.9	3.4	3.5	9.0	7.9	10.4	5.2	20.8	3.6	8.8	11.1	6.3	10.2	5.8	11.8	16.6	12.6	8.8	3.5	8.6	13.4	13.7	4.3	14.5	6.3	10.6	14.7	10.2	19.1	4.2	21.3	19.5	17.2	19.0	13.5	18.6	36.1	21.5	15.2	19.7	18.7	18.0	25.2	23.8	17.1	18.7	9.9	32.6	26.2	15.4	29.4	10.1	9.6	44.2	17.4	17.6	18.4	44.3	38.2	13.1	23.6	17.4	26.5	21.1	21.8	22.1	35.7	17.5	20.1	34.6	27.8	29.9	8.5	23.2	33.1	70.4	17.4	10.6	24.1	25.9	22.2	13.8	48.1	21.9	13.9	21.5	30.0	34.6	23.8	13.6	10.2	43.8	14.2	12.9	16.6	25.0	16.3	32.0	14.6	3.1	1.4	2.2	0.2	1.5	0.3	0.3	0.3	0.6	1.5	0.3	0.3	0.3	3.7	0.7	1.8	0.6	0.5	0.5	3.3	3.1	4.6	4.1	5.0	3.6	3.4	3.5	3.6	3.5	4.3	4.2	15.8	48.1	40.0	32.3	27.3	57.6	27.7	12.0	30.7	8.4	25.6	20.7	16.7	10.0	19.7	3.7	2.1	31.1	39.1	31.5	5.9	6.7	5.1	55.7	36.1	15.9	21.0	32.2	39.3	7.4	20.4	20.2	32.6	58.3	24.1	18.0	11.0	11.7	15.1	10.1	33.8	16.8	10.2	38.8	65.6	4.9	24.2	43.6	24.9	52.5	33.1	9.5	12.3	22.1	23.5	16.7	15.2	21.1	14.8	25.4	18.2	8.0	16.3	5.4	0.0	18.9	19.6	22.5	18.6	46.9	117.6	43.1	26.2	20.3	22.8	72.3
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	16.9	15.6	11.3	10.7	16.1	31.7	19.7	21.8	16.6	20.3	9.2	19.6	12.1	19.1	21.4	14.5	18.2	12.4	22.7	11.1	14.3	15.7	15.9	14.5	15.2	13.4	12.0	26.7	19.7	20.8	16.9	14.9	14.6	23.9	13.8	30.5	19.5	24.5	65.2	19.2	18.7	14.0	11.5	18.6	16.2	33.7	12.6	19.2	31.9	51.7	14.6	18.8	18.0	22.3	15.5	13.9	25.1	14.4	21.3	20.2	26.4	18.3	18.3	20.0	20.2	12.0	20.9	22.8	11.6	23.7	13.9	23.4	20.6	18.2	15.4	21.5	10.9	21.4	22.6	17.0	23.4	34.2	19.8	22.0	16.6	21.9	27.3	22.4	11.8	23.2	21.0	29.2	29.9	11.2	16.8	18.8	27.2	11.3	14.4	17.8	49.6	27.3	17.2	28.5	16.0	32.5	46.7	24.3	33.6	24.1	29.9	23.3	17.1	17.5	19.7	23.2	20.4	23.5	18.4	30.1	15.2	19.6	15.9	27.2	12.4	45.9	8.8	12.5	11.8	15.4	9.4	9.7	13.7	11.4	16.0	11.6	20.8	19.8	14.3	14.5	12.7	8.8	11.3	16.1	21.8	16.6	11.1	14.3	13.4	12.0	14.6	11.5	12.6	22.3	23.1	38.5	44.4	67.6	23.0	14.5	10.7	16.4	29.6	43.7	29.0	25.9	73.4	24.3	24.9	14.7	35.5	26.7	30.2	16.6	21.5	10.4	70.4	22.0	37.4	17.7	34.2	29.8	121.9	15.4	14.8	24.0	28.1	26.6	19.6	21.7	21.8	20.8	20.5	23.5	101.1	17.3	16.2	22.3	14.2	122.6	22.4	24.6	23.2	49.6	22.2	24.1	14.4	87.9	131.6	10.4	15.8	27.1	28.1	12.5	24.1	22.8	22.2	47.7	0.0	33.2	24.8	65.4	35.1	33.1	16.9	25.4	22.6	22.7	17.5	9.0
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560679	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	14.4	14.5	10.6	8.3	10.8	5.4	12.6	11.0	12.4	10.1	15.7	14.6	11.6	14.2	12.2	9.8	11.9	9.4	29.8	10.5	10.8	14.0	18.5	11.8	12.5	10.8	10.5	10.0	14.1	18.7	11.3	13.0	11.3	13.3	10.4	8.3	10.7	11.0	28.1	9.6	11.4	12.0	11.1	11.5	14.6	11.5	10.7	12.5	11.1	27.1	9.5	15.5	10.2	11.7	28.6	8.9	7.3	6.0	21.8	22.9	24.7	16.8	17.7	15.2	15.0	6.9	14.6	28.2	9.7	10.3	19.7	15.3	10.8	19.9	17.6	15.6	28.8	10.8	10.6	21.4	18.6	13.7	14.1	17.5	19.9	14.8	22.9	21.2	14.2	11.2	19.9	9.2	25.2	9.2	11.8	23.7	19.9	21.9	24.1	16.5	20.1	12.1	29.9	18.4	11.2	19.3	9.3	20.4	25.8	15.4	10.1	7.2	14.4	21.5	13.1	16.6	20.6	26.0	23.1	20.8	15.1	9.0	17.1	1.4	1.4	6.5	3.3	1.7	5.5	7.3	3.9	4.9	1.9	11.6	5.5	4.5	0.5	3.1	1.7	6.1	5.1	1.3	10.6	10.8	11.0	12.4	10.5	10.8	10.8	10.5	11.3	11.1	10.7	11.7	21.7	16.0	12.8	0.0	36.1	24.5	31.0	27.9	31.3	23.5	20.1	24.5	55.6	32.9	20.9	16.5	6.2	44.6	34.8	20.6	31.3	37.8	27.4	27.4	19.7	19.4	13.2	18.7	0.0	35.3	50.3	38.5	20.4	19.7	12.7	16.4	20.3	30.0	24.2	15.2	0.0	27.1	20.3	17.2	14.6	13.6	66.8	15.4	23.2	0.0	23.2	31.3	29.9	0.0	0.0	27.0	36.3	44.8	15.6	45.1	23.3	38.1	18.8	22.4	32.9	28.5	29.6	79.5	30.6	18.9	18.6	45.7	27.1	30.9	29.2	27.3
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468910-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA		25000	"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	28.9	17.1	5.8	33.9	7.4	18.7	18.6	6.9	7.1	19.1	7.5	14.9	11.4	22.3	13.7	19.8	14.9	20.6	26.9	5.7	7.1	14.9	15.7	22.9	40.9	8.9	7.3	14.8	9.9	10.8	5.3	22.2	8.5	15.9	18.2	9.9	10.1	17.8	12.5	18.5	13.5	30.4	7.7	31.6	14.5	10.5	8.0	34.3	16.6	19.7	38.4	26.1	10.3	9.1	61.6	61.1	46.5	34.7	94.3	116.1	52.3	119.9	101.6	76.2	88.7	68.5	49.9	73.6	43.5	83.7	94.0	44.3	51.2	60.4	108.5	122.1	31.9	89.8	65.6	30.0	35.9	62.3	66.1	64.8	30.1	109.0	79.1	67.6	87.2	50.6	33.0	36.1	102.3	31.2	70.0	73.6	77.1	18.3	41.6	56.8	184.7	57.2	29.6	42.5	12.8	35.7	86.9	23.6	62.0	159.0	58.3	37.4	115.6	105.9	67.4	93.9	111.6	14.3	46.3	161.3	88.9	35.9	80.2	21.4	18.6	18.0	31.2	32.3	31.5	30.3	29.3	30.9	24.0	26.6	19.1	26.7	8.7	36.9	31.0	17.8	44.8	24.0	5.8	7.4	6.9	7.1	5.7	7.1	8.9	7.3	8.5	7.7	8.0	9.1	56.1	22.4	18.8	6.2	45.0	23.6	15.4	23.3	22.2	11.8	14.7	14.7	8.7	10.0	22.1	14.7	14.6	13.0	59.0	5.8	9.8	20.3	1.4	15.9	41.0	45.7	9.7	30.3	15.1	24.8	27.5	45.6	7.7	17.6	52.6	23.1	30.7	15.9	27.9	15.2	9.4	6.5	12.2	35.3	26.1	2.2	22.1	50.8	30.2	12.2	50.6	16.9	64.9	10.1	19.1	31.8	4.2	37.6	33.5	7.3	4.3	12.4	25.1	10.8	13.1	33.1	34.9	7.6	12.7	20.8	42.9	3.6	53.6	31.8	8.0	10.5
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"	O94761	8	144511288-144517845	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;testis: 22.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.5;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	1.7	1.8	3.0	5.8	3.7	25.4	2.0	7.7	7.0	2.9	0.1	4.7	6.0	2.5	0.4	13.3	2.1	2.1	1.8	2.6	1.6	2.5	2.7	2.3	6.8	6.9	2.3	2.7	3.1	0.7	3.1	2.5	7.4	8.6	1.6	1.5	5.8	0.8	2.5	10.1	5.2	1.0	1.7	6.5	3.2	22.4	4.1	7.4	3.4	0.5	2.5	2.5	3.1	3.6	33.7	58.8	27.0	57.1	1.6	2.6	47.1	33.2	5.9	24.2	20.2	58.4	48.4	22.8	21.5	5.6	14.2	40.1	18.0	14.2	6.6	40.3	68.6	82.4	118.5	44.3	0.5	21.2	65.7	3.3	2.1	27.1	5.5	3.4	6.8	45.4	83.3	28.9	8.5	104.1	77.3	56.9	18.8	27.8	69.5	80.0	21.2	37.9	6.7	35.8	52.9	32.0	45.2	37.3	12.1	7.4	45.5	45.7	9.2	38.9	117.4	47.3	62.6	16.0	18.1	39.3	22.4	64.6	39.9	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.7	7.7	7.0	2.6	1.6	6.9	2.3	7.4	1.7	4.1	3.6	0.7	0.0	0.0	2.0	2.2	1.5	0.7	0.9	1.2	2.7	3.7	2.7	1.8	1.5	0.5	0.0	4.2	3.9	1.0	5.9	0.0	0.5	3.9	2.1	0.9	0.7	0.0	6.1	2.0	0.4	8.1	1.8	4.6	2.0	0.0	8.8	0.0	0.7	3.6	0.0	1.6	4.1	0.0	0.6	1.1	7.4	1.2	1.0	0.0	0.0	0.3	0.3	1.0	0.0	0.8	0.3	0.2	1.5	9.1	0.7	0.7	0.5	0.7	1.7	0.0	1.4	1.2	23.5	20.6	6.6	1.0	1.5	1.2	0.5	7.0	0.7
RELA	"NFKB3, p65"	ENSG00000173039	"RELA proto-oncogene, NF-kB subunit"	Q04206	11	65653597-65663090	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004264, CAB005030, HPA063461"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016"	"unprognostic (9.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.30e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.53e-1)"	67.3	42.8	27.4	38.5	29.9	79.7	63.1	28.7	35.0	61.7	26.9	63.3	31.3	61.0	23.0	60.8	62.3	34.7	49.4	27.3	29.6	50.0	66.6	70.3	39.7	35.5	30.0	65.3	49.0	25.9	32.3	27.8	31.8	55.6	23.8	9.8	54.4	35.4	74.9	66.1	49.1	39.8	29.1	59.7	56.8	24.1	31.4	30.3	45.0	26.9	36.7	60.3	59.4	33.4	66.9	68.4	31.4	45.2	49.1	49.6	32.2	52.9	65.6	62.3	49.9	33.0	71.1	53.0	85.5	75.4	72.0	63.9	36.8	66.6	35.5	62.1	53.2	57.5	50.1	47.5	56.7	43.8	78.8	55.4	65.3	70.4	79.2	58.9	76.6	43.7	56.6	61.4	48.5	90.3	74.1	38.5	20.9	43.6	64.6	61.5	29.6	80.6	50.7	60.9	26.6	59.5	47.1	72.7	72.4	22.2	82.3	29.4	100.3	65.8	55.3	103.3	50.9	86.0	80.5	53.6	71.7	30.8	65.4	12.5	14.0	18.6	22.7	17.1	25.5	17.3	19.8	22.4	15.4	14.0	18.4	20.0	21.2	25.2	15.4	15.3	21.4	16.5	27.4	29.9	28.7	35.0	27.3	29.6	35.5	30.0	31.8	29.1	31.4	33.4	43.2	32.1	25.5	9.1	33.9	47.3	54.4	41.3	33.0	9.4	31.6	27.9	23.1	17.2	30.9	11.0	8.4	24.0	40.7	30.9	29.4	41.4	5.1	32.8	25.7	43.9	19.7	19.0	5.5	45.1	24.8	30.1	33.1	50.0	44.3	26.2	32.9	20.3	24.3	15.2	5.9	25.0	32.6	24.9	40.4	7.7	28.9	28.0	32.0	10.3	35.2	14.5	28.8	7.5	13.8	65.4	20.8	26.4	30.7	66.8	22.2	17.4	23.4	9.5	13.1	30.5	34.7	14.3	20.3	29.2	43.2	43.6	37.9	21.0	21.6	75.1
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	15.6	19.0	13.7	16.7	19.2	33.1	22.2	15.4	15.6	16.9	12.0	15.3	13.3	19.2	17.4	13.8	14.6	12.2	16.5	13.5	14.9	20.8	25.5	18.2	30.2	16.5	15.6	26.1	29.0	31.4	14.7	14.6	18.0	17.8	14.8	24.3	16.6	16.1	11.6	14.9	13.8	17.1	15.4	17.0	14.9	11.8	14.8	28.0	23.1	15.9	30.2	13.5	14.1	25.5	43.5	19.4	53.7	44.1	25.4	32.0	27.5	49.1	44.6	49.2	58.2	37.8	43.1	106.5	32.4	33.2	52.8	20.7	49.8	42.6	78.5	19.5	33.9	48.0	35.6	34.7	30.6	67.5	30.7	24.6	33.8	49.9	55.3	39.1	38.8	52.1	48.0	22.1	37.9	17.5	99.7	43.4	33.0	26.8	24.2	78.1	97.8	33.7	21.4	30.1	37.6	36.4	29.1	11.3	37.6	33.4	29.8	37.5	30.0	40.3	49.6	37.8	63.1	31.0	45.8	101.3	33.1	69.3	41.2	8.2	8.6	3.8	13.7	6.9	10.1	14.6	11.7	11.9	6.9	16.1	13.8	12.2	3.9	12.6	8.9	14.3	11.5	5.5	13.7	19.2	15.4	15.6	13.5	14.9	16.5	15.6	18.0	15.4	14.8	25.5	65.5	64.1	120.6	33.0	62.9	20.6	37.9	26.5	47.3	67.8	60.5	62.4	86.1	45.8	37.0	57.0	60.5	43.1	83.8	30.6	72.4	54.8	73.0	45.9	79.1	56.1	30.0	57.9	22.0	66.0	48.5	54.9	28.1	60.0	25.9	82.2	57.8	82.0	30.7	85.8	32.1	58.2	12.2	44.3	16.6	32.3	82.0	35.1	16.0	22.5	58.1	82.7	107.1	38.7	95.7	51.1	34.2	91.7	75.0	50.0	36.1	124.2	32.6	83.3	59.2	61.6	54.6	49.0	66.5	38.2	21.3	32.2	63.7	70.8	49.1	44.5
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.0	6.0	7.3	19.3	7.6	41.5	13.8	8.9	11.9	8.8	7.4	15.4	10.9	14.1	6.6	11.8	10.8	7.7	9.1	7.5	7.5	7.3	10.7	7.2	31.5	7.3	7.4	15.0	11.0	8.0	5.7	14.5	7.6	7.7	20.4	11.2	8.6	7.0	8.3	11.7	11.7	17.6	7.5	14.3	10.4	22.7	8.1	35.7	7.3	6.7	34.5	7.8	8.2	8.3	167.3	56.2	130.8	83.6	18.8	20.1	103.0	78.9	49.9	123.6	135.8	84.8	77.9	119.5	177.4	38.0	118.0	86.1	116.5	77.5	151.1	180.5	102.5	123.3	86.3	86.3	14.6	131.8	79.5	17.3	27.5	84.9	66.1	27.6	42.0	183.8	97.9	165.4	85.3	79.7	167.2	122.8	116.0	148.1	76.0	129.9	112.5	164.3	44.9	60.7	126.3	63.3	97.3	107.6	90.3	97.6	183.0	123.7	19.6	74.4	93.3	125.8	239.9	91.9	216.9	398.9	65.3	142.8	100.0	0.0	2.8	9.7	11.5	4.2	11.1	13.1	11.4	12.0	5.0	15.1	11.2	10.2	0.6	9.8	14.7	9.6	21.8	7.7	7.3	7.6	8.9	11.9	7.5	7.5	7.3	7.4	7.6	7.5	8.1	8.3	5.1	0.0	2.2	3.3	14.0	6.0	15.3	18.1	5.2	16.1	4.1	8.1	7.5	5.7	9.3	11.0	0.0	43.0	9.7	4.4	5.9	15.3	27.3	5.6	7.0	6.1	1.2	46.3	5.2	16.6	55.7	8.3	6.6	6.0	8.2	25.3	6.1	3.0	23.9	8.4	4.4	7.1	10.2	2.6	4.9	10.0	10.5	6.2	1.8	4.7	12.2	14.9	9.2	2.5	4.3	9.2	4.1	7.9	23.8	3.8	2.8	7.9	7.9	14.4	6.6	10.2	13.1	86.7	50.5	7.9	3.0	11.2	9.6	8.8	13.9	4.7
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621399-74666877	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 47.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 42: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	5.2	3.9	2.5	9.9	3.5	47.7	7.6	4.0	3.2	6.4	4.4	8.0	6.5	6.2	5.3	9.4	6.8	6.5	2.9	2.3	2.9	6.7	5.8	6.1	15.4	3.3	3.1	7.0	10.2	6.8	3.8	8.0	3.2	4.9	9.3	6.2	5.8	5.1	3.3	12.6	6.1	6.1	2.8	8.1	6.2	25.2	3.4	27.1	6.6	2.7	16.7	7.2	6.8	4.7	46.1	57.5	42.6	31.2	8.8	11.9	47.8	40.5	30.9	63.0	54.5	75.4	46.8	63.6	32.1	31.8	31.6	53.9	70.3	42.1	76.9	20.0	42.1	56.3	46.0	43.0	7.6	57.3	56.3	8.6	13.2	79.6	48.7	16.3	27.3	53.2	86.7	27.7	48.1	72.8	84.0	52.2	84.0	26.8	27.7	128.7	28.8	55.9	22.7	47.8	31.5	33.6	65.2	22.8	28.8	38.2	41.7	48.4	26.7	46.0	43.9	26.2	51.4	37.4	75.1	188.3	32.8	43.5	57.0	12.1	4.4	6.5	5.5	4.1	6.1	4.9	4.5	5.1	4.6	5.4	6.7	4.8	4.9	6.2	7.7	3.5	7.2	4.4	2.5	3.5	4.0	3.2	2.3	2.9	3.3	3.1	3.2	2.8	3.4	4.7	6.0	0.0	5.9	4.2	13.2	10.8	6.8	4.0	10.2	6.6	8.4	8.3	3.9	2.8	5.4	1.8	10.4	12.1	15.3	7.6	11.7	6.2	5.4	6.9	5.7	7.2	9.5	22.5	8.9	7.6	8.3	5.9	5.1	6.6	4.5	13.5	11.7	7.4	8.9	3.3	7.1	9.7	2.0	12.2	6.0	6.3	3.7	7.8	16.0	15.0	7.6	3.0	10.3	6.6	15.2	10.0	2.7	4.1	11.6	12.7	4.3	4.6	5.9	6.7	6.6	6.4	5.6	48.5	31.7	9.5	9.2	7.5	10.6	3.6	9.5	11.4
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961530-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 144.2;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	5.8	6.1	1.2	2.0	1.2	2.4	6.4	4.3	2.4	9.8	0.5	6.0	2.3	7.0	0.8	7.7	7.4	1.3	7.4	1.3	1.6	7.2	8.7	6.6	1.7	1.1	1.1	8.8	7.8	2.2	16.6	1.5	0.7	8.0	0.5	1.1	7.3	1.6	7.9	7.4	7.1	0.6	0.5	9.2	6.7	22.1	2.0	1.7	9.9	0.8	1.0	5.9	7.7	0.8	3.3	3.2	1.7	2.1	1.0	1.2	5.1	1.8	1.1	2.0	1.7	3.3	3.2	1.8	3.6	0.9	1.7	4.2	1.2	1.2	0.7	2.0	7.0	2.1	3.8	3.0	1.8	2.1	4.3	0.9	1.3	1.8	1.0	1.7	1.5	1.5	5.5	1.9	1.0	4.8	3.9	4.6	3.9	1.7	4.8	3.4	1.8	2.6	1.9	1.7	6.9	3.7	3.0	2.6	2.6	0.9	2.9	2.2	1.8	3.4	2.8	3.8	3.1	4.7	2.3	1.2	2.7	2.0	3.1	0.2	1.1	0.6	0.4	0.4	0.4	1.0	0.5	0.5	0.6	1.1	0.5	0.6	3.7	1.1	0.7	1.2	0.3	0.4	1.2	1.2	4.3	2.4	1.3	1.6	1.1	1.1	0.7	0.5	2.0	0.8	26.1	16.0	8.9	3.6	25.9	5.6	8.8	8.7	10.8	29.6	25.9	21.1	11.2	14.3	11.3	22.0	35.5	9.7	34.4	24.0	9.8	11.9	144.2	14.3	31.2	13.4	16.7	29.9	12.0	9.6	12.7	14.5	14.3	25.2	11.4	10.2	20.3	17.5	10.7	23.5	10.2	19.5	10.2	24.5	12.0	119.2	25.7	17.2	1.8	10.3	15.4	13.4	14.4	4.5	4.9	9.7	14.0	27.8	19.9	6.8	13.8	17.4	4.6	46.7	13.1	25.8	13.1	33.9	20.5	7.8	7.5	19.0	20.4	8.3	15.6	6.7
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA049157: AB_2680658, HPA053330: AB_2682114"	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	30.2	20.2	27.3	21.4	30.2	41.1	29.6	29.4	34.8	28.6	25.8	30.5	21.4	28.4	14.1	40.2	34.8	13.6	27.4	27.1	29.3	36.6	20.6	25.8	31.1	31.1	28.1	27.1	29.6	23.1	24.3	18.2	29.0	32.3	11.1	8.7	34.1	14.2	31.6	34.9	27.6	13.0	28.6	38.9	31.8	12.7	28.7	28.4	38.0	15.0	22.1	26.1	27.1	29.9	60.0	36.6	25.6	50.2	8.7	24.2	64.5	29.0	30.3	48.8	47.7	30.7	121.4	58.2	72.9	30.2	20.8	43.6	21.9	56.2	21.5	40.4	33.7	46.7	36.7	45.1	89.4	66.8	94.6	44.7	32.4	42.8	31.0	29.8	49.1	56.8	94.4	64.2	27.1	119.3	88.0	88.3	30.7	62.6	82.0	73.5	26.1	101.9	41.5	39.8	21.0	43.6	30.3	38.2	70.4	17.1	54.1	134.8	49.1	25.4	27.9	63.3	47.6	73.5	86.9	87.7	37.6	82.3	52.2	48.5	29.4	52.2	23.9	32.7	20.4	41.7	27.2	26.5	34.2	41.4	27.1	26.6	13.4	33.3	24.6	54.2	40.5	29.0	27.3	30.2	29.4	34.8	27.1	29.3	31.1	28.1	29.0	28.6	28.7	29.9	33.4	32.1	36.9	6.5	28.9	22.0	33.8	77.9	28.5	10.0	30.5	33.5	3.4	31.5	39.5	31.3	2.1	63.5	24.9	46.2	76.3	44.0	6.4	48.4	29.7	35.7	37.2	45.8	1.2	57.4	61.3	26.8	35.2	37.7	31.8	31.4	33.2	16.7	63.1	15.2	1.4	40.0	40.7	44.5	27.8	11.1	30.4	34.1	21.4	8.4	57.8	27.6	36.0	3.5	3.3	59.3	44.4	19.2	27.9	27.0	56.5	70.7	57.6	12.3	39.5	14.6	37.5	6.3	20.1	35.4	24.6	45.6	29.4	28.5	46.9	27.1
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 380.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 300.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 398.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	43.9	232.5	247.5	20.0	248.6	26.9	47.7	169.0	313.0	46.7	224.2	39.4	35.7	36.4	59.3	48.5	47.0	23.2	54.7	255.0	380.1	97.7	99.8	72.0	16.2	216.3	252.8	61.2	56.8	182.8	299.6	16.5	274.5	79.0	16.0	39.1	53.3	94.8	35.0	49.4	44.9	11.8	187.5	50.2	57.6	87.2	321.2	19.9	91.1	11.6	12.5	45.3	43.6	208.3	24.0	80.2	34.5	57.9	16.3	11.5	12.8	12.8	50.6	26.6	27.2	43.6	59.7	7.5	13.0	26.3	59.4	33.7	22.4	17.6	10.3	25.9	46.3	9.0	48.0	41.4	45.0	13.8	61.5	25.0	35.7	31.1	12.3	43.9	20.4	51.2	19.0	51.6	26.9	165.3	26.1	74.9	31.7	41.0	45.1	19.4	22.7	66.8	47.2	42.9	43.3	88.7	59.3	107.8	47.9	23.2	66.3	23.2	20.4	43.5	39.6	29.2	27.9	48.4	18.5	12.9	50.4	20.4	59.9	398.8	62.8	79.0	80.0	66.1	68.9	51.7	89.1	71.7	63.0	50.8	72.5	65.3	104.7	63.6	35.1	49.7	126.8	61.2	247.5	248.6	169.0	313.0	255.0	380.1	216.3	252.8	274.5	187.5	321.2	208.3	20.5	41.7	31.9	16.6	23.7	23.2	46.5	127.6	18.2	34.9	42.3	22.4	8.8	55.8	76.8	86.5	33.3	54.8	20.7	48.3	19.6	94.1	171.2	30.2	12.8	26.9	89.8	10.3	27.0	102.1	41.3	34.7	39.8	16.2	192.7	72.4	57.8	43.1	45.5	18.5	31.9	35.1	128.1	35.9	32.7	300.8	42.6	47.8	60.5	5.6	21.4	68.8	29.9	13.0	11.0	78.1	37.6	52.6	27.9	47.8	52.8	52.5	89.3	35.7	6.6	19.0	26.4	57.3	29.7	27.9	23.7	52.0	61.2	198.1	30.2	50.1
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109051-120115913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 15.1"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 4.9"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	1.7	1.2	2.3	0.1	2.3	0.1	1.4	3.7	3.4	1.5	2.7	1.7	0.0	0.8	0.0	0.5	2.4	0.2	0.6	2.3	2.7	1.8	0.9	0.5	0.3	2.7	2.7	3.5	0.3	0.1	1.7	0.0	2.7	1.4	0.0	2.5	0.6	0.2	0.2	1.2	1.0	0.1	2.4	1.3	0.7	15.1	2.6	0.2	1.1	0.0	0.1	1.0	0.8	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.0	2.3	2.3	3.7	3.4	2.3	2.7	2.7	2.7	2.7	2.4	2.6	2.7	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.0	1.3	0.3	0.5	1.3	0.0	0.0	0.0	4.2	0.1	0.2	0.1	1.9	0.2	1.5	0.2	0.1	0.5	0.0	0.0	0.8	0.4	0.4	0.2	0.0	0.1	0.0	8.3	0.0	0.2	0.1	0.0	1.5	0.3	0.0	0.0	0.0	3.8	0.6	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.1	0.0	0.1	2.4	1.3	0.0	0.0	0.3	3.3	123.8	0.0	0.3	0.0	0.2	0.7	0.2	0.0
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757806-89791064	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 156.1;Langerhans cells: 121.3;Macrophages: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	4.1	1.6	4.0	5.6	4.0	8.9	5.1	4.0	5.5	4.7	3.3	2.9	1.7	5.5	2.4	3.0	2.7	9.4	4.4	4.1	5.5	3.7	5.6	6.0	6.5	4.6	4.0	2.5	4.4	4.2	1.9	4.7	5.1	5.3	2.9	1.5	5.0	2.7	0.6	4.2	2.4	5.7	5.3	4.8	2.9	2.9	3.7	2.8	4.2	1.3	6.7	9.4	2.6	6.0	17.8	6.0	3.2	4.9	7.9	10.8	5.5	19.2	36.1	10.7	13.6	4.6	9.7	14.4	28.0	11.7	7.6	4.2	8.9	6.9	20.2	8.7	8.0	11.9	2.8	5.5	22.2	4.5	5.8	8.8	5.6	15.6	49.8	11.4	11.4	0.0	5.4	4.7	10.2	3.4	0.0	9.6	1.5	8.4	14.4	3.2	4.1	7.5	26.1	8.4	0.4	3.1	4.7	12.6	10.0	4.0	12.0	5.6	10.1	6.5	6.0	11.2	9.1	8.9	4.2	8.8	16.2	0.4	4.3	13.7	6.6	23.2	3.5	12.5	4.1	7.6	5.4	4.6	8.1	4.8	4.9	5.4	5.1	4.4	14.9	2.6	1.3	4.6	4.0	4.0	4.0	5.5	4.1	5.5	4.6	4.0	5.1	5.3	3.7	6.0	19.3	35.3	18.1	25.5	29.8	57.6	33.7	13.3	16.5	2.1	17.2	8.9	5.2	4.3	22.9	3.7	0.0	13.3	32.8	2.8	5.9	80.1	6.6	82.3	23.7	15.0	0.0	9.9	12.9	60.8	45.7	27.3	9.7	156.1	43.1	7.1	6.1	3.2	41.7	3.3	9.1	5.4	24.4	32.4	121.3	2.5	7.8	105.1	19.6	15.0	42.1	12.1	8.2	15.6	12.8	50.0	2.7	6.0	22.0	59.2	2.2	10.4	11.6	0.3	13.1	19.2	19.6	7.9	12.8	14.7	48.3	83.7	30.4	7.5	8.1	49.5
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No		42000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	30.1	22.7	37.2	16.2	40.2	24.1	26.7	38.4	48.6	18.0	31.2	18.1	43.8	15.9	5.4	22.6	18.8	16.7	16.4	36.3	36.1	18.4	37.0	36.5	15.6	40.2	38.6	17.2	27.2	36.3	10.9	19.4	36.0	17.2	9.0	6.7	33.3	15.4	20.7	21.1	51.7	11.2	37.7	13.0	21.5	13.8	42.9	15.0	19.9	14.1	8.4	20.3	17.6	41.2	19.7	17.7	21.0	35.9	19.2	17.2	36.3	50.2	19.8	34.9	25.6	63.7	21.7	16.7	65.0	27.0	26.0	66.3	26.9	37.3	3.7	44.2	33.1	53.6	51.4	31.6	62.9	36.4	41.1	30.9	34.0	25.2	23.9	16.3	24.8	32.6	57.4	44.9	15.1	40.0	27.7	23.6	16.7	52.7	34.6	42.6	25.1	38.9	28.8	32.7	49.8	18.1	39.9	53.4	19.5	8.2	41.6	39.1	37.3	37.8	27.0	51.1	42.5	34.0	42.7	26.7	26.8	38.2	42.2	4.0	13.2	5.5	28.2	17.8	25.0	16.0	20.6	26.0	14.4	13.7	15.9	17.3	2.1	65.1	22.3	54.2	20.3	26.6	37.2	40.2	38.4	48.6	36.3	36.1	40.2	38.6	36.0	37.7	42.9	41.2	20.1	32.1	28.1	18.6	11.0	15.7	16.4	26.9	15.9	20.0	21.0	13.6	8.1	15.7	27.8	18.4	4.2	44.4	22.4	17.2	1.9	27.7	2.8	20.7	17.8	18.1	4.9	42.7	23.5	22.0	28.5	17.8	13.7	22.0	19.0	8.6	17.5	36.4	110.7	18.5	18.2	12.3	26.4	14.7	10.4	3.4	16.8	21.0	19.6	8.4	11.7	21.6	43.3	16.1	21.8	21.8	16.7	14.3	18.0	17.3	77.6	14.5	29.3	17.3	6.6	22.2	16.0	40.4	40.4	21.9	11.9	62.8	18.3	16.7	21.4	23.1
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806584-12813640	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	8.9	6.8	7.0	11.8	7.2	28.0	9.0	10.4	9.1	10.8	6.2	10.5	10.3	8.5	4.9	18.3	10.6	4.9	7.6	7.2	6.1	7.4	6.9	7.3	17.1	7.3	6.5	8.9	9.2	5.3	5.4	10.4	7.4	6.0	10.7	8.4	8.6	5.0	8.9	13.9	10.0	8.2	6.0	14.5	9.4	19.8	6.8	24.4	7.5	6.6	18.7	8.2	10.8	9.5	130.0	103.8	94.8	75.7	12.3	23.4	76.2	68.4	40.0	126.3	136.0	76.2	58.7	126.9	106.2	36.6	59.6	79.4	82.6	89.2	83.5	82.7	118.1	67.7	112.9	89.9	7.1	70.6	60.5	10.4	19.7	110.7	43.9	21.4	47.3	114.8	91.2	46.8	82.0	251.4	132.8	83.0	56.4	79.1	167.4	146.1	102.0	113.7	39.6	63.8	119.8	76.7	67.0	39.8	46.7	39.8	76.1	78.4	29.3	129.2	55.7	197.0	126.1	97.6	130.3	108.5	77.4	129.4	105.5	9.4	19.1	17.2	23.9	27.6	23.3	36.8	19.6	22.5	19.0	36.3	15.9	19.6	4.4	44.8	27.7	21.0	25.8	19.1	7.0	7.2	10.4	9.1	7.2	6.1	7.3	6.5	7.4	6.0	6.8	9.5	5.3	0.0	2.6	1.3	15.3	14.0	15.7	22.9	6.8	16.2	2.8	11.7	2.7	12.8	7.6	0.0	4.2	62.3	9.1	11.3	0.0	5.4	16.1	0.8	1.6	9.0	8.4	38.7	2.2	6.0	117.4	10.3	10.7	1.1	3.8	2.5	11.7	4.4	48.9	8.4	3.0	13.9	22.4	9.1	13.2	18.8	8.4	9.3	12.4	1.9	8.5	10.4	14.4	1.0	2.4	2.1	6.8	4.9	33.0	5.3	6.2	1.0	9.5	13.9	6.6	15.6	9.8	51.2	44.9	23.8	13.2	22.7	10.2	0.8	24.8	16.1
RNASEH2B	"AGS2, DLEU8, FLJ11712"	ENSG00000136104	"Ribonuclease H2 subunit B"	Q5TBB1	13	50909747-51024120	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 132.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 351.0;NB-4: 259.8;REH: 286.0;THP-1: 258.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040084, HPA041469"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA040084: AB_10697714, HPA041469: AB_2677496"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (2.54e-8)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	17.7	14.8	13.2	28.6	13.5	58.4	19.5	14.5	15.2	16.0	8.7	22.3	16.7	18.8	14.1	17.6	24.9	17.1	25.2	11.9	11.5	14.8	15.0	20.5	45.7	12.2	12.1	21.2	25.7	17.1	8.3	19.6	12.0	19.2	22.0	4.7	20.2	21.6	23.8	13.5	19.8	26.8	12.4	26.3	19.2	17.3	13.7	132.6	27.4	6.0	38.4	22.9	9.4	15.4	41.1	33.1	17.6	37.5	22.9	45.9	41.7	28.6	32.4	40.6	34.0	43.1	61.2	114.4	17.8	29.4	38.4	38.2	55.8	26.1	48.4	42.2	47.1	102.7	22.4	25.4	31.2	191.2	66.0	17.9	33.4	35.9	31.8	36.8	36.3	238.0	58.7	52.7	55.4	19.2	351.0	259.8	57.9	87.2	25.7	286.0	51.4	77.7	30.6	23.6	38.8	56.8	34.4	12.6	38.0	22.8	19.7	258.7	25.6	36.0	30.1	42.7	64.3	69.8	50.3	135.6	9.5	140.6	43.1	3.5	37.5	17.8	31.6	43.3	35.7	104.2	61.9	51.4	55.1	86.4	54.4	51.9	6.1	38.0	38.3	94.0	107.5	54.1	13.2	13.5	14.5	15.2	11.9	11.5	12.2	12.1	12.0	12.4	13.7	15.4	21.2	38.5	23.8	17.6	85.8	18.7	30.5	43.7	22.2	14.1	31.1	35.8	47.4	18.6	27.4	16.5	6.2	40.7	92.3	9.7	29.4	41.7	74.0	30.1	33.2	14.9	12.1	107.7	31.1	50.5	55.7	26.7	13.7	18.2	52.6	62.0	16.4	15.1	97.3	1.7	35.4	21.8	24.4	59.0	22.0	38.2	27.7	50.4	16.0	45.0	86.4	11.7	45.3	44.2	59.5	24.7	9.9	29.7	75.6	34.5	12.1	28.4	37.3	6.2	13.1	21.8	28.9	91.4	44.3	26.9	21.0	17.9	56.5	36.9	35.4	29.3
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 199.9;Late spermatids: 459.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	8.6	4.8	3.9	6.0	4.2	20.6	6.8	5.9	4.3	9.3	4.4	6.1	6.1	6.0	4.0	7.9	5.9	4.5	6.8	3.2	6.3	4.7	10.4	8.1	7.2	6.1	5.2	7.4	4.8	4.0	3.5	5.4	6.5	5.3	5.7	4.9	5.8	4.1	13.1	11.5	5.6	5.3	4.9	6.8	5.8	10.7	6.0	7.7	4.9	8.3	8.7	6.7	9.3	6.0	21.6	8.5	14.8	19.5	13.6	9.8	21.1	12.9	8.1	8.5	13.3	16.6	10.4	22.7	29.1	10.8	11.9	21.3	21.0	15.4	13.0	10.9	10.3	43.0	22.2	20.7	7.0	13.3	10.3	9.8	5.8	13.3	11.7	6.0	12.6	18.4	13.1	23.1	8.7	36.4	44.6	7.8	17.6	11.6	10.8	19.7	17.2	18.4	7.2	29.2	12.3	12.4	14.6	17.7	11.1	10.9	26.8	11.7	12.4	14.6	11.4	15.7	17.2	19.6	19.7	33.2	14.3	15.8	11.9	30.0	7.3	8.8	12.2	8.0	10.9	6.3	10.1	8.8	6.6	6.6	8.8	9.4	8.0	8.7	12.2	6.2	7.0	7.5	3.9	4.2	5.9	4.3	3.2	6.3	6.1	5.2	6.5	4.9	6.0	6.0	34.4	16.0	37.5	16.0	37.7	100.1	49.8	30.8	52.3	36.0	17.3	15.0	21.7	12.8	20.0	14.7	60.5	14.6	76.4	25.3	17.6	14.0	199.9	17.0	20.8	33.3	14.4	14.1	33.5	8.9	26.6	27.9	23.9	24.0	50.1	24.0	24.3	25.9	17.9	15.2	36.0	18.5	28.5	32.4	98.8	459.7	20.2	33.9	26.6	28.1	38.2	12.7	42.2	25.1	27.4	10.5	17.3	20.7	37.9	27.7	11.4	10.3	17.1	39.8	13.1	23.6	25.7	13.8	54.9	55.5	126.6	10.7	63.7	20.3	22.4	50.3
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748849-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	4.2	2.8	3.8	6.7	6.2	14.4	5.6	6.2	4.4	5.5	5.4	4.4	4.0	7.6	4.2	10.1	5.6	4.8	3.2	4.0	4.4	4.6	5.0	5.9	6.3	5.4	5.0	7.6	4.4	5.6	2.1	4.7	5.4	5.2	5.3	6.1	4.5	4.3	6.8	5.5	4.4	7.6	4.4	7.3	4.6	2.9	4.6	7.7	5.8	5.8	6.7	5.2	5.4	9.2	10.2	7.7	9.1	9.0	5.8	7.7	3.7	7.9	7.4	8.6	7.4	13.0	7.5	18.2	7.9	9.5	5.8	9.6	12.4	9.3	11.2	9.1	8.0	12.6	15.3	5.1	6.6	6.8	10.1	7.1	7.2	9.8	22.1	9.6	14.0	12.2	11.4	14.1	8.7	8.6	11.6	12.0	3.6	12.9	5.0	10.7	21.7	9.9	5.5	10.6	4.1	7.4	10.6	8.0	16.6	7.3	9.9	8.6	9.4	14.2	11.8	9.0	7.1	10.2	5.8	21.1	2.8	7.3	8.4	1.2	0.5	0.4	0.4	0.3	0.3	0.0	0.4	0.2	0.2	0.1	0.3	0.2	1.4	0.3	0.3	0.2	0.3	0.2	3.8	6.2	6.2	4.4	4.0	4.4	5.4	5.0	5.4	4.4	4.6	9.2	18.8	9.6	11.4	51.6	18.4	19.9	30.6	7.1	20.5	58.2	12.6	9.8	3.0	17.2	8.3	3.7	52.1	5.5	24.6	9.8	5.9	10.2	2.8	30.5	26.7	17.2	12.0	18.3	40.8	11.1	6.4	16.0	14.8	30.1	7.0	24.4	10.8	12.3	8.5	37.0	43.2	8.7	2.0	15.6	19.9	3.1	7.5	16.6	10.6	25.3	12.6	22.9	26.8	42.7	68.7	10.1	6.8	10.5	18.5	49.7	6.3	12.1	8.9	33.7	26.3	31.9	18.7	9.4	11.7	16.4	18.6	8.1	22.2	14.0	10.4	42.2
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045526-185102603	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	9.5	8.1	5.4	10.2	6.7	13.8	12.5	6.1	7.0	10.3	3.7	9.3	8.4	10.7	8.5	8.4	8.6	9.4	7.4	7.0	7.5	9.6	8.3	8.3	11.5	4.0	4.8	9.3	9.6	8.7	5.6	21.7	4.8	8.5	9.7	11.8	9.6	10.4	8.2	6.4	6.5	10.9	4.5	10.4	9.6	21.9	7.9	12.3	10.8	9.0	12.3	16.5	8.7	5.1	34.0	18.6	62.8	25.4	17.8	30.3	65.3	24.0	28.4	35.5	28.3	29.9	53.3	10.2	29.2	29.0	24.4	11.5	43.7	32.7	41.7	31.1	28.4	54.9	10.2	25.8	27.5	56.1	29.7	29.7	19.6	29.6	36.4	27.9	36.6	34.4	44.7	22.5	25.1	21.2	48.5	17.6	86.3	27.4	11.0	55.1	41.3	9.8	25.7	23.6	18.9	33.4	17.3	9.9	46.7	67.8	19.7	27.5	28.4	25.4	33.6	25.1	29.8	39.0	26.2	36.3	16.1	25.7	28.9	31.0	22.4	27.7	17.1	27.7	24.4	20.1	15.5	15.8	25.7	21.9	15.1	15.6	9.8	24.4	29.9	13.4	17.8	16.3	5.4	6.7	6.1	7.0	7.0	7.5	4.0	4.8	4.8	4.5	7.9	5.1	22.6	3.2	6.4	11.4	23.6	23.2	27.6	10.2	26.7	10.3	18.2	11.8	8.4	7.2	6.6	9.2	4.2	25.4	24.5	11.2	23.5	11.5	6.1	11.2	10.8	20.3	29.5	29.4	23.1	12.6	53.0	17.9	12.8	10.3	12.7	16.9	23.2	8.8	20.1	6.7	20.5	9.2	8.2	21.4	55.2	5.6	9.6	22.0	21.4	20.6	25.4	13.3	10.3	18.6	15.1	11.3	16.9	11.7	15.5	30.2	4.1	16.4	8.8	7.2	0.0	11.7	13.4	35.6	83.1	15.8	20.3	28.5	20.7	15.6	11.3	38.0
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533853-101563344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	17.8	17.8	21.3	16.3	24.6	14.8	19.0	22.0	22.8	17.0	21.4	17.7	11.1	19.0	19.2	21.6	19.8	14.1	26.4	20.4	23.2	21.4	15.7	16.3	18.6	22.8	23.7	21.5	21.3	28.1	10.3	14.6	23.7	20.9	16.9	30.4	16.7	17.9	29.7	17.3	12.3	18.9	22.0	17.6	14.5	32.5	22.6	19.9	23.4	24.9	21.0	15.0	15.0	26.8	25.8	64.2	36.4	40.0	43.8	34.4	31.0	44.1	35.3	43.1	37.6	39.2	26.8	56.8	23.2	34.3	36.0	64.0	42.6	37.5	44.1	59.7	19.8	30.5	55.9	39.7	32.2	53.0	35.2	34.0	39.4	38.2	49.2	32.4	25.7	20.7	29.5	32.5	47.4	33.6	41.4	14.0	80.5	57.8	32.3	39.4	125.7	28.3	17.8	24.5	38.7	48.6	62.1	32.9	36.1	36.3	29.7	24.7	36.6	39.8	39.7	28.6	37.3	35.1	118.0	30.4	35.1	19.6	49.2	24.5	15.2	23.7	20.4	20.3	15.5	15.3	16.7	15.4	14.6	12.4	17.3	16.4	15.7	17.1	30.0	9.2	14.7	13.4	21.3	24.6	22.0	22.8	20.4	23.2	22.8	23.7	23.7	22.0	22.6	26.8	15.9	25.6	31.2	10.7	16.8	6.4	9.7	13.7	17.1	32.4	11.6	11.4	49.5	8.6	23.9	22.0	6.2	16.7	10.2	17.9	5.9	18.3	54.5	20.3	18.5	18.7	24.6	22.3	16.3	13.8	11.5	16.9	10.2	11.5	22.1	19.7	11.7	18.1	16.4	43.7	18.7	12.1	16.2	27.4	4.3	21.4	18.0	20.0	10.6	8.4	31.4	31.4	33.0	11.1	21.9	11.0	13.0	23.7	13.1	9.3	10.1	11.5	28.5	26.5	32.9	21.8	17.5	76.0	16.7	18.3	5.8	7.7	16.1	15.4	15.3	6.4
RNF208	DKFZP761H1710	ENSG00000212864	"Ring finger protein 208"	Q9H0X6	9	137220247-137221581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 25.4;Horizontal cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 23.5;MCF7: 55.7;REH: 44.9;RPMI-8226: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021256, HPA021429"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA021256: AB_1844331, HPA021429: AB_2180654"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.12e-8)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.40e-2)"	6.1	23.1	29.0	0.8	27.1	0.6	6.8	5.0	83.0	8.9	0.0	9.4	1.6	4.9	0.6	32.5	8.1	0.8	42.3	36.9	7.5	15.6	22.6	5.0	0.8	21.1	8.4	5.0	9.0	5.6	19.8	0.5	20.0	14.2	0.4	2.6	13.1	4.1	15.4	15.3	5.1	0.6	2.2	5.2	10.0	5.8	19.8	0.4	14.4	3.7	0.9	7.8	13.4	36.9	1.5	2.8	1.9	3.3	1.3	0.3	5.8	0.8	1.1	1.4	1.2	8.3	5.2	0.7	4.1	0.9	0.3	4.4	4.6	0.2	0.3	2.1	1.7	5.9	10.1	23.5	4.2	1.2	2.0	1.0	1.5	1.3	0.6	5.1	1.4	8.4	8.3	0.4	0.5	55.7	3.0	2.8	2.4	5.5	6.1	44.9	0.4	25.1	1.4	0.2	5.4	19.0	0.6	1.7	1.2	1.0	19.5	4.3	0.6	0.9	1.2	2.0	0.1	0.7	0.8	0.3	2.6	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.0	27.1	5.0	83.0	36.9	7.5	21.1	8.4	20.0	2.2	19.8	36.9	1.9	6.4	2.2	2.9	1.2	0.4	1.0	2.0	0.6	9.3	7.7	5.8	9.3	4.3	1.7	7.3	12.5	0.3	0.4	5.5	25.4	5.3	0.6	4.4	1.2	1.4	7.8	0.4	13.1	2.2	0.2	1.4	1.5	5.9	0.0	13.0	1.4	9.1	1.3	16.8	13.4	4.4	0.0	0.6	0.8	1.1	1.2	1.8	1.8	5.6	1.6	8.7	0.0	1.5	2.9	3.6	5.1	3.4	0.3	1.9	4.4	9.4	3.9	5.6	0.0	2.5	1.8	1.5	2.4	2.7	1.8	0.3	0.5	2.7	3.8	1.6
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 262.3;monocytes: 299.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	163.5	137.2	27.3	29.0	41.8	46.3	133.7	42.4	33.9	156.4	28.9	123.0	27.1	140.8	10.0	215.0	119.5	29.7	198.0	26.3	32.5	118.6	111.9	146.7	30.8	48.6	39.7	119.1	89.5	25.6	80.6	27.3	38.2	100.9	8.8	5.6	112.5	31.0	145.9	257.4	91.1	25.3	35.3	113.3	101.1	90.1	38.3	15.6	106.6	21.8	13.9	144.5	160.3	49.4	86.5	123.9	13.2	39.8	66.3	93.8	43.9	70.6	51.3	68.9	58.3	61.9	92.9	41.8	54.3	175.1	41.9	72.7	20.6	76.5	10.4	51.3	104.9	28.2	28.5	65.7	243.3	39.8	90.0	77.1	108.2	40.2	46.7	29.2	47.9	27.7	36.2	71.3	37.7	86.6	30.5	78.4	19.8	45.3	112.6	37.7	22.3	55.8	40.7	34.6	35.7	23.2	41.8	59.1	73.7	7.4	44.6	122.2	77.3	109.3	32.8	39.8	49.5	44.9	53.0	32.2	117.5	81.9	74.3	37.6	246.2	57.3	51.1	298.9	59.9	63.0	55.3	51.1	262.3	48.4	49.8	45.1	17.1	54.2	299.1	71.7	58.4	236.5	27.3	41.8	42.4	33.9	26.3	32.5	48.6	39.7	38.2	35.3	38.3	49.4	156.0	112.2	83.5	18.9	92.3	202.1	239.0	265.0	89.4	102.4	82.0	105.5	83.3	88.6	138.6	79.1	110.5	222.2	85.3	126.6	225.0	188.8	105.1	72.8	132.4	136.1	57.4	59.7	10.9	164.4	217.4	194.9	64.2	82.8	140.2	93.8	101.7	68.6	374.0	168.2	14.5	115.6	148.5	191.8	323.0	42.7	211.6	230.3	193.9	12.2	334.2	144.6	79.3	10.1	70.8	171.6	120.5	179.8	101.7	161.0	139.4	242.3	97.9	146.4	177.5	99.1	178.0	153.4	157.8	140.0	260.0	305.5	96.5	199.7	114.4	217.4
ROBO1	"DUTT1, FLJ21882, SAX3"	ENSG00000169855	"Roundabout guidance receptor 1"	Q9Y6N7	3	78597239-79767998	"Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 309.4;Inhibitory neurons: 1518.9;Oligodendrocyte precursor cells: 348.3;Oligodendrocytes: 479.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013524, HPA052968, HPA074461"	Uncertain		Enhanced	"Plasma membrane"		NA	NA		16000000	"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256"	"unprognostic (2.89e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.16e-2)"	12.4	8.6	12.7	10.7	13.7	0.2	4.9	4.3	9.5	13.4	0.0	7.8	3.1	9.5	7.2	12.3	4.7	7.7	6.7	7.8	10.8	3.1	3.6	7.6	9.3	8.8	16.3	16.4	1.9	1.8	7.4	7.8	9.9	12.9	6.0	3.9	5.4	11.9	4.5	20.5	4.3	10.5	7.5	9.0	4.8	10.3	15.5	13.3	4.8	5.4	18.2	13.9	11.1	12.4	0.2	26.9	25.7	41.3	35.0	22.8	1.4	21.1	28.0	16.3	13.8	0.6	11.5	0.0	0.1	26.2	13.0	10.9	31.5	21.6	20.5	0.4	39.1	16.4	51.4	43.4	8.4	0.3	4.1	38.3	28.9	61.9	29.1	30.5	16.5	0.0	2.2	49.0	16.8	13.1	0.0	0.1	32.8	7.9	9.6	0.9	27.2	0.3	0.1	8.9	19.7	13.7	45.5	9.9	16.2	24.6	31.8	0.4	0.3	54.1	23.4	32.7	36.1	1.7	0.0	0.0	49.2	0.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	12.7	13.7	4.3	9.5	7.8	10.8	8.8	16.3	9.9	7.5	15.5	12.4	4.3	3.2	11.0	81.0	1.9	33.1	20.6	17.9	39.9	11.7	4.1	3.6	3.6	0.0	9.0	7.3	4.2	9.7	0.0	0.1	0.0	0.5	23.9	1.6	23.2	14.3	1.2	4.0	309.4	0.2	8.3	34.6	3.6	2.3	1.3	5.1	16.1	0.3	1.5	1.7	1518.9	1.4	22.4	2.6	10.0	65.9	19.9	1.5	14.2	51.5	1.9	5.7	0.0	348.3	479.3	0.2	5.1	24.5	1.3	20.5	4.9	0.4	2.9	1.0	13.1	24.7	16.8	2.7	7.0	30.3	33.8	5.6	0.9	71.1	2.6	52.7
RP9	PAP-1	ENSG00000164610	"RP9 pre-mRNA splicing factor"	Q8TA86	7	33094797-33109404	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	12.6	15.0	26.3	8.7	26.1	21.6	12.6	28.0	51.2	17.0	26.7	16.7	9.0	14.4	15.5	10.1	14.0	6.2	29.2	25.8	26.3	17.2	13.8	12.0	15.6	26.6	26.3	16.2	20.2	10.5	10.3	10.2	26.7	14.4	9.8	16.7	11.5	11.7	36.3	13.8	15.9	8.4	25.8	20.8	13.5	18.1	26.9	13.8	16.0	34.3	16.7	14.3	13.1	27.4	20.9	28.8	29.7	34.1	18.5	17.2	14.3	26.4	21.6	28.9	23.0	25.6	14.6	26.2	17.0	21.1	35.4	20.4	36.4	22.0	36.8	11.9	25.1	19.2	22.8	24.4	32.4	26.0	13.0	17.5	20.2	32.8	64.5	23.3	24.0	27.1	35.2	23.0	29.1	42.6	27.7	69.6	25.4	27.2	21.9	28.2	26.4	17.1	21.1	19.3	28.7	39.5	18.7	39.6	46.2	35.1	20.8	35.0	19.4	28.4	40.9	25.6	42.8	38.1	37.2	51.7	20.0	36.3	56.1	21.9	12.0	21.6	15.2	9.8	14.1	57.8	16.3	17.4	13.2	77.3	19.1	18.0	2.0	15.7	12.5	28.4	15.8	8.8	26.3	26.1	28.0	51.2	25.8	26.3	26.6	26.3	26.7	25.8	26.9	27.4	21.3	12.8	10.1	4.9	35.6	21.0	15.1	11.3	29.0	15.8	17.7	27.9	41.7	17.2	10.9	14.7	14.6	20.2	16.8	12.6	21.5	16.0	5.6	14.6	28.2	24.1	10.2	19.4	6.5	15.8	20.0	20.4	20.4	16.6	3.8	26.8	15.4	16.4	18.4	8.4	7.5	19.3	24.4	10.1	14.9	3.2	18.0	12.0	23.2	5.6	10.1	21.9	21.6	3.0	8.7	14.6	8.0	16.1	24.4	22.9	16.1	18.6	8.5	16.4	26.3	19.4	30.3	31.6	54.3	24.4	18.0	10.4	19.9	22.9	18.4	12.0
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm		NA	NA		82000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	21.1	17.7	14.1	22.5	15.7	22.0	20.6	18.1	16.3	21.8	15.6	21.8	20.8	22.8	17.5	23.4	25.4	15.5	26.7	14.4	17.1	14.6	17.1	17.1	35.8	15.0	15.2	31.8	15.3	18.9	14.8	16.9	17.2	22.2	17.2	22.4	21.8	21.8	52.4	25.9	20.6	21.9	16.6	21.8	17.0	14.4	16.3	37.6	23.2	34.3	37.8	22.1	19.7	19.0	93.5	90.7	77.9	76.2	35.3	35.9	88.1	73.5	40.7	85.1	87.7	132.0	41.2	128.4	68.1	41.3	34.9	83.4	93.4	58.3	93.5	86.3	116.3	77.8	113.6	51.0	23.4	57.7	65.5	29.9	37.0	84.1	36.2	30.1	62.9	77.0	75.8	72.4	60.2	47.8	127.3	33.7	63.5	58.2	53.2	173.8	44.0	72.1	37.3	62.3	34.9	54.7	103.9	35.1	63.8	52.0	75.1	43.4	56.2	66.5	56.7	75.3	113.9	19.8	56.5	76.0	46.5	88.6	82.2	43.2	25.0	54.5	53.1	36.4	54.2	51.2	55.1	53.0	30.2	35.8	53.0	48.4	11.9	80.8	47.8	31.7	56.7	60.5	14.1	15.7	18.1	16.3	14.4	17.1	15.0	15.2	17.2	16.6	16.3	19.0	14.9	9.6	14.7	12.4	24.3	29.6	16.3	22.4	17.6	19.2	25.1	21.0	23.7	22.8	14.4	40.5	4.2	69.4	27.0	13.5	5.9	20.6	18.9	13.4	16.6	21.7	15.6	67.6	12.2	19.8	68.9	23.2	7.7	14.2	33.7	25.0	25.4	24.2	46.1	37.0	14.0	19.3	26.4	49.1	14.6	42.4	32.3	35.1	28.4	14.0	37.6	39.7	35.0	12.1	18.2	15.0	7.2	34.6	23.0	14.1	24.6	11.7	19.4	19.5	0.0	19.2	21.5	14.7	21.8	24.3	29.1	43.5	30.3	15.6	23.1	11.7
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 162.3;Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	28.4	25.0	33.3	39.7	35.1	40.7	43.8	33.4	42.4	32.0	37.4	26.6	18.5	33.7	43.4	32.3	49.1	30.6	39.2	34.5	36.1	32.4	31.8	28.7	75.1	33.7	33.2	52.0	21.0	40.7	31.3	30.2	33.9	28.7	30.2	43.8	24.0	31.3	72.3	40.3	26.1	30.7	36.7	42.3	25.6	63.7	34.0	53.4	52.9	63.2	67.6	30.3	24.9	36.7	60.9	57.4	86.4	68.5	59.3	52.8	57.2	106.1	70.3	130.0	113.5	80.2	72.7	148.9	69.4	41.1	48.4	55.8	126.5	60.3	122.4	121.0	126.0	174.3	73.0	71.3	30.9	229.7	115.1	24.6	33.2	123.8	62.3	40.3	59.1	133.1	196.2	127.1	75.7	63.6	163.9	105.1	181.7	115.1	122.0	115.0	128.7	74.2	49.1	65.2	78.3	75.8	123.3	47.3	100.7	68.1	50.9	71.8	36.6	32.2	73.0	186.2	76.3	105.8	251.0	135.8	81.4	213.5	64.3	322.3	97.4	290.0	279.7	80.0	304.4	272.5	252.9	257.4	112.1	232.0	287.4	282.7	100.1	294.1	106.5	172.3	255.5	435.5	33.3	35.1	33.4	42.4	34.5	36.1	33.7	33.2	33.9	36.7	34.0	36.7	26.5	22.4	15.7	10.4	64.0	21.0	28.5	47.1	16.5	28.4	25.7	27.8	29.0	24.3	30.4	22.0	2.1	95.2	77.8	10.1	35.2	35.0	49.0	14.6	18.8	27.9	13.8	39.1	8.8	20.6	67.3	34.8	7.1	15.1	60.9	33.3	26.4	16.6	51.9	8.4	8.4	14.0	71.2	31.5	27.6	22.6	41.3	34.1	37.4	7.5	86.7	100.0	95.8	9.5	14.3	29.5	10.4	46.3	32.6	19.3	11.2	23.6	28.8	34.5	32.9	48.0	24.7	162.3	183.5	20.6	22.4	55.7	59.9	33.9	19.3	20.1
RPAP3	"FLJ21908, hSpagh, spag, Tah1"	ENSG00000005175	"RNA polymerase II associated protein 3"	Q9H6T3	12	47661249-47706030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038311, HPA038312"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA038311: AB_10671527, HPA038312: AB_10672512"	"unprognostic (5.76e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.47e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (9.89e-2)"	"unprognostic (9.87e-3)"	"unprognostic (6.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-2)"	10.0	10.6	6.1	19.1	6.0	12.7	15.8	8.4	7.1	12.7	6.5	12.5	13.8	13.9	14.6	13.6	14.6	12.1	16.2	5.7	7.6	13.0	15.4	10.2	29.6	6.2	8.6	19.4	8.5	17.3	8.2	13.1	7.8	12.9	12.8	11.1	9.7	12.5	22.8	11.2	12.6	15.4	6.4	17.4	11.0	15.8	7.9	23.5	13.8	23.7	29.2	16.9	9.2	7.8	42.6	39.1	46.5	32.1	24.5	34.7	39.2	41.4	42.5	51.4	43.8	54.5	47.2	93.9	55.6	37.0	37.0	41.5	40.7	24.6	59.5	50.2	38.0	63.3	25.1	26.6	21.1	68.0	42.4	17.1	29.6	60.2	21.7	41.7	32.6	36.2	70.6	28.0	45.9	30.5	58.7	48.9	49.9	39.1	33.2	46.9	56.1	46.0	41.9	38.3	33.5	24.3	48.5	39.4	41.9	49.0	40.5	40.4	23.5	35.4	47.0	39.3	46.5	21.8	43.7	66.5	33.3	148.5	22.3	3.7	10.6	32.9	10.2	20.5	10.5	20.9	11.5	11.1	14.3	17.9	14.5	13.3	19.7	13.3	25.8	9.9	15.7	9.0	6.1	6.0	8.4	7.1	5.7	7.6	6.2	8.6	7.8	6.4	7.9	7.8	16.8	12.8	17.6	11.4	30.0	13.3	14.8	20.3	24.5	18.1	18.3	19.3	41.7	11.5	21.2	11.0	8.4	23.4	33.7	7.3	23.5	17.3	9.5	51.3	23.4	13.8	13.1	18.3	15.3	19.7	16.3	21.0	15.3	26.9	12.0	22.5	8.6	18.0	18.3	11.8	12.7	12.2	14.2	19.2	16.9	7.1	21.8	24.9	7.2	14.0	44.0	13.4	25.7	16.1	16.8	11.7	16.8	20.7	31.0	7.5	9.6	30.2	30.1	14.8	6.6	16.8	18.2	48.0	37.1	22.7	10.2	17.0	21.3	18.0	14.6	9.1
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		520000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	3787.4	2419.1	1394.0	2169.7	1436.7	4648.6	4838.0	1413.7	1627.7	4522.8	1418.2	3090.4	1960.7	3234.2	2327.8	3175.9	4434.1	1996.7	2795.8	1340.4	1450.2	2318.6	2457.5	2593.7	4447.8	1490.4	1395.4	7892.2	8248.7	1574.9	1262.1	1879.3	1495.2	2998.1	2852.0	605.3	3991.5	2220.8	4760.6	4580.4	2644.6	2899.6	1535.3	3002.5	3262.2	372.8	1456.6	3691.0	2499.0	3882.7	5285.1	3395.7	3633.5	1537.6	5771.5	2604.6	2556.3	1973.1	5665.6	10627.4	2257.6	2147.4	4944.5	4036.4	5092.8	2323.7	2507.2	11250.6	5101.5	3609.5	4017.7	2175.5	5072.8	5166.9	3441.7	2507.6	4032.6	1534.4	1719.4	2591.8	6623.5	3314.4	2163.5	8104.7	8023.2	2435.8	7540.7	6953.8	6482.3	4734.1	2197.3	3482.7	4027.7	2869.8	3643.7	3212.1	2023.6	5617.9	4482.1	4301.7	2425.2	6334.8	4477.5	2015.0	2043.5	3397.3	526.0	4516.0	6630.0	2442.8	1643.7	4541.0	3144.3	1405.7	2655.1	3210.9	4865.5	8226.6	6458.7	11466.6	2139.0	4722.1	1803.6	2544.3	4388.3	622.1	4542.5	3596.8	7775.4	8121.0	7534.8	5653.3	4873.3	7698.6	8993.4	6990.0	410.0	5161.3	3275.5	5417.4	5907.4	18184.4	1394.0	1436.7	1413.7	1627.7	1340.4	1450.2	1490.4	1395.4	1495.2	1535.3	1456.6	1537.6	5788.7	1791.6	2556.0	46.7	10527.8	12070.0	13158.5	11320.6	8610.2	480.8	13969.8	18711.5	332.5	4499.5	4867.7	2039.7	248.1	6871.3	8329.8	1997.2	6751.9	4614.2	76.2	2214.5	6544.8	5970.8	2893.6	4044.6	45.3	13505.4	10754.4	5761.0	3039.8	3854.9	2982.2	5292.3	6493.4	4196.6	7070.4	269.2	50.7	6837.3	3196.2	8756.2	13887.5	284.8	8462.7	6722.9	8167.8	49.6	10601.8	1879.6	6844.6	56.3	89.0	7721.0	5174.6	3567.3	7282.8	12796.7	5976.0	8673.5	1751.3	859.1	2991.1	7996.0	6645.8	94.6	354.5	9576.3	14556.9	7562.7	9597.3	5236.0	6657.3	13414.3
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560677-89564542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		190000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: AB_2681579"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	2508.9	1855.2	1068.8	1015.2	1070.1	2207.4	2514.6	1007.8	1300.0	2885.7	1027.9	2382.3	1082.7	1830.7	799.8	2804.1	2342.7	756.7	1661.7	984.6	1007.1	1722.4	2142.4	1560.6	2106.2	1129.1	1023.0	5001.9	4316.1	896.0	1581.0	636.9	1076.3	2852.9	719.0	215.3	2413.8	826.7	2404.7	4466.0	2067.4	689.9	1159.2	2545.7	2148.6	856.8	1078.9	1718.3	1609.7	1175.1	1635.1	2301.1	2682.5	1123.0	1402.1	1524.2	1063.0	1733.2	1869.8	3083.4	2218.9	863.7	1857.6	1768.8	712.9	2316.0	2113.8	1954.1	1729.3	1484.1	700.0	1903.0	1279.4	2281.5	873.2	551.7	3534.0	666.7	817.4	3149.0	3985.0	818.9	781.2	3770.4	4759.6	1136.6	2847.0	2870.3	1870.2	2424.6	2074.1	1084.5	1380.2	4385.7	2272.4	6404.2	2180.5	2755.6	1601.9	3323.5	1128.8	2786.0	2205.4	1162.1	1491.3	2176.3	1195.0	1544.6	2735.2	665.7	3044.3	4780.1	1101.8	1132.3	1218.4	1008.8	1211.3	1626.1	1668.7	2104.6	1479.4	2863.7	1220.5	1017.1	3191.4	507.1	3779.3	2446.7	7007.7	7792.3	6813.4	5173.6	3626.5	8215.0	8509.1	6722.0	323.4	4085.8	1910.1	5071.9	5277.8	13749.1	1068.8	1070.1	1007.8	1300.0	984.6	1007.1	1129.1	1023.0	1076.3	1159.2	1078.9	1123.0	3260.3	1804.5	3489.0	39.8	9318.5	12528.7	15921.0	7329.9	8523.7	675.1	10709.1	13191.6	465.3	3808.9	4064.9	1616.6	189.7	6201.2	5935.5	1800.0	4652.6	4068.5	4125.7	2011.7	5627.8	4627.9	2937.8	3784.5	39.1	10909.9	11178.8	4536.6	2934.8	2679.4	2651.1	6392.0	5119.5	4261.1	5228.5	249.0	52.5	6292.1	2089.4	7058.1	8832.3	12884.5	8244.9	5051.4	5457.0	66.5	7569.8	1941.5	5395.5	158.3	86.4	7077.2	4715.7	3652.3	4667.7	14016.4	5245.4	7448.2	1834.7	786.9	2084.0	5936.3	5693.8	1721.1	1052.9	9022.1	16171.5	6165.5	7831.2	7839.7	7465.8	15137.1
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204840	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 37509.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	2108.0	1641.8	1232.8	1325.7	1302.0	3445.4	2213.5	1236.2	1473.8	2449.2	1230.5	1983.7	1161.3	1717.3	1256.1	2160.0	1997.7	1159.4	1539.0	1175.0	1252.5	1725.6	1485.2	1453.6	2835.1	1303.7	1237.8	3638.0	3006.2	1537.0	1362.5	1050.7	1304.9	1733.7	1231.5	383.6	2136.0	1214.5	2763.0	2809.4	1733.8	1104.6	1324.2	2003.5	1872.5	615.5	1268.5	2335.8	1462.6	1879.2	2543.6	1915.1	2121.1	1325.7	1943.7	2617.7	1849.0	2258.4	3300.1	4133.6	1894.3	1788.5	3631.1	3629.7	2895.6	2872.0	1801.2	4740.4	3047.1	2580.8	2122.7	3228.2	2807.4	3714.8	1852.4	1922.4	4931.8	1693.5	1876.5	3797.5	5133.2	4201.0	2240.4	4647.6	3995.5	2805.3	5031.4	3396.2	3177.6	3991.6	3007.3	2696.5	2544.2	1939.5	5610.7	5814.7	1891.0	2269.3	1912.1	3270.3	2620.6	4777.9	3324.4	2419.1	2225.5	2457.9	1084.0	37509.3	5867.6	1982.1	3626.8	5201.1	1883.8	1410.9	1894.7	2165.8	3336.2	3504.5	3756.7	3505.5	1906.0	3147.3	1854.1	1051.1	2648.2	975.0	2486.9	2147.2	3862.3	4698.0	3984.2	3158.7	3263.9	4349.1	4920.5	4086.9	380.6	2830.2	1793.7	3012.9	3456.9	9398.3	1232.8	1302.0	1236.2	1473.8	1175.0	1252.5	1303.7	1237.8	1304.9	1324.2	1268.5	1325.7	2477.2	884.6	1438.4	49.0	5591.4	5551.7	6227.1	4092.6	3998.1	241.7	5532.9	7926.2	556.3	2332.0	2100.3	1138.5	93.8	3720.2	4011.1	1443.7	3623.4	3025.0	1451.9	1129.0	2357.2	2714.5	1957.2	2708.2	30.8	6238.2	5441.3	2425.2	1705.4	1503.7	1586.0	3024.3	2836.8	2406.3	4189.9	132.9	33.6	3550.3	1464.8	4218.0	5326.1	4539.9	3920.2	3259.8	3272.8	46.9	4282.6	1495.1	3932.1	20.1	51.1	3972.8	3267.4	2040.2	3289.0	6219.8	3226.4	5182.0	1049.1	390.5	1531.7	3215.1	3875.5	962.9	981.4	5376.4	6619.2	3899.7	4615.5	3399.1	3895.2	7406.6
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686718	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		44000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA051653: AB_2681564"	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (5.37e-2)"	1220.4	963.7	1179.4	795.9	1197.2	1813.7	2016.7	1206.7	1802.8	1786.4	1168.9	1269.8	843.8	1272.5	1658.1	1155.1	1363.2	709.5	1161.8	1152.6	1190.2	1145.5	1195.3	882.4	1514.7	1190.0	1168.8	2886.8	1989.8	967.9	1101.6	889.8	1190.1	1124.9	937.9	588.3	1605.5	795.5	1501.5	1285.7	866.2	822.5	1216.9	917.6	1117.4	324.3	1203.7	1558.3	1217.1	1347.0	1338.5	1222.0	1282.4	1226.6	3341.0	1122.5	1638.4	1892.9	1823.4	3249.1	2499.1	1832.0	2161.4	2560.1	1868.3	2262.4	1480.2	3669.7	2253.5	1494.6	1002.0	1749.4	1967.8	2398.5	2584.5	1982.6	1939.0	2147.6	857.8	1715.0	1772.2	2451.8	1122.7	3142.6	3062.3	1585.9	2863.5	2474.3	2226.2	1741.3	2028.0	1830.4	2427.7	2323.0	2566.8	3835.9	2991.2	3052.1	2372.1	2332.6	1598.0	3622.8	2686.7	1508.6	3587.0	1629.7	966.3	1775.0	4454.7	1413.3	2184.7	4483.3	1579.9	1138.3	2019.4	613.4	2332.7	1512.4	2049.7	6425.0	1484.6	2643.4	1919.2	668.3	1239.3	311.8	1468.5	1083.5	2151.6	2246.8	2305.6	1787.9	1641.5	2185.0	2880.6	2249.1	194.6	1677.3	1115.5	1957.8	2261.4	4700.1	1179.4	1197.2	1206.7	1802.8	1152.6	1190.2	1190.0	1168.8	1190.1	1216.9	1203.7	1226.6	1628.0	948.7	1279.6	15.7	2074.3	2283.7	3314.0	1938.2	2129.6	268.3	2541.6	4149.7	333.2	1313.9	1327.7	610.6	85.5	2064.2	1870.1	882.2	2267.6	1579.1	885.8	1200.6	2281.6	1502.9	1364.3	1421.6	22.5	2930.3	3255.0	1518.4	813.5	1574.5	1350.0	1547.4	1509.5	1509.9	1594.8	117.8	22.0	2147.0	708.0	1759.2	2028.7	689.6	3003.4	1452.0	1378.5	30.0	2166.2	1045.3	1578.8	20.1	26.8	2412.1	1728.7	1501.5	1499.8	3372.3	1679.5	2895.9	676.1	432.6	874.4	2783.8	2675.9	498.4	345.7	2210.2	2326.7	2341.6	1952.8	2206.1	2242.3	3363.9
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		170000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	1871.8	1549.8	1111.3	1009.9	1116.5	2929.2	1962.9	1098.5	1512.7	2052.8	1111.9	1884.1	802.3	1550.5	994.9	1984.2	1652.8	740.8	1495.4	1092.8	1126.1	1276.4	1316.9	1278.5	1999.4	1122.6	1109.6	2598.8	2232.2	850.4	894.8	951.0	1119.0	1483.8	894.1	394.5	1530.7	749.8	2544.6	2726.6	1467.8	854.4	1124.4	1802.0	1559.6	409.4	1127.1	1682.4	1067.7	1510.1	1378.5	1650.9	1820.8	1132.8	2288.0	2867.0	1701.7	2480.6	2983.9	4422.4	2741.5	2594.6	2162.4	2777.2	1979.1	4107.0	1751.0	4309.7	2143.3	2087.9	1477.4	1948.8	2000.9	3363.7	2670.5	1996.4	4741.8	1694.3	2147.4	4431.8	3669.4	4908.1	1698.9	4175.7	2847.4	1867.0	2381.3	2795.0	2356.9	2241.9	3237.8	2584.2	2618.6	2253.4	4127.7	4153.0	2577.8	2634.0	1821.4	2841.1	4775.1	4927.8	2374.2	3092.9	1909.6	2094.8	1016.8	1982.1	4341.5	2299.8	3341.2	5076.5	2617.1	2021.7	1988.7	2497.2	3885.7	2219.6	4004.7	4327.4	1816.5	3030.7	2107.7	1007.1	1762.8	553.5	1773.1	1633.6	2518.3	3055.1	2633.3	2095.8	2115.1	2792.7	2987.8	2673.6	358.7	2155.7	1284.9	2726.2	2059.6	4601.4	1111.3	1116.5	1098.5	1512.7	1092.8	1126.1	1122.6	1109.6	1119.0	1124.4	1127.1	1132.8	770.3	734.0	1103.9	11.1	2217.2	2530.2	2296.2	1759.2	941.8	138.9	1779.8	1725.0	725.8	1302.6	1175.0	518.6	89.6	2093.8	1873.8	948.5	1496.7	1822.6	435.6	524.0	1202.0	1245.7	912.0	1291.4	9.9	3028.9	3551.3	1025.1	510.7	660.9	991.3	983.7	1689.1	1859.0	2118.7	65.6	10.7	2016.4	671.4	2560.1	2977.0	1070.0	2434.3	1522.8	1426.5	22.5	3232.7	722.9	2669.4	7.5	16.3	2450.0	1585.4	1279.6	957.2	2462.7	1301.2	2383.0	574.6	230.6	867.8	1669.6	1874.7	384.8	476.4	1644.1	3371.3	2184.8	1833.0	1266.3	2175.4	2628.2
RPL27A	L27A	ENSG00000166441	"Ribosomal protein L27a"	P46776	11	8682788-8714759	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060776, HPA063379"	Supported		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		89000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA060776: AB_2684359, HPA063379: AB_2684997"	"prognostic favorable (7.84e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (2.83e-10)"	"unprognostic (2.28e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-2)"	1867.4	1586.5	1112.4	1138.4	1139.6	3242.1	2016.3	1103.5	1682.4	2307.6	1117.4	1835.7	1119.4	1509.5	1253.5	2532.6	1777.9	901.6	1434.4	1090.3	1137.3	1438.8	1513.7	1440.4	2469.0	1140.1	1117.4	3180.8	3079.8	550.4	1329.2	1034.8	1141.6	1798.9	1352.8	562.4	1872.7	559.2	2167.5	2731.4	1875.3	912.5	1148.6	2263.5	1881.1	397.9	1138.3	1569.0	1606.9	1159.8	2278.0	1816.8	2187.8	1161.9	3374.8	2282.4	1427.2	1723.1	1917.9	3636.8	2160.5	2131.4	2659.7	2386.0	1819.2	2904.7	3041.6	4726.7	1635.8	1877.3	1019.4	2400.8	1914.2	2976.5	1781.2	1742.6	4109.6	2101.8	2068.1	3642.3	3180.6	3846.3	2350.4	4015.9	5180.1	380.2	3959.2	3267.2	2398.7	2766.7	2203.9	1446.0	2043.8	2521.0	2863.4	5717.8	2332.9	2478.6	2375.5	2469.8	1504.9	2920.6	2292.2	3298.8	1631.2	2917.9	797.7	2987.9	3547.0	1494.5	1322.2	4282.8	2203.9	778.3	2093.9	2005.3	2746.5	1629.9	3909.0	3975.9	1772.1	2585.6	1433.3	3535.7	5105.6	1567.8	7665.6	4887.2	9888.7	13013.7	10807.7	9082.0	7409.3	11343.1	12593.4	10685.9	1149.1	6890.0	4553.8	7100.8	8081.2	27172.4	1112.4	1139.6	1103.5	1682.4	1090.3	1137.3	1140.1	1117.4	1141.6	1148.6	1138.3	1161.9	715.7	1121.8	1863.9	8.8	3163.6	4858.0	6358.1	4908.5	492.3	215.3	3316.7	1895.8	934.4	2174.7	2795.5	987.7	114.7	5885.0	2461.3	1680.5	2856.5	2520.9	861.4	1138.4	2272.9	2077.8	2118.2	1701.9	7.1	5396.5	7518.8	1703.8	407.8	1787.8	2132.2	1410.6	3162.6	2776.8	4393.9	80.8	8.6	5111.4	1617.4	4642.2	6081.0	1902.1	3623.5	2177.5	2833.5	7.5	4730.9	1006.9	4985.7	8.0	11.0	3962.9	4511.8	1957.0	678.2	5412.4	4146.2	3282.9	1236.0	352.8	1558.1	2338.6	2218.2	503.8	482.7	1064.4	6060.7	6015.7	2992.7	1341.3	5098.3	7041.0
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433137-39435949	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064222	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		No	No		66000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA064222: AB_2685218"	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	2066.2	1324.7	798.1	879.8	835.8	1620.8	2008.5	795.8	967.9	2510.0	825.8	2148.1	738.9	1858.7	479.5	2097.7	1978.7	622.2	1817.6	766.2	806.7	1441.4	1565.9	1510.3	1710.4	830.8	794.2	4203.5	2970.3	547.7	934.3	739.1	834.3	1615.4	540.7	353.9	1548.0	495.9	2746.6	2516.9	1665.1	572.1	839.0	1889.3	1918.6	461.2	832.1	1190.8	1324.5	1391.5	1152.9	1877.2	2027.6	843.8	2467.5	5000.7	1350.4	1532.5	1939.7	2339.0	1237.4	1101.9	1229.3	1357.5	1238.9	3198.4	1315.0	2031.9	1385.6	1352.5	532.5	799.6	1562.2	2618.4	848.4	2412.3	3743.7	1628.3	1567.4	3393.7	1972.1	2412.1	1062.9	2779.4	3934.7	1215.3	1923.9	1896.4	1761.4	2602.9	2091.4	2251.5	1431.2	3675.5	3334.0	2400.6	1675.5	3079.8	1839.9	2199.4	1395.6	2489.8	1527.5	2664.4	1347.7	1950.3	825.4	3672.6	2999.5	905.9	1052.2	4589.3	1111.5	1149.8	1537.2	1247.2	2447.7	3155.8	3400.5	2644.9	1202.5	2217.9	1146.0	350.3	1144.7	180.1	1224.6	931.6	1759.2	2334.1	2023.4	1543.3	1424.7	2147.3	2531.4	2095.3	201.2	1187.1	800.4	1650.5	1520.8	4276.8	798.1	835.8	795.8	967.9	766.2	806.7	830.8	794.2	834.3	839.0	832.1	843.8	910.4	1131.4	1882.8	14.4	3414.1	3891.4	3738.4	2461.1	2290.1	317.5	2872.0	2269.1	1043.3	1983.2	1869.9	814.7	193.9	4378.5	2221.4	1360.9	2208.9	2060.1	596.1	1173.6	2134.8	1782.9	1477.7	1833.5	9.9	4296.3	6085.5	1656.8	846.6	1591.3	1121.0	1849.0	1788.3	2609.9	2812.3	114.4	14.5	2971.8	767.0	3231.7	4694.9	1402.8	4220.6	2451.1	2036.6	23.4	4047.9	1192.7	2671.5	6.0	23.9	2510.0	2427.6	1858.1	1983.1	3836.9	1742.4	3524.6	1041.6	614.4	1281.9	2376.7	1775.6	466.9	929.6	2878.6	4533.1	4741.0	2853.2	1988.4	3314.4	4435.0
RPS23	"S23, uS12"	ENSG00000186468	"Ribosomal protein S23"	P62266	5	82273320-82278396	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Not detected"	"Not detected"			HPA054853	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		180000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA054853: AB_2682625"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (6.61e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (3.87e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-1)"	1840.0	1001.7	1102.6	919.8	1139.3	2295.9	2649.1	1097.2	1494.2	1922.8	1136.2	1575.0	866.4	1493.4	1196.0	1539.8	1672.4	756.6	1211.1	1074.2	1125.0	1218.3	1076.0	1134.6	1864.9	1130.3	1100.3	3535.9	1900.1	984.2	838.4	1032.9	1137.0	1249.4	1205.8	470.0	1327.3	986.0	2805.4	2306.5	1430.2	1131.3	1171.9	1552.4	1316.7	366.8	1148.1	2694.5	1038.7	2442.4	2518.1	1468.9	1717.5	1161.6	2194.6	847.0	2383.6	1836.5	3911.6	5242.6	2418.7	2052.4	3094.7	3039.4	2997.3	1198.9	1451.9	5113.6	1398.9	2675.8	1875.0	1105.9	3616.3	5911.6	3136.4	1871.9	2042.4	2101.5	1239.3	1178.4	5159.4	3068.6	1461.8	5082.4	6870.2	2325.0	6036.4	4522.6	3980.7	3201.0	2227.1	1562.5	2659.7	1412.7	3396.2	3089.5	1523.5	1162.4	1956.0	2244.6	3408.7	4676.7	2983.4	911.2	1526.7	1982.2	1057.1	1810.3	4447.1	2355.6	1377.1	4649.1	2839.5	428.0	1674.5	1057.9	3279.8	2227.0	3570.0	3590.9	1014.3	3878.9	965.3	193.0	852.3	128.5	784.5	761.0	1202.8	1945.0	1339.2	1065.9	1358.1	1736.1	1731.5	1494.5	80.8	943.5	645.5	1540.2	1054.5	2806.0	1102.6	1139.3	1097.2	1494.2	1074.2	1125.0	1130.3	1100.3	1137.0	1171.9	1148.1	1161.6	2726.7	1064.1	1527.2	28.7	6648.3	5904.9	6058.5	4170.7	4319.6	392.6	6217.4	10450.4	305.7	2573.6	2153.2	1138.5	173.0	4912.5	4340.2	1276.9	3813.2	2523.5	1016.2	1431.7	3705.0	3112.3	1903.4	3545.2	24.5	4768.9	7030.8	2927.9	1667.2	2001.0	1700.8	3926.3	3285.8	3044.2	4261.2	233.9	28.5	4024.3	1175.9	4330.3	6276.8	1790.6	6175.3	3562.9	2865.5	41.2	5041.5	1465.2	3478.9	19.1	34.1	3569.5	3167.2	3089.2	3083.4	6281.6	3384.4	5720.4	861.0	665.2	1702.6	4593.8	3792.9	734.0	995.2	6141.4	7107.0	5202.6	4322.9	3981.9	4731.8	6359.5
RPS24	"eS24, S24"	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033760-78056813	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003364, HPA073508"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		90000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA003364: AB_1079847, HPA073508: "	"prognostic favorable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	2458.4	1993.8	1538.1	1424.8	1549.0	4673.1	4757.9	1530.6	2756.8	3012.3	1536.9	2576.1	1756.5	2519.4	2811.2	2293.7	2474.3	1606.6	1604.1	1488.8	1645.6	1754.0	2209.3	1458.8	2669.4	1576.3	1569.3	5844.6	2955.3	1438.5	1178.1	1754.5	1586.4	1958.8	2573.9	964.5	2512.4	1637.4	3019.3	3045.0	1693.7	1946.0	1586.5	1916.9	1651.7	776.1	1538.2	2798.0	2252.7	2553.7	2707.5	2652.8	2547.2	1623.3	3390.5	1308.2	3303.3	5221.9	4021.6	7048.4	2884.3	3654.6	5055.0	3773.7	3323.4	1878.5	2339.0	7039.0	1940.5	3205.9	1303.4	2612.8	3847.7	4674.9	3460.7	2403.0	4325.8	2868.1	822.8	1879.0	4533.9	6943.1	1575.6	6732.0	6867.2	2652.4	9675.7	7591.6	4592.2	2981.8	4007.0	1455.6	4191.8	1388.2	3770.5	11229.0	2318.2	5976.0	12085.6	2567.9	3934.7	3482.3	4773.4	1608.2	1658.6	3234.9	1805.2	6010.8	4716.9	3414.2	3356.5	7559.6	3894.3	1175.5	2712.7	1570.9	4896.7	1774.5	3875.7	5354.8	1459.5	9444.0	970.5	1058.0	2124.4	809.3	1585.0	2036.3	2627.9	2796.4	2178.6	2037.5	2932.4	2380.3	2861.9	2644.0	276.9	2801.9	1626.7	2569.0	1916.3	4390.5	1538.1	1549.0	1530.6	2756.8	1488.8	1645.6	1576.3	1569.3	1586.4	1586.5	1538.2	1623.3	2643.8	743.6	1535.6	44.1	4070.7	4105.7	5007.7	2774.6	5333.8	344.3	4139.9	6421.4	617.1	2051.8	1719.2	801.9	108.4	3406.3	3424.5	1200.3	3279.1	2335.3	1414.9	1799.8	4602.7	2194.2	2090.5	3250.6	40.4	4508.1	6260.1	2099.8	2310.4	2451.6	1237.2	3541.5	2346.6	2252.0	3311.9	151.4	42.6	3944.5	880.9	4754.9	4734.0	5440.1	5670.8	3861.9	2031.3	49.6	5590.7	1395.6	3262.7	23.1	45.9	2886.9	3231.4	2588.2	3109.6	4622.7	2703.3	3770.5	768.5	465.7	1268.8	3609.7	2661.0	653.8	709.0	7289.7	4590.1	3541.8	3518.7	4105.6	4384.9	4943.2
RPS26	"eS26, S26"	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044697	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 494.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	720.5	1265.1	387.6	271.7	388.8	395.5	690.2	382.8	480.4	707.7	384.0	731.2	177.1	569.7	410.7	875.4	724.0	123.3	713.0	380.9	416.6	701.8	926.6	521.9	512.9	396.3	399.7	1120.6	1170.2	274.3	476.7	251.6	389.9	627.3	403.3	69.8	592.3	335.9	778.2	857.3	744.1	307.2	383.4	832.0	717.5	208.8	394.0	616.8	544.1	390.6	715.6	734.3	698.0	389.2	639.2	763.3	853.6	319.5	1153.3	1696.4	852.0	633.4	929.5	1027.7	596.0	1182.7	281.7	1408.3	383.5	670.6	339.5	293.2	970.5	544.0	698.1	558.9	1552.8	743.9	482.1	719.0	1062.3	490.5	392.2	1036.9	1705.6	544.3	614.0	404.0	794.3	989.6	517.2	458.1	845.1	983.2	371.8	886.0	839.7	766.7	1710.8	496.7	254.8	884.3	871.4	634.9	318.2	552.4	245.8	542.2	372.2	252.1	479.4	538.6	260.8	255.0	524.3	328.0	518.0	369.3	810.2	770.9	284.0	969.2	334.4	334.8	394.8	262.5	650.7	410.2	723.2	872.3	841.4	711.8	508.4	720.3	898.4	863.6	154.8	607.5	373.0	643.6	963.7	1264.1	387.6	388.8	382.8	480.4	380.9	416.6	396.3	399.7	389.9	383.4	394.0	389.2	1114.5	224.4	237.7	5.2	2483.4	1760.6	852.7	2533.9	3266.8	131.0	1968.1	2542.2	29.2	1425.5	985.7	430.4	62.6	1237.2	1377.0	1803.5	972.4	1031.5	85.4	862.0	876.0	992.0	860.5	1977.9	5.2	2625.0	2835.4	1006.2	1666.7	861.2	514.4	1242.7	1647.4	2125.4	1369.2	75.7	5.1	1406.6	732.4	1557.8	1925.7	57.3	295.4	1146.8	1462.1	6.5	754.7	706.4	563.4	6.6	7.1	1806.8	1756.4	221.5	2590.7	1221.2	2448.3	1503.0	557.4	193.1	309.0	719.1	935.9	305.9	304.0	4236.6	1814.2	1708.2	2103.6	1318.5	1411.0	1000.6
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099624-151104642	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		300000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	2233.9	1361.3	1032.4	1357.8	1063.0	4321.5	4603.8	1034.9	1672.3	3236.5	1041.5	1964.3	1314.5	1964.8	2303.4	2250.6	2307.9	1186.8	1430.3	992.0	1052.4	1657.2	1371.0	1471.0	3341.7	1038.8	1025.1	4877.7	3514.8	1107.6	1325.8	1372.7	1059.4	1982.7	1778.1	861.8	2107.7	1322.9	1967.9	2992.3	1848.5	1337.8	1102.5	2038.6	1898.7	586.2	1056.2	2991.3	1965.5	1499.1	2764.4	1969.9	2486.8	1089.1	2090.9	1501.8	2780.1	2751.6	3524.5	6867.8	2849.1	2150.7	3334.5	3006.4	1848.2	2933.6	2944.4	9381.3	1048.4	2383.2	1050.5	1339.3	2877.1	3624.3	2840.5	2075.6	2762.0	2023.6	1589.8	3421.2	4067.8	4855.0	1999.1	5125.5	7353.9	1849.5	4874.5	4195.4	3639.4	3417.8	3320.0	4722.3	3632.8	3124.8	5289.7	5604.8	2624.1	3296.7	1147.0	3798.0	2719.3	3175.4	3505.2	2487.1	2668.0	2635.2	971.4	3495.1	5019.9	1954.5	2341.0	5780.5	2212.2	1451.6	1915.8	1618.1	2424.7	3626.8	6367.6	5820.6	1863.4	3508.9	1758.5	1918.8	3362.4	977.5	3828.9	2626.4	6462.8	7155.1	6390.5	5052.0	5393.2	6165.0	8750.8	7174.2	495.2	5199.2	2256.0	6377.8	5103.3	18540.3	1032.4	1063.0	1034.9	1672.3	992.0	1052.4	1038.8	1025.1	1059.4	1102.5	1056.2	1089.1	2387.5	971.2	1605.1	15.0	5574.2	6158.3	8280.0	5535.6	4255.3	412.4	6080.4	8681.6	381.3	2194.8	2530.5	825.8	120.9	4538.4	4799.4	1188.9	4284.8	2316.3	1754.6	1570.1	3613.3	2564.2	2154.3	3366.6	17.8	3732.2	7502.1	2388.6	1599.9	1895.7	1468.6	3424.3	2653.9	1441.0	3403.7	163.2	18.6	4137.0	1454.6	4309.4	5658.7	4012.5	4428.4	3332.7	3260.3	20.6	5502.6	1760.6	4551.0	23.6	22.4	2788.3	3029.1	2592.3	2412.5	6111.5	2682.0	5073.3	1084.8	593.9	1768.4	4410.8	3918.5	834.4	820.8	5042.0	6756.0	4591.7	4520.4	4186.2	5049.9	7641.8
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380236	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 16920.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		320000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favorable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	2449.1	1527.7	1230.0	1483.1	1315.9	3988.9	3070.3	1218.7	1877.5	2746.3	1206.5	2056.1	1485.0	2008.1	1857.3	2788.4	2192.6	927.2	1419.4	1155.2	1268.7	1807.1	1330.8	1520.1	2961.1	1299.0	1255.9	4555.2	3817.4	1069.3	1427.4	1008.9	1322.1	2250.4	1643.0	716.4	2066.9	969.4	1747.9	3577.8	1929.2	1124.2	1314.7	2032.4	2122.9	697.6	1262.2	2341.4	1663.3	1250.8	2493.5	2378.2	2538.4	1357.3	3146.0	2013.7	2004.4	2363.6	3318.8	5075.0	2399.4	2066.1	2675.8	2423.3	2011.5	1686.4	1409.3	7139.0	1986.4	1988.0	859.3	1500.9	2274.1	3180.3	2611.8	3750.0	2173.6	4721.4	2328.7	3106.0	4041.3	2533.2	2256.0	4248.4	5692.5	1620.0	4727.2	3469.1	2964.4	3160.6	2022.8	2830.1	2653.9	1886.9	5406.2	16920.1	3772.8	2466.3	1354.6	4159.9	2025.5	3447.5	3412.7	2646.9	1993.2	2674.3	781.7	3280.0	4564.1	1597.1	2139.0	9080.4	2194.5	1386.6	1486.6	1453.3	3293.5	1324.9	2750.6	4935.9	939.6	3747.0	829.8	1125.0	2374.7	735.3	3116.0	2085.1	5427.4	7104.3	5693.8	4240.7	4059.2	6035.0	7515.6	6032.8	374.2	4153.1	1946.8	3766.4	4744.0	14744.9	1230.0	1315.9	1218.7	1877.5	1155.2	1268.7	1299.0	1255.9	1322.1	1314.7	1262.2	1357.3	1666.2	1653.8	3379.0	28.7	5653.1	9735.5	13864.1	9387.7	4797.6	270.6	10286.6	10100.4	820.4	2965.4	5237.5	1276.3	127.2	5414.0	3535.8	1396.0	5791.2	3073.2	2516.7	1356.0	3150.4	3882.7	2052.9	3987.8	23.0	6777.1	9231.6	2652.7	1988.8	1730.0	3234.5	2265.7	4298.1	2248.6	4065.7	75.7	23.7	4887.3	2541.0	4150.7	6491.3	7208.8	4631.0	3029.8	4605.0	37.5	5131.6	1404.2	4136.0	25.1	42.9	4532.4	4207.9	2423.4	2549.8	11104.9	2807.8	6997.6	2168.7	461.5	1485.7	4699.9	4234.9	1260.7	962.3	6520.0	12082.7	5409.2	4876.4	2935.1	6434.2	12610.3
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 70.0;dendritic cells: 75.0;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 10.5;monocytes: 2.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	15.0	13.1	14.8	11.8	16.1	10.9	12.5	17.0	17.9	13.7	10.5	16.8	9.8	16.5	2.8	31.0	12.0	4.7	16.2	15.3	13.7	14.2	12.0	16.4	12.0	14.7	14.7	8.5	12.2	3.3	6.8	11.7	14.7	13.1	5.6	2.1	12.5	5.6	16.0	22.8	17.1	6.8	14.4	25.0	15.8	3.5	15.1	5.7	10.2	5.0	9.5	16.6	14.6	14.3	76.1	41.5	5.9	15.0	12.8	11.9	84.0	39.4	20.6	30.2	14.9	41.7	38.8	7.9	44.9	22.9	38.6	69.1	7.1	32.1	14.7	24.1	14.0	17.8	36.8	21.6	12.8	18.0	32.0	12.0	29.7	25.7	20.9	10.9	18.4	14.2	7.4	10.6	15.6	69.2	16.6	28.4	6.5	29.2	88.1	31.8	24.4	25.3	21.1	34.4	8.7	6.9	40.7	24.8	35.6	8.5	28.6	22.3	37.0	41.0	51.7	74.7	35.9	12.5	10.4	7.8	27.0	20.6	21.2	1.3	2.7	1.4	0.7	2.1	0.7	0.4	0.5	0.6	2.2	0.2	0.3	0.3	0.2	0.2	1.3	10.5	0.5	2.6	14.8	16.1	17.0	17.9	15.3	13.7	14.7	14.7	14.7	14.4	15.1	14.3	11.8	3.2	3.0	8.5	6.4	12.1	6.8	8.6	8.6	7.3	5.4	4.8	15.2	7.2	5.4	3.7	4.2	70.0	75.0	25.2	5.9	20.1	0.8	3.5	8.7	9.9	8.4	9.9	6.6	25.2	38.2	9.3	26.0	7.6	19.1	5.7	10.8	7.8	29.6	8.4	5.3	14.3	2.0	30.5	13.2	1.5	11.1	25.8	8.8	11.2	26.6	3.6	10.3	4.5	5.4	65.1	12.8	6.8	5.7	10.2	16.2	8.4	3.1	2.1	0.0	6.0	10.2	0.7	6.5	13.9	10.7	46.7	11.3	7.5	19.9	9.6
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847861-91060641	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 162.0;Oligodendrocytes: 156.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	2.6	0.9	2.4	2.9	7.8	3.3	7.5	14.7	3.7	3.1	1.0	6.6	3.7	4.9	0.3	5.3	4.1	2.8	2.6	1.6	3.0	1.9	1.7	2.8	3.4	4.1	3.8	4.6	1.5	3.0	2.6	3.4	4.1	3.1	5.1	3.0	4.9	4.3	9.0	3.7	4.9	3.9	2.9	3.1	5.4	2.4	4.5	5.0	4.0	9.9	3.5	5.4	4.1	8.0	1.3	2.1	2.7	1.4	0.0	0.5	9.4	0.9	1.3	2.9	4.1	1.2	2.7	6.7	2.8	2.8	1.8	4.7	2.2	1.8	5.1	1.0	3.5	7.5	1.8	0.4	0.0	7.1	31.8	0.8	4.3	1.7	1.3	0.7	3.2	5.1	0.7	7.1	2.9	3.1	2.0	2.2	0.9	4.6	3.4	3.3	11.2	3.2	3.2	2.9	10.4	3.2	2.7	14.8	8.1	1.8	3.0	1.9	0.6	0.8	1.5	0.6	3.4	2.8	3.5	5.9	1.7	5.0	10.6	16.9	3.0	9.0	3.7	2.5	6.1	4.5	4.6	3.5	2.7	5.8	5.5	3.0	19.8	10.4	3.5	1.2	7.9	2.6	2.4	7.8	14.7	3.7	1.6	3.0	4.1	3.8	4.1	2.9	4.5	8.0	13.2	19.2	26.5	80.3	53.7	40.4	45.2	20.4	53.5	32.9	41.4	42.9	20.7	14.3	22.7	7.3	16.7	43.7	21.0	36.7	0.0	11.1	9.1	96.2	19.0	21.4	16.3	22.5	65.4	5.1	6.5	21.8	13.3	162.0	92.2	32.5	20.3	6.5	7.1	26.9	32.5	17.3	4.1	17.6	13.4	3.1	14.0	21.8	19.6	53.4	21.2	10.5	23.7	36.7	156.1	3.5	13.0	11.7	26.0	29.3	41.9	3.7	31.3	32.1	13.1	51.9	22.3	21.2	23.7	35.5	46.3	111.8	48.6	7.2	20.8	52.7
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		290000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	1838.1	1827.8	968.1	1263.3	996.7	3485.5	2382.9	960.6	1219.3	2442.2	981.5	1524.8	1195.0	1642.4	1374.2	2245.4	1928.1	992.2	1051.9	924.3	990.0	1152.9	1081.3	1080.0	2599.6	1010.5	958.9	5416.4	2647.7	800.3	1015.0	1237.3	1021.9	1591.5	1241.2	330.7	1794.6	903.9	1677.0	2755.2	1403.7	1147.3	1051.9	1577.9	1376.4	332.0	993.7	1888.8	1095.1	1233.4	2230.7	1661.8	2073.9	1049.9	2441.2	1215.3	1875.4	2510.4	3244.1	5078.7	3072.1	1749.9	2806.5	2463.5	1966.2	2104.1	2601.9	4624.8	1869.5	2168.8	1554.5	1629.2	2474.1	3090.7	1814.6	1684.7	4320.2	1721.5	1606.0	2864.5	4578.2	3450.8	1612.1	4061.4	5060.2	1638.3	4357.4	3481.0	3002.5	2729.6	2630.2	3148.3	2334.1	1961.4	3810.0	3659.2	4103.8	2046.8	2070.8	3020.4	2294.4	5221.6	2795.6	2097.6	2026.9	2298.2	946.6	5242.8	7264.1	1814.9	1835.0	6739.3	2030.0	1204.7	2069.4	1857.6	3031.1	2418.8	2600.5	3553.2	1458.2	4134.2	1478.9	201.9	847.4	259.3	827.7	813.6	1414.6	2308.1	1504.1	1152.2	1266.5	1942.3	1855.5	1597.6	78.9	1020.7	652.7	1553.9	1384.4	3322.6	968.1	996.7	960.6	1219.3	924.3	990.0	1010.5	958.9	1021.9	1051.9	993.7	1049.9	2553.4	1416.6	2077.3	17.9	8208.6	7906.9	9285.2	4955.0	10969.2	235.7	6782.7	6808.8	749.2	2836.7	2980.6	1092.5	91.8	5226.0	3583.3	1280.8	4149.8	2597.7	491.8	2480.8	7101.2	3339.7	2141.2	5081.3	22.7	6066.6	7604.6	3510.7	3144.2	2929.1	1842.5	4531.7	3832.6	2417.2	3576.9	60.6	24.8	4271.4	1249.2	4339.4	5493.4	663.3	6143.9	3744.2	2947.3	23.4	4350.2	1090.6	2637.5	19.6	24.2	3967.8	3960.4	2751.4	6055.5	7588.1	2355.6	4494.0	1621.0	281.4	1505.4	4004.0	4560.2	415.9	479.9	14643.0	11209.1	5363.5	4833.7	4645.1	5165.6	8250.4
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 46.0;Excitatory neurons: 70.1;Inhibitory neurons: 66.3;Microglial cells: 32.8;Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	5.9	4.6	3.5	4.4	3.3	4.1	3.6	2.0	4.4	4.3	0.1	5.7	4.8	5.6	1.8	4.5	4.5	2.9	6.1	3.8	2.6	3.1	3.4	4.2	3.3	3.3	2.8	4.8	5.5	5.3	4.0	3.6	3.3	4.5	2.4	2.6	4.6	5.0	14.1	5.1	4.5	4.6	2.0	3.8	4.4	4.0	3.5	4.4	3.6	7.0	2.7	5.4	3.6	3.2	16.2	34.7	6.8	12.9	9.5	7.0	15.5	12.7	9.5	17.9	12.4	21.5	13.8	13.3	10.1	12.9	13.8	11.6	10.5	15.7	8.9	5.6	19.6	20.8	16.8	21.2	8.9	19.8	15.3	12.3	9.9	17.3	9.1	5.9	16.6	15.7	24.9	4.6	8.6	8.8	12.4	7.8	7.4	9.2	24.0	10.2	12.9	11.2	4.6	17.8	13.4	17.4	14.4	22.9	14.9	6.6	16.3	14.5	9.6	37.1	17.8	11.6	15.7	8.9	3.9	12.6	22.4	10.1	23.6	0.0	0.1	0.0	0.5	0.3	0.3	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.0	1.0	0.4	3.5	3.3	2.0	4.4	3.8	2.6	3.3	2.8	3.3	2.0	3.5	3.2	4.3	0.0	3.9	46.0	8.5	3.2	3.0	2.4	4.6	6.8	4.2	3.3	4.5	5.7	1.6	5.5	4.2	4.4	7.2	3.8	1.9	3.6	6.7	3.9	5.4	4.3	6.0	4.8	70.1	3.8	5.9	4.8	8.2	4.9	2.5	7.5	2.2	7.5	4.7	11.8	66.3	3.1	6.1	5.7	3.2	10.9	3.1	6.7	1.8	32.8	1.7	4.3	2.1	50.8	66.2	4.7	3.5	5.3	9.4	4.5	4.6	2.7	2.0	7.0	0.0	5.5	4.1	4.5	3.5	5.1	3.0	4.4	9.3	6.0	5.6	3.8
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 497.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 588.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.8;plasmacytoid DC: 44.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		320000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	64.2	72.3	27.0	62.8	41.9	28.1	54.6	41.1	32.2	69.1	52.3	98.3	76.1	59.5	55.0	67.8	45.1	71.5	59.1	27.5	35.3	77.4	219.0	80.2	28.2	49.3	42.2	48.3	497.7	72.4	63.4	107.9	45.5	66.5	65.9	17.7	228.2	63.4	21.9	43.6	82.7	46.0	37.7	57.7	123.1	48.4	40.9	14.4	130.4	14.7	27.0	57.6	55.2	49.2	173.5	121.0	35.7	80.4	160.3	172.2	186.2	264.3	221.3	110.0	148.2	271.2	159.3	66.5	87.3	252.2	113.4	170.4	38.7	215.4	89.1	30.9	29.7	76.2	34.9	283.6	229.4	29.0	93.0	228.9	63.8	178.7	104.3	161.7	109.7	23.4	32.6	62.9	167.6	78.8	11.4	65.5	41.6	383.3	115.8	20.1	94.2	231.3	93.0	58.4	18.2	13.7	151.1	353.2	108.4	75.0	62.0	43.5	198.7	232.7	85.9	122.1	88.5	114.6	93.6	21.6	88.1	30.7	121.1	11.7	8.4	37.8	4.3	5.5	3.2	1.0	1.4	2.6	4.6	1.4	1.4	1.6	7.8	10.7	8.4	44.4	1.5	3.1	27.0	41.9	41.1	32.2	27.5	35.3	49.3	42.2	45.5	37.7	40.9	49.2	146.8	96.1	197.1	15.0	72.5	59.1	92.3	90.3	55.2	21.9	127.0	76.3	46.4	144.4	158.2	95.6	31.3	262.0	180.6	588.9	45.0	199.7	47.2	117.5	228.4	155.8	97.0	31.6	3.0	414.6	235.8	219.7	294.6	322.8	118.9	78.1	118.9	279.9	117.4	25.2	4.9	507.9	50.8	62.0	85.7	44.3	127.1	91.6	71.2	17.8	75.1	144.3	79.3	23.1	27.6	357.7	452.3	83.1	570.6	145.6	221.6	57.2	121.8	35.5	32.9	165.1	169.8	77.5	139.9	73.2	55.8	532.9	56.9	114.6	329.3	218.5
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102238961	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.5	21.2	10.5	11.5	12.1	7.1	12.1	13.6	11.5	12.5	26.5	15.3	15.0	11.6	15.1	11.2	13.5	11.9	16.7	10.1	13.7	24.4	22.6	22.0	20.1	13.6	12.4	12.0	13.5	45.0	10.3	13.8	13.9	15.7	15.5	21.9	10.9	13.8	30.4	11.0	10.1	11.7	14.1	14.3	9.5	9.7	12.6	10.1	39.9	34.9	19.6	11.2	5.4	16.8	15.3	26.5	30.7	18.3	43.7	41.3	24.6	34.8	41.4	18.1	21.0	9.6	11.9	97.5	31.8	38.7	18.5	5.7	15.1	35.2	25.3	15.8	16.2	24.4	10.3	20.9	35.3	7.6	50.0	53.1	66.1	20.2	30.5	43.0	51.8	16.3	18.2	14.6	59.1	15.2	13.1	14.6	17.7	16.5	19.2	8.2	12.7	20.1	43.1	17.1	7.8	15.4	17.9	9.7	21.1	76.3	25.5	17.1	39.4	27.8	53.7	19.6	9.6	15.3	15.3	88.0	41.0	11.5	30.2	15.7	6.3	7.0	2.7	5.4	3.8	6.6	2.3	3.2	7.7	8.6	2.6	2.8	23.1	4.1	11.5	2.2	1.8	3.3	10.5	12.1	13.6	11.5	10.1	13.7	13.6	12.4	13.9	14.1	12.6	16.8	16.2	57.7	29.3	10.1	33.5	19.4	8.2	11.8	34.1	13.5	17.0	9.4	22.8	20.0	23.9	40.5	14.6	13.8	13.9	7.3	25.4	6.8	2.3	36.2	11.1	14.9	29.4	3.8	14.6	8.2	5.9	14.8	6.1	11.8	11.4	11.2	18.5	23.6	12.6	10.1	17.6	9.7	10.2	26.2	39.5	1.4	14.3	23.8	17.8	20.6	18.2	24.5	7.2	16.1	12.1	5.7	5.7	14.7	9.3	10.7	8.1	22.7	39.9	18.3	6.6	16.2	16.8	13.2	14.5	26.2	18.5	4.8	12.2	8.6	12.1	6.7
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	8.0	8.2	8.0	6.5	8.7	5.3	7.3	7.4	10.2	6.9	4.8	6.4	5.0	7.1	3.3	16.0	6.4	4.0	7.0	9.2	7.2	7.6	13.0	5.3	8.1	8.9	8.1	8.0	9.7	4.8	5.5	4.9	8.0	7.2	3.0	1.7	8.1	4.2	12.9	11.9	5.9	3.4	6.6	8.2	7.5	7.9	7.6	5.0	6.0	5.3	6.1	7.3	7.9	10.8	37.6	19.6	13.5	22.6	7.3	8.2	25.6	18.5	10.9	25.7	18.1	52.1	21.6	35.5	14.9	10.4	23.8	18.8	25.2	18.5	11.7	17.7	47.9	50.4	18.8	32.1	14.9	32.6	17.5	11.0	17.0	26.0	20.6	6.7	13.7	32.9	67.3	26.9	12.2	43.2	28.7	44.7	44.8	26.1	28.7	52.0	10.7	66.4	13.4	20.5	31.6	18.8	19.3	21.0	25.3	3.8	21.5	22.1	15.6	17.2	19.1	18.2	33.0	32.1	29.8	37.1	25.7	53.7	22.6	0.1	5.0	1.7	10.7	4.8	13.4	11.0	11.0	11.1	10.2	13.0	11.9	8.0	1.1	13.1	2.3	8.8	6.8	7.0	8.0	8.7	7.4	10.2	9.2	7.2	8.9	8.1	8.0	6.6	7.6	10.8	12.9	16.0	19.4	9.4	17.3	72.3	40.2	55.9	23.3	18.7	14.4	12.7	6.1	18.6	45.3	7.3	20.9	31.4	12.7	18.6	7.9	40.0	4.2	14.9	15.5	18.8	20.9	19.0	6.2	33.1	39.0	24.5	18.8	16.1	20.3	20.1	9.3	16.0	32.7	8.4	6.3	19.3	32.6	8.4	35.0	2.7	19.3	13.6	42.7	2.8	15.3	12.3	13.4	2.5	11.6	41.4	9.1	20.7	19.2	59.4	10.5	21.0	24.3	17.6	32.9	23.8	20.6	21.4	30.0	32.2	70.2	30.4	15.0	21.4	29.5	46.1
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 90.9;skeletal muscle: 38.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 26.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	8.1	10.2	2.6	9.2	3.4	90.9	5.6	1.1	7.6	5.6	2.4	4.9	6.0	7.4	3.6	8.5	7.3	7.2	11.4	3.2	2.7	6.8	5.7	6.7	6.7	4.3	4.4	6.1	16.0	9.3	10.2	4.3	4.1	6.3	3.8	3.4	8.3	4.0	38.5	10.3	4.7	6.0	0.2	7.6	6.3	10.9	3.7	4.7	5.5	9.7	6.1	9.3	5.7	4.6	38.9	50.8	13.2	28.6	10.0	11.6	28.9	24.2	14.4	24.2	18.7	55.6	35.0	42.3	30.4	15.1	21.6	48.7	36.3	28.0	16.3	23.1	44.2	32.8	19.5	43.6	16.5	51.7	41.5	12.2	38.6	59.9	54.6	27.0	13.7	23.5	47.7	27.4	14.0	50.8	35.0	33.0	57.0	20.4	34.0	38.1	18.0	42.1	16.8	21.4	17.7	37.9	19.2	18.1	24.1	10.4	43.7	26.5	18.2	16.1	27.9	36.5	76.4	55.7	52.7	48.6	23.2	64.9	17.9	0.4	11.2	6.9	2.7	13.6	3.3	3.9	1.6	2.2	6.2	4.2	2.5	2.8	26.7	1.9	16.9	5.0	1.2	6.0	2.6	3.4	1.1	7.6	3.2	2.7	4.3	4.4	4.1	0.2	3.7	4.6	8.8	35.3	31.1	5.9	18.5	23.5	14.2	5.1	25.0	5.8	12.7	9.9	11.6	7.2	21.5	14.7	41.7	5.2	7.7	10.6	0.0	8.7	7.2	17.1	10.6	10.6	21.5	7.2	15.1	8.7	7.5	13.5	27.0	20.1	41.7	12.9	3.9	8.9	11.5	5.0	9.5	13.8	4.1	12.5	7.1	4.8	3.7	30.3	7.2	2.8	12.3	1.9	3.1	5.0	4.4	8.5	6.4	2.6	31.8	17.1	3.7	6.8	24.6	12.7	0.0	19.4	6.7	10.6	20.6	22.7	19.6	9.2	11.0	13.5	11.5	13.6
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659560-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 131.3;Early spermatids: 213.2;Late spermatids: 222.8;Rod photoreceptor cells: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	8.8	5.9	7.9	12.2	8.9	6.2	9.1	7.0	7.8	7.2	5.9	7.2	6.7	9.1	5.5	8.6	9.1	6.1	4.9	7.4	7.2	4.9	8.7	6.7	17.4	7.8	7.9	13.1	10.2	7.2	4.3	5.8	7.2	7.5	7.3	28.4	10.2	6.8	12.1	8.8	6.4	8.8	7.4	11.0	7.8	12.0	7.8	16.1	6.5	8.8	14.8	9.8	6.5	8.6	52.5	30.4	31.8	48.1	20.2	21.5	26.0	27.0	19.3	29.3	24.0	69.4	22.2	101.9	17.2	21.5	33.9	22.8	78.9	46.5	34.6	34.6	62.8	60.3	34.8	43.9	27.9	95.0	22.9	22.4	29.2	35.1	40.3	18.1	33.1	43.2	96.0	29.1	26.1	27.4	76.1	28.9	108.4	33.7	33.4	98.7	32.1	71.2	21.2	24.8	62.7	33.6	50.6	36.9	37.9	11.7	24.2	29.4	29.7	9.0	28.3	24.0	49.8	39.1	53.8	119.3	28.5	100.7	30.1	2.0	2.5	0.7	6.2	2.5	7.3	5.6	7.9	7.5	3.0	4.3	7.2	8.6	0.1	5.8	2.2	2.4	6.6	5.5	7.9	8.9	7.0	7.8	7.4	7.2	7.8	7.9	7.2	7.4	7.8	8.6	15.5	32.1	16.4	8.8	32.7	22.8	17.7	15.0	28.5	30.3	13.8	11.0	13.4	17.2	21.0	5.5	131.3	8.6	27.1	5.7	1.9	17.0	213.2	10.5	28.8	19.1	5.4	23.7	19.0	15.6	17.0	18.9	14.8	10.8	36.0	25.5	12.8	18.4	18.7	25.2	20.0	9.2	6.1	13.9	12.7	222.8	22.4	13.4	8.8	21.5	17.0	17.9	35.0	18.6	22.2	20.9	3.7	26.7	48.5	23.6	6.8	9.9	16.7	143.5	0.0	29.9	18.1	26.3	33.6	32.0	31.7	4.4	35.7	32.6	16.5	17.4
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	12.5	17.9	10.8	16.5	12.9	25.7	15.4	43.9	13.7	17.1	1.5	12.8	9.4	20.0	8.9	14.1	14.5	16.6	14.0	8.7	15.4	14.3	11.7	13.2	15.3	8.3	8.5	26.3	16.9	17.3	6.5	18.5	8.5	15.4	12.6	25.9	10.2	13.4	11.7	9.3	10.8	17.5	8.0	16.3	13.5	23.8	12.0	22.6	22.3	13.4	13.5	17.0	8.4	15.5	27.7	18.2	62.0	33.3	20.6	25.9	23.3	31.7	31.0	25.5	31.4	48.0	37.5	46.7	33.2	22.3	39.4	28.1	36.8	23.8	47.7	33.4	16.3	43.9	25.1	13.0	19.6	42.2	30.0	21.8	17.5	35.0	55.8	29.7	32.7	15.2	72.8	43.0	29.7	18.7	29.7	23.4	36.1	32.9	24.8	49.1	107.5	30.6	13.5	35.5	37.3	37.6	48.8	19.1	18.5	32.2	34.3	20.6	41.2	45.0	38.8	71.0	23.1	25.7	35.7	106.3	11.9	28.1	34.5	49.3	17.8	32.8	27.4	16.9	18.8	34.3	16.6	17.6	14.2	35.0	22.7	22.9	46.4	23.7	30.1	32.0	17.0	7.5	10.8	12.9	43.9	13.7	8.7	15.4	8.3	8.5	8.5	8.0	12.0	15.5	100.3	118.6	113.5	99.6	98.0	90.5	69.3	89.7	93.9	123.0	68.8	85.1	97.1	54.3	84.3	73.5	75.0	57.8	85.1	53.0	46.9	79.2	112.4	72.9	95.2	96.5	85.6	71.8	129.4	55.3	50.6	90.5	51.0	86.0	95.5	132.5	79.9	46.2	45.6	146.4	129.3	64.7	71.2	62.9	68.5	40.3	126.8	66.5	56.9	98.4	93.9	124.6	120.5	157.8	144.7	73.1	63.4	118.1	74.8	97.6	44.1	38.2	69.7	97.6	105.2	99.3	100.4	114.8	109.4	57.2	84.0	67.5	99.9	141.7	58.1	91.6
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851580	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	"Nucleoli rim,Mitotic chromosome"		Yes	No		18000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nucleoli rim, Mitotic chromosome"		"HPA043483: AB_2678504"	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.95e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	39.3	32.2	11.1	36.9	11.7	46.7	78.8	13.4	14.1	47.6	12.2	35.7	32.6	44.0	28.8	38.2	44.5	30.5	33.7	11.9	12.5	33.0	39.1	26.4	48.2	11.6	11.4	118.5	43.6	28.8	13.2	30.0	12.2	33.3	37.9	15.1	42.0	34.0	87.3	34.1	29.2	36.6	13.3	26.9	25.1	22.4	13.3	41.8	34.8	51.7	65.1	48.0	26.4	15.4	90.7	84.3	69.1	87.1	88.6	157.9	81.9	82.1	91.4	104.0	105.9	82.6	83.1	225.6	133.1	68.6	72.1	62.5	186.7	124.4	168.4	88.8	100.7	111.6	75.9	188.0	165.4	159.5	71.3	116.6	173.2	107.6	248.2	77.8	102.4	87.0	198.6	101.5	129.3	100.8	125.7	92.6	177.7	108.1	86.1	129.2	127.3	240.1	92.9	78.0	96.4	79.2	155.0	116.6	110.0	70.9	100.5	122.2	63.2	69.0	77.3	66.0	120.0	81.3	126.2	261.7	75.0	164.9	94.1	14.1	123.2	12.6	69.7	119.1	129.6	132.6	129.5	91.7	130.8	117.3	185.4	136.8	7.1	124.6	120.7	80.2	100.9	253.0	11.1	11.7	13.4	14.1	11.9	12.5	11.6	11.4	12.2	13.3	13.3	15.4	111.2	141.1	156.6	5.5	198.1	330.9	338.6	251.0	299.3	39.9	241.1	344.4	188.4	74.4	198.1	49.7	22.9	186.4	118.7	41.2	135.0	134.5	22.8	76.0	181.1	118.1	94.5	104.5	11.0	186.2	286.8	180.9	88.2	100.0	152.6	106.6	64.2	78.5	147.6	38.7	11.6	126.4	107.8	153.0	177.3	18.5	199.4	141.0	92.5	3.7	276.5	52.8	113.3	3.5	7.3	135.4	75.1	126.0	104.6	226.5	110.5	155.0	81.3	30.8	59.2	245.4	151.5	111.2	136.0	203.5	290.2	160.6	166.5	162.8	184.3	225.1
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197049	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062724, HPA063392"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	67.0	62.0	47.9	60.2	50.4	238.6	121.8	59.7	71.1	69.6	43.9	57.9	48.2	89.8	68.7	55.2	59.8	55.2	66.1	50.0	51.9	64.2	73.0	48.3	88.0	49.1	49.1	138.6	77.0	52.5	34.2	45.8	50.1	55.1	53.0	54.1	65.2	49.0	91.2	51.6	48.7	61.8	51.3	52.0	60.3	51.0	49.0	82.2	74.3	74.5	76.6	75.0	46.1	59.9	122.0	115.2	130.2	168.5	95.7	172.4	104.6	126.1	127.5	95.6	117.0	112.2	70.8	361.8	110.5	86.5	100.9	141.4	165.3	137.2	125.9	183.6	104.1	191.3	89.1	148.7	219.6	365.0	121.7	154.1	282.4	98.9	286.0	162.6	120.5	275.2	352.0	256.2	114.3	122.5	202.5	324.3	159.8	246.9	105.9	156.7	162.8	565.2	148.3	108.8	181.0	218.7	57.6	159.2	430.1	100.6	152.3	524.9	90.4	82.1	98.5	99.3	181.6	249.5	420.2	382.3	129.3	353.9	142.4	61.3	99.2	51.1	76.9	101.5	124.8	123.6	115.9	98.2	116.9	98.1	173.9	134.8	24.9	103.3	108.9	90.0	142.4	229.9	47.9	50.4	59.7	71.1	50.0	51.9	49.1	49.1	50.1	51.3	49.0	59.9	146.9	99.3	79.8	6.8	259.2	580.6	425.7	437.4	275.4	85.4	258.9	299.5	69.0	140.2	177.6	84.6	22.9	150.2	219.9	51.2	285.7	182.2	100.6	127.2	177.7	154.9	140.2	189.9	14.8	271.1	247.6	191.9	99.4	126.3	152.8	103.6	114.5	64.0	143.1	15.2	15.2	128.0	197.4	212.2	414.4	40.8	203.5	164.2	284.6	11.2	247.2	91.0	170.0	8.5	13.9	218.9	118.2	149.3	174.8	347.4	114.6	355.1	105.0	62.8	157.8	274.6	215.6	116.9	151.8	173.3	522.2	174.4	251.7	118.3	144.3	332.5
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266216-100292769	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		38000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	21.7	20.8	14.1	20.4	15.0	31.9	17.1	14.7	17.0	13.1	15.7	22.2	34.5	12.9	26.6	23.8	12.7	16.7	28.4	15.4	16.3	34.5	22.4	15.8	26.3	15.6	14.0	11.0	24.1	23.7	14.3	23.2	16.2	21.6	23.3	22.3	18.7	14.5	39.3	15.8	31.6	15.5	14.0	21.7	23.9	12.5	15.0	19.2	18.0	35.4	23.4	18.5	15.7	15.7	56.8	28.6	27.8	37.4	34.5	55.4	75.7	65.7	32.0	41.9	35.9	47.0	27.7	57.6	48.4	42.0	51.4	28.0	34.3	31.1	50.2	57.8	28.5	38.0	32.8	59.9	52.9	70.2	57.3	45.5	48.0	54.9	72.5	41.3	52.9	41.1	66.6	84.7	64.1	18.6	36.4	54.3	42.7	40.0	54.8	25.7	49.6	25.5	51.7	45.5	22.2	27.6	42.3	60.5	93.3	43.3	13.2	88.5	45.7	39.2	27.5	62.0	80.1	48.7	51.9	46.3	82.5	60.0	23.7	11.8	10.9	9.4	11.8	14.4	15.5	10.6	11.1	14.2	9.6	9.0	10.2	11.6	5.3	13.5	26.1	9.3	24.7	9.3	14.1	15.0	14.7	17.0	15.4	16.3	15.6	14.0	16.2	14.0	15.0	15.7	20.5	6.4	16.2	15.0	27.1	13.6	13.7	23.2	17.6	24.2	19.8	14.0	52.8	11.5	20.4	18.4	12.5	56.7	30.9	30.5	25.4	42.1	19.3	23.0	17.2	20.7	19.2	25.0	20.7	34.5	85.9	18.8	18.8	24.0	13.3	19.8	21.0	17.4	80.9	21.9	22.2	26.2	20.3	48.8	14.5	9.0	19.3	29.5	16.0	21.5	46.2	25.5	25.7	21.1	33.5	57.3	31.9	12.8	36.0	16.1	79.4	73.9	21.0	29.7	6.6	14.3	20.2	43.0	23.2	21.7	14.6	46.4	32.1	25.7	33.0	20.2
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870776	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 160.6;pituitary gland: 60.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.4;monocytes: 3.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		150000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	11.1	12.0	111.1	9.3	127.5	0.4	7.2	57.0	134.7	2.2	0.0	7.6	2.5	1.3	0.4	1.6	12.8	5.5	0.9	133.0	160.6	1.6	1.0	6.4	2.7	37.5	24.9	0.7	4.0	17.4	60.1	2.4	46.7	6.4	2.8	34.1	3.4	1.9	0.8	3.2	4.1	2.4	10.8	18.3	3.9	2.3	68.3	1.0	2.5	0.7	1.8	1.9	3.6	50.2	0.0	0.0	0.7	1.0	2.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.1	0.4	0.0	2.1	61.7	0.0	0.0	3.4	0.1	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.4	0.0	0.3	0.7	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	71.8	115.1	14.9	0.0	0.0	0.2	0.0	0.0	0.0	9.9	2.8	0.1	5.6	0.0	0.0	0.0	19.4	4.4	0.7	0.0	2.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.7	111.1	127.5	57.0	134.7	133.0	160.6	37.5	24.9	46.7	10.8	68.3	50.2	1.0	0.0	1.1	64.3	0.5	4.8	0.4	0.0	0.0	34.1	11.4	4.3	1.0	1.5	0.6	0.0	25.0	1.2	1.4	0.8	0.0	0.0	16.2	23.5	0.3	2.9	54.2	0.8	495.8	0.0	5.0	1.5	5.6	0.4	0.0	0.2	0.0	0.5	17.8	240.6	394.3	3.6	0.0	14.4	59.7	21.4	2.8	23.8	10.6	87.1	22.8	14.3	0.0	188.0	247.7	1.4	0.1	1.2	0.1	5.8	0.8	0.9	0.7	33.3	0.0	10.7	2.5	2.3	3.8	0.2	6.5	2.5	0.7	0.1	0.5	0.3
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 3547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 95.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 1801.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		3400000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	586.2	302.7	376.3	150.9	461.9	115.4	253.1	465.9	534.3	118.0	297.1	186.9	236.2	153.9	176.5	217.9	130.0	196.8	166.0	411.8	431.6	442.5	551.9	211.8	83.6	498.6	456.5	132.0	122.7	236.7	84.0	177.3	524.8	223.9	179.2	640.6	127.1	183.4	996.0	252.9	292.5	246.4	440.8	110.3	124.0	78.6	453.2	87.1	130.7	777.9	88.2	291.2	147.9	591.2	402.9	285.3	273.3	71.7	908.4	845.0	153.2	1301.6	1097.4	393.5	365.7	235.5	371.7	87.1	673.8	889.9	657.7	355.6	181.5	524.4	596.2	248.3	139.4	120.3	159.6	376.6	1801.9	218.1	59.7	638.5	490.8	540.3	1041.9	792.3	751.3	215.6	249.8	195.0	1724.1	117.8	268.3	222.0	245.9	86.8	252.0	118.5	360.3	180.0	924.0	475.9	179.2	211.3	297.7	173.3	378.1	465.1	147.2	165.1	1074.9	764.8	326.1	304.8	756.5	118.0	103.4	56.1	778.7	247.9	630.1	95.8	9.5	27.5	9.2	11.6	7.6	6.8	14.7	8.2	9.2	3.8	24.1	10.2	15.6	41.1	19.0	13.7	37.6	9.9	376.3	461.9	465.9	534.3	411.8	431.6	498.6	456.5	524.8	440.8	453.2	591.2	451.4	176.3	203.4	201.4	102.3	1062.1	1456.6	367.0	225.9	644.6	297.6	260.6	182.0	243.1	251.0	676.8	379.5	529.6	173.6	408.6	291.6	559.7	459.7	316.6	264.6	308.0	222.1	98.2	454.5	323.4	611.9	421.9	98.4	324.7	150.4	161.5	181.3	633.4	669.1	425.7	370.4	280.5	231.9	339.0	578.4	266.6	167.4	371.7	341.5	215.5	396.4	3547.4	137.0	249.3	1334.3	571.2	309.7	226.1	81.6	921.4	897.1	678.3	233.6	540.0	216.9	420.5	324.6	382.7	90.1	247.1	1059.3	362.0	145.5	100.1	238.1	1226.5
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318670	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 208.4;pituitary gland: 98.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.4;Early spermatids: 24.4;Enteroendocrine cells: 39.0;Excitatory neurons: 46.1;Horizontal cells: 32.0;Inhibitory neurons: 30.4;Late spermatids: 83.4"	"Group enriched"	"Detected in many"	5	"glioma: 8.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 62.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Enhanced	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	0.3	14.3	149.2	0.4	159.5	2.3	0.3	93.0	208.4	0.2	45.6	3.4	1.2	0.5	0.2	0.8	0.2	0.3	1.8	169.4	105.3	1.8	0.2	0.4	0.2	108.0	106.4	0.8	3.8	3.1	98.3	1.5	108.5	0.8	0.6	31.2	0.3	0.3	0.1	7.9	1.3	0.5	79.2	1.6	2.3	15.2	109.4	0.4	1.4	0.3	0.1	0.2	0.7	135.7	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	4.3	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.9	0.2	0.0	0.5	0.3	0.3	0.1	0.1	1.1	0.3	0.1	62.5	40.3	0.3	0.0	0.3	0.1	0.5	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.2	159.5	93.0	208.4	169.4	105.3	108.0	106.4	108.5	79.2	109.4	135.7	0.1	0.0	0.6	17.3	0.0	0.3	0.3	0.0	0.0	55.4	0.2	0.3	1.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	1.3	24.4	0.2	0.3	0.2	39.0	18.7	46.1	3.1	0.0	1.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	32.0	30.4	0.5	4.1	0.3	0.5	83.4	1.5	0.3	0.0	4.7	0.1	6.5	1.0	16.1	12.5	1.0	1.2	3.4	0.0	0.4	0.0	0.8	0.0	16.8	0.0	0.8	0.5	1.4	1.3	0.0	0.4	0.1	0.1	3.0	0.1	0.3
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"RUNX family transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 175.5;Glandular and luminal cells: 155.8;Microglial cells: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 23.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.9"	"Cell line enhanced"	"Detected in many"		"HEL: 251.3;HMC-1: 145.3;JURKAT: 226.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	14.8	3.8	2.9	20.3	2.1	45.5	27.1	2.6	4.0	15.3	5.1	6.7	5.1	3.3	3.1	9.2	4.7	16.0	6.3	2.8	3.2	4.6	7.0	22.4	11.3	6.0	4.3	6.3	4.0	1.5	5.1	8.5	6.5	13.5	6.5	0.3	39.2	3.5	18.9	11.6	6.8	9.2	4.9	10.2	16.9	3.8	9.1	28.2	4.8	1.4	9.9	20.8	12.8	7.9	50.9	3.8	0.1	0.3	12.5	16.0	32.0	28.1	28.4	15.3	11.6	2.5	37.7	24.9	1.8	24.9	25.5	45.0	3.0	33.6	21.4	38.7	3.8	251.3	10.1	11.6	22.9	29.4	145.3	30.9	19.8	46.6	45.6	21.2	8.8	226.3	17.3	14.1	32.7	10.7	119.3	46.5	2.2	27.4	14.5	119.2	84.6	15.3	20.7	19.9	1.4	0.0	28.9	7.2	10.5	6.8	14.7	67.8	37.0	25.1	32.4	37.8	42.8	46.4	20.7	23.3	31.2	63.4	37.4	23.9	3.1	7.1	3.4	1.4	3.2	4.1	3.0	3.2	0.9	3.6	4.5	3.7	3.4	1.5	4.7	3.4	4.5	2.2	2.9	2.1	2.6	4.0	2.8	3.2	6.0	4.3	6.5	4.9	9.1	7.9	6.2	54.5	35.4	1.6	27.0	41.6	52.7	61.2	54.7	2.3	175.5	94.6	3.2	28.6	60.8	20.2	0.0	2.1	39.5	18.7	1.9	39.7	19.4	89.6	21.5	9.2	6.0	47.3	3.5	28.1	21.4	49.2	84.6	155.8	17.7	29.2	4.6	5.4	68.4	0.0	3.2	12.4	28.5	77.0	122.5	27.1	4.7	84.4	28.4	195.8	42.2	0.5	39.1	1.5	1.6	101.0	15.8	4.5	27.7	43.6	8.3	1.6	78.6	0.8	0.0	111.3	51.2	29.0	28.0	53.7	20.2	2.5	41.6	2.7	17.0	75.3
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320894-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	27.0	26.6	42.0	11.6	40.7	12.8	23.2	39.9	66.0	38.0	11.3	39.2	21.6	28.8	8.7	49.5	24.8	16.8	28.8	38.9	41.1	32.1	12.6	23.7	10.7	55.2	34.0	27.5	22.5	11.7	45.0	18.2	53.2	32.1	22.9	11.9	32.0	20.3	14.1	37.3	29.9	18.6	28.3	18.0	27.3	6.6	41.4	18.6	19.3	13.3	11.3	26.6	39.2	41.0	70.4	43.5	24.5	36.4	29.6	32.1	47.2	32.7	20.8	42.2	47.1	50.1	45.2	13.7	24.4	33.2	24.2	95.1	38.3	47.4	18.2	18.8	48.8	19.8	44.7	26.6	24.5	19.9	32.9	33.0	29.3	42.5	14.6	20.4	43.9	29.7	30.5	9.4	36.9	133.4	25.0	25.3	48.4	128.4	68.3	33.6	17.1	24.3	40.3	52.7	25.2	40.5	27.6	76.9	16.8	39.8	114.8	33.6	20.2	54.0	44.4	51.4	65.8	7.4	18.0	8.6	38.2	26.5	15.0	5.8	8.0	4.0	6.3	9.8	7.2	3.6	5.1	6.4	8.8	1.5	2.8	6.0	1.1	3.3	25.2	8.4	5.5	5.4	42.0	40.7	39.9	66.0	38.9	41.1	55.2	34.0	53.2	28.3	41.4	41.0	18.2	9.6	12.7	4.9	8.0	28.0	20.1	29.5	22.8	16.9	21.3	19.3	10.2	15.7	27.9	18.4	6.2	30.8	14.8	82.2	23.5	22.4	0.4	9.9	14.7	20.0	15.6	14.5	23.8	17.7	76.6	19.1	25.5	23.6	8.2	9.8	16.4	7.8	21.0	37.0	30.5	51.7	18.3	12.8	20.3	0.5	18.3	11.9	19.6	6.5	11.7	13.4	15.5	7.1	8.2	25.6	43.7	18.0	8.4	29.4	51.8	27.9	10.4	7.0	19.7	12.7	22.2	2.3	8.9	41.4	34.9	38.0	15.2	6.7	40.1	26.0
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 94.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.4;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 15.8"	"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		240000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	7.6	1.1	0.9	3.6	1.1	1.8	4.2	0.8	1.3	6.9	0.6	2.8	0.5	3.9	0.2	17.2	3.3	1.7	2.6	0.8	1.4	13.8	0.2	16.6	1.8	1.4	1.6	1.1	0.8	0.1	0.7	2.2	1.2	3.0	1.1	0.0	4.2	1.7	1.0	94.6	1.9	2.1	1.1	0.8	1.4	0.5	2.8	0.4	1.5	1.9	5.1	6.9	9.6	1.4	7.3	87.0	0.1	0.1	8.1	5.2	0.0	6.1	31.4	7.9	12.8	2.6	2.8	0.1	19.0	16.1	10.7	22.2	0.1	45.7	3.7	0.3	0.0	0.3	51.4	15.3	2.2	0.0	0.3	4.1	24.9	17.9	19.9	4.5	1.7	0.0	0.0	0.0	39.8	0.5	0.0	0.0	0.6	0.2	11.5	0.0	5.9	4.7	26.0	18.3	1.2	0.0	5.4	6.1	2.0	24.7	0.2	0.6	8.6	2.9	4.8	47.4	6.3	1.4	1.6	0.2	38.2	0.7	19.1	0.0	0.1	0.0	0.0	3.1	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	7.4	0.1	0.4	0.9	1.1	0.8	1.3	0.8	1.4	1.4	1.6	1.2	1.1	2.8	1.4	2.0	3.2	0.5	0.7	0.0	10.3	2.3	15.4	4.0	0.0	0.3	0.4	0.3	1.5	5.9	0.0	0.0	0.3	0.0	0.0	1.9	21.7	0.0	2.3	18.4	7.4	0.0	1.3	0.0	24.0	4.4	8.4	0.0	1.3	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.1	0.1	4.1	0.4	1.8	0.0	3.6	0.0	0.0	0.0	0.0	24.2	0.0	0.4	0.0	1.5	0.0	0.3	1.1	0.0	0.0	24.7	9.6	0.1	0.0	5.6	6.5	1.5	0.5	1.1	0.0	2.0
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 37545.1;Urothelial cells: 17431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 17071.6;RPTEC TERT1: 20988.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		7000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favorable (7.56e-4)"	1873.9	666.6	435.5	1129.7	452.5	2003.6	1499.2	456.2	549.9	2306.1	425.9	2872.2	1504.1	1058.4	404.8	1300.4	879.9	1485.5	1046.0	425.8	593.7	2326.6	91.9	2216.9	365.1	520.2	488.9	556.8	204.2	68.4	311.2	709.2	489.1	827.7	2252.2	36.6	1123.5	1169.3	478.1	858.6	1367.0	965.1	488.8	519.1	1586.3	170.1	573.3	191.6	970.0	1010.8	504.8	3867.5	1276.0	530.4	3666.6	4412.8	4.3	330.6	7597.2	10482.0	9.3	4560.1	13403.9	2582.7	3352.7	273.3	8022.5	4.5	1319.7	7774.8	2078.7	1589.3	80.7	7340.5	1322.0	1340.0	1.6	731.2	2579.1	255.8	2730.2	28.1	458.7	4550.0	6406.8	2638.7	4734.2	3259.1	6078.3	0.7	3.2	12.3	7052.7	589.4	11.4	292.3	9.6	17071.6	7563.4	5.5	463.0	1250.1	20988.4	3918.8	1019.8	142.6	6251.9	6380.9	4628.4	3.7	835.3	1095.9	7473.3	2228.2	489.8	4463.8	7452.6	8.8	11.9	15.5	8619.0	728.4	4773.0	5517.3	6053.2	2413.8	1806.1	3258.0	1983.1	937.8	1664.9	1773.1	4240.8	583.7	1037.2	1378.3	9637.7	297.4	3066.5	2145.0	2217.6	8320.4	435.5	452.5	456.2	549.9	425.8	593.7	520.2	488.9	489.1	488.8	573.3	530.4	1177.8	4708.3	2663.1	17.6	343.0	1488.3	6868.7	7856.4	2416.5	4.9	1494.4	1445.2	326.6	1474.1	7013.9	8165.9	0.0	1368.2	999.9	8832.0	7446.5	6206.3	21.3	1148.6	3473.2	1801.5	2035.6	637.5	14.7	9903.1	2440.0	4102.1	2276.3	814.3	1817.4	126.3	946.3	21.6	2430.3	58.9	7.1	6823.9	5706.7	2853.5	7378.0	115.0	3013.4	3110.9	3070.0	30.0	6073.8	168.0	926.9	7.5	23.0	37545.1	9094.3	1143.8	346.6	9900.7	8570.5	224.3	4962.3	8.7	131.5	3234.0	2978.8	28.7	13.2	1718.7	997.6	1573.4	1283.0	5881.5	3218.9	17431.0
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		37000	"Cluster 32: T-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	43.9	34.7	33.1	18.7	33.9	21.5	38.9	30.2	39.9	47.8	29.7	115.7	9.9	58.5	4.9	53.0	44.5	14.7	44.3	34.2	34.3	29.4	32.4	39.5	23.1	33.4	33.5	36.4	29.3	22.1	27.2	21.6	33.4	38.5	15.8	11.0	31.0	22.3	53.6	41.3	43.2	27.6	30.5	51.8	59.1	76.6	35.6	36.5	50.8	17.7	24.9	68.1	42.3	34.4	126.7	71.6	189.2	81.8	57.9	68.8	51.3	180.7	130.3	154.7	192.7	76.0	61.6	131.4	72.6	112.0	89.6	49.4	179.6	93.2	141.0	138.4	172.0	117.4	45.2	62.7	68.4	142.3	81.7	64.0	42.2	75.4	72.0	58.9	142.2	141.3	138.7	51.3	135.9	68.0	127.1	396.8	87.3	116.0	68.5	171.7	110.2	47.9	56.2	77.1	59.9	79.3	126.8	87.9	79.3	84.3	70.8	75.9	72.7	71.0	103.8	47.0	161.9	97.0	352.1	206.5	44.7	108.7	98.5	55.3	37.6	21.7	41.6	34.7	45.2	37.2	50.4	43.2	45.2	29.6	69.9	54.6	18.9	63.8	23.6	30.1	69.4	65.3	33.1	33.9	30.2	39.9	34.2	34.3	33.4	33.5	33.4	30.5	35.6	34.4	29.2	9.6	18.7	11.4	24.1	25.6	32.6	33.2	16.5	20.1	19.2	16.3	21.9	15.7	18.6	12.9	6.2	77.7	20.5	18.5	11.7	41.6	13.1	13.3	34.4	39.4	19.2	36.6	20.9	34.9	107.2	30.8	17.3	22.0	15.2	40.2	22.1	21.0	57.6	20.2	21.8	25.2	42.7	17.2	25.0	19.1	15.5	19.2	46.2	10.3	48.5	25.8	41.2	10.6	16.3	38.1	20.1	18.8	26.3	32.6	11.4	15.6	7.2	16.6	52.6	16.5	39.0	151.3	113.7	22.4	24.6	57.5	33.5	35.4	32.5	30.5
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	NA		67000	"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	43.4	40.1	27.9	34.5	31.6	55.6	44.2	37.1	33.8	52.5	24.0	50.4	28.8	49.7	14.0	45.2	45.2	17.3	46.0	27.6	31.4	39.3	42.6	45.8	39.0	32.0	29.2	54.4	44.3	22.7	43.4	27.7	31.0	46.4	17.7	32.1	42.8	19.6	85.3	60.9	48.4	20.6	23.9	58.9	43.2	43.4	32.4	43.4	42.6	30.2	29.4	43.4	47.6	44.6	94.1	81.8	95.3	62.0	41.6	36.4	111.5	68.0	43.7	56.8	47.4	124.2	52.0	149.7	52.9	33.8	48.3	86.4	92.7	55.7	58.1	101.6	94.6	109.9	75.1	118.0	39.4	136.7	93.6	33.6	50.9	50.8	53.2	40.4	45.5	65.9	156.7	75.0	43.5	84.7	146.2	109.9	128.3	63.7	81.1	144.4	105.1	104.8	44.4	76.6	88.2	76.4	76.3	61.2	76.2	54.3	56.3	74.4	71.4	57.6	71.6	72.2	106.2	121.5	112.0	133.3	55.4	112.6	77.7	65.4	47.4	84.1	55.9	47.8	57.1	53.1	55.1	54.9	53.2	47.6	56.8	55.1	53.1	54.6	79.8	44.6	58.6	55.4	27.9	31.6	37.1	33.8	27.6	31.4	32.0	29.2	31.0	23.9	32.4	44.6	34.8	32.1	21.0	33.3	59.1	65.6	50.2	41.0	51.2	41.3	28.9	30.2	43.4	17.2	47.6	16.5	35.5	53.6	47.7	41.0	25.4	44.0	10.0	56.6	55.6	38.9	29.8	29.6	28.6	35.0	55.2	42.6	33.1	46.4	50.6	52.6	23.2	28.1	38.0	50.5	29.8	43.4	32.6	23.0	52.6	8.2	35.8	37.0	30.2	30.9	55.6	30.0	50.4	34.2	41.5	32.3	29.9	25.9	50.9	44.8	33.7	28.1	72.9	47.2	19.7	44.5	45.1	89.7	94.3	37.2	65.4	62.5	52.2	44.0	40.5	38.9
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"testis: 4.8"	"Cell type enriched"	"Detected in some"	9	"Spermatogonia: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.5;K-562: 15.6;Karpas-707: 25.5;U-2 OS: 7.0;U-266/70: 8.9;U-266/84: 23.8"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	8.9	23.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.3	0.4	0.5	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802521	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9;thyroid gland: 5.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 26.9"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 25.0;AN3-CA: 17.5;BEWO: 33.2;NTERA-2: 60.2;SiHa: 15.6;SuSa: 39.7"	"Not detected"	"Not detected"							"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.2	0.3	0.2	0.2	0.2	0.8	0.2	0.4	0.2	0.2	0.3	0.2	0.1	0.2	0.4	0.2	0.2	0.0	0.1	0.2	0.4	0.8	1.6	0.2	0.1	0.2	0.3	0.1	2.1	2.0	0.5	0.2	0.2	2.4	0.2	0.5	0.9	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.2	3.9	0.3	0.0	5.8	0.0	0.1	0.4	0.1	0.4	0.0	1.7	25.0	17.5	0.0	0.1	33.2	0.0	0.2	0.1	0.3	9.0	0.2	0.0	0.3	0.3	0.3	4.3	0.2	0.1	0.3	0.4	0.0	0.0	7.0	0.4	0.1	0.0	1.9	0.7	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.8	0.0	0.1	60.2	0.2	0.4	2.3	0.0	0.0	0.0	0.5	5.7	3.1	15.6	0.1	1.5	39.7	0.1	1.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.4	0.1	0.0	2.0	1.6	0.0	0.0	1.1	0.1	0.0	0.4	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	3.6	0.0	0.2	0.1	0.2	1.2	0.0	4.1	0.2	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.6	0.2	26.9	3.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.2	1.0	2.0	2.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.7	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016800, HPA059385"	Approved		Enhanced	Cytosol		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA016800: AB_1856552, HPA059385: AB_2684000"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	46.1	39.7	37.3	24.5	48.1	20.3	42.1	31.1	37.5	56.6	18.1	47.1	18.9	49.7	16.8	65.0	47.3	26.7	39.6	34.2	34.5	33.2	31.2	45.7	15.1	51.9	45.9	60.8	34.2	36.3	48.1	26.2	39.9	41.9	15.8	23.4	42.8	33.3	36.0	54.9	34.9	27.9	35.9	32.9	40.2	41.4	40.7	19.2	44.1	19.2	15.1	46.1	52.9	53.6	97.8	131.0	65.6	49.7	62.7	75.1	54.1	55.1	60.0	43.2	35.7	114.6	53.2	32.3	70.2	88.4	56.0	46.2	65.3	50.4	29.5	65.3	106.1	32.4	55.5	48.6	64.7	35.5	32.7	74.1	58.5	70.8	52.3	52.6	41.3	42.9	97.6	34.0	53.3	65.8	38.1	17.3	52.2	63.5	51.6	45.9	42.2	28.3	36.3	77.8	66.6	65.0	72.1	48.8	39.2	49.4	39.5	37.8	54.6	70.0	50.6	153.5	97.8	64.0	62.2	35.8	93.4	26.7	70.2	1.2	1.0	1.5	1.0	0.4	0.7	1.2	0.8	0.9	0.8	0.6	1.3	0.9	2.7	0.9	0.3	0.9	0.3	0.5	37.3	48.1	31.1	37.5	34.2	34.5	51.9	45.9	39.9	35.9	40.7	53.6	28.8	12.8	30.4	55.8	21.6	33.3	62.7	22.4	12.0	56.9	37.1	32.9	8.4	24.3	18.9	36.8	166.8	25.7	21.7	26.4	5.9	26.2	6.9	44.9	42.5	31.9	51.0	19.8	26.6	27.3	23.1	39.1	19.9	55.3	18.9	39.0	36.8	26.6	20.7	52.2	31.0	28.1	10.2	25.5	38.2	5.4	43.8	28.5	19.6	25.3	18.4	31.4	16.5	34.2	106.0	41.0	19.6	33.1	19.3	65.7	20.2	12.3	30.7	67.9	65.7	43.9	30.9	70.3	42.7	15.6	43.5	54.6	20.4	33.8	24.5	65.9
SAP30BP	"HCNGP, HTRG, HTRP"	ENSG00000161526	"SAP30 binding protein"	Q9UHR5	17	75667251-75708062	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042382, HPA052943"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA042382: AB_10793881, HPA052943: AB_2681995"	"unprognostic (6.92e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.31e-3)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.06e-2)"	"unprognostic (6.58e-2)"	17.7	13.1	30.7	14.5	31.9	23.2	17.3	31.1	33.5	20.6	37.9	22.1	11.9	17.0	17.1	20.0	17.0	15.3	19.6	30.8	30.8	20.3	19.0	15.1	19.6	34.6	32.6	17.3	16.2	18.6	17.7	18.0	31.8	19.8	15.1	14.7	23.0	17.1	17.8	17.8	16.0	17.0	31.8	21.1	18.2	14.7	31.6	22.7	15.8	22.2	22.9	19.6	19.0	36.5	28.2	36.9	27.8	26.7	25.6	26.9	31.5	29.2	31.4	53.2	54.8	31.8	23.2	30.2	15.1	27.8	48.8	23.5	33.5	32.0	53.1	10.7	40.1	23.7	26.2	33.2	25.4	25.4	21.5	25.5	28.7	39.9	43.2	30.6	73.5	30.8	29.2	23.0	41.9	29.9	42.0	24.4	23.7	41.7	41.0	27.4	40.4	22.7	44.7	24.7	19.3	31.8	26.4	28.2	33.7	40.7	42.8	22.9	28.7	47.0	30.9	20.9	40.5	17.1	7.1	35.9	31.4	18.8	38.4	18.0	23.1	24.6	24.3	19.8	26.8	21.6	22.0	25.2	19.4	21.7	22.0	22.7	22.8	27.7	23.7	32.0	25.6	22.9	30.7	31.9	31.1	33.5	30.8	30.8	34.6	32.6	31.8	31.8	31.6	36.5	72.4	54.5	62.7	25.5	54.1	49.5	117.7	65.5	34.1	19.6	34.0	43.2	53.5	30.0	71.1	22.0	12.5	59.5	68.3	71.2	68.4	71.3	47.5	32.8	48.4	63.5	35.9	26.9	15.9	73.2	67.0	55.9	45.9	56.3	77.2	38.9	52.8	34.2	57.5	10.1	14.2	43.8	59.0	35.5	48.1	93.6	44.4	48.0	56.9	10.3	59.7	72.6	55.6	22.6	30.5	103.3	109.2	34.6	57.4	52.0	43.3	47.2	58.0	17.3	65.7	50.9	64.3	34.8	34.3	36.1	45.5	96.0	59.8	31.7	37.2	94.0
SARS1	"SARS, SERS"	ENSG00000031698	"Seryl-tRNA synthetase 1"	P49591	1	109213918-109238182	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 98.8;Cytotrophoblasts: 186.0;Extravillous trophoblasts: 147.6;Hofbauer cells: 88.1;Syncytiotrophoblasts: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Approved		Enhanced	Cytosol		NA	NA		330000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	86.9	89.4	78.6	55.9	78.6	35.7	80.5	77.2	98.1	79.3	57.4	89.1	63.6	85.8	64.2	97.1	71.5	53.6	96.0	81.9	92.6	77.4	102.4	102.3	60.9	88.3	81.1	78.5	150.1	102.1	88.6	76.2	91.1	66.2	74.8	68.0	86.1	73.9	113.3	111.9	69.9	79.3	72.9	64.5	112.4	46.3	78.1	66.7	139.8	87.9	76.4	88.3	82.1	90.9	208.5	82.1	152.3	230.3	224.2	201.4	261.6	213.1	222.1	183.7	227.1	161.4	62.7	224.1	107.7	307.2	102.8	111.6	241.1	305.9	212.4	159.0	150.4	86.6	96.3	118.4	448.1	110.5	93.7	249.4	526.5	217.1	467.7	155.9	221.9	279.5	201.9	273.2	181.3	205.8	124.8	57.5	63.4	125.6	193.5	101.1	192.5	102.6	139.9	111.0	210.0	111.2	102.5	164.7	601.4	114.9	93.5	131.2	174.5	108.3	135.0	155.5	151.8	205.6	89.6	183.7	341.3	119.8	376.7	191.5	193.9	219.6	228.6	212.2	240.0	235.8	238.2	227.3	198.8	252.4	246.4	229.4	89.7	193.5	226.6	128.2	300.9	460.5	78.6	78.6	77.2	98.1	81.9	92.6	88.3	81.1	91.1	72.9	78.1	90.9	30.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.8	0.0	0.0	0.0	0.0	186.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	147.6	23.9	0.0	0.0	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	188.4	5.9	0.0	0.0	0.0
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP"	O43290	11	65961728-65980137	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	24.6	18.3	15.5	18.3	16.8	41.6	23.1	15.4	17.4	29.2	14.7	26.0	15.6	29.1	8.0	22.7	25.6	8.6	23.2	14.9	16.1	20.4	21.8	22.9	20.3	16.6	16.2	29.2	25.8	11.7	21.4	14.0	15.9	21.7	7.7	8.0	22.2	14.4	38.1	32.0	24.3	10.9	14.6	32.7	24.8	23.5	15.7	20.9	23.5	13.0	13.3	26.2	24.6	17.9	50.4	60.8	27.2	36.8	26.1	20.7	40.8	37.5	27.2	43.8	28.6	44.2	34.3	56.9	42.4	33.8	52.9	48.7	34.6	35.6	22.0	45.8	33.5	65.6	43.6	41.4	39.0	57.4	52.7	26.2	26.4	40.8	36.3	17.4	27.6	42.3	42.2	39.8	25.6	92.6	74.0	83.5	45.7	27.3	55.9	80.8	39.0	60.7	18.4	33.7	30.5	43.0	35.6	37.2	45.5	12.6	41.7	47.0	40.6	54.5	53.0	53.9	54.1	59.6	49.4	48.3	45.0	28.8	47.0	1.4	2.8	8.1	4.3	3.5	3.6	3.9	4.8	4.4	3.6	3.5	3.5	3.9	4.1	2.8	2.0	3.2	5.4	1.8	15.5	16.8	15.4	17.4	14.9	16.1	16.6	16.2	15.9	14.6	15.7	17.9	17.5	6.4	9.1	7.8	27.8	22.7	24.0	12.2	17.6	19.2	12.2	9.1	9.4	21.5	11.3	16.5	10.4	34.1	27.2	30.5	5.9	23.7	9.0	14.2	16.3	19.8	12.5	32.8	5.1	29.3	31.9	17.6	21.9	16.8	32.4	21.8	21.0	15.6	29.4	16.8	4.8	26.5	16.2	22.5	23.6	8.7	37.0	22.9	17.8	6.5	35.7	23.8	34.0	7.1	7.8	26.3	20.1	33.1	31.2	20.5	28.3	18.5	17.5	26.0	32.9	27.6	34.9	26.7	29.7	18.3	21.7	45.3	28.4	15.5	27.5	18.2
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	31.1	21.2	22.3	41.7	29.6	89.6	40.1	38.7	23.7	28.0	36.5	31.6	29.4	34.5	41.2	26.7	26.6	30.9	30.0	19.7	25.2	29.9	42.4	31.0	54.7	30.2	26.5	37.7	23.5	39.8	17.2	31.5	32.5	29.4	34.9	60.8	27.0	24.9	35.2	40.3	31.7	29.2	25.9	43.0	29.6	29.0	26.3	44.4	34.7	38.6	49.8	31.8	23.6	38.3	56.4	49.4	60.6	50.7	41.0	55.7	56.0	64.7	52.6	54.8	39.3	180.3	60.1	116.7	71.0	69.3	32.3	54.0	62.4	52.2	61.9	62.1	42.1	108.8	64.5	47.0	32.3	115.6	70.4	46.4	54.7	47.2	71.1	62.9	57.1	50.0	85.1	62.3	70.3	51.9	87.2	63.4	47.0	0.6	67.4	70.2	81.7	57.9	52.4	70.5	34.2	35.0	71.9	60.8	35.0	47.6	56.4	123.4	71.6	55.9	46.3	42.5	34.9	44.4	36.0	187.9	47.0	245.0	21.8	39.4	19.6	29.5	21.7	19.9	19.9	28.6	20.6	21.3	16.0	28.2	22.2	20.0	51.5	21.3	23.5	30.2	20.8	12.9	22.3	29.6	38.7	23.7	19.7	25.2	30.2	26.5	32.5	25.9	26.3	38.3	180.2	176.3	164.0	91.4	200.4	128.5	127.6	87.4	132.1	134.9	101.8	96.8	187.4	88.6	131.7	79.1	127.2	86.3	229.6	96.1	54.8	117.8	57.7	133.3	148.7	146.2	103.3	118.4	75.3	107.9	72.5	135.3	69.3	152.4	222.7	224.7	114.5	138.9	109.8	107.7	81.7	123.3	67.1	158.0	160.9	39.2	121.8	157.3	67.6	141.5	211.7	105.2	185.3	119.6	122.4	103.4	103.4	103.8	126.4	121.6	97.2	83.5	149.6	198.4	124.9	176.3	129.7	157.6	82.5	116.4	120.5	61.0	170.6	114.2	107.5	145.0
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733378-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	19.2	11.8	7.9	15.6	10.3	37.2	18.9	17.8	9.9	18.2	2.7	14.9	12.7	22.1	16.4	13.2	17.4	13.6	14.8	6.9	8.5	16.6	15.4	16.2	22.6	7.3	8.5	27.0	14.9	21.3	10.2	18.9	6.2	16.9	17.6	23.2	15.6	15.6	18.7	18.3	14.3	20.3	6.8	19.1	15.2	23.5	8.7	26.8	21.3	19.1	20.8	15.3	14.7	10.4	16.2	15.3	44.6	27.1	29.3	29.8	27.2	25.7	35.8	33.1	33.4	24.2	16.0	49.7	20.4	29.6	29.4	21.1	39.5	33.8	44.2	21.7	19.7	44.6	16.0	29.8	33.8	41.7	28.8	32.3	35.0	29.0	45.0	25.7	28.6	21.6	52.6	29.4	30.8	29.1	44.6	28.2	31.0	24.4	11.3	42.3	24.4	27.1	28.1	29.0	27.4	32.3	26.7	34.7	19.9	32.1	22.8	47.8	26.3	18.8	23.0	24.6	26.2	27.2	21.7	54.0	23.4	25.6	30.0	0.6	1.5	1.8	2.8	2.0	2.8	2.4	3.0	2.9	1.7	2.6	3.0	2.7	1.9	3.1	3.8	1.6	4.0	1.4	7.9	10.3	17.8	9.9	6.9	8.5	7.3	8.5	6.2	6.8	8.7	10.4	23.1	25.6	18.1	89.8	22.6	12.6	12.2	11.9	17.6	19.5	14.6	12.4	33.9	7.2	11.7	12.9	25.0	11.1	23.2	15.8	1.9	11.3	3.6	18.8	25.4	16.6	13.1	18.7	105.4	11.8	8.8	17.5	23.0	25.0	34.2	29.3	18.5	11.6	13.3	13.5	114.2	14.1	6.1	20.8	9.7	5.4	16.4	16.6	10.6	119.9	13.5	16.1	8.2	121.2	145.8	13.6	11.8	12.4	13.7	13.7	11.7	6.5	15.8	21.4	26.3	24.5	16.3	21.4	21.2	14.8	10.7	10.7	19.2	19.5	16.1	15.4
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347233-100364826	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1233.7;brain: 839.9;liver: 583.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 389.6;Granulosa cells: 187.3;Hepatocytes: 840.3;Oligodendrocytes: 451.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 2534.2;CAPAN-2: 1824.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	1233.7	131.2	408.7	25.7	525.8	23.0	261.5	535.7	522.1	43.2	156.6	42.9	93.1	15.4	25.5	107.8	5.0	28.7	47.1	349.1	457.5	18.5	583.8	142.8	17.2	775.0	508.9	49.6	22.6	79.5	10.3	19.9	637.8	100.1	39.7	17.9	112.6	11.2	6.1	27.0	36.0	15.9	574.4	15.3	25.2	51.8	538.7	18.4	13.0	7.2	21.0	22.5	41.9	839.9	411.2	373.3	777.6	536.4	2534.2	1449.4	158.2	43.4	948.3	101.6	536.6	323.8	1824.4	173.3	33.7	102.2	461.8	716.4	433.7	1549.5	88.9	59.4	179.6	97.5	219.3	653.4	488.4	136.9	100.9	795.5	459.4	395.0	688.9	273.1	196.2	375.3	275.4	513.3	41.7	646.8	155.9	163.3	270.7	120.7	106.3	72.6	287.4	550.4	443.8	455.3	48.9	185.3	85.8	399.7	834.9	224.2	447.7	291.3	79.0	10.0	115.9	9.1	89.8	141.4	81.5	262.9	184.4	416.0	65.9	0.0	0.8	0.0	1.4	1.6	2.3	0.6	0.5	0.7	2.7	0.9	0.4	1.3	0.1	1.4	0.0	1.5	0.0	1.2	408.7	525.8	535.7	522.1	349.1	457.5	775.0	508.9	637.8	574.4	538.7	839.9	3.8	54.5	389.6	34.0	15.7	3.7	4.5	121.8	0.6	6.5	16.1	6.2	11.2	28.6	66.2	0.0	6.2	3.0	4.7	21.5	0.0	14.6	52.6	13.9	9.0	12.5	25.8	15.8	4.8	67.9	71.7	15.9	25.0	26.9	6.3	187.3	32.9	840.3	34.1	26.9	5.2	16.4	52.9	113.5	4.2	93.0	3.7	21.2	58.7	8.4	10.2	11.9	2.1	18.6	451.5	29.6	2.7	1.5	3.7	31.4	16.2	4.9	31.0	6.2	0.0	3.6	25.7	2.0	1.2	26.7	2.3	17.4	6.6	97.8	38.9	8.2
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060924-238099413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 39.1"	"Group enriched"	"Detected in many"	13	"Early spermatids: 90.6;Late spermatids: 156.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		300000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	5.1	4.3	7.2	5.3	9.4	5.0	4.9	9.4	9.3	6.8	6.4	7.3	8.5	8.1	5.6	5.9	6.3	3.8	8.1	6.8	8.2	12.9	39.1	4.7	5.7	9.2	8.8	6.3	22.8	6.1	5.0	2.0	9.4	5.9	3.2	4.6	4.4	4.1	6.4	3.5	8.6	3.9	7.3	7.2	5.8	16.8	8.3	5.9	7.2	3.5	4.3	7.8	5.1	10.4	11.1	19.1	11.9	31.1	9.0	6.4	23.2	11.2	5.6	11.3	14.3	11.6	8.0	18.9	3.3	5.9	35.4	16.4	44.1	21.5	10.9	21.2	41.8	21.1	24.0	37.6	16.7	17.6	18.2	7.1	11.6	21.3	22.0	5.1	21.0	26.1	38.0	5.1	11.7	16.9	17.9	33.0	36.4	16.0	15.6	22.0	23.3	18.2	11.3	3.6	13.1	28.9	12.0	19.4	20.6	8.2	6.3	26.5	8.5	16.3	11.8	24.2	23.7	14.2	13.3	9.3	11.3	37.0	14.4	1.1	3.2	4.0	2.6	2.3	2.0	2.6	3.1	4.4	3.3	1.6	2.3	2.6	0.5	2.9	3.5	0.6	3.2	2.8	7.2	9.4	9.4	9.3	6.8	8.2	9.2	8.8	9.4	7.3	8.3	10.4	2.2	0.0	0.0	0.0	4.6	1.7	2.4	1.9	5.7	5.4	1.7	1.9	2.6	1.5	1.2	0.0	8.4	1.4	3.4	1.9	3.9	5.3	90.6	1.7	3.4	2.4	2.4	9.4	0.0	3.7	2.1	1.9	5.1	2.6	0.0	3.5	1.8	3.3	4.0	6.7	0.0	3.3	8.2	0.9	3.2	156.3	3.1	2.1	1.8	0.0	2.7	2.6	2.1	0.0	0.0	3.0	5.0	0.0	4.9	1.9	3.9	2.7	1.9	6.9	0.0	1.9	3.2	6.2	5.6	3.4	1.6	0.7	4.4	2.2	4.8	1.8
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribble planar cell polarity protein"	Q14160	8	143790920-143815773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 100.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	18.7	17.1	11.5	7.2	10.8	5.6	23.6	6.0	10.4	45.6	0.0	32.3	9.1	24.7	0.9	100.5	26.0	3.4	24.6	8.7	2.7	27.7	25.4	21.3	4.0	10.7	8.1	23.0	38.8	5.2	24.8	5.0	5.9	28.4	3.4	1.0	40.2	5.2	54.3	68.3	26.5	2.0	4.9	22.9	30.0	26.4	9.0	3.0	24.6	1.7	3.9	27.8	52.6	15.3	55.7	33.1	12.7	20.5	5.1	6.9	33.0	30.9	5.3	11.2	9.1	15.3	29.8	24.2	39.7	7.2	4.6	52.4	7.9	32.9	1.7	30.8	58.5	24.6	30.5	26.1	10.8	13.0	14.8	5.1	29.9	9.4	5.5	5.1	11.5	19.8	42.2	6.4	7.5	93.0	38.1	26.9	15.7	25.0	55.1	44.5	10.6	25.0	5.6	45.5	29.6	27.1	31.4	30.5	33.6	4.5	41.5	28.2	25.7	10.1	64.1	25.2	44.7	31.6	31.0	23.8	13.1	9.5	19.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	10.8	6.0	10.4	8.7	2.7	10.7	8.1	5.9	4.9	9.0	15.3	12.3	0.0	9.9	33.0	4.4	8.5	5.0	10.2	13.6	11.3	16.8	17.0	11.1	11.5	8.3	14.7	14.6	11.0	9.7	28.7	3.9	8.6	1.5	14.0	7.7	7.8	13.8	13.7	5.0	9.4	6.3	7.3	29.6	27.3	0.0	17.9	3.6	8.8	6.5	5.0	6.2	17.8	18.3	6.0	4.1	0.7	9.0	6.6	8.8	6.5	5.0	10.0	5.2	12.1	15.2	11.5	22.8	9.8	5.6	9.3	16.9	4.5	9.9	16.0	13.1	12.0	8.7	9.4	10.0	19.9	10.7	5.1	7.3	8.0	23.2	7.1
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"SHH signaling and ciliogenesis regulator SDCCAG8"	Q86SQ7	1	243256034-243500091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 284.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Centrosome		"HPA025737: AB_2671761, HPA044477: AB_2678955, HPA072495: AB_2686527"	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	11.6	9.8	7.1	3.8	7.6	3.5	11.3	7.1	7.4	9.6	6.8	8.4	2.9	7.9	7.3	8.0	9.4	7.5	8.8	7.6	7.1	9.3	7.4	11.8	5.2	8.6	7.9	11.0	14.3	7.0	11.6	4.5	7.7	8.9	3.1	3.7	8.4	3.8	12.1	8.1	7.6	3.0	8.3	8.3	8.4	5.3	7.7	3.3	17.1	2.3	2.7	8.9	8.9	8.9	6.2	5.4	2.0	3.8	7.3	3.4	6.3	4.4	3.4	2.1	1.7	4.9	10.9	2.4	6.5	3.7	0.7	2.2	0.6	4.9	2.0	3.7	6.9	2.3	3.7	2.0	3.7	2.2	5.1	7.0	6.2	4.8	7.7	7.9	5.5	5.2	3.2	3.3	3.9	1.9	0.9	4.9	1.2	9.4	9.5	3.1	1.1	2.1	7.5	4.1	5.6	5.7	4.3	2.6	10.6	0.9	4.3	2.8	5.2	6.8	1.5	2.4	2.5	5.1	2.7	1.2	3.0	4.1	29.9	7.6	7.8	6.6	3.8	8.0	2.8	5.2	4.3	5.3	7.1	6.9	6.1	4.2	4.7	9.0	4.5	5.6	3.8	3.8	7.1	7.6	7.1	7.4	7.6	7.1	8.6	7.9	7.7	8.3	7.7	8.9	30.6	41.7	103.6	139.7	39.0	37.2	39.6	59.1	56.9	69.8	34.9	37.1	28.5	50.1	52.0	40.5	87.6	48.1	16.1	16.5	76.3	63.1	17.8	60.9	31.6	36.2	31.9	23.3	170.5	30.0	86.3	38.5	24.5	31.4	49.9	29.8	45.7	27.8	130.1	65.6	153.2	18.1	63.1	51.0	32.5	33.8	52.8	51.7	35.6	188.3	45.9	67.1	22.6	165.4	284.0	50.1	26.4	44.4	30.8	33.6	31.5	39.0	73.5	80.3	39.5	34.8	32.0	51.4	20.7	38.8	49.2	26.3	23.1	50.0	25.2	29.9
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999343	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	17.4	8.5	5.5	11.3	7.0	32.9	11.8	6.4	6.6	9.0	4.8	8.3	9.0	11.8	7.8	9.6	7.4	10.5	7.7	4.9	6.0	9.2	14.6	9.2	12.4	6.9	6.6	10.2	9.6	11.1	4.4	11.8	6.6	9.8	9.1	5.1	6.7	7.3	12.7	10.8	9.0	9.8	6.6	10.4	7.7	8.3	6.1	22.8	12.5	9.6	10.6	11.6	7.8	8.4	13.1	9.3	14.9	15.9	10.2	11.3	18.5	13.7	12.9	18.4	14.0	13.7	14.7	19.2	20.9	11.6	7.2	16.5	18.9	11.9	22.2	14.7	15.3	21.1	7.9	12.7	18.6	21.0	24.6	12.5	16.9	19.6	24.6	10.3	12.8	22.6	39.3	22.6	13.7	3.8	29.5	16.6	20.8	20.2	9.8	24.4	19.1	24.9	11.1	9.2	13.3	22.0	15.6	16.9	26.3	11.9	16.6	25.4	12.7	15.6	11.0	20.3	30.4	13.4	10.3	23.4	16.1	12.9	31.5	21.8	6.3	5.9	8.0	6.4	10.8	8.0	8.1	7.8	7.1	7.0	8.1	7.7	18.5	13.5	7.9	8.1	6.7	6.9	5.5	7.0	6.4	6.6	4.9	6.0	6.9	6.6	6.6	6.6	6.1	8.4	36.0	28.9	22.6	4.2	39.9	43.6	17.2	11.2	29.0	6.2	19.8	13.6	9.4	2.8	20.1	9.2	0.0	9.6	29.3	14.3	15.6	6.5	72.8	24.8	15.1	24.8	17.4	56.2	4.7	7.1	10.2	17.8	13.3	35.9	35.5	9.7	12.8	20.6	11.1	15.2	5.0	10.8	16.2	16.4	28.8	20.4	9.9	27.0	19.6	1.9	7.4	12.6	10.3	4.5	8.6	9.7	9.4	6.4	26.6	14.2	9.5	12.7	12.7	8.9	6.6	28.8	23.9	23.9	14.4	26.5	59.1	14.2	23.2	21.0	9.9	18.2
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SEC23IP	p125	ENSG00000107651	"SEC23 interacting protein"	Q9Y6Y8	10	119892730-119944657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038403, HPA043305"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA038403: AB_10675796, HPA043305: AB_2678416"	"unprognostic (4.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.81e-3)"	"unprognostic (3.43e-2)"	10.3	9.7	3.5	12.0	3.9	14.1	11.8	6.2	4.6	11.2	6.4	12.6	10.4	11.9	12.1	9.4	8.8	9.6	7.7	4.0	4.0	10.3	12.6	10.2	13.7	4.2	4.3	10.0	11.1	9.8	8.5	12.4	4.0	13.1	13.0	9.0	10.3	9.9	9.8	10.4	9.5	16.4	3.1	11.7	17.5	11.5	4.6	11.1	12.5	8.4	13.4	12.0	8.3	6.3	32.4	30.2	24.3	31.9	22.4	25.3	19.0	27.2	39.5	26.1	31.6	31.0	22.9	30.2	14.7	36.2	32.5	23.9	27.9	29.2	39.5	27.2	28.7	25.1	16.3	34.0	31.0	29.6	29.9	31.4	18.4	30.8	30.5	28.3	36.3	15.5	19.1	21.4	28.7	19.2	25.9	28.2	29.5	28.6	20.9	23.7	44.7	17.3	26.1	25.6	9.6	25.5	25.0	19.9	24.1	24.9	17.5	21.7	29.6	15.8	18.5	23.8	35.1	33.5	32.6	38.7	27.6	37.4	14.1	14.3	10.5	10.3	10.7	16.3	13.9	11.3	10.5	12.4	11.9	9.1	11.1	10.7	3.8	13.0	18.1	7.2	11.9	9.6	3.5	3.9	6.2	4.6	4.0	4.0	4.2	4.3	4.0	3.1	4.6	6.3	15.1	12.8	28.3	21.9	20.9	8.4	19.3	18.1	13.1	17.3	19.1	12.1	17.4	27.1	24.5	18.4	6.2	17.8	18.7	19.7	5.9	16.8	26.1	15.1	22.1	19.9	19.9	21.2	28.3	14.4	18.9	21.4	44.9	15.5	22.1	21.0	14.3	25.5	23.3	11.8	30.2	24.3	26.4	24.6	12.2	24.9	14.0	23.3	8.8	39.4	21.3	14.6	16.5	31.7	37.5	20.2	19.8	15.1	23.7	23.4	16.0	19.2	25.4	23.7	0.0	16.8	17.9	25.0	19.8	19.1	13.9	23.1	18.2	24.2	20.8	21.1
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747433-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 128.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 82.1"	"Group enriched"	"Detected in many"	4	"memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2"	"Group enriched"	"Detected in many"	4	"B-cells: 42.0;dendritic cells: 38.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 287.9;OE19: 217.9;U-698: 187.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 100.4"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	9.3	5.5	8.7	61.5	11.3	13.6	9.3	82.1	11.1	54.0	8.7	72.1	82.0	7.9	68.8	8.7	11.0	53.6	5.3	12.5	4.2	14.5	11.6	40.7	124.8	2.8	5.2	5.6	48.5	45.5	3.7	37.5	4.7	18.9	68.8	35.2	38.3	4.0	2.9	2.9	72.4	7.8	2.9	63.2	104.8	6.6	8.2	18.7	10.9	2.8	128.3	42.4	2.2	5.9	21.5	23.0	16.7	5.6	2.7	3.3	2.6	10.4	28.3	7.9	25.2	14.6	97.0	287.9	48.9	72.0	66.7	13.3	12.4	45.1	10.6	15.7	7.2	3.3	35.4	19.6	70.0	40.1	2.0	5.7	35.8	27.8	10.9	31.3	105.7	5.8	19.3	0.3	5.6	16.2	0.1	2.8	48.2	217.9	20.1	1.5	91.3	40.6	60.9	71.2	41.0	8.0	69.2	1.0	7.1	23.0	3.3	49.0	46.6	0.5	32.6	0.6	30.6	1.8	0.5	187.9	125.0	16.7	19.3	0.9	0.2	0.0	5.7	0.0	6.8	42.0	7.0	6.4	1.4	41.8	3.0	4.8	0.7	8.0	0.3	38.2	9.6	3.3	8.7	11.3	82.1	11.1	12.5	4.2	2.8	5.2	4.7	2.9	8.2	5.9	13.2	12.8	36.0	57.1	114.7	0.9	3.4	16.8	1.2	4.0	1.6	0.9	1.8	61.5	51.9	3.7	0.0	30.7	71.0	46.3	0.0	64.9	60.8	6.0	1.5	11.5	11.5	10.5	40.1	33.2	1.3	2.5	71.9	19.3	2.5	3.4	13.6	4.2	4.9	0.0	26.6	92.6	22.4	23.1	4.6	78.3	1.5	14.4	8.8	4.7	14.6	33.2	10.3	128.7	1.4	38.3	22.6	0.4	271.7	13.6	46.9	10.7	24.2	32.8	0.0	0.8	4.7	0.7	2.5	0.7	1.6	16.4	27.8	0.2	36.8	6.1
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 229.2;Glandular and luminal cells: 211.7;Pancreatic endocrine cells: 226.1;Syncytiotrophoblasts: 303.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 606.9"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 606.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	65.6	75.4	30.6	48.4	32.8	50.6	55.0	33.8	39.8	50.1	39.7	82.4	80.0	41.9	75.5	55.6	44.6	45.5	66.3	29.8	32.7	48.7	84.7	59.6	49.2	35.2	33.2	41.6	103.7	51.1	44.5	57.6	35.3	53.6	87.2	28.7	73.8	49.1	71.0	48.4	82.2	42.9	33.7	58.7	67.2	92.7	32.4	24.1	55.8	48.7	53.1	60.7	45.3	36.3	45.3	68.8	61.2	54.5	129.8	91.1	52.4	136.4	100.2	89.8	90.2	82.3	105.0	33.6	49.6	117.5	150.8	125.1	66.6	59.7	58.6	63.5	91.8	57.2	62.5	86.8	206.5	43.5	63.9	80.2	166.3	60.3	177.7	70.7	68.1	44.3	58.3	369.0	97.4	71.7	31.7	67.6	46.8	169.9	45.7	41.6	50.1	74.7	90.7	104.2	34.5	88.5	93.0	85.7	193.8	79.9	64.0	96.2	73.6	84.0	57.1	116.4	103.3	272.5	246.3	49.9	92.2	50.8	104.2	134.4	66.4	81.2	94.1	84.0	91.1	62.2	71.4	101.1	58.6	51.4	53.7	79.6	23.1	95.6	100.1	606.9	71.4	63.7	30.6	32.8	33.8	39.8	29.8	32.7	35.2	33.2	35.3	33.7	32.4	36.3	164.0	118.6	108.6	0.0	47.8	0.0	0.0	0.0	0.0	0.0	172.5	129.4	0.0	0.0	64.4	154.5	0.0	125.9	87.7	0.0	31.3	183.9	0.0	127.0	165.2	53.3	0.0	0.0	0.0	189.3	229.2	91.6	0.0	211.7	30.3	53.5	0.0	0.0	120.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.4	0.0	0.0	92.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	101.0	0.0	0.0	73.0	56.9	0.0	0.0	0.0	78.5	0.0	0.0	0.0	0.0	303.7	40.4	100.9	0.0	0.0
SENP1		ENSG00000079387	"SUMO specific peptidase 1"	Q9P0U3	12	48042897-48106079	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 32.5;testis: 61.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.0	3.6	3.1	9.1	3.9	14.4	5.6	8.3	3.7	6.2	1.9	4.9	4.8	7.5	5.1	7.5	4.7	5.5	3.8	2.7	5.0	3.8	3.8	4.6	12.0	3.0	3.6	5.5	4.4	6.3	3.3	6.5	3.7	4.8	6.8	6.5	32.5	4.7	3.7	6.8	4.7	7.0	2.2	6.3	4.8	61.8	3.4	12.2	5.8	4.3	12.9	6.1	3.9	5.0	13.8	17.7	22.4	16.3	6.4	9.8	15.7	14.9	17.1	25.8	20.7	22.2	22.3	38.0	12.8	13.9	9.9	13.0	28.0	13.0	25.7	34.6	11.4	33.9	17.9	10.9	10.1	32.2	22.4	7.4	10.4	22.7	20.1	11.4	13.7	25.2	30.2	15.9	13.4	12.0	40.1	11.2	20.0	9.5	12.8	36.6	23.6	19.1	7.2	17.3	22.8	15.4	21.9	13.2	8.8	12.7	20.6	14.4	12.2	21.1	18.4	12.5	16.4	18.4	32.5	36.7	13.3	71.4	10.0	0.8	0.8	2.9	1.6	1.1	2.1	1.0	1.6	1.6	1.4	1.8	1.4	1.5	1.6	1.6	0.8	1.5	1.9	1.0	3.1	3.9	8.3	3.7	2.7	5.0	3.0	3.6	3.7	2.2	3.4	5.0	11.2	9.6	8.9	18.9	14.3	3.7	4.7	4.7	6.8	7.9	6.7	4.7	3.2	4.3	7.6	3.7	4.2	4.0	9.1	3.6	3.9	3.9	16.7	5.6	11.6	9.1	3.5	11.1	14.0	6.5	3.4	7.3	7.7	5.0	6.3	9.8	6.8	6.6	4.5	15.2	15.9	4.2	8.2	9.5	4.2	6.0	6.2	7.7	1.8	15.0	7.2	5.2	5.2	17.6	17.8	5.8	1.9	6.8	13.5	4.4	2.8	3.7	4.6	8.7	0.0	9.8	8.3	86.5	31.0	8.5	6.1	2.7	12.2	7.4	4.2	3.8
SEPTIN2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		3300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	246.0	155.0	192.8	159.7	216.1	125.3	177.2	208.8	220.6	233.8	183.2	179.7	140.8	209.0	176.7	161.1	168.7	193.8	211.8	180.5	209.6	212.6	117.1	184.5	157.2	227.2	203.3	221.7	214.2	220.1	112.7	217.3	232.2	186.1	188.6	114.0	163.3	218.2	160.6	119.0	154.8	253.1	224.1	164.9	152.6	145.0	198.3	141.8	224.6	163.5	180.5	221.0	116.7	245.3	245.1	207.7	561.7	370.8	511.5	555.0	289.1	517.3	508.9	329.1	417.2	118.7	258.4	96.1	119.4	599.0	176.7	209.6	377.7	347.9	535.5	241.9	262.2	388.9	200.5	444.5	311.6	374.4	228.0	495.1	224.8	275.0	259.1	369.8	576.2	240.9	357.4	138.0	491.9	171.5	226.7	227.3	412.5	215.2	152.8	216.2	707.4	204.7	483.5	359.9	401.4	270.0	363.0	245.7	353.0	397.9	146.9	333.4	555.5	399.2	166.2	392.9	320.6	267.7	251.9	340.9	344.7	225.1	571.6	172.0	165.0	98.3	101.0	184.1	125.1	87.4	97.9	104.2	183.8	77.2	84.4	89.6	58.9	191.4	144.8	138.7	108.0	241.2	192.8	216.1	208.8	220.6	180.5	209.6	227.2	203.3	232.2	224.1	198.3	245.3	89.9	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	135.9	39.9	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	190.1	50.4	0.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	139.0	6.5	0.0	0.0	0.0
SEPTIN9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		770000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	68.7	87.9	58.8	148.8	61.7	89.2	72.8	81.6	85.3	99.3	59.9	137.8	94.9	127.5	27.0	81.9	89.0	88.3	70.5	68.1	68.6	75.2	99.5	77.8	223.8	111.5	62.0	76.4	38.7	67.2	63.3	80.7	76.6	96.0	51.9	15.6	76.8	75.6	73.1	80.3	145.1	84.5	68.2	152.8	103.1	60.0	65.7	260.2	52.9	43.1	151.5	122.9	82.4	71.8	246.1	342.0	221.3	186.4	257.0	417.1	121.7	188.9	214.1	122.4	89.0	278.4	243.4	338.7	153.4	388.5	161.2	149.1	96.6	354.8	90.4	6.2	65.0	128.8	147.3	483.2	212.0	84.6	218.3	215.6	128.8	159.6	136.0	180.3	167.5	196.4	144.6	44.1	110.7	258.1	628.1	72.0	207.5	281.4	281.1	290.7	192.6	117.1	197.5	337.9	171.0	324.3	214.2	349.6	207.2	248.6	260.2	60.7	243.6	165.8	147.6	197.4	130.2	10.5	19.5	562.6	245.6	73.7	348.7	4.2	18.4	31.1	22.3	46.3	19.0	16.3	28.7	26.4	17.0	17.4	29.6	25.8	6.1	16.9	55.3	38.7	31.8	24.9	58.8	61.7	81.6	85.3	68.1	68.6	111.5	62.0	76.6	68.2	65.7	71.8	29.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	78.2	34.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	152.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	70.6	6.8	0.0	0.0	0.0
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	116.2	79.6	45.9	110.1	48.9	130.5	106.9	45.7	48.5	98.3	44.4	91.2	99.6	89.9	65.7	188.2	81.5	66.5	93.4	42.5	46.5	85.9	131.4	76.6	123.8	51.6	47.5	86.8	121.1	131.5	48.0	92.9	52.4	77.3	84.5	47.6	119.0	66.2	336.9	149.6	92.7	82.1	50.3	81.4	94.1	82.9	49.3	125.7	91.1	159.0	118.1	101.4	118.4	52.8	444.4	272.4	274.9	280.4	236.9	214.0	420.9	452.9	163.8	294.7	241.6	524.8	195.4	828.9	341.1	236.0	294.6	337.4	435.2	411.2	309.5	375.7	535.8	764.1	488.7	460.7	207.0	614.9	290.8	221.3	272.1	384.6	356.0	205.9	319.7	276.0	867.4	293.0	236.2	314.9	494.9	412.9	978.1	298.1	355.2	566.3	600.4	429.8	231.0	349.8	468.8	330.8	351.0	385.6	442.4	231.1	212.0	386.4	345.9	283.4	351.5	421.2	618.3	273.6	369.2	747.9	233.0	603.3	326.9	37.8	84.1	53.7	100.4	92.5	125.4	101.3	99.0	100.9	107.5	102.1	114.6	105.6	27.1	147.4	90.1	98.2	131.5	119.2	45.9	48.9	45.7	48.5	42.5	46.5	51.6	47.5	52.4	50.3	49.3	52.8	251.3	250.0	225.5	17.6	262.6	686.4	437.3	363.8	536.7	146.7	262.1	251.8	144.8	214.4	311.4	117.7	91.8	271.5	343.7	200.0	242.6	324.4	555.9	368.1	411.9	314.9	230.1	398.8	24.1	361.5	531.0	231.0	169.7	400.5	219.2	215.6	179.2	331.5	297.9	143.0	24.6	338.7	183.1	247.7	281.2	240.9	221.2	214.2	192.1	27.2	298.4	153.6	325.4	26.7	33.2	349.3	192.0	278.7	277.4	540.5	168.4	323.0	206.3	139.7	138.1	301.6	516.0	569.8	281.6	597.9	719.7	229.3	271.4	318.8	405.0	470.2
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013047	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 155.4;Excitatory neurons: 114.9;Inhibitory neurons: 123.9;Late spermatids: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658"	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	16.1	17.5	35.9	9.4	37.4	6.4	16.4	49.6	42.8	19.5	32.2	25.4	7.4	16.8	18.4	12.5	16.5	9.9	18.9	39.0	39.1	19.6	14.0	14.0	10.7	37.4	53.9	27.5	23.1	17.1	36.8	5.7	43.8	21.3	12.3	22.5	15.1	18.0	22.7	20.2	13.8	16.4	34.8	12.8	19.7	5.0	37.3	12.3	27.7	21.7	13.5	21.5	17.7	39.1	10.8	13.2	10.6	22.3	19.1	18.6	7.2	9.0	18.3	9.5	12.0	8.5	3.7	9.5	11.0	12.2	26.1	14.5	37.3	27.6	7.5	21.0	37.7	15.3	10.6	36.3	21.5	13.5	16.6	17.7	27.4	4.8	20.4	28.6	10.5	20.8	9.2	17.6	15.2	16.0	14.0	30.0	8.9	33.7	16.2	18.3	13.0	10.0	21.2	16.1	27.1	5.9	15.8	16.1	17.1	21.1	7.2	12.1	6.2	8.9	12.1	13.1	10.2	12.3	16.1	12.9	15.5	15.4	10.2	15.6	21.3	17.1	34.5	17.6	28.6	25.5	35.5	25.8	26.1	18.7	34.8	30.5	2.3	22.4	17.5	10.5	41.4	25.9	35.9	37.4	49.6	42.8	39.0	39.1	37.4	53.9	43.8	34.8	37.3	39.1	12.7	6.4	6.8	58.4	14.3	26.5	25.3	30.5	15.9	14.1	18.5	20.8	11.6	10.0	13.6	11.0	2.1	6.4	14.4	7.8	39.2	17.1	155.4	3.3	5.1	9.0	48.5	7.4	114.9	24.5	12.5	14.4	4.6	5.2	14.5	26.7	12.5	14.7	14.3	11.8	123.9	14.7	34.6	17.8	14.9	258.3	19.6	9.3	21.4	44.0	12.9	31.7	17.5	82.9	46.5	14.0	9.8	21.4	11.6	18.7	12.3	46.0	7.6	10.9	6.6	13.3	16.9	9.0	7.6	8.7	20.2	3.1	18.2	15.6	13.0	20.0
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.1	9.7	7.3	225.0	7.1	157.1	100.6	9.1	21.3	105.7	11.1	151.0	278.6	42.3	5.3	10.1	22.4	352.3	12.5	7.3	11.1	621.2	34022.4	570.7	37.0	20.9	14.4	5.4	201.0	5.2	9.1	26.6	15.8	12.6	178.8	2.6	33.6	140.5	3.7	8.2	760.9	75.7	12.2	313.6	282.5	3.0	16.2	15.0	23.0	11.9	25.2	55.8	9.1	16.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.3	7.1	9.1	21.3	7.3	11.1	20.9	14.4	15.8	12.2	16.2	16.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36674020-36697839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;endometrium 1: 23.9;fallopian tube: 35.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 9.6;Bipolar cells: 17.9;Endometrial ciliated cells: 5.7;Excitatory neurons: 10.8;Granulosa cells: 14.2;Inhibitory neurons: 17.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 18.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 1.2;HEK 293: 1.4;NTERA-2: 3.6;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"			Enhanced	Vesicles		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		6.2	1.3	7.3	0.0	6.0	0.0	0.6	0.1	8.1	12.3	0.0	0.2	0.1	23.9	0.7	0.0	35.3	0.0	0.4	18.9	0.0	0.1	0.0	5.4	0.0	0.0	1.7	6.4	0.3	1.3	11.5	0.0	3.6	0.9	0.0	3.3	0.0	0.6	0.0	0.2	0.0	17.1	0.3	0.0	0.4	0.3	0.4	0.0	9.2	0.0	0.0	0.3	6.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	6.0	0.1	8.1	18.9	0.0	0.0	1.7	3.6	0.3	0.4	1.2	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	10.8	0.0	0.0	1.3	0.0	0.6	0.0	14.2	0.0	0.0	0.0	1.7	17.9	0.0	0.0	0.0	0.4	0.0	0.3	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SESTD1	"DKFZp434O0515, Solo"	ENSG00000187231	"SEC14 and spectrin domain containing 1"	Q86VW0	2	179101678-179264832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 175.5;Horizontal cells: 301.2;Oligodendrocytes: 311.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058236, HPA077408"	Approved		Enhanced	"Intermediate filaments"		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Intermediate filaments"		"HPA058236: AB_2732619, HPA077408: AB_2732344"	"unprognostic (2.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (9.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"unprognostic (9.21e-2)"	"prognostic favorable (2.78e-11)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-2)"	15.4	2.4	11.6	3.2	17.2	4.7	11.2	12.5	11.4	6.2	0.9	7.1	2.0	5.8	3.9	4.5	4.5	6.4	6.3	8.2	10.3	6.7	3.4	9.2	3.4	16.2	13.5	4.5	3.3	3.9	3.6	6.8	14.6	4.2	3.8	7.5	11.0	4.6	3.6	4.5	5.4	8.1	15.1	3.5	5.5	9.0	18.1	2.9	3.7	5.8	4.9	10.0	4.8	23.6	0.0	2.1	25.5	4.6	45.2	19.5	13.5	9.0	3.7	3.7	6.3	4.6	6.0	4.5	11.7	8.7	4.5	4.2	11.0	5.1	6.8	3.3	2.9	5.5	11.2	12.3	3.5	3.1	2.3	14.6	2.1	5.7	14.3	8.9	15.2	4.6	0.8	2.3	6.4	3.1	7.2	0.3	6.6	4.7	2.6	10.3	16.8	2.9	10.0	23.2	5.6	9.5	8.0	3.4	2.5	18.7	0.5	3.4	26.7	12.3	6.2	6.3	4.7	1.3	0.0	11.0	6.2	1.2	3.7	0.0	0.9	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.3	1.6	0.0	0.0	0.2	11.6	17.2	12.5	11.4	8.2	10.3	16.2	13.5	14.6	15.1	18.1	23.6	46.2	109.0	29.9	53.2	30.6	9.8	24.7	19.1	7.4	31.3	30.4	15.6	15.3	28.6	32.9	12.9	18.8	10.7	5.7	11.9	17.6	31.3	9.8	61.3	33.1	32.1	25.0	7.2	110.8	27.7	73.4	65.1	13.7	175.5	0.0	23.1	21.4	9.6	12.3	301.2	147.9	7.3	14.2	28.7	43.4	7.3	12.2	37.2	14.2	89.0	21.9	33.4	5.2	86.5	311.1	33.3	13.3	30.5	4.7	67.7	22.5	39.1	42.8	10.4	19.7	43.7	29.2	34.9	66.0	10.2	10.1	18.1	5.7	9.8	9.7	119.9
SET	"2PP2A, IGAAD, IPP2A2, PHAPII, TAF-I, TAF-IBETA"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	124.9	122.7	125.2	195.6	134.6	261.8	174.2	115.9	137.6	147.7	111.0	160.1	125.5	174.7	88.0	196.3	154.9	149.1	152.7	109.1	115.3	155.5	159.8	129.3	308.5	120.3	126.1	190.6	175.3	143.3	78.6	206.2	126.9	135.8	169.7	142.4	139.4	134.9	182.5	154.1	132.2	164.6	141.1	170.4	139.8	105.3	124.2	286.8	211.2	134.5	300.4	220.8	122.9	147.6	579.4	644.4	908.7	723.6	265.2	412.2	835.7	465.8	511.8	656.9	449.9	892.0	688.8	1483.4	383.1	482.8	513.6	1053.0	1358.8	700.1	745.2	681.2	577.8	855.2	968.5	734.5	591.3	1581.1	535.5	346.7	535.7	561.6	1114.6	526.1	626.1	781.8	1692.1	583.3	545.4	974.2	1333.9	580.0	1521.8	876.7	678.6	1198.7	1128.2	1198.7	506.5	640.5	921.0	576.5	1024.4	679.0	560.5	641.6	847.6	483.9	604.4	770.6	576.9	481.4	784.1	455.0	1417.0	1737.1	367.1	824.8	753.1	165.1	207.3	182.0	224.0	235.4	277.6	287.4	253.0	240.4	215.1	258.0	241.0	286.1	141.4	329.2	199.5	271.6	223.1	335.1	125.2	134.6	115.9	137.6	109.1	115.3	120.3	126.1	126.9	141.1	124.2	147.6	249.9	121.8	145.0	25.1	337.1	673.6	507.5	134.0	352.8	187.6	372.3	250.6	204.2	238.8	134.0	196.8	43.8	316.7	365.9	136.8	389.4	254.6	43.5	318.3	502.1	266.9	256.1	355.6	41.7	218.7	504.0	194.8	126.9	438.5	132.3	308.3	193.1	198.5	239.4	124.5	40.2	261.8	93.6	264.0	436.5	33.6	164.1	249.0	327.3	22.5	274.3	240.6	211.2	38.2	36.6	294.5	132.5	173.4	356.2	647.6	106.7	338.6	87.0	132.5	131.5	323.9	297.0	124.6	259.7	448.0	702.1	314.5	292.3	238.9	342.8	580.9
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B, histone lysine methyltransferase"	Q9UPS6	12	121804009-121832656	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	14.3	8.9	2.8	8.6	2.5	15.1	12.1	7.6	4.4	19.4	1.3	28.5	7.5	26.0	4.7	14.0	19.6	4.5	8.0	2.7	0.7	8.4	11.3	9.2	6.9	1.7	1.4	15.8	12.5	5.5	9.2	5.5	0.7	15.6	3.7	3.4	11.4	10.0	9.0	11.6	15.6	7.1	0.5	13.1	16.7	9.4	1.6	8.4	13.9	4.2	4.8	22.0	14.1	1.5	7.4	14.8	7.4	12.5	6.9	4.7	11.2	6.8	5.4	5.1	2.9	8.1	4.4	5.4	6.1	7.6	3.2	11.3	8.6	5.3	3.0	9.7	10.5	16.3	20.3	7.1	5.9	15.3	14.0	5.7	6.4	7.0	5.6	6.2	5.6	10.6	17.1	3.7	3.9	17.1	22.5	21.5	10.6	3.6	8.5	17.3	4.8	7.9	5.0	15.1	9.0	6.9	15.0	10.5	5.7	5.5	12.8	13.8	9.5	7.6	9.4	10.8	7.7	7.3	4.0	3.2	6.3	9.7	8.8	1.4	0.2	0.6	0.4	0.5	0.3	0.3	0.3	0.4	0.2	0.3	0.5	0.3	1.0	0.3	0.2	0.5	0.3	0.2	2.8	2.5	7.6	4.4	2.7	0.7	1.7	1.4	0.7	0.5	1.6	1.5	10.1	3.2	7.3	9.8	11.2	11.7	3.2	5.7	26.2	13.8	12.7	9.5	9.7	10.0	6.7	5.5	8.4	7.9	17.6	8.5	0.0	5.1	9.8	13.9	14.5	9.5	7.3	7.8	10.6	7.2	7.0	8.5	8.6	20.3	3.8	10.1	12.1	13.8	6.5	11.8	11.7	7.8	4.1	17.7	14.8	21.4	11.5	10.8	1.8	5.6	13.9	5.0	9.2	5.0	6.8	6.5	10.5	10.1	11.2	9.1	6.8	3.2	5.4	10.0	6.6	10.6	12.9	11.3	3.5	29.4	12.9	13.1	13.3	8.1	6.6	9.1
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	24.9	28.1	22.3	19.3	22.0	14.9	25.4	33.7	24.9	29.5	20.9	30.5	15.2	27.6	30.2	25.0	30.2	18.8	23.0	23.5	22.3	18.3	27.6	33.5	23.1	20.5	20.3	33.2	28.5	18.0	26.5	24.0	21.1	25.6	20.9	33.9	28.3	20.4	23.9	32.8	25.6	23.2	18.6	26.1	23.9	17.8	22.2	25.5	30.5	21.5	26.7	26.5	28.1	24.2	25.3	28.6	57.8	27.0	36.5	33.6	138.5	24.9	30.2	31.6	35.4	29.1	30.2	53.5	14.3	33.4	29.8	20.0	50.6	29.8	35.5	38.4	27.6	50.6	56.4	29.8	36.7	42.0	31.9	35.0	52.2	49.3	55.1	37.3	35.7	35.6	50.0	40.0	32.6	36.4	35.7	38.1	42.2	19.5	23.9	37.7	47.6	26.2	29.6	37.7	22.3	34.6	34.2	29.8	22.6	52.6	39.7	30.8	41.6	35.3	41.6	21.0	28.9	27.4	34.2	83.6	26.9	30.4	33.2	0.4	0.4	0.2	0.9	0.2	0.8	0.7	0.6	0.7	0.3	0.7	0.5	0.5	1.1	1.1	0.2	0.8	0.1	0.1	22.3	22.0	33.7	24.9	23.5	22.3	20.5	20.3	21.1	18.6	22.2	24.2	51.5	41.7	50.6	136.1	53.6	93.9	54.4	28.5	86.6	110.6	45.1	26.2	25.5	41.5	50.0	42.3	114.7	38.9	50.4	39.1	3.9	37.3	7.9	45.9	60.3	62.5	62.4	34.3	175.0	34.0	41.3	62.2	45.9	49.4	48.1	60.6	63.1	50.1	24.4	55.5	188.5	51.9	26.4	32.4	70.7	11.7	66.8	30.8	44.4	108.7	39.7	33.4	39.1	263.9	131.7	44.2	46.2	53.8	67.7	88.2	39.4	12.8	52.9	60.9	13.1	65.3	52.8	50.6	37.8	75.2	91.5	57.3	49.6	56.2	47.8	84.2
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356919	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		87000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	36.2	29.7	14.1	45.4	19.0	58.0	35.0	19.2	20.5	33.4	12.6	31.2	29.8	36.3	20.5	34.0	31.8	21.3	28.0	15.3	12.7	25.5	27.5	31.0	44.1	16.6	14.8	46.4	32.9	42.8	24.3	29.0	14.1	29.4	27.0	36.4	33.3	28.1	51.1	40.5	32.8	29.9	13.3	42.0	31.8	49.2	15.9	42.6	31.6	25.8	41.4	33.2	32.8	20.7	86.2	58.9	79.4	77.6	46.4	41.3	94.8	66.5	42.7	71.4	52.8	78.8	55.9	106.4	44.6	47.7	55.9	80.4	101.6	70.8	77.7	97.4	88.4	99.3	69.1	65.3	41.8	202.1	106.3	41.7	49.6	89.5	72.4	40.1	52.1	56.6	112.5	108.0	52.8	49.1	99.4	46.2	132.0	65.7	48.4	139.5	99.4	86.8	40.9	93.6	82.2	74.9	84.4	50.8	78.4	52.5	62.3	65.4	72.9	90.2	80.0	65.1	124.4	83.2	108.2	106.9	69.4	73.8	95.0	6.7	8.9	14.1	10.9	9.8	11.2	10.4	11.0	11.8	9.2	11.0	12.0	11.2	14.1	11.0	13.0	5.6	14.5	8.0	14.1	19.0	19.2	20.5	15.3	12.7	16.6	14.8	14.1	13.3	15.9	20.7	32.4	57.7	66.5	12.1	60.8	26.1	25.4	19.0	37.0	17.6	25.7	24.4	27.6	34.3	30.5	31.3	16.7	32.5	49.2	30.8	17.6	25.7	106.1	30.5	23.1	32.6	25.1	36.1	7.5	29.4	39.7	29.1	35.2	29.1	52.6	76.3	28.2	28.4	40.6	26.9	9.4	30.7	16.2	37.2	28.3	116.8	35.1	39.8	17.8	5.6	58.5	27.1	46.4	6.0	7.1	28.8	31.3	37.6	45.5	26.4	31.8	17.0	39.4	20.3	46.0	29.0	27.3	64.3	41.6	37.8	27.3	34.6	55.8	26.7	33.9	25.8
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197388515-197435079	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		94000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	183.8	173.9	101.7	132.7	112.4	304.8	180.7	120.5	126.1	222.8	136.8	170.9	110.4	195.8	200.0	136.8	183.8	123.2	135.7	98.2	100.8	135.4	168.5	162.8	203.0	105.7	101.9	226.5	200.7	154.9	147.8	165.3	111.0	163.2	147.3	138.4	180.4	133.2	172.4	156.5	231.6	116.5	107.5	287.8	169.2	91.4	104.9	221.9	167.8	144.8	199.3	154.4	167.1	135.8	134.9	105.4	288.6	155.9	222.8	219.2	237.8	172.6	196.7	163.2	205.9	233.0	147.2	247.5	116.6	193.1	165.8	133.7	273.4	151.2	271.8	196.5	154.8	237.5	257.4	294.3	155.4	270.1	198.6	232.1	163.0	175.9	209.3	278.6	205.9	171.0	210.2	174.0	192.3	134.2	251.1	285.6	231.4	167.5	163.8	234.4	197.9	182.9	245.8	286.4	154.2	186.7	174.7	118.2	139.2	345.1	115.2	242.5	186.8	126.9	109.4	123.3	145.8	168.7	238.8	342.0	123.7	174.8	146.5	49.8	50.4	57.5	54.5	51.7	55.4	46.1	46.2	50.9	60.5	44.1	48.7	49.2	60.8	56.7	52.5	37.5	71.3	56.2	101.7	112.4	120.5	126.1	98.2	100.8	105.7	101.9	111.0	107.5	104.9	135.8	175.6	179.5	222.9	92.4	187.4	119.0	172.0	127.1	125.7	103.4	96.4	83.3	129.2	72.9	194.0	92.0	73.0	116.8	224.1	90.1	56.7	104.8	9.2	123.9	191.0	143.1	110.5	109.0	55.5	94.8	102.3	151.6	132.0	179.0	246.9	171.1	107.1	74.4	100.6	94.2	59.7	108.1	89.5	124.7	144.1	20.6	120.2	166.1	76.5	75.9	163.9	111.1	116.4	87.0	121.1	112.0	68.3	104.6	195.6	103.8	84.2	70.5	221.5	98.5	118.3	159.5	227.9	104.6	100.5	94.3	118.8	142.7	216.2	119.4	91.4	156.1
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	116.0	96.0	117.5	80.4	127.1	144.6	109.0	119.4	139.5	123.3	125.1	97.4	70.7	111.6	95.5	96.6	112.3	55.2	94.7	117.9	120.4	107.1	112.0	104.3	99.0	124.2	118.9	136.1	137.4	88.9	137.2	80.6	121.3	99.2	77.0	96.5	91.3	73.8	108.1	116.9	98.5	80.0	121.4	113.9	102.9	145.2	124.0	109.4	115.2	54.6	114.0	108.3	104.7	136.9	226.9	177.3	189.0	178.9	184.3	163.5	153.1	168.4	210.5	234.9	176.8	149.8	188.9	212.5	185.7	186.7	249.5	202.9	263.2	177.8	208.8	170.2	143.5	223.3	164.2	245.5	187.8	229.7	171.5	137.9	174.0	242.5	287.8	171.3	172.7	180.5	215.2	348.7	191.4	309.8	257.5	343.2	196.1	166.2	163.9	235.6	162.9	299.0	192.3	186.0	147.8	218.0	165.9	175.9	257.0	136.3	217.2	147.1	156.7	206.9	178.0	229.0	194.3	267.5	337.0	270.8	229.6	151.6	191.9	152.1	96.2	167.9	135.3	117.2	131.1	106.8	120.3	128.2	98.5	110.2	116.7	116.8	130.2	116.3	160.1	78.8	131.8	147.5	117.5	127.1	119.4	139.5	117.9	120.4	124.2	118.9	121.3	121.4	124.0	136.9	86.5	128.2	131.0	18.6	144.3	111.3	148.9	165.9	129.1	94.9	69.1	65.0	68.5	98.7	141.5	66.2	89.6	195.9	131.8	114.3	92.0	172.2	278.2	119.5	103.2	104.4	82.5	113.6	19.2	214.8	183.7	117.6	95.8	92.0	120.8	119.0	80.7	72.4	124.9	107.7	19.3	112.4	130.2	103.6	115.0	78.5	120.2	103.8	65.8	10.3	195.6	122.1	155.5	12.1	28.9	158.9	96.3	130.1	198.3	136.6	101.1	108.1	214.7	109.4	78.9	106.1	153.7	220.1	172.0	103.2	99.0	186.6	145.5	118.7	122.3	130.8
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094884-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	105.8	180.4	121.2	79.5	125.6	251.9	110.1	130.7	140.7	99.1	128.0	121.8	93.1	101.8	100.8	152.3	127.8	86.0	149.3	126.2	124.8	159.8	191.1	94.3	129.7	128.0	122.9	107.2	146.9	132.5	149.6	75.6	126.8	104.3	111.0	32.3	112.4	83.8	158.5	133.0	104.6	91.7	125.9	119.3	113.6	93.7	126.2	147.1	114.2	161.2	125.5	116.8	97.7	129.2	124.1	164.2	184.6	343.4	211.9	239.3	109.8	125.5	209.6	252.3	286.8	175.0	110.2	204.7	219.7	205.3	244.5	143.6	214.0	288.5	177.2	213.0	302.5	223.8	136.0	391.3	203.4	441.2	138.0	246.0	382.5	277.7	275.3	162.8	310.0	278.0	292.3	290.1	229.7	436.5	287.1	396.2	119.3	192.9	196.8	176.5	241.7	208.0	276.0	109.8	252.6	159.6	175.1	211.5	242.2	93.0	154.1	266.9	169.0	129.0	175.5	233.6	276.7	216.3	284.6	197.3	208.8	366.8	162.5	181.9	377.9	191.8	171.5	277.7	213.0	211.2	192.2	203.6	326.2	197.2	190.3	189.1	101.0	199.0	256.3	364.0	241.3	364.1	121.2	125.6	130.7	140.7	126.2	124.8	128.0	122.9	126.8	125.9	126.2	129.2	97.8	89.8	137.8	5.2	151.9	271.1	168.4	282.5	97.3	45.5	178.4	238.9	87.2	170.1	171.2	123.2	12.5	224.5	180.9	244.9	457.8	253.7	240.9	149.3	159.3	136.6	267.7	157.8	3.8	315.5	221.8	151.6	100.4	138.5	178.7	156.6	163.9	265.6	328.1	43.7	4.9	423.3	201.4	224.0	239.5	109.8	134.8	165.3	252.5	7.5	258.0	132.2	176.1	6.6	13.2	259.8	259.6	108.7	214.7	233.7	304.2	625.7	153.3	58.4	105.2	119.8	135.6	169.6	59.1	164.7	324.2	206.5	168.9	203.9	342.4	222.7
SFMBT1	"DKFZp434L243, RU1, SFMBT"	ENSG00000163935	"Scm like with four mbt domains 1"	Q9UHJ3	3	52903572-53046750	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 136.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036152, HPA064564"			Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA036152: AB_2674972, HPA064564: AB_2685288"	"unprognostic (2.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.57e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.55e-2)"	3.2	2.4	2.6	5.6	3.1	6.9	5.8	5.5	3.4	3.6	3.8	7.3	4.8	2.3	5.0	6.6	5.4	3.6	7.2	3.0	3.5	6.3	7.8	4.2	7.6	3.2	3.1	1.3	9.0	11.9	5.3	4.6	3.2	3.7	7.6	6.4	7.4	2.8	13.0	5.2	5.2	3.5	2.7	3.9	6.3	45.6	2.9	5.1	5.9	8.7	8.5	5.1	3.1	3.5	25.6	6.8	10.9	19.8	2.3	1.7	22.3	5.5	5.2	16.3	20.1	14.1	21.5	13.2	6.3	3.4	17.8	2.1	11.0	7.0	19.7	23.8	6.9	11.0	14.9	6.4	3.7	17.4	10.9	1.6	10.1	11.2	7.5	1.8	3.0	14.8	3.8	18.9	5.4	8.0	11.1	7.0	5.7	9.7	7.2	9.8	10.2	7.3	2.2	27.1	12.8	8.1	23.6	9.6	11.8	1.2	6.3	16.0	1.9	7.2	16.2	12.5	17.2	9.0	34.1	27.3	6.6	7.1	12.4	1.3	1.5	9.1	2.5	0.7	3.3	6.2	3.9	2.3	0.6	5.2	3.6	4.0	2.4	2.9	0.7	0.7	1.9	1.9	2.6	3.1	5.5	3.4	3.0	3.5	3.2	3.1	3.2	2.7	2.9	3.5	2.5	9.6	9.4	42.7	22.7	11.6	8.6	5.1	9.6	15.4	11.7	6.2	17.0	10.0	6.0	1.8	45.9	10.0	7.3	11.0	7.9	8.2	56.2	5.1	3.5	4.1	6.0	16.0	37.1	13.4	8.7	6.2	10.7	5.1	8.9	8.2	3.6	16.8	6.5	8.4	47.3	8.3	0.0	6.7	7.9	58.5	2.1	6.9	0.0	46.9	3.6	6.2	17.5	60.3	41.8	9.4	6.9	7.5	11.5	9.1	6.0	7.6	11.1	23.2	6.6	5.2	4.2	136.6	27.0	9.8	8.7	5.3	14.4	8.4	12.2	5.3
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193145	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		640000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	62.9	46.7	25.1	62.1	26.0	215.1	53.2	38.5	32.3	54.0	23.4	46.9	44.6	60.2	51.0	59.8	54.6	39.9	43.8	24.8	30.7	48.8	50.6	40.8	76.4	30.2	27.2	74.4	52.8	44.9	34.4	51.8	25.2	49.8	54.4	47.4	52.8	35.6	63.9	60.0	47.6	52.9	23.0	54.1	48.0	45.8	24.9	85.5	44.8	27.4	94.5	58.1	52.5	44.6	180.5	147.3	251.1	142.9	60.5	90.0	234.7	96.1	97.1	160.4	116.3	161.5	126.4	325.6	130.1	111.8	100.6	160.4	276.1	188.3	217.0	175.2	183.0	245.5	156.2	193.6	81.5	258.2	140.1	72.4	71.7	139.4	67.3	70.9	142.3	169.1	282.6	150.9	158.3	156.8	304.2	220.1	299.7	107.8	140.7	304.5	170.4	213.6	156.2	214.4	180.1	200.3	138.6	106.3	147.1	174.4	125.0	181.7	152.3	127.7	188.3	84.7	208.9	171.2	156.5	327.6	91.1	168.6	185.9	2.6	4.1	3.0	4.7	5.8	5.4	4.1	4.6	3.8	3.8	4.5	4.3	4.8	2.1	3.4	4.7	7.3	5.6	2.3	25.1	26.0	38.5	32.3	24.8	30.7	30.2	27.2	25.2	23.0	24.9	44.6	286.7	169.9	237.7	149.8	317.4	357.5	239.3	80.6	234.5	230.0	231.6	191.0	149.6	82.9	146.2	110.3	191.8	206.5	339.0	149.7	82.2	120.1	126.8	230.1	318.9	222.2	219.6	198.9	127.3	138.4	222.9	255.8	267.6	333.1	155.8	450.5	123.5	109.1	141.4	171.6	143.4	189.5	59.0	129.4	216.9	361.9	142.9	258.5	140.5	104.9	146.2	152.6	127.7	248.8	183.1	162.0	126.7	116.6	291.8	159.9	94.8	87.6	114.8	223.6	52.6	530.6	259.2	199.1	171.9	287.9	327.3	305.5	313.7	223.7	220.0	167.7
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 99.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 99.8;T-cells: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	7.6	15.4	14.0	18.2	14.8	21.9	8.1	15.0	17.4	9.3	15.0	28.1	19.3	8.5	8.0	14.7	8.7	9.8	12.3	13.3	15.3	41.6	99.7	5.9	27.0	12.1	12.6	18.7	13.1	15.8	12.9	15.3	13.2	9.6	17.7	20.7	9.6	10.4	10.9	8.8	20.1	11.3	13.0	10.5	14.6	6.6	13.8	24.0	10.5	15.7	27.0	13.8	11.2	14.8	39.9	123.1	61.7	67.0	21.0	44.4	99.2	99.1	41.5	81.3	78.3	156.5	77.6	82.3	74.9	51.9	100.4	49.7	119.0	171.9	87.8	202.1	102.4	60.6	103.4	69.0	30.3	119.6	73.3	36.5	33.1	90.3	39.2	48.3	63.3	74.9	89.1	63.4	60.2	138.3	140.3	9.7	48.7	66.5	41.1	116.3	63.1	87.8	31.3	154.2	104.6	66.7	95.6	88.9	47.8	50.5	43.1	38.3	62.3	63.9	100.3	47.5	130.2	80.2	101.8	184.6	105.1	104.9	68.1	99.8	5.1	26.3	26.2	6.7	21.4	10.7	36.4	29.2	7.3	9.3	28.4	29.3	1.6	12.7	4.3	3.5	32.3	14.2	14.0	14.8	15.0	17.4	13.3	15.3	12.1	12.6	13.2	13.0	13.8	14.8	6.0	3.2	13.5	55.2	29.1	19.5	33.5	30.6	48.9	59.3	13.7	9.9	18.1	17.2	18.8	18.4	47.9	41.4	19.0	68.9	25.4	27.7	1.2	10.9	23.3	14.2	31.2	45.4	77.3	18.7	74.2	24.8	26.0	11.3	9.5	38.1	12.8	98.7	17.2	77.4	62.9	23.9	26.4	8.1	11.4	4.0	47.2	9.5	10.6	30.9	9.0	19.8	37.0	55.3	60.1	31.8	20.1	35.0	63.4	31.6	89.8	51.1	15.5	49.9	26.3	21.7	23.1	2.8	7.4	43.6	21.6	30.9	61.9	67.2	21.7	27.0
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Metabolic proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 177.5;Proximal enterocytes: 119.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	20.1	10.7	16.2	11.8	19.0	6.2	14.9	19.4	21.2	17.9	15.7	13.9	31.7	18.0	21.5	8.1	18.3	16.4	15.1	19.7	12.9	12.0	4.3	21.3	7.9	18.5	15.8	12.7	9.1	18.3	9.0	21.0	19.2	12.0	10.4	23.4	11.1	16.5	3.6	22.2	37.5	25.4	12.7	10.7	11.0	7.2	18.2	6.4	9.9	7.9	7.1	14.9	14.7	19.3	44.4	16.9	1.7	5.2	43.5	46.0	4.4	26.4	92.7	33.0	26.4	28.1	47.4	1.9	24.8	62.1	27.7	31.8	7.9	57.7	14.4	12.3	10.2	5.3	27.1	20.4	29.8	4.2	41.2	31.8	8.3	29.1	27.3	91.8	73.5	12.5	0.4	1.4	54.4	7.3	1.9	6.4	2.1	16.2	40.3	4.3	32.5	12.0	48.5	6.8	9.0	44.1	14.4	1.7	39.3	11.8	13.8	31.2	60.9	29.0	22.7	26.0	13.1	6.6	2.7	0.2	70.7	23.7	23.7	10.6	18.1	9.1	11.0	13.4	8.5	2.4	7.4	7.6	19.1	1.1	4.5	5.6	3.2	5.5	7.8	2.9	8.7	11.7	16.2	19.0	19.4	21.2	19.7	12.9	18.5	15.8	19.2	12.7	18.2	19.3	17.1	12.8	5.3	7.5	3.9	13.9	5.0	6.3	2.8	60.2	6.9	7.0	3.2	18.6	4.6	5.5	47.9	1.2	21.2	7.3	1.9	31.7	51.9	25.2	13.4	17.5	5.4	4.8	14.2	15.3	40.9	17.4	7.7	5.6	14.5	55.5	20.0	0.9	37.4	10.1	12.2	7.8	4.1	21.3	29.9	177.5	17.4	24.3	33.8	1.0	12.0	7.7	9.2	5.0	16.0	38.5	10.8	14.7	10.4	2.9	119.1	14.3	38.8	24.0	13.1	6.7	12.0	1.4	0.7	1.3	10.9	10.9	19.7	2.7	5.6	3.4
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200584096	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9;testis: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.6;Endometrial ciliated cells: 12.1;Extravillous trophoblasts: 31.0;granulocytes: 11.4;Granulosa cells: 23.4;Hofbauer cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	3.3	0.9	0.6	4.4	0.9	6.8	1.9	0.8	0.9	0.9	0.3	3.1	2.5	1.8	0.7	2.4	1.4	1.2	1.0	0.5	0.9	0.9	0.8	1.5	7.9	0.9	0.9	1.9	0.5	1.1	0.3	2.6	0.9	1.4	3.2	0.9	0.7	0.7	0.4	2.3	2.6	2.0	0.7	2.0	1.8	32.6	0.9	14.9	1.2	0.6	8.1	1.5	0.9	1.2	34.6	16.2	37.0	17.4	5.2	7.9	23.7	38.7	16.6	32.0	33.1	24.3	23.5	22.5	18.6	18.1	34.4	25.3	33.6	20.1	54.5	48.0	16.9	43.5	21.6	17.5	1.6	43.9	33.1	3.4	2.5	32.9	17.3	8.0	29.4	31.3	33.1	31.6	61.4	15.4	35.9	17.9	26.7	24.9	41.2	28.8	49.1	21.3	13.3	13.6	22.2	15.4	28.6	13.3	16.3	29.2	14.1	25.2	18.1	33.9	34.0	31.6	34.0	14.3	33.5	49.8	21.4	28.9	49.4	16.7	1.4	4.5	2.2	1.4	1.4	2.7	2.4	2.2	0.8	3.2	1.8	2.2	1.0	2.0	1.7	1.7	3.6	1.2	0.6	0.9	0.8	0.9	0.5	0.9	0.9	0.9	0.9	0.7	0.9	1.2	9.4	3.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.8	7.1	0.0	0.0	6.2	0.0	0.0	11.6	7.8	0.0	3.9	3.9	0.0	12.1	5.3	3.3	0.0	0.0	0.0	2.7	31.0	6.7	0.0	3.6	11.4	23.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	1.7	0.0	0.0	2.5	8.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.4	3.8	4.0	0.0	0.0
SH2D4A	"FLJ20967, PPP1R38, SH2A"	ENSG00000104611	"SH2 domain containing 4A"	Q9H788	8	19313693-19396218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 87.7;Pancreatic endocrine cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 181.7;OE19: 102.5;U-2197: 130.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001871, HPA001919"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001871: AB_1079949, HPA001919: AB_1079947"	"unprognostic (9.08e-2)"	"unprognostic (8.40e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.70e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (6.02e-8)"	"unprognostic (1.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	5.0	8.8	1.6	4.1	1.4	0.1	6.2	1.2	2.0	13.6	1.9	13.6	12.7	4.0	1.7	20.4	9.1	11.1	3.1	1.6	1.5	12.6	39.1	15.8	1.0	1.6	1.6	36.9	13.1	18.2	1.4	17.7	1.9	7.4	10.8	9.6	24.0	10.1	0.6	7.2	12.6	2.0	1.3	3.3	29.9	2.2	1.5	1.3	16.8	1.6	7.4	18.3	10.5	2.0	60.5	67.3	0.2	0.1	6.5	8.0	44.9	73.9	36.6	70.7	68.3	55.7	53.4	0.0	17.4	181.7	11.2	30.5	2.7	20.0	73.6	0.2	1.0	0.0	40.7	8.6	38.3	1.6	0.3	7.8	24.5	48.4	8.8	42.5	0.3	0.0	0.1	0.1	12.0	27.2	0.1	0.7	15.8	102.5	25.4	0.1	0.0	19.5	19.5	62.6	4.1	0.1	66.0	70.6	0.2	10.4	13.3	5.3	1.2	22.9	0.1	130.8	22.4	0.0	0.7	0.2	23.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.2	0.0	1.8	0.1	0.0	0.0	0.1	0.0	1.6	1.4	1.2	2.0	1.6	1.5	1.6	1.6	1.9	1.3	1.5	2.0	8.5	64.1	33.9	6.5	0.9	1.5	15.0	22.2	5.2	2.2	9.4	5.6	2.0	34.3	26.2	46.0	27.1	87.7	0.3	20.1	43.0	50.3	25.3	30.9	6.0	5.4	3.0	0.0	1.5	67.0	69.4	11.7	67.8	34.4	1.3	43.3	2.5	45.5	37.7	1.7	1.0	24.8	54.9	8.5	1.6	53.5	6.2	6.3	0.0	1.9	0.6	3.5	0.0	11.1	0.3	99.1	8.3	11.3	0.4	14.6	20.5	10.9	46.9	36.2	19.7	3.0	6.5	0.5	2.8	31.9	2.6	30.6	1.0	52.0	26.3	31.2
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254353-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 200.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 349.3;MCF7: 118.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	78.3	200.5	21.2	35.2	22.7	72.6	72.0	38.4	26.1	71.1	16.0	27.4	15.7	77.5	13.5	26.9	85.6	45.7	24.1	23.3	21.0	52.8	17.3	73.2	59.9	21.4	20.0	116.2	15.9	47.9	35.7	40.8	22.4	25.0	8.4	27.4	49.9	34.1	71.7	25.6	27.0	37.3	20.8	30.9	16.1	30.9	20.9	37.4	51.1	19.1	35.7	33.0	50.6	35.1	27.4	16.5	6.4	14.1	53.1	46.8	349.3	13.6	10.9	9.3	10.4	10.8	13.4	21.3	6.2	40.8	16.1	3.6	2.9	14.2	5.9	19.5	12.8	15.7	72.3	1.9	21.9	4.4	8.6	36.9	9.3	41.6	7.9	34.2	116.0	31.3	18.4	8.5	10.3	118.1	57.6	23.2	13.6	3.5	20.6	1.1	27.2	115.6	8.8	53.5	16.8	7.8	18.6	19.2	21.7	21.6	18.1	10.9	84.3	22.8	29.5	21.9	12.0	3.3	7.6	15.2	44.7	16.3	31.5	8.1	7.8	9.1	52.9	2.5	15.9	19.1	24.1	36.1	8.9	24.3	12.9	16.6	13.9	25.4	4.6	3.9	11.1	20.4	21.2	22.7	38.4	26.1	23.3	21.0	21.4	20.0	22.4	20.8	20.9	35.1	195.9	0.0	16.3	2.3	115.2	17.0	6.0	8.2	11.4	41.3	23.5	32.1	0.7	5.7	13.9	68.0	14.6	12.5	73.7	0.6	3.9	2.7	192.2	13.1	33.0	150.7	2.4	7.0	49.5	8.7	356.3	97.5	3.6	13.7	2.5	28.1	165.0	7.0	33.1	65.6	38.4	2.5	12.2	87.2	133.3	97.8	49.0	113.1	33.8	26.2	33.3	5.1	167.9	12.5	60.6	3.2	1.1	118.5	67.1	8.5	4.7	36.2	7.5	44.4	6.6	56.8	13.4	3.0	4.5	14.2	12.1	173.2	51.5	81.6	1.4	10.2
SH3GL1	"CNSA1, EEN, MGC111371, SH3D2B, SH3P8"	ENSG00000141985	"SH3 domain containing GRB2 like 1, endophilin A2"	Q99961	19	4360370-4400547	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021485	Approved		Enhanced	Cytosol		NA	NA		390000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"HPA021485: AB_1856816"	"unprognostic (1.32e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (6.85e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.36e-8)"	"unprognostic (5.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	61.1	64.7	25.0	29.4	28.8	54.4	50.0	32.8	38.1	69.8	24.2	41.3	40.9	45.1	8.2	175.8	43.9	25.4	37.6	34.4	20.5	39.2	57.4	43.8	22.8	24.8	22.5	49.0	41.8	10.8	46.8	38.9	23.8	48.8	9.2	7.0	51.8	24.0	21.2	119.8	43.7	20.8	21.1	46.8	35.9	28.1	24.7	16.8	37.1	10.1	19.8	53.0	91.6	28.0	111.3	49.2	50.0	66.8	57.4	89.0	92.2	94.2	80.3	82.2	81.1	77.4	56.8	24.9	39.0	94.1	39.8	89.5	35.6	103.7	21.9	33.1	59.8	30.0	66.5	102.7	82.6	27.2	32.6	75.0	70.9	69.4	42.4	40.6	97.8	23.7	78.9	55.1	67.1	92.6	26.5	28.4	126.0	40.4	54.3	20.8	69.8	43.6	65.8	96.4	49.1	75.7	83.3	81.9	59.3	23.5	56.5	42.5	149.3	78.6	57.1	166.7	97.2	34.8	23.2	26.7	112.9	70.0	110.4	0.8	2.3	3.1	2.7	1.1	2.6	3.7	4.0	3.9	3.0	2.7	2.2	2.5	5.6	2.3	3.4	3.8	4.1	2.3	25.0	28.8	32.8	38.1	34.4	20.5	24.8	22.5	23.8	21.1	24.7	28.0	31.6	9.6	21.5	11.8	15.2	60.8	41.0	43.2	19.4	17.1	17.1	15.7	3.6	11.5	25.1	9.2	6.2	41.2	14.7	23.6	13.7	32.1	7.2	17.9	33.8	30.7	10.2	30.7	23.4	29.3	153.7	37.5	19.9	29.5	9.5	23.4	32.9	27.3	51.5	10.1	14.0	18.6	20.3	19.4	51.8	6.7	32.6	22.3	23.2	14.0	14.7	20.3	15.5	12.5	10.3	50.4	17.0	24.0	16.4	38.0	61.6	22.9	15.4	8.7	13.1	17.2	29.3	15.7	11.5	36.8	85.8	44.2	15.1	50.1	19.8	67.1
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936578-146081791	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 58.1;skeletal muscle: 42.4;skin 1: 56.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7869.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 6.1;cerebral cortex: 4.1;thalamus: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 70.3;GAMG: 29.8;hTERT-RPE1: 33.5"	"Region enriched"	"Detected in many"	14	"basal ganglia: 26.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.7"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	1.9	0.9	0.6	2.5	6.1	0.0	4.7	0.0	4.1	7.6	0.2	14.3	16.0	1.1	3.6	34.1	6.1	11.9	58.1	0.9	0.5	0.9	7.0	2.7	0.2	0.0	0.3	0.4	15.4	0.0	1.6	0.1	0.0	2.7	14.3	0.5	12.1	0.6	42.4	56.8	13.7	1.1	0.0	0.0	20.5	6.8	1.7	1.0	6.3	8.8	7.7	1.2	20.6	0.4	21.0	5.7	0.2	1.1	0.0	0.0	0.0	0.2	1.7	4.1	1.7	70.3	19.0	0.0	10.5	0.9	29.8	18.9	0.0	22.4	4.0	0.3	0.3	0.0	8.5	9.5	1.2	0.0	0.0	0.2	11.9	6.4	14.8	33.5	0.2	0.5	0.0	0.0	1.8	0.1	0.0	0.0	1.6	17.3	1.5	0.0	0.2	0.0	8.7	2.0	0.0	0.0	1.2	0.4	0.5	1.0	6.6	0.1	9.8	0.8	17.3	1.5	6.7	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	6.1	0.0	4.1	0.9	0.5	0.0	0.3	0.0	0.0	1.7	0.4	4.1	16.0	2.3	1.6	0.0	55.1	5.4	14.5	38.7	0.4	3.9	3.3	510.0	8.6	6.7	1.8	0.0	0.2	0.2	38.9	0.0	5.7	1511.3	11.9	0.9	9.7	1.2	0.0	10.5	8.7	0.0	15.4	50.4	26.7	1.3	0.1	0.7	8.4	0.2	0.0	2.2	16.1	8.2	0.0	4.9	7869.1	25.7	2.6	8.8	10.3	0.6	1.6	0.0	1.5	0.7	21.4	22.9	34.6	0.6	2.2	26.6	0.9	4.4	0.1	13.1	1.6	6.3	31.4	20.7	70.9	50.0	0.0	0.7	2.9	33.2	6.6
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37915898-38069227	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"OE19: 35.3"	"Low region specificity"	"Detected in all"							"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	12.8	7.6	6.4	1.9	9.6	3.1	9.8	6.1	9.2	8.8	8.2	11.2	3.6	6.6	1.2	26.2	7.2	4.9	24.9	6.7	6.3	23.1	35.2	13.9	1.3	8.5	9.7	4.7	20.0	4.1	15.0	2.5	7.8	16.1	2.6	0.9	23.2	4.6	6.8	17.3	7.1	3.2	5.6	6.6	10.6	4.1	9.4	1.7	8.3	1.3	2.5	13.6	16.1	12.8	8.3	14.6	1.4	0.2	1.5	3.8	2.5	9.8	11.5	6.9	5.0	4.5	5.8	0.0	10.9	8.5	16.9	8.8	5.8	14.2	4.8	6.7	11.0	0.0	5.3	10.7	10.8	0.4	0.4	3.4	4.9	11.2	7.8	16.1	6.5	1.4	3.6	2.4	7.7	6.2	0.9	0.3	3.7	35.3	13.0	0.4	4.3	0.5	13.1	3.8	15.8	12.1	1.3	10.9	2.2	11.9	6.5	0.4	9.2	3.3	11.0	1.6	16.2	0.7	0.2	0.1	18.3	0.8	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.6	6.1	9.2	6.7	6.3	8.5	9.7	7.8	5.6	9.4	12.8	21.5	6.4	5.6	9.8	0.6	20.4	96.9	9.9	33.0	0.6	12.7	6.0	9.6	35.8	9.0	22.0	8.4	10.2	1.1	17.3	15.6	18.0	1.9	8.3	2.5	19.0	7.8	5.2	6.4	20.3	1.5	5.5	14.8	18.3	0.0	0.9	10.4	21.6	6.1	0.0	5.4	12.1	2.0	2.6	19.4	3.8	0.6	5.8	7.2	8.4	0.4	2.9	0.0	5.0	43.7	22.2	6.8	0.4	1.9	31.1	7.5	24.9	5.1	1.4	0.0	5.7	3.9	1.2	9.4	19.3	34.0	4.0	1.2	9.3	11.1	45.9
SHC1	"p66, SHC, ShcA"	ENSG00000160691	"SHC adaptor protein 1"	P29353	1	154962298-154974395	"Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001844, CAB005374, CAB016305"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826"	"unprognostic (4.12e-2)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (7.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-1)"	147.4	103.8	30.9	90.3	29.8	72.8	126.7	28.9	32.0	91.3	32.2	71.8	72.1	86.0	53.7	73.5	87.5	88.8	67.0	28.0	33.2	71.4	94.5	106.3	50.6	36.2	32.6	70.7	57.7	61.8	120.5	77.0	36.4	85.0	70.9	16.5	58.7	70.2	63.3	59.2	73.0	107.6	32.7	72.8	69.7	23.3	39.5	47.4	86.4	56.2	52.8	96.6	83.2	30.4	110.8	223.7	168.9	272.3	180.6	359.3	88.6	393.5	355.3	223.6	168.7	80.2	258.5	59.3	314.0	476.4	64.1	92.9	45.5	389.6	200.2	72.7	25.0	152.0	185.7	143.9	471.1	49.3	164.8	538.3	452.4	279.4	344.0	605.8	497.7	25.0	68.2	461.3	473.8	90.0	56.8	29.8	147.9	89.7	94.2	51.1	56.1	122.6	107.1	82.5	21.6	582.1	234.8	130.2	126.3	293.3	189.8	102.9	595.6	349.6	217.5	75.1	209.0	206.6	146.2	101.7	341.4	65.9	463.5	32.4	36.7	58.0	39.0	47.7	38.7	22.4	30.7	34.6	38.0	20.8	24.6	22.4	29.2	23.2	48.2	17.5	24.6	39.1	30.9	29.8	28.9	32.0	28.0	33.2	36.2	32.6	36.4	32.7	39.5	30.4	86.0	28.9	23.6	7.5	14.1	35.7	54.5	76.5	40.9	5.1	24.0	30.6	2.2	20.0	19.1	5.5	6.2	25.7	13.1	44.1	7.9	29.0	0.7	14.7	58.8	88.0	12.6	16.0	5.4	28.0	58.0	36.3	26.0	26.9	17.7	16.8	77.8	44.5	23.3	25.2	3.7	24.5	34.6	22.3	25.1	2.7	23.0	19.5	17.8	2.8	14.5	8.7	11.3	4.5	2.1	34.0	27.6	34.6	29.1	53.5	34.4	9.6	13.0	7.4	19.7	22.7	35.7	3.8	4.9	26.9	36.4	60.9	16.2	24.5	22.4	50.0
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 7.6"	"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 7.6;pons: 7.5"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"BJ: 18.5;BJ hTERT+: 8.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"midbrain: 2.7;thalamus: 3.8"	"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	0.7	0.4	0.2	0.3	0.3	0.9	0.2	1.4	0.6	0.0	0.0	0.2	0.6	0.1	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.3	1.2	7.6	0.1	0.3	0.2	0.0	0.1	7.5	0.3	0.2	0.4	0.6	0.0	1.2	0.4	0.4	0.1	0.1	0.7	0.2	0.1	1.4	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.1	0.1	0.2	0.1	3.0	18.5	8.4	2.7	2.9	0.3	0.2	0.2	0.1	0.4	0.7	0.2	0.2	0.0	0.9	0.1	0.1	0.1	1.4	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.1	0.0	2.9	0.6	0.6	0.4	0.3	0.4	0.5	0.3	0.3	0.1	0.7	0.4	0.5	1.7	0.7	0.6	0.6	0.3	0.3	0.2	0.3	1.4	0.6	0.2	0.2	1.2	7.6	7.5	0.1	1.4	1.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"	Q9Y2K2	11	116843402-117098437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	10.1	7.2	19.3	11.4	36.6	12.7	9.2	15.0	34.3	9.6	0.0	11.7	8.5	12.6	7.2	10.4	12.4	9.8	12.8	19.7	19.4	10.3	13.8	9.7	9.9	22.0	23.1	16.5	15.4	17.7	10.0	12.1	22.5	8.2	8.8	19.1	9.8	11.3	19.5	7.5	8.7	14.1	11.5	11.8	9.7	21.4	36.1	12.3	17.1	14.4	10.4	10.1	7.5	41.1	11.8	8.9	13.9	14.7	11.7	12.6	22.2	8.8	15.7	6.8	7.6	21.8	13.3	13.9	14.0	16.3	15.0	18.1	11.6	12.7	9.4	38.5	7.4	31.2	9.7	13.6	10.9	11.2	11.8	13.9	7.2	14.5	23.3	8.7	9.2	9.0	15.2	10.1	9.4	4.0	10.2	12.1	7.7	8.0	6.6	12.9	8.0	11.1	9.3	2.2	13.5	10.8	23.7	10.3	4.4	10.5	6.8	11.8	10.6	8.3	10.4	14.0	8.9	7.1	5.6	17.5	7.7	18.2	11.4	2.0	0.4	0.0	0.3	0.5	0.5	0.1	0.3	0.1	0.6	1.0	0.0	0.0	0.9	0.6	1.5	0.0	0.0	0.2	19.3	36.6	15.0	34.3	19.7	19.4	22.0	23.1	22.5	11.5	36.1	41.1	25.8	9.6	22.1	375.5	34.9	26.5	26.0	6.8	7.4	42.6	26.1	21.5	22.2	10.0	12.4	5.5	112.6	8.7	47.3	12.5	5.9	7.6	89.2	64.4	27.9	20.4	17.3	12.4	384.4	7.3	2.8	22.1	12.8	71.5	17.2	37.4	17.2	26.3	7.7	47.1	399.6	11.1	6.1	21.7	45.1	214.9	10.2	31.4	16.0	161.1	25.6	36.3	12.3	457.9	1679.9	9.2	8.2	14.3	28.1	22.0	9.7	6.9	20.5	63.9	0.0	35.0	23.2	18.0	14.8	7.4	24.3	29.7	44.2	14.8	11.4	30.0
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 47.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.2;Inhibitory neurons: 57.4;Spermatocytes: 83.1;Theca cells: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	5.3	28.0	6.8	4.0	6.2	3.8	4.3	7.0	6.8	12.0	7.5	7.1	5.8	12.2	9.9	4.3	13.4	4.0	4.1	6.0	7.3	3.9	8.7	5.0	5.3	4.7	5.0	47.0	6.5	6.0	14.1	5.1	5.3	9.6	6.9	4.6	3.7	6.5	12.1	5.4	7.5	8.5	3.9	10.2	10.2	33.5	8.2	6.8	4.0	4.4	5.5	8.4	6.4	5.9	2.8	6.9	21.6	17.2	11.1	11.3	11.2	9.6	8.7	9.8	11.2	25.7	7.3	0.1	11.5	10.7	20.0	2.5	24.2	18.1	11.9	4.8	17.9	12.7	4.7	3.3	24.5	13.7	9.3	7.4	7.1	6.4	12.1	6.9	9.3	4.6	32.6	11.5	11.5	12.5	13.2	12.3	8.2	3.3	7.5	19.2	15.2	16.6	6.8	5.1	14.3	15.0	11.0	1.7	10.6	8.3	6.1	26.4	6.6	11.6	6.2	10.6	8.4	3.1	3.5	18.9	4.3	9.2	6.9	7.2	3.7	7.0	3.3	3.5	4.0	4.4	4.0	2.6	5.2	4.1	3.3	2.7	0.4	7.3	2.8	2.6	2.9	2.7	6.8	6.2	7.0	6.8	6.0	7.3	4.7	5.0	5.3	3.9	8.2	5.9	4.9	9.6	5.6	24.2	12.6	2.9	5.9	3.2	8.6	18.1	2.1	3.0	4.0	2.8	3.4	1.8	4.2	0.4	15.0	8.9	1.9	3.8	46.5	2.9	15.6	3.6	13.2	2.5	49.1	3.6	2.9	9.2	19.9	4.9	0.0	58.2	5.3	7.2	2.2	18.5	57.4	9.9	0.0	5.7	2.0	14.4	29.8	4.2	5.4	30.9	5.7	6.1	11.3	30.7	7.7	4.7	7.8	34.6	5.7	7.1	12.0	1.9	3.0	5.3	32.9	5.6	6.3	83.1	33.8	5.9	2.6	0.8	7.7	102.8	8.9	3.1
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	19.2	12.4	10.0	19.8	10.9	42.5	18.0	21.0	11.7	21.0	12.5	19.6	13.8	25.6	16.6	19.1	24.3	17.4	14.8	9.6	13.3	15.1	16.0	18.0	25.9	11.7	12.0	30.0	15.3	22.5	12.1	20.1	10.3	19.7	16.1	24.1	16.6	20.7	16.6	21.5	16.3	19.6	8.3	22.1	16.5	29.6	14.0	43.2	27.2	18.7	26.3	20.2	16.7	10.8	31.2	63.6	55.5	36.7	27.0	28.4	32.1	22.9	35.3	33.0	35.2	35.2	41.2	67.8	23.3	34.0	45.0	54.5	81.2	34.4	35.9	55.0	42.1	64.0	46.2	27.9	20.5	61.4	52.5	34.7	26.1	38.5	39.8	34.0	30.0	47.5	51.5	73.2	27.0	36.2	60.7	39.1	54.2	41.3	26.3	60.5	73.3	41.8	23.6	56.4	43.7	43.7	56.6	25.0	31.0	53.0	38.1	47.9	26.4	40.6	54.5	27.2	34.3	49.8	85.0	70.8	24.2	61.2	23.2	2.9	4.2	5.9	6.3	3.8	9.6	7.0	8.1	8.1	5.2	7.7	8.2	7.2	7.3	8.1	7.4	3.5	7.7	5.7	10.0	10.9	21.0	11.7	9.6	13.3	11.7	12.0	10.3	8.3	14.0	10.8	26.0	35.3	32.4	13.7	35.8	39.4	23.6	21.2	60.9	19.7	36.5	25.4	13.4	17.2	30.5	27.6	31.3	23.5	29.0	17.8	5.9	15.1	10.1	35.7	30.8	32.1	17.3	24.4	19.2	12.8	11.1	24.4	15.3	42.1	29.9	30.1	26.0	17.4	13.2	20.2	18.3	19.0	10.2	21.3	31.7	5.8	23.0	19.5	10.6	27.2	18.8	16.8	24.7	16.6	24.1	14.1	14.0	20.3	33.1	29.8	13.7	9.2	33.4	33.8	13.1	34.7	24.7	42.1	42.7	37.5	53.1	21.9	34.6	21.2	19.2	19.4
SIPA1L1	"E6TP1, KIAA0440, SPAR1"	ENSG00000197555	"Signal induced proliferation associated 1 like 1"	O43166	14	71320449-71741229	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 575.1;Inhibitory neurons: 447.6;Oligodendrocyte precursor cells: 221.2;Oligodendrocytes: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 101.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002875, HPA077689"	Approved		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments"	"HPA002875: AB_1079974, HPA077689: "	"unprognostic (1.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.64e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (6.80e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.03e-2)"	6.2	14.5	29.7	11.6	33.4	11.7	9.0	6.1	27.8	9.4	31.3	12.1	10.3	7.1	11.0	14.4	13.8	15.5	3.3	30.9	4.5	14.9	12.3	11.5	11.0	2.7	0.5	4.7	12.7	19.2	16.0	5.1	1.4	7.9	11.7	13.3	10.7	8.5	3.0	8.7	11.1	10.5	0.6	25.3	18.1	19.8	10.1	12.5	14.3	2.8	15.8	12.7	6.1	11.3	27.0	8.3	18.9	14.2	5.6	16.0	34.2	35.9	42.4	14.3	18.1	48.1	14.8	12.6	9.1	59.1	12.9	26.1	13.9	32.3	27.1	11.4	6.5	26.5	55.3	11.3	46.3	3.2	9.8	11.7	26.7	22.1	52.0	16.3	15.5	17.5	11.8	30.7	19.8	40.5	10.8	3.0	10.8	24.6	22.4	15.7	20.4	13.4	10.2	41.1	23.2	61.9	36.8	28.6	2.6	12.1	17.0	1.4	43.3	101.4	37.2	11.6	20.8	25.0	30.3	18.3	17.3	8.6	34.6	6.9	5.2	1.1	1.7	5.8	3.8	3.2	1.5	2.4	1.3	7.4	1.0	1.1	22.9	2.2	7.1	0.4	1.6	2.3	29.7	33.4	6.1	27.8	30.9	4.5	2.7	0.5	1.4	0.6	10.1	11.3	14.4	67.3	30.5	163.9	53.8	11.9	15.2	20.2	30.7	19.6	13.0	21.2	5.3	21.5	23.6	14.7	18.8	7.8	23.9	19.3	13.7	24.6	74.4	28.8	18.8	12.9	32.4	1.3	575.1	19.9	8.5	11.3	46.9	35.3	13.9	26.4	5.0	17.5	5.1	58.9	447.6	16.8	10.2	21.4	67.2	31.2	7.8	49.2	5.4	120.9	34.6	58.2	9.2	221.2	251.3	23.0	15.5	35.3	24.9	16.2	18.3	28.4	34.4	15.9	0.0	5.4	18.2	22.4	36.8	17.3	8.4	9.4	24.3	102.0	22.5	27.2
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667068-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 313.5;Kupffer cells: 192.2;Late spermatids: 354.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 149.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	32.1	24.0	6.6	30.1	7.3	21.2	16.3	5.9	7.6	9.8	4.3	23.2	15.9	5.1	17.7	13.7	13.6	14.1	4.5	7.3	8.4	27.9	11.9	25.5	32.0	16.0	8.3	18.8	6.0	26.9	4.0	8.0	15.3	9.0	21.9	4.0	5.4	11.9	6.6	10.9	21.0	13.0	19.4	36.3	12.5	15.7	9.3	11.4	7.2	3.2	30.0	25.5	9.2	26.0	38.1	19.8	2.0	48.5	9.0	7.4	12.0	15.2	22.5	7.4	18.4	15.8	149.4	29.2	65.2	28.9	54.1	20.2	26.9	15.5	15.6	16.8	43.0	32.3	5.3	20.9	11.9	60.2	109.0	32.3	14.2	21.6	29.2	1.3	45.4	0.0	17.5	14.8	29.6	7.0	0.1	30.2	1.7	33.9	19.3	38.8	4.7	2.3	90.2	29.4	23.7	0.9	27.6	14.8	20.9	10.9	20.4	31.2	67.0	12.2	0.4	41.2	15.9	23.1	31.7	50.8	29.3	76.3	48.0	28.7	33.9	55.8	9.6	42.1	13.2	26.3	5.2	7.8	26.4	21.5	1.2	7.0	100.9	23.5	53.7	33.8	10.1	20.0	6.6	7.3	5.9	7.6	7.3	8.4	16.0	8.3	15.3	19.4	9.3	26.0	93.0	19.2	28.3	9.4	98.9	26.5	38.7	9.9	42.7	12.5	29.5	27.2	5.3	2.8	12.4	23.9	12.5	13.4	101.2	51.4	64.6	8.3	313.5	20.1	1.8	50.5	43.1	54.7	76.1	23.1	22.7	34.5	9.7	19.9	53.2	11.1	110.7	10.8	91.4	5.0	36.0	65.2	34.6	192.2	58.9	354.2	9.0	149.4	19.6	119.0	115.4	12.3	63.8	3.0	15.9	19.4	37.6	10.9	29.9	18.3	54.4	103.1	20.2	12.8	0.0	11.5	33.5	26.7	45.0	38.1	43.3	18.6	36.4	41.8	48.8	35.1
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341529-48426201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		210000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	24.9	12.6	7.0	14.6	6.6	15.5	17.0	10.5	9.0	21.4	9.0	27.3	13.4	23.6	18.6	38.7	25.7	18.5	40.6	6.1	7.2	18.6	26.7	21.0	16.5	6.9	7.1	22.2	15.1	29.6	7.8	22.2	6.8	25.8	24.0	15.8	19.1	30.2	71.8	32.5	16.3	35.4	6.0	16.3	18.2	40.3	8.1	24.4	20.0	98.8	21.0	26.3	21.9	8.5	32.8	12.7	22.2	22.0	33.9	41.6	15.6	49.3	62.3	43.0	44.5	12.6	26.8	19.4	29.7	56.7	76.7	21.2	91.5	46.1	75.6	16.1	9.5	34.1	17.5	14.4	36.5	31.5	33.4	35.4	67.1	50.0	58.0	32.2	25.8	17.1	22.3	21.1	43.7	16.5	36.4	25.9	9.4	25.7	18.2	20.6	43.1	12.4	38.0	35.4	14.7	18.7	20.0	14.8	21.2	20.4	18.6	22.2	33.0	46.8	44.2	29.9	50.5	28.6	32.1	16.3	36.8	35.2	34.5	9.5	6.5	7.7	6.6	4.7	7.2	5.1	8.1	9.9	6.6	7.5	6.6	7.1	5.8	8.8	7.3	2.3	5.7	3.6	7.0	6.6	10.5	9.0	6.1	7.2	6.9	7.1	6.8	6.0	8.1	8.5	37.2	54.5	38.7	43.8	27.9	84.2	50.6	32.6	38.7	15.8	26.5	19.4	79.6	18.6	32.3	27.6	14.6	29.3	31.7	35.0	21.5	29.9	162.4	145.1	64.7	28.8	25.2	16.6	47.0	34.9	29.1	31.9	28.5	57.4	21.6	20.3	21.8	33.0	21.6	35.3	47.3	34.5	22.4	20.5	31.0	319.2	27.4	29.2	19.6	38.4	37.5	20.7	28.8	54.3	43.1	32.2	27.9	36.9	26.2	53.9	23.4	26.4	85.1	41.0	32.9	54.1	43.1	98.7	48.8	55.0	91.5	75.5	35.0	32.8	25.6	58.3
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957593	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	20.7	10.4	35.7	11.8	36.1	4.3	7.5	37.8	99.4	7.1	37.8	46.8	32.5	28.6	22.8	15.3	13.1	14.8	67.9	33.5	35.2	11.4	55.6	4.9	9.5	38.6	35.9	7.9	2.0	10.0	5.2	34.0	37.0	14.4	35.3	68.9	3.5	11.2	67.5	13.0	16.6	39.2	37.0	6.6	26.6	29.8	38.3	11.7	8.6	59.6	11.6	11.9	7.1	38.2	111.1	24.0	86.9	74.3	61.9	52.1	272.7	64.6	51.1	52.0	80.9	85.4	67.1	113.8	82.3	61.6	32.6	113.1	126.3	124.8	96.8	75.6	105.2	108.9	63.4	112.9	104.6	123.2	9.9	72.2	144.6	75.7	146.4	79.2	131.4	53.8	131.3	78.0	61.9	19.9	70.2	70.1	271.4	36.7	74.5	67.9	130.7	92.8	67.3	1.9	86.9	46.5	121.8	3.8	97.5	130.0	3.7	48.9	80.9	45.4	72.0	89.3	93.1	39.7	33.9	116.7	137.1	78.5	56.0	0.0	1.4	0.0	1.5	1.6	1.7	0.9	1.8	2.0	2.5	0.3	0.8	1.5	0.1	0.6	0.3	0.2	6.1	0.8	35.7	36.1	37.8	99.4	33.5	35.2	38.6	35.9	37.0	37.0	38.3	38.2	15.1	0.0	2.6	8.5	16.5	89.3	6.5	39.9	87.6	16.9	16.5	9.9	126.3	10.0	5.7	0.0	158.4	77.4	20.3	99.8	0.0	2.5	107.2	14.3	70.7	22.8	3.5	20.2	9.8	3.3	67.6	32.8	67.2	35.8	8.9	322.8	6.4	37.5	15.4	20.2	11.6	17.3	20.3	9.0	15.7	118.3	11.8	12.8	39.2	20.6	4.3	184.8	0.0	9.0	23.8	7.4	7.7	7.5	25.5	16.5	9.3	10.8	3.9	277.5	0.0	38.2	22.1	45.3	23.6	29.6	39.5	46.0	20.9	49.6	23.3	1.3
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 294.5;U-266/70: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	4.3	26.4	49.1	9.1	46.8	13.4	13.6	32.1	48.6	14.0	18.0	9.4	6.1	12.8	8.2	7.5	4.8	3.9	6.2	43.4	56.6	1.9	9.0	4.9	10.7	37.2	43.1	13.2	29.6	5.5	13.7	6.6	52.1	9.6	8.4	19.3	7.5	7.1	40.1	18.6	5.6	12.3	29.5	7.5	8.1	11.7	59.9	20.5	5.7	17.0	19.0	4.8	6.2	30.3	15.3	11.6	6.6	34.9	14.7	9.5	9.4	28.5	14.0	11.7	19.8	3.2	2.2	49.7	6.5	44.8	14.7	43.2	13.7	3.6	12.0	20.1	5.4	26.0	13.1	30.9	31.0	43.8	23.1	4.4	73.8	15.8	24.2	3.9	7.3	49.1	20.7	122.0	8.4	13.5	37.7	29.1	4.7	20.1	13.9	13.5	1.9	125.5	4.9	7.7	29.3	14.1	17.9	16.1	294.5	3.0	19.3	47.8	1.6	16.0	19.0	31.2	17.5	132.8	71.2	118.8	23.6	86.5	86.2	0.0	2.1	1.8	0.9	4.8	1.2	0.9	0.9	1.5	3.9	0.3	0.0	0.8	0.0	5.1	9.4	7.2	3.5	1.4	49.1	46.8	32.1	48.6	43.4	56.6	37.2	43.1	52.1	29.5	59.9	30.3	3.6	0.0	2.7	69.9	13.6	20.0	2.1	6.7	46.1	6.3	21.0	7.1	5.5	1.5	1.7	1.8	33.3	2.4	20.2	2.9	0.0	2.0	32.4	5.4	8.2	5.3	8.4	6.1	20.6	9.3	1.3	4.0	5.1	5.6	7.0	49.2	7.5	13.1	17.7	6.7	25.5	9.0	6.1	6.8	11.8	47.5	11.1	11.1	85.4	8.4	5.1	14.6	2.1	5.0	3.9	7.1	0.8	29.7	65.7	2.6	0.4	1.5	5.4	17.7	0.0	5.1	7.3	2.0	0.9	5.9	6.1	2.5	10.9	0.4	5.8	1.0
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 148.6;Erythroid cells: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 95.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	97.2	15.9	5.8	29.6	6.5	60.9	77.7	6.6	6.1	57.4	6.1	50.1	16.2	39.1	98.0	98.0	48.9	36.5	26.4	5.9	8.5	45.6	8.1	65.3	27.9	15.8	11.1	45.8	73.2	2.9	24.5	46.9	13.3	98.6	42.4	1.4	120.5	77.0	8.5	55.7	36.2	33.0	9.5	40.4	55.5	40.3	9.8	19.9	14.1	10.7	30.3	109.6	83.0	11.5	179.6	323.6	76.3	116.1	194.7	164.3	180.0	249.6	283.0	183.2	264.1	296.1	197.1	194.8	118.9	624.2	105.2	281.1	224.9	296.9	135.5	130.1	203.7	324.3	115.1	281.9	501.3	228.2	182.9	268.6	727.3	215.5	541.1	61.3	98.9	255.0	348.9	500.1	99.5	304.5	105.4	611.1	134.0	636.5	140.9	117.8	86.5	282.7	104.2	384.8	117.3	86.0	123.4	331.8	275.4	58.8	191.6	296.6	74.1	109.4	174.1	86.4	205.7	308.0	325.3	164.0	206.3	281.0	274.3	0.1	36.1	2.9	14.1	55.0	11.4	17.8	8.0	9.9	50.2	8.1	1.9	6.0	1.0	21.0	66.3	95.8	15.5	27.8	5.8	6.5	6.6	6.1	5.9	8.5	15.8	11.1	13.3	9.5	9.8	11.5	63.6	0.0	17.3	0.0	31.1	57.7	148.6	95.9	64.9	0.2	52.0	43.1	20.3	21.5	41.2	0.0	0.0	80.8	86.3	44.6	3.9	38.5	27.0	2.6	32.9	29.0	10.7	143.3	0.6	65.7	129.3	48.0	21.9	2.7	29.2	20.9	29.6	0.7	38.4	0.0	0.8	111.3	40.7	21.6	34.7	14.0	19.0	39.8	19.6	3.7	26.0	0.6	12.3	0.0	0.6	43.4	74.8	19.5	68.6	59.0	6.5	23.1	13.0	0.8	6.6	15.8	44.0	35.9	4.0	69.0	28.3	24.4	38.7	6.1	62.9	100.0
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134043-108200849	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		19000	"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	10.0	6.2	0.8	5.3	0.7	3.8	8.2	0.6	1.3	12.5	0.8	13.5	11.4	6.6	3.2	6.0	6.7	6.8	4.9	0.7	0.8	6.3	1.6	9.1	5.1	0.8	0.7	5.9	4.2	8.2	2.8	9.4	0.9	4.0	16.0	6.7	6.7	4.6	3.7	4.3	12.3	8.7	0.6	5.7	6.9	3.2	1.0	5.0	7.1	4.5	4.9	10.1	7.0	0.7	38.2	8.9	28.8	8.6	17.9	23.4	11.4	13.0	17.0	25.1	27.4	11.3	12.9	0.0	10.3	28.7	10.9	14.1	7.9	24.0	35.1	7.9	4.4	2.4	13.4	5.2	14.9	6.1	4.9	17.6	17.0	15.0	18.5	16.8	19.6	5.7	6.2	13.0	32.2	28.7	3.7	1.4	14.3	17.3	8.1	5.7	33.9	12.6	16.9	22.8	5.0	8.7	17.4	14.9	17.5	27.5	13.3	10.7	10.5	13.8	6.2	23.2	15.0	3.0	2.3	0.0	5.0	11.8	8.2	0.4	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.2	0.4	0.4	0.1	0.3	0.1	0.2	0.7	0.3	0.4	0.1	0.8	0.7	0.6	1.3	0.7	0.8	0.8	0.7	0.9	0.6	1.0	0.7	33.9	54.5	27.8	5.5	24.2	15.6	20.4	20.6	17.1	14.7	25.5	16.8	15.5	17.2	33.5	18.4	8.4	7.1	16.3	126.7	21.5	31.2	3.2	62.0	46.7	28.6	18.1	6.7	18.0	36.9	60.2	23.2	40.2	61.7	22.2	20.9	29.6	1.2	54.1	10.1	14.9	43.2	18.3	51.8	32.8	2.9	19.6	50.0	23.2	16.9	44.7	12.7	11.3	14.6	20.8	67.6	51.2	18.0	9.7	14.3	54.4	24.9	55.2	33.9	52.6	27.2	26.5	6.2	2.4	24.8	14.9	6.2	23.9	41.8	59.1	33.8
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730400-127774292	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Spermatogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	272	"testis: 47.3"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 198.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.2	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 12.6;monocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.3;MCF7: 30.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	18.9	5.0	4.1	3.3	4.1	2.5	17.7	3.3	5.7	8.3	4.6	8.8	2.4	6.3	37.7	6.1	9.8	5.7	8.3	4.0	4.1	11.1	20.4	19.0	4.7	4.2	5.6	9.2	8.0	9.2	9.9	6.4	3.9	7.1	5.0	0.6	5.1	8.0	3.1	12.3	7.7	5.8	3.6	8.6	19.3	12.2	3.9	2.3	9.4	3.7	2.8	7.4	9.5	4.0	2.6	0.5	3.1	1.5	53.3	10.8	0.8	0.5	3.9	1.2	1.0	1.8	1.8	1.1	1.6	2.4	0.6	9.3	3.0	1.5	0.7	0.4	1.4	1.5	2.8	1.9	6.7	1.4	5.8	5.5	6.6	0.3	1.4	1.1	7.0	0.3	0.8	1.4	0.3	30.8	0.3	8.1	3.4	12.2	1.4	8.6	0.6	0.9	1.5	0.9	2.7	1.7	0.6	9.6	3.0	4.1	3.9	5.5	0.0	1.5	2.8	3.3	0.1	2.4	2.4	0.3	2.5	5.7	1.2	9.5	10.7	12.6	2.1	8.8	1.3	0.6	0.6	2.1	7.4	0.7	0.2	0.6	0.9	2.5	11.1	1.0	0.2	3.4	4.1	4.1	3.3	5.7	4.0	4.1	4.2	5.6	3.9	3.6	3.9	4.0	47.3	19.2	51.8	6.5	5.5	11.7	12.6	9.0	8.0	0.9	4.4	11.3	4.6	34.3	10.1	3.7	0.0	27.2	20.7	4.2	0.0	4.3	0.6	5.1	12.1	42.4	4.2	0.4	2.6	7.3	13.0	20.3	16.8	7.9	25.4	1.8	106.1	30.6	33.2	1.7	2.6	23.7	6.1	31.7	39.8	3.2	19.0	21.3	23.2	1.9	44.6	2.0	35.0	0.5	1.6	3.1	42.3	14.3	7.9	3.4	2.5	3.6	6.6	1.0	6.6	3.4	15.7	1.7	2.9	5.5	7.7	8.8	13.0	5.2	10.7	7.0
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925353-42958893	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 98.7;skin 1: 79.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	6.9	3.6	24.1	2.5	26.1	41.6	7.8	33.7	27.7	28.6	43.6	6.1	0.4	5.1	1.4	54.1	8.2	1.7	10.0	20.6	28.5	14.2	1.7	3.3	1.0	31.9	29.3	5.5	2.1	4.5	4.8	98.7	34.5	6.0	1.0	24.6	17.6	5.1	2.0	79.8	4.6	0.4	24.7	7.5	8.4	2.1	41.2	1.0	3.0	1.5	2.1	19.3	54.2	29.4	60.5	52.9	66.3	6.2	3.5	1.2	241.0	47.8	36.9	15.5	27.8	219.9	96.3	22.2	138.9	6.0	26.5	43.6	12.5	52.3	14.8	16.4	10.3	29.8	20.9	157.4	12.9	16.8	8.1	3.3	21.3	18.3	20.5	96.7	2.9	12.8	81.2	1.5	11.7	46.6	7.4	11.7	35.1	22.1	17.9	8.4	20.6	23.3	21.7	17.9	27.0	23.8	47.7	95.6	11.0	70.0	3.8	16.9	14.9	25.6	28.6	6.1	83.8	5.3	6.5	11.5	57.1	8.2	25.5	0.5	0.1	1.2	10.6	0.3	8.5	10.9	5.1	6.7	3.7	8.3	3.8	4.8	0.2	4.3	0.1	18.4	6.2	4.0	24.1	26.1	33.7	27.7	20.6	28.5	31.9	29.3	34.5	24.7	41.2	29.4	3.1	0.0	1.8	12.7	25.4	286.1	48.8	286.3	66.0	15.8	41.4	21.8	26.7	20.0	159.3	27.6	66.7	833.8	33.5	53.1	5.9	53.2	4.0	112.1	46.0	100.5	18.4	520.4	2.8	11.7	536.4	25.9	11.7	118.9	6.3	6.8	2.2	2.1	84.8	5.0	3.2	22.4	65.1	1.6	34.2	0.3	7.8	5.0	21.4	71.2	36.0	350.1	18.6	8.0	9.9	120.3	51.9	14.7	11.6	31.2	1.9	2.2	118.1	32.1	0.0	9.8	32.1	0.1	2.4	99.1	238.3	2482.5	20.8	5.5	11.8	105.8
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133987581-134052624	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 14.5;Syncytiotrophoblasts: 36.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;hTERT-RPE1: 14.8;SuSa: 21.7;U-2 OS: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.5	1.0	3.6	0.3	4.8	0.0	1.1	7.8	4.6	3.0	87.3	2.1	7.3	8.2	2.1	6.1	2.8	2.6	10.7	5.7	2.6	5.8	6.8	3.1	0.1	2.3	3.1	1.2	1.1	2.3	1.4	1.6	2.5	22.4	1.0	2.3	5.1	9.3	3.8	2.7	9.8	3.1	1.6	0.1	14.3	0.4	3.4	1.0	0.2	4.1	1.2	3.5	1.2	3.1	2.5	0.9	2.3	0.0	1.4	0.7	0.1	1.5	5.4	0.7	2.9	0.0	7.6	0.3	1.2	0.1	5.7	5.9	0.0	0.5	1.0	0.0	5.3	0.0	0.8	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	14.8	0.4	0.4	0.5	0.8	0.1	0.8	0.1	0.1	2.0	0.0	0.5	0.0	1.0	2.2	1.6	0.8	0.2	0.7	0.1	2.1	0.0	21.7	0.1	0.0	0.1	0.2	7.6	0.2	0.9	3.2	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	4.8	7.8	4.6	5.7	2.6	2.3	3.1	2.5	1.6	3.4	3.1	0.2	0.0	7.7	24.8	0.1	2.0	1.0	3.3	8.6	0.4	0.5	2.2	6.3	0.0	2.2	0.0	0.0	2.0	0.1	1.2	3.9	1.5	0.1	3.4	0.4	2.3	4.2	0.0	8.0	0.2	0.6	2.2	2.6	1.6	0.0	0.4	0.0	1.1	0.3	0.0	3.2	0.2	6.1	0.0	0.3	0.0	0.0	0.1	0.0	4.7	0.1	9.8	0.0	4.5	14.5	1.1	2.4	1.5	1.6	10.5	0.5	0.5	10.4	0.5	0.0	2.1	1.3	0.0	0.0	8.6	1.8	36.7	0.2	3.5	0.4	1.3
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035106-9088478	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 97.3;intestine: 109.1;skeletal muscle: 78.8;testis: 76.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Paneth cells: 55.6;Plasma cells: 35.3;Proximal enterocytes: 189.4;Spermatocytes: 83.2"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 23.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 23.3"	"Group enriched"	"Detected in some"	5	"Daudi: 190.3;THP-1: 47.8;U-266/70: 154.0;U-698: 178.2;U-937: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	7.7	3.4	9.2	5.4	9.2	97.3	5.1	10.5	11.8	2.6	10.1	4.8	109.1	1.3	10.5	3.9	2.6	1.1	2.3	10.3	12.0	38.4	0.6	1.2	20.4	24.1	14.5	2.8	0.6	1.5	2.9	4.9	20.4	15.1	3.6	2.7	2.4	5.1	78.8	6.9	85.3	4.4	14.3	5.6	0.9	76.4	16.1	1.7	0.8	65.9	18.3	3.0	4.2	19.6	0.3	0.1	0.0	0.2	0.2	1.2	0.5	0.2	0.7	0.0	0.6	1.3	0.0	190.3	0.2	0.4	0.1	0.4	1.7	0.1	0.4	25.1	0.2	0.2	3.4	0.0	0.3	3.0	1.6	2.7	2.6	0.6	0.0	2.9	0.0	0.1	0.3	2.0	0.0	0.0	0.1	10.0	0.2	0.0	0.2	4.9	0.0	5.9	0.2	2.0	0.6	0.3	0.3	0.5	0.7	0.1	0.3	47.8	0.2	3.0	0.9	0.5	0.2	154.0	0.2	178.2	0.2	68.2	0.2	4.8	2.5	0.2	0.2	0.5	0.2	4.3	0.2	0.2	0.9	23.3	0.2	0.2	1.4	0.3	0.1	0.2	0.1	1.2	9.2	9.2	10.5	11.8	10.3	12.0	24.1	14.5	20.4	14.3	16.1	19.6	0.3	0.0	0.0	2.0	5.2	2.0	2.0	0.2	10.2	0.0	0.1	0.4	1.9	0.0	0.0	1.8	0.0	0.1	0.0	1.4	7.9	0.3	64.3	0.1	0.3	4.9	1.2	0.0	1.0	0.0	1.1	0.8	0.0	0.4	1.3	0.1	0.4	0.1	4.3	0.0	1.2	7.6	0.0	0.8	1.2	19.3	2.8	2.7	0.0	31.9	0.6	0.6	0.0	2.5	0.9	0.6	55.6	0.4	35.3	2.1	189.4	24.2	0.0	0.1	6.6	2.1	0.4	83.2	8.2	2.7	0.6	0.5	0.3	0.3	8.0	0.2
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	10.3	8.9	4.0	8.5	4.8	4.2	10.1	5.2	4.8	10.1	5.1	10.0	8.6	9.2	7.5	8.8	8.0	9.0	7.6	4.0	4.5	11.7	11.2	8.4	9.8	5.0	4.4	9.0	10.4	11.3	4.3	12.1	4.9	8.8	10.0	6.0	7.7	7.8	7.8	8.0	8.4	9.4	4.8	7.8	9.2	6.2	4.4	9.4	11.8	7.6	10.3	9.9	5.6	6.2	27.7	20.3	20.5	18.0	25.4	22.6	22.7	25.3	25.0	20.4	18.5	15.8	25.4	13.1	16.4	20.4	23.4	17.0	24.7	17.4	25.8	26.6	13.7	28.6	10.9	20.3	16.3	30.4	16.9	17.0	26.7	27.4	21.8	20.7	16.6	9.2	24.6	17.2	23.6	10.2	16.1	13.9	31.0	30.8	10.6	14.2	24.7	19.3	22.5	23.9	15.3	23.3	19.9	21.2	20.4	19.0	11.7	13.6	14.3	25.9	14.3	17.2	30.3	23.1	43.5	19.2	23.0	23.4	26.6	12.8	2.4	1.9	2.5	2.0	3.5	3.0	2.3	2.8	2.9	2.7	3.4	3.2	2.4	7.0	2.3	2.0	4.6	2.0	4.0	4.8	5.2	4.8	4.0	4.5	5.0	4.4	4.9	4.8	4.4	6.2	8.6	9.6	9.9	19.9	14.9	9.1	5.3	14.9	13.6	4.5	9.0	5.7	4.1	8.6	8.3	7.3	6.2	19.8	8.4	9.5	5.9	7.5	2.8	7.4	10.1	10.9	3.6	13.2	29.2	8.7	14.7	9.5	11.7	10.5	3.8	12.9	11.4	15.3	10.7	1.7	31.0	7.9	14.2	8.8	9.3	1.0	6.5	6.6	8.8	10.3	7.7	7.5	12.3	27.2	37.2	9.8	7.0	7.9	20.0	8.7	9.1	8.3	10.0	7.1	13.1	7.3	7.3	12.3	9.4	13.6	6.3	27.5	9.5	9.0	9.0	5.2
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572415	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: AB_2684713"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	10.7	9.8	5.9	5.6	4.8	8.0	9.6	3.7	6.6	9.6	6.3	9.2	6.6	8.5	5.9	11.5	7.4	6.1	10.1	5.6	4.7	7.8	11.4	9.1	7.1	4.8	5.9	8.8	22.3	15.2	11.2	7.2	5.0	11.7	6.1	7.4	15.4	10.0	20.5	11.9	7.7	6.8	3.6	6.7	15.3	4.1	9.1	8.5	9.2	14.0	8.1	10.1	8.7	4.5	26.2	10.4	6.9	16.2	25.2	19.8	16.4	17.8	20.3	15.1	18.2	11.8	18.7	13.6	30.2	29.3	14.9	17.6	19.7	21.5	15.2	15.8	29.5	11.9	11.6	14.4	21.1	19.6	14.5	16.5	24.2	17.0	24.5	19.2	14.8	16.0	19.9	17.3	19.4	25.3	15.3	9.3	8.1	24.8	34.6	14.9	10.6	16.6	15.7	16.1	11.9	11.9	12.3	19.6	11.5	8.3	14.7	9.9	15.3	19.5	9.6	26.9	21.2	23.6	26.9	15.1	29.3	21.4	12.6	1.8	1.3	3.2	1.3	0.9	1.8	2.2	1.4	1.3	1.0	0.8	1.0	0.8	1.3	1.8	2.0	1.1	1.8	1.1	5.9	4.8	3.7	6.6	5.6	4.7	4.8	5.9	5.0	3.6	9.1	4.5	21.7	38.5	42.5	6.8	14.9	21.9	15.3	22.1	5.7	28.8	34.1	21.5	16.1	22.8	31.3	29.5	35.5	14.4	43.3	25.2	0.0	20.4	3.6	26.6	20.1	20.2	18.5	13.7	13.9	36.8	29.8	14.8	13.3	50.8	8.2	21.2	22.9	26.9	17.4	30.3	13.9	29.7	8.2	21.1	28.0	4.2	17.1	23.3	8.8	10.3	22.8	19.4	17.5	9.0	6.2	41.7	13.1	21.1	29.3	30.9	22.1	7.0	24.0	29.4	6.6	30.1	14.3	10.2	14.3	13.6	25.9	32.6	29.4	16.2	20.4	28.4
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81244811-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		70000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	37.6	37.0	12.7	23.4	14.0	30.8	31.2	12.7	16.1	33.0	14.7	31.7	31.8	35.3	17.3	24.0	31.7	25.8	36.8	10.5	13.8	31.6	75.2	31.4	21.4	21.5	14.9	37.7	91.4	15.6	62.1	24.6	15.7	34.2	9.5	4.4	51.1	20.8	20.0	25.2	34.7	15.4	13.3	43.8	38.8	30.5	16.6	12.9	41.3	6.3	10.6	37.6	26.8	19.4	45.2	77.5	13.3	70.2	49.8	23.3	77.6	53.7	48.2	32.5	38.2	36.1	73.0	34.4	59.2	37.3	36.0	53.0	13.5	27.1	12.0	34.7	40.0	34.6	28.5	61.2	44.4	34.1	78.4	40.7	19.7	29.2	18.9	26.2	62.2	24.5	26.3	51.3	24.6	56.5	21.0	59.4	12.9	41.3	37.6	33.8	27.8	34.8	22.2	42.3	25.7	65.7	43.2	26.9	59.2	18.3	38.1	70.0	61.9	52.2	29.9	38.9	29.4	44.6	21.4	20.0	30.9	51.8	54.5	12.7	10.6	18.6	7.4	11.9	8.7	6.2	7.1	9.1	6.2	7.0	4.8	5.4	8.0	4.6	15.9	9.8	5.6	9.5	12.7	14.0	12.7	16.1	10.5	13.8	21.5	14.9	15.7	13.3	16.6	19.4	24.4	25.6	35.6	25.8	28.6	8.3	12.3	21.9	13.6	10.9	25.3	18.0	19.3	31.5	24.6	11.0	18.8	61.0	29.8	66.4	5.9	31.9	25.4	17.3	13.7	22.4	45.0	22.3	12.3	26.9	62.4	35.9	44.9	32.8	15.2	64.6	27.5	79.2	49.3	25.2	14.3	58.8	12.2	40.6	15.1	75.6	32.9	35.7	14.2	28.1	29.1	27.7	23.7	9.0	20.5	25.1	53.1	27.4	96.5	16.0	59.1	23.9	21.4	9.1	32.9	17.0	21.2	19.7	22.8	11.8	7.2	62.5	25.0	39.9	48.2	11.4
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879050-58933679	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	31.2	21.5	27.3	31.5	30.6	57.7	29.5	35.6	34.6	29.9	26.3	30.0	30.0	27.6	20.8	38.5	27.8	23.8	28.4	25.6	28.6	33.6	34.9	28.2	42.7	28.3	29.1	29.6	24.9	36.1	28.4	21.0	28.6	29.2	32.1	44.9	30.6	24.2	46.1	35.1	33.4	25.8	27.5	38.1	38.9	27.8	28.7	57.3	34.1	43.6	44.1	33.8	31.3	31.3	77.8	84.1	72.0	36.6	48.1	36.2	60.6	55.1	64.3	49.9	48.2	58.4	45.7	144.6	50.5	50.8	54.4	67.9	72.3	62.9	68.7	93.7	46.4	105.4	91.8	44.7	42.0	83.8	78.1	34.1	61.0	52.8	44.1	30.4	46.9	66.0	95.5	81.7	58.2	56.1	84.1	64.6	80.9	46.3	40.5	63.6	65.4	70.1	60.2	99.8	58.9	50.8	57.0	55.1	57.8	79.3	44.0	90.1	48.6	60.2	88.5	66.3	74.6	57.3	123.1	105.5	47.6	101.7	61.5	67.9	30.3	44.4	45.2	29.5	46.1	53.5	36.0	39.3	31.2	47.3	39.2	35.6	42.8	47.0	37.7	53.6	36.5	22.7	27.3	30.6	35.6	34.6	25.6	28.6	28.3	29.1	28.6	27.5	28.7	31.3	92.5	153.8	161.2	61.4	125.8	96.9	100.2	85.6	107.0	116.3	77.3	66.0	107.8	64.3	122.8	106.7	98.0	73.5	155.9	88.4	78.2	98.4	100.8	110.5	99.0	94.7	73.4	115.7	67.7	115.7	160.1	94.3	99.4	119.1	118.9	75.3	63.9	104.1	63.9	119.5	67.3	94.4	59.0	88.6	73.0	120.8	86.3	108.8	78.2	72.1	121.0	84.9	126.7	74.4	141.8	131.1	76.5	88.4	140.0	92.4	57.4	90.6	103.9	145.3	72.3	106.6	95.6	215.1	85.2	100.0	104.6	112.5	134.9	78.0	94.0	125.6
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585269-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA		31000	"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	12.2	8.1	19.6	18.6	21.1	21.2	23.5	16.2	19.6	19.3	17.0	23.0	14.7	18.3	15.6	20.1	13.1	11.8	9.4	15.9	17.7	20.0	13.8	13.1	22.2	18.3	19.8	17.8	19.5	14.3	8.3	22.2	18.8	22.4	21.9	9.6	17.0	17.1	19.0	24.1	16.9	16.3	19.7	16.3	16.9	16.7	18.9	34.8	17.7	10.3	30.3	21.0	15.9	20.9	45.1	23.4	95.7	74.9	21.0	35.7	64.3	35.1	32.7	44.5	45.1	42.3	46.6	104.3	27.7	44.4	25.8	37.7	91.2	54.3	64.6	50.3	54.1	102.4	38.4	57.7	31.4	94.8	45.3	30.1	47.0	50.1	55.2	33.1	52.8	68.7	87.5	34.4	48.4	33.4	124.4	48.9	126.8	43.2	35.4	55.1	55.5	92.0	47.2	58.0	42.6	85.5	54.5	52.7	38.9	66.5	45.8	87.1	42.7	29.6	41.7	33.9	58.0	41.9	57.1	122.0	21.6	88.1	42.5	1.9	1.6	1.7	2.7	2.6	2.4	3.9	3.0	3.7	2.1	2.6	2.8	3.3	1.9	2.0	1.9	2.2	3.1	1.9	19.6	21.1	16.2	19.6	15.9	17.7	18.3	19.8	18.8	19.7	18.9	20.9	30.4	41.7	45.9	56.5	61.7	53.0	60.5	37.4	71.7	29.3	60.3	45.5	31.5	34.3	58.9	57.0	37.5	79.7	43.7	30.1	13.7	67.9	88.9	60.2	72.3	38.3	91.6	76.9	47.3	46.7	113.0	32.7	49.5	115.7	24.6	103.8	22.1	37.8	30.2	20.2	52.2	64.5	34.6	32.3	36.9	113.1	25.4	41.6	23.2	42.2	57.7	18.9	52.5	98.0	104.9	58.8	29.0	28.6	65.3	83.7	24.1	38.0	34.0	33.0	39.5	44.7	60.1	59.4	108.3	86.0	66.8	72.5	52.4	77.6	61.8	62.4
SMARCC2	"BAF170, CRACC2, Rsc8"	ENSG00000139613	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2"	Q8TAQ2	12	56162359-56189567	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004321, HPA021213, HPA061788"	Supported		Enhanced	Nucleoplasm		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	36.6	33.5	48.1	23.8	52.1	23.5	38.5	48.7	56.3	43.8	19.9	39.3	27.7	42.9	22.8	30.5	40.8	23.3	26.4	49.6	50.9	31.6	19.8	29.7	29.5	44.2	43.8	51.9	32.6	35.5	32.4	25.3	40.2	34.8	23.4	39.2	37.2	33.5	46.7	36.5	34.5	28.4	40.2	31.9	33.0	32.8	49.1	39.0	49.8	30.5	28.7	39.1	37.4	51.6	49.3	74.9	77.2	56.4	47.2	48.9	32.4	42.6	45.3	50.3	48.4	43.5	59.5	71.4	40.0	50.0	47.7	54.8	49.9	42.9	45.1	54.3	47.6	112.2	51.6	27.8	25.6	53.4	79.8	46.4	31.5	47.6	23.7	91.3	65.4	54.7	65.5	57.2	48.1	52.1	90.4	56.0	26.4	39.0	50.4	53.5	62.0	55.0	38.6	63.4	56.6	59.0	72.8	49.4	20.6	40.3	84.3	49.3	56.1	42.5	51.7	38.4	31.8	54.8	41.9	48.4	44.3	35.5	46.9	15.4	8.5	21.0	11.4	10.2	12.3	8.6	8.2	8.6	7.3	9.4	6.0	7.6	7.9	8.3	13.9	6.0	8.6	11.6	48.1	52.1	48.7	56.3	49.6	50.9	44.2	43.8	40.2	40.2	49.1	51.6	40.8	67.3	43.5	40.1	40.9	20.5	43.2	24.5	62.6	59.3	26.6	28.8	25.7	34.3	40.6	42.3	39.6	20.4	39.0	17.9	7.9	25.4	1.6	24.3	42.8	38.5	22.7	51.9	39.5	18.0	11.9	40.2	33.6	36.3	65.1	56.3	33.9	17.3	16.6	38.7	37.5	22.3	32.6	20.6	20.7	7.8	69.0	29.3	19.6	23.4	36.0	42.3	70.0	33.2	23.4	22.7	17.1	55.3	44.6	32.2	19.8	17.3	25.0	66.0	19.7	47.9	42.3	45.5	31.7	55.9	22.6	13.3	49.9	36.6	21.4	37.7
SMARCD2	"BAF60B, CRACD2, PRO2451, Rsc6p"	ENSG00000108604	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2"	Q92925	17	63832081-63843065	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059934, HPA061348"			Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA059934: AB_2684170, HPA061348: AB_2684486"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.79e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.75e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.80e-2)"	53.8	55.2	23.3	44.6	28.1	71.6	65.9	35.5	28.5	48.0	29.1	49.9	51.1	37.4	58.5	71.3	52.9	33.1	31.2	22.9	23.2	26.4	54.9	46.7	66.0	27.7	26.7	38.3	89.5	42.8	36.7	47.8	27.0	52.7	46.6	17.6	78.0	49.0	25.3	97.0	49.8	32.4	25.5	60.6	68.2	42.7	25.6	70.2	33.8	34.2	70.1	52.3	55.9	31.7	142.9	87.9	21.3	93.0	133.6	196.1	139.7	52.5	64.1	97.5	61.7	101.7	76.8	163.0	32.5	79.0	43.9	99.4	65.7	99.1	57.3	61.1	169.5	109.3	40.3	141.7	102.3	159.5	128.9	154.3	122.0	55.3	42.1	56.4	78.3	110.8	89.5	101.7	57.2	279.1	203.8	132.3	51.3	202.0	96.9	195.0	77.8	185.0	66.9	96.0	80.2	145.9	79.2	228.4	97.1	69.3	212.2	121.7	58.4	67.7	52.5	61.4	90.7	119.8	113.2	113.5	54.1	129.6	50.4	4.2	9.1	8.8	9.4	8.4	5.6	7.2	9.9	9.8	12.1	9.5	6.3	8.5	10.8	8.0	10.0	10.1	11.5	6.0	23.3	28.1	35.5	28.5	22.9	23.2	27.7	26.7	27.0	25.5	25.6	31.7	14.8	28.9	42.4	19.9	18.2	22.9	23.6	14.3	26.2	9.7	47.1	41.0	5.9	30.0	25.2	16.5	6.2	54.9	21.1	36.0	3.9	16.9	1.0	17.6	25.3	17.4	33.0	12.6	7.2	19.6	38.2	25.8	18.8	20.7	14.0	88.1	25.7	83.3	22.0	11.8	5.8	42.0	12.2	36.9	19.6	5.4	49.4	23.1	14.2	8.4	31.9	16.9	15.5	6.6	10.7	21.0	26.2	30.9	12.6	19.0	30.0	11.6	23.8	12.4	32.9	21.9	14.6	12.3	22.4	29.7	31.1	52.9	16.7	101.7	40.8	24.1
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Metabolic proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 126.4;skeletal muscle: 129.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.5;Peritubular cells: 88.4;Sertoli cells: 65.7"	"Cancer enhanced"	"Detected in all"		"glioma: 28.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.6;granulocytes: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	20.7	40.3	104.0	5.0	101.9	7.1	22.1	70.7	126.4	25.0	59.8	25.2	3.0	22.8	14.7	8.4	30.6	14.6	78.9	105.3	90.4	18.8	2.8	18.8	4.6	79.5	89.8	37.6	14.3	27.2	42.2	5.7	83.2	27.7	3.8	10.0	14.3	23.2	129.0	11.5	11.0	13.4	72.4	9.2	18.3	17.4	99.9	1.9	18.1	69.4	2.5	22.7	18.2	84.8	0.8	6.1	19.6	69.3	30.0	13.3	1.6	13.3	13.0	7.5	4.3	4.5	4.2	7.7	4.7	20.4	3.0	1.3	15.7	1.3	3.0	2.4	10.2	0.0	4.5	1.4	25.9	0.4	12.5	31.8	1.8	2.4	0.2	32.7	1.5	19.5	16.4	2.5	39.5	8.3	1.3	10.3	6.1	2.0	2.5	0.5	31.7	0.3	6.6	0.0	11.2	22.6	12.4	2.1	9.5	3.1	2.0	19.7	2.6	6.1	7.7	15.7	4.9	16.1	0.0	6.5	14.2	17.6	21.6	0.4	5.5	0.0	0.1	1.3	0.1	0.1	0.5	0.0	1.6	0.0	0.3	0.5	1.9	0.0	0.2	0.0	0.4	1.3	104.0	101.9	70.7	126.4	105.3	90.4	79.5	89.8	83.2	72.4	99.9	84.8	7.5	6.4	21.7	33.6	0.7	10.7	38.3	3.1	47.8	15.2	28.5	29.6	67.5	21.5	4.6	11.0	4.2	0.4	1.2	0.2	31.3	24.8	2.5	3.9	24.4	5.2	3.5	1.3	16.7	2.6	0.5	28.0	1.5	3.4	2.5	44.3	2.9	0.5	3.6	11.8	23.9	0.3	0.0	17.0	5.7	14.0	50.7	16.0	7.2	8.4	19.7	23.7	0.0	16.1	7.4	2.8	0.1	88.4	0.1	14.6	0.0	2.1	4.7	5.7	65.7	40.9	56.9	1.7	20.0	1.5	4.7	1.1	4.7	22.8	0.2	9.0
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm		NA	NA		33000	"Cluster 27: Non-specific - Gene expression"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	16.6	11.8	8.7	28.4	11.7	30.3	17.2	15.0	9.5	13.8	9.6	20.0	18.6	21.0	8.0	17.1	16.7	11.5	15.6	7.8	9.5	16.3	18.8	16.0	34.4	10.2	10.7	19.1	14.4	25.8	6.3	18.2	10.7	14.0	18.4	21.0	15.1	13.0	17.9	18.1	15.9	22.9	8.7	20.1	15.7	7.8	11.3	58.1	16.8	18.8	29.9	15.5	12.4	13.9	110.0	115.1	92.4	76.1	32.4	35.4	51.5	68.0	37.0	76.4	59.4	71.6	60.5	115.8	54.1	40.7	105.2	78.9	162.9	92.6	85.1	91.7	176.0	94.3	133.9	51.1	15.4	134.9	120.9	20.6	23.3	86.0	52.8	19.4	67.5	68.7	144.7	64.7	58.6	69.2	122.0	40.8	139.9	47.8	55.6	117.2	165.5	100.1	34.4	69.4	92.8	83.5	176.9	84.4	33.5	122.8	87.9	54.0	45.7	63.3	68.0	65.1	62.2	45.8	77.9	91.9	39.1	152.1	64.1	2.7	6.8	4.5	7.3	8.5	7.6	5.4	5.8	6.7	8.4	5.8	5.2	6.3	2.7	4.6	12.4	4.6	5.7	6.7	8.7	11.7	15.0	9.5	7.8	9.5	10.2	10.7	10.7	8.7	11.3	13.9	40.7	44.8	39.9	16.0	45.6	24.1	37.0	27.7	28.5	46.6	30.7	27.4	63.5	27.1	47.4	20.2	27.1	43.2	57.7	49.6	7.9	31.6	10.5	46.5	62.6	41.7	19.9	70.7	12.0	27.1	61.4	37.2	29.0	44.0	35.4	42.7	18.9	54.1	47.6	60.6	14.2	43.5	22.4	41.1	27.6	7.6	37.9	51.5	23.2	24.4	55.2	38.1	59.8	16.6	30.2	33.1	23.6	36.1	61.2	40.7	29.0	24.6	47.1	48.4	39.5	49.5	71.0	54.5	51.2	39.8	24.4	48.4	47.9	34.0	51.4	32.0
SMCR8	"DENND8A, FLJ34716"	ENSG00000176994	"SMCR8-C9orf72 complex subunit"	Q8TEV9	17	18315293-18328056	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021557, HPA024646"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA021557: AB_1857283, HPA024646: AB_1857284"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.11e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.09e-3)"	"unprognostic (7.11e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.41e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.27e-2)"	5.2	5.0	1.7	5.0	1.9	12.5	5.0	2.2	1.9	4.7	2.6	5.8	3.3	5.3	2.6	5.3	4.8	2.7	4.5	1.8	2.4	4.6	4.0	5.5	5.7	2.0	1.8	4.9	5.1	5.8	5.3	2.9	1.9	4.8	3.7	2.7	6.4	3.0	6.4	5.8	7.2	3.0	1.6	8.4	6.2	4.9	2.2	5.4	4.7	3.5	5.6	5.3	3.9	2.3	7.0	9.6	4.7	5.5	6.5	4.3	8.6	4.9	6.6	8.5	8.1	14.8	2.9	4.1	3.6	6.1	9.6	9.1	9.4	5.8	7.8	8.4	7.9	7.7	10.0	4.2	7.0	3.0	18.1	5.5	7.3	9.8	6.1	5.6	6.1	5.9	6.5	3.8	5.1	4.3	5.1	4.4	4.5	9.0	4.0	5.6	12.1	6.5	3.9	7.9	2.5	5.8	5.6	7.1	10.5	24.7	14.4	6.1	6.1	4.8	5.8	12.8	6.6	5.7	7.0	2.1	6.7	4.7	5.0	2.5	0.5	0.4	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.7	0.3	0.2	0.3	1.7	1.9	2.2	1.9	1.8	2.4	2.0	1.8	1.9	1.6	2.2	2.3	5.6	6.4	11.0	2.3	7.0	0.4	3.4	0.0	4.6	6.7	8.2	6.1	3.3	5.7	5.6	11.0	2.1	3.8	6.4	8.2	0.0	5.4	3.3	8.9	9.0	6.3	3.6	5.2	5.1	5.4	2.9	4.6	7.7	13.9	8.8	7.4	10.4	5.3	8.7	6.7	5.5	6.0	0.0	23.5	0.3	2.0	4.1	15.1	0.0	5.6	18.7	2.9	4.1	2.5	3.7	6.9	4.5	4.1	3.5	6.8	6.3	6.4	2.2	5.9	0.0	5.4	4.3	9.3	7.8	3.9	0.6	6.0	6.3	6.2	6.1	7.5
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304938	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	16.3	12.0	7.0	15.1	7.5	31.8	13.7	10.8	11.1	13.8	7.7	13.4	9.9	14.4	8.7	16.2	13.3	11.6	12.4	6.5	7.2	13.6	14.9	14.2	16.9	7.1	6.9	13.5	10.2	13.1	8.9	18.4	7.0	10.0	11.1	16.6	11.5	10.2	24.8	13.2	11.5	14.6	7.5	14.7	11.5	13.1	7.1	20.4	12.1	17.9	18.3	17.3	13.7	9.4	36.2	27.0	38.9	44.9	29.6	35.1	28.9	41.0	42.6	53.3	54.6	35.1	43.7	51.2	25.7	25.9	30.5	38.5	57.8	28.2	59.9	29.0	30.6	51.1	21.9	41.2	35.3	56.9	47.2	27.4	29.7	42.2	71.1	39.5	30.0	29.0	46.8	46.5	41.9	17.1	61.0	55.0	43.5	27.8	18.4	52.0	77.9	26.8	30.0	25.7	19.4	26.0	26.6	22.4	48.9	33.3	27.7	32.3	33.0	31.2	35.2	28.9	52.9	37.8	42.4	76.7	31.4	77.9	24.6	5.7	8.9	14.5	5.2	9.2	6.4	5.4	6.8	6.7	8.6	4.8	5.9	5.9	16.6	6.3	9.8	5.2	8.1	4.3	7.0	7.5	10.8	11.1	6.5	7.2	7.1	6.9	7.0	7.5	7.1	9.4	57.7	28.9	37.1	6.8	53.4	69.6	42.5	27.2	89.4	27.3	31.7	26.7	23.4	14.3	27.9	11.0	20.9	33.0	55.7	23.9	33.2	22.8	10.7	34.2	52.0	41.5	18.6	37.0	7.8	18.0	32.0	39.1	37.8	58.8	58.3	27.3	27.1	26.5	32.4	33.7	8.0	21.4	38.7	40.9	79.7	4.4	29.2	47.7	35.6	6.5	45.8	23.0	22.6	5.0	11.2	21.7	21.0	22.2	45.7	53.3	20.6	40.9	28.6	33.0	19.7	30.8	39.7	46.2	37.7	72.4	83.4	46.1	57.4	33.5	24.1	65.8
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762420-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 171.9;Spermatocytes: 215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 153.7;hTERT-HME1: 153.7;U-2 OS: 207.6;U-251 MG: 146.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	6.2	9.0	2.7	6.4	3.6	6.0	5.9	4.9	3.4	10.1	4.1	3.5	3.6	7.0	4.9	6.0	6.4	7.7	8.3	2.7	2.9	7.0	5.2	4.8	8.1	4.3	5.7	6.1	3.6	7.9	5.8	8.7	4.5	6.8	3.0	6.6	5.2	6.9	4.4	5.2	3.2	4.8	3.0	6.8	3.2	20.0	3.0	7.1	7.2	4.7	6.9	10.0	5.2	4.6	57.6	11.0	10.7	22.8	11.7	13.6	12.7	47.4	31.4	53.3	31.4	3.9	11.5	11.9	61.5	20.3	153.7	17.7	10.6	14.3	87.3	13.0	7.6	7.1	5.7	8.1	30.8	7.5	15.2	13.1	9.5	45.0	153.7	20.7	20.7	16.2	8.0	10.6	51.4	7.4	18.3	12.0	10.3	6.4	35.9	13.9	28.3	4.4	43.9	8.8	7.6	18.3	31.3	5.5	39.0	13.2	11.0	11.7	31.8	58.4	207.6	38.2	146.6	7.0	7.8	10.5	39.7	9.5	35.3	7.7	5.0	4.5	4.4	4.3	5.7	8.4	5.4	3.8	5.2	8.8	8.8	5.7	4.9	7.0	3.8	6.9	6.5	3.6	2.7	3.6	4.9	3.4	2.7	2.9	4.3	5.7	4.5	3.0	3.0	4.6	22.6	35.3	18.3	10.1	28.0	95.3	56.2	171.9	43.3	10.2	11.5	18.0	24.6	11.5	53.6	29.5	2.1	16.8	31.2	3.4	7.9	28.6	70.7	70.1	28.7	29.3	4.2	10.7	12.8	15.9	31.5	31.1	4.1	47.6	41.8	20.2	26.7	6.9	17.3	8.4	13.3	4.0	42.7	11.7	32.6	17.1	22.1	31.6	17.8	10.3	12.4	40.4	4.1	10.6	14.6	20.3	1.9	20.3	7.9	28.8	5.6	13.3	83.9	12.6	19.7	38.3	34.7	215.0	67.7	23.5	64.5	5.6	29.0	20.6	6.8	20.8
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652194-128092609	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1800000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	48.5	52.5	19.1	57.8	22.6	65.8	56.7	25.3	21.4	76.9	41.0	51.3	54.2	67.2	90.6	47.7	65.1	37.3	45.3	19.9	33.3	33.9	67.5	46.7	53.0	29.7	29.4	87.3	179.0	50.8	52.7	86.7	29.9	59.0	49.4	32.1	102.2	57.7	41.9	43.7	45.3	66.5	26.2	45.8	65.7	38.5	25.4	67.5	66.0	40.0	65.3	50.0	41.8	33.5	160.0	141.8	106.3	193.5	156.6	162.7	145.3	183.5	214.8	163.8	182.5	184.6	134.6	210.6	90.4	225.7	137.8	130.4	150.7	198.1	158.6	116.1	127.2	116.1	153.0	177.9	284.2	181.9	109.6	241.3	216.3	140.0	232.3	185.7	206.2	85.1	131.3	204.9	165.0	118.6	199.5	135.6	119.5	159.7	173.6	136.8	94.6	476.1	128.1	110.5	133.0	143.7	132.8	606.6	217.5	157.8	76.2	127.2	207.3	132.3	86.4	243.3	144.7	250.1	101.1	217.0	265.6	153.6	245.2	49.7	86.4	17.1	67.0	76.6	78.0	70.1	50.0	54.0	87.4	44.6	34.9	39.8	6.2	59.7	66.1	92.9	43.4	92.9	19.1	22.6	25.3	21.4	19.9	33.3	29.7	29.4	29.9	26.2	25.4	33.5	20.3	16.0	44.7	60.4	56.7	19.6	24.7	32.9	22.2	17.1	41.0	28.6	29.2	35.8	28.9	29.5	20.9	255.0	44.3	28.8	17.6	62.8	20.1	21.9	51.9	30.3	73.1	47.5	128.0	96.7	106.1	40.7	54.6	39.5	34.9	54.4	25.0	49.8	81.9	30.3	116.0	59.4	18.3	52.8	36.7	68.1	45.7	50.8	33.8	78.7	72.5	16.7	32.0	84.9	89.9	58.6	29.8	41.3	124.6	42.8	38.2	33.1	19.0	32.7	32.9	27.0	34.4	23.4	28.0	37.6	27.4	267.6	37.2	74.0	58.3	27.0
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		74000	"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	77.2	106.0	30.1	41.3	28.2	49.5	79.1	29.2	46.0	108.1	29.8	90.6	39.4	96.6	21.0	103.9	95.4	13.8	88.1	28.4	32.4	83.4	96.3	81.2	43.5	28.6	28.5	107.7	95.9	28.6	104.9	26.8	27.9	107.4	21.9	18.5	92.9	23.3	104.2	95.2	90.5	20.7	24.6	106.7	94.3	72.9	28.4	45.8	103.5	16.7	33.0	81.9	94.4	34.1	178.5	224.0	142.3	101.6	56.4	34.3	155.3	125.4	81.7	136.1	118.1	140.4	103.5	203.9	127.1	89.0	123.1	152.2	176.6	128.2	101.0	137.0	468.2	185.9	103.6	164.9	29.2	209.1	125.2	48.0	35.4	99.6	67.2	64.5	103.0	107.2	195.4	65.7	84.4	175.3	218.8	338.3	175.3	102.9	167.4	254.7	133.7	124.6	87.9	113.7	112.3	136.9	158.3	96.1	94.8	94.5	98.9	132.3	147.0	101.8	190.5	86.7	223.5	164.3	156.5	263.2	84.1	135.9	95.2	0.8	2.0	1.8	1.8	1.5	1.1	4.0	1.4	0.8	2.0	1.7	2.0	1.5	0.8	4.1	1.8	1.7	1.2	0.8	30.1	28.2	29.2	46.0	28.4	32.4	28.6	28.5	27.9	24.6	28.4	34.1	86.6	19.2	63.0	198.5	107.2	139.4	166.8	78.4	93.9	108.7	97.8	109.5	31.6	55.8	66.0	75.4	89.6	179.7	97.5	89.8	46.9	108.1	23.7	101.8	141.9	84.2	118.0	76.6	81.0	105.1	208.6	92.3	110.1	123.0	55.1	111.7	61.4	97.4	125.8	114.4	99.2	121.4	77.3	58.7	97.7	21.3	130.1	77.8	69.4	74.0	75.8	82.6	76.2	110.6	151.9	116.0	80.0	110.6	112.0	177.1	95.0	77.5	59.3	109.6	124.9	102.3	101.2	109.7	108.6	92.3	130.7	176.4	96.3	115.4	119.6	154.7
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.7	73.9	68.4	67.7	73.7	176.7	74.2	73.1	84.5	67.0	75.3	78.5	73.1	83.5	63.1	85.5	84.8	48.9	195.7	70.5	71.8	91.7	92.0	62.6	101.6	72.2	70.5	75.0	87.0	78.2	57.6	73.5	73.1	65.8	65.6	39.7	75.2	55.3	162.0	67.4	75.6	65.3	75.4	84.7	81.8	124.4	72.6	115.5	75.3	125.0	95.3	73.9	66.6	78.4	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	68.4	73.7	73.1	84.5	70.5	71.8	72.2	70.5	73.1	75.4	72.6	78.4	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	47.1	33.3	27.6	33.6	29.5	91.2	42.7	30.6	35.9	39.2	29.1	38.4	32.6	39.0	28.4	38.4	38.3	26.7	39.5	27.0	29.0	38.7	33.6	37.1	46.2	29.5	28.6	41.4	38.6	31.3	30.3	33.0	29.8	32.2	32.1	43.3	34.0	21.9	64.8	50.7	38.5	30.9	28.6	44.6	36.6	48.5	28.4	49.0	33.9	35.9	41.9	38.8	38.0	32.9	91.0	66.6	67.0	70.8	54.5	60.6	76.5	61.3	54.6	66.8	61.2	66.0	81.0	88.3	54.5	46.1	50.8	88.2	81.8	58.9	90.3	71.1	63.5	71.8	59.1	66.7	77.7	50.5	81.0	46.8	76.1	60.0	82.8	71.5	65.8	83.7	103.9	64.7	51.9	93.1	90.7	85.4	74.2	103.1	87.8	97.3	85.5	61.7	61.4	82.6	71.2	76.5	84.7	73.6	87.3	68.1	106.6	95.5	69.9	71.6	81.7	64.9	73.9	62.9	95.5	98.7	65.5	79.8	80.9	94.5	71.0	95.6	57.5	76.9	65.5	59.2	64.5	65.9	72.6	67.0	67.6	63.9	67.8	94.5	92.1	43.2	94.5	76.1	27.6	29.5	30.6	35.9	27.0	29.0	29.5	28.6	29.8	28.6	28.4	32.9	86.5	93.0	49.3	13.1	64.2	56.5	80.4	89.1	33.6	56.0	40.1	50.0	49.9	47.1	77.9	53.3	35.5	79.4	75.4	38.0	76.3	79.0	43.5	97.2	81.3	69.9	43.6	85.0	17.9	70.1	100.1	64.9	26.5	80.5	92.3	61.5	55.6	33.7	76.4	38.7	18.6	50.8	54.9	53.6	52.0	24.0	77.9	70.7	39.2	30.0	95.6	66.7	65.9	15.6	31.9	71.3	43.8	74.1	46.3	48.9	48.8	57.3	88.1	72.2	65.7	60.9	89.5	300.5	140.7	39.7	54.3	109.0	76.8	54.4	47.9	70.9
SNX1	"HsT17379, MGC8664, SNX1A, Vps5"	ENSG00000028528	"Sorting nexin 1"	Q13596	15	64094123-64146090	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 177.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA047373, HPA052761"	Approved		Enhanced	Endosomes,Lysosomes		NA	NA		6100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"		"HPA047373: AB_2680018, HPA052761: AB_2681939"	"unprognostic (3.99e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (9.88e-6)"	"unprognostic (2.27e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.95e-1)"	63.4	69.0	47.1	59.0	64.1	34.8	46.2	60.9	49.8	52.8	44.5	60.2	49.8	47.6	67.7	60.6	37.5	42.9	50.4	46.2	51.4	56.8	69.3	54.7	67.1	67.5	63.6	39.0	44.3	72.1	32.0	57.8	66.4	51.9	47.6	27.0	55.4	64.4	69.1	48.5	52.4	53.0	62.5	61.0	54.8	34.2	57.2	79.5	102.9	36.8	66.8	62.1	51.2	76.8	75.4	93.5	69.1	60.8	116.4	81.3	23.0	93.5	91.5	81.4	94.5	64.6	115.6	74.4	100.5	86.7	79.7	113.8	102.6	95.2	63.5	136.1	56.0	101.2	110.4	98.2	63.6	94.7	108.0	102.9	62.6	65.2	50.2	59.7	86.1	77.0	74.0	29.2	85.1	107.8	111.4	80.2	54.5	103.2	52.1	100.0	65.3	118.1	127.1	170.5	56.3	56.4	91.4	61.1	86.3	59.5	87.0	86.6	103.0	80.1	120.2	50.8	52.5	93.4	220.5	120.1	72.9	123.5	85.8	144.1	149.1	162.1	83.4	143.1	70.9	101.1	70.4	82.2	127.3	101.9	67.0	66.6	113.7	98.1	144.2	86.1	95.8	156.0	47.1	64.1	60.9	49.8	46.2	51.4	67.5	63.6	66.4	62.5	57.2	76.8	34.4	115.4	74.2	35.6	32.9	26.5	38.1	39.3	29.0	18.9	29.7	29.2	50.6	34.3	52.8	18.4	22.9	51.5	51.6	32.1	33.2	40.9	3.7	36.4	36.7	34.2	26.5	26.5	44.2	37.2	35.1	36.2	27.5	44.9	39.2	44.9	35.3	34.2	72.2	15.2	39.3	28.3	28.5	46.8	27.4	4.0	32.3	42.7	32.0	44.0	56.3	19.7	35.0	121.7	177.7	34.6	30.3	37.6	34.0	32.7	39.2	53.6	31.9	16.5	46.0	36.0	64.0	33.3	23.4	33.8	27.1	47.7	35.0	39.3	28.8	33.9
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377535	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Cytosol	"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	62.5	74.6	32.2	23.1	32.6	19.8	57.0	35.3	31.8	59.7	32.1	58.5	17.3	62.8	16.6	62.2	57.7	22.1	60.3	30.3	32.7	54.6	62.9	53.8	32.3	33.5	33.1	62.4	53.9	42.5	61.1	28.1	37.1	54.2	23.3	12.8	50.3	31.6	49.2	57.0	53.3	33.4	36.3	80.8	54.1	34.1	35.0	43.9	54.3	33.9	33.8	59.8	50.9	37.0	40.1	70.0	45.3	56.4	85.9	71.5	29.0	47.3	85.2	71.8	52.2	43.5	37.8	39.5	55.4	113.9	61.9	23.7	42.4	63.8	57.9	40.7	72.5	44.8	20.3	55.4	80.9	47.6	41.6	66.9	56.7	49.6	59.5	54.1	78.3	32.7	35.5	32.8	87.2	47.7	50.2	31.3	29.2	62.5	67.1	22.7	74.0	64.9	53.5	34.1	46.3	55.1	38.6	39.0	18.1	31.9	30.5	29.6	50.6	57.4	31.6	33.8	45.5	56.8	47.5	49.4	50.0	49.8	60.9	87.5	138.7	88.9	65.6	135.2	66.9	72.7	61.2	67.6	135.6	73.2	57.5	60.6	30.8	72.2	146.9	73.8	78.5	231.9	32.2	32.6	35.3	31.8	30.3	32.7	33.5	33.1	37.1	36.3	35.0	37.0	60.8	16.0	39.1	6.5	68.3	32.5	48.2	78.3	32.5	30.9	47.1	61.3	31.5	35.8	43.3	29.5	14.6	173.5	69.3	56.9	82.2	84.0	8.9	34.4	39.9	52.7	55.1	49.2	6.8	63.9	132.7	60.3	35.2	25.6	43.1	64.5	47.5	64.9	134.9	45.4	7.7	48.3	79.3	118.1	42.7	9.7	58.4	83.4	69.4	2.8	141.9	80.1	76.2	11.1	11.2	64.8	54.1	85.0	60.3	41.4	75.4	95.3	38.6	23.2	32.9	41.4	68.4	58.0	53.2	55.0	34.4	99.6	63.2	102.1	60.0	34.9
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 165.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	14.6	165.3	4.2	18.1	5.7	17.5	8.2	5.5	6.6	13.7	9.0	13.0	12.2	11.7	6.6	4.8	17.9	20.5	5.4	3.3	6.8	12.7	14.1	20.9	15.1	10.1	6.1	10.7	27.0	13.4	6.3	19.1	8.0	27.7	14.8	10.3	39.4	9.3	4.0	5.7	12.7	16.5	8.0	15.1	16.3	11.0	6.7	8.1	9.2	3.7	13.1	11.7	4.5	12.8	74.6	34.1	27.7	41.0	104.7	56.6	147.3	35.1	61.7	76.2	88.3	35.2	82.6	42.0	53.9	64.4	92.6	26.8	88.6	20.9	81.8	48.0	18.2	19.5	26.7	36.9	42.9	33.5	7.5	45.4	13.3	89.2	75.8	32.1	33.3	50.5	42.7	21.0	120.0	15.9	35.9	10.8	13.4	11.8	11.2	44.4	35.8	24.4	66.1	45.9	8.4	21.5	54.3	22.9	20.1	32.3	24.0	22.8	31.9	89.8	43.1	99.5	78.2	29.4	115.3	35.5	35.7	17.9	170.6	55.4	53.4	1.6	26.4	34.2	25.0	12.9	24.0	24.8	48.9	10.4	23.0	23.3	39.3	37.9	23.7	8.8	33.2	32.5	4.2	5.7	5.5	6.6	3.3	6.8	10.1	6.1	8.0	8.0	6.7	12.8	14.9	22.4	33.4	11.4	16.0	9.9	10.1	11.3	8.0	7.3	7.2	4.6	8.5	30.0	14.5	20.2	14.6	17.6	21.2	16.0	1.9	42.5	29.5	34.9	32.8	16.0	59.9	9.0	12.1	25.0	51.6	21.3	18.3	34.5	14.0	9.2	15.4	24.2	70.3	6.7	15.0	25.5	22.4	77.4	41.9	14.5	32.6	74.9	23.2	29.0	55.4	7.6	19.6	10.6	7.3	20.3	13.3	25.9	17.7	26.7	8.7	14.9	46.2	14.5	26.3	9.2	13.5	6.8	9.7	5.0	5.3	8.8	24.8	44.3	15.5	8.5
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659666-31668931	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1645.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 3357.9;Proximal tubular cells: 3285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	50000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	257.6	597.1	558.0	118.4	577.4	166.4	233.5	605.2	805.1	206.6	586.6	251.0	360.3	179.5	228.4	221.1	197.1	206.0	477.3	575.1	619.9	483.2	1645.6	153.9	169.6	619.8	604.6	302.1	117.1	210.6	236.7	155.8	653.1	203.9	180.5	248.6	160.5	204.2	428.0	152.1	266.7	136.6	588.1	147.5	210.4	132.1	585.8	165.7	197.4	355.9	151.7	232.1	220.6	634.7	526.8	451.4	309.2	312.8	407.3	282.1	257.8	430.2	258.0	291.3	217.4	593.6	326.0	628.2	441.2	405.8	517.7	186.1	453.3	320.6	239.9	463.3	540.0	1008.2	579.5	866.3	267.4	451.7	363.1	294.8	240.6	406.5	225.2	327.9	331.2	469.0	704.4	773.2	357.4	860.0	489.0	454.5	466.1	830.0	475.4	413.0	622.0	981.4	579.4	320.5	335.9	281.4	805.1	419.4	438.3	279.2	484.3	393.4	387.4	222.9	489.2	304.7	322.0	583.4	1374.2	741.8	455.7	654.3	301.9	204.2	159.7	194.0	313.4	234.0	365.3	427.1	509.2	402.4	212.8	310.1	521.8	412.1	37.8	241.4	465.4	240.6	746.0	474.5	558.0	577.4	605.2	805.1	575.1	619.9	619.8	604.6	653.1	588.1	585.8	634.7	319.8	294.9	175.1	38.2	248.1	491.4	672.7	479.2	319.8	226.6	264.1	352.9	721.0	527.6	294.7	391.8	47.9	703.4	250.2	703.5	1631.7	426.3	277.0	410.7	241.2	261.0	288.4	898.8	39.7	807.3	574.9	365.8	198.8	216.3	220.0	278.9	318.1	3357.9	363.3	282.7	45.5	402.7	366.2	220.0	318.5	952.2	521.9	224.2	419.8	29.0	313.1	598.5	239.0	28.6	68.7	322.8	600.9	528.1	178.2	567.0	1158.3	3285.9	638.3	216.5	440.4	313.6	404.5	211.7	506.3	379.9	349.8	725.9	423.1	470.3	593.6	497.7
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SOX12	SOX22	ENSG00000177732	"SRY-box transcription factor 12"	O15370	20	325552-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 52.3;Cone photoreceptor cells: 41.7;Horizontal cells: 32.0;Rod photoreceptor cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA055052, HPA061627"			Enhanced	Nucleoplasm		No	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA055052: AB_2682685, HPA061627: AB_2684571"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	4.0	8.2	10.1	2.4	9.1	3.0	3.8	12.3	11.4	9.7	6.7	10.6	1.8	9.9	5.1	4.8	8.5	2.1	6.7	9.2	7.5	10.4	4.8	3.9	2.6	10.2	8.1	11.7	6.5	3.7	6.8	2.3	9.2	8.1	1.2	8.5	4.1	6.1	1.1	4.4	5.3	3.7	7.1	6.1	5.4	8.9	8.3	4.0	9.8	1.3	1.7	7.2	6.4	10.6	7.9	27.1	26.0	17.7	12.3	9.0	7.8	10.6	9.2	9.5	9.4	5.5	8.0	17.5	8.0	12.3	19.9	9.2	18.9	3.5	5.4	8.8	13.3	11.3	10.9	55.3	15.8	15.7	2.9	12.4	10.9	8.0	3.2	15.4	12.6	11.8	26.9	9.0	6.2	19.2	5.4	38.4	42.3	4.4	35.3	27.7	6.6	14.2	13.5	1.0	31.7	36.9	7.1	30.9	41.0	10.6	29.4	21.7	14.3	36.5	36.0	1.0	9.5	25.5	28.8	18.1	6.8	15.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	10.1	9.1	12.3	11.4	9.2	7.5	10.2	8.1	9.2	7.1	8.3	10.6	3.8	0.0	3.2	15.3	2.6	3.4	2.5	2.7	15.4	52.3	8.5	6.2	11.3	5.7	0.8	7.3	41.7	1.4	1.6	2.3	15.6	1.3	0.9	12.1	16.2	8.6	9.1	5.5	6.5	0.4	0.4	5.3	0.5	6.6	0.0	22.8	8.9	8.7	2.3	32.0	9.2	4.5	2.0	1.3	4.5	2.0	10.2	1.7	5.4	6.5	0.8	9.9	1.0	10.6	10.1	0.4	0.8	12.4	0.8	3.3	1.1	5.1	1.2	39.1	0.0	3.2	7.6	1.3	6.9	3.9	1.1	0.7	2.9	18.4	3.9	0.5
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box transcription factor 13"	Q9UN79	1	204073115-204127743	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.8;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.9;SK-BR-3: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051790: AB_2681610, HPA054843: AB_2682622"	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	39.9	15.4	16.8	4.9	18.5	0.5	29.2	16.3	14.7	36.6	13.0	28.5	14.0	41.0	8.8	15.9	39.8	9.5	17.4	12.1	14.8	31.4	22.6	36.8	4.7	21.6	23.5	19.2	17.2	24.3	8.6	25.9	18.6	35.4	8.1	2.0	21.8	17.8	21.1	17.5	21.4	17.9	18.2	14.2	14.6	7.1	18.3	1.9	17.2	13.9	3.9	29.7	33.2	19.8	24.8	15.6	32.7	2.2	30.6	9.2	65.9	9.4	5.5	14.7	9.0	13.1	18.0	0.2	30.4	6.0	3.8	39.0	12.6	12.2	6.9	11.5	6.4	0.0	11.2	14.6	6.9	0.2	14.0	9.5	6.1	9.2	8.0	7.0	21.7	0.5	0.2	0.1	3.0	30.1	0.3	0.2	43.6	39.5	18.6	0.2	11.1	15.3	11.0	55.9	5.1	2.7	9.5	138.2	42.4	29.0	61.7	3.0	12.4	3.2	8.6	14.2	6.6	0.1	0.1	0.0	5.2	0.5	8.8	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.4	0.5	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.0	0.1	16.8	18.5	16.3	14.7	12.1	14.8	21.6	23.5	18.6	18.2	18.3	19.8	20.5	6.4	7.7	26.8	0.2	2.2	8.7	3.5	2.8	0.9	8.7	7.6	28.3	5.7	4.9	9.2	0.0	5.2	3.9	16.3	1.9	3.6	9.2	13.3	13.0	17.4	7.7	0.0	0.5	1.5	5.6	8.4	5.1	22.3	17.1	0.2	8.9	6.0	1.4	0.0	7.6	5.3	8.2	0.9	2.1	27.7	20.8	1.2	1.8	21.5	0.0	4.9	4.1	50.8	16.8	3.7	7.6	19.5	0.5	7.8	16.0	4.5	4.1	1.0	39.5	9.7	22.3	0.3	0.5	6.6	1.6	1.9	2.3	2.9	5.5	7.7
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box transcription factor 15"	O60248	17	7588178-7590094	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 87.4;skin 1: 48.2"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 209.2;Basal squamous epithelial cells: 447.3;Squamous epithelial cells: 388.1;Suprabasal keratinocytes: 169.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 6.7;non-classical monocyte: 10.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 10.6"	"Group enriched"	"Detected in many"	8	"A-431: 130.6;HaCaT: 142.1;HBEC3-KT: 57.8;hTCEpi: 56.6"	"Not detected"	"Not detected"							"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	2.2	0.9	15.0	0.8	14.6	2.7	3.4	17.4	23.3	21.1	11.8	12.4	0.7	8.2	1.7	87.4	11.0	1.0	8.6	14.5	15.3	1.7	1.3	1.5	0.5	14.3	15.0	15.3	1.0	0.2	7.9	0.3	14.1	12.1	0.5	5.0	14.6	7.1	2.3	48.2	3.5	1.3	14.5	1.1	4.7	2.6	14.7	1.0	2.3	1.8	2.8	10.4	32.7	15.0	130.6	3.2	1.8	1.0	0.1	0.3	9.6	1.4	0.5	1.1	1.7	2.5	0.8	0.4	1.2	0.1	0.4	142.1	0.1	57.8	0.4	3.3	3.9	0.5	1.7	0.5	0.2	0.3	2.6	0.0	56.6	0.7	11.9	3.6	0.0	2.6	2.9	0.8	0.2	0.9	0.6	1.5	3.6	0.3	0.7	1.6	1.8	1.0	2.7	0.7	0.8	2.2	1.5	0.5	0.7	5.5	1.1	1.0	1.6	1.3	2.3	1.6	4.4	0.9	1.5	1.6	4.4	1.7	3.2	0.1	2.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.6	1.0	0.0	0.4	15.0	14.6	17.4	23.3	14.5	15.3	14.3	15.0	14.1	14.5	14.7	15.0	0.8	0.0	0.0	2.6	0.1	209.2	51.8	72.7	447.3	13.6	6.3	13.0	4.7	0.0	20.6	1.8	14.6	1.7	0.7	0.5	1.9	0.1	0.2	0.4	4.9	3.1	1.2	0.0	8.1	0.5	2.0	10.4	0.0	0.4	0.0	1.3	1.4	0.0	0.4	10.1	7.7	0.4	10.2	1.2	19.3	1.1	31.4	0.9	26.6	1.0	1.2	50.0	0.0	4.0	2.4	0.5	0.1	36.9	4.9	21.2	0.3	0.2	16.2	9.4	32.9	7.8	7.1	0.7	10.9	388.1	169.9	1.1	1.1	0.6	0.8	73.8
SOX2		ENSG00000181449	"SRY-box transcription factor 2"	P48431	3	181711925-181714436	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;esophagus: 24.5"	"Group enriched"	"Detected in some"	6	"Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0"	"Low region specificity"	"Detected in all"							"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	0.3	0.9	58.0	0.5	58.5	0.0	0.2	47.1	56.6	2.1	8.6	5.5	0.4	0.1	0.2	24.5	3.1	0.2	0.5	46.5	59.0	0.0	0.1	1.8	0.0	50.5	58.9	0.3	0.1	0.0	13.6	0.0	45.2	2.5	0.4	15.0	18.4	0.3	0.1	0.6	1.4	0.2	59.8	0.0	7.9	1.9	59.2	0.4	0.1	0.1	5.3	1.3	4.8	62.2	0.1	9.0	277.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.1	0.0	0.2	0.7	118.6	3.2	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	226.2	12.4	0.5	0.0	0.6	0.0	31.0	0.4	0.5	1.2	0.0	0.0	0.1	45.7	1.7	0.1	0.0	0.0	4.2	0.0	54.0	0.0	0.0	0.0	0.2	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	58.5	47.1	56.6	46.5	59.0	50.5	58.9	45.2	59.8	59.2	62.2	0.2	0.0	6.0	0.0	0.0	0.3	35.5	28.5	362.0	4.9	0.2	0.4	0.5	0.0	48.4	3.7	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.1	1.6	19.4	0.0	1.3	0.2	0.7	0.1	0.1	0.0	0.0	0.5	38.7	0.0	0.4	0.4	0.6	0.8	3.6	0.0	0.0	383.5	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	0.0	0.1	52.8	13.1	0.0	0.2	1.6	3.9	0.4	229.1	0.4	0.3	0.6	0.2	0.0	7.5
SOX3	PHP	ENSG00000134595	"SRY-box transcription factor 3"	P41225	X	140502985-140505069	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;fallopian tube: 9.2;testis: 2.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 2.9;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 2.0;Skeletal myocytes: 3.1;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HEK 293: 8.1;NTERA-2: 17.9;SuSa: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA054720: AB_2682584, HPA075003: AB_2686727"					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.0	0.1	1.0	0.0	1.2	0.0	0.0	0.8	1.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.7	4.9	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	2.3	3.7	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.0	0.7	4.9	1.2	1.2	0.9	1.1	3.7	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	7.3	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SOX8		ENSG00000005513	"SRY-box transcription factor 8"	P57073	16	981770-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 127.4"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 156.1;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 66.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 114.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm		No	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA041640: AB_10964357, HPA058665: AB_2683792"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	0.9	0.5	58.3	0.9	90.4	0.1	1.7	66.7	71.8	1.3	23.6	3.1	0.1	0.4	0.1	0.4	0.6	0.5	4.1	54.0	57.9	0.7	0.2	0.3	2.0	73.6	79.8	0.3	1.0	0.1	1.2	0.4	64.9	1.2	0.6	14.8	8.3	0.4	0.8	5.4	1.8	0.2	58.7	1.0	0.9	2.5	71.2	0.4	0.5	0.6	2.3	1.4	1.6	127.4	0.0	0.6	2.2	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.4	5.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	3.3	1.8	0.2	0.0	114.7	4.5	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	58.3	90.4	66.7	71.8	54.0	57.9	73.6	79.8	64.9	58.7	71.2	127.4	1.5	0.0	0.0	10.1	0.2	0.4	0.5	0.0	0.0	1.8	8.7	10.4	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.6	2.6	0.0	0.0	4.6	0.2	0.1	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.3	0.5	3.4	0.3	1.8	3.7	0.6	156.1	0.0	64.3	66.0	0.1	0.3	1.9	0.5	1.9	0.0	0.0	0.0	8.0	0.0	9.9	0.9	0.0	3.9	0.4	1.0	0.0	0.9	0.1	0.9	0.3
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box transcription factor 9"	P48436	17	72121020-72126416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.7;salivary gland: 80.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Basal squamous epithelial cells: 166.8;Breast glandular cells: 141.0;Cholangiocytes: 190.1;Gastric mucus-secreting cells: 144.8;Muller glia cells: 141.3;Squamous epithelial cells: 273.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 78.1;Hep G2: 97.0;OE19: 74.3;U-251 MG: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.2	54.7	4.4	50.4	0.1	28.0	42.3	58.5	7.4	46.8	17.1	19.7	2.9	0.9	13.7	7.5	13.0	15.8	50.6	49.3	12.7	3.5	3.1	1.1	73.7	72.2	0.3	38.4	0.1	10.3	0.3	48.8	24.8	17.8	15.0	80.1	10.9	2.7	23.3	15.1	1.2	56.9	0.2	40.5	30.7	51.4	0.5	20.2	1.2	4.4	1.9	6.4	49.0	31.1	19.2	38.9	78.1	3.9	1.1	0.1	4.8	4.2	8.2	4.4	27.0	40.8	0.0	2.9	1.1	43.8	31.3	0.0	18.6	7.5	0.0	2.5	0.0	4.2	97.0	0.3	0.0	0.1	0.7	1.6	9.5	9.0	47.0	0.0	0.0	0.0	0.1	11.7	0.4	0.0	0.1	1.5	74.3	29.1	0.0	31.4	0.4	35.2	2.0	1.9	1.9	4.0	4.7	0.1	21.0	16.7	0.2	0.0	15.8	42.0	8.5	66.5	0.0	0.0	0.1	11.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.4	42.3	58.5	50.6	49.3	73.7	72.2	48.8	56.9	51.4	49.0	1.1	12.8	5.6	160.0	1.9	55.4	88.2	28.9	166.8	3.0	141.0	108.2	13.6	190.1	21.1	36.8	0.0	0.3	2.8	52.1	7.9	55.3	5.1	18.4	0.9	3.2	59.7	0.0	3.1	46.7	0.0	26.0	144.8	21.7	4.5	1.9	0.0	3.4	0.2	0.0	1.5	99.0	24.4	0.0	3.4	14.5	4.4	2.3	12.4	9.4	1.0	141.3	0.0	4.5	11.1	40.8	39.1	0.4	2.8	81.1	17.7	61.0	36.4	6.8	6.6	59.9	14.5	10.2	3.1	273.5	17.8	0.1	2.8	0.1	103.8	77.2
SP1		ENSG00000185591	"Sp1 transcription factor"	P08047	12	53380176-53416446	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000330, HPA001853, HPA012292"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394"	"unprognostic (1.12e-1)"	"unprognostic (8.52e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.12e-2)"	23.6	18.6	10.7	23.1	15.1	29.9	26.2	20.3	12.5	23.7	11.6	24.8	30.9	29.8	21.0	38.6	25.5	25.6	13.4	10.6	11.7	20.7	17.0	22.8	24.2	16.4	14.0	29.8	18.6	22.1	10.7	23.7	16.2	20.8	29.8	20.4	27.5	22.0	25.2	40.1	31.2	26.4	13.0	28.0	28.6	19.4	13.5	36.7	19.6	25.8	30.2	24.2	25.3	17.6	34.2	31.3	40.5	31.2	34.7	39.4	32.1	23.1	29.0	27.2	26.9	27.9	70.3	43.9	29.3	27.1	18.3	49.2	43.6	32.9	33.0	31.3	23.8	38.5	48.2	18.3	24.3	39.4	33.1	40.3	36.4	27.0	53.9	55.1	31.0	35.5	37.6	63.8	23.1	50.2	53.9	31.9	22.4	28.0	25.0	37.8	38.5	28.5	25.7	57.8	21.0	30.5	47.7	42.9	26.8	33.5	52.3	42.6	29.5	35.3	30.3	26.4	25.3	21.3	25.4	42.5	26.3	29.9	28.2	3.1	2.6	1.6	1.3	1.7	1.6	1.4	1.3	1.3	1.5	1.5	1.4	1.5	6.9	1.0	1.9	1.8	1.1	1.0	10.7	15.1	20.3	12.5	10.6	11.7	16.4	14.0	16.2	13.0	13.5	17.6	29.7	22.4	15.0	13.1	18.5	23.8	19.9	22.4	33.6	10.6	28.3	19.4	8.2	24.3	26.8	31.3	8.4	16.2	16.6	55.8	5.9	16.1	64.1	21.8	23.4	24.7	12.6	25.2	7.7	13.8	16.3	21.5	23.9	34.7	6.3	17.2	28.2	28.4	18.2	16.8	7.2	29.8	6.1	38.6	16.1	50.3	27.4	24.5	8.8	16.9	42.2	22.7	18.6	12.5	20.4	18.8	21.0	25.9	12.0	35.4	34.8	20.8	23.9	10.8	13.1	31.4	21.0	29.4	22.1	44.2	31.3	21.3	14.8	11.7	26.2	47.7
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	14.8	10.7	9.4	16.6	11.6	19.4	15.4	16.1	11.5	12.9	6.9	14.3	14.9	14.7	12.0	17.2	15.1	11.5	18.3	9.6	10.1	12.5	8.7	14.9	20.6	12.4	10.4	15.1	16.0	23.5	9.8	13.6	11.1	13.5	13.3	10.5	16.2	12.5	32.2	14.8	15.6	12.8	8.3	17.7	13.0	17.8	11.8	25.3	18.1	26.6	15.0	13.6	13.4	13.3	33.5	37.3	25.1	21.6	12.1	11.2	26.1	19.3	13.6	19.0	17.1	41.3	16.2	28.6	17.4	24.7	20.1	25.6	17.5	16.4	19.9	41.7	26.6	28.5	25.6	22.3	11.2	26.4	34.2	16.4	19.1	22.4	21.1	13.5	18.5	26.3	31.8	47.5	18.8	45.0	64.6	16.8	11.8	29.6	24.9	30.8	34.4	18.6	13.4	52.1	26.8	31.4	16.9	17.9	20.0	15.0	26.7	25.6	30.3	34.8	18.1	24.2	30.1	42.3	50.6	26.0	19.0	18.5	29.2	13.6	6.1	9.9	8.3	7.0	7.3	4.9	6.3	7.9	4.9	5.6	7.1	7.4	11.3	9.7	6.6	4.5	7.2	6.6	9.4	11.6	16.1	11.5	9.6	10.1	12.4	10.4	11.1	8.3	11.8	13.3	14.6	9.6	19.5	5.2	17.7	6.2	15.8	7.8	12.0	9.0	9.8	9.9	9.7	12.8	8.3	11.0	0.0	10.7	11.3	16.4	15.6	7.0	9.8	8.1	6.2	11.6	15.6	25.2	5.2	7.6	9.2	9.4	8.6	10.7	13.3	5.5	8.2	7.5	8.9	11.8	4.8	9.0	14.2	10.9	8.2	10.5	10.5	14.2	8.8	6.5	11.7	12.1	17.5	9.0	9.9	7.3	13.2	3.4	12.7	11.0	8.6	8.1	10.2	6.5	6.6	12.6	12.5	9.8	6.3	9.6	7.5	20.5	14.8	5.3	7.9	17.0
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428043-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	1.9	2.5	2.1	4.5	3.2	6.8	3.6	10.0	2.5	3.7	1.4	2.0	1.7	5.5	3.0	2.2	4.3	2.5	3.8	1.7	2.8	2.9	2.1	3.5	6.5	2.4	1.8	11.3	2.3	7.2	2.5	2.0	1.9	4.0	2.4	8.9	2.2	2.7	3.6	1.9	2.4	2.9	2.1	5.9	2.9	3.8	2.7	13.5	7.8	7.6	6.8	2.9	1.7	4.4	3.6	2.2	6.7	10.6	2.1	1.4	2.0	3.4	2.2	3.6	4.7	5.5	3.5	14.1	2.3	2.0	9.6	4.2	10.0	2.9	6.9	4.6	4.5	6.5	4.6	2.1	1.5	5.4	7.7	1.4	2.4	3.8	4.3	1.8	7.1	9.6	9.5	9.2	2.9	1.3	13.8	3.7	17.5	6.4	2.7	33.1	11.6	4.6	1.2	2.2	8.8	11.0	7.1	3.0	2.5	6.6	3.6	4.0	3.2	5.7	8.3	3.5	6.5	14.0	15.0	21.0	3.4	8.7	8.1	5.7	0.8	8.9	6.9	1.0	8.2	3.7	6.4	6.6	1.0	5.9	8.2	6.9	2.1	3.9	2.1	1.8	8.4	3.8	2.1	3.2	10.0	2.5	1.7	2.8	2.4	1.8	1.9	2.1	2.7	4.4	11.0	3.2	9.0	19.6	21.8	12.6	11.6	2.5	14.2	17.5	10.0	7.5	9.7	8.6	5.7	0.0	8.4	0.9	13.1	1.6	0.0	2.2	7.0	5.4	7.0	7.8	10.7	21.9	31.0	2.2	1.3	6.3	5.6	7.9	5.1	10.8	10.8	4.6	1.8	18.5	31.3	2.2	2.0	6.0	6.4	4.8	5.6	6.0	7.2	27.2	4.5	10.3	18.6	50.3	60.2	1.7	12.3	6.8	7.1	7.7	1.2	2.0	1.6	21.0	0.0	17.3	6.9	7.3	8.4	4.8	11.1	1.5	22.2	2.8	3.1	5.3
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120868	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.2;neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 12.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: AB_2684528"	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (8.10e-4)"	32.2	22.6	50.9	19.0	64.6	26.7	22.4	60.7	58.4	21.5	38.2	23.1	20.4	27.6	12.3	29.1	18.7	26.7	22.6	44.2	55.1	33.0	32.9	30.4	13.6	64.0	56.0	30.1	30.6	27.4	17.5	32.0	65.1	17.9	19.7	36.6	14.3	19.3	66.3	22.6	21.0	27.0	58.7	18.4	15.9	51.0	60.1	19.3	40.1	40.6	15.7	29.6	20.0	99.1	53.3	58.5	73.3	36.0	68.0	59.9	64.7	42.6	41.5	46.8	57.9	53.0	35.7	28.6	29.1	70.3	94.1	44.7	48.5	35.8	86.4	43.5	57.7	23.9	46.4	39.5	51.1	34.9	26.8	43.4	40.7	63.3	112.4	44.9	38.9	14.2	53.6	30.9	66.9	26.6	22.0	14.5	19.5	35.5	74.8	24.7	81.8	25.3	42.8	99.4	56.6	78.8	37.6	34.5	38.8	44.0	28.5	40.9	54.6	129.6	30.3	101.0	63.4	43.5	67.4	46.2	44.3	20.4	46.0	9.2	1.2	0.7	1.2	0.8	0.9	1.0	1.0	1.2	1.3	0.9	0.6	0.8	12.1	0.4	0.5	1.0	1.7	0.5	50.9	64.6	60.7	58.4	44.2	55.1	64.0	56.0	65.1	58.7	60.1	99.1	162.5	131.4	121.3	190.3	53.1	165.1	149.7	37.5	107.6	96.0	45.7	38.7	62.6	41.5	41.1	25.8	125.1	43.2	60.2	189.0	27.4	56.7	243.0	151.6	142.1	122.9	69.8	20.4	110.2	57.6	28.4	106.5	81.6	337.1	43.1	52.8	74.3	48.7	36.7	67.3	130.5	56.0	24.4	43.3	246.6	137.8	76.1	123.1	71.2	104.9	49.8	32.7	25.7	192.5	304.7	89.6	123.5	67.0	59.7	156.9	69.6	86.9	39.0	85.5	65.7	109.0	86.4	215.1	54.8	93.8	172.3	138.9	59.4	56.3	56.3	182.5
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 65.3"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 102.6;Oligodendrocytes: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 33.4;HDLM-2: 46.4"									"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favorable (1.16e-4)"	6.9	14.3	17.7	18.8	31.6	31.2	14.4	26.2	31.5	10.6	34.2	11.0	11.9	9.4	14.2	3.7	9.9	12.1	8.6	19.7	23.5	21.8	24.4	20.4	23.4	42.3	31.8	14.4	38.4	6.5	9.6	10.6	37.3	14.6	12.4	4.8	8.2	6.6	2.5	7.8	13.3	7.5	25.7	65.3	17.9	6.4	29.6	18.6	12.9	6.4	16.6	9.6	5.2	40.1	3.1	5.0	25.6	3.2	0.9	2.1	1.0	7.7	33.4	3.9	3.3	6.5	13.2	20.4	4.1	7.0	2.0	5.7	7.4	2.3	9.7	46.4	8.9	4.9	4.6	7.5	1.2	7.9	3.7	2.8	0.3	4.2	2.4	3.4	6.5	10.7	0.0	16.7	4.1	11.2	14.6	2.7	8.4	21.5	6.4	12.5	9.9	11.0	17.3	9.9	9.3	7.1	1.5	16.3	15.0	5.5	2.3	4.5	7.6	5.1	4.0	0.4	5.5	3.8	0.1	0.0	4.4	7.5	24.4	5.0	6.4	0.0	33.6	8.4	26.2	2.6	28.6	35.3	4.7	2.0	30.1	31.3	39.2	20.4	10.6	5.2	29.8	13.3	17.7	31.6	26.2	31.5	19.7	23.5	42.3	31.8	37.3	25.7	29.6	40.1	9.0	3.2	23.9	61.0	8.6	5.4	3.2	2.5	4.6	3.2	39.5	17.9	5.3	0.0	17.8	14.7	0.0	1.3	18.6	27.4	3.9	25.3	10.8	58.3	12.9	29.0	32.3	6.3	9.2	15.8	14.1	12.5	51.0	102.6	70.2	4.9	0.0	0.0	10.1	0.0	11.1	24.9	4.1	0.0	8.5	6.3	7.5	29.8	5.4	62.8	15.2	14.1	66.9	19.6	206.5	13.5	32.0	7.5	2.8	23.8	25.0	7.2	40.5	0.8	0.0	21.9	8.2	2.2	2.2	4.6	6.1	22.3	37.8	34.5	23.7	17.0
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 144.8;Spermatogonia: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 6.0;dendritic cells: 8.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	7.8	9.1	10.3	11.0	6.5	9.4	15.3	12.8	12.8	10.9	11.0	11.6	11.1	7.9	6.8	6.9	11.1	7.1	11.5	6.2	9.6	4.8	8.0	15.7	10.7	7.8	8.0	12.2	21.5	13.8	8.9	11.1	9.9	11.5	10.1	18.4	6.1	11.1	16.3	10.3	11.3	4.4	10.8	13.1	26.1	8.1	13.2	12.9	6.4	18.1	10.3	13.1	10.4	17.9	39.7	33.2	38.7	19.1	29.3	10.7	20.8	29.8	34.2	29.6	36.0	39.0	44.4	47.5	18.4	22.5	20.8	28.9	39.1	43.8	33.9	17.2	40.4	28.2	29.1	34.7	11.1	23.1	25.6	19.0	53.8	50.9	111.8	82.0	19.8	21.7	38.9	35.2	32.3	22.7	16.5	34.2	29.0	40.1	32.7	56.5	53.4	31.9	22.5	37.2	33.4	45.4	28.6	49.0	20.4	49.2	12.0	75.7	15.1	36.5	13.5	13.2	52.4	65.7	37.5	19.7	18.6	22.0	1.6	1.3	0.3	1.7	0.4	1.7	6.0	1.4	1.0	4.1	3.2	1.2	1.0	0.9	1.3	0.3	8.0	1.1	1.1	9.1	11.0	15.3	12.8	11.5	6.2	10.7	7.8	11.1	4.4	8.1	10.4	35.0	19.2	19.8	34.6	33.8	58.0	48.8	52.0	25.0	44.5	29.9	29.8	9.9	35.8	19.6	36.8	22.9	9.7	19.2	9.6	5.9	26.0	77.4	28.3	63.1	44.6	36.6	22.7	114.0	27.9	12.0	34.8	23.0	45.1	10.8	37.1	29.3	5.6	8.0	42.1	67.6	21.6	20.3	9.2	39.8	46.3	31.7	15.3	19.6	27.2	15.0	22.3	16.5	59.3	30.6	46.4	11.7	33.4	144.8	36.4	13.3	12.4	10.1	5.9	52.6	20.5	27.7	137.3	138.1	17.0	60.4	5.3	16.2	31.5	30.2	29.4
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 478.4;Paneth cells: 467.4;Proximal tubular cells: 568.2;Skeletal myocytes: 470.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 16.8;granulocytes: 48.0;T-cells: 31.6"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 475.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	47.1	27.0	36.9	37.2	38.4	10.4	31.7	35.2	48.6	77.5	44.2	85.5	82.1	37.5	26.6	65.3	81.6	114.8	117.3	41.4	41.0	70.0	110.3	47.6	24.1	42.1	45.0	66.0	60.6	41.9	40.4	68.8	44.0	50.7	83.2	16.5	166.1	67.8	70.6	33.6	82.8	51.3	43.6	39.1	101.4	28.9	39.9	40.8	42.9	36.3	22.9	81.2	45.7	46.7	174.8	94.6	113.0	13.8	74.0	96.4	43.4	299.6	100.1	193.2	143.8	262.6	190.0	1.0	69.1	197.4	108.5	167.5	35.2	186.9	130.4	109.5	47.2	1.4	80.0	315.2	138.8	28.9	12.3	121.4	182.5	134.3	128.3	138.0	75.4	21.6	41.1	119.0	280.0	55.4	4.4	8.3	28.2	303.4	226.7	0.6	388.2	11.1	475.5	134.2	3.1	31.9	77.0	45.5	127.0	165.3	23.9	39.5	120.9	131.3	129.3	41.4	170.9	34.9	36.3	2.2	104.1	14.1	179.5	48.0	5.2	7.6	5.8	5.9	14.0	2.8	6.3	6.0	16.8	3.3	2.6	3.1	4.2	6.8	4.7	12.8	31.6	2.8	36.9	38.4	35.2	48.6	41.4	41.0	42.1	45.0	44.0	43.6	39.9	46.7	83.4	86.6	26.2	104.5	11.2	91.1	262.5	123.6	67.7	21.4	63.2	51.4	127.8	403.2	70.3	172.9	12.5	19.4	9.5	478.4	111.6	157.7	75.9	129.8	59.4	64.2	55.1	15.1	116.4	147.0	38.2	101.8	151.9	56.9	56.5	51.4	94.2	230.0	82.5	60.6	202.9	246.6	54.9	139.6	98.1	22.4	165.6	56.1	128.1	68.4	18.0	8.7	2.1	79.9	106.5	210.8	467.4	142.1	9.4	284.9	153.2	568.2	167.1	56.4	78.9	470.9	89.3	38.0	82.6	68.4	77.9	9.9	28.2	6.6	78.4	198.8
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25 component of NDC80 kinetochore complex"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.5;Erythroid cells: 29.9;Extravillous trophoblasts: 37.9;Muller glia cells: 17.2;Spermatocytes: 26.2;Spermatogonia: 20.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA047144: AB_2679952, HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.74e-6)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.6	0.8	0.6	0.7	0.6	4.2	1.0	0.3	1.5	0.7	0.5	2.1	3.7	0.5	0.0	4.4	0.3	0.5	0.4	1.6	0.7	1.1	0.8	0.9	3.9	0.6	0.7	0.5	1.3	0.1	0.1	1.1	0.8	0.4	1.6	1.7	1.0	0.0	0.6	1.1	2.1	1.0	0.1	2.1	1.6	3.4	0.6	8.5	0.2	0.1	3.7	0.5	1.5	1.8	1.0	16.8	40.6	22.8	1.8	1.9	14.5	22.9	9.3	23.5	18.1	5.6	16.2	15.7	9.0	3.4	31.9	20.9	15.9	0.0	20.7	10.0	21.5	30.2	7.2	2.2	0.1	20.3	8.9	0.3	1.0	14.3	0.0	4.7	10.3	28.2	0.8	15.7	6.4	9.8	16.1	26.3	0.9	11.2	21.0	28.8	38.1	5.6	9.6	13.7	30.4	0.5	16.8	14.4	3.9	13.5	0.4	16.4	2.5	3.6	42.1	13.4	18.2	31.4	56.0	12.5	4.1	0.5	14.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.6	0.6	0.3	1.5	1.6	0.7	0.6	0.7	0.8	0.1	0.6	1.8	0.4	0.0	1.1	0.7	4.2	5.4	1.5	7.1	1.2	0.0	1.5	2.4	0.6	0.0	2.6	0.0	0.0	23.5	1.5	3.7	0.0	0.2	2.0	0.5	1.8	1.6	0.0	29.9	0.3	0.0	37.9	4.6	2.0	1.8	0.0	10.1	2.9	1.2	15.1	0.0	0.5	5.2	2.0	1.9	2.4	1.6	0.6	2.0	0.0	0.0	0.0	17.2	0.0	5.0	0.2	0.5	0.1	1.2	15.3	1.0	1.0	0.2	0.1	0.6	0.0	1.3	4.4	26.2	20.1	7.3	1.4	5.7	2.7	1.7	9.9	2.5
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15836095-15940456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	15.3	8.6	11.3	11.5	14.6	23.2	14.0	22.6	12.9	13.3	4.8	12.0	8.8	14.4	8.5	13.3	15.5	8.0	10.8	10.4	14.6	9.6	11.0	14.8	12.9	14.2	12.4	21.3	17.5	16.4	10.7	11.8	11.4	11.1	9.1	15.1	12.8	9.9	20.5	17.3	13.4	9.8	8.0	12.7	11.0	10.3	12.6	16.6	15.6	19.8	13.3	13.0	13.6	20.7	25.4	20.9	26.1	19.6	25.0	15.2	13.8	12.9	16.6	13.5	11.4	19.3	19.5	35.6	15.0	25.1	15.9	36.0	24.0	22.6	21.4	32.1	68.5	44.6	20.5	12.4	11.3	37.1	20.8	11.2	15.9	20.2	28.9	12.9	15.5	26.5	47.1	35.9	11.1	14.0	30.7	14.7	11.6	14.4	15.9	29.5	25.1	21.9	7.5	22.4	20.5	19.9	36.2	17.4	14.8	11.6	6.5	18.4	28.9	12.8	15.5	24.4	18.5	21.5	15.0	39.6	12.2	29.2	17.9	7.4	1.9	1.6	1.4	1.7	0.9	1.3	1.1	1.0	0.5	3.0	0.9	1.0	8.5	1.1	1.3	2.8	0.9	0.5	11.3	14.6	22.6	12.9	10.4	14.6	14.2	12.4	11.4	8.0	12.6	20.7	55.7	80.1	85.3	68.9	69.4	104.6	44.9	18.3	90.5	67.1	35.0	27.9	52.6	30.0	43.2	5.5	52.1	12.2	52.8	44.4	3.9	18.5	7.0	90.4	67.4	51.6	31.7	47.1	57.2	17.6	15.0	45.9	41.8	146.5	62.6	34.3	20.0	32.6	15.2	95.9	66.0	27.4	8.2	34.6	69.6	4.9	27.4	53.2	21.4	64.6	56.3	28.3	68.0	51.8	88.7	23.6	34.6	35.7	74.5	46.7	16.8	7.5	29.4	53.2	19.7	85.7	56.6	59.5	45.9	89.8	101.6	15.7	52.3	33.1	32.8	56.3
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor Kazal type 5"	Q9NQ38	5	148025683-148137382	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 338.5;esophagus: 1015.0;skin 1: 318.2;vagina: 582.6"	"Cell type enriched"	"Detected in many"	4	"Squamous epithelial cells: 1622.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.7;HeLa: 22.7;Karpas-707: 19.3;SuSa: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		43000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	1.1	0.3	0.0	0.5	0.1	0.0	17.5	0.0	0.2	338.5	0.0	4.8	0.3	0.6	0.3	1015.0	0.4	1.8	1.7	0.1	0.0	0.8	0.4	2.0	0.1	0.1	0.1	0.3	0.8	1.0	2.0	2.4	0.2	1.3	10.6	0.0	145.0	0.5	1.8	318.2	0.6	0.4	0.0	0.3	5.0	1.6	0.1	9.1	2.2	1.1	292.9	0.7	582.6	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	1.8	0.0	0.0	14.7	0.0	1.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.9	19.3	0.0	2.1	0.0	0.0	2.6	2.0	0.3	0.0	0.0	0.0	0.0	5.7	2.8	0.0	0.6	0.0	0.0	6.6	4.6	0.0	0.0	0.0	0.1	0.0	0.0	5.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	5.7	9.6	45.4	0.3	0.2	53.7	1.5	331.1	102.4	0.0	4.2	3.4	1.2	34.3	115.6	0.0	0.0	1.9	0.0	177.9	0.0	0.2	11.0	2.5	0.7	12.9	4.2	0.0	0.7	1.3	2.1	2.6	17.9	4.8	1.3	0.0	7.9	0.2	0.1	0.0	0.8	33.8	16.2	0.8	2.1	3.8	0.6	0.7	3.6	2.8	0.0	0.0	0.0	2.0	1.2	7.6	60.3	0.0	3.7	0.7	0.0	0.0	9.4	0.0	0.0	0.2	2.4	1.3	4.6	1622.6	64.4	1.5	1.1	1.0	97.9	2.7
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 2424.4;kidney: 3587.6;placenta: 2791.9"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 60702.5"	"Group enriched"	"Detected in all"	4	"glioma: 1690.9;renal cancer: 1385.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"neutrophil: 24.8"	"Lineage enriched"	"Detected in single"	249	"granulocytes: 24.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 4825.8;Hep G2: 2469.7;RPTEC TERT1: 10348.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 316.8"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	73000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	113.1	24.4	276.0	59.5	490.3	1.0	70.2	652.0	736.4	27.5	265.0	44.9	9.5	131.2	9.8	4.8	52.8	2424.4	37.0	301.6	417.1	3587.6	35.6	18.8	9.1	813.2	645.3	9.9	292.0	19.2	20.6	2791.9	781.8	15.7	7.6	745.5	88.7	22.1	16.0	2.7	14.4	38.3	472.6	9.2	11.0	11.7	633.1	8.4	8.3	0.4	5.7	25.0	6.0	855.0	2.2	144.0	19.1	1.1	0.0	0.2	0.3	5.6	4.4	1.4	9.1	0.6	0.2	0.2	4825.8	2.3	371.5	1.4	0.0	0.0	3.1	11.2	0.0	0.0	1.8	2469.7	0.3	6.8	5.1	0.5	0.3	34.9	0.1	118.8	4.2	0.2	0.1	10.8	1.3	0.2	1.2	21.3	227.5	0.3	0.0	2.4	0.5	1189.8	10348.3	1.8	1.1	0.9	0.3	0.8	339.1	441.9	0.5	5.2	0.3	11.5	27.1	0.4	25.8	0.9	7.9	13.9	436.3	1.1	457.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	276.0	490.3	652.0	736.4	301.6	417.1	813.2	645.3	781.8	472.6	633.1	855.0	35.7	3.2	4.7	5.2	34.0	1.5	5.2	0.1	1.2	46.6	1767.7	22.4	17.9	1584.2	0.3	2183.1	27.1	335.6	6.9	0.0	1003.7	7273.8	0.1	61.2	25.2	367.9	0.0	2.7	1.4	71.7	294.5	48.9	0.0	154.2	0.0	1.7	5.7	5.0	60702.5	785.7	9.9	0.0	0.0	57.4	7.7	1.0	0.9	247.7	1.8	99.3	69.2	3862.9	0.0	4.5	532.1	215.4	0.0	0.0	0.1	0.4	0.0	5594.0	1.6	169.7	0.0	0.9	21.6	0.5	0.2	1.1	1.0	667.8	30.0	0.4	0.0	9.9
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606403-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	7.5	8.7	2.3	8.6	2.4	34.3	10.0	3.6	5.9	10.6	4.3	7.8	7.0	7.6	5.6	8.1	6.6	10.1	4.9	3.0	2.7	8.9	10.3	7.3	8.2	2.3	2.9	9.7	7.8	8.1	4.0	8.7	2.4	8.7	8.2	4.5	9.4	5.6	7.9	7.4	6.5	7.8	2.4	7.3	7.5	4.2	2.7	8.5	10.0	7.5	9.6	9.4	5.3	3.1	11.8	11.2	9.0	12.7	14.3	15.1	13.5	17.3	18.9	14.2	16.8	10.4	5.2	27.0	9.3	16.3	11.0	12.1	15.3	13.4	20.5	14.1	14.0	10.6	6.4	9.5	14.1	22.6	20.4	12.7	13.6	9.3	17.8	10.1	15.3	15.8	15.3	41.7	15.9	12.2	15.5	9.3	8.5	22.8	12.6	14.2	25.1	11.4	14.9	16.9	8.8	12.3	15.1	17.8	12.3	11.7	11.0	9.6	13.7	13.7	11.7	27.1	10.8	14.3	19.0	21.0	16.4	12.6	11.8	4.7	1.9	2.9	2.7	2.9	4.1	1.2	2.6	2.8	1.7	1.1	2.4	2.6	2.2	3.7	2.8	1.4	3.1	1.8	2.3	2.4	3.6	5.9	3.0	2.7	2.3	2.9	2.4	2.4	2.7	3.1	42.3	25.6	47.7	5.2	38.0	55.8	19.6	17.1	32.5	13.7	55.0	39.5	21.6	18.6	29.9	27.6	10.4	14.3	75.3	31.7	17.6	25.3	2.4	47.4	53.8	29.1	44.3	15.4	9.9	24.9	26.5	35.3	40.2	74.1	57.7	20.5	22.9	28.5	16.3	11.8	9.6	39.4	24.4	33.4	49.6	3.2	19.0	44.3	16.0	15.0	24.4	12.4	49.4	9.0	8.9	27.7	29.8	13.9	83.6	28.0	21.0	17.4	47.5	11.4	32.9	42.9	28.2	14.2	17.3	41.6	66.3	27.5	69.7	27.1	24.4	29.2
SQSTM1	"A170, OSIL, p60, p62, p62B, PDB3"	ENSG00000161011	"Sequestosome 1"	Q13501	5	179806398-179838078	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Differentiation, Immunity"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1183.4"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 2045.0;Urothelial cells: 2233.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 1923.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004587, HPA064165, HPA068843"	Supported		Enhanced	Vesicles,Cytosol		No	No		81000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"		"CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.01e-1)"	335.0	472.6	171.4	86.0	208.8	135.8	269.5	199.6	207.2	242.8	218.9	262.0	112.1	278.8	91.7	192.3	207.5	188.2	310.1	163.8	200.6	221.5	392.0	263.4	81.4	203.9	183.3	235.6	231.3	121.4	181.5	118.7	190.5	206.2	82.3	46.4	289.7	174.2	1183.4	194.7	187.4	132.7	179.5	179.0	263.6	65.7	205.7	89.4	316.4	287.2	96.4	347.3	211.0	236.5	130.1	740.6	36.9	114.3	547.8	384.8	546.3	187.9	596.3	164.1	201.2	154.6	532.9	16.0	522.7	298.9	898.3	170.8	79.9	181.9	76.9	1923.9	97.6	58.5	303.9	223.4	1167.2	59.9	365.0	337.1	181.2	273.0	441.5	390.8	152.6	17.3	68.0	472.1	327.0	111.6	26.4	62.0	93.8	410.0	195.1	54.8	78.8	213.7	243.6	609.6	79.0	74.5	253.2	274.3	662.2	62.3	143.8	120.4	286.2	243.1	103.4	252.3	271.6	723.7	819.3	73.5	521.1	111.6	338.4	807.6	412.3	422.2	194.7	268.3	231.3	156.5	170.1	174.6	227.5	168.2	131.8	139.1	672.6	196.3	260.3	89.6	262.1	439.8	171.4	208.8	199.6	207.2	163.8	200.6	203.9	183.3	190.5	179.5	205.7	236.5	411.1	185.9	248.8	36.9	280.0	297.5	1289.0	320.4	799.6	81.7	280.7	253.0	38.5	314.5	247.8	121.4	54.2	266.8	276.4	572.9	234.8	906.0	34.2	408.7	255.4	415.8	340.4	89.0	35.2	686.7	133.2	516.0	1270.6	589.7	386.3	73.8	142.5	297.8	288.3	90.9	37.2	337.2	236.0	149.8	556.3	72.2	325.3	388.3	231.3	28.1	611.3	143.3	125.7	16.6	62.2	639.4	618.9	259.2	606.5	1281.6	311.3	327.1	190.1	73.5	164.3	356.4	316.1	45.5	48.0	595.4	259.1	2045.0	259.9	133.4	242.3	2233.9
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	5.6	6.5	6.7	4.4	6.8	20.2	5.9	8.0	8.4	7.4	9.9	6.7	4.5	8.0	5.2	5.4	7.0	4.2	4.9	6.3	7.2	4.8	6.1	6.2	5.9	6.1	6.4	6.4	8.5	6.6	8.1	5.2	6.1	5.4	4.3	9.5	7.0	3.8	4.7	9.0	7.4	3.2	6.0	7.4	6.5	4.8	7.0	5.8	8.0	3.3	4.1	5.5	5.7	7.4	5.5	6.7	8.5	5.5	3.9	7.5	9.5	6.1	3.3	3.1	3.4	9.5	6.3	8.3	7.4	4.5	4.1	7.4	4.3	5.7	5.3	6.0	10.3	7.9	18.0	7.2	3.4	7.0	8.9	4.5	5.6	3.7	4.2	6.4	5.2	4.6	7.4	5.5	3.4	5.6	7.2	16.2	4.8	2.1	3.3	10.2	4.1	6.3	5.6	9.2	10.3	7.3	5.8	2.7	5.1	6.1	7.2	8.7	5.9	5.2	3.3	7.3	6.4	6.0	4.5	8.9	5.1	11.2	5.5	4.9	2.7	2.8	2.4	2.1	2.6	3.2	2.2	2.8	2.3	3.8	2.6	2.6	2.1	3.8	1.9	3.1	2.4	1.5	6.7	6.8	8.0	8.4	6.3	7.2	6.1	6.4	6.1	6.0	7.0	7.4	72.6	93.0	143.5	70.2	67.6	66.0	84.8	69.3	58.6	64.3	64.1	51.4	80.8	60.1	98.8	46.0	116.7	84.6	72.1	59.5	37.2	59.3	46.5	91.2	124.1	83.3	77.8	65.6	71.4	55.4	86.7	80.1	72.4	107.5	97.0	80.5	55.0	68.3	50.2	67.3	73.3	64.2	79.3	54.4	50.2	62.3	83.6	55.4	42.7	40.3	62.3	63.4	53.5	98.0	85.2	54.7	41.8	76.8	70.7	83.7	49.8	32.8	112.2	89.8	46.0	92.3	87.2	78.9	62.0	49.1	69.3	120.7	63.7	85.2	62.5	91.2
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673281	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		20000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	43.2	32.8	28.5	30.7	32.9	68.9	45.3	37.2	35.8	62.6	33.8	48.8	27.7	50.7	83.8	37.5	58.4	22.9	40.5	28.3	29.4	31.2	32.1	40.2	40.3	32.6	31.1	79.2	35.7	26.2	37.6	33.3	33.7	53.5	26.9	52.4	40.6	31.9	52.0	54.8	43.2	30.6	27.4	45.7	36.8	39.3	30.7	31.4	39.8	21.5	37.0	41.6	50.3	46.0	52.4	40.4	79.2	74.2	44.4	46.0	78.0	57.7	40.5	59.1	67.4	45.2	88.1	115.0	36.6	50.4	39.2	66.0	82.1	58.2	78.4	39.2	54.3	89.9	83.3	53.0	30.7	101.3	58.5	30.6	34.9	48.4	68.1	66.4	53.7	55.2	92.8	65.5	61.5	44.1	96.3	69.6	139.4	42.9	29.0	89.4	63.3	58.0	52.4	51.6	49.3	43.0	63.5	54.5	45.5	59.8	49.3	50.7	56.7	54.2	53.2	71.4	62.5	54.7	46.0	138.3	58.4	122.4	61.0	32.3	18.1	20.9	21.6	23.3	26.7	19.9	20.4	21.3	20.7	20.0	18.6	21.6	23.2	29.7	27.5	16.8	16.5	16.9	28.5	32.9	37.2	35.8	28.3	29.4	32.6	31.1	33.7	27.4	30.7	46.0	231.5	157.0	165.3	67.9	266.8	302.3	280.8	194.6	271.5	178.4	164.6	188.0	154.8	128.7	172.7	121.4	118.9	152.1	315.1	146.5	199.6	174.1	330.2	211.3	247.6	170.7	118.4	230.1	53.6	147.2	170.0	177.2	142.2	260.0	241.0	148.6	140.7	225.6	149.5	124.5	56.7	174.4	120.1	178.7	311.3	134.1	167.7	205.3	154.7	45.9	286.6	187.1	256.4	58.8	173.2	147.5	149.1	150.8	236.8	329.8	141.8	198.4	145.5	186.9	138.1	252.3	220.3	219.4	223.3	282.5	295.4	241.2	288.6	135.9	194.3	308.9
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752626-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 150.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"		NA	NA		17000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: AB_2685630"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.77e-4)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	195.2	215.4	203.8	115.7	211.0	270.4	193.4	229.1	374.7	255.3	232.5	239.3	127.0	219.7	69.9	222.8	253.9	94.3	246.5	205.6	201.2	212.5	252.5	198.6	125.4	222.7	197.7	265.5	315.1	115.9	171.0	89.2	208.7	217.8	102.8	134.1	243.0	86.9	306.6	224.6	261.5	100.3	180.2	250.7	269.6	146.9	227.5	108.4	231.4	96.9	95.2	211.5	211.7	234.5	108.1	134.7	212.9	147.1	147.1	141.9	125.1	119.8	68.1	105.5	93.5	111.5	123.1	192.2	87.3	134.6	88.2	151.6	170.2	153.6	110.9	139.3	177.5	164.8	284.5	192.9	65.6	171.9	229.6	146.3	145.6	155.0	182.8	210.4	110.5	136.5	187.5	184.1	98.7	186.5	162.6	270.9	196.9	76.4	75.1	286.2	84.0	150.4	136.4	109.7	138.1	120.8	158.1	162.0	98.7	141.7	147.2	137.4	157.1	148.8	150.3	97.9	149.8	161.2	131.6	402.9	51.7	124.0	102.2	150.8	24.0	13.3	8.2	10.6	7.9	15.9	10.4	8.1	5.8	22.9	9.1	12.0	48.2	60.5	10.5	31.9	5.9	3.0	203.8	211.0	229.1	374.7	205.6	201.2	222.7	197.7	208.7	180.2	227.5	234.5	286.4	141.1	232.4	134.8	221.3	310.5	430.1	204.0	178.2	416.5	271.8	283.3	139.0	147.3	180.5	167.3	291.9	179.3	289.0	244.4	66.5	156.3	83.1	285.4	457.7	230.3	189.6	191.6	71.1	179.5	204.8	235.0	296.2	379.3	134.8	273.1	158.8	183.8	157.2	439.1	76.7	245.2	162.8	124.5	238.7	77.2	251.6	208.1	120.9	116.2	160.9	239.8	195.7	94.0	109.6	159.9	188.4	192.2	262.3	352.3	192.5	99.3	146.6	358.1	197.2	366.8	391.0	231.8	253.7	219.2	365.1	276.2	237.5	339.5	236.5	377.8
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875103-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 251.1;Late spermatids: 329.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	50.1	64.6	38.8	47.2	43.2	115.2	52.4	44.1	43.8	69.9	41.8	54.7	37.7	56.8	30.3	63.4	56.5	28.7	46.3	38.8	43.2	63.0	74.7	49.4	62.3	43.2	40.1	71.3	63.0	33.0	64.1	33.2	40.7	73.6	25.2	30.8	59.3	30.6	51.1	69.6	60.4	26.8	37.7	75.0	55.3	159.9	42.0	51.0	64.2	23.6	40.6	49.6	60.0	44.7	104.3	122.5	123.6	121.2	51.6	36.8	115.2	112.9	56.6	113.0	96.7	161.3	114.5	172.7	75.6	82.0	84.6	96.1	149.6	101.0	56.0	154.0	128.3	163.3	150.3	134.7	46.4	213.6	270.4	55.2	39.0	100.8	28.8	51.3	62.1	103.8	147.1	135.6	79.4	180.9	198.7	235.6	127.5	89.0	107.4	183.1	94.9	103.4	73.6	113.0	97.6	94.4	111.0	136.5	75.4	62.9	85.9	130.7	95.2	127.1	122.7	109.4	154.8	85.5	132.8	185.2	70.6	141.4	122.6	7.7	14.6	22.2	28.3	23.0	18.3	12.2	18.7	38.8	15.7	15.5	16.0	23.0	10.9	10.4	18.1	14.2	9.7	20.9	38.8	43.2	44.1	43.8	38.8	43.2	43.2	40.1	40.7	37.7	42.0	44.7	22.7	25.6	49.2	17.3	37.6	38.5	27.8	24.1	63.7	23.3	22.4	21.8	21.5	14.3	39.2	16.5	14.6	42.7	43.2	24.4	7.9	31.7	251.1	25.6	36.2	25.9	32.9	51.9	8.6	32.0	50.4	29.2	51.5	41.7	27.1	31.3	12.8	13.1	26.5	26.9	8.5	29.1	18.3	15.0	35.9	329.5	33.8	28.4	16.0	9.4	25.1	29.4	26.8	12.5	12.7	26.3	17.9	27.8	67.2	22.8	16.0	12.2	30.5	46.0	19.7	31.7	41.7	133.3	65.8	52.4	43.5	54.2	62.8	33.9	32.3	21.4
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		23000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: AB_2683164"	"unprognostic (2.08e-3)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	210.9	188.4	68.1	149.5	72.5	456.9	229.8	60.3	108.2	174.2	125.9	231.8	129.2	222.5	218.0	217.9	240.9	130.1	154.4	75.9	69.7	119.6	183.8	214.8	210.1	75.5	71.1	220.0	136.6	188.1	215.5	105.1	74.1	172.7	164.8	233.8	235.8	126.7	217.6	282.0	256.6	180.3	66.0	211.8	212.8	104.1	69.5	214.7	224.8	68.3	155.0	189.3	177.4	97.1	456.4	133.5	313.8	141.4	192.7	179.6	177.4	214.6	239.7	177.6	183.7	164.7	283.6	473.1	110.4	301.8	174.7	210.2	242.5	309.2	209.7	407.4	142.3	354.3	386.7	183.6	224.3	334.7	255.7	350.9	201.2	199.7	216.3	260.4	247.0	401.8	255.4	268.3	114.3	382.1	385.1	232.4	182.0	356.6	128.2	324.0	148.5	183.3	237.2	563.1	165.9	236.3	364.3	214.1	296.0	188.5	235.9	292.3	299.7	98.4	264.2	110.9	205.6	261.6	184.5	754.8	232.3	286.1	140.1	137.1	65.8	103.6	93.1	117.9	94.9	109.5	83.1	85.0	70.1	108.7	81.1	79.6	161.9	86.2	129.6	99.8	74.8	77.2	68.1	72.5	60.3	108.2	75.9	69.7	75.5	71.1	74.1	66.0	69.5	97.1	380.7	253.2	309.1	218.1	392.8	138.0	768.6	610.1	204.9	387.4	248.6	259.1	195.0	240.2	386.6	183.9	239.8	444.3	542.9	471.8	320.8	201.7	190.3	224.2	169.8	293.6	302.9	195.4	199.5	171.8	261.5	288.0	188.6	225.3	480.2	251.3	249.9	225.4	217.7	378.6	177.7	376.6	380.5	236.2	154.3	105.0	345.5	314.7	133.4	104.9	323.4	277.4	428.5	128.2	268.7	226.6	538.5	267.1	212.3	376.7	484.7	228.2	373.4	317.3	276.1	583.7	354.2	201.8	149.8	196.4	145.6	749.2	456.6	201.6	275.5	542.1
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavorable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	68.3	44.5	30.5	59.3	31.8	132.8	53.3	32.3	36.0	37.3	33.9	55.0	30.4	43.8	40.7	65.3	45.2	24.0	37.7	32.3	33.6	47.0	49.4	50.5	72.0	30.8	30.2	34.6	33.6	36.1	30.0	50.7	30.8	38.9	52.2	25.0	37.4	34.5	41.9	37.8	46.2	52.9	33.3	45.8	50.6	54.0	30.7	87.0	34.3	27.7	90.1	68.4	40.9	34.4	271.3	229.3	304.4	197.1	91.8	71.8	213.7	225.2	96.6	222.9	177.9	272.9	202.4	436.1	150.9	148.2	206.9	149.2	385.7	277.1	266.7	274.7	240.9	264.3	154.8	281.2	78.1	329.3	185.4	43.4	92.8	153.3	295.0	94.3	187.9	180.3	388.5	171.1	191.6	298.9	421.2	289.9	331.5	313.3	208.4	367.8	253.4	248.0	168.2	257.3	207.2	201.6	215.3	190.1	156.5	189.7	172.8	295.0	163.1	134.3	210.2	116.3	317.6	186.6	297.8	658.9	159.1	339.1	189.3	23.4	71.2	27.8	59.8	103.3	65.0	63.3	46.1	60.3	142.4	40.7	51.4	59.7	6.8	65.7	61.7	85.8	53.4	77.5	30.5	31.8	32.3	36.0	32.3	33.6	30.8	30.2	30.8	33.3	30.7	34.4	445.1	80.1	208.8	31.3	453.7	259.5	460.8	255.9	220.3	122.7	226.9	367.2	67.8	87.2	177.0	64.4	118.9	313.7	730.0	214.7	156.5	195.4	173.6	104.6	193.5	245.7	178.0	153.5	96.6	132.2	478.1	264.0	258.9	130.4	320.4	273.2	150.0	85.3	241.9	121.1	82.2	222.5	140.4	123.4	242.6	45.2	138.5	289.2	152.9	65.6	222.6	253.9	239.9	74.9	100.8	149.0	179.3	109.9	337.7	309.9	192.1	94.1	116.4	225.8	118.3	317.9	408.1	286.7	287.3	163.0	243.5	250.2	652.4	186.4	242.8	344.7
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 281.7;Excitatory neurons: 263.4;Inhibitory neurons: 350.0;Microglial cells: 339.2;Oligodendrocytes: 340.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 136.8;MOLT-4: 132.4;REH: 196.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605, HPA071780"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB020834: , HPA068605: AB_2732116, HPA071780: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	28.8	12.7	25.9	13.0	27.9	14.0	26.5	37.0	26.1	31.2	24.1	29.7	5.7	29.1	30.2	24.4	29.9	16.2	31.8	24.1	34.2	12.8	3.3	16.2	19.8	25.0	33.2	37.1	11.2	47.3	28.0	13.7	27.7	19.2	12.9	53.3	20.8	21.3	23.6	27.2	15.5	29.8	26.2	12.5	17.8	7.9	31.3	96.4	17.7	22.2	24.3	25.7	26.1	27.2	3.8	6.8	85.1	48.8	48.0	72.6	5.2	18.1	16.4	16.5	16.9	0.3	7.1	60.8	1.2	21.3	8.2	0.4	23.6	9.7	15.9	26.1	10.1	12.8	14.6	0.3	27.1	6.4	32.5	74.8	82.1	2.8	15.9	35.6	7.1	136.8	8.4	29.2	17.9	8.7	132.4	10.7	11.7	0.1	3.8	196.2	19.3	47.2	8.8	3.3	44.2	39.7	19.1	21.1	6.6	34.3	31.1	18.1	4.9	6.5	10.4	12.3	4.9	30.4	25.1	101.6	21.8	11.3	4.4	60.4	19.0	61.1	5.0	17.5	8.0	23.9	16.2	9.3	18.3	33.6	31.3	11.1	27.9	61.3	29.6	5.9	7.8	18.7	25.9	27.9	37.0	26.1	24.1	34.2	25.0	33.2	27.7	26.2	31.3	27.2	43.7	9.6	18.6	281.7	39.0	34.9	40.3	44.3	122.9	75.0	25.1	38.1	45.3	12.8	34.4	29.5	27.1	7.7	12.5	4.1	17.6	14.0	5.9	25.2	27.3	21.4	15.0	29.7	263.4	10.0	3.7	48.6	10.2	22.0	25.3	5.4	23.9	2.3	20.5	42.1	350.0	5.4	61.1	17.0	21.7	4.2	37.9	29.9	35.6	339.2	15.6	122.4	5.2	185.0	340.2	6.1	13.6	48.5	14.9	14.9	2.5	4.5	34.1	49.3	52.6	48.9	59.4	10.0	29.8	60.3	36.2	7.4	23.9	9.9	4.4	27.3
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13 Hsp70 interacting protein"	P50502	22	40824535-40856639	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1091.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	163.2	157.5	131.9	84.2	148.3	99.0	161.6	149.9	171.9	163.0	140.4	135.6	96.7	197.5	137.2	116.6	180.6	122.8	121.9	123.8	156.8	254.2	296.7	97.0	111.7	147.3	140.5	542.6	126.2	150.8	92.3	135.3	154.8	145.0	108.0	146.4	111.3	142.6	341.2	98.4	108.3	165.0	147.2	89.0	111.1	107.7	136.1	131.6	176.6	217.9	126.2	131.5	113.5	191.9	249.0	195.1	290.6	255.4	265.7	407.1	263.7	229.0	293.2	279.6	242.3	353.7	144.3	356.8	193.2	232.9	253.7	177.3	387.7	226.3	331.2	228.4	250.3	255.0	379.1	406.4	241.2	374.6	198.5	365.5	235.7	252.6	169.7	351.2	293.6	219.3	313.2	151.2	271.3	187.1	329.5	200.1	166.4	302.0	130.7	375.7	246.4	281.9	284.2	369.8	96.4	97.1	265.0	211.7	337.7	334.1	205.5	233.2	220.8	232.1	223.0	197.0	188.2	173.5	367.9	333.4	317.4	172.0	228.2	108.9	79.5	85.7	84.7	108.7	129.1	146.2	133.0	101.9	107.1	131.6	206.6	160.7	26.3	110.6	146.3	75.5	122.3	162.6	131.9	148.3	149.9	171.9	123.8	156.8	147.3	140.5	154.8	147.2	136.1	191.9	187.0	141.1	220.5	28.1	217.5	311.6	384.6	267.7	279.4	89.5	364.6	359.2	140.1	334.6	232.5	171.0	16.7	382.8	141.7	192.9	563.4	284.8	513.2	431.6	349.8	204.1	262.0	296.3	37.4	205.1	381.2	239.7	107.0	289.6	207.1	305.0	227.7	539.2	328.6	38.7	41.5	263.7	183.1	270.6	374.5	1010.4	510.4	210.3	211.7	15.0	286.7	265.1	157.6	27.2	53.7	193.7	210.8	413.3	129.0	312.2	369.6	1091.8	281.8	73.0	223.5	212.0	268.7	306.9	191.2	193.5	274.5	500.9	200.6	227.3	333.2	325.8
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074746-76634603	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Group enriched"	"Detected in many"	4	"Microglial cells: 912.5;Oligodendrocytes: 698.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.8;HUVEC TERT2: 45.9;SK-MEL-30: 62.3;TIME: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	8.8	1.4	5.8	1.8	13.3	3.1	6.4	14.3	8.4	1.9	10.4	2.0	0.7	5.9	0.5	1.9	2.7	2.5	4.4	6.9	9.0	8.7	2.0	5.2	2.0	15.2	10.6	2.3	0.9	4.4	2.1	3.1	17.2	1.1	2.4	3.9	1.1	1.6	1.6	0.8	1.4	4.5	13.3	1.4	1.5	0.3	11.3	0.9	13.3	6.5	0.7	2.6	1.6	21.0	0.2	0.0	35.8	0.0	0.6	0.0	0.0	0.0	4.2	0.6	0.4	11.9	0.1	0.6	2.4	0.3	2.3	0.1	0.0	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.0	0.0	1.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	2.9	0.0	1.8	1.7	0.0	0.0	0.0	2.7	8.8	0.0	0.0	62.3	8.3	0.0	0.2	20.6	0.3	2.8	0.1	3.3	0.0	0.0	0.0	0.0	8.4	5.5	0.0	6.3	2.8	0.0	2.2	0.0	2.6	0.3	0.5	2.3	3.8	1.3	1.4	3.9	0.3	4.3	0.0	0.0	1.9	5.8	13.3	14.3	8.4	6.9	9.0	15.2	10.6	17.2	13.3	11.3	21.0	59.8	3.2	1.5	174.3	5.6	0.3	0.2	0.0	0.6	3.2	0.6	1.0	1.2	0.0	0.0	3.7	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.1	4.5	23.2	0.0	0.4	107.0	0.0	0.1	2.5	3.6	0.1	0.0	0.8	66.0	0.8	1.1	0.0	101.4	0.5	0.0	9.8	0.7	0.8	0.0	3.7	5.4	912.5	3.0	12.3	1.0	23.1	698.3	0.2	3.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.3	0.2	0.7	0.1	0.4	0.1	2.0	6.9	0.3	0.1
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251188	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	40	"skeletal muscle: 2315.3;tongue: 1169.0"	"Cell type enriched"	"Detected in many"	7	"Skeletal myocytes: 287.7"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;monocytes: 5.8"	"Cell line enriched"	"Detected in many"	23	"RH-30: 2282.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA039285: AB_2676427, HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	2.7	2.0	2.7	7.3	2.5	17.8	2.1	4.6	5.3	1.4	2.3	2.6	2.0	0.8	2.8	31.2	1.7	2.3	1.5	2.6	2.3	1.8	4.4	6.5	8.9	2.7	2.6	1.0	1.4	2.6	2.1	2.9	2.7	23.0	3.0	3.2	43.9	1.1	2315.3	3.4	2.6	2.5	2.1	9.1	1.7	11.9	2.6	4.1	2.1	1169.0	7.4	2.4	1.3	3.1	0.6	0.8	2.1	4.0	1.3	2.2	0.8	0.5	0.5	0.5	0.7	0.5	1.9	55.0	1.1	1.2	0.0	1.0	0.9	1.1	0.2	1.4	1.0	27.9	0.3	0.6	0.5	17.2	97.1	10.0	1.6	0.4	0.6	1.3	0.9	6.1	2.9	2.2	7.5	5.4	1.6	36.3	0.1	0.8	1.0	13.0	2282.0	2.6	1.3	1.2	1.4	1.1	1.6	1.5	0.3	0.3	0.9	48.4	1.0	0.5	0.4	1.6	0.4	2.2	1.2	9.6	1.1	32.9	0.7	0.0	4.4	0.3	0.0	5.8	0.0	0.7	0.0	0.2	3.6	0.3	0.0	0.1	0.2	0.0	2.9	1.0	0.2	1.4	2.7	2.5	4.6	5.3	2.6	2.3	2.7	2.6	2.7	2.1	2.6	3.1	0.4	0.0	0.6	1.3	1.9	1.5	0.4	1.1	0.6	7.5	1.2	1.4	0.3	1.5	0.4	0.0	2.1	1.0	2.8	0.9	0.0	0.8	13.5	1.1	0.6	0.7	2.4	0.4	3.0	1.0	0.7	0.8	1.1	0.9	5.7	1.5	1.8	1.3	39.9	1.7	2.4	1.2	4.1	37.3	16.3	8.9	1.2	24.1	0.0	0.0	26.3	1.5	0.0	1.5	1.2	0.9	1.0	0.7	0.5	1.0	1.6	0.7	2.3	2.5	0.0	287.7	1.0	3.4	1.4	0.6	0.3	1.4	1.6	0.8	1.2	0.4
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336236-136752403	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	13.7	9.1	7.6	12.3	8.8	15.7	15.6	17.0	8.3	16.9	9.9	13.5	9.6	19.3	10.6	10.8	13.5	10.3	10.5	6.5	8.7	12.0	10.8	11.2	14.7	9.3	7.8	21.9	12.4	13.7	5.0	17.6	9.0	10.8	14.4	13.2	11.6	12.1	15.0	13.7	11.0	16.1	8.8	11.8	10.0	8.9	7.8	22.5	15.8	15.8	15.9	12.0	11.5	11.2	34.6	17.6	29.1	25.1	21.5	36.8	15.7	37.9	48.4	35.0	33.0	30.2	14.9	26.9	23.3	39.7	28.1	23.4	31.6	17.3	47.4	33.2	14.9	28.8	25.1	16.7	16.3	50.6	27.7	23.4	19.3	25.6	28.6	20.3	27.5	28.8	18.7	52.7	22.3	29.5	33.6	16.4	19.0	23.7	13.9	29.6	31.6	35.7	19.1	24.5	14.2	22.8	40.8	16.0	17.5	15.0	22.9	21.2	23.3	40.1	29.0	36.0	33.9	39.1	28.9	59.5	24.6	17.0	26.2	4.0	3.0	4.6	4.4	3.0	4.6	6.4	3.7	4.0	2.8	4.4	4.1	3.3	8.7	5.5	3.5	4.5	4.8	2.1	7.6	8.8	17.0	8.3	6.5	8.7	9.3	7.8	9.0	8.8	7.8	11.2	44.5	25.6	24.2	95.6	42.4	40.0	31.4	18.7	38.7	43.8	24.8	26.7	10.8	22.8	23.5	16.5	39.6	29.3	39.5	42.1	11.7	20.7	2.8	23.7	59.5	34.1	18.7	29.7	161.8	22.2	26.7	33.8	23.9	39.6	22.2	30.3	31.4	21.5	18.6	28.6	166.8	27.9	8.2	16.9	22.0	4.8	49.4	25.1	16.0	231.4	27.2	25.6	42.2	223.2	188.4	27.4	17.5	32.4	53.1	27.2	24.2	13.2	14.5	68.1	26.3	67.1	36.2	54.8	50.5	27.5	36.7	31.7	39.2	16.0	23.4	24.3
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190908460-191020960	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 533.6;BJ hTERT+ SV40 Large T+ RasG12V: 595.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		92000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	Cytosol	"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	41.2	35.6	8.0	113.3	7.7	35.1	27.1	5.1	10.2	33.9	5.6	43.4	51.3	27.5	15.1	35.8	25.1	66.6	35.6	11.1	14.7	45.3	66.0	69.1	145.6	18.8	9.4	33.0	40.7	39.0	23.8	28.9	13.4	34.8	40.6	20.0	107.4	24.2	29.8	24.9	41.8	47.5	27.3	114.5	55.7	31.2	17.4	104.3	33.4	29.7	59.0	62.2	25.1	13.2	54.8	58.6	26.8	41.4	105.7	158.8	79.3	82.4	257.1	533.6	595.5	95.1	62.8	21.7	48.1	180.8	173.9	45.9	29.8	62.0	108.6	179.6	24.6	99.0	43.8	47.3	72.2	48.4	58.3	94.7	36.8	100.4	31.0	56.5	63.5	38.4	56.8	103.9	93.6	42.5	38.0	41.1	36.6	34.2	95.3	31.4	71.4	27.9	58.9	70.1	37.9	35.0	100.3	35.7	236.5	37.5	38.6	59.9	56.2	105.1	57.5	90.0	51.4	202.1	330.7	21.0	80.8	40.3	47.8	50.0	143.9	104.9	51.6	191.1	71.4	38.3	129.3	77.4	61.4	31.7	128.2	94.2	203.9	77.3	117.3	28.9	227.8	210.2	8.0	7.7	5.1	10.2	11.1	14.7	18.8	9.4	13.4	27.3	17.4	13.2	46.8	73.7	34.3	14.0	48.8	22.2	17.5	32.3	22.2	13.3	27.6	26.0	44.6	51.5	40.3	53.3	25.0	13.6	48.0	44.4	7.9	47.5	18.5	30.9	43.9	42.1	21.0	15.5	9.0	37.8	53.9	44.1	51.5	39.3	51.4	38.5	28.5	54.1	92.6	3.3	12.2	26.7	16.2	72.0	26.2	5.2	21.8	96.9	17.8	31.9	107.3	13.7	62.8	25.1	11.9	36.0	21.7	29.7	69.4	26.7	24.7	44.0	47.7	19.3	39.5	35.4	31.1	25.4	24.6	28.8	31.3	8.3	78.1	37.9	29.2	26.9
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 78.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 101.0;HEL: 153.5;HMC-1: 85.2;K-562: 262.4;MOLT-4: 163.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	78.9	40.6	4.3	28.9	5.7	52.1	48.8	5.3	4.8	19.1	5.4	24.0	8.6	17.8	5.7	9.9	19.0	13.9	13.9	3.6	7.5	13.9	8.1	23.3	37.5	8.0	7.6	22.5	12.2	2.4	10.5	7.3	7.4	15.4	9.1	1.2	15.7	13.7	23.8	18.4	22.4	14.3	6.7	29.8	14.0	4.9	7.7	24.4	13.3	13.8	27.1	24.1	15.4	8.6	3.9	4.9	0.5	0.0	35.7	17.5	0.4	2.1	8.6	4.0	2.3	0.0	3.7	0.3	9.0	8.5	0.2	0.3	0.8	0.3	1.1	101.0	0.0	153.5	9.3	1.3	15.5	13.5	85.2	36.8	2.1	1.7	2.0	0.0	12.3	2.0	262.4	0.1	2.3	0.1	163.5	64.7	1.4	2.5	0.0	4.5	1.1	13.8	1.1	2.6	0.3	0.0	10.0	3.9	17.8	0.9	2.5	13.9	7.2	8.0	2.6	3.9	0.1	0.2	0.1	0.0	1.0	25.4	2.5	9.8	15.1	7.9	10.3	18.6	14.4	8.2	18.3	15.2	18.7	6.6	18.0	15.0	18.3	17.4	24.9	6.6	14.5	12.9	4.3	5.7	5.3	4.8	3.6	7.5	8.0	7.6	7.4	6.7	7.7	8.6	14.0	0.0	10.6	2.6	18.7	7.4	3.8	4.5	5.7	2.9	35.8	24.5	29.6	5.7	3.4	5.5	0.0	1.2	17.7	5.5	5.9	5.0	0.4	7.2	5.2	21.2	0.0	33.2	0.2	13.6	2.9	15.3	5.1	11.9	22.8	6.8	6.1	3.3	21.4	0.0	1.3	4.2	0.0	24.5	41.3	3.5	32.6	31.8	8.8	5.6	41.0	3.9	8.2	2.5	5.0	9.6	8.1	41.0	12.5	12.2	1.8	14.4	8.4	0.7	6.6	13.7	10.2	0.0	0.9	4.4	7.7	1.4	29.2	7.7	6.5	7.0
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892, HPA072004"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB020839: , HPA049892: AB_2680938, HPA072004: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	46.4	40.4	33.6	34.1	36.5	66.0	40.5	35.5	41.5	41.5	33.7	45.2	54.9	42.3	36.8	47.2	66.3	48.7	49.6	33.5	35.2	88.4	122.8	41.8	36.8	39.3	39.1	36.3	69.7	81.4	15.0	49.9	39.4	46.3	47.1	36.4	39.2	46.1	62.5	41.6	50.9	52.1	37.2	33.3	52.8	35.9	36.5	42.8	69.6	47.1	40.9	51.9	31.1	42.5	113.9	85.1	90.7	40.2	90.1	111.3	100.7	84.4	100.8	246.8	111.2	292.0	121.8	77.1	141.7	106.2	118.3	121.5	122.4	150.8	205.9	30.2	70.5	63.3	62.1	233.0	76.1	51.7	59.9	89.6	126.9	100.5	117.0	100.9	123.0	57.4	112.3	46.7	94.6	72.3	90.7	83.5	74.5	109.1	117.9	69.1	119.4	75.0	100.1	98.2	104.8	93.1	209.9	199.0	124.8	91.6	127.4	72.9	113.0	148.2	128.1	92.6	101.6	41.8	52.3	86.8	108.5	54.6	87.4	31.5	19.3	19.8	17.8	15.8	19.7	16.8	18.9	19.1	16.9	15.4	17.1	16.7	38.0	14.2	20.2	15.9	22.9	13.6	33.6	36.5	35.5	41.5	33.5	35.2	39.3	39.1	39.4	37.2	36.5	42.5	76.5	89.8	82.0	45.7	66.4	112.5	125.5	79.9	95.0	32.9	87.5	65.0	63.1	97.2	71.3	77.3	14.6	105.4	72.2	98.4	93.9	130.6	18.6	146.1	80.1	83.0	76.0	137.4	47.9	118.2	45.0	84.8	71.4	87.3	48.1	79.2	72.8	158.3	64.7	43.7	42.2	77.5	59.0	62.9	91.3	21.9	65.6	66.8	49.8	26.2	85.9	57.0	61.8	39.2	51.2	138.5	89.9	70.0	86.8	189.7	107.8	170.0	105.9	29.1	59.2	72.6	74.2	109.1	69.8	92.1	119.8	194.4	78.5	64.6	69.3	196.5
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		1900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	40.6	18.4	32.9	22.3	31.5	46.4	33.1	18.1	34.5	40.4	30.5	33.7	18.1	39.3	18.2	65.6	39.0	25.1	24.0	30.5	23.1	20.0	38.0	26.8	29.8	17.4	22.9	41.2	30.1	43.7	18.0	17.5	18.9	26.0	24.6	11.4	61.1	24.3	111.9	47.1	31.3	34.3	18.6	31.5	32.2	25.4	26.9	68.6	40.9	49.7	29.7	32.2	40.4	22.4	42.4	48.5	14.1	23.5	60.9	55.4	22.2	31.1	31.0	22.6	28.5	24.3	13.8	44.7	35.4	46.2	50.9	74.3	20.1	21.5	19.3	36.7	30.5	70.1	19.2	36.0	53.0	58.9	40.1	56.8	53.2	32.0	90.7	28.2	31.7	59.6	44.2	80.1	24.7	9.8	55.8	20.7	5.4	23.3	18.1	13.8	22.1	41.7	38.2	23.7	3.4	14.2	51.2	33.5	19.2	22.5	12.7	32.4	34.0	40.2	13.8	42.2	25.1	88.0	71.9	22.5	33.4	24.0	26.0	16.6	11.2	20.0	17.8	14.8	14.5	7.9	13.1	19.5	9.6	11.4	14.8	13.3	16.7	20.8	25.5	8.3	14.7	17.1	32.9	31.5	18.1	34.5	30.5	23.1	17.4	22.9	18.9	18.6	26.9	22.4	20.1	16.0	8.2	53.8	22.2	16.4	7.4	9.5	17.6	5.3	16.5	13.2	4.6	18.6	10.5	5.5	14.6	27.3	35.2	27.9	1.9	12.4	4.9	17.5	35.5	12.6	9.1	18.1	63.5	14.5	13.5	20.2	10.7	24.0	29.8	4.7	20.3	32.6	15.7	16.8	56.3	13.0	12.2	22.2	15.2	9.2	27.4	18.7	17.8	57.1	11.0	16.5	36.0	77.4	5.1	12.3	6.7	11.3	14.8	11.2	7.9	3.6	14.2	3.9	26.3	17.1	18.4	21.4	13.5	50.6	22.3	17.4	28.5	1.6	11.8	11.9
STK11IP	"KIAA1898, LIP1, LKB1IP, STK11IP1"	ENSG00000144589	"Serine/threonine kinase 11 interacting protein"	Q8N1F8	2	219597857-219616451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 15.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036837, HPA036838, HPA053192"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075"	"unprognostic (3.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-3)"	"unprognostic (8.36e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	7.6	10.0	12.0	9.5	12.4	19.5	7.1	11.3	13.8	9.2	12.6	9.8	9.2	9.2	15.0	9.6	10.4	9.5	8.0	12.4	10.6	11.2	5.9	9.3	14.0	12.0	11.9	24.5	9.5	7.5	21.5	8.2	12.3	9.9	7.8	12.3	8.1	6.5	5.8	18.4	10.0	8.3	10.0	15.1	8.6	31.2	12.0	19.5	11.1	4.3	11.1	9.0	8.3	11.8	10.1	15.4	16.1	11.0	5.6	9.9	16.5	8.7	7.6	13.9	11.7	14.3	16.7	5.8	8.7	8.4	12.6	24.4	7.7	18.7	10.3	8.7	11.7	15.1	17.2	11.6	7.4	15.9	38.2	9.6	16.5	11.7	5.9	14.2	8.6	9.7	11.4	8.5	7.9	19.7	9.3	19.6	16.2	4.8	8.4	17.5	5.9	4.5	13.8	15.8	10.6	16.8	5.7	13.8	12.0	12.9	8.8	15.3	6.5	15.0	12.6	14.5	8.6	9.4	4.5	10.8	11.4	8.7	9.5	1.5	4.3	5.3	2.6	5.8	2.1	1.7	1.2	2.1	7.7	1.2	1.0	1.0	1.4	3.7	6.5	15.1	2.1	2.6	12.0	12.4	11.3	13.8	12.4	10.6	12.0	11.9	12.3	10.0	12.0	11.8	3.5	6.4	6.7	12.4	3.9	2.3	2.1	6.3	1.2	7.8	5.1	5.5	3.6	1.5	7.8	7.3	18.8	10.0	10.3	14.6	1.9	5.0	14.0	11.9	4.0	4.6	13.1	6.9	10.7	6.5	5.6	5.3	17.3	5.8	12.7	29.7	4.2	3.3	8.4	11.8	8.0	8.8	6.1	8.6	5.7	30.9	25.4	8.9	3.6	8.4	7.0	4.9	4.1	8.5	7.4	4.2	3.3	14.7	2.8	1.7	5.4	2.7	19.9	12.6	13.1	3.2	4.9	18.5	13.8	3.5	2.7	16.1	4.5	5.4	8.8	2.8
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882387-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.07e-4)"	"prognostic unfavorable (5.10e-4)"	70.4	70.2	48.1	54.7	52.5	51.8	49.8	44.4	63.7	51.8	41.4	55.5	46.2	52.2	50.5	60.9	44.4	46.9	93.1	54.8	65.3	84.9	80.3	46.8	54.9	49.9	54.5	40.3	72.0	83.9	58.4	64.6	61.6	49.3	52.8	85.5	48.8	48.7	135.9	44.1	44.9	68.8	47.6	40.3	48.5	50.3	59.0	66.5	77.7	114.6	57.2	70.4	41.3	50.9	195.6	226.2	209.7	179.8	182.3	180.6	280.5	227.9	158.2	200.8	186.4	325.9	167.2	215.6	110.6	233.5	199.3	138.0	254.6	251.0	293.2	291.3	206.1	218.6	163.8	144.7	298.8	258.2	102.0	176.9	209.7	224.6	248.6	221.6	237.9	139.6	170.9	63.9	264.3	137.3	215.6	122.6	743.6	124.8	145.8	162.4	289.7	124.5	232.5	197.8	134.8	228.8	184.7	125.5	258.7	415.8	235.5	135.9	201.3	149.0	177.0	160.3	284.7	73.0	106.1	351.5	183.7	140.1	193.9	74.2	73.9	65.8	66.3	87.4	75.1	76.1	67.8	64.2	92.5	66.7	65.8	70.0	33.7	64.3	80.5	56.8	92.2	84.5	48.1	52.5	44.4	63.7	54.8	65.3	49.9	54.5	61.6	47.6	59.0	50.9	111.7	38.5	45.2	19.9	111.2	243.4	177.6	131.5	116.7	90.1	87.8	65.9	104.0	51.5	84.8	66.2	35.5	154.3	121.2	41.5	275.9	171.1	44.3	63.2	82.1	100.3	106.2	103.7	42.8	137.2	201.2	109.7	61.7	78.6	46.3	112.1	71.7	82.1	108.8	60.6	43.4	59.7	128.1	86.2	143.8	86.2	69.9	89.4	128.1	22.5	99.2	207.9	93.7	24.1	33.9	144.2	66.1	102.0	119.5	218.3	56.0	228.5	58.9	100.9	78.9	96.4	139.0	168.1	80.4	115.6	227.9	295.1	111.3	135.2	95.6	192.5
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773219-27824443	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	64.2	30.1	38.1	26.6	39.0	10.8	37.0	40.8	45.6	28.8	25.4	30.7	36.3	30.9	62.9	39.2	23.9	39.8	20.9	37.3	41.7	35.2	29.1	50.0	25.6	42.0	45.3	22.1	30.3	46.5	26.6	33.3	43.6	30.7	32.5	43.2	26.9	32.1	21.4	27.0	32.8	35.9	42.2	30.5	65.5	13.4	38.4	17.3	94.7	27.1	22.2	39.1	23.4	44.6	23.2	10.9	28.8	19.0	53.9	65.0	14.8	47.9	70.3	43.1	48.5	13.5	29.5	25.2	49.6	64.6	18.5	19.0	19.2	23.9	42.9	22.2	22.8	14.4	12.0	13.7	42.2	16.1	29.0	61.3	28.7	60.6	34.5	35.3	70.3	14.3	19.1	24.6	47.7	8.5	13.7	12.3	12.1	34.3	15.3	8.7	23.1	15.5	38.1	37.5	32.3	17.6	22.4	19.3	35.2	23.3	13.1	14.0	76.2	21.9	12.5	50.0	16.6	14.5	11.2	14.3	35.1	24.1	31.2	24.6	35.7	13.7	6.1	39.4	10.6	13.6	7.3	9.7	25.2	10.8	8.1	6.8	16.5	9.2	40.6	12.4	7.9	17.4	38.1	39.0	40.8	45.6	37.3	41.7	42.0	45.3	43.6	42.2	38.4	44.6	93.0	54.5	36.3	25.1	43.6	109.4	97.2	30.7	51.2	46.2	42.0	25.7	18.9	30.0	40.8	57.0	31.3	30.0	28.3	82.8	37.2	51.9	2.0	34.7	33.1	71.1	41.3	17.7	70.9	58.4	33.5	53.2	108.6	49.4	22.8	26.7	47.8	20.4	50.6	26.9	65.7	29.5	14.2	91.4	77.7	4.2	36.1	62.3	53.4	56.2	41.3	67.9	36.0	34.7	59.1	68.4	58.6	47.4	33.9	74.9	51.3	69.7	27.4	51.2	39.5	45.7	57.5	20.0	20.1	69.9	99.2	78.0	31.6	54.0	29.9	99.9
STX16	"hsyn16, SYN16"	ENSG00000124222	"Syntaxin 16"	O14662	20	58651253-58679526	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041019, HPA042033"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA041019: AB_10964273, HPA042033: AB_10963935"	"unprognostic (7.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (7.32e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.89e-2)"	39.5	44.5	42.3	34.7	43.6	54.3	42.7	38.8	45.5	60.9	36.8	56.4	26.2	50.1	44.6	40.8	58.9	24.9	38.5	39.1	39.5	47.6	45.9	44.2	46.3	44.4	42.1	58.9	50.0	21.2	68.7	26.4	44.4	52.7	26.0	38.7	43.5	30.0	33.3	53.7	49.3	27.8	39.4	65.3	44.3	36.3	42.5	33.0	49.2	19.5	32.4	55.5	49.5	50.8	37.2	21.4	27.6	26.9	49.7	52.6	38.2	45.1	30.5	45.3	28.0	41.9	53.0	42.5	61.3	32.4	56.7	53.9	25.5	53.6	37.3	20.2	26.9	26.6	63.9	51.3	49.2	38.2	57.8	58.9	80.4	30.5	46.0	84.6	46.4	49.2	31.3	36.8	36.9	86.9	29.8	45.9	11.2	30.1	35.9	27.3	25.8	29.6	34.6	27.3	18.2	27.7	47.7	82.8	83.2	46.4	33.1	50.1	49.5	74.1	36.0	28.6	50.3	75.7	37.7	23.4	54.7	29.2	31.7	18.2	5.8	5.0	4.3	5.3	4.8	2.3	3.9	3.1	3.8	3.7	5.1	4.9	12.6	5.4	3.9	3.9	4.7	4.1	42.3	43.6	38.8	45.5	39.1	39.5	44.4	42.1	44.4	39.4	42.5	50.8	40.2	22.4	46.6	0.0	27.0	26.9	19.3	22.8	29.0	65.2	44.3	41.5	24.3	41.5	31.2	29.5	85.5	24.2	33.7	23.4	5.9	16.6	6.2	32.6	51.2	36.3	46.1	26.5	0.0	13.7	20.6	28.3	38.2	26.1	19.6	54.8	37.1	30.8	22.2	42.1	0.0	25.4	20.3	42.9	35.9	8.9	22.7	37.1	21.4	0.0	44.0	29.5	33.0	0.0	0.0	19.7	22.5	29.0	16.2	20.1	30.0	12.5	45.6	52.8	13.1	32.1	30.4	47.5	20.2	35.2	42.3	17.5	42.6	27.8	26.0	21.5
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	38.3	44.0	33.1	34.2	36.2	22.3	33.9	37.4	36.4	36.3	32.3	37.5	38.3	31.4	24.4	35.8	29.8	27.7	39.8	33.2	37.8	33.5	35.8	36.2	31.1	38.0	36.6	30.4	27.7	38.4	23.2	32.3	37.7	29.9	28.6	8.5	29.9	26.5	45.8	44.3	35.9	31.6	36.1	43.7	32.4	14.9	36.2	28.4	29.5	33.8	37.1	38.1	32.6	39.0	51.9	70.6	16.0	36.1	51.1	52.1	33.8	47.7	79.2	47.5	48.7	22.1	53.2	35.4	58.9	80.8	54.4	36.6	15.2	52.6	45.6	60.3	43.8	25.3	48.7	59.7	58.3	29.2	80.1	50.2	36.1	82.1	61.1	58.5	64.3	22.3	29.9	38.6	84.9	80.3	28.0	44.8	33.1	36.9	36.7	24.0	47.1	46.1	45.9	38.7	13.1	24.6	40.6	41.1	17.4	20.7	33.7	38.7	74.4	48.3	21.8	55.8	26.6	41.2	37.0	14.6	73.3	46.4	29.7	21.3	21.7	27.3	17.6	23.8	15.4	12.7	14.7	17.9	18.8	17.5	11.0	14.2	23.0	24.6	21.9	11.1	9.0	11.2	33.1	36.2	37.4	36.4	33.2	37.8	38.0	36.6	37.7	36.1	36.2	39.0	34.9	44.8	22.7	7.8	32.6	65.1	34.6	56.3	31.9	7.4	22.3	20.6	23.6	48.6	35.2	22.0	12.5	31.1	35.9	69.7	29.4	60.6	12.9	22.1	26.6	46.0	25.7	11.1	4.8	67.7	35.7	51.7	43.3	29.0	60.3	42.1	33.9	20.0	89.5	5.0	3.6	39.5	38.7	49.6	149.9	15.7	38.5	83.2	30.2	2.8	51.7	24.1	42.2	3.0	16.0	73.4	58.5	35.3	23.0	61.6	77.7	50.8	31.3	6.9	39.5	40.6	36.4	9.4	6.7	27.0	65.1	33.1	35.4	39.0	47.9	36.2
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	9.5	7.4	13.7	11.2	14.9	2.7	9.2	15.9	17.9	9.5	11.6	7.9	7.5	8.2	7.7	17.5	7.4	7.1	5.8	15.6	13.5	8.7	4.8	11.3	10.9	13.8	13.7	8.2	4.1	7.4	4.5	11.5	12.6	7.2	8.1	8.1	8.0	6.7	4.0	12.8	7.6	8.7	13.2	9.3	7.9	5.6	14.1	17.2	11.4	4.9	14.1	14.2	11.2	16.6	16.9	18.6	18.0	24.1	18.5	21.7	30.3	21.2	27.3	16.4	13.9	17.4	16.5	17.0	28.7	23.4	10.2	29.4	16.5	37.4	19.0	12.3	12.1	11.4	14.2	17.2	18.4	16.4	14.1	19.9	33.6	27.6	28.3	29.3	33.6	15.7	21.3	11.8	22.0	24.2	15.9	15.4	28.2	21.0	9.2	13.7	22.0	24.7	19.6	41.7	25.5	27.0	22.2	42.3	23.9	30.7	25.8	14.9	28.0	22.4	11.8	21.2	17.3	19.8	11.8	12.3	11.0	15.8	13.5	2.6	1.6	2.1	0.7	1.3	0.8	0.7	1.1	1.1	2.2	0.7	1.4	0.9	1.4	0.2	1.1	0.7	1.4	0.6	13.7	14.9	15.9	17.9	15.6	13.5	13.8	13.7	12.6	13.2	14.1	16.6	13.9	16.0	18.6	32.3	11.8	48.9	21.3	19.0	41.5	12.8	16.0	11.7	6.4	2.8	13.7	18.4	6.2	25.7	15.8	10.5	11.7	10.7	8.9	19.4	16.6	23.0	23.4	16.0	54.7	9.8	24.9	12.7	19.4	22.7	12.0	12.7	14.6	4.8	26.4	8.4	38.0	11.1	16.2	26.1	28.0	11.8	8.4	31.9	7.2	23.4	25.2	6.7	15.5	50.3	30.7	14.9	13.9	13.2	10.0	22.2	10.2	11.5	13.3	11.4	6.6	8.2	12.2	5.6	15.4	47.8	37.6	20.5	14.0	16.4	10.6	22.8
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 194.2"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 262.5;Macrophages: 249.1;monocytes: 368.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 248.6;classical monocyte: 471.0;eosinophil: 295.6;intermediate monocyte: 604.8;myeloid DC: 239.7;neutrophil: 356.2;non-classical monocyte: 893.3"	"Group enriched"	"Detected in all"	6	"dendritic cells: 239.7;granulocytes: 356.2;monocytes: 893.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 244.8;U-937: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol		No	No		870000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA015564: AB_1857626, HPA063868: AB_2685136"	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.68e-4)"	"prognostic favorable (5.13e-6)"	24.2	22.8	5.2	65.9	6.3	194.2	24.3	4.8	10.9	22.2	9.3	52.5	67.4	8.4	33.2	73.1	27.7	28.4	7.5	5.1	6.2	62.4	49.0	89.6	51.0	8.3	6.6	5.3	86.7	36.1	29.4	36.3	7.9	52.1	37.0	4.2	79.4	22.8	2.9	52.3	63.9	14.6	6.7	162.2	71.9	74.9	8.8	85.3	52.0	3.0	34.6	34.6	34.8	9.3	113.0	39.1	0.9	0.5	0.0	0.9	75.6	14.2	1.5	2.7	7.4	92.5	69.6	29.6	55.4	11.3	49.5	75.5	4.1	67.5	2.7	124.1	46.9	127.8	49.7	55.8	63.6	83.2	244.8	4.4	67.4	13.4	38.0	0.3	58.5	74.7	81.4	98.5	0.0	70.9	41.2	193.2	28.7	72.7	68.0	41.8	0.3	114.7	55.0	128.1	11.5	0.6	34.0	49.6	2.2	35.6	61.9	212.7	61.7	0.4	21.8	1.5	0.8	108.4	58.6	38.8	1.2	224.8	2.7	248.6	471.0	295.6	69.9	604.8	56.7	47.3	52.7	63.8	239.7	52.2	36.6	44.3	356.2	74.7	893.3	91.5	78.9	306.9	5.2	6.3	4.8	10.9	5.1	6.2	8.3	6.6	7.9	6.7	8.8	9.3	2.1	0.0	7.7	0.7	44.1	23.6	48.2	105.1	18.8	6.0	38.0	22.9	0.9	31.5	68.5	35.0	2.1	97.7	56.2	181.4	33.2	100.3	99.9	32.5	5.4	6.7	59.8	38.3	0.6	118.8	123.2	5.7	150.3	47.6	71.8	34.6	16.4	19.6	168.4	0.0	0.4	108.2	105.8	262.5	46.6	233.5	1.8	249.1	14.2	1.0	368.2	0.9	72.1	0.0	0.0	132.8	152.6	1.9	54.7	49.1	171.7	75.9	42.5	4.0	6.6	1.0	8.6	45.7	20.2	35.3	21.3	153.0	47.7	6.0	79.3	68.7
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 115.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 325.8;Excitatory neurons: 441.9;Inhibitory neurons: 300.1;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.8;eosinophil: 9.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"HEL: 210.2;HMC-1: 219.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	7.0	9.1	7.2	9.5	12.7	34.3	7.8	24.2	13.2	9.5	0.0	14.2	8.0	8.3	7.7	13.7	5.9	9.5	5.9	9.5	6.5	3.6	3.9	6.6	7.8	0.6	0.5	5.5	15.5	115.8	7.7	6.3	0.5	11.4	16.3	20.1	5.5	14.5	7.7	15.4	11.2	10.9	0.0	8.3	8.0	22.2	0.6	9.4	6.3	8.1	9.6	8.5	9.9	8.5	10.8	9.4	4.9	16.5	23.4	48.8	5.4	24.5	36.1	17.8	19.9	8.0	7.0	7.8	5.6	48.8	30.5	12.7	14.1	21.5	21.6	17.1	11.0	210.2	27.2	9.0	26.8	72.7	219.6	35.6	15.0	35.6	72.0	42.1	23.2	12.2	57.8	9.6	35.4	15.7	11.6	18.8	4.0	8.9	21.4	1.7	25.4	3.0	9.7	18.4	10.6	7.6	18.9	13.3	8.2	8.7	3.9	28.0	26.9	25.4	9.2	12.6	22.5	7.9	0.1	9.1	14.0	26.2	18.5	3.8	0.3	9.2	0.9	0.4	0.9	0.3	0.5	1.1	0.4	0.9	0.8	1.3	3.1	0.4	0.5	0.3	0.2	0.3	7.2	12.7	24.2	13.2	9.5	6.5	0.6	0.5	0.5	0.0	0.6	8.5	12.1	16.0	8.8	325.8	5.7	3.6	2.6	1.9	3.4	38.8	6.7	7.7	14.1	11.5	6.7	16.5	31.3	5.2	9.5	18.7	0.0	4.8	39.0	10.1	10.5	10.8	41.1	10.1	441.9	12.9	4.6	10.1	14.3	20.5	44.2	5.1	8.9	4.5	4.7	33.7	300.1	30.3	0.0	7.8	3.1	42.8	7.8	7.8	10.6	97.4	8.5	5.4	6.2	206.1	150.4	11.7	21.4	7.2	5.8	10.4	29.3	1.9	2.2	29.0	13.1	12.7	5.6	13.1	11.5	11.0	6.7	3.8	9.3	5.4	19.3	3.6
SUCLA2	LINC00444	ENSG00000136143	"Succinate-CoA ligase ADP-forming subunit beta"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 232.2;tongue: 271.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 256.2;Late spermatids: 314.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	53.9	40.6	28.4	20.2	30.8	13.6	38.7	36.6	39.2	32.4	33.6	37.1	58.2	27.2	24.8	33.1	24.7	20.3	100.2	30.7	38.2	77.5	29.0	18.2	22.0	30.6	30.0	30.9	25.4	71.2	20.4	28.1	32.3	35.8	36.3	44.2	33.9	31.3	232.2	20.5	44.7	33.1	30.6	19.9	29.7	17.9	33.8	30.7	36.4	271.9	23.9	26.0	25.3	35.1	44.9	49.5	60.6	37.1	68.4	51.3	38.9	64.8	72.4	66.9	44.5	91.3	47.9	61.3	49.3	63.9	39.9	60.0	81.9	61.9	81.6	59.8	75.9	69.2	45.8	58.0	47.6	69.9	38.9	48.4	71.2	45.3	52.6	54.4	49.0	70.7	47.7	21.1	65.8	31.4	73.1	80.8	64.4	150.2	64.7	60.9	55.4	49.3	94.4	41.9	34.7	41.2	54.5	49.3	39.1	66.5	43.8	60.8	39.0	36.2	24.1	53.0	45.7	23.0	37.4	72.7	22.8	50.9	54.8	12.6	50.2	27.8	34.4	53.7	41.9	34.6	38.0	42.2	62.5	33.1	47.7	47.5	8.8	51.8	46.1	49.8	46.6	36.5	28.4	30.8	36.6	39.2	30.7	38.2	30.6	30.0	32.3	30.6	33.8	35.1	20.8	25.6	16.8	17.6	20.1	32.4	37.7	57.5	21.1	44.8	28.9	26.5	148.8	17.2	40.2	31.3	12.5	48.7	18.1	29.1	164.4	32.3	256.2	50.9	32.0	22.0	19.2	21.0	37.0	17.8	42.7	37.7	19.9	52.6	33.7	25.2	16.1	14.7	29.9	45.4	39.0	19.5	71.2	16.7	20.4	314.2	37.0	21.7	42.7	21.5	24.9	43.3	13.4	26.2	38.2	20.2	30.6	46.3	22.1	35.9	62.3	127.4	29.9	42.4	39.5	33.3	50.0	36.3	29.0	22.8	31.7	52.1	19.7	47.3	30.4	39.0
SUGP1	"DKFZp434E2216, F23858, RBP, SF4"	ENSG00000105705	"SURP and G-patch domain containing 1"	Q8IWZ8	19	19276018-19320509	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004890	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA004890: AB_1079935"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"unprognostic (5.21e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.25e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.42e-3)"	5.3	5.5	2.7	4.1	3.1	2.5	5.1	2.4	3.4	4.7	2.5	6.4	4.0	6.3	2.5	6.8	5.0	1.7	8.4	3.3	3.0	4.8	4.1	4.0	3.0	3.0	3.3	4.5	4.3	4.0	4.1	2.7	3.1	4.1	2.4	2.0	5.7	3.0	15.0	5.9	5.7	2.9	2.5	5.5	6.0	14.9	3.0	5.6	4.4	5.6	3.5	5.3	4.7	4.1	13.2	2.7	6.3	8.1	5.8	5.7	15.6	8.1	11.2	11.1	8.9	3.9	9.4	11.1	12.8	10.9	6.7	9.4	6.4	10.3	6.4	7.9	5.2	9.3	3.5	4.0	6.0	8.3	11.9	10.4	5.4	10.0	3.7	6.3	7.4	7.8	14.1	6.9	9.9	8.2	16.1	12.1	14.9	10.2	8.0	15.0	7.1	11.9	8.5	6.0	10.5	12.5	6.3	8.6	15.4	6.9	8.4	13.1	14.7	9.0	9.6	12.8	11.0	11.4	11.8	13.3	11.8	9.1	11.0	6.4	8.9	9.0	9.2	10.8	7.2	7.6	7.9	9.5	9.0	7.4	7.8	8.1	10.2	10.9	13.9	6.9	8.3	9.5	2.7	3.1	2.4	3.4	3.3	3.0	3.0	3.3	3.1	2.5	3.0	4.1	6.4	16.0	14.1	14.4	11.4	4.7	6.5	20.1	12.5	11.5	6.2	6.9	21.5	14.3	16.9	14.7	4.2	18.6	10.7	11.8	17.6	15.1	44.1	9.2	7.6	9.5	9.6	19.0	12.1	14.1	14.3	8.9	13.7	7.2	9.5	11.8	10.4	8.2	14.2	1.7	13.4	10.3	8.2	9.4	7.2	115.2	11.1	10.3	10.6	3.7	17.6	15.2	14.4	10.1	8.6	13.4	13.7	12.4	8.4	3.3	16.5	16.4	10.4	10.2	6.6	8.9	13.7	32.5	17.8	7.1	5.7	16.8	12.0	24.1	11.1	4.4
SUGP2	"KIAA0365, SFRS14"	ENSG00000064607	"SURP and G-patch domain containing 2"	Q8IX01	19	18990888-19034023	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 237.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041557, HPA061111"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA041557: AB_10794301, HPA061111: AB_2684432"	"unprognostic (1.35e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.94e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.60e-2)"	24.5	36.2	29.0	18.2	30.1	41.7	28.4	30.8	37.6	37.5	28.0	35.9	17.1	30.2	20.5	25.6	35.5	12.7	36.6	34.5	22.7	36.0	31.7	32.9	23.5	21.5	23.5	39.4	23.9	17.0	54.3	14.2	21.7	46.9	16.4	45.1	32.3	16.1	37.7	22.4	31.6	15.6	18.0	37.4	27.0	87.7	24.4	22.7	60.9	24.3	20.2	30.9	32.8	30.6	27.7	25.7	64.6	46.7	29.7	29.2	32.2	33.8	25.4	38.8	33.1	16.9	24.0	54.3	27.3	27.2	45.8	20.1	53.2	20.6	35.2	19.3	47.0	34.3	42.6	22.2	21.4	29.2	33.3	30.4	21.5	23.7	19.3	51.8	20.6	41.8	52.6	38.1	42.6	23.5	34.3	54.5	33.5	32.4	36.1	33.8	33.2	30.6	19.7	27.5	71.5	29.4	29.9	20.7	14.8	49.5	21.6	26.9	22.6	38.0	22.8	44.6	40.2	48.0	39.1	40.0	38.3	45.0	40.9	4.1	1.4	1.3	2.1	1.5	1.1	1.1	1.3	1.2	1.5	1.8	1.2	1.4	1.3	4.4	1.3	1.9	1.3	0.8	29.0	30.1	30.8	37.6	34.5	22.7	21.5	23.5	21.7	18.0	24.4	30.6	24.5	41.7	45.1	69.9	22.9	17.6	22.6	17.9	18.8	91.2	30.0	23.5	34.7	22.8	33.3	27.6	93.8	16.7	57.0	19.2	9.8	16.2	84.9	44.4	44.7	25.2	41.5	35.3	106.5	10.5	10.2	29.1	31.6	40.7	27.1	94.9	21.8	28.5	23.4	106.0	90.3	22.5	26.4	31.4	19.9	132.0	40.4	29.1	12.4	34.7	31.2	44.5	57.7	42.7	45.2	18.7	23.2	37.6	36.1	26.1	14.5	11.3	42.5	108.6	52.6	33.5	22.8	237.7	56.2	17.2	18.8	7.5	29.3	79.8	26.9	23.6
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552172-48599425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 286.0;skin 1: 186.5;vagina: 145.9"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 62.3;Proximal enterocytes: 75.9;Squamous epithelial cells: 56.0;Suprabasal keratinocytes: 137.4;Urothelial cells: 114.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 74.2;MCF7: 46.8;OE19: 122.9;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041724, HPA043539, HPA076510"	Enhanced		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Cytosol	"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.3	0.2	0.5	0.4	0.4	0.1	11.5	0.6	0.8	74.4	0.4	0.8	9.3	0.5	6.8	286.0	1.2	2.7	0.2	0.5	0.5	13.0	0.3	9.4	0.0	0.5	0.7	0.1	0.7	7.9	0.4	1.5	0.5	22.6	0.2	0.0	53.6	3.7	0.4	186.5	18.2	0.1	0.4	0.1	3.5	0.5	0.9	0.4	1.9	0.0	28.3	0.7	145.9	0.5	12.6	15.8	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.9	74.2	0.1	0.1	0.0	0.7	3.9	0.1	0.3	0.0	0.5	0.4	0.0	0.5	0.5	0.0	0.0	7.2	0.2	2.1	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	46.8	0.0	0.5	0.0	122.9	0.0	0.1	0.0	0.1	0.0	3.5	0.2	0.1	0.0	6.2	0.3	0.0	36.7	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.3	0.5	0.1	0.0	0.3	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.6	0.8	0.5	0.5	0.5	0.7	0.5	0.4	0.9	0.5	0.4	19.2	0.5	1.0	0.0	24.1	30.5	11.6	0.0	0.0	16.8	12.4	0.6	5.7	40.2	9.2	0.0	3.2	0.0	4.4	0.0	12.2	0.0	15.7	1.4	0.9	4.8	0.0	1.0	1.2	3.1	1.2	2.6	17.5	0.0	0.1	0.0	0.3	0.7	0.0	0.9	12.6	24.4	0.0	4.8	0.9	0.3	0.4	12.4	1.0	0.0	1.6	0.0	0.5	0.8	18.5	7.9	0.0	0.0	62.3	75.9	1.3	6.7	0.6	0.0	0.1	2.2	0.2	11.1	56.0	137.4	1.9	0.6	2.0	9.2	114.6
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	68.6	58.1	58.5	56.7	64.6	118.8	63.6	50.6	75.5	55.5	55.9	55.2	55.1	52.9	50.3	57.2	52.1	44.6	74.3	64.4	71.8	64.0	59.3	61.7	68.8	53.3	59.0	57.6	49.4	44.7	38.3	49.1	58.3	46.2	45.8	72.0	66.5	47.4	106.6	51.0	58.0	39.8	54.5	61.6	56.3	28.8	68.5	63.7	54.8	73.9	57.5	50.0	53.6	50.9	226.4	88.8	131.7	80.2	105.1	147.9	86.5	152.0	177.2	211.5	173.6	133.6	137.2	78.4	234.6	165.4	122.4	53.0	96.8	123.0	166.3	110.0	106.3	322.7	78.8	123.1	113.3	184.5	172.1	126.0	139.5	123.9	89.9	87.8	109.8	164.6	188.7	215.2	173.8	293.1	220.0	127.7	254.4	223.1	174.9	239.0	8.0	217.1	120.2	111.9	98.8	153.4	136.5	196.2	126.3	48.1	190.6	218.6	172.4	99.1	151.4	151.6	172.8	155.4	234.8	198.7	77.9	265.2	138.6	2.8	123.1	52.0	78.9	130.0	79.7	84.6	74.9	76.5	133.3	77.7	88.7	81.0	14.0	70.6	122.3	162.8	91.2	157.8	58.5	64.6	50.6	75.5	64.4	71.8	53.3	59.0	58.3	54.5	68.5	50.9	83.4	64.1	50.4	5.5	76.5	96.0	121.7	127.9	74.6	72.2	99.4	88.5	59.5	67.2	66.5	95.6	20.9	122.9	98.1	95.6	166.3	121.7	63.1	36.4	51.7	101.4	59.2	113.8	14.3	112.4	107.8	76.7	52.0	37.9	29.8	63.8	92.8	116.6	200.5	62.2	13.3	91.5	81.4	143.4	172.3	114.2	72.1	137.9	97.8	10.3	280.0	132.4	111.2	3.5	6.5	148.7	112.6	72.6	58.2	150.7	129.2	130.2	33.0	60.5	59.2	43.8	68.7	90.7	77.5	82.7	77.9	136.3	78.2	43.2	99.9	145.1
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 343.8;Late spermatids: 576.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	72.4	26.9	26.1	17.9	25.4	8.3	60.7	43.4	30.7	75.3	29.1	52.3	33.8	73.3	38.5	43.8	66.1	28.2	77.4	25.2	24.3	44.3	28.2	41.7	23.6	23.5	27.2	84.1	34.1	53.0	59.0	47.3	23.1	39.2	30.2	41.4	44.7	34.0	119.2	87.1	42.1	41.5	23.8	38.8	48.1	45.5	24.3	20.0	44.3	99.1	25.1	38.9	57.4	25.3	128.7	34.2	40.2	65.5	43.4	61.6	39.2	31.7	53.4	58.0	59.0	29.1	139.8	30.5	32.2	43.7	113.5	156.8	33.3	55.9	55.9	13.2	33.3	10.0	51.0	27.8	55.3	15.2	24.3	31.0	65.6	46.3	76.4	53.7	42.7	19.0	41.9	22.4	58.6	44.5	10.1	25.2	56.0	44.3	39.0	21.9	22.3	28.7	59.1	40.7	77.2	49.9	40.1	81.4	31.5	64.6	64.6	15.4	32.5	52.8	47.6	55.1	53.2	20.4	25.6	19.0	36.6	12.7	74.4	11.6	9.4	2.5	4.0	8.3	4.2	6.8	7.9	4.6	7.5	5.5	11.0	7.2	0.5	6.6	6.4	1.5	7.3	6.4	26.1	25.4	43.4	30.7	25.2	24.3	23.5	27.2	23.1	23.8	24.3	25.3	107.0	44.8	36.4	63.0	26.5	106.7	96.9	73.2	50.7	72.4	48.0	38.1	103.7	31.5	68.5	40.5	87.6	37.4	14.1	61.9	27.4	41.5	343.8	168.5	40.3	79.9	40.7	31.5	76.5	23.2	23.5	52.6	60.1	143.7	17.1	73.4	62.4	39.1	17.9	112.7	64.5	45.1	59.0	20.0	34.3	576.2	57.2	16.8	42.7	43.1	16.6	24.0	10.3	48.7	49.8	55.8	68.4	42.5	26.4	84.6	37.7	21.9	163.5	67.6	65.7	53.5	73.4	40.9	49.4	36.1	85.7	38.4	22.0	26.1	38.2	137.4
SUPT5H	"FLJ34157, SPT5, SPT5H"	ENSG00000196235	"SPT5 homolog, DSIF elongation factor subunit"	O00267	19	39436156-39476670	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029273, CAB034370"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB034370: AB_2196394, HPA029273: AB_10603896"	"unprognostic (3.96e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (7.00e-5)"	"unprognostic (7.30e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.38e-1)"	43.3	46.2	44.7	44.9	46.6	106.1	41.7	38.2	48.3	45.3	35.3	48.1	40.3	49.7	29.6	42.7	46.2	34.6	41.2	42.7	42.6	38.8	52.1	45.4	51.6	40.4	40.6	55.9	49.5	49.3	72.6	38.2	40.7	48.5	30.0	33.0	54.7	36.1	87.2	50.0	51.3	33.7	37.5	46.7	46.9	102.1	45.1	40.2	51.1	35.6	41.4	45.0	40.2	49.1	134.1	209.5	75.2	76.4	70.7	50.4	64.8	115.4	70.5	66.0	73.2	137.9	80.1	159.7	106.4	104.7	55.0	50.8	101.9	73.5	51.6	161.6	100.3	179.2	99.7	84.5	64.0	148.5	117.4	78.9	54.6	83.9	86.2	72.2	64.0	137.3	137.9	80.4	66.2	132.5	108.5	44.5	94.0	109.8	52.3	108.8	111.0	80.5	68.3	214.1	72.7	98.1	134.0	104.6	71.7	63.3	63.6	80.1	137.6	67.1	77.8	84.1	145.5	130.9	240.8	196.0	81.8	84.1	84.7	49.0	22.1	19.0	13.7	11.5	13.9	23.0	9.6	11.5	11.1	16.2	10.6	9.0	46.3	15.3	17.2	42.6	11.4	15.6	44.7	46.6	38.2	48.3	42.7	42.6	40.4	40.6	40.7	37.5	45.1	49.1	45.1	44.8	82.7	26.4	51.9	51.6	26.8	34.1	43.3	47.4	40.2	51.9	58.8	30.0	51.6	44.1	85.5	36.5	79.6	62.6	13.7	37.4	69.9	73.2	57.2	43.8	89.2	40.4	16.6	35.1	45.3	39.1	72.9	92.2	46.2	36.0	32.5	62.5	36.7	48.8	17.6	62.4	26.4	32.2	68.9	79.1	45.1	51.4	40.9	15.0	41.2	28.4	47.4	15.1	23.1	53.5	46.3	41.3	86.5	32.8	58.1	22.9	67.9	57.6	19.7	57.3	38.1	84.4	80.4	41.0	49.6	54.0	72.6	31.0	50.4	31.2
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356550-133361158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 105.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 448.9;Late spermatids: 992.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	15.3	16.4	13.2	5.4	13.0	5.4	15.3	13.5	15.6	13.8	12.5	16.9	7.6	13.1	6.0	25.8	13.4	3.5	18.9	12.9	12.6	27.7	22.6	12.1	7.1	14.3	13.5	13.2	28.9	5.8	24.2	3.1	13.2	17.7	2.9	4.7	17.0	4.4	21.6	28.3	14.2	2.3	12.6	15.6	20.1	105.8	13.5	6.1	15.5	3.9	4.9	16.5	15.6	13.3	17.4	29.4	12.1	15.1	8.7	6.7	25.4	8.6	7.5	13.5	7.0	40.5	14.0	17.1	12.2	5.8	11.6	46.5	19.2	21.1	6.1	16.7	26.8	13.5	34.7	15.3	17.3	22.6	9.9	8.1	24.5	19.3	28.1	4.8	6.3	20.6	21.9	11.5	9.3	104.3	23.4	15.0	38.1	41.3	56.0	25.7	18.1	40.4	11.8	19.6	44.8	22.7	19.3	31.7	27.0	7.3	33.8	10.6	12.1	20.3	20.7	21.2	31.2	14.3	30.6	18.7	13.0	13.3	20.8	23.7	23.0	18.6	24.3	24.8	32.1	22.3	29.7	28.0	20.3	27.5	27.9	26.6	10.3	21.1	18.6	22.7	42.1	20.8	13.2	13.0	13.5	15.6	12.9	12.6	14.3	13.5	13.2	12.6	13.5	13.3	26.7	12.8	11.5	3.3	23.2	84.1	27.6	53.7	50.7	18.3	31.1	55.1	13.3	35.8	27.3	22.0	2.1	37.8	25.0	30.6	105.7	73.0	448.9	44.4	16.8	20.9	36.5	28.2	3.5	81.6	28.4	19.3	19.9	16.5	9.5	12.9	22.5	23.6	29.7	13.5	2.9	21.5	36.7	25.5	31.7	992.3	26.1	18.7	42.7	0.0	33.1	28.2	34.0	1.0	3.5	63.8	37.4	24.5	19.6	28.8	81.4	78.0	60.2	23.6	65.7	24.4	26.8	169.9	107.3	43.0	88.2	25.6	38.2	52.2	30.1	23.2
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328776-133336188	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 91.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	10.4	11.7	8.1	4.1	7.8	4.9	10.3	8.7	7.5	12.4	5.9	13.6	6.2	11.9	2.6	12.5	11.2	2.5	10.5	7.2	7.5	11.7	12.3	8.5	5.5	7.7	7.8	13.1	11.2	3.9	8.1	3.3	7.8	11.5	3.4	3.3	9.7	4.0	17.9	13.2	12.1	2.7	7.5	11.4	9.9	7.9	7.9	4.6	10.6	3.9	3.7	12.2	11.1	8.1	5.6	8.7	6.5	9.8	4.0	3.7	10.8	8.8	5.1	7.7	4.8	13.8	9.2	16.2	6.7	4.9	5.6	16.7	8.4	9.3	2.8	10.8	9.6	11.2	10.5	8.3	7.2	19.1	9.3	5.3	8.0	8.0	7.4	6.8	4.0	15.6	25.1	8.4	6.8	14.7	15.5	15.7	19.1	22.7	15.6	16.1	9.1	16.7	6.7	5.3	13.7	11.6	8.6	13.7	7.8	3.9	12.2	10.6	8.4	17.3	9.3	8.9	12.0	6.2	9.6	21.0	6.5	12.9	10.4	3.3	3.0	1.4	4.3	2.9	4.5	4.6	3.9	3.9	3.3	5.1	5.2	4.4	0.8	3.2	2.7	6.0	3.6	2.5	8.1	7.8	8.7	7.5	7.2	7.5	7.7	7.8	7.8	7.5	7.9	8.1	25.7	44.8	27.3	4.6	20.9	23.7	15.7	11.0	24.5	26.5	33.4	32.3	30.0	28.6	24.5	22.0	6.2	32.2	20.3	36.8	21.5	29.2	1.3	21.1	42.2	23.6	33.6	14.1	4.3	19.6	25.2	21.2	18.8	25.1	25.3	25.4	16.4	35.2	21.2	21.9	4.8	40.3	6.1	14.7	10.2	4.1	27.7	13.7	7.2	5.6	18.6	15.2	29.9	5.0	4.1	29.0	33.3	27.8	14.4	24.8	50.6	26.1	13.2	19.6	0.0	15.8	20.3	19.2	23.6	26.3	27.6	19.0	18.1	91.1	57.7	13.3
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719612-16765340	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	15.3	25.1	5.8	11.2	6.5	25.5	12.4	7.1	7.8	13.1	11.8	14.6	17.4	9.2	8.7	11.3	11.1	13.2	9.5	6.8	7.4	16.0	29.4	9.1	10.3	7.1	6.7	10.9	11.8	15.5	7.6	8.7	7.0	12.8	13.0	7.8	10.7	8.0	12.6	10.3	15.6	9.9	6.6	7.1	13.2	6.4	7.7	7.9	11.5	7.6	10.7	10.8	8.3	8.8	29.2	24.1	17.0	32.0	22.6	25.6	7.8	22.7	16.2	18.6	18.4	22.8	23.5	22.6	32.4	22.3	37.9	16.9	21.0	29.7	24.7	14.8	41.9	9.0	25.4	21.9	16.2	15.5	13.4	17.6	13.7	32.2	27.1	21.5	26.0	6.9	19.8	12.2	25.4	34.2	8.4	16.6	19.9	16.1	26.3	9.1	21.5	22.8	27.8	18.9	17.3	21.3	42.2	29.7	23.1	22.0	39.5	13.8	20.6	23.7	12.5	48.7	18.6	13.4	12.2	26.1	23.3	7.7	19.8	7.4	7.2	9.3	9.9	7.9	8.1	9.0	8.4	9.2	7.8	7.0	8.3	8.7	12.0	10.1	11.4	6.5	10.5	6.5	5.8	6.5	7.1	7.8	6.8	7.4	7.1	6.7	7.0	6.6	7.7	8.8	60.4	64.1	75.6	14.4	96.0	64.1	107.0	69.5	37.0	20.2	116.0	78.2	74.3	88.6	92.2	79.1	22.9	66.5	273.8	164.3	111.6	119.6	214.8	219.3	84.7	53.3	106.1	45.9	13.9	132.1	83.3	65.5	72.4	176.3	210.0	38.3	71.4	216.0	49.5	23.5	16.0	107.4	63.1	70.8	241.0	296.2	42.3	171.5	67.6	8.4	55.7	49.4	64.9	11.6	26.9	183.6	159.2	54.5	185.5	80.3	148.3	164.3	169.7	21.5	59.2	56.9	68.1	15.3	21.5	42.0	52.6	150.5	156.6	48.5	118.6	104.4
SYCE1L	MRP2	ENSG00000205078	"Synaptonemal complex central element protein 1 like"	A8MT33	16	77199408-77213215	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 23.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 89.5;Breast myoepithelial cells: 125.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 11.1;U-698: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA062464, HPA066691"			Enhanced	"Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 35: Glandular cells - Unknown function"	"Intermediate filaments"		"HPA062464: , HPA066691: AB_2685702"	"unprognostic (5.54e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (9.27e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.73e-2)"	2.7	1.5	1.7	0.4	1.3	1.2	3.6	7.9	2.3	5.5	1.6	1.7	0.8	3.0	1.5	1.5	3.2	0.4	1.4	1.2	3.0	3.2	1.4	1.4	1.0	2.0	2.7	5.2	2.0	0.7	2.1	0.5	1.7	7.0	0.5	2.8	5.1	0.6	0.8	2.9	2.1	0.5	2.0	2.0	1.1	23.5	1.6	0.4	3.4	0.0	0.6	2.4	4.1	1.1	2.4	0.9	2.3	0.9	0.2	0.0	0.3	0.6	0.2	0.3	0.6	0.4	4.6	1.3	2.6	0.4	0.1	3.4	0.2	0.0	0.2	1.4	11.1	0.3	0.8	0.0	1.5	0.8	0.8	0.0	0.3	0.1	0.2	0.3	1.6	2.0	0.6	0.1	0.2	3.6	0.5	0.9	1.4	0.3	3.8	5.7	0.6	0.4	2.3	0.5	2.3	2.2	0.3	0.2	0.0	0.1	0.0	0.8	5.1	0.3	5.1	0.6	0.1	4.1	1.9	8.0	1.9	0.4	0.1	4.5	1.3	13.9	6.8	2.6	7.8	4.0	8.2	9.0	1.8	2.6	8.9	8.4	1.4	3.6	2.1	13.8	12.6	3.4	1.7	1.3	7.9	2.3	1.2	3.0	2.0	2.7	1.7	2.0	1.6	1.1	19.5	3.2	3.7	6.5	7.6	17.3	10.9	15.2	15.9	3.7	89.5	125.7	1.7	32.9	7.4	27.6	10.4	6.8	8.9	22.4	15.6	24.8	24.7	7.1	4.5	15.9	22.4	1.3	5.9	27.9	4.0	13.8	2.6	15.2	1.3	5.0	18.2	13.2	2.3	1.7	9.2	52.0	12.2	15.8	9.7	55.5	13.7	3.6	19.6	5.6	2.9	35.1	3.1	7.5	10.6	13.9	27.2	6.8	6.9	16.7	22.3	31.9	2.6	44.5	6.6	19.9	5.4	30.4	9.9	6.7	17.0	2.9	9.4	0.5	52.5	7.1
SYNDIG1	"C20orf39, DSPC2, FLJ14220, IFITMD5, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469629-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;heart muscle: 26.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 157.4;Microglial cells: 472.2;Oligodendrocytes: 214.3"	"Cancer enhanced"	"Detected in many"		"glioma: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 15.4;RH-30: 43.4;RPMI-8226: 43.6;SCLC-21H: 10.0;U-87 MG: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.16e-6)"	"unprognostic (1.40e-3)"	1.8	0.9	23.7	1.5	23.2	0.0	0.5	27.6	26.8	3.2	8.6	0.8	1.2	3.2	0.7	0.2	4.2	8.8	26.9	21.1	21.0	4.9	0.0	0.7	2.0	28.4	23.0	0.9	0.7	0.2	0.7	0.2	28.4	3.3	0.9	1.8	0.3	12.3	0.1	0.2	2.1	2.2	27.8	0.7	1.6	0.8	25.3	1.6	4.8	0.1	2.4	1.7	2.0	36.4	0.0	0.3	2.6	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	15.4	0.0	0.8	0.0	0.0	2.6	0.0	0.0	0.0	43.4	43.6	0.0	0.0	10.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	23.2	27.6	26.8	21.1	21.0	28.4	23.0	28.4	27.8	25.3	36.4	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.2	0.7	0.6	1.2	0.0	0.0	157.4	0.0	0.0	2.0	0.0	0.8	0.0	21.9	0.0	0.0	0.1	3.3	69.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	472.2	0.0	1.9	0.0	41.7	214.3	1.5	0.0	7.2	0.0	0.0	0.0	5.9	0.0	0.5	0.0	0.5	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2"	"Cell type enriched"	"Detected in some"	52	"Cardiomyocytes: 665.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	0.1	0.5	0.7	0.1	0.7	0.3	3.6	0.8	0.9	0.4	0.1	0.0	0.1	0.1	0.1	11.8	0.1	0.1	262.3	0.7	0.5	0.1	0.1	1.2	0.2	0.7	0.6	0.2	0.4	0.0	0.1	0.6	0.5	3.1	0.0	0.4	4.8	0.0	279.2	0.3	0.0	0.0	0.5	0.2	0.1	0.3	0.6	0.1	0.2	87.2	0.2	0.0	1.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.6	0.1	0.0	4.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	3.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.7	0.7	0.8	0.9	0.7	0.5	0.7	0.6	0.5	0.5	0.6	0.7	0.5	3.2	0.0	0.3	0.9	1.5	1.4	0.0	2.2	1.9	1.0	0.8	665.1	0.0	0.7	0.0	2.1	0.2	0.5	0.0	0.0	0.0	2.6	0.1	0.4	5.0	0.0	0.0	0.3	0.0	0.2	12.6	0.0	0.3	1.3	0.3	0.0	0.4	0.2	0.0	0.9	0.0	0.0	0.6	2.1	1.1	0.9	0.8	1.8	1.0	0.3	0.4	0.0	1.5	1.1	0.0	0.0	0.4	0.3	0.9	0.0	0.2	0.7	1.2	0.0	12.0	5.2	0.8	1.3	0.4	0.4	0.0	0.7	0.2	0.0	1.0
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
TACC3	"ERIC-1, ERIC1, maskin, Tacc4"	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1712891-1745171	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.9;lymphoid tissue: 52.4;testis: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 70.4;Hofbauer cells: 43.9;Late spermatids: 69.9;Spermatocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	5.3	3.9	4.2	24.9	4.3	58.9	3.5	5.2	5.3	3.6	5.2	10.3	6.6	3.3	4.8	14.9	2.8	4.2	3.3	4.5	4.4	2.7	3.5	6.5	43.2	4.8	5.3	2.2	1.4	2.3	2.6	8.7	4.8	2.4	10.6	1.9	3.9	2.5	2.0	6.4	12.9	6.4	4.2	22.1	6.4	50.6	5.1	52.4	2.8	3.4	39.3	5.0	5.4	4.7	106.7	88.7	129.5	72.2	6.7	15.2	72.9	114.6	62.1	135.4	87.6	93.5	122.8	133.8	48.0	65.4	149.9	71.4	142.5	86.8	131.1	59.8	77.0	113.8	67.2	85.8	5.9	146.6	85.5	5.2	5.7	85.6	46.0	26.0	102.2	110.3	106.3	90.8	123.8	87.1	207.5	204.0	139.3	89.2	111.6	139.1	90.5	55.0	73.8	125.5	99.8	62.8	70.1	42.3	33.1	95.2	83.3	90.5	56.4	75.4	90.0	65.4	176.7	69.5	102.5	207.1	43.2	141.1	109.1	45.5	30.0	37.9	8.5	12.5	11.1	7.8	16.5	11.5	15.3	10.8	28.3	13.1	91.8	12.2	9.6	8.3	42.5	32.5	4.2	4.3	5.2	5.3	4.5	4.4	4.8	5.3	4.8	4.2	5.1	4.7	6.0	0.0	6.7	2.0	16.5	2.2	1.2	3.2	1.2	1.7	2.4	3.0	2.6	2.8	3.4	9.2	8.4	19.5	6.4	11.2	0.0	2.2	70.4	4.2	2.8	5.2	1.2	37.2	2.3	0.7	20.4	6.0	12.8	4.3	5.1	24.5	8.9	5.1	43.9	5.0	3.2	9.5	4.1	23.2	10.8	69.9	2.8	34.1	0.0	4.7	24.4	1.4	6.2	0.5	0.8	2.9	4.2	2.6	18.0	1.3	2.6	2.8	0.9	2.7	6.6	2.0	4.8	94.3	37.7	12.8	1.4	4.0	23.2	2.2	16.1	2.7
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600882-63608365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9;Proximal enterocytes: 81.2;Proximal tubular cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	12.8	18.6	16.6	8.2	17.4	8.3	10.9	18.9	18.4	8.8	17.7	17.8	18.9	11.1	9.7	13.4	9.3	5.5	42.3	16.5	17.5	30.1	69.2	7.7	10.4	17.4	17.4	8.3	12.0	18.2	9.5	8.3	17.3	9.5	16.1	9.4	11.4	9.2	61.5	11.3	16.7	9.7	16.9	11.5	15.1	12.1	17.6	9.9	9.4	55.9	12.2	11.8	9.2	16.7	39.6	61.2	19.4	20.2	16.5	23.5	25.7	28.5	26.8	56.2	44.4	40.5	23.2	32.6	21.2	33.1	38.9	35.8	43.0	41.5	52.6	17.3	58.1	32.0	29.8	72.3	45.5	38.3	21.7	29.0	28.6	48.5	51.1	20.9	29.6	24.2	44.4	24.1	26.6	71.6	44.7	28.7	16.8	42.5	62.9	28.1	47.7	40.8	33.2	27.6	29.5	32.4	19.6	64.0	55.3	25.3	53.3	29.1	26.4	39.9	29.9	27.5	50.7	25.9	27.2	38.7	30.4	26.0	29.6	2.2	9.4	9.0	9.8	8.5	10.7	7.5	13.7	9.7	10.6	9.9	12.4	10.3	1.4	17.8	7.4	7.0	10.2	9.4	16.6	17.4	18.9	18.4	16.5	17.5	17.4	17.4	17.3	16.9	17.6	16.7	9.8	3.2	6.3	2.6	12.0	2.5	8.0	21.1	8.6	8.2	7.8	10.9	54.0	17.2	11.5	14.7	2.1	32.1	8.2	32.9	54.8	29.1	15.3	8.0	11.4	14.2	13.8	17.4	4.0	27.4	28.9	14.1	16.8	6.4	9.5	16.2	8.6	87.9	26.3	6.7	3.9	21.7	12.2	10.7	3.9	46.0	11.8	9.2	10.6	2.8	22.0	15.5	14.4	1.5	3.2	30.0	25.8	11.3	10.7	11.6	81.2	109.7	9.1	13.4	19.7	10.7	14.6	26.8	13.9	18.6	4.3	19.8	10.1	40.7	32.8	7.1
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076003	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	37.0	17.5	22.5	23.3	24.2	49.7	22.4	23.8	26.3	25.5	14.8	26.4	16.1	21.1	21.9	33.9	12.2	27.3	30.5	19.9	24.7	34.4	32.0	18.3	15.0	25.0	24.5	7.0	17.0	25.7	8.7	33.4	25.7	25.2	27.7	9.2	15.1	17.2	66.9	18.9	17.0	34.9	28.9	12.8	20.9	17.0	27.8	12.9	28.0	48.4	24.3	34.7	9.2	25.6	74.5	19.3	28.7	42.0	80.7	75.2	47.6	172.3	72.5	68.7	69.0	30.6	16.4	28.1	64.2	115.6	40.8	30.7	50.9	62.2	102.8	48.6	11.5	28.5	43.0	31.9	63.8	50.7	41.5	67.5	73.0	115.4	62.3	36.8	59.6	25.8	55.5	26.7	93.9	42.8	26.7	13.6	57.6	34.4	39.2	20.7	51.7	11.5	80.0	63.6	29.8	37.2	84.6	54.2	63.7	50.8	18.5	35.5	78.5	112.7	43.1	80.3	95.5	32.4	88.5	36.9	119.8	26.2	171.2	2.0	2.3	2.0	0.8	1.7	0.7	0.7	0.5	0.8	0.8	0.6	0.5	0.8	4.0	0.2	1.6	1.5	1.3	0.5	22.5	24.2	23.8	26.3	19.9	24.7	25.0	24.5	25.7	28.9	27.8	25.6	46.4	19.2	24.6	1.0	10.3	70.2	10.7	12.3	8.6	5.5	14.7	10.2	63.6	10.0	20.3	7.3	0.0	16.7	21.2	35.6	13.7	16.2	55.2	29.4	24.0	21.4	31.8	9.3	4.5	20.9	30.1	20.9	11.7	48.8	14.5	5.1	25.7	37.9	18.2	6.7	3.8	30.2	18.3	28.3	37.6	6.6	9.3	26.5	14.2	1.9	14.5	13.8	5.2	3.0	3.6	31.8	21.7	12.8	9.8	21.9	25.4	31.1	16.8	7.5	6.6	23.6	20.1	10.8	18.2	10.7	82.3	54.9	13.8	6.8	17.9	29.0
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	62.0	74.8	56.2	74.5	54.4	69.2	57.3	52.9	68.4	74.3	55.2	71.9	56.4	69.9	40.9	102.7	61.6	33.4	80.2	52.0	61.1	63.8	82.1	57.2	90.0	56.3	56.9	66.0	74.0	54.4	71.3	48.2	55.8	63.0	48.6	54.2	65.8	38.2	130.2	80.0	78.6	38.0	54.3	76.4	76.6	87.8	56.1	95.5	58.5	38.3	75.2	74.6	72.1	57.0	216.8	347.3	190.2	191.2	149.6	88.5	108.3	247.9	79.1	109.7	107.0	244.5	151.1	440.1	166.9	145.2	122.2	239.6	254.0	232.8	166.0	112.9	187.1	250.6	264.3	261.1	145.3	401.1	168.4	135.7	143.6	155.3	266.0	137.0	140.1	238.5	233.3	188.9	148.1	270.4	442.0	96.0	117.0	205.9	40.2	255.7	279.6	164.7	149.3	399.1	130.1	136.6	299.6	97.8	98.3	231.0	224.5	144.9	214.1	86.1	178.3	115.8	310.1	165.6	198.4	303.4	173.7	190.1	134.1	1.4	1.0	1.2	1.7	1.4	2.0	1.0	1.0	1.2	0.7	1.2	0.9	1.2	0.9	2.0	1.5	1.0	1.5	0.9	56.2	54.4	52.9	68.4	52.0	61.1	56.3	56.9	55.8	54.3	56.1	57.0	38.1	16.0	55.1	90.4	71.4	36.1	59.7	57.9	93.9	57.8	29.3	31.0	41.6	40.0	57.0	60.7	41.7	82.1	63.1	38.4	3.9	42.7	7.5	51.4	55.0	52.6	49.1	75.3	108.4	29.6	50.8	36.9	66.3	53.8	55.8	32.4	36.8	60.7	43.1	60.6	111.7	52.2	46.8	44.0	32.9	10.4	30.7	49.0	33.8	78.7	56.0	75.1	54.6	100.0	124.2	29.2	29.4	40.6	53.2	43.4	50.3	31.6	47.2	45.4	46.0	48.0	51.7	84.9	74.7	115.3	37.2	78.0	78.8	55.6	58.5	44.8
TAF4	"TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135"	ENSG00000130699	"TATA-box binding protein associated factor 4"	O00268	20	61953469-62065810	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008599, CAB031484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"CAB031484: AB_671207, HPA008599: AB_1080183"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.99e-2)"	5.0	5.3	1.7	2.0	1.6	2.8	5.0	3.2	2.0	6.3	0.1	6.1	2.6	6.3	0.5	6.2	5.6	0.9	5.0	1.2	0.5	6.2	7.6	5.0	1.8	1.5	1.0	9.8	6.9	1.2	4.4	1.5	1.1	5.2	0.9	1.6	4.8	1.2	8.8	6.8	6.2	1.1	0.3	6.0	5.8	10.0	1.6	2.7	5.2	1.7	1.1	5.6	5.8	2.0	6.6	6.1	3.6	4.2	1.6	1.2	7.3	3.2	1.4	5.2	2.8	20.5	5.4	5.3	8.1	1.7	3.9	8.4	3.2	3.8	2.2	4.6	4.7	12.3	7.1	9.5	1.7	5.9	10.7	0.9	3.4	2.4	2.4	1.5	2.1	6.5	10.1	4.6	0.9	7.1	16.7	7.2	5.3	4.7	8.6	15.3	8.3	5.7	1.7	6.1	6.1	5.3	9.8	10.2	3.4	2.6	6.3	7.2	2.6	6.7	9.7	6.8	6.0	6.4	6.4	8.5	4.0	3.5	4.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.7	1.6	3.2	2.0	1.2	0.5	1.5	1.0	1.1	0.3	1.6	2.0	5.6	6.4	14.1	13.1	4.7	7.6	3.2	4.5	4.6	8.8	8.3	4.4	7.3	5.7	4.4	5.5	2.1	5.6	6.1	11.6	0.0	5.7	21.1	7.4	5.8	7.1	3.6	10.8	16.3	3.8	5.0	5.7	8.6	11.3	1.3	7.9	6.4	12.6	5.9	15.2	17.3	9.9	12.2	11.0	5.5	7.0	9.3	7.1	3.6	15.0	10.5	3.9	5.2	17.6	22.1	6.0	10.1	10.5	4.3	8.0	9.8	4.9	7.4	9.1	6.6	5.4	6.2	8.6	13.1	7.6	9.7	8.3	7.5	5.2	9.9	5.6
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	13.7	9.8	5.9	12.8	6.4	21.1	10.8	4.2	6.8	8.5	7.8	9.8	10.5	8.8	6.8	10.1	7.5	8.4	18.0	5.3	5.3	11.3	8.6	9.5	15.6	6.4	5.5	8.0	7.4	16.0	6.6	12.7	5.3	9.0	9.2	8.7	9.5	8.9	16.9	8.5	8.5	10.1	4.4	11.6	10.8	7.9	6.4	23.6	13.9	15.4	15.0	9.8	8.6	7.1	17.2	18.4	14.9	16.7	16.5	15.1	13.6	7.9	13.7	20.4	20.9	31.8	10.0	26.2	16.4	11.5	20.9	12.5	24.5	16.7	15.7	22.6	23.6	33.4	23.3	15.7	20.2	19.5	23.4	20.6	13.0	14.6	18.4	10.0	23.0	31.8	41.7	26.6	11.5	22.7	17.9	29.2	9.3	45.5	8.4	36.1	17.7	20.2	18.0	13.9	15.4	13.7	14.3	11.0	15.7	12.2	16.5	23.6	21.2	18.1	18.8	8.2	16.3	23.0	24.4	55.5	8.3	21.2	10.4	23.0	17.0	27.0	16.0	18.2	11.1	18.2	14.4	12.6	17.8	18.3	14.7	14.4	19.9	10.8	37.4	26.5	13.4	11.0	5.9	6.4	4.2	6.8	5.3	5.3	6.4	5.5	5.3	4.4	6.4	7.1	16.8	19.2	21.1	14.0	17.2	7.0	13.1	14.8	14.2	16.0	14.1	10.4	28.6	10.0	17.4	11.0	31.3	22.1	21.0	12.3	31.3	9.5	12.0	26.5	12.8	16.9	9.0	21.9	7.6	9.9	8.6	11.7	6.6	47.4	19.0	14.2	9.7	9.6	13.5	21.9	8.2	13.3	14.2	21.6	9.5	17.5	14.9	13.1	7.2	13.1	19.3	10.7	33.0	18.6	14.2	8.8	8.3	11.7	19.0	14.4	10.5	16.5	9.8	23.2	13.1	10.6	13.3	15.3	12.9	12.0	8.4	21.5	19.8	19.4	11.1	15.0
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 550.8;Late spermatids: 924.3;Spermatocytes: 370.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	42.1	43.5	35.5	31.9	38.6	108.2	46.0	35.4	41.4	28.3	34.4	42.5	34.2	31.5	50.4	37.4	31.1	28.8	52.7	39.2	43.0	38.4	55.7	27.7	46.6	37.1	36.4	37.8	40.8	35.5	50.6	38.0	40.5	33.7	47.5	47.2	34.7	27.7	58.0	36.1	33.2	35.9	36.6	35.0	38.0	140.4	37.7	50.9	28.7	41.7	52.3	50.6	30.3	36.1	107.0	109.3	67.7	121.6	114.4	143.5	179.3	100.1	159.8	172.3	227.0	109.7	135.1	135.9	70.2	146.7	322.2	82.2	92.4	208.1	227.4	65.6	111.0	120.4	154.0	157.8	261.3	118.7	168.3	159.4	137.4	117.1	247.7	122.5	143.1	121.4	122.4	119.8	165.9	147.7	126.1	189.5	82.0	42.6	81.6	83.0	119.7	169.0	152.7	120.7	118.1	82.6	108.3	64.3	192.8	111.3	100.9	175.7	103.3	65.9	98.2	78.2	173.1	93.2	118.3	175.6	101.3	145.7	82.8	149.3	107.8	122.5	52.8	101.3	81.2	90.1	79.7	64.2	83.9	75.4	89.6	73.6	16.0	58.7	88.4	47.0	95.5	134.4	35.5	38.6	35.4	41.4	39.2	43.0	37.1	36.4	40.5	36.6	37.7	36.1	67.4	19.2	29.3	0.0	55.2	174.0	151.4	238.7	39.3	24.1	49.9	81.4	69.3	42.9	108.8	23.9	14.6	118.0	45.1	33.8	90.1	67.1	550.8	47.6	44.9	58.6	30.7	93.2	0.0	80.4	166.7	57.3	36.7	38.1	38.6	53.5	34.6	41.9	107.7	20.2	0.0	49.5	146.5	42.8	99.8	924.3	65.3	55.2	99.6	0.0	66.9	35.1	35.0	0.0	0.0	85.1	37.2	34.3	76.5	87.3	47.4	90.2	85.2	43.0	32.9	49.1	95.5	370.7	78.0	60.7	163.2	104.5	50.7	75.0	64.2	149.6
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11030528	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	NA		29000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	83.4	80.1	71.9	87.1	80.6	69.7	83.3	84.7	79.0	93.9	78.1	94.5	77.4	90.9	78.8	111.1	84.1	58.7	93.0	69.4	78.5	93.8	105.5	91.6	106.5	75.5	77.2	103.5	77.2	86.7	89.1	82.7	76.4	90.1	94.5	119.9	86.6	78.8	138.9	96.1	94.5	81.2	74.8	97.4	82.4	68.2	74.7	115.1	96.6	102.9	122.9	87.6	95.8	86.0	244.7	164.4	270.4	143.5	143.9	118.2	160.3	164.7	142.3	263.6	195.5	187.9	175.6	316.3	118.1	180.6	154.3	169.2	333.1	187.6	336.0	175.1	153.8	241.2	275.2	257.9	119.4	290.5	158.9	99.5	211.4	184.5	147.9	143.8	188.6	126.7	319.0	176.4	221.7	195.0	215.6	228.6	221.0	232.2	141.7	256.9	214.4	206.2	186.0	179.1	187.9	150.8	221.3	173.7	128.8	197.1	173.8	200.9	174.8	173.8	207.8	146.3	236.9	133.3	176.2	336.3	116.2	288.2	192.0	38.0	38.0	33.7	46.7	48.6	57.4	55.2	46.9	45.4	61.7	39.6	46.3	50.5	15.4	67.2	50.0	43.1	54.3	36.4	71.9	80.6	84.7	79.0	69.4	78.5	75.5	77.2	76.4	74.8	74.7	86.0	35.5	32.1	74.4	29.4	57.6	114.6	89.9	40.8	52.3	37.6	52.0	38.6	68.0	31.5	57.0	29.5	29.2	63.2	46.3	54.2	33.2	50.8	9.7	50.7	50.0	54.9	66.3	63.5	29.5	54.2	84.5	45.2	34.7	61.7	42.3	45.8	40.0	51.7	50.1	37.0	29.8	50.1	38.7	45.9	46.3	12.3	47.2	37.8	35.6	23.4	54.3	36.2	35.0	37.2	57.2	52.9	36.1	51.6	48.8	71.7	43.2	43.9	54.4	38.8	32.9	42.8	56.9	64.9	32.8	52.4	114.5	73.5	41.3	23.6	52.6	71.3
TASOR	"C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1"	ENSG00000163946	"Transcription activation suppressor"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	9.5	8.4	4.0	15.4	8.4	11.8	11.4	8.7	5.3	12.0	1.7	11.7	10.0	12.3	7.4	11.1	13.1	11.7	6.2	2.2	3.6	10.2	7.9	11.3	20.7	5.1	5.6	14.2	12.4	21.1	4.4	9.4	6.0	9.3	12.4	9.9	8.9	9.4	2.6	7.1	11.3	12.3	5.9	14.7	12.8	29.2	4.5	21.3	18.8	6.9	19.3	12.5	3.8	12.0	49.2	19.2	29.2	23.0	15.5	26.7	14.6	21.4	22.0	20.1	21.1	15.8	35.8	77.3	7.9	21.6	33.9	19.1	29.3	25.1	29.2	38.3	14.8	30.4	27.3	7.1	10.9	32.2	46.1	12.9	20.6	19.6	35.1	23.7	26.5	28.8	29.8	43.3	26.0	17.3	39.8	6.4	16.3	25.9	29.0	20.9	28.9	25.9	19.0	35.5	19.3	23.9	46.9	18.5	23.2	16.6	30.6	36.7	28.6	25.9	23.7	23.8	33.1	39.2	58.5	38.6	30.1	46.7	35.0	0.6	0.8	1.1	1.2	0.6	0.7	0.7	1.0	1.2	1.0	1.1	1.1	1.2	0.2	0.9	0.7	0.7	1.0	0.6	4.0	8.4	8.7	5.3	2.2	3.6	5.1	5.6	6.0	5.9	4.5	12.0	25.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	14.5	12.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	9.2	2.1	0.0	0.0	0.0
TASOR2	"bA318E3.2, C10orf18, FAM208B, FLJ20360, KIAA2006"	ENSG00000108021	"Transcription activation suppressor family member 2"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cardiomyocytes: 28.0;Cytotrophoblasts: 11.7;dendritic cells: 18.4;Extravillous trophoblasts: 10.5;Fibroblasts: 8.1;Hofbauer cells: 10.3;Plasma cells: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	9.5	8.6	3.1	12.0	4.4	14.3	12.5	19.5	8.0	13.2	9.8	10.9	6.6	13.0	15.3	9.7	10.7	10.2	9.3	2.3	9.0	8.9	10.8	8.1	17.2	2.5	5.1	12.7	10.9	14.5	10.7	12.6	3.5	9.9	11.9	14.1	9.5	10.9	12.1	8.9	9.2	13.3	1.2	10.0	10.3	24.6	4.6	14.9	16.4	14.4	17.0	17.5	8.0	10.5	38.2	31.7	19.9	34.0	25.1	29.7	28.0	31.7	20.1	26.7	33.6	33.7	22.0	77.2	19.8	31.4	16.9	29.3	57.5	32.5	43.0	15.2	38.7	36.1	24.7	22.8	25.0	26.9	20.7	22.9	35.6	43.5	36.8	17.9	31.4	29.4	59.1	17.6	30.2	25.7	35.0	9.5	24.3	24.6	20.3	25.8	27.7	27.1	16.0	34.1	24.4	27.5	31.5	28.3	22.2	22.3	37.2	20.9	31.6	33.6	36.2	65.5	43.7	21.3	21.9	67.8	16.6	26.1	18.1	1.0	1.2	0.2	1.2	1.2	1.1	1.0	0.9	1.1	0.7	1.8	0.9	1.5	0.9	4.3	0.4	1.1	1.3	0.5	3.1	4.4	19.5	8.0	2.3	9.0	2.5	5.1	3.5	1.2	4.6	10.5	19.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	11.7	18.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	10.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	7.3	2.7	0.0	0.0	0.0
TBC1D10A	"AC004997.C22.2, EPI64, TBC1D10"	ENSG00000099992	"TBC1 domain family member 10A"	Q9BXI6	22	30291990-30326947	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007725, HPA008142, HPA076041"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.52e-2)"	22.6	17.0	6.9	10.2	8.2	8.2	23.7	5.8	10.2	29.6	9.3	18.3	8.6	14.7	4.6	44.1	14.9	12.7	11.2	7.5	9.3	21.3	17.9	23.7	17.2	7.4	8.1	21.1	10.8	24.5	19.5	17.5	7.0	21.3	5.5	10.8	23.2	12.9	5.6	45.3	17.3	6.8	6.2	24.2	17.3	21.6	9.7	18.4	19.0	6.9	10.4	19.9	39.9	6.4	18.9	7.1	2.9	9.0	8.4	10.8	23.9	10.7	14.9	11.8	18.7	8.4	7.2	9.5	10.2	17.8	16.2	18.3	4.3	9.9	6.2	7.2	12.4	2.6	6.4	6.0	21.9	3.7	12.9	14.0	15.5	23.4	4.0	12.3	5.5	20.5	5.1	8.8	8.9	22.1	26.9	7.9	1.9	33.9	9.5	12.3	12.4	8.8	11.6	17.9	4.9	3.8	11.0	15.7	24.5	7.8	13.8	2.3	10.8	22.9	10.4	13.1	5.8	8.8	4.2	8.3	15.6	5.6	13.1	37.5	14.9	37.9	26.6	30.1	29.3	13.4	30.9	27.2	21.7	20.7	40.7	34.0	10.6	24.3	45.5	37.5	28.8	28.4	6.9	8.2	5.8	10.2	7.5	9.3	7.4	8.1	7.0	6.2	9.7	6.4	27.8	6.4	3.4	24.8	18.2	49.2	40.2	40.3	32.5	7.8	18.4	12.4	2.7	14.3	23.6	5.5	18.8	57.6	19.5	26.8	23.5	20.1	10.7	8.8	5.4	14.4	10.7	3.0	3.0	10.2	80.6	18.3	19.4	16.4	9.5	20.1	11.0	8.6	27.5	1.7	3.5	14.2	18.3	12.9	46.0	6.9	21.8	15.9	26.6	10.3	78.1	28.1	28.8	2.5	1.0	18.7	18.7	9.1	12.3	24.3	14.9	20.5	6.6	39.3	39.5	7.4	17.1	33.2	13.5	27.6	37.1	116.3	28.0	20.2	11.0	28.3
TBC1D23	FLJ11046	ENSG00000036054	"TBC1 domain family member 23"	Q9NUY8	3	100260992-100325251	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038151, HPA038152"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA038151: AB_10672405, HPA038152: AB_10672620"	"unprognostic (9.23e-3)"	"unprognostic (6.01e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.87e-3)"	"unprognostic (6.16e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.32e-1)"	15.1	17.4	4.8	12.7	7.0	23.0	14.8	10.8	6.7	13.5	5.0	15.1	17.9	14.3	10.2	16.2	9.3	13.9	14.3	5.9	6.4	17.1	22.7	12.6	12.5	6.6	5.4	16.2	18.2	17.9	5.1	21.6	7.1	11.7	15.5	16.8	15.2	9.9	17.2	13.5	18.4	14.1	7.0	12.5	15.2	17.1	6.7	14.4	14.1	15.3	15.5	15.6	8.2	10.9	72.9	15.0	17.4	9.8	34.4	44.3	17.5	40.4	45.7	46.6	53.6	28.6	13.3	18.3	20.6	46.9	26.0	25.5	64.5	29.4	72.4	9.0	15.1	49.9	16.6	19.3	33.9	23.2	39.1	35.9	23.7	23.3	38.1	39.0	25.2	14.1	41.0	26.8	30.1	16.3	17.9	11.4	20.3	26.2	27.8	14.8	37.9	21.6	27.3	16.3	24.8	13.5	23.4	18.4	29.8	22.7	19.6	22.0	24.1	32.9	30.9	15.5	26.9	25.6	28.1	31.8	42.1	21.2	27.4	27.8	17.8	22.7	12.2	20.5	12.4	12.0	11.7	10.7	18.7	12.7	10.3	10.9	10.2	21.8	24.8	8.2	17.4	17.4	4.8	7.0	10.8	6.7	5.9	6.4	6.6	5.4	7.1	7.0	6.7	10.9	24.0	41.7	12.6	19.6	24.5	31.5	18.6	14.8	16.5	18.6	17.9	11.7	26.1	11.5	20.5	12.9	14.6	20.1	19.1	24.8	31.3	26.8	46.8	17.5	28.4	22.5	7.2	54.1	50.9	29.5	19.3	31.9	13.7	31.7	29.8	19.0	13.9	19.0	13.9	35.3	42.4	17.5	18.3	17.1	20.2	44.2	20.5	21.9	24.9	48.7	14.0	18.7	12.3	41.7	56.4	36.1	16.9	14.3	34.5	22.3	21.1	19.9	19.3	30.2	13.1	27.6	25.9	20.8	15.2	20.4	38.8	65.8	21.1	21.8	14.3	30.2
TBC1D2B	KIAA1055	ENSG00000167202	"TBC1 domain family member 2B"	Q9UPU7	15	77984036-78077724	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7;Theca cells: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041833, HPA048174, HPA052663"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906"	"unprognostic (3.13e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-3)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.19e-2)"	23.1	15.4	4.8	20.4	5.1	22.5	17.3	4.6	5.0	25.1	9.3	15.8	12.9	23.3	11.7	11.4	20.8	28.2	10.2	4.1	6.6	7.7	16.3	33.9	23.1	9.7	5.5	46.1	18.3	17.1	5.9	25.0	6.0	11.5	17.4	4.5	8.7	14.3	5.1	13.4	16.0	21.2	6.3	25.5	12.9	12.6	6.7	23.8	12.1	10.8	19.3	19.1	14.9	6.6	12.0	9.4	11.1	10.5	76.2	60.4	19.3	27.1	40.7	24.9	27.3	12.0	4.8	18.5	10.6	23.0	13.8	17.1	24.4	29.9	18.9	35.2	18.8	11.8	9.1	8.2	36.1	30.1	17.3	59.2	20.4	16.5	11.0	36.8	28.6	23.5	6.2	12.5	32.5	13.2	11.2	19.7	8.8	9.3	9.0	16.8	50.9	4.1	12.7	45.1	5.9	16.0	25.3	17.0	31.9	10.2	5.6	31.1	35.5	27.1	17.8	8.6	14.5	20.9	23.8	9.7	9.3	39.8	14.6	0.0	0.8	0.3	1.4	0.6	0.8	0.0	0.9	1.6	0.5	0.1	0.7	0.6	1.4	1.4	0.2	1.2	0.5	0.6	4.8	5.1	4.6	5.0	4.1	6.6	9.7	5.5	6.0	6.3	6.7	6.6	13.9	3.2	17.3	26.4	6.4	9.3	7.3	13.9	1.8	10.7	5.3	4.3	3.3	14.3	9.7	5.5	6.2	20.6	24.0	12.8	0.0	8.8	10.0	7.1	33.7	16.1	7.3	4.4	23.3	10.0	6.9	28.0	17.3	6.3	9.5	6.3	21.4	90.7	19.0	15.2	20.3	19.7	10.2	31.9	29.3	10.3	42.6	21.5	14.2	45.9	23.7	6.2	6.2	12.5	10.4	15.3	13.4	42.2	9.5	6.3	15.3	4.3	10.9	8.9	26.3	19.4	18.2	6.0	7.1	4.5	9.9	28.5	26.0	79.0	15.7	8.1
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64452090-64502114	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	11.6	15.3	6.0	10.1	6.1	16.9	11.4	5.6	6.9	10.6	5.3	10.5	15.1	11.0	6.7	11.3	9.5	10.1	9.4	5.8	5.6	11.8	17.4	12.9	14.6	6.5	6.9	9.6	7.5	11.6	9.8	13.7	6.1	10.6	8.5	6.3	10.2	9.0	18.4	8.6	11.4	10.8	5.3	13.4	10.2	23.5	6.7	6.8	8.5	14.9	12.9	16.0	10.2	7.1	23.3	24.2	11.1	10.6	24.7	26.1	29.0	22.9	37.6	22.5	21.1	14.9	12.4	31.5	21.4	26.8	34.4	19.0	19.4	20.0	26.4	29.5	17.1	33.0	15.3	19.1	30.2	35.2	36.4	18.5	19.1	23.1	23.6	42.3	32.4	11.0	27.9	38.7	31.6	27.0	0.9	17.0	29.9	22.9	13.8	14.9	15.3	31.8	25.1	36.9	9.8	14.7	33.3	36.0	23.5	23.5	33.1	24.9	25.9	20.2	18.1	14.9	24.0	25.4	54.3	30.3	28.1	18.6	26.1	41.8	10.1	24.3	13.9	17.7	16.3	12.8	10.1	15.2	12.2	10.1	2.8	8.7	17.8	26.6	15.5	2.1	13.6	10.0	6.0	6.1	5.6	6.9	5.8	5.6	6.5	6.9	6.1	5.3	6.7	7.1	23.7	19.2	20.5	28.4	21.6	11.0	25.7	20.1	15.4	17.0	14.9	9.1	10.9	8.6	23.4	22.0	10.4	28.8	30.0	14.1	11.7	19.3	34.5	19.2	17.9	28.6	17.3	18.3	50.5	23.6	32.6	21.3	15.3	30.2	43.1	17.5	16.8	17.1	20.2	18.5	42.2	10.5	12.2	23.0	30.2	29.2	19.3	31.1	14.2	46.9	31.4	12.7	33.0	39.2	52.3	16.9	10.9	20.7	25.6	43.7	13.6	12.3	20.8	16.3	26.3	22.4	18.7	68.9	12.7	14.0	14.9	92.6	27.1	11.5	10.1	41.6
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972053-1982929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 113.8;Late spermatids: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	3.6	3.5	1.8	3.2	2.2	2.1	3.9	4.5	2.7	3.4	1.0	3.4	2.4	3.8	0.6	4.9	3.0	1.4	4.7	2.3	2.3	3.3	3.1	2.8	2.3	3.3	2.0	3.7	5.9	2.8	2.4	1.2	3.4	2.8	1.0	1.5	4.8	1.1	10.6	5.4	3.5	1.4	1.7	3.0	3.7	6.8	1.8	2.0	3.1	3.1	1.5	3.3	3.5	2.7	7.1	13.4	3.6	7.2	3.5	2.8	11.8	6.4	4.2	5.4	4.4	17.3	13.3	9.4	14.6	4.9	4.9	18.8	5.9	7.5	2.8	6.9	8.5	5.9	7.1	6.6	4.0	10.3	5.4	2.8	5.5	6.7	3.9	4.3	6.8	5.6	12.1	6.7	3.2	11.3	13.2	5.8	8.6	6.2	5.4	23.1	6.7	15.7	2.6	2.7	8.4	6.5	5.8	14.6	6.0	3.5	11.1	6.9	10.8	7.4	8.8	6.6	12.6	12.1	5.6	15.0	4.5	6.5	8.7	4.5	9.4	5.5	10.6	11.0	9.3	6.4	7.6	10.4	10.4	6.9	9.7	7.4	2.2	14.5	11.8	5.3	9.2	8.5	1.8	2.2	4.5	2.7	2.3	2.3	3.3	2.0	3.4	1.7	1.8	2.7	9.1	3.2	12.2	2.3	11.9	13.0	15.8	21.9	12.0	13.0	12.6	10.4	16.4	7.2	16.4	18.4	8.4	26.4	10.7	23.4	7.9	25.4	113.8	7.4	8.5	11.2	13.8	18.5	2.0	22.5	26.0	10.5	20.4	9.7	14.7	14.5	7.1	12.7	19.6	10.1	2.1	16.1	18.3	8.9	6.6	72.1	14.9	8.5	7.2	0.0	24.1	13.6	9.2	2.0	2.0	24.0	22.0	10.9	13.5	15.6	31.9	16.9	8.8	9.8	26.3	11.1	24.7	21.8	20.8	13.7	18.3	22.4	11.1	11.6	24.2	14.4
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 126.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	12.1	11.7	16.9	12.0	18.9	37.5	10.5	19.0	23.0	10.4	12.7	11.7	13.3	12.3	8.1	11.7	13.1	11.8	11.9	19.3	19.4	9.2	13.7	9.7	21.3	14.2	12.9	12.5	8.1	10.4	11.7	14.8	14.2	12.2	14.3	15.0	9.1	12.3	6.4	9.0	12.9	11.1	11.7	12.6	11.7	126.7	20.0	19.8	16.8	9.2	16.9	15.1	9.8	16.5	16.5	19.6	43.9	28.5	32.6	33.3	24.5	29.9	31.5	39.1	51.1	23.0	13.0	49.8	20.2	24.1	43.8	21.2	28.0	32.3	46.8	38.3	35.9	87.8	11.5	25.5	33.0	46.4	32.8	20.8	32.2	43.8	47.1	30.7	37.6	43.3	129.3	33.4	28.1	37.0	39.2	27.8	49.2	23.6	25.1	26.7	26.4	19.5	23.2	14.3	56.5	56.2	17.7	23.2	37.8	36.9	10.5	18.5	34.4	22.5	32.4	50.0	33.6	27.2	31.5	32.8	37.7	30.0	27.4	133.1	31.7	81.8	62.7	33.3	69.8	67.6	53.1	67.1	29.8	60.2	50.6	59.5	74.8	52.5	38.3	35.4	60.5	64.0	16.9	18.9	19.0	23.0	19.3	19.4	14.2	12.9	14.2	11.7	20.0	16.5	35.6	6.4	12.2	10.7	43.2	70.7	27.0	46.7	46.1	22.8	29.8	34.2	12.8	28.6	21.1	7.3	18.8	40.7	59.1	16.8	29.4	29.1	407.5	20.6	17.1	40.8	71.0	51.4	35.3	25.2	69.7	30.8	36.7	14.8	40.0	13.5	22.9	11.2	24.4	15.2	25.2	26.5	48.8	14.8	43.2	75.1	21.1	38.3	32.0	22.5	21.3	23.3	42.2	27.2	27.7	31.4	24.2	18.4	35.2	39.7	17.9	28.4	28.2	12.3	19.7	27.3	35.1	557.4	72.8	36.7	65.8	244.9	50.0	11.0	24.3	37.6
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	24.5	29.5	19.3	23.0	21.8	23.0	24.0	22.8	21.4	22.9	23.5	36.1	29.4	23.1	7.9	35.8	21.2	11.9	56.5	19.7	21.6	29.6	43.3	19.0	25.5	22.4	21.1	24.0	21.3	21.9	17.4	19.5	23.0	24.5	18.7	6.6	24.1	15.6	83.0	32.4	28.6	15.6	21.4	28.5	26.2	34.4	22.0	21.9	18.9	66.2	17.9	29.3	25.5	23.2	49.4	113.1	35.7	77.3	31.5	28.9	70.2	39.2	35.9	74.6	61.5	123.8	67.5	93.8	58.7	39.9	103.3	125.6	82.6	89.3	37.6	49.0	77.8	64.5	73.6	84.4	51.6	74.5	63.4	39.7	81.7	71.2	50.7	26.7	46.6	79.3	181.1	46.0	46.2	84.5	75.9	168.0	111.0	110.6	88.6	65.9	45.3	136.2	44.1	50.4	69.9	65.6	40.4	218.8	77.6	45.6	97.7	120.4	36.4	54.6	65.7	33.9	64.8	81.0	87.6	137.5	50.1	104.9	125.7	17.3	23.8	20.6	31.1	44.3	29.5	27.9	25.6	30.0	35.9	20.9	34.5	33.3	1.9	18.1	39.5	13.6	27.2	33.0	19.3	21.8	22.8	21.4	19.7	21.6	22.4	21.1	23.0	21.4	22.0	23.2	13.3	3.2	16.3	9.4	21.0	35.1	33.2	39.8	15.4	15.1	17.0	15.0	28.0	15.7	24.1	20.2	0.0	61.5	18.4	32.9	43.0	31.1	24.6	12.5	13.8	14.2	22.2	14.3	6.5	18.3	72.5	17.9	24.5	16.9	14.0	25.4	10.4	31.8	34.5	11.8	7.1	32.5	36.7	12.3	17.8	19.6	16.4	18.0	17.8	3.7	34.6	14.7	14.4	4.5	8.4	29.5	28.0	11.7	17.9	33.8	33.5	47.4	11.2	14.2	13.1	17.1	25.5	72.4	33.0	17.0	29.3	47.9	19.2	44.7	53.3	30.2
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leydig cells: 283.6;Peritubular cells: 387.8;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	34.9	54.7	33.9	13.8	35.6	9.9	39.4	33.6	47.1	107.9	32.6	61.1	15.2	140.8	40.3	37.8	114.3	34.8	32.2	36.0	37.8	25.1	19.0	30.5	14.1	31.7	31.4	174.8	20.3	31.9	33.9	17.8	35.2	63.3	16.8	14.7	16.1	79.3	55.1	17.3	29.2	95.0	31.4	26.2	40.3	20.1	35.8	12.2	31.9	33.6	9.8	97.9	58.3	33.6	21.8	20.6	11.4	15.8	48.2	33.2	15.2	30.2	30.3	28.9	31.2	9.1	21.1	10.0	30.4	39.3	43.9	21.2	19.2	16.0	21.4	0.0	23.9	13.6	27.2	17.8	21.7	0.1	19.7	40.9	30.4	22.4	12.3	47.7	30.1	11.4	5.1	5.5	58.7	24.1	12.1	0.3	3.8	19.3	32.9	12.4	36.8	0.1	40.4	21.3	15.7	13.2	30.6	14.4	35.4	8.3	13.5	12.7	24.0	20.9	7.7	49.3	15.7	5.4	18.6	0.3	27.4	0.1	21.3	26.8	13.2	0.8	15.3	9.4	22.5	31.9	13.7	12.9	26.4	24.9	18.2	20.8	1.4	22.6	4.0	20.9	13.2	12.8	33.9	35.6	33.6	47.1	36.0	37.8	31.7	31.4	35.2	31.4	35.8	33.6	26.5	16.0	31.2	9.4	10.4	29.7	52.7	38.4	24.5	21.8	47.3	42.8	32.9	28.6	37.2	25.8	2.1	30.0	8.9	6.2	56.7	22.9	2.5	27.5	50.0	32.2	27.6	9.1	22.1	24.6	29.8	37.4	7.7	21.9	26.6	22.7	46.1	19.7	34.7	21.9	20.4	13.2	30.5	21.0	23.1	11.7	283.6	16.5	19.6	6.5	19.7	38.6	19.6	16.6	10.3	11.7	17.5	387.8	5.1	18.4	15.0	52.8	48.0	12.3	151.2	32.6	45.3	6.0	8.5	15.5	21.3	7.3	11.3	32.5	19.4	17.6
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204"	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	11.6	8.6	6.6	15.5	6.1	28.1	12.0	7.9	10.0	11.6	4.1	12.2	10.5	13.3	6.4	13.1	12.5	7.3	10.0	6.4	5.2	9.2	6.7	10.5	17.7	5.5	5.1	13.7	9.0	8.9	11.3	12.4	5.5	10.4	10.8	16.9	10.9	8.4	23.7	13.2	11.2	10.4	4.2	12.0	11.7	10.3	5.3	19.0	10.0	13.6	17.1	12.4	12.3	8.8	51.7	37.6	56.6	39.1	15.2	23.9	72.0	38.0	30.6	42.1	48.8	61.0	53.8	89.0	27.8	31.7	30.0	44.6	70.1	48.1	63.8	52.6	56.3	58.1	43.4	37.4	16.3	87.8	43.5	16.8	28.0	40.8	43.7	23.0	37.3	73.5	69.4	31.9	32.2	36.8	76.8	49.3	56.3	29.2	42.3	74.3	66.9	58.7	26.3	40.2	36.8	45.6	42.7	44.6	28.3	34.1	47.5	43.9	42.2	36.3	42.1	31.0	60.2	32.4	38.3	116.8	33.7	73.0	41.3	0.9	5.7	2.5	5.7	8.8	6.9	5.5	6.6	7.2	9.7	5.5	6.8	6.8	0.5	9.5	11.9	4.9	6.5	5.3	6.6	6.1	7.9	10.0	6.4	5.2	5.5	5.1	5.5	4.2	5.3	8.8	35.8	54.5	49.8	50.6	49.5	44.9	49.5	35.6	54.7	54.1	32.4	33.1	35.6	14.3	39.9	23.9	62.6	48.6	42.9	20.8	1.9	31.9	3.2	23.8	62.1	37.6	28.2	77.0	100.9	33.4	60.7	43.3	56.6	44.1	37.9	57.4	21.4	17.6	30.8	35.3	91.0	36.9	24.4	28.9	30.4	7.4	28.6	36.5	24.9	42.2	33.1	20.8	35.0	73.4	76.3	44.9	25.3	24.5	61.9	60.7	13.8	7.6	33.8	38.4	19.7	53.2	51.1	73.3	60.8	66.6	45.7	43.9	42.8	43.7	47.5	62.2
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114681-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 604.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;T-cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 28.8;memory CD4 T-cell: 49.7;memory CD8 T-cell: 29.0;naive CD4 T-cell: 97.2;naive CD8 T-cell: 62.3;NK-cell: 43.0"	"Group enriched"	"Detected in many"	20	"NK-cells: 43.0;T-cells: 97.2"	"Cell line enriched"	"Detected in many"	6	"MOLT-4: 1324.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	4.1	5.3	2.0	56.4	1.8	16.4	4.0	1.8	1.9	3.2	21.3	5.8	16.0	3.9	41.5	3.5	43.1	6.2	2.4	3.1	1.5	4.0	5.8	5.6	94.4	5.9	2.7	1.8	9.4	2.1	6.4	3.5	2.2	5.0	6.8	1.5	8.0	3.5	1.4	4.3	20.4	1.8	3.8	34.6	11.0	3.4	2.1	604.3	6.3	1.0	70.0	9.8	2.0	2.6	0.2	7.8	8.2	29.2	3.9	16.2	11.4	2.2	4.4	0.7	0.8	61.6	19.3	0.4	14.0	13.4	32.3	1.0	13.1	3.1	0.6	3.0	12.2	0.2	7.4	46.4	0.4	0.4	1.6	1.1	0.1	12.6	0.7	5.7	1.8	218.2	7.9	0.3	1.3	0.7	1324.2	1.4	9.0	19.2	10.4	1.6	0.0	1.4	3.0	1.4	3.4	25.1	6.0	1.8	1.6	6.4	1.6	7.3	1.9	81.2	0.5	37.0	2.8	1.3	0.1	0.4	42.7	0.5	4.1	2.2	0.3	3.2	12.3	0.2	28.8	3.5	49.7	29.0	0.2	1.4	97.2	62.3	1.9	43.0	0.2	0.5	6.5	21.8	2.0	1.8	1.8	1.9	3.1	1.5	5.9	2.7	2.2	3.8	2.1	2.6	6.0	3.2	1.9	4.6	27.3	15.7	27.9	6.9	2.8	28.6	14.5	14.9	3.1	10.0	2.9	3.7	73.0	21.6	47.4	18.4	0.0	6.1	3.8	57.6	30.4	9.6	12.6	5.3	2.4	9.9	30.5	11.7	6.6	35.8	20.3	12.1	6.8	3.0	7.1	10.1	2.0	17.0	6.1	9.7	20.0	2.3	6.2	8.7	10.6	1.0	17.1	12.4	41.2	3.5	4.1	23.6	18.5	4.5	9.3	24.6	50.8	1.4	2.5	58.4	0.0	61.4	16.1	4.0	11.0	3.3	11.4	30.0	108.3	8.6	24.1	14.9
TCL1A	TCL1	ENSG00000100721	"TCL1 family AKT coactivator A"	P56279	14	95709947-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 267.6"	"Group enriched"	"Detected in some"	4	"B-cells: 282.5;dendritic cells: 210.3"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	296	"memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9"	"Group enriched"	"Detected in all"	350	"B-cells: 2160.3;dendritic cells: 1099.9"	"Group enriched"	"Detected in some"	142	"Daudi: 459.4;REH: 599.4;U-698: 616.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	1.0	0.1	0.1	34.4	0.1	20.3	0.2	0.1	0.1	0.1	0.0	2.4	0.8	0.8	0.6	0.5	0.1	3.6	0.6	0.1	0.1	0.4	0.4	1.0	267.6	0.1	0.1	0.1	0.3	0.0	0.0	0.8	0.2	0.3	2.0	0.0	4.0	0.0	0.1	0.4	14.2	0.3	0.0	56.7	3.4	7.7	0.1	19.1	1.1	0.0	216.0	2.7	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	459.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.6	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	599.4	0.3	0.8	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.1	1.0	1.0	0.2	2.8	0.6	0.2	0.5	3.9	616.2	0.2	0.1	0.1	4.6	1.4	1.8	0.5	0.5	1.3	874.7	0.9	0.4	2.2	2160.3	1.5	0.5	3.3	1.3	1.6	1099.9	1.2	92.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	1.3	0.0	282.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	210.3	0.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.9	0.6	2.8	0.0	0.0	2.7	0.0	3.1	0.0	0.0	0.0	0.2	0.4	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	28.7	60.2	0.0	0.0	0.0	2.7	0.0	0.3	0.0
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357629-150400308	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	13.0	10.8	44.2	14.5	43.8	13.9	13.5	43.4	104.8	15.4	40.1	20.4	7.3	16.7	7.4	16.6	14.8	6.5	14.9	43.3	42.2	14.8	9.5	12.5	18.3	44.3	43.6	15.7	14.8	9.9	11.0	10.3	44.5	15.7	8.7	9.6	12.1	10.8	21.4	16.6	15.3	11.7	40.9	18.8	14.3	14.5	45.0	20.5	12.6	9.7	16.2	19.7	14.1	48.9	78.3	85.0	42.7	80.3	16.2	21.4	115.1	59.4	24.5	81.1	80.9	211.5	59.3	113.1	53.2	21.9	92.6	88.2	93.0	107.4	57.4	59.9	100.8	54.9	55.6	80.8	17.4	91.5	40.7	18.0	24.8	94.1	71.4	20.1	36.1	59.2	80.2	32.8	27.7	70.7	100.4	67.4	128.8	35.3	80.4	91.4	67.4	64.8	19.5	54.3	58.0	59.7	68.5	111.0	55.2	66.8	49.7	36.1	35.0	59.3	73.5	71.8	113.4	40.6	55.6	123.4	46.6	78.2	54.1	1.6	2.2	1.1	3.8	2.0	4.8	4.6	3.6	3.8	2.1	4.2	3.1	3.4	1.4	8.3	2.1	2.2	2.4	3.2	44.2	43.8	43.4	104.8	43.3	42.2	44.3	43.6	44.5	40.9	45.0	48.9	18.5	9.6	22.4	7.8	41.7	40.0	21.1	14.5	15.9	25.4	13.6	12.7	17.9	11.5	10.4	11.0	41.7	21.7	29.7	24.0	5.9	19.6	8.4	13.2	17.3	24.4	18.7	23.3	7.4	23.4	41.0	20.1	18.3	17.6	23.5	29.1	12.8	10.0	28.8	21.9	6.4	18.8	16.2	27.9	53.3	6.8	19.0	40.0	12.4	2.8	27.8	9.7	33.0	3.0	8.9	15.2	8.4	15.8	26.1	37.8	15.1	6.3	10.1	25.6	26.3	20.3	17.7	27.6	34.1	22.7	39.1	8.9	26.3	20.1	32.0	19.3
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 169.1;granulocytes: 152.3;Inhibitory neurons: 128.9;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	8.8	8.2	14.2	6.8	18.7	5.8	12.0	18.2	16.4	10.6	12.7	9.9	9.5	10.8	9.9	10.4	9.8	9.2	10.7	11.8	16.0	11.4	9.4	12.5	9.1	17.1	15.5	14.0	14.1	10.9	7.7	6.0	16.6	8.0	11.1	10.9	9.3	7.4	16.7	11.3	8.7	9.2	16.0	8.7	11.2	12.3	17.9	11.9	12.0	18.5	9.2	8.1	7.7	21.2	6.7	7.3	15.3	36.7	5.9	13.3	9.5	7.6	8.4	8.7	5.6	4.9	10.9	16.0	3.0	11.1	7.4	8.9	12.6	11.0	9.4	12.5	10.1	30.4	13.7	9.4	12.0	21.3	15.4	8.9	15.4	5.1	15.1	17.9	12.0	13.3	6.7	9.7	9.5	7.4	19.5	11.4	11.7	24.4	5.5	10.1	7.5	11.0	12.0	8.8	13.8	16.4	10.9	13.2	27.9	10.9	6.8	9.3	10.2	5.4	5.6	6.1	8.5	18.8	17.7	13.7	5.0	11.0	16.7	0.3	1.4	1.6	3.2	2.2	2.3	2.2	3.7	3.7	2.1	1.4	3.0	3.8	0.1	2.1	1.7	4.6	4.5	1.3	14.2	18.7	18.2	16.4	11.8	16.0	17.1	15.5	16.6	16.0	17.9	21.2	24.5	22.4	30.0	169.1	13.8	7.9	9.6	9.3	14.8	30.9	10.8	10.2	44.4	11.5	18.2	11.0	54.2	8.8	18.7	11.5	21.5	13.4	20.9	18.8	24.4	15.9	17.4	7.2	101.1	17.8	10.6	18.5	18.3	15.7	152.3	26.1	11.7	8.8	6.9	20.2	128.9	12.8	12.2	9.5	7.8	24.4	19.0	22.2	19.6	69.3	12.2	12.7	20.6	142.7	168.7	10.6	19.2	18.4	14.6	7.1	12.4	12.3	22.8	30.6	6.6	32.9	12.9	38.9	21.6	14.1	6.7	6.7	20.9	30.6	14.0	8.0
TEAD1	"AA, TCF13, TEF-1"	ENSG00000187079	"TEA domain transcription factor 1"	P28347	11	12674421-12944737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 230.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057339, HPA062471"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA057339: AB_2683413, HPA062471: AB_2684773"	"unprognostic (1.00e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.40e-3)"	"unprognostic (8.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.18e-2)"	29.5	12.1	11.1	8.2	11.6	0.0	17.8	8.6	8.5	23.4	30.6	36.1	7.7	26.4	7.1	29.8	19.2	18.5	31.3	14.5	14.8	17.2	13.6	15.9	4.2	15.1	12.3	21.9	15.2	27.1	14.4	33.3	10.5	18.8	13.0	10.5	10.2	20.1	67.5	13.2	11.9	27.2	13.3	7.3	16.4	8.6	15.6	4.2	17.8	72.6	5.6	33.9	14.7	12.9	62.8	52.1	43.9	58.7	59.9	62.1	65.4	89.2	76.2	71.6	69.7	53.8	54.5	0.4	23.0	120.9	32.3	37.0	53.7	35.9	115.5	0.2	17.6	0.0	107.3	18.1	55.8	0.0	4.7	51.8	18.3	50.4	68.2	58.6	15.2	3.9	26.0	0.2	111.2	13.1	0.1	0.6	17.2	14.5	23.5	0.3	64.8	33.2	48.2	37.2	26.9	31.2	90.9	43.1	59.0	63.8	20.0	4.4	32.0	107.8	76.2	84.9	59.5	8.6	17.3	12.0	41.6	0.2	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	11.6	8.6	8.5	14.5	14.8	15.1	12.3	10.5	13.3	15.6	12.9	37.9	89.8	21.7	230.8	0.4	99.3	32.2	19.3	39.9	12.9	16.4	20.2	75.0	31.5	33.1	49.7	12.5	24.1	0.2	11.0	1.9	16.6	6.5	80.8	97.4	33.3	46.7	0.0	101.8	12.8	52.4	46.5	18.8	142.9	0.0	57.7	25.7	39.8	3.7	1.7	108.4	13.5	10.2	1.9	16.0	7.2	23.6	1.9	24.9	91.8	0.0	31.2	0.0	121.2	69.7	34.8	8.1	24.0	1.4	69.4	6.7	29.8	53.8	17.5	6.6	73.5	46.7	3.0	22.3	29.9	54.8	12.3	2.0	45.5	10.4	54.6
TEAD2	"ETF, TEF-4, TEF4"	ENSG00000074219	"TEA domain transcription factor 2"	Q15562	19	49340595-49362457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 51.1;Early spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"memory B-cell: 1.7;naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	27	"B-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 135.3;AN3-CA: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066292, HPA069963"			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA066292: AB_2685651, HPA069963: AB_2686222"	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	32.8	17.8	7.5	15.4	7.1	0.2	31.6	6.6	7.9	41.8	16.2	50.4	7.6	39.6	12.4	11.0	34.2	15.5	55.5	7.5	6.8	34.5	11.9	35.7	9.0	8.7	8.3	33.5	26.8	19.4	9.2	17.7	7.7	26.5	11.2	3.4	18.5	22.7	12.9	10.7	18.5	38.4	7.6	14.8	31.3	26.6	8.3	3.1	16.9	22.1	7.3	27.2	24.4	6.6	12.5	28.6	135.3	147.6	14.2	20.8	24.3	22.8	23.9	25.6	29.7	2.3	6.8	1.2	29.6	38.5	13.1	13.9	37.5	7.7	14.1	0.1	17.5	0.0	27.2	19.3	24.6	0.1	0.3	24.8	17.8	17.4	8.4	50.6	92.1	0.1	22.0	0.0	36.1	15.3	0.0	0.2	45.4	35.2	36.2	0.0	40.8	0.2	23.3	0.2	0.2	82.0	38.1	5.6	10.1	46.1	40.5	3.5	55.0	45.9	28.1	9.9	1.8	0.1	0.1	4.8	1.7	0.6	18.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	7.1	6.6	7.9	7.5	6.8	8.7	8.3	7.7	7.6	8.3	6.6	26.1	3.2	3.2	0.0	3.8	3.3	6.9	5.9	8.6	0.4	21.1	9.5	1.0	8.6	3.4	12.9	0.0	0.6	0.4	1.3	1.9	51.1	76.6	7.3	20.7	29.5	7.1	3.2	0.1	26.2	23.7	15.0	9.7	6.5	0.0	14.7	21.4	2.8	0.6	0.0	0.1	6.6	8.2	0.9	3.6	29.6	15.2	0.7	5.4	1.9	0.0	15.9	0.0	0.0	0.1	22.7	4.9	22.2	0.1	7.2	0.1	0.2	1.2	0.4	32.9	7.6	28.7	2.1	2.4	2.0	1.6	1.2	0.5	4.4	6.8	2.8
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906238	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	4.9	6.0	4.4	5.9	4.6	2.2	6.7	5.7	6.0	4.0	5.5	5.7	5.6	4.9	4.1	5.2	4.8	4.1	8.9	4.6	4.4	9.6	8.8	4.0	7.3	4.5	4.4	4.8	3.3	6.6	3.2	6.8	4.6	5.0	6.6	6.9	5.4	4.8	6.8	5.3	4.6	5.1	4.3	5.7	5.1	4.2	4.6	5.4	5.4	11.7	6.7	5.4	2.9	5.1	12.8	19.2	10.7	14.9	12.7	12.4	10.1	13.1	9.5	23.7	21.4	15.6	7.2	17.4	12.7	8.1	15.5	21.6	18.6	9.1	22.4	5.5	23.9	8.8	15.1	15.5	8.5	18.7	11.2	7.9	11.7	13.4	6.9	7.2	11.9	12.4	19.1	14.3	13.9	11.7	16.0	24.3	8.9	19.6	12.1	10.5	22.9	17.6	19.2	14.4	16.3	7.5	9.8	11.7	15.4	10.9	23.7	14.1	7.8	10.9	14.7	11.2	13.8	7.9	14.0	16.2	7.3	13.8	13.2	2.6	7.7	6.5	6.4	12.2	8.8	9.8	8.2	6.5	8.1	6.3	9.9	9.2	2.3	8.6	9.9	7.0	10.0	7.1	4.4	4.6	5.7	6.0	4.6	4.4	4.5	4.4	4.6	4.3	4.6	5.1	10.1	16.0	10.6	13.7	11.3	4.1	8.0	22.6	9.1	17.8	6.8	6.9	5.8	11.5	13.6	9.2	8.4	26.0	11.5	5.4	25.4	13.4	10.4	12.6	15.3	9.6	5.4	6.9	27.1	8.5	17.3	10.2	5.1	7.8	5.1	17.2	10.4	10.1	20.4	16.8	27.3	7.4	22.4	7.8	3.0	6.3	8.1	9.6	7.2	21.5	14.0	15.0	16.5	27.2	32.2	12.5	5.6	7.5	7.1	5.2	9.4	17.7	17.8	19.4	19.7	11.0	11.6	27.7	17.8	8.7	4.3	17.8	10.0	18.9	7.9	4.7
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355567-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.2	14.4	19.8	17.2	20.6	18.5	14.1	22.7	29.1	15.3	9.1	15.5	13.4	17.9	15.1	15.0	15.4	13.7	15.1	21.8	21.0	13.0	14.8	12.6	35.6	17.6	19.9	19.2	16.7	18.3	12.4	16.1	16.8	13.3	14.4	21.0	11.9	14.1	31.9	15.9	14.0	19.1	14.5	15.8	12.6	16.4	18.4	21.0	16.6	22.1	44.7	15.6	13.4	23.3	21.6	34.4	30.5	30.8	28.5	20.9	26.0	21.5	26.9	50.1	38.7	31.7	28.6	98.2	28.6	26.7	17.9	34.0	37.8	26.4	46.7	18.6	29.3	28.8	18.2	29.1	24.2	28.6	23.0	21.5	26.2	40.2	48.7	22.2	35.0	38.4	54.8	14.2	32.8	29.2	57.0	36.4	35.1	23.6	16.7	78.5	20.2	56.8	21.6	15.8	34.4	27.0	71.4	16.1	19.6	27.5	30.6	32.8	21.5	31.3	27.4	21.9	25.9	36.8	42.1	124.9	27.1	25.5	30.8	14.9	3.5	4.3	5.9	3.3	4.3	13.0	5.6	5.0	3.7	8.4	6.3	6.2	4.2	4.6	3.5	5.0	5.0	2.8	19.8	20.6	22.7	29.1	21.8	21.0	17.6	19.9	16.8	14.5	18.4	23.3	16.2	16.0	10.2	15.0	20.9	12.5	12.8	5.0	5.7	25.3	13.4	8.5	17.2	5.7	5.1	9.2	18.8	8.3	13.0	15.5	1.9	5.3	33.4	15.5	20.8	17.9	10.2	8.6	18.3	7.5	7.7	13.5	8.6	20.5	14.0	14.9	14.3	18.2	12.5	45.4	19.9	11.6	2.0	15.4	12.3	19.5	9.3	11.0	3.6	16.9	8.9	19.3	16.5	18.6	26.5	7.9	7.3	14.3	11.2	14.8	9.5	8.4	8.3	13.9	19.7	18.8	12.1	8.8	13.1	9.6	12.9	8.3	12.1	17.0	11.1	12.8
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210506-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 197.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 386.6;Glandular and luminal cells: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 230.0;hTCEpi: 263.6;SK-BR-3: 267.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA		34000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	29.3	7.2	2.7	54.4	2.7	44.1	32.2	3.4	3.6	29.0	10.0	134.7	41.1	105.9	21.7	58.2	45.2	37.4	14.7	2.3	2.9	19.3	10.1	41.0	49.6	6.4	3.5	7.3	20.8	15.3	5.7	25.6	3.4	55.2	69.0	13.4	34.2	197.1	5.1	23.2	47.5	147.6	3.2	30.0	52.1	39.9	4.3	33.5	66.4	8.9	51.3	87.1	41.1	3.0	115.9	24.0	27.0	0.2	11.7	29.7	62.3	58.9	28.9	10.9	10.6	60.4	126.2	0.0	230.0	41.7	1.3	116.9	14.4	87.3	26.4	57.3	46.0	11.5	53.1	30.5	69.9	53.6	0.2	66.4	263.6	37.7	95.0	74.9	31.1	0.0	11.9	39.5	3.0	24.4	0.2	0.7	17.8	134.0	67.4	0.2	0.4	46.0	110.9	44.0	12.4	113.4	85.5	267.1	68.2	77.6	0.3	21.5	52.3	0.6	1.5	86.2	0.7	92.6	48.9	1.3	7.4	27.2	89.3	274.7	79.2	221.5	150.2	132.1	144.7	104.6	113.4	137.6	86.9	95.5	111.0	127.6	41.6	205.1	170.5	20.7	130.4	162.8	2.7	2.7	3.4	3.6	2.3	2.9	6.4	3.5	3.4	3.2	4.3	3.0	40.8	243.6	47.0	0.0	60.4	200.4	196.2	64.8	60.3	2.2	62.2	57.0	16.1	47.1	81.7	36.8	12.5	23.2	121.3	140.8	21.5	110.7	386.6	176.7	29.9	49.0	50.6	17.7	0.1	112.3	78.1	23.6	84.1	283.9	18.9	54.1	25.7	11.9	15.4	1.7	0.1	100.7	34.6	58.0	119.0	112.5	1.8	78.0	28.4	10.3	77.6	24.7	201.8	0.0	0.3	196.8	112.1	0.4	76.3	102.4	65.3	13.6	68.1	13.9	6.6	9.0	42.3	19.1	10.6	55.9	122.7	29.1	79.2	8.8	79.7	135.9
TESK2		ENSG00000070759	"Testis associated actin remodelling kinase 2"	Q96S53	1	45343883-45491163	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 222.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;RT4: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	3.8	2.1	7.1	2.8	10.6	10.2	6.6	10.3	8.3	6.4	4.8	5.3	8.6	3.2	3.7	7.1	3.0	2.6	2.4	7.3	8.0	2.5	6.9	3.9	3.9	10.8	10.1	9.8	3.6	3.4	2.4	3.5	10.3	15.5	7.0	2.8	8.4	2.6	8.3	12.7	10.8	2.9	8.5	5.3	4.5	9.6	9.9	4.2	3.4	4.7	5.2	4.7	7.4	15.1	1.9	0.0	0.9	0.1	3.5	1.8	14.6	0.7	4.9	2.1	3.6	4.3	1.7	6.2	0.6	1.8	5.4	2.3	3.9	3.1	1.6	4.4	4.9	4.2	2.0	3.2	1.9	1.4	11.1	1.9	3.2	2.4	3.4	3.2	1.7	8.1	0.8	12.4	1.4	0.7	3.6	2.9	3.8	1.8	1.8	5.2	0.1	1.5	1.9	14.7	0.4	1.6	3.8	7.3	14.1	8.6	11.3	1.8	0.0	0.2	2.1	1.3	1.3	8.0	5.0	1.2	1.1	0.0	1.0	12.8	4.6	13.3	2.7	3.4	1.9	8.0	2.5	1.8	2.4	6.6	4.1	2.3	19.0	1.5	8.0	1.3	1.9	3.4	7.1	10.6	10.3	8.3	7.3	8.0	10.8	10.1	10.3	8.5	9.9	15.1	3.9	0.0	2.8	54.2	10.7	7.8	7.1	2.8	14.2	2.4	11.9	9.4	1.3	4.3	3.4	0.0	14.6	8.3	4.2	13.9	0.0	1.3	23.7	4.6	1.8	3.2	4.2	5.0	10.2	2.7	2.8	3.7	7.7	8.9	7.0	2.4	2.2	6.3	6.8	0.0	6.7	6.9	4.1	5.5	4.4	7.8	2.8	6.0	3.6	15.9	4.6	1.1	4.1	18.6	222.9	1.1	7.3	1.9	9.8	10.6	14.9	1.2	2.0	3.1	6.6	2.6	6.1	22.0	13.6	12.6	8.5	14.8	4.7	1.8	4.9	8.0
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385345-58399220	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 631.4;Late spermatids: 933.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	16.5	20.1	5.7	21.6	6.1	38.1	17.3	10.8	8.4	11.4	6.8	20.0	21.0	13.7	9.5	14.7	12.6	10.7	18.5	5.5	7.3	21.5	22.6	10.9	27.7	5.8	6.1	17.8	13.9	16.2	6.3	20.4	6.5	14.5	17.3	9.8	17.3	11.4	17.7	9.0	17.8	11.6	7.0	17.3	16.1	33.0	6.4	24.9	19.6	16.1	23.0	16.7	7.5	8.8	85.7	47.7	52.8	54.7	15.3	19.4	59.8	37.9	37.3	46.8	51.1	170.0	88.6	170.1	53.9	17.6	34.8	65.2	97.6	53.5	73.4	73.4	85.7	64.1	33.4	64.5	23.3	164.7	49.4	19.2	24.4	57.0	51.6	22.2	41.1	49.9	153.4	74.8	33.2	46.4	130.2	65.1	100.0	39.2	49.9	102.9	113.0	76.0	28.3	57.0	69.8	48.1	75.1	103.7	97.0	42.9	112.8	47.9	32.0	34.4	109.5	39.5	102.5	75.6	125.8	214.2	44.1	125.1	26.4	1.0	9.5	4.0	8.3	9.5	10.8	12.8	10.0	8.8	12.1	12.5	12.4	10.1	7.1	15.0	8.3	14.7	9.0	6.9	5.7	6.1	10.8	8.4	5.5	7.3	5.8	6.1	6.5	7.0	6.4	8.8	46.4	54.5	27.9	6.2	52.5	50.1	44.0	52.4	59.2	25.1	48.6	62.9	35.0	38.6	51.0	20.2	16.7	98.1	56.8	17.1	88.0	41.0	631.4	36.8	44.5	39.5	15.5	46.7	10.1	44.7	77.4	38.8	25.0	41.2	29.7	34.1	26.0	64.1	44.0	38.7	11.5	37.5	18.3	21.9	19.3	933.1	41.3	32.3	23.2	2.8	36.3	38.2	48.4	10.6	11.7	35.2	23.0	30.9	35.8	47.3	14.1	72.0	31.4	21.4	26.3	74.8	40.5	55.3	63.9	48.6	54.7	52.5	38.3	69.1	48.1	31.8
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 32.8;skin 1: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;pons and medulla: 1.0"	"Low region specificity"	"Detected in many"			"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.5	0.4	0.4	0.1	0.3	0.1	32.8	4.1	0.4	7.5	0.2	1.1	0.5	0.3	21.8	29.9	0.4	0.2	0.9	0.3	0.1	7.4	0.1	0.5	0.4	3.0	1.3	0.4	0.2	0.6	0.4	29.6	2.1	9.8	0.5	8.1	23.5	9.3	0.5	66.7	0.8	0.1	0.5	0.1	1.4	2.2	0.5	0.2	0.5	0.1	5.1	3.5	16.6	0.6	51.8	17.8	0.1	87.9	0.4	0.0	19.7	40.2	30.3	31.7	31.4	2.1	19.3	3.2	4.9	12.0	17.5	53.2	4.3	66.1	30.9	104.7	45.2	0.4	44.5	0.0	0.0	1.7	1.5	0.0	97.3	0.1	66.6	18.3	0.0	0.9	3.3	0.1	0.3	12.2	0.0	17.2	0.5	3.3	24.7	5.9	5.0	2.2	18.8	21.8	12.5	0.3	44.1	82.7	82.3	97.3	56.0	1.7	0.0	9.9	2.7	7.1	25.3	0.1	5.1	0.8	5.1	1.7	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.3	0.1	3.0	1.3	2.1	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.4	130.6	45.5	50.3	167.9	25.9	98.2	65.7	2.7	0.0	30.5	31.3	2.1	285.8	0.5	1.0	7.9	2.2	5.3	1.2	0.7	2.1	1.2	0.0	0.0	0.4	260.6	4.2	0.0	1.5	0.0	0.1	0.0	0.0	20.4	80.8	0.0	0.5	46.8	0.0	6.1	3.8	0.6	0.5	124.5	0.0	0.0	4.3	0.0	0.0	0.1	3.7	0.5	0.0	1.2	58.2	0.1	0.3	21.5	4.6	0.0	0.3	4.1	6.5	16.8	147.7	138.4	700.1	0.3	0.3	0.5	46.7
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540561-246566261	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	11.6	23.5	3.6	9.4	3.7	24.2	12.1	6.2	5.0	8.5	6.3	12.6	11.4	7.2	9.5	10.9	8.6	7.1	14.0	3.4	3.9	21.2	37.8	6.3	13.3	3.4	3.5	6.9	15.6	10.8	6.3	9.1	3.5	8.8	12.9	5.0	11.3	7.5	22.7	9.3	9.1	8.0	3.8	7.0	10.1	8.7	3.9	9.3	13.6	24.3	13.2	13.3	6.1	4.1	33.9	31.9	12.1	21.5	14.8	21.1	42.2	24.2	24.8	26.9	24.6	39.0	31.6	59.8	36.9	24.7	17.4	28.5	29.3	25.7	36.8	23.4	11.3	30.3	18.1	34.5	24.2	54.1	26.3	21.0	30.2	23.1	25.8	14.8	21.2	20.9	89.2	19.8	23.4	15.7	27.5	24.1	53.8	58.6	32.1	27.2	23.9	72.9	24.5	36.7	26.7	53.8	23.4	41.9	82.2	13.3	30.6	51.3	15.6	18.7	22.7	26.6	63.8	57.1	102.9	47.6	23.0	52.6	23.9	0.3	5.4	1.5	9.1	5.7	11.5	11.9	8.0	9.7	12.9	12.0	10.3	8.9	1.2	14.8	9.8	11.1	12.3	5.3	3.6	3.7	6.2	5.0	3.4	3.9	3.4	3.5	3.5	3.8	3.9	4.1	11.9	6.4	9.4	4.2	17.2	53.3	13.7	27.9	31.9	3.2	12.4	11.9	16.5	14.3	18.4	16.5	10.4	24.4	13.1	7.6	29.4	13.8	1.5	17.6	12.9	13.2	11.4	8.6	8.1	15.5	28.1	10.2	18.8	22.4	14.0	7.5	5.7	33.9	11.9	0.0	7.2	14.3	6.1	9.3	7.7	3.4	6.5	7.3	5.4	1.9	6.9	6.6	7.2	6.0	5.5	11.0	10.3	4.5	12.7	17.2	7.8	39.2	15.4	3.4	13.1	14.4	12.2	13.2	21.6	21.3	44.9	21.1	10.9	17.7	19.8	10.4
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	7.5	5.9	3.9	12.4	4.0	7.6	10.2	3.6	3.8	10.5	8.6	8.6	4.8	22.0	4.4	5.7	24.2	8.6	6.3	3.7	3.9	9.2	9.3	8.6	16.9	5.7	4.6	13.7	15.1	13.2	3.0	11.6	4.6	9.0	5.5	5.2	10.2	7.8	2.1	5.8	8.3	18.6	4.8	14.6	7.0	11.4	4.9	17.8	8.5	3.7	18.7	9.5	6.6	4.5	16.1	4.2	45.0	52.3	6.2	5.6	16.1	8.9	10.3	21.3	15.5	22.9	20.5	42.5	23.2	9.2	9.7	16.4	36.1	23.6	20.8	20.0	13.2	53.5	10.6	30.5	9.6	23.6	12.7	9.1	15.0	4.8	16.4	19.1	20.9	20.6	26.1	27.3	10.4	22.8	38.8	43.6	37.1	23.0	11.1	33.2	52.7	24.0	13.8	10.7	13.5	40.0	3.1	23.3	23.1	34.8	28.7	51.2	15.6	3.7	13.7	0.3	17.2	29.6	11.9	40.3	0.3	27.2	16.6	16.0	5.0	1.6	4.0	4.3	4.4	7.2	3.6	4.1	6.7	4.9	6.0	5.1	2.0	3.8	3.0	6.7	3.8	3.8	3.9	4.0	3.6	3.8	3.7	3.9	5.7	4.6	4.6	4.8	4.9	4.5	11.5	9.6	8.8	0.0	41.7	44.6	31.4	10.5	50.7	0.2	25.5	16.6	17.3	14.3	9.4	7.3	2.1	6.6	26.5	1.3	7.9	19.7	2.8	11.4	13.4	17.9	6.6	13.5	0.0	7.7	1.7	12.9	8.6	13.7	16.5	35.7	10.8	5.8	10.4	0.0	0.0	3.7	10.2	10.0	25.8	3.2	6.2	13.2	14.2	0.0	12.7	7.4	3.1	0.0	0.0	15.9	4.8	7.5	35.3	27.5	0.3	7.0	5.3	2.0	6.6	10.0	13.9	3.0	19.8	11.6	25.4	9.0	27.0	11.0	4.2	16.4
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328296	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		12000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	70.0	67.5	37.5	82.6	42.1	129.9	58.3	38.5	44.0	63.5	32.2	85.8	110.6	62.0	60.9	41.1	65.1	75.7	63.5	39.6	45.3	120.8	136.5	86.8	73.9	45.5	43.4	61.3	56.0	67.1	26.9	76.6	44.9	66.9	102.3	31.8	59.8	62.5	34.7	40.1	111.9	74.0	40.4	83.2	74.8	37.1	45.1	65.2	91.3	46.2	66.1	61.4	41.0	50.0	46.5	116.4	51.8	68.6	124.0	129.0	120.7	144.1	172.2	98.5	78.5	100.6	142.2	60.6	108.3	207.1	132.9	76.4	37.8	71.9	161.8	96.5	36.7	87.2	41.3	113.3	67.1	173.0	189.5	96.2	45.2	125.5	76.1	152.1	144.4	49.5	50.9	94.1	147.1	43.9	54.0	86.3	46.0	109.3	47.5	55.4	193.1	45.6	104.8	73.2	47.4	40.5	127.2	95.5	83.6	61.7	50.7	77.0	155.7	205.5	73.9	158.6	173.5	58.7	81.9	58.1	152.3	131.1	137.3	62.6	78.0	68.5	32.4	73.3	25.0	25.0	23.8	22.4	41.5	24.4	24.3	23.6	96.3	25.1	103.5	15.9	20.9	75.6	37.5	42.1	38.5	44.0	39.6	45.3	45.5	43.4	44.9	40.4	45.1	50.0	104.4	102.5	96.4	22.5	89.7	38.2	57.1	72.5	43.9	53.3	89.2	56.4	64.3	150.2	84.2	180.3	39.6	59.4	116.9	216.1	9.8	92.7	6.0	86.3	89.5	91.7	89.5	39.5	29.5	93.2	80.9	87.5	64.7	105.7	158.8	70.5	86.7	245.0	113.0	208.6	37.9	99.0	52.9	187.1	85.3	7.8	49.4	145.6	60.5	33.7	126.9	47.8	95.8	25.1	50.6	101.6	121.8	69.2	74.0	62.8	211.2	82.8	111.4	36.5	65.7	85.0	65.8	36.1	37.1	32.6	34.9	44.6	91.1	61.9	100.3	70.8
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034984-36054739	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 18.8;Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA064056: AB_2685184, HPA070139: AB_2686230"	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	3.3	3.2	9.1	2.5	9.8	0.9	2.7	9.4	9.6	5.0	6.3	9.5	3.7	4.7	3.4	3.7	3.8	3.5	3.5	8.3	9.7	4.1	4.6	2.8	3.1	10.1	9.8	3.5	2.8	3.7	3.4	2.8	10.2	3.6	2.4	4.6	3.0	4.3	10.2	5.2	3.5	4.4	8.9	3.4	3.6	9.7	9.7	4.0	3.1	3.3	2.2	6.6	4.0	11.2	3.3	8.2	4.4	3.7	11.6	8.0	2.8	2.7	4.8	5.5	7.8	3.6	2.3	4.5	9.7	4.5	5.7	1.5	2.5	3.3	2.1	3.2	1.6	2.8	3.0	4.3	12.7	1.6	2.7	6.2	5.0	3.8	2.6	6.2	2.6	8.2	2.4	5.3	5.8	5.5	4.1	3.4	3.9	5.6	3.1	3.9	1.4	4.2	4.5	2.9	8.1	6.1	4.6	3.9	3.3	5.7	4.1	2.2	2.3	7.3	4.5	4.5	2.2	5.2	4.5	3.3	8.0	2.6	4.7	7.1	6.5	7.9	5.2	7.6	5.9	4.1	5.5	5.4	4.7	3.0	4.1	6.1	2.7	6.2	6.6	4.5	5.8	4.1	9.1	9.8	9.4	9.6	8.3	9.7	10.1	9.8	10.2	8.9	9.7	11.2	1.4	3.2	3.7	3.6	3.4	1.1	1.2	3.2	2.8	2.2	3.0	2.4	3.7	5.7	2.9	7.3	2.1	10.2	3.5	2.1	1.9	5.7	3.0	1.5	3.9	2.5	6.6	1.3	2.7	0.5	5.5	3.8	4.1	2.7	5.7	8.8	3.9	3.5	15.8	3.3	3.3	1.3	12.2	4.4	0.8	6.1	1.8	3.2	1.8	1.9	4.4	5.2	8.2	4.5	5.5	2.6	2.7	4.1	2.5	1.2	5.3	11.7	1.2	3.0	0.0	1.7	2.9	18.8	21.5	2.3	2.3	10.5	2.5	5.8	2.2	1.0
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	6.0	5.2	8.7	8.1	9.7	7.5	5.8	10.0	12.2	5.5	9.8	6.6	6.3	4.7	4.5	6.5	4.1	4.6	4.6	8.8	8.8	7.5	9.9	4.6	12.3	9.4	9.0	4.7	3.9	6.7	3.7	6.4	9.9	5.1	5.5	5.8	6.9	4.1	6.2	6.3	5.9	5.7	8.8	6.3	5.3	16.8	9.5	12.8	4.7	6.2	11.6	9.5	3.8	10.7	27.0	15.8	32.4	26.1	20.8	15.4	40.2	15.4	14.5	29.8	31.1	30.8	16.1	37.2	11.9	20.0	46.0	17.1	43.0	24.4	36.9	12.3	19.1	22.2	18.4	21.0	16.0	50.5	20.2	10.6	14.4	33.3	21.8	13.6	33.3	34.5	52.3	17.4	27.3	20.5	38.1	29.6	31.5	34.2	21.1	53.3	30.3	33.4	17.2	26.1	21.2	16.6	39.0	19.9	25.3	36.7	14.0	37.1	16.6	26.6	29.9	21.8	48.3	15.9	26.4	54.7	22.2	36.0	22.8	13.4	7.3	6.4	9.8	10.7	14.8	13.3	11.7	12.4	11.9	11.5	13.5	13.4	0.7	11.2	9.4	7.2	12.8	6.6	8.7	9.7	10.0	12.2	8.8	8.8	9.4	9.0	9.9	8.8	9.5	10.7	20.4	19.2	11.7	48.3	21.0	12.9	15.6	16.8	23.9	30.8	13.1	14.1	9.6	2.8	17.9	11.0	20.9	24.7	23.2	6.0	15.6	16.5	67.1	15.0	23.6	16.7	9.5	21.0	45.3	8.2	16.7	19.9	9.2	21.9	27.3	32.4	8.2	10.3	16.1	28.6	51.6	8.7	10.2	6.9	11.1	11.6	19.3	15.0	3.6	32.8	14.3	12.9	10.3	41.7	74.6	12.7	7.0	17.0	15.6	16.7	9.2	10.2	10.5	27.6	6.6	21.6	22.9	73.4	30.5	13.8	9.1	18.7	22.3	17.7	13.4	12.9
THOC3	"MGC5469, TEX1"	ENSG00000051596	"THO complex 3"	Q96J01	5	175917873-176034680	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 132.1;Early spermatids: 187.0;Squamous epithelial cells: 226.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042764, HPA044009, HPA045071"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	Vesicles	"HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-3)"	"unprognostic (6.48e-3)"	"unprognostic (8.60e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.91e-1)"	12.0	14.5	22.0	11.4	15.9	35.1	21.4	23.0	40.6	23.1	19.1	27.0	12.5	13.4	63.2	82.9	15.1	8.0	9.3	40.2	14.9	16.3	22.2	11.9	29.1	15.5	13.3	18.8	15.3	10.0	15.9	17.4	15.9	14.6	21.1	12.1	22.5	14.9	12.6	26.5	16.2	12.2	13.2	17.7	17.5	51.3	15.4	39.2	20.5	17.6	45.5	17.4	33.5	15.9	82.1	44.7	47.0	102.7	44.1	39.3	168.0	48.4	44.6	104.5	120.4	63.5	65.2	105.6	68.3	27.9	112.6	69.2	71.6	206.0	109.7	73.5	103.3	57.3	46.2	70.7	14.6	94.6	49.2	33.3	85.9	90.0	45.2	23.3	58.3	98.0	88.1	46.5	66.9	98.7	64.0	57.9	40.1	82.3	160.3	110.7	59.3	110.4	75.2	60.7	89.5	51.4	100.0	48.5	52.5	67.4	55.3	86.1	45.1	35.9	40.8	55.6	88.2	23.2	44.1	64.4	26.7	90.1	28.5	16.5	26.9	15.1	39.3	33.5	48.4	49.6	81.7	48.9	43.1	70.6	99.7	62.4	3.9	42.3	31.5	39.8	133.6	59.1	22.0	15.9	23.0	40.6	40.2	14.9	15.5	13.3	15.9	13.2	15.4	15.9	14.9	12.8	8.6	2.0	35.8	44.5	34.1	64.5	132.1	12.3	17.7	18.0	4.0	10.0	24.4	25.8	10.4	40.8	25.1	8.1	41.1	25.1	187.0	50.2	18.4	16.1	16.8	63.9	5.2	19.2	84.3	15.2	26.5	44.9	12.0	18.8	13.9	20.3	24.6	6.7	3.7	16.3	26.4	13.2	14.9	122.0	14.6	14.3	8.8	1.9	15.4	8.9	27.8	4.5	2.0	21.9	11.6	19.2	55.9	18.4	10.4	46.8	15.8	12.0	19.7	10.6	22.8	107.9	48.3	226.5	40.9	20.0	33.3	25.0	27.7	31.1
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224432-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		59000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	41.9	40.6	24.0	45.9	24.7	44.6	43.7	28.5	26.3	36.6	31.2	40.2	33.9	39.5	34.9	40.6	39.3	29.6	47.2	24.3	26.2	32.3	45.8	37.4	57.1	25.6	24.6	45.3	35.6	52.0	30.0	40.1	26.7	50.4	38.7	40.9	38.8	31.3	115.3	38.2	35.1	42.1	24.1	48.0	37.8	34.3	25.0	63.1	46.0	64.0	60.8	37.1	36.2	28.1	100.7	63.9	110.1	94.9	88.0	69.7	90.9	104.6	107.4	107.2	109.8	74.7	91.5	187.5	38.5	113.8	73.8	89.1	125.2	106.9	131.3	97.4	70.1	157.7	94.3	85.6	94.6	157.2	102.5	105.7	65.7	107.1	86.7	75.2	118.4	107.5	127.8	93.5	77.6	57.8	180.4	92.7	130.5	64.2	50.4	163.6	133.4	99.4	77.0	125.4	69.6	83.9	117.5	77.0	92.7	108.7	73.1	69.3	122.4	89.2	100.4	82.5	111.6	56.7	80.7	162.4	82.2	109.2	92.7	85.8	36.9	64.7	51.5	43.9	46.0	53.6	43.9	46.5	42.4	61.0	46.4	43.1	80.8	51.2	48.6	46.7	40.7	47.3	24.0	24.7	28.5	26.3	24.3	26.2	25.6	24.6	26.7	24.1	25.0	28.1	101.0	115.4	101.7	32.3	136.1	56.7	94.5	126.9	78.0	98.0	76.4	65.5	113.7	75.8	106.2	47.8	31.3	150.7	151.9	64.3	97.8	155.7	9.7	92.1	114.7	96.2	72.4	114.9	65.6	104.1	147.2	98.3	58.6	106.0	92.9	120.5	80.7	78.8	101.6	87.5	63.2	70.1	89.5	77.1	71.7	12.0	80.2	89.9	72.9	53.4	155.5	129.4	196.7	47.7	53.4	111.5	61.9	83.5	119.7	125.2	51.6	76.0	87.6	93.2	92.1	114.6	116.5	145.9	118.4	89.6	68.5	144.1	129.0	141.0	87.1	86.4
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362971-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	14.5	15.5	10.1	15.0	11.5	33.0	18.0	12.7	11.0	18.1	14.0	19.1	16.8	16.3	16.7	20.9	14.7	13.6	24.6	9.9	11.7	20.0	23.4	14.2	18.8	11.2	10.6	14.7	15.5	25.8	12.1	15.1	12.0	19.5	19.0	22.0	15.9	17.9	26.9	13.6	14.3	14.4	11.6	14.3	14.1	59.4	10.9	18.3	23.1	26.4	17.7	16.4	9.6	15.2	40.0	53.0	36.4	18.7	46.5	44.4	146.3	47.2	38.3	47.1	35.8	40.2	41.0	41.0	35.8	43.5	74.1	26.0	66.4	48.3	47.9	45.6	39.1	51.0	51.2	35.3	44.8	66.0	35.3	36.2	53.7	55.7	58.1	38.0	31.5	65.1	80.2	58.2	62.9	55.3	78.9	27.2	69.3	44.0	50.1	49.4	62.7	57.9	29.7	60.4	15.5	48.9	39.6	27.5	43.5	37.2	45.2	42.1	22.8	45.0	38.9	54.9	53.1	73.1	186.7	129.2	55.0	60.5	65.7	19.1	17.8	17.6	20.5	23.4	26.2	17.2	17.6	21.9	20.8	20.0	28.0	21.5	3.6	17.7	29.0	20.5	18.4	14.1	10.1	11.5	12.7	11.0	9.9	11.7	11.2	10.6	12.0	11.6	10.9	15.2	14.9	25.6	21.8	10.1	14.0	10.7	29.3	42.6	16.5	21.6	19.5	23.2	45.3	17.2	34.6	22.0	16.7	34.7	13.1	10.0	52.8	39.2	270.0	19.2	26.8	14.9	3.0	9.7	9.7	29.4	28.4	22.3	12.2	20.9	28.4	21.9	13.2	25.3	27.4	38.7	13.2	15.5	38.7	14.8	6.8	145.3	20.5	18.0	12.4	9.4	20.2	31.4	18.6	18.1	12.5	28.2	9.8	25.9	16.2	32.6	10.9	32.6	20.1	35.2	6.6	28.5	24.5	183.5	52.9	18.9	12.9	27.5	18.4	49.2	20.0	20.9
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TIMM10	"TIM10, TIM10A, TIMM10A"	ENSG00000134809	"Translocase of inner mitochondrial membrane 10"	P62072	11	57528464-57530803	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039946	Supported		Enhanced	Mitochondria		NA	NA		16000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039946: AB_10673023"	"unprognostic (9.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.40e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.15e-2)"	40.5	41.6	55.1	28.5	56.9	34.8	42.5	56.3	68.3	24.8	53.2	35.5	27.0	27.2	43.8	44.1	25.1	20.3	60.9	56.7	57.4	50.7	77.6	27.9	45.8	55.8	55.6	25.5	33.6	45.1	29.2	21.7	56.1	31.0	35.9	15.1	28.0	30.2	77.8	33.7	27.8	27.5	58.5	37.9	35.3	35.6	56.1	38.5	29.7	67.7	50.1	33.7	27.2	58.0	115.6	171.9	79.1	76.0	67.6	57.2	99.7	96.6	77.0	151.1	85.9	127.6	97.9	218.1	108.0	86.5	131.4	86.3	114.0	112.6	136.4	74.8	84.9	139.4	67.0	167.5	71.3	183.3	148.0	54.2	89.6	146.1	101.4	40.0	95.2	142.8	157.1	96.7	112.7	241.1	99.4	243.5	83.4	99.9	184.4	163.5	167.0	190.3	77.6	78.2	64.0	82.2	101.5	198.6	128.6	77.7	150.1	69.3	60.2	86.0	160.5	150.6	188.1	133.2	192.6	176.1	79.2	91.3	146.2	30.9	88.3	20.9	71.5	84.2	81.6	187.6	86.4	79.0	146.4	179.0	118.0	103.6	4.9	67.3	81.3	146.6	84.0	145.1	55.1	56.9	56.3	68.3	56.7	57.4	55.8	55.6	56.1	58.5	56.1	58.0	53.2	12.8	11.0	3.9	66.4	122.9	42.9	94.5	54.1	16.9	103.1	142.2	124.1	78.6	45.6	44.1	4.2	68.0	52.5	78.2	211.3	84.1	134.7	36.7	28.1	55.8	27.0	56.8	3.2	125.6	88.2	42.0	24.5	39.1	52.6	30.1	40.4	212.3	125.9	8.4	3.9	61.0	48.8	71.7	100.3	284.7	46.3	52.9	81.8	3.7	103.2	55.0	56.7	3.0	5.6	85.3	63.5	51.1	51.5	102.4	120.3	227.3	23.2	15.5	13.1	50.5	71.3	85.9	52.8	78.1	129.7	39.5	42.2	37.7	92.6	52.4
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955503-201970664	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	31.4	48.3	29.3	35.4	30.6	36.8	29.3	31.2	35.8	27.4	34.9	35.2	31.4	25.7	41.1	31.9	20.9	19.0	72.2	31.3	32.5	42.2	80.6	23.7	30.9	30.2	30.6	18.5	23.4	55.8	24.8	31.3	31.0	25.0	38.0	33.3	23.0	28.4	86.1	20.9	23.9	35.3	30.5	24.9	29.1	19.7	30.7	30.3	38.2	94.9	35.8	42.8	23.2	29.4	89.1	88.9	78.5	94.9	64.5	67.2	132.5	138.4	98.0	110.5	98.4	104.8	89.7	122.5	49.7	118.6	81.1	69.2	145.3	82.4	118.3	90.4	90.7	67.7	119.1	99.7	66.7	145.5	69.5	78.0	89.8	113.2	93.9	79.5	117.4	75.4	173.1	66.7	131.7	56.9	78.9	78.3	99.6	88.3	47.0	76.5	91.4	152.6	136.2	83.1	118.0	83.2	84.6	213.5	130.7	98.7	118.5	97.0	95.2	73.6	78.7	86.7	146.4	99.9	115.9	102.3	78.4	109.2	84.2	18.5	32.0	29.2	21.7	44.5	28.6	30.3	23.5	28.1	50.1	23.6	22.4	26.2	7.7	29.7	46.7	33.6	37.0	32.2	29.3	30.6	31.2	35.8	31.3	32.5	30.2	30.6	31.0	30.5	30.7	29.4	31.7	38.5	37.2	9.4	54.7	92.2	100.2	123.3	34.1	24.1	43.2	36.2	129.5	37.1	73.0	38.6	35.5	115.2	44.2	38.8	137.0	94.5	69.7	40.1	55.2	46.0	34.0	36.6	18.1	86.0	187.0	55.9	40.2	48.1	55.2	37.9	32.9	168.0	114.8	35.3	17.4	58.1	81.4	44.0	177.7	32.0	33.5	52.8	53.4	4.7	80.4	49.4	26.8	6.6	14.9	109.4	30.4	38.4	98.6	85.0	37.2	131.8	55.8	31.7	26.3	46.6	75.3	42.6	61.5	60.6	98.9	265.6	46.2	62.9	58.3	118.1
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943667	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043052, HPA073108"	Supported		Enhanced	Mitochondria		NA	NA		9100	"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA043052: AB_10795713, HPA073108: "	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	15.2	25.1	16.1	11.2	15.2	8.4	13.0	15.9	22.8	20.2	16.3	27.6	16.9	18.3	7.0	20.9	13.9	6.8	52.3	15.8	15.4	20.0	34.6	10.7	11.1	15.4	15.2	16.2	17.6	13.5	14.4	8.3	15.6	17.5	8.2	4.2	14.0	11.6	62.1	15.7	14.3	10.2	16.6	19.4	20.8	11.0	17.6	7.7	13.8	49.2	8.1	20.1	15.3	16.2	64.5	37.2	24.4	52.0	28.6	28.6	33.3	34.9	26.6	43.8	39.6	82.5	18.1	98.5	45.5	27.5	37.3	46.6	75.7	38.4	21.7	45.5	98.7	53.6	31.4	70.1	72.4	66.3	21.9	31.6	60.1	37.0	53.5	19.4	30.4	53.3	97.2	55.7	20.7	58.5	59.2	53.7	61.3	61.8	116.8	60.4	35.6	68.8	24.9	42.0	46.2	28.3	39.0	50.5	112.8	19.3	29.7	64.4	19.6	30.1	40.2	69.7	72.5	70.4	84.8	99.5	24.2	92.7	48.6	14.3	12.9	4.1	11.3	14.1	10.4	8.6	11.0	10.9	16.4	7.9	9.9	10.6	1.1	10.3	8.7	12.5	9.8	9.5	16.1	15.2	15.9	22.8	15.8	15.4	15.4	15.2	15.6	16.6	17.6	16.2	20.0	35.3	16.4	13.7	31.8	27.9	33.7	41.9	14.2	53.0	43.8	37.6	36.1	32.9	21.5	29.5	41.7	38.5	25.6	48.4	66.5	47.8	11.7	24.8	42.1	22.2	40.1	28.2	13.5	42.9	43.2	25.4	19.4	31.6	33.0	26.4	20.3	62.2	34.9	52.2	13.9	45.5	26.4	21.7	11.1	13.7	36.7	17.2	21.4	1.9	22.9	23.5	44.3	11.1	10.9	42.1	29.0	29.3	25.8	31.8	45.9	75.1	12.4	63.6	32.9	25.0	33.7	38.7	33.9	18.7	19.9	32.6	20.2	29.5	64.6	30.9
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498547-119525090	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	10.5	12.0	13.4	10.7	14.3	6.3	13.1	14.2	15.4	15.0	13.2	11.3	8.9	9.3	17.9	15.9	12.8	14.4	44.0	12.7	13.9	17.8	14.2	11.0	17.7	14.3	13.6	10.9	11.1	23.1	7.1	17.1	13.9	13.0	13.7	4.2	14.6	19.7	27.3	15.8	7.7	12.1	14.0	9.9	8.5	10.6	14.1	11.4	19.1	49.2	14.8	14.2	7.0	14.6	26.9	24.5	12.4	10.4	45.5	30.6	27.0	7.7	25.3	21.7	24.7	16.7	16.0	19.5	13.7	27.1	15.1	12.2	30.8	24.8	35.0	16.4	10.9	14.4	10.7	18.8	23.9	11.3	9.1	28.0	37.4	18.4	22.4	13.9	31.5	18.5	19.8	18.1	40.3	33.2	12.0	23.7	16.2	22.4	30.1	10.0	8.4	25.4	32.0	13.1	15.8	29.4	7.8	11.8	28.0	16.2	19.5	30.4	16.1	12.2	9.3	11.3	13.8	12.1	11.8	28.3	20.7	28.5	19.6	11.1	17.6	21.3	10.8	17.6	12.5	16.2	10.4	12.0	17.4	17.6	12.2	10.9	4.3	13.1	20.9	15.1	20.7	22.1	13.4	14.3	14.2	15.4	12.7	13.9	14.3	13.6	13.9	14.0	14.1	14.6	61.2	25.6	39.3	18.6	24.0	37.5	50.4	110.2	31.3	25.0	44.8	55.0	165.3	41.5	63.7	40.5	14.6	157.5	28.9	44.0	150.6	73.2	12.2	39.9	41.1	56.0	28.8	43.1	17.4	62.7	112.7	48.2	29.0	31.1	41.2	34.1	31.8	52.4	86.3	21.9	23.9	43.5	87.5	32.7	40.4	10.0	47.2	39.4	44.4	15.0	65.7	73.6	18.6	22.6	35.6	52.7	40.9	54.5	30.2	43.5	50.5	146.5	63.0	35.4	72.3	43.9	52.5	111.1	58.2	45.9	42.1	177.5	29.7	48.0	45.7	46.7
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 233.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA059061: AB_2683895, HPA069807: AB_2686203"	"prognostic favorable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	47.2	76.4	17.6	17.3	19.1	20.1	44.0	18.9	23.6	42.2	17.7	40.7	11.5	43.7	21.0	63.2	36.1	12.8	39.4	17.6	18.4	48.5	33.5	44.1	22.7	19.5	18.6	32.2	44.6	233.5	31.9	14.2	19.5	37.9	15.7	12.8	37.6	16.2	45.2	40.8	38.4	19.4	18.8	55.8	41.8	16.3	18.7	29.2	40.7	16.1	26.6	40.9	41.4	20.0	18.4	16.4	23.2	12.2	25.1	18.5	11.8	18.3	23.1	26.3	24.5	7.1	20.0	26.7	10.3	26.1	19.0	17.5	13.2	16.5	16.5	34.1	6.7	16.8	15.1	28.5	21.6	17.9	23.1	20.5	26.0	21.1	20.0	24.5	28.9	25.0	6.7	33.1	21.5	20.0	27.0	8.8	5.4	19.3	20.1	21.9	14.8	19.5	23.7	25.8	14.2	13.2	19.1	18.0	17.0	15.3	12.9	11.4	23.3	12.2	14.9	21.0	14.6	25.2	19.5	15.1	14.8	9.9	18.6	124.6	47.8	113.7	59.7	51.1	48.1	58.7	46.5	56.2	41.1	65.1	48.3	48.4	60.2	63.5	49.3	34.9	61.5	75.8	17.6	19.1	18.9	23.6	17.6	18.4	19.5	18.6	19.5	18.8	18.7	20.0	34.6	16.0	23.0	6.2	54.5	16.8	63.8	35.7	26.7	23.0	18.4	17.7	13.5	15.7	29.3	18.4	8.4	31.8	51.1	19.2	35.2	35.1	8.1	12.8	15.7	31.4	13.1	15.8	4.1	47.2	26.5	28.1	16.8	18.7	40.5	10.0	27.8	16.5	35.5	15.2	4.1	16.3	32.6	30.1	19.7	10.7	23.6	29.9	21.4	7.5	43.3	41.8	72.1	3.5	7.5	40.5	23.8	29.7	31.5	38.9	22.0	25.4	9.5	18.8	26.3	25.8	29.9	24.3	26.2	27.4	25.1	42.3	46.5	29.4	15.6	53.0
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	24.4	32.1	25.5	17.3	36.6	18.5	24.4	28.2	32.8	31.8	23.5	30.1	20.3	31.1	10.1	16.7	28.8	13.4	24.8	26.3	29.3	21.8	25.9	21.7	20.6	34.0	33.3	37.2	33.2	13.2	24.5	14.9	31.2	31.3	9.2	11.3	24.0	14.5	44.1	19.7	25.9	15.1	25.7	32.2	26.0	20.3	35.1	17.1	30.4	16.7	14.9	28.7	23.5	49.4	40.6	15.7	27.1	40.7	21.5	20.1	30.0	25.1	26.8	26.2	28.4	23.8	17.2	22.4	18.6	23.3	25.0	35.0	22.9	30.0	16.8	38.7	35.2	28.5	30.8	26.3	25.8	29.2	39.6	23.0	39.7	32.6	28.6	20.7	17.4	28.6	24.9	41.2	23.5	22.5	28.7	48.3	23.7	69.0	23.9	34.2	17.8	24.0	16.3	22.1	17.8	24.7	21.4	13.0	33.5	16.7	23.2	56.7	15.3	34.9	26.9	29.3	37.9	30.0	26.9	40.0	15.3	33.1	30.2	13.6	7.1	5.7	7.1	8.2	9.2	6.3	5.8	6.2	5.4	6.7	6.5	7.2	4.0	5.5	7.5	5.7	3.5	7.1	25.5	36.6	28.2	32.8	26.3	29.3	34.0	33.3	31.2	25.7	35.1	49.4	10.9	12.8	10.3	12.1	10.3	7.5	14.7	9.3	13.6	11.1	9.9	13.0	7.7	10.0	6.3	12.9	29.2	21.3	7.3	7.2	3.9	10.0	1.4	7.3	10.6	10.5	11.4	7.8	11.6	8.4	18.6	10.6	8.6	9.8	14.7	21.9	8.2	8.3	9.8	8.4	9.4	8.5	14.2	7.7	8.7	2.2	10.5	9.1	5.4	14.0	8.3	10.0	6.2	19.6	117.1	9.5	7.2	12.8	10.2	14.9	7.9	6.2	5.9	15.2	6.6	9.5	10.0	14.1	14.8	4.9	3.7	18.7	9.8	10.6	7.0	9.0
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968915	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 893.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	37.4	16.5	22.1	4.4	35.3	1.1	30.8	21.4	24.4	33.2	17.9	30.5	7.1	42.3	16.5	60.4	27.8	12.6	37.1	22.0	22.2	24.3	18.6	34.0	5.7	26.6	28.6	22.3	30.0	13.4	16.8	31.6	25.2	20.4	9.5	10.0	29.6	10.9	22.0	27.8	19.8	17.4	20.6	13.5	25.8	29.7	30.3	3.7	24.8	5.0	10.2	23.8	35.3	42.6	62.4	36.8	29.1	18.4	17.0	31.7	28.9	18.6	21.1	18.0	20.2	59.2	22.9	0.3	24.8	24.6	21.3	47.4	20.1	23.8	19.0	0.5	14.9	0.3	22.3	24.7	57.9	0.1	0.8	16.5	15.8	21.4	39.2	23.0	38.2	0.1	24.3	12.5	14.2	32.2	0.2	0.7	21.9	23.4	14.6	0.1	35.0	0.2	28.1	33.4	12.9	16.8	39.2	12.8	16.8	42.9	13.3	0.6	54.7	14.3	23.9	12.5	25.6	4.4	4.6	0.4	17.8	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	35.3	21.4	24.4	22.0	22.2	26.6	28.6	25.2	20.6	30.3	42.6	212.1	169.9	49.2	299.7	1.6	35.8	115.2	36.4	39.3	42.4	53.7	28.6	107.2	51.5	48.6	58.8	10.4	32.3	0.8	87.7	25.4	116.0	19.1	132.2	97.0	166.0	46.0	2.7	293.8	83.7	11.3	56.6	86.6	290.7	5.7	87.7	100.3	49.1	3.8	126.2	187.3	45.4	32.6	6.1	12.1	13.7	33.8	5.2	64.0	266.1	1.6	32.8	0.0	345.3	893.8	178.3	82.0	63.9	5.9	151.4	37.8	26.0	39.2	52.4	78.9	64.1	118.7	63.0	83.9	139.2	60.1	33.7	4.1	120.8	33.1	194.6
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69274615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.4;Rod photoreceptor cells: 267.6;Urothelial cells: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 237.5"	"Low region specificity"	"Detected in all"							"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	44.4	14.9	35.1	11.6	45.3	12.0	30.2	44.5	42.6	16.9	25.7	39.0	54.4	19.8	13.1	45.8	23.8	24.4	35.8	38.0	45.4	44.7	64.8	47.6	9.7	52.6	39.9	37.0	21.9	57.9	5.3	18.4	52.6	24.8	35.1	122.0	37.1	21.9	14.1	35.0	49.6	16.1	55.0	5.7	58.3	32.1	39.9	32.5	44.9	15.1	23.1	55.3	22.3	66.3	237.5	6.4	24.4	25.8	92.9	90.3	108.5	37.3	26.7	54.9	29.0	31.8	106.6	33.0	37.0	20.3	31.4	158.3	33.2	79.3	75.9	115.3	20.7	34.5	22.5	165.2	28.9	13.8	59.1	71.3	65.2	43.1	32.4	19.6	143.6	9.9	19.7	24.7	34.3	36.0	5.5	2.3	49.5	194.5	50.0	23.1	26.9	2.9	192.0	194.2	8.3	14.9	13.3	111.2	3.4	55.7	37.0	7.9	196.3	44.3	48.3	32.4	38.6	23.0	5.2	0.9	48.0	19.6	16.1	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.8	0.1	35.1	45.3	44.5	42.6	38.0	45.4	52.6	39.9	52.6	55.0	39.9	66.3	2.9	44.8	22.8	76.4	2.3	65.1	79.1	26.3	4.6	212.4	4.6	1.3	38.5	40.0	33.1	3.7	35.5	27.9	2.7	74.4	0.0	32.5	3.5	7.1	1.7	36.4	11.5	10.5	10.1	24.3	25.6	15.5	64.2	9.9	5.7	0.2	27.5	104.9	5.6	18.5	13.4	45.0	36.7	14.6	28.9	6.7	29.2	8.2	28.4	22.5	9.0	111.1	1.0	21.6	82.5	44.2	65.8	13.9	5.2	115.4	73.4	1.9	51.3	267.6	0.0	4.9	13.1	19.6	18.0	40.6	64.1	43.2	3.2	0.2	50.3	244.5
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708362-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.0;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 238.7;Early spermatids: 405.1;Paneth cells: 140.4;Proximal enterocytes: 130.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.2;MAIT T-cell: 3.9;memory CD4 T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.2;T-reg: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.0;CAPAN-2: 41.1;MCF7: 20.3;OE19: 37.4;SK-BR-3: 25.7;T-47d: 52.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.2	4.7	0.1	0.1	4.0	0.1	0.4	6.3	7.4	34.1	43.0	1.5	2.4	25.5	13.7	6.2	0.0	0.4	0.1	5.8	7.1	5.2	0.4	0.2	0.4	0.1	6.4	7.5	1.7	1.6	0.2	4.0	13.2	0.1	20.8	5.3	0.7	7.3	37.4	0.5	0.0	0.5	27.0	2.5	0.0	0.2	6.9	0.0	2.6	4.1	6.0	0.3	0.3	8.3	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	13.0	41.1	8.2	1.3	0.0	0.1	10.4	0.6	0.0	0.0	0.5	0.2	0.0	0.7	2.9	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.3	0.0	20.3	0.0	0.3	0.9	37.4	0.2	0.1	0.0	6.2	1.4	6.8	0.2	0.2	1.6	25.7	0.0	3.3	52.2	0.2	0.0	0.1	1.0	0.1	0.0	1.7	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	3.9	0.4	3.1	2.4	0.0	0.6	3.3	1.2	0.0	0.0	0.0	0.0	3.8	1.2	0.2	0.1	0.1	0.4	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.3	0.1	9.6	13.7	0.3	1.9	0.0	7.0	21.0	0.0	0.0	20.3	6.3	0.9	34.3	42.1	31.3	0.0	32.1	0.8	238.7	19.6	21.1	405.1	31.2	1.1	0.5	12.5	0.0	0.9	23.6	4.2	0.6	52.5	13.2	4.5	0.1	0.0	7.3	2.7	0.0	0.9	50.9	24.4	0.3	0.3	36.5	1.8	0.8	3.6	0.0	0.1	0.0	0.0	0.5	1.4	21.8	140.4	1.2	0.2	6.5	130.4	8.0	86.1	0.0	0.0	0.0	3.4	4.3	4.8	8.0	0.1	40.2	4.3	0.0	62.1	25.6
TKT		ENSG00000163931	Transketolase	P29401	3	53224712-53256052	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 667.0"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 696.7;monocytes: 624.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6"	"Group enriched"	"Detected in all"	9	"dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		150000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	152.2	93.2	78.0	66.2	80.0	667.0	71.9	93.2	82.3	59.7	60.5	73.2	84.2	44.7	19.2	168.5	53.7	97.2	27.4	72.3	96.9	68.2	58.1	93.4	69.2	89.2	89.9	87.7	154.0	41.4	45.6	61.2	93.8	48.8	48.8	21.7	54.9	50.9	12.8	47.0	58.1	51.6	77.4	99.8	66.1	20.2	87.9	82.9	116.1	15.2	67.4	130.9	85.5	97.2	313.0	1542.9	216.0	241.5	470.8	570.8	439.5	206.2	353.8	348.8	330.8	430.1	779.3	388.5	96.8	302.9	673.3	438.3	377.9	775.8	102.4	131.0	210.3	259.6	1022.2	655.2	573.9	321.4	168.1	416.0	437.5	418.5	213.7	949.2	444.9	323.8	188.3	164.7	144.5	381.6	338.6	358.1	737.1	603.0	367.9	201.1	98.5	726.2	550.3	520.2	139.6	103.7	383.4	605.3	365.1	656.7	188.8	437.4	335.9	107.2	164.2	320.0	401.9	94.5	190.3	235.7	234.4	321.0	203.8	51.5	447.9	274.4	17.8	199.0	22.8	39.7	25.8	20.6	203.8	21.1	26.6	20.7	375.3	30.8	242.6	34.4	36.7	312.4	78.0	80.0	93.2	82.3	72.3	96.9	89.2	89.9	93.8	77.4	87.9	97.2	79.5	134.6	125.6	46.7	92.1	79.4	384.6	325.3	287.4	41.0	99.3	80.5	14.9	75.8	149.5	62.5	29.2	349.0	69.7	139.1	80.3	197.7	6.5	87.4	79.6	81.8	52.6	150.3	16.9	269.8	249.8	80.2	168.7	95.5	62.7	123.6	75.0	83.4	256.0	37.0	23.9	149.6	142.4	696.7	110.5	8.9	157.2	333.3	76.5	17.8	624.4	88.8	46.4	17.1	39.3	193.6	81.4	106.8	109.4	337.7	141.5	219.1	99.2	46.3	52.6	35.9	102.1	16.8	30.6	409.3	67.1	413.6	78.8	427.2	276.7	413.6
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295795-154330350	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 127.1"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 166.9;Spermatogonia: 491.5"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.3;medulla oblongata: 1.7"	"Group enriched"	"Detected in many"	5	"eosinophil: 60.9;gdT-cell: 24.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 60.9;T-cells: 24.4"	"Cell line enriched"	"Detected in some"	163	"THP-1: 495.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 1.2"	"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.3	0.1	0.3	0.4	0.4	0.9	0.2	0.2	4.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.8	0.3	0.3	0.3	0.2	1.0	0.4	1.7	0.2	0.1	0.0	0.0	0.9	0.3	0.6	0.1	0.0	2.2	0.0	0.0	0.3	0.2	0.1	0.1	0.5	0.7	0.0	127.1	0.5	0.4	0.1	0.5	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.0	495.2	0.0	0.0	0.0	0.1	0.2	0.0	3.0	2.7	0.0	0.0	0.4	1.6	0.1	60.9	24.4	0.4	3.5	0.1	2.9	2.2	0.0	0.1	6.0	5.4	1.0	7.8	0.3	0.2	3.5	5.8	0.3	0.4	0.2	4.3	0.3	0.3	1.7	0.2	0.6	0.5	0.5	0.5	0.2	0.0	0.0	0.7	0.5	0.3	0.0	0.0	0.6	0.3	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	44.8	0.0	0.1	0.7	0.0	0.4	0.4	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2	25.2	0.4	0.0	0.0	0.3	3.7	22.5	4.1	1.9	0.0	1.0	0.6	6.0	20.6	1.0	0.1	0.0	0.0	1.9	1.3	0.0	0.0	0.1	0.0	1.0	26.3	1.4	1.6	166.9	491.5	0.1	0.1	0.0	4.1	0.1	0.0	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"brain: 9.0"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Group enriched"	"Detected in many"	6	"cerebellum: 9.0;medulla oblongata: 2.3;spinal cord: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	2.3	0.6	1.0	5.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.6;Late spermatids: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.4	11.9	4.4	17.9	4.6	12.5	18.0	5.4	6.7	10.8	5.1	13.0	11.0	15.8	6.9	14.3	11.4	9.9	9.2	4.4	5.1	12.1	13.5	8.9	22.0	4.8	4.7	16.8	14.8	9.5	5.3	14.0	5.0	11.8	11.8	5.7	14.4	9.9	9.6	14.4	10.1	13.0	4.9	16.1	12.8	26.7	4.5	19.1	11.6	7.6	20.0	13.9	10.8	6.2	49.1	24.1	43.0	37.3	20.1	32.6	41.3	56.3	29.8	34.2	28.5	23.4	65.4	108.1	22.7	34.0	27.0	25.2	54.6	43.0	43.0	58.1	42.6	154.3	23.3	41.3	39.6	120.2	46.7	22.6	40.0	27.1	36.4	29.5	34.5	39.4	55.1	79.9	39.7	47.2	74.9	68.4	45.6	28.4	43.0	67.7	38.3	68.9	26.2	23.8	22.5	35.2	36.8	46.3	43.4	25.7	30.3	51.3	59.3	23.5	46.0	22.9	61.2	55.8	75.8	124.7	47.3	64.0	72.3	11.7	37.0	3.5	18.4	58.8	26.1	55.6	32.4	23.5	42.3	51.7	29.8	26.1	1.3	35.3	48.4	74.8	31.3	19.4	4.4	4.6	5.4	6.7	4.4	5.1	4.8	4.7	5.0	4.9	4.5	6.2	25.7	22.4	31.2	3.3	51.2	32.9	36.3	52.0	29.6	15.4	42.9	40.5	37.6	47.1	31.7	33.1	4.2	53.8	25.6	16.4	64.6	53.2	165.6	19.0	61.4	30.0	30.5	28.8	8.8	71.0	92.3	37.9	15.3	17.9	29.1	41.6	36.0	55.6	36.4	15.2	7.3	37.5	20.3	43.3	23.4	179.2	55.6	25.4	26.6	6.5	44.4	15.8	16.5	11.6	11.0	54.9	30.6	32.0	30.0	57.8	11.9	71.7	19.0	14.3	39.5	30.4	33.7	103.9	42.1	28.5	39.6	30.5	24.1	43.7	44.0	28.9
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 1021.6;Urothelial cells: 601.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	53.4	61.3	39.2	42.6	75.1	11.3	35.2	62.0	70.8	45.9	36.0	32.4	32.0	34.0	31.1	55.8	31.6	46.0	37.3	40.8	51.1	41.6	19.3	52.7	32.6	84.8	72.0	22.3	40.1	32.3	24.0	60.5	78.9	37.8	33.3	15.0	40.4	30.6	17.1	26.2	27.9	40.0	54.5	37.0	39.2	13.7	65.8	24.0	37.8	17.2	42.5	78.8	42.7	117.4	74.6	30.4	47.1	50.2	143.5	105.4	50.0	138.6	212.7	98.0	106.7	34.2	108.3	76.9	98.3	85.9	56.2	53.8	50.0	56.8	98.9	43.8	46.4	66.0	50.1	66.6	89.1	92.1	75.1	109.1	72.7	55.9	37.3	82.4	113.2	25.6	112.8	47.8	116.5	54.5	73.0	76.5	51.7	97.8	70.6	52.0	35.5	42.1	148.6	70.2	48.3	64.7	69.8	261.0	85.8	46.3	41.2	65.3	98.3	83.1	49.6	37.0	102.5	44.4	38.5	48.3	98.9	77.2	67.9	23.7	40.4	26.0	15.2	35.7	17.0	19.0	14.3	17.8	36.5	11.5	12.1	14.4	28.6	18.1	35.9	28.4	18.3	30.2	39.2	75.1	62.0	70.8	40.8	51.1	84.8	72.0	78.9	54.5	65.8	117.4	119.6	54.5	52.4	42.7	87.9	245.1	277.8	295.0	147.4	50.6	85.8	42.7	32.2	71.4	214.9	79.1	81.3	112.5	97.7	42.4	17.6	171.1	32.1	123.6	99.1	108.0	50.4	79.1	58.2	163.5	157.2	110.4	76.0	173.8	21.0	57.6	113.8	18.4	105.7	28.6	71.5	69.4	77.3	97.9	145.7	24.7	58.7	109.5	88.9	59.0	117.5	53.2	123.6	71.4	1021.6	248.0	48.6	63.6	117.1	239.3	51.3	50.0	125.2	91.9	98.6	92.2	129.0	37.8	24.6	169.4	268.8	80.6	81.6	90.6	61.6	601.6
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787402-62790400	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: AB_2684676"	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	52.1	60.3	32.4	22.0	34.7	21.5	55.0	33.7	36.4	50.5	41.8	48.7	34.7	44.4	71.2	47.9	46.7	28.4	34.0	30.8	32.9	54.3	64.3	51.0	26.9	35.3	33.3	39.6	58.7	34.1	31.0	30.0	35.6	45.8	40.1	10.4	59.1	26.4	27.2	58.2	49.8	26.3	33.7	48.1	53.9	41.6	33.0	33.0	55.4	21.6	29.8	43.3	46.0	36.9	35.6	68.8	17.7	35.7	136.3	34.3	22.6	38.2	47.5	29.8	34.2	39.3	82.9	16.5	53.1	78.0	44.2	64.8	33.4	35.4	23.2	48.6	44.9	24.1	29.2	36.3	90.8	30.9	32.2	65.8	55.8	57.1	70.0	60.0	30.3	46.9	33.2	46.3	34.5	81.1	40.2	59.5	26.5	76.8	74.6	26.5	28.8	86.1	57.7	42.6	24.4	26.7	49.3	65.3	70.4	35.8	76.2	37.8	42.2	39.6	29.4	73.3	32.2	51.2	32.5	22.6	57.0	19.0	47.3	302.9	300.4	332.7	149.4	305.0	147.9	169.2	135.5	144.9	198.2	140.6	118.2	117.3	224.3	140.2	305.9	366.1	146.6	282.5	32.4	34.7	33.7	36.4	30.8	32.9	35.3	33.3	35.6	33.7	33.0	36.9	119.6	60.9	59.2	15.3	52.7	68.7	73.9	175.6	86.0	12.4	108.0	122.2	1.3	65.8	121.1	60.7	0.0	174.5	71.7	91.2	37.2	138.1	5.8	75.2	54.5	83.7	65.2	40.4	9.9	149.0	160.5	76.8	54.6	66.5	54.6	43.8	69.9	81.9	133.2	8.4	9.0	103.5	128.1	63.7	83.0	11.0	75.8	76.5	106.7	12.2	98.3	74.4	91.6	16.1	28.1	124.0	137.1	45.9	93.9	97.1	179.4	87.5	122.9	14.7	65.7	50.5	57.8	120.8	100.5	93.2	76.0	185.1	60.0	90.4	94.8	97.5
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	140.5	120.1	89.7	60.4	98.6	60.4	88.4	101.9	110.7	108.3	113.6	83.9	62.3	88.9	120.4	57.3	87.1	97.7	101.4	88.2	100.2	145.7	197.8	75.8	81.0	98.9	95.1	97.4	95.1	99.3	89.5	72.5	99.1	105.5	88.7	107.4	78.9	83.1	107.1	34.4	70.2	88.9	95.3	71.8	87.6	49.7	96.0	85.6	135.5	148.3	76.6	93.3	56.6	111.8	157.2	108.1	139.1	105.2	307.1	271.6	105.6	124.0	185.4	119.9	131.4	86.0	152.4	74.8	99.5	180.7	136.6	127.1	104.5	185.2	172.3	83.6	119.6	132.6	31.5	266.3	196.3	154.9	52.8	189.3	202.4	92.2	183.3	167.0	160.1	163.6	126.1	200.3	199.2	44.7	156.9	143.8	106.3	298.8	152.4	100.4	93.2	161.5	182.5	79.4	116.8	141.7	74.6	154.8	270.0	149.0	123.9	145.6	135.7	154.7	90.5	150.1	135.2	133.2	284.3	147.5	62.5	132.2	166.3	128.9	175.4	116.7	136.5	187.1	166.3	170.7	145.8	145.3	163.8	153.1	150.8	148.6	55.7	153.9	180.6	161.2	147.6	349.2	89.7	98.6	101.9	110.7	88.2	100.2	98.9	95.1	99.1	95.3	96.0	111.8	126.6	57.7	64.6	15.3	123.4	70.4	126.7	148.7	65.4	89.6	151.7	133.7	51.3	111.5	95.1	154.5	64.6	173.4	127.8	55.0	502.9	146.6	200.3	77.1	103.2	109.5	95.8	103.7	20.2	111.2	208.8	141.6	59.1	64.1	114.1	82.8	126.7	147.5	212.8	62.2	27.7	123.1	126.1	162.9	172.9	89.5	212.2	121.9	199.3	14.0	215.6	113.9	151.4	13.0	49.6	100.2	130.0	220.4	161.7	129.6	102.0	363.2	81.9	113.3	85.5	100.4	128.0	99.4	97.5	68.1	60.5	148.0	118.2	184.2	125.6	152.1
TMEM63A	KIAA0792	ENSG00000196187	"Transmembrane protein 63A"	O94886	1	225845536-225882380	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 365.5;salivary gland: 121.1"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 112.2;SK-BR-3: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066504, HPA066936, HPA068918"			Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Centriolar satellite"		"HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057"	"unprognostic (5.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.92e-2)"	24.5	17.9	58.1	27.0	167.3	42.7	29.1	132.2	120.4	35.9	24.6	33.8	26.3	25.7	22.7	15.2	28.2	27.3	20.9	71.6	94.9	33.3	40.2	31.2	35.6	199.1	127.1	28.4	56.7	17.8	11.8	24.2	191.7	57.6	37.0	3.6	121.1	37.3	16.5	21.5	34.5	18.1	95.7	31.6	47.7	5.3	135.3	27.8	19.0	13.7	27.0	26.4	23.2	365.5	27.6	8.3	7.0	20.2	54.1	18.7	47.7	20.6	22.2	22.5	22.6	29.7	20.0	7.7	37.1	25.2	13.3	41.4	7.5	12.5	10.3	25.8	13.4	33.4	21.0	18.0	12.6	12.5	84.1	19.5	7.8	13.5	8.1	31.1	14.8	17.0	28.2	6.3	18.0	17.4	11.2	12.7	37.8	87.5	13.2	11.1	21.3	112.2	34.1	71.8	0.6	3.7	15.2	119.3	14.5	16.0	27.7	11.9	17.8	12.9	8.9	12.1	18.9	2.5	10.4	2.0	11.9	7.0	24.3	6.3	3.9	3.6	10.3	3.1	11.4	5.8	13.1	9.8	2.9	5.5	11.4	6.9	5.5	10.2	5.3	11.5	19.8	6.9	58.1	167.3	132.2	120.4	71.6	94.9	199.1	127.1	191.7	95.7	135.3	365.5	11.0	6.4	9.2	45.7	23.3	3.3	24.9	5.7	2.2	0.8	30.0	16.8	6.5	34.3	14.0	20.2	2.1	38.7	37.0	34.7	1.9	36.3	9.1	43.1	10.6	8.6	19.2	6.3	1.0	25.5	6.6	8.9	48.9	49.8	17.2	44.8	10.8	22.2	16.7	0.0	1.7	35.0	24.4	11.7	5.3	13.5	18.3	14.2	3.6	26.2	10.4	12.9	40.2	5.5	323.2	18.4	29.0	13.2	9.1	41.6	13.0	14.8	23.1	1.8	26.3	8.8	10.8	0.6	5.3	4.2	4.1	22.4	23.3	7.2	57.6	35.1
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 163.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	12.4	19.6	18.1	9.5	18.9	17.9	12.6	18.9	24.7	17.8	15.1	24.6	17.1	11.4	12.1	34.6	10.7	12.8	26.5	25.1	21.0	17.1	39.2	38.3	5.8	19.9	17.5	12.1	12.6	20.2	15.6	13.6	20.4	17.4	19.4	31.6	20.9	8.6	51.6	41.4	18.5	9.9	15.7	9.8	25.4	31.0	19.8	8.6	16.2	21.2	8.6	18.8	23.2	18.3	41.7	23.1	21.1	34.6	32.3	18.6	34.6	17.0	22.8	18.7	17.7	16.1	15.7	7.2	25.5	25.3	30.1	37.8	25.6	62.6	12.3	20.6	19.5	20.8	17.2	49.1	22.2	4.6	19.2	24.8	55.5	26.2	16.7	37.8	18.9	15.3	67.7	11.2	22.0	42.7	4.6	10.3	11.4	163.7	11.2	5.8	14.0	13.2	52.2	44.5	24.3	18.8	15.2	35.5	35.8	26.0	40.1	11.6	21.8	23.8	27.0	17.9	20.7	14.0	11.1	8.8	35.9	6.6	30.7	0.2	0.4	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.4	0.2	18.1	18.9	18.9	24.7	25.1	21.0	19.9	17.5	20.4	15.7	19.8	18.3	7.2	16.0	19.7	17.6	3.3	13.6	14.9	41.3	21.1	18.4	11.2	9.3	3.8	10.0	25.1	11.0	16.7	14.1	4.2	75.1	1.9	17.0	72.9	10.6	8.9	6.9	18.6	28.4	26.3	15.2	16.6	11.0	45.9	25.1	0.0	11.0	11.7	43.4	26.4	16.8	28.4	32.4	30.5	11.7	11.4	87.6	11.8	9.1	7.2	15.0	8.5	9.4	5.2	21.6	12.1	32.5	45.7	9.1	6.4	21.9	32.7	10.8	15.7	27.6	6.6	10.4	12.0	2.1	14.7	19.4	18.3	20.0	5.5	7.1	24.3	29.4
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.0;stomach 1: 23.0"	"Group enriched"	"Detected in many"	4	"Proximal enterocytes: 285.4;Urothelial cells: 88.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 7.5;CACO-2: 14.1;CAPAN-2: 10.6;EFO-21: 21.4;OE19: 16.8;SuSa: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA063009: AB_2684921, HPA069820: AB_2686208"	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.0	0.4	0.9	0.4	0.4	0.3	0.2	0.5	2.1	0.1	2.2	16.0	0.8	0.0	0.7	0.6	4.4	0.1	0.3	0.3	1.0	8.3	2.6	0.1	0.8	0.4	2.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.0	2.7	0.0	0.0	0.2	19.0	0.3	0.4	0.2	23.0	0.2	0.6	0.0	0.0	0.0	0.1	1.5	1.4	0.4	0.7	7.5	0.1	0.0	0.0	0.1	1.5	0.2	0.1	0.0	0.0	14.1	10.6	0.0	21.4	0.2	2.8	0.1	0.1	1.6	0.0	3.6	0.2	0.1	0.7	0.9	0.2	0.0	0.1	0.2	1.4	0.0	0.4	1.6	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	3.1	16.8	3.5	0.2	0.0	2.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.2	0.5	0.0	0.3	2.0	0.0	0.1	0.0	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.5	0.3	0.3	0.8	0.4	0.5	0.4	0.6	0.4	0.1	3.2	21.7	0.0	0.0	0.5	15.8	26.5	1.8	0.0	9.7	0.0	0.3	18.6	16.1	7.3	0.0	0.1	0.0	5.9	0.0	7.9	0.1	2.3	2.1	1.2	5.4	0.0	0.0	19.6	2.8	0.8	34.1	19.5	0.0	0.0	2.2	15.6	0.4	0.0	0.0	24.4	0.0	0.6	0.7	0.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	45.1	14.8	0.0	0.2	19.1	285.4	0.0	3.5	0.0	0.0	0.0	1.5	0.1	1.6	0.2	1.0	0.0	0.3	0.0	19.8	88.3
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515579-98550351	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 139.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	17.1	13.9	8.4	44.0	9.4	93.2	24.3	19.1	15.1	23.2	10.1	34.5	34.1	30.8	34.4	27.0	22.8	17.7	11.0	9.1	9.6	21.7	37.2	21.9	78.7	9.7	8.9	56.2	25.3	17.8	8.4	29.4	9.6	17.2	36.4	20.7	16.5	19.1	12.2	22.7	39.6	22.3	8.8	39.1	35.7	23.1	9.6	139.9	15.2	12.2	78.1	20.7	20.7	14.2	180.5	117.5	283.3	145.5	23.1	30.7	166.2	145.0	77.1	193.9	139.5	129.5	88.9	314.4	86.2	85.6	70.7	113.0	240.8	110.1	177.1	217.7	148.5	269.1	103.3	86.5	21.2	315.4	170.8	17.6	35.4	115.0	61.2	66.9	112.8	192.0	231.8	118.1	122.0	114.7	514.9	248.6	170.1	167.2	108.6	421.3	187.2	218.6	69.3	167.7	221.9	132.2	248.9	155.2	79.3	110.6	174.3	149.2	60.4	111.1	96.5	76.8	150.8	125.9	231.9	344.0	32.0	179.5	151.0	48.6	30.4	13.4	18.9	54.1	20.5	22.4	21.9	21.6	23.4	27.2	30.0	23.5	2.4	20.7	75.9	12.9	28.5	30.5	8.4	9.4	19.1	15.1	9.1	9.6	9.7	8.9	9.6	8.8	9.6	14.2	45.4	32.1	27.9	3.6	70.1	27.8	23.7	18.7	28.5	21.1	21.2	28.6	9.0	25.8	33.5	31.3	12.5	36.0	48.5	63.0	31.3	19.5	42.7	29.5	29.8	38.0	28.7	172.1	20.3	31.5	89.7	32.2	56.1	42.7	29.1	70.1	34.2	50.0	38.2	10.1	15.3	63.4	16.2	63.1	34.9	32.1	28.6	73.4	17.8	23.4	63.5	20.3	54.6	14.6	19.1	26.7	28.5	40.6	81.9	21.1	33.7	33.1	25.6	52.6	19.7	27.3	32.0	54.0	59.4	62.8	23.3	11.8	60.8	32.4	62.4	21.8
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 211.8;Langerhans cells: 323.4;Syncytiotrophoblasts: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 155.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	72.4	5.1	4.2	62.3	4.1	65.5	19.3	8.9	7.0	15.9	31.2	17.8	16.1	13.3	17.1	25.3	10.5	16.6	8.5	3.9	4.0	16.4	10.1	19.1	117.8	4.9	4.1	3.5	16.8	14.8	1.6	52.5	4.8	18.9	19.0	2.4	11.2	14.4	3.3	31.6	31.3	15.5	1.7	61.1	28.6	17.5	5.1	100.0	25.3	5.6	115.9	43.6	17.8	6.6	27.7	19.0	10.0	16.1	20.5	17.2	91.2	15.0	40.4	11.1	23.0	10.2	31.6	51.0	4.7	16.7	17.6	38.4	8.3	45.4	15.7	56.6	17.9	81.4	41.1	17.6	9.9	99.6	86.4	19.1	42.0	33.7	15.9	21.2	15.4	99.9	32.0	155.2	15.5	10.7	84.5	128.9	15.0	16.0	8.9	25.6	44.1	75.8	44.5	54.8	5.1	7.8	56.6	10.9	5.5	32.1	9.4	111.4	8.1	20.2	7.8	14.1	17.9	76.0	90.0	103.3	23.3	104.8	11.9	491.9	96.1	305.0	111.0	105.1	217.3	267.2	221.9	164.7	133.6	243.5	260.8	169.7	54.6	111.4	86.7	63.8	188.4	213.0	4.2	4.1	8.9	7.0	3.9	4.0	4.9	4.1	4.8	1.7	5.1	6.6	8.9	9.6	18.7	1.6	174.9	160.5	80.9	81.9	123.5	0.2	14.4	10.8	10.3	12.8	38.3	18.4	0.0	142.6	83.6	2.7	17.6	55.4	4.4	11.8	7.8	23.2	1.2	34.5	0.8	101.0	158.8	30.1	17.9	9.5	211.8	0.7	6.4	1.9	48.9	0.0	2.3	9.9	20.3	59.4	323.4	1.4	2.1	126.0	37.4	24.4	196.6	4.3	111.2	1.0	6.8	125.7	2.7	1.9	45.6	63.9	0.9	19.8	47.2	0.4	46.0	4.0	32.9	1.1	18.0	93.1	119.2	292.7	139.0	35.2	4.3	103.6
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756342	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	30.0	19.9	15.8	16.5	16.6	23.9	26.3	16.3	18.5	20.9	15.7	32.1	17.7	20.2	6.4	27.2	18.1	10.6	31.4	14.8	15.9	37.1	30.1	29.9	17.6	18.0	16.9	18.8	22.8	5.5	19.7	15.7	17.0	24.5	10.5	2.6	19.2	9.2	41.5	19.6	39.4	9.9	16.9	31.2	27.8	22.9	17.3	10.8	22.3	13.6	15.9	30.2	20.8	16.3	24.4	32.6	10.1	15.4	31.5	21.6	43.7	25.8	22.9	23.6	22.9	37.2	38.5	22.1	28.7	28.3	52.9	15.8	18.3	29.8	13.8	17.2	23.0	26.4	19.9	41.9	39.0	21.9	32.2	27.9	26.5	26.1	23.5	18.1	33.9	19.8	27.4	30.4	16.5	50.6	29.0	53.6	26.6	35.9	55.0	18.9	15.3	11.6	25.5	26.9	15.1	17.0	20.2	21.0	29.6	17.2	23.0	32.0	40.0	18.2	20.1	29.0	40.4	31.3	22.8	16.0	33.3	39.1	20.2	7.6	8.9	27.1	7.4	13.9	8.1	9.6	11.3	12.5	8.7	14.4	9.2	7.6	8.4	5.7	14.8	4.0	13.3	6.3	15.8	16.6	16.3	18.5	14.8	15.9	18.0	16.9	17.0	16.9	17.3	16.3	48.2	6.4	9.8	3.6	40.7	61.3	49.3	42.5	19.4	2.0	25.3	17.8	13.2	7.2	19.0	14.7	2.1	52.4	44.6	56.0	13.7	58.2	2.3	26.0	26.4	46.7	19.2	8.2	1.1	59.6	106.1	28.4	28.5	33.3	13.3	21.4	41.0	16.7	34.5	0.0	0.7	38.0	24.4	21.2	112.7	7.5	21.5	34.6	26.6	3.7	71.8	12.4	48.4	0.5	3.4	71.8	63.0	17.7	21.2	86.6	174.3	46.8	13.0	6.8	19.7	18.7	38.0	23.6	62.4	28.1	79.0	95.6	44.9	17.1	38.0	84.7
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039555: AB_10672000, HPA041537: AB_2677539"	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	16.1	16.9	17.1	19.3	17.7	34.3	15.7	19.0	18.7	14.1	16.3	18.4	16.4	15.6	17.8	21.1	16.2	13.0	15.6	17.3	19.9	19.1	22.9	16.0	23.4	17.0	17.6	20.5	15.1	21.1	10.0	14.8	19.3	16.6	20.1	16.5	15.5	18.0	32.6	18.1	16.6	19.5	17.2	17.7	19.7	26.4	19.0	30.1	22.8	27.0	28.8	18.6	15.1	17.6	59.1	65.3	49.7	84.3	47.3	40.5	42.3	51.8	45.0	47.4	55.5	53.7	52.9	73.3	23.6	55.7	89.7	42.3	101.6	49.8	67.6	61.3	45.0	54.0	52.2	42.2	45.0	99.8	44.2	38.1	49.7	57.9	51.4	41.4	59.9	59.5	124.7	51.3	61.2	43.7	86.9	73.4	142.6	64.4	59.7	61.0	46.3	60.0	48.0	54.6	61.5	48.7	55.2	25.7	58.3	71.4	29.0	61.3	45.2	59.7	29.4	71.1	71.5	65.3	54.6	99.3	86.3	100.5	106.1	26.7	14.1	22.0	16.4	17.3	14.6	16.1	13.3	14.8	16.1	15.5	13.0	15.2	15.5	14.5	23.9	7.7	15.1	11.7	17.1	17.7	19.0	18.7	17.3	19.9	17.0	17.6	19.3	17.2	19.0	17.6	20.4	16.0	16.7	30.7	31.4	6.8	15.6	5.7	27.3	23.4	20.3	13.8	21.4	20.0	11.6	18.4	22.9	24.7	26.9	20.4	7.9	23.2	41.4	19.1	17.7	18.8	11.5	38.5	45.8	24.8	37.2	17.4	22.4	27.7	10.8	30.5	19.6	27.9	27.8	37.0	46.8	22.2	2.0	25.7	9.5	25.4	16.8	24.9	8.8	31.9	44.4	13.6	17.5	37.7	47.5	30.3	17.7	17.7	28.5	17.6	21.7	18.7	13.1	21.7	13.1	18.5	19.4	76.3	31.8	32.5	8.2	35.0	23.5	33.1	24.8	30.4
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	30.4	18.3	10.8	29.0	8.9	51.8	30.1	16.2	14.2	40.8	2.2	56.3	25.3	57.6	16.4	26.0	43.5	22.4	22.1	10.3	0.5	22.9	19.8	32.0	16.1	6.2	1.7	46.0	29.5	35.0	22.2	30.6	1.6	36.1	22.6	12.2	28.8	34.3	24.0	33.2	29.0	36.4	1.3	25.2	33.8	22.6	5.1	17.2	32.6	11.1	14.6	40.8	31.9	3.2	72.8	63.4	51.5	43.4	42.9	50.6	133.8	50.4	47.3	27.4	29.0	26.3	62.4	49.3	48.3	74.7	60.8	79.7	30.2	60.5	23.0	21.6	19.2	31.4	56.6	43.1	37.1	104.3	111.2	51.2	70.0	54.8	63.2	39.5	31.3	43.6	45.4	27.2	35.3	120.0	24.6	127.2	4.5	47.5	48.0	27.0	25.7	37.3	22.3	91.3	22.3	53.4	38.8	102.5	37.0	23.1	106.9	106.1	78.7	78.3	109.6	47.0	36.7	38.6	44.1	46.2	44.1	72.6	94.1	14.2	3.8	3.6	1.7	1.5	1.2	2.2	1.2	1.0	1.4	2.3	0.9	1.7	20.8	3.2	2.1	5.4	1.9	0.2	10.8	8.9	16.2	14.2	10.3	0.5	6.2	1.7	1.6	1.3	5.1	3.2	25.6	9.6	29.0	59.7	7.4	9.3	3.7	9.8	13.6	51.7	15.8	25.9	7.5	14.3	12.4	14.7	2.1	14.5	20.4	33.6	1.9	5.0	14.4	22.2	29.7	17.3	31.3	9.7	40.9	6.6	3.8	17.8	19.4	36.2	14.0	48.3	29.6	25.4	11.2	50.5	45.6	30.4	8.2	41.8	12.4	18.8	18.3	22.8	5.4	71.2	25.9	31.0	11.3	32.6	20.3	9.0	10.6	19.9	12.1	6.5	7.4	5.4	11.1	4.0	19.7	18.4	21.2	0.4	2.1	12.5	8.8	10.0	12.3	18.6	25.1	3.8
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218033982	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Cardiomyocytes: 339.0;Leydig cells: 169.6;Peritubular cells: 504.0;Sertoli cells: 368.1;Smooth muscle cells: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.1;ASC TERT1: 74.1;fHDF/TERT166: 66.6;REH: 75.4;TIME: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	248.2	60.3	51.6	42.9	98.0	42.3	100.9	71.7	45.5	99.5	45.1	373.4	23.4	253.7	44.3	117.8	136.2	80.4	170.4	34.0	53.4	74.6	39.6	117.2	11.5	82.3	79.2	110.4	55.2	33.2	15.4	54.5	106.4	126.1	41.7	7.7	52.9	225.0	171.6	47.8	78.9	178.0	72.2	70.1	115.2	23.5	80.9	21.5	65.8	207.2	7.5	228.4	82.6	82.9	0.3	0.4	8.9	0.1	135.1	74.1	0.8	22.9	7.8	1.3	0.9	10.0	0.1	0.0	13.1	66.6	1.5	1.7	1.4	1.3	0.7	9.4	0.8	19.8	5.7	2.6	9.8	0.1	2.3	35.2	0.0	24.4	0.2	43.6	32.2	0.1	0.6	2.6	18.8	4.4	0.1	1.4	0.9	0.2	0.4	75.4	16.8	1.0	4.8	0.2	2.1	10.1	3.9	9.7	2.0	6.1	3.1	8.5	63.2	16.6	29.5	17.5	4.9	1.1	0.1	0.1	9.8	2.7	1.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.8	51.6	98.0	71.7	45.5	34.0	53.4	82.3	79.2	106.4	72.2	80.9	82.9	93.3	173.1	85.9	29.7	1.1	16.2	48.6	29.5	42.1	4.8	7.2	21.2	339.0	38.6	27.5	14.7	0.0	8.7	0.5	0.1	7.9	36.1	2.2	3.0	29.5	76.6	0.0	143.1	3.9	19.1	1.5	52.4	1.1	3.8	30.4	8.8	71.7	38.5	13.0	42.1	5.3	0.0	6.1	15.3	19.3	11.9	169.6	16.7	10.6	32.8	1.3	14.1	0.0	15.6	52.0	17.0	0.0	504.0	0.4	12.1	0.0	26.1	22.3	1.3	368.1	29.7	183.5	1.1	1.9	5.7	11.8	1.9	4.1	20.7	0.2	17.3
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 4.0;intermediate monocyte: 3.2;memory B-cell: 2.3;myeloid DC: 2.6;naive B-cell: 1.9;non-classical monocyte: 3.2;plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	7	"B-cells: 2.3;dendritic cells: 3.7;monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"A549: 266.7;LHCN-M2: 170.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		8100	"Cluster 14: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 68: Oligodendrocytes - Mixed function"	"Focal adhesion sites"		"HPA055338: AB_2682789, HPA056015: AB_2683010"	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	30.4	35.3	57.3	23.8	59.0	6.3	20.9	57.3	51.6	26.2	59.2	19.3	18.7	24.6	6.5	6.4	21.9	21.3	23.8	55.2	64.7	59.7	51.6	40.7	36.7	81.4	63.3	38.3	57.0	30.8	10.5	56.7	73.2	16.3	16.9	9.1	48.5	16.0	22.0	14.4	23.9	16.6	63.2	42.0	30.3	9.4	73.9	8.3	29.8	15.0	19.4	16.2	16.6	63.6	26.5	266.7	15.9	27.7	35.6	28.8	50.6	23.6	133.8	22.7	34.7	60.5	34.7	13.4	40.9	86.4	84.8	49.4	25.9	38.6	20.6	0.2	1.6	37.4	37.3	32.3	36.8	0.1	0.4	28.7	16.3	13.0	20.7	147.3	18.1	0.0	0.1	80.6	170.0	16.4	0.1	0.8	15.4	38.1	31.5	12.1	38.7	44.5	77.5	53.0	1.5	32.3	46.5	9.3	26.9	79.6	35.2	27.6	72.6	35.0	27.1	0.4	36.5	51.7	72.4	30.6	8.7	26.0	129.6	0.2	4.0	0.0	0.0	3.2	0.1	2.3	0.0	0.0	2.6	1.9	0.0	0.0	0.5	0.0	3.2	3.7	0.0	1.4	57.3	59.0	57.3	51.6	55.2	64.7	81.4	63.3	73.2	63.2	73.9	63.6	8.5	67.3	15.8	90.8	10.9	4.8	6.5	26.3	14.2	1.6	8.5	10.3	23.9	35.8	18.8	31.3	0.0	27.7	7.1	41.3	1.9	15.5	11.8	19.8	11.0	12.4	15.0	6.3	2.4	18.4	59.2	14.9	18.3	23.2	0.0	11.4	31.4	40.3	77.4	0.0	6.4	14.0	10.2	41.3	8.4	18.5	6.2	28.9	16.0	76.8	23.1	35.2	1.0	150.8	3.7	23.8	9.9	15.4	5.3	10.5	33.6	14.1	11.1	1.4	26.3	45.5	21.8	2.2	3.0	1.5	3.3	30.0	3.5	20.1	17.0	3.2
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45340052-45343973	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 36.6;Spermatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	4.8	5.1	4.9	5.9	4.9	8.0	5.5	4.8	6.1	3.7	4.8	6.8	6.7	6.7	8.4	3.7	5.4	3.5	3.7	4.7	5.4	4.7	5.5	5.1	7.9	5.1	5.0	6.2	4.8	7.5	3.2	6.8	5.1	5.0	8.2	4.1	5.3	5.0	3.0	3.9	5.0	6.5	5.0	5.8	5.6	11.8	5.4	9.0	7.1	2.4	8.3	5.5	3.3	5.1	15.8	9.1	16.5	15.7	7.6	5.9	23.9	15.6	12.9	26.6	24.7	16.7	9.6	29.9	12.1	16.2	23.4	15.9	21.0	22.5	21.3	19.6	17.3	36.0	21.9	15.6	7.3	23.7	17.2	8.8	4.8	28.4	17.8	9.4	19.5	22.5	28.4	19.6	18.9	14.6	34.8	18.4	31.1	20.6	14.2	24.9	24.5	13.6	11.5	28.7	13.9	13.4	14.5	36.3	27.5	25.7	9.8	33.2	14.6	12.6	23.3	19.1	29.7	15.0	19.4	19.9	14.8	26.5	14.7	20.0	5.8	6.2	7.3	6.9	8.4	5.9	6.3	7.3	6.0	8.4	6.4	7.0	0.6	4.1	6.1	5.2	8.6	5.1	4.9	4.9	4.8	6.1	4.7	5.4	5.1	5.0	5.1	5.0	5.4	5.1	6.5	6.4	4.8	2.3	12.4	1.8	6.3	8.8	4.6	10.7	4.5	5.0	1.8	7.2	8.1	7.3	12.5	36.6	9.2	9.2	7.9	5.4	13.9	2.1	6.2	9.0	3.0	14.1	2.5	6.2	13.8	6.6	4.6	3.4	11.4	10.5	8.6	5.0	9.3	8.4	2.7	7.3	8.2	3.5	2.6	9.4	6.8	6.2	3.6	1.9	12.3	13.1	9.2	2.0	2.1	3.4	10.7	6.4	7.0	6.5	8.8	7.9	4.7	18.3	13.1	8.0	7.1	51.7	18.9	3.8	1.4	22.7	9.0	10.2	6.9	4.6
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109341-235128837	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	71.5	83.5	80.0	39.2	89.0	96.6	130.8	63.0	111.9	82.9	63.4	64.3	61.0	83.5	91.6	67.8	95.6	48.3	86.4	91.7	79.9	100.4	88.3	60.2	53.7	76.9	71.5	119.5	103.1	111.6	54.3	68.2	81.2	80.5	67.9	51.3	125.1	70.1	83.0	82.5	54.5	59.3	81.7	47.2	69.4	32.8	84.1	57.1	142.9	82.4	56.6	66.4	56.7	83.3	198.7	102.4	131.6	111.6	101.4	202.6	203.5	138.8	119.3	127.9	92.5	133.1	135.6	239.3	180.1	121.0	36.1	154.0	147.8	135.0	166.9	57.9	314.8	146.2	126.2	253.9	169.2	331.3	84.2	182.3	180.8	128.6	175.4	173.0	140.7	92.2	312.1	85.9	141.9	58.2	141.9	149.4	296.6	131.2	54.9	170.9	100.3	312.6	144.5	140.2	172.5	402.8	108.0	149.2	306.7	53.6	230.9	358.6	125.6	111.5	67.5	143.0	299.6	201.2	203.1	172.4	131.2	155.4	193.1	37.7	18.8	6.5	19.4	19.7	23.6	23.0	24.8	24.3	22.7	18.2	30.1	24.2	5.6	15.8	22.9	30.6	23.7	21.5	80.0	89.0	63.0	111.9	91.7	79.9	76.9	71.5	81.2	81.7	84.1	83.3	167.2	137.8	163.5	25.1	201.9	267.4	254.9	158.5	251.6	49.9	299.2	307.0	137.8	160.2	151.3	49.7	29.2	171.3	195.5	98.3	160.4	161.6	318.4	180.2	254.3	156.8	160.5	127.0	69.0	211.2	462.5	139.9	121.3	216.9	157.7	146.4	129.9	160.1	159.9	50.5	61.1	273.4	99.7	197.7	164.6	354.0	155.0	175.7	149.4	28.1	187.5	145.4	116.4	26.2	55.8	220.1	172.3	153.4	176.7	340.4	247.0	223.5	99.7	60.9	105.2	201.4	207.5	186.5	71.1	273.3	286.1	199.5	179.5	196.1	272.6	333.4
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681957-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003037	Supported		Enhanced	Mitochondria		NA	NA		230000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	19.6	21.1	27.6	19.0	28.5	30.4	17.2	29.0	29.7	16.6	29.4	22.6	24.5	15.5	19.2	28.4	20.5	11.5	29.1	27.7	28.7	23.9	28.5	12.7	25.3	28.6	28.2	19.1	21.1	22.5	9.9	15.7	28.9	15.1	27.6	8.6	21.4	12.5	34.6	22.1	19.4	19.4	28.0	17.0	20.3	17.0	29.6	27.0	17.1	31.0	30.5	23.8	17.8	28.3	61.7	35.5	53.4	56.9	38.6	35.7	57.5	49.7	34.3	71.1	53.1	65.0	35.8	62.0	39.9	48.9	48.7	49.7	81.8	75.2	56.7	53.8	89.9	83.4	25.2	63.0	50.2	223.2	56.7	49.0	52.6	64.1	41.6	37.0	52.9	59.5	64.4	48.2	48.1	47.9	67.7	103.3	82.0	80.8	71.5	73.9	69.2	58.8	47.7	44.3	62.4	41.3	58.1	72.7	59.1	36.1	50.5	73.1	54.3	43.4	81.8	40.1	76.2	65.9	85.7	94.3	54.3	76.0	60.6	12.9	50.9	16.6	35.4	51.1	44.9	48.7	37.8	37.5	66.4	37.8	38.0	41.4	5.0	42.7	43.1	58.0	48.7	72.8	27.6	28.5	29.0	29.7	27.7	28.7	28.6	28.2	28.9	28.0	29.6	28.3	62.4	25.6	30.4	4.2	123.3	167.0	134.8	158.7	109.8	30.1	79.5	67.7	70.2	82.9	68.0	71.7	16.7	180.0	89.7	74.8	223.0	135.3	139.6	50.5	58.8	77.1	105.1	98.8	7.3	133.2	232.1	70.4	65.7	50.6	74.3	100.3	69.9	101.4	163.9	28.6	8.4	133.5	99.7	120.2	130.7	143.2	55.3	93.3	113.8	4.7	153.2	76.1	105.0	4.5	8.7	116.2	85.2	54.5	130.3	153.4	116.2	245.9	35.2	33.7	72.3	73.3	76.9	130.1	148.2	185.5	210.3	135.6	102.6	100.9	189.7	158.7
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA		45000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	34.6	59.7	31.3	25.1	30.1	32.9	29.0	33.6	37.2	25.2	28.0	34.7	28.4	25.0	14.1	51.8	25.3	10.8	46.1	30.7	33.5	33.5	50.8	28.4	23.6	32.6	33.5	24.9	26.6	31.4	25.3	20.0	33.6	24.7	23.0	18.0	24.1	17.4	64.0	34.4	26.1	16.4	30.2	26.4	29.3	22.0	35.0	25.2	22.3	34.4	22.6	29.9	29.5	32.2	147.6	244.6	87.6	121.3	32.2	28.4	110.3	103.3	57.1	192.1	136.6	268.8	99.5	215.3	107.7	68.8	108.7	155.2	228.9	149.1	87.0	84.0	206.1	145.3	93.5	214.7	68.0	187.6	125.1	45.2	83.4	149.3	94.1	36.0	67.3	102.4	232.6	73.3	76.4	184.2	205.4	137.1	153.6	209.6	149.1	206.1	99.2	125.3	89.6	201.8	135.2	86.4	109.9	229.4	75.2	48.4	77.1	188.2	55.9	132.0	133.6	93.1	273.7	78.3	176.0	212.9	98.2	197.0	142.1	0.7	3.6	3.7	2.8	4.6	3.2	5.8	2.8	4.1	4.6	2.4	4.9	5.4	0.7	3.2	4.3	4.6	3.5	1.4	31.3	30.1	33.6	37.2	30.7	33.5	32.6	33.5	33.6	30.2	35.0	32.2	26.2	16.0	7.3	8.8	34.9	87.4	73.7	17.1	35.9	68.2	32.7	30.9	15.7	25.8	14.3	31.3	29.2	104.5	28.9	78.8	39.2	48.1	11.3	22.7	41.0	31.0	29.3	52.4	11.3	38.6	169.9	38.6	40.2	29.5	19.1	57.8	12.5	24.2	100.1	70.7	16.9	59.4	28.5	21.0	44.9	7.2	26.8	35.0	39.2	4.7	31.9	46.6	27.8	5.5	12.8	53.6	32.4	24.5	47.9	139.0	34.5	39.5	4.9	60.2	19.7	49.1	47.8	46.2	64.5	60.5	89.4	72.9	26.7	105.9	132.1	75.5
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401089	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	29.7	23.1	21.8	19.5	38.7	16.6	31.5	20.6	24.4	19.8	19.1	27.7	29.3	24.5	21.3	28.9	20.4	16.1	38.8	23.6	23.0	36.8	61.7	15.9	22.2	21.3	18.6	30.8	26.8	27.2	14.8	23.4	21.9	26.4	29.8	45.4	21.9	26.9	66.4	19.8	24.4	26.7	17.9	19.2	21.5	19.6	22.9	29.6	30.1	76.1	25.9	27.3	17.8	19.5	70.2	48.3	39.8	57.9	55.4	60.0	52.0	57.9	49.6	52.2	53.8	68.7	39.0	83.2	49.9	49.7	46.6	67.4	73.1	53.4	76.7	31.6	33.7	95.2	30.3	67.3	34.6	117.2	41.8	53.7	48.6	46.5	75.6	46.5	38.8	40.1	69.2	65.6	63.3	51.9	79.6	47.5	55.2	107.4	101.2	72.0	80.9	89.0	42.6	52.2	72.2	60.1	42.3	67.0	77.9	38.2	87.1	65.8	35.2	45.5	60.3	25.8	44.0	71.1	108.8	139.1	44.1	70.0	35.2	1.1	1.0	1.2	1.9	1.1	2.3	2.0	2.3	2.0	1.4	1.4	2.3	2.5	0.2	2.7	1.3	1.4	1.0	0.8	21.8	38.7	20.6	24.4	23.6	23.0	21.3	18.6	21.9	17.9	22.9	19.5	24.2	6.4	25.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	30.0	20.2	0.0	0.0	11.2	14.7	0.0	26.8	11.5	0.0	11.7	19.0	0.0	13.8	34.9	10.0	0.0	0.0	0.0	20.1	33.2	12.9	0.0	25.4	7.6	27.1	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.3	0.0	0.0	48.6	10.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	16.3	6.3	32.9	0.0	0.0
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	27.1	25.5	15.3	38.9	17.6	49.1	34.7	25.2	16.5	36.2	12.0	30.1	28.8	42.9	25.5	34.1	29.7	26.2	38.5	15.3	16.0	32.1	27.7	28.0	50.4	13.5	16.2	40.6	28.8	53.2	11.7	34.4	15.1	38.7	33.3	112.3	27.1	34.2	29.9	32.4	28.6	34.2	16.4	36.4	32.1	19.5	14.6	82.5	45.8	36.7	46.6	43.7	18.5	25.3	57.6	58.6	125.9	155.3	41.1	51.7	50.1	54.4	69.6	49.4	53.9	30.1	44.6	176.9	37.1	79.2	30.5	47.7	105.6	60.5	82.5	85.5	56.7	268.5	71.2	50.6	28.9	212.8	137.4	37.1	29.7	55.3	48.2	49.8	81.7	118.6	92.0	84.3	64.4	64.0	138.5	52.5	95.9	38.5	44.1	569.9	71.0	82.6	43.9	199.5	63.2	109.7	81.1	57.4	49.9	72.2	59.7	187.1	78.7	68.3	52.6	55.2	58.9	129.6	78.6	185.1	44.9	155.6	46.5	3.2	1.4	2.8	3.0	1.7	3.3	2.0	2.9	3.1	2.2	2.5	3.3	3.0	1.0	3.9	2.6	2.8	2.3	1.1	15.3	17.6	25.2	16.5	15.3	16.0	13.5	16.2	15.1	16.4	14.6	25.3	36.4	64.1	62.7	65.3	47.3	39.1	47.9	30.9	31.3	62.4	44.4	31.9	121.5	34.3	36.1	25.8	56.3	47.8	65.8	29.9	13.7	34.3	3.6	48.0	58.8	36.6	59.3	65.6	77.8	33.4	24.5	40.2	28.5	45.1	34.1	71.4	25.0	35.1	26.2	60.6	89.8	32.3	20.3	40.7	50.1	6.0	39.1	45.3	23.2	43.1	49.8	51.3	68.0	76.4	113.0	35.5	22.2	33.4	46.0	56.2	20.6	25.6	39.2	95.7	32.9	56.5	51.0	94.9	44.0	57.9	37.6	46.7	53.7	48.4	39.2	64.3
TOR1AIP1	"FLJ13142, LAP1, LAP1B, LAP1C"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179920077	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 275.9;Late spermatids: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	39.7	34.8	20.4	27.2	23.6	84.5	33.9	22.4	25.0	42.6	29.0	46.5	15.9	40.5	35.9	40.6	31.6	34.3	38.5	18.1	21.4	36.5	38.4	35.5	34.2	23.6	23.3	54.5	27.9	36.9	20.1	28.5	22.0	43.8	22.8	25.1	31.5	43.2	54.1	20.1	23.6	41.0	21.2	35.0	31.3	27.0	21.5	27.5	46.8	74.8	27.6	40.4	26.4	24.5	37.1	36.4	24.9	32.3	109.7	73.6	47.7	48.2	57.7	44.5	45.6	28.5	68.5	9.7	52.1	50.2	31.8	63.5	23.6	39.6	52.8	62.9	23.2	26.4	31.5	28.5	50.4	90.8	78.4	57.8	29.8	55.3	51.3	50.1	40.9	39.5	39.2	47.6	47.9	33.1	37.4	28.5	35.5	47.9	13.9	22.8	38.9	25.5	43.7	71.3	20.9	29.2	60.7	57.9	83.6	36.6	44.3	91.9	41.9	60.7	26.5	42.0	58.8	53.4	75.3	19.5	23.6	49.3	95.1	177.7	86.0	205.3	76.4	94.8	89.6	54.9	68.9	76.8	90.8	66.7	71.0	73.1	132.8	74.6	127.5	65.1	81.9	115.5	20.4	23.6	22.4	25.0	18.1	21.4	23.6	23.3	22.0	21.2	21.5	24.5	42.4	32.1	36.1	21.2	33.9	43.3	64.4	21.3	48.3	11.8	27.5	17.8	30.2	18.6	24.2	20.2	16.7	16.2	44.1	13.1	13.7	20.5	275.9	25.9	30.9	33.6	20.3	25.2	13.6	25.2	26.0	51.7	23.4	48.4	36.1	19.8	36.8	27.4	27.6	6.7	16.9	10.6	20.3	48.5	26.1	190.0	47.5	40.4	14.2	21.5	36.6	40.5	35.0	15.6	26.9	29.0	12.5	58.6	32.8	48.4	11.1	19.2	29.2	13.6	26.3	72.5	38.0	14.0	20.4	38.1	37.5	18.2	47.5	23.6	8.3	54.0
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	12.5	19.5	9.4	8.3	9.0	41.5	10.6	9.7	9.4	8.7	13.8	9.5	16.3	8.9	19.4	15.2	8.2	10.8	10.5	11.9	13.0	12.0	41.5	14.3	7.1	10.2	12.7	14.0	14.4	16.8	10.7	21.8	10.8	8.9	8.5	9.8	8.9	12.7	19.7	14.6	19.8	11.4	8.9	9.8	12.0	9.4	11.2	8.2	10.5	15.7	10.1	10.3	9.8	9.9	25.3	23.3	19.0	40.2	45.5	24.1	78.1	32.7	39.6	26.0	25.5	36.6	40.5	21.0	39.7	35.3	14.0	35.9	34.4	34.7	33.5	23.4	18.9	25.4	40.8	32.1	35.7	27.4	27.3	41.4	26.2	34.4	37.1	22.7	37.5	19.4	51.3	21.5	31.2	15.0	20.1	19.9	47.8	27.4	6.2	21.8	27.3	30.4	20.0	43.0	16.3	41.8	36.4	41.9	33.3	37.9	40.0	19.5	48.9	37.8	34.2	20.2	25.3	34.1	47.8	41.5	20.2	19.2	35.4	21.5	6.1	7.7	6.3	8.3	6.0	6.8	6.1	5.5	4.2	5.9	6.6	6.5	12.7	5.0	8.3	9.0	5.6	2.6	9.4	9.0	9.7	9.4	11.9	13.0	10.2	12.7	10.8	8.9	11.2	9.9	48.4	153.8	59.0	27.7	22.6	250.7	70.3	37.0	62.0	28.5	52.5	27.7	37.0	125.8	57.9	77.3	37.5	109.6	39.5	67.9	25.4	65.2	30.9	77.1	71.0	50.2	22.0	36.0	52.5	63.8	187.8	51.9	36.2	117.2	19.0	45.7	45.3	237.1	43.0	32.0	43.2	52.5	44.7	53.1	118.6	19.2	58.4	39.2	48.0	29.0	49.8	46.6	41.2	30.7	38.3	85.8	43.1	85.4	30.2	67.3	215.2	44.6	41.3	34.8	52.6	47.4	43.7	27.5	31.4	66.1	249.6	180.3	41.9	69.9	51.0	118.1
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52436417-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;retina: 17.6;stomach 1: 20.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.4	3.0	4.7	1.4	5.6	0.0	3.8	1.2	6.0	7.6	0.3	15.6	9.3	1.3	4.4	0.6	3.1	6.9	0.0	5.3	4.4	9.5	5.2	1.4	0.1	4.6	3.5	0.9	2.6	0.0	2.3	0.2	3.0	1.8	17.9	17.6	8.9	0.5	4.0	0.7	9.3	1.0	5.1	0.0	20.3	0.6	8.4	1.3	0.0	0.5	0.2	5.7	1.0	6.8	0.0	5.8	46.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	3.5	0.0	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	25.8	0.0	0.0	8.0	0.2	10.7	97.1	30.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.6	1.2	6.0	5.3	4.4	4.6	3.5	3.0	5.1	8.4	6.8	0.2	6.4	8.2	1.3	0.0	1.0	0.5	2.8	0.6	4.1	20.0	12.6	0.7	52.9	7.7	35.0	0.0	0.0	0.0	47.6	3.9	1.6	3.2	1.6	0.4	0.3	61.7	0.0	3.9	5.1	0.0	1.5	29.6	6.1	0.0	0.1	0.7	4.6	0.1	40.4	138.9	31.7	2.0	0.0	0.3	1.8	0.6	0.2	0.0	8.4	0.0	162.1	0.0	51.8	75.0	15.3	15.2	0.0	0.2	11.8	16.6	14.0	12.3	3.8	0.0	3.3	0.8	0.1	0.8	0.3	0.3	0.0	0.4	9.7	32.6	6.5
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779893-223845954	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: AB_2681124"	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	11.7	8.5	35.3	12.2	37.2	49.8	9.5	34.7	39.4	11.4	35.6	9.9	8.5	12.6	10.0	16.8	10.1	18.4	12.2	33.0	34.4	9.7	14.9	18.4	12.8	34.9	35.8	13.8	12.0	15.8	7.1	8.9	33.2	8.9	9.9	38.0	12.4	8.1	13.0	13.0	10.0	11.1	33.5	9.3	12.4	11.2	37.4	15.8	20.7	11.2	13.1	16.6	11.7	35.8	32.8	16.2	42.9	27.3	15.0	14.5	27.3	20.6	29.3	29.4	25.1	33.6	19.2	0.0	17.5	17.3	21.3	21.9	33.9	12.3	39.3	62.9	33.2	43.1	15.2	11.5	30.3	36.0	28.9	17.5	13.3	27.2	27.7	22.1	17.7	23.6	55.7	31.7	24.8	9.5	27.5	22.2	37.0	19.7	15.6	36.0	44.7	3.7	26.5	20.4	36.9	47.6	22.8	27.9	29.9	27.9	15.8	48.6	20.7	30.0	21.1	32.7	39.2	15.4	17.3	26.4	18.1	23.9	35.0	4.8	1.2	0.8	0.9	1.3	1.2	0.9	1.1	1.8	1.3	0.8	1.1	0.8	1.4	3.3	1.0	0.8	0.8	1.0	35.3	37.2	34.7	39.4	33.0	34.4	34.9	35.8	33.2	33.5	37.4	35.8	18.2	48.1	22.7	76.4	23.7	17.2	41.6	7.2	21.1	8.1	12.6	8.0	20.3	18.6	28.3	7.3	52.1	10.3	24.2	13.0	1.9	20.4	1.1	45.0	42.2	19.1	14.9	54.3	1.7	10.7	5.9	22.6	21.9	152.0	48.8	14.1	8.6	10.7	9.8	0.0	5.3	8.7	14.2	14.1	44.4	2.4	10.5	41.7	8.8	23.4	9.6	10.0	7.2	27.2	29.0	21.4	7.3	8.6	27.4	30.9	6.7	5.5	15.6	45.5	0.0	41.2	26.3	12.3	20.1	21.1	11.6	4.8	38.8	31.4	10.2	40.6
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185914558-185938103	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 444.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		62000	"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	38.2	41.3	18.1	35.2	19.1	46.3	30.2	23.0	31.1	25.2	25.7	41.7	21.5	31.3	26.3	38.7	27.1	16.0	31.7	19.6	22.3	41.6	37.5	21.5	38.7	19.8	17.2	25.5	28.3	28.9	20.3	26.3	20.4	25.8	24.9	18.5	27.0	18.4	34.1	25.5	27.0	25.2	17.4	36.2	31.1	22.4	19.5	47.6	23.2	23.2	43.9	28.7	26.8	26.3	145.0	44.2	135.0	67.8	30.3	27.3	78.2	101.5	71.1	117.5	90.2	75.3	67.6	124.5	134.4	53.2	79.5	94.1	140.9	104.5	120.9	117.5	89.6	122.0	40.1	92.7	42.4	133.3	101.1	26.5	44.3	75.1	51.0	36.5	90.4	63.5	120.4	81.6	79.6	66.4	344.9	164.1	191.3	113.0	85.5	201.1	109.4	147.5	94.3	58.9	98.0	104.0	73.3	90.1	117.8	66.5	101.1	138.0	52.7	81.3	110.8	68.2	170.1	159.6	444.0	272.0	78.0	151.0	130.6	84.1	39.2	33.0	36.3	33.1	32.8	71.2	36.1	34.0	35.3	64.0	45.0	40.9	44.0	41.3	39.6	73.2	36.4	21.5	18.1	19.1	23.0	31.1	19.6	22.3	19.8	17.2	20.4	17.4	19.5	26.3	236.3	64.1	122.0	46.4	201.7	258.4	196.9	136.6	157.1	107.8	206.0	148.2	67.2	140.2	104.0	69.9	196.0	188.9	196.6	156.2	72.4	126.8	156.9	152.7	284.5	181.6	227.6	233.4	49.7	109.5	230.7	147.2	92.2	274.6	197.6	155.9	189.9	93.0	174.6	72.3	53.7	259.8	85.5	280.7	283.1	46.6	127.7	228.1	135.2	74.0	196.9	115.5	167.9	78.4	67.0	97.5	129.1	117.4	152.1	218.3	121.2	59.1	66.7	219.5	105.2	177.0	214.7	168.2	151.5	141.3	260.7	214.9	212.6	89.4	232.4	163.7
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	8.3	7.9	14.9	13.8	16.9	16.1	9.1	20.0	18.8	10.6	13.2	11.1	9.9	8.3	4.1	15.3	8.3	6.0	11.0	15.6	14.3	10.3	15.1	9.6	20.2	17.9	15.7	7.3	8.0	4.8	10.1	8.3	18.2	12.5	5.5	4.2	11.5	8.3	8.5	12.1	12.0	6.2	14.9	16.8	9.6	17.8	15.7	17.8	14.1	5.1	14.7	11.0	11.5	18.1	25.4	76.3	20.2	18.0	5.6	8.8	39.5	20.5	11.1	29.2	19.8	47.5	44.5	31.2	25.8	12.8	39.3	65.0	27.9	33.3	11.8	47.9	22.8	23.6	76.2	30.0	8.3	23.5	23.4	6.6	9.9	23.7	13.4	10.9	13.9	28.5	40.5	34.5	13.2	36.6	38.3	33.6	33.1	57.4	33.9	35.8	31.1	42.7	18.0	19.6	32.9	15.4	25.6	58.9	23.7	22.5	42.4	27.2	15.7	37.8	24.2	24.6	34.8	14.3	25.2	31.2	13.3	19.2	28.5	2.0	4.8	9.1	12.3	5.8	17.8	15.2	13.4	15.6	6.5	12.3	10.7	13.2	4.2	14.0	12.0	14.8	24.0	8.3	14.9	16.9	20.0	18.8	15.6	14.3	17.9	15.7	18.2	14.9	15.7	18.1	7.9	0.0	6.4	7.5	12.5	11.9	14.1	18.1	4.0	6.9	8.3	7.0	7.5	12.8	8.7	5.5	0.0	19.4	7.4	23.3	3.9	19.2	3.2	4.4	4.3	11.0	11.4	9.0	5.6	12.8	28.9	6.9	9.7	6.1	10.2	11.8	4.2	4.1	13.3	18.5	4.5	16.1	6.1	2.2	8.7	4.1	3.4	6.2	14.2	2.8	32.7	4.5	11.3	2.5	5.7	20.8	6.2	7.9	11.3	20.0	15.6	6.3	5.6	9.8	19.7	4.1	7.4	17.5	23.8	5.3	12.8	17.8	13.9	6.5	15.4	10.0
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717553	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	46.4	50.6	32.5	32.7	35.6	35.6	45.7	28.9	37.6	54.0	22.7	50.0	39.7	42.5	18.5	72.2	59.0	33.3	88.1	34.5	34.2	59.9	121.5	33.3	47.6	33.1	32.2	58.8	76.2	39.9	35.3	33.3	33.5	41.6	36.9	22.3	46.1	26.5	193.9	67.7	36.7	30.3	26.8	39.9	49.5	40.1	36.7	27.5	33.3	138.9	36.4	48.9	50.4	32.5	113.4	277.6	56.7	150.2	61.1	62.1	167.6	67.6	60.7	152.2	95.3	347.9	156.5	361.1	123.7	65.1	41.1	207.3	223.0	167.7	67.1	139.3	241.8	105.9	225.1	246.0	105.3	192.0	69.4	74.2	114.6	121.1	188.2	55.0	106.1	122.5	338.4	120.8	50.5	367.8	138.6	141.5	106.0	133.8	140.1	314.1	118.9	500.6	112.8	83.0	268.4	102.2	70.0	254.5	135.8	46.5	184.5	137.2	60.2	63.7	112.9	112.5	99.5	135.5	161.1	289.2	39.7	152.1	88.8	0.1	24.0	0.8	24.7	38.9	47.3	42.1	36.0	31.5	54.9	30.7	42.1	35.9	2.6	31.9	29.8	8.4	33.4	33.0	32.5	35.6	28.9	37.6	34.5	34.2	33.1	32.2	33.5	26.8	36.7	32.5	20.4	22.4	17.5	16.3	21.3	25.4	44.3	63.2	38.1	29.3	32.4	36.8	2.1	45.8	39.8	31.3	10.4	112.6	5.9	28.7	88.0	67.7	24.1	30.6	21.1	21.3	35.5	42.1	31.6	53.8	56.2	23.7	36.2	28.1	16.5	41.5	12.8	48.8	46.1	47.1	31.1	37.5	59.0	14.5	14.8	13.0	16.4	14.7	12.4	12.2	26.3	20.2	12.3	11.6	16.2	31.9	14.5	21.4	37.9	45.9	14.1	140.9	30.1	22.2	19.7	29.9	29.4	37.2	70.9	70.7	28.1	67.2	15.1	58.9	74.9	42.8
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	1.1	0.6	0.0	11.0	0.0	2.7	0.8	0.0	0.0	0.4	0.0	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.0	0.3	1.3	2.1	23.9	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.5	2.4	0.4	0.0	79.8	0.4	0.4	12.4	2.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406835	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	10.2	12.1	12.7	8.9	16.0	30.7	10.4	23.9	15.2	14.7	10.1	13.6	7.7	11.5	4.5	20.7	12.7	6.1	8.7	14.4	11.6	12.2	10.2	11.8	12.2	11.6	9.9	11.9	11.9	6.7	9.8	5.6	10.8	15.4	7.1	2.0	17.1	7.0	5.0	17.1	14.6	4.6	8.6	24.1	12.9	14.9	13.2	10.1	11.0	3.1	8.7	11.7	15.6	11.0	28.3	26.3	13.8	19.1	10.2	8.4	65.1	18.1	12.1	20.5	16.4	32.2	24.0	21.1	19.7	12.2	13.5	45.1	16.8	17.4	8.6	23.6	40.5	17.5	26.7	17.6	27.6	22.2	25.6	11.3	27.2	21.3	10.6	10.5	10.2	33.9	40.7	26.4	10.7	18.2	27.1	35.1	35.3	23.9	22.9	26.3	12.5	25.8	13.4	34.0	22.9	42.0	15.1	42.2	24.7	5.6	29.9	36.8	11.6	13.0	18.3	30.6	37.9	26.9	19.3	18.9	16.1	17.7	20.9	5.2	4.5	5.6	5.5	5.3	5.9	3.7	6.4	7.1	4.4	3.5	3.6	5.1	6.2	6.2	7.5	3.5	6.4	3.9	12.7	16.0	23.9	15.2	14.4	11.6	11.6	9.9	10.8	8.6	13.2	11.0	7.8	3.2	5.8	1.6	12.1	15.8	16.3	7.4	10.8	12.1	13.3	10.7	3.6	12.8	10.4	1.8	2.1	15.7	21.6	28.1	17.6	14.8	154.2	11.2	10.2	10.1	14.4	12.6	9.8	11.0	15.5	8.5	23.4	17.1	5.7	13.4	8.9	5.7	11.8	5.0	4.7	21.7	4.1	12.6	9.3	16.5	9.6	11.0	5.4	2.8	22.0	10.3	30.9	3.0	3.2	18.3	21.1	7.5	12.8	17.4	17.8	9.9	7.3	1.6	6.6	8.4	9.1	7.3	12.4	15.8	19.5	57.3	18.9	14.9	17.6	30.1
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460259-138589996	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"AF22: 146.5;HMC-1: 196.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	7.5	25.7	6.0	6.9	6.8	10.6	9.1	5.8	7.0	6.4	5.2	8.1	10.0	8.8	8.4	9.0	5.7	5.3	10.4	6.0	7.1	8.0	23.1	11.4	8.0	6.8	6.4	30.0	10.8	14.2	3.8	12.3	6.3	11.7	9.2	12.2	8.3	5.2	13.9	8.6	9.7	7.6	6.2	7.2	11.6	27.3	8.2	17.3	9.1	16.4	7.8	7.5	6.1	9.0	15.0	18.1	146.5	42.7	9.6	8.9	11.4	13.7	14.4	10.5	10.2	28.7	13.6	28.7	13.2	13.2	21.5	7.9	71.9	11.4	15.4	22.1	17.7	63.1	13.1	88.9	13.1	49.8	196.8	7.9	11.8	8.8	13.9	7.3	25.0	15.4	72.6	17.1	12.7	29.2	85.2	44.8	56.3	77.6	16.0	66.5	17.3	24.2	23.6	43.9	30.3	68.8	25.5	22.6	7.5	50.6	15.5	32.3	10.7	12.1	9.9	21.4	19.1	15.6	18.2	47.8	20.1	32.1	18.0	0.3	0.6	1.0	0.5	0.6	0.1	0.2	0.4	0.3	0.5	0.3	0.4	0.5	0.9	0.6	0.3	0.3	0.7	0.2	6.0	6.8	5.8	7.0	6.0	7.1	6.8	6.4	6.3	6.2	8.2	9.0	29.0	51.3	46.9	26.1	9.5	13.9	13.4	13.8	10.8	13.6	14.7	14.4	39.7	20.0	18.8	7.3	16.7	28.4	14.9	12.2	5.9	7.1	70.4	16.7	22.9	18.9	10.1	31.3	27.9	12.4	15.2	16.0	20.4	25.2	40.4	85.2	14.3	31.9	10.3	40.4	46.6	10.9	14.2	9.5	14.9	38.7	14.0	13.8	14.2	21.5	12.2	23.3	9.2	64.3	67.1	9.5	9.5	16.1	13.7	12.2	6.8	10.6	14.5	22.4	13.1	21.5	17.6	72.8	14.7	22.2	11.8	22.2	15.8	34.6	19.4	12.8
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544064-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 2817.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	103.1	111.0	83.5	103.8	85.9	217.5	104.4	91.1	100.1	152.9	77.5	159.9	90.8	163.3	42.8	132.6	142.8	73.6	114.7	83.1	80.1	122.1	104.6	103.5	142.5	85.5	83.4	228.1	183.7	89.4	98.7	108.9	89.1	128.8	57.8	39.4	108.4	108.8	172.4	143.3	117.7	94.6	86.0	137.4	136.7	215.5	82.8	186.6	117.9	77.0	109.2	147.7	115.1	97.2	481.6	1080.4	491.9	365.1	218.9	186.5	616.5	321.5	291.1	311.4	237.0	732.8	375.0	562.5	196.1	270.7	492.8	317.7	590.5	480.5	163.6	281.3	2817.1	1012.8	407.6	537.7	254.4	640.9	577.5	252.4	248.2	385.9	274.9	220.1	301.3	597.7	507.1	259.4	284.8	705.0	756.5	640.8	372.8	443.6	637.5	761.9	340.9	550.2	260.8	730.6	517.1	403.4	343.9	359.3	170.7	131.9	273.2	493.1	272.4	643.1	273.2	148.6	562.5	397.7	665.7	604.7	293.0	432.9	418.6	1.9	9.7	8.2	12.8	11.1	17.2	15.9	18.0	17.4	13.7	19.1	22.8	20.5	4.3	24.9	7.9	21.2	12.4	10.1	83.5	85.9	91.1	100.1	83.1	80.1	85.5	83.4	89.1	86.0	82.8	97.2	60.8	12.8	18.6	18.3	51.0	64.2	60.2	34.7	47.3	61.8	86.6	87.5	9.5	51.5	29.0	33.1	27.1	61.2	72.4	88.3	23.5	44.8	96.9	70.7	53.3	49.7	64.6	46.7	10.3	56.3	61.6	48.3	65.7	80.2	21.6	136.3	35.7	31.9	46.9	55.5	12.6	79.4	14.2	36.5	70.7	110.6	65.9	48.3	28.4	6.5	32.8	49.8	19.6	10.6	18.2	56.3	50.0	41.3	43.5	52.1	47.3	36.3	28.7	34.1	59.2	69.3	61.6	158.7	83.1	58.0	60.7	56.1	54.5	80.9	94.1	45.6
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75896951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359"	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	13.0	7.8	12.5	8.5	15.2	7.4	10.7	15.3	13.5	15.5	11.0	14.1	8.8	14.7	6.8	14.2	13.1	7.1	10.3	11.5	13.2	11.2	8.4	12.9	10.5	15.0	14.6	14.1	15.7	7.4	11.8	5.4	14.8	11.7	7.9	7.2	12.6	8.1	13.2	14.6	13.5	8.3	13.8	16.6	11.3	3.9	14.5	6.5	12.2	6.9	8.2	14.6	14.0	17.0	19.8	20.2	7.8	22.2	13.5	19.2	4.0	8.3	8.9	11.1	9.4	9.1	17.0	21.4	6.5	7.2	15.6	13.7	16.8	18.6	6.8	11.1	28.9	16.9	20.4	12.5	13.4	17.2	18.9	12.0	14.4	8.9	16.0	9.3	29.2	27.2	29.3	19.5	8.7	20.6	38.0	33.7	17.7	20.0	19.5	31.3	11.2	30.9	11.2	8.2	16.1	14.9	11.4	21.3	22.7	9.7	21.2	24.2	14.5	26.6	13.5	13.3	16.9	17.9	7.4	6.2	16.2	32.2	11.8	1.4	1.1	1.8	1.9	1.0	2.2	1.4	1.4	1.9	0.9	2.0	1.5	1.5	1.1	1.9	0.6	1.3	1.3	0.6	12.5	15.2	15.3	13.5	11.5	13.2	15.0	14.6	14.8	13.8	14.5	17.0	8.4	6.4	4.8	13.1	7.5	2.9	5.7	2.4	3.4	19.0	3.7	3.0	4.3	5.7	3.4	9.2	12.5	0.9	9.0	3.6	1.9	3.2	0.4	2.8	9.2	8.2	0.0	9.5	4.5	3.4	3.6	6.6	7.1	4.0	7.0	8.6	5.7	3.8	8.9	5.0	5.9	6.6	6.1	5.4	9.3	0.5	13.7	6.9	8.8	3.7	4.9	6.3	3.1	6.6	9.3	5.3	2.9	9.4	5.8	5.1	4.8	5.9	1.8	12.9	0.0	9.3	5.2	0.8	2.9	6.7	3.7	0.5	8.5	6.4	5.9	2.8
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102644479-102658318	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	80.1	47.6	67.2	21.5	68.1	26.0	58.4	62.9	55.0	63.0	35.8	50.9	17.8	53.5	9.3	42.0	55.6	22.0	67.8	55.0	56.5	77.9	62.2	70.3	18.3	72.4	72.7	45.2	80.4	36.6	43.5	21.3	64.7	55.5	9.5	18.1	69.1	21.9	80.8	48.3	43.8	17.1	60.4	42.8	61.9	20.1	84.4	18.7	67.4	38.8	11.8	62.9	49.9	54.2	96.4	18.7	16.3	28.7	17.2	40.6	21.1	34.4	59.3	32.1	24.6	30.7	93.0	30.7	102.9	57.5	11.4	32.7	12.2	40.4	21.3	34.4	23.4	78.3	12.9	67.4	55.8	15.5	28.3	47.0	21.9	64.8	32.9	83.4	40.6	13.6	17.3	33.4	24.3	45.5	27.8	57.7	12.7	25.6	38.0	18.6	49.2	16.6	37.4	48.0	12.3	26.2	18.8	17.2	42.6	16.9	58.4	28.2	94.8	40.9	22.4	23.3	68.8	49.0	28.5	16.3	65.5	39.2	9.7	14.0	5.2	2.7	6.8	4.6	6.5	8.9	7.3	5.4	4.5	7.4	6.4	5.7	17.9	6.0	5.7	12.4	7.5	4.5	67.2	68.1	62.9	55.0	55.0	56.5	72.4	72.7	64.7	60.4	84.4	54.2	46.0	57.7	71.2	33.6	29.5	31.5	12.6	21.2	21.6	33.4	53.9	45.3	38.0	38.6	33.6	88.3	8.4	13.0	52.8	15.4	41.1	63.2	1.1	91.5	61.7	30.1	21.6	2.5	8.9	44.9	2.6	38.9	20.4	81.6	8.8	32.2	31.8	33.3	25.4	28.6	13.6	32.8	18.3	40.5	24.1	1.7	31.1	43.5	17.8	13.1	58.1	26.1	24.7	18.1	17.6	65.0	16.4	34.3	18.6	30.5	32.0	53.0	38.5	15.1	13.1	35.7	38.4	2.4	5.1	19.8	22.9	10.9	26.6	38.9	21.4	30.1
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	10.4	10.5	4.7	8.6	8.8	7.6	10.5	10.8	7.4	11.6	13.5	10.1	10.4	9.7	6.7	12.1	7.7	10.1	10.6	3.5	5.4	13.5	12.9	8.0	9.4	6.2	7.3	11.0	25.5	19.2	4.8	11.6	6.8	9.6	9.8	10.6	11.0	8.5	11.8	8.9	7.9	10.2	6.2	8.6	15.3	13.6	6.5	11.2	16.7	15.6	11.4	10.4	5.8	10.7	22.8	22.5	14.4	15.2	24.8	38.1	21.8	35.3	27.0	17.1	19.5	13.8	36.0	15.8	25.3	31.3	13.3	29.1	19.1	17.1	37.0	24.1	5.8	17.9	20.4	13.1	18.9	21.2	17.1	14.7	20.4	30.3	25.8	18.9	27.8	8.7	11.9	17.8	27.0	31.7	12.2	5.2	6.6	22.1	16.0	14.8	27.5	8.0	15.3	36.5	10.5	9.5	28.5	16.6	11.0	14.5	36.2	10.5	36.9	19.8	13.8	20.8	16.1	15.7	25.9	14.2	23.2	11.7	25.3	9.3	9.7	20.2	13.9	9.0	13.6	13.0	14.7	13.1	7.9	23.7	14.2	14.9	9.6	14.8	16.1	14.3	14.5	4.3	4.7	8.8	10.8	7.4	3.5	5.4	6.2	7.3	6.8	6.2	6.5	10.7	66.8	54.5	79.8	57.5	32.5	16.6	30.7	31.7	21.6	61.1	39.9	40.0	115.7	34.3	54.0	38.6	73.0	44.2	41.4	29.8	17.6	72.5	13.6	58.2	81.2	53.9	32.2	30.7	58.1	46.2	32.0	51.7	39.8	56.5	37.9	68.7	32.9	37.5	24.4	43.7	74.7	40.4	32.6	25.7	11.2	14.7	62.1	30.4	7.2	51.5	41.6	56.5	47.4	66.9	92.4	44.7	29.5	54.2	26.3	39.0	31.6	23.4	56.4	70.4	59.2	76.6	50.4	105.0	65.8	19.5	17.0	72.5	30.2	79.8	32.9	35.1
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937228-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatogonia: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	7.4	9.7	5.1	7.3	5.3	13.8	5.9	5.9	6.3	5.9	4.5	5.8	3.4	6.6	6.0	9.1	5.7	3.5	7.7	5.4	5.2	8.0	5.5	4.9	9.3	5.8	5.1	5.6	7.3	6.8	8.4	5.1	5.8	5.2	5.5	3.7	6.1	9.9	20.2	7.8	5.9	5.6	4.9	6.6	5.8	11.5	4.8	8.8	5.9	7.3	9.0	11.0	6.4	5.1	55.5	27.8	17.1	25.9	10.4	11.8	21.4	24.7	12.5	24.5	20.6	36.5	22.2	62.1	13.1	15.1	33.8	39.9	36.3	41.8	40.3	13.3	25.5	50.6	12.0	32.2	19.8	47.8	13.3	13.6	21.8	44.4	33.4	8.6	10.0	25.6	32.3	18.0	28.8	14.4	50.6	26.2	39.5	36.9	33.9	33.4	33.6	36.1	18.3	31.3	33.9	51.1	29.2	39.3	45.0	16.2	20.2	24.4	8.8	28.5	27.1	26.8	52.1	31.6	64.1	74.6	13.3	37.9	29.3	2.1	7.8	6.3	9.1	9.1	10.9	8.6	9.9	11.5	18.0	8.1	10.1	11.1	0.7	15.6	8.3	7.5	12.5	7.2	5.1	5.3	5.9	6.3	5.4	5.2	5.8	5.1	5.8	4.9	4.8	5.1	11.7	6.4	20.3	2.0	20.0	21.4	26.1	35.8	25.0	19.8	12.6	14.9	25.9	15.7	31.3	29.5	10.4	26.2	12.4	6.3	35.2	26.3	3.9	18.2	14.8	17.8	13.8	10.7	6.4	30.7	26.8	19.7	12.8	16.2	34.9	25.5	5.0	19.1	17.6	26.9	4.9	8.6	26.4	15.0	47.5	6.5	11.5	35.0	17.8	11.2	13.6	13.2	20.6	4.5	4.0	22.4	7.3	7.2	17.5	33.8	3.8	22.7	30.8	11.0	13.1	26.7	28.7	70.4	103.6	17.4	24.0	29.3	21.0	18.7	12.6	20.6
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	11.8	14.5	6.1	5.2	6.0	9.0	12.2	8.3	6.8	13.7	3.6	13.4	5.1	12.0	6.5	10.1	11.8	5.4	14.0	6.0	5.1	13.1	10.9	11.4	6.3	4.5	5.2	18.2	12.8	7.4	16.2	9.3	4.9	13.1	7.1	8.3	11.4	5.4	14.9	15.8	12.6	7.9	1.1	14.9	12.2	22.8	4.5	6.7	17.3	14.6	8.6	11.4	12.7	4.4	8.3	9.7	13.0	10.7	13.0	12.2	24.2	10.3	17.6	11.5	11.0	16.5	9.5	19.4	4.7	20.9	17.0	21.0	15.4	11.0	11.3	9.4	8.2	6.1	19.9	13.6	15.6	9.4	8.0	13.6	8.2	14.3	17.4	11.1	13.0	16.9	11.1	10.2	12.9	15.4	8.3	7.8	17.8	12.1	7.8	9.9	24.5	11.0	5.0	10.7	6.4	10.0	12.7	7.9	6.2	15.2	14.4	5.5	13.8	18.1	10.8	11.4	7.7	5.7	13.8	18.5	10.3	5.2	8.2	2.1	2.3	2.8	3.2	3.8	3.5	0.9	1.7	2.9	1.7	1.2	2.9	2.6	0.9	3.0	1.8	0.9	3.1	1.5	6.1	6.0	8.3	6.8	6.0	5.1	4.5	5.2	4.9	1.1	4.5	4.4	14.7	22.4	27.2	35.3	10.8	7.5	6.2	5.1	9.6	26.6	11.2	9.5	29.2	7.2	10.3	11.0	37.5	15.1	13.5	7.1	13.7	11.7	45.9	18.0	22.2	12.7	16.8	15.8	53.6	7.2	24.0	14.0	14.3	25.8	8.8	27.4	9.7	5.9	9.2	25.2	59.0	10.0	10.2	7.7	7.9	133.1	15.5	12.8	12.4	19.7	10.8	9.7	7.2	30.7	47.8	12.5	7.9	11.3	12.4	9.0	8.9	7.3	16.2	24.4	19.7	19.5	15.4	22.4	20.0	11.8	8.7	21.1	11.9	23.2	10.6	11.0
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047967-2089491	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	12.6	10.0	3.8	10.2	4.6	10.9	12.6	4.5	6.1	16.7	0.9	15.3	12.4	17.4	7.3	12.0	16.0	10.9	12.6	5.9	1.3	9.6	9.0	12.0	7.7	3.1	1.5	18.4	14.8	14.7	16.5	9.2	2.7	12.4	9.1	17.7	21.3	15.6	31.1	14.4	12.8	11.4	0.1	11.4	15.7	16.2	2.6	11.7	18.6	14.5	7.8	14.0	12.8	12.5	13.5	21.4	28.9	32.5	33.7	28.1	24.3	31.7	21.7	23.4	19.7	25.7	25.4	20.5	27.6	26.2	11.0	22.0	17.5	23.1	17.3	15.5	28.5	19.2	39.6	10.7	23.0	24.0	22.4	33.5	14.3	18.9	13.9	27.9	22.3	14.4	19.0	17.7	21.0	27.0	28.9	7.1	29.8	10.1	21.2	45.3	31.6	25.7	9.4	12.1	22.1	41.3	45.2	29.4	15.3	28.2	26.8	17.5	35.5	24.5	16.5	22.0	16.5	39.0	42.7	40.8	10.2	9.7	29.6	3.2	2.7	2.8	3.1	2.1	2.8	1.8	1.9	1.7	2.5	1.8	1.3	2.1	3.5	1.6	1.7	0.6	1.4	2.2	3.8	4.6	4.5	6.1	5.9	1.3	3.1	1.5	2.7	0.1	2.6	12.5	23.8	25.6	18.9	43.8	16.8	9.2	8.1	10.1	14.8	53.8	23.7	20.2	41.8	21.5	15.3	20.2	93.8	13.0	17.3	34.5	3.9	15.2	13.1	47.8	26.3	25.6	32.5	17.4	22.8	14.1	8.0	19.7	44.9	62.1	8.8	49.0	32.2	38.7	11.4	45.4	22.4	26.6	8.2	17.6	9.9	29.3	28.3	13.8	8.8	15.9	12.1	19.0	36.0	18.6	25.7	21.4	17.5	25.9	14.4	9.4	25.4	8.9	17.8	64.7	13.1	17.2	20.4	18.3	37.7	12.9	9.8	9.3	18.8	31.6	28.9	10.6
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484421-12541549	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.9	9.4	3.4	1.1	3.9	0.3	8.9	4.4	4.8	11.5	3.7	11.5	1.4	10.9	2.6	8.6	12.0	1.8	15.5	3.5	3.7	10.2	8.5	6.0	2.2	3.6	3.5	14.2	12.1	3.2	10.9	0.9	3.6	10.0	2.3	3.4	6.7	3.2	15.9	8.3	6.9	3.2	3.3	6.6	9.7	6.7	3.9	2.6	9.0	3.8	2.2	11.5	9.7	3.8	6.2	11.8	5.5	7.4	6.3	7.7	7.6	5.8	4.3	6.6	5.1	4.2	5.2	5.5	3.3	4.0	5.8	5.8	7.8	9.4	5.4	5.5	9.8	5.1	9.1	5.7	5.4	9.3	2.1	4.9	11.2	10.1	9.7	3.3	4.7	8.8	10.7	3.4	6.5	11.9	9.6	6.1	6.5	10.5	13.5	4.6	2.3	13.5	9.9	4.8	1.5	4.5	6.7	5.0	4.8	3.1	10.1	5.1	4.5	4.2	3.9	4.7	9.7	3.1	8.6	6.2	5.6	11.8	5.4	0.6	1.9	0.0	2.7	1.6	4.4	3.7	4.6	3.8	2.3	3.2	6.2	5.1	0.4	2.5	1.7	3.4	1.6	2.6	3.4	3.9	4.4	4.8	3.5	3.7	3.6	3.5	3.6	3.3	3.9	3.8	5.5	3.2	3.3	26.1	8.9	2.9	11.2	5.6	13.1	28.1	3.7	4.3	7.0	10.0	3.8	11.0	43.8	8.8	2.6	9.2	1.9	6.2	1.6	7.1	7.4	6.2	4.2	8.4	42.8	4.2	4.3	5.7	13.7	3.7	5.1	17.7	3.6	5.0	4.6	10.1	46.4	5.2	4.1	3.5	1.7	2.8	9.0	3.6	3.6	16.9	2.4	8.0	6.2	19.1	31.8	4.5	5.0	10.1	3.8	6.2	2.3	6.9	11.1	34.1	6.6	7.9	6.3	14.0	23.0	7.1	4.8	1.9	4.6	15.3	8.4	8.0
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31149979-31349436	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 32.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 54.0;Excitatory neurons: 34.4;Inhibitory neurons: 84.7;Oligodendrocyte precursor cells: 59.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.2;RH-30: 46.4;U-138 MG: 32.8;U-87 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	7.0	3.6	4.6	4.8	4.5	1.1	6.2	0.0	8.6	18.8	0.3	16.1	2.2	21.5	9.2	5.7	13.0	9.3	5.7	5.7	0.4	3.2	1.3	6.3	1.2	3.1	1.0	32.8	1.5	1.3	4.6	5.7	1.5	11.6	4.0	1.8	3.3	9.5	1.9	3.0	5.5	18.4	3.9	5.4	6.7	2.7	3.1	0.8	10.2	2.3	0.5	14.8	8.8	4.9	0.0	2.0	0.7	0.0	9.4	22.2	0.0	6.0	8.8	3.7	6.6	0.0	1.2	0.0	0.0	14.8	7.0	1.0	2.7	5.3	8.2	0.0	2.2	0.0	0.0	0.0	19.4	5.2	9.1	13.0	4.5	13.7	6.8	0.0	0.0	4.4	0.0	0.0	16.9	0.9	0.0	0.0	0.7	0.0	0.0	5.9	46.4	0.0	0.0	0.0	0.0	13.8	0.1	0.0	4.7	4.4	0.0	3.6	0.0	32.8	10.3	3.4	8.8	0.0	0.0	0.0	21.2	8.8	0.9	0.0	0.9	0.0	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.3	1.9	0.0	0.1	0.0	0.3	0.3	4.6	4.5	0.0	8.6	5.7	0.4	3.1	1.0	1.5	3.9	3.1	4.9	8.3	3.2	1.1	10.1	0.2	4.8	7.3	9.2	15.4	14.0	0.8	2.4	2.1	1.5	5.1	3.7	0.0	0.4	2.5	0.0	0.0	0.4	0.2	1.3	54.0	9.0	0.0	0.4	34.4	0.6	0.3	20.2	0.0	1.3	1.3	2.6	17.2	0.2	11.6	16.8	84.7	0.0	2.0	9.7	10.4	1.1	17.7	5.0	5.4	14.0	6.4	0.2	0.0	59.3	1.9	0.6	0.0	29.3	0.3	3.8	0.0	0.1	1.3	0.2	0.0	29.7	7.8	0.3	4.0	1.7	1.7	0.8	1.7	1.0	0.0	3.2
TSNAX	"C3PO, TRAX"	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528541-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 194.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		36000	"Cluster 10: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	22.7	31.9	12.2	20.2	12.8	15.1	25.4	11.5	15.1	19.5	17.8	18.4	17.7	21.5	22.8	19.4	18.0	18.7	26.2	13.2	15.2	31.7	26.0	20.8	26.4	11.9	12.7	18.3	16.3	40.0	17.0	20.4	12.3	22.8	19.6	19.9	18.1	20.5	50.5	21.8	17.3	20.7	13.4	28.5	17.7	20.9	13.2	26.6	29.8	40.7	25.7	19.9	14.9	13.7	30.3	24.1	36.7	29.7	27.1	32.6	41.4	33.1	50.9	42.2	36.0	21.4	40.8	42.3	55.0	38.0	15.7	31.9	29.3	31.4	53.9	38.4	51.7	40.7	23.9	28.6	35.8	67.8	82.1	40.4	32.4	40.9	32.3	26.4	30.7	31.6	66.6	28.8	58.0	12.9	44.0	32.9	53.4	26.5	28.3	42.8	39.8	56.8	46.9	33.9	34.1	65.7	35.3	43.3	116.8	14.5	63.2	113.0	28.9	28.3	26.3	57.6	61.0	48.2	68.9	46.4	46.8	52.0	79.7	194.4	34.8	85.6	30.6	40.2	30.3	28.5	33.5	30.6	33.2	28.3	34.6	34.0	37.7	51.9	55.7	22.3	39.4	33.6	12.2	12.8	11.5	15.1	13.2	15.2	11.9	12.7	12.3	13.4	13.2	13.7	48.3	28.9	41.3	0.0	25.5	43.8	21.4	42.4	8.6	59.2	27.2	20.1	24.1	40.0	25.3	42.3	29.2	44.4	36.9	21.8	54.8	30.6	12.6	23.6	20.5	46.1	28.9	59.5	0.0	31.1	51.5	28.1	11.7	19.3	77.3	26.2	31.8	32.8	49.5	65.6	0.0	28.2	38.7	62.2	35.0	9.4	33.5	40.5	26.6	0.0	51.7	72.0	37.0	0.0	0.0	26.5	21.8	36.1	13.4	17.3	22.4	45.8	31.9	47.1	39.5	34.4	30.2	40.8	65.4	13.0	51.4	36.3	30.5	46.8	25.6	14.9
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089503	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.4;intestine: 55.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 109.0;neutrophil: 109.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 109.8;NK-cells: 86.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9"	"Region enhanced"	"Detected in all"		"white matter: 842.5"	"Low region specificity"	"Detected in many"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	7.2	1.8	3.5	10.1	1.9	20.8	4.5	0.9	1.4	10.7	1.3	55.4	5.4	47.4	7.5	14.6	22.2	7.4	7.4	1.0	3.6	8.4	0.8	6.5	1.4	5.4	4.1	2.9	2.9	10.2	2.1	3.0	5.7	15.4	12.0	2.0	3.0	28.3	2.8	2.0	11.0	42.7	2.1	3.8	13.8	1.1	5.7	2.7	2.7	5.2	1.1	24.7	8.0	1.2	15.1	0.3	1.2	0.0	0.0	0.2	0.1	2.1	1.0	2.4	3.8	3.1	9.5	0.0	58.8	3.5	3.3	2.2	1.9	0.0	2.7	3.1	1.2	0.5	1.1	0.0	0.2	0.1	0.0	0.0	0.4	0.7	0.0	16.9	0.1	11.1	0.0	0.9	0.0	0.8	8.2	1.3	13.8	3.2	1.6	0.1	0.8	0.0	0.4	5.8	3.0	4.5	3.5	1.6	0.2	8.2	0.3	0.6	0.2	0.2	5.7	0.4	14.1	12.5	0.4	0.1	0.1	26.9	6.9	109.0	9.1	55.8	17.4	0.2	5.6	0.6	20.5	22.6	4.1	0.3	3.4	17.0	109.8	86.2	0.1	3.8	3.3	13.1	3.5	1.9	0.9	1.4	1.0	3.6	5.4	4.1	5.7	2.1	5.7	1.2	18.7	0.0	0.6	0.3	1.4	8.0	23.2	10.9	1.8	2.5	1.5	7.6	9.6	0.0	4.4	11.0	0.0	1.4	19.9	0.1	0.0	35.3	12.2	14.3	0.9	16.3	39.4	3.0	2.8	2.4	4.3	4.0	0.5	16.3	0.0	2.0	6.4	0.0	0.7	0.0	5.4	1.3	4.1	0.6	3.7	4.6	0.6	3.0	3.6	2.8	2.7	0.0	40.2	1.5	0.2	10.9	0.0	3.0	3.3	30.0	0.0	1.3	10.7	0.4	6.6	1.4	16.2	0.1	0.9	0.2	2.7	0.3	17.2	0.1	1.4	21.6
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042467-41044337	"Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 50.1"	"Cell type enriched"	"Detected in some"	115	"Erythroid cells: 253.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060691, HPA066996"			Enhanced	"Plasma membrane"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.1	0.6	50.1	0.0	0.1	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.5	0.6	0.2	0.1	0.8	0.4	0.1	0.1	0.0	0.0	1.2	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.7	0.0	0.2	1.3	0.5	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.0	11.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.7	0.1	0.4	0.8	0.4	0.9	0.2	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.0	253.9	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0
TTC1	TPR1	ENSG00000113312	"Tetratricopeptide repeat domain 1"	Q99614	5	160009113-160065543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036557, HPA057502"	Approved		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA036557: AB_10670112, HPA057502: AB_2683450"	"unprognostic (4.34e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.16e-2)"	37.0	46.5	77.6	35.6	79.7	26.2	39.4	84.2	111.7	31.5	71.2	44.5	27.3	32.2	58.1	37.4	32.2	26.2	59.9	79.4	83.1	49.5	45.5	33.0	47.8	90.6	85.4	32.6	27.4	45.1	29.8	35.5	88.7	33.4	45.4	42.9	39.4	37.2	91.2	34.8	30.9	41.8	80.3	36.6	34.6	33.8	83.8	48.7	35.7	77.0	55.9	35.7	27.6	84.1	83.2	85.1	62.2	104.4	71.9	51.6	70.5	90.8	80.4	97.7	115.6	120.2	94.0	84.5	172.7	78.2	132.9	63.9	83.5	124.7	156.6	157.7	88.4	75.9	63.0	87.3	102.0	127.2	61.2	48.7	81.0	86.5	71.8	71.8	118.8	74.2	73.6	81.7	112.3	65.0	92.8	99.8	70.7	67.3	85.8	88.4	87.0	93.6	124.2	76.8	51.2	57.7	63.1	74.4	175.1	58.3	117.6	121.5	84.4	64.8	55.8	58.5	141.9	58.4	114.8	82.3	89.6	143.3	85.9	109.8	72.8	105.7	57.6	80.9	73.4	92.6	68.3	68.0	73.5	86.0	62.5	69.1	103.0	87.7	80.6	65.4	90.2	113.1	77.6	79.7	84.2	111.7	79.4	83.1	90.6	85.4	88.7	80.3	83.8	84.1	48.6	67.3	50.8	20.9	55.0	47.0	33.6	89.2	28.5	38.4	40.4	47.0	237.0	40.0	67.4	46.0	20.9	108.7	36.0	58.0	162.4	114.2	115.3	62.8	46.5	61.3	35.3	89.2	54.0	106.5	77.9	57.4	23.4	54.8	83.4	41.3	52.1	72.8	90.0	35.3	47.6	51.4	83.4	48.1	34.7	39.9	46.9	52.4	28.4	23.4	70.1	99.1	68.0	43.7	57.0	98.5	54.7	63.9	42.9	37.6	53.7	144.9	89.4	50.2	59.2	55.7	59.2	142.9	101.5	37.8	47.3	99.9	50.8	53.6	53.7	21.9
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999784-16045015	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA023010: AB_1858429, HPA052380: AB_2681806"	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	6.6	11.4	8.1	3.8	7.8	11.2	7.5	19.4	11.6	6.9	8.4	8.0	10.3	6.9	5.2	6.8	5.8	5.2	8.6	8.8	9.6	8.7	7.7	6.6	4.6	7.9	7.4	6.9	12.4	11.2	8.0	5.8	7.9	6.8	5.7	9.9	9.1	4.2	8.8	9.5	9.8	3.8	6.3	4.5	8.4	3.6	8.0	3.9	10.6	4.4	3.3	6.3	6.7	10.5	7.0	4.1	7.6	12.1	6.4	5.6	4.0	3.1	4.6	3.1	3.8	6.5	12.8	8.9	9.8	4.3	4.6	9.1	9.9	8.3	3.8	12.5	10.2	8.2	9.2	6.3	9.1	9.3	11.6	5.6	7.0	2.6	11.4	9.6	7.1	12.4	4.6	7.7	6.8	7.6	7.5	6.8	10.0	11.8	3.0	7.8	8.0	8.2	11.6	10.5	6.6	5.5	7.6	9.8	16.6	24.6	6.9	4.6	13.1	4.2	1.2	6.1	7.5	4.8	1.5	4.2	9.8	9.8	9.5	5.2	0.7	1.8	0.7	0.7	1.2	0.9	0.9	1.2	0.7	1.1	1.0	1.3	0.7	0.6	0.7	1.1	1.0	0.4	8.1	7.8	19.4	11.6	8.8	9.6	7.9	7.4	7.9	6.3	8.0	10.5	51.0	41.7	38.6	69.5	60.8	105.3	83.5	30.8	70.6	147.8	65.1	47.9	34.8	42.9	35.4	46.0	143.9	75.7	62.8	59.7	70.5	50.0	59.4	49.4	41.5	60.3	45.6	32.4	115.1	41.2	41.9	34.2	43.8	67.9	31.1	46.8	42.8	36.0	25.6	129.5	100.9	52.3	26.4	25.8	76.7	7.2	41.0	46.5	55.2	35.6	34.8	73.9	70.0	54.3	57.8	47.7	57.9	33.4	34.5	89.1	75.4	47.1	26.5	180.4	46.0	56.5	40.2	30.2	31.1	56.9	116.8	65.5	68.9	69.9	63.3	72.7
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 59.5"	"Group enriched"	"Detected in many"	9	"Early spermatids: 425.0;Late spermatids: 616.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 70.6;MCF7: 52.4;SK-BR-3: 153.7;T-47d: 111.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028098, HPA043440"	Uncertain		Enhanced	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028098: AB_10601705, HPA043440: AB_2678483"	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	2.2	8.2	3.5	3.3	3.5	1.7	35.9	3.0	9.6	14.1	0.0	29.5	6.1	1.0	15.9	18.4	7.5	14.9	15.3	1.0	11.4	26.6	2.8	9.1	1.4	7.4	5.3	0.3	13.5	13.5	11.0	0.3	14.0	20.5	35.2	4.6	11.5	4.2	4.1	10.5	8.1	1.6	2.2	0.3	29.4	59.5	7.7	0.5	10.1	1.7	2.0	8.0	9.4	3.7	6.4	3.4	0.7	0.3	0.4	0.7	28.2	0.3	0.2	0.2	0.2	18.2	2.8	0.1	9.6	0.4	0.4	0.2	3.8	0.2	0.1	70.6	9.7	0.5	1.8	3.2	1.1	0.0	0.7	0.1	1.6	0.1	0.0	0.8	1.4	0.2	0.4	0.1	0.2	52.4	0.6	0.2	4.8	33.8	0.6	0.1	0.2	4.3	28.6	9.1	22.1	1.6	0.5	153.7	1.8	2.0	111.7	0.8	0.8	0.4	2.5	0.5	0.5	5.4	7.1	0.2	2.1	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	31.7	0.0	0.3	3.5	3.5	3.0	9.6	1.0	11.4	7.4	5.3	14.0	2.2	7.7	3.7	0.4	3.2	25.2	1.3	1.1	1.5	5.3	1.7	0.0	2.5	30.8	15.1	13.0	5.7	6.4	9.2	0.0	0.5	15.3	29.3	11.7	38.9	425.0	5.4	3.0	1.9	41.4	9.7	9.7	52.7	4.8	0.9	21.9	9.5	3.8	0.5	0.4	0.6	2.0	0.0	10.2	56.0	6.1	0.3	1.3	616.8	2.5	0.9	0.0	1.0	2.6	1.7	0.0	0.0	0.9	30.5	13.7	2.6	0.4	12.0	2.7	24.4	9.3	7.3	6.6	1.8	1.3	22.8	6.5	4.8	6.5	3.4	1.7	0.5	20.7	14.6
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513185	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	5.6	6.9	5.0	6.7	5.5	7.9	6.4	6.6	6.2	6.6	5.5	6.1	5.6	6.2	6.5	6.4	6.5	4.7	7.5	4.9	5.5	6.8	7.4	4.6	10.8	5.4	5.4	5.8	4.7	9.6	5.7	5.8	5.6	6.1	6.0	5.5	6.1	5.1	9.1	6.5	5.5	6.1	5.4	7.6	5.5	12.9	5.5	10.6	6.6	6.9	11.4	6.7	6.0	5.8	8.2	15.1	19.6	19.5	14.8	9.7	8.1	12.2	13.7	20.0	19.6	12.4	6.9	23.3	17.8	9.1	17.8	14.2	31.2	14.3	17.6	10.6	10.0	14.5	8.4	12.9	15.9	13.1	13.4	8.2	17.9	14.9	13.3	12.1	17.7	30.2	21.7	17.9	14.1	16.8	39.0	13.2	25.9	23.0	10.4	26.0	15.6	11.1	11.2	8.9	23.5	12.3	11.8	10.9	14.8	17.7	11.2	10.4	10.7	12.4	10.9	13.0	12.0	9.6	10.0	34.2	12.1	13.0	13.5	19.9	20.9	35.8	24.2	24.5	23.6	18.6	21.1	23.3	19.4	22.9	24.1	21.5	23.0	23.3	27.5	14.0	25.2	19.8	5.0	5.5	6.6	6.2	4.9	5.5	5.4	5.4	5.6	5.4	5.5	5.8	5.6	6.4	4.8	5.9	8.3	5.4	7.8	7.7	8.0	6.3	3.9	3.4	0.7	1.5	8.7	7.3	20.9	9.9	5.0	3.5	3.9	9.4	21.9	7.4	9.3	7.0	3.0	15.4	4.7	9.2	9.5	6.1	3.6	7.2	3.8	8.1	3.6	5.5	9.3	6.7	5.0	6.2	6.1	5.5	3.1	4.2	6.8	5.4	5.4	3.7	10.8	6.1	5.2	3.5	5.7	6.3	2.2	7.5	5.2	7.5	5.6	7.7	8.5	11.5	6.6	6.2	5.5	40.4	10.5	5.0	8.1	8.8	6.0	7.7	5.6	4.9
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184686-49189080	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1313.3"	"Cell type enhanced"	"Detected in all"		"Ductal cells: 1162.0;Respiratory ciliated cells: 1173.3;Smooth muscle cells: 1005.3"	"Cancer enriched"	"Detected in all"	9	"glioma: 942.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1660.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 3100.7;SCLC-21H: 1983.9"	"Low region specificity"	"Detected in all"							"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-3)"	150.3	133.5	803.3	166.9	990.4	152.0	179.7	1083.4	882.6	185.8	692.7	466.4	54.4	406.3	166.6	140.0	342.0	193.1	156.5	784.4	1066.9	64.9	21.1	214.3	71.7	1209.8	1002.4	172.8	53.5	79.1	163.4	123.9	1136.6	173.4	126.5	259.7	104.7	267.3	37.4	107.9	125.9	865.4	1083.5	84.7	135.6	69.0	987.8	162.7	39.7	94.1	55.9	210.1	117.1	1313.3	3.2	154.4	3100.7	419.3	263.1	613.9	10.5	286.4	325.6	163.2	390.4	9.4	54.8	120.7	322.4	824.7	304.0	6.4	388.0	97.3	120.3	97.0	138.1	41.5	27.6	34.4	54.1	70.2	3.2	359.5	33.8	325.0	31.8	627.1	945.9	237.2	45.0	124.5	888.7	70.3	276.5	59.2	335.0	3.6	112.5	225.4	232.3	14.1	718.9	13.8	1983.9	1150.3	79.1	4.5	106.0	449.9	210.4	97.3	929.1	178.6	108.5	21.2	80.5	41.5	126.9	234.2	93.8	117.2	191.6	503.5	260.5	824.7	159.0	554.9	118.1	158.2	140.0	146.7	314.0	166.9	134.2	125.2	1660.9	89.9	812.8	101.1	172.8	495.5	803.3	990.4	1083.4	882.6	784.4	1066.9	1209.8	1002.4	1136.6	1083.5	987.8	1313.3	296.9	230.8	181.5	49.9	220.8	87.2	250.6	179.3	59.7	233.0	140.0	291.6	187.9	25.8	148.1	64.4	77.2	10.5	202.9	4.5	25.4	1162.0	10.0	414.9	413.6	334.2	785.8	48.0	78.2	16.2	12.8	391.5	63.2	102.4	547.9	695.0	165.6	2.8	452.0	249.0	60.6	15.5	329.6	80.7	277.6	20.7	193.6	204.2	183.2	37.5	616.6	788.9	77.2	73.4	432.6	333.3	12.8	142.6	32.5	60.4	1.5	73.3	1173.3	349.6	164.3	542.7	1005.3	15.4	31.2	20.9	99.3	15.9	266.5	40.6	12.4	95.7
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249710-219278170	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 360.2;tongue: 210.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 423.0;Late spermatids: 823.0;Pancreatic endocrine cells: 613.5;Smooth muscle cells: 408.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 265.9;HBEC3-KT: 439.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		NA	NA		130000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	14.3	41.4	33.6	34.1	47.5	107.1	16.4	22.3	133.1	27.7	8.1	32.9	18.6	9.8	10.1	84.8	12.6	13.5	97.7	42.6	32.3	31.9	29.5	26.7	56.7	46.3	27.3	12.9	18.2	34.6	23.1	5.0	31.4	19.7	27.8	39.2	46.9	22.4	360.2	161.4	35.5	12.8	3.9	56.8	30.6	32.4	14.9	16.9	12.3	210.3	63.4	22.6	57.3	54.0	106.0	90.0	0.0	0.3	9.1	6.9	0.3	16.2	49.7	2.8	1.9	20.4	106.7	144.2	172.2	11.7	172.7	265.9	49.3	439.9	3.9	81.7	0.7	184.2	154.5	15.4	7.3	60.9	60.8	6.7	158.0	23.7	49.2	27.4	17.3	2.4	20.5	91.3	100.6	4.3	0.3	107.9	32.3	83.2	107.4	6.5	139.0	84.5	129.7	7.5	85.8	1.5	213.2	18.7	0.7	1.8	8.0	50.9	12.3	49.8	27.4	58.4	56.7	38.0	48.8	171.4	183.3	116.4	2.5	141.7	63.3	170.2	107.1	45.7	110.1	124.9	150.3	142.8	20.9	95.5	140.2	138.4	331.2	82.0	71.9	3.8	143.8	270.9	33.6	47.5	22.3	133.1	42.6	32.3	46.3	27.3	31.4	3.9	14.9	54.0	55.3	44.8	47.1	16.3	160.6	181.8	201.2	235.3	68.9	123.3	42.3	51.6	60.9	28.6	62.0	49.7	77.2	0.7	311.6	87.3	140.8	199.3	423.0	9.8	3.3	36.5	107.9	56.2	34.8	205.6	0.5	11.5	40.8	26.1	15.8	0.1	36.0	33.0	6.0	67.3	22.5	141.9	48.8	15.3	54.9	823.0	16.8	159.5	78.2	9.4	27.8	38.6	50.4	10.6	10.6	613.5	51.2	7.5	202.3	46.7	87.5	137.5	11.1	72.9	0.0	21.1	408.5	5.7	5.0	130.6	244.5	2.5	290.1	1.4	58.9	113.0
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846348	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		610000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	69.7	114.6	69.6	67.1	74.2	75.1	65.8	78.9	78.1	59.4	93.3	101.5	104.4	64.9	34.7	105.2	73.6	46.6	177.8	68.1	75.3	107.3	145.1	58.3	69.2	73.1	77.4	61.4	114.2	117.1	55.4	47.6	74.1	57.7	86.1	35.8	88.9	59.7	224.4	76.0	83.9	53.6	72.9	66.2	106.1	73.3	77.0	59.9	62.7	221.5	79.3	67.1	62.9	74.3	176.2	323.1	102.4	216.2	144.9	131.4	208.7	125.8	144.4	194.9	183.0	351.3	189.4	390.5	228.5	126.4	112.4	337.6	244.2	242.9	116.2	155.4	370.8	151.7	254.8	433.6	171.7	273.8	134.8	169.9	188.1	211.9	208.7	126.8	235.2	213.0	339.0	150.3	144.4	355.0	262.3	266.3	231.8	213.9	196.9	361.8	187.3	569.6	169.3	168.4	178.8	219.6	110.0	388.5	180.2	84.6	231.5	217.6	150.1	115.9	136.4	146.7	196.6	229.8	253.6	172.2	148.6	336.8	157.1	94.6	155.8	72.3	103.1	153.6	115.3	100.6	97.2	108.7	199.3	98.8	91.7	95.3	32.4	97.2	119.2	123.1	140.1	185.6	69.6	74.2	78.9	78.1	68.1	75.3	73.1	77.4	74.1	72.9	77.0	74.3	108.2	70.5	76.7	29.4	144.6	168.1	262.5	322.0	158.2	102.4	165.1	139.2	134.4	190.1	182.6	176.6	87.6	333.1	113.2	260.0	334.6	230.2	381.8	116.1	92.5	111.3	148.5	148.1	17.5	289.8	299.2	111.2	153.4	79.6	105.9	170.6	108.5	247.1	253.8	74.0	19.9	230.5	217.7	167.5	146.4	669.0	109.3	128.6	138.7	14.0	167.5	140.6	88.6	28.6	30.3	199.7	215.3	111.7	264.9	245.3	330.7	451.9	237.3	116.3	85.5	105.5	129.1	205.7	177.4	230.1	156.0	287.0	120.2	288.2	418.7	277.6
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467046-36481640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No		84000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	60.3	182.3	89.8	45.5	92.4	64.7	58.0	94.6	98.2	57.4	92.4	65.3	84.0	50.0	51.7	79.8	64.1	49.4	122.3	87.9	90.7	91.5	149.5	44.7	59.2	92.9	91.3	75.8	59.2	99.1	43.4	47.3	91.9	59.3	63.6	43.0	59.5	52.5	159.4	60.5	64.3	48.3	91.2	65.7	76.1	48.8	97.0	50.9	67.7	180.1	59.9	59.0	54.0	91.7	52.8	80.4	75.4	126.8	115.2	125.0	81.3	70.8	108.1	114.8	128.7	87.9	52.1	133.3	64.2	116.8	54.5	76.1	151.7	127.4	66.1	93.6	131.8	147.7	91.7	125.4	94.6	189.6	125.8	162.3	98.9	101.9	79.3	99.5	118.2	78.4	157.7	104.1	106.1	80.3	87.5	128.2	60.0	170.3	95.3	75.3	79.5	92.6	116.4	84.8	99.9	98.3	70.2	148.1	125.3	61.3	103.6	165.9	83.7	120.5	95.0	69.8	65.9	81.4	64.2	128.6	111.0	109.5	74.1	30.2	173.5	32.3	102.5	194.3	108.9	140.4	101.2	109.0	223.4	133.8	116.4	108.6	59.3	145.4	170.1	167.1	110.9	224.3	89.8	92.4	94.6	98.2	87.9	90.7	92.9	91.3	91.9	91.2	97.0	91.7	68.9	60.9	53.0	12.1	66.4	83.5	87.7	154.0	108.1	105.6	124.3	137.7	105.4	88.6	82.5	69.9	39.6	213.2	62.8	128.5	303.3	93.0	19.6	45.7	70.6	73.7	89.5	114.0	8.3	106.2	275.8	74.0	75.4	57.2	69.1	148.0	81.0	122.7	173.4	116.1	10.3	132.4	95.6	100.5	80.7	36.8	56.5	80.7	78.2	8.4	91.9	168.9	77.2	9.0	13.5	82.5	104.3	50.8	79.5	52.7	252.2	213.7	49.0	59.4	19.7	61.1	67.1	49.1	42.4	124.5	89.8	207.1	62.4	287.0	179.6	87.1
TXNDC9	APACD	ENSG00000115514	"Thioredoxin domain containing 9"	O14530	2	99318982-99340702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031844, HPA031845, HPA031846"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916"	"unprognostic (3.63e-3)"	"unprognostic (4.26e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (2.06e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	18.7	17.9	10.0	21.3	10.8	17.5	28.7	11.0	13.2	19.3	10.4	24.6	18.4	16.6	25.9	26.1	18.1	18.6	28.6	10.8	11.7	28.8	27.2	20.1	29.2	11.6	11.5	10.7	10.9	15.4	11.3	23.5	11.9	19.6	26.3	11.0	15.1	16.1	18.2	19.0	17.6	24.4	11.8	18.6	18.5	17.8	10.9	26.1	24.8	16.2	34.0	24.9	14.1	12.5	78.3	27.6	55.0	27.7	55.8	57.8	65.8	83.1	79.5	88.5	85.0	71.1	55.5	58.0	66.9	72.6	77.0	52.7	55.2	88.2	102.6	44.0	53.5	60.4	34.5	77.0	54.2	71.8	44.2	53.0	76.7	74.3	53.8	46.1	101.9	32.1	73.0	51.1	103.7	41.5	43.4	63.6	43.4	46.4	68.7	32.5	53.0	56.4	123.9	62.6	37.1	31.5	41.7	56.2	93.7	69.8	64.3	60.9	69.4	65.1	62.7	40.6	62.6	21.2	37.1	65.6	51.9	76.8	58.6	110.6	54.1	61.1	56.7	60.5	70.2	69.1	66.6	64.4	60.3	57.6	61.9	62.5	53.5	77.7	82.6	60.9	91.2	87.0	10.0	10.8	11.0	13.2	10.8	11.7	11.6	11.5	11.9	11.8	10.9	12.5	46.6	9.6	13.4	8.8	33.4	35.2	29.7	137.1	25.0	11.3	21.5	26.3	27.6	25.8	67.0	36.8	8.4	75.7	31.3	26.2	84.1	79.8	75.7	37.3	29.9	46.2	20.9	47.8	13.3	69.4	82.5	29.2	22.4	25.5	17.7	21.0	38.2	24.4	56.9	13.5	12.8	25.7	91.6	25.4	31.3	21.1	27.7	30.2	26.6	4.7	55.5	26.9	44.3	12.5	16.7	84.5	21.6	23.3	31.8	24.0	21.9	121.5	72.8	19.8	26.3	17.8	89.3	52.8	42.7	29.4	38.9	81.3	35.1	40.1	26.6	21.9
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597209-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1100000	"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	38.3	55.9	45.4	38.6	47.5	83.0	49.1	49.1	63.6	42.5	40.1	41.7	42.1	38.3	66.9	54.2	35.2	40.0	80.0	50.0	50.9	51.7	80.7	30.6	41.2	47.7	47.2	47.1	62.2	51.4	38.2	48.1	49.5	40.5	43.4	77.9	48.5	39.3	149.0	36.5	40.6	43.4	46.2	32.2	46.7	41.9	47.5	48.0	197.9	146.8	49.9	51.8	35.1	54.0	77.7	74.8	99.2	102.8	83.2	121.6	70.2	90.2	91.8	113.4	95.4	67.0	74.2	83.4	78.1	98.4	82.3	93.7	94.4	81.3	116.9	85.7	43.1	114.9	58.3	127.1	98.3	168.9	71.7	92.9	82.4	107.4	97.4	118.8	93.0	62.9	85.5	136.0	116.0	74.4	98.1	109.8	71.9	53.5	79.6	78.2	66.8	145.9	133.0	118.6	81.6	74.5	51.3	70.9	88.1	78.3	77.5	89.1	74.3	118.7	62.9	41.9	89.5	130.8	151.1	130.5	77.2	127.0	89.1	98.5	63.1	48.3	26.9	55.8	37.2	38.9	33.0	35.8	54.8	35.4	32.0	32.9	48.3	43.3	54.9	47.0	42.9	61.5	45.4	47.5	49.1	63.6	50.0	50.9	47.7	47.2	49.5	46.2	47.5	54.0	89.7	57.7	45.9	25.5	80.0	134.3	123.1	177.1	75.7	82.7	89.3	110.4	110.1	67.2	108.3	29.5	139.7	242.3	82.7	72.2	109.5	150.5	246.9	88.0	90.0	84.2	75.9	153.8	43.8	128.3	130.9	86.1	52.0	90.3	53.2	167.5	52.8	78.0	150.1	57.2	43.6	111.6	77.3	97.3	97.0	294.1	77.6	90.5	65.8	15.9	121.8	86.0	78.2	26.2	55.6	139.5	83.7	83.8	88.9	121.2	110.0	144.7	75.1	97.1	65.7	73.0	167.1	204.1	108.0	93.9	126.0	358.6	72.4	171.0	109.7	123.1
TXNRD3	"TGR, TR2, TR2IT1, TRXR3, TXNRD3IT1, TXNRD3NB, TXNRD3NT1"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126571779-126655124	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 20.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	4.9	4.0	2.4	2.2	2.4	1.1	6.1	3.4	1.9	4.7	3.1	2.4	1.3	5.1	5.9	4.8	3.6	3.6	3.1	1.8	3.3	5.7	8.7	4.2	1.1	2.8	3.0	6.7	6.3	8.2	1.7	2.9	2.8	3.8	3.0	1.9	3.7	4.1	5.6	3.2	1.4	4.9	3.0	2.6	3.6	20.4	3.0	4.6	6.1	5.8	1.4	3.2	1.9	2.8	16.0	3.8	4.9	8.3	8.7	13.1	2.7	6.7	5.8	5.4	7.4	7.6	8.7	0.0	8.5	9.7	3.4	6.4	6.3	7.1	6.4	0.0	5.1	1.5	3.7	5.9	7.8	6.4	0.6	13.1	5.9	1.8	12.1	7.0	3.8	5.2	3.7	0.0	9.0	12.2	1.4	3.4	7.3	4.3	3.4	0.5	4.2	2.6	6.0	8.0	8.9	5.1	19.9	5.7	10.3	3.7	8.0	2.6	6.9	6.8	1.8	9.3	3.3	4.0	1.9	0.0	3.5	2.2	5.6	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	2.4	2.4	3.4	1.9	1.8	3.3	2.8	3.0	2.8	3.0	3.0	2.8	1.3	3.2	7.2	14.4	0.4	1.0	5.7	1.6	6.2	2.0	2.9	2.4	4.1	4.3	3.0	3.7	2.1	9.4	0.1	0.5	3.9	5.1	18.2	1.5	4.0	1.7	4.2	3.0	7.5	3.8	5.4	5.3	4.1	1.0	5.7	6.1	2.9	8.0	2.9	0.0	5.8	2.4	0.0	0.8	0.7	4.0	4.7	1.0	0.0	3.7	0.0	3.2	0.0	11.1	4.7	3.8	0.3	8.6	0.1	5.5	0.1	4.5	3.3	0.9	0.0	5.7	2.8	71.5	18.2	6.1	0.6	7.3	0.6	6.6	1.5	3.2
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177875-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"skin 1: 31.6"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 184.9"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	995	"SK-MEL-30: 426.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	426.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.3	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.5	5.2	0.3	0.0	184.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.0	0.0	0.1	0.0	0.0	0.0
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132679794	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease variant, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 418.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017235, HPA076042"	Supported		Enhanced	Vesicles,Cytosol		NA	NA		43000	"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Vesicles	"HPA017235: AB_1858507, HPA076042: "	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	18.3	29.2	15.6	18.6	17.5	21.5	23.0	15.2	16.3	18.0	30.9	21.5	24.0	17.2	30.4	17.2	16.6	16.9	23.8	16.7	15.8	31.3	31.8	17.7	22.4	12.6	13.6	16.9	52.1	31.0	22.3	25.8	14.1	24.8	22.6	25.2	48.0	20.2	31.4	22.0	24.8	17.7	13.8	21.1	26.7	17.0	14.2	19.7	31.8	24.4	24.9	17.2	11.8	16.5	67.2	24.4	42.1	35.3	28.4	31.9	44.5	57.1	57.2	34.4	39.6	44.9	24.2	52.1	41.1	40.8	23.3	39.6	41.6	43.6	49.5	51.3	18.1	63.6	39.6	50.1	27.9	79.6	36.7	28.0	24.8	32.8	48.7	31.8	38.6	28.6	41.0	76.2	38.0	59.4	44.1	29.2	38.6	56.3	22.9	38.6	37.0	99.8	31.0	50.9	40.2	35.8	33.5	32.0	51.3	37.8	40.0	39.5	35.9	36.7	36.2	17.8	29.8	71.7	51.8	98.3	40.9	28.1	33.5	8.3	7.1	7.0	12.4	8.2	14.6	15.1	13.8	19.1	15.9	10.2	16.1	16.3	1.6	26.0	9.5	19.2	15.5	10.5	15.6	17.5	15.2	16.3	16.7	15.8	12.6	13.6	14.1	13.8	14.2	16.5	23.1	35.3	25.9	37.2	24.0	17.2	18.9	26.4	21.1	22.1	26.1	13.1	36.9	22.8	24.4	7.3	14.6	63.0	28.4	8.3	68.4	30.3	124.8	17.7	22.2	20.5	21.6	10.9	37.6	44.9	48.0	24.8	28.5	17.4	24.1	16.8	13.2	22.8	22.6	21.9	35.6	22.6	34.6	10.3	11.4	418.2	16.8	13.9	17.8	16.9	21.6	26.1	16.5	37.7	28.4	23.2	16.7	27.1	85.4	23.1	35.4	43.1	20.8	23.6	32.9	23.5	28.2	49.4	23.1	15.9	18.5	99.7	20.4	29.7	18.3	18.1
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701155	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		12000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	6.7	6.6	5.9	9.9	8.0	17.1	8.3	7.5	7.5	10.6	4.9	7.1	8.1	6.8	6.2	11.4	5.7	8.0	5.3	5.6	7.9	6.3	10.7	7.8	12.4	9.7	8.0	7.7	6.2	7.9	12.0	9.8	10.0	7.7	8.4	14.4	6.7	5.5	5.2	8.4	8.6	8.7	8.4	10.2	9.4	10.0	8.7	10.4	7.9	6.5	13.6	10.2	10.6	16.0	34.4	18.8	30.5	24.0	14.8	17.4	20.6	69.5	27.1	31.1	36.2	19.8	45.1	43.4	24.2	28.7	31.8	19.8	31.9	34.6	46.6	50.0	8.9	27.8	30.7	18.7	12.6	49.3	20.4	12.5	10.9	40.3	24.3	21.2	27.8	21.9	67.2	25.0	37.2	13.0	51.5	11.2	18.0	24.3	22.6	30.0	62.6	16.1	25.3	38.3	14.9	18.8	39.2	27.5	13.0	25.3	18.4	13.0	40.6	28.6	31.9	23.6	30.8	17.8	15.0	43.0	50.9	13.5	28.1	6.4	1.8	2.9	2.4	2.3	2.7	3.0	2.8	3.2	2.2	3.0	2.0	2.4	1.3	5.7	2.6	3.1	2.5	1.4	5.9	8.0	7.5	7.5	5.6	7.9	9.7	8.0	10.0	8.4	8.7	16.0	34.6	25.6	21.7	54.5	46.5	70.1	65.2	43.0	37.5	45.8	30.8	17.0	13.5	10.0	34.6	16.5	54.2	29.2	45.0	34.7	3.9	24.6	2.3	28.6	24.8	39.0	32.3	23.8	66.3	17.1	17.8	26.6	39.8	45.3	31.0	62.3	20.0	20.9	23.2	33.7	78.1	27.0	28.5	29.9	54.0	5.8	21.5	31.4	24.9	37.5	34.6	14.6	26.8	77.9	115.7	53.3	36.6	19.9	44.8	87.0	21.2	15.9	34.9	39.9	19.7	28.0	24.0	57.7	43.9	30.9	46.2	58.8	37.6	40.4	22.8	149.0
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558954	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 1197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No		49000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	46.3	66.1	133.2	39.2	138.8	82.2	42.8	116.7	199.7	48.9	104.0	72.5	41.7	48.1	36.3	61.8	51.3	30.9	111.0	141.2	129.3	63.2	45.6	46.3	43.4	123.5	124.4	46.0	47.5	84.5	69.7	45.0	127.7	48.3	32.5	49.7	48.5	46.1	174.0	56.6	41.6	39.5	111.9	49.3	55.8	81.0	124.4	51.7	44.3	104.5	43.7	58.3	45.8	139.1	161.8	272.1	119.3	124.8	61.7	71.9	112.2	166.0	117.4	97.8	82.8	162.7	109.7	161.9	135.5	93.4	198.1	105.9	130.1	138.6	69.2	207.3	1197.4	235.5	163.7	113.7	154.4	197.3	192.9	82.1	107.1	145.9	167.3	102.6	117.8	146.3	119.6	179.4	127.3	158.2	177.2	223.7	87.1	155.1	306.5	171.7	106.7	204.5	111.6	166.8	239.5	205.5	133.1	149.7	163.3	41.6	94.4	188.4	105.2	333.4	80.5	110.6	281.3	262.3	411.9	169.6	206.0	177.6	220.5	6.7	3.6	4.2	3.0	2.6	2.2	2.8	3.2	3.2	2.8	3.8	3.3	2.2	10.1	1.7	2.7	6.7	2.9	1.9	133.2	138.8	116.7	199.7	141.2	129.3	123.5	124.4	127.7	111.9	124.4	139.1	75.1	6.4	13.0	14.7	32.7	40.4	36.3	15.9	6.2	100.0	74.5	81.3	38.5	20.0	11.6	18.4	20.9	21.0	72.9	63.9	7.9	17.3	25.7	89.6	68.0	40.1	41.2	39.8	22.9	30.6	22.4	38.9	21.9	63.3	19.7	103.3	28.5	38.0	35.4	109.4	20.8	43.8	20.3	27.0	33.5	34.0	17.4	42.5	35.6	15.9	21.1	142.3	14.4	8.5	17.9	41.8	21.4	13.9	35.4	59.1	37.9	33.9	18.6	81.1	26.3	41.5	55.4	27.1	7.9	17.0	56.8	52.5	41.0	156.1	41.6	56.2
UBE2V1	"CROC-1, CROC1, UBE2V, UEV-1, UEV1A"	ENSG00000244687	"Ubiquitin conjugating enzyme E2 V1"	Q13404	20	50081124-50115959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 74.0;Erythroid cells: 80.1;Plasma cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	61.2	57.8	50.1	56.9	54.9	51.3	51.3	43.1	72.2	51.2	44.2	70.7	58.4	45.4	53.2	71.9	46.6	48.0	66.7	55.8	48.8	58.9	78.2	59.3	68.4	45.2	44.5	44.2	64.7	61.1	37.4	66.3	46.3	53.5	61.2	47.2	55.6	55.0	87.9	65.9	51.9	73.5	38.3	55.5	56.7	40.9	48.9	60.8	49.9	70.8	89.1	67.8	53.6	48.6	155.0	94.1	174.3	104.8	141.6	238.7	97.3	172.6	168.0	356.3	169.9	466.6	112.8	148.8	155.9	223.8	155.1	134.5	129.5	235.4	307.1	105.0	81.2	146.0	66.2	212.2	125.9	178.3	113.2	192.4	140.4	176.1	115.1	199.6	243.5	120.4	185.2	88.4	200.9	102.7	162.9	143.8	121.9	204.5	164.7	89.0	196.8	136.4	248.7	109.9	101.8	123.2	174.4	301.0	136.7	173.2	115.0	161.2	215.1	196.5	182.3	165.7	140.8	85.7	118.5	119.0	213.9	92.2	139.4	120.7	162.3	146.5	219.9	161.5	221.9	149.2	178.9	210.7	165.3	134.1	180.3	197.2	55.8	233.6	147.9	130.4	189.5	351.7	50.1	54.9	43.1	72.2	55.8	48.8	45.2	44.5	46.3	38.3	48.9	48.6	18.9	51.3	30.9	0.0	39.1	5.9	5.0	18.4	74.0	4.6	10.6	7.9	9.2	7.2	36.3	11.0	6.2	6.4	24.6	10.7	23.5	11.5	19.1	36.3	32.0	18.4	10.2	80.1	0.0	11.3	5.7	21.2	38.2	36.1	36.6	4.8	16.8	14.5	7.0	0.0	0.0	5.2	8.2	17.8	5.9	19.8	7.8	29.6	8.8	0.0	18.4	3.0	12.3	0.0	0.0	16.1	15.4	4.9	79.4	2.8	7.7	27.2	47.8	5.4	6.6	6.9	14.8	12.9	6.7	67.8	8.5	7.1	41.1	5.4	4.9	5.1
UBN2	"FLJ25778, KIAA2030"	ENSG00000157741	"Ubinuclein 2"	Q6ZU65	7	139230356-139308236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 140.7;Late spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"basophil: 8.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019743, HPA020122, HPA020124"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.05e-2)"	3.4	4.6	4.2	2.4	2.9	5.9	4.7	12.2	5.9	5.6	2.0	4.2	2.4	4.7	6.8	4.3	5.3	2.7	3.8	3.4	5.0	3.4	4.4	3.6	2.6	1.8	1.7	6.2	6.6	4.0	8.4	3.0	1.1	4.6	3.3	13.5	5.0	3.0	7.3	9.7	3.8	3.0	0.1	3.5	3.9	14.5	2.5	3.3	5.8	4.8	2.5	4.1	5.1	8.0	3.3	3.1	4.9	6.1	3.8	3.5	3.7	1.8	2.7	1.6	2.0	3.7	3.2	5.5	3.4	2.3	4.2	3.0	6.3	1.5	2.9	2.8	3.7	4.2	5.8	4.1	2.2	8.2	3.1	2.4	4.3	2.2	3.4	3.0	3.3	2.9	9.9	4.1	2.1	5.0	5.9	9.4	6.9	3.3	2.2	3.4	4.6	3.9	2.3	2.4	8.0	5.8	5.7	3.9	2.7	4.5	2.5	5.4	3.7	2.0	2.3	3.1	2.4	4.8	5.8	9.5	3.4	4.9	3.0	8.5	0.6	0.0	0.3	0.2	0.2	0.5	0.3	0.3	0.2	0.6	0.4	0.3	0.5	1.9	0.2	0.7	0.2	0.1	4.2	2.9	12.2	5.9	3.4	5.0	1.8	1.7	1.1	0.1	2.5	8.0	21.0	6.4	23.6	58.1	11.7	23.3	18.6	9.9	15.4	54.0	23.2	13.6	27.2	21.5	15.0	22.0	93.8	9.0	21.8	16.5	7.9	8.0	140.7	58.3	38.2	17.7	23.4	24.8	97.5	6.9	8.9	20.2	14.3	68.8	11.4	28.7	17.5	22.6	7.1	45.4	95.1	16.7	10.2	11.5	17.9	178.6	22.4	15.4	8.8	53.4	19.0	23.6	16.5	79.4	84.9	9.2	14.0	21.4	16.2	41.5	15.7	11.0	36.5	58.2	19.7	37.6	22.8	44.6	31.6	20.9	28.8	14.6	14.3	27.2	13.5	28.4
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563627-56567868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.8	20.2	24.9	14.9	26.8	11.1	12.1	19.7	30.6	15.9	12.7	15.7	11.2	16.6	15.9	18.7	17.5	14.5	21.6	27.4	25.5	13.5	19.4	13.8	18.4	20.2	20.4	25.7	10.5	23.6	16.3	15.8	22.1	20.2	12.1	22.2	14.4	20.0	28.0	13.6	12.4	18.4	21.3	14.9	13.1	4.4	22.6	18.9	20.7	22.8	18.6	18.6	11.1	25.5	36.3	26.5	25.9	30.6	58.3	37.0	16.3	28.6	33.9	21.0	23.2	14.9	16.6	27.6	30.5	34.0	32.9	20.7	50.0	31.9	25.3	43.0	30.1	11.2	34.2	15.9	30.6	22.1	23.7	34.7	39.6	28.3	24.6	30.3	18.7	17.6	13.3	29.5	33.6	16.9	28.5	19.2	21.7	11.6	31.1	25.3	33.7	26.3	42.8	27.9	31.9	29.9	41.3	18.1	17.4	45.2	30.4	16.1	21.2	22.2	22.5	32.4	17.5	11.1	14.8	18.9	24.9	23.1	19.3	50.0	23.6	24.1	15.1	31.1	17.1	7.8	22.9	17.7	17.8	8.6	30.3	18.9	20.4	20.9	34.2	6.5	23.5	20.3	24.9	26.8	19.7	30.6	27.4	25.5	20.2	20.4	22.1	21.3	22.6	25.5	13.9	22.4	17.2	0.0	30.5	31.2	41.6	27.4	20.5	42.3	14.5	11.3	37.6	15.7	25.0	18.4	18.8	28.8	15.4	12.1	17.6	20.0	0.1	11.8	22.7	18.9	34.2	18.3	0.0	16.6	26.7	27.9	13.7	15.7	12.7	14.2	18.2	20.3	24.7	42.1	0.0	20.3	18.3	30.7	25.3	1.6	24.8	21.1	17.8	0.0	35.9	22.3	42.2	0.0	0.0	18.9	12.7	36.5	23.5	32.0	20.7	16.4	27.5	35.8	13.1	25.4	29.8	0.3	1.5	32.7	30.4	40.0	28.7	12.2	19.3	35.6
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor"	P17480	17	44205033-44221626	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	34.8	36.5	36.2	44.8	33.7	54.9	35.4	38.2	37.1	50.6	30.1	49.4	33.6	50.8	27.5	41.8	41.9	32.5	38.8	35.5	32.7	38.1	36.1	32.3	67.6	34.0	34.5	41.6	41.4	38.2	33.8	29.2	32.2	41.6	28.2	23.1	37.7	40.8	63.7	47.4	42.5	36.3	31.6	49.8	34.7	20.8	34.9	73.6	46.4	36.6	51.7	45.1	41.8	35.0	69.1	104.3	77.3	93.2	49.6	56.5	72.3	70.6	46.7	70.1	52.0	50.7	54.8	250.0	69.3	65.3	51.9	63.6	99.1	59.2	57.9	145.3	109.5	100.5	73.8	83.7	32.5	192.1	85.7	56.9	52.2	44.6	65.6	67.2	58.9	108.8	117.4	75.9	58.9	113.7	188.3	75.0	73.7	46.6	81.6	184.0	104.3	112.0	40.4	54.5	119.5	90.3	70.4	62.2	54.2	47.9	89.9	120.8	75.5	109.9	133.1	65.1	95.0	66.6	61.7	151.1	64.8	86.0	100.1	9.6	5.7	6.1	15.5	6.3	16.7	11.7	10.8	16.2	6.7	14.1	12.2	13.1	9.7	15.7	11.6	12.7	10.0	11.3	36.2	33.7	38.2	37.1	35.5	32.7	34.0	34.5	32.2	31.6	34.9	35.0	41.4	41.7	42.1	14.7	57.5	20.5	19.6	17.9	57.5	88.8	31.0	29.6	44.5	35.8	32.2	38.6	79.2	30.9	60.3	41.7	35.2	27.2	2.3	39.3	57.7	42.7	47.3	61.2	8.5	40.8	40.7	38.9	23.9	48.1	31.7	43.1	32.5	26.5	25.9	26.9	8.2	32.5	12.2	18.4	13.3	3.6	36.7	27.4	23.2	8.4	38.1	33.9	54.6	3.5	10.6	28.1	30.7	50.8	42.2	17.4	26.7	25.4	26.5	57.6	52.6	48.5	45.9	5.3	44.0	52.1	24.3	32.7	53.1	40.2	32.8	11.8
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA048441: AB_2680394, HPA049442: AB_2680769"	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	6.5	7.5	5.3	7.5	7.5	21.7	8.2	17.5	7.1	8.3	7.4	6.9	5.5	10.1	8.1	6.6	8.4	5.7	4.9	5.4	9.3	6.8	6.4	6.7	9.0	6.3	7.3	12.8	7.4	10.8	7.3	9.5	6.9	7.3	6.8	18.1	6.6	6.7	5.0	10.7	6.3	7.9	5.8	8.9	6.6	11.9	7.6	13.9	8.1	7.0	8.7	6.2	7.0	10.9	25.2	7.7	29.8	15.8	15.2	26.6	13.0	20.3	13.4	11.4	10.4	19.9	10.5	23.0	41.6	13.7	15.4	20.0	22.5	12.0	21.2	9.5	13.8	36.9	16.5	11.3	11.6	18.8	11.5	16.0	13.5	16.0	20.0	20.4	18.7	17.2	17.8	15.5	13.5	10.8	19.6	9.9	17.3	10.2	9.7	22.7	22.3	15.8	9.4	10.9	20.0	15.4	32.6	9.0	15.7	23.7	24.2	15.7	23.5	13.0	11.6	11.8	21.7	21.6	31.3	33.5	12.0	21.0	9.9	9.9	4.7	7.0	4.4	3.7	4.0	6.9	3.8	2.9	5.0	5.9	6.5	5.9	8.4	6.2	5.4	2.2	6.6	2.5	5.3	7.5	17.5	7.1	5.4	9.3	6.3	7.3	6.9	5.8	7.6	10.9	27.1	44.8	18.8	29.7	31.4	47.3	14.3	16.2	40.5	38.0	22.2	16.0	16.8	12.8	21.1	20.2	70.9	18.0	32.9	14.8	5.9	10.8	38.3	47.8	46.3	27.8	46.5	34.0	35.3	10.0	10.5	30.7	18.8	35.1	8.8	46.0	21.8	12.0	12.5	32.0	41.3	15.9	12.2	25.4	41.0	24.7	29.8	24.7	23.2	27.2	28.4	21.5	33.0	36.7	47.8	12.2	11.8	28.2	34.3	31.7	13.3	11.7	30.5	46.5	32.9	37.3	25.6	34.7	23.8	38.6	54.7	18.9	29.8	33.2	15.8	25.3
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	10.0	8.1	8.2	9.9	10.3	44.6	9.7	14.9	10.4	12.9	10.4	11.6	6.2	12.9	10.0	8.3	9.9	7.9	7.2	8.7	9.2	8.1	7.9	7.8	17.3	9.4	8.6	12.4	10.7	9.7	5.4	12.1	9.4	15.3	9.2	9.2	8.5	12.6	11.0	7.7	8.5	14.0	8.8	10.4	8.3	8.4	10.0	21.2	8.1	11.9	16.6	11.4	10.1	14.3	18.1	18.8	26.7	11.9	21.4	30.7	20.5	43.9	23.4	23.7	41.2	12.4	12.0	26.9	9.2	19.2	21.8	11.9	24.6	22.5	36.0	53.6	14.9	46.3	36.2	19.7	17.8	19.3	16.1	13.5	14.1	18.4	44.5	44.4	93.2	25.4	5.1	24.0	56.0	5.9	37.0	79.2	10.8	24.8	14.8	43.1	12.4	8.7	17.2	11.3	24.8	9.4	16.6	11.0	25.6	32.1	14.0	41.9	78.6	25.2	10.0	11.0	34.4	7.2	23.2	30.4	12.4	18.2	10.2	4.0	0.5	2.7	1.2	0.5	0.8	1.8	1.8	1.0	0.3	2.9	1.0	1.2	0.5	0.6	0.9	1.2	1.9	0.6	8.2	10.3	14.9	10.4	8.7	9.2	9.4	8.6	9.4	8.8	10.0	14.3	27.5	6.4	14.4	24.2	33.9	21.5	10.2	6.2	12.0	22.0	13.8	13.1	59.0	4.3	8.4	12.9	31.3	13.2	31.3	9.1	1.9	5.2	23.6	12.8	22.9	24.1	7.1	34.9	44.2	4.0	9.9	16.0	20.9	24.5	17.7	27.8	12.8	14.6	10.7	28.6	53.3	14.8	4.1	12.6	9.3	8.1	19.3	15.6	21.4	51.5	12.5	6.4	16.5	46.8	78.6	6.2	14.4	14.7	30.1	16.0	10.2	7.3	6.3	34.8	13.1	14.4	18.8	46.2	23.4	16.1	19.0	5.9	29.0	13.7	12.6	9.8
UPF3B	"HUPF3B, MRX62, MRX82, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.9	8.1	17.0	10.2	17.2	13.6	9.5	21.1	30.0	11.9	16.3	11.8	11.8	11.7	10.5	12.7	9.9	6.9	7.5	16.5	20.0	11.4	12.4	9.0	15.4	17.5	17.3	13.3	8.1	11.3	12.9	8.8	17.4	10.8	10.5	22.0	8.8	9.0	12.9	15.5	10.0	9.3	16.0	11.3	8.6	15.7	17.8	14.7	11.5	10.9	15.6	10.5	11.7	18.6	29.2	17.3	35.1	28.8	15.7	10.3	22.5	27.4	15.3	20.9	18.3	32.7	20.4	51.9	22.6	11.5	29.9	27.1	45.9	16.6	26.5	29.9	33.9	48.3	57.9	17.2	17.9	52.7	23.0	8.7	12.4	35.8	43.3	19.0	19.7	30.5	47.4	41.8	17.6	35.9	36.8	65.6	67.7	37.1	46.8	35.9	40.2	38.2	17.3	14.5	46.7	32.1	55.6	22.4	42.4	36.2	11.9	30.4	17.3	21.6	16.6	34.9	58.6	23.1	27.5	69.5	17.5	76.1	25.7	8.1	4.4	6.5	5.9	4.8	4.8	12.5	5.6	4.8	3.3	13.7	6.3	6.4	4.9	7.7	5.6	8.7	7.4	2.2	17.0	17.2	21.1	30.0	16.5	20.0	17.5	17.3	17.4	16.0	17.8	18.6	26.3	32.1	25.7	31.6	47.4	37.7	31.1	31.6	47.8	50.7	26.4	28.2	19.0	17.2	38.7	25.8	56.3	39.0	46.1	33.5	5.9	31.6	157.3	26.1	23.5	31.1	27.6	52.2	30.6	26.4	48.2	25.5	23.0	33.8	58.9	32.8	23.2	22.9	28.5	28.6	39.5	35.5	26.4	19.1	43.3	31.7	30.4	28.2	24.9	27.2	44.9	32.6	56.7	33.7	45.4	21.5	33.6	32.7	32.5	33.8	30.4	16.5	35.2	99.0	13.1	34.4	42.0	65.8	41.4	38.8	38.1	64.3	39.9	28.1	37.6	25.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108736	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 250.1;Extravillous trophoblasts: 260.3;Macrophages: 199.5;Paneth cells: 260.8"	"Cancer enhanced"	"Detected in all"		"testis cancer: 62.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"hTERT-HME1: 362.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.4	9.4	3.8	7.5	4.4	12.5	10.0	3.0	5.8	16.8	2.0	9.8	4.3	3.9	0.8	66.9	5.7	5.9	8.9	3.1	3.9	39.8	11.9	18.8	3.7	4.2	2.8	1.9	4.6	5.0	7.4	3.8	3.7	4.9	5.3	0.5	14.2	1.1	3.7	3.1	6.5	3.4	1.3	20.3	4.1	2.2	4.4	1.2	8.0	0.9	6.6	9.1	31.2	3.7	19.5	26.0	2.4	5.2	8.9	4.0	29.7	7.9	15.5	14.5	17.5	10.8	9.9	0.0	2.5	9.7	89.9	13.9	5.2	46.1	9.4	4.1	4.5	0.8	4.8	4.6	7.4	0.9	1.3	5.0	21.8	6.4	362.8	5.9	9.1	0.4	1.5	13.5	7.6	2.3	0.0	2.9	9.4	4.2	20.7	0.0	4.8	6.0	33.7	11.5	2.3	1.6	10.2	3.0	63.4	29.3	2.4	0.9	12.4	29.6	22.9	7.3	22.6	21.4	34.7	3.7	29.6	3.0	77.8	11.5	16.0	12.2	11.8	12.1	8.9	0.2	7.8	8.7	6.5	0.6	8.1	8.1	6.2	5.4	14.8	0.5	8.4	10.9	3.8	4.4	3.0	5.8	3.1	3.9	4.2	2.8	3.7	1.3	4.4	3.7	107.4	19.2	58.5	5.2	19.1	46.8	26.3	104.4	19.4	27.6	9.0	16.1	11.6	24.3	51.0	11.0	33.3	15.1	122.9	250.1	70.5	50.5	1.0	42.1	22.4	108.1	13.1	4.4	16.5	40.5	260.3	34.1	5.1	91.1	25.9	3.8	72.5	17.5	110.0	16.8	29.4	35.0	85.5	130.5	118.1	2.4	5.3	199.5	87.2	1.0	61.4	13.3	71.1	4.0	3.6	117.9	260.8	2.2	30.3	30.4	42.8	23.3	11.9	29.2	6.6	21.1	32.2	0.3	9.5	42.9	29.8	78.7	71.0	1.5	29.1	34.9
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21953288-21983660	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 722.2;tongue: 933.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 556.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		180000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	158.8	117.7	69.0	103.1	71.2	127.7	108.4	75.5	90.0	90.8	113.9	259.8	292.5	98.2	72.7	157.4	109.7	99.5	559.4	72.4	73.7	240.0	245.1	75.4	120.0	74.1	69.5	114.5	89.7	257.2	39.8	96.5	72.7	95.6	262.8	142.3	133.8	104.3	722.2	85.4	233.6	121.2	65.8	80.9	153.2	55.8	76.5	131.3	107.9	933.2	149.3	153.6	59.8	73.3	173.9	193.1	116.5	66.4	154.3	186.8	169.1	163.8	160.6	177.5	174.5	347.9	177.7	338.9	144.3	170.4	129.8	324.6	222.3	212.7	193.7	151.4	178.4	185.9	166.1	494.3	164.6	249.1	501.2	232.3	229.4	130.3	186.2	169.4	248.1	224.1	217.9	159.1	177.2	230.6	288.6	175.0	124.6	261.1	148.8	310.9	263.6	390.0	285.8	214.6	154.4	114.9	237.2	318.6	190.3	151.6	354.4	264.1	179.3	103.3	98.1	104.0	148.0	126.3	87.2	302.7	188.7	239.8	126.4	80.1	128.7	71.4	80.0	147.8	103.3	96.0	98.3	89.3	153.9	77.9	106.8	97.6	45.9	101.8	148.1	67.6	134.8	157.3	69.0	71.2	75.5	90.0	72.4	73.7	74.1	69.5	72.7	65.8	76.5	73.3	105.5	64.1	52.5	81.9	81.1	90.6	190.8	444.0	74.6	109.1	91.7	79.6	556.2	84.4	194.9	71.7	87.6	238.3	82.6	233.4	455.9	124.5	88.0	72.0	55.7	91.3	113.8	92.4	65.0	109.6	157.6	89.0	144.3	65.8	92.6	99.6	84.3	122.3	195.5	69.0	74.0	224.4	238.0	145.1	100.6	89.9	68.3	104.6	131.6	27.2	162.1	108.0	91.6	60.3	50.7	97.2	214.0	97.0	72.9	114.4	378.0	306.9	110.2	152.6	78.9	94.1	109.5	68.9	56.7	132.0	88.4	278.3	91.3	170.2	358.7	204.3
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866630-132868847	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1301.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3312.4;Hepatocytes: 5039.2;Proximal tubular cells: 3336.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria		NA	NA		18000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	226.5	378.7	277.6	91.8	283.7	132.6	189.2	309.6	391.9	151.7	293.2	313.0	220.8	147.9	211.2	332.4	138.6	78.3	1301.6	283.6	315.5	460.7	1036.6	149.0	69.1	291.2	285.6	120.0	269.4	318.5	222.8	89.0	294.9	272.9	232.2	187.4	253.8	122.2	1024.7	182.3	244.5	98.5	286.6	151.8	372.3	128.9	294.7	130.3	167.3	873.5	92.3	219.9	193.3	302.3	300.9	391.1	246.7	599.9	364.2	292.2	209.3	216.3	310.6	341.7	424.9	556.4	353.8	126.5	433.4	291.5	424.5	302.7	229.5	536.6	300.7	222.9	466.0	169.4	606.3	459.9	312.7	188.8	276.2	314.0	366.5	247.4	341.6	229.6	274.1	258.3	219.2	398.6	369.7	547.5	450.5	442.1	175.3	568.1	367.0	288.4	271.7	541.7	460.9	573.4	410.7	335.8	269.1	302.7	493.9	170.4	451.9	422.5	168.3	316.0	392.1	257.2	438.7	423.1	616.3	236.6	417.9	350.0	320.6	474.1	528.3	355.5	245.6	431.0	251.8	317.2	280.3	280.2	472.0	260.6	273.5	263.6	258.8	322.9	410.0	516.7	326.1	658.2	277.6	283.7	309.6	391.9	283.6	315.5	291.2	285.6	294.9	286.6	294.7	302.3	252.0	250.0	349.3	17.6	258.1	348.3	334.0	1046.6	235.6	97.8	575.5	657.7	3312.4	993.7	556.9	787.2	120.9	720.4	200.6	1678.3	1813.7	685.6	470.0	424.1	308.5	288.4	549.3	319.4	13.9	947.7	484.1	330.2	438.3	467.5	294.5	277.0	333.8	5039.2	771.4	72.3	17.0	1047.6	807.7	421.1	448.6	1116.6	282.4	301.6	715.1	11.2	394.7	459.2	260.6	13.6	23.5	705.7	1460.8	288.9	416.2	537.1	2476.1	3336.0	512.5	271.5	184.1	217.8	388.7	308.1	174.7	570.1	514.0	562.7	205.0	235.9	1205.6	500.2
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis homolog"	Q14146	1	229626247-229660200	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	4.9	2.8	2.2	3.9	2.6	4.5	3.2	2.6	2.4	2.1	1.9	2.6	2.2	3.2	1.8	3.7	2.8	2.6	2.6	2.0	2.3	2.2	2.8	2.1	4.5	2.6	2.7	2.9	4.7	2.5	4.3	3.3	2.5	2.0	2.4	2.6	2.3	1.8	6.9	3.0	2.5	3.3	2.6	3.0	2.7	5.7	2.5	4.6	2.2	4.5	4.7	4.9	2.2	3.1	13.6	20.1	12.8	17.2	7.9	6.5	39.1	10.6	6.6	16.1	12.1	20.1	10.4	28.0	11.9	7.6	8.6	18.3	32.0	13.0	14.6	13.8	30.4	17.5	16.8	11.9	7.5	25.8	14.5	6.4	9.3	16.0	12.4	4.1	7.8	16.2	37.7	12.7	10.1	10.7	29.0	12.6	43.1	24.1	13.2	32.0	18.2	27.9	7.1	17.0	19.1	23.4	12.5	12.9	10.6	4.4	14.6	14.6	8.6	13.1	16.6	16.8	30.8	13.9	14.4	41.6	7.0	19.0	24.4	0.1	0.9	0.2	1.2	1.7	2.2	0.8	1.1	1.4	1.1	1.0	1.6	1.3	0.1	0.8	0.6	0.7	1.4	1.4	2.2	2.6	2.6	2.4	2.0	2.3	2.6	2.7	2.5	2.6	2.5	3.1	5.4	0.0	1.1	3.6	6.0	10.1	8.6	1.8	4.0	6.4	5.1	4.3	2.7	1.5	2.6	5.5	29.2	5.3	4.5	2.0	0.0	2.4	0.4	2.8	5.0	4.6	6.6	6.9	7.1	2.7	11.7	3.6	4.1	3.2	0.0	3.5	3.9	3.7	2.8	3.3	7.2	2.5	4.1	1.3	2.7	0.9	2.1	2.8	5.4	6.5	2.7	2.6	2.1	10.1	7.0	2.7	0.8	3.4	4.4	8.7	0.6	2.3	1.3	16.7	0.0	11.6	4.0	8.0	4.0	5.5	9.1	3.3	4.2	3.1	3.1	5.5
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favorable (1.95e-5)"	15.3	18.2	26.3	18.9	26.2	17.5	13.9	26.2	27.2	14.8	25.7	18.4	18.5	14.3	14.2	13.8	16.8	14.6	18.4	26.5	26.6	15.7	21.0	18.4	27.8	26.0	25.5	16.7	11.4	20.5	11.4	18.1	26.4	15.1	18.3	17.0	14.0	18.2	32.7	15.3	19.6	18.1	26.0	30.5	14.9	7.6	28.2	36.0	12.9	29.4	32.7	20.7	13.7	26.9	17.2	25.5	29.9	35.0	39.4	22.3	39.9	14.0	30.3	42.9	33.3	17.9	21.2	22.1	29.0	23.5	18.6	21.0	35.6	22.3	24.0	20.6	21.2	19.1	20.9	18.9	23.0	26.7	25.4	18.3	22.0	31.1	25.1	27.3	40.7	36.8	31.7	23.1	27.2	20.1	41.5	29.2	61.8	37.0	32.9	35.6	23.3	26.9	21.0	26.8	16.9	32.3	25.5	32.8	18.1	42.9	27.5	85.5	24.0	21.5	13.5	13.2	23.1	19.5	26.6	34.3	18.3	25.9	16.7	2.5	2.6	1.4	1.9	2.1	1.1	1.5	1.1	1.3	2.6	1.7	1.2	1.2	4.1	0.9	2.1	2.7	1.3	1.3	26.3	26.2	26.2	27.2	26.5	26.6	26.0	25.5	26.4	26.0	28.2	26.9	13.1	6.4	6.9	3.6	18.0	2.3	0.6	3.1	9.1	3.3	2.7	3.9	1.0	0.0	3.2	3.7	2.1	2.2	14.5	7.1	1.9	2.1	0.4	5.5	8.1	6.0	3.0	5.0	6.3	1.3	4.4	4.6	14.8	5.6	11.4	4.0	1.1	0.4	3.1	5.0	5.4	3.4	6.1	2.1	3.5	0.2	0.3	12.4	5.4	4.7	4.7	1.6	4.1	4.0	5.8	2.3	7.1	0.0	20.0	1.6	7.3	3.1	7.9	3.5	6.6	3.3	4.9	0.5	0.4	8.5	1.8	3.4	9.3	7.7	4.9	1.9
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268962-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	126.7	132.5	188.9	130.4	191.7	177.7	105.4	190.2	192.9	109.3	147.9	120.8	105.3	104.4	51.5	104.6	104.1	66.3	196.6	181.0	180.3	97.8	185.2	102.2	154.9	192.9	185.4	164.5	121.1	109.4	149.1	63.5	187.2	99.8	54.1	90.4	97.9	57.2	359.3	122.0	112.7	52.4	186.4	160.5	104.1	51.7	191.7	101.3	125.8	195.1	96.7	100.2	99.9	183.2	189.2	190.2	93.6	91.1	161.7	81.5	89.2	101.0	119.7	90.4	69.3	87.3	95.5	183.7	157.6	86.3	96.4	56.5	88.6	79.6	45.4	306.4	135.8	107.5	111.1	143.1	97.8	182.5	177.5	71.7	108.3	58.6	89.1	151.3	62.2	119.6	135.3	260.0	70.5	218.8	200.7	69.8	78.7	171.3	61.1	190.9	123.2	171.2	74.8	119.5	159.3	120.7	188.2	200.4	346.7	80.7	81.8	142.4	107.4	150.0	101.0	99.5	134.4	260.0	286.6	199.7	139.4	114.8	201.0	44.5	8.3	11.1	6.8	11.2	8.2	10.2	7.0	9.0	13.4	13.5	6.3	6.0	7.8	11.7	6.9	50.6	13.8	7.7	188.9	191.7	190.2	192.9	181.0	180.3	192.9	185.4	187.2	186.4	191.7	183.2	58.2	6.4	22.4	29.7	72.5	23.7	23.7	18.7	20.5	66.0	42.2	38.4	71.6	35.8	15.5	31.3	33.3	24.2	108.1	50.7	56.7	33.5	1.1	25.6	31.3	36.5	52.1	37.2	19.7	57.8	38.5	32.7	30.5	34.0	20.3	45.7	38.6	50.5	107.0	94.2	16.9	33.6	20.3	66.8	42.9	3.4	32.0	91.9	26.6	28.1	37.8	118.9	35.0	12.1	19.5	36.0	37.1	31.2	63.8	23.1	58.1	51.7	11.0	53.9	13.1	40.9	35.8	9.0	10.6	34.3	24.7	17.5	56.2	52.0	33.0	35.6
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724577-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		170000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	35.0	38.7	13.1	32.3	14.7	13.0	39.0	15.6	19.0	44.3	26.1	33.9	35.6	32.3	64.2	50.1	30.1	32.0	57.4	14.9	16.1	38.7	76.8	30.4	32.5	16.7	14.4	56.9	57.5	37.7	31.5	43.7	16.4	39.9	36.9	39.2	54.7	37.5	219.2	36.2	33.7	35.7	14.9	26.3	40.8	43.1	15.6	30.7	53.4	138.7	39.7	40.2	27.6	19.2	46.8	36.0	49.5	66.7	118.6	155.8	45.5	106.2	129.4	57.2	69.2	36.2	70.4	60.6	64.0	98.0	49.2	52.8	74.9	66.5	85.6	67.2	29.3	41.8	31.4	76.3	93.0	55.8	46.2	89.2	80.6	59.8	116.4	110.6	87.1	41.7	73.7	67.9	85.8	30.9	55.4	29.5	67.9	98.2	21.3	36.3	47.2	49.2	85.5	53.1	39.4	38.3	39.1	82.4	67.3	73.6	60.6	45.1	67.4	52.2	32.2	95.8	40.7	63.6	36.6	29.5	77.6	33.1	63.2	21.9	13.1	11.9	16.4	18.7	22.2	9.8	13.6	15.7	16.8	11.2	13.9	13.8	8.1	22.2	26.9	13.4	15.1	13.7	13.1	14.7	15.6	19.0	14.9	16.1	16.7	14.4	16.4	14.9	15.6	19.2	34.5	60.9	84.5	59.1	43.2	38.0	52.8	59.6	51.2	33.3	35.0	28.4	126.9	28.6	71.7	25.8	43.8	47.9	32.6	32.0	35.2	38.4	11.1	35.7	57.5	36.4	40.1	20.8	70.9	48.6	49.0	62.7	61.2	55.0	48.8	126.2	32.9	62.0	42.8	26.9	68.7	63.7	40.7	38.0	35.1	10.9	78.6	41.3	28.4	60.9	54.8	32.8	45.3	77.4	113.7	48.5	33.4	68.4	106.9	78.2	44.3	50.4	66.4	51.2	39.5	54.0	50.5	73.8	68.2	58.7	40.3	90.6	37.8	36.3	41.9	63.8
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	43.9	37.9	20.0	21.5	21.9	46.6	32.9	29.3	23.9	32.6	27.5	31.2	13.4	26.8	22.9	25.0	34.2	18.7	30.2	21.4	20.6	34.4	30.3	36.1	20.6	22.6	21.3	67.4	44.5	18.1	50.3	26.0	21.5	36.2	15.8	26.3	24.9	13.1	30.3	40.4	26.6	16.3	19.4	30.7	31.2	22.2	21.2	15.1	31.6	11.7	20.5	29.3	29.8	30.1	42.7	50.3	14.6	26.9	30.5	33.7	27.8	34.1	34.5	32.1	21.5	49.2	21.0	54.0	16.9	30.6	34.8	30.6	34.5	25.4	57.0	13.0	52.1	49.4	81.0	51.9	31.3	54.7	26.0	29.5	41.0	45.8	101.6	24.7	28.3	24.1	40.0	55.3	26.8	32.6	50.1	55.1	22.6	31.6	39.9	38.1	31.8	36.3	20.2	44.1	42.8	25.8	24.5	112.5	63.7	31.3	29.2	34.4	24.3	75.2	35.3	44.3	61.1	40.7	17.4	66.1	29.6	41.9	24.0	10.1	3.0	2.4	5.5	4.2	6.5	5.1	5.2	4.8	1.8	4.7	5.7	5.6	4.3	4.5	2.7	9.7	3.8	1.9	20.0	21.9	29.3	23.9	21.4	20.6	22.6	21.3	21.5	19.4	21.2	30.1	27.4	12.8	37.4	23.5	55.9	51.7	28.4	8.2	40.9	33.2	18.1	16.9	14.1	18.6	18.8	14.7	33.3	8.3	66.3	14.4	5.9	10.2	20.7	22.3	24.0	28.4	18.5	14.7	19.0	9.6	11.3	26.6	25.0	42.7	20.3	12.8	12.1	16.5	43.3	26.9	22.5	18.6	10.2	24.5	72.8	8.5	11.8	49.4	30.2	10.3	14.9	13.2	16.5	13.6	19.8	13.2	8.4	12.4	57.1	32.4	7.3	5.0	11.1	32.1	6.6	22.1	23.1	18.4	16.5	24.4	43.3	12.9	73.6	13.1	18.6	22.2
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6 small subunit processome component"	Q9NYH9	17	31860904-31901708	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	17.7	14.3	24.2	7.8	24.3	9.5	15.8	24.9	39.8	21.5	25.4	17.0	4.4	15.3	12.9	17.7	17.1	4.3	17.2	24.2	24.1	21.1	24.4	14.5	11.4	24.0	24.3	20.5	19.1	5.1	19.7	6.4	24.0	22.3	6.4	10.2	13.1	5.7	16.2	17.4	17.1	6.9	23.6	25.7	15.1	18.7	24.5	9.1	18.0	6.3	12.5	16.7	17.0	24.7	14.4	9.0	12.3	7.4	11.9	8.0	15.3	11.8	6.7	17.6	13.6	32.8	7.8	20.9	14.0	11.3	16.7	18.6	16.7	14.1	16.0	4.6	26.4	13.1	21.2	31.6	14.1	19.8	13.5	13.2	15.1	16.7	12.5	16.3	11.4	13.2	23.1	11.9	13.8	11.6	19.4	56.4	16.9	17.2	14.6	20.6	17.8	21.4	19.0	12.9	8.4	12.8	12.5	9.3	22.7	19.4	22.7	39.0	11.5	27.8	20.5	14.3	24.3	13.0	25.9	31.8	18.9	14.4	15.4	15.5	10.6	7.4	7.1	11.3	7.0	12.6	7.7	7.7	14.7	15.2	6.6	7.7	13.7	5.9	11.1	21.3	8.1	7.8	24.2	24.3	24.9	39.8	24.2	24.1	24.0	24.3	24.0	23.6	24.5	24.7	22.5	19.2	24.3	17.9	32.7	25.7	30.7	29.1	12.5	16.7	13.5	16.3	15.6	14.3	31.7	5.5	8.4	42.4	34.3	10.6	9.8	29.7	35.6	23.4	29.0	21.1	5.4	29.5	23.0	24.0	50.3	26.2	16.3	33.5	36.2	20.5	12.1	15.6	35.8	11.8	21.4	16.3	20.3	21.0	17.6	5.4	18.6	29.4	8.8	18.7	43.4	16.4	7.2	17.6	16.2	26.3	8.4	17.0	17.4	31.9	12.7	18.5	30.3	16.4	6.6	28.2	23.7	102.9	66.2	17.2	26.0	38.3	19.9	21.0	16.7	31.2
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"VAC14 component of PIKFYVE complex"	Q08AM6	16	70687439-70801160	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	17.3	25.0	20.6	14.5	19.3	11.3	17.1	19.5	24.7	16.2	18.0	16.7	12.1	16.9	8.6	19.0	15.1	10.2	20.3	20.8	20.5	26.3	27.1	16.9	24.7	21.5	20.0	14.3	23.7	17.5	16.6	10.9	21.4	17.5	8.3	6.8	17.4	10.7	24.3	23.0	17.9	11.5	19.2	22.5	20.7	16.2	21.6	15.5	21.4	12.0	13.9	18.1	14.9	21.6	25.9	25.3	21.0	23.6	29.9	20.3	32.0	18.5	29.0	34.6	15.5	31.6	41.0	33.3	23.3	22.5	39.9	32.3	27.8	30.1	16.3	10.0	28.2	16.9	18.6	39.5	76.8	29.1	33.7	36.0	30.9	50.7	45.1	20.7	33.0	29.2	30.1	14.6	30.1	37.3	27.1	48.5	36.9	20.4	22.7	32.3	14.9	48.6	16.7	17.4	24.9	26.7	60.9	18.5	43.0	15.2	27.4	27.0	26.7	45.7	25.9	29.2	20.4	20.4	27.5	62.9	76.1	25.1	21.3	0.8	2.7	4.4	1.5	3.6	1.4	2.5	2.2	3.1	5.6	3.9	2.0	1.8	1.0	2.4	3.6	3.1	1.3	1.1	20.6	19.3	19.5	24.7	20.8	20.5	21.5	20.0	21.4	19.2	21.6	21.6	5.1	3.2	4.2	15.0	10.1	4.2	7.8	7.0	9.6	8.4	8.4	7.4	12.6	12.8	8.0	3.7	2.1	16.7	4.0	11.5	5.9	19.2	20.4	14.2	5.4	8.2	9.1	5.7	11.7	22.5	29.2	5.9	11.7	6.7	5.7	11.6	16.4	15.9	42.9	10.1	13.8	10.0	14.2	18.3	13.5	74.4	6.2	15.6	10.6	10.3	19.2	6.8	8.2	8.5	16.3	20.8	10.8	3.4	15.8	8.9	13.7	15.0	14.6	7.7	6.6	5.9	7.9	4.8	13.5	10.3	9.1	19.6	6.5	8.7	12.6	7.1
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914016-9960021	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		580000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	33.1	67.1	21.5	24.2	26.8	97.1	29.5	30.7	28.1	30.2	21.5	38.6	31.2	32.9	24.8	47.5	29.3	31.9	37.5	23.2	24.9	32.6	36.6	33.9	25.7	34.9	26.3	39.1	40.9	36.2	17.7	29.8	34.5	24.5	35.4	20.1	32.6	22.0	69.7	32.3	30.6	27.4	27.8	26.7	38.9	29.1	25.5	30.0	35.2	38.4	26.3	36.5	32.2	30.7	58.1	34.4	40.7	26.7	46.9	50.5	56.8	69.9	57.9	62.3	67.9	46.6	55.9	56.5	63.6	61.5	53.9	39.7	39.8	66.7	70.7	35.6	49.8	92.4	33.8	72.3	110.8	126.3	169.7	47.8	66.3	59.0	69.6	48.7	64.0	45.4	94.6	57.3	55.2	31.2	97.4	72.9	26.2	197.6	54.3	50.4	55.2	77.5	60.9	57.3	57.2	31.2	81.1	48.7	53.2	37.2	45.7	64.2	68.9	100.7	75.3	105.6	86.3	101.9	89.2	66.6	57.0	53.5	70.8	131.3	143.3	251.0	69.8	127.9	82.9	100.0	72.1	75.4	118.1	94.4	78.1	72.1	226.2	90.8	109.5	84.6	98.9	183.9	21.5	26.8	30.7	28.1	23.2	24.9	34.9	26.3	34.5	27.8	25.5	30.7	173.6	128.2	178.8	63.0	160.0	673.4	358.4	356.5	278.3	113.9	248.2	179.3	218.3	167.3	229.4	207.8	62.6	296.9	148.0	427.2	457.8	291.8	10.5	235.9	182.2	232.4	144.6	188.1	91.4	361.3	321.6	221.4	156.0	255.8	225.2	220.2	211.3	141.1	287.8	136.3	93.2	180.6	390.6	288.2	459.8	21.7	182.0	285.9	279.3	63.7	350.4	124.3	108.1	102.1	150.4	310.2	262.7	216.3	146.6	335.4	255.9	390.4	265.5	79.5	190.7	204.8	371.4	231.3	201.4	267.3	622.5	452.6	190.2	253.6	201.0	390.8
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389229-58451101	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		240000	"Cluster 32: T-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	15.7	36.4	32.1	11.2	30.4	4.2	14.2	29.6	30.1	13.7	20.3	24.2	19.6	16.4	10.3	19.3	14.9	9.7	29.4	28.8	33.5	24.8	35.0	14.1	9.6	34.6	34.0	17.9	18.9	27.9	21.0	9.2	36.2	17.8	9.9	14.3	16.2	12.3	46.4	13.0	18.2	11.6	36.4	15.0	19.0	8.8	37.0	12.2	23.3	39.6	6.7	18.1	12.9	31.5	31.0	30.4	33.6	18.0	30.3	12.5	29.5	27.0	11.2	41.0	20.1	123.0	29.0	27.2	37.7	18.3	32.3	57.6	27.1	38.9	24.6	12.8	20.2	16.5	32.2	38.9	30.2	15.5	19.8	28.9	44.4	22.8	18.7	19.8	20.5	26.7	39.5	14.9	20.0	96.7	24.5	30.6	17.7	60.2	40.0	24.2	31.3	18.0	31.6	40.7	47.1	32.6	44.7	117.0	48.0	18.4	48.0	23.2	28.6	65.8	31.9	33.3	36.9	19.9	23.1	31.4	55.7	16.8	33.8	2.1	2.3	3.1	3.9	2.4	4.5	2.8	4.6	3.2	2.3	2.3	3.3	4.8	3.7	3.7	3.0	2.3	2.7	2.6	32.1	30.4	29.6	30.1	28.8	33.5	34.6	34.0	36.2	36.4	37.0	31.5	22.5	44.8	26.8	31.6	18.7	11.7	13.5	17.2	23.9	29.7	23.6	21.1	46.5	24.3	16.6	31.3	29.2	34.8	20.7	28.6	35.2	35.1	5.0	18.2	20.9	23.2	21.7	18.7	34.3	30.5	50.3	24.0	20.4	16.0	9.5	23.3	15.7	40.3	16.1	35.3	34.7	23.4	22.4	18.5	10.0	6.1	18.6	17.3	14.2	40.3	22.8	34.3	20.6	35.2	43.7	37.5	22.4	25.2	14.0	17.7	38.9	42.9	19.1	29.7	13.1	22.2	26.0	22.0	29.4	18.2	10.5	44.5	20.5	37.4	27.6	16.6
VARS1	"VARS, VARS2"	ENSG00000204394	"Valyl-tRNA synthetase 1"	P26640	6	31777518-31795752	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"U-266/84: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		110000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	22.2	24.6	2.0	6.6	1.6	3.2	21.9	0.4	2.4	20.1	0.0	21.0	5.6	29.4	0.9	32.5	22.1	1.1	20.0	0.7	2.3	19.2	29.3	19.8	3.0	2.4	1.9	19.7	37.3	2.5	33.6	2.2	2.2	17.6	1.7	1.3	20.6	1.2	58.2	34.3	21.9	3.5	0.8	30.0	23.3	63.6	2.6	3.0	18.5	3.1	2.8	23.5	20.7	1.5	36.2	11.6	12.4	36.9	9.1	8.5	84.0	52.2	10.8	25.2	13.3	11.5	9.9	58.3	60.2	18.4	18.9	22.0	33.5	32.4	8.8	46.0	74.0	31.7	18.4	21.3	18.3	75.7	60.6	12.5	8.2	14.8	16.5	6.2	13.5	22.9	92.2	48.8	12.7	13.2	51.0	16.2	35.0	11.9	32.5	55.5	20.5	132.7	13.0	12.4	42.1	26.2	12.0	31.0	19.5	5.8	23.2	34.0	31.2	24.2	37.8	28.2	72.5	87.9	140.4	44.1	14.6	31.1	29.0	0.0	0.3	0.1	0.2	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0.3	0.1	0.1	0.5	0.3	0.6	0.1	0.5	2.0	1.6	0.4	2.4	0.7	2.3	2.4	1.9	2.2	0.8	2.6	1.5	4.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	23.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	48.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	16.6	0.4	0.0	0.0	0.0
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 339.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 568.3;hTERT-RPE1: 547.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		750000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	85.8	19.1	9.9	52.2	10.6	41.5	45.3	8.4	11.3	73.9	33.4	180.3	35.3	167.6	45.9	92.2	75.9	69.4	132.2	10.5	11.3	37.2	24.1	68.7	18.7	10.3	10.3	45.2	40.3	51.3	13.8	88.6	13.3	131.7	73.1	12.5	31.6	151.9	136.9	37.9	52.7	224.7	9.9	41.9	63.5	41.3	12.1	12.8	39.6	144.1	23.9	135.7	56.3	8.4	147.2	97.0	174.2	123.8	213.2	246.2	95.8	188.5	568.3	126.3	141.9	88.4	124.0	6.5	153.1	331.6	86.3	183.3	115.7	95.0	132.5	12.3	49.6	69.4	92.2	37.2	116.5	14.1	101.8	205.0	25.0	171.5	154.8	547.4	171.0	11.6	50.7	14.3	213.1	25.2	2.0	16.6	82.8	69.9	342.4	24.0	90.9	18.6	180.4	185.8	6.5	25.8	104.7	117.2	53.9	152.8	54.5	21.2	230.9	136.9	57.0	67.0	179.4	2.6	6.0	28.4	160.0	38.9	39.7	15.0	13.6	36.2	14.9	17.1	10.4	5.6	7.1	7.8	20.7	2.3	2.6	5.3	11.2	4.4	19.0	8.0	1.9	28.3	9.9	10.6	8.4	11.3	10.5	11.3	10.3	10.3	13.3	9.9	12.1	8.4	68.0	99.3	39.7	56.5	13.4	114.7	161.4	68.4	30.7	13.4	39.4	58.5	339.5	37.1	79.8	42.3	85.5	51.5	46.7	91.2	3.9	60.8	5.0	98.2	152.6	60.4	38.3	5.9	63.2	61.6	78.6	74.4	66.3	149.1	35.4	45.5	56.7	34.4	23.6	16.8	47.5	44.5	22.4	31.9	51.0	7.5	50.1	77.9	26.6	55.3	44.7	9.7	61.8	18.6	4.6	125.5	48.3	76.8	8.0	100.1	13.7	14.8	37.7	34.5	105.2	49.6	179.9	18.6	13.7	45.6	93.1	39.7	18.3	44.5	48.7	94.8
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VEZF1	"DB1, ZNF161"	ENSG00000136451	"Vascular endothelial zinc finger 1"	Q14119	17	57971547-57988259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027520, HPA048315"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA027520: AB_10602680, HPA048315: AB_2680353"	"unprognostic (7.24e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.14e-5)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.03e-2)"	22.1	29.1	20.8	18.7	33.4	56.6	24.0	26.7	23.9	30.9	26.0	40.7	19.1	37.6	16.0	24.8	37.7	25.0	29.2	20.4	25.9	26.2	16.6	28.5	21.9	32.1	28.6	32.1	25.7	24.8	20.5	26.3	31.0	29.3	23.1	70.5	27.5	27.2	65.7	16.0	24.3	33.0	24.3	23.9	26.0	18.9	27.5	34.9	37.4	44.5	20.2	32.7	24.2	47.3	42.5	48.1	93.8	30.1	22.9	32.4	28.9	35.1	50.9	44.7	41.0	22.9	44.4	20.6	55.3	40.3	41.6	23.7	38.1	40.7	60.3	58.2	23.7	41.7	39.5	25.6	27.1	36.0	33.6	23.0	47.6	29.9	52.1	59.3	42.2	29.5	30.9	28.9	44.2	15.3	58.0	20.0	30.5	38.4	48.7	43.4	68.9	16.9	25.6	40.9	36.6	63.2	32.3	15.3	51.8	39.3	90.3	33.1	40.2	59.7	59.3	37.5	56.1	30.9	26.3	33.9	40.5	30.4	76.3	31.6	15.2	30.1	17.9	19.0	18.0	12.8	13.8	19.3	18.6	14.3	18.0	16.2	25.2	30.7	33.9	17.2	14.3	16.4	20.8	33.4	26.7	23.9	20.4	25.9	32.1	28.6	31.0	24.3	27.5	47.3	44.4	83.3	60.9	29.0	32.2	36.2	39.5	25.8	70.0	73.6	42.6	37.6	111.0	40.0	41.5	25.8	66.7	16.3	49.5	24.9	25.4	36.2	28.9	73.5	41.4	44.6	49.0	23.8	8.1	36.5	19.2	48.6	23.4	64.3	57.0	44.4	34.2	18.3	22.6	33.7	14.5	29.7	24.4	34.9	48.5	36.6	36.1	36.5	42.7	19.7	39.4	44.5	34.0	43.2	81.9	30.9	21.1	27.8	20.2	48.3	21.1	23.8	63.0	65.7	52.6	102.8	60.5	42.1	24.5	36.0	21.0	19.8	34.3	21.8	26.7	35.3
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141778-10153667	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 146.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031631, HPA031632, HPA068954"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: "	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	14.0	13.7	11.5	21.1	11.0	27.9	14.7	13.6	12.1	11.8	6.7	14.8	15.7	14.1	9.8	12.3	13.4	11.5	7.9	11.8	14.9	12.6	14.1	11.8	29.6	9.4	9.4	12.6	12.7	11.7	9.0	14.1	9.3	14.0	15.7	8.9	14.5	10.2	11.4	14.2	17.2	12.8	9.6	22.5	16.0	13.4	16.6	23.4	15.8	7.7	29.7	12.5	10.9	12.5	19.5	18.2	39.9	24.6	36.0	27.7	146.5	16.8	24.0	21.1	24.5	21.5	23.7	67.9	22.2	23.0	29.9	16.4	37.2	23.6	25.7	33.0	33.7	52.7	30.5	30.6	34.3	47.3	41.3	28.1	26.3	28.0	35.1	28.4	24.6	42.5	48.3	50.3	21.1	35.0	45.5	40.9	26.7	21.1	23.4	57.3	34.6	34.6	25.5	48.7	15.0	49.4	35.0	18.7	21.0	23.9	37.0	59.1	21.3	20.8	27.7	19.6	26.8	35.7	78.1	105.6	23.2	55.3	19.4	4.6	3.2	2.3	2.6	2.2	1.9	2.5	1.8	2.2	2.0	3.3	1.7	1.8	5.6	3.0	2.0	2.3	1.7	1.2	11.5	11.0	13.6	12.1	11.8	14.9	9.4	9.4	9.3	9.6	16.6	12.5	12.4	12.8	12.5	9.1	38.7	14.7	17.8	14.3	24.5	14.7	10.7	6.1	6.1	20.0	9.6	16.5	18.8	16.8	21.9	10.7	7.9	11.8	9.6	13.1	26.1	14.8	14.4	30.5	15.9	5.1	18.7	12.8	20.9	19.9	5.1	18.4	18.9	14.3	14.9	18.5	14.2	11.3	16.2	27.1	45.8	7.3	14.0	32.3	12.4	7.5	31.9	9.1	28.8	12.1	14.9	10.7	11.7	11.3	33.3	23.8	12.3	9.5	9.7	15.3	6.6	17.4	11.9	15.4	24.0	26.7	20.5	17.2	23.5	21.4	10.2	25.9
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419121-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 436.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 56.4;stomach cancer: 23.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	97	"CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		6800	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.6	1.1	0.0	10.3	0.1	0.3	0.8	0.3	0.2	0.7	0.0	175.9	395.0	0.5	0.0	0.9	0.7	28.1	1.0	0.0	0.0	25.9	31.4	0.7	0.3	0.0	0.0	1.1	29.4	0.0	1.4	0.3	0.0	1.0	184.0	0.0	0.6	0.4	0.4	1.1	436.3	8.1	0.0	1.2	6.9	2.0	0.0	0.0	0.6	0.0	0.0	0.8	0.9	0.1	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	762.5	0.5	0.1	5.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	365.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	1.7	0.8	321.9	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	0.8	0.4	0.1	0.0	1.8	0.3	0.6	0.5	24.3	0.1	0.0	2.1	0.3	0.8	243.8	3.9	12.3	1.9	1.3	0.9	0.4	113.6	3.2	0.7	42.9	0.2	0.8	6.6	1.6	8.9	0.3	0.7	32.6	0.1	1.7	0.5	143.6	0.0	2.2	1.5	0.5	0.0	5.1	0.0	0.0	0.2	0.5	0.0	0.0	0.3	10.9	216.2	0.0	0.3	0.9	558.5	35.1	0.0	1.2	0.0	1.7	0.7	0.8	0.8	0.6	0.9	0.3	1.5	0.0	161.8	0.3
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69174412	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		41000	"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	37.0	27.1	23.6	24.4	25.9	36.2	32.9	27.6	32.3	26.9	23.7	32.1	24.8	26.8	22.1	41.7	22.7	22.7	22.0	24.3	25.9	34.0	30.4	27.5	23.3	26.0	25.9	25.8	23.8	38.1	12.0	39.9	25.6	24.6	32.3	19.6	26.1	20.9	33.4	37.3	25.5	25.7	26.7	23.1	24.1	42.7	24.9	27.8	29.9	31.3	27.9	33.0	29.9	29.0	113.1	42.5	51.7	87.1	80.8	73.8	46.1	66.3	106.0	79.7	90.1	91.8	110.9	34.3	53.1	72.3	78.2	75.9	73.1	63.5	108.5	31.3	38.7	54.0	36.7	52.2	104.9	80.6	39.4	66.3	90.8	79.8	161.5	99.8	81.9	40.8	104.7	46.0	119.2	35.8	35.8	86.4	34.0	51.9	97.9	44.2	85.0	40.4	86.6	68.3	30.5	45.5	89.3	119.5	117.6	44.5	50.3	62.9	97.9	53.0	69.7	91.7	83.8	28.0	74.4	57.4	71.2	123.6	27.8	54.6	39.6	38.6	40.8	46.6	37.4	26.3	30.7	42.2	44.8	20.0	26.7	37.7	38.1	54.6	40.9	17.7	38.3	44.4	23.6	25.9	27.6	32.3	24.3	25.9	26.0	25.9	25.6	26.7	24.9	29.0	49.0	73.7	56.6	21.5	40.6	120.7	83.4	79.6	60.3	24.4	43.0	34.8	44.2	40.0	75.2	40.5	14.6	117.1	59.2	47.3	80.3	69.3	59.4	29.8	42.2	52.7	16.2	58.3	29.4	53.4	87.8	57.4	30.5	42.0	45.5	32.4	35.3	29.4	85.8	20.2	30.3	38.3	85.5	53.2	108.7	29.6	42.3	66.0	62.2	28.1	62.4	63.2	52.5	21.6	39.8	65.7	43.3	44.8	28.2	65.2	30.5	80.6	45.5	27.4	13.1	48.0	61.9	89.3	73.7	57.5	107.0	243.7	59.5	38.2	44.4	77.6
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54 subunit of GARP complex"	Q9P1Q0	2	63892146-64019428	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	11.7	11.5	8.1	10.6	9.7	15.0	14.5	13.5	9.6	13.5	10.9	11.6	13.0	14.4	12.3	10.8	12.4	10.4	8.4	7.8	8.5	16.0	14.4	13.1	11.1	8.8	8.7	14.6	17.0	28.3	13.0	13.5	8.9	17.4	13.4	17.3	36.8	12.8	9.3	10.9	12.2	12.8	8.5	12.9	14.4	13.4	8.5	13.2	17.7	9.9	11.2	10.9	9.8	11.0	23.3	11.9	22.5	17.4	15.7	17.1	16.6	14.3	21.4	15.0	14.9	22.0	14.9	15.8	10.5	20.1	22.3	10.7	22.1	12.9	27.1	23.0	15.9	14.7	10.0	38.9	15.0	10.3	6.2	16.3	19.8	10.5	22.7	18.0	23.0	11.3	16.6	13.4	19.4	10.1	10.9	11.5	13.8	22.9	9.1	10.8	21.8	9.0	17.1	13.1	13.1	19.6	12.8	16.3	17.8	17.3	11.9	20.6	16.8	19.3	15.3	11.8	23.9	30.8	8.7	20.4	14.3	20.5	16.4	1.0	0.7	0.3	0.5	0.6	0.5	0.6	0.4	0.5	0.4	0.7	0.6	0.5	0.6	0.7	0.5	0.6	0.9	0.2	8.1	9.7	13.5	9.6	7.8	8.5	8.8	8.7	8.9	8.5	8.5	11.0	16.6	16.0	22.3	62.7	5.2	11.1	8.7	6.4	3.4	20.9	11.8	9.8	14.3	15.7	14.2	1.8	12.5	6.5	6.4	11.1	1.9	6.8	53.9	9.3	16.6	13.4	13.2	2.1	71.6	13.2	6.8	11.8	15.8	11.0	2.5	15.2	10.8	15.4	8.1	23.5	81.8	17.4	2.0	9.8	9.3	37.4	18.6	12.2	5.4	76.8	9.6	9.4	3.1	105.6	108.9	11.3	12.8	12.4	7.7	17.3	11.6	9.9	10.6	16.2	19.7	13.4	12.8	14.9	8.3	9.4	10.4	5.5	7.5	15.9	12.9	13.8
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647085-67674820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	53.8	26.9	55.5	20.4	56.8	22.3	39.8	54.4	102.1	22.7	49.8	42.9	28.3	18.4	53.5	44.3	18.5	28.7	60.1	56.6	58.1	53.0	41.6	26.8	23.8	55.1	56.6	21.0	44.0	23.9	17.1	21.3	56.8	22.3	35.2	23.0	30.1	13.6	46.5	31.0	24.1	22.4	56.0	26.5	40.0	30.8	56.3	12.1	34.0	28.2	27.0	33.3	23.4	56.9	111.7	54.8	31.4	18.1	61.9	37.2	45.4	48.1	30.5	23.8	23.7	27.3	38.5	32.9	40.2	54.5	27.5	30.6	36.8	36.6	37.7	34.3	22.6	33.4	32.5	34.8	26.6	20.9	22.9	36.3	39.6	25.6	26.1	60.5	27.2	23.1	22.2	25.4	34.5	131.1	26.6	77.7	20.3	76.6	88.0	31.8	35.6	12.2	35.1	65.0	17.4	35.5	33.8	45.5	71.4	23.7	41.9	58.0	38.5	62.6	93.8	51.4	45.6	23.8	27.8	53.2	52.9	38.9	29.0	88.8	61.5	143.8	49.4	80.4	42.4	49.0	43.1	51.1	59.6	43.0	40.5	50.3	27.2	56.4	70.2	38.6	60.2	58.3	55.5	56.8	54.4	102.1	56.6	58.1	55.1	56.6	56.8	56.0	56.3	56.9	47.6	25.6	35.0	13.1	48.7	42.3	61.4	91.7	33.0	23.2	82.2	65.4	30.5	67.2	64.4	66.2	22.9	107.4	47.5	138.2	217.2	109.1	141.7	58.5	43.2	51.5	46.6	102.7	15.8	131.4	167.9	51.6	40.8	49.5	64.0	43.6	73.9	95.3	131.4	15.2	18.2	96.0	50.8	99.8	49.2	493.5	41.7	80.9	71.2	11.2	121.6	65.4	78.2	13.6	17.1	130.7	119.4	39.9	51.0	120.5	165.4	268.6	55.3	44.8	19.7	36.5	58.2	104.5	57.2	58.2	52.8	125.9	46.8	35.5	91.9	124.6
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115404-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"granulocytes: 563.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 57.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	17.2	24.9	18.7	12.8	16.1	3.1	24.2	12.8	19.4	22.4	14.3	37.9	26.5	13.9	25.3	15.0	15.0	31.1	6.8	16.9	44.0	21.7	6.4	30.8	12.2	21.3	25.6	10.2	20.7	4.4	37.4	10.2	27.9	17.8	43.3	11.9	30.0	19.2	4.3	28.5	36.6	16.0	17.0	8.3	28.2	9.6	47.1	8.0	11.5	12.3	14.6	22.8	12.6	16.2	0.0	0.6	7.6	0.5	7.9	7.4	2.8	1.1	0.6	0.6	0.3	0.4	59.7	0.0	7.2	1.3	10.3	0.4	1.5	13.6	0.0	20.9	0.2	44.1	10.5	1.4	32.1	0.6	19.8	21.8	1.5	1.3	4.4	2.9	39.5	5.8	2.4	7.3	2.4	0.2	0.9	0.7	11.9	0.0	1.5	0.0	26.2	0.3	43.0	0.5	6.7	0.7	1.1	0.4	2.1	17.3	5.4	1.9	1.0	0.2	5.5	0.3	0.0	2.7	2.5	0.0	24.1	0.9	0.4	57.8	7.9	0.9	4.7	5.5	1.1	7.1	5.0	2.7	8.0	3.8	6.3	4.1	0.6	8.1	9.3	4.3	12.7	6.1	18.7	16.1	12.8	19.4	16.9	44.0	21.3	25.6	27.9	17.0	47.1	16.2	5.0	9.6	28.3	4.6	1.3	17.2	14.6	14.9	4.6	3.8	12.6	8.8	2.6	5.7	33.2	33.1	2.1	7.9	2.0	25.0	9.8	27.8	50.6	11.5	4.8	4.3	15.0	3.4	4.0	28.1	2.5	11.4	17.3	7.6	563.0	3.8	3.9	3.2	35.7	32.0	17.1	22.3	30.5	6.6	7.2	6.0	2.8	6.7	5.4	1.9	3.6	14.3	3.1	8.0	2.6	17.7	16.8	0.4	2.5	6.5	50.6	15.1	59.1	1.4	0.0	9.5	5.7	0.7	4.1	4.8	12.5	1.9	9.4	5.9	23.7	13.6
WAC	"BM-016, FLJ31290, MGC10753, PRO1741, Wwp4"	ENSG00000095787	"WW domain containing adaptor with coiled-coil"	Q9BTA9	10	28532493-28623112	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036528, HPA042609, HPA074604"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: "	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.27e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.36e-1)"	53.2	39.9	18.4	30.8	24.3	51.6	48.9	45.2	22.0	49.4	17.9	66.3	27.3	50.3	16.7	45.9	47.1	23.7	44.8	19.6	20.5	38.1	35.9	50.4	31.6	19.2	21.9	53.1	39.5	34.0	36.9	31.6	19.6	40.6	23.2	34.5	44.2	25.6	55.1	50.2	47.4	25.0	19.1	45.6	45.8	37.3	21.8	45.8	43.7	34.0	28.4	54.9	46.7	26.3	72.4	45.2	65.5	51.1	40.7	31.4	59.9	58.2	33.1	60.9	50.5	68.7	73.2	71.8	42.8	46.6	44.6	63.1	51.5	46.8	55.1	92.1	54.0	89.0	40.6	41.2	51.2	39.9	66.7	33.0	57.7	65.6	46.7	38.4	44.4	65.8	76.8	69.9	38.4	60.0	87.8	24.6	41.9	48.1	21.4	71.8	109.3	56.2	29.3	36.1	60.1	56.8	50.7	57.4	78.2	40.6	45.8	56.1	47.9	38.5	64.3	40.1	52.8	40.8	44.4	82.6	47.8	70.5	38.8	13.7	10.7	9.2	10.5	15.0	10.5	12.7	8.7	12.7	11.2	12.3	10.3	9.2	13.0	13.4	14.3	7.3	9.2	8.5	18.4	24.3	45.2	22.0	19.6	20.5	19.2	21.9	19.6	19.1	21.8	26.3	110.8	93.0	75.1	114.6	94.1	176.0	94.6	44.2	105.9	114.5	95.8	78.9	109.6	81.5	52.9	40.5	95.9	59.2	115.7	77.1	31.3	47.0	99.8	92.9	107.4	92.8	69.5	97.8	117.8	47.6	61.5	86.4	58.6	142.4	55.8	94.1	75.3	61.4	53.6	107.7	107.1	86.2	44.7	111.5	154.8	123.6	83.0	107.2	76.5	138.7	92.1	68.4	87.6	142.7	180.9	55.0	68.5	82.8	86.0	128.5	73.2	59.4	45.5	92.4	59.2	113.5	85.1	85.9	59.2	80.5	184.1	99.1	100.4	83.4	71.6	134.5
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169130	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045666: AB_2679411, HPA046737: AB_2679778"	"unprognostic (2.68e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	22.4	21.1	9.4	30.9	13.8	23.8	20.8	13.8	12.2	20.7	11.8	16.1	15.3	20.1	19.9	15.1	13.1	22.6	14.3	9.1	13.8	23.5	29.7	20.2	44.0	17.8	13.0	22.8	18.3	20.4	8.5	30.5	18.4	19.2	18.4	15.4	16.1	15.8	12.2	31.2	18.4	19.8	15.2	32.9	17.9	12.1	14.5	18.0	22.1	14.2	39.5	17.6	12.6	22.1	24.0	28.2	24.6	18.2	56.3	56.6	29.5	36.5	41.5	41.7	38.0	20.2	13.5	53.4	19.8	61.0	26.5	21.9	21.5	22.3	33.5	19.2	15.3	11.1	25.6	16.8	38.4	30.9	20.5	45.7	25.7	37.3	30.4	45.1	68.7	18.1	22.1	18.6	45.9	12.1	17.1	32.6	30.1	16.8	23.5	32.7	32.8	16.6	55.6	27.5	15.4	19.0	37.7	26.4	37.9	31.0	19.6	32.9	84.1	49.8	13.6	32.1	23.9	23.3	23.9	42.7	35.4	26.1	51.4	21.3	15.1	9.2	3.0	18.4	4.4	16.2	4.7	4.1	11.9	12.9	4.9	4.7	16.7	8.0	34.2	5.8	3.5	6.9	9.4	13.8	13.8	12.2	9.1	13.8	17.8	13.0	18.4	15.2	14.5	22.1	37.5	35.3	24.3	0.0	25.3	0.0	0.0	0.0	0.0	0.0	16.4	11.0	0.0	0.0	11.8	44.1	0.0	24.1	17.5	0.0	19.6	25.8	0.0	23.8	48.3	18.0	0.0	0.0	0.0	22.1	28.0	14.6	0.0	31.7	26.5	30.7	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	24.2	0.0	0.0	5.2	0.0	0.0	41.8	17.5	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	32.0	8.9	29.1	0.0	0.0
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091819	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322"	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	18.1	18.6	10.5	18.5	16.9	21.3	19.6	14.9	13.2	17.2	16.5	18.5	18.1	16.2	15.7	16.6	13.3	17.8	16.1	11.1	12.5	22.9	18.5	17.1	19.6	14.7	13.7	15.6	13.0	24.8	9.5	21.2	14.6	17.4	20.1	11.4	14.3	16.1	15.9	13.6	14.7	20.2	14.0	19.3	16.1	9.5	13.8	21.8	23.3	18.5	21.0	21.1	10.3	24.7	40.0	45.4	24.9	30.6	55.3	58.8	16.3	42.0	63.6	43.0	45.8	17.0	42.1	36.1	29.1	54.1	25.3	30.6	40.2	37.7	56.8	47.5	23.1	48.1	26.5	22.8	53.8	14.8	46.6	58.7	25.1	35.5	31.2	33.2	49.9	30.9	28.3	35.6	53.0	87.6	44.3	11.8	23.7	66.7	46.7	29.8	22.4	36.7	33.2	48.5	13.1	26.3	48.8	109.2	39.5	25.8	47.3	25.5	44.7	23.6	51.9	39.4	37.7	31.7	31.2	31.7	62.4	27.5	33.4	10.4	17.0	12.5	13.5	20.9	14.3	9.5	12.8	13.9	19.7	10.6	10.1	14.3	5.8	17.2	29.3	7.2	16.9	13.0	10.5	16.9	14.9	13.2	11.1	12.5	14.7	13.7	14.6	14.0	13.8	24.7	10.9	3.2	19.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	14.4	9.3	0.0	0.0	5.0	11.0	0.0	13.4	6.9	0.0	5.9	12.2	0.0	9.9	13.5	4.9	0.0	0.0	0.0	17.2	11.0	5.4	0.0	14.8	8.8	11.1	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	16.2	0.0	0.0	1.9	0.0	0.0	17.2	4.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	12.3	3.8	9.6	0.0	0.0
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938949-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 15.5;Spermatocytes: 15.0;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	1.3	0.8	0.5	3.8	1.0	7.2	2.2	0.9	0.9	1.2	0.1	2.8	1.8	2.1	0.6	2.4	1.6	1.3	0.9	0.7	0.2	1.1	1.2	1.3	5.5	0.2	0.2	1.4	0.9	1.5	0.3	2.8	0.2	1.0	4.0	1.8	0.7	0.8	0.6	2.0	1.7	2.6	0.3	1.7	1.6	5.3	0.4	8.0	0.9	0.8	6.7	1.7	1.1	0.9	39.6	24.7	48.4	21.4	4.6	11.2	28.1	37.5	16.1	29.6	36.0	16.6	25.9	44.9	18.6	10.8	21.4	32.8	72.9	21.5	61.7	30.0	12.7	29.8	23.7	16.2	1.9	56.7	21.8	5.9	3.8	36.6	14.3	7.1	19.6	28.8	37.8	22.0	28.7	21.7	53.5	11.1	38.6	21.1	25.7	49.5	69.7	17.3	8.4	26.0	28.1	19.8	39.8	10.0	12.8	35.1	26.8	11.3	12.8	37.3	43.9	27.5	32.1	6.5	14.4	58.8	17.1	27.4	30.0	1.7	0.3	0.6	0.9	0.2	1.2	1.2	1.0	1.3	0.5	1.8	1.3	1.8	0.4	2.0	0.4	0.7	1.6	0.6	0.5	1.0	0.9	0.9	0.7	0.2	0.2	0.2	0.2	0.3	0.4	0.9	2.3	0.0	2.0	3.9	5.1	3.8	2.2	3.5	3.4	2.9	1.8	1.9	1.7	0.0	4.0	3.7	0.0	8.7	3.6	1.8	0.0	1.8	0.8	1.9	3.1	2.0	0.0	15.5	10.3	1.0	8.4	3.4	2.6	2.5	0.0	12.4	0.7	0.9	4.1	3.3	6.5	2.4	6.1	2.1	1.2	1.1	0.0	2.4	1.8	5.6	1.4	1.4	2.1	4.5	10.1	1.1	0.3	3.0	7.8	0.6	0.5	6.2	3.5	3.1	0.0	2.4	3.0	15.0	19.3	6.1	2.4	2.6	3.6	2.8	5.2	1.7
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385146-224437033	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	33.7	28.3	21.9	32.1	21.3	88.9	26.7	20.0	22.0	28.9	27.5	28.9	21.2	26.5	20.8	52.1	22.7	27.1	28.0	23.4	22.8	23.7	35.4	35.1	33.8	21.5	22.0	24.3	24.4	26.4	20.6	35.6	20.2	26.1	25.4	31.5	28.7	25.0	57.1	40.9	26.5	28.6	18.8	38.2	26.7	37.4	22.1	36.0	26.0	45.0	33.2	32.6	31.5	21.9	49.7	28.0	54.6	29.7	76.8	74.6	47.6	58.4	86.4	51.7	48.0	39.0	46.8	51.9	74.4	86.3	21.7	40.6	40.2	47.2	76.1	55.3	53.6	36.2	31.5	31.0	74.7	40.3	68.6	70.8	58.4	55.0	52.1	72.6	80.8	31.7	52.7	51.4	62.4	24.8	42.4	34.7	65.7	41.5	32.0	42.6	66.1	44.2	55.1	48.3	29.5	56.0	64.8	94.9	74.9	55.5	117.5	67.0	88.7	47.7	28.7	41.5	71.3	66.8	33.6	35.2	53.3	26.1	66.8	2.1	1.0	2.1	1.4	1.4	0.8	0.8	0.8	1.0	0.9	0.6	0.7	1.0	4.8	1.5	2.4	1.0	1.1	0.8	21.9	21.3	20.0	22.0	23.4	22.8	21.5	22.0	20.2	18.8	22.1	21.9	32.6	105.8	54.2	55.2	34.4	111.4	29.6	30.9	43.3	24.6	54.1	30.5	49.2	40.0	48.2	35.0	31.3	30.4	54.3	34.8	5.9	22.2	243.3	60.6	35.2	44.2	35.4	53.7	63.4	23.8	15.7	37.9	26.5	71.0	48.1	34.1	41.4	44.2	53.4	38.7	61.3	44.4	40.7	133.4	96.4	102.1	37.0	74.5	46.2	67.5	45.7	16.3	32.0	63.3	70.0	34.2	26.2	28.2	33.0	49.0	19.2	22.8	55.4	24.2	19.7	35.2	41.4	37.1	25.8	63.9	122.3	68.3	45.1	37.9	25.0	63.7
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702067	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Excitatory neurons: 57.2;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA037497: AB_10671503, HPA037498: AB_2675509"	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	5.1	4.5	2.8	3.1	2.2	2.6	6.7	3.1	3.1	9.5	5.9	6.7	3.4	8.1	4.8	6.3	9.9	3.3	3.5	2.3	2.0	5.0	4.4	4.7	4.1	2.4	2.5	10.9	6.1	3.1	5.1	3.0	2.2	6.8	3.6	2.5	6.2	2.0	4.1	4.7	6.1	2.2	1.7	4.8	5.8	10.5	2.7	3.5	10.0	0.8	3.0	6.4	8.0	2.0	3.8	6.5	17.6	6.4	4.2	8.3	4.4	5.8	1.6	3.5	4.1	6.1	4.8	3.1	3.5	1.8	5.0	8.5	3.1	4.4	5.1	4.0	6.0	6.7	13.4	6.1	2.5	3.3	1.0	4.3	4.1	4.4	3.3	6.5	6.5	7.3	15.6	6.1	4.6	4.9	2.1	12.3	4.6	2.8	3.3	5.0	3.6	5.6	3.3	3.5	7.3	7.5	3.8	3.6	2.1	4.7	4.3	6.1	5.6	4.6	3.7	4.3	5.1	5.8	2.2	7.5	4.2	7.7	4.7	0.0	0.1	0.3	0.3	0.1	0.8	0.3	0.4	0.4	0.1	0.8	1.6	0.2	0.0	0.1	0.1	0.4	0.4	0.3	2.8	2.2	3.1	3.1	2.3	2.0	2.4	2.5	2.2	1.7	2.7	2.0	7.0	9.6	3.9	44.1	6.6	2.2	5.6	6.7	8.0	13.5	8.5	9.0	4.3	7.2	5.4	12.9	6.2	5.2	3.2	3.2	0.0	2.3	28.3	26.9	15.5	7.2	4.2	7.8	57.2	1.5	2.8	7.3	11.2	6.2	3.8	13.7	9.3	4.1	2.2	21.9	52.6	4.7	2.0	2.4	2.5	10.3	8.1	3.4	3.6	38.4	1.4	5.9	4.1	51.3	47.4	2.1	5.7	9.8	4.8	4.3	4.2	2.1	25.7	12.7	0.0	5.2	6.3	21.7	10.7	8.1	1.1	1.9	5.4	6.3	7.0	5.4
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	9.1	6.3	2.2	8.4	2.8	2.9	9.3	2.8	2.6	7.3	7.4	5.9	5.4	6.7	4.2	6.6	7.4	3.1	4.4	2.6	3.1	5.9	11.2	4.5	7.1	2.2	2.7	7.6	5.1	9.2	3.0	6.2	2.2	5.8	7.7	4.3	4.4	4.9	10.3	5.0	4.9	8.0	2.3	6.2	6.6	11.7	2.7	8.5	6.0	7.4	11.8	9.4	4.3	2.7	35.6	22.2	21.7	33.5	23.0	18.8	24.9	24.1	15.9	27.8	24.3	23.8	11.6	42.4	32.4	18.2	17.7	23.1	55.0	28.4	44.4	34.3	28.1	39.7	22.7	19.0	19.1	74.8	20.0	18.5	19.8	35.4	53.3	16.3	27.2	29.1	49.7	20.2	24.2	20.4	35.9	15.5	78.7	30.7	34.7	33.9	75.5	32.5	13.8	23.4	33.4	30.1	27.8	33.6	39.6	29.6	13.5	29.9	24.0	20.9	33.1	38.4	54.9	29.3	36.8	64.5	30.5	47.2	55.0	0.1	6.8	0.6	9.3	7.1	12.0	9.3	8.4	11.0	13.5	8.6	12.9	11.9	0.6	9.6	8.1	7.4	12.4	7.4	2.2	2.8	2.8	2.6	2.6	3.1	2.2	2.7	2.2	2.3	2.7	2.7	11.4	9.6	14.3	5.9	13.1	20.9	21.9	13.1	15.4	11.3	11.2	9.7	14.9	8.6	23.4	7.3	6.2	10.7	8.6	4.6	9.8	12.8	33.2	11.7	20.4	13.2	3.6	10.7	12.4	13.8	9.9	14.9	8.2	7.5	16.4	11.9	8.9	27.4	7.9	15.2	12.5	6.4	14.2	7.3	5.7	43.6	12.5	7.1	10.6	5.6	8.2	7.4	10.3	13.0	7.5	12.3	4.1	11.7	10.9	31.4	3.0	7.4	17.6	7.3	13.1	23.0	13.8	52.3	50.8	21.7	22.4	5.1	10.6	31.1	9.8	15.4
WDR33	"FLJ11294, NET14, WDC146"	ENSG00000136709	"WD repeat domain 33"	Q9C0J8	2	127701027-127811187	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026897, HPA046527"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA026897: AB_1858803, HPA046527: AB_2679686"	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-2)"	20.2	16.1	16.2	18.5	16.9	17.3	20.4	35.0	19.0	24.5	19.8	21.9	14.7	19.9	14.4	20.9	21.6	11.8	20.0	16.2	17.0	19.9	27.9	18.9	22.0	15.0	16.5	27.8	20.1	19.1	23.0	16.8	16.3	22.1	15.1	24.5	19.3	12.9	21.2	26.6	22.2	15.0	14.2	27.8	18.5	20.6	16.6	30.9	24.2	21.3	23.9	19.9	22.9	20.0	40.3	22.3	38.2	31.2	22.3	22.9	39.0	36.0	28.5	37.3	35.2	52.1	30.3	50.5	39.0	24.0	34.4	31.8	43.6	30.5	48.6	46.5	26.0	48.9	28.2	56.6	25.1	59.7	35.1	22.4	31.7	35.9	30.3	26.7	32.4	45.0	41.5	44.4	26.6	25.1	62.3	43.7	46.5	25.9	24.6	43.1	38.6	40.4	21.5	51.6	35.5	27.5	32.3	29.6	26.0	35.7	23.0	34.4	29.8	29.3	42.6	33.0	31.1	42.8	70.5	96.4	23.9	23.4	27.8	35.7	20.6	35.1	24.9	22.7	25.8	30.5	25.2	24.2	27.4	28.3	26.6	25.7	14.1	34.7	25.0	19.7	34.4	18.5	16.2	16.9	35.0	19.0	16.2	17.0	15.0	16.5	16.3	14.2	16.6	20.0	63.0	35.3	45.0	47.3	77.9	110.0	77.3	83.8	51.2	50.7	41.3	41.4	46.5	64.3	51.5	36.8	64.6	80.7	74.7	31.4	46.9	48.1	42.4	38.3	39.8	55.0	39.4	35.9	66.2	44.8	87.9	49.3	40.8	47.4	64.7	49.8	43.2	72.5	49.5	60.6	68.9	36.6	75.3	42.0	82.0	25.2	50.4	50.8	76.5	45.0	69.2	32.2	64.9	73.4	83.5	38.9	37.0	50.4	110.1	51.2	42.3	56.7	35.6	61.3	46.0	48.8	71.3	113.3	81.2	53.7	115.8	110.5	79.2	59.7	43.2	65.5
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	9.9	9.2	5.2	9.5	5.4	12.9	9.2	6.2	5.6	7.6	6.8	10.6	9.3	7.8	4.3	13.4	7.4	6.1	7.7	5.4	5.8	9.4	12.3	8.8	10.1	6.4	5.6	7.5	11.1	6.1	9.0	7.6	6.0	8.8	10.3	4.0	10.5	5.4	9.1	11.0	11.0	6.4	5.4	12.6	10.5	4.9	5.7	7.8	7.4	6.0	10.6	8.9	7.9	5.9	13.2	18.0	8.5	34.4	12.8	10.1	23.7	12.9	15.5	13.3	15.2	31.1	17.7	12.3	16.8	16.6	24.3	16.1	11.5	22.4	10.2	11.6	9.6	14.1	15.9	12.7	12.2	14.8	25.5	12.2	12.7	18.3	9.6	9.2	14.4	13.7	9.9	9.3	14.9	19.2	14.0	13.3	8.9	18.9	15.2	11.6	12.2	11.6	15.9	19.7	8.3	11.1	17.7	51.3	20.2	10.4	36.3	15.8	13.0	17.5	9.0	20.3	17.6	15.6	12.9	9.6	22.7	19.5	10.6	6.4	10.2	7.8	11.3	16.6	11.7	8.5	10.5	9.8	9.9	7.3	8.3	8.5	9.0	10.3	14.2	7.2	12.6	10.0	5.2	5.4	6.2	5.6	5.4	5.8	6.4	5.6	6.0	5.4	5.7	5.9	17.1	9.6	16.7	5.9	16.9	14.5	10.9	9.1	9.6	13.5	15.5	10.3	5.3	5.7	16.2	18.4	12.5	21.6	28.9	31.9	21.5	20.2	29.3	20.6	13.1	12.9	14.9	13.9	7.2	28.2	42.8	12.6	25.0	13.9	19.7	16.4	12.5	14.9	20.8	23.5	7.0	22.6	8.2	16.1	13.9	9.7	9.6	18.3	8.8	1.0	20.5	5.7	23.7	4.5	6.5	27.2	39.3	7.5	23.0	15.6	24.9	20.8	17.2	8.3	13.1	13.0	14.1	7.9	9.8	15.1	13.4	23.3	21.0	14.2	26.0	16.4
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299703	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		28000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	38.8	52.7	34.5	29.6	36.5	61.5	59.9	50.4	63.0	40.8	31.1	39.5	36.2	34.9	115.7	40.1	46.6	28.6	41.0	40.8	40.4	60.8	50.9	34.6	37.4	41.5	41.2	34.6	41.3	55.6	49.9	35.5	40.0	46.0	43.5	49.4	39.5	37.4	45.4	52.1	30.4	41.4	38.2	29.9	33.5	49.0	37.0	48.5	56.8	38.2	46.0	41.4	32.4	61.5	39.3	92.4	74.3	77.4	74.1	61.6	56.1	60.9	68.6	76.6	73.6	87.9	67.9	80.7	72.6	69.8	119.2	78.2	165.8	71.5	58.3	53.9	123.8	66.2	79.9	84.6	62.6	99.2	63.3	52.8	50.5	30.8	24.0	52.7	82.7	80.0	113.1	78.8	92.5	116.6	82.3	81.6	54.3	98.5	76.2	74.7	59.7	89.1	81.3	112.3	103.7	56.2	88.0	90.9	323.7	76.9	56.0	124.2	58.2	53.7	66.0	38.2	103.6	69.3	113.7	113.0	80.5	153.3	112.6	39.0	91.2	33.6	59.6	100.0	65.0	66.4	59.7	62.1	134.2	53.5	62.2	68.6	7.7	72.4	86.0	71.6	72.7	89.1	34.5	36.5	50.4	63.0	40.8	40.4	41.5	41.2	40.0	38.2	37.0	61.5	38.7	35.3	44.7	20.5	26.7	49.1	61.5	105.0	31.9	57.2	44.8	47.2	25.8	28.6	57.5	38.6	47.9	106.1	29.2	23.2	125.2	62.5	32.2	41.5	38.6	42.2	23.4	37.6	34.6	55.6	78.1	51.0	20.4	29.1	47.5	49.1	40.0	47.0	66.1	43.7	36.8	38.0	93.6	37.0	47.2	12.4	50.1	37.0	58.7	12.2	61.1	81.9	42.2	17.1	33.1	41.0	28.5	50.8	36.4	51.6	35.4	132.7	70.1	50.7	6.6	37.8	90.2	122.4	60.2	38.3	58.7	92.4	31.7	59.4	52.4	57.7
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.3;testis: 63.7;tongue: 63.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.5	5.4	0.4	0.9	0.7	0.9	0.2	0.9	1.1	0.6	0.2	3.7	0.7	0.2	22.1	0.4	0.2	0.4	0.7	0.7	2.9	0.5	0.5	0.3	0.2	0.1	0.4	0.5	0.5	0.7	0.5	6.7	1.3	0.2	110.3	2.7	1.2	0.7	0.2	2.0	0.9	63.7	0.4	5.0	0.4	63.1	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.5	0.9	0.7	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WIZ	ZNF803	ENSG00000011451	"WIZ zinc finger"	O95785	19	15419978-15449956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	13.9	13.7	22.2	10.2	18.0	7.5	13.2	11.1	28.2	13.5	8.3	15.8	9.6	18.7	3.6	12.2	13.4	6.6	18.7	21.4	12.2	13.3	12.3	9.9	6.6	14.0	15.4	14.0	19.7	9.3	7.9	6.7	13.7	12.0	3.5	3.6	10.4	10.3	14.4	13.7	10.2	8.3	12.2	9.5	15.8	21.3	17.7	6.6	9.1	7.3	4.0	16.0	11.6	15.7	23.0	13.1	22.6	28.0	32.2	13.4	17.0	23.2	10.8	19.8	13.4	14.1	43.0	18.8	36.7	22.9	12.1	20.3	12.5	17.3	5.0	13.8	21.3	14.6	13.5	11.3	21.2	15.2	19.9	23.8	22.9	14.7	16.4	12.3	18.3	14.4	22.5	16.8	13.8	48.4	30.2	15.9	28.7	23.8	38.2	27.7	10.4	19.9	13.2	18.5	31.0	36.4	20.2	19.5	15.7	8.3	21.4	16.0	29.2	45.4	16.7	36.0	32.0	22.8	15.6	21.2	18.0	19.1	31.5	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.5	1.0	0.3	0.2	0.1	22.2	18.0	11.1	28.2	21.4	12.2	14.0	15.4	13.7	12.2	17.7	15.7	11.3	12.8	6.9	6.5	4.1	15.8	7.2	7.8	5.7	9.4	16.2	17.8	10.9	8.6	5.6	12.9	0.0	7.1	8.4	8.4	3.9	14.9	9.0	6.3	15.3	14.9	6.7	3.0	3.2	20.0	9.9	10.3	9.2	12.1	1.3	17.3	14.3	14.7	7.8	6.7	3.2	9.0	4.1	11.3	7.2	10.0	15.8	8.7	7.2	3.7	6.7	8.5	2.1	2.0	2.8	19.1	3.9	19.2	3.1	14.1	6.2	5.3	2.5	7.4	13.1	9.5	12.7	34.8	21.9	9.3	20.3	7.4	5.4	16.8	10.0	12.8
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 29.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	4.1	3.7	3.4	4.5	3.5	7.6	4.0	3.4	3.5	4.3	5.0	4.2	2.7	4.5	2.3	4.5	14.5	3.0	4.2	3.4	3.5	4.0	3.6	4.1	6.9	3.9	5.0	3.3	4.5	3.1	4.1	3.4	3.8	3.0	3.5	3.4	3.6	3.0	6.2	4.4	4.7	3.9	4.0	6.9	4.3	5.2	3.5	8.0	3.5	4.5	6.5	3.8	3.6	4.0	22.7	40.6	28.9	29.5	9.2	8.0	16.5	14.3	14.9	45.6	42.1	24.2	13.2	23.3	15.0	13.1	18.7	24.0	33.8	24.5	35.2	14.4	41.4	12.0	22.6	20.5	7.9	8.1	14.7	6.8	9.3	39.9	8.9	6.8	28.8	27.4	12.0	7.7	18.7	21.1	27.0	22.2	15.4	16.7	20.5	35.0	19.3	14.0	17.2	7.7	13.3	19.4	23.1	11.9	12.1	14.0	16.7	10.3	10.1	17.4	19.0	0.1	36.6	5.3	15.9	13.1	16.8	15.2	21.4	29.4	5.8	5.0	5.3	6.3	6.1	3.0	4.2	6.2	5.3	4.2	3.8	4.2	2.5	5.0	2.8	7.4	8.9	3.8	3.4	3.5	3.4	3.5	3.4	3.5	3.9	5.0	3.8	4.0	3.5	4.0	4.6	3.2	3.4	2.3	7.0	3.8	5.2	12.9	2.8	5.6	4.1	4.6	3.6	2.8	7.0	11.0	6.2	12.3	9.2	4.5	3.9	10.1	3.9	22.4	3.4	5.8	3.0	10.8	2.0	10.4	17.0	4.4	4.1	4.1	1.3	7.3	5.3	4.6	7.7	1.7	2.1	5.6	18.3	7.2	3.1	1.9	2.5	5.4	3.6	1.0	8.7	7.2	12.3	5.0	2.8	6.9	3.7	2.2	8.8	2.2	5.2	6.5	51.0	6.3	0.0	6.4	6.3	13.3	6.7	3.5	4.5	4.1	5.7	5.8	7.2	2.9
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"WT1 transcription factor"	P19544	11	32387775-32435564	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 67.6;fallopian tube: 52.3;ovary: 45.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	26.5	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.1	18.4	0.0	0.7	0.0	67.6	5.3	0.0	52.3	1.3	4.5	0.1	0.0	16.3	0.1	0.8	0.0	0.2	0.1	45.8	0.1	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	33.1	0.0	19.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	20.7	0.0	1.2	4.7	10.8	29.9	0.0	0.0	3.4	0.0	0.0	0.0	0.7	19.6	0.0	2.0	0.0	11.2	37.2	0.8	0.0	6.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	2.1	19.6	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	20.2	0.0	1.0	0.0	0.0	0.0	0.0	3.6	2.2	70.1	16.3	0.0	0.0	0.1	0.0	0.5	7.3	0.0	1.4	0.0	9.3	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.3	8.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	2.3	0.0	0.0	6.6	0.0	2.0	4.5	1.0	0.0	0.0	0.8	0.5	0.4	0.0	0.1
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 560.1;Suprabasal keratinocytes: 455.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	86.2	63.7	35.3	62.3	35.7	245.1	74.9	40.0	41.3	71.7	41.3	54.6	34.9	64.7	65.1	65.0	64.2	52.2	54.3	35.0	42.5	54.8	50.7	68.6	77.5	38.2	38.3	70.5	63.3	53.2	49.8	61.8	39.4	65.1	55.2	35.6	62.0	44.6	179.7	72.5	61.6	51.5	36.9	67.0	58.5	34.9	40.1	89.7	57.4	67.4	80.7	102.6	65.1	41.2	55.5	51.1	115.8	100.2	136.5	147.7	67.1	86.2	299.4	108.7	145.4	95.7	49.0	126.8	50.8	92.6	238.4	70.4	112.2	94.3	138.1	70.0	71.9	135.0	46.7	144.2	108.4	116.1	75.4	172.0	94.7	120.0	155.0	82.6	81.6	130.7	149.1	114.2	116.0	53.5	170.5	165.0	91.9	88.6	44.2	107.4	74.3	94.4	114.0	62.6	104.5	74.5	158.2	83.5	45.7	77.5	41.3	152.6	72.6	70.0	81.4	100.1	125.0	83.9	109.6	206.5	67.8	120.9	76.8	46.6	24.5	31.0	28.1	31.7	31.7	33.1	33.9	34.3	29.1	27.5	29.9	31.4	42.9	32.1	38.3	24.3	40.2	20.2	35.3	35.7	40.0	41.3	35.0	42.5	38.2	38.3	39.4	36.9	40.1	41.2	131.1	35.3	57.3	31.3	138.1	419.0	198.0	52.9	113.8	30.0	144.2	123.6	58.1	74.4	39.9	60.7	35.5	107.3	138.5	61.2	86.1	128.1	47.1	86.4	125.5	118.8	61.6	59.3	41.5	81.4	126.7	226.9	97.9	171.9	40.0	56.7	58.2	90.5	75.4	37.0	36.6	65.7	24.4	99.7	560.1	50.7	65.3	168.6	243.7	33.7	113.7	49.7	88.6	44.7	57.0	75.8	59.7	50.8	111.5	307.5	49.6	106.5	35.3	36.2	72.3	222.2	124.5	93.8	73.9	113.0	455.3	149.3	138.6	54.7	74.0	150.9
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178621	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	22.9	17.2	14.3	16.4	17.3	10.2	22.9	15.6	14.6	27.2	15.2	20.1	19.0	24.9	17.6	16.1	25.3	16.6	13.1	12.9	17.3	24.8	24.2	20.7	24.5	16.8	17.4	34.6	21.6	24.0	25.8	15.6	17.4	22.9	15.6	15.2	18.5	23.6	21.3	31.9	24.0	17.5	15.2	24.2	17.4	12.4	16.0	21.2	26.7	9.8	21.7	22.9	20.3	18.3	14.3	33.8	36.7	22.6	51.0	35.8	124.8	33.6	88.7	29.9	22.3	11.8	14.7	46.6	14.5	37.5	14.7	15.6	23.6	49.3	23.6	21.5	24.7	24.9	35.7	21.7	45.0	16.8	42.2	50.1	56.4	39.7	77.4	34.2	34.5	19.0	31.2	22.5	32.5	27.2	17.9	16.3	23.5	20.4	21.2	19.3	17.9	33.7	36.2	36.9	8.8	29.9	36.1	27.2	23.5	54.6	29.9	13.8	57.1	11.2	32.1	18.4	15.4	54.5	46.4	25.4	26.5	19.4	41.6	41.4	20.2	26.8	23.2	16.6	22.7	27.1	26.7	23.5	17.9	25.0	28.3	20.8	73.1	24.3	23.3	17.4	24.7	16.9	14.3	17.3	15.6	14.6	12.9	17.3	16.8	17.4	17.4	15.2	16.0	18.3	26.0	60.9	63.2	16.6	39.9	13.8	20.4	25.5	59.2	35.6	19.0	25.9	11.8	31.5	47.7	16.5	39.6	42.5	38.9	13.4	35.2	19.3	2.3	32.2	44.8	29.9	16.3	20.8	18.0	19.2	20.3	29.2	15.3	25.5	47.4	25.0	22.9	40.5	18.2	26.9	22.0	13.9	20.3	23.9	14.9	2.7	30.7	19.6	8.8	15.0	40.1	24.9	54.6	17.1	27.5	19.5	15.0	28.2	29.1	18.9	32.7	66.1	55.0	51.0	26.3	43.3	27.7	28.7	54.9	21.4	11.1	32.0	42.3	26.3	18.1	10.5
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	19.7	19.4	13.2	22.9	13.6	23.3	20.1	13.1	14.8	19.7	17.2	32.2	51.7	19.4	22.7	25.1	22.3	27.5	27.9	15.3	13.4	21.4	18.9	19.2	25.4	13.2	12.7	19.8	62.0	24.5	19.2	26.6	13.1	21.7	40.4	18.7	30.4	15.7	28.4	29.5	61.8	28.2	13.2	19.3	24.4	18.1	13.3	19.5	23.6	22.1	28.4	24.6	19.3	13.7	78.1	33.6	52.3	72.1	83.6	77.4	40.2	42.4	85.5	61.8	66.5	65.4	65.2	110.3	35.9	65.0	31.3	40.5	41.7	52.2	60.4	33.0	40.3	74.0	20.5	27.6	58.2	58.3	59.0	76.9	31.8	67.8	60.1	94.6	103.1	70.0	24.3	34.3	80.1	26.3	41.7	36.0	20.6	58.7	35.7	46.1	105.3	19.8	78.5	24.3	15.9	60.5	36.9	23.1	70.6	56.9	28.3	53.6	53.9	25.3	32.9	40.4	38.1	58.4	30.4	92.8	59.4	80.0	20.3	25.7	26.8	11.3	19.5	42.2	13.4	10.6	12.6	17.5	46.4	8.9	8.7	11.7	2.2	30.5	36.8	36.4	15.5	29.6	13.2	13.6	13.1	14.8	15.3	13.4	13.2	12.7	13.1	13.2	13.3	13.7	13.4	6.4	14.4	24.5	14.6	8.9	13.2	32.9	11.4	20.5	12.1	9.7	17.0	18.6	26.3	3.7	6.2	38.2	33.1	34.5	17.6	37.4	6.4	12.3	16.5	18.2	16.8	14.7	18.9	72.9	29.6	22.7	24.5	13.6	11.4	17.0	15.7	12.1	30.9	26.9	25.3	37.1	18.3	20.5	9.6	5.1	18.3	37.5	8.8	15.9	33.5	27.1	24.7	21.6	27.0	54.4	35.1	29.7	18.1	22.5	63.5	31.1	22.8	19.5	13.1	9.8	14.2	17.5	35.9	18.6	8.7	25.2	19.4	30.0	36.5	27.1
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522334-43576038	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	7.3	8.0	4.6	9.1	5.3	8.3	8.5	5.1	5.8	7.6	4.1	7.2	6.3	8.0	9.1	12.0	6.9	5.8	7.0	4.7	4.7	7.4	6.7	6.5	8.7	4.8	4.6	6.3	14.0	11.1	6.5	7.6	4.5	7.9	8.8	11.7	8.1	7.1	11.2	12.3	6.4	9.7	4.2	6.9	8.3	23.7	5.2	12.0	13.1	6.0	11.2	11.2	7.9	4.7	48.8	28.5	46.7	94.4	23.7	19.9	43.3	24.8	17.3	47.9	34.4	79.1	16.5	65.6	31.4	23.7	45.1	40.8	78.4	36.2	53.5	48.0	61.9	63.6	34.5	57.8	34.0	71.0	32.6	14.5	36.8	50.4	78.0	17.2	34.6	46.0	138.5	50.2	32.6	59.5	53.9	35.1	50.1	132.3	28.7	57.9	49.5	49.2	27.6	37.6	95.7	39.7	34.5	31.5	44.7	40.6	36.3	56.1	29.2	35.2	41.9	34.0	52.8	31.8	37.1	126.3	12.6	60.7	38.4	0.0	4.3	3.1	4.8	5.4	4.4	2.8	4.3	5.3	4.9	2.4	3.4	4.6	0.4	7.1	10.8	1.4	4.7	4.0	4.6	5.3	5.1	5.8	4.7	4.7	4.8	4.6	4.5	4.2	5.2	4.7	4.7	6.4	3.3	21.2	6.0	8.9	6.8	4.6	5.2	11.3	7.0	7.4	6.5	2.8	3.5	11.0	8.4	5.5	8.4	3.6	1.9	6.7	12.3	7.1	10.9	6.6	14.4	9.4	31.7	7.7	6.5	7.5	10.2	7.5	11.4	13.4	2.5	4.6	6.2	21.9	35.2	5.9	2.0	5.3	2.5	13.5	4.1	4.9	1.8	25.3	5.1	4.5	13.4	26.7	32.0	6.6	2.2	8.2	10.8	13.0	4.1	4.7	5.5	14.3	0.0	10.0	7.3	26.9	23.5	10.2	7.1	4.4	5.4	11.5	7.2	5.8
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404392-64451125	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol		NA	NA		9800	"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA048067: AB_2680246, HPA057602: AB_2683481"	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.79e-4)"	19.5	15.9	18.5	21.0	22.4	32.2	15.5	20.4	21.7	15.8	24.6	12.6	10.7	14.5	19.3	18.8	12.2	12.6	10.8	18.3	22.0	13.6	20.9	15.9	21.2	21.5	21.7	11.6	31.5	26.3	13.8	19.3	22.3	14.9	14.5	33.1	20.2	13.0	14.7	18.0	10.9	16.9	20.6	15.8	15.5	18.9	21.5	21.7	50.4	13.1	22.8	17.4	16.4	24.3	76.3	51.9	51.5	64.9	76.2	80.9	94.1	99.4	83.3	65.5	59.2	52.0	25.4	153.9	69.3	126.9	69.8	56.0	99.1	77.2	94.7	96.6	52.3	85.8	46.6	46.0	134.5	159.2	74.1	57.8	194.5	73.2	223.7	84.6	59.3	112.7	145.0	299.0	70.3	93.8	88.6	63.5	98.5	53.8	91.8	69.5	61.9	116.5	36.2	44.2	57.2	66.9	58.3	66.3	146.4	49.9	117.4	157.3	62.4	51.1	51.4	74.4	78.9	186.4	154.2	118.3	114.0	122.3	84.5	6.7	7.4	10.2	9.9	7.3	13.3	7.1	11.2	10.4	9.9	5.0	10.0	8.7	2.2	11.2	6.9	3.4	10.2	6.8	18.5	22.4	20.4	21.7	18.3	22.0	21.5	21.7	22.3	20.6	21.5	24.3	17.9	12.8	9.1	39.2	13.4	19.6	19.0	16.3	14.2	16.8	16.8	10.2	11.3	12.8	14.3	14.7	12.5	24.4	17.3	7.6	17.6	9.4	7.3	16.0	32.1	18.1	11.4	15.8	25.9	13.0	20.5	19.0	9.2	13.1	24.7	13.0	19.6	33.6	14.4	13.5	34.8	11.1	8.2	21.9	21.7	5.3	20.2	15.7	21.4	23.4	11.4	80.3	10.3	18.1	29.6	15.2	6.6	20.3	22.6	26.1	5.4	13.4	15.8	25.4	13.1	14.5	16.2	12.4	17.1	21.6	22.4	17.0	18.4	10.8	12.9	18.7
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	18.5	16.4	15.3	18.0	15.6	24.4	17.9	18.5	17.1	23.6	13.5	20.4	14.6	23.5	16.2	16.1	23.2	14.4	15.5	14.6	15.6	15.7	10.8	16.2	22.9	15.7	15.2	32.0	19.6	17.6	32.3	16.6	14.0	16.2	11.4	16.7	16.3	15.6	19.5	21.0	15.7	17.3	13.5	20.1	18.5	23.9	16.6	29.0	20.6	15.7	20.9	18.6	18.0	15.6	57.4	51.4	54.4	48.2	23.6	24.6	27.0	28.4	36.0	42.5	46.3	32.0	40.4	44.1	39.1	28.9	39.1	30.0	33.2	36.8	24.7	46.4	33.9	57.5	49.4	36.1	23.2	34.5	42.9	27.3	24.8	53.5	26.4	48.8	37.2	49.1	35.9	42.5	37.3	48.9	57.5	52.5	18.5	44.2	21.3	57.0	35.4	25.8	34.3	44.1	44.5	26.5	41.6	35.3	20.7	26.8	33.9	67.4	23.3	55.7	40.4	16.3	39.9	44.2	44.2	32.0	42.8	28.0	58.7	18.6	13.1	15.6	10.8	11.9	12.3	11.7	13.8	14.6	11.6	10.5	11.3	10.9	15.1	10.4	7.9	9.1	14.5	11.7	15.3	15.6	18.5	17.1	14.6	15.6	15.7	15.2	14.0	13.5	16.6	15.6	10.2	16.0	9.8	5.9	13.4	6.1	7.1	17.5	12.5	12.6	10.2	9.0	7.6	7.2	14.7	7.3	6.2	29.8	12.5	9.1	19.6	15.4	32.2	18.7	13.3	12.2	13.7	15.4	8.2	11.6	19.2	13.3	8.2	13.7	19.7	22.0	11.4	7.1	21.0	5.0	9.2	15.3	10.2	18.0	10.1	19.5	10.2	12.6	14.2	3.7	14.3	8.6	8.2	4.5	8.1	12.2	9.7	12.8	17.7	4.1	9.2	16.9	39.0	12.7	6.6	9.6	17.7	21.4	14.1	10.8	7.1	20.0	14.6	16.4	13.7	4.7
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA062422: AB_2684757, HPA068953: AB_2686062"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	9.8	6.0	8.7	8.7	12.5	31.9	9.3	7.2	10.3	13.7	11.9	11.1	6.9	10.4	1.7	13.9	10.9	6.6	8.3	6.6	5.8	7.9	7.7	12.1	15.4	13.6	9.7	12.7	9.8	1.7	8.6	5.2	9.7	13.4	7.5	4.5	12.7	3.3	12.4	39.0	12.6	2.8	7.7	21.3	9.1	13.8	9.7	10.0	10.5	2.5	11.0	9.6	12.4	14.3	32.4	58.4	31.5	38.5	2.8	7.9	57.0	35.5	11.6	48.9	52.3	32.4	50.3	51.8	29.5	7.5	38.4	50.3	34.6	52.4	29.9	31.3	36.1	50.6	31.6	30.4	4.9	45.3	30.8	6.0	5.2	43.2	26.7	10.4	20.2	51.3	31.8	30.4	25.2	70.7	79.6	35.8	26.4	47.1	42.0	63.7	45.7	19.8	10.5	44.2	31.1	25.7	41.3	21.7	14.3	17.4	34.6	35.0	17.5	25.1	28.9	80.0	38.8	26.2	25.8	63.7	15.6	36.9	38.4	0.7	0.5	0.9	1.0	0.9	1.0	1.1	0.8	0.8	0.5	0.9	0.8	0.5	0.3	0.7	0.7	0.4	0.6	1.3	8.7	12.5	7.2	10.3	6.6	5.8	13.6	9.7	9.7	7.7	9.7	14.3	2.2	0.0	0.0	2.6	2.5	1.5	1.9	2.1	1.8	1.7	3.2	3.6	0.2	2.8	2.5	0.0	2.1	10.2	1.8	6.9	1.9	1.5	0.7	1.9	2.2	2.0	1.2	7.4	2.6	1.8	6.1	1.2	0.5	2.0	0.0	4.7	0.4	0.3	4.4	3.3	1.0	7.4	0.0	0.0	2.0	1.8	0.3	1.5	0.0	1.0	1.5	1.7	2.1	1.5	1.4	1.7	2.6	1.2	4.4	1.6	0.7	0.2	1.7	2.3	0.0	2.6	1.2	3.1	5.8	2.8	1.3	3.1	2.0	4.2	8.3	1.2
XRCC4		ENSG00000152422	"X-ray repair cross complementing 4"	Q13426	5	83077498-83353787	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 80.8;Pancreatic endocrine cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 61.6"	"Low region specificity"	"Detected in all"							"HPA006801, HPA051538"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA006801: AB_1858899, HPA051538: AB_2681526"	"prognostic unfavorable (1.80e-5)"	"unprognostic (3.05e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.91e-2)"	4.4	4.2	2.8	6.0	3.1	4.4	6.1	3.1	3.9	3.1	2.5	5.9	7.6	3.5	3.2	3.8	3.9	5.2	7.9	3.2	3.3	7.2	5.4	4.7	8.5	3.2	3.1	2.3	2.5	2.4	2.1	5.4	3.2	3.9	5.7	2.3	3.4	4.3	2.6	3.3	5.1	3.9	3.3	4.8	4.3	8.8	3.0	10.3	4.3	2.4	9.0	5.5	2.9	3.4	15.1	11.7	14.1	12.5	7.8	11.3	13.2	13.7	11.2	14.8	17.3	10.0	21.8	20.9	10.3	11.0	21.2	12.8	9.4	30.7	24.2	10.0	11.8	11.1	8.3	12.4	5.2	12.5	17.2	7.9	14.3	19.3	10.8	15.6	12.4	13.8	8.2	9.8	17.6	12.1	23.1	16.0	7.9	8.8	17.2	19.0	61.6	20.7	14.1	6.8	9.2	11.8	8.9	6.5	18.4	11.8	13.2	19.5	7.8	8.2	17.6	8.9	19.0	7.8	12.3	26.6	14.8	22.2	13.5	17.6	17.3	12.4	5.9	25.8	6.1	9.3	6.2	6.5	13.6	8.8	8.3	6.8	16.5	15.2	25.4	10.1	7.7	9.1	2.8	3.1	3.1	3.9	3.2	3.3	3.2	3.1	3.2	3.3	3.0	3.4	10.4	16.0	5.5	39.8	13.0	5.4	13.2	28.0	5.2	4.7	5.5	5.0	15.3	8.6	19.2	5.5	0.0	17.4	12.9	7.6	15.6	17.4	10.2	14.8	12.6	8.9	0.0	6.3	16.6	28.4	38.9	11.6	11.2	10.0	10.8	11.9	11.4	5.5	19.1	1.7	18.7	7.8	22.4	20.7	12.1	5.9	7.8	20.5	8.8	30.9	25.1	7.8	14.4	53.3	80.8	65.7	6.7	7.2	11.3	4.4	7.2	26.5	16.9	4.5	0.0	4.6	11.9	33.1	25.3	7.1	4.4	11.9	12.6	8.0	6.2	8.2
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm		NA	NA		940000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322"	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	79.6	74.0	52.8	102.4	58.4	112.0	114.6	56.0	69.9	96.4	38.1	91.0	82.2	103.3	85.3	96.8	95.8	83.2	77.1	58.1	56.4	100.2	140.6	76.6	127.8	52.4	50.7	104.0	71.7	118.4	61.4	87.1	54.4	84.7	106.6	102.0	71.6	91.3	103.1	91.6	82.3	100.1	59.1	83.9	77.0	69.5	51.0	176.8	129.2	92.7	140.9	131.7	72.7	65.6	234.4	194.9	427.0	230.5	185.5	210.9	256.6	269.9	279.2	307.1	328.5	421.0	225.7	225.6	214.8	239.1	269.2	203.5	425.2	329.5	469.7	215.0	291.0	488.5	282.9	398.0	229.2	437.1	230.0	193.5	172.1	361.2	156.6	218.4	368.0	272.1	314.4	199.7	405.9	225.9	496.7	221.7	498.0	236.0	170.6	429.8	376.7	186.5	331.9	262.6	372.6	314.6	217.8	159.9	201.1	428.5	196.7	325.8	264.2	287.3	241.5	190.6	312.3	240.0	311.4	493.6	223.4	339.5	290.0	253.2	172.7	175.0	153.6	177.1	165.3	121.2	148.1	157.0	168.0	121.6	147.6	149.1	192.7	172.9	217.4	102.1	167.5	330.4	52.8	58.4	56.0	69.9	58.1	56.4	52.4	50.7	54.4	59.1	51.0	65.6	129.0	105.8	126.3	65.6	131.0	113.7	174.0	242.4	90.5	136.7	93.6	87.1	163.0	105.8	190.0	101.2	45.9	210.5	141.6	79.8	97.8	304.3	103.0	147.4	175.4	142.4	133.3	159.4	73.9	235.8	238.8	134.1	74.5	159.1	146.7	140.2	82.8	222.5	157.3	89.2	82.4	90.7	173.0	100.5	85.3	30.0	101.5	130.7	69.4	108.7	310.9	142.0	138.0	93.0	111.4	247.9	70.3	129.4	132.5	137.4	82.8	139.9	160.1	114.0	111.7	142.9	161.3	252.2	179.2	114.7	120.3	165.5	149.7	165.3	112.0	161.2
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 579.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	143.7	183.4	84.9	153.4	89.3	218.2	143.3	87.8	100.8	152.1	87.2	159.5	136.8	153.8	111.3	192.1	151.4	105.5	176.1	89.2	94.7	136.9	142.4	133.2	196.6	89.5	86.8	169.8	119.0	156.5	122.6	155.0	92.2	132.7	164.9	115.6	130.8	144.4	273.0	168.3	142.8	161.0	93.5	143.1	138.6	231.2	87.9	224.1	137.8	184.3	222.2	162.6	142.0	96.4	554.6	388.0	527.9	455.5	313.5	279.5	413.8	394.7	464.6	794.9	656.4	570.4	335.7	886.2	319.8	478.1	357.4	400.6	739.2	486.8	803.2	493.4	921.2	478.8	435.2	559.5	281.5	1142.2	520.5	252.7	323.1	501.2	275.0	319.8	505.6	371.6	470.2	360.1	523.1	589.9	589.0	390.6	482.1	1138.4	452.1	660.0	562.3	695.6	440.4	404.4	243.3	174.6	644.1	328.2	455.7	392.9	382.2	439.0	366.2	394.3	546.2	354.0	522.4	354.0	671.9	896.1	369.4	441.3	476.4	146.0	264.3	227.6	243.6	296.5	258.4	256.5	269.5	269.2	324.1	246.9	293.2	262.5	69.2	253.2	307.0	191.7	325.9	600.8	84.9	89.3	87.8	100.8	89.2	94.7	89.5	86.8	92.2	93.5	87.9	96.4	96.6	96.1	142.5	18.6	132.6	124.0	201.0	219.0	83.1	107.1	80.1	83.4	89.4	115.8	160.4	82.8	62.6	422.3	104.9	97.3	166.3	205.4	119.6	86.1	87.0	117.0	98.6	125.4	24.5	182.7	317.2	123.9	73.4	105.9	119.7	156.4	70.3	103.7	170.2	87.5	29.5	114.7	166.8	98.1	116.7	62.9	126.8	110.4	88.9	17.8	182.8	149.7	89.6	26.2	30.5	150.9	106.6	126.7	116.0	112.0	113.7	140.3	112.6	103.6	164.3	102.4	127.4	579.8	314.4	91.5	102.1	362.2	136.9	150.6	166.8	137.5
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303331-21389825	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	36.1	36.1	14.7	42.6	17.2	73.3	42.9	18.5	15.8	33.4	21.1	29.9	24.3	37.0	31.3	25.9	33.2	35.8	24.8	13.6	16.5	34.8	42.7	34.4	43.2	16.5	15.5	36.7	32.8	45.2	18.7	37.4	17.0	28.4	32.4	24.8	27.0	33.6	38.2	24.3	24.8	39.4	16.1	36.1	24.9	29.9	16.1	46.8	41.2	26.5	45.8	46.5	23.1	18.3	91.9	106.7	115.1	88.7	84.1	102.7	113.7	82.3	107.1	107.2	124.1	71.8	102.2	89.7	47.8	86.8	146.1	106.0	131.0	138.7	136.6	40.8	66.0	116.0	37.7	136.5	73.9	105.7	96.8	98.0	68.7	118.5	103.1	95.3	93.6	84.5	94.9	74.7	101.0	71.7	156.5	69.6	89.8	88.8	71.1	113.1	195.4	76.9	91.0	95.6	88.9	115.2	96.0	116.6	89.9	88.6	65.5	123.9	87.0	107.0	79.8	24.8	105.4	65.3	90.0	95.0	41.5	48.5	82.5	36.0	68.6	49.2	34.6	54.8	46.4	30.5	37.7	38.1	61.1	30.9	39.8	38.7	69.2	43.9	71.8	26.2	49.2	54.3	14.7	17.2	18.5	15.8	13.6	16.5	16.5	15.5	17.0	16.1	16.1	18.3	118.6	60.9	112.2	29.7	72.4	63.6	90.8	81.2	64.9	44.9	85.0	75.2	58.7	52.9	94.4	40.5	41.7	106.2	99.1	36.6	27.4	123.8	157.6	119.5	128.5	99.9	59.5	62.6	45.7	120.9	96.8	80.1	39.8	113.7	83.5	92.0	41.0	70.4	105.4	50.5	48.9	52.6	67.1	129.6	57.9	26.8	57.8	111.2	60.5	49.6	165.9	55.1	85.5	46.8	67.6	96.1	53.7	55.7	77.1	91.6	45.1	80.6	102.7	49.7	59.2	120.1	108.1	104.1	116.6	65.6	67.2	105.2	83.5	99.4	68.1	89.7
YARS1	"tyrRS, YARS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase 1"	P54577	1	32775237-32817380	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 17.5;Cytotrophoblasts: 41.8;Extravillous trophoblasts: 48.1;Hofbauer cells: 41.0;Syncytiotrophoblasts: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		1400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	24.9	40.3	39.9	35.0	51.2	19.9	21.3	38.1	60.4	20.5	30.1	27.5	26.0	16.9	25.0	34.4	21.6	15.3	22.4	42.1	46.6	20.6	47.7	27.8	38.2	37.5	38.4	15.1	85.6	34.1	14.8	26.2	42.3	18.8	32.4	38.0	29.6	29.0	31.9	26.0	21.6	35.4	38.5	22.0	40.8	31.2	44.2	34.6	42.3	36.6	50.0	34.6	14.0	49.6	157.1	92.1	86.1	194.5	111.2	117.7	91.7	151.0	136.7	133.2	165.0	116.6	103.0	287.5	63.1	173.2	112.7	90.8	269.0	204.4	198.9	122.6	113.9	254.2	117.2	114.2	383.4	202.9	147.3	129.0	252.3	212.7	544.2	98.3	140.9	245.8	291.8	268.7	117.8	107.8	233.0	159.3	149.1	185.3	134.5	198.3	75.2	234.9	109.8	76.5	149.5	94.2	89.0	102.7	300.8	99.2	95.2	247.5	103.6	73.6	135.7	152.1	135.7	242.8	265.2	255.7	184.8	297.7	203.6	56.1	33.3	17.8	59.0	35.2	58.4	23.8	35.4	55.1	45.8	20.3	25.2	39.0	6.9	98.1	35.0	26.9	40.9	51.5	39.9	51.2	38.1	60.4	42.1	46.6	37.5	38.4	42.3	38.5	44.2	49.6	7.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	41.8	11.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	48.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	37.6	1.4	0.0	0.0	0.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	33.5	33.0	20.0	26.7	21.0	63.9	38.3	22.1	24.8	27.5	29.5	32.0	29.4	27.8	43.6	37.5	27.7	27.0	27.0	21.3	22.5	31.8	42.2	35.6	35.6	20.2	19.6	29.3	27.4	37.1	18.0	34.4	20.6	22.9	33.8	20.2	39.8	23.9	43.9	41.9	26.2	32.9	21.4	32.1	27.6	29.3	21.2	44.1	28.0	33.7	43.8	32.8	26.1	23.1	68.8	46.3	99.6	96.8	75.5	58.1	117.8	66.1	80.7	80.0	80.4	42.8	78.1	117.8	64.4	84.4	47.8	62.2	117.3	105.7	94.0	76.0	91.9	98.7	60.7	78.4	90.0	105.1	74.4	78.5	106.4	86.1	121.1	70.0	99.0	70.0	101.9	55.6	89.7	53.3	112.1	80.8	161.8	61.1	61.1	95.4	74.2	96.8	111.3	95.8	85.7	91.2	68.6	102.1	181.7	82.6	67.8	95.8	69.4	55.4	57.8	52.5	93.5	68.2	47.7	133.3	63.3	81.2	89.9	108.3	78.4	78.7	66.1	91.1	88.3	80.3	72.7	80.3	96.7	59.0	77.9	73.2	26.5	92.4	94.4	62.6	92.3	109.5	20.0	21.0	22.1	24.8	21.3	22.5	20.2	19.6	20.6	21.4	21.2	23.1	70.8	51.3	61.2	13.7	70.8	152.7	104.9	111.0	109.8	45.4	110.2	101.3	52.8	77.2	85.3	44.1	31.3	149.6	79.5	46.4	66.5	102.0	16.3	65.8	78.2	78.5	75.7	52.8	22.5	69.6	108.3	64.5	49.5	76.6	72.3	63.6	77.4	102.3	77.3	58.9	20.4	76.0	105.8	65.4	75.4	19.3	71.1	56.7	37.4	21.5	74.1	66.4	73.2	14.1	23.5	80.7	43.8	75.2	71.0	78.6	42.4	96.0	53.8	45.9	92.1	61.5	83.0	142.2	115.5	95.3	161.7	260.2	69.2	69.5	65.9	118.7
ZBED8	"Buster3, C5orf54"	ENSG00000221886	"Zinc finger BED-type containing 8"	Q8IZ13	5	160393148-160400054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 12.6;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045445, HPA055817"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045445: AB_10959608, HPA055817: AB_2682933"	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.47e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.96e-3)"	2.6	4.6	5.4	1.1	6.9	0.2	3.9	10.7	7.3	7.5	5.3	5.0	1.6	6.1	7.8	2.1	5.4	2.5	4.2	5.0	6.0	4.1	1.8	2.4	1.6	5.6	5.8	10.9	3.1	3.2	9.9	4.6	5.8	4.7	1.9	8.8	5.0	4.8	2.6	2.8	2.0	3.8	6.0	2.4	2.7	4.3	5.6	2.1	5.6	3.1	1.8	4.9	4.3	9.0	5.7	4.4	10.8	9.6	8.5	6.2	4.4	4.8	4.5	5.8	8.8	4.0	4.4	4.7	9.1	1.6	13.7	6.0	6.2	2.8	7.7	4.8	6.2	3.0	6.7	5.2	3.1	1.9	3.6	2.4	5.8	4.3	2.8	5.3	3.0	4.0	2.1	4.4	6.2	2.3	1.8	3.2	2.6	2.3	4.7	2.3	12.5	3.1	2.7	1.6	11.1	3.7	6.4	1.8	5.5	4.3	4.2	2.0	2.1	8.7	5.7	2.7	4.1	4.0	7.2	1.2	6.2	2.9	8.7	0.0	0.7	0.3	0.7	0.5	0.4	0.2	0.6	0.5	0.9	0.1	0.4	0.3	0.0	1.1	1.0	0.8	0.0	0.4	5.4	6.9	10.7	7.3	5.0	6.0	5.6	5.8	5.8	6.0	5.6	9.0	1.4	0.0	0.5	4.2	0.2	0.0	1.0	0.0	1.8	5.7	1.6	1.3	3.3	0.0	0.6	1.8	2.1	4.0	0.1	0.5	1.9	1.4	1.3	2.6	3.0	1.7	0.0	1.7	4.0	0.4	1.6	3.4	1.1	1.3	0.0	7.2	1.1	0.2	1.5	3.3	5.5	0.7	0.0	0.9	0.0	0.4	6.5	0.6	0.0	1.0	1.1	6.1	0.0	4.5	12.6	0.7	0.7	5.7	0.4	0.7	0.4	1.2	5.1	4.1	13.1	2.4	3.2	3.8	5.1	0.8	0.0	1.4	0.3	2.1	0.7	0.3
ZBTB10	"FLJ12752, RINZF"	ENSG00000205189	"Zinc finger and BTB domain containing 10"	Q96DT7	8	80485619-80526265	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 142.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021554, HPA050569"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA021554: AB_1858937, HPA050569: AB_2681179"	"unprognostic (7.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.63e-2)"	7.9	7.9	4.1	4.8	5.2	23.7	8.2	12.1	4.4	8.7	3.9	6.9	2.0	11.2	6.1	3.7	11.8	7.4	7.5	3.3	5.1	10.2	18.5	6.2	5.3	4.9	4.4	12.7	14.0	7.1	3.5	17.8	5.0	14.1	7.8	7.3	7.6	6.3	5.4	1.9	2.2	8.9	4.3	7.0	4.6	11.2	4.7	8.6	10.1	8.0	3.4	5.5	3.3	5.7	0.0	4.2	21.1	10.7	9.1	6.9	28.5	3.9	0.0	3.0	3.0	9.2	3.4	12.7	11.0	5.8	9.2	0.9	16.7	5.3	3.5	0.0	26.8	6.5	2.8	7.3	5.3	2.2	2.9	6.5	4.6	3.7	10.6	2.5	7.7	10.5	5.9	24.2	2.5	6.7	12.6	5.5	5.3	1.3	6.6	14.7	11.1	4.5	8.4	12.5	12.6	14.6	5.2	48.5	14.8	23.6	9.4	9.1	9.9	7.3	13.5	0.1	3.6	7.0	3.7	14.0	2.8	0.0	9.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.0	0.5	0.2	0.9	0.0	0.0	4.1	5.2	12.1	4.4	3.3	5.1	4.9	4.4	5.0	4.3	4.7	5.7	37.1	25.6	17.0	18.9	55.3	28.4	21.1	8.1	44.3	13.4	48.8	39.8	36.1	25.8	11.8	12.9	16.7	38.3	34.1	38.9	3.9	13.1	83.7	82.4	60.6	34.5	60.4	3.0	12.8	6.9	41.0	29.3	40.8	142.6	9.5	37.0	16.8	31.7	13.3	32.0	11.1	43.0	20.3	21.3	79.6	29.7	19.3	32.0	49.8	13.1	11.2	20.8	8.2	19.6	13.4	8.3	14.8	21.1	24.5	82.1	0.4	14.5	19.4	10.6	26.3	46.6	49.5	14.6	10.6	13.6	12.6	105.2	28.4	19.6	34.7	19.6
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677132	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	7.3	7.2	6.1	10.6	7.0	38.0	10.0	11.8	10.3	8.2	5.9	6.7	8.3	9.8	7.2	7.6	6.8	7.4	5.6	6.9	5.9	7.3	9.6	8.2	13.5	5.6	6.0	10.4	9.6	9.9	5.5	9.2	6.2	8.1	7.6	12.4	9.2	6.7	9.1	12.4	7.2	7.1	6.6	13.1	7.8	10.5	6.3	13.7	8.4	10.0	12.7	8.6	6.8	10.0	14.8	16.5	10.7	14.0	16.7	16.3	18.7	14.4	14.2	13.0	14.3	15.0	10.0	18.1	11.4	11.0	11.6	18.0	16.3	16.4	23.3	18.8	11.3	40.1	15.8	14.1	12.8	28.8	14.2	13.1	20.8	12.1	27.8	11.6	13.0	20.6	23.7	21.2	14.1	18.4	25.5	12.8	10.1	15.7	24.0	20.6	16.7	22.1	12.2	17.4	31.0	11.4	18.7	15.0	19.1	6.5	19.1	15.3	14.7	19.6	14.2	8.2	14.5	24.2	21.7	33.4	12.2	18.6	13.9	6.7	3.7	4.2	3.6	4.6	4.7	2.9	3.1	4.0	4.6	3.8	3.5	3.0	2.4	3.0	7.3	2.7	3.8	2.8	6.1	7.0	11.8	10.3	6.9	5.9	5.6	6.0	6.2	6.6	6.3	10.0	19.0	32.1	20.8	12.7	28.2	46.4	20.0	8.4	51.8	14.2	21.4	17.4	12.1	10.0	19.3	1.8	33.3	10.2	40.3	14.0	0.0	6.6	3.2	44.7	50.4	20.1	20.2	12.4	32.7	5.5	7.5	19.4	15.8	70.2	8.8	13.7	13.2	10.3	7.9	21.9	28.2	14.5	14.2	23.0	24.4	3.9	8.4	25.9	19.6	12.2	20.3	12.0	21.6	15.1	27.6	7.6	4.4	14.3	32.6	18.3	8.2	6.2	20.1	22.8	6.6	25.0	19.1	25.5	21.8	50.0	49.0	16.8	34.1	14.3	14.2	24.1
ZBTB12	"C6orf46, D6S59E, G10, NG35"	ENSG00000204366	"Zinc finger and BTB domain containing 12"	Q9Y330	6	31899613-31902086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.6;Erythroid cells: 2.5;Horizontal cells: 3.3;Oligodendrocytes: 2.2;Rod photoreceptor cells: 1.7;Squamous epithelial cells: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.5;HEK 293: 3.1;NTERA-2: 2.5;REH: 4.6;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047161, HPA070639"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047161: AB_2679962, HPA070639: "	"unprognostic (2.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (8.98e-3)"	1.8	2.8	0.6	0.0	0.6	0.0	1.9	0.5	0.7	5.7	0.0	2.7	0.0	5.0	0.0	2.7	4.1	0.1	1.7	0.5	0.3	1.9	1.3	1.5	0.0	0.7	0.7	6.4	2.1	0.0	2.2	0.0	0.6	3.2	0.0	0.0	2.4	0.0	2.0	1.5	2.4	0.0	0.6	2.4	2.1	2.3	0.7	0.0	2.5	0.0	0.0	4.2	3.1	1.1	1.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	1.1	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.5	0.2	2.5	0.0	1.2	4.6	0.3	0.2	0.0	0.0	1.1	1.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.1	1.4	3.1	0.6	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.7	0.5	0.3	0.7	0.7	0.6	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.3	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.4	0.0	2.5	0.4	0.0	0.0	0.2	0.5	0.2	0.0	1.0	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	1.7	0.0	0.3	1.1	0.0	0.0	1.5	0.0	0.0	0.2	0.5	0.1	0.1
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314500-115147288	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	4.1	3.9	24.5	1.1	43.8	2.5	3.4	66.5	43.7	3.4	5.7	1.7	0.8	3.6	9.6	1.2	2.4	2.3	3.5	65.9	30.9	5.2	5.4	1.8	1.8	43.8	42.6	6.8	3.4	2.3	1.4	1.0	32.9	5.4	1.4	8.5	3.0	4.9	7.9	2.3	0.8	2.9	29.9	2.5	1.7	15.8	39.4	1.9	5.0	8.9	1.7	1.6	0.7	41.1	1.4	2.7	1.0	2.8	4.2	1.8	0.0	1.3	2.5	0.8	0.6	1.7	0.5	0.4	3.7	3.2	0.8	0.0	4.0	0.6	0.7	0.3	0.1	0.4	1.7	1.3	0.8	0.1	0.0	1.8	0.2	1.4	0.4	2.4	0.8	0.2	0.1	0.6	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.4	0.0	2.9	0.0	0.3	0.7	0.5	0.0	0.9	0.1	0.0	0.3	4.8	1.0	3.5	0.2	1.8	0.9	0.0	0.1	1.7	0.2	1.3	9.7	1.5	6.4	6.8	2.3	4.6	20.4	6.4	6.4	1.9	11.3	8.3	6.8	3.5	5.3	4.6	4.9	3.6	3.5	24.5	43.8	66.5	43.7	65.9	30.9	43.8	42.6	32.9	29.9	39.4	41.1	278.1	160.3	122.6	1998.0	115.4	25.7	38.2	11.3	22.2	123.6	103.7	81.8	48.5	108.7	25.2	294.3	60.5	0.2	56.1	10.3	49.0	231.4	450.3	109.8	628.3	106.4	31.8	20.4	72.3	82.9	0.6	174.5	36.7	170.5	80.6	194.5	56.0	106.0	4.3	80.8	462.3	14.5	40.7	20.4	28.5	111.1	105.6	36.0	32.0	855.4	29.3	127.7	36.0	1908.5	2090.4	107.8	10.5	120.7	58.4	28.0	19.2	198.4	36.4	108.6	85.5	301.2	124.6	6.9	8.7	14.2	18.5	0.5	67.4	140.7	17.2	25.0
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 41.2"	"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/70: 60.4;U-266/84: 57.0"	"Low region specificity"	"Detected in all"							"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032"	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	8.9	35.6	3.2	6.0	3.6	41.2	8.1	4.6	5.6	7.9	2.2	5.7	4.0	13.7	7.1	6.5	6.6	11.9	4.6	3.9	7.2	6.5	11.2	6.9	5.1	5.3	7.2	8.5	9.4	14.0	4.8	6.9	5.0	7.8	4.9	14.2	4.1	4.2	2.5	8.8	4.7	8.5	2.2	6.5	6.5	12.2	5.3	6.4	9.5	3.1	5.4	9.6	5.1	5.4	12.8	10.0	9.6	10.9	13.3	10.2	9.3	11.6	16.6	10.9	16.5	12.0	6.2	22.5	5.1	11.6	19.6	9.5	14.1	8.2	17.6	11.9	13.9	2.6	10.3	7.3	10.2	8.9	5.2	5.9	17.2	15.2	19.9	4.8	6.2	12.2	15.1	38.0	7.8	18.6	24.0	4.3	9.5	9.3	12.3	10.1	10.7	26.4	4.8	10.1	13.6	7.9	16.1	23.8	11.2	4.8	8.5	4.2	7.0	16.0	8.9	11.3	11.5	60.4	57.0	20.9	21.0	14.5	10.6	0.1	2.4	1.2	1.6	2.8	1.9	2.6	1.8	1.3	2.4	1.9	2.6	1.9	2.3	0.5	3.2	2.1	1.3	1.2	3.2	3.6	4.6	5.6	3.9	7.2	5.3	7.2	5.0	2.2	5.3	5.4	19.0	6.4	41.1	8.1	24.7	60.0	32.9	6.2	26.2	14.5	15.6	15.9	4.9	12.8	12.4	7.3	2.1	6.7	20.8	7.1	11.7	5.4	14.0	20.8	34.8	19.6	4.2	2.1	13.8	5.0	5.5	31.9	10.2	27.1	16.5	6.7	9.3	20.4	6.1	32.0	15.5	10.2	10.2	6.3	24.8	5.3	4.1	14.5	35.6	5.6	7.2	10.1	5.2	4.5	8.1	3.9	6.0	10.5	20.3	24.7	5.4	4.8	13.5	13.6	6.6	36.1	21.0	21.5	14.1	19.3	63.2	9.7	20.8	7.3	5.6	20.9
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA054699: AB_2682579"	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	6.6	6.1	6.5	8.3	7.9	7.6	6.1	8.8	8.5	7.3	6.5	7.4	3.6	6.1	8.3	4.1	8.4	5.4	11.0	7.1	6.2	4.8	6.9	6.9	11.1	8.7	7.3	8.0	6.7	6.2	9.0	4.3	8.0	6.7	4.9	11.1	4.7	4.8	11.2	7.7	7.8	5.6	7.3	8.4	5.1	6.4	8.8	12.7	8.8	8.9	11.1	7.6	6.5	11.0	20.2	8.7	5.6	5.4	8.0	10.0	11.2	3.4	6.1	5.5	7.2	4.0	13.8	14.9	3.9	5.7	6.9	18.1	5.7	5.7	6.7	15.6	1.8	3.4	14.1	1.9	9.2	2.3	7.6	12.8	5.5	5.4	10.7	11.7	5.1	14.0	2.1	23.7	6.6	8.7	8.5	3.5	2.9	7.1	8.9	6.5	6.2	6.4	6.3	9.4	5.5	6.0	7.1	5.3	4.5	5.2	6.8	1.8	5.5	7.5	11.2	3.5	5.2	20.9	5.1	6.7	11.1	3.0	5.7	3.8	2.4	1.6	6.5	1.6	8.6	6.6	9.3	6.4	1.7	3.9	10.7	10.8	2.4	7.0	1.4	2.9	8.9	7.5	6.5	7.9	8.8	8.5	7.1	6.2	8.7	7.3	8.0	7.3	8.8	11.0	7.2	6.4	13.0	15.3	25.1	7.9	8.4	13.9	12.5	19.4	7.1	7.6	19.2	8.6	7.8	7.3	18.8	7.1	19.3	2.3	9.8	8.5	47.9	15.6	9.4	8.7	3.5	14.1	23.1	6.6	9.8	10.8	6.1	7.6	6.3	11.9	7.1	10.9	10.8	8.4	28.1	2.6	8.2	11.1	19.1	54.1	13.4	12.6	17.8	15.9	10.5	7.5	27.8	26.7	37.0	7.2	3.7	10.9	19.3	6.3	3.8	7.7	15.4	22.4	0.0	12.5	10.2	11.9	11.8	7.7	8.4	4.0	33.2	8.7	4.6	5.9
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	6.4	7.0	6.4	8.5	7.0	19.5	15.4	7.1	9.0	6.8	4.7	6.8	7.7	6.2	9.4	9.9	8.2	7.3	4.9	6.4	9.2	6.4	19.0	8.7	13.2	7.3	8.7	9.7	8.4	13.7	4.8	8.8	8.5	7.4	6.5	5.7	10.4	6.0	5.4	18.8	6.4	4.8	8.4	11.5	8.6	5.7	9.3	16.2	10.2	7.7	12.8	8.0	4.8	9.7	13.6	12.9	19.6	18.1	15.9	17.8	23.4	10.3	13.5	11.7	14.5	9.0	11.7	19.5	18.8	10.4	15.7	20.7	31.9	15.7	15.3	22.0	21.6	20.3	20.3	12.7	11.6	21.2	22.7	12.7	19.9	11.2	17.6	17.1	20.9	18.7	13.5	23.2	14.6	15.6	19.2	14.1	24.3	20.9	15.3	21.9	14.9	32.0	12.5	22.2	35.6	15.2	20.9	21.3	25.3	14.9	11.5	29.6	19.6	9.5	6.9	14.3	18.5	12.7	13.1	24.7	12.6	29.4	11.9	11.5	4.2	5.6	2.9	6.4	5.0	2.4	3.8	3.9	6.2	2.2	4.6	3.4	0.9	4.0	4.2	6.7	3.5	3.6	6.4	7.0	7.1	9.0	6.4	9.2	7.3	8.7	8.5	8.4	9.3	9.7	15.7	16.0	7.0	3.9	7.9	12.7	7.8	5.1	12.5	4.5	11.5	13.1	5.2	8.6	11.9	1.8	0.0	7.7	21.7	5.3	1.9	5.5	0.1	12.9	8.7	8.5	8.4	10.3	3.4	6.7	8.7	7.9	7.1	10.3	0.0	16.0	7.9	16.6	7.6	3.3	4.6	7.0	6.1	12.8	10.3	0.4	4.4	8.2	3.6	3.7	14.6	7.0	14.4	5.0	4.6	6.9	5.7	2.6	5.4	9.5	6.8	4.0	15.3	1.6	6.6	6.9	4.1	5.0	10.0	12.7	13.1	9.3	8.7	11.2	6.0	11.9
ZBTB38	"CIBZ, FLJ35036, PPP1R171, ZNF921"	ENSG00000177311	"Zinc finger and BTB domain containing 38"	Q8NAP3	3	141324213-141449792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 284.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 261.2;RPMI-8226: 395.1;U-266/70: 259.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014865, HPA059378"			Enhanced	Nucleoplasm		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA014865: AB_2732412, HPA059378: AB_2683998"	"unprognostic (1.78e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	27.1	42.3	7.7	30.4	14.4	11.3	25.4	34.1	18.1	47.8	11.9	39.1	28.8	65.5	20.3	26.8	32.3	47.3	42.1	9.8	9.6	34.1	24.2	31.7	34.4	11.8	12.8	38.2	33.6	53.5	8.3	34.8	13.9	28.1	40.8	39.0	33.0	33.9	55.1	16.7	31.5	56.0	8.0	23.9	29.2	30.1	14.0	14.3	38.0	31.0	38.7	35.0	11.6	28.3	56.4	82.0	9.3	18.7	84.8	79.4	12.5	89.0	106.7	84.6	122.8	43.0	32.4	1.9	36.1	78.1	65.7	15.5	10.8	75.4	191.5	54.5	15.2	15.8	74.4	25.2	94.0	1.0	22.4	60.1	43.8	89.9	180.6	137.8	65.6	1.5	16.9	261.2	96.9	6.0	1.0	3.5	9.7	15.7	10.1	1.1	27.5	395.1	54.3	34.3	3.6	13.7	130.7	12.4	46.0	16.4	26.8	13.8	159.5	68.5	17.5	134.9	42.2	259.7	163.4	19.8	116.7	1.8	38.5	27.9	5.5	15.2	25.9	8.2	19.3	16.6	16.7	26.4	8.1	7.2	12.9	21.0	6.3	24.1	7.2	3.9	24.4	11.5	7.7	14.4	34.1	18.1	9.8	9.6	11.8	12.8	13.9	8.0	14.0	28.3	70.7	76.9	64.6	38.2	48.0	20.4	33.8	36.3	24.5	89.8	44.0	41.1	114.8	64.3	61.2	58.8	75.0	32.6	66.5	57.8	29.4	39.3	284.2	63.4	107.9	81.2	36.0	17.7	115.4	31.8	17.0	59.3	35.2	125.9	68.9	40.0	59.3	34.9	32.6	141.3	107.9	37.0	24.4	23.4	43.1	118.6	70.5	37.9	39.2	65.6	70.8	59.3	55.6	56.8	105.3	69.6	37.0	103.0	221.9	36.8	38.9	51.1	46.6	73.3	118.3	71.9	106.9	9.4	11.4	19.0	18.6	124.9	88.4	35.6	82.5	43.5
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 135.2;Proximal enterocytes: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	24.9	35.3	12.9	18.1	15.8	30.0	27.9	15.8	12.9	25.3	11.7	55.4	61.9	16.1	6.4	95.4	17.9	11.0	25.2	11.2	13.6	19.7	48.4	25.0	16.2	18.3	17.5	12.7	29.9	15.6	20.0	9.0	17.3	30.5	18.6	6.5	40.2	12.8	40.6	111.9	71.2	9.9	15.8	31.6	37.7	6.1	17.7	9.0	25.5	17.6	15.2	20.4	44.4	17.9	16.5	29.0	2.5	8.8	12.7	7.2	34.7	11.1	13.1	11.4	13.2	19.5	23.4	7.2	19.5	12.6	9.1	24.5	8.1	15.7	2.4	39.4	9.1	12.0	51.4	13.1	18.6	9.2	31.7	9.4	54.8	15.6	19.3	15.3	9.1	1.1	17.3	32.2	6.7	31.2	0.2	20.7	8.7	26.4	23.8	6.8	1.9	45.6	17.2	16.9	16.1	16.5	21.4	56.5	8.9	10.6	35.2	30.7	7.7	7.4	12.9	14.8	9.5	38.1	25.1	7.6	17.3	30.3	8.6	0.4	1.5	1.3	0.6	1.4	0.2	0.6	0.7	0.3	0.9	0.7	0.6	0.2	2.3	0.7	1.2	0.0	1.0	2.5	12.9	15.8	15.8	12.9	11.2	13.6	18.3	17.5	17.3	15.8	17.7	17.9	6.5	9.6	0.0	11.1	8.5	35.2	9.3	8.8	29.6	13.6	35.2	15.6	2.6	18.6	7.1	5.5	2.1	11.9	6.9	135.2	11.7	13.3	4.3	15.4	6.7	5.6	6.7	6.1	1.0	15.1	14.6	4.9	27.5	21.3	5.7	2.8	6.1	29.9	14.8	16.8	1.1	32.7	14.2	28.7	40.3	8.3	9.0	20.7	16.0	4.7	25.8	5.4	11.3	0.0	8.6	16.8	57.7	7.2	6.8	24.9	158.5	10.0	4.2	10.3	0.0	3.2	5.7	0.5	1.2	51.7	53.6	27.5	11.3	4.4	38.5	24.4
ZC3H14	"FLJ11806, NY-REN-37, UKp68"	ENSG00000100722	"Zinc finger CCCH-type containing 14"	Q6PJT7	14	88562970-88627596	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"testis: 173.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1282.6;Late spermatids: 460.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049798, HPA053510"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"	"Nucleoli, Nucleoli rim"	"HPA049798: AB_2680888, HPA053510: AB_2682174"	"unprognostic (5.80e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.47e-3)"	"unprognostic (9.57e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.25e-2)"	20.9	21.0	9.5	16.3	10.7	23.6	22.5	26.9	14.9	23.7	38.3	26.9	19.7	25.7	25.1	20.2	27.7	18.7	24.7	10.8	8.1	24.3	43.3	24.2	18.2	5.5	5.1	26.1	37.4	33.2	24.3	23.0	6.8	23.6	31.2	41.1	31.4	23.6	30.2	21.4	21.2	28.2	4.4	15.7	21.6	173.6	9.0	20.0	32.2	25.1	23.6	22.1	19.5	13.1	39.5	75.4	64.7	54.8	50.8	48.6	68.3	58.6	54.2	85.2	74.7	55.3	63.2	55.1	41.9	61.4	46.3	44.4	46.8	55.7	115.9	43.4	34.7	26.7	51.6	42.5	51.2	57.3	34.3	39.2	65.2	68.2	66.9	53.3	56.7	47.2	54.2	21.0	75.8	86.3	52.8	28.1	39.9	60.8	64.1	46.1	83.9	23.1	54.3	68.2	45.6	37.0	75.2	75.4	37.3	54.3	75.3	36.3	39.2	101.3	65.1	43.1	59.2	29.3	30.0	61.7	49.0	27.1	48.0	19.1	20.7	29.4	18.9	25.3	20.4	16.8	18.0	20.8	22.1	15.4	17.2	16.9	3.8	25.9	29.6	12.5	17.2	17.4	9.5	10.7	26.9	14.9	10.8	8.1	5.5	5.1	6.8	4.4	9.0	13.1	25.2	121.8	57.0	38.2	18.1	22.7	24.5	25.2	21.1	61.2	27.0	24.9	22.6	28.6	37.6	20.2	77.2	49.2	25.4	28.4	35.2	25.6	1282.6	53.0	46.6	28.7	31.8	17.1	88.8	23.0	27.4	30.5	20.9	34.3	45.6	51.8	24.3	38.1	20.3	65.6	65.5	31.4	34.6	14.9	16.3	460.1	39.4	19.6	5.4	34.7	20.0	33.6	18.6	64.3	62.9	22.0	16.4	47.4	18.6	26.0	27.4	32.4	53.0	78.9	13.1	46.6	35.4	217.9	81.5	23.0	19.7	40.6	20.1	39.2	32.8	16.3
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486253-186509361	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	42.6	47.5	39.2	44.3	42.0	128.8	45.9	43.4	52.5	35.1	38.6	40.8	48.3	39.8	47.0	40.2	26.3	36.5	37.0	42.6	44.5	53.8	67.3	28.4	53.9	42.2	40.9	32.6	47.9	41.2	27.2	48.8	41.7	37.0	46.0	53.0	45.3	32.4	50.3	44.3	46.1	36.9	39.4	38.6	36.8	40.6	41.7	50.2	49.3	44.9	51.4	54.0	29.2	42.4	103.5	68.9	83.3	107.8	93.0	93.4	124.9	112.7	76.7	102.3	91.5	202.9	81.8	140.3	100.2	80.9	130.9	73.6	155.8	137.5	144.0	128.7	118.1	201.9	101.1	221.9	124.9	208.7	118.6	77.2	149.6	111.4	157.2	89.9	111.9	86.0	197.0	106.8	108.4	93.5	133.7	146.5	157.6	135.7	171.8	105.2	113.0	131.6	127.6	124.0	100.3	73.6	71.5	96.4	167.3	124.3	68.1	149.7	95.7	114.7	99.1	70.9	136.4	92.0	167.0	199.8	101.7	145.7	102.3	59.9	47.9	49.1	44.7	61.6	55.8	55.0	54.8	57.4	54.7	42.2	50.5	53.9	28.8	60.4	75.1	48.0	66.6	41.5	39.2	42.0	43.4	52.5	42.6	44.5	42.2	40.9	41.7	39.4	41.7	42.4	107.1	73.7	83.6	26.4	137.0	212.2	169.1	116.6	99.6	75.0	101.9	118.9	95.8	57.2	104.8	115.8	60.5	131.3	116.1	131.4	256.3	112.0	153.1	110.1	125.5	106.4	101.7	98.7	38.0	104.3	167.0	107.4	67.8	127.1	112.2	220.1	62.4	137.0	124.3	57.2	39.8	136.1	87.5	107.4	104.8	307.1	78.6	113.2	64.0	33.7	142.5	82.6	126.7	19.6	32.8	111.6	106.2	87.3	128.0	179.5	164.1	330.2	68.3	130.2	32.9	156.2	127.6	215.6	174.4	116.1	209.1	177.6	117.3	319.6	151.2	163.5
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570403-88631964	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favorable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	14.1	11.0	10.7	18.7	11.3	25.5	13.6	14.4	14.2	14.3	5.7	16.1	14.9	17.4	4.3	14.5	14.2	8.8	14.3	10.6	11.4	10.9	12.0	13.1	18.4	10.1	9.6	14.1	13.7	12.3	10.1	11.9	9.2	11.5	8.1	9.0	13.6	8.2	22.8	15.3	15.6	10.1	7.5	17.4	14.5	25.3	10.2	19.1	13.1	10.1	12.3	15.3	13.7	12.1	45.3	59.6	42.6	42.8	20.7	17.7	68.3	44.5	24.1	40.8	18.5	58.8	38.3	55.1	36.9	21.1	27.3	53.0	40.3	33.7	25.6	32.5	51.2	36.6	29.2	50.6	26.2	28.5	30.7	16.1	25.2	43.3	20.8	16.9	25.5	37.8	101.4	17.8	20.4	87.4	91.6	50.5	66.7	35.3	35.5	111.0	29.3	40.4	18.5	28.3	44.9	38.7	85.2	23.5	25.2	24.8	53.3	38.1	35.1	43.6	45.2	32.0	45.5	39.5	67.2	130.8	38.6	65.7	47.0	2.3	2.0	2.0	2.5	2.3	2.8	2.3	2.4	2.7	1.9	1.9	2.1	1.7	3.4	3.1	5.4	2.8	3.3	2.1	10.7	11.3	14.4	14.2	10.6	11.4	10.1	9.6	9.2	7.5	10.2	12.1	24.9	28.9	24.2	11.1	29.6	16.8	17.0	11.1	13.1	26.6	13.8	14.4	10.2	20.0	23.9	16.5	35.5	24.1	45.6	30.1	7.9	16.5	76.2	21.9	28.7	21.3	25.0	28.6	12.0	16.6	22.1	18.7	22.4	32.1	20.8	26.6	16.4	12.9	18.2	28.6	11.9	18.5	10.2	20.1	21.1	10.0	21.8	30.5	14.2	12.2	23.9	18.1	46.4	7.1	15.7	17.5	21.7	17.0	35.5	20.5	20.3	8.4	13.1	44.0	6.6	28.8	19.5	41.4	37.5	19.6	22.3	25.2	39.2	25.1	24.7	16.6
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113776	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.23e-4)"	8.0	7.7	11.6	8.3	11.6	5.6	8.1	11.9	9.8	9.7	3.3	10.3	6.7	11.5	3.2	11.5	9.1	3.7	8.7	9.6	8.3	8.4	10.4	6.9	9.0	11.5	11.1	10.6	10.8	4.8	9.8	3.8	9.7	9.1	4.0	5.2	8.3	4.7	10.5	10.4	10.3	4.7	9.3	12.5	9.0	11.2	11.2	9.6	9.4	5.3	6.3	9.6	8.8	11.0	14.4	22.2	13.5	19.3	7.4	4.6	13.7	11.3	6.4	10.4	7.0	15.9	15.8	30.3	8.2	7.7	6.4	24.5	5.9	16.1	6.6	18.8	9.6	21.6	13.9	12.2	6.4	20.7	22.1	7.8	4.4	9.6	7.6	5.6	8.6	18.4	21.2	11.2	6.9	25.2	23.6	34.9	20.1	9.7	7.4	36.5	11.6	13.7	8.0	23.2	16.4	23.1	17.3	14.3	8.6	6.5	15.0	16.6	15.2	14.1	13.7	9.1	16.1	14.5	12.7	26.4	11.0	16.6	20.5	2.6	0.9	1.5	2.2	1.6	2.3	2.1	1.9	2.3	1.2	1.9	1.7	1.9	2.7	2.3	1.6	3.0	1.3	0.6	11.6	11.6	11.9	9.8	9.6	8.3	11.5	11.1	9.7	9.3	11.2	11.0	19.4	3.2	13.1	10.7	16.6	22.3	6.2	8.4	6.8	23.8	18.0	10.0	12.8	28.6	11.7	20.2	14.6	6.6	14.7	20.0	9.8	10.8	18.0	13.0	16.0	14.7	19.2	20.0	8.8	11.6	7.4	12.7	9.7	18.2	12.6	17.5	19.2	16.5	12.9	16.8	9.9	18.4	8.2	28.3	20.0	6.8	16.8	18.9	7.2	13.1	23.3	14.3	17.5	12.5	17.6	10.9	14.6	9.8	8.2	9.7	15.1	11.5	12.6	23.8	6.6	16.0	13.8	15.6	9.8	14.7	22.4	8.6	16.1	9.8	17.1	7.5
ZC3HAV1	"ARTD13, FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043515-139132122	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 85.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 194.8;Glandular and luminal cells: 359.9;T-cells: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA		24000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	13.5	12.7	8.7	19.1	8.9	85.9	11.1	8.1	15.2	8.6	12.2	12.9	9.7	8.6	10.3	12.9	9.7	11.4	6.4	8.1	13.6	11.1	11.0	16.1	24.0	12.3	11.5	10.9	7.3	9.2	6.2	9.3	12.3	9.5	13.7	2.5	14.3	9.1	3.2	13.1	13.9	13.8	12.7	21.0	10.4	6.5	14.9	24.0	10.6	5.6	23.8	11.9	8.7	12.4	25.1	29.5	4.1	24.7	37.4	35.9	17.6	27.5	21.2	46.9	47.7	21.6	31.4	21.9	25.2	43.9	40.6	27.6	33.2	32.6	26.3	37.2	12.2	43.8	29.7	26.9	21.8	51.1	38.6	37.0	20.3	53.3	11.8	17.4	35.3	32.1	37.6	23.5	20.1	23.3	41.9	59.0	16.6	18.6	17.6	48.5	14.6	21.0	32.0	31.0	7.5	15.4	43.1	29.2	37.8	9.3	17.4	30.9	45.3	9.9	14.3	27.6	23.1	17.9	20.2	49.9	22.4	47.0	24.0	78.7	19.6	30.8	43.0	26.0	56.0	32.2	61.9	53.1	15.2	35.3	59.0	58.6	52.5	38.7	30.6	17.7	58.8	30.6	8.7	8.9	8.1	15.2	8.1	13.6	12.3	11.5	12.3	12.7	14.9	12.4	150.3	25.6	41.1	8.1	119.4	28.7	21.7	17.5	62.6	2.8	70.8	44.8	6.2	21.5	21.1	53.3	4.2	12.6	194.8	57.0	9.8	20.2	2.8	185.9	77.7	74.5	53.2	64.4	0.8	21.2	23.1	68.1	60.6	359.9	32.3	41.6	49.2	36.1	35.1	0.0	3.0	42.2	8.2	43.9	150.0	1.9	18.6	84.4	39.2	33.7	57.1	13.9	88.6	27.6	1.0	23.8	33.8	26.7	104.2	41.5	28.0	36.4	29.9	1.3	13.1	79.5	53.6	1.0	1.1	61.7	22.3	2.3	222.3	41.3	35.8	28.0
ZC3HAV1L	"C7orf39, MGC14289"	ENSG00000146858	"Zinc finger CCCH-type containing, antiviral 1 like"	Q96H79	7	139025706-139036042	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 5.6;Gastric mucus-secreting cells: 4.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 10.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020386, HPA050741"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA020386: AB_2257412, HPA050741: AB_2681224"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-3)"	3.1	3.7	2.2	2.6	2.8	1.3	3.4	0.0	2.1	3.3	9.9	2.3	3.2	6.7	2.2	4.3	4.9	3.2	2.6	3.3	3.8	2.8	0.8	2.5	2.5	1.4	1.2	9.3	1.8	2.3	1.6	9.5	0.9	3.9	3.2	0.5	2.6	4.3	1.7	8.7	2.6	5.2	0.6	4.6	2.8	2.0	4.4	2.9	8.3	1.6	3.0	2.7	2.8	1.0	14.9	11.9	8.6	28.8	7.1	10.8	0.4	7.2	3.2	5.3	7.3	19.9	8.4	0.4	10.1	7.8	0.0	10.5	12.1	3.0	16.0	8.8	0.1	19.0	12.6	6.8	5.7	0.1	6.6	8.3	4.6	7.9	3.7	0.3	9.1	9.3	8.3	0.5	10.9	0.1	20.4	11.4	1.5	2.0	7.4	21.1	29.2	0.2	4.9	7.9	5.8	26.1	17.7	2.5	10.6	1.7	10.9	7.7	12.7	9.5	8.5	3.2	0.1	0.5	0.1	0.3	5.3	0.1	9.0	10.2	0.1	0.9	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.9	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.2	2.2	2.8	0.0	2.1	3.3	3.8	1.4	1.2	0.9	0.6	4.4	1.0	2.4	0.0	0.0	1.6	0.1	0.4	0.9	0.2	2.8	0.3	0.8	1.7	0.5	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.0	0.2	0.0	1.4	4.4	1.6	0.0	3.8	5.6	0.0	1.6	2.0	4.6	0.8	4.5	3.0	1.1	0.0	0.9	0.0	2.3	0.0	0.0	0.3	0.3	0.0	1.8	0.5	0.0	9.4	0.0	0.6	0.0	5.5	0.2	0.2	0.0	1.5	1.5	0.6	0.0	0.3	0.1	0.0	0.0	0.9	2.3	0.0	0.6	2.9	1.0	0.7	0.2	3.8	0.2	0.5
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120574-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 225.6;Inhibitory neurons: 229.6;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 124.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	8.3	7.4	5.8	12.7	5.5	13.7	13.2	18.7	8.8	9.3	5.1	8.2	7.9	11.6	11.3	7.5	9.6	7.9	6.4	5.3	5.4	7.4	8.1	6.5	23.2	5.6	6.2	16.6	11.2	7.1	9.4	7.9	6.6	7.0	10.9	9.9	7.8	7.1	5.9	8.2	8.2	9.5	4.4	10.6	7.7	12.1	7.4	12.9	12.3	6.0	24.8	9.5	7.5	9.2	17.2	9.4	17.5	18.4	17.4	27.0	15.5	17.4	21.3	14.0	19.2	11.8	8.6	54.8	8.1	14.0	15.9	7.2	16.6	17.1	19.9	26.3	8.8	19.1	19.3	10.7	27.3	32.5	17.5	18.6	26.3	14.2	56.7	26.0	16.0	24.4	53.3	21.8	12.7	8.2	24.9	18.2	18.3	20.3	17.3	124.7	11.0	16.2	17.6	7.1	17.5	12.9	12.6	15.3	17.1	16.9	10.2	21.4	12.7	9.9	11.8	14.1	10.3	5.0	13.2	76.4	14.9	20.8	18.7	8.4	7.6	20.6	12.9	9.0	12.8	32.6	14.9	15.0	7.2	48.9	18.6	17.3	15.3	18.4	17.2	13.2	13.4	9.3	5.8	5.5	18.7	8.8	5.3	5.4	5.6	6.2	6.6	4.4	7.4	9.2	27.7	35.3	18.5	126.3	110.3	28.3	29.5	28.2	32.5	15.5	21.7	23.7	10.7	15.7	21.7	5.5	10.4	15.3	32.8	7.7	27.4	16.3	52.2	17.6	37.6	18.7	19.1	38.5	225.6	15.8	25.4	31.0	30.1	24.2	23.5	18.0	16.4	11.6	15.2	11.8	229.6	22.5	40.7	17.9	22.8	20.8	27.1	20.3	16.0	121.8	19.8	18.2	28.8	196.1	250.0	12.8	13.6	19.5	44.7	34.9	17.7	22.5	19.1	24.9	6.6	33.9	25.4	60.1	44.8	29.3	32.7	18.6	42.2	32.4	20.3	26.0
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471599-122501073	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 43.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	10.2	8.2	3.6	8.9	4.0	43.7	9.9	7.5	4.8	10.8	5.5	9.3	9.0	9.8	8.8	9.8	10.2	6.5	6.3	3.4	3.5	7.9	10.3	8.5	10.5	4.2	3.6	11.5	9.4	8.9	8.9	8.1	3.9	7.9	8.1	10.8	9.7	6.6	16.8	11.8	10.4	7.5	3.0	11.0	10.7	12.1	3.9	10.7	10.8	8.7	11.8	8.9	9.6	5.5	14.8	14.4	21.7	21.0	8.4	10.8	25.2	18.0	11.3	21.5	16.1	13.9	13.0	26.6	10.9	7.6	12.5	17.4	23.1	9.8	19.6	20.9	14.0	17.5	21.0	11.5	19.8	30.5	16.9	9.4	15.7	12.9	18.2	19.2	10.9	26.8	24.3	17.0	11.3	8.4	20.7	23.9	18.5	10.0	15.3	24.2	17.8	21.4	10.5	9.3	15.6	17.2	20.5	9.5	23.0	21.1	20.0	20.3	12.2	14.3	15.3	14.2	17.7	18.2	11.6	36.6	7.8	19.6	8.6	5.5	3.4	2.2	3.5	3.6	3.6	4.5	4.1	4.3	2.8	4.0	4.6	3.8	2.9	4.3	4.3	2.9	5.7	2.5	3.6	4.0	7.5	4.8	3.4	3.5	4.2	3.6	3.9	3.0	3.9	5.5	21.6	32.1	22.6	20.5	26.8	20.5	27.2	13.5	27.3	30.5	23.1	21.5	9.4	21.5	27.0	9.2	125.1	17.4	32.6	13.3	1.9	11.8	78.5	30.7	40.6	21.0	19.6	48.2	21.7	9.5	17.6	22.8	26.0	41.4	19.0	22.5	10.4	17.9	12.8	15.2	24.6	15.5	14.2	15.6	20.2	48.1	14.9	22.4	16.0	26.2	23.5	12.4	21.6	27.6	25.3	14.1	12.2	14.7	29.6	21.3	18.8	6.6	20.4	72.7	6.6	33.6	21.0	34.4	17.1	24.0	25.7	32.3	26.2	19.0	17.3	22.9
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type palmitoyltransferase 22"	Q8N966	14	77131270-77142734	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 17.3;Excitatory neurons: 8.8;Inhibitory neurons: 13.4;Late spermatids: 5.0;Oligodendrocyte precursor cells: 24.6"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 3.6;NTERA-2: 3.8;RH-30: 6.4;SCLC-21H: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA049471: AB_2732553, HPA072213: AB_2686496"	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	0.0	0.2	14.9	0.0	15.3	0.0	0.0	25.9	33.8	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	21.2	12.8	0.0	0.0	0.0	0.0	1.2	22.7	0.0	0.0	0.0	4.7	0.0	1.0	0.0	0.1	7.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.5	51.3	0.0	0.1	0.4	0.0	0.1	0.0	13.9	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	3.8	0.0	0.5	0.0	6.4	0.0	0.0	0.0	7.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	15.3	25.9	33.8	21.2	12.8	1.2	22.7	1.0	0.0	51.3	13.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	24.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZFPL1	"D11S750, MCG4"	ENSG00000162300	"Zinc finger protein like 1"	O95159	11	65084210-65088398	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014909, HPA017347"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA014909: AB_1859055, HPA017347: AB_1859056"	"unprognostic (2.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.12e-6)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.63e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.34e-2)"	"unprognostic (6.94e-2)"	30.8	32.5	23.0	11.5	25.7	29.3	29.3	24.9	29.8	29.5	22.6	30.4	17.9	31.4	18.7	30.0	27.8	10.0	30.7	22.4	23.9	27.9	32.6	21.4	11.9	25.1	24.5	29.3	32.0	15.6	40.5	12.8	24.0	31.5	9.1	7.6	30.8	16.8	37.8	35.2	28.1	12.7	23.8	25.4	30.4	27.5	25.2	11.0	27.1	20.4	8.3	31.1	26.5	26.3	60.3	41.1	25.4	26.5	22.3	31.5	40.5	26.0	33.8	31.8	25.2	27.5	40.9	19.5	51.2	39.5	31.0	30.8	15.0	34.4	11.1	27.7	25.0	20.0	29.3	54.3	48.0	14.8	27.0	29.7	45.2	24.0	40.6	20.2	31.2	30.4	24.3	29.4	23.9	83.1	25.6	35.8	17.2	19.9	35.7	23.3	14.5	53.7	25.0	27.9	27.6	22.3	21.5	41.8	63.5	12.1	61.7	25.4	30.1	21.2	35.0	47.2	21.4	19.4	21.0	24.0	33.2	14.6	41.2	77.1	19.7	42.2	15.1	21.4	16.3	18.0	14.0	15.9	20.0	20.1	15.3	13.8	27.3	23.8	21.2	19.6	26.1	12.0	23.0	25.7	24.9	29.8	22.4	23.9	25.1	24.5	24.0	23.8	25.2	26.3	22.6	12.8	18.4	6.8	16.1	11.0	29.6	45.0	19.4	20.4	27.4	27.1	4.4	21.5	35.3	12.9	4.2	49.9	19.0	49.6	58.7	39.4	18.6	24.1	17.9	17.9	22.8	14.5	6.4	47.9	47.1	19.4	25.0	29.6	9.5	30.0	16.4	20.7	32.1	23.5	6.1	40.1	32.6	15.7	11.9	47.0	20.5	12.8	17.8	3.7	25.0	39.2	18.6	5.0	23.7	44.0	44.4	20.3	29.5	29.8	55.0	32.6	25.8	19.5	19.7	17.5	27.5	35.7	18.3	24.4	12.5	68.3	13.6	17.0	37.5	36.1
ZFYVE16	"KIAA0305, PPP1R69"	ENSG00000039319	"Zinc finger FYVE-type containing 16"	Q7Z3T8	5	80408013-80483379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 620.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 21.2;neutrophil: 21.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 80.7"					"Low region specificity"	"Detected in all"			"HPA035935, HPA035936"	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 6: Non-specific - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"		"HPA035935: AB_10672076, HPA035936: AB_10669662"	"unprognostic (1.11e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.23e-2)"	8.4	8.7	5.1	8.1	12.0	5.2	8.7	5.7	6.4	15.1	4.3	6.4	5.1	12.7	2.5	7.2	7.2	11.2	14.0	4.1	8.2	9.5	10.3	9.1	5.6	7.0	8.5	12.3	6.4	9.0	3.9	13.0	7.6	8.5	6.3	8.6	5.0	6.6	6.1	4.3	6.8	9.9	6.5	9.0	6.6	9.3	8.3	5.0	9.5	8.4	4.5	9.5	4.7	15.5	11.9	13.4	23.4	21.9	14.0	14.3	15.5	17.6	15.2	15.4	20.7	9.9	16.5	7.9	12.5	14.6	16.4	11.9	17.2	14.4	16.9	5.1	10.9	8.6	16.3	11.3	11.6	2.6	6.3	15.4	7.5	12.9	12.4	12.4	18.0	7.3	8.5	12.0	16.8	14.9	5.7	2.5	5.3	6.1	6.5	11.7	48.3	8.4	12.9	22.1	8.8	19.5	25.3	11.6	80.7	14.1	20.2	7.7	16.0	9.2	10.3	14.3	14.6	3.6	7.6	7.8	12.1	8.0	21.0	21.2	4.5	2.5	1.8	2.8	1.0	3.6	0.9	1.6	1.8	3.2	0.7	0.9	21.3	3.0	5.4	3.0	1.0	0.4	5.1	12.0	5.7	6.4	4.1	8.2	7.0	8.5	7.6	6.5	8.3	15.5	49.3	25.6	22.2	127.0	25.8	18.2	14.0	16.4	15.4	94.9	23.4	18.2	52.3	14.3	33.8	31.3	114.7	22.1	28.9	20.3	9.8	16.2	7.4	47.6	85.6	33.1	21.6	7.8	87.7	12.3	11.8	33.7	23.9	37.5	10.1	59.7	35.7	16.8	26.5	80.8	114.0	11.3	2.0	59.8	71.5	7.0	37.9	71.4	19.6	64.6	34.7	26.3	17.5	182.0	620.2	16.4	20.2	44.4	19.0	16.5	16.3	13.6	49.9	75.3	32.9	58.6	43.3	49.0	22.0	15.6	25.4	37.4	17.5	44.7	12.9	20.1
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142089-52348671	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 131.0;Inhibitory neurons: 162.6;Oligodendrocyte precursor cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570"	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	9.3	8.2	13.7	3.3	14.5	1.1	11.2	20.5	16.6	12.4	31.1	8.3	5.7	12.0	7.3	9.1	10.0	6.9	7.2	15.5	13.2	12.9	9.2	9.8	2.2	13.0	13.2	16.3	15.0	25.7	8.9	6.3	14.2	11.1	8.2	13.7	9.2	11.1	25.7	10.7	5.5	11.2	10.9	3.6	7.4	13.8	13.5	5.3	16.9	20.2	3.4	8.9	8.6	13.5	17.9	8.3	11.7	15.1	27.5	25.0	19.2	14.2	18.8	16.5	18.8	9.6	1.4	0.0	8.7	20.0	22.7	6.5	20.8	22.5	25.1	0.1	14.6	5.1	9.3	11.4	18.0	4.5	2.9	16.7	24.9	14.2	31.9	20.1	24.0	11.8	8.0	3.2	22.2	3.9	6.5	3.3	15.4	4.7	14.8	5.7	20.1	1.7	9.4	38.5	9.9	10.2	15.9	13.4	18.4	23.2	6.2	5.9	22.3	16.6	6.7	12.8	8.6	4.5	2.9	2.2	11.8	5.4	6.8	1.3	0.0	0.1	0.2	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.1	13.7	14.5	20.5	16.6	15.5	13.2	13.0	13.2	14.2	10.9	13.5	13.5	11.5	9.6	5.9	61.7	0.7	5.1	10.0	4.0	10.8	19.9	6.6	5.7	13.6	7.2	9.4	1.8	4.2	5.5	1.1	8.8	7.9	6.4	12.6	6.3	19.1	9.3	17.5	0.0	131.0	7.4	5.3	11.0	23.4	7.9	1.3	16.0	5.0	8.5	0.5	23.5	162.6	8.1	2.0	0.6	1.3	17.3	15.2	0.5	7.2	45.9	0.2	10.0	1.0	80.9	37.5	4.1	7.9	16.6	3.5	7.8	8.2	10.2	2.5	14.3	13.1	20.9	8.3	45.5	46.8	11.7	7.4	2.9	3.8	15.0	6.3	6.4
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781655-122974510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Astrocytes: 252.1;Microglial cells: 81.5;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 176.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 49.3;REH: 53.1;U-698: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.6	11.7	18.5	14.0	25.7	6.8	11.5	19.4	19.5	15.2	10.0	8.8	5.4	14.7	7.0	9.7	15.1	12.3	20.6	18.7	18.6	10.2	15.0	13.8	27.6	23.0	21.4	27.6	17.7	7.7	12.0	6.4	21.8	15.1	6.5	11.7	13.3	9.7	33.8	9.3	12.0	11.5	19.2	15.8	7.9	2.8	21.8	14.2	13.7	21.9	23.2	13.0	10.7	31.3	5.7	2.7	14.9	3.0	7.1	2.2	0.0	3.2	9.9	3.5	4.6	0.6	18.0	49.3	13.0	10.7	2.7	4.7	10.1	6.3	3.8	22.8	7.0	22.3	3.3	17.5	7.9	5.5	7.0	6.4	7.4	3.3	17.2	16.6	4.2	8.9	0.8	16.7	4.2	16.2	5.2	5.1	8.7	2.9	3.7	53.1	8.1	4.1	17.2	13.5	6.6	3.7	12.9	38.8	6.8	9.9	6.6	12.6	6.9	2.8	7.3	3.4	7.0	4.5	0.1	48.4	2.8	4.3	4.7	13.0	1.0	5.5	6.5	1.3	6.8	11.6	4.7	6.3	1.2	10.0	6.8	5.7	5.2	7.0	2.1	5.4	5.2	3.5	18.5	25.7	19.4	19.5	18.7	18.6	23.0	21.4	21.8	19.2	21.8	31.3	6.0	6.4	4.6	252.1	24.8	5.5	5.1	3.4	8.6	1.8	12.0	6.2	11.2	12.8	2.7	9.2	0.0	0.5	19.5	3.5	3.9	10.7	7.7	4.2	9.1	7.1	4.2	1.7	4.4	6.2	0.4	15.4	5.6	11.8	8.2	3.0	5.7	11.5	1.9	5.0	23.5	5.0	8.2	5.5	18.0	2.6	10.5	5.5	10.6	81.5	4.1	12.6	8.2	200.6	176.9	6.2	3.9	19.5	16.6	13.0	4.9	5.2	2.8	0.8	0.0	21.4	9.8	0.6	0.1	8.3	8.8	1.4	16.1	4.2	4.0	10.2
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 38.8;Theca cells: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA003211: AB_1080661, HPA075255: AB_2732287"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	10.0	29.2	19.5	8.6	18.9	7.1	10.2	10.7	18.2	17.3	9.5	15.5	7.1	15.9	18.6	9.9	19.2	9.9	9.6	17.8	20.4	13.2	13.6	11.0	12.1	12.8	14.4	37.1	10.8	11.6	18.1	7.9	14.2	15.5	7.8	13.3	11.6	17.1	10.8	11.4	12.0	14.6	13.0	15.5	12.2	20.5	25.9	16.0	15.8	5.7	10.9	13.3	13.3	13.7	15.4	27.9	66.2	35.2	18.8	18.9	16.7	14.0	20.8	29.7	27.8	31.1	22.9	39.0	34.1	25.3	26.8	14.2	57.1	21.2	22.3	13.1	30.6	33.9	25.6	27.9	8.7	31.9	20.3	22.3	12.1	21.6	13.4	52.8	25.2	30.8	39.7	20.9	22.0	25.5	38.6	40.6	65.9	19.0	24.2	47.7	20.3	28.7	22.0	18.6	31.5	21.7	23.8	14.7	13.7	47.8	21.7	20.7	19.5	14.6	26.7	21.5	12.8	18.9	12.1	32.9	17.6	42.9	16.4	6.1	5.2	4.3	4.2	4.8	4.8	7.1	4.8	3.9	4.8	6.6	4.0	4.0	0.3	4.9	4.2	10.1	4.8	4.0	19.5	18.9	10.7	18.2	17.8	20.4	12.8	14.4	14.2	13.0	25.9	13.7	5.6	12.8	11.9	14.7	6.9	3.8	2.7	12.2	6.8	12.9	9.2	10.0	10.6	7.2	15.0	31.3	10.4	8.5	4.7	3.3	1.9	6.7	1.1	12.0	8.5	7.5	4.8	7.6	15.8	8.9	7.0	7.0	6.6	9.4	2.5	38.8	8.9	15.3	9.8	13.5	17.3	9.2	6.1	11.9	6.7	4.0	13.7	6.6	3.6	6.5	11.2	9.5	7.2	7.1	12.3	5.5	8.8	23.3	4.9	1.9	4.5	15.1	12.0	7.7	6.6	5.3	9.9	1.5	4.0	9.3	3.8	4.2	5.2	40.0	7.1	2.0
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	13.2	13.5	12.5	13.9	12.8	28.4	19.5	17.3	21.7	13.8	10.0	13.2	10.0	17.6	9.6	14.4	12.6	12.9	9.6	12.8	12.4	12.0	14.3	11.4	20.3	11.4	11.9	15.9	12.2	11.7	10.7	16.9	11.9	12.6	13.2	14.7	10.4	9.0	15.8	18.2	12.0	15.9	11.3	15.9	11.6	32.6	12.3	26.7	11.8	17.1	17.5	15.0	13.3	14.2	25.4	15.2	32.4	43.2	30.1	20.6	27.3	32.8	26.6	31.9	26.9	24.0	22.2	50.8	25.9	22.1	29.7	17.7	38.9	20.8	44.9	24.8	34.1	31.4	92.2	18.0	27.7	55.0	24.7	18.8	38.2	23.5	38.3	22.8	24.7	39.0	40.7	52.7	36.8	24.5	53.9	68.8	21.5	23.4	24.9	35.3	49.4	39.9	27.1	24.4	20.0	29.4	83.5	39.8	43.2	21.7	22.3	51.6	18.5	39.8	37.3	20.5	31.1	21.1	32.5	58.4	21.0	71.2	27.1	10.4	8.2	5.8	19.1	9.5	19.2	13.1	18.5	18.5	11.9	16.8	22.3	18.3	3.9	17.2	6.6	11.3	14.9	10.0	12.5	12.8	17.3	21.7	12.8	12.4	11.4	11.9	11.9	11.3	12.3	14.2	42.5	22.4	21.9	28.7	44.7	49.6	51.4	24.1	53.5	52.1	32.3	29.7	17.5	22.8	19.4	9.2	52.1	27.0	53.3	28.0	31.3	15.3	52.9	30.0	47.7	32.8	31.2	39.1	31.2	11.8	25.0	32.4	23.0	49.7	24.1	39.4	24.7	13.3	16.4	38.7	33.6	29.7	20.3	25.8	35.4	19.5	20.5	30.9	21.4	14.0	27.5	29.0	49.4	38.7	24.2	17.9	24.7	21.1	27.8	38.5	34.9	13.1	15.7	70.0	26.3	57.0	43.2	109.6	80.3	45.9	65.5	25.4	59.3	37.3	38.7	35.6
ZNF207	BuGZ	ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350132-32381885	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	71.8	65.5	36.8	74.0	40.2	239.5	67.8	50.3	45.3	72.0	44.4	68.7	55.1	70.6	72.0	111.1	62.3	58.5	60.5	38.6	37.7	63.2	63.4	72.3	101.0	39.3	37.2	71.7	55.3	72.0	61.3	78.7	40.7	57.2	81.3	61.9	71.6	56.4	84.5	76.3	63.6	77.8	40.7	69.3	63.6	66.3	39.4	103.8	63.0	62.1	128.6	93.2	78.2	48.0	169.9	203.5	215.8	122.4	113.0	121.3	172.6	165.5	231.9	230.1	205.3	195.2	157.3	231.5	124.8	204.6	178.5	170.6	282.1	200.6	258.1	120.0	188.9	237.9	183.8	202.9	118.2	305.0	209.4	141.3	118.3	162.0	89.6	129.4	215.9	115.5	245.9	173.2	223.9	154.6	245.2	142.5	187.1	160.8	114.8	217.5	193.5	217.0	191.5	324.9	150.6	167.7	155.8	113.2	148.1	183.9	204.8	178.7	154.1	129.4	153.4	132.5	227.8	146.7	235.6	369.5	110.6	141.9	204.9	110.5	75.7	78.1	67.6	84.8	70.2	59.7	61.7	62.7	99.8	44.7	50.8	59.1	38.6	83.9	92.5	47.1	86.9	90.6	36.8	40.2	50.3	45.3	38.6	37.7	39.3	37.2	40.7	40.7	39.4	48.0	119.3	80.1	114.7	135.8	131.1	149.4	195.5	120.8	149.1	134.2	108.8	64.1	32.9	65.8	146.1	64.4	225.2	123.3	191.1	118.2	54.8	94.9	62.0	101.9	116.9	110.1	115.9	125.1	171.2	105.7	175.5	101.3	124.9	144.2	75.3	152.8	85.3	58.4	98.7	101.0	163.0	95.2	93.6	98.8	130.2	26.1	107.2	133.1	55.2	123.7	175.8	55.0	168.9	215.7	257.4	146.5	91.2	97.8	144.9	160.3	101.7	57.7	115.0	141.0	124.9	146.3	145.6	136.3	113.5	175.9	148.5	178.7	143.8	90.0	109.9	250.3
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567071-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 129.1;Glandular and luminal cells: 154.8;Squamous epithelial cells: 118.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 148.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051857	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA051857: AB_2681641"	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	15.0	4.2	4.0	20.5	3.8	31.1	22.0	4.0	3.8	17.9	9.6	18.1	12.8	11.8	8.3	13.1	11.1	15.1	5.4	3.2	3.9	11.0	14.5	12.2	29.6	6.0	6.0	9.7	10.1	17.3	4.8	19.0	5.4	16.5	17.5	0.8	18.9	8.2	3.4	16.9	13.5	8.9	4.7	29.2	17.9	22.1	5.9	26.0	10.9	6.4	23.7	21.8	11.6	5.0	28.7	33.4	27.5	40.3	25.1	28.5	60.1	31.3	31.8	34.8	17.1	21.5	31.2	27.5	32.9	38.4	44.9	27.5	22.3	33.0	40.1	19.9	6.3	8.9	14.3	37.8	19.5	14.5	36.7	15.6	31.1	18.6	51.4	27.4	20.1	28.2	19.8	126.9	26.4	113.8	50.1	31.9	29.2	16.2	32.8	38.9	23.0	32.3	20.3	62.8	2.8	7.6	29.2	148.2	30.5	34.6	44.3	60.3	14.2	69.7	25.6	36.0	38.9	52.4	62.4	23.0	25.4	16.0	22.8	9.1	6.1	10.9	3.2	7.4	4.1	5.6	3.4	4.1	4.9	4.3	3.8	3.8	23.3	6.8	15.8	5.0	3.6	3.1	4.0	3.8	4.0	3.8	3.2	3.9	6.0	6.0	5.4	4.7	5.9	5.0	18.7	0.0	8.0	7.5	30.6	129.1	40.3	25.3	71.7	0.6	41.7	22.5	8.2	20.0	26.1	18.4	0.0	16.4	43.7	58.5	9.8	27.5	39.1	76.2	34.4	21.6	6.0	24.4	0.5	16.7	17.7	21.7	42.8	154.8	12.0	24.8	14.6	26.8	16.1	0.0	0.5	32.0	22.4	43.6	52.3	25.9	6.8	39.6	21.4	22.5	43.0	1.8	20.6	3.0	3.4	22.2	39.8	5.3	31.7	65.8	13.8	11.0	30.4	0.5	0.0	13.3	22.7	8.0	23.3	118.8	106.8	45.1	40.5	12.3	24.7	87.1
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000923-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 184.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA016736: AB_1859133, HPA054893: AB_2682632"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.11e-5)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.3	13.5	19.8	21.9	21.3	25.7	41.1	20.5	26.1	22.8	18.1	21.0	18.9	30.6	23.5	10.9	25.7	17.6	23.9	19.1	21.0	25.2	38.7	23.1	36.1	25.1	20.7	35.8	39.6	13.3	8.6	40.0	21.5	22.8	21.6	19.2	22.7	19.6	21.1	8.4	18.2	23.9	21.4	27.1	22.8	9.0	20.9	70.4	23.9	25.7	35.1	18.1	10.9	22.9	46.7	7.4	63.3	39.3	32.1	23.2	0.5	21.6	44.5	54.7	58.8	25.5	38.6	48.4	33.5	32.5	12.0	7.8	62.1	23.2	77.3	30.3	1.1	50.3	11.3	0.3	68.8	98.5	17.0	41.6	33.3	22.3	0.9	0.5	87.7	127.8	67.8	84.9	43.7	1.4	184.0	148.5	38.0	26.8	12.9	133.8	87.8	69.4	43.0	39.2	60.5	52.7	19.3	38.8	32.3	57.5	8.4	96.7	48.4	39.2	72.2	27.2	73.3	48.0	51.0	46.4	24.4	3.6	42.6	28.2	28.1	37.6	51.7	27.5	62.5	42.2	33.6	53.8	37.8	54.4	45.3	56.6	2.9	70.8	18.3	64.7	21.1	38.1	19.8	21.3	20.5	26.1	19.1	21.0	25.1	20.7	21.5	21.4	20.9	22.9	69.3	28.9	27.4	5.9	45.7	19.2	65.5	34.1	42.1	33.6	51.2	68.6	9.9	68.6	25.2	33.1	10.4	71.7	48.0	7.0	56.7	58.7	6.3	22.1	48.7	72.9	40.0	67.5	5.0	43.3	55.8	49.5	21.4	25.4	33.5	59.1	91.8	58.6	49.3	38.7	7.6	37.2	38.7	28.7	28.4	3.6	44.4	32.7	19.6	4.7	61.4	57.2	89.6	7.5	11.3	35.7	15.1	51.1	31.9	57.9	6.9	54.6	28.4	32.7	32.9	77.1	48.4	40.1	37.1	23.9	13.2	53.2	36.4	58.7	34.7	27.6
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412461-9435571	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 74.2"	"Low region specificity"	"Detected in all"							"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: AB_2672018, HPA054110: AB_2682383"	"unprognostic (2.50e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favorable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favorable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (9.15e-5)"	21.0	17.6	8.7	12.7	9.1	17.5	22.8	10.5	10.7	26.3	10.1	22.8	10.2	20.6	53.3	17.5	21.7	9.7	15.3	8.4	8.9	16.3	15.4	21.8	23.8	8.9	8.9	24.2	15.1	15.7	20.1	15.0	9.0	31.5	15.9	12.6	19.0	14.6	11.4	25.1	29.4	14.0	8.8	44.1	19.4	16.7	9.1	27.6	26.3	8.6	27.9	20.0	20.3	9.9	21.5	5.4	13.0	26.6	10.8	15.3	10.3	19.4	18.9	19.1	27.5	10.1	7.1	22.5	12.6	10.7	7.4	6.3	19.3	10.8	22.1	6.8	29.6	27.1	21.8	13.9	9.2	16.9	17.3	16.4	16.0	9.6	14.3	15.5	14.2	25.7	18.0	0.0	16.7	2.1	25.8	74.2	16.6	9.9	16.5	9.6	16.4	16.9	13.6	22.2	13.0	19.5	10.5	11.0	14.0	14.0	8.8	14.2	13.7	16.6	6.9	23.1	11.8	32.1	55.6	28.0	4.5	14.8	11.3	4.0	3.5	4.9	9.6	4.1	6.8	4.8	5.7	7.4	2.9	5.3	7.5	8.1	2.0	11.1	5.4	2.7	7.5	4.8	8.7	9.1	10.5	10.7	8.4	8.9	8.9	8.9	9.0	8.8	9.1	9.9	8.8	0.0	14.3	10.4	15.3	4.0	5.9	5.3	11.4	8.0	9.0	8.8	5.5	4.3	8.7	3.7	12.5	4.8	22.4	7.2	3.9	5.5	0.7	5.0	5.4	7.5	9.5	14.3	12.5	3.7	3.3	6.6	11.2	6.5	12.0	12.9	10.8	3.1	4.8	8.4	12.0	7.1	6.1	11.4	7.2	1.4	6.2	9.1	5.4	14.0	11.3	4.2	20.6	14.1	15.1	4.7	5.2	4.5	10.5	5.6	7.6	1.4	6.6	9.5	6.6	7.2	6.2	5.5	8.7	6.4	4.7	4.7	17.1	6.5	7.4	6.4
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA051228: AB_2681396"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	7.7	3.3	6.3	10.7	12.0	33.5	7.9	10.8	9.8	6.9	4.2	4.6	5.4	7.0	3.9	3.2	4.3	10.1	4.2	7.1	7.6	7.1	21.6	7.5	11.3	8.8	8.9	5.7	5.7	5.6	2.6	8.9	8.3	4.7	4.3	10.7	5.5	4.3	5.7	2.7	4.1	9.0	7.0	9.7	5.1	9.6	8.6	12.6	5.1	7.9	11.7	7.9	2.0	20.7	19.9	19.8	27.2	12.5	10.8	14.5	22.2	21.0	33.3	21.0	19.6	19.7	15.7	29.0	11.6	24.2	24.4	13.4	29.6	19.7	24.9	30.6	17.5	23.6	15.6	20.4	11.6	21.3	12.9	14.1	21.9	22.6	24.5	26.2	19.1	15.6	33.9	4.6	21.5	9.8	22.5	13.8	61.1	6.3	17.1	20.6	18.8	17.2	21.7	10.3	9.2	24.4	21.1	13.8	18.6	42.4	27.0	15.4	25.7	38.1	28.2	8.7	22.3	16.8	17.8	37.0	20.2	16.8	20.5	15.2	8.1	30.3	9.9	8.5	9.7	10.7	8.3	10.4	8.0	9.1	13.6	11.9	38.1	8.1	8.3	8.3	10.9	3.4	6.3	12.0	10.8	9.8	7.1	7.6	8.8	8.9	8.3	7.0	8.6	20.7	30.2	64.1	40.3	7.2	35.1	48.2	26.2	24.0	37.5	55.1	46.3	26.9	14.5	28.6	25.9	27.6	29.2	15.4	24.6	13.8	13.7	22.1	2.6	21.6	37.1	38.9	26.8	22.9	16.0	10.5	31.0	21.2	11.2	41.4	6.3	16.3	30.0	76.9	19.6	18.5	19.6	11.4	8.2	52.1	25.8	3.6	9.9	43.5	23.2	15.0	30.6	15.5	26.8	22.6	59.4	17.8	13.3	7.9	31.7	25.4	10.9	20.3	20.5	37.0	13.1	21.1	32.9	50.1	42.4	18.9	22.7	12.3	29.5	14.2	12.9	20.4
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 13.3;Granulosa cells: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 36.1"					"Low region specificity"	"Detected in all"			"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	3.6	1.0	2.3	2.6	3.2	2.7	4.5	3.8	2.8	6.5	2.3	3.6	2.7	7.4	2.3	5.1	4.4	3.3	3.2	2.3	2.9	7.4	1.2	2.4	3.0	3.0	3.1	10.2	5.5	0.8	2.4	1.5	3.1	5.4	2.7	9.1	2.8	2.3	0.9	4.4	3.8	4.0	2.6	3.9	4.7	6.4	2.9	2.8	6.9	1.5	2.9	4.5	4.9	3.5	2.1	4.7	28.2	0.0	2.4	5.8	0.0	7.1	5.6	6.1	8.7	2.4	3.5	0.0	6.1	5.9	18.3	4.2	0.0	16.2	9.5	0.0	9.3	0.0	36.1	3.9	5.0	0.2	0.1	8.9	5.0	12.7	14.7	8.6	10.4	0.1	0.0	15.1	6.1	0.0	0.0	1.5	27.2	0.0	0.0	0.0	4.1	8.5	4.4	5.3	15.9	26.2	16.7	14.3	9.8	17.1	9.4	0.0	4.6	8.1	3.4	5.9	12.9	0.5	0.2	0.0	0.8	0.1	17.1	0.0	0.1	0.3	0.1	0.4	0.0	0.2	0.2	0.0	0.3	1.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	2.3	3.2	3.8	2.8	2.3	2.9	3.0	3.1	3.1	2.6	2.9	3.5	2.0	0.0	0.5	0.3	1.8	1.5	3.1	2.3	7.4	4.0	2.3	1.7	0.6	1.5	2.7	7.3	0.0	0.7	1.9	0.3	1.9	2.5	3.2	1.8	5.3	2.3	3.0	4.0	0.8	1.6	2.2	3.8	13.3	1.9	0.0	11.5	1.8	0.2	0.5	0.0	1.9	1.4	2.0	1.0	1.2	0.9	2.5	0.8	0.0	5.6	1.5	3.3	3.1	5.5	6.7	1.8	0.1	1.2	0.3	2.0	0.6	1.8	0.8	4.3	6.6	4.1	2.8	7.2	3.7	5.9	2.3	0.8	1.2	2.7	1.8	3.0
ZNF317		ENSG00000130803	"Zinc finger protein 317"	Q96PQ6	19	9140397-9163424	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042075, HPA048625"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA042075: AB_10796471, HPA048625: AB_2680464"	"unprognostic (3.81e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.70e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.42e-3)"	15.8	17.5	21.3	10.2	22.0	26.2	14.7	22.4	34.1	15.1	22.3	17.4	11.2	16.4	11.5	17.4	15.5	8.3	16.1	21.4	21.8	22.2	21.1	14.2	14.2	21.4	21.6	16.4	19.6	12.4	15.8	9.1	21.3	17.8	10.4	12.9	13.6	9.6	14.6	22.8	17.9	10.3	21.3	24.7	18.3	6.7	21.9	15.0	14.5	12.7	15.3	17.7	15.1	22.7	17.4	14.6	15.7	21.0	15.7	14.9	13.6	14.3	22.3	19.2	23.2	16.6	9.2	29.5	17.9	15.3	22.8	17.2	25.7	24.7	24.8	24.4	34.5	26.6	13.3	18.4	20.9	27.8	26.0	17.9	32.2	21.9	38.1	16.6	17.0	25.8	24.8	33.6	19.6	14.6	34.8	88.3	29.0	18.4	30.9	24.4	19.8	23.6	17.0	29.4	27.0	18.6	19.9	17.4	22.7	13.7	13.1	28.7	15.1	13.6	12.3	31.2	19.3	42.0	42.8	33.3	13.1	24.2	17.8	19.4	14.8	16.1	13.0	15.5	20.5	20.8	17.3	15.2	15.0	16.4	16.4	17.9	9.0	22.8	13.4	13.6	22.5	14.2	21.3	22.0	22.4	34.1	21.4	21.8	21.4	21.6	21.3	21.3	21.9	22.7	5.7	9.6	13.4	6.8	11.8	7.4	7.1	4.4	6.2	8.3	8.9	6.7	7.3	7.2	9.4	5.5	6.2	5.6	12.6	9.5	3.9	5.3	0.7	8.9	9.0	7.6	7.2	9.1	6.1	6.4	5.2	7.9	12.2	13.1	13.9	8.1	6.4	10.1	8.0	8.4	7.4	8.6	6.1	15.9	6.2	1.4	3.7	10.1	5.4	7.5	8.1	4.6	8.2	10.6	9.3	8.5	4.7	3.8	10.5	9.5	5.8	9.8	9.4	5.3	0.0	5.7	5.4	2.4	1.0	7.0	6.5	10.9	10.3	7.7	9.6	11.7
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995110-90035533	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 52.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 79: Retina - Phototransduction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	11.0	9.5	5.9	5.5	7.2	21.0	11.1	8.9	6.7	13.5	6.8	12.8	8.8	12.5	7.4	15.3	11.0	5.3	10.4	7.1	5.2	12.2	12.8	8.5	6.9	7.3	6.5	17.2	17.0	4.5	10.3	6.2	7.3	9.3	8.5	52.6	13.4	3.9	9.8	10.2	12.6	5.0	6.7	8.0	10.3	6.9	5.8	5.3	10.9	2.4	6.0	9.6	12.4	10.2	9.2	6.9	17.9	7.1	6.1	4.3	16.4	11.1	4.5	6.6	5.0	7.2	8.1	13.3	5.7	5.6	6.3	9.5	10.8	7.2	8.8	5.9	7.2	10.6	14.3	7.0	2.4	12.6	6.1	4.3	4.3	6.8	5.7	8.5	4.6	7.8	11.7	5.8	7.1	4.0	13.3	9.6	11.2	6.1	8.0	11.1	11.1	3.0	6.2	15.5	11.3	10.9	10.1	10.6	5.0	10.2	7.8	4.2	8.0	9.3	7.7	8.3	8.4	7.2	3.8	8.8	2.7	10.1	5.3	1.0	1.1	1.2	0.9	1.4	0.8	0.9	0.8	0.9	0.7	1.5	0.8	1.0	0.8	2.0	1.5	1.7	0.6	0.4	5.9	7.2	8.9	6.7	7.1	5.2	7.3	6.5	7.3	6.7	5.8	10.2	43.0	22.4	50.9	48.0	40.5	65.1	61.5	43.3	37.0	140.8	35.3	39.0	39.2	28.6	43.4	23.9	373.2	46.4	46.7	81.6	19.6	54.2	5.1	45.0	50.3	43.5	70.3	66.9	29.1	54.8	85.3	35.6	35.2	48.9	51.8	68.4	29.6	35.1	26.1	69.0	35.1	47.8	38.7	19.4	38.2	7.3	43.2	34.0	39.2	28.1	40.9	57.0	28.8	58.8	61.3	47.7	70.6	33.8	33.0	53.8	61.0	19.6	44.6	458.4	26.3	45.0	53.6	58.5	35.8	53.2	45.3	49.4	31.6	71.0	50.0	82.0
ZNF335	"bA465L10.2, NIF-1"	ENSG00000198026	"Zinc finger protein 335"	Q9H4Z2	20	45948660-45972203	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063999, HPA071230"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA063999: AB_2685170, HPA071230: AB_2686369"	"unprognostic (1.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (4.48e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (7.04e-4)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.88e-3)"	12.8	12.1	8.2	11.6	8.4	29.6	13.2	11.8	10.0	14.7	5.4	13.2	10.3	13.9	4.2	14.2	14.1	6.5	9.6	8.6	6.4	11.6	12.1	13.1	14.4	6.9	6.4	17.9	15.2	8.3	17.4	6.4	6.9	16.1	5.7	4.8	13.0	7.4	14.6	20.8	17.6	6.7	5.4	22.1	14.4	13.8	6.9	13.3	17.8	7.7	10.2	12.5	12.7	8.7	12.6	12.6	11.0	11.9	5.7	7.2	23.2	11.0	7.6	10.7	7.7	27.3	13.8	15.0	16.0	10.9	9.8	17.7	10.7	16.6	4.9	10.3	14.6	12.6	20.0	14.6	8.8	16.4	20.5	11.6	13.8	14.1	10.0	7.7	9.3	15.5	12.0	19.6	7.5	25.7	19.4	15.8	7.5	8.4	20.4	15.8	7.3	12.7	9.5	19.5	11.0	9.7	16.4	22.7	11.6	6.5	17.2	13.4	9.8	23.0	10.0	14.8	15.2	22.7	12.6	15.4	18.6	10.0	12.9	1.2	1.7	2.4	3.3	2.2	1.6	1.4	1.6	2.2	1.7	1.5	1.3	1.5	1.7	4.2	1.8	1.2	1.8	2.0	8.2	8.4	11.8	10.0	8.6	6.4	6.9	6.4	6.9	5.4	6.9	8.7	16.9	12.8	15.0	16.6	17.3	18.7	12.1	5.3	14.8	19.3	13.7	14.2	3.8	5.7	5.9	1.8	27.1	8.1	21.5	22.7	0.0	4.4	32.1	10.0	12.3	10.9	21.5	5.7	14.8	5.9	8.5	9.5	22.4	15.4	7.0	15.2	7.1	5.1	6.1	13.5	12.4	11.7	6.1	10.0	11.3	24.8	7.5	14.5	8.8	9.4	6.7	6.0	21.6	7.1	12.4	7.9	12.7	5.3	18.5	10.5	14.6	2.7	4.6	11.6	0.0	21.7	10.3	3.8	7.2	12.9	22.4	11.9	23.1	7.8	12.3	12.8
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144772224-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725"	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.3	4.2	8.5	2.8	9.3	3.3	8.6	12.8	10.5	10.4	8.1	10.2	2.2	9.1	4.7	3.8	10.0	3.6	5.8	8.6	9.4	6.0	5.0	5.5	3.9	9.0	9.0	10.8	5.1	6.2	9.7	4.7	9.6	7.5	3.6	12.4	4.5	7.3	6.3	8.1	5.6	6.6	8.4	4.9	5.6	6.4	9.0	5.4	8.2	6.4	3.0	9.1	7.4	10.9	2.1	3.0	5.7	4.7	4.7	4.8	1.4	1.8	4.1	4.6	3.8	0.8	3.3	3.1	3.4	4.9	2.6	2.0	3.4	3.9	3.6	2.9	2.8	6.3	5.4	2.7	4.3	1.8	3.4	4.8	4.4	3.5	7.7	5.0	3.2	2.0	4.2	2.6	4.1	5.0	3.8	2.7	3.9	4.7	3.3	3.3	2.1	4.1	2.6	2.2	5.6	4.0	4.1	3.0	3.1	3.6	3.2	2.3	2.0	4.3	3.9	3.4	3.9	3.4	1.2	3.9	3.1	2.7	5.1	8.2	6.7	12.9	6.6	6.5	5.7	7.2	6.2	7.8	10.2	7.4	4.3	6.5	1.0	6.1	16.3	4.8	5.1	4.8	8.5	9.3	12.8	10.5	8.6	9.4	9.0	9.0	9.6	8.4	9.0	10.9	17.2	6.4	5.1	3.3	5.5	3.7	2.8	3.9	5.2	7.8	4.6	9.1	3.0	1.5	3.9	0.0	0.0	2.7	2.4	1.4	5.9	3.0	10.6	3.2	7.7	7.9	0.0	1.7	4.8	1.3	3.1	6.7	1.1	4.9	5.1	3.8	2.9	2.1	1.8	13.5	6.2	1.7	6.1	1.2	4.5	7.9	7.2	4.1	3.6	2.8	8.2	6.2	2.1	3.0	8.2	1.1	3.2	4.9	2.7	2.0	2.8	2.3	1.1	9.1	6.6	8.5	7.5	16.4	9.9	8.4	4.8	2.3	4.9	4.2	2.3	0.9
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99473877-99504857	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 97.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Approved		Enhanced	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	13.3	9.6	8.6	10.3	9.5	97.0	12.5	16.4	8.3	11.9	8.8	12.5	10.3	10.4	6.9	12.6	12.5	7.3	12.2	7.7	9.0	10.4	10.1	13.3	13.6	9.8	9.1	13.9	9.7	7.7	9.4	8.1	9.0	13.5	8.6	5.4	10.2	7.7	12.2	15.4	14.3	7.8	8.5	19.2	11.5	10.6	9.4	12.8	10.2	9.6	11.3	11.9	12.2	10.6	10.3	10.2	6.6	14.0	10.4	7.1	13.1	8.5	11.6	9.9	9.7	11.0	11.0	12.4	12.2	9.2	13.5	9.6	9.2	11.2	9.8	9.1	12.0	12.2	12.0	12.1	8.3	17.4	20.0	9.4	9.6	9.6	10.2	7.3	11.6	10.5	17.6	24.0	9.3	19.6	18.3	28.8	15.0	12.9	12.0	10.2	7.3	22.1	11.0	14.7	7.8	16.5	10.2	24.6	16.9	16.5	6.4	21.8	11.9	11.7	12.0	17.4	10.9	19.7	22.1	20.0	8.5	17.4	12.9	56.8	20.6	36.6	31.7	25.5	33.2	24.5	31.8	34.3	22.6	23.6	38.5	30.8	37.8	36.8	26.8	32.8	37.7	24.6	8.6	9.5	16.4	8.3	7.7	9.0	9.8	9.1	9.0	8.5	9.4	10.6	29.3	16.0	19.7	5.2	37.1	35.6	36.1	16.4	16.5	9.7	20.6	14.6	11.4	8.6	16.6	11.0	12.5	15.8	56.7	26.3	17.6	15.7	10.4	17.3	12.9	22.2	20.8	31.5	4.6	14.1	18.2	17.5	25.0	24.4	58.9	17.1	17.5	12.3	18.9	15.2	5.0	16.9	8.2	25.5	29.6	2.9	15.5	29.3	28.4	1.9	19.3	13.6	45.3	7.1	5.6	16.4	20.8	13.5	31.8	29.2	29.7	11.7	19.4	11.7	13.1	22.6	19.7	41.9	30.6	21.5	35.5	29.7	54.3	24.6	18.6	65.6
ZNF423	"Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	9.1	2.9	13.5	2.3	9.6	0.3	6.7	14.0	10.2	6.3	1.0	4.3	1.3	5.4	3.4	4.7	9.3	5.8	7.8	9.7	11.0	2.0	0.7	2.9	1.9	14.9	30.4	7.6	3.4	3.0	4.0	4.2	11.8	6.0	2.7	3.6	2.8	9.5	27.5	2.0	2.6	6.5	8.6	1.4	2.0	4.5	26.3	1.8	4.3	14.7	1.2	3.9	5.4	7.8	0.0	0.0	62.6	3.3	5.1	0.6	7.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	1.9	0.5	0.0	3.6	0.1	0.2	0.0	0.0	4.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	8.8	0.4	33.2	0.0	0.0	27.5	0.1	0.0	0.0	1.7	35.1	87.7	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	1.0	16.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	9.6	14.0	10.2	9.7	11.0	14.9	30.4	11.8	8.6	26.3	7.8	12.7	0.0	0.0	75.4	0.0	2.7	0.3	0.1	1.2	9.8	0.6	0.6	2.6	0.0	0.0	0.0	0.0	0.5	0.1	2.3	1.9	0.2	23.5	2.7	7.6	11.4	0.0	0.0	10.9	0.2	0.7	15.8	0.0	0.6	0.0	1.6	15.4	0.9	0.7	0.0	7.4	1.0	0.0	0.3	5.1	115.7	27.7	0.4	1.8	53.4	0.0	11.7	0.0	38.7	5.1	0.2	0.4	54.5	0.2	0.1	0.2	0.6	0.0	1.1	0.0	4.5	6.4	0.8	1.9	0.1	1.7	0.3	0.3	5.5	0.7	0.1
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031378-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 26.9;Rod photoreceptor cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518"	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (4.11e-5)"	6.3	13.4	3.2	3.7	3.9	8.0	6.5	5.7	3.7	6.5	8.8	5.5	5.2	7.0	8.7	6.6	6.0	3.5	6.0	3.4	5.5	5.1	4.1	5.6	4.3	3.9	3.7	6.8	18.0	5.6	12.4	4.4	3.9	11.8	4.3	24.6	7.1	4.5	4.1	7.8	5.2	4.3	2.9	4.4	6.4	7.2	4.3	4.0	6.7	4.4	4.1	5.0	6.5	4.8	4.6	3.7	8.2	13.0	5.6	7.2	2.8	5.2	3.9	3.7	5.9	3.2	2.7	3.1	1.6	5.6	4.0	3.4	4.8	4.5	6.4	3.2	11.8	9.5	9.2	6.0	2.6	0.0	8.5	7.3	3.6	5.4	7.9	7.1	4.9	3.7	2.6	14.0	6.8	2.6	9.3	5.2	3.0	2.4	6.3	4.9	9.5	5.4	5.5	22.2	4.8	5.0	8.1	4.4	2.6	5.8	3.9	3.7	7.0	3.1	4.7	3.7	5.5	7.2	10.7	7.5	7.2	0.8	6.1	0.9	1.1	1.3	1.4	1.3	1.0	1.9	0.8	0.8	0.9	1.2	1.5	1.1	1.0	0.6	0.6	0.6	1.2	0.8	3.2	3.9	5.7	3.7	3.4	5.5	3.9	3.7	3.9	2.9	4.3	4.8	6.2	16.0	10.0	8.1	8.0	2.0	3.3	3.4	3.4	9.8	3.8	3.2	6.0	2.8	11.6	9.2	16.7	2.7	6.4	3.7	3.9	3.5	14.7	11.9	6.4	5.7	10.2	2.5	9.4	1.6	5.8	5.8	6.6	9.0	12.6	7.8	3.9	1.3	2.3	26.9	6.7	4.9	4.1	4.1	1.3	12.4	3.7	3.2	3.6	9.4	3.8	7.7	10.3	9.0	6.9	2.1	5.2	4.5	4.0	3.6	2.0	2.7	11.6	30.7	6.6	7.1	6.4	10.0	8.4	2.2	2.3	4.9	6.5	4.2	3.1	3.3
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 118.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	13.2	23.4	33.8	6.3	31.4	3.2	15.8	28.3	36.3	24.1	31.3	32.5	11.4	24.9	7.7	16.5	26.1	9.3	23.9	30.5	30.2	23.7	64.3	18.1	5.7	38.6	32.4	26.0	46.4	7.8	29.3	4.8	31.4	35.2	4.2	5.7	21.6	19.6	18.6	14.6	19.0	5.9	29.1	17.7	32.0	21.3	32.6	16.0	28.8	7.0	4.4	25.8	17.7	32.1	11.3	21.1	19.0	16.7	8.0	8.1	12.5	14.0	9.2	11.7	12.6	23.1	12.4	19.7	12.2	8.1	5.9	10.3	11.8	9.5	4.9	17.3	118.4	19.6	15.3	42.4	13.0	8.7	17.4	9.5	8.5	9.5	7.3	17.6	10.6	24.1	25.7	8.6	8.3	14.6	28.4	24.4	20.5	22.3	38.2	32.7	12.3	10.7	13.0	10.2	20.4	28.0	7.1	23.2	11.2	10.3	23.2	15.7	14.4	20.8	18.2	4.6	15.6	20.5	18.9	15.1	13.1	11.8	13.9	1.9	1.1	2.4	2.3	0.9	2.5	1.2	4.0	4.0	1.2	2.3	4.0	2.7	0.1	2.2	0.6	2.1	2.9	1.4	33.8	31.4	28.3	36.3	30.5	30.2	38.6	32.4	31.4	29.1	32.6	32.1	12.2	3.2	18.1	26.1	11.0	3.1	17.4	15.3	5.2	17.9	13.9	11.8	13.9	28.6	17.6	11.0	8.4	18.8	5.6	15.6	9.8	26.4	28.6	16.2	8.9	15.1	29.3	6.1	10.0	21.9	9.7	10.0	20.9	9.2	10.2	16.8	18.5	38.9	10.7	20.2	10.0	28.0	20.3	7.2	6.1	39.2	12.2	5.5	16.0	5.6	13.6	17.7	12.3	14.6	19.0	18.3	9.9	12.0	8.6	13.5	18.7	26.9	18.3	13.4	26.3	8.5	12.6	13.6	25.6	3.4	5.3	12.4	11.2	43.4	22.9	11.0
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: AB_2683565"	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	4.1	3.2	1.7	2.5	1.9	2.2	4.1	4.4	3.1	5.4	1.8	4.7	2.8	6.0	1.6	3.2	4.9	1.9	3.0	2.4	1.1	3.0	2.7	3.1	3.1	2.3	1.7	6.6	3.6	2.6	4.0	2.2	1.1	4.8	1.7	1.7	4.2	2.6	3.3	4.5	3.5	1.5	0.5	4.7	3.6	3.8	1.4	2.4	4.6	1.4	2.2	4.8	4.4	3.0	1.8	7.2	2.3	6.2	2.7	2.4	10.7	5.2	5.7	6.4	4.3	3.2	3.4	3.8	4.4	2.8	2.3	4.0	4.5	2.7	4.6	2.8	7.4	3.1	10.8	4.4	3.8	2.3	3.3	2.9	6.5	2.9	5.3	6.2	3.6	4.8	4.7	5.9	2.5	4.0	4.7	4.0	3.0	1.4	2.6	8.1	5.6	7.6	2.1	2.0	8.7	5.7	4.5	6.6	2.0	1.6	4.3	3.6	4.1	6.0	4.4	6.7	2.5	5.6	4.1	3.4	1.8	1.9	3.8	1.3	1.0	1.5	1.5	1.0	1.2	2.1	0.9	1.1	0.5	1.9	1.5	1.9	1.1	1.2	0.7	2.6	1.7	1.0	1.7	1.9	4.4	3.1	2.4	1.1	2.3	1.7	1.1	0.5	1.4	3.0	4.8	12.8	2.7	5.5	5.8	2.4	3.2	3.6	1.8	19.1	3.7	3.0	5.3	5.7	3.0	7.3	25.0	6.8	10.1	4.6	1.9	4.6	8.9	5.1	6.4	5.5	8.4	5.7	8.8	3.1	4.4	5.9	4.6	2.9	7.0	12.0	12.1	4.1	3.3	18.5	6.3	6.8	4.1	4.8	3.8	1.8	11.5	3.4	1.8	3.7	8.4	11.1	6.2	6.0	5.9	3.5	2.3	11.3	4.3	5.2	7.3	3.3	6.6	20.8	0.0	8.0	4.8	13.2	8.8	1.7	2.3	4.5	5.0	9.8	5.5	1.8
ZNF512B	"GM632, MGC149845, MGC149846"	ENSG00000196700	"Zinc finger protein 512B"	Q96KM6	20	63956704-63969930	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.4;Cone photoreceptor cells: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006688, HPA008731"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA006688: AB_10963053, HPA008731: "	"unprognostic (7.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.99e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.72e-2)"	8.6	11.4	8.4	5.5	8.4	5.9	10.4	4.8	11.4	12.9	0.9	10.9	4.4	13.8	2.8	17.2	12.2	5.9	9.6	8.8	7.0	12.4	21.3	8.4	6.2	5.1	5.5	14.2	15.0	9.1	20.8	7.9	4.5	13.0	1.4	4.5	12.6	7.7	12.1	14.4	7.2	5.9	2.9	10.3	10.3	10.2	6.3	8.3	19.7	5.2	4.1	11.4	10.9	5.8	10.2	16.8	18.6	19.8	8.1	5.9	17.0	14.4	11.2	42.3	13.8	33.1	16.8	6.6	34.5	12.6	7.8	12.8	14.1	21.4	10.1	11.0	20.3	16.4	26.4	31.9	12.9	8.9	18.9	12.5	17.3	14.7	8.4	11.1	13.3	29.4	23.1	9.9	8.5	24.3	43.6	19.2	12.9	12.9	21.8	19.8	1.7	20.1	7.6	16.9	27.2	15.8	11.9	19.4	9.8	8.8	40.9	21.4	18.8	40.4	6.2	10.3	12.6	23.6	12.1	18.3	14.5	0.1	17.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.4	8.4	4.8	11.4	8.8	7.0	5.1	5.5	4.5	2.9	6.3	5.8	6.7	3.2	5.6	1.6	3.1	5.4	3.5	5.3	4.6	22.4	10.3	9.5	2.9	5.7	6.5	1.8	22.9	7.8	6.1	0.1	1.9	3.7	0.1	5.2	12.0	5.8	6.0	3.4	1.1	6.1	2.9	6.7	3.6	9.6	0.0	14.0	8.6	19.4	3.9	13.5	1.4	0.8	8.2	1.9	2.5	1.3	6.5	1.7	5.4	1.0	2.3	7.3	4.1	1.5	0.6	3.2	0.2	6.8	5.2	3.5	2.2	5.7	2.6	10.6	0.0	8.7	5.6	6.5	4.1	11.1	7.0	5.1	3.6	14.3	1.2	2.8
ZNF521	"EHZF, Evi3"	ENSG00000198795	"Zinc finger protein 521"	Q96K83	18	25061924-25352190	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 221.7;Oligodendrocytes: 104.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 95.9"	"Group enriched"	"Detected in some"	6	"basophil: 11.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"AF22: 67.6;fHDF/TERT166: 32.7;HUVEC TERT2: 46.9;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"HPA023056, HPA023849"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023056: AB_1859315, HPA023849: AB_1859316"	"unprognostic (8.80e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.82e-4)"	13.4	11.9	8.8	3.1	10.5	2.3	11.4	95.9	9.5	10.8	29.9	4.7	1.7	15.3	4.3	3.9	9.0	10.6	9.1	6.0	14.7	3.2	1.2	6.3	3.8	17.4	14.3	20.5	1.2	1.1	7.6	8.6	21.2	2.6	3.6	5.7	9.0	3.0	3.7	6.1	4.4	13.6	12.4	21.0	2.7	3.6	10.8	4.3	6.8	6.0	2.8	5.8	6.8	13.5	0.1	0.0	67.6	0.1	10.6	18.4	0.2	10.0	14.3	3.4	2.1	0.0	0.1	0.0	0.0	32.7	0.0	0.3	0.0	0.0	2.8	0.0	4.0	14.0	0.6	0.5	1.9	0.0	20.2	23.0	0.0	0.3	0.0	0.0	46.9	16.4	0.3	0.1	6.0	0.0	9.2	0.0	4.7	0.0	0.0	0.0	15.2	1.1	0.0	0.0	8.7	5.5	0.8	0.0	0.0	6.1	0.0	38.9	26.9	26.5	2.0	8.0	1.5	0.1	0.0	0.3	10.0	0.0	22.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.1	8.8	10.5	95.9	9.5	6.0	14.7	17.4	14.3	21.2	12.4	10.8	13.5	19.0	0.0	3.0	170.1	0.3	3.7	0.1	0.0	1.2	42.4	8.0	10.9	11.9	0.0	0.6	0.0	2.1	0.1	1.7	0.0	0.0	0.0	2.1	0.5	3.3	28.6	1.2	13.9	16.5	0.0	0.0	21.4	0.0	0.2	13.3	4.7	20.3	0.0	0.1	15.2	22.7	0.1	0.0	0.6	5.5	3.3	9.9	0.9	14.2	53.4	0.1	0.7	0.0	221.7	104.6	0.0	0.0	7.9	0.1	0.2	0.0	4.0	1.5	3.0	0.0	13.7	6.0	0.1	6.1	0.8	4.4	0.1	0.8	17.2	0.0	0.2
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819868-2836735	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Not detected"	"Not detected"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	2.0	2.0	2.9	0.6	2.8	0.5	2.5	2.7	4.0	3.0	1.5	2.6	1.3	2.6	1.2	2.5	2.3	0.6	3.3	2.7	2.8	2.9	3.1	1.4	0.6	2.9	2.4	3.7	3.1	1.5	2.9	1.1	2.9	2.7	0.8	2.5	2.7	0.9	5.2	3.5	2.3	0.6	1.8	1.9	2.5	2.5	3.5	0.9	2.6	2.1	0.7	2.7	2.6	2.4	1.2	0.2	0.9	1.3	0.7	0.9	1.3	0.7	0.6	1.0	0.7	0.1	0.3	1.5	0.6	0.4	1.1	0.7	0.2	0.7	0.8	0.0	0.5	0.5	0.8	0.4	0.6	0.2	0.5	0.7	1.0	0.4	0.7	0.9	0.3	1.1	1.1	0.8	0.5	0.6	1.1	0.3	0.7	0.2	0.1	1.3	0.6	0.3	0.5	1.1	1.5	1.8	0.5	0.3	1.1	0.9	0.4	0.8	0.2	0.4	0.4	0.6	0.4	2.3	2.8	0.4	0.6	0.7	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	0.0	0.6	0.3	0.1	0.1	0.2	0.2	0.9	0.1	0.2	2.9	2.8	2.7	4.0	2.7	2.8	2.9	2.4	2.9	1.8	3.5	2.4	2.2	12.8	12.5	2.9	3.5	1.3	2.8	1.0	4.0	4.9	2.3	2.2	4.6	1.5	4.6	0.0	8.4	2.8	1.5	3.4	3.9	2.6	0.8	2.1	1.9	3.1	3.6	3.4	4.0	1.4	1.3	3.4	1.5	2.7	0.0	4.4	3.3	2.9	1.5	3.3	4.8	2.0	2.0	2.4	2.5	0.7	3.1	1.6	0.0	1.0	1.4	4.7	5.2	3.5	2.7	1.7	1.0	2.6	3.3	3.3	5.9	3.0	5.5	4.9	0.0	3.8	2.3	7.0	12.2	2.7	1.4	8.8	2.7	3.7	2.2	2.1
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466355-9498616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 79.2;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.5;HMC-1: 4.8;NTERA-2: 19.7;SuSa: 9.2"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.8	2.5	0.0	1.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	20.5	0.0	0.0	1.4	0.0	4.8	2.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	79.2	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.0	0.0	0.0	0.2	0.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	9.5	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169908-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	35.8	31.8	20.0	12.6	21.0	20.3	30.7	21.4	25.6	18.1	20.6	23.6	13.0	22.7	6.6	32.5	23.0	6.1	37.9	20.3	23.0	40.2	63.9	21.8	10.1	21.1	22.3	32.1	61.5	16.4	25.7	9.3	22.7	31.3	6.2	2.5	24.3	7.6	101.3	32.4	21.1	7.0	20.6	28.2	39.0	16.3	20.8	4.6	28.0	21.9	8.3	25.5	20.7	21.5	76.0	41.3	13.1	48.4	13.3	17.3	72.2	32.8	16.5	37.3	36.3	62.8	44.4	87.2	58.9	21.0	29.7	48.3	47.2	43.5	13.5	53.1	150.6	59.6	33.6	98.3	56.6	82.5	50.0	31.4	41.8	41.8	43.7	15.5	32.3	20.6	91.4	32.7	23.1	58.1	34.1	154.7	53.0	72.7	143.0	42.0	23.6	89.8	27.7	32.8	35.7	39.4	39.8	98.4	132.1	10.7	41.0	46.3	33.6	35.7	42.0	75.8	62.4	64.1	71.3	97.2	42.2	171.1	46.9	0.5	41.3	0.6	35.6	69.1	33.0	64.2	48.7	34.9	57.5	63.3	36.1	34.6	1.9	44.6	70.9	70.4	58.4	39.3	20.0	21.0	21.4	25.6	20.3	23.0	21.1	22.3	22.7	20.6	20.8	21.5	38.9	12.8	57.9	2.6	56.8	171.3	180.9	67.7	128.1	18.0	116.1	142.0	6.0	88.6	50.6	60.7	2.1	114.5	29.8	86.1	103.7	102.2	6.7	70.7	62.6	45.1	109.8	26.5	2.5	147.0	158.5	49.7	75.4	83.4	50.9	62.2	40.7	201.5	79.4	3.3	3.2	156.7	36.7	59.9	52.3	14.3	32.3	37.3	49.8	0.0	47.2	20.9	21.6	2.0	2.1	130.8	61.6	23.3	94.9	197.2	71.7	218.0	27.8	16.7	13.1	65.1	57.7	39.0	52.2	111.6	168.4	222.6	28.8	68.0	128.4	185.3
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179535-5191868	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.8;Horizontal cells: 15.2;Inhibitory neurons: 15.7;Oligodendrocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	1.8	3.3	2.8	4.2	3.9	0.7	4.9	6.0	3.8	4.4	4.5	3.9	1.6	5.1	4.2	1.9	4.4	2.2	2.9	3.0	2.7	4.2	2.2	2.2	6.2	3.8	2.8	10.7	3.3	5.4	6.2	3.2	3.1	5.1	2.7	11.7	3.8	4.3	4.0	2.1	4.0	3.0	2.0	5.1	2.9	4.5	3.4	5.1	5.6	2.9	5.9	3.6	2.9	6.8	5.8	2.5	10.5	8.3	1.6	1.8	8.9	3.8	1.9	6.6	6.2	7.3	2.1	13.1	5.9	3.0	4.9	6.2	6.8	0.2	8.3	7.0	6.9	4.2	10.2	3.7	2.4	0.0	4.0	1.4	1.1	4.0	0.0	1.7	0.7	7.5	1.7	3.2	2.2	5.7	3.6	1.8	4.9	0.9	3.5	7.6	8.9	1.7	1.9	1.5	6.2	8.4	2.8	1.5	5.8	4.6	3.4	3.1	0.1	0.1	3.7	3.4	2.7	2.0	4.5	3.0	0.6	0.0	4.1	0.2	0.4	0.5	1.4	0.5	1.0	1.6	1.5	1.4	0.4	2.5	2.3	1.6	0.2	1.3	0.5	2.2	2.4	0.6	2.8	3.9	6.0	3.8	3.0	2.7	3.8	2.8	3.1	2.0	3.4	6.8	1.8	6.4	3.9	14.0	3.6	1.1	1.3	0.4	1.2	9.5	2.5	2.2	5.5	4.3	2.8	5.5	6.2	1.4	1.3	0.7	7.9	1.6	0.8	0.8	3.1	2.1	1.2	2.5	17.8	1.1	0.7	2.7	1.5	0.8	3.8	9.9	3.9	0.7	1.1	15.2	15.7	1.5	0.0	1.4	0.6	4.3	3.4	1.2	0.0	8.4	1.5	7.7	3.1	14.6	20.3	0.7	1.5	2.6	0.8	0.9	0.6	1.0	5.0	9.2	0.0	3.3	2.4	2.5	4.1	0.9	0.3	0.3	1.8	5.2	1.3	0.5
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.4;Cone photoreceptor cells: 141.8;Excitatory neurons: 142.1;Microglial cells: 139.6;Oligodendrocytes: 208.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	9.5	8.3	11.3	8.3	10.1	5.5	8.5	13.0	9.6	11.3	8.8	12.0	8.7	12.0	4.5	7.8	11.9	7.2	8.1	11.2	12.6	6.7	7.1	10.9	8.7	10.6	10.4	20.5	7.2	14.1	8.4	11.9	7.4	10.3	7.8	20.5	9.7	9.5	7.2	9.6	8.7	11.1	8.3	9.8	8.2	22.0	10.1	18.0	9.0	9.9	8.3	11.3	10.8	12.1	11.1	27.6	29.1	11.2	11.0	13.8	9.9	14.2	18.8	17.5	17.5	17.1	17.2	19.0	11.7	16.9	23.9	23.2	43.1	19.6	18.2	22.2	9.2	34.7	16.0	8.4	20.2	20.2	22.3	14.1	17.6	18.3	35.8	25.3	32.8	15.9	55.6	12.0	14.5	10.1	15.7	8.5	22.1	14.8	7.7	14.3	26.5	10.0	12.7	19.7	23.6	18.0	19.5	21.9	13.1	27.7	10.9	14.0	33.0	16.2	25.8	8.4	17.9	13.3	16.1	16.6	10.1	21.6	13.4	1.3	0.4	0.6	0.5	0.1	0.3	0.2	0.3	0.4	0.1	0.2	0.8	0.8	0.5	1.1	0.2	0.5	0.2	0.2	11.3	10.1	13.0	9.6	11.2	12.6	10.6	10.4	7.4	8.3	10.1	12.1	14.6	12.8	25.4	123.4	8.8	18.0	16.2	10.5	8.0	35.8	12.6	11.8	20.1	24.3	20.3	18.4	141.8	19.1	13.9	12.2	3.9	13.8	22.6	42.2	21.9	18.4	18.6	11.1	142.1	14.6	14.7	13.6	13.7	16.1	10.1	19.4	18.9	14.6	10.0	45.4	116.5	11.9	4.1	30.5	18.3	12.7	18.0	16.4	14.2	139.6	19.1	17.3	19.6	108.6	208.0	13.2	13.5	13.9	10.5	22.9	9.9	3.9	33.8	54.9	19.7	14.4	16.9	48.3	17.0	9.3	17.3	31.2	17.0	20.8	11.2	20.1
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA065518: AB_2685501, HPA071440: AB_2686395"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	13.0	10.0	15.7	5.9	18.9	7.1	12.9	15.0	16.5	12.7	13.4	11.2	5.3	11.2	8.1	9.5	11.5	5.7	9.4	13.2	17.1	15.2	12.4	13.2	6.2	19.4	16.3	12.0	12.2	7.7	14.6	5.5	19.4	14.4	5.7	7.4	12.1	6.9	7.2	10.0	11.7	6.1	17.0	12.7	10.7	7.6	17.5	5.5	13.2	5.6	6.1	11.0	11.5	21.0	8.9	5.0	12.2	12.0	7.8	13.4	6.9	9.5	11.1	11.7	11.6	11.1	4.8	3.7	6.9	12.4	8.8	3.1	12.2	7.2	13.7	14.9	15.1	12.4	20.8	10.1	13.6	11.6	11.8	10.4	14.9	12.2	19.0	12.7	9.9	4.4	13.3	10.8	10.1	5.6	2.9	13.8	7.7	3.5	10.2	1.1	8.2	4.4	6.1	11.0	4.3	10.9	10.2	6.9	12.0	11.7	11.4	9.4	13.1	20.2	9.8	10.2	13.4	16.1	17.4	8.3	9.9	8.6	12.5	2.5	1.0	0.9	1.3	1.3	0.8	2.3	1.3	1.8	0.9	3.3	1.6	1.2	1.2	1.8	0.7	1.3	1.3	0.7	15.7	18.9	15.0	16.5	13.2	17.1	19.4	16.3	19.4	17.0	17.5	21.0	13.2	9.6	12.3	22.5	9.6	1.5	5.2	2.3	9.1	13.8	6.3	5.0	12.1	10.0	7.7	11.0	12.5	5.5	9.5	4.9	5.9	7.7	10.8	11.1	16.4	12.0	10.2	12.4	4.1	5.6	3.5	9.0	7.7	12.2	3.8	15.0	5.0	5.6	3.7	15.2	4.2	7.1	4.1	8.1	3.0	7.9	7.5	6.9	3.6	11.2	9.4	7.1	10.3	19.1	26.1	7.5	4.9	12.0	8.8	6.6	6.7	3.2	4.6	16.7	0.0	13.6	9.1	10.6	6.3	7.5	1.8	5.5	8.1	12.9	5.8	4.4
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 342.3;Oligodendrocytes: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	21.1	22.1	35.7	21.6	48.9	28.2	24.6	77.6	52.3	23.0	37.7	22.0	15.6	29.2	18.4	19.8	22.1	19.1	41.0	35.7	41.3	24.2	30.9	21.2	25.0	41.9	36.8	37.3	21.9	27.9	24.9	23.2	41.9	22.2	19.5	48.6	21.0	19.5	51.5	16.8	19.0	22.9	34.8	23.1	21.8	29.7	38.9	30.9	29.8	33.7	22.6	21.3	17.1	82.5	36.2	51.0	77.0	36.1	44.4	48.3	59.2	40.4	46.6	33.6	30.0	49.2	34.6	59.2	36.6	37.1	52.3	29.9	72.1	41.4	48.7	60.5	40.1	77.8	54.8	45.4	38.3	72.0	50.6	30.8	39.5	36.1	66.7	47.8	52.5	39.2	79.4	33.8	49.6	36.1	50.9	52.9	66.7	54.1	32.4	43.0	116.5	41.7	36.0	54.3	59.0	38.7	49.8	34.7	52.8	76.3	32.3	43.7	54.3	41.4	60.0	31.1	41.2	27.6	45.7	57.4	34.8	46.3	45.8	64.1	17.0	33.5	18.1	16.3	17.2	25.4	17.1	17.2	14.0	26.0	22.5	16.7	29.1	21.5	24.1	17.7	16.0	10.8	35.7	48.9	77.6	52.3	35.7	41.3	41.9	36.8	41.9	34.8	38.9	82.5	63.1	67.3	112.4	227.9	63.9	31.7	56.8	40.8	46.1	111.5	36.8	35.4	107.0	27.1	59.0	40.5	123.0	42.5	46.7	39.2	19.6	43.0	15.7	54.2	63.7	65.9	38.4	57.2	286.9	40.9	29.0	83.5	50.0	59.2	79.1	112.8	38.6	48.6	32.5	67.3	268.4	34.2	32.6	41.9	33.3	15.8	75.2	49.6	23.2	225.8	71.6	56.4	56.7	342.3	619.5	39.6	35.7	63.9	50.5	60.0	38.1	21.6	74.7	104.0	32.9	98.3	73.1	110.1	78.3	37.4	30.3	50.2	56.1	74.0	36.8	58.9
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	13.4	14.8	13.4	11.7	14.8	13.5	13.1	17.9	14.1	13.3	14.6	16.1	11.3	14.3	7.7	19.1	14.9	7.8	30.2	12.8	13.4	22.3	26.1	17.0	14.8	17.2	14.8	11.1	18.0	16.2	17.1	9.3	14.8	24.0	8.4	10.7	17.6	8.2	49.5	17.9	16.8	8.1	14.0	19.8	16.9	16.0	14.9	15.8	20.2	35.7	14.0	16.8	13.7	15.8	19.4	21.5	17.2	19.5	9.4	6.6	33.0	17.8	9.7	12.7	13.6	11.8	19.7	22.0	18.1	11.7	9.6	18.8	9.4	13.3	8.0	32.5	5.3	33.7	20.0	16.0	12.0	14.6	24.4	7.4	10.7	16.6	11.5	10.2	11.7	15.2	41.5	17.6	8.8	13.8	26.8	14.5	20.0	22.3	36.5	49.1	16.3	17.4	12.9	15.6	25.5	22.2	16.0	24.0	15.9	10.2	13.8	30.1	10.0	17.5	10.5	11.6	37.3	52.8	22.2	13.2	16.0	25.1	14.5	9.2	16.3	11.9	8.8	15.9	7.2	11.9	6.3	8.8	24.3	15.0	6.7	6.3	9.2	12.7	15.4	13.6	7.8	14.0	13.4	14.8	17.9	14.1	12.8	13.4	17.2	14.8	14.8	14.0	14.9	15.8	10.7	3.2	15.2	5.9	22.3	13.0	28.2	10.1	6.8	22.0	12.8	9.8	20.2	14.3	8.1	16.5	12.5	32.0	22.0	19.5	21.5	18.3	7.8	9.5	5.7	12.0	18.0	17.0	2.2	10.7	19.9	10.0	10.2	8.9	28.0	12.5	7.5	17.2	16.8	10.1	4.0	17.6	8.2	16.4	16.9	14.6	5.6	20.6	12.4	1.9	17.8	19.5	20.6	2.5	5.2	14.6	19.7	5.7	9.6	21.1	26.5	15.8	9.0	30.5	6.6	17.5	11.7	32.4	23.4	5.5	14.6	71.3	13.5	10.6	16.9	22.5
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292176	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.5;monocytes: 4.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA021193: AB_1859415, HPA023948: AB_2671380"	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	8.5	10.9	9.0	8.2	9.9	31.2	8.7	12.6	10.2	9.9	6.9	10.7	8.6	10.5	5.5	11.0	9.7	7.0	8.9	8.5	8.4	10.2	9.7	8.6	10.1	10.5	9.6	11.7	16.0	14.1	13.0	7.1	9.5	11.3	5.7	9.4	12.0	8.6	10.9	12.3	11.3	6.1	8.9	14.4	10.8	14.5	9.7	9.3	10.8	6.9	7.5	10.4	8.7	10.5	14.8	21.5	20.4	12.6	11.3	9.5	26.3	7.6	12.9	13.8	13.1	18.1	19.6	12.6	18.7	12.3	14.7	22.3	18.1	15.2	6.1	17.3	18.3	11.9	18.8	20.1	12.1	14.3	16.7	14.7	15.3	11.6	12.1	12.3	9.4	13.4	19.5	22.6	7.8	44.8	19.2	16.8	27.6	19.8	16.5	16.9	16.1	22.8	11.6	22.1	18.5	27.7	20.8	24.6	19.7	19.2	32.2	30.1	9.2	11.0	12.1	13.9	11.6	26.2	24.1	31.3	14.0	9.4	14.2	0.5	1.8	13.5	0.5	2.3	0.5	1.0	0.5	0.4	0.9	1.1	0.7	0.8	8.8	0.4	4.5	0.8	0.4	1.2	9.0	9.9	12.6	10.2	8.5	8.4	10.5	9.6	9.5	8.9	9.7	10.5	4.3	3.2	4.6	3.6	5.8	4.7	2.8	4.9	5.7	6.7	6.0	5.5	1.4	10.0	3.5	1.8	10.4	6.7	3.8	9.3	3.9	5.5	3.1	4.3	3.7	4.4	2.4	3.0	1.6	6.0	5.3	4.2	7.7	5.3	0.0	8.5	2.9	4.5	5.3	8.4	1.9	5.6	8.2	5.2	4.1	2.8	6.2	5.8	0.0	2.8	6.0	5.2	5.2	3.0	1.7	7.3	3.5	7.2	5.8	4.7	10.2	4.1	3.4	10.8	13.1	4.4	3.9	6.9	6.8	4.3	3.4	9.4	4.3	6.5	7.3	5.1
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	13.0	16.5	35.1	4.7	36.3	7.5	16.3	36.3	48.5	26.6	34.1	20.1	5.1	17.1	8.2	23.2	25.3	4.9	18.0	35.0	34.7	27.0	21.7	12.5	6.2	36.5	35.5	27.6	28.2	7.4	29.1	4.2	37.7	34.9	3.6	8.5	17.8	5.3	17.7	18.7	16.6	3.8	34.1	23.5	19.7	38.9	35.7	7.0	24.7	4.7	4.4	21.3	20.8	36.8	7.1	6.4	6.1	14.7	4.7	2.5	26.4	6.1	1.9	6.2	4.0	8.2	9.8	8.8	11.7	2.3	2.5	9.5	9.1	8.8	3.9	12.6	5.7	9.9	17.8	2.2	3.5	11.4	8.3	3.2	10.2	6.8	17.5	5.8	5.9	11.1	21.1	6.2	2.9	3.8	5.9	23.7	12.2	17.1	13.1	19.3	3.6	16.9	11.9	4.5	11.7	8.8	6.3	10.1	12.2	2.3	13.1	18.5	4.5	2.7	5.0	2.7	8.0	17.0	11.3	5.8	6.2	14.9	4.7	0.0	1.5	1.4	3.6	1.1	3.3	3.0	2.9	4.0	3.1	2.3	4.1	3.0	3.3	8.1	1.0	2.5	3.5	2.0	35.1	36.3	36.3	48.5	35.0	34.7	36.5	35.5	37.7	34.1	35.7	36.8	7.8	9.6	8.6	27.1	10.7	9.6	12.5	19.0	11.4	15.3	16.8	18.7	5.4	7.2	10.8	11.0	22.9	12.8	10.3	10.0	5.9	7.6	14.3	6.1	7.0	6.7	8.3	22.7	20.6	4.0	10.4	8.1	15.8	6.8	5.7	15.9	2.9	6.2	6.5	11.8	19.7	12.3	12.2	6.0	5.5	7.8	10.2	5.4	16.0	10.3	6.1	8.3	9.2	8.5	23.5	5.7	5.2	7.2	6.6	17.3	11.6	4.1	10.8	13.6	0.0	8.4	8.0	52.7	15.4	11.0	8.0	6.2	11.3	9.5	14.3	10.0
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407414-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 35.6;REH: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	4.6	7.2	9.4	1.5	9.9	1.2	4.8	8.6	15.7	7.8	1.9	10.6	1.3	13.3	2.0	4.4	9.9	1.4	6.9	10.7	8.7	7.8	13.2	3.2	0.9	8.4	6.8	10.8	4.9	2.9	8.1	0.5	6.6	9.5	1.4	1.8	4.0	3.7	12.6	3.8	4.7	2.9	4.7	2.5	6.2	3.7	8.4	1.0	5.2	1.5	1.1	10.2	5.4	8.9	4.5	5.2	6.7	5.6	9.3	4.0	5.2	6.3	3.1	3.9	4.1	2.1	2.2	5.2	10.4	3.1	4.8	3.2	6.9	2.8	4.0	1.9	35.6	4.4	3.6	6.8	4.8	2.3	4.9	6.0	2.2	4.9	3.0	4.2	4.0	5.4	10.9	3.1	3.3	8.1	5.4	7.0	5.3	2.7	3.9	23.7	5.1	3.4	2.3	1.8	10.6	6.7	3.4	3.1	4.8	3.4	3.8	2.6	3.8	6.7	8.0	3.9	4.6	4.6	5.4	2.8	4.5	4.9	4.4	0.8	0.7	0.5	1.8	1.4	2.6	1.4	2.2	2.2	1.7	3.3	3.1	2.0	1.0	1.2	0.3	2.3	2.6	1.6	9.4	9.9	8.6	15.7	10.7	8.7	8.4	6.8	6.6	4.7	8.4	8.9	5.4	3.2	0.5	6.2	3.7	5.1	11.5	1.8	22.2	12.0	9.1	15.7	7.1	20.0	1.5	5.5	10.4	5.5	7.2	7.8	33.2	6.2	1.6	4.5	12.3	7.6	4.2	4.4	8.6	4.4	3.3	12.4	5.6	9.0	1.3	12.6	13.2	19.1	3.5	11.8	9.4	10.0	0.0	1.6	2.4	2.2	25.1	3.2	5.4	5.6	1.3	15.9	2.1	5.5	5.4	2.5	5.1	29.7	4.4	15.5	8.6	29.4	0.7	8.0	13.1	15.2	12.0	1.2	1.8	8.5	6.7	3.6	5.1	9.5	10.0	4.3
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472890-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA029500: AB_10603009, HPA050793: AB_2681240"	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (5.31e-6)"	5.2	5.7	8.2	4.7	8.3	7.6	5.5	11.0	9.9	7.7	8.1	8.7	8.5	6.1	7.2	5.0	7.1	2.6	4.6	8.3	8.7	9.8	8.8	4.9	6.2	8.4	8.7	7.9	7.6	3.3	11.8	2.6	8.8	16.4	7.3	11.7	6.1	4.3	5.7	7.3	9.8	3.7	8.0	10.7	6.1	13.4	8.5	4.5	8.4	2.9	5.8	5.1	5.2	9.2	12.0	3.8	6.1	11.0	1.9	1.8	8.4	5.8	2.2	3.7	7.9	6.0	7.7	8.6	4.8	2.7	3.7	5.0	3.2	3.3	5.0	4.0	6.0	6.6	10.3	11.8	3.1	4.3	14.5	2.1	2.8	7.2	3.5	2.2	3.9	11.1	10.2	7.7	3.3	11.6	5.7	12.0	6.1	5.7	5.6	7.0	6.2	9.4	4.9	3.4	5.9	6.6	4.2	11.8	7.3	3.4	3.0	7.5	6.1	6.4	8.0	9.9	5.9	5.0	7.6	11.9	10.8	8.2	6.9	2.0	1.5	1.5	2.3	1.0	2.7	2.3	3.0	2.6	5.2	3.6	6.0	3.7	0.3	4.2	1.3	13.5	5.1	1.8	8.2	8.3	11.0	9.9	8.3	8.7	8.4	8.7	8.8	8.0	8.5	9.2	8.2	0.0	6.3	11.8	9.5	5.5	4.2	4.0	4.6	18.3	6.3	6.7	2.4	1.5	4.6	1.8	14.6	4.4	14.0	6.3	1.9	3.8	33.9	5.2	4.8	7.2	5.4	8.6	10.4	5.4	3.2	4.7	9.2	5.6	3.8	11.8	1.8	3.5	6.9	6.7	12.7	6.3	4.1	3.1	6.5	8.4	3.4	4.6	7.2	10.3	3.8	12.0	5.2	12.5	10.6	4.3	5.4	4.5	6.1	2.7	5.2	4.6	4.9	14.7	0.0	6.5	4.8	20.8	4.8	6.7	5.3	2.2	6.9	8.5	6.6	3.4
ZNF830	"CCDC16, MGC20398, OMCG1"	ENSG00000198783	"Zinc finger protein 830"	Q96NB3	17	34961540-34963777	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024754, HPA027211"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA024754: AB_1859464, HPA027211: AB_1859465"	"unprognostic (2.87e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (8.63e-2)"	8.0	7.0	5.9	9.5	6.3	11.1	8.4	7.9	7.2	7.9	6.3	8.3	8.6	9.4	6.8	8.7	8.9	6.8	7.0	5.9	6.1	9.0	10.4	6.5	13.9	5.9	6.0	12.8	8.2	8.0	5.5	7.8	6.1	8.1	6.4	6.3	7.8	6.7	8.0	8.5	10.6	6.5	5.8	14.7	8.9	10.1	6.1	13.7	9.0	8.5	11.8	9.4	7.5	7.4	7.9	15.2	13.5	12.5	14.1	10.9	9.3	9.5	9.6	12.2	12.0	11.5	10.5	14.3	8.5	9.3	12.7	18.2	14.5	8.6	13.7	8.7	19.7	16.9	15.5	14.5	14.3	25.4	23.2	10.7	19.9	10.2	19.7	12.3	11.1	17.4	24.6	20.5	11.1	6.1	23.2	28.5	8.9	10.6	7.4	15.4	18.3	19.1	11.3	10.6	15.9	13.6	9.3	5.7	15.4	12.9	13.2	27.5	11.7	12.8	9.4	9.5	16.7	22.6	18.5	19.1	11.0	13.4	11.7	30.8	12.3	40.7	16.2	12.1	16.2	13.1	17.3	18.0	13.5	13.0	26.2	20.9	11.6	15.8	8.7	14.4	16.9	12.3	5.9	6.3	7.9	7.2	5.9	6.1	5.9	6.0	6.1	5.8	6.1	7.4	27.6	38.5	21.3	4.2	35.3	24.0	45.3	26.7	25.0	19.9	23.3	18.7	8.3	17.2	30.9	12.9	14.6	24.5	45.8	25.7	35.2	19.0	7.1	14.1	27.3	23.6	18.5	20.2	5.1	13.1	16.7	23.2	23.0	17.3	17.1	20.4	15.4	10.6	14.4	10.1	4.8	21.1	22.4	11.5	16.7	3.8	26.8	15.8	21.4	6.5	18.3	20.4	51.5	4.5	11.6	13.4	25.3	27.4	21.3	27.7	26.5	22.4	15.4	31.8	26.3	27.2	22.6	44.8	46.4	18.6	24.2	26.7	36.3	22.6	28.2	34.3
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081289	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	41.0	39.4	29.7	45.3	31.1	60.0	52.6	36.9	47.0	45.0	36.8	40.8	35.5	70.7	67.6	29.3	45.4	29.6	42.7	30.7	29.1	35.3	30.2	40.4	62.5	32.0	27.7	56.7	33.8	33.2	64.5	36.3	31.6	44.2	42.9	62.1	39.5	38.0	58.9	43.4	37.9	50.1	29.3	42.6	35.6	50.4	30.3	47.6	48.5	38.9	49.3	37.9	35.2	38.8	86.8	31.1	122.3	73.0	46.5	79.8	71.0	103.2	55.6	89.2	113.2	58.7	55.5	177.6	89.0	64.2	82.7	53.5	111.1	63.9	133.4	127.5	79.9	154.5	127.3	50.0	70.8	171.5	62.7	61.7	80.3	86.1	73.5	98.1	76.3	90.3	165.1	93.6	69.6	29.3	145.0	58.4	128.7	52.9	59.6	159.8	92.3	108.4	60.5	72.6	93.8	58.3	88.7	58.8	91.4	63.7	74.7	76.8	102.5	65.9	62.1	51.9	103.8	75.7	100.6	193.8	96.4	160.3	94.6	99.1	33.4	32.1	44.5	32.3	51.2	68.8	47.5	44.0	26.8	63.1	61.2	48.7	30.7	48.2	33.8	73.4	49.6	31.2	29.7	31.1	36.9	47.0	30.7	29.1	32.0	27.7	31.6	29.3	30.3	38.8	86.9	99.3	154.5	83.6	109.8	50.6	94.4	66.1	59.7	166.5	61.4	66.5	99.9	50.1	68.4	49.7	129.3	55.1	136.9	85.8	49.0	60.2	190.3	79.9	123.5	63.5	73.0	87.1	135.3	68.2	50.4	92.6	62.7	85.7	87.4	132.8	50.7	41.8	45.4	213.7	114.7	64.5	54.9	34.5	39.7	46.2	185.4	55.7	48.0	73.1	74.8	116.6	139.0	90.5	131.9	69.2	76.5	115.5	127.5	54.8	41.2	41.1	76.5	202.2	118.3	88.1	99.2	218.7	113.0	55.3	46.5	63.5	89.6	96.4	55.1	68.5
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267058-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	9.9	11.1	18.5	10.3	19.1	6.8	15.1	24.3	23.0	20.2	14.4	16.2	8.9	18.9	13.5	9.6	14.3	12.7	13.0	19.5	20.4	12.1	9.9	10.3	11.0	19.0	17.9	30.2	11.9	14.0	16.4	9.3	18.6	17.1	10.0	26.6	10.2	18.1	11.9	9.9	11.6	16.3	17.3	17.5	10.9	7.8	18.7	11.4	14.4	10.4	12.2	13.6	12.2	22.4	8.1	6.6	18.8	16.2	19.0	18.5	4.2	16.2	15.0	19.9	19.8	4.9	5.7	4.6	22.9	10.1	15.1	5.7	8.6	11.3	21.5	9.8	9.6	12.2	10.6	9.9	13.2	10.1	7.1	15.5	10.7	15.4	14.0	25.8	20.5	7.0	10.2	9.2	16.0	6.7	10.9	13.3	5.6	4.3	10.5	10.7	16.1	7.8	17.2	7.9	13.6	10.3	9.6	4.0	13.2	15.2	6.5	6.9	13.7	16.3	11.7	5.8	19.2	9.9	14.5	8.7	5.8	11.0	14.3	17.9	7.9	14.0	16.1	6.4	19.0	16.3	16.0	17.6	12.5	19.9	19.4	16.0	5.8	22.5	5.5	6.0	15.6	12.5	18.5	19.1	24.3	23.0	19.5	20.4	19.0	17.9	18.6	17.3	18.7	22.4	8.8	0.0	5.6	15.3	9.2	0.0	2.7	0.0	4.0	8.9	4.7	8.3	10.4	2.8	6.2	0.0	4.2	4.9	9.2	1.8	3.9	5.6	5.9	3.8	7.8	7.0	6.7	7.8	23.5	5.0	2.8	8.1	2.0	3.1	6.3	11.1	4.6	1.8	5.9	1.7	26.1	2.6	0.0	5.1	0.0	2.5	9.0	4.3	0.0	8.4	2.3	12.8	14.4	30.7	28.8	3.6	4.0	13.2	3.5	2.2	4.9	4.6	1.5	9.6	19.7	7.7	7.5	7.5	8.7	2.9	0.0	1.4	7.2	8.1	3.4	0.8
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4
ZZZ3	"ATAC1, DKFZP564I052"	ENSG00000036549	"Zinc finger ZZ-type containing 3"	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 73.8;Excitatory neurons: 102.1;Inhibitory neurons: 100.7;Microglial cells: 77.8;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 280.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	8.9	12.2	6.3	10.2	10.8	9.7	17.1	5.6	6.9	13.0	2.6	9.6	9.0	13.0	9.2	9.8	11.2	8.6	11.1	5.3	7.5	14.5	16.7	8.2	12.8	5.7	7.2	16.9	9.7	13.9	6.0	10.5	8.0	11.9	9.5	11.3	10.4	12.2	8.7	10.8	8.1	12.0	7.1	9.8	10.4	6.5	7.9	14.3	19.8	10.2	12.4	10.4	6.5	16.0	27.9	12.4	22.4	17.9	21.3	30.3	26.0	32.6	27.9	27.7	31.3	15.5	12.9	34.8	29.3	27.2	32.3	24.3	29.3	22.2	44.4	25.9	26.9	41.1	26.9	19.8	33.2	45.5	12.0	26.0	34.2	31.0	63.4	30.1	31.2	24.2	41.4	24.0	27.3	13.1	22.0	13.7	35.1	15.9	29.5	25.9	40.3	17.1	22.5	26.1	30.0	26.5	19.2	23.0	60.6	16.4	13.0	25.7	24.9	23.7	29.9	40.2	44.6	20.3	30.8	36.7	27.2	39.2	19.3	0.1	4.3	5.3	6.1	4.5	9.6	7.3	7.6	7.7	7.4	9.0	9.5	8.6	0.8	7.8	5.0	4.9	10.4	5.1	6.3	10.8	5.6	6.9	5.3	7.5	5.7	7.2	8.0	7.1	7.9	16.0	11.3	0.0	0.0	73.8	22.2	17.2	13.6	10.9	27.9	18.1	0.0	0.0	0.0	15.7	5.6	0.0	8.4	13.3	14.3	6.9	0.0	0.0	5.1	0.0	0.0	10.5	19.8	17.4	102.1	0.0	12.3	11.0	16.3	0.0	0.0	0.0	15.0	15.1	14.1	16.8	100.7	14.1	6.1	13.2	11.8	3.9	16.8	8.2	12.4	77.8	7.5	16.1	17.5	141.8	280.3	0.0	14.0	19.5	14.9	18.7	10.1	0.0	4.2	19.7	6.6	29.6	11.4	7.8	9.7	28.1	19.6	8.5	14.2	0.0	14.2	14.2